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Are you recently graduated, 
mentoring a new graduate or 
returning to work after a break?
Exclusive to BSAVA members, our online 
PDP Resource Bank provides hours of 
FREE CPD matched directly to the 
RCVS professional development 
phase (PDP) requirements.
■ Online CPD at home, work 
or on the move
■ Access via phone, tablet 
or laptop
■ Choose from webinars, 
podcasts, PDF articles 
and podcasts
■ Bite size CPD from 
15 to 90 minutes
■ Employer specific 
support pages
See www.bsava.com/pdp
for more details
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07860 047512*
Don’t leave a lecture with 
a burning question
Available text locations
Please remember to start your 
message with a capital letter 
and leave no spaces in 
the location
Hall1 Hall3 Hall4
Hall5 Hall6 Hall7
Hall8 Hall9 Hall10
Hall11 Hyatt Kingston
*There is no fee for this service – texts will be charged at your 
standard message rate
Exclusive Member Offer
Save £5
BSAVA Members save an extra £5 
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VETERINARY MANAGEMENT OPEN TO ALLNURSING PRACTICAL BEYOND THE CLINICS ADVANCE PURCHASE REQUIREDINTERACTIVE
Programme · Thursday 4 April
Hall 1 Hall 3 Hall 4 Hall 5 Hall 6 Hall 7 Hall 8
MY TOP TIPS IN…
OBESITY
SURGICAL 
COMPLICATIONS ONCOLOGY
RCVS EXOTICS
BSAVA Manual of Reptiles, 
3rd edition
DERMATOPHYTOSIS
08:30–09:15
Neurology
Rick LeCouteur (USA)
08:30–09:15
The principles of 
weight 
management: using 
scientifi c evidence 
to maximise success
Alex German (UK)
08:30–09:15
My wound broke 
down: what now?
Mickey Tivers (UK)
08:30–09:15
Paraneoplastic 
syndromes
Erik Teske (NL)
08:30–08:50
Graduate outcomes review: 
looking to the future
Stephen May (UK)
08:30–09:15
Updates on rabbit 
medicine & surgery
Chris Mans (USA)
08:30–09:15
Dermatophytosis 
casebook: common 
impersonators and 
atypical 
presentations
Susan Paterson (UK)
08:55–09:15
Leadership for all with the 
Edward Jenner Leadership 
Programme
Amanda Boag (UK)
09:25–10:10
Oncology
Gerry Polton (UK)
09:25–10:10
The practicalities of 
weight 
management: 
making it work in 
your practice
Georgia Woods (UK)
09:25–10:10
My enterotomy is 
leaking: what now?
Mickey Tivers (UK)
09:25–10:10
Biopsies: getting 
good results
Jon Bray (UK)
09:25–10:10
RCVS Mind Matters 
Initiative: disclosure
09:25–10:10
Sedation, analgesia 
and anaesthesia in 
small mammals
Chris Mans (USA)
09:25–10:10
Is it a false positive? 
Current 
recommendations 
for diagnosis of 
dermatophytosis
Susan Paterson (UK)
Morning Tea & Coff ee Break
11:05–11:50
Reproduction
Gary England (UK)
11:05–11:50
Tackling the obese 
patient with 
concurrent disease: 
what are your 
priorities?
Alex German (UK)
11:05–11:50
Having diffi  cult 
conversations
Christine Magrath 
(UK)
11:05–11:50
Pathology reports: 
what a clinician 
needs to know
Erik Teske (NL)
11:05–11:50
RCVS Mind Matters 
Initiative: &me live 
part I
11:05–11:50
Managing chelonian 
shell disorders
Chris Mans (USA)
11:05–11:50
Managing multiples: 
dermatophytosis 
disease outbreaks
Susan Paterson (UK)
DEALING WITH MDR 
STAPHYLOCOCCAL 
INFECTIONS12:00–12:45
Soft tissue surgery
Mickey Tivers (UK)
12:00–12:45
Can obesity be 
prevented?
Alex German (UK)
12:00–12:45
Something is 
bleeding: 
what now?
Rachel Hattersley (UK)
12:00–12:45
Is advanced imaging 
always better?
Gerry Polton (UK)
12:00–12:45
RCVS Mind Matters 
Initiative: &me live 
part II
12:00–12:45
Avian clinical 
techniques
Chris Mans (USA)
12:00–12:45
The lab report says 
MRSP: what do I 
need to know?
Anette Loeﬄ  er (UK)
REPRODUCTION Lunch in Arena Birmingham
14:05–14:50
Cardiology
Ruth Willis (UK)
14:05–14:50
Hormonal testing
Gary England (UK)
14:05–14:50
I didn’t get surgical 
margins: what now?
Mickey Tivers (UK)
14:05–14:50
Planning 
oncological surgery
Jon Bray (UK)
14:05–14:50
VN Futures: a VN’s 
guide to wellbeing
Laura Black (UK)
14:05–14:50
Clinical applications 
of rabbit endoscopy
Paolo Selleri (IT)
14:05–14:50
Tough choices: 
treatment options 
for MRSP pyoderma
Anette Loeﬄ  er (UK)
15:00–15:45
Orthopaedic 
surgery
Duncan Barnes (UK)
15:00–15:45
Managing the 
pregnant bitch
Angelika von 
Heimendahl (UK)
15:00–15:45
I left a urolith 
behind: what now?
Rachel Hattersley (UK)
15:00–15:45
Chemotherapy: 
the basics
Erik Teske (NL)
15:00–15:45
VN Futures: a VN’s 
guide to the 
Practice Standards 
Scheme
Liz Cox (UK)
15:00–15:45
Clinical applications 
of reptile endoscopy
Paolo Selleri (IT)
15:00–15:45
Top hygiene tips for 
dealing with 
multi-drug resistant 
skin pathogens in 
practice
Anette Loeﬄ  er (UK)
Afternoon Tea & Coff ee Break
President’s 
Welcome, 
BSAVA 
Awards and 
Keynote 
Lecture with 
MATTHEW 
SYED
Hall 1
16:00–17:30
15:50–16:35
Managing 
parturition: when do 
I reach for the 
scalpel?
Angelika von 
Heimendahl (UK)
15:50–16:35
Oncology 
treatments: new 
and on the horizon
Gerry Polton (UK)
15:50–16:35
VN Futures: a VN’s 
guide to Schedule 3 
and Delegation
Julie Dugmore (UK)
15:50–16:35
Top tips for ferret 
surgery
Paolo Selleri (IT)
MATTHEW 
SYED
Hall 1 16:00–17:30
Join one of the 
world’s most 
inﬂ uential thinkers in 
the ﬁ eld of high 
performance and 
cultural change, 
Mathew Syed, as he 
discusses how to 
build a mindset of 
continuous 
improvement in the 
context of a complex 
and fast-changing 
world.
16:40–17:25
First 48 hours
Sylvia Chastant (FR)
16:40–17:25
VN Futures: a VN’s 
guide to Advanced 
Practitioner Status
Susan Howarth (UK)
16:40–17:25
Reptile diagnostic 
imaging
Paolo Selleri (IT)
17:00–19:00 Drinks in the Exhibition
13:15 Upper deck, BSAVA Stand
Encouraging a rational approach to the use of antibiotics in small animal practice
Fergus Allerton
Hall 1 16:00–17:30
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Education Zone, Arena Hyatt Ballroom Hall 9 Hall 10 Hall 11 Kingston Theatre Vista Room, Arena Venues as listed
EXHIBITOR STREAM
NEW TO BUSINESS 
LEADERSHIP OPHTHALMOLOGY CONSULTATIONS GENERAL NURSING ZOETIS LEARNING ACADEMY
OTHER CPD
08:30–09:15
Leadership: the 
art of managing 
uncertainty 
in veterinary 
practice
Brian Faulkner (UK)
08:15–09:00
Common eye 
conditions: 
medical and 
surgical
Charlotte Dawson 
(UK)
08:15–09:00
Surgical nursing 
clinics
Nicola Ackerman 
(UK)
08:15–09:00
Mentoring and 
supporting 
students
Andrea Jeff ery 
(UK)
Paula Hotston 
Moore (UK)
Thursday 
4 April
Hall 5, ICC
20:00
Join us for 
a relaxed 
showing of
MAMMA 
MIA!
on Thursday 
evening.
07:00–08:00
Yoga for all
12:45–13:10
Do we really 
need to worry 
about ticks?
Ian Wright
13:20–13:45
Tick-borne 
diseases in cats
Stephanie Sorrell
13:50–14:15
Fleas: clear and 
hidden dangers
Sarah Warren and 
Ian Wright
14:35–15:00
The ‘Wright 
parasite’ 
interactive game 
show
Ian Wright
15:05–15:30
How Zoetis 
grows your 
parasitic 
business: the 
win-win of good 
medicine and 
good business
Hugh McConville 
and Sophie Duguid
15:45–16:10
The approach to 
the pruritic dog 
in a 10-minute 
consultation
Sarah Warren
16:15–16:40
21st century 
dermatology: 
which should I 
prescribe, a JAK 
or a MAB?
Stan Baker
08:00–09:00
Executive 1, ICC
SMALL GROUP 
SESSION – VET
Breakfast with a 
specialist
Gary England (UK)
09:00–11:00
Repeated at 
12:00–14:00 and 
15:00–17:00
Birmingham 
Medical School*
WETLAB
Dental 
radiography
Peter Haseler (UK)
09:00–11:00
Repeated at 
12:00–14:00 and 
15:00–17:00
Birmingham 
Medical School*
WETLAB
Rabbit dentistry
John Robinson 
(UK)
09:00–12:00
Repeated at 
14:00–17:00
Birmingham 
Medical School*
WETLAB
Basic eye surgery
Ben Blacklock (UK)
Elena Fenollosa-
Romero (UK)
13:15–14:45
Executive 2, ICC
SMALL GROUP 
SESSION – 
OPEN TO ALL
Dispensing errors
Michael Stanford 
(UK)
14:00–17:00
Executive 1, ICC
SMALL GROUP 
SESSION – VET
Emergency 
thoracic and 
abdominal 
radiology
Raquel Salgüero 
(SP)
Jennifer Kinns (UK)
10:10–10:55
Metronomic 
chemotherapy in 
veterinary 
oncology
Soﬁ a Carvalho
11:05–11:50
Sutures
Julian Hoad
12:00–12:45
Blurred lines: 
lung patterns 
made simpler
Tim Trevail
13:00–13:45
Osteoarthritis: 
facing the 
challenge of 
chronic pain 
using integrated 
treatments
Mathilde Granger
14:00–14:45
Spotlight on 
LivingArt: My 
career as a 
veterinary 
illustrator
Samantha 
Elmhurst
15:00–15:45
Management 
and use of 
wound drains 
and diff usion 
catheters
Sam Bell
16:00–16:45
Canine nutrition 
trends: facts, fads 
and fi ction
Sean McCormack
17:00–17:45
Capnography, 
ventilators and 
IPPV:breathing 
for our patients
Cathy Woodlands
09:25–10:10
Acquiring the 
‘right’ to lead: the 
diff erence 
between 
knowledge and 
self-belief
Brian Faulkner (UK)
09:10–09:55
Surgical 
preparation and 
instrumentation 
for ophthalmic 
patients
Charlotte Dawson 
(UK)
09:10–09:55
Nurse clinics: 
should we be 
charging?
Nicola Ackerman 
(UK)
09:10–09:55
Infection control: 
a challenge for 
the whole team
Louise O’Dwyer 
(UK)
Morning Tea & Coff ee Break
11:05–11:50
Leadership and 
culture: two sides 
of the same coin
Brian Faulkner (UK)
10:50–11:35
Post-op nursing 
considerations for 
ophthalmic patients
Charlotte Dawson 
(UK)
10:50–11:35
How to 
implement 
running a clinic
Helen Tottey (UK)
10:50–11:35
Lungworm: 
should we be 
worried?
Emily Thomas (UK)
11:05–11:50
Extra-mural studies: how 
do we balance student 
experience and staff  
workload?
David Charles (UK)
NEUROLOGY
12:00–12:45
Leading your 
sub-team 
managers
Brian Faulkner (UK)
11:45–12:30
How to do more 
clinics
Helen Tottey (UK)
11:45–12:30
Where have all 
the nurses gone 
and why are they 
leaving?
Andrea Jeff ery 
(UK)
11:45–12:30
Nursing the brain 
injury patient
Holly Smith (UK)
Lunch in Arena Birmingham POSTGRADUATE CERTIFICATE
14:05–14:50
Setting up from 
scratch
Brian Faulkner (UK)
13:50–14:35
Nursing and 
rehabilitating 
patients with 
neuromuscular 
disease
Joe Fenn (UK)
13:50–14:35
Communication 
skills for 
consulting nurses
Helen Tottey (UK)
13:50–14:35
Nursing and 
treatment 
options for the 
hyperthyroid cat
Suzanne Rudd (UK)
14:00–15:00
Award ceremony
15:00–15:45
So you’re now a 
Clinical Director. 
Help!
Brian Faulkner (UK)
14:45–15:30
Rehabilitation 
post spinal 
surgery
Holly Smith (UK)
14:45–15:30
Medical clinics: 
what can we be 
doing?
Nicola Ackerman 
(UK)
14:45–15:30
Ill 
communication: 
eff ective team 
handovers
Louise O’Dwyer 
(UK)
15:00–17:00
Case studies
Clinical Research 
Abstract: BSAVA 
Masters in Clinical 
Veterinary Research 
Project. Can 
telemetric surface 
electromyography be 
used to measure 
post-operative 
recovery of the 
quadriceps muscle 
group following 
surgery for cranial 
cruciate ligament 
rupture?
Helen Torrington 
(UK)
Inspiring research
Johanna Forsyth 
(UK)
Inspiring mentorship
Hilary O’Dair (UK)
Inspiring advanced 
practitioner careers
Aoife O’Sullivan (UK)
Afternoon Tea & Coff ee Break CLINICAL ABSTRACTSAustin Court
BOULTON ROOM
08:30–10:15
Nephrology/urology
11:05–12:50
Hepatology/gastroenterology
14:05–15:35
Endocrinology
TELFORD ROOM
08:30–10:15
Canine general practice
13:35–14:20
Diagnostic imaging
14:35–15:35
Nutrition and obesity
17:00–19:00 Drinks in the Exhibition
*Transport provided
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VETERINARY MANAGEMENT OPEN TO ALLNURSING PRACTICAL BEYOND THE CLINICS ADVANCE PURCHASE REQUIREDINTERACTIVE
Programme · Friday 5 April
Hall 1 Hall 3 Hall 4 Hall 5 Hall 6 Hall 7 Hall 8
OPHTHALMOLOGY
CLINICAL PATHOLOGY 
ON A BUDGET HAEMATOLOGY
DENTISTRY
in association with BVDA
STUDENT STREAM
PR AND MARKETING BOURGELAT(STATE OF THE ART)
08:30–10:10
The cracked or dirty 
windshield: 
disorders of the 
ocular surface
Caryn Plummer (USA)
08:30–09:15
Getting more for no 
more from your 
laboratory
Ian Ramsey (UK)
08:30–09:15
Approach to 
anaemia
Vicki Black (UK)
08:30–09:15
Odontogenic 
tumours
Philippe Hennet (FR)
08:30–08:50
The 10 minute consult: dealing 
with problem ears
Sophie Tyler (UK)
08:30–10:10
Effective 
consultation: 
how to make clients 
your best marketing 
tool
Discussion panel
John Chitty (UK)
Anne McBride (UK)
Christine Magrath 
(UK)
Ian Holloway (UK)
08:30–09:15
Imaging the 
adrenals
Raquel Salgüero (SP)08:55–09:15
The 10 minute consult: itchy 
and scratchy – approach to the 
pruritic dog in 10 minutes
Sophie Tyler (UK)
09:25–10:10
Cytology: 
fine-needle aspirate 
techniques and 
solid lumps
Kathleen Tennant (UK)
09:25–10:10
Transfusion 
medicine
Dan Lewis (UK)
09:25–10:10
Jaw opening and 
closing disorders
Philippe Hennet (FR)
09:25–09:45
The 10 minute consult: 
my dog is drinking buckets! 
– PU/PD
Jen Stallwood (UK)
09:25–10:10
Atypical 
hypoadreno-
corticism
Michael Herrtage (UK)09:50–10:10
The 10 minute consult: 
skinny kitties
Fiona Whitworth (UK)
Morning Tea & Coffee Break BIG ISSUES
11:05–11:50
The “bulging eye”: 
how do I know, how 
do I treat?
Ron Ofri (IL)
11:05–11:50
Cytology: don’t 
forget the blood 
smear
Kathleen Tennant (UK)
11:05–11:50
Management of 
IMHA
James Swann (UK)
11:05–11:50
Flap techniques in 
palatal surgery
Philippe Hennet (FR)
11:05–11:50
Images: what can 
you see?
Vicki Black (UK)
11:05–12:45
ABC: achievements, 
Brexit and 
challenges
Professor the 
Lord Trees (UK)
Chris Laurence (UK)
Sheila Voas (UK)
Christianne Glossop 
(UK)
11:05–11:50
Diagnosis of canine 
hyperadrenocorti-
cism: is it always 
straightforward?
Michael Herrtage (UK)
12:00–12:45
Glaucoma: 
understanding and 
treating a leading, 
and painful cause of 
blindness
Ron Ofri (IL)
12:00–12:45
Cytology: fluids
Kathleen Tennant (UK)
12:00–12:45
Approach to the 
suspected 
coagulopathic 
patient
Vicki Black (UK)
12:00–12:45
Mandibular 
fracture repair 
considerations
Alexander Smithson 
(UK)
12:00–12:45
Emergency cases
Sophie Adamantos 
(UK)
12:00–12:45
Monitoring 
treatment in canine 
hyperadreno-
corticism
Ian Ramsey (UK)
Lunch in Arena Birmingham RECENT GRADUATES AVP
14:05–14:50
Ophthalmic 
manifestations of 
endocrin opathies
Caryn Plummer (USA)
14:05–14:50
When to test and 
when to treat
Ian Ramsey (UK)
14:05–14:50
Management  
of thrombo-
cytopenia
James Swann (UK)
14:05–14:50
Oral masses in cats: 
inflammatory or 
neoplastic
Philippe Hennet (FR)
14:05–14:50
Tooth extraction
Alexander Smithson 
(UK)
14:05–14:50
Medicines: ensuring 
supply despite crises
Peter Borriello (UK)
Dawn Howard (UK)
14:05–14:50
Management of 
intraoperative 
hypotension
Delphine Holopherne-
Doran (UK)
15:00–15:45
Masquerading eye 
disease: when one 
disease looks like 
another
Caryn Plummer (USA)
15:00–15:45
Point-of-care 
meters
Ian Ramsey (UK)
15:00–15:45
Investigation of 
polycythaemia
Erik Teske (UK)
15:00–15:45
Feline chronic 
stomatitis: a 
frustrating and 
debilitating disease
Philippe Hennet (FR)
15:00–15:45
Pale, bruised, 
bleeding: what’s 
going on?
Dan Batchelor (UK)
15:00–15:45
The perils of passports and 
certification: avoiding litigation
Philip Lhermette (UK)
Mauricio López (UK)
Michael Stanford (UK)
15:00–15:45
Infection control for 
the surgical patient
Kelly Bowlt Blacklock 
(UK)
CLINICAL PATHOLOGY 
REFRESHER Afternoon Tea & Coffee Break
16:50–17:35
Cataract: what can 
I do about it?
Ron Ofri (IL)
16:50–17:35
Small mammals
John Chitty (UK)
16:50–17:35
Investigation of 
leucopenia
Erik Teske (UK)
16:50–17:35
Periodontal therapy
Alexander Smithson 
(UK)
16:50–17:35
Is this murmur 
significant?
Ruth Willis (UK)
16:50–18:30
Telemedicine: 
patient care in the 
digital world
Kate Richards (UK)
Thom Jenkins (UK)
Richard Guest (UK)
Simon Doherty (UK)
16:50–17:35
Top tips for great 
medical and surgical 
case reports
Rachel Hattersley (UK) 
Ian Ramsey (UK)
17:45–18:30
Will my dog see 
again? Examination, 
assessment and 
differential diagnosis 
of the blind patient
Ron Ofri (IL)
17:45–18:30
Reptiles and birds
John Chitty (UK)
17:45–18:30
Haemolytic 
anaemia: when is it 
not IMHA?
Vicki Black (UK)
17:45–18:30
Feline extraction 
techniques
Alexander Smithson 
(UK)
17:45–18:30
How to manage 
cases that aren’t 
going well
Dan Batchelor (UK)
17:45–18:30
Options for the treatment 
of combined cranial 
cruciate ligament 
insufficiency and medial 
patellar luxation
Duncan Barnes (UK)
17:00–18:30 Drinks in the Exhibition
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Education Zone, Arena Hyatt Ballroom Kingston Theatre Hall 9 Hall 10 Hall 11 Vista Room, Arena Venues as listed
CT STREAM
NEW TO MANAGEMENT RCVS KNOWLEDGE
ECC
SURGICAL BEHAVIOUR, 
WELFARE & 
ETHICS
ZOETIS LEARNING 
ACADEMY
OTHER CPD
09:00–09:45
I want a CT scanner: 
considerations prior to 
purchase
Chris Warren-
Smith (UK)
08:30–09:15
Internal 
marketing
Stacey Davidson 
(UK)
08:30–09:00 
How good are you 
and can you prove it?
Chris Gush (UK)
08:15–09:00
Nursing the 
trauma patient
Louise O’Dwyer 
(UK)
08:15–09:00
Caesareans
Paul Aldridge (UK)
08:15–09:00
Dog bite 
prevention: 
in practice or on 
the street
Shakira Free Miles 
(UK)
07:00–08:00
Yoga for all
10:15–10:40
Top tips to identify 
when cats need 
analgesia
Jo Murrell
10:45–11:10
Understanding a 
cat’s quality of life
Jacky Reid
11:20–11:45
Current 
understanding of 
diagnosing and 
managing feline 
osteoarthritis
Evelyn Maniaki
12:30–12:55
Benefi ts of 
wellness screens 
in cats
Joanna Parker
13:00–13:25
Challenges of 
compliance in cats
Louise Longstaff 
13:40–14:05
What is CIRD? 
Should we worry?
Jenny Stavisky
14:10–14:35
Challenges of 
preventing canine 
infectious 
respiratory disease
Jenny Stavisky
14:45–15:10
Diagnosing 
pancreatitis: 
the benefi ts of cPL 
testing
Joanna Parker
15:25–15:50
Apoquel/
Cytopoint: 
innovative 
products to 
support 
management of 
stressful 
derm cases
Stan Baker
15:55–16:20
Top tips on 
managing stress 
and enhancing 
wellbeing
David Bartram
08:00–09:00
Executive 1, ICC
SMALL GROUP 
SESSION – VET
Breakfast with a 
specialist
Jon Bray (UK)
09:00–10:30
Repeated at 
11:15–12:45 and 
15:00–16:30
Lodges, Austin Court
PRACTICAL – VET
Flexible endoscopy
Paul Higgs (UK)
David Walker (UK)
Sophie Keyte (UK)
Florent Duplan (UK)
Lucy Barker (UK)
09:45–12:45
Executive 1, ICC
SMALL GROUP 
SESSION – VN
Anaesthesia: 
case-based 
discussions
Emma Archer (UK)
14:00–17:00
Executive 1, ICC
SMALL GROUP 
SESSION – 
OPEN TO ALL
Obesity: turning 
failure into success
Alex German (UK)
09:10–10:10
How to apply 
best evidence to 
manage and care 
for epilepsy 
patients in daily 
clinical practice
Holger Volk (UK)
Paul Pollard (UK)
09:50–10:35
I have a CT 
scanner: 
what now?
Matthew Winter 
(UK)
09:25–10:10
External 
marketing
Richard Casey (UK)
09:10–09:55
Nutrition myths 
in critical patients
Nicola Ackerman 
(UK)
09:10–09:55
The VN’s role 
during acute 
surgical 
haemorrhage
Claire Roberts (UK)
09:10–09:55
Adopting street 
dogs: health and 
behaviour 
concerns
Heather Bacon 
(UK)
Morning Tea & Coff ee Break
11:05–11:50
How to look at a 
CT scan: a 
beginner’s guide
Matthew Winter 
(UK)
11:05–11:50
Understanding 
the fi nancial 
basics
Georgina Hills (UK)
11:05–11:50
Research into 
small animal 
practice: why 
evidence matters
Peter Denys 
Cockcroft (UK)
10:50–11:35
Common toxins 
in dogs
Sarah Egleston 
(UK)
10:50–11:35
Does what we 
wear in the 
theatre, impact 
patient safety?
Claire Roberts (UK)
10:50–11:35
Good intentions 
and good 
welfare 
outcomes
Hayley Walters 
(UK)
12:00–12:45
Breathe in: 
thoracic CT
Chris Warren-
Smith (UK)
12:00–12:45
How practice 
fi nances work
Miles Russell (UK)
12:00–12:45
Learning from a rabbit 
anaesthetic death: 
implementing an 
evidence-based approach 
to rabbit anaesthesia in a 
practice setting
Molly Varga (UK)
Pam Mosedale (UK)
11:45–12:30
Bleeding 
nightmares
Emily Thomas (UK)
11:45–12:30
Thoracic wall 
trauma
Paul Aldridge (UK)
11:45–12:30
Positive patient 
welfare: what the 
RVN can do
Hayley Walters 
(UK)
Lunch in Arena Birmingham
CLINICAL 
ABSTRACTS
Austin Court
BOULTON ROOM
08:30–10:15
Dermatology, 
infectious 
diseases and 
antimicrobials
11:05–12:20
Cardiology and 
respiratory
14:45–15:45
Oncology
16:50–18:05
Oncology
TELFORD ROOM
08:30–10:15
Soft tissue 
surgery
14:30–15:45
Neurology
16:50–18:05
Anaesthesia
14:05–14:50
Around the 
abdomen: 
indications for 
abdominal CT
Matthew Winter 
(UK)
14:05–14:50
Team 
development
Renay Rickard (UK)
14:05–15:45
First do no harm: 
how systems can 
reduce the rate 
of morbidity and 
mortality by 50%
Richard Killen (UK)
Laura Playforth 
(UK)
Richard Byrne (UK)
13:50–14:10
How to manage a chest 
drain
Emily Thomas (UK)
13:50–14:10
Pre-op surgical site 
infection prevention
Claire Roberts (UK)
13:50–14:35
Breed-specifi c 
legislation
Shakira Free Miles 
(UK)14:15–14:35
How to place nasal 
oxygen catheters
Sarah Egleston (UK)
14:15–14:35
How to reduce post-op 
HAI
Claire Roberts (UK)
15:00–15:45
A headache or a 
pain in the neck? 
Head and 
neck CT
Chris Warren-
Smith (UK)
15:00–15:45
Getting the best 
out of clinical 
workfl ow
Gillian Page (UK)
14:45–15:30
Nursing the 
septic abdomen 
patient
Sarah Egleston 
(UK)
14:45–15:30
Diffi  cult skin 
closures: what 
options do we 
have?
Paul Aldridge (UK)
14:45–15:30
Geriatric welfare
Heather Bacon 
(UK)
Afternoon Tea & Coff ee Break
16:50–17:35
Give the dog a 
bone: 
orthopaedic CT
Chris Warren-
Smith (UK)
16:50–17:35
Crisis, what 
crisis?
Julie Beacham 
(UK)
16:50–17:35
Reliable care in 
the NHS: building 
safer systems in a 
just culture
Margaret Mary 
Devaney (UK)
16:35–17:20
Dying to pee: 
nursing the 
blocked cat
Suzanne Rudd (UK)
16:35–17:20
Loco-regional 
blocks
Louise O’Dwyer 
(UK)
16:35–17:20
Welfare 
conundrums
Heather Bacon 
(UK)
17:45–18:30
Could I, should I, 
would I? 
When can I use 
spinal CT?
Matthew Winter 
(UK)
Friday 5 April · Hall 5, ICC · 20:00
Join us for a relaxed showing of 
MAMMA MIA! Here We Go Again
on Friday evening.
17:30–18:15
Managing the 
dyspnoeic 
patient
Emily Thomas (UK)
17:30–18:15
Rehabilitation of 
orthopaedic 
patients
Holly Smith (UK)
17:30–18:15
Acute pain and 
its welfare 
implications
Hayley Walters 
(UK)
17:00–18:30 Drinks in the Exhibition
Don’t forget to book 
your ticket for
V19
BEaCH PaRTY
Saturday 6 April
ICC from 19:30
13:15 Upper deck, BSAVA Stand
Pain in companion animals – where have come from and what is the future of pain treatment?
Ian Self
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VETERINARY MANAGEMENT OPEN TO ALLNURSING PRACTICAL BEYOND THE CLINICS ADVANCE PURCHASE REQUIREDINTERACTIVE
Programme · Saturday 6 April
Hall 1 Hall 3 Hall 4 Hall 5 Hall 6 Hall 7 Hall 8
CRITICAL CARE
BSAVA Manual of Canine 
and Feline Emergency and 
Critical Care, 3rd edition
FANTASTIC FOREIGN 
BODIES AND HOW 
TO FIND THEM!
NEUROLOGY CARDIORESPIRATORY
SHELTER MEDICINE
BSAVA Manual of 
Canine and Feline 
Shelter Medicine
EFFECTIVE 
COMMUNICATION
IMAGING
08:30–09:15
Basic introduction 
to the use of blood 
gases
Dan Lewis (UK)
08:30–09:15
Tracking foreign 
bodies: a review of 
imaging techniques
Francisco Llabres Diaz 
(UK)
08:30–09:15
How to get the 
most from your 
neuro exam
Steven De Decker (UK)
08:30–09:15
Approach to the 
young coughing 
dog
Simon Tappin (UK)
08:30–09:15
Caring for pets of 
homeless people
Jenny Stavisky (UK)
Ruth Serlin (UK)
08:30–09:15
You’re diff erent 
from me: four 
communication 
styles
Alan Robinson (UK)
 08:30–09:15
Is this a bone tumour? 
Diff erentiating benign 
and malignant bone 
disease with 
radiographs
Jennifer Kinns (UK)
09:25–10:10
Advanced blood gas 
analysis
Dan Lewis (UK)
09:25–10:10
Foreign bodies of 
the head
Jon Bray (UK)
09:25–10:10
Cerebrovascular 
disease: do dogs 
have strokes?
Rick LeCouteur (USA)
09:25–10:10
Older dog with a 
cough: is it cardiac 
or respiratory? Top 
tips on how to tell
Simon Tappin (UK)
09:25–10:10
A pragmatic 
approach to dog 
diarrhoea in the 
shelter environment
Jenny Stavisky (UK)
09:25–10:10
Meetings, meetings: 
make them work
Alan Robinson (UK)
09:25–10:10
A waste of time? 
Should we still be 
doing skull 
radiographs in 
2019?
Jennifer Kinns (UK)
Morning Tea & Coff ee Break
11:05–11:50
Techniques for 
oxygen therapy
Dan Lewis (UK)
11:05–11:50
Endoscopic 
management of 
foreign bodies
David Walker (UK)
11:05–11:50
Poorly puppies: 
neurological disease 
in the young animal
Steven De Decker (UK)
11:05–11:50
Approach to 
pulmonary 
hypertension
Kieran Borgeat (UK)
11:05–11:50
Prepubertal 
neutering: 
a pragmatic 
approach
David Yates (UK)
11:05–11:50
When they say ‘No’: 
managing 
expectations
Alan Robinson (UK)
11:05–11:50
Is this elbow 
dysplasia? What 
radiographs tell us 
and when to use CT
Francisco Llabres Diaz 
(UK)
12:00–12:45
Nutrition in critical 
care
Isuru Gajanayake (UK)
12:00–12:45
‘For the chop’: 
surgical 
management of 
thoracic and 
abdominal foreign 
bodies
Georga Karbe (UK)
12:00–12:45
Cervical 
spondylomyelopathy  
(‘Wobblers’): diagnosis 
and treatment options
Steven De Decker (UK)
12:00–12:45
How I perform a 
bronchoscopy
Simon Tappin (UK)
12:00–12:45
A pragmatic 
approach to the 
skinny old cat in the 
shelter environment
Rachel Dean (UK)
12:00–12:45
Could do better: 
managing high 
performers
Alan Robinson (UK)
12:00–12:45
From head to tail, 
imaging the 
neurological patient: 
when are radiographs 
still useful?
Francisco Llabres Diaz 
(UK)
Lunch in Arena Birmingham AVP
13:15 Upper deck, BSAVA Stand
Getting the balance right: biosecurity versus cats’ welfare needs in shelters
Maggie Roberts
14:05–14:50
Approach to DKA
Sophie Keyte (UK)
14:05–14:50
Needle in a 
haystack: dealing 
with tracking foreign 
bodies
Georga Karbe (UK)
14:05–14:50
Spinal cord 
disorders on a 
budget
Rick LeCouteur (USA)
14:05–14:50
Thoracic imaging 
picture quiz: is it 
cardiac or is it 
respiratory?
Kieran Borgeat (UK)
14:05–14:50
Ophthalmological 
manifestation of 
systemic disease
Ben Blacklock (UK)
14:05–14:50
All together now: 
creating team 
dynamics
Alan Robinson (UK)
14:05–14:50
Now, your turn: 
interactive 
orthopaedic fi lm 
reading
Jennifer Kinns (UK)
15:00–15:45
Emergency 
management of 
urethral obstruction
JD Foster (USA)
15:00–15:45
The recurrent 
foreign body: what 
to do next?
Jon Bray (UK)
15:00–15:45
Cranial nerve 
disorders: fi guring 
out the fl oppy faces
Rick LeCouteur (USA)
15:00–15:45
The punctured pet: 
dealing with 
thoracic bite 
wounds/stick 
injuries
Georga Karbe (UK)
15:00–15:45
Cardiac 
manifestation of 
systemic disease
Ruth Willis (UK)
15:00–15:45
Five signs of a high 
performance team
Alan Robinson (UK)
15:00–15:45
Now, your turn: 
interactive head and 
neck fi lm reading
Raquel Salgüero (SP)
Afternoon Tea & Coff ee Break
16:50–17:35
Acute kidney injury
JD Foster (USA)
16:50–17:35
A logical approach 
to vestibular disease
Steven De Decker (UK)
16:50–17:10
Top tips on chest drain 
placement
Georga Karbe (UK)
16:50–17:35
Management of 
refractory epilepsy
Jeremy Rose (UK)
16:50–17:35
Yes, please: 
improving client 
compliance
Alan Robinson (UK)
16:50–17:35
Orthopaedic weird 
and wonderful: an 
interactive 
radiographic 
journey
Jennifer 
Kinns (UK)
17:15–17:35
Top tips on thoracic cytology
Kathleen Tennant (UK)
17:45–18:30
Management of 
canine acute 
pancreatitis
Isuru Gajanayake (UK)
17:45–18:05
Diagnosis and medical 
management of pyothorax
Simon Tappin (UK)
17:45–18:30
Acute kidney injury: 
practical 
management
David Walker (UK)
17:45–18:30
Diffi  cult client or 
diffi  cult 
communication?
Alan Robinson (UK)
17:45–18:30
Now your turn: 
interactive spine fi lm 
reading
Francisco Llabres Diaz 
(UK)
18:10–18:30
Diagnosis and surgical 
management of pyothorax
Georga Karbe (UK)
17:00–18:30 V19 Pre Drinks in the Exhibition Arena Birmingham / Exhibition closes at 18:30
Preparation for
V19 Beach Party
 Programme.indd   10 08/03/2019   16:36
BSAVA CONGRESS 2019 PROCEEDINGS [ xi ]
Education Zone, Arena Hall 9 Hall 10 Hall 11 Kingston Theatre Vista Room, Arena Venues as listed
EXHIBITOR STREAM ONCOLOGY MEDICINE
ANAESTHESIA
LOCO-REGIONAL 
ANAESTHESIA
ZOETIS LEARNING 
ACADEMY
OTHER CPD
09:10–09:55
Rampant regurg and 
remorseless refl ux: 
how to deal with 
these unwanted 
visitors in 
anaesthetised dogs
Ian Self
10:05–10:50
How health plans 
can unlock hidden 
value in your 
practice
Liam Moriarty, CEO & 
Founder of TrustVet
11:00–11:45
Sutures
Julian Hoad
12:00–12:45
Canine nutrition 
trends: facts, fads 
& fi ction
Sean McCormack
13:00–13:45
Helping the 
veterinary 
profession to 
resolve and 
minimise 
complaints and 
retain client 
relationships
Jennie Jones
14:00–15:30
Gut stasis: 
it takes two
Molly Varga
Jo Hinde
15:45–16:30
‘He’s just slowing 
down.’ Early 
identifi cation of 
Canine OA and how 
to work within 
owners budgets
Hannah Capon
08:15–09:00
Common cancers 
and paraneoplastic 
syndromes
Fiona McDowall (UK)
08:15–09:00
IBD
Gina Parkes (UK)
08:15–09:00
The pre-anaesthetic 
exam
Emma Archer (UK)
08:30–09:15
Basic LA plus 
pharmacology
Jaime Viscasillas (UK) 07:00–08:00
Yoga for all
10:00–10:25
Top tips for the fi rst 
presentation of a 
pruritic dog
Kate Griﬃ  ths
10:30–10:55
When is Apoquel 
indicated?
Louise Longstaff 
11:00–11:25
An update on 
canine demodicosis 
and top tips on 
diagnosing and 
treating
Kate Griﬃ  ths
11:50–12:15
Optimising 
compliance in 
chronic atopic 
dermatitis cases
Kate Griﬃ  ths
12:25–12:50
Match that scratch: 
case-based 
examples of 
complex pruritic 
patients
Victoria Robinson
12:55–13:20
What to do next; top 
tips on managing 
chronic derm cases
Victoria Robinson
13:30–13:55
Which patients are 
most suited to 
Cytopoint
Sophie Duguid
08:00–09:00
Executive 1, ICC
SMALL GROUP 
SESSION – VET
Breakfast with a 
specialist
Karen Perry (USA)
08:30–11:30
Lodges, 
Austin Court
PRACTICAL – VET
Drains
Rachel Hattersley (UK)
Tom Cox (UK)
08:30–11:30
Executive 2, ICC
SMALL GROUP 
SESSION – VET
Reptile anaesthesia, 
analgesia and 
sedation
Chris Mans (USA)
09:30–12:30
Executive 1, ICC
SMALL GROUP 
SESSION – VET
Ocular emergencies
Ben Blacklock (UK)
14:00–17:00
Executive 1, ICC
SMALL GROUP 
SESSION – VET
Extraction 
complications in 
cats and dogs: 
prevention and 
treatment
Phillipe Hennet (FR)
Alex Smithson (UK)
09:10–09:55
Oncology 
emergencies
Nicola Read (UK)
09:10–09:55
Diabetes mellitus: 
let’s not sugar 
coat it!
Gina Parkes (UK)
09:10–09:55
Anaesthesia of the 
head trauma patient
Denise Prisk (UK)
09:25–10:10
LA equipment
Matt Read (USA)
Morning Tea & Coff ee Break
10:50–11:35
Staging the 
oncology patient
Nicola Read (UK)
10:50–11:35
Feline diabetes: they 
are not small 
diabetic dogs
Gina Parkes (UK)
10:50–11:35
Anaesthesia of the 
RTA cat
Claire Woolford (UK)
11:05–11:50
Local block in the 
head
Jaime Viscasillas (UK)
11:45–12:30
Radiotherapy
Linda Roberts (UK)
11:45–12:30
DKA
Gina Parkes (UK)
11:45–12:30
Anaesthesia of the 
brachycephalic 
patient
Denise Prisk (UK)
12:00–12:45
Thoracic limb LA 
techniques
Matt Read (USA)
Lunch in Arena Birmingham
13:50–14:35
Chemotherapy: 
administration and 
adverse eff ects
Fiona McDowall (UK)
13:50–15:30
Transfusion 
medicine and 
common bleeding 
disorders
Rachel Pickes (UK)
13:50–14:35
Anaesthesia of the 
young and old
Emma Archer (UK)
14:05–14:50
Epidural anaesthesia
Jaime Viscasillas (UK)
14:45–15:30
Palliative care for 
cancer patients
Linda Roberts (UK)
14:45–15:30
Anaesthesia for the 
acute abdomen
Claire Woolford (UK)
15:00–15:45
Pelvic limb LA 
techniques
Matt Read (USA)
CLINICAL ABSTRACTS
Austin Court
BOULTON ROOM
09:00–10:15
Exotics
11:05–12:50
Therapeutics, non clinical, behaviour 
and welfare
14:00–15:45
Haematology/immunology
16:50–18:05
Haematology/immunology
FARADAY ROOM
08:30–10:30
Ophthalmology
10:50–12:50
Orthopaedics
14:30–16:00
Orthopaedics
16:50–17:35
Orthopaedics
Afternoon Tea & Coff ee Break
16:35–17:20
Novel treatments: 
what’s new and 
advances
Nicola Read (UK)
16:35–18:15
Endocrinology
Rachel Pickes (UK)
16:35–16:55
Central lines
Claire Woolford (UK)
16:50–17:35
Abdominal/thoracic 
LA techniques
Matt Read (USA)
17:00–17:20
Arterial lines
Claire Woolford (UK)
17:30–18:15
Client support for 
patients with 
terminal illness
Fiona McDowall (UK)
17:30–18:15
Anaesthesia and 
analgesia of patients 
with complex 
medical conditions
Emma Archer (UK)
17:45–18:30
LA and analgesia 
cases – interactive
Matt Read (USA)
Jamie Viscasillas (UK)
17:00–18:30 V19 Pre Drinks in the Exhibition Arena Birmingham / Exhibition closes at 18:30
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VETERINARY MANAGEMENT OPEN TO ALLNURSING PRACTICAL BEYOND THE CLINICS ADVANCE PURCHASE REQUIREDINTERACTIVE
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Hall 1 Hall 4 Hall 5 Hall 6 Hall 7 Hall 8
MY PRAGMATIC 
APPROACH TO… CARDIOLOGY
ORTHOPAEDICS
BSAVA Manual of Canine and 
Feline Musculoskeletal 
Disorders, 2nd edition
IMMUNOLOGY MANAGEMENT SAFETY STREAM
09:00–09:45
PU/PD
Sophie Keyte (UK)
09:00–09:45
Cardiac therapeutics: 
atrioventricular valve 
disease
Sonya Gordon (USA)
08:45–09:30
FL lameness in cats: 
sources and solutions
Karen Perry (USA)
08:45–09:30
Understanding 
immunological testing
James Swan (UK)
08:45–09:30
Top 5 reasons vets get 
sued and how to avoid 
them as a recent 
graduate
Dave Nicol (AUS)
08:45–09:30
Pre-op safety and 
preparation: what really 
helps and do pre-op 
bloods improve 
outcome?
Matt Read (UK)
09:55–10:40
Hypercalcaemia
Sophie Keyte (UK)
09:55–10:40
Cardiac therapeutics: 
feline cardiology
Kieran Borgeat (UK)
Morning Tea & Coffee Break
10:05–10:55
HL lameness in cats: 
sources and solution
Karen Perry (USA)
10:05–10:55
Immune-mediated skin 
disease
Laura Buckley (UK)
10:05–10:55
Putting you first: how to 
manage body and mind 
to avoid burnout, 
depression and other 
negatives
Dave Nicol (AUS)
10:05–10:55
How equipment harms 
patients
Matt McMillan (UK)
Morning Tea & Coffee Break
11:15–12:00
Juvenile lameness
Duncan Barnes (UK)
11:15–12:00
Cardiac therapeutics: 
dilated cardiomyopathy
Sonya Gordon (USA)
11:00–11:45
Feline OA: diagnosis and 
management
Karen Perry (USA)
11:00–11:45
Novel immunotherapy
James Swan (UK)
11:00–11:45
Personal branding for 
vets: why you need one 
and how to become the 
local pet celebrity
Dave Nicol (AUS)
11:00–11:45
How to use checklists 
to improve safety 
(and how not to)
Matt McMillan (UK)
12:10–12:55
Seizures
Jeremy Rose (UK)
12:10–12:55
Cardiac therapeutics: 
medical treatment of 
arrhythmias (in dogs 
with DCM)
Sonya Gordon (USA)
Coastal Cookout Hall 3, ICC
13:05–13:50
Coronoid disease in 
dogs: where are we 
now?
Laura Cuddy (IE)
13:05–13:50
Glomerulonephritis
JD Foster (UK)
CONGRESS 
PODCASTS
Did you know?
BSAVA members get 
complimentary 
access to audio and 
video podcasts a 
couple of weeks after 
Congress closes.
Podcast access can 
also be purchased 
for £100.
Visit the BSAVA  
stand or go to  
www.bsava.com for 
more information.
13:05–13:50
What anaesthetic 
monitoring really helps
Matt McMillan (UK)
Coastal Cookout Hall 3, ICC
14:15–15:00
Prescription foods
Isuru Gajanayake (UK)
14:15–15:00
Challenging cases: 
approach to the patient 
with cardiac disease and 
renal dysfunction
JD Foster (USA)
14:00–14:45
Humeral intercondylar 
fissures in dogs
Laura Cuddy (IE)
14:00–14:20
How to collect CSF samples
Paul Higgs (UK)
14:00–14:45
Clinical audit: how to 
set up
Pam Mosedale (UK)
14:25–14:45
How to perform joint taps
Paul Higgs (UK)
15:10–15:55
Pruritic skin disease
Laura Buckley (UK)
15:10–15:55
Challenging cases: 
approach to the cardiac 
patient with concurrent 
respiratory disease
Kieran Borgeat (UK)
14:55–15:40
Ununited anconeal 
process: what to do?
Laura Cuddy (IE)
14:55–16:35
Stiff, painful and pyrexic: 
an interview with a 
medic, neurologist and 
orthopod
Duncan Barnes (UK) 
Vicki Black (UK) 
Jeremy Rose (UK)
14:55–15:40
An anaesthetist’s day 
from hell: interactive 
cases
Matt McMillan (UK) 
Matt Read (UK)
16:05–16:55
Chronic diarrhoea
Eilidh Gunn (UK)
16:05–16:55
Cardiac therapeutics: 
pericardial disease
Sonya Gordon (USA)
15:50–16:35
Elbow incongruence: 
what to do when
Laura Cuddy (IE)
15:50–16:35
M and M rounds
Catherine Oxtoby (UK)
CONGRESS CLOSES
Thank you for being part of BSAVA Congress 2019. Join us next year in Birmingham 2–5 April 2020
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Hall 9 Hall 10 Hall 11 Kingston Theatre Telford Room Venues as listed
EXOTICS NURSING LEADERSHIP AND MANAGEMENT NUTRITION AGM
BEYOND THE CLINICS
VDS TRAINING
OPEN TO ALL
OTHER CPD
09:20–10:05
Help: rabbit anaesthesia
Jo Hinde (UK)
09:20–10:05
Leadership: what are the 
benefi ts for RVNs
Liz Cox (UK)
09:20–10:05
Making and 
implementing a 
nutritional assessment
Georgia Woods (UK)
09:00–09:45
Taking time out to get 
time back
Penny Barker (UK)
Morning Tea & Coff ee Break
10:45–12:00
BSAVA AGM
All BSAVA Members 
welcome
09:55–10:40
The three Ps for having 
a good day: present, 
proactive and positive
Carolyne Crowe (UK)
10:15–12:15
Executive 1, ICC
SMALL GROUP SESSION 
– VN
Better vet visits: working 
towards fear free 
practice
Linda Ryan (UK)
10:40–11:25
Preventative medicine 
for rabbits
Jo Hinde (UK)
10:40–11:25
Challenges of the head 
nurse and how to lead 
your team eff ectively
Renay Rickard (UK)
10:40–11:25
Compliance for 
nutritional 
recommendations
Georgia Woods (UK)
Coff ee Break
11:35–12:20
Rabbit obesity clinics
Jo Hinde (UK)
11:35–12:20
Leadership skills for all 
roles
Liz Cox (UK)
11:35–12:20
Feeding the renal 
patient
Georgia Woods (UK)
11:15–12:00
Leaning into colleagues, 
clients and cases
Carolyne Crowe (UK)
Coastal Cookout Hall 3, ICC IN CONVERSATION WITH…
12:10–12:55
Stepping up and 
speaking out
Penny Barker (UK)
13:35–14:20
Nursing patients with 
ileus
Jo Hinde (UK)
13:35–14:20
Managing your team 
through a change
Renay Rickard (UK)
13:35–14:20
Nutritional management 
of the hyperthyroid cat
Georgia Woods (UK)
13:35–14:20
Pete Wedderburn (IRE)
BSAVA President Phil 
Lhermette in 
conversation with Pete 
Wedderburn, a small 
animal vet, journalist 
and broadcaster
14:30–15:15
Is it all about hay and 
grass: rabbit nutrition
Nicola Ackerman (UK)
14:30–15:15
Swapping between 
leadership and 
management: 
multi-tasking nurses!
Liz Cox (UK)
14:30–15:15
Nutritional management 
of gastrointestinal 
disease I
Aarti Kathrani (UK)
15:20–16:05
Exotic pet welfare and 
ethics
Shakira Free Miles (UK)
15:20–16:05
A simple approach to 
development reviews
Renay Rickard (UK)
15:20–16:05
Nutritional management 
of gastrointestinal 
disease II
Aarti Kathrani (UK)
CONGRESS CLOSES
Join us at BSAVA Scottish Congress 2019 7–8 September in Glasgow
JOIN BSAVA TODAY
BSAVA members enjoy substantial savings on Congress 
registration along with a host of other beneﬁ ts. Join today for 
exceptional value CPD courses, great savings on BSAVA 
publications, access to exclusive member only online resources 
and much more.
Visit the stand in Hall 3 Foyer or go to www.bsava.com.
MAPPING 
YOUR FUTURE
Hall 1 and 3 Foyer 10:00–14:00
Join us at the Mapping your Future 
career diversity fair, with practical 
career insight from:
■ PDSA
■ Vets4Pets
■ WVS and Mission Rabies
■ Cats Protection
■ Educational
- BSAVA Volunteering
- PG Certifi cates
- AVP, Resident, Intern, Clinician
■ FIVP
■ CVS
■ Medivet
■ Vets Now
■ SPVS/VMG
■ APHA
■ DEFRA
■ GVS
■ AGV
■ Vetlife
 Programme.indd   13 08/03/2019   16:36
As the UK’s largest veterinary employer, IVC offers both fantastic career 
opportunities and the resources to support your development goals. 
Whether you’re starting out, need to relocate, take on more responsibility or 
further qualifications, at IVC you can take your career to the next level with 
confidence in the UK or Europe.
All our staff receive fantastic benefits:
• 25-30 days paid holiday, plus your birthday
• Outstanding Academy and Leadership programmes
• Excellent CPD Allowance including CPD leave
• Professional memberships paid
• Pension & company sick pay
• Relocation allowance
• Sponsorship for overseas employees
• And lots more!
Find out more about career opportunities with IVC
Contact Debbie on 07702 333522 
dloding@independentvetcare.co.uk
or visit independentvetcare.co.uk/job-finder
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Nicola Ackerman 
BSc(Hons) RVN CertSAN  CertVNECC 
VTS(Nutrition) HonMBVNA
Nicola Ackerman works as the Head  Medical 
Nurse at The Veterinary Hospital in 
 Plymouth, UK. Nicola graduated from 
 Hartpury College with an honours degree in Equine 
 Science, and subsequently qualified as a veterinary nurse 
in 2002. Nicola has written for many veterinary publica­
tions and textbooks, and is the editor of Aspinall’s 
 Complete  Textbook of Veterinary Nursing and is on the 
editorial board of The Veterinary Nurse. Nicola won the 
BVNA/Blue Cross award for animal welfare in 2010, 
 various SQP awards in 2011, 2012, 2013 and 2014, and 
the College of Animal Welfare Professional Development 
Award in 2012. Nicola is currently studying for a Master’s 
degree in Advanced Veterinary Nursing with Glasgow 
University.
Sophie Adamantos 
BVSc CertVA DipACVECC  
DipECVECC FHEA MRCVS
Sophie Adamantos graduated from  Liverpool 
and worked in first opinion and referral 
practices prior to becoming a Diplomate of 
the American College of Veterinary Emergency and 
 Critical Care in 2005. Sophie remained at the RVC as a 
lecturer and then senior lecturer. Sophie spent 5 years 
developing the ICU and acute medicine services at 
 Langford Veterinary Specialists before becoming Clinical 
Director of Paragon Veterinary Referrals in November 
2018. Sophie enjoys all aspects of emergency and acute 
medicine.
Paul Aldridge 
BVSc CertSAS MRCVS
Paul Aldridge graduated from the University 
of Liverpool, and currently works as staff 
surgeon at Vets Now Referrals in  Manchester 
where he sees referred soft tissue and 
orthopaedic cases. His clinical interests include all areas 
of traumatology and acute abdominal surgery. Paul is 
widely involved in delivering CPD, both nationally and 
internationally.
Emma Archer 
RVN DipAVN(Surgical)  
VTS(Anaesthesia)
Emma Archer qualified as a Veterinary 
Nurse in 2001 in general practice, gaining 
her advanced veterinary nursing diploma 
(surgical) in 2006. Since 2008, she has been an Anaes­
thesia Technician at The Animal Health Trust and is a 
 Veterinary Technician Specialist (VTS) in Anaesthesia & 
Analgesia and a member of the Academy of Veterinary 
Technician Anaesthetists. Emma is passionate about 
continuing education and has a keen interest in teaching 
and CPD for veterinary nurses and is currently under­
taking an MSc.
Heather Bacon 
BSc(Hons) BVSc CertZooMed MRCVS
Heather Bacon graduated from the Univer­
sity of Bristol and, after several years work­
ing overseas, now runs international 
veterinary training projects out of the 
Jeanne Marchig International Centre for Animal Welfare 
Education at the University of Edinburgh; Heather has a 
keen interest in dog behaviour and welfare, veterinary 
training and zoological medicine.
Lucy Barker 
BVMBVS BVMedSci PGCert
Lucy Barker is a graduate from the Univer­
sity of Nottingham. She is currently a sec­
ond year resident in small animal internal 
medicine at the University of Bristol, and 
has a keen interest in all areas of internal medicine.
Penny Barker 
BVetMed BSc MRCVS
Penny Barker is a Royal Veterinary College 
graduate, former small animal vet, pro­
gramme manager and management con­
sultant. She has a passion for helping people 
to both realise their potential and to work more effec­
tively together. This led her to becoming an NLP Practi­
tioner and gaining Diplomas in both personal and 
corporate coaching. She now runs her own leadership 
coaching and team development business as well as 
working back within the profession she loves as an 
 associate with VDS training.
Duncan Barnes 
MA VetMB DipSAS(Ortho) MRCVS RCVS 
Recognised Specialist in Small Animal Surgery 
(Orthopaedics)
Duncan Barnes qualified from the Univer­
sity of Cambridge in 2001, and spent 9 years 
in general small animal practice, where he gained 
the RCVS Certificate of Small Animal Surgery (CertSAS) 
in  2006. In 2010 he set up the orthopaedic referral 
 service at Eastcott Referrals in Swindon, and he com­
pleted a part­time externship at Anderson Abercromby 
Veterinary Referrals in 2014. He was awarded the RCVS 
Diploma in Small Animal Orthopaedics, completing 
this  via the  alternate track, in August 2016. Duncan is 
 currently  head of the orthopaedics department at 
 Eastcott  Referrals.
Dan Batchelor 
BVSc PhD DipSAM DipECVIM-CA MRCVS
Dan Batchelor is a Bristol graduate and a 
European and RCVS Specialist in Small 
 Animal Internal Medicine. Dan works at the 
University of Liverpool Institute of Veteri­
nary Science and is Head of Small Animal Medicine; he 
has an interest in all areas of internal medicine.
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Julie Beacham 
BSc(Hons) CVPM 
Julie Beacham has over 20 years’ experience 
in the veterinary world and manages Wendo­
ver Heights Veterinary Centre, a large, mixed, 
independent practice in  Buckinghamshire. 
She relishes the diversity and unpredictability of the role 
and enjoys finding solutions to the problems that arise. Julie 
has been a member of the  Veterinary Practice Management 
Association (VPMA) Council & Board since 2011, was a 
member of the  Certification and Training Committee for six 
years, and is now the 2018­2019 President under its new 
name, The Veterinary Management Group. 
Laura Black RVN 
CertNEBOSH (Occupational Health and 
Wellbeing) (Occupational Health & Safety) 
Laura Black has been a Veterinary Nurse for 
26 years, working in both private and char­
ity sectors. She is Head of Health, Safety & 
Wellbeing at Vets Now. She has a keen interest in improv­
ing wellbeing within our profession, through raising 
awareness of good mental health, encouraging the 
 practice team to look after themselves and improving the 
quality of sleep.
Vicki Black 
MA VetMB ECVIM-CA FHEA MRCVS
Vicki Black graduated from University of 
Cambridge Veterinary School in 2009 and 
worked in small animal practice before 
completing an internship at Davies Veteri­
nary Specialists and a residency at Bristol Veterinary 
School in 2016. Since achieving her European Diploma in 
Small Animal Internal Medicine she has remained at 
 Bristol Veterinary School as a Clinical Teaching Fellow. 
Vicki has a special interest in haematological and 
immune­mediated disorders.
Ben Blacklock 
BVSc(Hons) DipECVO MRCVS
Ben Blacklock graduated from the Univer­
sity of Bristol in 2009. After spending time in 
mixed practice in Lancashire, he undertook 
an internship and then residency in oph­
thalmology at the Animal Health Trust in Newmarket. 
Upon completion of his residency, Ben moved to Dick 
White Referrals. He is an RCVS and European Specialist in 
Ophthalmology.
Kieran Borgeat 
BSc(Hons) BVSc MVetMed(Dist) CertVC 
DipACVIM DipECVIM-CA MRCVS
Kieran Borgeat is a Bristol graduate, who 
completed his Certificate in Veterinary 
 Cardiology in general practice and then 
completed a Residency and Masters degree at the Royal 
Veterinary College. He is an American and European 
 Diplomate and an RCVS Recognised Specialist in 
 Cardiology. He is Clinical Lead in Cardiology at Langford 
Vets, University of Bristol. He is particularly interested in 
interventional procedures, cardiac therapeutics, feline 
myocardial disease and clinical decision making processes.
Peter Borriello 
PhD
Peter Borriello is a microbiology graduate 
and Fellow of University College London. 
His career history includes appointment as 
Head of a Medical Research Council Unit 
working on pathogenicity of bacterial infections; found­
ing Director of the Institute of Infections and Immunity, 
University of Nottingham; and was appointed Director of 
the Central Public Health Laboratory, which was the 
National Centre for Reference Microbiology, and then 
Director of the Government a centre for Infections, His 
last post was as Chief Executive of the Veterinary Labora­
tories Agency. He is currently Chief Executive of the Vet­
erinary Medicines Directorate.
Kelly Bowlt 
Blacklock BVM&S DipECVS PGCert FHEA 
MRCVS
Kelly Bowlt graduated from the University of 
Edinburgh in 2005 and after 18 months in 
small animal general practice, completed a 
rotating internship at the Royal Veterinary College and a 
three­year ECVS approved residency programme in 
Small Animal Surgery at the University of Bristol. Kelly 
joined the Animal Health Trust in 2011, where her par­
ticular interests include minimally invasive surgery, 
trauma management and reconstructive/oncological 
surgery. She is a member of the European College of 
 Veterinary Surgeons (ECVS) and the Association of 
 Veterinary Soft Tissue Surgeons (AVSTS). 
Jonathan Bray 
MVSc MSc(Clin Onc) MANZCVS CertSAS 
DipECVS MRCVS
Jonathan Bray graduated from Massey Uni­
versity, New Zealand in 1988 and became a 
Diplomate of the European College of Vet­
erinary Surgeons in 1997. He obtained a Master’s degree 
in Veterinary Science in 1990, and a Master’s degree in 
Clinical Oncology in 2013. He is currently completing a 
PhD, with the hope of developing better prognostic tools 
and treatments for soft tissue sarcoma. Jonathan is now 
a Senior Surgeon at Fitzpatrick Referrals Oncology and 
Soft Tissue in Guildford, UK.
Laura Buckley 
BVetMed CertVD DipECVD MRCVS
Laura Buckley is a Royal Veterinary College 
graduate and a RCVS and European Spe­
cialist in Veterinary Dermatology. After 
completing her residency training at the 
University of Liverpool, she worked in private referral 
practice for Guide Dogs as part of UK VetDerm, Davies 
Veterinary Specialists and Calder Vets. She returned to 
the University of Liverpool in 2014 and is currently in post 
as Senior Lecturer in Veterinary Dermatology. She is 
interested in all areas of dermatology, in particular 
chronic otitis and feline dermatology.
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Richard Byrne
BVetMed MRCVS
Richard Byrne is a Royal Veterinary College 
graduate and Director at West Bar Veteri­
nary Hospital, Banbury in Oxfordshire. 
Richard spends most of his time involved in 
the clinical work of a busy first opinion mixed practice. 
Richard has a keen interest in using technology in first 
opinion practice to improve clinical outcomes and pro­
cesses, improve client care and improve the quality of the 
work environment for staff.
Richard Casey
MBA AssocCIPD
Richard Casey is a charity veterinary profes­
sional and works as Clinical Development 
Manager at Blue Cross, as well as a Director 
of the Veterinary Management Group. His 
areas of expertise include service innovation and people 
development.
David Charles
David Charles is a final year student at Bristol 
Vet School and Senior Vice President of the 
Association of Veterinary Students. Prior to 
attending Bristol, he studied biology at the 
University of Birmingham. His presidential 
year saw the launch of the AVS EMS Grants, the inaugural 
EMS Experience survey and the first student led session at 
London Vet Show. David is passionate about improving the 
student experience and accessibility in vet schools and 
on placements for students of all backgrounds. For the last 
5 years he has worked either full or part time to help fund 
his veterinary studies and associated expenses.
Sylvie Chastant
DVM PhD Habil DipECAR
Sylvie Chastant is a French vet, whose pas­
sions are teaching and applied research in 
the field of reproduction. She developed 
research on canine neonatology and paedi­
atrics, within a dynamic team called Neocare (Toulouse 
National Vet School, Toulouse, France), dedicated to 
reproduction, neonatology and kennel/cattery medicine 
with special interests in colostrum and milk, birth weight, 
and alert criteria to decrease the risk of mortality in pup­
pies and kittens.
John Chitty
BVetMed CertZooMed MRCVS 
John Chitty is a CVS Advanced Practitioner 
in Zoological Medicine. John qualified from 
the Royal Veterinary College in 1990 and 
gained his RCVS Certificate in Zoological 
Medicine in 2000. John Co­Directs a small animal/exotics 
practice in Andover, Hampshire with a 100% avian/exotics/
small mammal caseload of both referral and first opinion 
patients. John is consultant to seven zoological collec­
tions, a commercial laboratory and the Great Bustard 
Reintroduction project as well as Co­ editor of two texts 
on avian medicine, one on rabbit surgery and co­author of 
a textbook of tortoise medicine. John is the author of vari­
ous book chapters and papers on a range of species, Vice­
President of the European Association of Avian 
Veterinarians, and Senior Vice President of the British Small 
Animal Veterinary Association.
Peter Cockcroft
BA MA MSc MBA Vet.MB DVM&S DCHP 
DipECBHM FHEA MRCVS
Peter Cockcroft is Professor of Veterinary 
Education within the School of Veterinary 
Medicine at the University of Surrey, where 
he is responsible for the design, delivery and develop­
ment of the veterinary curriculum. With Mark Holmes, he 
co­authored the Handbook of Evidence­Based Veteri­
nary Medicine and the Handbook of Clinical Veterinary 
Research. Peter is the Editor in Chief of RCVS Knowl­
edge’s journal Veterinary Evidence.
Elizabeth Cox
CertSAN RVN
Elizabeth Cox works for Independent 
Vetcare as Veterinary Project Manager, is 
also the Senior Vice Chair of RCVS 
Veterinary Nurses Council and an appointed 
member of the RCVS council. She also Co­Chairs the 
RCVS and BVNA Veterinary Nurses Future Project. Having 
worked within a wide range and style of practices over 
the years, Elizabeth is passionate about veterinary nurs­
ing with a strong focus on the future and direction of the 
profession. With the rapid changes and advances in the 
industry, she is keen that nurses develop their own career 
and the profession as a whole. 
Thomas Cox
BVSc CertAVP(GSAS) MRCVS
Thomas Cox is a graduate of Liverpool 
University, qualifying in 2012, he spent three 
years in first opinion practice before com­
pleting rotating and surgical internships. 
He is now in his final year of a surgical residency at the 
Small Animal Teaching Hospital, Liverpool. He has a keen 
interest in all areas of small animal surgery.
Carolyne Crowe
BVetMed(Hons) BSc(Hons) MSc Dip Coaching 
Dip Stress Management and Wellbeing MRCVS 
Carolyne Crowe is an experienced equine 
vet, an award winning personal perfor­
mance coach, mentor, international speaker, 
researcher and lecturer. Carolyne has a Master’s degree 
in Workplace Health and Wellbeing and continues to do 
research in veterinary team health, wellbeing, perfor­
mance and engagement. She is a master trainer in DISC 
behavioural profiling, a CPCAB trainer in Stress manage­
ment and Wellbeing, a certified trainer in Resilience, a 
Mental Health First Aider and an Honorary Lecturer of the 
University of Liverpool. Carolyne is a training consultant 
at VDS Training. 
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Laura Cuddy 
MVB MS DipACVS-SA DipECVS DipACVSMR 
DipECVSMR MRCVS
Laura Cuddy is a graduate of University 
 College Dublin. She is an American, 
 European, RCVS and VCI Specialist in Small 
Animal Surgery and an American and European  Specialist 
in Veterinary Sports Medicine and Rehabilitation. Laura is 
Director of Veterinary Specialists Ireland. She has a keen 
interest in all aspects of orthopaedic, soft tissue, neuro­
logic and oncologic surgery, specifically minimally­ 
invasive techniques, traumatology and rehabilitation of 
the postoperative patient. Her research interests include 
orthopaedic biomechanics, as well as teaching and pro­
ficiency assessment in minimally­invasive procedures.
Stacey Davidson  
Stacey Davidson is Champion of Culture and 
Community at The Ralph Veterinary Referral 
Centre – a role which combines her two 
greatest passions; communications and 
people. She is a true advocate and champion 
of the far­reaching effects that a positive organisational 
culture can have on individuals and teams. She also 
believes that at its heart, great communication is about 
creating an authentic story, told in a genuine way, with 
simplicity and purpose. 
Charlotte Dawson 
BVetMed MVetMed PGCertVetEd FHEA 
DipECVO MRCVS
Charlotte Dawson graduated from the RVC 
in 2009, and after a year in general small 
animal practice she went on to complete 
two rotating internships. The first at a private referral 
practice and the second at the RVC. Having also under­
taken specialist training in the RVC’s Ophthalmology 
 Service, she is now Lecturer in Veterinary  Ophthalmology 
and head of the service.
Rachel Dean 
BVMS PhD MSc(EBHC) DSAM(Fel) SFHEA 
MRCVS
Rachel Dean, a graduate from University of 
Glasgow, has worked in mixed, dairy and 
small animal general practice. She holds the 
RCVS Diploma in Feline Medicine, has a PhD in epidemi­
ology and an MSc in Evidence­based Healthcare. Rachel 
is currently the Director of Clinical Research and Excel­
lence in Practice for Vet Partners, the inaugural chair of 
the Association of Charity Vets and the chief editor of the 
BSAVA Manual of Shelter Medicine. 
Steven De Decker 
DVM PhD DipECVN MvetMed PGCertVetEd 
FHEA MRCVS
Steven De Decker graduated from Ghent 
University in Belgium. After graduation, he 
performed a rotating internship there and 
undertook a PhD studying ‘wobbler syndrome’ in dogs. 
This was followed by a Residency in Neurology and 
 Neurosurgery at the Royal Veterinary College. He is 
 Senior Lecturer and the Head of Service of the neurology 
and neurosurgery team at the Royal Veterinary College. 
Although he is interested in all aspects of veterinary 
 neurology, most of his research and publications focus 
on spinal disorders and neurosurgery.
Margaret Mary Devaney 
Margaret Mary Devaney was invited to join the 
RCVS Knowledge Quality Improvement Advi­
sory Board in 2018. She brings with her the 
unique experience and perspective of an NHS 
improver. As well as being a registered nurse, 
she has undertaken leadership roles such as Head of Patient 
Safety at the Royal Free London NHS Foundation Trust and 
currently as Assistant Director for Quality & Risk at East and 
North Hertfordshire NHS Trust. Margaret Mary has experi­
ence as a Quality Improvement Advisor with the Academic 
Health Science Network UCL Partners and through in­
depth studying with the Institute for Healthcare Improve­
ment (IHI) Improvement Advisor Programme. 
Simon Doherty 
BVMS CertAqV MRCVS MRQA CBiol FRSB
Simon is the president of the British Veteri­
nary Association and a Senior Lecturer 
(Education) in Animal Health & Welfare at 
the Institute of Global Food Security, 
Queen’s University Belfast. He is a trustee of the BVA Ani­
mal Welfare Foundation and of international livestock 
development charity, Send a Cow. Through his own busi­
ness, Blackwater Consultancy Ltd, Simon delivers men­
torship in business development for innovative start­up 
and spin­out companies working in the agri­tech & agri­
food sectors, and he was appointed as a GlobalScot by 
Scottish Development International during 2018.
Julie Dugmore 
RVN
Julie Dugmore qualified as a veterinary 
nurse in 1987 after spending her training 
years in small animal practice. Her keen 
interest in student training led her to take a 
teaching position in 2000 and since leaving full time 
practice she has kept her clinical skills up to date. Julie’s 
position with the Royal College of Veterinary Surgeons 
has been varied; starting in 2002 as an external verifier 
and progressing through the ranks to become the Direc­
tor of Veterinary Nursing responsible for eight members 
of staff working to support the Veterinary Nurse Council 
in the college’s regulatory remit.
Florent Duplan 
DVM MRCVS
Florent Duplan is Resident in Small Animal 
Internal Medicine at Langford Vets, Univer­
sity of Bristol. In 2015, he graduated from 
Alfort Veterinary School in France and per­
formed a small animal rotating internship in Canada, at 
the University of Prince Edward Island.
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Sarah Egleston 
RVN VTS(ECC)
Sarah Egleston graduated from the Univer­
sity College Dublin in 2010, after which she 
worked in general practice before moving 
to a large emergency referral hospital in 
central London, where she was the transfusion nurse and 
clinical lead. In 2017, Sarah became a member of the 
Academy of Veterinary Emergency and Critical Care 
Technicians, when she obtained her VTS (ECC) qualifica­
tion. Sarah is currently an ECC nurse at the QMHA RVC.
Gary England 
BVetMed PhD DVetMed DipVR DipVRep 
DipECAR DipACT PFHEA FRCVS
Gary England is Professor of Comparative 
Veterinary Reproduction at the School of 
Veterinary Medicine and Science, University 
of Nottingham. He gained a PhD in canine reproduction, 
is a Diplomate of the European College of Animal 
 Reproduction and the American College of Theriogeno­
logists, and he holds the RCVS Diploma in Veterinary 
Reproduction.
Brian Faulkner 
BSc(Hons) BVM&S CertGP(SAM) CertGP(BPS) 
MBA MSc(Psych) MRCVS 
Brian Faulkner is a clinician, veterinary busi­
ness consultant and confidence coach. 
Brian has set up, developed and exited 4 
veterinary practices. He is the creator of Colourful 
 Consultation.com and founder of The British Veterinary 
Receptionist Association. He is a SPVS past president.
Joe Fenn 
BVetMed MVetMed DipECVN FHEA MRCVS
Joe Fenn graduated from the Royal Veteri­
nary College in 2009 and spent some time 
in general practice in Derbyshire. He then 
returned to the RVC to complete a rotating 
internship and residency in veterinary neurology and 
neurosurgery. Following completion of his residency, 
Joe stayed at the RVC as staff clinician, and in 2017 was 
appointed as a Lecturer in Veterinary Neurology and 
Neurosurgery. Joe is a European and RCVS Recognised 
Specialist in Veterinary Neurology. He is interested in all 
aspects of veterinary neurology and neurosurgery, 
including the management of acute spinal cord injury 
and advanced neurosurgery.
Elena Fenollosa-Romero 
DVM CertVOphthal MRCVS
Elena Fenollosa­Romero is a third year ECVO 
resident at Dick White Referrals. She enjoys 
all aspects of Ophthalmology but mainly 
corneal and intraocular surgery.
JD Foster 
VMD DACVIM(SAIM)
JD Foster graduated from the University of 
Pennsylvania. After spending a year in pri­
vate practice general medicine, he com­
pleted an internship followed by a residency 
in small animal internal medicine at the University of Wis­
consin. JD is now a staff veterinarian at the Friendship 
Hospital for Animals in Washington DC. There, he runs 
the only extracorporeal blood purification service in the 
region. His research interests include glomerulonephri­
tis, acute kidney injury, novel usage of extracorporeal 
blood purification, and biomarkers of renal injury. JD is 
the current president of the American Society of Veteri­
nary Nephrology and Urology. He has published numer­
ous textbook chapters, peer reviewed research and 
review articles, and has spoken internationally on many 
topics within renal and urinary disease.
Shakira Free Miles 
RVN Bsc 
Shakira Free Miles qualified in 2009 and has 
worked in a wide variety of clinics all over 
the world. Shakira is a passionate and active 
RVN focusing on animal welfare and has a 
strong voice within the profession on breed specific laws 
and animal cruelty.
Isuru Gajanayake 
BVSc CertSAM DipACVIM DipECVIM-CA 
DipACVN MRCVS
Isuru Gajanayake is an American, European 
and RCVS Specialist in Small Animal Internal 
Medicine, and an American Specialist in 
Small Animal Nutrition. Isuru is the Head of Internal Medi­
cine at Willows Veterinary Centre and Referral Service, 
where he works as a specialist in internal medicine and 
clinical nutrition.
Alex German 
BVSc PhD CertSAM DipECVIM-CA SFHEA 
FRCVS
Alex German holds the position of Royal 
Canin Professor of Small Animal Medicine at 
the University of Liverpool. He is a 1994 
graduate of the University of Bristol and, after spending 
two years in mixed practice, returned to Bristol to under­
take a PhD in mucosal immunology, and then a residency 
in small animal internal medicine. He is a Diplomate of 
the European College of Veterinary Internal Medicine, a 
RCVS Recognised Specialist in Internal Medicine, and a 
Senior Fellow of the Higher Education Academy. His clini­
cal and research interests include comparative obesity 
biology, ageing, preventing chronic disease, gastroenter­
ology and evidence­based veterinary medicine. For 
14 years, he has run the Royal Canin Weight Management 
Clinic at the University of Liverpool. This specialist clinic 
aims to improve the quality of life of all overweight pets 
through clinical excellence, research and education.
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Sonya Gordon 
DipACVIM Cardiology
Sonya Gordon is a graduate of the Ontario 
Veterinary College (Canada) where she 
also  completed her cardiology residency 
training and advanced degree in veterinary 
cardiology. Sonya has been on faculty at Texas A&M 
 University since 1998. She teaches in all years of the DVM 
program and is the cardiology residency program direc­
tor. Sonya practices medicine 30%–50% of the  time, 
which facilitates her research interests that are realized in 
large part through involvement in multicentre collabora­
tive clinical trials and collaborative translational research. 
These opportunities, coupled with her involvement in 
multicentre international studies, have provided her with 
a global perspective with respect to veterinary  cardiology.
Richard Guest 
MA (Hons) CEO Morgan Frey, Telemedicine 
Consultancy
Richard Guest graduated from Oxford Uni­
versity and has driven innovation across a 
number of industries. Most recently Richard 
launched the NHS GP at hand service with Babylon 
health, saving patients time and taking pressure off the 
rest of the NHS.
Eilidh Gunn 
BVMS DVMS DipECVIM-CA MRCVS
Eilidh Gunn is a graduate of the University 
of Glasgow and, following a residency at the 
University College Dublin, obtained her 
ECVIM diploma in small animal internal medi­
cine. Eilidh is a clinician at North Downs Specialist  Referrals 
and is interested in all areas of internal medicine.
Chris Gush 
BSc MSc
Chris Gush is the Executive Director of 
RCVS Knowledge, which aims to advance 
the quality of veterinary care for the benefit 
of animals, the public and society. Chris 
began his career as a microbiologist. Having left the 
 laboratory, a move to the Department of Health saw him 
co­develop the Showcase Hospitals Programme. Later, 
at the Health Protection Agency, Chris managed investi­
gations into microbiology testing leading to improved 
standards. In his previous role as Assistant Director of 
Clinical Inno vation and Research at the Royal College of 
General Practitioners, Chris led on the development of 
resources to help improve the quality of patient care.
Peter Haseler 
BVetMed MRCVS
Peter Haseler is a Royal Veterinary College 
graduate. Pete works as a first opinion and 
referral vet at Acorn Veterinary Centre, 
Studley. He has a keen interest in veterinary 
dentistry, is a past President of the British Veterinary 
 Dental association and is the Treasurer of the European 
Veterinary Dental society.
Rachel Hattersley 
BVetMed(Hons) CertSAS DECVS MRCVS
Rachel Hattersley is a Royal Veterinary Col­
lege graduate and an RCVS and EBVS Spe­
cialist in Small Animal Surgery. Rachel is a 
member of the soft tissue surgery team at 
Dick White Referrals. She has a keen interest in all areas 
of  soft tissue surgery but her specific areas of interest 
include brachycephalic obstructive airway syndrome, 
feline nephroureterolithiasis and surgical oncology. 
Philippe Hennet 
DV DipAVDC DipEVDC
Philippe Hennet is an American, European 
and French Specialist in Dentistry and Oral 
Surgery. Philippe works at ADVETIA Veteri­
nary Referral Hospital and is Head of 
 Dentistry, Oral and Maxillofacial Surgery.
Michael Herrtage 
MA BVSc DVSc DVR DVD DipSAM FRCVS 
DipECVIM DipECVDI RCVS and European 
Specialist in Small Animal Medicine 
Mike Herrtage graduated from the Liverpool 
University and was until recently Professor 
of Small Animal Medicine at the University of Cambridge 
and Dean of the Cambridge Veterinary School. He was in 
charge of the small animal medicine and diagnostic 
imaging services at the Queen’s Veterinary School Hos­
pital. His clinical responsibilities include all aspects of 
small animal medicine and diagnostic imaging, but he 
has a particular interest in endocrine and metabolic 
 disorders.
Paul Higgs 
MA VetMB CertSAM DipECVIM-CA MRCVS
Paul Higgs qualified from the University of 
Cambridge in 2006. He completed a resi­
dency in internal medicine at the University 
of Bristol and became a Diplomate of the 
European College of Veterinary Internal Medicine in 
2014. Since then he has worked in private referral  practice 
and is currently part of the internal medicine team at 
Highcroft Referrals, Bristol.
Georgina Hills 
RVN CVPM
Georgina Hills is a Veterinary Management 
Group Director and works as an Operations 
Manager for Independent Vetcare, previ­
ously having worked as an RVN and practice 
manager. Georgina sits on the VMG committee for the 
Certificate in Veterinary Practice Management (CVPM) 
and has a keen interest in promoting the benefits of non­
clinical CPD and management training for all members of 
the team, including the leaders, to improve practice life.
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Jo Hinde 
RVN
Jo Hinde is a Registered Veterinary Nurse 
with a special interest in rabbit medicine. Jo 
is a director of LagoLearn which provides 
rabbit specific CPD to veterinary profes­
sionals in the UK and internationally. She is also a BVNA 
Council member and has won awards for her dedication 
to animal welfare.
Delphine Holopherne-Doran 
DVM MSc PhD DipECVAA AFHEA MRCVS
Delphine Holopherne­Doran is an EBVS Spe­
cialist in Veterinary Anaesthesia and  Analgesia. 
She works as a clinical anaesthetist at High­
croft Veterinary Referrals; she has a keen 
interest in all areas of anaesthesia and analgesia.
Paula Hotston Moore 
MEd RVN
Paula Hotston Moore is a Registered Veteri­
nary Nurse, working at the University of 
Bristol for 13 years up until December 2018. 
Paula has worked in veterinary nurse edu­
cation for a number of years. Paula was Senior Tutor for 
the veterinary nursing courses and had responsibility for 
the pastoral support of undergraduate students.
Dawn Howard 
Chief Executive of NOAH
Dawn Howard, prior to joining NOAH in 
2014 was based in Brussels and spent a 
number of years representing UK agricul­
ture in the office of the UK National Farmers 
Union where her responsibilities included animal health 
and welfare. She later headed up the European body for 
farm animal breeders, EFFAB. Dawn previously worked in 
Defra’s Animal Health and Welfare policy unit in West­
minster and prior to that both Plant Health and pesticides 
policy in York, originally joining as a field­based inspec­
tor.Whilst originally qualified as a botanist, Dawn has a 
passion for raising animal health and welfare standards.
Susan Howarth 
BSc(Hons) DipAVN(Surg) DipAVN(Med) CertEd 
FHEA RVN 
Susan Howarth is the Programme Manager 
of Veterinary Nursing courses at Harper 
Adams University and sits on the RCVS 
 Veterinary Nursing Education Committee and Veterinary 
Nurse Council. She has an interest in veterinary nurse 
education, in particular post professional education. 
Andrea Jeffery 
RVN MSc DipAVN(Surg) CertEd FHEA
Andrea Jeffery is a Veterinary Nurse  Educator 
and has worked in both further education 
and now higher education for the past 
twenty years. Andrea is Programme Director for the 
undergraduate veterinary nursing programmes at the 
University of Bristol and is currently Chair of the VN Edu­
cation Committee at the RCVS. She has a keen interest in 
patient care and client compliance as well as improving 
professional practice.
Thom Jenkins 
MA VetMB MRCVS
Thom is Founder and CEO of Gula, a 
mobile­first veterinary telemedicine plat­
form enabling veterinary clinics to offer 
video consultations to pet owners. Thom 
previously served as the Chief Operating Officer of multi­
site veterinary groups in both Europe and Asia. Thom 
serves as Chair of VetForum USA, UK and APAC events, is 
Non Executive Director at Recruit4vets and is an advisor 
to YLD, one of London’s fastest growing software engi­
neering consultancies working with brands such as The 
Economist, Trainline and Thomas Cook.
Georga Karbe 
DVM PhD DACVS-SA MRCVS
Georga Karbe graduated from the Freie 
University Berlin, Germany after which she 
pursued specialist surgical training in the 
United States. She spent time at Colorado 
State University and the University of Pennsylvania, 
where she completed a research fellowship as well as 
surgical internship and residency. Georga is a Diplomate 
of the American College of Veterinary Surgeons and is 
currently working as a soft tissue consultant at Dick 
White Referrals. She has a strong interest in all aspects of 
soft tissue surgery, particularly minimally invasive surgery 
and reconstructive surgery.
Aarti Kathrani 
BVetMed(Hons) PhD DACVIM(SAIM) DACVN 
MRCVS
Aarti Kathrani graduated from the Royal 
Veterinary College in 2006 before complet­
ing her rotating small animal medicine and 
surgery internship at the Queen Mother Hospital for 
Animals, RVC, in 2007 and her PhD in canine  inflammatory 
bowel disease at the RVC in 2011. Aarti then completed a 
three­year residency program in small animal internal 
medicine at Cornell University in 2014 and is a diplomate 
of the American College of Veterinary Internal Medicine. 
She also completed a two­year small animal clinical nutri­
tion residency program at the University of  California­Davis 
in 2016. She is a diplomate of the American College of 
Veterinary Nutrition. Aarti works at the RVC as a senior 
lecturer in small animal internal medicine. 
Sophie Keyte 
BVMS(Hons) MVetMed(Dist) FHEA DACVIM 
MRCVS
Sophie Keyte is a Glasgow University gradu­
ate and an American and RCVS Specialist in 
Small Animal Internal Medicine. She enjoys 
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all aspects of internal medicine, however her main areas 
of interest are endocrinology and infectious disease. 
During her residency she was a member of the “Feline 
Acromegaly Team” at the Royal Veterinary College. 
Sophie is currently a Clinical Teaching Fellow at the Uni­
versity of Bristol and leads the canine hypophysectomy 
service, alongside the Neurology and Emergency and 
Critical Care team, at Langford Veterinary Services. 
Richard Killen 
BVSc MRCVS
Richard Killen qualified from Bristol Univer­
sity and for many years was partner at the 
Highcroft Vet Group in Bristol. Since 2016 
he has been the Director of Clinical Services 
for CVS Group, his responsibilities include helping main­
tain the clinical and practice standards within CVS prac­
tices. Richard is also a senior assessor for the RCVS PSS.
Jennifer Kinns 
VetMB DipECVDI DACVR MRCVS
Jennifer Kinns is a Cambridge Veterinary 
School graduate and an American, 
 European and RCVS Specialist in Diagnostic 
Imaging. Jennifer works as a radiology 
 consultant and medical manager with Idexx Telemedi­
cine and is exam director for the European College of 
Veterinary Diagnostic Imaging. She has a particular inter­
est in teaching radiographic interpretation to general and 
emergency practitioners.
Chris Laurence 
MBE QVRM TD BVSc FRCVS
Chris Laurence qualified as a vet from Bris­
tol in 1968 and worked in mainly small 
animal practice until 1998. Chris was subse­
quently Chief Veterinary Officer at the 
RSPCA and Veterinary Director of Dogs Trust. He retired 
in August 2011. He was awarded the MBE for services to 
animal welfare in 2007 and granted Fellowship of the 
Royal College of Veterinary Surgeons in 2017.
Chris is currently Chairman of the Canine and Feline Sec­
tor Group and Chairman of the Animal Welfare Founda­
tion and the British Veterinary Behaviour Association. He 
also works for other charities
Richard LeCouteur 
BVSc PhD DipACVIM(Neurology) DipECVN
Richard LeCouteur is a graduate of The 
 University of Sydney, and a Diplomate of the 
American College of Veterinary Internal 
Medicine (Neurology) and the European 
College of Veterinary Neurology (ECVN). Currently Rick is 
a Professor Emeritus of Neurology and Neurosurgery at 
The University of California, Davis.
Dan Lewis 
MA VetMB CertVA DipACVECC DipECVECC 
MRCVS
Dan Lewis is a Cambridge graduate and an 
American, European and RCVS Specialist in 
Small Animal Emergency & Critical Care. 
Dan is national clinical lead in ECC for Vets Now and is 
based in their Glasgow referral hospital. He is interested 
in all aspects of emergency & critical care, but particu­
larly in the treatment of sepsis and the use of blood 
 products in the critically ill patient.
Philip Lhermette 
BSc (Hons) CBiol FRSB BVetMed FRCVS
Philip Lhermette is the principal and founder 
of Elands Veterinary Clinic, near Sevenoaks 
in Kent. After completing an honours degree 
in animal physiology at the University of Not­
tingham in 1977, Philip went on to complete his degree in 
veterinary medicine at the Royal Veterinary College, Lon­
don, in 1982. Following four years in mixed practice in Sur­
rey Philip moved to Kent to establish his own practice 
which moved to new purpose­built premises in 2010.
Philip has a particular interest in surgery – and more spe­
cifically, minimally invasive (keyhole) surgery using both 
rigid and flexible endoscopes. Philip trained with human 
minimally invasive surgeons in the UK and veterinary 
endoscopists in the USA. Having practised rigid endos­
copy since 1995, Philip has extensive experience in 
endoscopy and endosurgery and has run a referral ser­
vice since 2001. He pioneered laparoscopic bitch spays 
and laser endosurgery in veterinary medicine in the UK, is 
author and editor of the BSAVA Manual of Canine and 
Feline Endoscopy and Endosurgery and has contributed 
to numerous other publications and lectures extensively 
in minimally invasive techniques throughout the UK, 
Europe and Asia. In 2011 Philip received the BSAVA Simon 
Award for outstanding contributions in the field of veter­
inary surgery. in 2016 he was awarded Fellowship of the 
Royal College of Veterinary surgeons for meritorious 
contributions to clinical practice and in 2017 he was 
awarded Fellowship of the Royal Society of Biology. He is 
an Official Veterinary Surgeon (OV) currently on the fol­
lowing panels: ES, EX, SX, CA.
Francisco Llabrés-Díaz 
DVR DipECVDI MRCVS
Francisco Llabrés­Díaz has been working in 
the field of referral small animal diagnostic 
imaging for 20 years. He is an RCVS Specia­
list in Veterinary Diagnostic Imaging, hold­
ing the RCVS and ECVDI Diplomas. Francisco has worked 
at different referral centres in the UK and has been Chair 
of the British and Irish Division of the European Associa­
tion of Veterinary Diagnostic Imaging and the East Anglia 
Region of BSAVA.
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Anette Loeffler 
DrMedVet PhD DVD DipECVD MRCVS
Anette Loeffler graduated from Ludwig­Max­
imilians­University Munich, worked in mixed 
practice in Cumbria for six years and is now 
assistant professor in veterinary  dermatology 
at the Royal Veterinary College, involved in clinical work, 
teaching and research. She is a European and RCVS Spe­
cialist in Veterinary Dermatology and has a keen research 
interest in bacterial skin diseases, antimicrobial resistance 
and zoonotic transmission of MRSA and MRSP.
Christine Magrath 
BVMS HonFRCVS
Christine Magrath was appointed by the 
VDS in 1999 to initiate and develop a pro­
gramme which specifically deals with every 
day communication with clients and add­
ressing difficult situations. The programme has had an 
impact at practice level and on undergraduate training, 
and in light of this Christine was awarded an Honorary 
Fellowship of the Royal College in 2009 and presented 
with the Chiron award from the BVA in 2010. Christine is 
recognised as a leader in this field and has co­authored 
books on the subject. She is a past President and 
 Treasurer of SPVS and was a partner for 12 of her 17 years 
in practice. 
Christoph Mans 
DrMedVet DipACZM DipECZM(ZHM)
Christoph Mans is a native of Germany and 
received his veterinary degree from the Uni­
versity of Leipzig (Germany). He completed 
an internship in Avian and Exotic Animal 
Medicine at the Ontario Veterinary College (Canada) 
 followed by employment in private practice in Hong 
Kong. He then completed a 3­year­residency in zoolo­
gical medicine at the University of Wisconsin­Madison, 
the Milwaukee County Zoo and the International Crane 
Foundation. He is currently a clinical associate professor 
of zoological medicine at the University of Wisconsin­
Madison, USA.
Stephen May 
MA VetMB PhD DVR DEO FRCVS DipECVS 
FHEA
Stephen May is Professor of Education and 
Senior Vice­Principal at the Royal Veterinary 
College, and Senior Vice­President of the 
Royal College of Veterinary Surgeons, currently chairing 
its Graduate Outcomes Working Group. He is interested 
in professional identity and capability and learning that 
supports this, including communication skills, leadership 
and team­working, scientific, clinical and ethical reason­
ing, and professionalism. He pioneered new approaches 
to teaching, learning and assessment, and has extensive 
experience of curricular development. His research 
focuses on the scholarship of primary care, reflective 
practice and learning, professional development and 
assessment methods.
Anne McBride 
PHD
Anne McBride’s degree was in Psychology 
and her PhD in animal behaviour. She has 
been a practising clinical animal behaviour­
ist for over 30 years. She has taught about 
owner psychology, counselling and listening skills to 
behaviour counsellors and animal training instructors for 
20+ years. Understanding and interacting with owners is 
core to the success of any treatment or programme 
aimed at improving animal welfare in any context.
Fiona McDowall 
PGDipVN Oncology PGCertTLHE CertAAB 
DipAVN DipCVN RVN
Fiona McDowall is the Senior Oncology 
Nurse at the Royal Dick School of Veteri­
nary Studies, Edinburgh. Fiona is currently 
 studying towards a Master’s Degree in Veterinary  Nursing 
Oncology and has a keen interest in medical oncology 
and client support techniques.
Matt McMillan 
BVM&S DipECVAA MRCVS
Matt McMillan is the Principal Clinical 
Anaesthetist at Cambridge Vet School. His 
interests are patient safety, error, ethics and 
education.
Pam Mosedale 
BVetMed MRCVS
Pam Mosedale is a Lead Assessor for the 
RCVS Practice Standards Scheme. She is 
also an SQP assessor for AMTRA, organises 
CPD for SQPs, edits the BSAVA Guide to the 
Use of Veterinary Medicines and organises the BSAVA 
Dispensing Course. Pam is a member of RCVS Knowl­
edge’s Quality Improvement Board and has a keen 
 interest in all aspects of clinical governance and quality 
improvement in practice.
Dave Nicol 
BVMS CertMgmt MRCVS
Dave Nicol is a veterinary marketing, perfor­
mance management and leadership expert. 
He has written three books, most recently ‘So 
You’re A Vet…Now What?’, and publishes the 
weekly Freewheelin’ Vet Biz Q&A Show on YouTube. Plus, 
he hosts Blunt Dissection Podcast, a monthly conversation 
about success with the rock stars of veterinary medicine 
(which receives more than 60,000 plays per year), and is 
the founder of VetX Graduate, an independent teaching, 
mentoring and networking community helping vets thrive 
in practice (not just survive), by teaching essential non­
clinical skills. In his spare time, he helps to run Roundwood 
Vets, a small, independent veterinary practice in London. 
You can access all of his content (the majority of which is 
free) and get in touch at www.drdavenicol.com.
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Louise O’Dwyer 
MBA BSc(Hons) VTS(Anaesthesia/Analgesia & 
ECC) DipAVN(Medical & Surgical) RVN
Louise O’Dwyer currently works as Clinical 
Support Manager for Vets Now and is based 
at their 24/7 Emergency and Specialty Hos­
pital in Manchester. Louise gained her Diploma in 
Advanced Veterinary Nursing (Surgical) in 2004 followed 
by her Diploma in Advanced Veterinary Nursing (Medical) 
in 2007, Veterinary Technician Specialist (Emergency and 
Critical Care) in 2011 and Veterinary Technician Specialist 
(Anaesthesia) in 2014. Louise has contributed to over 
45 books, journal articles and book chapters, and  lectures 
regularly worldwide. In 2016, she was the recipient of the 
prestigious Bruce Vivash Jones Veterinary Nurse Golden 
Jubilee Award by the RCVS for exceptional contribution 
to veterinary nursing. Louise became the President of the 
Academy of Veterinary Emergency and Critical Care 
Technicians in September 2018.
Ron Ofri 
DVM PhD DipECVO
Ron Ofri was a member of the charter class 
of the Koret School of Veterinary Medicine, 
Hebrew University of Jerusalem, Israel, and 
has a PhD from the University of Florida. Ron 
is a European Specialist in Veterinary Ophthalmology, 
and a Professor in his alma mater. He is winner of numer­
ous Teacher of the Year awards, a popular international 
speaker, author of more than 80 refereed papers and 
 co­author of the popular textbook Slatter’s Fundamen­
tals of Veterinary Ophthalmology (4th and 5th editions). 
In 2002­2005 he served as President of the European 
Society of Veterinary Ophthalmology.
Catherine Oxtoby 
BVSc PhD MRCVS
Catherine Oxtoby qualified from Bristol Vet 
School in 2000 and worked as a small animal 
and equine vet in the South West for 13 years. 
In July 2017, she completed a PhD in Patient 
Safety at Nottingham Vet School, co supervised by the 
School of Psychology. Catherine’s research investigated 
the causes of errors in veterinary practice, the effect of 
organisational culture, and the adaptation of an inter­ 
professional teamwork training programme from human 
medicine for use in veterinary practice. Catherine pres­
ently works for the Veterinary Defence Society, applying 
human factors principles to develop system strategies and 
training programmes to help vets and veterinary practices 
mitigate errors and improve patient outcomes.
Gillian Page 
BSc RVN Cert(B&PS)
Gillian Page was one of the first RVNs in the 
UK to own a veterinary practice and was 
 co­founder of Ayrton Veterinary Hospital. 
Opening in 1999 and progressing to a pur­
pose­built Veterinary Hospital in 2006. As Centre 
Manager for The College of Animal Welfare, she was 
involved as Deputy Programme Leader in the setting up 
of Scotland’s first BSc (Hons) Degree in Veterinary Nurs­
ing. Gillian’s interest is in Leadership, practice culture, 
clinical workflow and standards; believing that structure 
and standardisation in practice can help achieve quality 
assurance and professional confidence. She obtained 
the European School of Veterinary Post Graduate Studies 
(ESVPS) Certificate in Business & Professional Skills 
(Cert B&PS) in 2011. Gillian is currently the Junior Vice 
 President of the Veterinary Management Group (VMG).
Gina Parkes 
DipAVN(small animal) PGCertVetEd FHEA 
Gina Parkes qualified in Northern Ireland 
in  2008 and currently works at the Royal 
Veterinary College’s Queen Mother  Hospital 
for Animals as the Head Medicine Nurse. 
This year she completed her Postgraduate Certificate in 
Veterinary Education and has a keen interest in evidence 
based veterinary nursing.
Sue Paterson 
MA VetMB DVD DipECVD FRCVS
Sue Paterson is a Cambridge graduate and a 
RCVS and European Specialist in Veterinary 
Dermatology. She is a Fellow of the RCVS 
through meritorious contribution to clinical 
practice. She is the Senior Vice President of the European 
Society of Veterinary Dermatology and chairs the Edu­
cation Board at the World Association of Veterinary 
 Dermatology. Sue is a Director of Virtual Vet Derms, a 
Dermatology Telemedicine Service. She is incoming 
President of BSAVA.
Karen Perry 
BVM&S CertSAS DipECVS PGDipVetEd FHEA 
MRCVS
Karen Perry graduated from The Royal (Dick) 
School of Veterinary Studies,  Edinburgh 
in 2005. Following a short period in mixed 
practice, she completed an internship at Fitzpatrick 
Referrals prior to undertaking a residency in small animal 
surgery back at the R(D)SVS. Following achievement of 
ECVS status in 2011, she joined the Royal Veterinary Col­
lege as a lecturer in small animal orthopaedics. After four 
years there she moved to Michigan State University 
where she is currently an Assistant Professor in Small Ani­
mal Orthopaedics. Her main research interests are feline 
orthopaedics, limb deformities associated with medial 
patellar luxation and traumatology.
Rachel Pickles 
DipAVN(Medical) RVN
Rachel Pickles has her Diploma in Advanced 
Medical Nursing. Rachel is one of the head 
nurses at Anderson Moores Veterinary Spe­
cialists. Rachel was one of two nurses that 
helped set up Anderson Moores when it opened in 
August 2006. She is particularly interested in transfusion 
medicine and endocrinology.
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Laura Playforth
BVM&S PGDipAdvHCP(Open) MRCVS 
Laura Playforth graduated from the Royal 
(Dick) School of Veterinary Studies and 
currently works as Head of Veterinary 
Standards for Vets Now. Laura has a keen 
interest in quality improvement and is currently complet­
ing a Masters in Advancing Healthcare Practice.
Caryn Plummer
DVM DACVO
Caryn Plummer is a graduate of the Uni­
versity of Florida College of Veterinary Med­
icine (Go Gators!). Following veterinary 
school, she completed an internship in small 
animal medicine and surgery at Michigan State University 
College of Veterinary Medicine followed by a residency in 
comparative ophthalmology at the University of Florida. 
She is a Diplomate of the American College of Veterinary 
Ophthalmologists (2006) and is currently a tenured asso­
ciate professor at the University of Florida. Her research 
interests include corneal wound healing and glaucoma. 
She has lectured extensively both in the USA and abroad 
on many topics associated with clinical veterinary oph­
thalmology and animal models of ophthalmic disease, 
especially glaucoma. She is also a charter member of and 
currently serves as the secretary/treasurer for the Interna­
tional Equine Ophthalmology Consortium.
Paul Pollard
MVB Cert AVP Cert Vet Ed FHEA MRCVS
Paul Pollard graduated from Dublin in 1990 
and has worked in mainly first opinion 
practice. He is the head vet at the RVC first 
opinion hospital in Camden where he 
teaches final year students day one skills. His interests 
include cardiology and veterinary education.
Gerry Polton
MA VetMB MSc(Clin Onc) DipECVIM-
CA(Oncology) MRCVS
Gerry Polton graduated from Cambridge 
University. He is an EBVS Specialist in Onco­
logy and an RCVS Recognised Specialist in 
Veterinary Oncology. Gerry is the Clinical Director of 
Oncology at North Downs Specialist Referrals.
Denise Prisk
VTS(Anaesthesia & Analgesia) 
DipAVN(Surgical) LTCL LCGI RVN
Denise Prisk has had a long career in small, 
mixed and referral practice. She has taught 
veterinary nursing for many years and has 
been involved in the RCVS exam system for over 20 years. 
Denise has lectured extensively on all aspects of 
anaesthesia. She has been a contributing author to 
anaesthesia and general nursing textbooks and has pub­
lished journal articles. Denise works at Anderson Moores 
Veterinary Specialists part time as well as running her 
own in­ practice training and CPD business and is cur­
rently the exam Chair for the Academy of Veterinary 
Technicians in Anesthesia and Analgesia.
Professor the Lord Trees
Lord Trees qualified as a veterinarian in 1969 
and worked in general practice, industry 
and, for most of his career, academia. At the 
University of Liverpool, he was Professor of 
Veterinary Parasitology (from 1994) and 
Dean 2001–2008. He was RCVS President 2009­2010 
and is currently Chair of the Moredun Research Institute, 
Veterinary Editor in Chief of the Vet Record and In Prac­
tice, and an Honorary Fellow of the Royal Society of 
Edinburgh. In 2012 he was appointed a Crossbench Peer 
in the House of Lords, and has been a member of the EU 
Select Committee and its Sub­Committee on Energy and 
Environment.
Ian Ramsey
BVSc PhD DSAM DipECVIM-CA FHEA FRCVS
Ian Ramsey is Professor of Small Animal 
Medicine at Glasgow University. He has 
lectured and published in many aspects of 
small animal medicine but his main interest 
is in endocrinology. He is the editor­in­chief of the 
BSAVA  Canine and Feline Formulary and was awarded 
the BSAVA Woodrow Award for contributions to small 
animal medicine in 2015.
Matt Read
DVM MVSc DACVAA
Matt Read graduated from the Western 
College of Veterinary Medicine in Canada in 
1998. He completed a residency in veteri­
nary anaesthesiology at the WCVM and became board­
certified with the American College of Veterinary 
Anesthesia and Analgesia in 2002. Matt enjoys sharing his 
passion and enthusiasm for anaesthesia and pain man­
agement with anyone who will listen, and even those 
who don’t! He has delivered over 100 lectures and work­
shops and is currently preparing the second edition of a 
text book, Small Animal Regional Anesthesia and Analge­
sia. Matt works as an anaesthesiologist for MedVet in 
Columbus, Ohio.
Nicola Read
PGCert(Onc) DipAVN(Med) AFHEA RVN
Nicola Read is the Head Oncology Nurse 
at the Queen Mother Hospital for Small Ani­
mals; together alongside a dedicated team 
of nurses, residents and specialist veterinar­
ians, Nicola strives towards delivering individualised care 
for both the patient and client. Nicola has a keen interest 
in advancing comparative oncology and is an advocate 
for continued learning through sharing the understand­
ings and experiences of oncological caregivers with the 
veterinary nursing community.
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Kate Richards 
BVM&S DipM MA MRCVS
Kate Richards graduated from the Dick Vet, 
spending the next fifteen years in farm ani­
mal practice. She moved into industry and 
then government, firstly as a veterinary 
advisor before diversifying into communication and pol­
icy roles. Kate recently graduated with an MA in Creative 
and Life Writing, has a portfolio of non­executive direc­
torships and is a member of the RCVS Council and Chair 
of the Standards Committee.
Renay Rickard 
RVN CVPM
Renay Rickard is the current Senior Vice 
President of the Veterinary Management 
Group. Renay is practice manager and direc­
tor of Kernow Veterinary Group, a mixed 
multi­site practice in mid Cornwall. She has a special inter­
est in the career development of Veterinary Nurses.
Claire Roberts 
DipAVN(Surg) PGCertVetAA CertVNECC RVN
Claire Roberts works part time as part of the 
theatre team at Northwest Veterinary Spe­
cialists where she also chairs the infection 
control committee and is the owner of 
 SynergyCPD which delivers in house CPD to the veteri­
nary team.
Alan Robinson 
BVSc MRCVS DMS
Alan Robinson has been a veterinary sur­
geon in practice for 20+ years, a successful 
business consultant for 18 years to over 600 
practices and a director of Vet Dynamics. 
His mission is helping independent practice owners 
improve performance and quality of life in practice. His 
company, Vet Dynamics, works with independent prac­
tices to provide personalized resources for Practice 
 Performance, Business Intelligence, Leadership and 
 Culture, and Team Engagement.
John Robinson 
BDS(London)
John Robinson qualified as a dentist and 
worked in general dental (NHS) practice for 
6 years. Veterinary dentistry became his full 
time occupation in 1992. He has extensive experience of 
treating 1st opinion and specialist (referral) small animal 
dental cases. He is an external lecturer in dentistry at 
Cambridge Vet School and University College Dublin. 
Currently, the main focus of his work is advancing the 
provision of  dentistry in general veterinary practice.
Jeremy Rose 
MA VetMB DipECVN MRCVS
Jeremy Rose is a Cambridge graduate and a 
European and RCVS Specialist in Neurology. 
Jeremy works at Fitzpatrick Referrals and 
is a senior surgeon in neurology; he has a 
keen interest in all areas of neurology but particularly 
 stabilisation surgeries.
Suzanne Rudd 
DipAVN(medical) RVN
Suzanne Rudd started work in a small  animal 
practice in Nottingham before  qualifying 
from the Berkshire College of Agriculture 
1999. In 2002 she moved to Bristol to 
become a feline nurse at the University of  Bristol’s Feline 
Centre. In 2004 she gained her advanced medical nursing 
diploma. Suzanne is now the senior feline nurse at The 
Feline Centre and is involved in teaching the veterinary and 
veterinary nursing undergraduates as well as lecturing 
around the UK on a wide range of feline nursing topics. 
She is also one of the lectures for the BSAVA Medical Vet­
erinary Nursing Award and part of the nursing editorial 
board for International Cat Care.
Miles Russell 
Miles Russell is a director and practice man­
ager of The George Veterinary Group, a large 
independent practice based in Malmesbury, 
Wiltshire with four species specific depart­
ments. Miles has management responsibility 
for all non clinical activities of the practice, including 
finance. He trained with one of the four big accountancy 
firms before working and becoming a partner in a firm of 
chartered surveyors. He has been working in the veteri­
nary industry now for 10 years and joined the board of 
VMG in 2018.
Linda Ryan 
DipAVN(Medical) VTS(Oncology)  
KPA-CTP RVN
Linda Ryan started her nursing career in 
general practice, qualifying in 2002. She 
then spent many years working in specialist 
clinics at two university referral hospitals. She has 
attained the Diploma in Advanced Nursing (Medical) and 
the Veterinary Technician Speciality (Oncology). She is a 
qualified animal trainer, behaviour practitioner and, in 
autumn 2018, Linda became a Veterinary Technician 
Specialist in Behaviour. She is passionate about collabo­
rative care and patient­friendly practice, and regularly 
teaches various veterinary nursing & behaviour/training 
topics locally, nationally, internationally & online, 
&  regularly writes for veterinary publications. She contin­
ues to study in the field of animal behaviour & welfare. 
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Raquel Salgüero
DVM MA DipECVDI MRCVS
Raquel Salgüero is a graduate from the Uni­
versity Complutense of Madrid, Spain. She 
undertook her residency at the University of 
Cambridge and has worked as a radiologist 
in different referral hospitals. Raquel is a European and 
RCVS Specialist in Diagnostic Imaging. She is Head of the 
Diagnostic Imaging Department at Hospital Veterinario 
Puchol in Madrid and is a part­time Assistant Professor at 
the University Complutense of Madrid. She is interested 
in all areas of Diagnostic Imaging.
Paolo Selleri
DMV PhD SpecPACS DipECZM
Paolo Selleri is a diplomate of the European 
College of Zoological Medicine (Small 
Mammal and Herpetology) and is the head of 
the Clinica per Animali Esotici, an exotics­
only animal hospital site in Rome. Paolo frequents world­
class veterinary structures, courses and conferences. 
Paolo worked as a clinical professor in the Universities of 
Padua, Naples and Teramo, transmitting his passion for 
herpetological medicine to undergraduate students. 
Beyond daily clinical activity, Paolo strongly supports the 
application of evidence­based standards for exotic animal 
medicine in Italy and is the co­author of several books and 
papers. He is the past­president of the Italian association 
of exotic animal veterinarians and is currently the Vice 
President of the Association of Italian Veterinarians.
Ruth Serlin
BVetMed Cert VA MRCVS PGCAP FHEA
Ruth Serlin graduated from the Royal Veteri­
nary College and has spent over 25 years 
working in small animal charity practices. 
She is now a Lecturer in Veterinary Profes­
sionalism at the RVC. Ruth has volunteered her time in a 
number of outreach projects treating pets owned by 
homeless people since the ‘90s and is a founding trustee 
of Street Vet.
Holly Smith
RVN
Holly Smith is an RVN, has a diploma in 
advanced surgical nursing and currently 
works at the Royal Veterinary College, Queen 
Mother Hospital in the neurology team. She 
has always had a passion for the rehabilitation and care of 
neurological patients. Holly has also helped to set up and 
run the hydrotherapy unit at the Queen Mother Hospital.
Alex Smithson
BVM&S BDS(Hons) CertEndodontology MRCVS
Alex Smithson is a dual­qualified Veterinary 
Surgeon and human Dental Surgeon. He 
is  Director of Orosurgeon Ltd, providing 
veterinary dental, oral and maxillofacial 
referrals. First qualifying as a vet, Alex undertook six 
years’ specialist training in veterinary dentistry, oral and 
maxillofacial surgery followed by qualifying as a human 
Dental Surgeon and gaining the human post­graduate 
Certificate in Endodontology. He has a keen interest in 
endodontology (pulp treatment e.g. root canal), compar­
ative dentistry and oral and maxillofacial surgery. 
Jennifer Stallwood
BVSc BSc (hons) Cert AVP (ECC) MRCVS
Jennifer Stallwood is a Bristol University gra­
duate and recently completed a residency 
in small animal internal medicine. Jennifer 
works in a private referral practice in the 
Southwest and is interested in acute medicine.
Michael Stanford
BVSc FRCVS
Michael Stanford qualified from Liverpool 
University in 1987. He set up Birch Heath 
Veterinary Clinic in Cheshire specialising in 
the veterinary care of exotic pets, zoo and 
wildlife patients. He was awarded the RCVS Diploma of 
Fellowship by thesis in 2006 for his work on calcium 
metabolism in grey parrots, became a RCVS Specialist in 
Zoological and Wildlife Medicine in 2007 and is a recipi­
ent of the BVA William Hunter medal. He has been a 
Claims Consultant for the Veterinary Defence Society 
since 2007 and is their Newsletter Editor. Michael is a 
recent past President of the BVZS.
Jenny Stavisky
MRCVS BVM&S PhD PGCHE FHEA
Jenny Stavisky is an Edinburgh graduate and 
after several years in mixed practice took an 
accidental PhD in epidemiology and virol­
ogy. She is interested in all aspects of charity 
and shelter medicine and works at the University of Not­
tingham as Assistant Professor in Shelter Medicine.
James Swann
MA VetMB MVetMed DipACVIM DipECVIM 
MRCVS
James Swann is an American and European 
Specialist in Small Animal Internal Medicine. 
He is currently completing a PhD in immu­
nology and haematology at the University of Oxford. He 
has a particular interest in haematological diseases of 
dogs and cats, winning an International Canine Health 
Award from the Kennel Club Charitable Trust for his 
research work in 2015.
Simon Tappin
MA VetMB CertSAM DipECVIM-CA MRCVS
Simon Tappin graduated from the Univer­
sity of Cambridge and after 2 years in prac­
tice undertook a residency at the University 
of  Bristol in Small Animal Medicine and 
Intensive Care, where he gained his European Diploma 
in Small Animal Medicine. He is currently head of inter­
nal medicine and a director of the internship program at 
Dick White Referrals where he sees cases in all areas of 
internal medicine.
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Kathleen Tennant
BVetMed CertSAM CertVC FRCPath MRCVS
Kathleen Tennant graduated from the Royal 
Veterinary College and fell into a life of clini­
cal pathology. She is currently the Clinical 
Lead for the diagnostic laboratories for 
Langford Vets. Her interests include cytology and infec­
tious diseases.
Erik Teske
PhD DVM DipECVIM-CA(Int Med)(Oncol)
Erik Teske is a European Specialist in Com­
panion Animal Oncology. He is Professor in 
Medical Oncology at the Veterinary Faculty 
in Liege and Head of Medical Oncology at 
the Veterinary Faculty in Utrecht. He is author of more 
than 130 publications and more than 15 book chapters. 
His special areas of interest are oncology, cytology and 
epidemiology. He is an Honorary Member of the 
European College of Veterinary Clinical Pathology and 
was awarded the WSAVA Hill’s Excellence in Veterinary 
Healthcare Award in 2006 and the WSAVA International 
Award for Scientific Achievement in 2016.
Emily Thomas
BA VetMB DACVECC DECVECC MRCVS
Emily Thomas is a Senior Lecturer in 
Emergency and Critical Care at the Royal 
(Dick) School of Veterinary Studies, and an 
American and RCVS Specialist in ECC. She 
heads up the Intensive Care Unit in the Hospital for Small 
Animals at the University of Edinburgh. She has a particu­
lar interest in CPR, but enjoys all aspects of ECC. 
Mickey Tivers 
BVSc(Hons), PhD, CertSAS, DipECVS, 
MRCVS, RCVS and EBVS® European Specialist 
in Small Animal Surgery 
Mickey Tivers is Head of Surgery at Paragon 
Veterinary Referrals in Wakefield, West 
Yorkshire. Mickey’s main area of clinical and research 
expertise is in congenital portosystemic shunts and he 
has published widely on the subject. He continues to 
have active research into this fascinating condition. 
Mickey graduated from the University of Bristol in 2002. 
He finished a residency in small animal surgery at the 
RVC in 2008 and became a diplomat of the European 
College of Veterinary Surgeons in 2009. Following this he 
undertook a PhD on congenital portosystemic shunts in 
dogs, also at the RVC.
Helen Tottey
RVN
Helen Tottey qualified in 1996 and set up full 
time nurse consulting in 1997 developing 
the role to become an integral part of the 
practice for clients, their pets and the busi­
ness. Helen has worked for Petplan and Onswitch, and 
owned her own practice. She currently works for 
VetPartners as Business Support Trainer. Helen has 
always had a passion for helping pet owners through 
education and support that nurse consulting enables as 
well as providing additional income stream for the 
business and job satisfaction for nurses.
Sophie Tyler 
Sophie Tyler graduated from the RVC in 
2007. After working in first opinion small 
animal practice in the UK, Australia and New 
Zealand she completed a rotating internship 
followed by a dermatology residency at the 
University of Bristol in 2019. She is currently working 
towards the ECVD diploma examination.
Molly Varga
BVetMed DZooMed MRCVS
Molly Varga is an RCVS Specialist in Zoo and 
Wildlife Medicine. She has published and 
lectured widely on a range of topics related 
to exotic animal medicine, and her primary 
clinical interest is rabbit medicine and surgery.
Jaime Viscasillas
DipECVAA MA AFHEA MRCVS
Jaime Viscasillas graduated at the University 
of Zaragoza (Spain) and is an European and 
RCVS Specialist in Veterinary Anaesthesia 
and Analgesia. Jaime works as a lecturer in 
Veterinary Anaesthesia and Analgesia at the Royal Veteri­
nary College. One of his main interest is the develop­
ment, use and teaching of local anaesthesia techniques 
for perioperative and chronic pain management.
Holger Volk
PGCAP PhD DipECVN FHEA MRCVS
Holger Volk is Professor of Small Animal 
Diseases and the Head of Department of 
the Small Animal Clinic, University of Veter­
inary Medicine Hanover, the Past­President 
of the European College of Veterinary Neurology and the 
current treasurer of the European Board of Veterinary 
Specialisation. After graduating University in 2001, where 
he also earned his PhD in Neuropharmacology, Holger 
completed his specialist clinical education doing an 
internship and a residency in Neurology and Neurosur­
gery at the Royal Veterinary College. Holger is interna­
tionally known for his work in the field of Chiari­like 
malformation/syringomyelia and epilepsy. He has been a 
recipient of several Jim Bee educator excellent in teach­
ing awards, the prestigious Bourgelat Award from BSAVA 
and the International Canine Health Award from the 
Kennel Club.
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Angelika von Heimendahl 
MScAg BVM(Berlin) MScVetSc DipECAR MRCVS
Angelika von Heimendahl is a graduate of 
both Agriculture and Veterinary Medicine 
from the University of Berlin. She runs her 
own small animal reproduction referral 
practice near Cambridge, and teaches undergraduates, 
veterinary surgeons and veterinary nurses. Angelika was 
the President of EVSSAR (European Veterinary Society 
for  Small Animal Reproduction) in 2010/11, president of 
the ECAR (European College of Animal Reproduction) 
examination board 2016/17 and is now an ECAR board 
member. In recent years she has also developed an  interest 
in conservation and is a member of the  Cambridge Con­
servation Forum.
David Walker 
BVetMed(Hons) DACVIM DipECVIM-CA MRCVS
David Walker is a Royal Veterinary College 
graduate and an American, European, and 
RCVS  Specialist in Small Animal Internal 
Medicine. David works at Anderson Moores 
Veterinary Specialists and is Head of Medicine; he has a 
keen  interest in all areas of internal medicine.
Hayley Walters 
MBE RVN
Hayley Walters spent 7 years in mixed prac­
tice in Derbyshire before relocating to China 
for 3 years in 2006 to work for ‘Animals Asia’ 
with bears rescued from the bile farming 
industry. Hayley is the welfare veterinary nurse at The 
Royal (Dick) School of Veterinary Studies, teaching nurs­
ing and clinical skills to veterinary students in developing 
countries and helping two vet schools in Sri Lanka and 
India set up their first veterinary nurse training pro­
gramme. In 2018 Hayley received an MBE for services to 
veterinary education and animal welfare.
Chris Warren-Smith 
BVetMed MVetMed CertVDI DipECVDI MRCVS
Chris Warren­Smith is a graduate of the 
Royal Veterinary College and an RCVS and 
European Specialist in Veterinary Diagnostic 
Imaging. Chris is Head of Imaging at 
 Langford Veterinary Services/University of Bristol; his main 
area of interest is cross sectional imaging, in particular CT.
Ruth Willis 
BVM&S DVC MRCVS
Ruth Willis graduated from the Royal (Dick) 
School of Veterinary Studies. Ruth spent 
two years in mixed practice before starting 
a cardiology residency at Glasgow Univer­
sity Vet School which resulted in her obtaining the RCVS 
Certificate and Diploma in Veterinary Cardiology. She has 
held RCVS Specialist status since 2003 and currently 
works at Dick White Referrals. Ruth has a special interest 
in the diagnosis and treatment of arrhythmias. She has 
extensive experience of ambulatory heart monitor 
recording analysis and has written a chapter on this topic 
in the BSAVA Manual of Canine and Feline Cardiorespira­
tory Medicine. She is a co­editor of The Guide to Canine 
and Feline Electrocardiography.
Matthew Winter 
DVM DACVR
Matthew Winter is a graduate of Cornell Uni­
versity College of Veterinary Medicine and a 
Diplomate of the American College of Veter­
inary Radiology. Matt is an active educator, 
and has spent 13 years in academic practice at Iowa State 
University and the University of Florida, where he served 
as service chief of Diagnostic Imaging and Medical Direc­
tor of the Small Animal Hospital. Matt is currently the Vice 
President of Veterinary Consultants in Telemedicine in 
North America and continues working at the University of 
Florida as a Clinical Associate Professor of Diagnostic 
Imaging. Matt loves all imaging modalities, but has a spe­
cial passion for cross­sectional imaging, specifically Com­
puted Tomography and Magnetic Resonance Imaging.
Georgia Woods 
RVN CertCFVHNut PHC
Georgia Woods qualified as a Veterinary 
Nurse in 2004 from Myerscough College, 
Preston. In 2010 Georgia moved to a Head 
Nurse and Clinical Coach position in Chesh­
ire, developing suc cessful obesity and other nursing clin­
ics. In June 2015, Georgia took the position of ROYAL 
CANIN® Weight Management Clinic Nurse at the Univer­
sity of Liverpool, Small Animal Teaching Hospital, where 
she is now dealing exclusively with obesity and nutrition. 
Georgia has recently gained her Certificate in Canine and 
Feline  Veterinary Health Nutrition.
Claire Woolford 
RVN VTS(Anaesthesia and Analgesia)
Claire Woolford began nursing in 1998 and 
spent 8 years working in general practice. In 
2006 Claire joined Anderson Moores Veteri­
nary Specialists in Hampshire where she is a 
head nurse and in charge of running the Soft Tissue 
department. She achieved her VTS in Anaesthesia and 
Analgesia in 2013 and is a member of the AVTAA Creden­
tials Committee. Claire also works with SynergyCPD pro­
viding in house anaesthesia and CPR training for practices 
across the south of England.
David Yates 
BVSc MRCVS
David Yates is a Liverpool graduate and 
Hospital Director of the RSPCA Greater 
Manchester Animal Hospital. He is involved 
in teaching charity vet practice to final year 
students from Bristol and Nottingham Universities.
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Thursday 4 April
Hall 1
My top tips in…
20 08:30–09:15Neurology
Richard LeCouteur
21 09:25–10:10Oncology
Gerry Polton
22 11:05–11:50Reproduction
Gary England
23 12:00–12:45Soft tissue surgery
Mickey Tivers
24 14:05–14:50Cardiology
Ruth Willis
25 15:00–14:45Orthopaedic surgery
Duncan Barnes
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Neurology
Richard LeCouteur
Understanding the organization and relationship of 
structures is essential for a clinician caring for animals 
with neurological diseases because a clinician deals with 
the entire animal and with the entire nervous system. 
This requires a global approach that is based on an 
appreciation of how the functions of the various parts 
contribute to the function of the whole.
NORMAL FUNCTIONS MUST BE KNOWN 
BEFORE ABNORMAL FUNCTIONS CAN BE 
RECOGNIZED
Abnormal functions must be recognized because neuro-
logical diseases are manifested clinically almost entirely 
by dysfunction. It is uncommon for the clinical signs to 
include readily detectable anatomical changes. There-
fore, a clinician must rely on signs of abnormal function 
to identify structures that are malfunctioning.
General divisions of the nervous system are: brain, 
spinal cord, and peripheral nerves and muscles. The 
highest functional subdivision of the brain, and therefore 
the highest functional level of the nervous system, is the 
cerebrum. The cerebrum is the seat of consciousness 
and cognitive functions. It receives all sensory signals 
that reach consciousness, makes decisions on the most 
appropriate response, and initiates that response if one is 
needed.
In most cases the response the cerebrum initiates is 
a movement. This is called a voluntary movement. It is 
done by muscles innervated by lower motor neurons of 
the spinal cord or brainstem. The specific movement that 
is initiated is a phasic (on again, off again) event that may 
consist of nothing more than movement at one joint of 
an extremity. However, no matter how simple such 
movements may be, they require adjustments of other 
muscles so that opposing muscles relax or so that some 
joints are fixed while others are moved, or so that weight-
bearing on the legs is adjusted to accommodate shifts 
in the centre of gravity.
The voluntary movement is initiated by the cerebral 
cortex and may be said to be an event of consciousness. 
The associated muscle activity is carried out subcon-
sciously by successively lower levels of the nervous 
 system: basal nuclei, midbrain, pons and medulla, cere-
bellum, spinal cord and brainstem, peripheral nerves and 
cranial nerves, and effector organs. The function of these 
lower levels is vital and without them voluntary move-
ments become impossible.
In ourselves, we are conscious of the effects of these 
subconscious operations but we are not conscious of the 
complex neuronal transactions that produce them. These 
activities can be blocked normally only by very powerful 
cerebral cortical override and then only  incompletely in 
most cases. Presumably animals also are not conscious of 
the functions of these subcortical systems and presuma-
bly they might have even less success in overriding them 
if they somehow chose to do so.
ABNORMALITIES OF MOVEMENT 
AND POSTURE PRODUCE THE MOST 
COMMON NEUROLOGICAL SIGNS 
IN ANIMALS
A very large proportion of these signs are caused by dis-
eases that affect the subconscious events that occur in 
the many structures interposed between the cerebral 
cortex and the lower motor neurons. Because of the 
importance of these functions and the structures that 
produce them, recognizing signs of their dysfunction is 
an essential feature of that part of the general physical 
examination that we call the neurological examination.
KEY LEARNING OBJECTIVES
■■ Understand the components of the nervous system 
and ‘how the nervous system works’
■■ Understand that normal neurological functions 
must be known before abnormal functions can be 
recognized
■■ Understand that abnormalities of movement and 
posture produce the most common neurological 
signs in animals
MULTIPLE CHOICE QUESTIONS
1. Which of the following is most likely to be a 
clinical sign of cerebral dysfunction?
(A) Disturbance of consciousness
(B) Paresis of voluntary movement
(C) Disturbances of all types of sensory 
function
(D) Seizures
2. Which of the following is NOT a function of the 
cerebellum?
(A) To coordinate all of the subsystems that 
operate in locomotion and posture
(B) To initiate coordinated movement
(C) To coordinate eye position
(D) To coordinate eye movements
3. Which of the following statements regarding 
neurological diseases is UNTRUE?
(A) Neurological disease can be acute or 
chronic, progressive or non-progressive
(B) Neurological signs of dysfunction reflect 
both the location and the cause of a  
lesion
(C) Neurological diseases may result from 
causes inside the nervous system or 
outside the nervous system
(D) The clinical signs of neurological disease 
are caused by dysfunction of the neurons
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Oncology
Gerry Polton 
FINE-NEEDLE ASPIRATION 
If you are presented with a mass, always advise perform-
ing fine-needle aspiration (FNA). You should especially 
do this if the owner comes to you expressing concern 
about the presence of a mass. Failing to offer a diagnos-
tic test and simply directing owners to monitor a mass 
will result in one of two outcomes. First, the mass remains 
benign, nothing bad happens and the owner forgets 
that  you ever offered them your sage advice. Second, 
the mass grows, takes on characteristics of a malignant 
tumour and further action must be taken. Invariably, the 
mass is bigger and more infiltrative by this time. It might 
have developed metastasis (this might have been present 
at the outset but no-one will ever know). In this example, 
the owner has every reason to be cross if this simple test 
was never discussed at the original visit and the patient 
may die prematurely. FNA can be performed in a standing 
patient in almost all cases. Many times, the test will prove 
non-diagnostic. The likelihood of this is reduced with 
practice, but many mass lesions simply do not yield suffi-
cient material for diagnosis. A non-diagnostic sample is 
still good because it makes it very unlikely that you were 
presented with a mast cell tumour. If you only get blood 
repeatedly, consider the possibility that you are dealing 
with a haemangioma or haemangiosarcoma.
LYMPHOMA SUBTYPES
Lymphoma is not a single entity. There are multiple lym-
phoma subtypes and the different types have different 
patterns of behaviour, responses to therapy and pro-
gnoses. Characterization of lymphoma subtype is best 
achieved with a combination of histology and immuno-
histochemistry, or cytology and flow cytometry. Some 
forms of lymphoma may be poorly responsive to treat-
ment. Some forms are very responsive to therapy and 
patients can be expected to live considerably longer with 
treatment than the stated average. Knowledge of these 
subtypes can be very helpful in counselling owners about 
whether to pursue chemotherapy or not (and in treat-
ment selection).
MAST CELL TUMOURS: IF IT LOOKS BAD, 
IT IS BAD
Although we all know that the (histological) grade of a 
mast cell tumour cannot be judged by any means other 
than histology, you can get a very good idea that a mast 
cell tumour is going to behave badly if its clinical presen-
tation already tells that story. Rapid growth, ulceration, 
being fixed to underlying tissues, pain, volatility in size 
and multiplicity of satellite nodules are all clear signs of ill 
intent. If a diagnosis of mast cell tumour is made cytolog-
ically, further histological detail is not always necessary 
to judge that this tumour is going to behave in a high-
grade manner.
NO SURGERY IS BETTER THAN 
BAD SURGERY
There are many reasons why we can find ourselves on 
the  precipice of an ill conceived oncological surgical 
 procedure. If you find yourself in this situation, please trust 
your instinct and reconsider. Operating to remove a 
tumour without knowledge of the tumour behaviour 
increases the risk of incomplete removal. Hypoxia in a sur-
gical site arising due to tension across sutures, infection, 
disruption of vascular supply by surgical dissection, even 
seromas, increases the survivability of residual cancer cells 
in the surgical site. Furthermore, those surviving cells are 
actually made more malignant by this hypoxic  environment.
KEY LEARNING OBJECTIVES
■■ Fine-needle aspiration is a safe, quick, cheap and 
useful test in veterinary practice
■■ Appreciate that differences exist between different 
lymphoma subtypes and that these differences have 
therapeutic and prognostic implications
■■ Be prepared to believe your clinical judgment in the 
context of aggressive-looking mast cell tumours 
and ill conceived oncology surgeries
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements about 
fine-needle aspirates is pertinent to sampling 
of enlarged lymph nodes?
(A) Lymphoid cells are very fragile, best results 
are achieved without negative pressure
(B) Haemodilution impairs cytological 
interpretation 
(C) FNA is expensive and associated with risks 
(D) Best results are often achieved with the 
combination of a 21-gauge needle and a 
5-ml syringe
2. Which of the following statements about steroids 
and canine mast cell tumours is NOT true?
(A) Steroids induce shrinkage of the overall 
radius of infiltration of neoplastic mast 
cells from the centre of a mast cell tumour 
enabling complete tumour excision with a 
smaller surgical margin
(B) Steroids reduce intratumoral blood flow
(C) Steroids reduce the readiness with which 
mast cells release their intracytoplasmic 
granules
(D) Steroids impair the survival of some 
neoplastic mast cells
3. In the World Health Organization (WHO) 
classification, a ‘normal’ lymphoma manifesting 
as a generalized peripheral lymphadenopathy 
without signs of systemic ill health is most likely 
to be which of the following?
(A) T zone lymphoma
(B) Peripheral T cell lymphoma – not 
otherwise specified
(C) Diffuse large B cell lymphoma
(D) Acute lymphoblastic lymphoma
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Reproduction 
Gary England 
The reproductive cycle of the bitch is complex. Of par-
ticular note are the variability between bitches in the 
time of puberty, and individual differences in length of 
proestrus and oestrus. Interestingly, the day of ovulation 
may be as early as day 5 after the onset of proestrus or as 
late as day 30. Ovulated oocytes are not immediately 
fertilizable and maximum fertility occurs on days 3–5 
after ovulation. Progesterone increases before ovulation 
to reach relatively high concentrations by the end of 
oestrus. The progesterone phase is similar in duration 
for pregnant and non-pregnant dogs; pseudopregnancy 
is common and normal. Following the 2-month luteal 
phase, hormone concentrations return to basal for the 
5  months of anoestrus. The duration of the cycle is 
7 months.
The following tips arise out of a review of questions 
from referring clinicians.
KNOW HOW TO DIFFERENTIATE STAGES 
OF THE CYCLE
The oestrogenic phase of the cycle can most easily be 
detected using vaginal cytology, whereas progesterone 
is elevated similarly in the luteal phase of pregnancy and 
non-pregnancy. Hormone concentrations are basal in 
anoestrus but differ to spayed females.
APPRECIATE THAT PUBERTAL PROBLEMS 
ARE COMMON
Failure of ovulation is common at puberty and is evident 
as prolonged proestrus/oestrus (lasting 8–10 weeks), 
or  regression of oestrus with a short interval return 
(‘split  oestrus’). Ovulation may occur spontaneously or 
be induced by exogenous gonadotrophin-releasing hor-
mone (GnRH) products or human chorionic gonadotro-
phin (hCG). Spay is not required but may be performed 
after establishing that packed cell volume (PCV)/clotting 
is normal.
RECOGNIZE THAT BACTERIAL INFERTILITY 
IS EXTREMELY RARE
Most vaginal and preputial bacteria are commensals and 
do not cause infertility. Routine bacteriological screening 
is pointless and ‘treatment’ is unwarranted. The com-
monest causes of infertility are mating at the incorrect 
time, an infertile male and uterine disease.
KNOW THAT TIMING OF MATING IS 
IMPORTANT
Ovulation may occur early or late in relation to onset of 
proestrus, so the time of optimal fertility is variable. Ovu-
lation is poorly predicted by the behaviour of the female 
and requires detection using either measurement of 
plasma progesterone, vaginoscopy or vaginal cytology. 
UNDERSTAND THAT PHYSIOLOGY IS 
CRITICAL FOR CAESAREAN PLANNING
Pregnancy may occur even with an early or late mating 
since both sperm and oocytes have prolonged survival in 
the female tract. This may result in a variable ‘apparent’ 
pregnancy length when assessed from mating day 
(58–72 days), whereas endocrinological pregnancy 
length is regulated at 63 ± 1 day from ovulation. Primary 
uterine inertia is common so that prediction of the day of 
whelping or Caesarean requires information collected 
during oestrus, fetal measurement during pregnancy, or 
assessment close to parturition.
KEEP ABREAST OF CHANGING 
KNOWLEDGE AND PRACTICES ABOUT 
SPAYING
Whilst it is clear that iatrogenic pseudopregnancy can be 
prevented by spaying at any time except weeks 4–12 post 
oestrus, more information relating to prepubertal spay, 
ovariectomy, laparoscopic spay, hysterectomy and hor-
monal control is becoming available.
KEY LEARNING OBJECTIVES
■■ Understand oestrous cycle endocrinology, how this 
is manifest clinically and how recognition of different 
phases of the cycle can assist with diagnosis
■■ Appreciate the physiology of ovulation and how this 
is important for the identification of the optimal 
time for mating, and the implications for the 
apparent pregnancy length
■■ Recognize pregnancy development and the cascade 
of events that lead to parturition and how these can 
be used for prediction of parturition and planning 
for Caesarean
MULTIPLE CHOICE QUESTIONS
1. Which one of the following statements in 
relation to reproductive physiology of the bitch 
is CORRECT?
(A) Counting the number of days from the onset 
of proestrous behaviour can be reliably used 
to determine the onset of ovulation
(B) Acceptance of mating can be reliably used 
to determine the onset of ovulation
(C) Increased oestrogen concentrations can 
be reliably used to determine the onset of 
ovulation
(D) Increased progesterone concentrations 
can be reliably used to determine the 
onset of ovulation
2. Which one of the following is LEAST USEFUL 
for determining the likely time of onset of 
parturition in the bitch?
(A) The date of mating
(B) Measurement of plasma progesterone to 
assess the optimal time for mating
(C) Assessment of vaginal cytology to assess 
the optimal time for mating
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(D) The date that the bitch last permitted 
breeding
3. You examine a bitch that has alleged overdue 
parturition. Clinical examination is 
unremarkable and rectal temperature is 
normal. You don’t have an ultrasound machine 
and so you run a progesterone assay which 
shows plasma concentrations are 1.2 ng/ml (4 
nmol/l). Which one of the following is the 
MOST LIKELY diagnosis in this case?
(A) Parturition should have started and is likely 
to be overdue
(B) Parturition is not yet due because 
progesterone concentrations are high
(C) Parturition is not yet due because rectal 
temperature has not decreased
(D) Parturition is not yet due because 
progesterone has not decreased and 
therefore there has been no decline in 
rectal temperature
Soft tissue surgery
Mickey Tivers 
INTRODUCTION
Soft tissue surgery is a very broad subject covering a wide 
variety of different conditions, organ systems and tech-
niques. Some ‘tips’ are very broad and transferable to 
many different situations and others are very specific to 
the management of certain disease processes. In gen-
eral, one of the best tips is to remember not to focus 
entirely on the surgery and to consider the preoperative 
assessment and post-surgical management in detail.
HALSTEAD’S PRINCIPLES
The surgeon should always follow these important prin-
ciples to reduce the risk of complications. Atraumatic 
instruments should be used appropriately, particularly 
when handling viscera. Monofilament, synthetic, absorb-
able suture material is recommended for most routine 
procedures.
PATIENT SAFETY
Surgical safety checklists have recently been adopted by 
the veterinary profession. Whilst in some circumstances 
they may be overly complicated, some form of checklist 
for surgery is undoubtedly a good thing. A swab count at 
the start and end of surgery and the use of swabs with 
radiopaque markers are both important ways to prevent 
swabs being retained. 
APPROPRIATE USE OF ANTIBIOTICS
With increasing concern over antimicrobial resistance, 
surgeons should ensure that antibiotics are used in the 
correct way for surgical prophylaxis.
USE OF GADGETS
There are increasing number sof devices available to aid 
the soft tissue surgeon, including electrocautery, vessel-
sealing devices and surgical staplers. These can facilitate 
surgery and may be particularly useful in emergency 
 situations. 
EXPLORATORY LAPAROTOMY
Exploratory laparotomy is commonly performed in small 
animal practice and it is important to have a logical and 
systematic approach. Exploratory laparotomy is made 
significantly easier by making a large incision and with 
the use of abdominal retractors. Suction is also invalua-
ble, particularly when dealing with haemoabdomen, 
uroabdomen and septic peritonitis. The duodenal and 
colonic manoeuvres are very useful, particularly in deal-
ing with haemorrhage during a bitch spay. 
SKIN MASSES
Cutaneous and subcutaneous masses are commonly 
removed in practice and most are benign. However, fine-
needle aspirate sampling of any suspicious mass prior to 
surgery can be invaluable to identify malignant tumours. 
It is also prudent to consider appropriate staging of 
known tumours prior to removal. The surgery should be 
carefully planned, with consideration given to appropri-
ate surgical margins, options for closure of the resultant 
defect and potentially a plan for dealing with incomplete 
margins. Ideally, all masses should be submitted for 
 histopathology, finances allowing.  
WOUND BREAKDOWN
Wounds that break down following surgery should be 
treated as contaminated and initially managed as an 
open wound with dressings, etc. Surgeons should not 
rush to close the wound, particularly if the underlying 
reason for the breakdown had not been addressed (e.g. 
infection or tension). 
DRAINS
Drains come in all shapes and sizes and are indicated for a 
wide variety of uses. Narrow-bore thoracostomy tubes 
can be conveniently placed via the Seldinger technique 
and are very effective for short-term use dealing with 
pneumothorax, pleural effusion and for post- thoracotomy 
management. Placement of cystostomy tubes is a very 
useful technique for dealing with animals suffering ure-
thral trauma. 
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KEY LEARNING OBJECTIVES
■■ To recognize and describe general ways to refine 
surgical technique and approach to surgical cases 
to maximize success and reduce complications
■■ To outline and describe the use of specific 
instruments and techniques designed to facilitate 
soft tissue surgery
■■ To outline and describe appropriate management 
techniques for common situations and 
complications in soft tissue surgery
MULTIPLE CHOICE QUESTIONS
1. What is the recommended antibiotic prophylaxis 
for a subcutaneous mass removal under aseptic 
conditions that is expected to be quick?
(A) Single subcutaneous injection of broad-
spectrum antibiotic at induction of 
anaesthesia
(B) Five-day oral course of broad spectrum 
antibiotic post-surgery
(C) Single intravenous injection of broad-
spectrum antibiotic approximately 
20 minutes prior to surgery
(D) No antibiotics should be given
2. What sort of suture material is recommended 
for gastrointestinal surgery?
(A) Multifilament, natural, absorbable 
(e.g. chromic catgut)
(B) Monofilament, synthetic, non-absorbable 
(e.g. nylon)
(C) Monofilament, synthetic, absorbable 
(e.g. PDS II)
(D) Multifilament, synthetic, absorbable  
(e.g. Vicryl)
3. What structure would you manipulate in order 
to find the left ovarian pedicle?
(A) Descending duodenum
(B) Descending colon
(C) Bladder
(D) Stomach
Cardiology
Ruth Willis
REMEMBER THAT CARDIAC DISEASE IS 
LOGICAL
Cardiac diseases form a spectrum ranging from benign 
physiological heart murmurs in athletic individuals to 
patients with severe life-threatening illness where imme-
diate intervention is required to preserve life. Deciding 
where an individual lies on this spectrum is done by 
assimilating information from history, clinical examina-
tion and the results of any diagnostic tests to arrive at a 
diagnosis that can then be used to guide treatment. 
Assuming that the patient is not showing imminent 
signs of cardiovascular collapse, a careful history to 
establish the severity and duration of clinical signs, espe-
cially with regard to ability to exercise and a precise 
description of any collapse events, is vital. It can also be 
useful to establish the owner’s primary concern, as this 
may be different to our concern and require discussion to 
prioritize investigations. 
As signs of cardiac disease can overlap with other con-
ditions (especially respiratory disease), the history can help 
us to decide whether we are treating cardiac or non- 
cardiac disease. The next step is to perform a careful clini-
cal examination and relate these findings to the history. It is 
important to relate auscultation findings to cardiac output 
signs. These points will be illustrated with case examples.
DECIDE WHETHER FURTHER DIAGNOSTIC 
TESTS ARE REQUIRED. IF SO, THEN 
WHICH ONE? 
It is much easier to treat cases appropriately when we 
have a secure diagnosis. Diagnostic tests perform well 
when applied to an appropriate population, the limita-
tions of the test are known and our tests are targeted to 
answering a specific clinical question.
Case examples will be provided illustrating when it 
would be appropriate to use an NTproBNP assay, resting 
and ambulatory electrocardiography, echocardiography 
and thoracic radiographs. A common clinical question 
we are asked is to differentiate stage B1 and B2 mitral 
valve disease and this will be illustrated during the lecture 
with case examples. 
BE ABLE TO RECOGNIZE ATRIAL 
FIBRILLATION
Atrial fibrillation is one of the most common tachyar-
rhythmias seen in general practice that is likely to require 
treatment. Atrial fibrillation is most often seen in large- 
and giant-breed dogs and is characterized by a chaotic 
heart rhythm that is often rapid. In most dogs there is 
underlying structural heart disease that will sometimes 
result in referable clinical signs. 
In cases with atrial fibrillation, the electrocardio-
graph shows an irregular, often rapid, narrow QRS com-
plex rhythm with P waves replaced by fibrillation waves. 
Further diagnostic testing in cases with atrial fibrillation is 
likely to involve echocardiography and sometimes a 
24 hour ambulatory electrocardiogram (ECG) to estab-
lish the mean heart rate and also assess whether there is 
significant malignant ventricular ectopy. The advantages 
and disadvantages of different anti-arrhythmic therapies 
and also treatment goals will be briefly discussed.
BE ABLE TO RECOGNIZE VENTRICULAR 
TACHYCARDIA
Ventricular tachycardia is a potentially life-threatening 
arrhythmia frequently seen in cases with severe underlying 
cardiac and/or systemic disease. The ECG trace in these 
cases will show wide, bizarre QRS complexes and the rate 
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is variable. Some cases may tolerate this rhythm but other 
dogs show intermittent or persistent  hypotension resulting 
in referable clinical signs. Decision making regarding 
 further testing and therapy will be briefly discussed.
KEY LEARNING OBJECTIVES
■■ Remember that cardiac disease is a logical series of 
events
■■ Understand how to select the most appropriate 
diagnostic test(s)
■■ Be able to recognize ventricular tachycardia and 
atrial fibrillation
MULTIPLE CHOICE QUESTIONS
1. What are the key ECG features that raise 
suspicion of atrial fibrillation?
(A) Regular, slow, narrow QRS complex 
rhythm with clear P waves
(B) Regular, fast, narrow QRS complex rhythm 
with clear P waves
(C) Irregular, rapid, narrow QRS complex 
rhythm without visible P waves 
(D) Regular, rapid, wide QRS complex rhythm 
without visible P waves
2. What are the key ECG features that raise 
suspicion of ventricular tachycardia?
(A) Regular, slow, narrow QRS complex 
rhythm with clear P waves
(B) Regular, fast, narrow QRS complex rhythm 
with clear P waves
(C) Irregular, rapid, narrow QRS complex 
rhythm without visible P waves
(D) Regular, rapid, wide QRS complex rhythm 
without P waves coupled to the QRS 
complexes
3. Thoracic radiography is the test of choice to 
determine which of the following?
(A) Presence of pulmonary oedema
(B) The dimensions of individual cardiac 
chambers 
(C) Indices of systolic function
(D) Aetiology of a heart murmur
Orthopaedic surgery
Duncan Barnes 
Performing orthopaedic surgery can be an extremely 
rewarding experience with the opportunity to rapidly and 
permanently resolve conditions which are causing signi-
ficant patient morbidity. To get the best outcomes, and 
reduce the chances of complications, it is important to 
have a logical and systematic approach to cases. Success 
in orthopaedic surgery starts long before entering 
 theatre, with an accurate and complete diagnosis of the 
problem being treated and any concomitant factors that 
could influence the outcome. Prior to any surgical pro-
cedure a thorough plan should be made, including alter-
native approaches if additional problems are found at 
surgery. The plan should include:
■■ The surgical approach to the bone or joint, with 
consideration of important anatomical structures 
such as nerves and blood vessels which need to be 
avoided or protected 
■■ Potential intraoperative and postoperative 
complications should be anticipated and strategies 
to address these formulated
■■ Ensure that all the necessary instrumentation and 
implants needed to action the plan are available and 
sterile
■■ Use a well designed preoperative checklist to 
reduce the chance that avoidable errors occur
The success of many orthopaedic surgeries can be 
improved by using a number of tips gleaned from both 
clinical research and clinical experience. This lecture will 
look at some general tips for successful orthopaedic 
 surgery as well as more specific tips for selected common 
surgeries including small animal fracture repair, cranial 
cruciate ligament disease and medial patellar luxation. 
FRACTURE REPAIR
■■ Use biological osteosynthesis techniques when 
there are three or more fragments in diaphyseal 
fractures of long bones
■■ Articular fractures should be repaired using rigid 
internal fixation following perfect reduction of the 
fracture fragments
■■ Distal tibial fractures in cats are prone to delayed 
union or non-union and can be reliably repaired 
using orthogonal plating techniques
CRANIAL CRUCIATE LIGAMENT DISEASE
■■ Tibial plateau levelling osteotomy (TPLO) has been 
shown to have the best clinical outcome compared 
to tibial tuberosity advancement (TTA) and lateral 
extracapsular suture techniques
■■ Performing a medial subpatellar arthrotomy 
significantly reduces patient morbidity compared to 
a lateral parapatellar arthrotomy
■■ Performing a cranial closing wedge ostectomy in 
juvenile dogs with cranial cruciate ligament avulsion 
allows continued growth of the tibia whilst 
effectively neutralizing cranial tibial thrust
MEDIAL PATELLAR LUXATION
■■ When performing tibial tuberosity transposition, 
ensure that the osteotomy is made sufficiently 
caudally and extends the entire length of the tibial 
crest to provide a large bone fragment. This will 
reduce the chances of the fragment splitting and 
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allows a greater degree of lateralization to be 
performed
■■ Performing a block recession sulcoplasty improves 
the contact area between the patella and the 
trochlear groove, especially at the proximal and 
distal ends of the groove, when compared to a 
wedge recession trochleoplasty
■■ Drilling a hole along the base of a block recession 
trochleoplasty reduces the chance of splitting the 
block when using an osteotome
KEY LEARNING OBJECTIVES
■■ Find out how to improve your orthopaedic surgical 
outcomes and reduce the chance of complications
■■ Find out how to select cases for orthopaedic 
surgery and avoid common pitfalls
■■ Learn tips to use when performing common 
orthopaedic procedures
(A) Knowledge of the surgical approach to the 
fractured bone
(B) Location of neurovascular structures
(C) Templating of appropriate sized implants
(D) All of the above
2. Which of the following does NOT reduce the 
chance of reluxation following surgical 
correction of medial patellar luxation?
(A) Performing recession sulcoplasty
(B) Performing secure closure of the lateral 
parapatellar joint capsule and  
retinaculum
(C) Preserving the articular cartilage of the 
trochlear groove
(D) Performing tibial tuberosity transposition
3. Which of the following fractures is best treated 
by dual bone fixation?
(A) Fractures of the radius and ulna in a cat
(B) Fractures of the tibia and fibula in a cat
(C) Fractures of the radius and ulna in  
a dog
(D) Fractures of the ilium and ischium in  
a dog
MULTIPLE CHOICE QUESTIONS
1. Which of the following is important during 
fracture planning?
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My wound broke 
down: what now?
Mickey Tivers 
INTRODUCTION
Wound breakdown can occur for a variety of reasons and 
often there is more than one factor playing a role. These 
factors can relate to the wound itself, to the animal or 
to  the surgery performed. Common causes of wound 
breakdown include excess tension or motion, infection, 
haematoma or seroma formation and patient interfer-
ence. It is important to identify and understand the 
 reasons for wound breakdown as this will help guide 
the correct management. Repeat surgery is unlikely to be 
successful unless the underlying reason for the wound 
breakdown has been addressed. It is important to avoid 
the downward spiral of repeat suturing and repeat break-
down! 
CAUSES OF WOUND BREAKDOWN
Wound breakdown can occur soon after surgery or 
 several days or weeks later. The clinician should consider 
what factors may have been involved in the breakdown. 
Patient interference, infection, haematoma or seroma 
may be obvious clinically or from the history. Although 
rarely the primary cause of wound breakdown, systemic 
factors that may inhibit wound healing, such as  metabolic 
disease, use of corticosteroids or chemotherapeutic 
agents, should be identified and addressed. Unfortu-
nately, excessive tension often plays a role in wound 
breakdown. 
DEALING WITH A WOUND BREAKDOWN
All wounds that break down should be treated as a 
 contaminated and ideally should not be closed until the 
contamination is resolved. 
Initial wound management:
1. Large clip around the wound
2. Surgical debridement and lavage with sterile saline
3. Deep swab or biopsy for culture and sensitivity 
testing
4. Treatment with broad-spectrum antibiotics
5. Use of appropriate dressings such as wet to dry or 
honey/Intrasite combined with semi-permeable 
foam dressing
Dressings are continued until granulation tissue 
develops. Once granulation tissue has formed then 
wound closure may be performed. However, many 
wounds will heal satisfactorily via secondary intention. 
It is very important to maintain excellent hygiene 
practices whilst managing a wound, to prevent spread 
of  infection. Hands should be washed before and after 
 handling the animal and gloves should be worn when 
changing the dressing and examining the wound. 
Immediate closure of a wound following breakdown 
may be indicated if vital structures such as the thoracic 
cavity or a joint are involved. In these circumstances, the 
wound should be flushed and debrided prior to closure, 
and a drain should be placed. 
PREVENTION OF WOUND BREAKDOWN
By following Halstead’s principles, surgeons can reduce 
the risk of complications that may lead to breakdown. 
Excessive tension is a major factor in wound breakdown 
and the surgeon should carefully assess the wound and 
select methods of closure that reduce or eliminate 
 tension. In some situations, this may require the use of a 
more advanced technique such as a subdermal plexus 
flap, axial pattern flap or skin graft. Surgeons should 
reflect on their own practice to determine whether asep-
sis or surgical technique could be improved. Wounds in 
certain locations, such as areas of high motion, may be 
more likely to have complications and these should be 
mitigated against. Importantly, animals should be appro-
priately rested and Elizabethan collars, body suits and 
bandages should be used to prevent interference. 
KEY LEARNING OBJECTIVES
■■ To describe and outline the management of wound 
breakdown
■■ To define and explain the different causes of wound 
breakdown
■■ To describe and outline the strategies for reducing 
the risk of wound breakdown
MULTIPLE CHOICE QUESTIONS
1. How should a wound that has broken down be 
classified?
(A) Clean
(B) Clean–contaminated
(C) Contaminated
(D) Infected
2. What factor may the surgeon need to consider 
the use of a skin flap to overcome?
(A) Tension
(B) Infection
(C) Seroma formation
(D) Malnutrition
3. What is the main property of a foam dressing?
(A) Adherent
(B) Occlusive
(C) Bioactive 
(D) Absorbent
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My enterotomy is 
leaking: what now?
Mickey Tivers 
INTRODUCTION
Enterotomy is commonly performed in small animal 
practice, typically for the removal of foreign bodies and 
for taking full-thickness biopsies of the small intestine. 
Whilst most enterotomies heal without issue, dehiscence 
and leakage results in septic peritonitis. Studies have 
reported dehiscence rates of 1.5–15% for enterotomy 
and enterectomy.  
Early recognition of clinical signs associated with 
peritonitis, rapid diagnosis, rapid correction of the cause 
and intensive supportive care are essential for successful 
management. However, septic peritonitis is challenging 
to treat and mortality rates for animals with peritonitis 
remain high. 
DIAGNOSIS OF ENTEROTOMY 
BREAKDOWN/SEPTIC PERITONITIS
Leakage from intestinal surgical sites typically occurs at 
3–5 days post surgery, when the wound is at its weakest 
as the initial fibrin seal is being replaced with collagen. 
Clinical signs associated with intestinal leakage and peri-
tonitis include abdominal pain, signs of hypovolaemic 
shock (tachycardia, poor pulse quality, pale mucous 
membranes and collapse), depression, anorexia, vomit-
ing and pyrexia. Rapid investigation and treatment should 
be performed if peritonitis is suspected following intesti-
nal surgery. Most animals with peritonitis will have an 
abdominal effusion and abdominocentesis and abdomi-
nal fluid cytology is the single most useful diagnostic 
test. A smear can be quickly stained and analysed ‘in 
house’. The presence of degenerate neutrophils with 
intracellular bacteria is indicative of septic peritonitis and 
surgery is mandatory. 
MANAGEMENT OF SEPTIC PERITONITIS
Rapid stabilization, exploratory laparotomy and repair of 
intestinal leakage, reduction of contamination, preven-
tion of ongoing infection/inflammation and intensive 
postoperative care and nutrition are the key steps for the 
successful management of septic peritonitis.
Stabilization
Initial therapy is aimed at improving the animal’s perfu-
sion status with intravenous fluid therapy. The use of 
shock rates of crystalloid fluids or artificial colloids 
(hydroxyethyl starches) may be necessary. Electrolyte 
abnormalities and hypoglycaemia must also be addressed. 
Animals should be administered analgesia soon after 
presentation, ideally with a pure opioid agonist. They 
should be treated with broad-spectrum intravenous anti-
biotics such as potentiated amoxicillin or cefuroxime.
Surgical management
An exploratory laparotomy is performed, and the site of 
leakage is identified and is revised to prevent further leak-
age. This can involve the placement of additional sutures, 
debridement of the edges of the enterotomy prior to 
resuturing or resection of the affected area and anasto-
mosis (enterectomy). The surgical site should be omen-
talized or a serosal patch placed. 
Reduction of infection is primarily achieved by copi-
ous lavage with warmed physiological saline solution. A 
sample of fluid should be taken for bacterial culture and 
sensitivity and broad-spectrum intravenous antibiotics 
should be continued pending the results.
Ongoing peritoneal drainage is often necessary 
 following surgery. This can be via closed suction drains 
or open peritoneal drainage. 
Postoperative care and outcome
Postoperative management can be challenging and is 
vital for ensuring a good outcome. Major body systems 
should be monitored closely along with electrolyte, 
acid–base and serum protein status. Many animals are 
anorexic following surgery. Placement of a feeding 
tube  at the time of surgery provides access for enteral 
nutrition which improves enterocyte function and may 
minimize bacterial translocation across intestinal walls. 
Mortality rates of 15–80% have been reported fol-
lowing intestinal dehiscence and peritonitis. 
KEY LEARNING OBJECTIVES
■■ To recognize the clinical signs associated with 
enterotomy breakdown and septic peritonitis and to 
describe the diagnosis of septic peritonitis
■■ To describe and outline the key steps in the 
management of septic peritonitis 
■■ To describe and outline the appropriate surgical 
technique for enterotomy
MULTIPLE CHOICE QUESTIONS
1. What is the single most useful test to identify 
that an enterotomy is leaking causing septic 
peritonitis?
(A) Contrast abdominal radiography
(B) Cytology of an abdominal fluid sample
(C) Computed tomography (CT) scan
(D) Neutrophil count on routine haematology
2. When, post-surgery, is enterotomy leakage 
most likely to occur?
(A) <24 hours
(B) 1–2 days
(C) 3–5 days
(D) 6+ days
3. What fluid is recommended for abdominal 
lavage?
(A) Saline
(B) Chlorhexidine gluconate
(C) Povidone–iodine
(D) Tap water
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Having difficult 
conversations
Christine Magrath
Difficult conversations with clients can be stressful par-
ticularly when they relate to surgical complications. There 
are three components of clinical communication skills:
■■ Content skills, i.e. what you communicate 
■■ Process skills, which is how you communicate and 
includes how you discover and provide information, 
as well as how you structure the interaction and 
how you relate to, and involve the client
■■ Perceptual skills, which is part of your own internal 
decision making and includes, not only your internal 
problem solving strategies, but also your own 
feelings, self-concept and self-confidence
Although all three components of clinical communi-
cation skills are important and inextricably linked, the 
 session will focus mainly on the process skills, which will 
be dissected to reveal some of the individual elements 
which are essential if we are to master and apply them. 
Extensive research has shown that when it’s a difficult 
conversation these core skills need to be delivered with 
greater intention, intensity and awareness. Often empha-
sis is put on the amount of information that is retained by 
clients but studies in veterinary and human medicine also 
show that individuals do not always understand the 
meaning of key messages nor are they necessarily happy 
or committed to the explanations that are given. Further-
more the language that is used along with our non- verbal 
behaviour can be key contributors as to whether the cli-
ent is on board or feels that something has gone wrong. 
MULTIPLE CHOICE QUESTIONS
1. To ensure you have informed consent, must 
you always have a consent form signed? 
(A) Yes
(B) No
2. In emotional situations, what makes up 
face-to-face communication?
(A) Words 7%, tonality 38% and body language 
55%
(B) Words 20%, tonality 40% and body 
language 40%
(C) Words 30%, tonality 20% and body 
language 50%
3. When providing information in a clinical 
setting, how much is recalled by the client?
(A) 40–50%
(B) 50–60%
(C) 60–70%
While delineating and discussing the specific skills can 
help ensure that the client goes down the  former route, 
the session will also look at how we can pick up cues and 
explore them when the client remains  unsatisfied. 
KEY LEARNING OBJECTIVES
■■ How to say sorry and mean it without admitting 
liability
■■ Understanding the importance of explicit 
signposting, i.e. a warning shot and the impact on 
the client if this is not delivered effectively
■■ How to best respond to emotional clients
Something is bleeding: 
what now?
Rachel Hattersley
INTRODUCTION
Post-surgical haemorrhage is potentially a life-threatening 
issue and one which should be closely monitored. 
 However, the decision as to if or when to re-open an 
abdomen post-surgery is not always cut and dried. This 
lecture will discuss the most common causes of post-
surgical haemorrhage and the decision making involved 
in  dealing with these. The most common cause of hae-
moabdomen post abdominal surgery is iatrogenic haem-
orrhage from a vessel which has been ligated at surgery, 
e.g. in ovariectomy or ovariohysterectomy. Technical 
error is reported to be responsible for 75–90% of signifi-
cant intraoperative haemorrhage in humans. However, 
haemorrhage can infrequently be seen secondary to 
coagulopathy.
CAUSES
■■ Trauma
■■ Iatrogenic:
 – Failure to adequately repair or ligate vessels 
transected at surgery
 – Failure to identify all sources of haemorrhage at 
surgery
 – Damage to other organs during the course of 
the surgery
■■ Coagulopathy:
 – Thrombocytopenia
 – Thrombocytopathia
 – Inherited disorders, e.g. von Willebrand  
disease
 – Acquired, e.g. vitamin K deficiency
 – Inherited factor deficiency, e.g. haemophilia A
IDENTIFICATION OF HAEMORRHAGE
■■ Clinical signs: 
 – Delayed capillary refill time
 – Pallor
 – Reduced pulse quality/hypotension
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 – Tachycardia (the compensated phase of 
hypovolaemic shock in cats can be short lived 
and they can therefore present with bradycardia)
 – Reduced urine output
■■ Do you have a reason to suspect postoperative 
haemorrhage? 
 – Is there is a recent history of surgery? If so – 
what surgery has been performed and is there a 
possibility of significant ongoing haemorrhage?
 – Do you have reason to suspect a coagulopathy? 
Is there haemorrhage from more than one site? 
(this makes coagulopathy more likely but 
single-site haemorrhage does not preclude 
coagulopathy); Is the dog a sighthound? 
(moderate to severe haemorrhage has been 
reported after routine gonadectomy in 25% of 
retired racing Greyhounds – this is thought to 
be due to altered fibrinolysis)
■■ Confirm your diagnosis:
 – Confirm the presence of haemorrhage – 
ultrasound-guided centesis and assessment of 
paced cell volume (PCV) of the fluid. If the PCV 
of the fluid is comparable to systemic PCV, this 
is suggestive of ongoing haemorrhage
 – Review platelet numbers (manual assessment 
as well as automated count)
 – Perform a buccal mucosal bleeding time 
(to assess platelet function)
 – Check coagulation times if appropriate
WHEN TO INTERVENE?
■■ Are there signs of hypovolaemic shock? If so 
instigate fluid resuscitation with the aim of 
correcting perfusion deficits without disrupting 
thrombus formation (the goal is to maintain systolic 
blood pressure of 90 mmHg). This may involve 
crystalloid, colloid or blood products
■■ If you suspect a technical or iatrogenic cause of 
haemorrhage, repeat exploration of the area should 
be considered and repeat ligation of vessels 
attempted. If ligation is not a viable option for 
control of haemorrhage, e.g. in the case of a hepatic 
capsular laceration, topical haemostatic agents such 
as Lyostypt can be applied
■■ If coagulopathy is suspected, treatment should be 
directed to the specific underlying cause
SUMMARY
Technical issues are the most common cause of post- 
surgical haemorrhage so ensure you explore this possibil-
ity thoroughly. Consider coagulopathy if there is a suspicion 
based on breed, clinical signs or laboratory testing.
KEY LEARNING OBJECTIVES
■■ Identifying possible causes of post-surgical 
haemorrhage
■■ Stabilization of the haemorrhaging patient
■■ Surgical management of haemorrhage
MULTIPLE CHOICE QUESTIONS
1. What is the name of the coagulopathy seen in 
sighthound breeds?
(A) Hyperfibrinolysis
(B) von Willebrand’s disease
(C) Haemophilia A
(D) Evan’s syndrome
2. What is our goal in terms of systolic blood 
pressure when performing fluid resuscitation?
(A) 60 mmHg
(B) 70 mmHg
(C) 80 mmHg
(D) 90 mmHg
3. What is the most common cause of post-
surgical haemorrhage in human medicine?
(A) Coagulopathy
(B) Ongoing haemorrhage in trauma patient
(C) Iatrogenic technical issues
(D) Thrombocytopenia
I didn’t get surgical 
margins: what now?
Mickey Tivers 
INTRODUCTION
For many tumours, complete surgical removal can be 
curative, assuming that the tumour has not metastasized. 
However, if the mass is not completely removed then this 
can result in tumour recurrence. It is recommended that 
all excised masses are submitted for histopathology. This 
allows confirmation of the tumour type and prediction of 
its biological behaviour based on its histopathological 
features (grade). The pathologist will examine the cut 
edges of the excised tissue or ‘margins’ to assess whether 
the whole tumour was removed or whether it is likely that 
some remains in the animal. 
COMMON SCENARIOS RESULTING 
IN INADEQUATE MARGINS
■■ The mass was removed with appropriately  
wide margins, intended to completely remove  
the tumour but the histopathology suggests  
that these were inadequate (incomplete  
margins)
■■ It was not possible to remove the mass with wide 
margins and therefore a marginal or limited excision 
of the mass was performed. The surgeon is 
expecting incomplete margins
■■ The mass was not sampled prior to surgery or was 
assumed to be benign and therefore surgical 
margins were inadequate
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The exact scenario may influence the next steps in 
dealing with the incomplete margins. Client finances and 
willingness to consider the various treatment options 
may play an important role in decision making.
DEALING WITH INCOMPLETE MARGINS
There are several strategies for dealing with incomplete 
margins and the type of tumour will have a significant 
influence on these options. It is very important to stage 
the tumour for local or distant metastases prior to mak-
ing the definitive decision, as this may limit the options 
available. 
Do nothing/monitor the surgical site
For some tumours, dirty margins do not necessarily 
mean that tumour recurrence is inevitable. Indeed, for 
low grade soft tissue sarcomas (STSs) and mast cell 
tumours (MCTs) the recurrence rate for incompletely 
excised tumours is low. This option may appeal to some 
owners, particularly if finances are limited. 
Repeat surgery
For low grade MCTs and STSs, complete surgical removal is 
the treatment of choice. Therefore, revision surgery to 
remove the scar from the previous surgery with wide mar-
gins is indicated. However, this may be more challenging/
impossible in areas with limited tissue such as the distal limb.
Radiotherapy
This can be an effective treatment for certain tumours, par-
ticularly if further surgery is not an option. Indeed, adjuvant 
radiotherapy is often planned for STS or MCT, where sur-
gery is challenging and incomplete margins are expected.
Chemotherapy
This can be a good option for certain types of tumour, 
particularly if further surgery is not possible or metasta-
ses are present (e.g. MCTs), but others do not respond to 
chemotherapy (e.g. STSs). 
Metronomic chemotherapy
This form of chemotherapy primarily inhibits angiogene-
sis and therefore prevents or delays tumour regrowth. 
It has been recommended for the treatment of incom-
pletely excised STSs to prevent recurrence.
REDUCING THE RISK OF INCOMPLETE 
MARGINS
In general, the best prognosis is if complete excision is 
achieved at the time of the first surgery. This emphasizes 
the need for preoperative sampling of masses, appropri-
ate tumour staging and considered surgical planning.
KEY LEARNING OBJECTIVES
■■ To outline and describe the different options for 
managing incomplete margins following tumour 
excision 
■■ To describe and explain the factors that influence 
the decision making in dealing with incomplete 
margins
■■ To define and recognize the ways in which the risk 
of incomplete margins can be reduced
MULTIPLE CHOICE QUESTIONS
1. What is the recommended treatment for most 
low-/intermediate-grade soft tissue sarcoma?
(A) Radiotherapy
(B) Wide surgical excision
(C) Chemotherapy
(D) Metronomic chemotherapy
2. What is the reported rate of recurrence of 
low-grade soft tissue sarcomas treated with 
marginal excision?
(A) 11%
(B) 21%
(C) 31%
(D) 41%
3. What is the primary mechanism of action of 
metronomic chemotherapy?
(A) Kills cancer cells
(B) Inhibits angiogenesis
(C) Modulates the immune system
(D) Anti-inflammatory effect
I left a urolith behind: 
what now?
Rachel Hattersley
INTRODUCTION
Incomplete urolith removal is reported in 20–42% of 
cases where surgical removal is attempted. This is obvi-
ously a significant number of cases! This lecture aims to 
provide practical tips on how to avoid incomplete urolith 
removal and what to do when you do find yourself in this 
situation.
UROLITH IDENTIFICATION
In an ideal world, knowing how many uroliths you are 
expecting to retrieve is a good place to start in terms of 
prevention of incomplete removal. There are obviously 
times where this is not practical (e.g. when the bladder is 
filled to capacity with uroliths); however appropriate 
imaging should help to approximate the number of 
 uroliths in at least some cases. 
Contrast radiography has an important role to play in 
imaging of the lower urinary tract as it allows assessment 
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of the urethra in addition to the bladder. Even when deal-
ing with radio-opaque uroliths, such as calcium oxalate, 
superimposition of the pelvis can obscure urethral calculi 
which have been shown to have the highest risk of 
incomplete removal. As brachycephalic breeds increase 
in popularity, so the incidence of cysteine uroliths (which 
are radiolucent) is likely also to increase. 
SURGERY
Retrohydropulsion can be used to flush urethroliths back 
in to the bladder lumen prior to surgery. However during 
preparation and positioning of the patient for surgery, it is 
common for uroliths to move back in to the urethra. The 
urethra must therefore be lavaged at surgery in both an 
antegrade and retrograde direction using copious vol-
umes of sterile saline (and the prepuce or vulva must be 
clipped and aseptically prepared so it can be accessed 
from the surgical field) and the largest-bore catheter 
which can be accommodated. Do not forget that it is 
possible to advance a rigid catheter past a urolith so pay 
particular attention to any ‘grating’ which you can feel as 
you advance your catheter along the urethra. 
POSTOPERATIVE IMAGING
Given the high rate of incomplete urolith removal follow-
ing cystotomy, postoperative radiography of the lower 
urinary tract should be performed after each surgery. 
Ideally this should involve positive-contrast radiography 
of the urethra, particularly in cases involving radiolucent 
uroliths. 
If you do identify incomplete removal of uroliths, 
don’t panic! Your next step is to inform the owner of the 
complication and document that you have done so in the 
clinical notes. It is preferable to retrieve the retained uro-
liths whilst the patient is still anaesthetized if possible 
(unless you already know the type of urolith and know 
the uroliths to be amenable to medical management). 
One option is to re-open the ventral cystotomy and 
remove the remaining uroliths. Cystoscopic removal is 
another option depending on availability of equipment 
and the size of the uroliths. If the retained uroliths are 
small (the exact dimensions will depend on patient size, 
but as a ball park, <3 mm) and the owners decline further 
surgery, monitoring using radiography (plain versus con-
trast) can be considered to see if the uroliths are voided. 
However, the owner must be made aware of the risk of 
repeat obstruction or ongoing infection/inflammation 
caused by the presence of the uroliths.
KEY LEARNING OBJECTIVES
■■ Use of postoperative imaging in urolithiasis
■■ How to avoid incomplete urolith removal
■■ Options for managing incomplete urolith removal
MULTIPLE CHOICE QUESTIONS
1. Uroliths are reported to be left in situ post 
cystotomy in up what percentage of cases?
(A) 17%
(B) 42%
(C) 63%
(D) 80%
2. Which type of urolith is associated with 
brachycephalic breeds and entire male dogs?
(A) Calcium oxalate
(B) Struvite
(C) Cysteine
(D) Urate
3. What is the most appropriate diagnostic test for 
identification of urethroliths?
(A) Plain radiography
(B) Positive-contrast cystogram
(C) Retrograde urethrogram
(D) Intravenous urogram
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Paraneoplastic 
syndromes
Erik Teske
Cancer patients may present in different ways to a clini-
cian. Often the owner has noticed an external mass in 
their pet, while the animal is without further complaints. 
However, frequently the primary tumour is not the rea-
son for the owner to visit their veterinary surgeon, but 
rather patients are presented for systemic complaints 
that initially seem unrelated to a tumour. Systemic or 
metastasized tumours could be the reason for that in 
oncology patients, but also the presence of so-called 
paraneoplastic syndromes. 
Paraneoplastic syndromes result from indirect 
effects of tumours due to the production and release of 
biologically active substances such as hormones, growth 
factors and cytokines. The immune system may be 
affected, and autoimmunity, immune-complex produc-
tion or immune suppression can occur. Occasionally, 
paraneoplastic syndromes may cause more morbidity 
than the original tumour itself. By definition paraneoplas-
tic syndromes are unrelated to size or location of the 
 primary tumour or its metastases. 
Paraneoplastic syndromes are divided into different 
categories depending on their target organ. They include 
endocrinopathies, disorders of haematopoiesis and 
 haemostasis, neuromuscular disorders and cutaneous 
syndromes. Cancer cachexia is usually treated separately 
as it affects multiple organ systems.
A timely detection of paraneoplastic syndromes is 
essential for several reasons: 
■■ They may be the first clinical manifestation of 
tumour, and early diagnosis may improve the 
prognosis for the underlying neoplasia
■■ The severity of the paraneoplastic syndromes can 
reflect the activity of the tumour cells, and give 
information on the progressive or regressive nature 
of the tumour
■■ The clinical signs caused by a paraneoplastic 
syndrome could be falsely interpreted as direct 
effects of the tumour itself or side effects of 
treatment, and lead to false prognostic 
considerations
■■ Paraneoplastic syndromes may affect the general 
condition of the animal, and significantly alter the 
prognosis of a specific tumour
The most important paraneoplastic syndromes will 
be discussed during this presentation.
KEY LEARNING OBJECTIVES
■■ Understand the importance of paraneoplastic 
syndromes in clinical practice
■■ Recognize the different types of paraneoplastic 
syndromes and their relationship with certain 
tumour types
■■ Understand the pathophysiology of the different 
paraneoplastic syndromes
MULTIPLE CHOICE QUESTIONS
1. Paraneoplastic syndromes can often lead to 
clinical symptoms before a tumour can be 
detected. There are many different types of 
paraneoplastic syndromes. Which of the 
following situations can be defined as a 
paraneoplastic syndrome?  
(A) A dog with chronic lymphatic leukaemia 
has a non-regenerative anaemia due to 
myelophthysis
(B) A dog with a bladder tumour has 
hypertrophic osteopathy
(C) A dog with splenic haemangiosarcoma has 
ventricular extrasystoles due to metastases 
in the myocardium
(D) A female dog with a large anaplastic 
mammary carcinoma on the fifth 
mammary gland on the right side, 
including enlargement of the ipsilateral 
superficial inguinal lymph node. The right 
hind leg is swollen and oedematous  
2. Hypercalcaemia is a common paraneoplastic 
syndrome. Which of the following statements 
is related to hypercalcaemia as a 
paraneoplastic syndrome is true?
(A) Hypercalcaemia is seen more often in cats 
with cancer than in dogs
(B) Anal sac carcinomas in the dog are the 
most common cause of hypercalcaemia 
in the dog
(C) Hypercalcaemia is associated with T cell 
malignant lymphoma in the dog and not 
with B cell malignant lymphoma
(D) PTH-related peptide, which is the cause of 
hypercalcaemia, is increased in primary 
hyperparathyroidism
3. Superficial dermatitis is a paraneoplastic 
syndrome. What is it associated with?
(A) Hepatic tumours and diabetes mellitus
(B) Renal carcinoma in the German Shepherd 
Dog
(C) The presence of acantholytic cells
(D) Administration of cytostatic drugs
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Biopsies: getting 
good results
Jonathan Bray 
WHY PERFORM A BIOPSY?
A biopsy is indicated to confirm, support or eliminate the 
diagnostic probabilities for a mass that has been identi-
fied from physical examination, radiographic evaluation 
or laboratory data. The results of a biopsy can be used to 
determine the likely prognosis for the patient, and to 
guide optimal treatment options for the patient, includ-
ing the extent of surgical resection that may be required, 
and the indication for neoadjuvant or adjuvant therapies.
WHY NOT PERFORM A BIOPSY?
Many hypothetical contraindications and concerns have 
been raised against performing a biopsy. The potential 
cost and apparent therapeutic delay associated with a 
biopsy procedure are common concerns; these are best 
countered by understanding what is to be gained by the 
biopsy in terms of improved patient management. 
The potential for encouraging seeding of metastatic 
cells during biopsy of a neoplastic mass is a problem 
 perceived by many clients. Development of metastatic 
disease is a complex biological process, requiring an 
interplay between neoplastic cells, the host and the site 
where a cell has become lodged. Therefore, the biopsy 
procedure is unlikely to induce metastatic spread of the 
tumour. However, local invasion (or seeding) of a tumour 
along biopsy tracts is an important and recognized phe-
nomenon. The impact of biopsy tract seeding can be 
controlled by ensuring the biopsy specimen is taken from 
a site which can be completely removed should tumour 
excision be required subsequently.
HOW TO PERFORM A BIOPSY
Clinical judgment must be used to decide which is the 
most appropriate and cost-effective sampling method to 
employ to ensure as much information about the mass is 
obtained as possible. 
Cytology: fine-needle aspirate
Diagnostic cytology is an extremely easy and cheap 
method for obtaining samples from a wide variety of 
masses and body cavity fluids. Aspiration is so easily per-
formed that it should be the first step in any diagnostic 
investigation of an abnormal mass/body cavity fluid. 
Histopathology: biopsy
Cytology does not reveal architectural information about 
the cancer. Also, some cancers may not exfoliate cells 
sufficiently to enable cytological examination. Architec-
tural information is useful to establish the grade, which 
can provide a measure of the cancer’s aggressiveness, 
which may influence the prognosis, and as a conse-
quence, the treatment strategy. 
■■ Incisional biopsy. Incisional biopsies can be 
performed with a scalpel, biopsy punches, needle 
core biopsy instruments, or trephine, using local 
anaesthetic or with sedation/anaesthesia. Care should 
be taken not to widely open uninvolved tissue planes 
that could become contaminated with released 
tumour cells. With good technique, percutaneous 
needle biopsy can provide reliable diagnostic 
information equivalent to a full surgical biopsy 
■■ Excisional biopsy. On occasion, complete excision 
of the mass may be performed without an 
intervening ‘histological’ evaluation. Definitive 
diagnosis and treatment are therefore performed 
concurrently. Determination of the appropriate 
surgical margin about the tumour will be based on 
empirical guidelines 
FUTURE CONSIDERATIONS
An important limitation of current biopsy strategies is the 
tendency to provide information on outcome for a sur-
gery that has already been performed – providing infor-
mation in hindsight of a treatment that has already been 
performed. Cancer surgery would be improved if we 
had foresight: we need to identify biomarkers that help 
improve the prediction of the persistent survival of 
microscopic disease within the tumour margin, or within 
the surgical margin following excision, allowing treat-
ment to be better targeted to the individual characteris-
tics of the tumour before treatment commences.
KEY LEARNING OBJECTIVES
■■ Describe the options for performing incisional 
biopsies, and discuss why a biopsy may not be 
indicated for every oncological case
■■ Recognize the limitations of histological analysis of 
margins, and understand how to improve 
■■ Define and explain the terms: grade, mitotic index, 
differentiation and prognostic markers
MULTIPLE CHOICE QUESTIONS
1. What is the difference between an incisional 
biopsy and an excisional biopsy?
(A) An excisional biopsy will cure the tumour, 
and avoids the need for a second 
procedure
(B) An incisional biopsy can usually be 
obtained in a sedated or conscious patient
(C) An incisional biopsy will cause a delay in 
definitive treatment of the tumour, risking 
a worsening in outcome for the patient
(D) An incisional biopsy is rarely representative 
of the whole tumour, so the results cannot 
be relied on for treatment planning
2. Which of the following is a reason not to 
perform an incisional biopsy of a mass before 
performing surgery?
(A) It adds unnecessary expense for the client
(B) It risks spreading the tumour, and making 
the prognosis worse
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(C) It will often not represent the true nature 
of the tumour
(D) It may not change the treatment plan 
beyond what is determined from cytology 
and clinical examination
3. Why is histological analysis of the tumour after 
surgery important?
(A) It provides confirmation for the owners 
that surgery was performed
(B) It brings additional income for  
the practice
(C) It provides accurate analysis of the tumour 
margin to guarantee complete removal
(D) None of the above
Pathology reports: 
what a clinician needs 
to know
Erik Teske
Clinicians usually only read the part of the pathology 
report in which the diagnosis is given and think that this is 
the absolute truth. They do not realize that this is the 
conclusion of a thought process in which the pathologist 
is considering several possibilities and, in the end, selects 
one of them as the diagnosis. Clues to how sure they are 
can often be found in the microscopic description sec-
tion of the report. However, it starts with the description 
of the macroscopic appearance and the quality of the 
biopsy specimen or section. In the microscopic appear-
ance section, the thought process of how the pathologist 
came to his diagnosis is described. Tissue origin and cri-
teria of malignancy are important aspects. If many crite-
ria of malignancy are listed here, then the reliability of the 
diagnosis of cancer may be much higher, depending on 
the tissue of origin, than if only few or no malignancy cri-
teria are listed. One should realize that a pathologist can 
come to a wrong interpretation of the histological fea-
tures of the tissue, for instance due to the fact that the 
biopsy is not representative of the underlying lesion, or 
they can just make a mistake. If a diagnosis is completely 
different from what the clinician was expecting, then the 
pathologist should be contacted and the case should 
be  discussed. A good relationship between submitting 
clinician and pathologist is therefore vital.
To know if the tumour was completely resected is, of 
course, very important. Often this is reported in the con-
clusion of the pathology report, but the reliability of this 
conclusion can only be evaluated if one reads the entire 
report. A pathologist will only look histologically at a rel-
atively small part of the surgical margins of the tumour 
and has to select an area of the whole specimen to make 
his sections for histological evaluation. The clinician can 
help him by inking interesting areas after resecting the 
tumour and before putting it into the fixative.
In order to have an idea about the prognosis, several 
criteria can be found in the pathology report. Of course, 
the already mentioned completeness of resection is one 
of them. When lymph nodes are also sent in, information 
on the presence of tumour cells or suspected tumour 
cells in these lymph nodes is important. Other malig-
nancy criteria are growth pattern, including aspects of 
infiltrating growth, presence or absence of encapsula-
tion, cellular morphology and differentiation, and signs 
of proliferation of the tumour cells (mitotic index, prolif-
eration markers). 
Much more information can be obtained from a his-
tology report than just reading the final conclusion on 
tumour type. A good and frequent contact with the 
pathologist will pay off in the clinic when treating cancer 
patients. But also the pathologist can only perform opti-
mally if an adequate description of the case is provided 
by the clinician and a good biopsy specimen is delivered. 
Like Victor Perman mentioned decades ago: Garbage in, 
Garbage out!
KEY LEARNING OBJECTIVES
■■ Understanding the magnitude of information that 
can be taken from the pathology report
■■ Recognizing the additional information that can be 
given in addition to the routine pathology report
■■ Learning to translate the information of a pathology 
report to the patient in the clinic
MULTIPLE CHOICE QUESTIONS
1. Which additional staining is characteristic for 
mesenchymal tumours?
(A) Cytokeratin
(B) Vimentin
(C) Toluidine blue
(D) CD18
2. What is the histological grading of a malignant 
tumour in part dependent on?
(A) Completeness of excision
(B) Stage of the disease
(C) Infiltrative growth pattern
(D) Involvement of the regional lymph node
3. What can PARR tests (PCR for antigen receptor 
rearrangements) be used for?
(A) Staging lymphomas
(B) Grading lymphomas
(C) Immunophenotyping lymphomas
(D) Diagnosing lymphomas with more than 
95% accuracy
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Is advanced imaging 
always better?
Gerry Polton 
For the purposes of this presentation, advanced imaging 
will be taken to mean computed tomography (CT) and 
magnetic resonance imaging (MRI). It will be assumed 
that all practitioners using these modalities can obtain 
images of high quality.
Optimal decision making in cancer requires an 
understanding of the patient’s burden of disease. Con-
sistently, one of the most significant determinants of out-
come is the anatomical extent of disease, what we term 
clinical stage. There are, of course, other important 
 considerations: cost; risk; compliance and expertise to 
highlight the main ones. The oncology practitioner 
must  navigate all of these variables when determining 
the  best management strategy for an owner and their 
pet. If detailed awareness of clinical stage is necessary 
for  decision making, CT imaging provides detail of ana-
tomical sites not ordinarily captured in routine thoracic 
 radiography and abdominal ultrasonography. Performed 
well, it also provides superior resolution.
MRI lends itself particularly well to investigations of 
the central nervous system. There are anatomical sites, 
particularly the nose, which can be imaged well by CT or 
MRI. If the option of either is available, in oncology we 
tend to opt for CT because image acquisition is quicker, 
anatomical detail is more accurate and because CT is 
superior for pulmonary metastasis detection.
There are significant drawbacks of a reliance on 
advanced imaging.
■■ Data excess: the practitioner needs to decide what 
to image. Total body CT is increasingly used in 
veterinary oncology for metastasis checks. 
However, if over 2000 individual images are 
generated, each with multiple anatomical structures 
to be scrutinized, it is very easy to overlook 
important changes. Scrutinizing these datasets 
requires significant time and a great deal of 
expertise
■■ Absence of pathology detail: imaging simply 
provides architectural information. Masses can be 
identified; metastases can be seen. But, nodular 
changes of uncertain significance frequently arise. 
Advanced imaging is frequently a prelude to 
further investigations such as image-guided 
biopsy
■■ Cost/benefit: CT and MRI typically incur significant 
costs. Education about the impact of these costs on 
the feasibility of subsequent therapy is a critical part 
of the oncology consultation process. These 
considerations must also take account of 
unexpected findings, for example, the nodules of 
uncertain significance alluded to above
■■ Geographic miss: if metastasis checks examine the 
thorax and abdomen and there is a metastasis to the 
brain, it will not be identified. If neurological 
examination is misinterpreted, lesions can similarly 
be missed. The increased cost of advanced imaging 
does not protect against these eventualities but it 
can inflame an interaction if this potential failing is 
not clearly expressed
Notwithstanding these pitfalls, advanced imaging, CT 
imaging in particular, has revolutionized veterinary (and 
human) oncology. Used well, it leads to superior out-
comes for patients. It enables better planning of surgery 
and radiation therapy. It also leads to non-intervention in 
some patients which would have otherwise experienced 
unnecessary morbidity.
KEY LEARNING OBJECTIVES
■■ Understanding that computed tomography (CT) and 
magnetic resonance imaging (MRI) provide ancillary 
information but do not provide all information 
required for optimal decision making in veterinary 
cancer
■■ Familiarity with clinical scenarios in which advanced 
imaging is desirable
■■ Knowledge of what procedures to perform prior to 
undertaking advanced imaging to ensure the best 
chance of achieving clinical benefit
MULTIPLE CHOICE QUESTIONS
1. Prior to performing surgery on a 2-cm 
diameter immunohistochemically high-grade 
(high ki-67) cutaneous mast cell tumour arising 
on the caudoventral abdomen, which would be 
the optimal test to define clinical stage of the 
tumour?
(A) MRI of the abdomen
(B) CT of the thorax
(C) Whole body CT
(D) Abdominal ultrasonography
2. You are presented with a soft tissue sarcoma is 
arising over the right gluteal region in a spaniel. 
Which imaging strategy would best define the 
degree of infiltration of the tumour into the 
neighbouring tissues?
(A) MRI
(B) CT
(C) Ultrasonography
(D) X-ray
3. Which is the most common cause of 
secondary brain metastasis in dogs?
(A) Osteosarcoma
(B) Mammary carcinoma
(C) Haemangiosarcoma
(D) Malignant melanoma
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Planning oncological 
surgery
Jonathan Bray 
WHY IS A PLAN IMPORTANT?
During the development of oncological surgery over 
many decades, surgeons in both human and veterinary 
fields have been driven to take wider and wider excision 
margins about the tumoru in the belief that ‘more must 
be better’. As we gain a greater understanding and inter-
est in cancer management, these relatively dogmatic 
treatment strategies are justifiably being reviewed. 
This does not mean it is fine to take smaller margins. 
It does mean the clinician has to have a greater under-
standing of the mass before embarking upon treatment 
as a single rule for treatment does not exist for every 
tumour.
It is wellestablished that the first attempt made at 
treatment of a tumour will be the optimum opportunity 
to achieve the best outcome for the patient. If this first 
treatment is inadequate or poorly focused, subsequent 
‘mop-up’ treatments – including radiotherapy, chemo-
therapy or additional surgery – are more likely to fail. 
Treatment failure may include increased prospects for 
both local or systemic recurrence.
WHAT IS MEANT BY A PLAN?
There are two important aspects of a treatment plan:
■■ What is the purpose and intent of treatment? Is a 
cure possible? Or will cure be impossible, even with 
heroic efforts. In the latter event, can any treatment 
achieve palliation of the tumour effects sufficient to 
restore an acceptable quality of life, and for an 
acceptable duration
■■ How is this goal achieved, and what are the sacrifices 
the patient must make to meet this goal? Is failure 
going to be due to local recurrence, or due to spread 
of the tumour to regional nodes or beyond
DEVELOPING A PLAN
Understand the mass
Before any treatment plan can be determined, the bio-
logical potential of the mass must be understood. Is the 
mass neoplastic, and if so, what is its tendency for local 
invasion, locoregional metastasis and distant metastasis? 
In most instances, this information can be gained by fine-
needle aspiration alone. If this proves non-diagnostic or 
inadequate, a biopsy may be required for histological 
analysis (see Biopsies: getting good results, elsewhere in 
this proceedings). 
Discussion with owners – expectations, 
finances and realities
An essential aspect of tumour management is involving 
the owners in developing the treatment plan. The goals 
of the treatment plan need to be agreed and understood, 
particularly if compromises are being made to an ideal 
solution due to finances, apparent comorbidities or other 
factors. If the tumour is large, located in a difficult loca-
tion or showing attributes that suggest an aggressive 
behaviour, early discussion with a specialist oncological 
surgeon is advised.
Role of imaging
Imaging is an increasingly important in tumour manage-
ment. Imaging serves two purposes: 
■■ It helps assess if the tumour has spread beyond the 
local site (i.e. staging) 
■■ It can assist with recognizing tumour boundaries 
and the tissue barriers necessary for effective 
surgical excision
A role for combination therapy
While surgery remains the more effective weapon against 
localized cancer, the planned incorporation of chemo-
therapy or radiotherapy can provide improved or similar 
outcomes for selected patients with less morbidity or risk 
of complications. The timing of these additional inter-
ventions will differ for certain tumours.
KEY LEARNING OBJECTIVES
■■ Recognize the role of tumour genetics and the 
microenvironment on cancer progression and 
prognosis, and the influence of this on treatment 
planning for the individual patient
■■ Understand the differences and possible impact 
of an unplanned excision, versus a curative-intent 
excision, a planned marginal excision and 
palliative care
■■ Understand the followings terms and their role in 
cancer management: staging, sentinel node, 
neoadjuvant, adjuvant, survival curve, curative-
intent, cytoreduction, palliation
MULTIPLE CHOICE QUESTIONS
1. What is the purpose of a treatment plan in 
cancer?
(A) To ensure that owners understand that 
cancer is a difficult disease, and recurrence 
is possible
(B) To draw lines on the patient with sterile 
marker pen prior to surgery
(C) To identify the goal of treatment for each 
individual patient, and devise a treatment 
solution that best meets this goal
(D) To provide a structured clinical report that 
your colleagues can understand in your 
absence
2. What does a treatment plan help recognize?
(A) Every tumour is individually unique, and 
generic application of a surgical ruler may 
lead to under- or over-treatment of a 
tumour
(B) Unplanned excisions of a tumour can be 
associated with increased rates of 
035-042 Oncology.indd   40 08/03/2019   17:57
BSAVA CONGRESS 2019 PROCEEDINGS [ 41 ]
treatment failure. Post-hoc use of 
chemotherapy and radiotherapy may not 
always overcome these failings
(C) Identification of tissue barriers using 
imaging prior to surgery can reduce 
surgical morbidity
(D) All of the above
3. Which of the following statements about 
removal of the regional lymph node is 
INCORRECT?
(A) Histological analysis of the regional lymph 
node is more accurate at detecting 
micrometastasis than cytology
(B) The regional node is considered important 
in directing the immune response to the 
tumour, and should be removed only if 
completely effaced by tumour
(C) Lymph node mapping may be important 
to help detect the draining site for a 
specific tumour, and improve accuracy of 
staging
(D) Removal of a positive lymph node can 
result in improved survival times for many 
cancers, so patients with a draining lymph 
node metastasis should not be considered 
to have a hopeless prognosis
Chemotherapy: 
the basics
Erik Teske
Surgery is still the cornerstone of treatment of most can-
cers. Most patients with cancer that are cured, are cured 
because of surgery. Chemotherapy, radiotherapy and 
other treatment modalities may extend life, but only cure 
a very small proportion of treated patients. In most 
instances they are used in a more palliative setting and 
meant to give the patient a prolonged, preferably 
tumour-free, survival time.
In systemic tumours and in proven or suspected 
metastasized tumours, chemotherapy can be indicated. 
It is therefore essential for all practioners to know about 
these treatments, their possibilities and their limitations. 
There are many reasons why chemotherapy is unlike 
normal conventional drug therapy and that it will require 
investment in material, equipment, additional knowledge 
and time. In this lecture the basic requirements for start-
ing chemotherapy in private practice will be discussed. 
Different tumours require different cytostatic drugs, 
often used in combination protocols. It is essential to 
know the right (sub)type of tumour before chemother-
apy is started. Also additional information on the health 
state of the patient needs to be collected. Several drugs 
have organ-specific toxicities, or need to be activated or 
excreted by specific organs. 
Knowledge about the different cytostatic drugs, their 
mode of action, their specific toxicities and their dosage 
is essential. Most tumours will become resistant towards 
the chemotherapy. Knowledge about the different 
mechanisms of this resistance is important in order to 
find alternative treatments.
Although chemotherapeutic drugs treat cancer they 
can also cause cancer. They are hazardous drugs for 
owner, veterinary surgeon and technician. The veterinary 
surgeon has to be aware of the different routes of poten-
tial contamination, not only during the preparation and 
administration of these drugs, but also through the 
patient itself. Owners need to be informed of this risk, and 
practice staff must be informed and trained.  Investments 
have to be made in the clinic in order to be able to 
 administer these drugs.
KEY LEARNING OBJECTIVES
■■ Knowing the indications and limitations for 
chemotherapy
■■ Learning to score the efficacy and side effects of 
chemotherapy
■■ Learning to prepare and administer cytostatic drugs, 
including awareness of the environmental hazards 
of chemotherapy
MULTIPLE CHOICE QUESTIONS
1. What is the Veterinary Cooperative Oncology 
Group (VCOG) toxicity score used for?
(A) To stage the patients before the start of 
chemotherapy for the risk of side effects of 
chemotherapy
(B) On the day of chemotherapy 
administration to see if dose adjustments 
are necessary
(C) Assessing haematological and biochemical 
indices
(D) To grade maximal toxicities after 
chemotherapy has been administered
2. Doxorubicin is a cytostatic drug. What is its 
mode of action?
(A) Inhibition of the spindle apparatus resulting 
in metaphase arrest
(B) Conversion of asparagine into aspartic acid
(C) Creating complexes with DNA/RNA 
(intercalation)
(D) Being an analogue of normal metabolites 
involved in cell division or cell function
3. With regards to the environmental hazards of 
cytostatic drugs it is important to know the period 
of the patient will be a risk for its surroundings. For 
how long does a dog treated with doxorubicin 
have elements of this drug in its urine?
(A) 1–2 days
(B) 3–4 days
(C) 4–7 days
(D) More than 1 week
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Oncology treatments: 
new and on the 
horizon
Gerry Polton 
NEW TREATMENTS
Human cancer therapy continues to move apace and it is 
exciting to say that veterinary cancer therapy isn’t doing 
too badly either. Tyrosine kinase inhibitors and metro-
nomic chemotherapy are relatively new treatments that 
we will discuss briefly. As some will be familiar with these 
treatments, I will focus on new knowledge and our cur-
rent understanding of their best uses.
Electrochemotherapy involves the anatomical tar-
geting of chemotherapy delivery to cancer cells by the 
direct application of a specifically shaped electrical field. 
Chemotherapy is introduced to the tumour field by intra-
venous or intratumoral injection. Application of the elec-
trical field then permeabilizes the cancer cells, causing a 
marked increase in drug delivery to the targeted tissue. 
Clinical indications include injection site sarcoma in cats, 
soft tissue sarcoma in dogs, facial squamous cell carci-
noma in cats among others.
NEW HORIZONS
The field of cancer immunotherapy is developing rapidly. 
Trials are currently underway for dendritic cell vaccina-
tion for canine malignant melanoma, chimaeric antigen 
receptor (CAR) T cell therapy for treatment-resistant B 
cell lymphoma and monoclonal antibody therapy for 
dogs with T cell lymphoma, to list a few. However, the 
most likely immunotherapy to reach clinical practice 
soon is a CD20 vaccine for canine B cell lymphoma. 
In  principle, vaccination is performed once complete 
remission has been achieved using conventional chemo-
therapy. In the context of minimal residual disease, 
immune tolerance of the lymphoma is overcome and the 
vaccine induces a lasting memory effect. Trials are ongo-
ing. The current obstacle to use is a need to define the 
optimal timing of vaccine administration in relation to 
chemotherapy delivery.
Away from the field of immunotherapy, an imagina-
tive solution to the perpetual problem of intractable 
pain associated with appendicular limb osteosarcoma in 
large- and giant-breed dogs comes in the form of an irre-
versible pain receptor toxin, resiniferatoxin. This agent, 
when injected intrathecally, causes permanent loss of C 
fibres in the dorsal root ganglion but does not induce a 
loss of other sensory functions.
KEY LEARNING OBJECTIVES
■■ Be familiar with best practice in relation to the use 
of tyrosine kinase inhibitors
■■ Be aware of clinical indications for and risks of 
metronomic chemotherapy
■■ Be invigorated by the extraordinary therapeutic 
possibilities that are just over the horizon in 
veterinary oncology
MULTIPLE CHOICE QUESTIONS
1. Tyrosine kinase inhibitor therapy is indicated in 
which of the following?
(A) All mast cell tumours
(B) All cancers
(C) All mast cell tumours for which owners 
decline chemotherapy
(D) Selected mast cell tumours
2. Metronomic chemotherapy involves the daily 
administration of agents believed to have an 
anti-angiogenic effect, thus limiting the ability 
of new cancer cells to grow. What other 
anti-neoplastic mode of action is attributed to 
low daily doses of cyclophosphamide?
(A) Sterile haemorrhagic cystitis
(B) De-repression of immune surveillance and 
activation
(C) Altered signal transduction pathways
(D) Mitochondrial failure
3. How are we going to cure cancer once and 
for all?
(A) Stronger chemo drugs
(B) Braver surgeons
(C) Immunotherapy
(D) We are not going to cure cancer once and 
for all
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Updates on rabbit 
medicine and surgery
Christoph Mans
BLOOD BIOCHEMISTRY
Blood biochemistry evaluation is one of the most 
 important diagnostic tests in critically ill rabbits, besides 
diagnostic imaging. Rabbits are frequently presented for 
evaluation of sudden-onset anorexia and lethargy. 
 Possible underlying causes include stress and underlying 
 disease process or pain. It can be challenging to identify 
the correct underlying cause in rabbits and this may 
result in the misdiagnosis of potential life-threatening 
conditions, such as gastrointestinal obstruction or liver 
lobe torsion. Blood biochemistry offers a simple and 
cost-effective way to rule out important underlying 
 diseases in a short period of time. In most clinics, these 
tests can be performed in-house and allow the veterinary 
surgeon to provide the best possible treatment options 
for rabbit patients.
THYMOMAS
Thymomas are the most common neoplasm of the 
 thoracic cavity in rabbits, and are increasingly diagnosed 
in older rabbits. Rabbits usually present with a history of 
bulging eyes, reduced activity or increased respiratory 
rate. Less commonly problems swallowing or choking 
may be reported by the owner. Physical examination can 
be unremarkable or may reveal bilateral exophthalmos, 
a  heart murmur, tachypnoea, or dyspnoea. Thoracic 
radiographs will reveal an intrathoracic soft tissue mass, 
 dorsal deviation of the trachea and displacement of 
the  heart. However, it may be difficult to distinguish a 
 thymoma from cardiomegaly in some cases. Therefore, 
thoracic ultrasonography or computed tomography are 
required to confirm the diagnosis of an intrathoracic 
mass. The diagnosis of thymomas is made by cyto-
logi cal evaluation of a fine-needle aspirate of the mass. 
 Treatments options for thymomas in rabbits include 
 radiation therapy or palliative medical therapy with pred-
nisolone. Often surgical therapy is not recommended 
due to the high risk of intraoperative and postanaesthetic 
 complications. 
LATERAL RHINOSTOMY
Lateral rhinostomy is a useful technique that has shown 
to effectively resolve upper respiratory tract disease of 
rabbits. This technique is associated with considerably 
less trauma and faster recovery times than is the dorsal 
rhinostomy approach and is indicated for rabbits with 
chronic unilateral sinusitis, in which medical treatment 
has failed to improve clinical signs.
KEY LEARNING OBJECTIVES
■■ Become confident interpreting plasma biochemistry 
values in critical rabbit patients and ruling out 
life-threatening conditions
■■ Recognize the clinical signs associated with 
thymomas in rabbits and be able to discuss different 
treatments options
■■ Understand when surgical treatment for chronic 
upper rhinosinusitis is indicated and what the 
differences are between published surgical 
techniques
MULTIPLE CHOICE QUESTIONS
1. Which of the following is TRUE regarding liver 
lobe torsion in rabbits?
(A) Affects only young rabbits (<2 years)
(B) Abdominal radiographs and physical 
examination are able to confirm liver lobe 
torsion in most cases
(C) Surgical treatment is not recommended, 
due to the high risk of complications
(D) A substantial increase in liver enzymes is 
highly suggestive of liver lobe torsion
2. Which of the following is TRUE about 
thymomas in rabbits?
(A) Highly responsive to radiation therapy
(B) Only reported in rabbits >12 years
(C) Not reported in Rex rabbits, since this 
breed lacks a thymus
(D) The cause of unilateral and bilateral 
exophthalmos
3. Why are blood glucose levels in rabbits of high 
diagnostic value?
(A) Diabetes mellitus is very common in obese 
rabbits
(B) Severe hyperglycaemia is highly suggestive 
of a painful abdominal disorder, such as an 
intestinal obstruction
(C) Hypoglycaemia is usually associated with 
insulinomas in rabbits >4 years of age
(D) Hypoglycaemia is commonly associated 
with stress and dental disease
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Sedation, analgesia 
and anaesthesia in 
small mammals
Christoph Mans
PROCEDURAL SEDATION 
Procedural sedation is defined as the state of drug-
induced altered consciousness, which allows the patient 
to better tolerate stressful or unpleasant procedures, 
without depressing protective airway reflexes or having 
a  significant cardiopulmonary depressant effect. Since 
most small mammal species are prey species, they are 
less tolerant to handling, manual restraint and other 
stressful or painful procedures. In particular, in small 
mammals in respiratory distress, sedation should be con-
sidered prior to prolonged manual restraint, for example 
for radiographic positioning. A variety of drugs can be 
used to induce effective sedation in small mammals. 
Some of these drugs have sedative, anxiolytic and amnes-
tic properties (e.g. midazolam), while other have mainly 
analgesic and sedative properties (e.g. butorphanol). 
The  combination of two drugs (e.g. midazolam with 
butorphanol) usually results in better sedation with fewer 
side effects, as compared to using a single drug at a 
higher dose. Most drug sused for sedation can be 
reversed, which allows for a more rapid recovery from 
sedation. Drugs, which cannot be reversed (e.g. ketamine) 
should be used at low doses only, in particular in animals 
with reduced liver and/or kidney function. Oxygen flow-
by should always be provided, since most sedation 
 protocols will result in a reduction of respiratory rate. 
Effective sedation protocols are species specific, and 
therefore extrapolation from one small mammal species 
to another does usually not result in satisfactory sedation. 
In addition, postanaesthetic reduction in food intake and 
faecal output have been demonstrated in small mammals. 
ANALGESIA
Analgesia of small mammals is a focus of recent research 
studies. With more research being performed, analgesic 
protocols, previously believed to be effective, which 
were based on extrapolation and clinical experience, 
have been questioned for their efficacy. A variety of drugs 
including buprenorphine, tramadol, meloxicam and 
 lidocaine have been investigated. Species-specific differ-
ences in drug dose requirements, dosing frequency and 
drug efficacy should be considered when considering a 
pain management plan for small mammal patients. 
GENERAL ANAESTHESIA
General anaesthesia in small mammals, is routinely 
 performed by many veterinary surgeons for a variety of 
elective and non-elective procedures. Recent develop-
ments in anaesthetic protocols and anaesthetic equip-
ment are aimed to reduce morbidity and mortality 
associated with general anaesthesia in small mammal 
patients.
KEY LEARNING OBJECTIVES
■■ Understand the basic principles of and  
indications for procedural sedation in small 
mammals 
■■ Formulate effective sedation protocols for a variety 
for small mammal species
■■ Be able to formulate different pain management 
plans for rabbits, guinea pigs, chinchillas, ferrets and 
hedgehogs
MULTIPLE CHOICE QUESTIONS
1. Which of the following is TRUE regarding 
sedation in small mammals?
(A) Due to their fast metabolism, injectable 
sedation protocols are usually not effective 
in small mammals
(B) Midazolam, if used as part of a sedation 
protocol, should not be reversed in rabbits 
in order to avoid excitation during the 
recovery phase
(C) Midazolam–butorphanol provides safe and 
effective sedation in ferrets
(D) Single-drug sedation protocols are 
generally preferred in small mammals, due 
to the reduced risk of cardiovascular 
adverse effects
2. Which of the following has been shown for 
tramadol?
(A) It is an effective analgesic in rabbits but not 
in guinea pigs
(B) It is ineffective as an analgesic drug in 
chinchillas
(C) It has a narrow margin of safety in  
ferrets
(D) It has long-lasting effects guinea pigs at 
5 mg/kg orally
3. Which of the following statements regarding 
buprenorphine is CORRECT?
(A) Duration of effects in guinea pigs and 
chinchillas is >8 hours
(B) Doses >0.1 mg/kg lead to profound 
sedation in chinchillas
(C) Oral–transmucosal administration can 
lead to therapeutic plasma levels
(D) A dose rate of 0.05 mg/kg has been shown 
to result in analgesia in chinchillas for 
6–8 hours
043-052 Exotics.indd   45 08/03/2019   17:56
Exotics
[ 46 ] BSAVA CONGRESS 2019 PROCEEDINGS
Managing chelonian 
shell disorders
Christoph Mans
The shell in turtles and tortoises represents unique 
 challenges to veterinary surgeons in regards to the 
 diagnosis and treatment of coelomic organ disorders. In 
addition, the shell itself can be affected by a variety of 
infectious and non-infectious disorders.
Pyramiding and other forms of shell deformation in 
chelonians are usually seen only in captivity. Different 
underlying causes have been proposed in the past, 
including dietary causes and lack of UVB light. Only low 
humidity has so far been clearly shown to predispose to 
pyramiding of the shell. It is believed that focal heat 
lamps also contribute to the development of pyramid-
ing. The keratin layer of the most dorsal aspects of the 
shell is  drying out, because they are in the closest prox-
imity to the heat lamps. This in consequence leads to 
interference with the growth of the underlying bone, 
resulting in a domed appearance of the dorsal aspect of 
carapace. Pyramiding in many cases has no conse-
quences for the tortoise and is considered a cosmetic 
problem. However, in severe cases, the shell deforma-
tion may lead to compression of the spinal cord. In order 
to prevent pyramiding, heat lamps should create a wide 
area of heat, instead of a narrow focal heat spot. Regular 
soaking and applying water to the carapace may assist in 
preventing dehydration of the keratin. Exposure to natu-
ral sunlight is strongly  preferred over artificial heat 
sources  whenever possible. 
Shell fractures can be a result of predator trauma, 
falls, drops or mechanical trauma (hit by car, lawnmower, 
etc.). Often the shell damage can be quite striking on 
 initial examination, but still carry a good prognosis 
depending on the area of damage and the patient’s 
 overall condition. Establishing the extent of injury, sup-
portive care and stabilization are the priorities. Surgical 
shell  fixation should be delayed until the patient has been 
 stabilized. If there is penetration of the coelomic cavity, 
degree of blood loss and damage to internal organs 
should be assessed prior to performing surgical shell 
repair. If there is a wound or fracture across the spinal 
column, or the patient is having difficulty ambulating, 
radiographs or computed tomography scans should be 
obtained. Fluid therapy, antibiotics and analgesics should 
be given before further treatment is attempted. Different 
techniques have been proposed for the stabilization of 
shell fractures. The author recommends the use of metal 
plates and stainless steel screws, in order to achieve 
 fracture stabilization. Open wound management should 
be performed for larger defects. 
Shell infections are usually secondary to trauma or 
poor husbandry. Besides bacterial infections, filamen-
tous fungal organisms should always be considered in 
chelonians presented for deep shell infections. Cytology 
or, if  non-diagnostic, histopathology should be per-
formed in all cases, in order to rule out the involvement 
of fungal organisms in the shell infection. Treatment of 
shell  infections depends on severity and species 
affected, and usually consists of surgical debridement, 
as well as   topical and, if deemed necessary, systemic 
 antimicrobials. 
KEY LEARNING OBJECTIVES
■■ Understand the basic principles of shell fracture 
stabilization and wound management
■■ Be able to discuss the different proposed aetiologies 
for shell deformations in captive chelonians
■■ Develop a diagnostic and therapeutic plan for a 
turtle patient which presents with shell lesions 
consistent with a deep shell infection
MULTIPLE CHOICE QUESTIONS
1. Which of the following is TRUE regarding shell 
fracture healing in chelonians?
(A) Shell fractures heal very slowly and usually 
take 3–4 months
(B) All turtles with shell fractures require  
dry-docking until healing is complete
(C) Use of metal plates, screws and wire is the 
preferred method for surgical fracture 
stabilization
(D) Epoxy-type products should be used to 
seal shell fractures in order to achieve 
stabilization and protection from infection
2. Which of the following is CORRECT regarding 
management of shell infections?
(A) Antifungal drugs should be given to all 
patients with suspected shell infections, 
due to the high risk of fungal infections
(B) Inappropriate substrate is not a common 
cause for infections of the plastron
(C) Shell debridement should not be 
performed, as it will disseminate infection 
into deeper shell layers
(D) Ceftiofur is an excellent antibiotic choice 
to empirically treat a bacterial shell 
infection in an aquatic turtle
3. In which of the following species and 
housing conditions is shell pyramiding most 
likely to occur?
(A) Red-eared slider, housed indoors
(B) Russian tortoise, housed outdoors
(C) Greek tortoise, housed indoors 
(D) Soft-shell turtle, housed indoors
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Avian clinical techniques
Christoph Mans
BLOOD COLLECTION 
Blood collection in avian patients can be performed 
safely in most patients, however, excellent manual 
restraint techniques are mandatory in order to avoid 
complications. The right jugular vein is the most com-
monly used blood collection site. This vein is usually 
 easily visualized and allows for the collection of larger 
blood volumes, compared to other sites. The ulnar vein 
should be avoided unless the patient is anaesthetized, 
due to the high risk of haematoma formation at this site. 
The medial metatarsal vein can also be used, but the 
 ability to obtain a diagnostic blood sample from this site 
varies by bird species. In chicken, waterfowl and raptors 
this vein is a reliable blood collection site. Approximately 
1% of a bird’s bodyweight in grams can safely be  collected 
in ml of blood. For example, in a 100-g cockatiel, 1 ml of 
blood can be collected. Lithium heparin is the preferred 
anticoagulant for avian blood.
SEDATION 
Sedation provides tremendous benefits for avian patients, 
including stress relief, anxiolysis and amnesia. Sedation 
allows for more thorough examination and safer sample 
collection and minimizes the need to use general anaes-
thesia in order to complete diagnostic and non-painful 
therapeutic procedures. Midazolam and midazolam–
butorphanol sedation protocols are most commonly 
used and have been shown to provide safe and effective 
procedural sedation in variety of species. However, drug 
dosages need to be adjusted based on the species, 
patient condition and procedures to be performed under 
sedation. Reversal of midazolam with flumazenil should 
be performed in most cases, in order to avoid prolonged 
recovery. Midazolam, butorphanol and flumazenil can 
be  given by intramuscular injection or by intranasal 
 administration.
FLUID THERAPY 
Fluid therapy is essential in systemically sick birds, which 
are usually dehydrated. In most cases, with the exception 
of hypovolaemic shock and severe dehydration, the sub-
cutaneous route is recommended. A subcutaneous fluid 
bolus of 3–5 ml/100 g bodyweight can be safely admin-
istered. The bird’s hydration status should be monitored, 
and the fluid administration repeated until euhydration is 
achieved. Intraosseous catheters are particularly useful in 
psittacine as well as smaller bird species, in which access 
for and maintenance of an intravenous catheter are chal-
lenging. In larger birds, such as chickens and waterfowl, 
intravenous catheters can be placed and maintained in 
the medial  metatarsal vein for intravenous fluid and drug 
administration.
EXTERNAL COAPTATION
External coaptation is a feasible and successful treatment 
option for a variety of fractures in captive birds. Tibiotar-
sal fractures are the most common fracture in small cage 
birds and are successfully treated with the application 
of  a tape splint. Fracture healing occurs usually within 
21 days. In cases in which a predator attack (dog, cat) was 
reported or in which deep pain was not present on pres-
entation, the chance for a successful outcome is lower. 
Tape splints should only be removed if complications 
are  noticed, otherwise they should remain in place for 
14–21  days, in order to avoid disruption of the healing 
fracture site.
KEY LEARNING OBJECTIVES
■■ Become comfortable selecting sedation protocols 
for common pet bird species 
■■ Understand when external coaptation is the feasible 
treatment option for fractures in birds
■■ Be able to recommend the appropriate blood 
collection sites and volumes for a variety of bird 
species
MULTIPLE CHOICE QUESTIONS
1. You decide to run a complete blood count 
and plasma biochemical profile on a 30-g 
budgerigar. What is the maximum volume 
of blood that you can safely collect from this 
patient?
(A) 2.5 ml
(B) 0.03 ml
(C) 0.6 ml
(D) 0.3 ml
2. Which of the following sites can be used 
for intraosseous catheterization and fluid 
administration in birds?
(A) Distal humerus
(B) Proximal tibiotarsus
(C) Proximal femur
(D) Coracoid
3. Which of the following statements regarding 
avian sedation is CORRECT? 
(A) Midazolam and diazepam should never be 
administered by intramuscular injection
(B) Sedation protocols which include 
butorphanol should always be reversed 
with naloxone
(C) Midazolam–butorphanol protocols provide 
deeper and more reliable sedation 
compared to midazolam protocols
(D) Sedation should never be performed in 
sick avian patients, due to the high risk of 
complications
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Clinical applications 
of rabbit endoscopy 
Paolo Selleri
Rigid endoscopy is a versatile tool for diagnostic and 
treatment in rabbit medicine. Its broad spectrum of use 
includes stomatoscopy, otoscopy, cystoscopy, thoracos-
copy and even laparoscopy. Due to the fact that it allows 
clear visualization of the internal organs and magni-
fication of the images, it can be applied to study and to 
treat various systems (respiratory, digestive, urinary and 
reproductive), it enables collection of samples for cul-
ture, cytology or pathology and can also be used as a 
tool for the veterinary surgeon to improve communi-
cation with clients, by showing them pictures and videos 
that are easy to understand.
The 2.7-mm endoscope, 18 cm long, with a 
30-degree angle is the most widespread endoscope in 
exotic animal medicine. The 30-degree angle is especially 
useful in stomatoscopy of rabbits presented for hypersal-
ivation. When the physical examination of the conscious 
rabbit does not give enough information the animal can 
be sedated to better visualize teeth and oral soft tissues. 
Other than dental diseases, hypersalivation can be caused 
by a foreign body stuck between two teeth or a neoplas-
tic lesion. These conditions could be missed without the 
use of an endoscope. Furthermore, the endoscope can 
assist for simple procedures, like mass resection, and also 
more complex ones, like extraction of a molar tooth, for 
visualizing the anatomy and better evaluation of whether 
another condition is  present.
When performing oral examination and surgery, it is 
always important to have the animal intubated. This is 
safer for all surgical procedures, particularly because a 
large number involve the rabbit’s head and a face mask 
is an impediment for the surgeon. Moreover, the use of 
a  face mask does not allow complete monitoring of 
anaesthesia as capnography cannot provide reliable 
results in these circumstances. Many methods have been 
described for endotracheal intubation. The endoscope 
makes intubation faster and safer. You can use the endo-
scope by placing it into the endotracheal tube or, if you 
prefer, you can pass it through the mouth and assist the 
placement of the tube in the trachea by watching the 
glottis. It is not unusual to find food at the opening of 
the  trachea! The use of a blind intubation technique 
may be risky, because we may push the food from the 
pharynx deep into the trachea or to the bronchi. This 
may cause suffocation during anaesthesia or aspiration 
pneumonia a few days after the procedure.
Almost all rigid endoscopic techniques applied in 
small animal medicine can be adapted for rabbits, but one 
in particular, which is very useful, is to diagnose and to 
treat urinary tract diseases. Intestinal calcium absorption 
in rabbits is not reduced in the case of excessive calcium 
intake, but urinary calcium excretion is increased. It is 
thought that dietary calcium is one of the major causes 
of urolithiasis. Polypoid cystitis is often not diagnosed if 
the urethra is not directly visualized. The endoscope is 
also essential in the removal of small stones and sludge. 
The presence of sludge into the bladder is a common 
condition and it is often the cause of discomfort and 
 cystitis, with a cat urinary catheter being often too thin 
to allow the passage of the sludge. Only the use of the 
endoscope placed in its protective sheath allows visuali-
zation of the bladder wall and removal of the sludge.
KEY LEARNING OBJECTIVES
■■ Understand how the endoscope can be applied 
every day to clinical practice in rabbit medicine
■■ Learning how endoscopy can guide the 
endotracheal tube entering the trachea
■■ Discuss benefits of rigid endoscopy to diagnose and 
treat lower urinary tract diseases
MULTIPLE CHOICE QUESTIONS
1. Which of the following can occur as a result 
of blind intubation?
(A) Oedema and laryngospasm consecutively 
(B) Complications associated with aspiration 
pneumonia
(C) Potentially lead to spinal lesions due to the 
extreme positioning of the animal 
(D) All of the above
2. Endoscopy is useful for removing sludge and 
calculi from the urinary bladder. What is this 
common disease caused by?
(A) The fact that intestinal calcium absorption 
rate in rabbits is reduced in the case of 
excessive calcium intake
(B) The fact that increased calcium intake will 
increase urinary calcium excretion 
(C) The fact that older animals are not able 
to excrete calcium
(D) The fact that rabbits are commonly fed 
salad, which has a high calcium 
concentration
3. When performing cystoscopy in a rabbit, what 
medium should be used to distend the bladder?
(A) Cold sterile solution
(B) Warm sterile solution
(C) Air 
(D) Carbon dioxide 
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Clinical applications 
of reptile endoscopy 
Paolo Selleri
A reptile’s anatomy may limit the usefulness of the 
 physical examination. Furthermore, haematology and 
biochemistry may not give clear information regarding 
the pathology involved. The use of the rigid endoscope 
(18 cm long, 2.7 mm diameter, 30-degree angle) allows 
for more accurate evidence-based diagnosis, offering 
more information and increasing the standards of care. 
Endoscopy of the coelomic cavity and organ biopsies 
are often necessary to reach a definitive diagnosis. 
Several techniques have been developed to explore 
the coelomic cavity of these species.
For ophidians, often presented for respiratory 
 disease, endoscopic examination of the lung is an impor-
tant diagnostic tool for the thorough evaluation of the 
respiratory tract. Although tracheoscopy has its limits, for 
example in large snakes the length of the lower respira-
tory tract or in smaller ones the diameter of the trachea 
(the endoscopes are too large for examination), lung and 
air sacs can be investigated and samples can be collected 
performing a transcutaneous approach. For this tech-
nique, the skin is incised on the right side, on the second 
row of scales approximately at the 40% of the length of 
the body. Scissors are then bluntly advanced through the 
subcutaneous and muscular tissue. The respiratory tract 
is then incised and the endoscope directed both cranially 
and caudally, for complete exploration of the air sac. The 
30-degree angle makes better visualization possible, 
without a lot of movement of the telescope.
For chelonians, often presented for traumatic lesions 
of the shell, the endoscope should be used to investigate 
every lesion that exposes the coelomic cavity. Haemor-
rhage is not easy to diagnose using radiography or 
 ultrasonography, rupture of organs is easily missed  without 
the use of an endoscope; besides that, fly larvae hidden in 
the soft tissue can be identified and physically removed.
Assisted surgical procedures can also be performed 
in these species. Ovaries and oviducts can be easily 
 identified, grasped, and placed in the surgical field, the 
prefemoral fossa. It is important to remember that the 
lungs and air sacs are not separated with a diaphragm, so 
the need for insufflation depends on the anatomy of the 
patient and the area of interest.
Another valuable diagnostic tool is cystoscopy in 
chelonians. The two main features of the chelonian 
 urinary bladder, anatomy and size, play an important role 
in choosing this technique. The fact that the urinary 
bladder wall is thin and transparent when distended and 
it is a greatly distensible organ that can accommodate 
large quantities of fluids (i.e. up to 30% of the total body 
weight of the chelonian), make it a reliable procedure 
that can help the veterinary surgeon visualize internal 
organs and have a better understanding of the clinical 
case, especially when other diagnostic techniques are 
not helping. The urethera is short and wide so an endo-
scope can be passed easily. It can be used for sex deter-
mination of hatchling chelonians, often requested from 
reptile breeders, and also to visualize the intestinal tract, 
pancreas, liver, spleen and, of course, the bladder wall 
itself and its content (urinary stones, eggs and parasites 
can be identified). Performance of biopsies is not possi-
ble via this route. 
KEY LEARNING OBJECTIVES
■■ Understand how the rigid endoscope can improve 
the level of care offered to our reptile patients
■■ Highlight how this instrument improves 
communication with clients
■■ Understand the application for non-invasive sex 
determination in hatchling chelonians
MULTIPLE CHOICE QUESTIONS
1. What is the best endoscope to perform 
cystoscopy in a tortoise?
(A) Rigid endoscope, 30-degree angle
(B) Rigid endoscope, 0-degree angle
(C) 5-mm large flexible endoscope
(D) An otoscope is reliable
2. Laparoscopy-assisted surgical techniques are 
most commonly used in which of the following?
(A) Crocodilians
(B) Lizards
(C) Snakes
(D) Chelonians
3. What are the limitations of endoscopy in snakes 
related to?
(A) Size and length of the telescope
(B) Size and length of internal organs
(C) Specific anatomy of these species
(D) Lack of diaphragm and possibility of 
insufflation
Top tips for ferret 
surgery 
Paolo Selleri
Many common disease syndromes of pet ferrets often 
require surgical treatment. Young ferrets enjoy chewing 
on and are more frequently exposed to the ingestion of 
foreign bodies such as rubber, cork, and occasionally 
cloth. When the obstruction is only partial the ferret may 
show signs of discomfort, intermittent anorexia and 
vomiting, but faeces are still produced. History, gentle 
palpation of the abdomen, and diagnostic imaging 
are  necessary to locate the foreign body. Most ferrets 
have a relaxed abdomen that makes objects easy to pal-
pate when they are in the intestine. When these objects 
are stuck in the stomach they can be more difficult to 
 palpate. Radiography may reveal direct signs of obstruc-
tion (the foreign body) or, more frequently secondary 
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signs (gas pattern). Surgical procedures of the gastroin-
testinal tract should follow those guidelines for cats. Due 
to the fact that ferrets are often presented with multiple 
conditions, before starting an abdominal surgical proce-
dure it is always recommended to perform a complete 
ultrasonography of the abdomen.
Some of these concurrent diseases, especially in 
older ferrets, are neoplastic. The most frequently encoun-
tered are insulinomas, adrenal gland carcinoma, skin 
mast cell tumours and lymphoma. Surgical excision and 
staging can be recommended for most cases, but in the 
case of lymphoma, chemotherapy is recommended.
Ferrets are strictly carnivorous mammals and they 
have acidic urine. When their diet is rich in vegetables the 
urine pH rises and sand or calculus can be found in the 
urinary tract. Cystotomy and urethrostomy (in the male) 
are the most common surgical procedures and the tech-
niques are similar to those used in small animals.
KEY LEARNING OBJECTIVES
■■ Understand the right approach to the surgery of 
an animal with a small body size
■■ Discuss the different options when dealing with 
neoplastic diseases
■■ Learning the fastest techniques to safely remove 
an enlarged spleen 
MULTIPLE CHOICE QUESTIONS
1. In which of the following neoplastic diseases is 
surgery contraindicated?
(A) Skin mast cell tumour
(B) Insulinoma
(C) Lymphoma
(D) Adrenal gland adenoma
2. What is the biggest concern regarding 
adrenalectomy in ferrets?
(A) Risk of life-threatening haemorrhage when 
performing left adrenalectomy 
(B) Risk of life-threatening haemorrhage when 
performing right adrenalectomy
(C) Acute kidney damage
(D) Pancreatitis
3. Which of the following is correct with regard 
to partial pancreatectomy?
(A) It is the treatment of choice in localized 
insulinomas
(B) It is used in conjuction with medical 
treatment including diazoxide
(C) Both (A) and (B) are incorrect
(D) Both (A) and (B) are correct
Reptile diagnostic 
imaging
Paolo Selleri
A deep knowledge of the anatomy, physiology and 
pathology of the species being investigated is mandatory 
for the correct interpretation of diagnostic imaging. 
Radiography is the first resource used in herpeto-
logical medicine. Skeletal fractures are often found in 
reptiles kept in captivity. They are usually assessed by 
means of plain radiographs. The clinician should be 
aware that, in reptiles, the fracture-healing process 
involves a mixture of fibrous tissue and osseous callus; 
therefore, clinical fracture stability occurs a long time 
before radiographic healing becomes evident. Metabolic 
bone diseases are also extremely common, but radio-
graphic visualization of the bone loss is only possible 
when loss of density is greater than 40%.
Other than skeletal disorders, radiography can rap-
idly identify gastrointestinal disorders (dilatation, foreign 
body obstruction), coelomic conditions, neoplasia or 
reproductive problems. Especially in chelonians and 
 lizards, follicular stasis or dystocia can be diagnosed via 
this imaging technique.
In lizards (such as iguanas or chameleons), another 
frequently encountered condition is renal disease. 
Enlargement of the kidneys can be seen on the lateral 
view. Secondary signs of kidney disease can be dilatation 
of the intestinal tract, secondary to the enlargement of 
the kidneys that can impede the passage of faeces 
through the pelvic canal. The kidneys lie in the pelvic 
area and can be visualized via a dorsal approach just 
 cranial to the iliac bones.
In chelonians horizontal radiographic beam orienta-
tion and horizontal positioning (lateral and craniocaudal) 
are often necessary to reduce errors in radiographic 
interpretation due to superimposition of the lung, blad-
der and internal organs on vertical views.
Although radiography is still very often used as the most 
common imaging technique in reptiles,  ultrasonography 
and computed tomography (CT) scanning are gaining 
ground, due to the fact that they can be used to evaluate any 
system in a reptile: the heart, liver, gallbladder, urinary 
 bladder, intestine and reproductive tract. 
Reptiles with thick and calcified scales can be prob-
lematic for ultrasonography due to artefacts caused by 
air pockets between the scales. Giving the patient a warm 
bath prior to investigation will reduce the potential air 
pockets, as will spraying the patient with water prior to 
applying the ultrasound gel. Animals undergoing ecdysis 
can also be problematic to scan due to the air between 
the old and the new skin layers. In small patient a water 
bath can be used with the transducer submerged below 
the surface.
Lizards can be placed in dorsal recumbency with the 
probe directed downwards or held in ventral recum-
bency with the probe directed from below. The ventral 
body wall is the main approach and provides information 
on the majority of the coelomic organs.
In young chelonians or soft-shelled subjects, scan-
ning through the shell is possible and this can be directed 
over the area of interest. In adult chelonians, the sites 
available for ultrasound are the prefemoral fossa and the 
region between the neck and the thoracic inlet. 
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KEY LEARNING OBJECTIVES
■■ Understand the importance of the correct 
positioning when performing a radiological study 
in a chelonian
■■ Discuss the limitations of conventional radiology 
compared to computed tomography 
■■ Discuss the different diagnostic imaging  
techniques when dealing with respiratory signs  
in a reptile
(C) It cannot be used in chelonians
(D) None of the answers is correct
2. Where can ultrasonography be performed in all 
chelonians?
(A) Through the prefemoral fossa and the 
region between the neck and thoracic inlet 
(B) Through the prefemoral fossa, the 
carapace and the region between the neck 
and thoracic inlet 
(C) Through the prefemoral fossa, the plastron 
and the region between the neck and 
thoracic inlet 
(D) In water, to hydrate the skin and minimize 
artefacts
3. What is the LL view is especially useful for 
diagnosing in lizards?
(A) Nutritional secondary hyperparathyroidism
(B) Renal disease
(C) Follicular stasis
(D) All of the above
MULTIPLE CHOICE QUESTIONS
1. Why is radiography used as a diagnostic 
technique in reptiles with metabolic  
disorders?
(A) Because it has high sensitivity in the first 
stage of the disease 
(B) To provide useful evidence regarding the 
prognosis of the patient 
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Dermatophytosis case 
book – common 
impersonators and 
atypical presentations
Sue Paterson
Dermatophytosis is an uncommon dermatological dis-
ease, representing less than 2% of dermatological disor-
ders in dogs and cats. The most common dermatophyte 
species found in domesticated animals belong to the 
genera Microsporum or Trichophyton. 
The clinical signs of dermatophytosis are protean 
and as such can mimic many different diseases. The 
 classical text book description of Microsporum canis 
infection in dogs and cats is of a well circumscribed, 
focal or multifocal, mildly pruritic, alopecic ‘cigarette’ 
scale lesions; but dermatophytosis can present with any 
combination of hair loss, papules, scales, crusts,  erythema, 
follicular plugging, hyperpigmentation and, particularly in 
dogs, with changes in nail growth/appearance. 
M. canis is the most commonly identified feline 
 dermatophyte and should be on the differential diagno-
ses list of any dermatological problem in the cat. This 
should include such diseases as the eosinophilic granu-
loma complex, including miliary dermatitis, eosinophilic 
plaques and granulomas. Any cat with an alopecic condi-
tion should be assessed for dermatophytosis whether the 
hair loss is traumatic due to over-grooming and asso-
ciated self-inflicted trauma, or due to spontaneous hair 
loss  due to follicular infection. Dermatophytosis can 
 present with focal or generalized scaling which can 
mimic a range of seborrhoeic and inflammatory  diseases, 
such as idiopathic seborrhoea, allergy and ectoparasite 
infestations (which are often seen in conjunction with 
dermatophyte infections). Immune-mediated diseases, 
such as mural folliculitis, and neoplastic diseases, such as 
epitheliotropic lymphoma or thymoma, may also have 
similar presentations to generalized dermatophytosis. 
Pododermatitis can be a presenting sign of dermatophy-
tosis in the cat. 
In the dog the most commonly identified dermato-
phytes are M. canis, M. persicolor and Trichophyton 
mentagrophytes. Whilst dogs with M. canis often present 
with the classical focal, alopecic grey, scaling lesions, this 
pathogen can also manifest with other signs.  Microsporum 
persicolor can present with generalized dorsal scaling, so 
that it should be investigated and ruled out in any inflam-
matory (allergy, ectoparasites); endocrine (hypothyroid-
ism, hyperadrenocorticism); neoplastic (epithelotropic 
lymphoma) or seborrhoeic disease with similar dermato-
logical signs. Animals with immunosuppressive disease 
are more susceptible to the  development of ringworm. 
They often present with atypical multifocal or diffuse 
lesions, so the addition of a dermatophyte  culture is use-
ful in any disease that leads to immune suppression. 
Infections with Trichophyton spp. are more inflammatory 
than infections with  Microsporum spp. They can there-
fore mimic many different ulcerative, inflammatory dis-
eases such as pyotraumatic dermatitis and pyoderma. 
Dermatophyte infection of nails, onychomycosis, is 
 typically characterized by onychogryphosis of one or 
multiple digits. Principal differential diagnoses for 
 onychomycosis include symmetrical lupoid onycho-
dys tro phy, dermatomyositis and leishmaniasis. Pustular 
 dermatophytosis has been described in dogs and it can 
histologically mimic pemphigus foliaceus.  
Both dogs and cats can develop nodular dermato-
phyte infections. These include kerion,  pseudomycetoma 
and mycetoma. Kerions present as single or multiple ery-
thematous, alopecic, dome-shaped, exudative nodules. 
Pseudomycetomas and mycetomas present as nodules 
that fistulate, ulcerate and drain serous to purulent debris 
with tissue grains. Nodular dermatophyte infections 
should be included in all differential diagnoses lists for 
hyperplastic and neoplastic diseases.  
KEY LEARNING OBJECTIVES
■■ Learn the most common presentations of 
dermatophytosis in dogs and cats
■■ Recognize the wide range of atypical presentations 
of dermatophytosis and the most common 
differential diagnoses
■■ Recognize the different nodular forms of 
dermatophytosis and the appropriate differential 
diagnoses that should be considered
MULTIPLE CHOICE QUESTIONS 
1. Which of these is not a recognized as a cause 
of dermatophyte infection in the dog? 
(A) Microsporum cati
(B) Microsporum canis
(C) Microsporum persicolor
(D) Microsproum gypseum 
2. Which of the following would not be 
considered as a differential diagnosis for 
onychomycosis in the dog? 
(A) Leishmaniasis 
(B) Pemphigus foliaceus 
(C) Dermatomyositis 
(D) Symmetrical lupoid onychodystrophy
3. Which of the phrases below best describes the 
typical lesions of Microsporum canis infection? 
(A) Nodular and exudative
(B) Grey scale and alopecia 
(C) Crusted and papular
(D) Erythematous and ulcerated
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Is it a false positive? 
Current 
recommendations for 
diagnosis of 
dermatophytosis
Sue Paterson 
DIAGNOSIS
Dermatophytosis is an infectious and contagious disease, 
so where it is suspected as a cause of clinical lesions in a 
cat or dog every effort should be made to make a diag-
nosis and start appropriate therapy as quickly as possible. 
There is no one ‘gold standard’ test, so multiple tech-
niques should be employed. A range of different tests can 
be employed to diagnose dermatophytosis. 
Woods lamp examination will identify the typical 
apple green fluorescence of Microsporum canis-infected 
hair shafts. Other dermatophytes do not fluoresce. Topi-
cal therapy with lime sulphur or enilconazole will not 
cause loss of fluorescence. False-positive fluorescence 
can be seen with topical medication but it does not 
involve the whole hair shaft and is not usually apple 
green. 
Dermoscopy is a non-invasive diagnostic technique 
using a tool that allows illuminated magnification of the 
skin. Findings that have been described that are unique 
to  cats with dermatophytosis include opaque, slightly 
curved or broken hairs with a homogeneous thickness 
(‘comma hairs’) and hairs with a corkscrew or coiled 
appearance. 
Direct examination of hair and/or scale taken from 
lesional skin can be useful. The sample is mounted in 
solutions of chlorphenolac, mineral oil, potassium hydrox-
ide and calcofluor. Stains such as lactophenol cotton 
blue and Indian ink can be added to the mounting 
medium to improve visualization of fungal elements. 
Fungal culture can be taken by hair coat brushing 
(toothbrush or sterile carpet square), hair pluckings or by 
sticky tape sampling. Sabouraud’s dextrose agar (SDA) or 
dermatophyte test medium (DTM) are suitable growth 
media. SDA encourages the development of typical 
 fungal growth characteristics, e.g. reverse pigmentation 
and macrocondia to allow identification; DTM relies on a 
colour change from yellow to red in the medium, within 
10 days, due to a pH change triggered by early dermato-
phyte growth. 
Polymerase chain reaction (PCR) can be used as a 
diagnostic tool. However, a positive PCR indicates the 
presence of dermatophyte but not that there is active 
infection. It is probably best employed in combination 
with other tests. 
Biopsy is not a useful diagnostic tool for dermatophy-
tosis. Histopathology with special stains may be  useful for 
nodular lesions.
TREATMENT
Dermatophytosis can be treated with both systemic and 
topical mediation. The current World Association for 
 Veterinary Dermatology (WAVD) recommendations 
for  topical therapy are lime sulphur, enilconazole or a 
 miconazole/chlorhexidine shampoo. Used twice weekly, 
these topical therapies can resolve localized dermato-
phytosis,  protect against infection and reduce environ-
mental contamination. In generalized disease they may 
be  combined with systemic medication to reduce the 
time to mycological cure. 
Itraconazole and terbinafine are the safest and most 
effective systemic therapies in dogs and cats. Ketocona-
zole and fluconazole are less effective and have been 
shown, particularly in cats, to produce gastrointestinal 
side effects. 
Lufenuron has been shown to have no in vitro activ-
ity against dermatophytes; it does not alter the course 
of  infection or enhance the activity of other topical or 
systemic drugs and has no place in therapy. 
Anti-fungal vaccines offer no protection against 
 dermatophyte challenge but do seem to produce some 
benefit when used in combination with other therapy.  
KEY LEARNING OBJECTIVES 
■■ Appreciate the different diagnostic tests that can be 
used to diagnose dermatophytosis
■■ Appreciate the different topical products that can be 
used in therapy
■■ Learn about the different systemic antimycotics that 
may be used to treat dermatophytosis
MULTIPLE CHOICE QUESTIONS
1. Which of the following is NOT considered to be 
a useful test to diagnose dermatophytosis? 
(A) Wood’s lamp examination 
(B) Examination of hair with calcofluor 
staining 
(C) Dermoscopy of hair
(D) Serum M. canis IgG levels
2. Which statement about these systemic 
therapies is true?
(A) Anti-fungal vaccines are useful in 
controlling dermatophytosis 
(B) Itraconazole is tolerated better in cats than 
ketoconazole
(C) Terbinafine is not a useful drug for 
dermatophytosis therapy
(D) Lufenuron has excellent activity against 
dermtophytes
3. Which of these topical products is  
recommended (WAVD guidelines) for topical 
therapy of dermatophytosis? 
(A) Lime sulphur
(B) Chlorhexidine 
(C) Benzoyl peroxide 
(D) Ethyl lactate  
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Managing multiples: 
dermatophytpsis 
disease outbreaks
Sue Paterson 
The management of multiple outbreaks can be challeng-
ing, especially where it involves a rescue centre where 
financial constraints can make therapy difficult. 
The first stage should be to diagnose which animals 
are infected and which are not infected. Diagnosis is 
most economically achieved by clinical examination and 
Wood’s lamp inspection with microscopic assessment. 
Fungal culture may be necessary in some cases but 
should not be used where other diagnostic methods are 
adequate. 
Animals should be divided into infected and non-
infected, and should be strictly isolated from each other. 
The non-infected group should be treated twice weekly 
with lime sulphur to prevent infection and treat any 
infected animals that have been missed by the initial 
diagnostic tests. This is safe for use on kittens, adult 
queens and breeding males. 
Infected animals should, where finances allow, be 
treated with a combination of topical and systemic med-
ication. Suitable protocols include oral itraconazole and 
twice-weekly limesulphur dips; oral terbinafine and twice 
weekly limesulphur dips; or itraconazole with twice 
weekly application of enilconazole. Studies have shown 
that combinations of topical and systemic medication 
can clear a shelter of dermatophytosis within a month. 
Animals should be monitored and once there is 
 evidence of clinical cure, fungal cultures should be per-
formed. Current recommendations suggest mycological 
cure is consistent with two negative cultures 7 days apart. 
Once mycological cure is achieved, animals can be 
transferred to the non-infected group.
Infection of animals and people from the environ-
ment without concurrent microtrauma is very rare. The 
main aim of environmental decontamination is to  prevent 
fomite contamination which can lead to false-positive 
fungal results as part of the treatment monitoring pro-
cess, leading to the unnecessary prolongation of therapy 
and extended periods of confinement. The clipping of an 
animal’s coat, together with topical therapy, can help to 
reduce environmental contamination. A range of differ-
ent strategies can be employed to remove infected mate-
rial from the environment. For non-porous surfaces this 
should involve three steps. The first is the mechanical 
removal of all debris by vacuuming or sweeping. The 
second step should be washing of the surface with a 
household detergent to clean the surfaces, followed by 
the application of an anti-fungal disinfectant. The use of 
a disinfectant without appropriate cleaning is often inef-
fective. Suitable disinfectants include: sodium hypochlo-
rite (household bleach), which has been shown to be 
effective at concentrations ranging from 1:10 to 1:100; 
enilconazole; accelerated hydrogen peroxide and potas-
sium peroxymonosulphate. The decontamination of soft 
fabric is not dependent on disinfectants but can be 
accomplished by mechanical washing in any water 
 temperature with or without sodium hypochlorite. Two 
washes on the longest wash cycles appear to be  effective; 
it is important not to over-fill the drum, so that adequate 
agitation can take place. Decontamination of carpets 
cannot be achieved by vacuuming alone. Pretreatment of 
the carpet with a disinfectant followed by a carpet sham-
poo was found to be effective. A small piece of carpet 
should be checked for colourfastness before any disin-
fectant is applied to large areas. 
KEY LEARNING OBJECTIVES
■■ Learn how to put in place a successful treatment 
plan for a cattery
■■ Learn which combinations of drugs produce the 
most rapid resolution of clinical signs
■■ Learn what measures need to be undertaken to 
achieve environmental decontamination 
MULTIPLE CHOICE QUESTIONS
1. Which combination of topical and systemic 
therapy is NOT recommended as part of a 
cattery treatment protocol? 
(A) Lime sulphur twice weekly with oral 
terbinafine
(B) Enilconazole twice weekly with oral 
itraconazole
(C) Lime sulphur twice weekly with oral 
itraconazole
(D) Potassium iodine twice weekly with oral 
terbinafine 
2. How is mycological curedefined, according to 
World Association for Veterinary Dermatology 
(WAVD) guidelines? 
(A) Two negative fungal cultures 7 days apart
(B) Absence of lesional skin for a period of 
7 days 
(C) Two negative cultures 14 days apart
(D) Lack of Wood’s lamp fluorescence 
3. Which phrase best describes the three 
necessary steps in environmental 
decontamination for dermatophytosis? 
(A) Disinfection, desiccation, drying
(B) Cleaning, detergent, disinfection
(C) Disinfection, detergent, drying
(D) Cleaning, disinfectant, detergent
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Ophthalmology
60 08:30–10:10The cracked or dirty windshield: disorders of the ocular surface
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Ron Ofri
62 12:00–12:45Glaucoma: understanding and treating a leading and painful 
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Ron Ofri
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The cracked or dirty 
windshield: disorders 
of the ocular surface
Caryn Plummer
The conjunctiva is associated with many adnexal and 
bulbar diseases due to its exposure and close proximity 
to both internal and external ocular structures. The key 
to the clinical management of conjunctival diseases is to 
determine and, if possible, eliminate the cause. The con-
junctiva plays a role in tear dynamics, immunological 
protection of the eye, ocular movement and corneal 
healing. A mucous membrane, the conjunctiva, lines the 
inside of the eyelids (palpebral conjunctiva), beginning 
at the eyelid margin and extending deep toward the orbit 
to create a fornix (conjunctival cul-de-sac or fornix), at 
which it reverses direction and extends over the globe to 
the limbus (bulbar conjunctiva). The bulbar conjunctiva 
is freely movable, except near the limbus, thereby facili-
tating its use as a graft tissue for the cornea. The con-
junctiva contains many lymphoid nodules, which receive 
antigen and to present it to circulating mononuclear 
cells. Goblet cells are also present in the epithelial layer 
of the conjunctiva. These cells produce a gel-like mucin, 
which forms the deepest of the three layers of the 
 preocular (i.e. precorneal) tear film. Deficiencies in the 
precorneal tear film may be either quantitative or quali-
tative. Disturbances of the tarsal or Meibomian glands 
(lipid layer of the tear film) and the conjunctival goblet 
cells (mucin layer of the tear film) may produce clinical 
signs of keratoconjunctivitis sicca (KCS) but Schirmer’s 
tear test measurements are usually within the normal 
range. 
The cornea, as a unique portion of the outer fibrous 
tunic of the eye, is transparent and serves a major 
refractive function while maintaining a tough, physical 
and impermeable barrier between the eye and the 
 environment. The cornea consists of an outer epithe-
lium and basement membrane, stroma, Descemet’s 
membrane, and the endothelium. Corneal transparency 
depends on the absence of blood vessels and pigment, 
its non-keratinized anterior surface epithelium, the 
stroma’s lattice organization and the small diameter of 
the stromal collagen fibrils. The corneal endothelium 
uses an active physiological pump to remove and trans-
port fluid into the anterior chamber. Ulcerations of the 
cornea are among the most common ocular diseases in 
small animal patients, however, a variety of inflamma-
tory and degenerative conditions may be problematic 
as well.
Maintaining the health of the tear film and the struc-
tures that comprise the ocular surface are critical to the 
integrity and clarity of the windshield. 
KEY LEARNING OBJECTIVES
■■ Recognize the clinical signs of tear film 
abnormalities and develop a plan for investigating 
and eliminating the underlying aetiology, instituting 
therapy and monitoring response
■■ Appreciate and differentiate between different types 
of opacities in the cornea and their underlying 
aetiologies
■■ Understand the pathogenesis and aetiology of 
corneal ulceration and recognize clinical signs that 
indicate a corneal wound is likely to progress
MULTIPLE CHOICE QUESTIONS
1. Which of the following can be used to 
specifically reduce the excessive enzymatic 
activity which results in corneal collagen 
destruction?
(A) Diclofenac
(B) EDTA
(C) Ciprofloxacin
(D) Atropine
2. Which of the following can result in clinical 
signs of dry eye?
(A) Feline herpesvirus-1
(B) Meibomianitis
(C) Facial nerve paralysis
(D) All of the above
3. Which of the following is NOT an indication 
that a corneal ulcer may be infected?
(A) Cellular infiltrate
(B) Profound uveitis
(C) Keratomalacia
(D) Re-epithelialization
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The ‘bulging eye’: 
how do I know; how 
do I treat? 
Ron Ofri
TRAUMATIC PROLAPSE
Prognostic indicators
■■ Skull conformation. Traumatic prolapse is common 
in brachycephalic dog breeds, due to the shallow 
orbit and poor lid closure. In these breeds minimal 
trauma may cause prolapse. In cats and in 
mesocephalic and dolichocephalic dogs the 
prognosis is poorer
■■ Depending on the duration of the prolapse, animals 
may present with corneal ulceration, necrosis or 
perforation
■■ Hyphaema is a bad prognostic indicator, implying 
trauma to the uvea or globe rupture. Ultrasound 
examination may reveal other intraocular injuries. 
■■ Pupillary light reaction (PLR) is an important sign. If 
the pupil cannot be seen, the consensual reflex 
should be checked
■■ Strabismus and extraocular muscles. Rupture of too 
many muscles will result in ocular ischaemia
Treatment
Anaesthetize the patient and pull the eyelids out over the 
equator. The globe is pushed back into the orbit using 
gentle pressure. A lateral canthotomy may facilitate 
replacement. Temporary tarsorrhaphy is performed to 
maintain lid closure. Make sure that the suture passes 
through the lid margin (Meibomian gland openings) and 
not through the palpebral conjunctiva. 
EXOPHTHALMOS 
Retrobulbar cellulitis/abscess
The disease is characterized by acute onset and by severe 
pain. This leads to refusal to eat and great resistance to 
opening the mouth for examination. Sedate the patient, 
open the mouth and then you may see a red swelling, or 
even an open draining tract, in the oral mucosa, behind 
the last upper molar tooth. If no gross lesion is visible, use 
imaging techniques, such as ultrasound or computed 
tomography (CT) that may also demonstrate foreign 
bodies, or allow performance of guided fine-needle 
aspirations for cytological diagnosis. 
To treat, incise the mucosa behind the last upper 
molar, and slowly inset a pair of curved hemostats to 
blindly explore the orbit and open pockets of exudate. If 
a pocket of exudate is encountered, copious amounts of 
exudate will flow out. In cases of retrobulbar cellulitis, no 
massive drainage of exudate will be seen. However, 
the  very act of establishing a draining tract is usually 
 sufficient to achieve a cure.
Flush the orbit with saline and antibiotics. The wound 
is not sutured. Systemic antibiotics are administered for 
10–14 days, and the animal fed soft food. Dramatic, and 
most rewarding, improvement is usually observed within 
1–2 days. 
Retrobulbar tumour
In contrast to retrobulbar abscesses, retrobulbar tumours 
are usually very slowly progressive, and non-painful. Fur-
thermore, patients with retrobulbar tumours are signifi-
cantly older than patients with retrobulbar abscesses. A 
retrobulbar tumour can cause deformation of the posterior 
part of the globe that can be visualized ophthalmoscopi-
cally, or using ultrasonography. However, ultimate localiza-
tion relies on ultrasonography, CT or magnetic resonance 
imaging (MRI). The diagnosis is confirmed by guided fine-
needle aspiration and cytology.
Solitary tumours in early stages may be removed 
by  oribitotomy, and it may be possible to preserve the 
globe and vision. Advanced cases may require radical 
orbitectomy, combined with radiation therapy and/or 
chemotherapy. However, most tumours are discovered 
in advanced stages, and due to their malignant nature 
they carry a very poor prognosis. 
KEY LEARNING OBJECTIVES
■■ What are the prognostic indicators in traumatic 
prolapse?
■■ How do I differentiate between exophthalmos and 
buphthalmos?
■■ How do I properly treat cases of traumatic prolapse 
and retrobulbar abscess?
MULTIPLE CHOICE QUESTIONS
1. In cases of traumatic prolapse, when should 
enucleation be offered?
(A) There is hyphaema
(B) There is no PLR
(C) There is retinal detachment
(D) Surgical replacement has failed
2. With which of the following do patients with a 
retrobulbar tumour present?
(A) Acute pain
(B) Refusal to open the mouth
(C) Elevated third eyelid
(D) Blindness
3. How are exophthalmos and buphthalmos are 
differentiated?
(A) Retropulsion test
(B) Estimating corneal curvature
(C) Ultrasonography
(D) All of the above
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Glaucoma: 
understanding and 
treating a leading and 
painful cause of 
blindness
Ron Ofri
DIAGNOSING GLAUCOMA
Measuring intraocular pressure
In most animals, the normal intraocular pressure (IOP) 
range is 15–25 mmHg. IOP should be similar in both 
eyes. Differences >10 mmHg between eyes may also 
indicate glaucoma. 
Examining the iridocorneal angle – 
gonioscopy
The angle is examined to determine the risk of glaucoma 
(in case of a breed with primary glaucoma, or if the other 
eye developed the disease). Gonioscopy is performed 
in  referral practices using a goniolens that allows us to 
visualize the entire angle, and to classify its state.
Based on clinical signs
Chronic or acute pain, buphthalmos, episcleral conges-
tion (‘red eye’), corneal oedema and striate keratopathy 
are commonly seen. The pupil may be sluggish, or fixed 
and dilated. Damage to the retina will cause progressive 
loss of vision, leading to complete blindness. In the end 
stage of the disease, due to chronic elevation of IOP, the 
ciliary body may atrophy, causing decreased aqueous 
production, lowering of pressure, and phthisis bulbi.
TREATMENT
Principles of glaucoma treatment
■■ The aims of treatment are preventing further loss of 
vision and decreasing the pain. Currently, it is 
impossible to restore vision lost due to glaucoma
■■ Primary glaucoma requires lifelong treatment. 
Owners must understand that the aim of the 
therapy is to stabilize the IOP, and that the disease is 
never cured
■■ Diagnosis or suspicion of primary glaucoma in 
one eye mandates prophylactic treatment in the 
other eye
Medical therapy of glaucoma
■■ Osmotic diuretics. These drugs serve for emergency 
lowering of pressure in cases of acute attacks. The 
most commonly used drug in this category is 
mannitol (1–2 g/kg i.v.), administered slowly, over 
30 minutes, and water is withheld for 3–4 hours
■■ Prostglandin analogues. These increase the 
unconventional outflow. They are most effective in 
the dog, because their effect is independent of the 
state of the angle. They are ineffective in cats 
(which lack the receptor), and are contraindicated 
in uveitis
■■ Carbonic anhydrase inhibitors. Carbonic 
anhydrase is a key enzyme in aqueous humour 
production, and its inhibition will result in lower 
production and decreased IOP. The topical form 
of the drug (dorzolamide, brinzolamide) has none 
of the systemic side effects observed with 
systemic drugs 
■■ Topical miotics. These drugs increase drainage by 
opening the iridocorneal angle. The most 
commonly-used drug in this category is pilocarpine 
(1–4%, q8–12h)
■■ Beta-blockers. These sympatholytic drugs reduce 
aqueous production by reducing flow of blood to 
the ciliary body. They are commonly used in 
humans, but their effectiveness in animals is 
controversial. Systemic side effects are common in 
small dogs, cats and animals with pulmonary/
cardiovascular diseases
Surgical treatment of glaucoma
Referral ophthalmology clinics may perform surgery to 
increase aqueous outflow (usually by implanting drain-
age tubes in the eye), or to decrease aqueous production 
(through partial destruction of the ciliary body, using 
laser or cryosurgery). However, treatment frequently 
fails, resulting in a blind and painful eye. Patient welfare 
requires the removal of this eye, through enucleation or 
evisceration (implanting a prosthesis in an empty scleral 
‘shell’, to provide a more cosmetic appearance). 
KEY LEARNING OBJECTIVES
■■ How do we classify glaucoma and why is it 
important?
■■ What are the clinical signs of glaucoma?
■■ How should I treat my glaucoma patients?
MULTIPLE CHOICE QUESTIONS
1. What is the drug of choice for treating primary 
canine glaucoma?
(A) Latanoprost
(B) Dorzolamide
(C) Pilocarpine
(D) Timolol
2. What is the drug of choice for treating feline 
glaucoma?
(A) Latanoprost
(B) Dorzolamide
(C) Pilocarpine
(D) Timolol
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3. Which of the following is TRUE about 
beginning preventive treatment in the 
unaffected eye in a dog presenting with 
unilateral, primary glaucoma?
(A) Is a waste of time and money, as the dog 
will get glaucoma in the unaffected eye 
within a week
(B) Guarantees the dog will never have 
glaucoma in the unaffected eye
(C) Will delay glaucoma in the unaffected eye 
by about 4–6 months
(D) Will delay glaucoma in the unaffected eye 
by about 2 years
Ophthalmic 
manifestations of 
endocrinopathies
Caryn Plummer
Small animal patients afflicted with various endocrinopa-
thies are at risk for the development of many ophthalmic 
conditions as the result of their endocrine hormone 
imbalances. The most well recognized ophthalmic con-
sequence of an endocrine disorder is the development 
of cataracts secondary to canine diabetes mellitus (DM). 
However, cataracts are not the only potential ocular 
complication of this pancreatic endocrine disease. 
 Secondary lens-induced uveitis, poor corneal wound 
healing and corneal neuropathy, altered lipid metabo-
lism, retinal lesions and systemic hypertension are also 
potential consequences of diabetes in small animals. The 
incidence and severity of ophthalmic manifestations of 
DM are generally related to the efficacy of glycaemic 
control.
Ocular complications are often not considered 
among the primary manifestations of hyperadrenocorti-
cism (HAC) in small animals. However, there is actually an 
extensive list of possible ophthalmic consequences to 
the excessive levels of corticosteroids present in this 
 disorder. Possible findings vary depending on the specific 
circumstances of the case and the location of the pri-
mary causative lesion, in the adrenal glands themselves 
or in the pituitary gland. Conversely, systemic hyperten-
sion and its repercussions are common regardless of the 
site of the primary lesion, as are metabolic changes 
 associated with hyperlipidaemia and lipoproteinaemia. In 
addition to its previously discussed lipid-laden aqueous 
and retinalis, hyperlipidaemia in the Cushingoid patient 
occasionally results in cholesterol infiltrates in the 
 cornea. Acute blindness from sudden acquired retinal 
degeneration has been associated with disease of the 
pituitary–adrenal axis. Concurrent DM seen in some 
cases contributes the additional risks of cataract devel-
opment and lens-induced uveitis, as well as the potential 
for retinal pathology.
Ocular signs associated with hypothyroidism are not 
common, but can occur. When they are observed, they 
are usually secondary to hyperlipidaemia or hyperlipopro-
teinaemia. However, there are other potential ocular con-
sequences of hypothyroidism, including those due to 
neurological dysfunction. Facial nerve paralysis can  initiate 
or exacerbate difficulties with exposure and subsequent 
keratitis. Horner’s syndrome, in which patients present 
with miosis, ptosis, enophthalmos and protrusion of the 
third eyelid, may also be present in some cases. Occasion-
ally, keratoconjunctivitis sicca (KCS) can result from a 
peripheral neuropathy affecting the innervation of the lac-
rimal gland and may even accompany facial paralysis. 
Corneal lipid deposits and infiltrates or lipid-laden aque-
ous humour and its associated uveitis are the most com-
mon metabolic consequences of hypothyroidism. The 
most predictable ophthalmic manifestations of hyperthy-
roidism are those associated with systemic hypertension.
Disorders of calcium homeostasis are unusual, but can 
occur, usually in the form of cataracts in hypocalcaemic 
patients or metastatic calcification of the ocular  tissues. 
KEY LEARNING OBJECTIVES
■■ Recognize and appreciate the many and varied 
ophthalmic consequences of endocrine disease and 
their clinical signs
■■ Understand the aetiopathogenesis of ophthalmic 
lesions that develop with endocrine disease
■■ Recognize when therapy is indicated for endocrine-
induced ophthalmic disease
MULTIPLE CHOICE QUESTIONS
1. Diabetes mellitus may be associated with which 
ocular abnormalities?
(A) Cataracts
(B) Recurrent or refractory corneal ulcers
(C) Retinal haemorrhage
(D) All of the above
2. Hyperlipoproteinaemia may result in which 
ocular abnormalities?
(A) Lipaemic aqueous humour
(B) Corneal ulceration
(C) Enophthalmos
(D) Facial paralysis
3. Ocular signs consistent with systemic 
hypertension may occur with which disease 
states?
(A) Hyperadrenocorticism
(B) Diabetes mellitus
(C) Renal failure
(D) All of the above
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Masquerading eye 
disease: when one 
disease looks like 
another
Caryn Plummer
There are two potential scenarios for a masquerading 
ocular disease. The first is that the eye disease is actually 
a manifestation of a systemic condition. The other 
involves an uncommon or lesser recognized eye condi-
tion that grossly resembles a common condition. This 
lecture will touch on both situations.
The eye is the window to the soul, as the saying 
goes … But it is also sometimes the window to the body. 
Due to the presence of various blood–ocular barriers, 
the impact of systemic disease on the eye is blunted. 
When systemic disease does affect the eye, the conse-
quences can be dire. The eye has only a limited capacity 
to respond to insult (inflammation and degeneration) 
and  if its own reactions to disease are not addressed 
promptly, the structures that permit vision can be irrevo-
cably damaged and significant pain can result. Any global 
disease process has the potential to affect the eye. Hae-
matological, biochemical, developmental, degenerative, 
metabolic, inflammatory, infectious, immune-mediated, 
neoplastic, nutritional, toxic, traumatic and vascular dis-
eases have all been reported to cause harm to the eye 
(remember the DAMNIT-V scheme?). In many instances, 
ocular involvement changes the required treatment or 
prognosis of systemic disease. The importance of includ-
ing a full ophthalmic examination with your physical 
examination cannot be stressed enough. Also, when a 
patient presents with ocular disease (especially if it is 
bilateral and inflammatory), a full physical examination 
should be performed to look for underlying systemic 
aetiologies. 
Lymphoma in dogs and cats is the ultimate masquer-
ader. It may manifest as corneal oedema, centrally 
migrating white bands of neoplastic cells, stromal haem-
orrhage, corneal vascularization, anterior uveitis with 
hyphaema, hypopyon, keratic precipitates and second-
ary glaucoma, and tortuous retinal vessels, retinal haem-
orrhages, perivascular sheathing, retinal detachment, or 
retinal tissue infiltration by tumour cells. Conjunctivitis, 
hyphaema, anterior uveitis, retinal detachment and glau-
coma may be caused by lymphoma. Lymphadenopathy 
combined with bilateral anterior uveitis or intraocular 
haemorrhages should cause suspicion of lymphoma. 
There is a variety of primary ocular conditions that 
are not what they seem. Benign cysts and solid tissue 
masses can be difficult to differentiate. Manifestations of 
pigment dispersion and proliferation may be especially 
difficult to tease apart. Neoplasms can appear similar to 
inflammatory conditions and corneal opacities may 
appear similar but be the result of significantly different 
disease processes. 
KEY LEARNING OBJECTIVES
■■ Recognize when an ophthalmic condition may be 
an ophthalmic manifestation of a systemic condition 
and when further diagnostics are indicated
■■ Appreciate subtle differences in clinical 
manifestation, coexisting clinical signs and 
signalment to help differentiate between ocular 
conditions with similar appearances
■■ Appreciate the many ocular manifestations of 
lymphoma in small animals
MULTIPLE CHOICE QUESTIONS
1. Uveal cysts may be associated with uveitis and 
glaucoma in what canine breed?
(A) Poodles
(B) Golden Retrievers
(C) Irish Wolfhounds
(D) Basenjis
2. Lymphoma may present with which of the 
following clinical signs?
(A) Uveitis
(B) Retinal detachment
(C) Exophthalmos
(D) All of the above
3. What might a diagnostic work-up for bilateral 
uveitis include?
(A) Complete blood count and serum 
biochemical profile 
(B) Geographically (including travel history) 
appropriate infectious disease serology
(C) Imaging of the thorax and abdomen 
(D) All of the above
Cataract: what can 
I do about it?
Ron Ofri
Cataract is an opacity of the lens. Potential causes 
include metabolic disease (e.g. diabetes mellitus), 
intraocular disease (e.g. uveitis) and aging. However, the 
most common cause of canine cataracts appears to be 
genetic predisposition. Cataracts have been demon-
strated to be hereditary in a score of breeds, and are sus-
pected of being hereditary in dozens of other breeds. 
Therefore, mating of animals with cataracts suspected of 
being inherited should be strongly discouraged.
Cataracts are commonly classified by their maturation. 
Incipient cataracts are a focal opacity. This usually pro-
gresses to involve most of the lens. At this stage, the imma-
ture cataract obscures funduscopic details, and vision 
deteriorates. As the cataract becomes completely opaque 
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(mature), tapetal reflection and vision are lost. In hyperma-
ture cataracts the lens proteins break down and leak 
through the capsule. Because lens protein is  immuno-
genic, the leakage will cause lens-induced  uveitis (LIU).
Currently, there is no efficacious medical treatment 
for slowing, halting or reversing the progression of cata-
racts. Cataracts remain a surgical problem.
There are several important considerations in choos-
ing the surgical candidate. The first is the stage of cata-
ract maturation. Patients with incipient cataracts do not 
require surgery, as the effect on vision is minimal. How-
ever, this may be an optimal time to refer the patient to a 
veterinary ophthalmologist who will assess the cataract 
and fundus. On the other hand, patients with hyperma-
ture cataracts make poor surgical candidates, as they 
usually suffer from severe LIU that gravely impacts surgi-
cal prognosis. Most ophthalmologists prefer to operate 
on immature cataracts, when there are significant visual 
deficits but minimal LIU. 
Obviously, cataract surgery will not restore vision 
to patients whose retina is dysfunctional. Therefore, preop-
erative assessment of retinal function is of utmost impor-
tance. Retinal function (and visual prognosis) is usually 
determined by recording the electrophysiological response 
of the retina to light. The presence of pupillary light reflexes 
does not rule out retinal degeneration; these reflexes may 
be sluggish, but are usually present. An ultrasound exami-
nation does not test retinal function, either. It is used to 
diagnose retinal detachment and/or vitreal disease.
Other considerations include the overall health of 
the eye and the patient. This is an elective surgery that 
can be postponed so that LIU, or any other ocular and 
systemic diseases, may be treated prior to surgery. Also, 
consider the personality of the dog and/or owner. Many 
cataract patients require vigorous or long-term postop-
erative treatment. Aggression in the dog, or a physical 
handicap of the owner, that would prevent administering 
such treatment to the patient will negatively impact the 
surgical outcome.
Referring veterinarians should also be aware of the 
perioperative medical treatment administered to 
patients, though this treatment may vary between veter-
inary ophthalmologists. Typically, it consists of various 
regimens of anti-inflammatory and mydriatic drugs. 
 Antibiotics and prophylactic glaucoma therapy may also 
be administered.
There is a long list of potential intraoperative compli-
cations. However, technological advances enable most 
surgeons to claim a success rate of over 90%. Unfortu-
nately, this rate may decline with time due to long-term 
complications, notably LIU and glaucoma.
KEY LEARNING OBJECTIVES
■■ What are the stages of cataract, and when should 
I refer?
■■ What examinations will be conducted to determine 
surgical prognosis?
■■ What other factors affect surgical prognosis? 
MULTIPLE CHOICE QUESTIONS
1. At which stage do cataract surgeons prefer to 
operate? 
(A) Incipient
(B) Immature
(C) Mature
(D) Hypermature
2. Preoperatively, how is retinal function 
determined?
(A) Patient signalment and history of night 
blindness
(B) Pupillary light reflexes
(C) Ultrasonography
(D) Electroretinography
3. Which is the best option for patients that 
cannot undergo cataract surgery?
(A) Should be euthanased
(B) The eye should be enucleated
(C) Should be treated with anti-inflammatory 
drugs and monitored for LIU
(D) Will learn to manage
Will my dog see again? 
Examination, 
assessment and 
differential diagnosis of 
the blind patient
Ron Ofri
HISTORY
As with any patient, begin by taking a history. Inquire 
whether the blindness is acute or of gradual onset. 
Inquire whether it was associated with preferential loss 
of night vision, a classic sign of inherited, degenerative 
diseases of the outer retina (progressive retinal atrophy, 
PRA). Finally, inquire whether the animal is healthy, or 
are  there other signs of illness, besides loss of vision. 
Blindness may be caused by numerous systemic or neu-
rological diseases that present with additional signs of 
clinical disease. 
LOCALIZING THE LESION IN THE 
BLIND PATIENT
Based on the results of the ophthalmic examination, the 
patient may be categorized into one of four general 
 categories:
■■ Abnormal ophthalmic findings combined with a 
normal/diminished pupillary light reflex (PLR). 
Patients in this category suffer either from opacity 
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of the ocular media (e.g. corneal oedema) or from 
retinal disease (e.g. PRA, chorioretinitis)
■■ Abnormal ophthalmic examination and lack of PLR. 
Common causes include glaucoma, retinal 
detachment and optic neuritis involving the 
proximal optic nerve
■■ Normal ophthalmic examination and lack of PLR. 
Common causes include sudden acquired retinal 
degeneration (SARD), optic neuritis involving the 
distal optic nerve, and neoplasia compressing the 
optic nerve or chiasm
■■ Normal ophthalmic examination and normal PLR. 
These are usually neurological cases
Diagnosis of diseases in the first category is usually 
based on the findings of the ophthalmic examination. 
Diseases in the fourth category are characterized by an 
unremarkable ophthalmic examination in a blind patient 
with normal PLRs. However, the diagnosis of patients 
 presenting with acute blindness and fixed, dilated pupils 
(the second and third categories) may be challenging. The 
leading differential diagnoses for this presentation include 
glaucoma, retinal detachment, SARD and optic neuritis.
■■ Glaucoma patients usually present with numerous 
ophthalmic signs besides acute blindness and loss 
of PLR, and therefore they can be readily 
distinguished from the other three causes of this 
presentation
■■ Retinal detachment may be diagnosed by an 
ophthalmoscopic examination. When the fundus 
cannot be visualized (e.g. due to severe corneal 
oedema or hyphaema), the detachment can be 
demonstrated in an ultrasound examination of 
the eye
■■ Optic neuritis may be divided into proximal and 
distal inflammation of the optic nerve. In the former, 
an ophthalmoscopic sign may reveal signs, 
including hyperaemia, congestion and 
haemorrhages of the disc and peripapillary area. 
However, distal optic neuritis and SARD patients will 
both present with acute blindness, fixed, dilated 
pupils and a normal-looking fundus. In such cases, 
an electroretinagraphy recording is recommended 
to differentiate between the two diseases
KEY LEARNING OBJECTIVES
■■ Learn key questions that should be asked when 
taking the history of blind patients
■■ Learn to properly assess vision in patients
■■ Learn the differentials for blind patients presenting 
with or without pupillary light reflexes
MULTIPLE CHOICE QUESTIONS
1. In which of the following diseases will PLR be 
present?
(A) Chorioretinitis
(B) Glaucoma
(C) Retinal detachment
(D) SARD
2. How can SARD and optic neuritis be 
differentiated?
(A) Presence of PLR
(B) Ophthalmoscopic examination
(C) Electroretinography
(D) Ultrasonography
3. What may a positive dazzle test replace the 
need for? 
(A) The menace test
(B) PLR
(C) Electroretinography
(D) Ophthalmoscopy
057-066 Ophthalmology.indd   66 08/03/2019   17:48
BSAVA CONGRESS 2019 PROCEEDINGS [ 67 ]
Friday 5 April
Hall 4
Haematology
68 08:30–09:15Approach to anaemia
Vicki Black
68 09:25–10:10Transfusion medicine
Dan Lewis
69 11:05–11:50Management of IMHA
James Swann
70 12:00–12:45Approach to the suspected coagulopathic patient
Vicki Black
71 14:05–14:50Management of thrombocytopenia
James Swann
71 15:00–15:45Investigation of polycythaemia
Erik Teske
72 16:50–17:35Investigation of leucopenia
Erik Teske
73 17:45–18:30Haemolytic anaemia: when is it not IMHA?
Vicki Black
067-074 Haematology.indd   67 08/03/2019   18:01
Haematology
[ 68 ] BSAVA CONGRESS 2019 PROCEEDINGS
Approach to anaemia 
Vicki Black
Anaemia is commonly encountered in the unwell canine 
or feline patient. Approach to anaemic animals, including 
interpretation of its significance and diagnostic work-up, 
including urgency of investigations and therapy, varies 
significantly depending upon patient presentation. 
Anaemia may be suspected based upon history and 
clinical examination. Owners may have noticed subtle 
signs, for example mild lethargy or reduced exercise tol-
erance, in addition there may be a history of pica (in par-
ticular eating of cat litter or licking concrete), alternatively 
owners may have detected pallor (pale mucous mem-
branes), or patients may present with signs more acutely 
concerning, for example collapse, tachypnoea (increased 
breathing rate), or tachycardia (increased heart rate).
Triage is a vital step in approach to the anaemic 
patient: necessity for treatment, especially blood transfu-
sion, should primarily be guided by these clinical param-
eters rather than laboratory values. Cats are often more 
tolerant of marked anaemia. In fact, anaemic cats may 
present in a compensated state with haematocrits lower 
than 10% in some circumstances.
History and clinical examination of the anaemic ani-
mal should be thorough with attention directed towards 
evidence of haemorrhage, in particular interrogating the 
likelihood of gastrointestinal haemorrhage by carefully 
asking about stool colour, and a rectal examination to 
assess for melaena. Cats with significant anaemia will 
sometimes present with evidence of left volume heart 
overload and may have jugular pulsation and a gallop 
sound. Signalment and concurrent illness are also very 
important in these cases. A sighthound, such as a Grey-
hound, should normally have an increased haematocrit, 
therefore in fact a haematocrit in the lower end of the 
reference range may in fact be ‘anaemic’ for this patient. 
In a cat with long-standing chronic kidney disease, a 
mildly low haematocrit may not cause concern.
Anaemia can be diagnosed with a packed cell vol-
ume; however, haematology is a vital step in the diagnos-
tic approach to these cases. Broadly speaking causes of 
anaemia can be categorized as regenerative or non-
regenerative. Regenerative anaemias are those where 
there is evidence of increased red blood cell production 
by the bone marrow, an appropriate response to the 
presence of anaemia, whereas in non-regenerative 
anaemia the same bone marrow response is not 
observed. The distinction can be made by presence of 
reticulocytes (immature red blood cells) and additional 
features of regeneration. After acute blood loss it can 
take up to 5 days to observe this regenerative response, 
therefore absence of regeneration on blood analysis 
does not exclude pre-regenerative anaemias. 
Causes of regenerative anaemia can be broadly 
divided into those resulting from haemorrhage or 
 haemolysis (rupture of red blood cells). History, clinical 
examination, clinical pathology results and, in some 
cases, imaging can help to discriminate between these. 
Non-regenerative anaemias can occur due a problem 
within the bone marrow itself or related to illness that 
reduces ability to produce red blood cells (erythropoie-
sis), such as iron deficiency, chronic kidney disease or 
inflammatory disease.
KEY LEARNING OBJECTIVES
■■ Understand the importance of triage in the 
approach to the anaemic patient
■■ Appreciate important steps in the clinical 
examination of an anaemic dog or cat
■■ Apply a logical approach to causes of anaemia 
based upon history, clinical examination and 
investigation findings
MULTIPLE CHOICE QUESTIONS
1. What cause of anaemia is most commonly 
associated with pica in cats?
(A) Haemorrhage
(B) Immune-mediated disease
(C) Flea infestation
(D) Paracetamol poisoning
2. Why should we be careful with intravenous 
fluid therapy in cats with anaemia?
(A) They might have high sodium
(B) They are often already in a state of volume 
overload
(C) You might dilute the red blood cells
(D) They might have kidney disease
3. What is the most helpful feature of 
haematology when looking for evidence of 
regeneration?
(A) Platelet count
(B) Mean cell volume (MCV)
(C) Reticulocyte count
(D) Nucleated red blood cells
Transfusion medicine
Dan Lewis
The use of blood products in veterinary medicine is 
increasing rapidly, with wider familiarity with their appro-
priate use and greater availability. However, for many vet-
erinary practices in the UK, blood product transfusion is 
still a relatively rare occurrence and the often urgent 
nature of their requirement means that all veterinary sur-
geons treating small animals should have a basic knowl-
edge of what blood products are available, when each is 
indicated, how to obtain a fresh whole-blood ‘donation’ 
and how to store and administer these products safely. 
This lecture will outline the advantages and disad-
vantages of the different blood products currently avail-
able in the UK and where they can be sourced from. We 
will also discuss some of the key factors to remember in 
relation to blood types. Probably the most important 
aspect of this to remember is that cats have pre-existing 
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antibodies against other blood types and can suffer fatal 
transfusion reactions as a result of an incorrect choice; it 
is therefore vital to always blood type cats (donor and 
recipient) prior to transfusion and only administer them 
type-matched blood products.
We will explore how blood donations can be 
obtained, as well as how to select an appropriate donor. 
The range of blood products commercially available will 
then be discussed and the indications (and contraindica-
tions) for each product highlighted. 
Finally, we will discuss how to calculate an effective 
dose and how to administer a transfusion safely to the 
benefit of our patients. 
KEY LEARNING OBJECTIVES
■■ To understand the basis of transfusion medicine and 
the therapeutic contributions that different blood 
products can make
■■ To recognize the importance of blood types and 
when to assess them
■■ To know where and how to obtain transfusion 
products and administer them safely
MULTIPLE CHOICE QUESTIONS 
1. Which is the most antigenic dog erythrocyte 
antigen (DEA)?
(A) 4
(B) 1
(C) Dal
(D) 7
2. Which is one of the best sources of factor VIII 
and von Willebrand’s factor?
(A) Cryosupernatant
(B) Fresh whole blood
(C) Cryoprecipitate
(D) Frozen plasma
3. A 17-kg Springer Spaniel has a PCV of 12%. To 
about what level should 200 ml of packed red 
blood cells (PCV 60%) raise its PCV?
(A) 21%
(B) 28%
(C) 35%
(D) 42%
Management of IMHA
James Swann
Immune-mediated haemolytic anaemia (IMHA) is con-
sidered to be the most common autoimmune disease of 
dogs, resulting in severe anaemia that produces consid-
erable morbidity and mortality. Almost all dogs are 
treated with glucocorticoids, but there is considerable 
variation in the dose rate, tapering regimen and dura-
tion of therapy used to treat individual dogs. Addition-
ally, many clinicians administer a combination of 
immunosuppressive drugs to limit adverse effects 
related to glucocorticoids; there is no evidence that this 
approach produces a more favourable outcome. In an 
effect to achieve consensus on some of these topics, 
the American College of Veterinary Internal Medicine 
recently commissioned a consensus statement on 
treatment of IMHA in dogs, due to be published by the 
end of 2018.
In agreement with this statement, there is no con-
clusive evidence to determine whether initial treatment 
with a glucocorticoid or with a glucocorticoid combined 
with another immunosuppressive drug (azathioprine, 
ciclosporin or mycophenolate mofetil) will result in a 
better outcome, so either approach seems to be clini-
cally acceptable. However, use of combination therapy 
should be considered particularly if dogs are expected to 
develop severe adverse effects related to glucocorti-
coids, if they appear to be very severely affected, or if 
they fail to respond to prednisolone alone within the first 
week of treatment. If combination therapy is used, the 
starting dose of the glucocorticoid may be lower than if 
used alone and could be tapered more rapidly. Use of 
cyclophosphamide is not recommended because this 
has been associated with a poorer outcome in dogs with 
IMHA in a previous study. A starting dose of predniso-
lone of 2–3 mg/kg per day is recommended, or 50 mg/
m2 for dogs weighing more than 25 kg. Higher doses will 
not produce a better or faster response but will increase 
the risk of severe adverse effects. Human intravenous 
immunoglobulin has been used for treatment of dogs 
with severe IMHA but there is no evidence that adminis-
tration of this product improves outcome; routine use 
is  therefore not recommended, even if it were easily 
 available.
Dogs with IMHA frequently develop thromboem-
bolic complications that may result in death. It is there-
fore recommended to administer an antithrombotic drug 
routinely to all dogs with IMHA. In the first 2 weeks of 
treatment, it may be advisable to administer injectable 
heparins but these drugs must be used with caution if 
monitoring tests are not available. Indeed, unfraction-
ated heparin has unpredictable pharmacokinetics and 
should not be used without individual adjustment of 
doses. A more practical strategy involves administration 
of oral antiplatelet drugs, of which clopidogrel is pre-
ferred to aspirin, because as many as 30% of dogs do not 
respond to commonly used dose rates.
KEY LEARNING OBJECTIVES
■■ Describe the major immunosuppressive drugs that 
may be used for treatment of immune-mediated 
haemolytic anaemia (IMHA) in dogs and their 
associated adverse effects
■■ Formulate a clinical approach to management of 
IMHA at initial diagnosis
■■ Consider the options available for antithrombotic 
treatment in dogs with IMHA
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MULTIPLE CHOICE QUESTIONS
1. Which immunosuppressive drug is no longer 
recommended for treatment of IMHA in dogs?
(A) Ciclosporin
(B) Mycophenolate mofetil
(C) Cyclophosphamide
(D) Azathioprine
2. What is the mechanism of action of 
azathioprine?
(A) Inhibition of de novo purine synthesis
(B) Inhibition of de novo pyrimidine synthesis
(C) Inhibition of calcineurin
(D) Inhibition of thiopurine methyltransferase
3. Which oral antiplatelet drug is preferred for its 
antithrombotic effect in dogs with IMHA?
(A) Clopidogrel
(B) Aspirin
(C) Romiplostim
(D) Tranexamic acid
Approach to the 
suspected 
coagulopathic patient
Vicki Black
Bleeding disorders represent a source of concern for cli-
ents and veterinarians alike. Disorders of haemostasis 
can appear complicated, often due to the inaccessibility 
of the coagulation cascade and cell-based model of 
haemostasis. Whilst the underlying mechanisms behind 
the formation of a blood clot and the pathophysiology of 
hypocoagulability is a highly complicated process, the 
approach to these animals can be simplified.
Bleeding disorders can be divided into those affect-
ing primary haemostasis, secondary haemostasis and 
fibrinolysis. Some cases will not neatly fit in to one of 
these categories and should always be considerations, 
including consumptive coagulopathy (disseminated 
intravascular coagulation), or Angiostrongylus infection. 
Disorders of primary haemostasis encompass those 
responsible for formation of the primary platelet plug. 
Patients with a primary haemostatic disorder will typi-
cally present with bleeding affecting skin or mucosal 
 surfaces, for example petechiae, ecchymoses, epistaxis, 
haematemesis or melaena, or haematuria. Although this 
is characterized by small surface bleeds, the blood 
loss,  in particular within the gastrointestinal tract, can 
be  haemodynamically significant and potentially fatal. 
Failure to form an effective primary platelet plug can 
be  divided into a disorder in platelet count (thrombo-
cytopenia) or platelet function (thrombocytopathia), 
which can be a direct platelet disorder or related to 
 inability for platelets to bind, for example related to urae-
mia or hyperglobulinaemia, or von Willebrand’s factor 
deficiency. The most common cause for disorders of 
 primary haemostasis in the United Kingdom is primary 
immune-mediated thrombocytopenia, a diagnosis 
which can be reached based upon appropriate platelet 
count and exclusion of underlying triggers.
Disorders of secondary haemostasis encompass 
those involved in the stabilization of the primary platelet 
plug, this is especially important in larger blood vessels 
where the platelet plug is insufficient alone to stop the 
haemorrhage. Patients typically present with intracavity 
bleeds, for example haemothorax or haemoabdomen, 
haemarthrosis, or haematomas. Broadly speaking these 
are disorders related to coagulation factors, the majority 
of which (aside from factor VIII) are exclusively manufac-
tured by the liver. Disorders include deficiencies and 
ineffective factors, the most important considerations 
are vitamin K deficiency-related coagulopathy, hepatic 
dysfunction and congenital factor defects.
Disorders of fibrinolysis have become more recently 
acknowledged in the context of systemically unwell 
dogs, especially Greyhounds. They occur due to exces-
sive breakdown of the fibrin following formation of the 
clot, therefore present as delayed bleeding. Diagnosis 
with current testing methods is challenging, and empiri-
cal treatment is sometimes adopted.
KEY LEARNING OBJECTIVES
■■ Understand the different presentations for primary 
and secondary haemostatic disorders
■■ Appreciate the investigations and therapy guided at 
disorders of primary haemostasis
■■ Appreciate the investigations and therapy guided at 
disorders of secondary haemostasis 
MULTIPLE CHOICE QUESTIONS
1. What is the most likely explanation for a dog 
presenting with petechiae, ecchymoses and 
melaena?
(A) Rodenticide toxicity
(B) Von Willebrand’s factor deficiency
(C) Angiostrongylus infestation
(D) Immune-mediated thrombocytopenia
2. In a dog with rodenticide toxicity with evidence 
of active severe haemorrhage what treatment 
would you consider in the short term?
(A) Fresh frozen plasma 
(B) Vitamin K
(C) DDAVP
(D) Platelet-rich plasma
3. What is the current treatment used in dogs with 
a suspicion of hyperfibrinolysis?
(A) Plasma
(B) DDAVP
(C) Tranexamic acid
(D) Platelet-rich plasma
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Management of 
thrombocytopenia
James Swann
Thrombocytopenia refers to a reduction in the number of 
circulating platelets, which may be related to decreased 
production in the bone marrow, increased peripheral 
destruction or sequestration outside the circulation. There 
are numerous causes for thrombocytopenia, and a fresh 
blood smear should always be evaluated in dogs and cats 
with apparent thrombocytopenia to ensure this is not due 
to artefactual clumping after sample collection. The most 
common cause of severe thrombocytopenia is immune 
thrombocytopenia (ITP), an autoimmune disease associ-
ated with production of antibodies specific for platelets, 
resulting in peripheral destruction. When the platelet 
count decreases below 30–40 x 109/l, there is a risk of 
spontaneous mucosal haemorrhage, which is normally 
identified as petechial or ecchymotic haemorrhages 
on  the skin and mucous membranes, or as melaena if 
haemorrhage occurs in the gastrointestinal tract.
There are few options available for immediate man-
agement of severe thrombocytopenia: platelets persist 
for only a few hours after transfusion of fresh whole 
blood, rendering this exercise futile in trying to control 
spontaneous haemorrhage. In people, tranexamic acid 
sometimes is administered to stabilize formation of fibrin 
clots, and this drug is being evaluated in a clinical trial of 
dogs with ITP. However, the drug is contraindicated in 
people with haematuria due to the risk of urinary tract 
obstruction if large blood clots form. In the USA, lyophi-
lized platelet concentrates are available, and some cen-
tres produce platelet-rich plasma, though neither option 
is currently available in the UK.
Immune thrombocytopenia typically is treated with 
glucocorticoids. Administration of a single dose of vin-
cristine may increase the rate of release of platelets from 
the bone marrow and shorten hospitalization time. A sec-
ond immunosuppressive drug (such as azathioprine or 
ciclosporin) is frequently used alongside prednisolone, 
but there is no evidence to suggest whether this improves 
outcome or to determine which drug would be most suit-
able. Intravenous immunoglobulins have been adminis-
tered to dogs with ITP but they appear to offer no benefit 
compared to use of vincristine, which is more widely 
available. In dogs with ITP and active haemorrhage, most 
blood is lost through the gastrointestinal tract, such that 
presence of melaena is associated with a poorer out-
come. It is therefore commonplace to administer ome-
prazole to dogs with ITP, though it is unclear whether this 
drug reduces the risk or severity of haemorrhage in the 
face of coagulopathy. Recently, there has been consider-
able interest in the use of romiplostim, a synthetic agonist 
of the receptor for thrombopoietin (TPO), which stimu-
lates production and release of platelets from the bone 
marrow, in ITP. Use of the drug has been reported in five 
dogs with ITP and it did not appear to cause any adverse 
effects, but it is unclear whether it offers any additional 
benefit compared to conventional treatment.
KEY LEARNING OBJECTIVES
■■ Describe the major causes and signs of 
thrombocytopenia in dogs and cats
■■ Formulate a plan for clinical management of 
emergency thrombocytopenia
■■ Describe a treatment plan for management of 
immune thrombocytopenia
MULTIPLE CHOICE QUESTIONS
1. What is the mechanism of action of 
romiplostim?
(A) Agonist at the thrombopoietin receptor
(B) Agonist at the erythropoietin receptor
(C) Agonist at the G-CSF receptor
(D) Agonist at the interleukin 3 receptor
2. Which clinical feature is associated with a poor 
outcome in dogs with ITP?
(A) Epistaxis
(B) Melaena
(C) Haematuria
(D) Haemoptysis
3. Which drug may be used to increase the rate of 
release of platelets from the bone marrow in 
dogs with ITP?
(A) Cyclophosphamide
(B) Ciclosporin
(C) Vincristine
(D) Azathioprine
Investigation of 
polycythaemia
Erik Teske
Polycythaemia or erythrocytosis is an increase in num-
bers of peripheral red blood cells (RBC), haemoglobulin 
and packed cell volume (PCV) or haematocrit. The 
 polycythaemia can be relative or absolute. A relative 
polycythaemia occurs when there is no real increase in 
red blood cell mass but, due to excessive fluid loss, a 
decreased plasma volume occurs resulting in haemo-
concentration. Another cause for relative polycythaemia 
could be splenic contraction due to anxiety. In absolute 
polycythaemia there is a true increase in RBC mass. 
The production of erythrocytes is normally regulated 
by erythropoietin. When there is an increased demand, 
the erythropoietin concentration will increase leading 
to  an enhanced erythrocyte production in the bone 
 marrow. Based on the production of erythropoietin, the 
absolute polycythaemia is subdivided into a primary 
erythrocytosis (polycythaemia vera), where there is an 
autonomous production of erythrocytes and no increase 
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in erythropoietin, and a secondary erythrocytosis as a 
result of an excessive erythropoietin production.
Polycythaemia vera is a rare chronic myeloproliferative 
disease. In contrast to humans, the increase in erythrocytes 
is usually not associated with a leucocytosis and thrombo-
cytosis. Also hepatosplenomegaly is not a common feature. 
In secondary erythrocytosis, the increase in erythrocyte 
numbers is due to an increase of erythropoietin. This could 
be an appropriate response due to a chronic state of 
 systemic hypoxia, resulting in increased erythropoietin 
 production by the kidneys. This can be seen in severe 
 cardiac and pulmonary conditions. However, it could also 
be the result of excess erythropoietin production without 
systemic hypoxia, called inappropriate secondary erythro-
cytosis. Possible mechanisms are ectopic erythropoietin 
production by a tumour, increased erythropoietin produc-
tion by the kidney in response to hypoxia of the kidney 
caused by its compression by a tumour, and increased 
 production of so-called hypoxia-inducible transcription 
factors which stimulate erythropoietin production.
The clinical signs of polycythaemia result from 
hyperviscosity of the blood and dilatation and decreased 
perfusion of small blood vessels, resulting in erythema, 
blindness, neurological disturbances, bleeding, polyuria 
and thrombosis.  
KEY LEARNING OBJECTIVES
■■ Understand the pathophysiology of polycythaemia
■■ Learn the differential diagnoses
■■ Learn about the management of this problem
MULTIPLE CHOICE QUESTIONS
1. A 3-year-old mixed-breed male dog is 
presented with a history of acute vomiting, 
diarrhoea and anorexia. Bloodwork reveals an 
increased haematocrit (0.70 l/l). Which of the 
following possibilities is the most likely cause 
of the polycythaemia?
(A) Relative polycythaemia
(B) Polycythaemia vera
(C) Appropriate secondary polycythaemia
(D) Inappropriate secondary polycythaemia
2. Which of the following will be seen in dogs 
with  polycythaemia vera?
(A) An increased erythropoetin production 
due to local renal hypoxia
(B) An increased autonomous erythropoietin 
production
(C) A low or normal erythropoietin 
concentration
(D) Abnormal erythrocytes circulating in the 
peripheral blood
3. Which of the following diagnostic tests is the 
most important in discriminating the different 
causes of absolute polycythaemia?
(A) Ultrasonography of the kidneys
(B) Radiography of the lungs
(C) Bone marrow aspirate 
(D) Plasma erythropoietin concentration
Investigation of 
leucopenia
Erik Teske
The blood leucocytes or white blood cells are the granu-
locytes (neutrophils, eosinophils and basophils), the 
 lymphocytes and the monocytes. In addition to this, 
 precursors may be observed in the blood in some condi-
tions. So theoretically a shortage of any of these types of 
cells may lead to leucopenia. However, the number of 
eosinophils, basophils and monocytes in normal healthy 
individuals is so low that a decrease in number will not 
lead to leucopenia. Lymphopenia, but even more neu-
tropenia, can result in overall leucopenia. Therefore, 
these conditions will be discussed further.
Lymphopenia is a common finding in dogs and cats. 
The most common cause is excess of corticosteroids 
(iatrogenic, hyperadrenocorticism or stress), possibly 
due to migration of lymphocytes from blood to lymphoid 
tissue. Other causes include disruption of lymphocyte 
circulation (chylothorax, lymphangiectasia), use of 
immunosuppressive drugs, viral infections (e.g. canine 
distemper and parvovirus) and severe septicaemia 
(although a corticoid excess cannot be excluded as 
cause). Rarely, lymphopenia can be the result of congen-
ital lymphocyte deficiency in the dog or cat.
Neutropenia usually has a more profound effect on 
the total number of leucocytes. It can be the result of 
decreased production in the bone marrow, cellular shift-
ing from the circulating to the marginal pool, increased 
utilization and possibly immune-mediated destruction. 
Decreased production of neutrophils can occur due to a 
variety of causes, such as cytostatic drugs, irradiation or 
oestrogens; all kinds of idiosyncratic drug reactions may 
also result in leucopenia. In addition, infections, e.g. 
canine parvovirus, Ehrlichia, immune-mediated diseases 
and myeloproliferative diseases can cause a decreased 
production of leucocytes. A congenital form of neutrope-
nia has been reported in grey collies (cyclic haemopoie-
sis). Neutropenia due to shifting from the circulating to the 
marginal pool is not uncommon, especially in cases with 
shock, anaphylaxis or toxaemia. An increased utilization 
(often in localized purulent inflammations) can lead to a 
situation in which the bone marrow cannot compensate 
enough with increased production, leading eventually to 
leucopenia. Often immature stages (metamyelocytes and 
bands) are seen in the peripheral blood combined with the 
absence of neutrophilia (degenerative left shift).
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MULTIPLE CHOICE QUESTIONS
1. Which of the following is a dog with leucopenia 
most likely to have?
(A) An eosinopenia
(B) A monocytopenia
(C) A basophilopenia
(D) A neutropenia
2. A dog is presented with a lymphopenia. Which 
of the following conditions could be 
responsible for this?
(A) Hypoadrenocorticism
(B) Testicular Sertoli cell tumour 
(C) Stress related
(D) Epinephrine-induced response
3. A shift of the neutrophils from the circulating 
pool to the marginated pool can be caused by 
which of the following?
(A) A severe fright reaction
(B) Severe stress
(C) Inflammation
(D) Cytostatic drugs
Haemolytic anaemia: 
when is it not IMHA?
Vicki Black
Haemolysis is a term used to describe shortening of the 
circulating lifespan of a red blood cell. The normal 
 circulating time is 110–120 days in a dog and 65–76 days 
in cats. Red blood cells pass over macrophages within 
the liver and spleen frequently throughout their lifespan, 
these macrophages are responsible for removal of aged 
blood cells from circulation; in a healthy state the rate 
of  removal matches the rate of production of red 
blood cells. 
Premature removal of red blood cells from cir-
culation may occur due to intravascular haemolysis 
or  extravascular haemolysis. Intravascular haemolysis 
occurs due to rupture of red blood cells within the circu-
lation, whereas extravascular haemolysis describes 
phagocytosis of red blood cells by macrophages (usually 
within the spleen and liver). Intravascular haemolysis is 
characterized by haemoglobinaemia and haemoglobi-
nuria, and can be accompanied with ghost red blood 
cells, whereas extravascular haemolysis can result in 
spherocytes. Both intravascular and extravascular hae-
molysis can result in jaundice.
Haemolysis can also be considered based upon the 
underlying aetiology, and either categorized as heredi-
tary or acquired. Hereditary non-immune haemolysis 
can occur due to enzymopathies, membrane defects or 
haemoglobin-related disorders. Enzymopathies are the 
best described in the dog and cat. They include phos-
phofructokinase deficiency of the English Springer 
 Spaniel, American Cocker Spaniel, Cockapoo ( American), 
German Spaniel (Wachtelhund), and Whippet, and pyru-
vate kinase deficiency in the Basenji, Beagle, Dachshund, 
Eskimo, West Highland White Terriers, Pug, Abyssinian 
and Somali cats, as well as Domestic Shorthaired cats. 
Membrane defects have been described, including 
spherocytosis in the Golden Retriever, stomatocytosis in 
the Alaskan Malamute, and band 3 deficiency in a single 
Jack Russell Terrier. Haemoglobin-related disorders are 
less commonly described, and a human equivalent of 
sickle cell disease has not been established in the dog or 
cat, although congenital porphyria has been  documented 
in the cat.
Acquired causes of non-immune haemolysis include: 
infections, drug or toxin-induced, aberrant macrophage 
activity, secondary to microangiopathies, or related to 
severe hypophosphataemia. Examples of infectious 
 cau ses include Babesia sp., Mycoplasma haemofelis and 
Leptospira sp. Drugs and toxins include paracetamol or 
onion toxicosis in cats, zinc poisoning, and snake or 
bee evenomation. Aberrant macrophage activity can be 
observed in some reactive or neoplastic histiocytic disor-
ders, for example haemophagocytic histiocytic sarcoma. 
Microangiopathies describes fragmentation injury to red 
blood cells related to a tortuous course and may be 
observed in vasculitis or disseminated intravascular coag-
ulation of any cause. Finally, severe hypophosphataemia 
is an uncommon cause of haemolysis, but when observed 
is most frequently in the context of diabetic ketoacidosis.
KEY LEARNING OBJECTIVES
■■ Appreciate non-immune haemolytic anaemia 
should be suspected in animals with evidence of 
haemolysis that do not present with investigation 
findings compatible with immune-mediated 
destruction
■■ Understand the approach to non-immune 
haemolytic anaemia
■■ Appreciate hereditary non-immune haemolysis is 
probably an underdiagnosed condition, although 
clinical significance may be minimal
KEY LEARNING OBJECTIVES
■■ Recognizing patients with leucopenia
■■ Learning the differential diagnoses of leucopenia
■■ Learning the approach to patients with leucopenia
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MULTIPLE CHOICE QUESTIONS
1. What is the diagnostic test of choice for 
phosphofructokinase (PFK) deficiency in the 
English Springer Spaniel?
(A) Blood smear
(B) Coomb’s test
(C) Genetic test
(D) Osmotic fragility
2. What is the cause of anaemia in heat stroke? 
(A) Disseminated intravascular coagulation
(B) Hypophosphataemia
(C) Immune-mediated haemolytic anaemia 
(D) Toxic injury
3. Which of the following is associated with a 
good prognosis?
(A) Phosphofructokinase deficiency in English 
Springer Spaniels
(B) Pyruvate kinase deficiency in West 
Highland White Terriers
(C) Pyruvate kinase deficiency in Abyssinian  
cats
(D) Stomatocytosis in Alaskan  
Malamutes
067-074 Haematology.indd   74 08/03/2019   18:01
BSAVA CONGRESS 2019 PROCEEDINGS [ 75 ]
Friday 5 April
Hall 8
AVP
76 14:05–14:50Management of intraoperative hypotension
Delphine Holopherne-Doran
77 15:00–15:45Infection control for the surgical patient
Kelly Bowlt Blacklock
78 16:50–17:35Top tips for great medical and surgical case reports
Ian Ramsey and Rachel Hattersley
79 17:45–18:30Options for the treatment of combined cranial cruciate ligament 
insufficiency and medial patellar luxation
Duncan Barnes
075-080 AVP Friday.indd   75 08/03/2019   18:01
AVP
[ 76 ] BSAVA CONGRESS 2019 PROCEEDINGS
Management of 
intraoperative 
hypotension
Delphine Holopherne-Doran
Hypotension, commonly defined as a mean arterial pres-
sure below 60 mmHg, is one of the most common 
 complications encountered in small animals under gen-
eral anaesthesia. It is generally multifactorial, with the 
direct or indirect effects of the sedative/anaesthetic/
analgesic drugs on the cardiovascular system playing a 
predominant part. Addressing hypotension under gen-
eral anaesthesia can be done following a simple and 
 logical algorithm. 
Ensuring that the measurement of the low blood 
pressure is accurate is a preliminary step. Then most 
likely causes for the drop in blood pressure should be 
addressed. In most cases, a decrease in the amount of 
anaesthetic drugs administered will reduce the burden 
on the cardiovascular system and allow the blood pres-
sure to come back within normal limits. Hence aiming to 
work with the lowest percentage of isoflurane or sevoflu-
rane, for example, can be crucial. Obviously, if the main 
reason for the hypotension is a true hypovolaemia, due 
for example to blood losses during the ongoing proce-
dure, fluid therapy is the logical first step of treatment. 
The choice of the most appropriate fluid in these circum-
stances will depend on the type of hypovolaemia, the 
severity of the losses and the objectives of the fluid 
resuscitation, especially in terms of timing. Whilst iso-
tonic crystalloid solutions (Hartmann’s or saline) are 
most commonly used, hypertonic crystalloid solutions, 
colloids or even blood products can have a role to play. 
The fluids also have a role to play in resuscitative treat-
ment of the most common case of relative hypovolaemia 
under general anaesthetic, i.e. when the hypovolaemia is 
only due to an expansion of the vascular compartment in 
response to vasodilatory drugs. Isotonic crystalloids are 
usually used in that case, administered as a bolus which 
can be repeated. If the fluid therapy does not suffice 
to  restore normal blood pressure, or if fluid therapy is 
contraindicated or limited, pharmaceutical intervention 
should be considered. 
Blood pressure is the product of systemic vascular 
resistances and cardiac output, itself the result of stroke 
volume and heart rate, therefore drugs targeting at least 
one of these three parameters can be used to increase 
blood pressure. If the hypotension is associated with 
bradycardia, the use of an anticholinergic drug such as 
atropine or glycopyrrolate, should be considered first. If 
the heart rate is normal, and drug-induced vasodilation is 
identified as the primary cause for the hypotension, a 
vasoconstrictor can be used. Whilst pure vasoconstric-
tors, such as phenylephrine, can be used, mixed sympa-
thomimetic agents like ephedrine are often preferred. 
Ephedrine, acting by release of noradrenaline, induces 
vasoconstriction alongside an increase in myocardial 
contractility. In severe, or non-responsive, hypotensive 
cases, the use of noradrenaline could be considered. In 
cases where hypotension is specifically related to poor 
myocardial contractility and thus a low cardiac output, 
the use of a more specific positive inotrope, such as 
 dobutamine, can be indicated. 
KEY LEARNING OBJECTIVES
■■ Describe the therapeutic steps to address 
hypotension under general anaesthesia
■■ Compare the different types of intravenous fluids 
used to counteract intraoperative  hypotension
■■ Choose and justify the use of parasympatholytic 
and sympathomimetic drugs to treat intraoperative 
hypotension
MULTIPLE CHOICE QUESTIONS
1. What would be the first step in addressing 
hypotension in a dog under general 
anaesthesia?
(A) Administer a 10 ml/kg intravenous bolus 
of Hartmann’s solution
(B) Decrease the percentage of isoflurane 
delivered if anaesthetic depth allows
(C) Administer 10 µg/kg of glycopyrrolate
(D) Incline the table (head down) to optimize 
venous return
2. What acid–base imbalance can be expected 
when using saline for an aggressive fluid 
resuscitation?
(A) Hypochloraemic metabolic alkalosis
(B) Hypochloraemic metabolic acidosis
(C) Hyperchloraemic metabolic acidosis
(D) Hyperchloraemic metabolic alkalosis
3. What cardiovascular effects does ephedrine 
induce?
(A) Vasoconstriction and increased myocardial 
contractility
(B) Vasodilation and increased myocardial 
contractility
(C) Vasoconstriction and decreased 
myocardial contractility
(D) Vasodilation and decreased myocardial 
contractility
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Infection control for 
the surgical patient
Kelly Bowlt Blacklock
A surgical site infection (SSI) is one which occurs in the 
surgical site within 30 days of surgery (or one year if an 
implant is present). See Figure 1.
Wound 
classification
Description SSI rate
Clean Non-traumatic elective 
operative wounds
2–4.8%
No entry into respiratory, 
gastrointestinal or 
urogenital tract
Clean– 
contaminated
Clean procedure with 
placement of drain
3.5–5%
Entry into respiratory, 
gastrointestinal or 
urogenital tract
Contaminated Major break in asepsis 4.6–12%
Surgery on traumatic non- 
purulent wounds 
Dirty Purulent discharge, foreign 
bodies, devitalized tissue
6.7–18.1%
Major spillage from a viscus
Figure 1: Infection rates seen in surgical wounds
RISK FACTORS FOR INFECTION
Patient considerations 
■■ Surgical site preparation. Techniques for aseptic skin 
preparation generally include a chlorhexidine- or 
povidone–iodine-based preparation. Importantly, 
solutions of diluted chlorhexidine can harbour 
bacterial organisms, particularly Pseudomonas, so 
each batch of scrub solution should be made up as 
required and not stored
■■ Anaesthetic induction agent. Propofol is associated 
with increased SSI rates in some studies, presumably 
because of increased microbiological growth in the 
lipid-based emulsion. It is imperative that aseptic 
technique is utilized and that unused propofol is 
stored according to manufacturer’s instructions
■■ Anaesthetic and surgical duration. Increasing 
duration of anaesthesia and surgery is associated 
with increased risk of an SSI
■■ Patient specific factors. There is an increased risk 
of SSI in patients with diabetes mellitus, 
hypothyroidism and hyperadrenocortisicm
■■ Drapes. An impermeable drape should be 
incorporated into distal leg wraps where surgery on 
a limb is anticipated in order to prevent bacterial 
strike-through
Staff considerations
■■ Theatre clothing. Masks should be disposable, 
changed between procedures (or sooner if damp) 
and should not be hung around the neck (which 
increases contamination) when not in use. Gloves 
should be worn to reduce wound contamination 
from the surgeon’s hands
■■ Hand preparation. The World Health Organization 
(WHO) currently recommends the use of alcohol-
based hand rubs
Facility considerations
■■ Theatres. The theatre list should be planned such 
that clean procedures occur early in the day and 
dirty procedures are scheduled to follow. A detailed 
daily schedule of maintenance should be 
established for the perioperative environment to 
ensure it is clean, dry and dust free. Periodic deep 
cleaning at locally determined intervals may be used 
to target specific areas and ensure high standards 
are maintained
■■ Instrumentation. Instruments should be rinsed and 
cleaned manually or mechanically using a 
commercial cleaner. Sterilization of the packaged 
instruments can occur by steam, ethylene oxide, 
plasma sterilization, radiation (gamma) or cold 
sterilization (e.g. glutaraldehyde). It is imperative 
that indicators are used to demonstrate that the 
method of sterilization has been effective. Once 
sterilized, packs should be stored for a limited 
period only in closed cabinets in a low-traffic area
■■ Tissue. The risk of an SSI can be minimized by 
adhering to Halstead’s surgical principles
ANTIBIOTIC USE 
Complete discussion regarding the use of antibiotics is 
outside the scope of this session but should not be used 
to compensate for poor preparation of the patient, sur-
geon or facilities. 
ACTIVE INFECTION SURVEILLANCE
Where possible, regular infection-control group meet-
ings within the hospital are beneficial. Any SSIs should be 
prospectively recorded and reviewed monthly to deter-
mine rates between procedures, surgeons, theatres, days 
of the week etc. In this way, the adequacy of current 
 protocols can be assessed and any alterations required 
can be implemented. 
KEY LEARNING OBJECTIVES
■■ Identify key aspects of patient and environmental 
perioperative care which contribute to surgical site 
infections
■■ Make informed choices about surgical hand hygiene
■■ Understand how to operate an active infection 
surveillance system within the practice
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MULTIPLE CHOICE QUESTIONS
1. Which of the following is true about a surgical 
site infection (SSI)?
(A) It occurs any time postoperatively
(B) It occurs within the first 10 days 
postoperatively
(C) It occurs within the first year if an implant 
is present
(D) It occurs within the soft tissue only
2. How is surgery on traumatic non-purulent 
wounds classified? 
(A) Dirty
(B) Clean
(C) Contaminated
(D) Clean–contaminated
3. Which of the following patient conditions is 
associated with increased risk of SSI?
(A) Diabetes mellitus
(B) Hypothyroidism 
(C) Hyperadrenocortisicm
(D) All of the above
Top tips for great 
medical and surgical 
case reports
Ian Ramsey and Rachel Hattersley
The RCVS Certificate in Advanced Veterinary Practice 
(CertAVP) is a flexible, modular approach to achieving 
veterinary postgraduate qualifications. You can design 
your own postgraduate certificate by choosing a combi-
nation of modules, or pursue one of the designated 
(named) qualifications. The majority of such certificates 
will require candidates to write case reports based on 
patients which they have treated in the clinic. The lecture 
will focus on the dual areas of appropriate case selection 
and making the most out of your ‘write-up’.
CASE SELECTION
■■ Avoid cases where the animal or owner (including 
financial issues) were a significant limiting factor in 
your diagnosis or management of the case (e.g. in 
cases of surgical oncology – histology must be 
performed)
■■ Avoid cases where the primary diagnosis was not 
confirmed but rather arrived at by a circuitous route 
(e.g. by response to treatment or by exclusion)
■■ Avoid cases whose primary management was not 
the discipline you are studying (e.g. surgery in a 
medicine case report or vice versa)
■■ Avoid excessively rare cases or ones that the 
examiners may not be familiar with (e.g. certain 
exotic diseases that are not present in the UK)
■■ Avoid the utterly routine and the excessively easy
■■ Make sure you have all the details about the case 
before you start writing (e.g. the imaging and an 
appropriate length of follow-up)
■■ Make sure you have the owner’s permission (as you 
will want to keep in touch!)
■■ Don’t be frightened to ditch a case that you have 
started writing up if the outcome is not ideally suited 
to purpose – it is not wasted time as you will have 
learnt from it
■■ Do not use a case that was substantially diagnosed 
or managed by someone else (e.g. a referral centre)
WRITING UP 
■■ Make sure you plan well ahead. Your first case will 
take at least a week of evenings to write up. Your last 
case will also take a week to write up
■■ Use appropriate scientific language (e.g. radiograph 
not X-ray)
■■ Your differential diagnosis list should be relevant to 
the individual case and particular set of clinical signs 
you are describing; avoid copying a list ad verbatim 
from a textbook
■■ Get several peer-reviewed references, read them and 
make sure you understand them. Use PubMed not 
Dr Google to find these references. Read the abstract, 
if they are appropriate then get the whole paper
■■ Read the papers fully to ensure that the paper 
supports the statement you have made – do not 
reference the introduction of a paper which is 
referencing the findings of another paper
■■ Do not reference In Practice or Vet Times articles, 
and where possible avoid referencing textbooks. 
Use common sense and look at the most recent 
papers first
■■ Include pictures that illustrate a point and all 
relevant laboratory data (with reference ranges). 
Try to get images of surgery, cytology, radiology 
and ultrasonography
■■ Review what you have read, get a friend/mentor to 
check what you have written. They will notice things 
and bits they do not understand that seem perfectly 
clear to you. This is allowed. They must not correct 
the work – but you can
■■ Use spelling and grammar checkers. If Word thinks it 
is wrong, it probably is
■■ Never fabricate data or images
■■ Never copy whole sentences without citation and 
remember that using more than a whole sentence 
requires quotation marks as well. Be aware that the 
majority of marking systems have software which 
will detect plagiarism
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■■ Ensure you interpret all abnormalities (even if only to 
say they were not considered significant)
■■ Your discussion should be relevant to the case and 
usually is a place to reflect on how you have 
managed the case and how you would improve that 
management based on the results of your research
KEY LEARNING OBJECTIVES
■■ To help candidates identify an appropriate case to use
■■ How to perform a useful search of the available 
literature
■■ Identifying and avoiding commonly made mistakes
Options for the 
treatment of combined 
cranial cruciate 
ligament insufficiency 
and medial patellar 
luxation
Duncan Barnes 
Cranial cruciate ligament insufficiency (CCLI) and medial 
patellar luxation (MPL) are common causes of lameness 
in dogs and will often occur concomitantly. The pres-
ence of CCLI can contribute to the pathogenesis of MPL 
and vice versa. CCLI can cause biomechanical changes 
which promote medial patellar luxation, including:
■■ Increased internal rotation of the tibia relative to the 
femur
■■ A reduction in the retropatellar force which pushes 
the patella into the trochlear groove
■■ Progressive collapse of the medial stifle 
compartment
The presence of MPL may lead to CCLI as a result of:
■■ Increased and abnormal loading of the CCL when 
the patella is luxated
■■ The presence of degenerative joint disease and 
inflammatory mediators which result in 
degeneration of the cranial cruciate ligament
Careful preoperative assessment is essential to allow 
the rational selection of treatment options for combined 
CCLI/MPL. Assessment should include:
■■ Full clinical history, gait assessment and clinical 
examination
■■ Patellar luxation grade
■■ Degree of stifle instability: 
 – Amount of cranial drawer 
 – Degree of rotational instability of the tibia 
relative to the femur
■■ Hind limb bone conformation:
 – Presence or absence of angular limb deformity 
such as distal femoral varus, femoral torsion, 
tibial valgus/varus
 – Tibial plateau angle
■■ Condition of the femoral trochlear and caudal 
articular surface of the patella:
 – Degree of crepitus on manipulation of the 
patellofemoral joint
 – Computed tomography (CT) contrast 
arthrography to identify the degree of articular 
cartilage erosion
 – Visual assessment at surgery
Several treatment options are available for combined 
CCLI/MPL. By carefully considering the reasons for CCLI/
MPL in an individual patient we can tailor the surgical 
approach, improving the clinical outcome and reducing 
the incidence of complications. Treatment options 
include:
■■ Conservative treatment
■■ Routine treatment for the predominant lesion
■■ Routine treatment of MPL (tibial tuberosity 
transposition (TTT), block recession trochleoplasty 
(BRT), lateral retinacular imbrication) with the 
addition of a lateral extracapsular suture to control 
cranial drawer and internal rotation of the tibia 
relative to the femur
■■ Transposed tibial plateau levelling osteotomy (TPLO) 
+ BRT + lateral retinacular imbrication
■■ TPLO + TTT + BRT + lateral retinacular imbrication
■■ TPLO + patellar groove replacement
■■ Distal femoral ostectomy + BRT + TTT + TPLO
In this lecture we will look at the options for treat-
ment and the situations in which each would be selected. 
KEY LEARNING OBJECTIVES
■■ Understand how the pathogenesis of cranial 
cruciate ligament insufficiency (CCLI) and medial 
patellar luxation (MPL) are related and the effect of 
this on the selection of treatment options
■■ Understand how to objectively assess cases with 
combined MPL and CCLI
■■ Consider the pros and cons of the treatment 
options available for combined MPL and CCLI
MULTIPLE CHOICE QUESTIONS
1. What biomechanical factors can promote 
medial patellar luxation following cranial 
cruciate ligament rupture?
(A) Loss of constraint to internal rotation of 
the tibia relative to the femur
(B) Decreased retropatellar force
(C) Genu varum resulting from medial 
femorotibial joint collapse
(D) All of the above 
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2. Which treatment option is most useful when 
there is severe malformation or erosion of the 
femoral trochlear groove?
(A) Distal femoral ostectomy
(B) Patellar groove replacement
(C) Lateral retinacular imbrication
(D) Rectus femoris release
3. Which trochleoplasty technique results in the 
greatest area of articular cartilage contact 
between the patella and the trochlear groove?
(A) Abrasion trochleoplasty
(B) Wedge recession trochleoplasty
(C) Block recession trochleoplasty
(D) Patellar groove replacement
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Imaging the adrenals
Raquel Salgüero
The adrenal glands are two small glands located in the 
retroperitoneal space, cranial and medial to the kidneys. 
They are divided in two parts: the outer cortex and the 
inner medulla. The adrenal cortex is divided into three 
zones which are indistinct: the zona glomerulosa is the 
outer one and produces mineralocorticoids (aldoster-
one), the zone fasciculata secretes glucocorticoids 
( cortisol) and the reticuralis zone secretes sex hormones 
(progesterone, oestrogens and androgens). The medulla 
plays an important role in stress and hypoglycaemia, as it 
produces epinephrine (adrenaline) and norepinephrine. 
Because of their hormone production, adrenal glands 
are involved in several important systemic pathologies of 
our patients, such as hyperadrenocorticism (Cushing’s 
disease), hypoadrenocorticism (Addison’s disease), 
hypertension and neoplasia. Because of this, correct 
knowledge their location, and identification of normal 
and pathological appearances, in the different imaging 
modalities are necessary.
Identification of normal adrenal glands in abdominal 
radiographs is not possible due to their small size. Some 
cats can have mineralized adrenal glands and, in those 
cases, these will be seen due to their different opacity. 
Adrenal gland changes can be identified in radiographs in 
cases of mineralization, or when large masses are pre-
sent and produce a mass effect displacing the adjacent 
organs. 
Ultrasonography has been the gold standard tech-
nique to diagnose adrenal gland changes in small animal 
practice thanks to its availability and sensitivity. In normal 
cats, adrenal glands have an oval or bean shape and are 
hypoechoic. In dogs, the shape can vary but the left one 
frequently has a peanut shape and the right one a more 
oval shape. Knowing the normal appearance will be 
helpful to identify any possible pathological change.
With the increase of cross-sectional imaging (mainly 
computed tomography), finding incidental adrenal 
lesions (incidentalomas) has become more common 
(hyperplasia, adenomas). Ultrasonography and com-
puted tomography are more sensitive to visualize normal 
and pathological glands as there is no superimposition of 
different organs and they are able to show different 
 densities. 
This lecture will focus on the imaging appearance of 
adrenal glands in dogs and cats. A brief introduction to the 
anatomy, localization, normal appearance in radiology, 
ultrasonography, computed tomography and magnetic 
resonance imaging will be included, as will their appear-
ance in the most common adrenal gland  pathologies. 
KEY LEARNING OBJECTIVES
■■ Understand localization of the adrenal glands in 
ultrasoography and radiology
■■ Use of abdominal radiographs to identify adrenal 
pathologies
■■ Knowledge of the ultrasonographic appearance of 
the adrenals in the most common pathologies 
MULTIPLE CHOICE QUESTIONS
1. What is the size of the adrenal glands in cases 
of hypoadrenocorticism? 
(A) <3 mm
(B) 7–10 mm
(C) >7 mm
(D) >10 mm
2. What is the most common ultrasound 
appearance of the adrenals in cases of 
pituitary-dependent hyperadrenocorticism?
(A) Small adrenal size
(B) Bilateral adrenal enlargement
(C) Adrenal mass
(D) Normal adrenal size
3. Which adrenal neoplasia secretes epinephrine?
(A) Carcinoma
(B) Adenoma
(C) Phaeochromocytoma
(D) Myelolipoma
Atypical 
hypoadrenocorticism
Michael Herrtage
Hypoadrenocorticism is a syndrome that results from a 
deficiency of both glucocorticoid and mineralocorticoid 
secretion from the adrenal cortices. Destruction of more 
than 95% of both adrenal cortices causes a clinical 
 deficiency of all adrenocortical hormones and is termed 
primary hypoadrenocorticism (Addison’s disease). Sec-
ondary hypoadrenocorticism is caused by a deficiency 
in  adrenocorticotrophic hormone (ACTH), which leads 
to atrophy of the adrenal cortices and impaired secretion 
of glucocorticoids. The production of  mineralocorticoids, 
however, usually remains adequate. Atypical hypodren-
corticism is the term used to describe cases of primary 
hypoadrencoorticism in which the serum sodium and 
potassium concentrations at the time of testing are 
within their reference ranges.
Primary hypoadrenocorticism is uncommon in the 
dog but is probably underdiagnosed because of the 
vague and non-specific clincial signs. 
PATHOPHYSIOLOGY 
Loss of or damage to the adrenal cortex leads to miner-
alocorticoid and glucocorticoid deficiency. Aldosterone 
is the major mineralocorticoid and deficiency causes 
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impaired ability to conserve sodium and water and 
 failure  to excrete potassium, leading to hyponatraemia 
and hyperkalaemia. Hyponatraemia induces lethargy, 
depression, and nausea and leads to the development 
of  hypovolaemia, hypotension, reduced cardiac output 
and decreased renal perfusion. Hyperkalaemia causes 
muscle weakness, hyporeflexia and impaired cardiac 
 conduction. Glucocorticoid deficiency causes decreased 
tolerance of stress, loss of appetite and a mild normo-
cytic normochromic anaemia.
CLINICAL SIGNS
There are no breed predilections but the possibility of an 
hereditary factor has been suggested in some breeds. 
Hypoadrenocorticism appears to be a disease of the 
young and middle-aged dog with an age range of 
3  months to 9 years and a median age of 4–5 years. 
Approximately 70% of reported cases are female. The 
progression of adrenocortical insufficiency may be 
acute or chronic. Chronic hypoadrenocorticism is more 
common than the acute disease in the dog.
Acute primary hypoadrenocorticism 
The clinical appearance of the acute form is that of hypo-
volaemic shock (adrenocortical crisis).
Chronic primary hypoadrenocorticism 
The clinical signs in the chronic form are often vague and 
non-specific. The diagnosis should be considered in any 
dog with a waxing and waning type of illness or which 
shows episodic weakness and collapse. 
DIAGNOSIS
Haematological changes may include lymphocytosis, 
eosinophilia and mild normocytic, normochromic non-
regenerative anaemia. However, these findings are not as 
consistent as the changes seen in hyperadrenocorticism.
The most consistent laboratory findings in hypoad-
renocorticism are prerenal azotaemia, hyponatraemia 
and hyperkalaemia. Sodium is usually <135 mmol/l and 
potassium >5.5 mmol/l. Approximately 10% of cases may 
have normal electrolyte concentrations at the time of 
presentation and these are are described as atypical 
hypoadrenocorticism.
Endocrine testing
Basal serum cortisol concentration has been shown to 
be a useful screening test for dogs with signs compatible 
with hypoadrenocorticism. The disease is unlikely in 
dogs if the serum cortisol concentration is >55 nmol/l. 
Basal cortisol concentrations <55 nmol/l cannot confirm 
a diagnosis of hypoadrenocorticism and an ACTH stimu-
lation test should be performed.
The ACTH stimulation test is the ‘gold standard’ 
 diagnostic test to confirm the presence of hypoadren-
ocorticism. Whilst aldosterone concentrations pre- and 
post-ACTH are not routinely measured, they have proved 
to be useful in addition to cortisol concentrations in 
those cases with normal electrolyte concentrations, to 
determine whether mineralocorticoid supplementation 
is likely to be indicated.
Plasma ACTH concentrations are required to differ-
entiate primary and secondary hypoadrenocorticism. 
Plasma ACTH concentrations are low in secondary 
hypoadrenocorticism and markedly raised in primary 
hypoadrenocorticism.
KEY LEARNING OBJECTIVES
■■ The definition of atypical hypoadrenocorticism
■■ Electrolyte abnormalities can be quickly corrected 
by intravenous fluid therapy
■■ Measuring serum aldosterone can help in 
determining whether mineralocorticioid 
supplementation is likely to be required
MULTIPLE CHOICE QUESTIONS
1. Atypical hypoadrenocorticism is a diagnosis 
made when which one of the following 
statements is satisfied?
(A) The clincial signs are unusual
(B) The serum sodium and potassium 
concentrations are normal
(C) The ACTH-stimulation test does not 
confirm the diagnosis
(D) The patient is only deficient in 
glucocorticoid production
2. Primary (as opposed to secondary) 
hypoadrenocorticism is confirmed by which 
one of the following tests?
(A) A plasma ACTH concentration
(B) Plasma cortisol concentrations before and 
after ACTH stimulation
(C) Serum sodium:potassium ratio of less than 
25:1
(D) Plasma aldosterone concentrations before 
and after ACTH stimulation
3. Which statement best describes primary 
hypoadrenocorticism?
(A) It is usually an inherited disease in most 
breeds
(B) It only affects young adults between 1 and 
3 years of age
(C) The clincial signs are usually 
pathognomonic
(D) It is usually caused by an immune-
mediated destruction of the adrenal cortex
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The diagnosis of canine 
hyeradrenocorticism. 
Is it always 
straightforward?
Michael Herrtage
Diagnostic testing for canine hyperadrenocorticism 
(HAC) should be performed only when there is a strong 
clinical suspicion of the disease. The ACVIM consensus 
statement for diagnosis of HAC recommended testing 
only when there is compatible history and physical 
examination findings; when a pituitary macroadenoma 
has been identified; when a dog with diabetes mellitus 
shows insulin resistance not easily attributed to other 
causes; when an adrenal mass has been identified; or 
when there is persistent hypertension. Biochemical or 
haematological abnormalities were not deemed by 
themselves an indication to pursue diagnostic testing. 
Also, if a dog has a serious illness, endocrine testing 
should be postponed, as it can affect the results of 
screening tests.
SCREENING TESTS
Screening tests are not necessarily diagnostic, but, 
instead, may identify individuals more likely to have the 
disease. In order to realize how good (or bad) a test 
is,  one should understand the terms sensitivity and 
 specificity, as these terms are used to evaluate the per-
formance of these screening tests. The sensitivity of the 
test reflects the probability that the test will be positive 
among those dogs which are diseased (i.e. reflects the 
prevalence of false-negative results), and the specificity 
of the test reflects the percentage of individuals without 
the disease who have a negative result (i.e. reflects the 
prevalence of false-positive results). As no screening 
test has 100% accuracy, diagnostic testing for naturally 
occurring HAC should be performed only when there is 
a strong clinical suspicion, otherwise false-positive 
results will occur. In the same way, if there is a strong 
clinical suspicion of naturally occurring HAC and a test 
result is negative, an alternative screening test should be 
performed. 
Low-dose dexamethasone-suppression test
Although the low-dose dexamethasone-suppression test 
(LDDST) is considered the test of choice for diagnosing 
HAC, it takes time to complete and is affected by more 
variables. The sensitivity of the LDDST is high (ranging 
from 85–100%). However the specificity for the LDDST is 
low as (range 44–73%), especially when assessed in a 
population of dogs with non-adrenal  illness. 
In cases where an adrenal mass has been previously 
identified, the LDDST is undoubtedly the test of choice 
due to the fact that the test is diagnostic in nearly all dogs 
with cortisol-secreting adrenocortical tumours. 
ACTH stimulation test 
The adrenocorticotrophic hormone (ACTH) stimulation 
test is the gold standard for diagnosis of iatrogenic HAC. 
Despite being used frequently to diagnose naturally 
occurring HAC, it is not the first-line test currently rec-
ommended in the latest ACVIM consensus statement. 
The sensitivity of the ACTH stimulation test in dogs with 
suspected pituitary-dependent HAC (PDH) ranges from 
80–83%. The main limitation of this test is in dogs with 
suspected ADH where the sensitivity is low (57–63%), so 
a negative result does not exclude the diagnosis of ADH. 
Specificity ranges from 59–93%.
The ACTH stimulation test can, however, be used 
in  cases of suspected atypical HAC. Measurement of 
17-hydroxyprogesterone (17-OHP) before and after 
ACTH can help diagnose atypical HAC by documenting 
an exaggerated response to ACTH. 
Urine cortisol to creatinine ratio 
The reported specificity when using a single urine corti-
sol to creatinine ratio (UCCR) is very low (20–25%). The 
specificity of the test increases if two separate urine 
 samples are collected. Sensitivity is, on the other hand, 
quite high (75–100%), so it is actually a good test to rule 
out HAC (as a negative test will make HAC an unlikely 
diagnosis). 
KEY LEARNING OBJECTIVES
■■ An understanding of the terms ‘sensitivity’ and 
‘specificity’ as they relate to the three screening 
tests for canine hyperadrenocorticism
■■ The advantages and disadvantages of each of the 
three screening tests
■■ An appreciation of the term ‘atypical’ 
hyperadrenocorticism
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements best 
describes a low-dose dexamethasone-
suppression test?
(A) It will always give a positive result in the 
presence of canine hyperadrenocorticism
(B) It is affected by more variables than the 
ACTH stimulation test 
(C) The specificity of the LDDST is higher than 
that of the ACTH stimulation test
(D) Serum cortisol assays reliably give similar 
results
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2. Which one of the following statements best fits 
with a urine cortisol to creatinine ratio?
(A) A single measurement is specific for the 
diagnosis of hyperadrenocorticism
(B) The result is less affected by stress than are 
other screening tests
(C) It is a good screening test to exclude the 
possibility of hyperadrenocorticism
(D) Timing and method of sampling do not 
affect the result
3. Adrenal-dependent hyperadrenocorticism is 
best diagnosed by which of the following tests?
(A) An ACTH stimulation test
(B) A low-dose dexamethasone-suppression test
(C) Clinical signs
(D) Abdominal ultrasonography
Monitoring treatment 
in canine 
hyperadrenocorticism
Ian Ramsey
Hyperadrenocorticism (HAC) is commonly treated with 
trilostane. This treatment is usually monitored using a 
combination of clinical signs and adrenocorticotrophic 
hormone (ACTH) stimulation tests, despite this test hav-
ing never being validated for this purpose. As trilostane is 
relatively short acting, there is considerable variation in 
the results from ACTH stimulation tests even in dogs on 
the same long-term dose. Moreover, sometimes when 
ACTH stimulation tests demonstrate very low levels of 
cortisol, dogs may continue to be treated with the same 
dose of trilostane, as these low cortisol levels are only 
short lived. In addition, in some countries ACTH is 
 expensive or hard to obtain. Efforts have been made to 
find an alternative to ACTH stimulation tests and the 
result is pre-trilostane cortisol monitoring. This tech-
nique appears to be cheaper, easier and better correlated 
with clinical control than performing ACTH stimulation 
tests. This talk will describe the research behind this 
technique and provide recommendations on how to 
interpret the results (Figure 1).
The aim of trilostane therapy should be to satisfacto-
rily control clinical signs, without resulting in iatrogenic 
hypocortisolism. Using a target range of 40–138 nmol/l, 
the pre-trilostane cortisol concentrations were found to 
be better than the post-ACTH cortisol concentrations at 
discriminating between dogs whose HAC was well con-
trolled and those that were undercontrolled with a sen-
sitivity of 55.4% and a specificity of 86.5%. In addition, 
pre-trilostane monitoring may be better able to identify 
oversuppression, when the result is less then 40 nmol/l, 
but further research is needed. No cortisol result corre-
lated well enough with the clinical score to be used as a 
standalone monitoring test.
The studies that have been performed to date ques-
tion the existing recommendations that ACTH stimula-
tion tests should be used to ensure either adequate 
control or to detect dogs with oversuppression. Pre-
trilostane cortisol appears to be an objective measure-
ment that has the potential to balance safety with 
effective therapy, however further studies are needed. 
The importance of owners and clinicians’ observations is 
paramount. This monitoring technique can also be used 
in dogs that receive twice daily trilostane or that have 
adrenal tumours. The effect of stress on pre-pill cortisol 
has not been fully investigated yet but there is a strong 
suspicion that it may be a significant effect, so it is rec-
ommended that efforts should be made to reduce stress 
at the time of sampling.
DECLARATION OF CONFLICT OF INTEREST
The study was funded by Dechra® Veterinary Products.  
KEY LEARNING OBJECTIVES 
■■ Understand the central importance of a good 
clinical history and the role that an owner’s records 
can play in monitoring treatment of any endocrine 
disease
■■ Understand the limitations of ACTH stimulation 
tests in monitoring trilostane treatment
■■ Know how to perform and interpret pre-trilostane 
cortisol measurements 
Figure 1: Interpretation of pre-trilostane monitoring.
MULTIPLE CHOICE QUESTIONS 
1. You are presented with a 13-year-old female 
neutered Bichon Frise that is being treated with 
trilostane for confirmed hyperadrenocorticism. 
The dog has a 1-week history of vague lethargy 
but the owner reports no recent changes in 
appetite, thirst, urination and defecation. 
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A detailed clinical examination is unremarkable. 
A pre-pill cortisol is 35 nmol/l. What should you 
advise the client, assuming that cost is not a 
factor for any of the options?
(A) Stop trilostane and perform an ACTH 
stimulation test tomorrow
(B) Stop trilostane and test thyroxine (T4) and 
thyroid-stimulating hormone (cTSH) 
tomorrow
(C) Stop trilostane for 1 week and see how the 
dog does
(D) Stop trilostane for 1 week and start 
prednisolone
2. You are presented with a 10-year-old 8-kg 
male Yorkshire Terrier cross that is being 
treated with 10 mg trilostane once daily for 
confirmed hyperadrenocorticism. The dog is 
still polyuric despite 1 month of treatment, 
however he is livelier and less polydipsic than 
he was. A detailed clinical examination is 
unchanged (he is still alopecic). A pre-trilostane 
cortisol is 235 nmol/l. What should you advise 
the client assuming that cost is not a factor for 
any of the options?
(A) Don’t change the dose of trilostane just yet 
and recheck in 1 month as is starting to 
improve
(B) Increase the dose of trilostane to 20 mg 
once daily
(C) Increase the dose of trilostane to 10 mg 
twice daily
(D) Increase the dose of trilostane to 15 mg 
once daily
3. You are presented with a 10-year-old 32-kg 
female neutered Greyhound that has been 
treated with 60 mg trilostane twice daily for 
4 months for confirmed pituitary-dependent 
hyperadrenocorticism due to a 
macroadenoma. The dog is still massively 
polyuric despite treatment, however she is 
livelier and less polyphagic than she was. Her 
mild alopecia has resolved. A pre-trilostane 
cortisol is 50 nmol/l. Urine culture is negative 
but there is significant proteinuria. What 
treatment (reason) should you advise the client 
assuming that cost is not a factor for any of the 
options?
(A) Course of antibacterials (pyelonephritis)
(B) DDAVP treatment trial is warranted (central 
diabetes insipidus)
(C) Increase the dose of trilostane to 90 mg 
twice daily (treatment underdose)
(D) Switch to mitotane treatment (treatment 
failure)
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I want a CT scanner: 
considerations prior 
to purchase
Chris Warren-Smith 
When deciding to install a computed tomography (CT) 
scanner there are four main factors to consider:
■■ What type of scans will I perform?
■■ Where will the scanner be situated?
■■ Who will acquire and read the images?
■■ Image storage and utilization
The type of scans to be performed affects the 
required type of scanner. Two distinct technologies exist, 
fan-beam or conventional CT scanners and cone-beam 
scanners (sometimes listed as veterinary specific). Fan-
beam CT is more common and can be used for many dif-
ferent pathologies but the scanners are generally more 
expensive. Cone-beam CT units are smaller and use a 
flat panel detector similar to a DR x-ray unit. Generally, 
cone-beam CT units are less expensive to purchase.
New and second-hand scanners are available. New 
units will represent recent technology and be provided 
with warranties. Reconditioned units are cheaper to 
acquire than new units but are often refurbished with the 
most important components replaced. However, recon-
ditioned scanners may represent older technology and 
run a higher risk of mechanical breakdown than new 
units.
Fan-beam units are considered all-rounders with fast 
acquisition and good spatial and contrast resolution. This 
makes them good for imaging all areas of the body, 
although very small body parts will suffer from lim-
ited spatial resolution. Cone-beam CT was originally 
designed for dental acquisition in human medicine. 
Cone-beam has superior spatial resolution to fan-beam 
CT for small regions, however for larger areas it will suf-
fer from distortion and scans will be slower than on a 
fan-beam unit. It also has lower contrast resolution than 
a fan-beam unit. Therefore, for imaging bone structures 
within the head and for smaller musculoskeletal applica-
tions, cone-beam CT may be superior to fan-beam but it 
remains suboptimal for thoracic and abdominal studies. 
Space is also often a premium when considering CT 
installation. Fan-beam units require larger rooms than 
cone-beam units and require extensive lead shielding 
installation to prevent scatter, while cone-beam units 
may be used in existing x-ray rooms and may not require 
additional shielding. The electricity requirements are also 
different, with fan-beam units requiring three-phase 
power, leading to expensive upgrade costs to power 
 supplies and a higher running cost. Cone-beam units 
may operate from standard 230-V supplies.
CT scanners are complicated units so who operates 
the unit is important. Ideally a trained radiographer 
should be acquiring images but if not then ideally limiting 
the number of operators will result in better scans as they 
become more rapidly comfortable with the unit. It is then 
important to consider who will read the scans. Images 
may be easily transmitted to teleradiology providers, but 
with study sizes ranging from 0.5–1 Gb in size, a fast 
 network connection is essential. Similarly, storage of the 
images will occupy significantly more space than for 
standard radiographs (approximately 10–20 Mb/image). 
KEY LEARNING OBJECTIVES
■■ Fan-beam computed tomography (CT) scanners are 
all-round scanners appropriate for all scanning
■■ Cone-beam CT scanners are appropriate for the 
skull and some joints but not for thoracic or 
abdominal scanning
■■ Large amounts of image storage capacity will be 
necessary compared to standard radiographs
MULTIPLE CHOICE QUESTIONS
1. A ‘multislice’ scanner is defined as a scanner 
with what number of slices?
(A) 4 or higher
(B) 8 or higher
(C) 16 or higher
(D) 64 or higher
2. What is the approximate average radiation dose 
from a thoracic CT scan?
(A) 0.1 mSv
(B) 3 mSv
(C) 7 mSv
(D) 15 mSv
3. Which key component of the scanner is 
typically not covered in basic service contracts?
(A) Patient bed
(B) Detector bank
(C) X-ray tube head
(D) Cooling system
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I have a CT scanner: 
what now?
Matthew Winter
Computed tomography (CT), is similar to radiography in 
that x-rays (ionizing radiation) are used to penetrate the 
patient, and transmitted x-rays are detected to generate 
an image. The similarities stop there. While the physics of 
CT are beyond the scope of this discussion, it is impor-
tant to note that CT is a cross-sectional imaging  modality 
that creates ‘slices’ of anatomy, eliminating the super-
imposition and distortion that hampers radiographic 
examination. In addition, CT technology uses calcula-
tions of attenuation coefficients to characterize tissues 
and fluids more accurately and objectively, based on 
their attenuation of x-rays. Attenuation of tissues can be 
objectively measured using Hounsfield Units, named for 
one of the inventors of CT. Therefore, in addition to elim-
inating superimposition, tissue contrast is superior to that 
of radiographs. CT can distinguish some fluids from soft 
tissues and can aid in the distinction between some 
 different types of soft tissue structures from one another. 
Spatial resolution has progressively increased over 
time. Recent technologies provide thin slices and excep-
tional spatial resolution. This means that very small struc-
tures can be detected, and two small structures located 
in close proximity to one another can distinguished as 
separate. 
The recent advances in technology have increased 
the speed with which a patient can be imaged. The 
mechanics of the rotating tube and detector array have 
improved dramatically, improving the speed with which a 
scan can be completed. Similarly, continuing advances 
in computing algorithms and processing speed have sig-
nificantly decreased reconstruction time, meaning that 
the images are available for review quickly. Combine this 
with teleradiology, the ability to send images anywhere in 
the world rapidly with a few clicks, and you have access 
to world-class image interpretation for your acquired 
studies.
CONCLUSION
The rapid evolution of CT and the increasing accessibility 
of this technology to veterinarians is elevating the use of 
imaging in daily practice and improving the standard of 
patient care. There are more uses than those that I have 
listed above, and the utility of CT in practice continues to 
grow. CT is not necessary for all work-ups, and radiogra-
phy remains one of the best, most available, fastest and 
inexpensive screening tests for the majority of routine 
imaging needs. However, for more advanced work-ups, 
CT is quickly becoming indispensable. 
KEY LEARNING OBJECTIVES
■■ Computed tomography (CT) is a cross-sectional 
imaging modality that eliminates superimposition 
of structures
■■ Spatial and contrast resolution of CT compared to 
radiographs is superior
■■ CT can be used for a multitude of applications, 
and is becoming more and more available and 
convenient 
MULTIPLE CHOICE QUESTIONS
1. Why is CT awesome?
(A) It has high spatial resolution
(B) It has high contrast resolution
(C) It eliminates superimposition of other 
structures
(D) All of the above
2. By what can a CT examination be limited?
(A) Gas in the intestines
(B) Fluid in the peritoneal space
(C) Metallic implants
(D) Faeces
3. What does CT use to measure density of tissue?
(A) The same system as radiographs
(B) Calculation of linear attenuation
(C) Calculation of McCormack units
(D) Echogenicity of tissue
How to look at a CT 
scan: a beginner’s guide
Matthew Winter
For all image interpretation it is important to use a sys-
tematic approach. In fact, the evaluation of advanced 
imaging studies deviates minimally from the approach 
used for the evaluation of radiographs. Yet evaluation of 
advanced imaging modalities seems far more daunting, 
primarily because there is more information, and more to 
see. The key ingredients for successful and accurate 
image interpretation remain standard: namely, using a 
systemic, modified Roentgen sign approach, having a 
thorough understanding of anatomy and anatomical 
 variation, and having a firm grasp of pathophysiological 
mechanisms.
Remember too that imaging tests rarely reveal the 
single, one-and-only true answer. In general, the pur-
pose of an imaging test is to narrow the list of differential 
diagnoses, or to decrease the level of uncertainty. Imag-
ing findings are always interpreted in the context of the 
clinical signs and the results of other diagnostics, and, 
together, these will help direct your next diagnostic or 
therapeutic steps. For this reason, synthesis is the fusion 
of the art and the science of image interpretation. The 
value of good image interpretation is the assignment of 
accurate value to imaging findings, and correlation with 
appropriate pathophysiological mechanisms.
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CONCLUSION
Having a systematic approach is key to successful image 
interpretation. In addition, it is critical that information be 
organized in a way that facilitates synthesis so that accu-
rate conclusions can be drawn, a succinct and prioritized 
differential list can be generated, and appropriate next 
steps chosen.
KEY LEARNING OBJECTIVES
■■ Use a systematic approach to interpretation, 
regardless of the imaging study
■■ Organize your information
■■ Use a modified Roentgen sign approach to describe 
lesions as you encounter them
MULTIPLE CHOICE QUESTIONS
1. What would a complete list of Roentgen signs 
modified for CT interpretation include?
(A) Size, shape, number, opacity, location, 
margination
(B) Size, shape number, attenuation, location, 
enhancement
(C) Size, shape, number, attenuation, 
margination, delineation
(D) Size, shape, number, attenuation, location, 
margination
2. How many sections is it helpful to divide the 
thorax and abdomen into for interpretation of 
CT studies?
(A) 2
(B) 3
(C) 4
(D) 5
3. In modern CT, what happens to contrast 
resolution and spatial resolution compared to 
radiography?
(A) Contrast resolution increased, spatial 
resolution decreased
(B) Contrast resolution decreased, spatial 
resolution increased
(C) Contrast resolution decreased, spatial 
resolution decreased
(D) None of the above
Breathe in: thoracic CT
Chris Warren-Smith 
Computed tomography (CT)  is now considered the gold 
standard for imaging of the thorax where it provides 
superior image quality for imaging the lung, body 
wall,  vasculature and skeletal structures of the thorax 
due  to the lack of superimposition compared to two- 
dimensional radiography. CT can be used to better char-
acterize lung changes to help differentiate between 
inflammatory, infectious and neoplastic diseases. CT is 
also superior to radiography for the identification of pul-
monary metastases, where it can detect nodules as small 
as 2 mm in diameter (vs. 5 mm for radiography). CT is also 
useful for assessment of mediastinal lesions where it can 
assess any masses or lesions present, including their 
relationship to other structures in the mediastinum in 
particular their vascular supplies. CT also allows biopsy 
or fine-needle aspiration (FNA) of lesions that may be 
inaccessible to ultrasound.
PROTOCOL FOR THE THORAX
■■ 120 kV, 100+ mAs, 1.5-mm detector with 3-mm 
slice reconstructions (smaller reconstructions can 
be considered for high definition)
■■ A lung window is required to review lung images 
with a soft tissue window for the soft tissue 
structures
■■ Additional bone reconstructions can be considered 
if the skeletal structures are of specific interest
PROCEDURE
Thoracic CT can be performed under sedation or under 
general anaesthesia (GA) especially with modern multi-
slice scanners, however atelectasis may become appar-
ent. Atelectasis should occur in the dependent aspect of 
the lung (typically ventral if the scan is performed in ster-
nal recumbency). Minimizing the time between sedation/
GA induction and scanning will reduce this but if under 
GA then manual ventilation of the lung to reduce atelec-
tasis may be necessary. Contrast is generally not useful 
for assessment of the lung (inflammatory and atelectic 
lung share the same appearance) however it is particu-
larly useful for assessing the vasculature and soft tissues 
of the thoracic wall. It also helps to identify pleural lining 
which may be useful in pleural effusion cases. 
ASSESSMENT
Assessment of the thorax should include assessment of 
the trachea and the bronchi for evidence of collapse or 
change within the structures. It should be possible to fol-
low each main bronchus to allow identification of each 
lung lobe. The lung should then be assessed with the 
same lung patterns used for thoracic radiographs. CT is 
more sensitive than radiography so more subtle lesions 
may become apparent. Following assessment of the lung 
then the pleural lining, vascular and skeletal structures 
and finally the muscles of the thoracic wall including the 
diaphragm may be assessed. It should be noted however 
that CT is generally not used as a first-line modality for 
cardiac disease although it may be used to assess cardiac 
structure with contrast. 
This lecture will concentrate on some of the disease 
processes seen in the thorax.
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2. What size of metastatic nodules may be 
detected on CT?
(A) 2 mm
(B) 3 mm 
(C) 4 mm
(D) 5 mm
3. What is the ‘classic’ appearance of 
Angiostrongylus on CT?
(A) Generalixed interstitial pattern
(B) Generalixed alveolar pattern
(C) Peripheral alveolar pattern
(D) Bronchial thickening
KEY LEARNING OBJECTIVES
■■ Computed tomography (CT) is the gold standard for 
thoracic imaging
■■ Atelectasis should be minimized to avoid artefacts 
on images
■■ Contrast is not indicated when assessing lung
MULTIPLE CHOICE QUESTIONS
1. What size of metastatic nodules may be 
detected on radiography?
(A) 2 mm
(B) 3 mm
(C) 4 mm
(D) 5 mm
Around the abdomen: 
indications for 
abdominal CT
Matthew Winter
INTRODUCTION
Radiography and ultrasonography have been the routine 
screening tests of choice for decades in veterinary medi-
cine, and in many practices constitute a portion of the 
minimum database for more complex work-ups. How-
ever, computed tomography (CT) is being used more 
 frequently for the evaluation of veterinary patients with 
abdominal disease. Applications range from characteri-
zation of masses and staging neoplastic disease to evalu-
ation of patients that present with acute abdominal signs.
STAGING DISEASE
As discussed in a prior session, CT has been used with 
increasing frequency to assess patients for neoplastic 
metastases including the detection of nodules, osseous 
lesions, generalized organomegaly, and lymphadenopa-
thy. The characterization of masses through evaluation of 
size and distribution, as well as attenuation and enhance-
ment characteristics, provides critical information regard-
ing prognosis and response to therapy. 
Characterization of masses is also useful for surgical 
planning, and for identifying involvement of nearby struc-
tures and/or vascular invasion. CT assessment of splenic 
masses has been reported with some features aiding in 
distinguishing between benign and malignant splenic 
masses. In the case of adrenal masses, specific imaging 
features have been described that allow for accurate 
characterization of masses as benign or malignant, and 
may potentially allow for the distinction between phaeo-
chromocytoma and adenocarcinoma.
ACUTE ABDOMEN
More recently, the utility of CT for the evaluation of 
patients with suspected intestinal obstruction has been 
described. Specifically, the accuracy of CT was compared 
to that of radiography and ultrasonography. The accuracy 
of CT was found to be slightly better than that of ultra-
sonography, especially when the operator dependence 
of ultrasonography is factored in. In addition, CT is rapid, 
and can typically be performed with sedation. For the 
evaluation of gastrointestinal obstruction, contrast was 
not necessary, but will likely provide additional informa-
tion depending on the ultimate diagnosis (i.e. luminal 
 foreign body vs. intestinal mass/neoplasia).
Pancreatitis cases can also be imaged via CT. Com-
plete sonographic evaluation of the pancreas is often not 
possible due to the presence of gas in intestinal seg-
ments or hyperattenuating fat. CT is not limited by these 
factors, and can often provide a complete assessment 
of  the pancreatic parenchyma and regional lymph 
nodes. CT has also proven valuable in the identification 
of  pancreatic neoplasms, including insulinomas.
GENITOURINARY TRACT
CT, as well as other techniques of more direct visualiza-
tion, has supplanted the excretory urogram for evalua-
tion of the urinary tract. CT excretory urography can be 
critical to evaluating renal function, ureteral patency, 
ureteral course and the trigone in cases of urinary 
 incontinence, stranguria or dysuria. While these studies 
can be technically demanding, they can reveal much 
about abnormalities in urinary tract anatomy and 
 pathophysiology.
VASCULAR LESIONS
Perhaps one of the most common applications of CT in 
the abdomen is for the evaluation and characterization of 
portosystemic vascular anomalies using CT angiography. 
Since the early 2000s there have been many researchers 
that have described the CT imaging features of portosys-
temic shunts, arteriovenous fistulas and other vascular 
malformations. Properly acquired studies obtained dur-
ing the different phases of enhancement (arterial, portal 
and venous) can yield images with detailed vascular 
anatomy. This information is often used for surgical plan-
ning or for planning other interventional procedures.
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CONCLUSION
While there are many uses for CT in the abdomen, the 
studies listed above and extrapolations thereof constitute 
the majority of our abdominal CT caseload. These are 
key questions that can be answered with a properly 
planned and executed CT examination.
KEY LEARNING OBJECTIVES
■■ Computed tomography (CT) is excellent for the 
evaluation of the acute abdomen
■■ Portosystemic shunts can be accurately detected 
and characterized using CT angiography
■■ CT is critical for characterization of masses, surgical 
planning and staging neoplastic disease
(B) Pancreatic adenocarcinoma from 
pancreatitis
(C) Hepatocellular carcinoma from  
hepatoma
(D) Intestinal adenocarcinoma from 
lymphoma
2. Which of the following is true as it pertains to 
the accuracy of CT in the diagnosis of 
gastrointestinal obstruction?
(A) CT is not as good as ultrasonography
(B) CT is not as good as radiography
(C) CT is better than ultrasonography
(D) CT is operator dependent
3. Accurate characterization of portosystemic 
vascular anomalies requires assessment of 
how many vascular phases? Which are they?
(A) 3: arterial, capillary, venous
(B) 2: arterial and venous
(C) 1: venous
(D) 3: arterial, portal, venous
MULTIPLE CHOICE QUESTIONS
1. What can CT be used to distinguish accurately?
(A) Adrenal adenomas from adrenal 
adenocarcinomas
A headache or a pain 
in the neck? Head 
and neck CT
Chris Warren-Smith 
Computed tomography (CT) eliminates superimposi-
tion and within the head this allows far superior evalua-
tion of the nasal chambers, frontal sinuses and the soft 
tissues of the head compared to conventional radiogra-
phy. CT may also be used to evaluate the cranial vault 
although it is worth noting that magnetic resonance 
imaging (MRI) remains superior to CT for evaluating the 
brain. CT can be considered for assessment of nasal 
disease for differentiating neoplasia from infectious and 
inflammatory disease, diseases of the larynx, salivary 
glands and lymph nodes and for assessment of dental 
changes.
For scanning the head, a bone and soft tissue recon-
struction should be performed with slice thickness of 
2 mm for soft tissue and a thickness of 1.5 mm or less for 
the bone reconstruction (Figure 1). Generally, pre- and 
post-contrast images are advised, with only soft tissue 
reconstructions required post contrast. When scanning the 
brain, noise should be minimized by using thicker recon-
structions, typically 3 mm (small dogs and cats) to 5 mm in 
larger patients. Sequential rather than helical scanning may 
also result in better images for the brain, although helical 
scanning is preferred for all other structures.
CT of the spine is particularly useful in patients with 
trauma, where the speed of CT and the bone detail is 
ideal for fracture detection while being able to keep the 
patient immobilized. This is particularly true for the neck. 
Other conditions where CT can be useful include atlanto-
axial subluxation, discospondylitis and some mineralized 
discs. CT is also useful for assessment of the thyroid 
glands, lymph nodes and muscles of the neck and also 
for stick injuries and tracking foreign bodies. 
KEY LEARNING OBJECTIVES
■■ Computed tomography (CT) is superior to 
radiography due to the lack of superimposition, thus 
improving sensitivity and specificity for lesions 
particularly in the nasal cavity
■■ Magnetic resonance imaging (MRI) remains superior 
to CT for assessing the brain
■■ Contrast administration must be performed for 
any soft tissue disease assessment in the head 
and neck
Area kV mAs Rotation time Pitch Detector size Reconstruction
Head (general) 130 220 1.5 s 0.8 0.6 mm 1.5 mm bone, 2 mm soft tissue
Brain sequence 130 270 1.5 s 7.2 mm 0.6 mm 3 mm
Neck (soft tissue) 130 130 1.0 s 0.8 1.2 mm 2–3 mm
Figure 1: Protocol suggestions for the head and neck
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MULTIPLE CHOICE QUESTIONS
1. When performing a CT scan for assessment of 
the brain which setting modification is correct?
(A) Decrease mAs
(B) Decrease kV
(C) Increase slice thickness
(D) Increase table movement speed
2. Which of the following features is specific to 
Aspergillus?
(A) Turbinate loss
(B) Sinus fluid
(C) Nasal septum loss
(D) Bone hyperostosis
3. What is the sensitivity of CT for wooden foreign 
bodies?
(A) 59%
(B) 69%
(C) 79%
(D) 89%
Give the dog a bone: 
orthopaedic CT
Chris Warren-Smith 
Computed tomography (CT) offers very fine detail which 
makes it an ideal modality for orthopaedic imaging. CT 
should be used for assessment of the skeletal structures 
but it remains useful for soft tissue imaging where it can 
detect subtle mineralization and swelling. However, 
magnetic resonance imaging (MRI) remains the gold 
standard for muscular imaging and, in particular, for eval-
uation of synovial changes and ligaments. Ultrasonogra-
phy may also be considered. It is also worth noting that 
CT is a useful adjunct to, rather than a replacement for, 
conventional radiography and is not appropriate in all 
 situations.
As part of the assessment of skeletal structures, 
multiplanar reconstructions should be used particularly 
when assessing joints, as subtle lesions may only 
become apparent when viewed from different angles 
(for example, osteochondrosis dissecans (OCD) in the 
elbow joint). Ideally these should be reconstructed from 
the original raw data on the CT reconstructor itself, as 
this will give the best image detail when isotropic voxels 
are used in the original scan protocol. Scanning proto-
cols should therefore be with the thinnest possible 
slices, with an overlapping reconstruction (Figure 1). 
However, the trade-off is that a large number of images 
are generated and there is excess stress on the tube 
head so this should be tempered against the length of 
the scan range. It is also worth considering the potential 
long-term effects of radiation, as typically these patients 
may be young, especially those with developmental 
 disease.
It is important to keep the field of view as small as 
possible to optimize image detail. Contrast administra-
tion should only be used when soft tissues are being 
assessed.
The other advantage of multiplanar reconstruction is 
for assessment of limb deformities such as femoral varus 
or angular limb where it allows assessment and meas-
urement of the degree of deformity. Three-dimensional 
(3D) models may also be generated from the CT data 
using surface rendering from viewing software, to allow 
3D printing to be performed (note these are typically 
exported as .stl files). Slices should be less than or equal 
to 1 mm for 3D printing.
KEY LEARNING OBJECTIVES
■■ For best assessment of bone slices of 1 mm or less 
should be acquired
■■ Evaluation of joints should involve examination in 
multiple planes using post-scanning reconstruction
■■ Field of view should be minimized at all times for the 
best spatial resolution
Area kV mAs Rotation 
time
Pitch Detector 
size
Reconstruction
Joints 130 80 1.5 s 0.75 0.6 mm 1 mm for soft tissue
<1 mm for bone
Large range scanning 
(e.g. angular limb)
130 190 0.6 s 0.85 0.6 mm 2 mm bone and soft tissue for general viewing
<1 mm for 3D reconstruction
Figure 1: Protocols for orthopaedic CT
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MULTIPLE CHOICE QUESTIONS
1. Contrast administration would be indicated for 
which of the following conditions?
(A) OCD
(B) Panosteitis
(C) Neoplasia
(D) Fractures
2. CT would NOT be indicated for which of these 
conditions?
(A) Elbow dysplasia
(B) Gastrocnemius contraction
(C) Angular limb deformity
(D) Hip dysplasia
3. What slice thickness is most appropriate for 3D 
model printing?
(A) 0.75 mm
(B) 1.5 mm
(C) 3 mm
(D) 5 mm
Could I, should I, 
would I? When can 
I use spinal CT?
Matthew Winter
INTRODUCTION
The utility of computed tomography (CT) for evaluation 
of the spine is fraught with challenges, however CT 
remains an excellent test when applied in appropriate 
 circumstances to appropriately chosen patients. Most of 
the controversy stems from the accuracy of CT relative to 
CT myelography and magnetic resonance imaging (MRI) 
applied in cases of thoracolumbar myelopathy. To be 
sure, these tests are often chosen for different reasons 
and have different availability. 
For example, radiography and myelography had 
been the mainstay for evaluation of intervertebral disc 
disease and spinal cord compression in veterinary 
patients for decades. CT and CT myelography enabled 
better visualization of the spinal cord and subarachnoid 
space as well as the surrounding components of the 
canal. Still, CT does not provide the level of contrast res-
olution that is available with MRI, and therefore evalua-
tion of the spinal cord parenchyma can be less accurate. 
In addition, MRI may be less available in your area. Also, 
many veterinarians are not skilled in myelographic 
 techniques. Technical errors and complications during 
intrathecal injection can result in a non-diagnostic study. 
THORACOLUMBAR MYELOPATHY
For chondrodystrophic breeds, CT alone can provide 
accurate information regarding the location and severity 
of a bulging, protruding or extruded mineralized disc. 
Some authors describe an increase in sensitivity and 
specificity with the addition of intravenous contrast, and 
clearly the addition of myelography can often help iden-
tify the most compressive lesions. It can be challenging 
to sort out the clinical significance of extradural com-
pressive lesions when more than one is present, and 
 separating chronic from acute protrusions can also be 
difficult. In these cases, it may be necessary to add 
 additional testing, either with CT myelography or MRI.
CERVICAL SPONDYLOMYELOPATHY
The utility of CT for the diagnosis and characterization 
of  the multiple forms of cervical spondylomyelopathy 
has been well documented. CT provides excellent 
 information regarding morphology of the vertebrae, the 
vertebral canal, the articular facet joints and vertebral 
alignment. Characterization of degenerative changes, 
vertebral canal narrowing and subluxation can be done 
quickly and easily with CT. As mentioned above, changes 
in spinal cord integrity are not easily assessed with CT, 
and the addition of MRI to the diagnostic imaging arsenal 
may be necessary for complete assessment. 
TRAUMA
Traumatic injury to the vertebral canal can be assessed 
quickly and easily with CT. A CT examination can reveal 
fractures, subluxations and luxations that may result in 
spinal cord trauma. Although the integrity of the spinal 
cord cannot be directly assessed, indirect information 
regarding changes in vertebral canal diameter, altera-
tions in intervertebral foramen diameter, and indirect 
assessment of the soft tissue/ligamentous structures 
responsible for stabilization (as in atlantoaxial subluxa-
tion) can be performed. A common use of CT is to evalu-
ate trauma patients quickly to determine the severity and 
location of fractures that may affect the axial skeleton 
and the central nervous system.
DISCOSPONDYLITIS
The imaging findings associated with discospondylitis 
have been welldescribed, although few reports describe 
the widespread use of CT for the diagnostic evaluation of 
discospondylitis. This is likely to be due to the fact that 
this lesion is readily diagnosed via radiography and 
advanced imaging is often unnecessary. While the sensi-
tivity and specificity of CT in the diagnosis of discospon-
dylitis has not been reported, CT provides an accurate 
assessment of aggressive osseous changes that accom-
pany this disease process.
NEOPLASIA, INFECTION, INFLAMMATION
In older patients in which the potential for neoplastic 
 spinal cord diseases may be greater, CT may not provide 
enough information. Contrast enhancing lesions may be 
detected on post-contrast studies, and aggressive lesions 
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involving the osseous structures of the vertebral column 
may also be welldescribed by CT. In cases that involve 
infection other than discospondylitis, inflammation such 
as meningoencephalomyelitis of unknown origin, or 
 vascular insult such as fibrocartilaginous embolic 
 myelopathy, CT is much less useful. 
CONCLUSION
The success of CT in evaluation of spinal disease is com-
pletely dependent on case selection. The decision to use 
CT should be made based on the patient’s signalment, 
history and clinical signs, which will significantly influ-
ence the value and utility of the examination and will help 
you and your clients manage expectations with regard to 
imaging results.
KEY LEARNING OBJECTIVES
■■ The utility of computed tomography (CT) in 
evaluating cases of thoracolumbar myelopathy is 
careful patient selection
■■ CT is an excellent test for chondrodystrophic breeds 
with signs of acute myelopathy
■■ CT, contrast CT and CT myelography are excellent 
tests for many cases of thoracolumbar myelopathy, 
MULTIPLE CHOICE QUESTIONS
1. Which of the following CANNOT be assessed 
well using CT?
(A) The vertebrae
(B) The intervertebral disc spaces
(C) The spinal cord
(D) The articular facet joints
2. Which of the following diseases CANNOT be 
diagnosed with CT?
(A) Mineralized intervertebral disc extrusion
(B) Meningoencephalomyelitis of unknown 
origin
(C) Discospondylitis
(D) Cervical spondylomyelopathy
3. Why is CT myelography performed less 
frequently than contrast-enhanced CT?
(A) It isn’t very useful
(B) It isn’t necessary
(C) It can be technically challenging
(D) It is often contraindicated
but may not provide information regarding the 
integrity of the spinal cord
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Tracking foreign 
bodies: a review of 
imaging techniques
Francisco Llabrés Díaz 
The main question is which imaging modality to use 
and, if several modalities are to be used, in which order. 
Four main scenarios are regularly seen.
GRASS SEEDS AND OTHER TRACKING 
FOREIGN BODIES
If the clinical signs are recent and the location of the sus­
pected foreign body is superficial, ultrasonography can 
be used to diagnose the foreign body and to attempt 
retrieval. The presence of a hypoechoic/anechoic sur­
rounding abscess and/or discharge sinus will aid the 
identification. Use forceps (haemostatic, crocodile or 
endoscopic) for retrieval.
Foreign bodies causing retroperitoneal/sublumbar 
infection will mostly benefit from the use of advanced 
imaging, particularly if chronic. Computed tomography 
(CT) allows the assessment of the lung fields in case 
the  foreign body travelled through the bronchial tree. 
Magnetic resonance imaging (MRI) may make the evalu­
ation of the extension of the infection easier (iliopsoas 
musculature, vertebral column and vertebral canal). 
PENETRATING INJURIES
These occur particularly as oral, oropharyngeal and 
 thoracic inlet injuries. In this scenario, CT tends to be 
recommended. Although radiography can detect air 
within the soft tissues, CT will offer more detailed evalu­
ation of the original injury and extension of any associ­
ated changes, helpful for surgical planning/retrieval. 
OESOPHAGEAL FOREIGN BODIES
Radiography is the preferred modality in this situation. 
The oesophagus sits very much at midline, and therefore 
it would be expected to be very central on a dorsoventral 
projection.
GASTROINTESTINAL FOREIGN BODIES
The author prefers ultrasonography over radiography 
in  this situation. Ultrasonography allows not only the 
detection of dilated intestinal loops but also evaluates 
the  intestinal contents and the appearance of the wall 
( reaction or ulceration).
When ultrasonography is not available, and with 
more widespread access to teleradiology, other modali­
ties are being regularly used. Pneumocolonography can 
be used to ascertain whether a dilated intestinal loop 
corresponds to colon or small intestine. The latter would 
support a mechanical obstruction.
It is the unusual and convincing relative focal dilation 
of small intestinal loop(s) when compared to the remain­
ing loops (dual population radiographic pattern) which 
should raise suspicion for mechanical obstruction rather 
than a particular radiographic measurement. 
KEY LEARNING OBJECTIVES
■■ Advanced imaging is likely to be useful in most 
situations. Judicious use of radiography and 
ultrasonography, however, can be practical and 
financially viable
■■ Factors to consider when choosing an imaging 
technique: financial considerations; chronicity; swift 
access to the technique and expertise on image 
interpretation
■■ Macerated or small remnants of a foreign body will 
be difficult to detect irrespective of the chosen 
technique
MULTIPLE CHOICE QUESTIONS
1. What is the typical appearance of a grass seed 
on ultrasonography?
(A) An echogenic continuous linear structure
(B) An interrupted anechoic curved structure
(C) A fusiform echogenic structure 
(D) Grass seeds are not visible on 
ultrasonography
2. Which statement about evaluation of a 
radiograph in a case of a large oesophageal 
foreign body is TRUE?
(A) It is limited to diagnosing the foreign body
(B) It is not a good choice of technique
(C) Can only help if the foreign body is 
surrounded by oesophageal gas
(D) Can diagnose aspiration pneumonia/
mediastinitis
3. Which of these results for the width of a 
distended loop would support an intestinal 
obstruction on radiography?
(A) Greater than 0.5 the diameter of the aorta 
in cats
(B) Greater than proximal femur width in cats
(C) Greater than 1.2 times the height of L2 
vertebral body in dogs
(D) Greater than 1.6 times the height of L5 
in dogs
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Foreign bodies of 
the head
Jonathan Bray 
NASAL FOREIGN BODIES
The nose has a limited repertoire of clinical signs, and 
many nasal diseases present with an identical clinical 
picture making differentiation on clinical examination 
alone difficult. Reverse sneezing is an important condi­
tion to recognize. Reverse sneezing is caused by spasms 
of the nasopharynx and is typified by violent, paroxysmal 
inspiratory effort. Reverse sneezing accurately localizes 
the site of irritation to the nasopharynx and diagnostic 
investigation should therefore focus more specifically on 
this region. Many foreign bodies lodge in the nasophar­
ynx, after being regurgitated or coughed up following 
inadvertent ingestion/inhalation.
Definitive analysis of nasal disease is best achieved 
with a combination of computed tomography (CT) and 
nasal endoscopy. Most foreign bodies can be removed 
via either of the nostrils, or from behind the soft palate, 
but the first challenge is to achieve a good visualization 
of the offending item. 
RETROBULBAR FOREIGN BODIES
Foreign bodies may enter the orbit through the conjunc­
tiva or the roof of the mouth. Grass awns are commonly 
implicated, but sharp pieces of bone or wood are also 
possible causes. Sometimes, infection is introduced as a 
penetrating injury only, and no residual foreign material is 
present.
Dogs with orbital foreign bodies may present with 
some degree of exophthalmos, protrusion of the third 
eyelid, and severe pain on opening of the mouth. Pyrexia 
and systemic malaise may be present. Possible differ­
entials include neoplasia, tooth root abscessation or 
trauma. Investigations will include imaging, and either 
ultrasound or CT will enable evaluation of the area. 
If an abscess is diagnosed, drainage and antibiotic 
therapy are indicated. To establish drainage, make an 
incision with a blunt haemostat into the mucous mem­
brane over the swollen area behind the fourth premolar 
tooth. The wound should be left open to allow for further 
drainage. 
If a foreign object is identified, surgical exploration 
of  the orbit may be required. CT images will assist with 
planning. In most instances, adequate exposure can be 
achieved by a combined dorsal and lateral approach, with 
access improved with removal of the zygomatic arch. 
PHARYNGEAL STICK INJURIES
Penetrating injury of the oropharynx is most commonly 
due to impact from a stick. While oral injuries can occur 
to a dog when carrying or chewing sticks, more severe 
injuries are seen when the stick is thrown by the owner. 
In these cases, the dog may run onto the stick at speed, 
or there may be a violent tussle between two dogs. This 
more severe impact can cause extensive penetrative 
trauma to the tongue, pharynx and oesophagus. Frag­
ments of wood or large pieces of stick may break off and 
become embedded, and the tissue planes of the neck 
and mediastinum can become heavily contaminated 
with organic debris and bacteria.
Although stick injuries are often observed by the 
owner, the full extent of injury may not always be appre­
ciated. In these cases, life­threatening sepsis can develop 
within a few days. If the original contamination was 
not  overwhelming, a more chronic draining sinus may 
develop.
If a stick injury is suspected, it is important to thor­
oughly inspect the sublingual region, caudal oropharynx, 
soft palate and hard palate. Lesions may not be penetrat­
ing. Cervical and thoracic radiography is useful to look 
for the presence of free gas within the cervical tissue 
planes. It is unlikely that a foreign body will be identified, 
unless outlined by gas. 
If a penetrating oropharyngeal lesion is identified 
and/or gas is observed within the cervical tissue planes then 
prompt ventral midline cervical exploration is essential. 
KEY LEARNING OBJECTIVES
■■ Recognize the clinical signs that may suggest 
foreign body penetration of the nasal, oral or 
pharyngeal tissues
■■ Understand the importance of coaxial imaging, and 
other imaging modalities, to assist with diagnosis 
and localization of the foreign body
■■ Recognize the variety of presentations for 
pharyngeal stick injuries, and the potential for 
life­threatening sepsis to develop
MULTIPLE CHOICE QUESTIONS
1. Why is reverse sneezing an important clinical 
sign to recognize?
(A) It is characteristic for a blade of grass 
being stuck in the nose
(B) It helps localize the site of irritation to the 
nasopharynx
(C) Clients find it very distressing
(D) It is potentially life­threatening for the dog
2. Which of the following statements about 
retrobulbar abscesses is INCORRECT?
(A) They may be caused by penetrating 
wounds from the oral cavity or the 
conjunctiva
(B) They are always associated with residual 
foreign material that needs to be removed
(C) Tumour extension from the nasal cavity 
may require a CT scan to diagnose with 
confidence
(D) Severe haemorrhage may occur if blind 
probing of the retro­orbital cavity from the 
oral cavity is performed with sharp 
implements
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3. Why can stick injuries to the oral cavity be 
life­threatening?
(A) The dog is unable to eat properly due to 
local swelling
(B) There is a risk of laryngeal obstruction due 
to oedema
(C) Bacterial contamination of the cervical 
tissues can lead to sepsis and  
mediastinitis
(D) Treatment is often expensive  
so the owners may elect  
euthanasia
Endoscopic 
management of 
foreign bodies
David Walker 
Endoscopic foreign body removal in dogs and cats pri­
marily involves removal of objects from the oesophagus, 
stomach, nose, nasopharynx and the larger airways. 
Some objects are relatively simple to remove with the 
correct equipment, whilst others prove to be a significant 
challenge. 
Oesophageal foreign bodies are usually bones and 
they typically lodge at the thoracic inlet, heart base or 
hiatus. They are considered to be an emergency and 
should be removed as soon as the patient is stable to 
reduce the risk of perforation. They can be removed with 
the help of endoscopy or fluoroscopy, although the 
author prefers the former. Endoscopy has the advantage 
that the oesophageal mucosa can be assessed for dam­
age. Large, rigid grasping forceps are passed alongside 
the endoscope and the foreign body is firmly grasped; 
care must be taken not to grasp the oesophageal wall. 
The foreign body is gently manipulated and if movement 
is evident it is withdrawn. If a bone foreign body has to be 
manipulated into the stomach, it will be rapidly digested 
and gastrotomy is not required. It is important to remem­
ber that the aborad side of the foreign body may be sharp 
and could damage the mucosa. Oesophagotomy is very 
rarely required. The major complications associated with 
oesophageal foreign body removal are perforation and 
stricture formation secondary to oesophagitis. 
Oesophageal fish hooks sometimes present a chal­
lenge. It is always worth checking under the tongue for 
fishing line and it is useful not to cut the line as it is some­
times helpful during manipulation. Fish hooks normally 
need to be pushed aborally to disengage them from the 
oesophageal wall. A small hole is left but there are rarely 
any complications. The point of the hook needs to be 
facing aborally for removal. 
Many gastric foreign bodies can be removed endo­
scopically avoiding the morbidity associated with gastro­
tomy. Various instruments are available for use through 
the working channel of the endoscope. 
The most common airway foreign objects in the 
author’s practice are large ears of wheat and grass awns. 
These foreign bodies tend to cause acute or chronic 
coughing and may cause only minor or no radiographic 
change. Stones, teeth and food are other reported airway 
foreign bodies. Different retrieval forceps can be used 
through the working channel of the endoscope  depending 
on the type of foreign body.  
KEY LEARNING OBJECTIVES
■■ Have an understanding of the range of instruments 
available for foreign body removal
■■ Have an understanding of the risks and 
complications associated with foreign body removal 
related to the site of the object
■■ Be able to make appropriate decisions with regards 
to which cases can be managed within your 
practice
MULTIPLE CHOICE QUESTIONS
1. Which of the following breeds are over­
represented with regards to oesophageal and/
or gastric foreign bodies?
(A) Affenpinscher and German Wirehaired 
Pointers
(B) Afghan Hounds and Shetland Sheepdogs
(C) Labrador Retrievers and Australian Cattle 
Dogs
(D) West Highland White Terriers and Bernese 
Mountain Dogs
2. Although, relatively uncommon, what is the 
major complication seen following 
oesophageal foreign body removal? 
(A) Peri­oesophageal abcessation 
(B) Oesophageal perforation 
(C) Oesophageal stricture
(D) Respiratory arrest
3. Which of the following would be the most 
appropriate endoscopic instrument with which 
to remove a stone gastric foreign body? 
(A) Alligator jaw forceps 
(B) Four wire basket forceps
(C) Rat tooth forceps
(D) Snare (30 mm)
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‘For the chop’: surgical 
management of 
thoracic and abdominal 
foreign bodies
Georga Karbe
Foreign bodies (FB) found in the thoracic or abdominal 
cavities can be inhaled, ingested or penetrate from exter­
nally. Ingested FB can lead to obstruction, organ tissue 
necrosis and perforation. Perforation of the oesophagus 
or gastrointestinal tract can result in generalized infec­
tion of the thoracic (pyothorax) or abdominal cavity 
(peritonitis). Inhaled foreign material may result in 
abscess formation within the pulmonary parenchyma or 
pleural space. This presentation will review preoperative 
assessment, emergency stabilization, surgical treatment 
and postoperative management using case examples.
THORACIC FOREIGN BODIES
Inhaled grass seeds or other foreign material can become 
lodged within the lower airways where they present a 
nidus for infection. Patients will present with an acute or 
chronic cough and/or generalized malaise. Often a single 
consolidated lung region can be seen on thoracic imag­
ing. Purulent material may be seen within the affected 
bronchus on bronchoscopy. 
Endoscopic retrieval of bronchial FB may be possible 
unless the material has become lodged in the smaller, 
peripheral airways. Surgical removal of the affected lung 
region is often indicated. Ruptured pulmonary abscesses 
or extrapulmonary pleural abscesses require surgical 
treatment either via median sternotomy, lateral thoracot­
omy or thoracoscopy. 
In some instances, thoracic foreign bodies can 
migrate through the diaphragm into the abdomen or 
 retroperitoneal space. Conversely, ingested foreign 
 bodies can penetrate from the abdomen through the 
diaphragm into the thorax. 
Intrathoracic oesophageal FB that cannot be 
retrieved via endoscopy will require surgical intervention. 
Oesophageal surgery carries a high risk of postoperative 
complications and patients must receive water and food 
via a gastrostomy tube exclusively while the oesophagus 
heals for a minimum of 10–14 days. Following thoracic 
exploration, a chest drain(s) is placed so that postopera­
tive fluid and air production can be monitored. Broad­
spectrum antimicrobial therapy is administered and 
adjusted based on culture results. Supportive care with 
intravenous fluids and analgesia is continued based on 
the status of the patient.
ABDOMINAL FOREIGN BODIES
Patients with ingested abdominal FB often present with 
an acute onset of vomiting, anorexia and lethargy. On 
physical examination, abdominal pain and evidence of 
dehydration are commonly found. Abdominal imaging 
and routine blood screening are necessary to diagnose 
and stabilize the patient prior to surgical intervention. 
Gastric FB can often be removed via endoscopy, whereas 
surgical intervention is required when material has 
moved out of the stomach and/or when organ perfora­
tion is suspected. The entire abdominal cavity and organs 
must be thoroughly evaluated via a standard ventral 
 midline laparotomy. Gastrotomy, enterotomy and/or 
enterectomy may be required to remove obstructive FB 
and remove necrotic intestinal segments. Once material 
has passed into the colon, surgical intervention is not 
generally recommended. 
Postoperatively, patients are offered food by mouth 
as soon as they have fully recovered from anaesthesia, 
early (within 24 hours) enteral nutrition is known to 
improve patient outcome. Supportive care is continued 
based on the status of the patient. The use of antimicro­
bials is indicated in patients with peritonitis, however not 
all patients undergoing gastrointestinal surgery require 
postoperative antimicrobials.
KEY LEARNING OBJECTIVES
■■ Identifying foreign bodies in the abdomen and 
thorax
■■ Surgical treatment for foreign body removal
■■ Postoperative management
MULTIPLE CHOICE QUESTIONS
1. Which of the following is NOT a recommended 
treatment option for patients with thoracic 
foreign bodies?
(A) Endoscopy
(B) Thoracoscopy
(C) Thoracic explore via median sternotomy
(D) No intervention needed, medical 
management only
2. Which of the following is TRUE regarding 
oesophageal surgery?
(A) Patients should be fed by mouth within the 
first 24 hours after surgery
(B) The oesophagus heals quickly and 
generally without complications
(C) Patients must receive water and food 
exclusively via gastrostomy tube
(D) Patients must receive food exclusively via 
gastrostomy tube, water can be offered by 
mouth
3. Which of the following is FALSE regarding 
gastrointestinal surgery?
(A) Postoperative antibiotics are 
recommended in all patients following 
gastrointestinal surgery
(B) Foreign bodies in the colon do not 
generally require surgery
(C) Postoperatively patients should be offered 
enteral nutrition within the first 24 hours
(D) Foreign bodies in the stomach can be 
retrieved via endoscopy
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Needle in a haystack: 
dealing with tracking 
foreign bodies
Georga Karbe
Foreign bodies (FB) such as grass awns, grass seeds and 
sticks are known to enter the body most commonly 
through small wounds in the extremities or the  oropharynx. 
Foreign bodies will frequently migrate away from the point 
of entry, resulting in swelling, pain and chronic draining 
tracts either near or distant to the entry site. Clinical signs 
often improve with antimicrobial therapy, but recur once 
treatment has been discontinued. This presentation will 
discuss diagnostics, surgical management and common 
pitfalls when treating migrating foreign bodies.
Patient signalment, history as well as temporary 
response to antimicrobial treatment may often arouse 
suspicion for migrating FB. Commonly, owners report 
coughing, gagging or ptyalism after their dog was seen 
playing with a stick or note lameness or excessive licking 
of a paw or other body part. Foreign bodies have been 
reported to track into the sublumbar musculature and the 
flank as well as into the pericardium or spine. Imaging 
such as ultrasonography, computed tomography (CT) or 
magnetic resonance imaging (MRI) scans are helpful in 
locating the FB and for surgical planning. If present, drain­
ing tracts can be probed, however this is often insuffi­
cient, and a wide surgical exploration and debridement 
are required. It is not uncommon for the foreign material 
not to be found on surgical exploration. This may in part 
be due to the body’s natural response of abscess forma­
tion and phagocytosis of these materials, making the FB 
unidentifiable. Wide surgical debridement of all infected 
tissues is therefore recommended, as it can be assumed 
that these tissues contain the FB. The removed tissues are 
submitted for culture and  histopathology and treatment is 
adjusted based on these results. 
MULTIPLE CHOICE QUESTIONS
1. How will patients with migrating foreign  
bodies commonly respond to antibiotic 
therapy?
(A) Clinical signs are unchanged
(B) Clinical signs worsen initially and then 
resolve once treatment is discontinued
(C) Clinical signs improve initially then recur 
once treatment is discontinued
(D) Patients with foreign bodies should not be 
treated with antibiotics
2. What reaction do foreign bodies cause in 
the body?
(A) Autoimmune reaction
(B) Allergic reaction
(C) Abscess formation
(D) Neurogenic reaction
3. What is the most common complication 
following migrating foreign body surgery?
(A) Recurrence
(B) Pancreatitis
(C) Bleeding
(D) Pneumothorax
Recurrence is the most common complication fol­
lowing FB removal/exploratory surgery. Recurrence can 
be seen within a few weeks or months after surgical 
treatment. Patients will present with similar signs 
although the swelling or draining tract may have moved 
away from the surgical area. Repeat imaging and explo­
ration are recommended. Multiple surgeries may be 
required in some patients. 
KEY LEARNING OBJECTIVES
■■ Possible behaviour of migrating foreign bodies
■■ Surgical planning and treatment
■■ Dealing with postoperative recurrence
The recurrent foreign 
body: what to do next?
Jonathan Bray 
Prior to the turn of this century, dogs with a draining sinus 
would likely undergo a mean of 2.0 surgical procedures 
(range, 1 to 5) before definitive resolution was achieved. 
In some animals, their disease was never successfully 
resolved and euthanasia was considered. 
If you have got this far through this lecture series on 
foreign body management, you will by now understand 
the importance of coaxial imaging and elimination of the 
nidus of infection to achieve complete resolution of the 
draining sinus. Therefore, if we assume that good first 
principles have been followed, and the original nidus of 
disease has been completely eliminated, the incidence of 
persistently draining sinuses is now uncommon. 
The incidence of the truly recurrent (i.e. a de novo) 
foreign body is undocumented, but is likely to be extremely 
low, and may be difficult to prove. With migrating grass 
seeds being a relatively sporadic and random occurrence, 
environmental and lifestyle circumstances are likely to 
play a role.
Some dogs are prone to serial ingestion of inorganic 
(e.g. toys, plastic wraps, sock etc.) or organic (e.g. bones, 
corn cobs, etc.) material that may be a cause for intesti­
nal obstruction, and repeated exploratory laparotomy/
enterotomy. Such pica is largely considered to be a 
behavioural problem and needs to be addressed as such. 
There do not appear to be any medical reasons to explain 
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this behaviour, which is more common in the younger 
animal.
There are, however, several conditions where recur­
rence of a foreign body could be considered a possibility, 
due to the persistence or development of similar clinical 
signs. 
ADHESIONS
There are a few published case reports and some anec­
dotal examples of cases where adhesions from previous 
intestinal surgery has led to episodes of partial or com­
plete obstruction of the bowel. 
INTERDIGITAL FURUNCULOSIS 
(INTERDIGITAL CYST)
Interdigital cysts can develop in many different breeds, 
but the Bulldog breed seems particularly susceptible. 
Interdigital cysts are rarely ‘cystic’, and are more typically 
a pyogranulomatous inflammation. The lesion will 
develop as an inflamed, nodular and irritable lesion on 
the interdigital webbing. There may be discharge and 
apparent sinus in the middle of the lesion, which may 
raise the suspicion for a foreign body.
The aetiology of the interdigital cyst is not entirely 
understood, and a variety of treatments have been pro­
posed to manage them.
DERMOID SINUS
Dermoid sinuses are located directly on the midline, 
and  have been reported on the nose, neck and spine. 
Dermoid sinuses are caused by incomplete separation 
of  the skin and the nervous system during embryonic 
development; the tube is lined with epithelium and hair 
may also develop. 
The depth of the defect varies, and the dermoid sinus 
may extend into the tissue just beneath the skin or extend 
deeper and terminate anywhere along the midline tissue 
planes (usually distinct fascial layers). They can even 
extend to the dura mater of the spinal cord in extreme 
cases. In other cases, the dermoid sinus may be a blind­
ended sac beneath the skin; in these situations, deeper 
abscessation can develop because drainage to the upper 
surface of the skin is obstructed. This can greatly confuse 
the clinical presentation. 
Successful resolution of a dermoid sinus requires 
complete removal of the abnormal tissue. This requires 
a meticulous dissection. Computed tomography (CT) or 
magnetic resonance imaging of the affected area is 
always helpful to guide the dissection. 
KEY LEARNING OBJECTIVES
■■ Recognize the potential for persistent draining 
sinuses to be associated with conditions other than 
migrating foreign material
■■ Understand the development aetiology of dermoid 
sinuses, and the importance of knowing their full 
extent prior to surgical exploration
■■ Appreciate the need for sound surgical technique to 
reduce the potential for intra­abdominal adhesions, 
which may be the cause of occult or overt clinical 
signs later in life
MULTIPLE CHOICE QUESTIONS
1. When may recurrence or persistence of a 
draining sinus occur?
(A) A foreign body was not located at the 
original surgery
(B) A CT scan was not performed 
(C) The animal lives near or is walked regularly 
on grassy terrain
(D) An infective nidus persists after exploratory 
surgery
2. Which of the following statements about 
dermoid sinus is INCORRECT?
(A) Dermoid sinuses have been reported to 
develop along the length of the spinal cord 
and the nose
(B) Category IV sinuses can connect with the 
spinal cord, with risk for infection 
spreading to the central nervous system
(C) Dermoid sinuses may be occult, and not 
manifest as a clinical disease until later 
in life
(D) A contrast fistulogram should never be 
performed as it may allow infective material 
to be spread into the cerebrospinal fluid
3. Which of the following statements about 
interdigital cysts developing in the interdigital 
webbing of dogs is correct? 
(A) They can be controlled with long courses 
of antibiotics, soaking of the feet with 
antiseptic solutions or immunosuppressive 
medications
(B) Fusion podoplasty may be required for 
salvage of severe cases
(C) Interdigital cysts develop due to ruptured/
inflamed hair follicles on the ventral skin 
surface, with the inflammation tracking 
dorsally
(D) All of the above
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How to get the most 
from your neurological 
examination
Steven De Decker
After performing a neurological examination, you can 
answer the following questions: Does the animal have a 
neurological disease? Which part of the nervous system 
is affected? And sometimes you can determine the prog-
nosis. This Information is crucial for obtaining a reliable 
list of differential diagnoses. 
BASIC COMPONENTS OF THE 
NEUROLOGICAL EXAMINATION
The neurological examination can be divided in the 
hands-off and hands-on examinations. The hands-off 
examination is of great importance and often reveals key 
findings. The neurological examination is further divided 
into seven components. 
■■ Mentation and behaviour: progressively decreasing 
levels of mentation are obtundation, stupor and 
coma. Mentation can be decreased in forebrain 
and brainstem disorders. Examples of abnormal 
behaviour include circling, compulsive pacing and 
head pressing. Abnormal behaviour is suggestive 
of forebrain disease
■■ Posture and gait: abnormalities in posture include 
low head carriage, kyphosis, head tilt. Abnormalities 
in gait include paresis, ataxia and lameness
■■ Proprioception: proprioceptive deficits are a reliable 
indicator for the presence of neurological disease. 
Proprioceptive deficits can occur in forebrain, 
brainstem and spinal disease
■■ Cranial nerves: isolated cranial nerve deficits can 
be associated with specific idiopathic conditions. 
Certain combinations of cranial nerve deficits can 
be suggestive for inner ear localizations, while 
multiple cranial nerve deficits can occur in 
brainstem or generalized lower motor neuron 
disorders
■■ Spinal reflexes: evaluation of spinal reflexes is 
indicated to recognize lower motor neuron disease, 
and to evaluate which spinal cord segment is 
affected in animals with spinal disease
■■ Spinal palpation: it is important to start with gentle 
palpation when you suspect the presence of spinal 
pain
■■ Nociception: because this part of the examination 
is unpleasant, evaluation of nociception or ‘pain 
sensation’ should only be performed in paraplegic 
and comatose animals
DETERMINING THE NEUROANATOMICAL 
LOCALIZATION
The combination of clinical signs and findings of the 
neurological examination is used to determine the 
 neuroanatomical localization. This will consist of one of 
the following: forebrain, cerebellum, brainstem, spinal 
cord and neuromuscular. 
■■ Forebrain: clinical signs include seizures, decreased 
mentation, abnormal behaviour and central 
blindness. Additional neurological deficits include 
decreased menace response, decreased response 
after stimulation of the nasal mucosa and 
proprioceptive deficits
■■ Cerebellum: clinical signs include ataxia without 
paresis, hypermetria, central vestibular disease and 
intention tremors. Additional neurological deficits 
include a decreased menace response
■■ Brainstem: clinical signs include decreased 
mentation, generalized ataxia, hemiparesis, 
tetraparesis and vestibular disease. Additional 
neurological deficits include proprioceptive deficits 
and cranial nerve deficits
■■ Spinal cord: clinical signs include a combination of 
ataxia and paresis, spinal hyperaesthesia, and 
bladder dysfunction. Additional neurological 
deficits include proprioceptive deficits and 
alterations in spinal reflexes
■■ Neuromuscular: the hallmark of neuromuscular 
disease is paresis without ataxia. Other clinical 
signs include changes in voice and regurgitation. 
Additional neurological deficits can include 
decreased spinal reflexes and cranial nerve  
deficits
KEY LEARNING OBJECTIVES
■■ Learn the basic components of a practical 
neurological examination
■■ Understand how a neuroanatomical localization 
is obtained by using a combination of clinical signs 
and neurological examination findings
■■ Learn how a reliable list of differential diagnoses 
is constructed
MULTIPLE CHOICE QUESTIONS
1. Which statement is CORRECT about evaluating 
spinal reflexes?
(A) Spinal reflexes are evaluated to determine 
prognosis
(B) Spinal reflexes are evaluated to determine 
the neuroanatomical localization
(C) Spinal reflexes are unaffected in 
generalized lower motor neuron disease
(D) Spinal reflexes are decreased in brainstem 
disease
2. Which statement is TRUE about proprioceptive 
deficits?
(A) Proprioception is typically decreased in 
cerebellar disease
(B) Proprioception is typically intact in 
forebrain disease
(C) Proprioception is typically decreased in 
spinal disease
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(D) Proprioception is typically decreased in 
animals with neuromuscular disease
3. Which statement is TRUE about forebrain 
disease?
(A) Forebrain disease is the only 
neuroanatomical localization associated 
with abnormal behaviour
(B) Forebrain disease is the only 
neuroanatomical localization associated 
with decreased mentation
(C) Forebrain disease is often associated 
with ataxia
(D) Forebrain disease does not result in 
proprioceptive deficits
Cerebrovascular 
diseases: do dogs 
have strokes?
Richard LeCouteur
The term ‘cerebrovascular disease’ is defined as any 
abnormality of the brain resulting from a pathological 
process compromising its blood supply. Pathological 
processes of the blood vessel include occlusion of the 
lumen by a thrombus or embolus, rupture of a blood 
 vessel wall, lesion or altered permeability of the vessel 
wall and increased viscosity or other changes in the 
 quality of the blood. A cerebrovascular accident (CVA), 
also known as stroke, is the most common clinical pres-
entation of cerebrovascular disease, defined as a sudden 
onset of non-convulsive and non-progressive focal brain 
signs secondary to cerebrovascular disease.
CAUSES
From a pathological point of view, the lesions affecting 
the cerebral blood vessels are divided into two broad 
categories:
■■ Ischaemic stroke, resulting from occlusion of a 
cerebral blood vessel by a thrombus or embolism, 
depriving the brain of oxygen and glucose
■■ Haemorrhagic stroke, resulting from rupture of a 
blood vessel wall within the brain parenchyma or 
subarachnoid space, causing bleeding into or 
around the brain
CLINICAL SIGNS
In ischaemic or haemorrhagic stroke, it is the abruptness 
with which the neurological deficits develop that is highly 
suggestive of the disorder as being vascular. This event 
is  then followed by a plateau and then resolution of 
the  neurological deficit in all except the fatal strokes. 
Worsening oedema can result in progression of neuro-
logical signs for 24–72 hours. Intracranial haemorrhage 
can be an exception and cause rapid progressive onset 
over a very short period of time. Clinical signs usually 
improve after 24–72 hours due to a decrease in size of 
the haematoma and oedema. 
Neurological deficits usually refer to a focal anatom-
ical diagnosis and depend on the neurolocalization of 
the vascular insult (telencephalon, thalamus, midbrain, 
pons, medulla, cerebellum).
DIAGNOSIS
Initial evaluation of animals with suspected stroke should 
focus on the differential diagnosis, including traumatic, 
metabolic, neoplastic, inflammatory/infectious and toxic 
encephalopathies. Fundus examination should be con-
sidered in all animals and may reveal tortuous  vessels 
(suggestive of systemic hypertension), haemorrhage 
(suggestive of coagulopathy or systemic hypertension), 
or papilloedema (suggestive of elevated intracranial 
pressure (ICP)). Imaging studies of the brain (computed 
tomography (CT), conventional and functional mag-
nestic resonance imaging (MRI)) are necessary to 
 confirm stroke, define the vascular territory involved, 
determine the extent of the lesion, and distinguish 
between ischaemic and haemorrhagic stroke. Imaging 
studies are also necessary to rule out other causes 
such as tumour, trauma and encephalitis. Once stroke is 
 confirmed, diagnostic tests focus on identifying an 
underlying cause.
KEY LEARNING OBJECTIVES
■■ Understand the causes and pathophysiology of 
cerebrovascular diseases of dogs
■■ Recognize the clinical signs of cerebrovascular 
diseases in dogs
■■ Discuss diagnostic and treatment options for 
cerebrovascular diseases in dogs
MULTIPLE CHOICE QUESTIONS
1. Which are reportedly the most common risk 
factors for the development of brain infarction 
in dogs?
(A) Phaeochromocytoma and lymphoma
(B) Essential hypertension and 
hypoadrenocorticism
(C) Chronic renal failure and 
hyperadrenocorticism
(D) Hypothyroidism and dilated 
cardiomyopathy
2. Which drug has been shown to predispose 
humans to ischaemic or haemorrhagic 
infarction?
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(B) CT has demonstrated a sensitivity of 80% 
in detecting ischaemic infarction within 
24 hours after occurrence
(C) Acute haemorrhagic infarction tends to 
result in hypodense lesions that are 
difficult to detect
(D) Temporal changes in CT findings following 
ischaemic infarction are similar to those of 
MRI but differ based on time from infarct 
to earliest detection
(A) Amlodipine
(B) Phenoxybenzamine
(C) Phenylpropanolamine
(D) Furosemide
3. Which statement regarding the use of CT in 
diagnosing ischaemic encephalopathies is 
INCORRECT? 
(A) CT is inferior to MRI in detecting ischaemic 
infarction
Poorly puppies: 
neurological disease 
in the young animal
Steven De Decker
Evaluating puppies with neurological disease is challeng-
ing. They can be considered uncooperative patients and 
their body systems are still in development. Interpreta-
tion of diagnostic tests is complicated by the fact that 
puppies are skeletally immature, and that the nervous 
system is still developing. It is easy to understand that 
congenital anomalies and infectious disorders should be 
considered important differential diagnoses in puppies 
with neurological signs. Important factors to take into 
account are therefore the specific breed, general physi-
cal examination findings, health status of littermates, 
vaccination status and country or region of origin. The 
following disorders can be considered more common 
causes of neurological disease in puppies.
HYPOGLYCAEMIA-INDUCED SEIZURES 
This is one of the most common causes of seizures in 
puppies and occurs most often in toy-breed dogs. This 
cause of seizures should be immediately suspected in 
every toy-breed puppy with acute onset seizures. Treat-
ment consists of administration of glucose.
HYDROCEPHALUS 
This is the most common brain malformation. Although 
every breed can be affected, it occurs most often in toy 
and brachycephalic breeds. Affected dogs can have a 
dome-shaped head. Although little is known about the 
natural progression of this condition, selected cases can 
be treated medically. Surgical treatment consists of 
placement of a ventriculoperitoneal shunt.
THORACIC HEMIVERTEBRA
This condition typically affects ‘screw-tailed’ brachy-
cephalic dogs. Hemivertebra can be associated with an 
abnormal dorsal (kyphosis) or lateral (scoliosis) curvature 
of the spine. Although this condition can cause  progressive 
spinal cord dysfunction, it should most often be consid-
ered an incidental finding on diagnostic imaging studies. 
Up to 94% of neurologically normal French bulldogs have 
radiographic evidence of hemivertebra. Hemivertebra 
are more likely associated with clinical signs when they 
occur in Pugs and when they are associated with severe 
kyphosis. Recent information suggests a poor response 
to  medical management, while surgical treatment is 
 technically challenging.
SPINAL ARACHNOID DIVERTICULA 
This is probably the most clinically important spinal 
 malformation. This condition is characterized by a focal 
dilatation of the subarachnoid space with progressive 
accumulation of cerebrospinal fluid. The most common 
locations are the cranial cervical vertebral column in 
large-breed and the thoracolumbar vertebral column in 
small-breed dogs. Pugs, French Bulldogs and Rottweilers 
are predisposed to this condition. Medical management 
results in 30% improvement, while surgery results in 80% 
long-term improvement.
ATLANTO-AXIAL INSTABILITY
This condition most often affects toy-breed dogs and is 
characterized by a dorsal and cranial displacement of the 
axis relative to the atlas. It is often associated with abnor-
malities of the dens and failure of ligamentous support. 
Excessive cervical flexion in a dog with atlanto-axial 
instability can have devastating and even fatal conse-
quences. Selected cases can be treated medically, while 
surgery is technically demanding.
STEROID-RESPONSIVE MENINGITIS AND 
ARTERITIS
Affected animals have a typical clinical presentation 
 consisting of severe cervical hyperaesthesia, lethargy, 
pyrexia and a stiff gait. Blood work often demonstrates a 
leucocytosis and a diagnosis is confirmed by evaluation 
of cerebrospinal fluid. Although relapses are possible, 
most dogs respond favourably to a prolonged period of 
corticosteroids.
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MULTIPLE CHOICE QUESTIONS
1. Spinal arachnoid diverticula most often occur 
in which of the following?
(A) Labrador Retrievers and Pugs
(B) French Bulldogs and Labrador Retrievers
(C) German Shepherd Dogs and Rottweilers
(D) Pugs and French Bulldogs
2. Which statement is correct about 
hemivertebra?
(A) Medical management is associated with a 
good prognosis
(B) Hemivertebra are more likely to result in 
clinical signs when associated with severe 
kyphosis
(C) Hemivertebra are more clinically relevant 
in French Bulldogs compared to Pugs
(D) Hemivertebra occur rarely in 
neurologically normal dogs
3. Which statement is correct about atlanto-axial 
instability?
(A) Excessive flexion can have devastating and 
even fatal consequences
(B) This condition most often affects 
Rottweilers
(C) Most affected cases have a normal dens
(D) This condition is characterized by a caudal 
and ventral displacement of the axis 
relative to the atlas
KEY LEARNING OBJECTIVES
■■ Understand why the neurological assessment in 
puppies is often more complicated than in mature 
dogs
■■ Become familiar of the most common neurological 
disorders that affect puppies
■■ Learn how common neurological conditions are 
diagnosed and treated in puppies
Cervical 
spondylomyelopathy 
(‘Wobblers’): diagnosis 
and treatment options
Steven De Decker
Cervical spondylomyelopathy or ‘wobbler syndrome’ is a 
complex, multifactorial, incompletely understood and 
controversial neurological syndrome. It can be consid-
ered a collective term for disorders in which cervical 
 vertebral canal stenosis is caused by a combination 
of  soft tissue and bony structures. Two major forms 
have  been recognized: disc-associated (DA-CSM) and 
 osseous- associated cervical spondylomyelopathy 
(OA-CSM). Clinical signs reflect those of a chronic and 
progressive cervical myelopathy.
DISC-ASSOCIATED CERVICAL 
SPONDYLOMYELOPATHY 
This condition typically affects older (>7 years old) large-
breed dogs with the Dobermann being over-represented 
in most studies. As the name suggests, caudal cervical 
spinal cord compression is caused by chronic protrusion 
of one or multiple intervertebral discs. The intervertebral 
discs at C6–C7 and C5–C6 are most often affected. In up 
to 50% of cases, multiple sites of spinal cord compres-
sion are observed. Other abnormalities that can be seen 
are dorsal spinal cord compression caused by liga-
mentum flavum hypertrophy, and an abnormal position 
and (mildly) abnormal shape of vertebral bodies. 
Although the diagnosis can be made by myelography and 
 post-myelography computed tomography, magnetic 
resonance imaging (MRI) is the imaging modality of 
choice. A high prevalence of complications is seen when 
 myelography is used for the diagnosis of cervical spon-
dylomyelopathy. The application of traction studies has 
been reported and can influence the choice of therapy. 
The application of dynamic studies with the neck in 
 flexion and extension is more controversial and not 
 necessarily part of a standard diagnostic approach.
Treatment of DA-CSM is considered one of the most 
controversial topics in veterinary neurology. Outcome 
after medical management is guarded with several stud-
ies suggesting around 40% success rates. More than 20 
surgical techniques have been and are being reported for 
this technique. This large number of techniques reflects 
the difficulty of treating this disorder and the fact that the 
best surgical technique is yet unknown. The reported 
surgical techniques can broadly be divided into three 
categories: 
■■ Direct decompressive surgery by a ventral slot 
procedure
■■ Distraction–stabilization techniques 
■■ Motion preservation techniques by artificial disc 
implants
Although most authors claim a success rate of 75%, 
up to a quarter of successfully treated cases will develop 
clinical signs at an adjacent intervertebral disc space. This 
is referred to as ‘adjacent segment disease’.
OSSEOUS-ASSOCIATED CERVICAL 
SPONDYLOMYELOPATHY
This condition typically affects young adult (often 18 to 
24 months of age) giant breeds, such as the Great Dane. 
As the name suggests, spinal cord compression is caused 
by bony structures. The predominant cause of cervical 
spinal cord compression is degeneration and hypertro-
phy of articular processes. In up to 85% of cases, multiple 
sites of spinal cord compression are seen at the time 
of  diagnosis. Other abnormalities that can be seen are 
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 ligamentum flavum hypertrophy and hypertrophy of the 
dorsal lamina. MRI is the diagnostic modality of choice. 
Little is known about the results of medical management. 
Surgical treatment typically consists of a (continuous) 
dorsal cervical laminectomy. Although long-term out-
come can be favourable, up to 80% of dogs experiences 
early postoperative neurological deterioration.
KEY LEARNING OBJECTIVES
■■ Understand the difference between disc-associated 
(DA-CSM) and osseous-associated cervical 
spondylomyelopathy (OA-CSM)
■■ Understand the different treatment options for 
DA-CSM and OA-CSM
■■ Be aware of the prognosis and most common 
complications after surgical treatment for DA-CSM 
and OA-CSM
MULTIPLE CHOICE QUESTIONS
1. Which statement is correct about  
 disc-associated cervical spondylomyelopathy?
(A) It most often affects young mature 
giant-breed dogs
(B) Computed tomography is the diagnostic 
method of choice
(C) The intervertebral disc spaces at C6–C7 
and C5–C6 are most often affected
(D) Medical treatment is associated with an 
excellent prognosis
2. Which statement is correct about osseous-
associated cervical spondylomyelopathy?
(A) The Dobermann is over-represented in 
most studies
(B) Spinal cord compression is typically 
caused by hypertrophy of the articular 
processes
(C) Distraction–stabilisation surgery is a 
common surgical technique
(D) Older (>7 years of age) large-breed dogs 
are most often affected
3. Which of the following is an important 
long-term complication after surgery for 
disc-associated cervical spondylomyelopathy?
(A) Adjacent segment disease
(B) Incomplete bony fusion
(C) Vertebral subluxation
(D) Collapse of the operated intervertebral 
disc space
Spinal cord disorders 
on a budget
Richard LeCouteur
A question faced by most veterinarians in private practice 
is: How do I approach a case with suspected spinal cord 
disease when referral is not an option due to financial 
limitations of the owner?
This lecture will discuss the two major aspects of this 
issue. First, what can be done before an animal with a 
spinal cord disorder is presented to a practitioner? 
 Second, what can be done after an animal with a spinal 
cord problem has been presented to a practitioner?
PRACTISING PREVENTATIVE CARE
■■ Inform your clients regarding the costs of 
veterinary care
■■ Advise clients to make a budget
■■ Advise clients to be proactive with the health of 
their pet
■■ Advise clients to schedule regular check-ups for 
their pet
FOLLOWING THE DIAGNOSTIC PLAN
Clinical signs associated with spinal cord dysfunction 
depend upon the location, the size and the rate of 
 development, of a lesion. The abilities to complete and 
interpret results of a neurological examination, compile a 
list of differential diagnoses and understand the available 
diagnostic procedures and current treatment recom-
mendations, are essential in the management of spinal 
cord disorders of cats and dogs.
Clinical syndromes affecting the spinal cord may be 
characterized by a single focal lesion (transverse myelop-
athy) or by several focal lesions (multifocal disorders). 
Myelopathies may be extrinsic, in which spinal cord 
 dysfunction is secondary to diseases of the vertebrae, 
meninges or epidural space, or may be intrinsic, in which 
the disease begins as an intramedullary lesion. Extrinsic 
myelopathies are almost always transverse myelopathies.
As the nervous system can respond in only a limited 
number of ways to the numerous causes of myelop-
athies, it is necessary to follow a systematic diagnostic 
approach in an animal with a spinal cord disorder.
KEY LEARNING OBJECTIVES
■■ Understand what can be done before an animal 
with a spinal cord disorder is presented to a 
practitioner
■■ Understand what can be done after an animal 
with a spinal cord disorder is presented to a 
practitioner
■■ Discuss the limitations and benefits of using 
‘clinical reasoning’ to aid decision making in the 
treatment of animals with suspected spinal cord 
disease
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MULTIPLE CHOICE QUESTIONS
1. When referral to a specialist is not an option 
due to financial limitations of the owner, which 
is the most critical factor in managing a case 
with suspected spinal cord disease? 
(A) Radiographs of the entire vertebral column
(B) An accurate neurological examination
(C) Cerebrospinal fluid analysis
(D) A complete blood count and serum 
chemistry panel
2. Certain spinal cord diseases consistently may 
be associated with a particular signalment, 
onset, progression and manifestation of 
apparent spinal pain. Which of the following 
disorders is most likely to have a chronic 
progressive course in the absence of apparent 
spinal pain?
(A) Ischaemic myelopathy
(B) Intervertebral disc extrusion
(C) Degenerative lumbosacral stenosis
(D) Degenerative myelopathy
3. The following clinical signs of spinal cord 
dysfunction are most consistent with a lesion in 
which location? 
■■ Ataxia and paresis of all four limbs
■■ Proprioceptive positioning deficits in all 
four limbs
■■ Normal or decreased spinal reflexes in 
thoracic limbs and normal or exaggerated 
spinal reflexes in pelvic limbs
■■ Depressed or absent cutaneous trunci 
reflex unilaterally or bilaterally
(A) Cervical (C1 to C5)
(B) Cervical enlargement (C6 to T2)
(C) Thoracolumbar (T3 to L3)
(D) Lumbar enlargement (L4 to Cd5) and 
cauda equina
Cranial nerve 
disorders: figuring out 
the floppy faces
Richard LeCouteur
In this lecture several common disease processes that 
result in peripheral cranial neuropathies in dogs and/or 
cats will be discussed.
OTITIS INTERNA
Inner ear infection (otitis interna) is the most common 
cause of peripheral vestibular disease in dogs and cats. It 
typically results from extension of bacterial infection within 
the external ear canal through a ruptured  tympanic mem-
brane, or from the nasopharynx via the  auditory tube.
The most commonly identified pathogens in dogs 
include Staphylococcus spp., Streptococcus spp., 
 Proteus spp. and Pseudomonas spp. In cats, Staphylo-
coccus spp., Streptococcus spp., Pasteurella spp. and 
anaerobic bacteria are the most commonly involved.
TRIGEMINAL NEURITIS AND IDIOPATHIC 
TRIGEMINAL NEUROPATHY
The most frequently recognized inflammatory entity in 
dogs affecting peripheral branches of cranial nerves is 
trigeminal neuritis or idiopathic trigeminal neuropathy. 
Affected dogs typically have an acute onset of clinical 
signs secondary to bilateral motor branch dysfunction of 
the trigeminal nerves. This bilateral involvement of the 
trigeminal nerve results in inability to close the mouth 
(drop jaw), difficulty prehending food, and drooling. About 
33% of dogs have sensory involvement of the trigeminal 
nerve, and <10% have Horner’s syndrome or facial nerve 
dysfunction. While the underlying  pathogenesis of this 
disease is not known, it is believed to be non-infectious 
and inflammatory in origin.
NERVE SHEATH TUMOURS
Nerve sheath tumours (NSTs) are perhaps the most com-
mon cause of chronic, progressive peripheral cranial 
nerve disease in older dogs. They arise from Schwann 
cells or pericytes, are typically slow growing, and are 
invasive to surrounding nervous system tissue. Metastasis 
is a rare event. Whereas they most commonly affect the 
brachial plexus and lumbosacral plexus, NSTs also can 
arise within cranial nerves, with the trigeminal nerve 
most frequently affected. 
IDIOPATHIC FACIAL NERVE PARALYSIS
Approximately 50% of dogs with peripheral facial nerve 
weakness are diagnosed with idiopathic facial nerve 
paralysis. Clinical signs are often relatively acute in onset. 
Cocker Spaniels are believed to be over-represented, and 
affected dogs usually are older than 5 years. Dysfunction 
may be bilateral or unilateral. The underlying aetiopatho-
genesis of idiopathic facial nerve paralysis in dogs is 
unknown but has been speculated to involve immune-
mediated neuritis or viral infection.
IDIOPATHIC VESTIBULAR SYNDROME
Idiopathic vestibular syndrome occurs in older dogs 
and cats of any age. It results in acute-onset, unilateral 
vestibular dysfunction, without concurrent Horner’s 
 syndrome or facial nerve signs. The underlying aeti-
opathogenesis is unknown, but possibilities include 
 transient viral infection similar to vestibular neuritis in 
humans or disturbance in endolymph flow, as seen in 
Ménière’s disease in humans.
107-116 Neurology.indd   113 08/03/2019   18:02
Neurology
[ 114 ] BSAVA CONGRESS 2019 PROCEEDINGS
CAVERNOUS SINUS SYNDROME
The cavernous sinus is a paired venous sinus that runs 
along either side of the pituitary gland on the floor of the 
calvarium. Cavernous sinus syndrome (CSS) refers to 
deficits in more than one of the cranial nerves III, IV, V 
and VI, as they are in close association in this region. 
Mydriasis and ophthalmoplegia are common signs of 
CSS. A mass lesion within the cavernous sinus is the most 
common cause.
KEY LEARNING OBJECTIVES
■■ Understand the most commonly occurring cranial 
neuropathies of dogs and cats
■■ Understand Idiopathic trigeminal neuropathy and 
idiopathic facial neuropathy
■■ Discuss the localization of vestibular disorders and 
distinguish between peripheral, central and bilateral 
vestibular syndromes
side and the left eye has a Horner’s syndrome. 
The remainder of the neurological and physical 
examination is normal. What is the most likely 
neuroanatomical diagnosis to account for all 
the above clinical signs?
(A) Left-sided middle/inner ear
(B) Right-sided middle/inner ear
(C) Left-sided brainstem
(D) Right-sided brainstem
2. Which of the following is NOT a function of the 
facial nerve (cranial nerve VII)?
(A) Sensory for taste (rostral two-thirds of 
tongue)
(B) Motor to the muscles of facial expression
(C) Innervates sublingual and mandibular 
salivary glands
(D) Sensory to the nasal mucosa, cornea and 
face
3. Which of the following clinical signs is 
PRESENT on the affected side of the head of 
a dog with a unilateral Horner’s syndrome?
(A) Exophthalmos
(B) Mydriasis
(C) Retraction of the third eyelid (nictitating 
membrane)
(D) Failure of the pupils to dilate to equality 
in the dark 
MULTIPLE CHOICE QUESTIONS
1. You are presented with an 8-year-old 
Rottweiler with an acute onset of head tilt to 
the left, rolling and falling to left, and a 
non-positional, rotary nystagmus with the fast 
phase to the right (and slow phase to the left). 
Also, the dog has facial weakness on the left 
A logical approach to 
vestibular disease
Steven De Decker
The vestibular system has a complex anatomy and clini-
cal signs can be localized by disorders outside or inside 
the central nervous system. These locations are also 
referred to as peripheral or central vestibular disease, 
respectively. The peripheral portions of the vestibular 
system consist of receptors in the inner ear, and the 
 vestibulocochlear nerve (CN VIII). The central vestibular 
components are located in the brainstem and  cerebellum.
CLINICAL SIGNS IN VESTIBULAR DISEASE
Dysfunction of the vestibular system can be associated 
with a combination of clinical signs. Head tilt is easy to 
recognize and the ventrally deviated ear is most often 
directed towards the affected side. Vestibular ataxia is 
characterized by a wide-based stance and a tendency to 
fall, drift or even roll towards the side of the lesion. 
Affected animals can also demonstrate circling towards 
the affected side with the circles being very tight. Ocular 
abnormalities can be more difficult to recognize and 
consist of pathological nystagmus and strabismus. 
 Nystagmus, or the involuntary movement of eyes, is 
 typically characterized by a jerk nystagmus, with the fast 
phase directed away from the lesion. The orientation of 
nystagmus can be horizontal, rotary, or vertical. Nystag-
mus can be physiological, which is evaluated during the 
vestibulo-ocular reflex, or pathological. Pathological 
nystagmus can be classified as spontaneous/resting or 
positional nystagmus. Animals with vestibular disease 
can also demonstrate ipsilateral ventrolateral strabismus.
DIFFERENTIATION BETWEEN PERIPHERAL 
AND CENTRAL VESTIBULAR DISEASE
Peripheral and central vestibular syndrome are associated 
with different underlying conditions and a different diag-
nostic approach (not necessarily a different prognosis). 
Because central vestibular disease is associated with dis-
orders affecting the cerebellum or brainstem, affected 
animals can demonstrate other brainstem or cerebellum 
signs. Presence of proprioceptive deficits and hemipa-
resis, tetraparesis, decreased mentation and multiple 
 cranial nerve deficits are therefore suggestive for central 
vestibular syndrome. Because the facial nerve (CN VII) and 
the sympathetic nerve are closely related to the inner ear, 
facial nerve paralysis and Horner’s syndrome can be seen 
in animals with peripheral vestibular syndrome. Although 
debatable, pure vertical nystagmus is consi dered sugges-
tive for central vestibular syndrome. Nystagmus that 
changes direction when the position of the head is 
changed and disconjugate nystagmus are also indications 
for central vestibular disease. Disconjugate nystagmus 
is  characterized by both eyes demonstrating nystagmus 
in  a different direction.  Although the presence of these 
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 abnormalities is suggestive for central vestibular syndrome, 
their absence does not exclude a central localization. A cen-
tral vestibular localization can be ruled in, but not ruled out.
COMMON CAUSES OF VESTIBULAR 
DISEASE
Common causes of peripheral vestibular disease include 
otitis interna, nasopharyngeal polyps, aural neoplasia, 
inner ear trauma, congenital vestibular disease, hypothy-
roidism, idiopathic (geriatric) vestibular syndrome and 
ototoxic drugs. Common causes of central vestibular 
 syn drome are neoplastic and inflammatory conditions, 
hydro cephalus, thiamine deficiency, metronidazole intoxi-
cation, trauma and cerebrovascular disease.
Animals with vestibular disease can also present as 
neurological emergencies. Two conditions are typically 
associated with a peracute onset of severe vestibular 
signs: cerebrovascular disease and idiopathic (geriatric) 
vestibular syndrome.
KEY LEARNING OBJECTIVES
■■ Recognize the clinical signs associated with 
vestibular disease
■■ Be aware of the anatomical structures that can 
cause vestibular disease
■■ Be able to recognize indications for central 
vestibular disease
MULTIPLE CHOICE QUESTIONS
1. Which statement is correct about central 
vestibular disease?
(A) Animals with central vestibular disease 
have a poor prognosis
(B) Central vestibular disease can be caused 
by a brainstem disorder
(C) Central vestibular disease can be caused 
by a lesion affecting the vestibulocochlear 
nerve
(D) Central vestibular disease can be 
caused by a lesion affecting the cerebral 
cortex
2. Which of the following findings is suggestive 
for a central vestibular syndrome?
(A) Head tilt
(B) Spontaneous nystagmus
(C) Proprioceptive deficits
(D) Strabismus
3. Which cranial nerve can be affected in 
peripheral vestibular disease?
(A) Facial nerve
(B) Trigeminal nerve
(C) Optic nerve
(D) Hypoglossal nerve
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Approach to the 
young coughing dog
Simon Tappin 
Coughing is a protective mechanism which allows clear-
ance of debris from the airway. Airway irritation and 
inflammation, excessive secretions and airway collapse 
will all trigger coughing. Productive or moist coughs are 
usually seen in infectious or inflammatory airway condi-
tions; however harsh or dry coughs can be seen in the 
earlier stages of disease.
As with any medical problem, evaluation starts by 
taking a detailed history, this is followed by a full clinical 
examination and careful thoracic auscultation of both 
the heart and the lung fields. In young dogs, acute-onset 
coughing is likely to represent infectious causes, such 
as  infectious tracheobronchitis (ITB, ‘kennel cough’), or 
parasites, such as Angiostrongylus vasorum or Oslerus 
osleri. However, airway foreign bodies, pneumonia (for 
example secondary to inhalation) and cardiac disease 
should also be considered possible causes, especially if 
signs are not self-limiting. 
Canine ITB is highly contagious and common in any 
large transient population of dogs. Dogs typical present 
with an acute-onset paroxysmal coughing (which may 
be productive) and sometimes oculonasal discharge. 
Many different agents contribute to the clinical syndrome 
of ITB, and multiple infections are likely to be common. 
The most frequently isolated agents are Bordetella bron-
chiseptica and canine parainfluenza virus. Other agents 
including adenovirus, herpesvirus and reoviruses are 
 isolated on occasions. The use of antibiotics in ITB cases 
generally has limited efficacy and is rarely indicated 
unless there are signs of bronchopneumonia or systemic 
infection. Antimicrobial resistance is widely reported in 
Bordetella species, so when required doxycycline or 
 trimethoprim/sulphonamide are usually used. In uncom-
plicated cases if the coughing is severe, anti-tussives 
(butorphanol or codeine), anti-inflammatories (non- 
steroidal anti-inflammatory drugs (NSAIDs) or low-dose 
prednisolone) and bronchodilators (theophylline, terb-
utaline) may be helpful. 
Respiratory parasites such as Oslerus osleri or Cren-
osoma vulpis are uncommon. However, In the last  couple 
of decades disease due to infection with Angiostrongylus 
vasorum has been increasingly documented across most 
of the UK, linked to the increased prevalence of infection 
in foxes and their increasing urbanization. Historically 
cases were limited to the south of Wales, and both the 
southeast and southwest of England, however recently 
both the incidence and geographical distribution appears 
to be increasing, with cases now being reported in 
 northern England and Scotland. Most dogs develop 
coughing due to larval migration, however a significant 
proportion develop signs secondary to coagulopathy. A 
rapid patientside blood test with good sensitivity and 
specificity has recently become available, greatly improv-
ing the ease of diagnosis. Imidacloprid/moxidectin, 
milbemycin and fenbendazole are all effective treatment 
options, with imidacloprid/moxidectin and milbemycin 
also being effective prophylactic treatments.
With acute-onset coughing in the clinically well dog, 
faecal parasitology or trial treatment will allow exclusion 
of respiratory parasites and symptomatic therapy may be 
appropriate at this stage. Thoracic radiographs are usu-
ally the first imaging step in further evaluating the cause 
of a more chronic or severe cough. Further investigations 
such as echocardiography, endoscopy and collection of 
airway wash samples may then be indicated.
KEY LEARNING OBJECTIVES
■■ Coughing is a protective mechanism that allows 
clearance of debris form the airway 
■■ In young dogs, infectious causes, such as infectious 
tracheobronchitis or parasitic infection, are most 
common
■■ Antibiotics are rarely indicated in well animals with 
acute-onset coughing
MULTIPLE CHOICE QUESTIONS
1. Which of the following viruses has NOT been 
implicated as a cause of canine infectious 
tracheobronchitis?
(A) Canine herpesvirus 
(B) Canine poxvirus 
(C) Canine adenovirus 1
(D) Canine influenza virus 
2. Which of the following statements about 
Angiostrongylus vasorum is correct?
(A) Fenbendazole is licensed for treatment of 
clinical disease 
(B) Angiostrongylosis only occurs in young 
dogs 
(C) A history of snail or slug ingestion is always 
documented when angiostrongylosis is 
present
(D) Increased levels of infection within the fox 
population have led to an increased 
prevalence and range of the parasite 
3. Which of the following is NOT a canine 
respiratory parasite?
(A) Angiostrongylus vasorum 
(B) Crenosoma vulpis
(C) Oslerus osleri
(D) Aelurostrongylus abstrusus
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Older dog with a 
cough: is it cardiac or 
respiratory? Top tips 
on how to tell
Simon Tappin 
Airway irritation and inflammation, excessive secretions 
and airway collapse will all trigger coughing. Whilst 
coughing is a protective mechanism which allows clear-
ance of debris from the airway, coughing excessively can 
be extremely frustrating for patient and owner alike. 
In older dogs, acute-onset coughing is most likely 
infectious such as secondary to infectious tracheobron-
chitis (ITB, ‘kennel cough’) or parasites such as Angios-
trongylus vasorum or Oslerus osleri. However, chronic 
coughing, usually defined as a cough that has been pre-
sent for more than 8 weeks, is more prevalent with 
increasing age and chronic bronchitis, tracheal collapse, 
laryngeal paralysis, neoplasia, pulmonary fibrosis and 
congestive heart failure all need to be considered as 
 possible causes. Diagnosis may not be straightforward, 
as several aetiologies may be present in older patients, 
worsening the signs seen. For example, there is usually 
much debate as to the cause of coughing in small-breed 
dogs with congestive heart failure. The presence of pul-
monary oedema alone does not usually lead to cough-
ing, however the presence of bronchomalacia leading to 
bronchial collapse will, and this may be exacerbated by 
dilation of the left atrium leading to airway compression. 
As with any medical problem, evaluation starts by 
taking a detailed history, this is followed by a full clinical 
examination and careful thoracic auscultation of both 
the heart and the lung fields. In acute-onset coughing in 
the clinically well dog, faecal parasitology or trial treat-
ment will allow exclusion of respiratory parasites and 
symptomatic therapy may be considered appropriate at 
this stage. 
For more chronic cases blood work is usually a good 
starting point, to exclude concurrent illness, although is 
rarely specific for the aetiology of the cough. Measure-
ment of NT-proBNP, which is produced by cardiac mus-
cle in response to volume overload, is helpful to ascertain 
if animals may be coughing due to cardiac or respiratory 
disease, allowing further diagnostic tests to be better 
focused. Thoracic radiographs are usually the first imag-
ing step, either conscious if there are concerns about 
cardiac function or, where possible, inflated views under 
general anaesthesia. Note that if tracheal collapse is 
 considered, both inspiratory and expiratory phases will 
be required to make a diagnosis. Where cardiac disease is 
suspected, echocardiography will be helpful to assess 
cardiac structure and contractility. The information 
gained by cardiac ultrasonography will vary depending 
on the degree of experience of the operator, however 
simple objective measurements such as left atrium to 
aortic root ratio (LA:Ao) and left ventricular fractional 
shortening will be helpful in determining if cardiac dis-
ease is present. When airway disease is suspected, endo-
scopic evaluation and collection of airway wash samples 
is helpful in understanding the underlying aetiology and 
making treatment decisions. 
Treatment will depend on the underlying aetiology 
and focus on addressing the cause of excessive cough-
ing, such as limiting airway inflammation in chronic 
bronchitis or controlling congestive change in heart 
dogs with heart failure. Anti-tussives should be used 
 judiciously, but will help limit airway sensitivity and as a 
result improve quality of life.  
KEY LEARNING OBJECTIVES
■■ Coughing is a protective mechanism that allows 
clearance of material from the airway
■■ Measurement of cardiac biomarkers, such as 
NT-proBNP, may help differentiate cardiac from 
respiratory disease as the cause of coughing, 
however they do not replace imaging in making a 
diagnosis
■■ Thoracic radiographs are the mainstay of diagnostic 
evaluation for the coughing dog
MULTIPLE CHOICE QUESTIONS
1. Which of the following types of cough would 
usually be associated with tracheal collapse?
(A) A honking or seal bark cough
(B) A dry, hacking cough
(C) A nocturnal cough 
(D) A soft ineffectual cough 
2. Which of the following statements is 
INCORRECT?
(A) Inspiratory dyspnoea reflects upper airway 
disease
(B) Hearing wheezing on thoracic auscultation 
suggests airway narrowing
(C) Percussion will always determine the 
presence of pleural effusion
(D) Expiratory dyspnoea reflects parenchymal 
disease 
3. Which of the following values for aortic root 
ratio (LA:Ao) would be supportive of the 
presence of congestive heart failure?
(A) <1.2
(B) <1.6
(C) >1.4
(D) >1.6
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Approach to 
pulmonary 
hypertension
Kieran Borgeat
PHYSIOLOGY AND BACKGROUND
The pulmonary system can be described as low pres-
sure, high flow. Resistance in the pulmonary vasculature 
is very low, with a huge surface area of capillaries to 
maximize surface area for gas exchange. Pulmonary 
arterial pressure in normal animals is around 25–30 
mmHg systolic, and 10 mmHg diastolic. Since the pri-
mary function of the pulmonary arteries is to perfuse 
oxygenated regions of the lung to re-oxygenate blood 
and return it to the left heart, vasoconstriction occurs in 
response to hypoventilation and/or hypoxia. This is a key 
contrast with the systemic vasculature, where hypoxic 
tissue requires perfusion, so vasodilation occurs. 
Another difference to the systemic vessels lies in the 
response to high flow; most systemic vessels subject to 
increased flow rates will vasodilate, to perfuse the tissue 
downstream. In contrast, pulmonary vessels will vaso-
constrict in the face of increased flow – presumably an 
evolutionary adaptation to prevent the development of 
pulmonary oedema or downstream capillary damage. 
These basic facts help us to understand the response 
of pulmonary vessels in states of disease, where these 
changes can become maladaptive and generate pulmo-
nary  hypertension.
DEFINITION AND CLASSIFICATION OF 
PULMONARY HYPERTENSION
Pulmonary hypertension (PH) is defined as pulmonary 
arterial pressure (PAP) >35 mmHg, and can be graded as 
mild (35–50 mmHg), moderate (50–80 mmHg) or severe 
(>80 mmHg). Classification of pulmonary hypertension is 
given in Figure 1. Diagnosis can be made by direct meas-
urement using a catheter placed in the pulmonary artery 
or right ventricle (RV) – where systolic pressure approxi-
mates PAP. Practically, a less invasive method of assess-
ing PAP is to perform echocardiographic measurements 
based on Doppler estimates of tricuspid or pulmonic 
regurgitation velocity. Since tricuspid regurgitation velo-
city is dependent on the pressure difference between the 
RV and right atrium (RA) in systole, and RV pressure in 
systole is similar to PAP, we can use this measurement of 
tricuspid regurgitation to infer PAP.
Worked example
Tricuspid regurgitation velocity measures 4.5 m/s
Pressure gradient between RV and RA  
= 4 × (maximum velocity)2
= 4 × (4.5)2
= 4 × 20.25 = 81 mmHg
In this case, the pressure in the right ventricle is at least 
81 mmHg, indicating severe PH.
One recent study suggests that echocardiographic 
methods underestimate PAP, and prior publications sug-
gest that Doppler estimates of PA pressure may not 
change in line with clinical improvements in dogs treated 
for PH. Clearly, echo estimates of PA pressure are imper-
fect, but are non-invasive and useful enough to make 
clinical decisions.
Class Description Examples
1 Pulmonary arterial 
 hypertension
Associated with congenital L>R shunting disease (e.g. large PDA, large VSD)
Primary idiopathic
Drug or toxin induced
2 Secondary to left heart 
disease
Mitral valve disease
Left ventricular systolic dysfunction
Left ventricular diastolic dysfunction
Congenital diseases affecting the left heart (e.g. mitral dysplasia or stenosis)
3 Secondary to lung diseases 
or hypoxia
Interstitial lung disease (e.g. fibrosis)
Chronic obstructive pulmonary disease
Chronic exposure to high altitude
4 Thrombotic or obstructive 
causes
Chronic or acute pulmonary thromboembolism
Parasitism (e.g. Dirofilaria immitis, Angiostrongylus vasorum)
Intravascular tumours
5 Unclear/multifactorial 
mechanisms
Paraneoplastic syndromes
Chronic haemolytic anaemia and other haematological disordersa
Glycogen storage diseasesa
Figure 1: Classification of pulmonary hypertension (based on European Society of Cardiology guidelines, 2015) 
auncertain if occurs in animals; PDA, patent ductus arteriosus; VSD, ventricular septal defect
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KEY LEARNING OBJECTIVES
■■ Understand which aspects of pulmonary vascular 
physiology can become maladaptive and lead to 
pulmonary hypertension
■■ Identify cases in practice which may be suffering 
from pulmonary hypertension, and understand how 
to make a diagnosis
■■ Consider treatment of pulmonary hypertension in 
different disease contexts, and understand what 
outcomes can be expected
(D) Type 5 – unclear/multifactorial causes
2. What is the mechanism of syncope in 
pulmonary hypertension thought to be 
related to?
(A) Ventricular arrhythmias caused by right 
ventricular hypertrophy
(B) Reduced left heart output caused by 
increased right heart filling
(C) Vagal output secondary to right ventricular 
pressure overload
(D) Long pauses in cardiac rhythm associated 
with high vagal tone
3. What is the mechanism of action of sildenafil to 
cause pulmonary vasodilation?
(A) Phosphodiesterase III inhibition
(B) Phosphodiesterase V inhibition
(C) Stimulation of beta-2 adrenoceptors
(D) Antagonism of beta-1 adrenoceptors
MULTIPLE CHOICE QUESTIONS
1. How would pulmonary hypertension in dogs 
with a large ventricular septal defect be 
classified?
(A) Type 1 – pulmonary arterial hypertension
(B) Type 2 – secondary to left heart disease
(C) Type 4 – obstructive causes of PH
How I perform 
bronchoscopy
Simon Tappin 
Bronchoscopy allows evaluation of the larynx, trachea 
and bronchial tree. With good-quality endoscopes 
becoming more readily available, it is becoming increas-
ingly possible to perform bronchoscopy in small animal 
patients in general practice. As with all forms of endos-
copy, although gross evaluation may reveal a definitive 
diagnosis (e.g. the presence of an airway foreign body), it 
is most commonly performed at the end of a diagnostic 
pathway. Bronchoscopy is useful in many patients but is 
most commonly used in the assessment of chronic 
coughing, respiratory distress and haemoptysis. Samples 
can also be collected and submitted for cytology and 
culture.
Bronchoscopy is always performed under general 
anaesthesia to control reflex coughing and gagging on 
passage of the endoscope. Premedication with an opioid 
and low-dose acepromazine is used in most cases. 
 Ter butaline, a bronchodilator, is useful to reduce bron-
chospasm and improve oxygenation. This is especially 
useful in cats and is usually given intramuscularly at the 
time of induction. General anaesthesia is most easily 
maintained by total intravenous anaesthesia (TIVA), with 
propofol being the agent of choice in most cases. 
In large dogs the endotracheal tube may have a large 
enough diameter to allow passage of the endoscope, 
without complete occlusion of the tube (at least 25% of 
the diameter of the tube should remain with the endo-
scope in place). In cats and small dogs, the endoscope is 
advanced directly into the airway which does not allow 
assisted ventilation, so careful consideration should be 
given to oxygen supplementation. Bronchoscopy is best 
performed in sternal recumbency, with the head elevated 
on a sand bag or foam pad to allow easy passage of the 
endoscope. A gag should be placed to protect the endo-
scope. 
Endoscopically the lumen of the trachea should 
appear round with the C-shaped cartilages visible under 
a smooth light-pink mucosa. Once the trachea has been 
examined the endoscope is gradually advanced to the 
tracheal bifurcation or carina which is a sharp division 
between the left and right mainstem bronchi. The right 
mainstem bronchus is usually straight ahead, with the 
left mainstem bronchus requiring some deflection to the 
right to allow entry. The bronchial tree should be system-
atically and fully evaluated, allowing visualization of each 
lobar bronchus and as many segmental divisions as pos-
sible. Each lung has a cranial and caudal lobe, with the 
right side having both a middle and accessory lobe. Each 
segmental airway should be evaluated for changes in 
shape, size and mucosal appearance. 
Once the airways have been fully examined, samples 
should be obtained for cytology and microbiology, as 
gross changes are not usually pathognomonic for spe-
cific disease. Sampling is best achieved via bronchoalve-
olar lavage (BAL) using 5–10-ml aliquots of sterile saline. 
These are instilled via a sterile wash catheter or the work-
ing channel of the endoscope, agitated within the chest 
by coupage and then retrieved using suction. The sample 
should be frothy due to the presence of surfactant and be 
stored in EDTA and plain tubes, for cytology and culture 
respectively. 
KEY LEARNING OBJECTIVES
■■ There are many indications for bronchoscopy, 
but coughing is the most common
■■ The normal endoscopic anatomy of the bronchial 
tree allows evaluation of the bronchi to all the lung 
lobes  
■■ Gross inspection rarely gives a definitive diagnosis, 
thus bronchoalveolar lavage samples should be 
collected for cytology and culture
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MULTIPLE CHOICE QUESTIONS
1. Which of the following statements about 
bronchoscopy is correct?
(A) Bronchoscopy can be performed under 
sedation 
(B) Terbutaline is useful to reduce 
bronchospasm and so improve ventilation 
(C) Rigid endoscopes allow good evaluation of 
the bronchial tree
(D) Lavage and collection of cytology and 
culture samples is rarely needed to make a 
diagnosis
2. Diagnosis of which of the following diseases 
would NOT be possible on gross endoscopy?
(A) Tracheal collapse 
(B) Bronchial foreign body 
(C) Bacterial pneumonia 
(D) Oslerus osleri
3. Which of the following orientations of the 
bronchial tree is correct?
(A) The right and left mainstem bronchi divide 
symmetrically to the left and right cranial 
and caudal lobes
(B) On reaching the tracheal bifurcation the 
left side is usually straight ahead
(C) The right middle and accessory lobe 
bronchi cannot be seen endoscopically
(D) The right and left mainstem bronchi divide 
to reveal the cranial and caudal lobes, with 
the right side having both a middle and 
accessory lobe
Thoracic imaging 
picture quiz: is it 
cardiac or respiratory?
Kieran Borgeat
THE SIX-WORD CARDIOLOGY TEXTBOOK
It has been said that the six-word cardiology textbook 
states, ‘How big is the left atrium?’ Although this over-
simplifies the differentiation of cardiac from respiratory 
causes of dyspnoea or cough, measuring left atrial size 
can be used as a barometer of risk, to identify patients 
who are likely to have haemodynamically significant 
heart disease. Obviously, this only works for left-sided 
cardiac disease – right-sided disease in isolation will not 
cause left atrial dilatation, but can generate pleural effu-
sions or significantly reduce cardiac output, mimicking 
respiratory disease by causing tachypnoea or exercise 
intolerance.
THORACIC RADIOGRAPHY: RELIABLE 
WAYS TO FIND THE LEFT ATRIUM
Thoracic radiographs should be evaluated from close up 
and then further away; the ‘6-inches and 6-feet’ approach. 
This minimizes the risk of missing significant abnormalities.
To identify left-sided congestive heart failure, the cli-
nician must pick out three concurrent abnormalities: left 
atrial dilation, pulmonary infiltrates (alveolar or intersti-
tial) and pulmonary venous distension. Without all three, 
congestive heart failure is uncertain. With only one of 
these detected, left-sided heart failure seems unlikely.
Reliably detecting left atrial dilatation on thoracic 
radiographs is difficult to consistently perform with con-
fidence. My advice: identify the dorsal border of the 
caudal vena cava, and the point where it intersects the 
cardiac silhouette. Then identify the bifurcation of the 
trachea. Next, draw an imaginary line between these 
points; none of the cardiac silhouette should protrude 
above this line if the left atrium is normal size. If there is 
any cardiac silhouette visible above this line, it is left atrial 
dilatation (Figure 1).
In a dorsoventral view, the left atrium sits between 
the left and right principal bronchi. The angle between 
the bronchi should be approximately 60 degrees in nor-
mal dogs. When left atrial dilatation occurs, the bronchi 
are split wider apart, more like 90 degrees. This is affec-
tionately known as the ‘cowboy legs’ sign.
THE BASICS OF LEFT ATRIAL SIZE 
ASSESSMENT ON ECHOCARDIOGRAPHY
Echocardiography is a skill which takes longer to acquire 
than radiography, but offers advantages over radiographs 
in that cardiac structure and function can be assessed in 
realtime, and left atrial dilatation is more sensitively 
detected. In long-axis, the left atrium is relatively angular 
(square or hexagonal) and the left atrial area fits roughly 
twice into the left ventricular area. In short-axis, the left 
atrial diameter is no more than 1.5–1.6 times the diame-
ter of the aortic root (Figure 2).
Figure 1: Identifying the left atrium on thoracic 
radiographs: lateral projection (left) and dorsoventral 
projection (right). In lateral projection, the left atrium 
protrudes above an imaginary line between the caudal 
vena cava and the tracheal bifurcation. In dorsoventral, 
the bronchi are split further apart – the cowboy legs signs
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Figure 2: Subjective measurement of left atrial size on 
echocardiographic long-axis (left) and short-axis (right) 
views
KEY LEARNING OBJECTIVES
■ Identify the position of normal anatomical 
structures on thoracic radiography with confidence
■ Find the left atrium on echocardiography and 
subjectively estimate its size in comparison to other 
cardiac structures
■ Gain confidence in differentiating cardiac from 
respiratory disease in dogs and cats based on 
imaging findings
MULTIPLE CHOICE QUESTIONS
1. In a dorsoventral radiograph, where is the body 
of the left atrium located?
(A) Between the mainstem bronchi, over 
the heart
(B) At 2–3 o’clock position on the cardiac 
silhouette
(C) Centrally, at the level of the fourth–fifth 
intercostal space
(D) At 1–2 o’clock position on the cardiac 
silhouette
2. On physical examination, what is a key clinical 
finding more suggestive of respiratory disease 
than cardiac disease?
(A) The absence of a heart murmur
(B) Muffled lung sounds ventrally
(C) Respiratory sinus arrhythmia
(D) Ventricular premature complexes
3. The severity of dynamic airway disease in 
dogs is best assessed using which imaging 
method?
(A) Echocardiography
(B) Bronchoscopy
(C) Radiography
(D) Fluoroscopy
The punctured pet:
dealing with thoracic 
bite wounds/stick 
injuries
Georga Karbe 
Puncture wounds commonly are the result of animal 
bites or penetrating foreign bodies. This talk will focus on 
the steps involved in assessing these patients using case 
examples. Surgical intervention as well as postoperative 
management will be discussed.
Bite wounds result in puncture wounds in addition to 
varying degrees of crushed tissues. The externally visible 
wounds frequently underestimate the true extent of the 
injury and are often called the ‘tip of the iceberg’. Tissue 
devitalization occurs secondary to crushing. Declaration 
of devitalized tissues is often delayed until 12–48 hours 
(or longer) after injury. Penetrating stick injuries or 
impalement injuries of the thorax are seen in dogs after 
playing with sticks or running through wooded areas. 
Sticks pushed deep into the tissues may not be visible 
externally. 
Patients can present in various stages of shock and 
respiratory compromise. Physical examination must be 
performed upon presentation and should be repeated at 
regular intervals. Patients may initially present in a stable 
condition but can quickly decompensate. Heart rate, 
respiratory rate and pattern, pulse quality, mucous 
membrane colour, capillary refill time, temperature, non-
invasive blood pressure and pulse oximeter readings will 
help guide the treatment plan. Intravenous fluid resuscita-
tion and analgesia should be started based on patient 
status, as well as oxygen supplementation if respiratory 
compromise is evident. Broad-spectrum antimicrobials 
should be administered early in the treatment course.
Early identification of penetration into the thorax, 
resulting in pneumothorax, haemothorax, pleural effu-
sion or pulmonary injury is critical. Emergency drainage 
of air, blood or fluid from the pleural space may be 
required. Wounds should be covered with sterile dress-
ings and addressed once the patient has been stabilized 
and fully assessed. Wounds sucking air need to be sealed 
and the air drained. Patients must be monitored for the 
development of tension pneumothorax. If a penetrating 
foreign body is known to have violated the pleural space, 
it should not be removed until the patient is under gen-
eral anaesthesia, intubated and positive pressure ventila-
tion available. Sticks may splinter or break upon entry into 
the body. Wound probing alone is often insufficient and 
wide surgical exploration is recommended to increase 
the chance of removing all stick debris. Imaging of the 
thorax and abdomen are performed to identify cavitary 
injuries. Bacterial contamination from the bite or pene-
trating foreign body is expected, therefore timely surgical 
exploration, lavage, collection of a culture samples and 
drain placement are recommended. 
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Patients are managed postoperatively with broad-
spectrum antimicrobials (altered based on culture res-
ults), analgesia, intravenous fluid therapy as well as 
tho racic drainage. Drains can be removed once no air is 
drained for 12–24 hours or fluid production decreases to 
2–3 ml/kg/24h.
KEY LEARNING OBJECTIVES
■■ Assessment and stabilization of the punctured 
patient
■■ Surgical treatment of penetrating thoracic wounds
■■ Postoperative management of the punctured patient 
(C) Laceration
(D) Abrasion
2. How long after a bite is the full extent of tissue 
damage apparent?
(A) Immediately
(B) 1–6 hours after injury
(C) 6–12 hours after injury
(D) 12–48 hours after injury
3. Which of the following is recommended when 
dealing with penetrating thoracic wounds?
(A) The foreign body should be removed 
immediately after injury
(B) The foreign body should be removed as 
soon as the patient has received analgesia
(C) The foreign body should be removed once 
the patient is intubated with positive 
pressure ventilation available
(D) The foreign body should be removed once 
the patient has been assessed as stable
MULTIPLE CHOICE QUESTIONS
1. What common concurrent tissue damage is 
expected with bite wounds?
(A) Crush 
(B) Burn
Top tips on chest drain 
placement
Georga Karbe
This presentation will review the practical placement 
techniques of different thoracic drains. The exact loca-
tion of where the drain should be placed depends on the 
condition that these drains aim to treat (air vs. fluid). In 
general, drains should enter the thoracic cavity in the 
ninth intercostal space and should be aimed from dor-
sally to ventrally. Care must be taken to aim away from 
the heart and major vasculature, the drain should run 
between the rib cage and lungs. 
Large-bore drains on a blunt-tip or sharp trocar 
must be placed carefully to avoid iatrogenic damage to 
intrathoracic structures. Prior to placement, the drain 
should be premeasured against the body wall from its 
planned insertion point toward the second rib. The tro-
car can be used to tunnel under the skin and latissimus 
dorsi muscle spanning two intercostal spaces toward 
the seventh to ninth intercostal space, where it can then 
be gently ‘popped’ or twisted through the intercostal 
 muscles. Once the drain has entered the thoracic cavity, 
the trocar should be drawn back slightly while the drain 
is advanced into its final position. Forcefully ‘popping’ 
the drain into the thorax is contraindicated as it carries a 
high risk of iatrogenic damage. Alternatively, a large 
curved artery forceps can be used to create the tunnel 
and then bluntly open a window into the intercostal 
muscles through which the drain can then be advanced. 
This method allows potentially more air to enter the 
 thorax during placement, however it decreased the risk 
for iatrogenic trauma. Large-bore drains must be 
secured in place with a friction knot technique (‘Roman 
sandal’ or ‘Chinese finger trap’) to prevent inadvertent 
drain removal.
Low-profile drains can be placed using a Seldinger 
technique. This technique eliminates the need for a 
 tissue tunnel and therefore causes less tissue trauma. A 
large-guage catheter is directly introduced into the ninth 
intercostal space. Once the needle has been removed 
from the catheter, a guide wire is passed through the 
catheter into the thorax. While maintaining the position 
of the wire, the catheter is drawn back over the wire. The 
drain is then threaded over the wire and advanced into 
the thorax. Once the drain is in the appropriate position, 
the wire is removed. Low-profile drains are sutured in 
place with the provided attachment equipment. 
After drain placement, orthogonal thoracic radio-
graphs are acquired to assess drain placement. The drain 
is also aspirated to remove air/fluid and to confirm 
 functionality. 
KEY LEARNING OBJECTIVES
■■ Basic steps involved in chest drain placement
■■ Deciding which type of thoracic drain to place
■■ Assessing proper chest drain placement
MULTIPLE CHOICE QUESTIONS
1. Where should chest drains enter the thoracic 
cavity?
(A) Fifth to seventh intercostal space
(B) Seventh to ninth intercostal space
(C) Tenth to tweflth intercostal space
(D) Second intercostal space
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2. To where should the chest drain  
be aimed?
(A) Fifth rib
(B) Seventh rib
(C) Second rib
(D) Ninth rib
3. What is the name of the technique by which a 
chest drain is placed with the use of a guide wire?
(A) Seldinger technique
(B) Slatter technique
(C) Salter Harris technique
(D) Soft wire technique
Top tips on thoracic 
cytology
Kathleen Tennant
Thoracic cytology encompasses airway washes, pleural 
and pericardial fluids and aspirates of intracavitary lesions 
or organs. 
Ideally, washes should be checked for cellularity 
before the animal is recovered – crystal clear, colourless 
fluids from a tracheal wash or bronchoalveolar lavage 
(BAL) do not often yield adequately cellular samples. The 
expected populations from the different areas should be 
contrasted to the cells on the slide – don’t forget that 
macrophages are a normal part of the lower airway 
 population. 
Inflammatory cells can be categorized in a 200 cell 
differential, usually excluding the epithelial cells present. 
Organisms should be actively sought if inflammation is 
present. Bacteria must be demonstrated inside neutro-
phils to confirm bacterial sepsis – particularly important 
in these sample types as oropharyngeal contamination 
of the sample is not uncommon. The presence of 
the  bacterium Simonsiella is a good indicator that this 
has taken place – culture results should be interpreted 
with  caution. Background mucus and the presence of 
 Curshmann’s spirals can also add information. Do not 
exclude the possibility of parasitic processes just because 
neutrophils are the dominant cell type. 
Neoplastic processes are less common, but both 
lymphoma and carcinoma can be found on washes. 
Pleural and pericardial fluids can also be assessed for 
inflammatory causes. Blood in haemorrhagic pericardial 
fluids as well as infectious agents, repeat drainage or 
merely the chronic presence of fluid can spark reactive 
changes in mesothelial cells which mimic neoplasia. 
Lung aspirates require confident imaging and sam-
pling skills, but on occasion allow identification of masses 
which have not yet exfoliated into the pleural space or 
broken through into airways. 
Cranial thoracic masses can also be challenging – 
lymphoma and thymoma are amongst the commonest 
findings here, but cystic structures and heart-base tumours 
can also occur. Some of these (e.g.  chemodectomas) can 
yield quite delicate cells and the smears should be made 
with a light hand. 
KEY LEARNING OBJECTIVES
■■ Recognize the best ways to obtain good-quality 
samples from airway washes and other thoracic 
cytology samples
■■ Appreciate some of the limitations of thoracic 
cytology
■■ Screen samples for inflammatory or neoplastic 
processes
MULTIPLE CHOICE QUESTIONS
1. Which of the following is a normal finding on 
tracheal washes? 
(A) 20% of cells being neutrophils
(B) Small cuboidal epithelial cells
(C) Ciliated columnar epithelial cells
(D) Squamous epithelial cells
2. Which of the following is true of thymoma 
cytology? 
(A) The dominant cell type should be 
spindle-shaped cells with criteria for 
malignancy
(B) Mast cells can routinely be found scattered 
in thymoma smears
(C) >90% of the cells should be large lymphoid
(D) Thymomas do not exfoliate well and 
cytology should always be avoided
3. Which of the following is true of cytology in 
Angiostrongylus infection? 
(A) Neutrophilic inflammation instead of 
eosinophilic inflammation rules out an 
Angiostrongylus infection
(B) Angiostrongylus eggs (which appear 
similar to those of Capillaria) have to be 
demonstrated in airway washes to 
diagnose infections
(C) Angiostrongylus larvae are approximately 
five times neutrophil size in length
(D) Angiostrongylus can, on occasion, be 
diagnosed on faecal smears
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Diagnosis and medical 
management of 
pyothorax
Simon Tappin 
Pyothorax is the accumulation of exudate within the 
pleural space caused by the presence of an infectious 
agent, and has been documented after thoracic trauma, 
migrating foreign bodies, extension of pulmonary 
abscesses and haematogenous spread from a distant 
focus. It is, however, unusual to document the underlying 
cause. When no obvious underlying aetiology can be 
found, the migration of inhaled grass awns is often 
 suspected. 
Animals with pyothorax will present with signs asso-
ciated with the presence of fluid in the pleural space, 
most commonly this is bilateral, but may be unilateral or 
asymmetric in distribution. The presence of the fluid 
leads to a restrictive or choppy breathing pattern, and 
leads to an absence of breath sounds ventrally on auscul-
tation and dullness on thoracic percussion. The presence 
of a large-volume infection within the pleural space may 
also be associated with signs of sepsis and associated 
hypotension and pyrexia. Diagnosis is usually made of 
the basis of documenting the presence of fluid within the 
pleural space, either on ultrasonography or radiography 
and then collecting a sample via thoracocentesis. Analy-
sis of this fluid will confirm the presence of an exudate 
with a high number of degenerate neutrophils and 
 bacteria. 
The treatment options for the management of pyo-
thorax include a wide range of medical and surgical 
techniques and there is much debate as to which treat-
ment option is best. In general, the placement of a chest 
drain to remove the accumulated exudate is needed, fol-
lowed by lavage and long-term antibiotics. Where under-
lying thoracic pathology is present (e.g. a pulmonary 
abscess), early explorative surgery is indicated to remove 
the underlying focus of infection. Once the chest drain is 
in place, it allows continued drainage of exudate and lav-
age of the pleural space by the instillation of sterile saline. 
Whilst the benefits of thoracic lavage are controversial, 
logically, there would seem to be some benefits of lavage 
to aid the removal of purulent material from the pleural 
space. However a published study suggested that the 
one-off drainage of pyothorax via a chest tube, followed 
by its removal and then long-term antibiotics resulted in 
a good clinical outcome in all cases treated. 
Systemic antibiotics should be continued for 6–8 
weeks or 2 weeks after the resolution of clinical and radi-
ographic signs. Many types of bacteria have been impli-
cated in pyothorax and a mixed culture is most commonly 
found with Escherichia coli, Actinomyces and Nocardia 
being amongst the most commonly cultured organisms. 
Cultures are a useful guide to antibiotic choice, how-
ever anaerobic bacteria are hard to culture and negative 
cultures are possible due to prior antibiotic use. Broad-
spectrum antibiotic combinations to cover both  anaerobic 
and aerobic bacteria are indicated, such as co-amoxiclav 
and metronidazole or a fluoroquinolone with either 
 metronidazole or clindamycin.
With appropriate treatment, the long-term prognosis 
of uncomplicated pyothorax is good. Survival past 48 
hours is a significant prognostic indicator, with most 
dogs making a recovery from this point.
KEY LEARNING OBJECTIVES
■■ Thoracocentesis is a safe technique to enable fluid 
collection from the pleural space enabling a 
diagnosis of pyothorax
■■ Chest drainage is needed to remove exudate from 
the pleural space, however the benefit of lavage is 
not well documented
■■ Mixed bacterial infections are commonly 
encountered and combinations of antibiotics are 
needed to cover both aerobic and anaerobic 
components 
MULTIPLE CHOICE QUESTIONS
1. Which of the following is NOT consistent with 
the presence of pyothorax?
(A) Large numbers of degenerate neutrophils  
(B) Presence of sulphur granules in the 
effusion 
(C) A protein level of 30 g/l
(D) Large numbers of medium-sized 
lymphocytes 
2. Which of the following statements about chest 
drain placement for the management of 
pyothorax is correct?
(A) A chest drain is always needed for the 
management of pyothorax 
(B) Instillation of antibiotics via the chest drain 
improves the prognosis 
(C) Lavage of the chest with saline has been 
shown to definitively improve outcome
(D) A chest drain can be uncomfortable, 
especially if the pleura is inflamed 
3. Which of the following antibiotic combinations 
would NOT be appropriate for the treatment of 
pyothorax? 
(A) Co-amoxiclav and metronidazole 
(B) Fluoroquinolone and clindamycin 
(C) Fluoroquinolone and metronidazole 
(D) Doxycycline and co-amoxiclav 
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Diagnosis and surgical 
management of 
pyothorax
Georga Karbe
This presentation will focus on surgical intervention 
and  postoperative management for the treatment of 
pyothorax. The most common bacteria species isolated 
from patients with pyothorax include anaerobes Bacteri-
oides, Fusobacterium, Peptostreptocous and aerobes 
Actinomyces and Pasteurella, as well as Escherichia coli, 
Klebsiella and Streptococcus. Patients can present with a 
variety of clinical signs, ranging from vague lethargy and 
exercise intolerance, to severe respiratory distress, col-
lapse or septic shock. Emergency stabilization includes 
oxygen supplementation, minimal stress and intravenous 
fluid therapy based on the patient’s cardiovascular status. 
Timely initiation of medical management, including 
broad-spectrum antimicrobials, drainage of pleural 
 effusion, thoracic lavage and supportive care, is recom-
mended. 
Surgical intervention is undertaken in patients where 
3–7 days of medical management has been unsuccess-
ful. Early surgical exploration is, however, indicated in 
patients with a known underlying condition, such as a 
foreign body or lung lobe abscess. Presurgical imaging, 
particularly thoracic computed tomography, can provide 
vital information regarding the source and location of 
infection and guide the surgical exploration. Thorough 
exploration of the entire thoracic cavity is essential for 
successful surgical treatment. This can be performed via 
median sternotomy or thoracoscopy. The pleural lining 
along the thoracic wall and diaphragm must be exa-
mined as well as the mediastinum and all lung lobes. 
Necrotic and infected tissues along the thoracic wall or 
mediastinum must be debrided. Pulmonary abscesses 
are removed via partial or complete lung lobectomy. 
Removed tissues are submitted for tissue culture and 
 histopathology. Prior to closure, the entire thoracic  cavity 
is thoroughly lavaged and thoracic drains are placed. 
Postoperative management consists of continued 
medical management including antimicrobials (adjusted 
based on culture results), fluid therapy and monitoring 
thoracic fluid production. Thoracic drains should be 
emptied every 2–4 hours initially and this can then be 
decreased to every 6–8 hours based on the amount of 
fluid drained. Fluid production is expected to decrease, 
and thoracic drains can be removed once fluid produc-
tion reaches 2–3 ml/kg/24h. Cell count and cytology of 
the thoracic fluid should be monitored to ensure that the 
infection is resolving. Persistence of high fluid produc-
tion, high cell count and evidence of intracellular bacte-
ria on cytology suggest that the nidus has not been fully 
removed or that antimicrobial therapy must be altered. 
Reported success rates for treatment of pyothorax range 
from 48–86%.
KEY LEARNING OBJECTIVES
■■ Stabilization of the pyothorax patient
■■ Surgical exploration of the thoracic cavity
■■ Postoperative care of the pyothorax patient
MULTIPLE CHOICE QUESTIONS
1. Via what approach can the thoracic cavity be 
explored?
(A) Laparotomy
(B) Coeliotomy
(C) Sternotomy
(D) Craniotomy
2. Which of the following is NOT a criterion for 
when thoracic drains can be removed?
(A) Fluid production decreases to  
2–3 ml/kg/day
(B) Fluid cell count decreases
(C) Fluid production increases 
(D) Fluid cytology shows no intracellular 
bacteria
3. How frequently should thoracic drains should 
be emptied initially after surgery?
(A) Every 2–4 hours 
(B) Every 24 hours
(C) Only if the patient shows respiratory signs
(D) No drains are needed after surgical 
treatment of pyothorax
117-128 Cardio Respiratory.indd   127 08/03/2019   18:02
117-128 Cardio Respiratory.indd   128 08/03/2019   18:02
BSAVA CONGRESS 2019 PROCEEDINGS [ 129 ]
Saturday 6 April
Hall 6
Shelter medicine
130 08:30–09:15Caring for pets of homeless people
Jenny Stavisky
130 09:25–10:10A pragmatic approach to dog diarrhoea in the shelter 
environment
Jenny Stavisky
131 11:05–11:50Prepubertal neutering: a pragmatic approach
David Yates
132 12:00–12:45A pragmatic approach to the skinny old cat in the shelter 
environment
Rachel Dean
129-134 Shelter medicine.indd   129 08/03/2019   18:01
Shelter medicine
[ 130 ] BSAVA CONGRESS 2019 PROCEEDINGS
Caring for pets of 
homeless people
Jenny Stavisky
This session is aimed at those currently working with 
homeless peoples’ pets, and also those who may be inter-
ested in becoming involved in this type of work. It will 
cover some background issues around homelessness 
and pet ownership, and an update on clinical aspects of 
veterinary care for homeless people’s pets.
The UK has a long history of providing charitable 
 veterinary care, and also of recognizing that homeless 
pet owners may benefit from extra support from within 
the veterinary profession. The Hope Scheme was set up 
around 30 years ago, and is currently funded and run by 
Dogs Trust. Over recent years, there has been an explo-
sion of interest in this special population of people and 
pets within the veterinary professions. This corresponds 
with a 200% increase in homelessness in the UK since 
2011, as the impact of the economic crisis and changes in 
governmental policies have been felt. One 2017 survey 
showed that over 4700 people sleep rough in the UK 
every night, and this is likely to represent a significant 
underestimate. In addition to rough sleepers, there are 
much larger numbers of ‘hidden homeless’, living in tem-
porary accommodation such as hostels, bed and break-
fasts and sofa surfing. Owners may have problems such 
as drug or alcohol addiction, mental health problems, be 
fleeing spousal abuse or simply have fallen on hard times. 
An estimated 9% of the population of England has been 
homeless at some point in their lives. How many of these 
are pet owners is not known, but in one USA study 23% of 
homeless people owned a pet.
For homeless people, owning a pet likely fulfils a sim-
ilar role to anyone else who owns a pet –  companion ship, 
protection, feeling needed. These functions may be 
heightened in homeless people, who are at increased risk 
of loneliness, social isolation and physical and psycho-
logical vulnerability. At the same time, pet ownership can 
be a barrier to accessing services such as housing. 
Accessing medical care or rehabilitation services may be 
deferred due to a lack of alternative care for the pet.
For those providing veterinary care to such pets, the 
initial impression is often surprise at how well cared for 
these animals are. Indeed, overweight or obese pets are 
more commonly seen than underweight patients. Where 
access to veterinary care has been previously unavaila-
ble, providing basics such as vaccination and endo- and 
ectoparasiticide treatment is often extremely  helpful. 
Proof of this treatment (e.g. a vaccine card) may be espe-
cially useful as an indicator of responsible ownership 
when the client is seeking accommodation. 
As Staffordshire Bull Terriers are overwhelmingly the 
most common pet seen, breed-related problems such as 
atopy and cruciate disease are likely to be relatively regu-
lar clinical presentations. Where problems are identified 
which require inpatient veterinary treatment, the feasibil-
ity of providing a good standard of care during recovery 
is an essential consideration. Preliminary data shows that 
separation-related distress is likely to be common within 
these animals, and this must also be taken into account 
when considering whether hospitalization is an option.
KEY LEARNING OBJECTIVES
■■ Homelessness is a broad term which encompasses 
more than rough sleeping, and can include those 
living in squats, tents, hostels and other temporary 
accommodation
■■ For many homeless pet owners, their animal is an 
important family member, and they may find it hard 
to agree to treatments which involve them being 
separated from their pet
■■ In general, most homeless people’s pets are very 
well cared for. However, they may be unused to 
being away from their owners and experience 
significant separation-related distress. This must be 
taken into account when treatment is proposed
A pragmatic approach 
to dog diarrhoea in the 
shelter environment
Jenny Stavisky
This session will address three of the main challenges 
when encountering diarrhoea in dog shelters:
■■ Prevention and management of outbreaks of 
diarrhoea, including canine parvovirus
■■ Tips for cost-effective work-ups of individual cases
■■ Rehoming dogs with potentially zoonotic infections
When considering prevention of any infectious dis-
ease in a shelter environment, it is essential to first take a 
full history and physical examination where the shelter 
itself is the patient. Understanding key management 
practices can enable evaluation of where the risk of 
introducing and transmitting infection can be reduced. 
Questions should include:
■■ Consideration of intake policies (where dogs 
come from; how they are transported; open/
controlled intake)
■■ Cleaning and biosecurity protocols (presence of a 
protocol; training of staff and volunteers; 
management of separate risk groups, e.g. new 
intake/puppies; use of cleaning and disinfectant 
materials; whether practice matches protocol)
■■ Preventive medicine protocols (which dogs are 
vaccinated, if any; how soon after entry to the 
shelter vaccines are given; management of puppies 
and adolescent dogs)
The World Health Organization defines an outbreak 
as the occurrence of cases of a disease in excess of what 
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is expected. Therefore, under some circumstances, a 
single case may be treated as an outbreak, and lead to 
the  implementation of more intensive biocontainment 
protocols. This is especially true in a disease such as 
 parvovirus, which is very contagious and persists in the 
environment for long periods. 
Treatment of individual cases of parvovirus generally 
focuses on barrier nursing, excellent nursing care and 
symptomatic treatment, including early enteral nutrition. 
Antibacterials are usually used due to the degree of com-
promise of the gut mucosa. Interferon has been shown to 
improve outcomes if used early in disease, but is unlikely 
to be cost effective in a shelter environment. The use of 
oseltamivir (Tamiflu) has been explored but evidence for 
its efficacy is poor. Given its intended human use, it is dif-
ficult to recommend it without further evidence. 
Containment of an outbreak requires careful tracing 
of routes of introduction and transmission. Following an 
outbreak, it is important to evaluate whether existing 
protocols and training were as effective as possible, or 
whether improvements can be made. 
When considering other types of diarrhoea, untan-
gling the role of potential pathogens can be complex. 
 In-house tests, such as faecal flotation, are relatively 
insensitive but quick and cheap to perform. Many orga-
nisms, including Campylobacter, Giardia and Salmonella 
(the latter especially in dogs fed raw meat), can be pre-
sent as part of normal gut flora, so definitively identifying 
them as causative becomes problematic. Heavy, pure 
growths of these bacteria in the absence of other obvi-
ous causes may be significant. Treatment in some cases 
may be indicated, but serial faecal samples to prove 
 elimination of infection are usually unhelpful, as infection 
may persist long beyond clinical cure. 
Prospective adopters should be informed when dogs 
have had a potentially zoonotic pathogen identified. 
However, in the author’s experience, once owners are 
reminded that all faeces contain potential pathogens, 
and should not therefore be ingested, this rarely poses a 
barrier to adoption.
MULTIPLE CHOICE QUESTIONS
1. What may a shelter vaccine protocol include?
(A) Dogs which are stressed
(B) Dogs already showing signs of concurrent 
illness, e.g. pyrexia, cough
(C) Puppies from 4 weeks
(D) All of the above
2. Which of the following is a poor prognostic 
indicator in canine parvovirus infections?
(A) Faecal polymerase chain reaction (PCR) 
showing high viral load
(B) Very low neutrophil count
(C) High albumin:globulin ratio
(D) Very high neutrophil count
3. Which of these organisms is unlikely  
to be found in the faeces of a clinically  
normal dog?
(A) Canine coronavirus
(B) Canine parvovirus
(C) Campylobacter upsaliensis
(D) Clostridium perfringens
KEY LEARNING OBJECTIVES
■■ A full history and physical examination where the 
shelter is the patient are key to preventing infectious 
disease problems, and to managing them when 
they occur
■■ Where necessary, vaccines may be used off-licence 
as one component of infectious disease 
management within a shelter. Precedent can be 
found in both the WSAVA and ASV (Association of 
Shelter Veterinarians) guidelines
■■ In-house microscopy can be a cheap and quick 
method to rule in (but not rule out!) pathogens such 
as Giardia
Prepubertal neutering: 
a pragmatic approach
David Yates
In the UK, the two most common reasons for dog and cat 
entry into an animal shelter are relinquishment by an 
owner and as a stray animal. Neutering is often endorsed 
by animal welfare organizations to control pet overpop-
ulation, limit oversupply and discourage casual pet 
acquisition. It is hoped that the procedure may have 
some preventive impact on future shelter intake.
Various factors may influence the neutering policy 
of the shelter, e.g. finance, facilities, throughput and 
veterinary advice. Some shelters may not enforce neu-
tering before adoption. Others may have a veterinary 
suite and neuter at the centre. Animals may also be 
transported to nearby veterinary practices. Neutering 
vouchers may be issued to owners at the time of adop-
tion and redeemed after the pet has settled into their 
new environment.
Neutering before adoption from a shelter optimizes 
population control. Other methods have attrition rates, 
e.g. vouchers are often difficult to administer and owner 
compliance may be problematic.
Prepubertal neutering is the optimal surgical method 
of population control. It is applicable in a number of 
 settings:
■■ Client-owned animals especially charity practice
■■ Shelter animals before adoption
■■ Trap and neuter schemes
With a few specific considerations, prepubertal neu-
tering can be accomplished by most practitioners in a 
variety of settings. Anaesthesia may be improved by 
using body surface area dosing and preventing patient 
hypothermia and hypoglycaemia. Surgical success may 
be delivered by meticulous haemostasis. Prepubertal 
patients display more rapid and complete recoveries than 
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their adult counterparts. The procedure carries a lower 
morbidity rate than adult gonadectomy.   
The long-term effects of prepubertal gonadectomy 
in the cat are likely to be similar to those of conventional 
gonadectomy. For example, many vets would neuter an 
owned kitten at around 5–6 months. On the other hand, 
prepubertal gonadectomy of such a kitten may be car-
ried out at second vaccination. This 2–3-month time dif-
ference is unlikely to be of significance to the individual, 
but is of enormous benefit in eliminating the possibility of 
unplanned breeding. 
Uncontrolled and unplanned dog breeding is less 
likely than in the cat. Puberty may be much later in large 
and giant breeds. Dogs are less likely to live an outdoor 
lifestyle and have unfettered access to a receptive mate. 
A successful mating must coincide with an infrequent 
‘heat’. For these reasons, the need for prepubertal gona-
dectomy is less evident in the dog. Furthermore, there 
may be more significant differences between prepuber-
tal and postpubertal neutered giant breeds of dog. For 
example, growth plate closure is delayed in animals 
 neutered before puberty.   
A balance must be found between the risks and 
 benefits of gonadectomy to the individual pet and the 
need to improve the welfare of the tens of thousands of 
relinquished animals entering UK shelters each year. 
KEY LEARNING OBJECTIVES
■■ In an ideal world, all pets would be responsibly 
owned. Annually, UK shelters receive over 200,000 
dogs and cats – most are relinquished or stray
■■ Prepubertal neutering is a simple procedure in dogs 
and cats which optimizes population control
■■ The case for prepubertal gonadectomy is highly 
persuasive in the cat. There are some important 
differences to consider in the dog
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements regarding 
anaesthesia of prepubertal puppies and kittens 
is NOT true?
(A) Hypothermia may be a significant cause of 
prolonged anaesthetic recovery
(B) The risk of hypoglycaemia may be reduced 
by prompt feeding on recovery
(C) Anaesthetic overdose is more likely using 
datasheet recommendations in young 
patients
(D) Body surface area dosing improves the 
reliability of alpha-2 adrenoreceptor 
agonists/ketamine combinations in kittens
2. Which of the following most accurately 
describes dog and cat reproduction in the UK?
(A) Most cat breeding is planned and few 
litters are unwanted
(B) Unplanned dog pregnancies are frequently 
discovered at routine gonadectomy
(C) Shelters have capacity to receive unwanted 
kittens because the breeding problem is 
non-seasonal
(D) Many pet owners are unaware of the 
reproductive capacity of their pets
3. Which one of the following statements is FALSE?
(A) Neutering generally increases life 
expectancy in the dog and cat
(B) Neutering before puberty will cause 
stunted growth in some dog breeds 
(C) Prepubertal gonadectomy may increase 
the risk of some forms of cancer in dogs
(D) Prepubertal gonadectomy may decrease 
the risk of some forms of cancer in dogs
A pragmatic approach 
to the skinny old cat 
in the shelter 
environment
Rachel Dean 
Investigating medical conditions of animals in shelters 
has some unique challenges. There is often an unknown, 
uncertain or very short clinical history. In addition, the 
person who presents the cat to you may not be the per-
son who cares for the cat or is responsible for the bill. Any 
demand on resources, in terms of time, money or people 
for the old cat presented to you may affect the rest of the 
shelter population. It is important to establish the ethos 
of the organization, whether the aim is to rehome the 
individual, and what their euthanasia policy is, to make 
sure everyone has a clear understanding of what is and is 
not possible for each case. Like all decisions in the  shelter 
environment, a degree of pragmatism and ‘herd health’ 
thinking is needed!
Weight loss and/or poor body condition in elderly 
cats is a common presentation and a feature of many dif-
ferent conditions. It is important to take a stepwise prag-
matic approach to each individual case, considering the 
possible prognosis and treatment options prior to under-
taking potentially expensive diagnostic tests. 
As with all cases the investigation starts with the 
 clinical history and physical examination, including body 
weight (ideally to two decimal places) and body condi-
tion score.  Even if the time the cat has been with the 
shelter is very short (sometimes it is a matter of hours!), 
taking a thorough history is important and attention 
should be paid to appetite, diet, thirst, mobility, behavi-
our, demeanour, urine and faeces, and coat condition. 
Similarly a complete physical examination is required, 
with particular attention to the mouth, eyes, cervical 
region, thorax, abdomen and musculoskeletal system 
(basically the whole cat!). If the cat is very new to the 
shelter and/or there are no significant abnormalities on 
clinical examination, it may be able to use the ‘test of 
time’ and ask for the cat to be observed for a short period 
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before proceeding. It is vital to know how much (and if!) 
a cat is eating before pursuing any investigations.
Ideally diagnostic investigations should be done 
consecutively so that one test is used to inform another 
and ensure no tests are done unnecessarily which will 
waste the budget and time.  Which test to do first should 
be driven by the clinical history and physical examina-
tion, and the right order will vary from one patient to the 
next. It is vital to only undertake a test if it will change 
what you do. It is important to remember expensive tests 
are not always the best tests, in-house tests are not 
always cheaper, urinalysis can teach you a lot, a treat-
ment trial can sometimes be a useful part of the investi-
gation and you do not always have to treat everything 
you find!
Case examples from shelters will be given in the 
 lecture to demonstrate some of these approaches to a 
number of common diseases.
KEY LEARNING OBJECTIVES
■■ Describe the key challenges of dealing with elderly 
feline patients in the shelter environment
■■ Calculate nutritional requirements for feline patients
■■ Create a stepwise investigation plan for a skinny old 
cat in a shelter 
MULTIPLE CHOICE QUESTIONS 
1. What is the best calculation for estimating the 
calorie requirement of a cat under 2 kg?
(A) 70 x (current body weight in kilograms)0.75
(B) (30 x current bodyweight in kilograms) + 70
(C) (50 x current bodyweight in kilograms) + 60
(D) 50 x (current body weight in kilograms) 0.75
2. What urine specific gravity would suggest a 
hydrated skinny feline patient may have a 
degree of chronic kidney disease?
(A) 1.060
(B) 1.050
(C) 1.040
(D) 1.030
3. Which blood biochemistry findings would 
increase the suspicion of hyperthyroidism in a 
skinny cat?
(A) Increased alanine aminotransferase (ALT) 
and decreased creatinine
(B) Increased alkaline phosphatase (ALP) and 
decreased urea
(C) Increased creatinine and decreased 
albumen
(D) Increased cholesterol and decreased ALT
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Ophthalmological 
manifestation of 
systemic disease
Ben Blacklock 
Ophthalmological assessment of patients suffering from 
systemic disease can be very useful in narrowing differential 
lists, targeting investigations and monitoring responses to 
therapy. The eye is unique in that nowhere else in the body 
can the central nervous system (optic nerve head) and the 
peripheral vasculature (retinal blood vessels) be directly 
 visualized. Furthermore, the very high rate of ocular blood 
flow means there is an increased likelihood of the uveal and 
retinal vasculature being exposed to haematogenous neo-
plastic cells and/or infectious organisms. 
The list of systemic diseases with possible ocular mani-
festations is extensive, and more information can be found 
in ophthalmology textbooks. As a result only the most 
 common or interesting diseases are mentioned here. 
UVEITIS
Uveitis is inflammation of the uveal tract (iris, ciliary body 
and/or choroid), which is the vascular tunic of the eye. 
Uveitis may be triggered by a long list of diseases (includ-
ing infectious, inflammatory, metabolic, toxic and several 
miscellaneous diseases), but an underlying cause is not 
found in a significant number of cases (i.e. idiopathic or 
immune-mediated uveitis). Because the eye is limited 
in  its ability to respond to injury, different diseases may 
 produce similar clinical signs. 
In a study at North Carolina State University of dogs 
presenting with uveitis, which had undergone a com-
plete diagnostic work-up, 58% of cases were idiopathic/
immune-mediated. Neoplasia was diagnosed in 24.5% 
of dogs (lymphosarcoma the most common cancer, in 
17 of 25 cases). Infectious diseases were found in 17.6% 
of cases (ehrlichiosis the most common, in 7 of 18 cases).
In cats, there is less information available, but a 1991 
histopathological study found that in cats with a con-
firmed cause of uveitis, feline infectious peritonitis and 
feline leukaemia virus (FeLV)-associated lymphosarcoma 
were the most common aetiologies. 
FELINE VIRAL DISEASE
■■ Feline herpesvirus type 1 (FHV-1) – causes upper 
respiratory tract disease (URTD) and conjunctivitis  
and/or keratitis
■■ Feline calicivirus (FCV) – causes URTD, oral mucosal 
ulceration and ocular surface disease (primarily 
conjunctivitis – typically mild)
■■ Feline immunodeficiency virus (FIV) – ocular 
disease is typically chronic anterior uveitis 
and conjunctivitis, and FIV is associated with 
lymphosarcoma in cats
■■ FeLV – primarily causes ocular disease through the 
induction of lymphosarcoma; with sites of ocular 
lymphosarcoma including the uveal tract, conjunctiva 
and orbit
■■ Feline infectious peritonitis (FIP) – ocular signs more 
common with non-effusive (dry) form, often 
associated with vasculitis, and include 
pyogranulomatous anterior uveitis, fibrin in the anterior 
chamber, keratic precipitates and choroidoretinitis 
(with retinal detachment and perivascular cuffing)
DIABETES MELLITUS
The majority of dogs with diabetes will develop cataracts 
(75% within a year of diagnosis). Furthermore, diabetic 
dogs have a relatively high chance of developing retinal 
haemorrhages and microaneurysms, and tend to have 
lower tear production than non-diabetic dogs. 
HYPERTHYROIDISM/SYSTEMIC 
HYPERTENSION
The eye is a major target organ for systemic hyperten-
sion, with the most common lesions being retinal blood 
vessel tortuosity, focal retinal oedema, bullous retinal 
detachment and retinal haemorrhage. If untreated, total 
retinal detachment and intravitreal haemorrhage may 
develop. The ocular changes seen in hyperthyroid pa tients 
are likely to be due to systemic hypertension. 
KEY LEARNING OBJECTIVES
■■ To understand why the eye is affected in many 
systemic disease processes
■■ To recognize uveitis and understand it is the ocular 
manifestation of many systemic diseases
■■ To recognize ocular signs of selected other more 
common systemic diseases, such as diabetes 
mellitus and systemic hypertension
MULTIPLE CHOICE QUESTIONS
1. Why should examination of the eye be part of a 
clinical examination when investigating 
systemic disease?
(A) Because quality of life of the patient will be 
severely impaired if they go blind
(B) Because many systemic diseases have 
pathognomonic ocular signs that will 
provide a diagnosis
(C) Because the eye is the only place in the  
body where the central nervous system 
(optic nerve head) and the peripheral 
vasculature (retinal blood vessels) be 
directly visualized
(D) Because there is a very limited number of 
systemic diseases that may cause ocular signs
2. Regarding the aetiology of canine uveitis, 
which of the following is true?
(A) Idiopathic/immune-mediated uveitis make 
up the majority of cases, followed by 
neoplasia and then infectious diseases
(B) Neoplasia is the most common cause of 
uveitis, followed by infectious diseases and 
then idiopathic/immune-mediated
(C) Infectious diseases are the most common 
cause of uveitis, followed by idiopathic/
immune-mediated and then neoplasia
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(D) Idiopathic/immune-mediated uveitis make 
up the majority of cases, followed by 
infectious diseases and then neoplasia
3. Regarding the ocular effects of diabetes mellitus 
in canine patients, which of the following is true?
(A) The majority of dogs will develop cataracts 
within a year of diagnosis
(B) Diabetic dogs have a higher incidence of 
retinal haemorrhages and microaneurysms 
than non-diabetic dogs
(C) Diabetic dogs tend to have lower  
tear production than non-diabetic  
dogs
(D) All of the above are true
Cardiac manifestations 
of systemic disease
Ruth Willis 
As the ‘engine’ of the body, the heart is susceptible to the 
effects of disease elsewhere. The response of the heart 
may be appropriate – for example sinus tachycardia in 
response to pain or hypovolaemia. However, in other 
 situations the effect of systemic disease on the heart 
may result in worsening haemodynamics and a specific 
therapeutic intervention may be required. Whilst numer-
ous systemic diseases will affect the heart, this lecture 
will highlight the more common conditions.
ELECTROLYTE ABNORMALITIES 
Conditions resulting in severe electrolyte imbalances can 
affect the heart. For example, in dogs with hypoadreno-
corticism at the time of an Addisonian crisis, there is 
 profound hypovolaemia and also multiple electrolyte 
imbalances, such as hyperkalaemia, often resulting in 
bradyarrhythmias that are potentially life-threatening. 
Specific anti-arrhythmic treatment is rarely required and 
treatment is directed at aggressively addressing the effects 
of mineralocorticoid and glucocorticoid deficiency.
VENTRICULAR TACHYARRHYTHMIAS
Ventricular arrhythmias are common in association with 
severe systemic disease. The pathophysiology is likely to 
be multifactorial and includes myocardial hypoxia and 
ischaemia, acid–base disturbances, microthrombi for-
mation and the effects of inflammatory mediators.
Common conditions associated with ventricular 
arrhythmias include:
■■ Splenic disease, especially haemangiosarcoma
■■ Gastric dilatation–volvulus (GDV)
■■ Immune-mediated haemolytic anaemia
■■ Immune-mediated thrombocytopenia
■■ Pancreatitis
In some cases the ventricular arrhythmia is haemo-
dynamically stable and resolves spontaneously with 
treatment of the underlying disease. Ventricular arrhyth-
mias are more likely to require treatment if:
■■ The rate is fast (>180 bpm)
■■ Predisposing factors, such as pain, hypovolaemia 
and electrolyte imbalances, have been appropriately 
managed and the arrhythmia persists
■■ There is systemic hypotension
Anti-arrhythmic treatment of ventricular tachyar-
rhythmias often involves the use of lidocaine as bolus(es) 
followed by a continuous rate infusion. 
LEFT VENTRICULAR HYPERTROPHY 
IN CATS
Cats commonly exhibit cardiac adaptations to systemic 
disease. For example left ventricular concentric wall hyper-
trophy is seen in cats with:
■■ Hyperthyroidism 
■■ Systemic hypertension (for example renal disease, 
hyperaldosteronism) 
■■ Acromegaly
PULMONARY HYPERTENSION
Non-cardiac conditions that may result in pulmonary 
hypertension include:
■■ Parasitism (for example Dirofilaria, Angiostrongylus)
■■ Chronic pulmonary disease (for example interstitial 
pulmonary fibrosis)
■■ Pulmonary vascular disease with proliferative 
change affecting the vessel walls
■■ Pulmonary thromboembolism secondary to 
systemic illness
Pulmonary hypertension may be diagnosed non- 
invasively using spectral Doppler echocardiography to 
measure the velocity of pulmonic (PI) and/or tricuspid (TR) 
insufficiency jets. PI >2.2 m/s and TR >2.8 m/s are  suggestive 
of pulmonary hypertension. In dogs pulmonary hyperten-
sion can often be ameliorated using sildenafil.
VAGOTONIA
Some conditions will increase parasympathetic tone, 
especially gastrointestinal disease, respiratory disease 
and conditions resulting in significant increases in intrac-
ranial pressure. These conditions augment parasympa-
thetic tone and can increase the likelihood of neurally 
mediated syncope. 
KEY LEARNING OBJECTIVES
■■ Give examples of systemic diseases likely to result in 
arrhythmias
■■ Give examples of systemic disease likely to result in 
left ventricular hypertrophy in cats
■■ Understand that treatment of malignant ventricular 
arrhythmias usually involves administration of 
intravenous lidocaine
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MULTIPLE CHOICE QUESTIONS
1. When may increased parasympathetic tone be 
seen in dogs?
(A) Hypovolaemia
(B) Chronic respiratory disease 
(C) Phaeochromocytoma
(D) Anaemia
2. When may left ventricular concentric 
hypertrophy be seen in cats?
(A) Inflammatory bowel disease
(B) Pancreatitis
(C) Hyperthyroidism
(D) Hypovolaemia
3. What is ventricular tachycardia causing  
systemic hypotension commonly treated with?
(A) Intravenous lidocaine
(B) Intravenous diltiazem
(C) Oral digoxin
(D) Oral atenolol
Management of 
refractory epilepsy
Jeremy Rose
Refractory epilepsy occurs when seizures do not respond 
adequately to medication, or when the side effects caused 
by medication result in a poor quality of life for the patient. 
Refractory epilepsy is very common in small animal 
 practice and managing these cases can be challenging. 
Effective management revolves around five main steps:
1. Establishing the patient has refractory epilepsy
2. Ensuring the episodes are epileptic seizures
3. Re-evaluating the patient to identify reasons for 
becoming refractory to treatment
4. Considering the anti-seizure regimen and alternative 
treatments
5. Resetting expectations
Many owners feel isolated and panicked whilst look-
ing after seizuring patients. They also report that many of 
the side effects of anti-seizure drugs, such as sleeping 
more and ataxia, affect their pet’s quality of life. As such, 
owners are prone to present their epileptic pet as refrac-
tory to the practitioner. It is important to educate owners 
on the expectations of treatment and collectively estab-
lish what is considered refractory for their pet so they can 
contact you for advice in this instance. As epilepsy often 
progresses with time, the definition of refractory for a 
particular patient is fluid. It is important to re-establish 
markers for being refractory to treatment so you can 
manage these patients effectively long term. 
Once you have established your patient is refractory 
to treatment it is important to review their history and 
examination. This includes a full neurological examina-
tion and description (or in some cases videos) of the 
 episodes. Many other paroxysmal episodes can resemble 
seizures and sometimes treatments may have started 
before full characterization of the episodes was possible. 
Repeat history and examination may identify a deteriora-
tion in cases of structural epilepsy or even change your 
differentials so a previously presumptive idiopathic 
 epileptic is now considered to have a structural cayse. 
This may lead to further investigations or treatments 
other than anti-seizure drugs. 
Where changes to the anti-seizure drug regimen are 
considered, it is important to check owner compliance. 
Following this, repeating bloods and checking serum 
 levels of the medications allows optimization of a mono-
therapy before another drug is used or added to the 
current treatment plan. Selecting another anti-seizure 
drug can be challenging but considering the potential 
efficacy alongside mechanism of action, pharmacoki-
netics, side effects and costs will help with the decision-
making process. Diet changes can help aid seizure 
control for some patients but there is no evidence 
 supporting the use of other treatments (e.g. transcranial 
magnetic stimulation, the use of essential fatty acids, and 
vagal nerve stimulators) in veterinary patients at this time. 
Alternative therapeutics may gather evidence with time 
and become options for helping you manage these 
refractory patients in the future. 
KEY LEARNING OBJECTIVES
■■ Develop guidelines to describe an individual as 
having refractory epilepsy 
■■ Evaluate a patient to determine reasons for being 
refractory to treatment
■■ Choose additional anti-seizure drugs for a refractory 
patient
MULTIPLE CHOICE QUESTIONS
1. Autoantibodies to which channels have been 
found in some cats with limbic encephalitis?
(A) Ligand-gated chloride channels
(B) Ligand-gated sodium channels
(C) Voltage-gated calcium channels
(D) Voltage-gated potassium channels
2. Which of the following findings on neurological 
examination would indicate a left-sided 
forebrain lesion?
(A) A horizontal nystagmus with fast phase to 
the right
(B) Absence of the right-sided pupillary light 
reflex on direct or indirect testing 
(C) Left-sided head tilt
(D) Right-sided menace response deficit
3. Which anti-seizure drug is proposed to act on 
the SV2A protein?
(A) Imepitoin
(B) Levetiracetam
(C) Phenobarbital
(D) Potassium bromide
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Acute kidney injury: 
practical management
David Walker 
Treatment goals for the patient with acute kidney injury 
(AKI) are aimed at limiting further renal damage and 
enhancing cellular recovery. Correction of fluid, electro-
lyte and acid–base disorders, achieving and maintaining 
normotension, and establishing/maintaining urine flow 
are the most important aspects of therapy in patients 
presenting with AKI. 
FLUID THERAPY
The most effective therapy in patients with AKI is careful 
management of fluid balance. Even in the absence of 
clinically detectable dehydration, a 5% fluid deficit should 
be suspected and the dehydration deficit should be 
 corrected over 4–6 hours; only then can urine output be 
accurately assessed. The rate of crystalloid fluid adminis-
tration after correction of dehydration should take into 
account insensible losses, sensible losses and urine out-
put. Insensible losses (fluid lost with respiration and nor-
mal stools alone) are typically estimated as 22 ml/kg/day, 
and sensible losses from vomiting and dehydration need 
to be estimated. Urine output (UOP), which is also a 
 sensible loss, is most reliably monitored by placing 
an  indwelling urinary catheter but it can be estimated 
by measuring free-catch samples every time a patient 
 urinates and/or by weighing soiled bedding. The urinary 
catheter should be aseptically placed and connected to a 
closed collection system because animals with AKI have 
depressed immunity to infection. 
In terms of the crystalloid fluid of choice, a balanced 
polyionic solution (i.e. lactated Ringer’s solution (LRS)) is 
appropriate in most situations. It is imperative to avoid 
volume overload in patients with AKI as this has repeat-
edly been shown to worsen outcome because it does not 
increase renal oxygen delivery despite improved cardiac 
output and renal blood flow. The ‘ins-and-outs’ method 
of fluid administration helps maintain an appropriate fluid 
balance by matching the volume administered to the 
 volume excreted. Anuric patients should receive fluids 
to  replace insensible losses only. If the patient is over-
hydrated, then insensible losses should be withheld. 
Overhydration in an anuric patient, or an inability to 
induce diuresis in an oliguric or anuric patient, is an indi-
cation for continuous renal replacement therapy (CRRT), 
which is the only other effective therapeutic option.
OLIGURIA AND ANURIA
Various values for urine output have been used to define 
oliguria, including <0.25 ml/kg/h, <0.5 ml/kg/h, and 
<1– 2 ml/kg/h. The author typically uses a value of <1 ml/
kg/h to define oliguria. Anuria is defined as essentially no 
urine production. If pathological oliguria or anuria persist 
despite correction of fluid deficits, diuresis should be 
considered to increase urine production. 
Furosemide is a loop diuretic; it can increase urine 
flow but has no effect on glomerular filtration rate (GFR) 
or renal blood flow. An initial furosemide bolus is given 
intravenously in oliguric patients. An increase in urine 
output should be seen within 20–60 minutes of intrave-
nous administration. If a response is seen, furosemide 
therapy can be repeated every 8 hours or continued as a 
continuous rate infusion (CRI).
Mannitol is an osmotic diuretic that promotes 
 natriuresis and will increase renal blood flow due to its 
intravascular volume-expanding effects. GFR may be 
improved with mannitol therapy due its renal vasodilator 
effects, and increased tubular blood flow may be benefi-
cial in flushing tubular obstructions caused by casts and 
cellular debris. Additionally, mannitol has free-radical-
scavenging properties and is thought to reduce cellular 
swelling. Mannitol should be given as an initial intrave-
nous bolus over 3–5 minutes. Diuresis should occur 
within 20–30 minutes and mannitol can be continued 
as a CRI. 
KEY LEARNING OBJECTIVES
■■ Understand how to differentiate acute kidney injury 
(AKI) from chronic kidney disease (CKD)
■■ Understand the ‘ins-and-outs’ method of fluid 
administration
■■ Be aware of when and how to use diuretics in dogs 
with AKI 
MULTIPLE CHOICE QUESTIONS
1. Which of the following is the most appropriate 
fluid choice in a dog presenting with AKI?
(A) Hetastarch  
(B) Hypertonic saline (7%) 
(C) Lactated Ringer’s solution (LRS)
(D) Saline (0.45%) 
2. Which of the following would be the most 
appropriate first-choice diuretic agent in an 
anuric dog with AKI? 
(A) Dopamine
(B) Fenoldopam 
(C) Furosemide
(D) Mannitol
3. Which of the following would be an indication 
for renal replacement therapy in a dog with AKI?
(A) Hypotension 
(B) Intractable hyperkalaemia
(C) Underhydration
(D) Polyuria
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Is this a bone tumour? 
Differentiating benign 
and malignant bone 
disease with 
radiographs
Jennifer Kinns
Radiographs are an important part of the work-up of 
skeletal lesions in small animal patients. The differen-
tiation between benign and malignant bone disease 
determines the next steps in clinical work-up and case 
management.
There are four key Roentgen findings that are asso-
ciated with aggressive bone lesions: the presence of 
 cortical destruction, a long zone of transition between 
normal and abnormal bone, an aggressive form of peri-
osteal reaction and an aggressive form of lysis (bone 
loss). Aggressive lesions are frequently lytic, but whether 
the lesion is primarily lytic or proliferative does not in 
itself determine if the lesion is aggressive. Not all features 
of aggressive bone disease may be present in a lesion, 
and some benign lesions may share features of a more 
aggressive process.
Cortical destruction is often identified in aggressive 
lesions, and if present is a good indicator of an aggressive 
lesion. It is only seen on radiographs if the affected cor-
tex is projected tangentially by the X-ray beam. At least 
two views of a lesion will increase the chances of visual-
izing this. In a benign process the cortex can be expanded 
without destruction.
Bone lysis is not evident radiographically until there 
is a 30% loss of bone density, and early primarily destruc-
tive lesions can therefore be very subtle. The pattern of 
bone lysis has been related to the character of aggressive 
bone lesions. Moth-eaten and permeative lysis are asso-
ciated with aggressive lesions whereas geographic (well 
defined, regional) lysis can occur with benign lesions, 
such as bone cysts. However, some aggressive lesions 
will also display a more geographic form of lysis and this 
distinction alone is not adequate to differentiate benign 
and aggressive disease. Multiple myeloma and synovial 
cell sarcoma for example can also have very well defined 
more focal lytic lesions.
Periosteal reaction also varies in characteristic 
between benign and aggressive forms. Aggressive lesions 
have a more active periosteal reaction which is irregular. 
Benign lesions tend to have smooth margins and good 
definition. The rate of change of periosteal reaction can 
also help differentiate benign from aggressive lesions. 
More aggressive lesions progress more rapidly.
The transition zone describes the junction between 
normal and abnormal bone. This is longer and less well 
defined with aggressive disease, whereas a benign lesion 
may have a distinct sclerotic margin.
The aetiology and location of the lesion affects the 
radiographic appearance of aggressive disease. Joint-
associated neoplasia, such as synovial cell sarcoma, is 
characterized by punctate lysis affecting multiple bones 
with minimal periosteal reaction. Lesions of the spine are 
often more lytic than proliferative and multiple myeloma 
typically appears as multifocal lytic lesions without 
 periosteal involvement. Primary osteosarcoma of the 
appendicular skeleton typically displays all the features of 
aggressive disease, but can be quite variable. It frequently 
occurs in predilection sites within the metaphyseal region 
(proximal humerus, distal radius, distal femur and proxi-
mal tibia), while metastatic lesions can occur  anywhere. 
There is marked variation in appearance depending 
on the stage of disease. Early osteosarcoma can be very 
subtle with faint periosteal reaction, but will typically 
progress rapidly. Histopathology is the gold standard for 
diagnosis, but if cost, patient factors or client choice are 
prohibitive, follow-up radiographs can be used to assess 
for progression in the lesion that would be expected with 
aggressive disease. 
This lecture will discuss the radiographic features of 
benign and aggressive bone disease using case  examples.
KEY LEARNING OBJECTIVES
■■ Recognize the radiographic features of aggressive 
bone disease
■■ Differentiate benign from malignant bone lesions 
more easily
■■ Recognize the characteristic features of some 
common bone malignancies
MULTIPLE CHOICE QUESTIONS
1. What is the characteristic radiographic feature 
of an aggressive periosteal reaction?
(A) A sunburst shape
(B) Pallisading appearance
(C) Irregular margin
(D) Elevation from the cortical surface
2. What is the predilection zone for osteosarcoma?
(A) Diaphyseal
(B) Epiphyseal
(C) Metaphyseal
(D) Mixed epiphyseal and metaphyseal
3. Which part of the skeleton is most commonly 
affected by multiple myeloma?
(A) Spine and pelvis
(B) Long bones
(C) Carpi and tarsi
(D) Skull
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A waste of time? 
Should we still be 
doing skull radiographs 
in 2019?
Jennifer Kinns
Skull radiographs are difficult to perform well, and are 
difficult to interpret. The question arises as to whether we 
should take them at all when other modalities, particu-
larly computed tomography (CT), may better answer the 
clinical question. They can be a waste of time if interpre-
tation is limited by poor positioning and an inadequate 
choice of views. However, not every clinic has access to 
CT, not every pet is insured and not every owner can 
afford to pay for a CT study. Done well, skull radiographs 
can answer important clinical questions that will impact 
the planning and prognosis for the patient. The short 
answer to the question title is, ‘Yes, some of us should still 
be doing skull radiographs for some cases.’ This lecture 
will outline how to take a diagnostic study of the skull, 
using case examples. It will also review the limitations of 
skull radiographs and when CT may be necessary.
General anaesthesia is almost always necessary to 
acquire a diagnostic study of the skull. The anatomical 
complexity requires very accurate and standardized 
positioning which is not possible in a conscious patient. A 
minimum number of views is necessary for a diagnostic 
study. Dorsoventral (DV) and lateral views are indicated 
in almost every case. The DV view is preferred to the ven-
trodorsal (VD) view as it is easier to obtain mandibular 
symmetry. Additional views will be required depending 
on the clinical presentation. These are summarized in 
Figure 1.
In general practice, skull radiographs can help iden-
tify the presence of aggressive osseous lesions in patients 
presenting with mass lesions. Although the extent of 
 disease may not be accurately assessed, this could allow 
the owner and clinician to make a decision as to the next 
appropriate step, such as biopsy and thoracic radio-
graphs or potentially euthanasia. Radiographs can also 
help identify the presence of middle ear disease, and in 
trauma patient’s skull radiographs can be used to identify 
osseous trauma. In most cases requiring surgical inter-
vention, advanced imaging, such as CT, will be necessary 
for more accurate assessment and surgical planning.
KEY LEARNING OBJECTIVES
■■ Recognize the clinical indications for skull 
radiography
■■ Understand the appropriate views and correct 
positioning for different clinical indications
■■ Understand when computed tomography of the 
skull is necessary
MULTIPLE CHOICE QUESTIONS
1. Which view is indicated for assessment of the 
tympanic cavities in addition to standard DV 
and lateral images?
(A) Intraoral dorsoventral
(B) Open-mouth rostrocaudal
(C) Open-mouth ventrorostral-dorsocaudal
(D) None of the above
2. If you acquire an open-mouth left 20-degree 
dorsal-right ventral radiograph of the skull, 
which structure will be projected ventrally?
(A) Left mandible
(B) Right mandible
(C) Left maxilla
(D) Right maxilla
3. Which anatomical structure will have to be 
elevated to produce a straight lateral projection 
of the canine skull?
(A) Base of the skull
(B) Neck
(C) Nose
(D) Ears 
Region of concern Radiographic projections indicated
Middle ear/tympanic bullae Open-mouth rostrocaudal; lateral obliquea (left rostral–right caudal for the right and 
right rostral–left caudal for the left); rostroventral-caudodorsal oblique
Nasal passages Open-mouth rostroventro-caudodorsal oblique; intraoral dorsoventral
Frontal sinuses Skyline/rostrocaudal frontal sinus view
Maxillary dental structures Lateral obliquea (open-mouth left ventral to right dorsal for the right and open-mouth 
right ventral to left dorsal for the left)
Mandibular dental 
structures
Lateral obliquea (open-mouth left dorsal to right ventral for the right and open-mouth 
right dorsal to left ventral for the left)
Temporomandibular joints Lateral oblique views as for tympanic bullae
Figure 1: Radiographic projections for the skull 
aThe lateral oblique views will be acquired at different angles depending on the skull type of the patient and the region 
of interest
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Is this elbow dysplasia? 
What radiographs tell 
us and when to use CT
Francisco Llabrés Díaz 
There has been a very significant shift towards the use of 
CT when evaluating cases of suspected elbow dysplasia 
(ED). This is mostly well justified although radiography 
can still offer a financially viable and quick assessment at 
the time of the original clinical presentation and in 
chronic cases where a flare-up has occurred.
RADIOGRAPHY
A three projection study of the elbow (neutral 110- 
degrees mediolateral, 45-degrees flexed mediolateral 
and a craniocaudal) is needed to evaluate this area. The 
BVA/KC scheme requires the first two as screening. The 
quality of the radiographs will have a very significant 
impact on the usefulness of the test. Particular care and 
training are needed at the time of obtaining the cranio-
caudal projections. 
Radiographs will be able to detect:
■■ Conspicuous primary lesions 
■■ Significant increase in opacity of the distal and 
caudal aspect of the ulnar notch (a useful 
radiographic sign of disease although difficult to 
detect if subtle and when evaluating poor-quality 
radiographs)
■■ Presence and severity/extension of osteoarthritis, 
useful as a baseline for monitoring
Radiographs will struggle (CT is here superior) to 
evaluate:
■■ The degree of incongruity, unless severe
■■ Subtle medial coronoid process alterations
COMPUTED TOMOGRAPHY
Advantages
■■ Lack of superimposition
■■ Exquisite anatomical detail
■■ Therefore higher sensitivity for those lesions where 
radiography can struggle
■■ Although not part of the ED complex, CT is also 
superior in cases with incomplete ossification of the 
humeral condyle or stress fractures at this level, an 
important clinical consideration, particularly in 
spaniel breeds
Disadvantages
■■ Poor at detecting cartilage-only lesions
■■ It can be difficult to differentiate osteochondritis 
dissecans from kissing lesions
■■ Joint congruity is not assessed on weightbearing/
overall range of motion
Situations where CT shines over radiography 
■■ The detection of mild/focal changes within the 
medial coronoid process
■■ Variable degrees of subchondral bone 
hypoattenuation
■■ Presence of fissures or small and minimally 
displaced fragments
■■ Presence of convincing but mild incongruity
■■ Hyperattenuation of the subchondral bone at the 
level of the distal/medial humeral condyle
The appearance of an ununited anconeal process 
and osteoarthritis will be the same as on radiographs.
INTERPRETATION
The link between morphological alterations and their 
clinical relevance and, most importantly, therapy is still 
under debate. From experience, large detached or dis-
placed medial coronoid process fragments and large 
ununited anconeal processes tend to be treated (arthro-
scopically or surgically) more promptly.
KEY LEARNING OBJECTIVES
■■ Elbow dysplasia (ED) is a multifactorial disease with 
a high genetic influence and heritability, often 
bilateral, although not necessarily symmetrical
■■ Radiographs are used to detect visible (not always 
conspicuous) primary lesions and secondary 
osteoarthritic changes
■■ It is not wrong to recommend computed 
tomography (CT) with a strong clinical suspicion of 
ED to minimize the chances of an uncertain result, 
but CT should not be used as a screening tool in 
cases of obscure lameness
MULTIPLE CHOICE QUESTIONS
1. Which one of the following findings is clinically 
relevant if radiographically testing for causes of 
elbow lameness?
(A) Nutrient foramen
(B) Open growth plates
(C) Mach bands
(D) Panosteitis
2. Which one of the following is NOT part of the 
elbow dysplasia complex?
(A) Ununited anconeal process
(B) Incomplete humeral condylar ossification
(C) Osteochondrosis
(D) Medial coronoid process fragmentation
3. At what age are dogs evaluated in the BVA/KC 
elbow dysplasia scheme?
(A) Only less than 1 year old
(B) Only if older than 1 year
(C) Only younger than 2 years
(D) No age restriction
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From head to tail, 
imaging the 
neurological patient: 
when are radiographs 
still useful?
Francisco Llabrés Díaz 
RADIOGRAPHY
It can be an ideal, quick and versatile technique:
■■ As part of a generic screening in cases of:
 – Suspected or known trauma
 – Suspected toxicity
 – Underlying neoplasia – staging
 – Metabolic or neuromuscular conditions 
(myasthenia gravis – megaoesophagus, 
aspiration pneumonia, underlying thymic 
disease)
■■ In cases where post surgical monitoring following 
the use of implants is being carried out regularly
There is no need to therefore always defer to 
advanced imaging techniques when dealing with neuro-
logical presentations. Conversely, examples where other 
modalities can frequently detect earlier changes include: 
discospondylitis, spondylitis, physitis and vertebral neo-
plasia. Radiography will not be generally recommended 
in cases with a clear suspicion of intracranial disease 
or  neurocompression or for the detailed evaluation of 
vertebral or skull fractures.
ULTRASONOGRAPHY
Ultrasonography is useful when survey imaging is to be 
performed, particularly with traumatic and oncological 
patients. It is also used for the diagnosis of portosystemic 
shunts and guided sampling.
COMPUTED TOMOGRAPHY
Computed tomography (CT) is good for quick and 
detailed screenings. It is particularly useful, however, in 
those cases of trauma, for screening and also in those 
cases with a suspected or known skull or vertebral frac-
tures (detailed fracture evaluation and clarification of the 
state of the neighbouring structures). CT will be quick 
and large haemorrhagic foci should be conspicuous 
through increased attenuation. In these cases, however, 
the evaluation of the brain and spinal cord parenchyma 
for oedema or contusions may be more difficult than 
with magnetic resonance imaging (MRI), particularly if 
the abnormalities are subtle and/or focal.
CT is also useful in chondrodystrophic breeds with 
an acute intervertebral disc extrusion, as the extruded 
material will frequently be mineralized. Conversely, it is 
accepted that non-mineralized disc material is likely to 
need of CT myelography or MRI to be diagnosed. In addi-
tion, CT is more limited than MRI for evaluation of the 
spinal cord for contusions, oedema or malacia.
MAGNETIC RESONANCE IMAGING 
Although it is more often than not the modality of choice, 
the previous paragraphs have hopefully demonstrated 
that each neurological case should be treated individu-
ally and when MRI would be better. Cases with intracra-
nial neurolocalizations or strong clinical suspicions of 
neurocompressive disease will benefit from undergoing 
MRI. The diagnosis of congenital malformations, vascular 
accidents, neoplasia, meningoencephalomyelitis or the 
detailed evaluation of the brain or spinal cord in cases of 
trauma are perfect examples of when MRI is preferred.
KEY LEARNING OBJECTIVES
■■ If one subtracts financial factors as well as 
availability from the choice of imaging technique, 
the use of certain modalities can be strongly linked 
to the clinical presentation/need of therapeutic 
guidance, with advanced imaging then being 
frequently chosen
■■ Radiography can and should still play an 
important role
■■ Advanced imaging is recommended for the 
detailed evaluation of head trauma and cases with 
a very strong clinical suspicion of neurocompressive 
disease
MULTIPLE CHOICE QUESTIONS
1. Which of the following is correct in diagnosis of 
discospondylitis?
(A) Radiography will always detect alterations
(B) Radiography and clinical signs will always 
match their severity
(C) Can only be diagnosed radiographically if 
using myelography
(D) Radiographic signs can vary markedly 
during the acute and chronic phases
2. Which of the following is correct for 
intervertebral disc extrusion?
(A) Is always associated with significant spinal 
cord compression
(B) Can sometimes be diagnosed on plain CT
(C) Can always be diagnosed on plain 
radiographs
(D) Only needs the evaluation of the vertebral 
canal on imaging studies
3. Which of the following is correct concerning 
ventral vertebral periosteal reaction as a 
radiographic finding?
(A) Is always pathological
(B) Is frequently seen from T2 to T4
(C) Can be an indirect sign of neoplastic 
spread
(D) Can be a sign of intervertebral disc extrusion
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Now, your turn: 
interactive orthopaedic 
film reading
Jennifer Kinns
Radiographic interpretation can be an integral part of 
the work-up of small animal orthopaedic patients. This 
 lecture will be a presentation of a series of interesting 
orthopedic cases. The cases will include examples of 
developmental bone disease, radiographic evaluation of 
trauma and fracture healing, some examples of aggres-
sive bone disease and examples of joint disease in canine 
and feline patients. It will be an interactive  session, and 
delegates will be asked their opinion on the findings and 
diagnosis in these cases by means of electronic voting.
KEY LEARNING OBJECTIVES
■■ Review some of the radiographic findings in 
common developmental orthopaedic conditions in 
canine patients
■■ Understand the need for additional views in some 
trauma patients with orthopaedic injury 
MULTIPLE CHOICE QUESTIONS
1. Which additional view would be recommended 
in a patient suspected of having medial 
collateral tarsal instability?
(A) Flexed lateral
(B) Dorsoplantar oblique
(C) Stressed dorsoplantar view 
(D) Flexed skyline projection
2. Which additional view could be used to help 
identify osteochondritis dissecans of the 
canine shoulder?
(A) Lateral oblique
(B) Supinated lateral
(C) Skyline view of the intertubercular groove
(D) Flexed craniocaudal
3. Which joints are most commonly affected by 
rheumatoid arthritis?
(A) Carpus and tarsus
(B) Elbows and stifles
(C) Shoulders and hips
(D) Stifles
■■ Review the radiographic findings in joint-associated 
disease
Now, your turn: 
interactive head and 
neck film reading
Raquel Salgüero
This interactive session will focus on the cases that are 
commonly seen in general practice that affect the head 
and neck. Pathologies of the head and neck are difficult 
to diagnose on radiographs as generally the normal anat-
omy is difficult to understand. Most of the times, advanced 
imaging techniques, such as computed tomog raphy or 
magnetic resonance imaging are needed to achieve a 
definitive diagnosis. This will be a case-based session 
using turning point to help to identify  normal anatomy in 
our patients and pathologies in dogs and cats.
KEY LEARNING OBJECTIVES
■■ Understand the principles of interpretation of head 
and neck radiographs
■■ Identify the most common pathologies seen in 
veterinary practice that can be diagnosed with 
radiographs
■■ Understand which next steps in imaging should be 
used to help achieve a diagnosis
MULTIPLE CHOICE QUESTIONS
1. Which are the most common tumours seen in 
the thyroid glands?
(A) Lymphoma
(B) Carcinoma
(C) Osteosarcoma
(D) Fibrosarcoma
2. Which is the best projection to evaluate the 
tympanic bullae in dogs?
(A) R10° V-Cd DO 
(B) Lateral
(C) Rostrocaudal with an open mouth
(D) Ventro-dorsal
3. What is the most common finding in 
radiographs in cases of nasal aspergillosis?
(A) Destructive rhinitis
(B) Mass effect
(C) Normal appearance
(D) Bilateral increased opacity
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Orthopaedic weird 
and wonderful: an 
interactive radiographic 
journey
Jennifer Kinns
This lecture will be a presentation of a series of the 
more unusual orthopaedic cases. The cases will include 
examples of less common osseous and metastatic neo-
plasia, examples of fungal osteomyelitis, metabolic bone 
disease and congenital bone disease. It will be an inter-
active session, and delegates will be asked their opinion 
on the findings and diagnosis in these cases by means of 
electronic voting.
KEY LEARNING OBJECTIVES
■■ Recognize some of the less common causes of 
aggressive bone disease
■■ Recognize some of the radiographic features of 
metabolic bone disease in small animals
■■ An introduction to the less common congenital 
bone diseases
Now your turn: 
interactive spine film 
reading
Francisco Llabrés Díaz 
Multiple clinical scenarios may benefit from imaging the 
vertebral column and/or the spinal cord. When consider-
ing vertebral or spinal imaging, however, the most likely 
underlying cause may not be particularly clear from 
the clinical presentation. The symptoms and chronicity 
or progression of the clinical signs will need to be con-
sidered when deciding on the imaging modality to 
 recommend. 
The general tendency is to move towards advanced 
imaging modalities to evaluate most of these cases, 
but  plain radiography can still be very useful. Typical 
 examples of this include:
■■ Trauma cases, where a survey of the areas 
suspected of having been damaged can be 
performed quickly and without great expense. 
Follow-up radiographs in cases of implant requiring 
surgery are also useful and routinely obtained
■■ Congenital malformations causing severe 
malangulation of the vertebral column and/or 
associated neurocompression through direct 
vertebral canal narrowing or indirect compression 
(associated secondary disc protrusion, for instance): 
some of these alterations may be associated with a 
dynamic component. This may be easier to test on 
radiography than with other imaging modalities
■■ Dyscospondylitis, physitis, spondylitis: although 
significant mismatches between the severity of the 
inflammatory process and the visible radiographic 
alterations may occur
■■ Metabolic conditions: secondary 
hyperparathyroidism, for instance, causing 
osteopaenia and potentially pathological fractures – 
more often described with nutritionally induced 
forms of the disease
■■ Neoplasia: detectable on plain radiography if there 
is significant bone alteration (can be lysis or new 
bone formation or a combination of both). Both 
primary and metastatic lesions can be detected, but 
not all cases of neoplasia will be associated with 
radiographic alterations
It is important to clarify that cases with a strong 
 suspicion of intervertebral disc extrusion, ischaemic 
 myelopathy, myelitis, epidural empyema or spinal cord 
neoplasia, to cite a few, are likely to benefit from advanced 
imaging sooner rather than later. In addition, if vertebral 
stabilization is to be performed following trauma, advanced 
imaging will offer a far more detailed evaluation of the 
affected vertebrae and the effect of the trauma on the 
geometry of the vertebral canal, to guide reconstruction.
KEY LEARNING OBJECTIVES
■■ The clinical presentation, rather than the imaging 
modality per se, can give you a strong hint as to 
whether plain radiography is potentially useful in 
a case
■■ Whenever possible, magnetic resonance imaging 
(MRI) or computed tomography (CT)/CT 
myelography should be considered ahead of 
myelography
MULTIPLE CHOICE QUESTIONS
1. Which part of the bone is affected by 
mucopolysaccharidosis (type VI) in cats?
(A) Epiphysis
(B) Diaphysis
(C) Metaphysis
(D) All parts are affected
2. Which part of the long bones are most often 
affected by fungal infection?
(A) Epiphysis
(B) Diaphysis
(C) Metaphysis
(D) Cortices
3. Which bones are most typically affected by 
hypertrophic osteopathy?
(A) Metacarpals and phalanges
(B) Long bones
(C) The vertebrae
(D) The pelvis
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■■ Postoperative radiographs can be very useful as a 
baseline for future comparisons or follow-up studies 
in cases where implants have been used
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements about 
diagnosing spinal cord neoplasia is true?
(A) Radiography will always detect  
alterations
(B) Radiography will never detect alterations
(C) Spinal cord neoplasia can only be 
diagnosed radiographically in cases of 
metastases to the spinal cord
(D) Radiographs can help if the vertebral body 
is remodelled
2. Which of the following statements about 
atlanto-axial luxation is true?
(A) Is always associated with alterations on 
plain radiographs
(B) May need dynamic studies to confirm 
instability
(C) Can only be diagnosed on myelography
(D) Only needs the evaluation of the dens of 
the atlas on imaging studies
3. Which of the following statements about a 
young dog involved in a road traffic accident 
and presenting with signs suggestive of 
vertebral column/spinal cord trauma is true?
(A) Should always be evaluated by CT
(B) Should always have the thorax and 
abdomen evaluated regardless of the 
neurolocalization of the lesion
(C) Should be evaluated with CT myelography 
to assess the spinal cord
(D) Should always have the imaging findings 
correlated with the neurological status
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Saturday 6 April
Kingston Theatre
Loco-regional 
anaesthesia
150 08:30–09:15Basic LA plus pharmacology
Jaime Viscasillas
150 09:25–10:10Local anaesthesia equipment
Matt Read
151 11:05–11:50Local blocks in the head
Jaime Viscasillas
152 12:00–12:45Thoracic limb local anaesthetic techniques
Matt Read
153 14:05–14:50Epidural anaesthesia
Jaime Viscasillas
154 15:00–15:45Pelvic limb local anaesthesia techniques
Matt Read
155 16:50–17:35Abdominal and thoracic local anaesthesia techniques
Matt Read
156 17:45–18:30LA and analgesia cases: interactive session
Matt Read and Jaime Viscasillas
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Basic LA plus 
pharmacology
Jaime Viscasillas
Lidocaine, bupivacaine, mepivacaine, procaine, ropiv-
acaine, mepivacaine, levo-bupivacaine, … we have many 
local anaesthetics available, so which one is the best? 
Which one should I buy? Which one should I use? Is the 
most expensive the best one? Fortunately, pharmacology 
will assist in answering every single question.
Initially, we need to understand the mechanism of 
action of local anaesthetics and why they are an excel-
lent tool for pain management. Transmission of pain is 
carried out by means of action potentials transmitted 
along a nerve fibre. Local anaesthetics basically blockthis 
transmission, in a reversible way. 
However, as with every drug we administer, we need 
to know their potential side effects plus how to avoid 
them, and what to do in case we encounter problems. 
Although it is possible to successfully treat systemic toxi-
city, it is undoubtedly better to avoid rather than treat 
complications.
The clinical decision of choosing one local anaes-
thetic over another one will be based on the specific 
clini cal scenario. Do I need a local anaesthetic that works 
very fast? Is the surgery going to be very long? Which 
local anaesthetic technique am I going to use? Again, the 
answers to these questions are based on the pharmacol-
ogy of local anaesthetics.
There are some concepts we need to remember, 
such as the molecular structure of local anaesthetics, 
pKa, solubility, potency, protein binding and concentra-
tion. Understanding these factors will help us decide 
which local anaesthetic is more suitable for each clinical 
scenario.
On top of the intrinsic factors related to the local 
anaesthetics, we can also combine them with other 
drugs in order to change or alter some of their character-
istics. As a well known example, adrenaline is mixed with 
lidocaine to increase the duration of action of the local 
anaesthetic effect. Other drugs which are currently used 
include bicarbonate, alpha-2 agonists, opioids or  steroids. 
This session will outline the advantages and potential 
disadvantages of these combinations.
KEY LEARNING OBJECTIVES
■■ To describe the mechanism of action of local 
anaesthetics
■■ To list the local anaesthetics we can use in small 
animals
■■ To recognize the main factors affecting the effect 
of local anaesthetics
MULTIPLE CHOICE QUESTIONS
1. How does pyothorax alter the efficacy and drug 
choice when applying an intrapleural block?
(A) The tissue is infected so pH of the tissue 
will be acidotic and dissociation of local 
anaesthetics will be compromised
(B) The absorption of the local anaesthetic is 
delayed so the effect will last much longer 
than expected
(C) The effect will depend on the 
concentration of the local anaesthetic: 
high concentration of local anaesthetic 
will work
(D) Local anaesthetics with high solubility 
diffuse much better through the infected 
tissues therefore they are the right choice
2. Which drug administered with bupivacaine will 
NOT increase the duration of the block?
(A) Adrenaline
(B) Medetomidine
(C) Dexamethasone
(D) Buprenorphine
3. Which local anaesthetic is more likely to cause 
systemic reactions?
(A) Lidocaine
(B) Procaine
(C) Bupivacaine
(D) Levo-bupivacaine
Local anaesthesia 
equipment
Matt Read
This session will introduce the learner to the equipment 
that is used to perform regional anaesthesia in small 
 animals. The characteristics of specialized needles will 
be discussed as they relate to performance and safety of 
nerve blocks. The considerations for using nerve stimu-
lation to confirm proximity of the needle to a peripheral 
nerve will be reviewed. The use of ultrasound for perfor-
mance of peripheral nerve blocks will be introduced, 
including the basics of ‘knobology’ (e.g. gain, depth, in-
plane vs. out-of-plane needle approaches).
Many different types of needles can be used for local 
or regional anaesthesia. Needles are generally selected 
based on tip design, length, gauge, absence or presence 
of insulation and/or echogenic characteristics, and clini-
cian preference depending on the size of the patient 
and  the planned block. Each type has its own inherent 
advantages and disadvantages, depending on the block 
being performed.
The shape of the needle tip affects the operator’s 
ability to appreciate the different tissue planes encoun-
tered as the needle is advanced into the patient during 
performance of the block. Hypodermic needles have 
long bevels and sharp edges and are not ideal for per-
forming most peripheral nerve blocks. Blunt needles 
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(e.g. 30-degree or 45-degree bevels, Tuohy needles, etc.) 
are better choices for local and regional anaesthetic 
techniques where multiple tissue planes are expected to 
be penetrated. The blunt design of these needle tips influ-
ences the subjective ‘feel’ of tissue layers as the needle is 
advanced, giving the operator more information about 
needle location in the patient and lessening the chances 
of inadvertently penetrating a vessel or the nerve itself. 
Peripheral nerve stimulators are used in conjunction 
with insulated needles and should be adjustable in terms 
of impulse frequency (Hz), pulse width (milliseconds) and 
current strength (milliamperes). Insulated needles are 
specifically designed for use with a peripheral nerve 
stimulator and are coated with a thin layer of non- 
conductive material over the length of the needle, except 
for a small exposed area at the needle tip. When con-
nected to a peripheral nerve stimulator, the current is 
conducted down the shaft of the metal needle and is 
released at the tip. As the needle is advanced towards the 
nerve, the current that is released from the tip will stimu-
late the target nerve. When this occurs, the operator will 
see contractions (referred to as ‘motor responses’) in the 
muscles that are innervated by the target nerve, assum-
ing the nerve is not strictly sensory in function. The out-
put of the nerve stimulator should be able to be adjusted 
in small increments across the clinically useful range of 
0.1 mA to 1.0 mA, allowing for close approximation of the 
needle-to-nerve distance.
Use of ultrasonography to perform nerve blocks is 
now considered to be the gold standard in people and 
it  is increasingly being used in animals for this same 
 purpose. The advantages of using ultrasonography over 
blind techniques (including nerve stimulation) is that it 
allows the operator to assess the patient’s anatomy prior 
to needle placement, to visualize the target nerve and its 
location relative to other important structures (e.g. blood 
vessels, pleura, etc.), and to observe the local anaesthetic 
spreading around the nerve in real time as it is being 
injected, minimizing the chance for complications such 
as intravascular or intraneural injections.
KEY LEARNING OBJECTIVES
■■ How the characteristics of a needle may affect 
performance of regional anaesthesia
■■ How nerve stimulation can be used to confirm 
proximity of a needle to the target nerve
MULTIPLE CHOICE QUESTIONS
1. Which of the following is CORRECT concerning 
needle selection for regional anaesthesia with 
nerve stimulation?
(A) The use of in insulated needle does not 
affect block success
(B) A needle with a long-bevel allows for 
better ‘feel’ as anatomic structures are 
penetrated
(C) A sharp needle is less likely to traumatize 
the target nerve
(D) The presence of distance markers along 
the needle shaft can be helpful once the 
needle is in situ
2. When using nerve stimulation to perform a 
peripheral nerve block under ultrasound 
guidance, which of the following should you do?
(A) Connect the red lead to the patient, the 
black lead to the needle, set the frequency 
to 2 Hz, and set the current output to 5 ma
(B) Connect the black lead to the patient, the 
red lead to the needle, set the frequency to 
2 Hz, and set the current output to 2 ma
(C) Connect the red lead to the patient, the 
black lead to the needle, set the frequency 
to 1 Hz, and set the current output to 0.5 ma
(D) Connect the black lead to the patient, the 
red lead to the needle, set the frequency to 
1 Hz, and set the current output to 2 ma
3. When using ultrasound guidance to perform 
a nerve block, which of the following should 
you do?
(A) Use the gain controls to help position the 
target nerve in the center of the screen
(B) Orientate the needle so as to approach the 
nerve using as acute an angle as possible
(C) Use an in-plane technique to position the 
tip of the needle adjacent to the nerve
(D) Use a low-frequency probe to obtain the 
best resolution of the image
■■ How to optimize an ultrasound image when 
regional anaesthesia is being performed
Local blocks in 
the head
Jaime Viscasillas
Many surgical procedures are performed in the head of 
small animals: dentals, eye surgery, ear surgery, rhinos-
copy, etc. The knowledge of the anatomy of the head will 
give information about the innervation of this area and 
the nerve(s) we need to block in order to anaesthetize a 
specific region.
But why do we need to use local anaesthesia tech-
niques for these procedures? The local anaesthetics 
will  provide very good analgesia during the surgical 
 procedures, therefore we will be able to decrease/avoid 
other drugs that potentially will cause hypotension (i.e. 
 isofluorane during maintenance). Additionally, many dogs 
and cats coming for dental procedures will be geriatrics, 
therefore kidney or liver function can be altered. Provid-
ing excellent local analgesia will avoid the use of  systemic 
drugs such as non-steroidal anti-inflammatory drugs 
(NSAIDs) or high doses of opioids which can compromise 
the recovery of the patient. Finally, the effect of local 
anaesthetics can last several hours into the postoperative 
period, therefore recovery will be smooth, pain free, 
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and  potentially less analgesic drugs will be needed 
 postoperatively.
Although head surgery is not as common as surgery 
to the rest of the body, many local blocks can be used. 
Several approaches have been described in the veteri-
nary literature for nerve blocks, and knowledge of the 
anatomy of each specific patient will help us deciding 
which approach is most suitable. Additionally, the use of 
some tools, such as ultrasonography, can offer advan-
tages in some patients.
In this lecture we will discuss and describe the use of 
different local blocks in the head, such as mental, inferior 
alveolar, infraorbital, maxillary, auriculotemporal, auricu-
lopalpebral, great auricular nerve blocks and retrobulbar 
block. Most of these techniques are performed blindly 
and require simple and inexpensive equipment (just the 
local anaesthetic, a hypodermic needle and a syringe). 
We will also mention other simpler options for specific 
procedures, such as patients with brachycephalic obs-
tructive airway syndrome (BOAS).
KEY LEARNING OBJECTIVES
■■ To understand the anatomy of the head from an 
anaesthetist’s point of view
■■ To list the main local anaesthesia techniques 
applicable to the head of dogs and cats
MULTIPLE CHOICE QUESTIONS
1. Which block would you use to provide 
analgesia for a rhinoscopy?
(A) Maxillary nerve block
(B) Infraorbital nerve block
(C) Alveolar inferior nerve block
(D) Mental nerve block
2. How many approaches have been described 
for the maxillary nerve block?
(A) 1
(B) 2
(C) 3
(D) 4
3. Which nerve or nerves do you need to block in 
order to provide analgesia for a total ear canal 
ablation?
(A) Auriculotemporal and auriculopalpebral 
nerve
(B) Auriculotemporal and great auricular nerves
(C) Auriculopalpebral and great auricular nerves
(D) We cannot do any block for that surgery
■■ To discuss the clinical scenarios where these 
techniques can be used
Thoracic limb local 
anaesthetic techniques
Matt Read
This session will introduce the learner to the clinically 
 relevant aspects of performing regional anaesthesia of 
the thoracic limb of small animals. Relevant anatomy will 
be reviewed and some of the newer techniques that are 
used to perform regional anaesthesia of the thoracic 
limb (e.g. brachial plexus blocks, RUMM blocks) will be 
discussed.
Many potentially invasive and painful surgical pro-
cedures are performed on the thoracic limb, making it 
important to be able to safely and effectively provide 
local and regional anaesthesia to this part of the body. In 
the past, blind approaches to the brachial plexus and 
other peripheral nerves of the limb were described, with 
varying levels of success despite the large volumes of 
drug that were recommended. Recently, development of 
techniques that use nerve stimulation and/or ultrasonog-
raphy to perform nerve blocks have resulted in much 
higher success rates with relatively small volumes of local 
anaesthetic.
In terms of regional anaesthesia, the nerves of the 
 distal limb that are most relevant to sensory and motor 
function are the musculocutaneous, radial, median and 
ulnar nerves. These main nerves (or their roots) can be 
blocked using one of several different techniques using 
nerve stimulation and/or ultrasonography. Blind tech-
niques are not usually associated with good success and 
are generally not recommended. Although nerve stimula-
tion is still considered to be a blind technique, the ability to 
induce motor responses in target muscle groups (e.g. 
elbow flexion as a result of biceps muscle contraction 
resulting from musculocutaneous nerve stimulation) does 
allow the operator to assume some degree of needle-to-
nerve proximity prior to injection of the local anaesthetic. 
Blocking the nerves in the brachial plexus using an axillary 
approach with nerve stimulation will typically result in 
anaesthesia of the thoracic limb distal to the humerus.
With ultrasonography, the individual nerves and 
associated blood vessels of the brachial plexus can be 
visualized, allowing the operator to position the needle 
tip adjacent to the target nerves without causing inad-
vertent injury to the patient. Visualizing the nerves also 
allows the operator to reposition the needle between 
injections instead of simply injecting a large volume at 
one location and hoping it reaches all of the nerves. This 
allows the local anaesthetic to be deposited more 
 precisely and the volume of drug potentially to be lower 
than when blind techniques are used. Depending on the 
technique that is used, use of ultrasonography for perfor-
ming a nerve block will typically result in anaesthesia of 
the thoracic limb distal to the scapula.
The radial, ulnar, median and musculocutaneous 
nerves can also be blocked at a more distal location, 
avoiding needle placement near the major vessels of the 
limb in the axilla. Although blind techniques at this 
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 location result in variable efficacy, use of ultrasonogra-
phy to visualize the nerves prior to injection can result in 
higher levels of success. Many people find a RUMM block 
easier to perform than a brachial plexus block due to the 
more superficial location of the target nerves and the 
distance of the nerves from other important structures. 
With ultrasonography, the individual nerves can be visu-
alized proximal to the elbow on the lateral (R) and medial 
(UMM) sides of the limb, allowing the operator to position 
the needle tip adjacent to the target nerves. Performing a 
RUMM block will typically result in anaesthesia of the 
limb distal to the elbow, making it very useful for a range 
of commonly performed surgical procedures.
KEY LEARNING OBJECTIVES
■■ Describe the anatomy that is considered relevant 
when performing peripheral nerve blocks of the 
thoracic limb
■■ Name two different regional anaesthetic techniques 
that can be used to provide anaesthesia and 
analgesia to the thoracic limb
■■ List the equipment and provide the name of a drug 
and the dose/volume that is required to perform 
each of these techniques
(A) Suprascapular, subscapular, 
brachiocephalicus, radial and 
musculocutaneous
(B) Suprascapular, subscapular, 
musculocutaneous, radial, axillary, medial 
and ulnar
(C) Brachiocephalicus, suprascapular, 
musculocutaneous, radial, medial  
and ulnar
(D) Musculocutaneous, radial, axillary, median 
and ulnar
2. Which of the following techniques could be 
used to provide anaesthesia for a radial 
fracture?
(A) RUMM block
(B) Sciatic nerve block
(C) Intercostal nerve block
(D) Transversus abdominis plane block
3. When approaching the radial nerve with a 
needle, which of the following would likely be 
the most difficult to perform?
(A) Approaching the nerve from a lateral-to-
medial direction
(B) Approaching the nerve from a cranial-to-
caudal direction
(C) Approaching the nerve from a caudal-to-
cranial direction
(D) It does not matter since the nerve can be 
approached easily from any direction
MULTIPLE CHOICE QUESTIONS
1. Which of the following nerves are responsible 
for providing sensory innervation to the 
thoracic limb?
Epidural anaesthesia
Jaime Viscasillas
Let’s do an epidural! Easy! But … which approach? Which 
drug? Which volume? Which concentration? Which 
equipment should I use? In which patients should I avoid 
the epidural route? Which side effects can I have and how 
can I avoid them? Single injection or epidural catheter? 
Where should I leave the tip of the catheter? How can I 
know if I am in the epidural space? The needle is in the 
subarachnoid space, what should I do? 
As we know, the epidural route is one of the most 
effective ways to provide analgesia in our patients. In 
fact, in human anaesthesia it is the gold standard for 
many surgical procedures, so why is it less popular in 
 veterinary anaesthesia? It can be used to control pain in 
surgical procedures, medical conditions, such as pancre-
atitis, or even chronic pain. Additionally, the epidural 
space runs from the head to the tail, so potentially it is a 
good route to treat pain in different locations ,such as 
tail, hind limbs, abdomen, thorax and even neck. It is 
important to understand the anatomy of the epidural 
space to recognize the advantages/disadvantages of the 
different approaches we can use to reach the epidural 
space. 
The epidural technique is considered an easy tech-
nique to be performed in the majority of cases. The most 
reported/used approach is the lumbosacral approach, 
where we have a big ‘window’ to reach the epidural 
space. However, we could use other approaches (i.e. 
sacrococcygeal, between T13 and L1 vertebrae, etc.) 
once we have enough experience with the lumbosacral 
approach. It is important to appreciate different app-
roaches since they can be used to provide analgesia to 
specific areas or for when the the lumbar approach is not 
an option (i.e. obesity, dermatitis, etc.).
We need to try to clarify all these questions and get 
the most out of the epidural analgesia for our patients. 
KEY LEARNING OBJECTIVES
■■ To discuss the different factors which need to be 
taken into account when performing an epidural 
technique
■■ To summarize the potential side effects and what to 
do if they happen
■■ To describe potential clinical uses of epidural 
anaesthesia
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MULTIPLE CHOICE QUESTIONS
1. Which are the main differences between spinal 
(subarachnoid) and epidural anaesthesia?
(A) Spinal anaesthesia has a faster onset of 
action, is more potent but does not last as 
long as epidural injection
(B) In dogs and cats the dural sac ends at the 
level of L7
(C) The volume of the drug administered in 
the epidural space must be half of the one 
administered in the subarachnoid space
(D) Epidural anaesthesia is contraindicated in 
patients with obesity and abnormal 
anatomy 
2. At which level would you put the tip of an 
epidural catheter in order to control pain in 
severe pancreatitis if local anaesthetics are 
going to be used?
(A) It does not matter
(B) At any point between L5 and L7
(C) At any point between T3 and T5
(D) At any point between T12 and L1
3. Which technique is currently not recommended 
to confirm the correct position of the tip of the 
needle inside the epidural space?
(A) Ultrasonography
(B) Lack of resistance to injection of air
(C) Lack of resistance to injection of saline
(D) Neurostimulation
Pelvic limb local 
anaesthesia techniques
Matt Read
This session will introduce the learner to the clinically 
 relevant aspects of performing regional anaesthesia of 
the pelvic limb of small animals. Relevant anatomy will be 
reviewed and some of the newer techniques used to per-
form regional anaesthesia of the pelvic limb (e.g. femoral 
nerve block, saphenous nerve block, sciatic nerve block) 
will be discussed.
Many potentially invasive and painful surgical proce-
dures are performed on the pelvic limb, making it impor-
tant to be able to provide local and regional anaesthesia 
safely and effectively to this part of the body. Innervation 
to the pelvic limb is provided primarily by the femoral and 
sciatic nerves, although the obturator and other nerves 
may also contribute some sensory function in some 
patients. The femoral nerve can be blocked at a proximal 
location as it courses through the psoas muscle or at a 
more distal location as it passes through the inguinal 
region alongside the femoral artery and vein. The sciatic 
nerve can be blocked anywhere along its course, but is 
most commonly blocked using nerve stimulation as it 
runs between the greater trochanter of the femur and 
the  ischiatic tuberosity, or using ultrasonography as it 
runs distally down the limb, deep to the biceps femoris 
muscle. 
Although blind approaches to blocking the femoral 
and sciatic nerves have been described, they generally 
result in low levels of success despite the large volumes 
of drug being injected. As a result, they have not been 
widely adopted by practitioners to any degree and epi-
dural or spinal anaesthesia currently remain the most 
common techniques for providing anaesthesia and anal-
gesia to the pelvic limb. However, over the past 10 years, 
a number of different techniques for performing femoral 
and sciatic nerve block using nerve stimulation and/or 
ultrasonography have been reported. Ultrasonography 
can easily be used to visualize the individual nerves of the 
pelvic limb, allowing the operator to position the needle 
tip adjacent to the target nerves. Visualizing the nerves 
also allows the operator to reposition the needle between 
injections instead of simply injecting a large volume at 
one location and hoping it reaches all of the nerves. 
Depending on the technique that is used, ultrasound-
guided blocks typically result in anaesthesia of the pelvic 
limb distal to the mid-femur, making these techniques 
useful for a range of commonly performed surgical 
 procedures.
Although most people think about the femoral nerve 
when considering the innervation of the pelvic limb, its 
sensory component, the saphenous nerve, is becoming 
much more relevant to regional anaesthesia as a result of 
us being able to visualize the nerve with ultrasonography. 
An important factor when considering how to perform a 
saphenous nerve block is the fact that the saphenous 
nerve is strictly sensory in function. As such, it is not pos-
sible to elicit a motor response when using nerve stimu-
lation so it is impossible to approximate needle-to-nerve 
distance unless ultrasonography is used. For this reason, 
landmark-based approaches to blocking this nerve have 
generally been unsuccessful. Now that we can use ultra-
sonography to visualize the saphenous nerve and posi-
tion the needle close to it, we can use this technique as 
an alternative to the other types of femoral nerve blocks, 
allowing sensory function to be blocked but motor func-
tion to that part of the pelvic limb to be spared.
KEY LEARNING OBJECTIVES
■■ Describe the anatomy that is considered relevant 
when performing peripheral nerve blocks of the 
pelvic limb
■■ Name three different regional anaesthetic 
techniques that can be used to provide anaesthesia 
and analgesia to parts of the pelvic limb
■■ List the equipment and provide the name of a drug 
and the dose/volume that is required to perform 
each of these techniques
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MULTIPLE CHOICE QUESTIONS
1. Following injection of a local anaesthetic into 
the iliopsoas muscle under ultrasound guidance, 
which of the following nerve(s) will be 
desensitized?
(A) The sciatic nerve
(B) The femoral and/or obturator  
nerves
(C) The femoral and/or sciatic nerves
(D) The sciatic and/or obturator  
nerves
2. You are preparing to perform a femoral nerve 
block using an inguinal approach and 
electrolocation. Which of the following is 
correct?
(A) The femoral nerve is located cranial to the 
arterial pulse
(B) The femoral nerve is located caudal to the 
arterial pulse
(C) The femoral nerve is located superficial to 
the arterial pulse
(D) The femoral nerve is located deep to the 
arterial pulse
3. When approaching the sciatic nerve from a 
caudal direction using an ultrasound-guided 
technique with electrolocation, which of the 
following are you most likely to do?
(A) Stimulate the tibial branch of the sciatic 
nerve first, eliciting dorsiflexion of the 
tarsus and paw
(B) Stimulate the peroneal branch of the 
sciatic nerve first, eliciting dorsiflexion of 
the tarsus and paw
(C) Stimulate the tibial branch of the sciatic 
nerve first, eliciting plantar extension of 
the tarsus and paw
(D) Stimulate the peroneal branch of the 
sciatic nerve first, eliciting plantar 
extension of the tarsus and paw
Abdominal and 
thoracic local 
anaesthesia techniques
Matt Read
This session will introduce the learner to the clinically rel-
evant aspects of performing local and regional anaes-
thesia of the thoracic and abdominal walls of small 
animals. Relevant anatomy will be reviewed and some 
of the newer approaches to performing regional anaes-
thesia of the trunk and abdomen limb (e.g. intercostal 
nerve block, thoracic paravertebral block, transversus 
abdominis plane (TAP) block) will be discussed.
Many potentially invasive and painful surgical proce-
dures are performed on the thorax and abdomen, mak-
ing it important to be able to provide local and regional 
anaesthesia safely and effectively to these parts of the 
body. Sensory function to the trunk relies on innervation 
by spinal nerves. Since there is overlap between adjacent 
spinal nerves in terms of the areas they innervate, it is 
important to use a technique that does not result in 
blockade of a single nerve, otherwise the block may fail 
to achieve its intended purpose.
For many years, regional anaesthesia of the lateral 
thorax has been accomplished with intercostal nerve 
blocks. Using this technique, several consecutive nerves 
are blocked with local anaesthetic at a mid-thoracic level 
(from dorsal to ventral), caudal to each rib. The technique 
can be performed blindly, with nerve stimulation, or 
with  ultrasound guidance. Unfortunately, performing 
intercostal nerve blocks in this way may not be entirely 
 effective for many patients, since this approach only 
blocks the ventral branches of the segmental spinal 
nerves, making it ineffective for providing anaesthesia for 
dorsal parts of the chest wall. For this reason, the recent 
development of an ultrasound-guided technique for 
depositing a local anaesthetic into the thoracic paraver-
tebral space has been met with great interest. Different 
approaches to this block have previously been described 
in people and it has been used for providing excellent 
anaesthesia for thoracic procedures for many years. 
Using this ultrasound-guided technique in dogs, several 
spinal nerves can be blocked at a location close to their 
point of exit from the vertebral canal, allowing the local 
anaesthetic to block both the dorsal and ventral branches 
of the nerves and making the block more versatile for a 
range of procedures.
One of the most common parts of the body to 
undergo surgery is the abdomen. The simplest form of 
locoregional anaesthesia to this area involves the admin-
istration of a local anaesthetic solution into the tissues of 
the ventral abdominal wall along the planned surgical 
site, commonly referred to as a ‘line’ or an ‘incisional’ 
block. Depending on the drug and the volume of local 
anaesthetic that is used, this approach has been shown 
to result in variable levels of success. Recently, a block 
that works well in people has been developed for use in 
small animals. The TAP block is a muscle plane block 
and, when performed bilaterally, can provide anaesthesia 
to the abdomen for a variety of procedures. Using this 
technique, ultrasound is used to visualize the muscles 
of  the abdominal wall and a needle is introduced into 
the  interfascial space between the internal abdominal 
oblique muscle and the transversus abdominis muscle. 
When done correctly, as the local anaesthetic solution is 
injected, the space will distend with the drug solution and 
the nerves that run through the space will be blocked.
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KEY LEARNING OBJECTIVES
■■ Describe the anatomy that is considered relevant 
when performing peripheral nerve blocks of the 
chest and abdomen
■■ Name three different regional anaesthetic 
techniques that can be used to provide anaesthesia 
and analgesia to the chest and abdomen
■■ List the equipment and provide the name of a drug 
and the dose/volume that is required to perform 
each of these techniques
MULTIPLE CHOICE QUESTIONS
1. Which of the following techniques would be 
most likely to provide dense and long-lasting 
unilateral anaesthesia for surgery involving the 
dorsal chest wall and thorax?
(A) Lumbosacral epidural anaesthesia 
performed using a local anaesthetic
(B) TAP blocks performed using a local 
anaesthetic
(C) Multilevel intercostal nerve blocks using a 
local anaesthetic
(D) Multilevel thoracic paravertebral blocks 
using a local anaesthetic
2. When performing a TAP block, where is the the 
local anaesthetic injected?
(A) Between the external oblique and internal 
oblique muscles
(B) Between the internal oblique and 
transversus abdominis muscles
(C) Between the transversus abdominis 
muscle and peritoneum
(D) Between the rectus abdominis and 
external oblique muscles
3. Which of the following is correct when 
performing intercostal nerve blocks?
(A) The needle should be carefully walked off 
the caudal aspect of each rib
(B) The needle should be carefully walked off 
the cranial aspect of each rib
(C) An opioid such as morphine should be 
injected into the area around the target 
nerve(s)
(D) Inadvertent injection of the drug into the 
pleural space will have no effect on block 
success
LA and analgesia cases: 
interactive session
Matt Read and Jaime Viscasillas
This session will use case examples to illustrate how 
novel local anaesthetic techniques can be used to con-
tribute to multimodal pain management in small animal 
patients. The use of indwelling perineural catheters will 
be discussed, as well as the use of a new formulation of 
local anaesthetic that has recently been made available 
for augmenting postoperative pain control. Delegates 
will be challenged to think about how they might be able 
to incorporate non-traditional methods of local anaes-
thesia into their own practice.
Several different approaches have been used in peo-
ple and animals in attempts to prolong the beneficial 
analgesic effects of locoregional anaesthetic techniques 
for perioperative pain control. Until now, this has typi-
cally been achieved by either adding another agent to the 
local anaesthetic solution prior to its administration, or 
using special equipment, such as indwelling catheters to 
continuously or intermittently deliver a local anaesthetic 
solution into the affected area.
The use of epidural and peripheral nerve catheters 
is  gaining popularity in veterinary medicine. Epidural 
catheters can be used to provide analgesia for surgical 
and non-surgical cases and the advantages and disad-
vantages of their use have previously been documented. 
More recently, the use of peripheral nerve catheters (e.g. 
brachial plexus, lumbar plexus or sciatic nerve) has been 
reported. Advantages to their use include providing 
 analgesia that is limited to the area that is innervated by 
that nerve/plexus and the ability to individualize the local 
anaesthetic solution that is administered through the 
catheter (i.e. volume, concentration, dosing interval) for 
the patient. Ultimately, these characteristics allow us to 
obtain good analgesia with minimal motor blockade. 
However, these techniques are still not commonly used, 
and training and continuous monitoring of the patient 
are needed in order to achieve positive outcomes.
Based on the limitations of using the above tech-
niques, a new, novel local anaesthetic formulation has 
recently become available in the USA for use in people 
and animals and its use will probably spread to other 
parts of the world in the near future. Liposome- 
encapsulated bupivacaine is a specially formulated local 
anaesthetic that slowly releases active bupivacaine from 
the site of injection over several days. This drug was orig-
inally approved for administration as a field block into the 
surgical site at the time of surgery. Since the new formu-
lation of the drug does not spread from the site of injec-
tion, it needs to be administered as multiple, small 
injections into all of the tissues of the surgical layers at 
the time of incisional closure, as opposed to a larger vol-
ume at only one or two sites. This new formulation has 
been shown to provide pain relief for up to 72 hours fol-
lowing a single dose in dogs and cats (and people) and is 
an excellent alternative to opioid-based analgesia for a 
variety of surgical procedures. Although it was initially 
approved only for infiltration use following cruciate repair 
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surgery in dogs, it has recently been approved for perineu-
ral use as well, opening up exciting new possibilities for 
providing multimodal pain management to our patients.
Finally, local anaesthetic techniques are commonly 
used in human medicine to treat chronic pain or to pro-
vide palliative care analgesia. As such, some of the perio-
perative techniques that we already apply in animals can 
be used as an alternative to systemically administered 
drugs in some of our patients, simply by changing the 
drugs that we administer with the block. Epidural injec-
tion of steroids is already an accepted technique to treat 
lumbosacral pain in dogs. Use of ultrasound-guided 
nerve root injections may prove to be another technique 
for providing analgesia to veterinary patients with chronic 
pain that are not good candidates for surgical treatment. 
KEY LEARNING OBJECTIVES
■■ Name a new local anaesthetic formulation that can 
provide up to 72 hours of analgesic effect
■■ Describe the indications for, and limitations of, using 
peripheral nerve catheters to manage perioperative 
pain
■■ Identify clinical scenarios in which to use local 
anaesthetic techniques for chronic pain 
management
MULTIPLE CHOICE QUESTIONS
1. Which is the most common complication related 
to the use of brachial plexus catheters in dogs?
(A) Catheter dislodgement
(B) Hypotension
(C) Nerve damage
(D) Infection
2. Which of the following statements about 
liposome-encapsulated bupivacaine is correct?
(A) It cannot be combined with any other drug 
or electrolyte solution
(B) It should be administered as a large 
volume at a single site
(C) It is designed to slowly release lidocaine 
over 72 hours
(D) It is approved for both perineural and 
infiltration use
3. How long do the analgesic effects of a nerve 
root injection with a steroid typically last?
(A) Between 1 week and 1 month
(B) Up to 6 months
(C) It depends on the patient
(D) No more than a year
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Sunday 7 April
Hall 4
Cardiology
162 09:00–09:45Cardiac therapeutics: atrioventricular valve disease
Sonya Gordon
163 09:55–10:40Cardiac therapeutics: feline cardiology
Kieran Borgeat
164 11:15–12:00Cardiac therapeutics: dilated cardiomyopathy
Sonya Gordon
165 12:10–12:55Cardiac therapeutics: medical treatment of arrhythmias  
(in dogs with dilated cardiomyopathy)
Sonya Gordon
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Cardiac therapeutics: 
atrioventricular valve 
disease
Sonya Gordon
Chronic atrioventricular valve disease (CVD) is the most 
common cause of heart disease and heart failure in the 
dog, accounting for approximately 75% of all canine 
heart disease. Older small-breed dogs are predisposed, 
but older large breeds are also at risk. The aetiology of 
CVD is unknown. CVD pathophysiology is characterized 
by myxomatous degeneration of the mitral valve, and can 
also involve the tricuspid valve (30%) and associated 
chordae tendinae. Progressive degeneration leads to 
increasing severity of regurgitation and associated atrial 
and ventricular dilatation. 
Progression of the preclinical stage of CVD is typi-
cally slow, lasting years, however some individual dogs 
may experience more rapid progression. A staging 
scheme for CVD was introduced in the 2009 ACVIM 
Consensus Statement and has been widely adopted in 
veterinary medicine. 
CLASSIFICATION SCHEME FOR CHRONIC 
ATRIOVENTRICULAR VALVE DISEASE
The ABCD classification scheme incorporates the pres-
ence and absence of signs of heart disease or heart fail-
ure with structural heart changes and provides a platform 
for discussion of both diagnosis and treatment of CVD. 
■■ Stage A dogs are at increased risk for developing or 
currently having preclinical heart disease. Stage A 
dogs are normal (asymptomatic and with no 
identifiable structural disorder of the heart)
■■ Stage B dogs have heart disease but have never 
developed clinical signs caused by heart disease (i.e. 
asymptomatic). Because there are important clinical 
implications for prognosis and treatment, this stage 
is subdivided into B1 and B2:
 – Stage B1 refers to asymptomatic dogs that have 
no radiographic or echocardiographic evidence 
of chamber enlargement
 – Stage B2 refers to asymptomatic dogs that 
demonstrate evidence of chamber enlargement
■■ Stage C dogs have either historical or current 
clinical signs of heart failure secondary to 
atrioventricular valve disease
■■ Stage D represents the end-stage of heart failure 
when dogs suffer from clinical signs that are 
refractory to ‘standard therapies’
STAGE-BASED MANAGEMENT STRATEGIES
Stage A patients will benefit from annual auscultation to 
detect if and when they develop a murmur characteristic of 
atrioventricular valve disease. Once a characteristic mur-
mur is detected the dog is considered stage B and imaging 
(e.g. echocardiography, thoracic radiographs) is  recom-
mended to determine if the heart is enlarged (stage B2) or 
not (stage B1). In stage B1, recommendations for therapy 
are not currently warranted and emphasis is on scheduled 
follow-up evaluation and client education. Stage B2 is 
characterized by heart enlargement and based on the 
results of the EPIC study, pimobendan is recommended if 
the degree of heart enlargement is sufficient in magnitude. 
Recommendations for stage C dogs are predominantly 
evidence based and multimodal, including a combination 
of furosemide, pimobendan, spironolactone and an 
angiotensin- converting enzyme inhibitor. Recommenda-
tions for stage D are often symptom-specific. All stages 
benefit from scheduled follow-up and client  education.
KEY LEARNING OBJECTIVES
■■ Know how to use the ABCD staging scheme for 
chronic atrioventricular valve disease (CVD) and 
understand how the classification scheme supports 
a logical approach to diagnostic, therapeutic and 
follow-up recommendations
■■ Review the new evidence-based recommendations 
for treatment of dogs with preclinical CVD
■■ Review recommendations for treatment of dogs 
with congestive heart failure secondary to CVD
MULTIPLE CHOICE QUESTIONS 
1. With respect to pimobendan treatment, which 
of the following is a current recommendation 
in dogs with CVD? Pimobendan treatment is 
indicated in dogs with CVD stage: 
(A) Stage B2 
(B) Stage B1 
(C) Stage A 
(D) None of the above
2. What therapy(s) is/are recommended in dogs 
with stage C CVD?
(A) Pimobendan
(B) Furosemide
(C) Benazepril
(D) All of the above
3. Which diagnostic test is recommended to 
assess heart size in dogs with stage B CVD?
(A) Echocardiogram
(B) Thoracic radiographs
(C) Systemic blood pressure
(D) Electrocardiogram
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Cardiac therapeutics: 
feline cardiology
Kieran Borgeat
EVIDENCE BASE AND CONSENSUS 
IS LACKING
In an era of evidence-based medicine, feline cardiology 
still lacks a good foundation of published therapeutic 
 trials to justify decision making in treatment. In the 
absence of evidence, the profession looks to expert 
 consensus to pull together our approach. Sadly, consen-
sus and evidence are out for lunch, so we are left with 
opinion and extrapolation. Herein, we will review my 
personal approach, and that of my department and some 
colleagues at other centres.
TREATMENT BEFORE SIGNS OF 
CONGESTIVE HEART FAILURE
Left ventricular outflow tract obstruction
In humans, left ventricular outflow tract obstruction 
(LVOTO) has been associated with clinical signs. This 
seems to be rare in cats, save those which present with 
syncope or open-mouth breathing after exercise or play. 
Atenolol, a beta-blocker, has been used to reduce the 
severity of LVOTO – however, one study (non- randomized, 
not blinded), suggested that there was no effect of 
atenolol treatment on 5-year outcome. In our clinic, we 
reserve atenolol, therefore, for the cats which appear to 
have  clinical signs associated with exertion.
Left atrial dilation with poor function
Cats with left atrial (LA) dilatation and poor LA function 
are at greater risk of arterial thromboembolism (ATE). The 
FATCAT trial (2015) identified that cats with ATE live 
longer if treated with clopidogrel vs. aspirin, so we pre-
scribe clopidogrel (18.75 mg orally q24h) to cats that we 
consider to be at risk of ATE, owing to LA dysfunction or 
the presence of spontaneous echocontrast.
Systolic dysfunction
Cats with systolic left ventricular (LV) dysfunction can be 
treated similarly to dogs with preclinical dilated cardiomy-
opthy (DCM); by using pimobendan (generally 1.25 mg/cat 
orally q12h). Pimobendan is not only not licensed for cats, 
but is stated to be ‘contraindicated’ in diseases where 
LVOTO may be present. It is rare for us to prescribe it in 
cats with LVOTO on echo – if you are not confident in 
assessing obstruction on echo, it may be worth being 
 cautious if the cat has a grade II–III or louder murmur; 
presume that LVOTO is present and avoid pimobendan.
TREATING THE CAT WITH HEART FAILURE
Atenolol is contraindicated, regardless of the presence 
or  absence of LVOTO – it will make heart failure signs 
worse. Clopidogrel should be used as before, and 
pimobendan if systolic dysfunction is present (without 
significant obstruction).
Pleural effusion should be drained via thoraco-
centesis and followed by injectable diuretics. Pulmonary 
oedema should be treated with parenteral furosemide, 
followed by oral dosing. Emergency patients should be 
handled with care, treated by sedation and oxygen ther-
apy, as well as injectable diuretics. At discharge, we aim 
for furosemide (1–2 mg/kg orally q12h), combined with 
clopidogrel at least. The use of angiotensin-converting 
enzyme inhibitors (such as benazepril) in cats is an added 
extra; no evidence of clinically meaningful benefit has 
been published, despite some trials having been under-
taken. We prescribe this if the cat is tolerating medication 
well and additional cost is no object. If hypokalaemia 
becomes an issue, or additional diuretics are required, 
spironolactone (2 mg/kg orally q24h) may prove useful.
KEY LEARNING OBJECTIVES
■■ Understand the rationale for drug selection in cats 
with heart failure
■■ Appreciate the ethical considerations of treating 
arterial thromboembolism in cats and how to select 
patients with the best survival probability to treat
■■ Identify cats with preclinical heart disease that may 
benefit from treatment with an anti-platelet drug
MULTIPLE CHOICE QUESTIONS
1. Cats with left ventricular outflow tract 
obstruction and clinical signs of syncope or 
exertional tachypnoea may rationally be 
treated with which of the following?
(A) Diltiazem
(B) Atenolol
(C) Clopidogrel
(D) Benazepril
2. When may pimobendan be used in cats with 
systolic dysfunction?
(A) Left atrial function on echo is poor
(B) The left ventricular dilation is present
(C) Furosemide is already prescribed
(D) Outflow tract obstruction is absent
3. Spironolactone may be useful in a cat with 
which of the following?
(A) Preclinical hypertrophic cardiomyopathy
(B) Escalating furosemide dose or 
hypokalaemia
(C) Pleural effusion caused by pericardial 
disease
(D) A history of syncope associated with exertion
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Cardiac therapeutics: 
dilated cardiomyopathy
Sonya Gordon
CLASSIFICATION SCHEME FOR DILATED 
CARDIOMYOPATHY
■■ Stage A dogs have an increased risk of developing or 
having dilated cardiomyopathy (DCM). Stage A dogs 
are normal (asymptomatic with no identifiable 
structural disorder of the heart)
■■ Stage B dogs have DCM but have never developed 
clinical signs attributable to DCM (i.e. asymptomatic/
preclinical). Because there are important implications 
for prognosis and treatment, stage B is subdivided 
into B1 and B2: 
 – Stage B1 dogs have arrhythmias and no evidence 
chamber enlargement 
 – Stage B2 dogs demonstrate evidence of chamber 
enlargement with or without concurrent 
arrhythmias
■■ Stage C dogs have either historical or current clinical 
signs of congestive heart failure (CHF) secondary to 
DCM with or without concurrent arrhythmias
■■ Stage D dogs suffer from clinical signs that are 
refractory to ‘standard therapies’
DIAGNOSIS 
Stage A
Stage A dogs should undergo echocardiographic screen-
ing when findings suggestive of DCM are detected in 
adult large- and giant-breed dogs based on history (e.g. 
mild exercise intolerance or syncope, unintended weight 
loss, mild increase in respiratory rate or effort) or physical 
examination (e.g. weak pulse, pulse deficits, arrhythmia, 
systolic murmur, gallop heart sounds), or annually in adult 
high-risk breeds.
Preclinical (stage B)
Definitive diagnosis and when to initiate therapy requires 
an echocardiogram and often an electrocardiogram 
(ECG)/Holter to detect/assess arrhythmias. Baseline 
 radiographs for future comparison may also be useful. 
Additional diagnostic tests may also be indicated in some 
cases. A chemistry and blood pressure assessment may 
also be warranted prior to therapy.
Clinical/congestive heart failure (stage C)
For definitive diagnosis of CHF, thoracic radiographs are 
required. For identification of the aetiology of CHF an 
echocardiogram is indicated and often an ECG/Holter. 
Other tests such as chemistry and blood pressure are 
also indicated. 
TREATMENT
Stage A
Treatment is not recommended.
Stage B1
Treatment is typically not recommended, rather  emphasis 
is on scheduled follow-up evaluation and client educa-
tion. However, if a significant arrhythmia is documented, 
therapy may be indicated. 
Stage B2
Pimobendan +/– angiotensin-converting enzyme inhib-
itors (ACEI) and anti-arrhythmics as indicated.
Stage C
Abdomino- or pleurocentesis as needed, furosemide, 
pimobendan, ACEI, spironolactone and anti-arrhythmics 
as indicated.
FOLLOW-UP
General comments
Owners should be made aware of the value of scheduled 
follow-up and what signs are associated with disease 
 progression/decompensation and thus warrant an 
unscheduled/emergency follow-up appointment. In 
addition, owners should be instructed to record weekly 
(stage B1) and daily (stage B2, C, D) home resting/sleeping 
respiration rates. 
Stage B1
Repeat echocardiogram +/– ECG/Holter in 6 months to 
assess disease progression or sooner if indicated. 
Stage B2
Recheck approximately every 6 months or sooner if 
 indicated. Rechecks typically include a thorough history 
and physical examination, thoracic radiographs,  systemic 
blood pressure and routine blood work. An ECG/Holter 
is  indicated if signs suggestive of a new or progressive 
arrhythmia develop. Otherwise an annual Holter is 
 recommended. 
Stage C
Follow-up is similar to that for stage B2 with the excep-
tion of the recheck frequency which is every 3–4 months 
or sooner if indicated.
KEY LEARNING OBJECTIVES
■■ Know how to use the ABCD staging scheme for 
dilated cardiomyopathy (DCM)
■■ Review the recommendations for treatment of dogs 
with preclinical DCM
■■ Review recommendations for treatment of dogs with 
congestive heart failure (CHF) secondary to DCM
MULTIPLE CHOICE QUESTIONS 
1. With respect to pimobendan treatment, which 
of the following is a current recommendation 
in dogs with DCM? Pimobendan treatment is 
indicated in dogs with DCM stage: 
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(C) Benazepril
(D) All of the above
3. Which finding(s) are suggestive of DCM in an 
older large-breed dog and warrant 
recommendation of an echocardiogram?
(A) Gallop heart sounds
(B) Arrhythmia (non-sinus)
(C) Weak pulses
(A) Stage B2
(B) Stage B1 
(C) Stage A 
(D) None of the above
2. What therapy(s) is/are recommended in dogs 
with congestive heart failure secondary to DCM?
(A) Pimobendan
(B) Furosemide
Cardiac therapeutics: 
medical treatment of 
arrhythmias (in dogs 
with dilated 
cardiomyopathy)
Sonya Gordon
DIAGNOSIS OF VENTRICULAR 
ARRHYTHMIA
Diagnosis of complex ventricular arrhythmia (VA) maybe 
suspected based on a history of exercise intolerance or 
collapse or represent an incidental finding on physical 
examination of dogs with any stage of dilated cardiomy-
opathy (DCM). The definition of complex VA is typically 
reserved for VA characterized by one or more of the 
 following: multiform, runs, triplets, pairs or a bigeminal 
pattern, frequent single ventricular premature complexes 
(VPCs) (>10% total beats on Holter) or extremely prema-
ture VPCs (instantaneous heart rate (HR) >180 bpm). 
Once complex VAs are suspected, evaluation of the 
 cardiac rhythm is indicated. A resting electrocardiogram 
(ECG) may confirm complex VA but in some cases a 
Holter (24-hour ambulatory ECG) will be required to both 
confirm the diagnosis and evaluate response to therapy. 
TREATMENT OF VENTRICULAR 
ARRHYTHMIA
Regardless of DCM stage, treatment of complex VA is 
recommended. Sotalol is the preferred chronic oral 
treatment (1–2.5 mg/kg, q12h). Sotalol should be used 
with caution and at the lower end of dosage range in 
dogs with congestive heart failure (CHF) and should not 
be combined with other beta-blockers or diltiazem. In 
dogs with ventricular tachycardia detected while they are 
in the hospital, a continuous rate infusion (CRI) of lido-
caine should be used for 4–24 hours while oral sotalol is 
started and given enough time to start working before 
the dog is weaned off the lidocaine. 
DIAGNOSIS OF ATRIAL FIBRILLATION
Diagnosis of atrial fibrillation (AF) maybe suspected 
based on a history of exercise intolerance or collapse or 
represent an incidental finding on physical examination 
of dogs with any stage of DCM. However, new-onset AF 
often precipitates the first episode or recurrence of CHF. 
Therefore, the clinical presentation maybe related to 
signs typical of CHF. Because AF is typically a sustained 
rhythm and frequently suspected based on physical 
examination, definitive diagnosis can be made with a 
resting ECG and a Holter is not required to establish a 
diagnosis. However, in some dogs a Holter is required to 
assess response to therapy. 
TREATMENT OF ATRIAL FIBRILLATION
Treatment for AF is typically based on average HR (based 
on ECG). In dogs with an average HR <150–160 bpm, 
medical management is typically not indicated. In dogs 
with an average HR >160 bpm, medical managements to 
reduce HR are typically indicated. The main goal of treat-
ment is to allleviate any associated clinical signs and 
reduce the average HR to 140–160 bpm (in the hospital). 
Oral diltiazem is the initial treatment of choice, even in 
emergency situations oral diltiazem is typically preferred 
(2–8 mg/kg, total daily dose, divided q8h (regular 
diltiazem) or q12h (extended release)). Initial therapy 
should start at the lower end of the dosage range with 
up-titration to the desired effect on HR. Up-titration is 
based on recheck examinations at intervals of 7–14 days. 
Dogs in the preclinical stage can tolerate higher initial 
and target dosages. Once adequate control of HR has 
been documented, diltiazem is continued at that dose. 
KEY LEARNING OBJECTIVES
■■ Know the clinical signs and how to diagnose and 
monitor dogs with dilated cardiomyopathy (DCM) 
complicated by atrial fibrillation (AF) and/or complex 
ventricular arrhythmias (VAs)
■■ Review recommendations for treatment of VA in 
dogs with preclinical and clinical DCM
■■ Review recommendations for monitoring treatment 
of AF in dogs with preclinical and clinical DCM
MULTIPLE CHOICE QUESTIONS 
1. In dogs with preclinical DCM or CHF secondary 
to DCM and significant ventricular arrhythmias, 
what oral therapy is recommended for 
treatment of the arrhythmia? 
(A) Sotalol 
(B) Amiodarone 
(C) Diltiazem
(D) Atenolol
(D) All of the above
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2. In dogs with preclinical DCM or CHF secondary 
to DCM and atrial fibrillation with an average 
heart rate of 180–200 bpm what oral therapy is 
recommended for treatment of the arrhythmia? 
(A) Sotalol 
(B) Amiodarone 
exercise intolerance and has fainted once while 
playing. The home sleeping breathing rate is 
17/min. Your physical examination is 
unremarkable. The respiration rate is 25 bpm 
and the heart rate is 130 bpm and regular. 
Which diagnostic test should be recommended 
in this dog? 
(A) Echocardiogram
(B) Thoracic radiographs
(C) Resting ECG
Challenging cases: 
approach to the patient 
with cardiac disease 
and renal dysfunction
J.D. Foster 
Cardiac and renal disease both have a high prevalence in 
humans and animals. Specialists and general practition-
ers consult on patients who are affected by these 
 diseases on a daily basis. For many years, it has been 
 recognized that a subpopulation of people may have 
both cardiac and renal disease simultaneously, and often 
these patients may have worse outcomes. Additionally, 
the therapy of cardiac disease has resulted in renal 
impairment, as much as treating kidney disease can lead 
to cardiovascular complications. 
Recognizing similar patient populations where both 
the heart and kidneys could have decreased function, or 
lead to worsening function of the other, a veterinary con-
sensus group comprising of cardiologists and nephrolo-
gists met in 2013 to define these disorders in small 
animals. Their opinions were published in 2015 using a 
refined title of cardiovascular renal disorders (CvRD) to 
highlight the role of vascular disease and complications 
within these patients. 
The following categories of veterinary cardiovascular 
renal disease have been proposed:
■■ CvRDH – this subtype includes patients who develop 
renal dysfunction due to primary cardiovascular 
disease
■■ CvRDK – this subtype identifies patients with primary 
kidney disease who develop subsequent 
cardiovascular injury or dysfunction
■■ CvRDO – this subtype is where a primary non-renal, 
non-cardiac disease is affecting both kidney and 
cardiac function
TREATING CARDIOVASCULAR RENAL 
DISORDERS IN VETERINARY PATIENTS
The management of patients with concurrent cardiac 
and renal disease remains challenging. Adverse drug 
effects and altered drug pharmacology occur in these 
patients, potentially creating more obstacles to providing 
an acceptable quality of life. Close monitoring of patients 
with frequent reassessment of cardiac and renal bio-
markers is an integral part of successful management.
■■ CvRD – in all forms of CvRD, patients should be 
monitored for derangements in blood pressure, 
intravascular volume, electrolyte disturbances, 
anaemia and adequate nutritional intake. When 
abnormal, therapy should be employed to correct 
such complications
■■ CvRDH – use the lowest dosage of a diuretic that 
successfully revolves congestion. Use of venous or 
arterial vasodilators may allow for reduced diuretic 
dosage. Monitor serum creatinine and renal 
biomarkers for evidence of renal injury-therapy 
should be adjusted if possible to resolve such 
complications
■■ CvRDK – judicious use of parenteral fluids to 
maintain intravascular volume and organ perfusion, 
while avoiding aggressive sodium, chloride and 
water administration. Correcting acid–base and 
electrolyte disturbances may allow for improvement 
in cardiac arrhythmias or contractility. Blood 
pressure control (both acute and chronic) is 
important to help prevent cardiac and vascular 
complications
FUTURE DIRECTIONS IN THE 
MANAGEMENT OF CARDIOVASCULAR 
RENAL DISORDERS
As biomarkers of both cardiac and renal injury and dys-
function become validated and widely available for clinical 
usage, some may provide earlier and more specific meth-
ods to identify patients with active cardiac or renal injury, 
thus providing the opportunity for intervention prior to 
the development of congestive heart failure or uraemia. 
Additionally, diagnostic screening in patients who may be 
at risk of developing CvRD (older animals with chronic 
 valvular disease, patients with advanced chronic kidney 
disease (CKD) with hypertension and anaemia, etc.) may 
select for more appropriate and safer therapeutics that 
can help avoid decompensation of organ function.
KEY LEARNING OBJECTIVES
■■ Review the pathophysiology of cardiovascular–renal 
axis disorders and clinical examples in veterinary 
patients
(C) Diltiazem
(D) Atenolol
3. You are presented with a dog that has a 
historical diagnosis of preclinical DCM and is 
currently receiving pimobendan. The owner 
reports that the dog maybe experiencing some (D) Holter
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■■ Understand how therapy for cardiac disease may 
negatively affect kidney function and vice versa
■■ Develop rational approaches for the patient with 
cardiovascular renal disorder to provide the best 
opportunity for successful management
MULTIPLE CHOICE QUESTIONS
1. Which of the following is not negatively 
affected by cardiovascular disease? 
(A) Renal perfusion
(B) Blood pressure
(C) Serum electrolyte concentrations
(D) Appetite
2. Which of the following is not negatively 
affected by renal disease? 
(A) Hydration status
(B) Blood pressure
(C) Anaemia
(D) Arterial oxygenation saturation
3. What may optimal management of patients 
with cardiovascular renal axis disorders require?
(A) Oral diuretic and subcutaneous fluid therapy
(B) Vasodilator and low-dose diuretic therapy
(C) Alpha- and beta-adrenergic receptor 
antagonists
(D) Angiotensin-converting enzyme inhibitors 
and non-steroidal anti-inflammatory drugs
Challenging cases: approach to the cardiac 
patient with concurrent respiratory disease
Kieran Borgeat
Factor Heart failure Respiratory disease
P
h
ys
ic
al
 e
xa
m
in
at
io
n
Tachycardia or bradycardia (pathological) Normal heart rate
Regular rhythm or frequent arrhythmia with no pattern Patterned irregularity of sinus arrhythmia
Poor pulse quality or hyperkinetic pulses Normal pulse quality
Mucous membrane pallor, prolonged capillary refill time Normal membranes and refill time
Rapid and shallow respiratory effort Greater respiratory effort; expiratory if lower 
 airways, inspiratory if upper airway
Increased lung noise or fine pulmonary crackles Loud crackles or wheezes
Normal to thin body condition Normal or obese body condition
T
h
o
ra
c
ic
 
ra
d
io
g
ra
p
h
s Cardiomegaly Normal heart size
Pulmonary venous distension Pulmonary veins normal/under-sized
Alveolar or interstitial pulmonary infiltrates, often 
 caudodorsal distribution
Bronchial or interstitial infiltrates most common, 
generalized or localized to a single lobe/side
E
c
h
o
c
ar
d
io
g
ra
p
h
y Left atrial dilatation Normal left atrial size; unless concurrent heart 
disease
Systolic dysfunction Normal systolic function
Possible pulmonary hypertension if chronic, severe left 
heart disease
Right ventricular remodelling associated with 
pulmonary hypertension if severe disease
B
lo
o
d
 w
o
rk
Often normal haematological profile Inflammatory leucogram if pneumonia, 
eosinophilia if parasitism or eosinophilic 
bronchopneumopathy
Azotaemia if severe drop in cardiac output, increased 
alanine aminotransferase if right-sided failure
Often normal biochemical profile
Figure 1: Heart failure vs. respiratory disease
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See Figure 1. In this lecture, we will discuss specific, real-
life cases and review how and why we approached the 
cases in the way that we did.
KEY LEARNING OBJECTIVES
■■ Consider clinical signs that help to identify dogs 
with heart failure vs. primarily respiratory signs
■■ Review thoracic imaging findings which highlight 
congestive heart failure cases
■■ Formulate a logical plan for treating respiratory 
disease in dogs with clinically significant heart disease
(A) Rapid and shallow
(B) Expiratory effort
(C) Inspiratory effort
(D) Paradoxical pattern
2. What is coughing in heart disease most likely to 
be caused by?
(A) Pulmonary oedema
(B) Left atrial dilation
(C) Bronchial oedema
(D) Vascular distension
3. What is circulating eosinophilia in a coughing 
dog most likely to represent?
(A) Aspiration pneumonia
(B) Reduced cardiac output
(C) A stress leucogram
(D) Pulmonary parasitism
MULTIPLE CHOICE QUESTIONS
1. What respiratory pattern is most suggestive of 
congestive heart failure?
Cardiac therapeutics: 
pericardial disease
Sonya Gordon
CAUSES OF CANINE PERICARDIAL DISEASE 
(MOST COMMON*)
■■ Congenital pericardial disease (PD): pericardial 
peritoneal diaphragmatic hernia (PPDH), pericardial 
defects, pericardial cysts
■■ Acquired PD*: pericardial effusion, constrictive 
pericarditis, constrictive-effusive pericarditis
CAUSES OF CANINE PERICARDIAL 
EFFUSION (MOST COMMON*)
■■ Neoplasia* (haemangiosarcoma*, chemodectoma*, 
mesothelioma, lymphoma, thyroid carcinoma, 
parathyroid masses)
■■ Idiopathic*
■■ Infectious: bacterial, fungal (coccidiomycosis, 
aspergillosis), viral
■■ Traumatic: atrial rupture in chronic degenerative 
valve disease, hit by a car, cardiac perforation 
(iatrogenic during catheterization)
■■ Coagulopathy, e.g. rodenticide toxicity
■■ Uraemia
■■ Congestive heart failure (CHF): typically scant/mild 
with no tamponade and therefore treatment is 
related to management of CHF without 
pericardiocentesis
■■ Migrating foreign body, e.g. porcupine quill
MANAGEMENT OF CANINE PERICARDIAL 
EFFUSION
Pericardial effusion (PE) can lead to life-threatening car-
diac tamponade. Cardiac tamponade results when the 
volume of PE causes an increase in pressure in the peri-
cardial space, which impairs preload reducing cardiac 
output. Tamponade is a function of volume of PE and the 
time it took for the PE to develop. Tamponade can occur 
in varying degrees of severity, with resultant clinical signs 
of exercise intolerance or complete circulatory shock. 
Moderate to severe tamponade should be treated 
with intravenous fluids which can help stabilize cardiac 
output while pericardiocentesis is attempted. Diuretics 
should not be administered because they will further 
reduce cardiac output. Emergency pericardiocentesis 
relieves tamponade and normalizes cardiac output. It is 
therefore essential for veterinary surgeons to recognize 
clinical signs of moderate to severe cardiac tamponade. 
Long-term prognosis and management recommenda-
tions depend on the underlying cause of the PE. Because 
moderate to severe tamponade is life-threatening, 
 referral is frequently not an option and stabilization is 
necessary prior to referral. Referral can be considered in 
dogs with no to mild tamponade. An echocardiogram 
(if available) should be performed prior to tapping if at all 
possible as the sensitivity for tumour identification is 
higher when effusion is present. Referral once stable can 
help make owners aware of all options with respect to 
chronic management. 
SIGNS CONSISTENT WITH CARDIAC 
TAMPONADE IN DOGS
Clinical signs
■■ Exercise intolerance, weakness, or collapse
■■ Abdominal distention caused by ascites and/or 
hepatomegaly
■■ Jugular distention or positive hepatojugular reflux 
test
■■ Sinus tachycardia with or without arrhythmias
■■ Weak femoral arterial pulses with or without deficits 
and pulsus paradoxus (reduction or absence of 
pulse during inspiration)
■■ Muffled heart sounds
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Echocardiographic signs
■■ Pericardial effusion
■■ Right atrial and/or ventricular collapse
■■ Small left ventricular chamber size in systole and 
diastole
Electrocardiographic signs
■■ Small QRS complexes
■■ Electrical alternans 
■■ Sinus tachycardia
■■ Arrhythmias: ventricular premature complexes or 
ventricular tachycardia
■■ ST-segment elevation or depression
CAUSES OF FELINE PERICARDIAL DISEASE 
(MOST COMMON*)
■■ Congenital disorders: PPDH* (rarely the result of 
trauma), pericardial cysts
■■ Acquired disorders*: PE
CAUSES OF FELINE PERICARDIAL 
EFFUSION (MOST COMMON*) 
■■ CHF*
■■ Infectious: feline infectious peritonitis (FIP), fungal 
infection (e.g. coccidiomycosis) 
■■ Neoplasia: lymphoma
MANAGEMENT OF FELINE PERICARDIAL 
EFFUSION 
Tamponade is rare and thus pericardiocentesis is rarely 
indicated. Since the most common cause of PE in the cat 
is CHF, the long-term prognosis is typically related to that 
of the underlying cardiomyopathy that led to CHF. 
 Pericardiocentesis in the cat (if necessary) typically 
requires general anaesthesia and is associated with a 
 significant risk of life-threatening complications. 
KEY LEARNING OBJECTIVES
■■ Know the common causes of pericardial disease 
(PD) in the dog and cat
■■ Know the signs of tamponade and when and how to 
perform pericardiocentesis
■■ Know when referral to a specialist is recommended 
in patients with PD
MULTIPLE CHOICE QUESTIONS 
1. Which of the following is/are a clinical sign(s) 
consistent with cardiac tamponade? 
(A) Pulsus paradoxus 
(B) Jugular distention 
(C) Tachycardia
(D) All of the above
2. Which of the following is the recommended 
therapy in dogs with cardiac tamponade?
(A) Furosemide
(B) Atropine
(C) Intravenous fluids
(D) Pimobendan
3. Which of the following is the most common 
cause of pericardial effusion in the cat?   
(A) Haemangiosarcoma
(B) Idiopathic
(C) Congestive heart failure
(D) Atrial rupture
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Understanding 
immunological testing
James Swann
Various clinical tests are available in cats and dogs to inves-
tigate whether the immune system is functioning normally; 
these typically are used for diagnosis of immune-mediated 
diseases or immunodeficiencies. In most cases, results of 
these tests must be interpreted in the context of other 
 clinical information, particularly the presenting complaints 
and results of other clinicopathological tests, such as 
 complete blood counts and biochemical profiles.
Most autoimmune diseases are associated with 
 production of autoreactive antibodies specific for normal 
antigens, even if these do not contribute to the develop-
ment of the clinical signs. Detection and measurement of 
the concentration of these antibodies in serum therefore 
represents an important diagnostic test for several 
immune-mediated diseases in dogs and cats, including 
immune-mediated haemolytic anaemia (IMHA), masti-
catory muscle myositis and myasthenia gravis. These 
antibodies may be detected using different methodolo-
gies with varying limitations. For example, anti-red blood 
cell antibodies may be detected in dogs with IMHA using 
either the direct antiglobulin (Coombs’) test or flow 
cytometry: direct antiglobulin tests are probably more 
specific but less sensitive than flow cytometry, because 
the former test will only produce a positive result if many 
antibodies are bound to each red blood cell. Most tests 
for autoantibodies are reported as semiquantitative titres, 
which reflect the maximum dilution of serum at which a 
positive result can still be observed. However, methods 
for performing these tests also vary among diagnostic 
laboratories, introducing further complications in their 
clinical interpretation. 
Immunodeficiencies usually are suspected in young 
animals presenting with persistent or recurrent infections. 
Such animals theoretically may have defects in any com-
ponent of the immune system, particularly granulocytes, 
T cells, B cells and antibodies. Complete blood counts will 
reveal deficiencies in the major groups of leucocytes, but 
flow cytometry may be used to investigate whether dif-
ferent groups of lymphocytes, such as CD4+ and CD8+ 
T cells are present in the correct proportions. In people, 
flow cytometry may also be used to determine whether 
leucocytes express important proteins on their surface, 
which are required for their functions in the immune 
response. Concentrations of the different classes of 
immunoglobulin, including IgG, IgM and IgA, may also be 
measured to determine if there is a selective deficiency in 
one type of antibody. These tests may be complemented 
by genetic tests available for diseases in particular breeds, 
such as leucocyte adhesion deficiency in Irish Setters.
KEY LEARNING OBJECTIVES
■■ Describe the major tests available for detection of 
autoreactive antibodies for diagnosis of immune-
mediated diseases in dogs and cats
■■ Understand the limitations associated with tests for 
autoreactive antibodies in dogs and cats, depending 
on the method used for their detection
■■ Formulate a sensible approach to immunological 
testing in dogs with clinical signs consistent with 
primary immunodeficiency
MULTIPLE CHOICE QUESTIONS
1. Which is the most common class of anti-red 
blood cell antibody observed in dogs with 
IMHA?
(A) IgG
(B) IgM
(C) IgA 
(D) IgD
2. Detection of which autoantibodies may be 
used to support a diagnosis of masticatory 
muscle myositis?
(A) Anti-neutrophil cytoplasmic antibodies
(B) Anti-2M antibodies
(C) Acetylcholine receptor antibodies
(D) Anti-ganglioside antibodies
3. Which class of antibody is deficient in Cavalier 
King Charles Spaniels infected with 
Pneumocystis jirovecii?
(A) IgM
(B) IgA
(C) IgG
(D) IgD
Immune-mediated 
skin disease
Laura Buckley 
Immune-mediated skin diseases (IMSDs) are well recog-
nised but uncommon diseases. Primary IMSD is made up 
of immunodeficiency, hypersensitivity (allergy) and auto-
immune disease. The latter is the focus of this lecture and 
occurs when the immune system fails to tolerate self-
antigens and mounts an immune response (via  production 
of antibodies or activated lymphocytes) against normal 
skin components. Secondary IMSD develops in response 
to a foreign antigen, most commonly drugs, bacteria or 
viruses. 
HISTORY AND CLINICAL SIGNS
The investigation of IMSD requires careful consideration 
of key historical features and the identification of a typi-
cal character and distribution of skin lesions. Diagnostic 
investigations are important in achieving a diagnosis but 
in some cases can be non-specific and, unless they are 
considered in the light of an accurate history and appro-
priate clinical signs, they may be misleading. Most IMSDs 
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have a classic clinical presentation and/or breed predi-
lections and these are discussed in detail in the lecture.
APPROACH TO DIAGNOSIS
Key historical features and the character and distribution 
of skin lesions are used to formulate a rational, prioritized 
differential diagnosis list, which is then used to make a 
diagnostic plan. The vast majority of IMSD are investigated 
by performing skin biopsy for histopathology with or with-
out direct impression smear cytology. The following guide 
to biopsy will aid in obtaining diagnostic  samples:
■■ Take multiple biopsy specimens
■■ Sample lesions most representative of suspected 
disease based on differential diagnoses
■■ Sample new lesions if possible
■■ Avoid heavily eroded or ulcerated lesions as these 
provide no information on epidermal pathology; 
sample from the margin of these lesions
■■ Take care when performing punch biopsies 
(minimum 6 mm); do not aseptically prepare site, 
ensure epidermis remains intact, take full skin 
thickness biopsy specimen, do not crush sample
■■ Performing wedge/elliptical biopsies with a scalpel 
may be necessary to remove large, intact lesions 
(vesicle, bulla) or to sample the margin of a lesion or 
sample difficult body site (pinna, nasal planum, foot)
■■ Submit samples in separate formalin pots indicating 
sample site and character of lesion 
■■ Submit samples to a laboratory that has a 
dermatohistopathologist and include history, clinical 
signs and differential diagnoses
In some cases, treatment may need to be started 
before all diagnostic tests are received, however, con-
firming the diagnosis will allow for prognostication, a 
more targeted treatment approach and will make review 
of therapy easier in poorly responsive cases.
TREATMENT
This involves removal or treatment of any external trig-
gers such as drugs, ultraviolet light or confirmed infec-
tions and control of the inappropriate immune response. 
The latter is usually achieved with immunosuppressive/
immunomodulatory drugs. Mild or localized disease may 
be treated less aggressively or by using topical therapies. 
For severe or relapsing disease, combination drug ther-
apy is generally more effective and often better tolerated. 
Baseline drug monitoring (usually complete blood count, 
biochemistry and urinalysis) are obtained prior to starting 
immunosuppressive therapy. There are three phases of 
treatment:
MULTIPLE CHOICE QUESTIONS
1. Autoimmune disease occurs as a result of an 
abnormal immune response directed towards 
which of the following?
(A) Drug antigens
(B) Self-antigens
(C) Bacterial antigens
(D) Viral antigens
2. Which of the following would be an 
appropriate lesion to sample by performing a 
punch biopsy?
(A) Pustule on ventral abdomen
(B) Bulla on oral mucosa
(C) Ulcer on the interdigital skin
(D) Vesicle on nasal planum
3. Blood monitoring should be performed every 
7–14 days during which phase of management 
of IMSD?
(A) Induction of remission
(B) Transition
(C) Maintenance
(D) Cure
1. Induction of remission: days to weeks, aggressive 
therapy, may need to change/add treatments if 
minimal response after 2–4 weeks, try to avoid 
severe adverse effects, regular treatment monitoring
2. Transition: weeks to months, taper to lowest 
effective dose, taper drugs with most risk of adverse 
effects first, treatment monitoring frequency 
reduces with time and absence of adverse effects, 
if no relapse with advanced dose tapering stop 
treatment to determine cures
3. Maintenance: months to years, maintain lowest 
effective dose and monitor for adverse effects in 
cases where relapses have occurred in transition 
phase, treatment monitoring as determined by 
treatment and dose, further tapering should be 
considered if disease in remission for many months
KEY LEARNING OBJECTIVES
■■ Evaluate patient history and clinical signs to create 
differential diagnosis lists 
■■ Understand the use of differential diagnosis lists to 
lead the investigation of immune-mediated skin 
diseases
■■ Accurately interpret diagnostic tests in the light of 
clinical findings to make a definitive diagnosis and 
initial treatment plan
Novel immunotherapy
James Swann
Traditionally, immune-mediated and hypersensitivity dis-
eases have been treated using broad-spectrum immuno-
suppressive drugs that inhibit many parts of the normal 
immune response. Whereas these drugs often are effec-
tive, they may cause adverse effects related to their lack 
of specificity. In particular, administration of glucocorti-
coids at high doses suppresses the immune responses 
but causes numerous metabolic and musculoskeletal 
changes that may compromise quality of life. There is 
therefore a major clinical need to develop new forms of 
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treatment that modulate aberrant activity of the immune 
system without causing off-target effects.
Development of monoclonal antibody therapies has 
been revolutionary in the management of many autoim-
mune and inflammatory diseases in humans because 
these molecules target a single molecule or cell type 
associated with disease. Examples include use of anti-
bodies specific for tumour necrosis factor alpha (TNFα) 
for rheumatoid arthritis and anti-CD20 antibodies for 
management of B cell lymphoma. Similar ‘biological’ 
therapies are currently being developed for use in dogs, 
including ‘caninized’ anti-CD20 antibodies for treatment 
of B cell lymphoma and anti-interleukin-31 antibodies 
(lokivetmab) for atopic dermatitis. It is likely that anti-
TNFα antibodies will also be produced and marketed for 
dogs, with potential applications in the management of 
inflammatory bowel disease and inflammatory arthritis.
Allergen-specific immunotherapy already is used 
widely in dogs with atopic dermatitis to try to restore toler-
ance to innocuous antigens, whereas injection of DNA 
encoding a tumour-related antigen may also be used to 
stimulate helpful immune responses in dogs receiving 
‘melanoma vaccines’. As demonstrated by these exam-
ples, responses to injection of antigens may vary widely 
depending on the form and concentration of the antigen, 
the route of delivery and the presence of any adjuvant, 
highlighting the need for extensive testing before these 
forms of therapy are introduced more widely for treat-
ment of immune-mediated diseases.
Various cell-based therapies are currently being tri-
alled in people, all involving infusion of leucocytes from 
the same patient or from a donor to try to control or 
cause an immune response. Therefore, in some people 
due to undergo transplantation, immunosuppressive 
regulatory T cells (Tregs) are harvested and expanded ex 
vivo before being infused back into the patient immedi-
ately after their operation to try to reduce the risk of 
rejection. In the context of cancer, a similar approach 
may be used to identify or modify T cells specific for 
 cancer antigens and expand them ex vivo; when re-
infused, these cells should target the tumour specifically. 
MULTIPLE CHOICE QUESTIONS
1. Antibodies specific for which cytokine are 
currently used for management of atopic 
dermatitis in dogs?
(A) Interleukin 21
(B) Interleukin 31
(C) Interleukin 41
(D) Interleukin 51
2. Which antigen is contained in melanoma 
vaccines currently administered to tumour-
bearing dogs?
(A) Tyrosinase
(B) Melanin
(C) Chitin
(D) Hyaluronic acid
3. Administration of anti-CD20 antibodies will 
preferentially deplete which type of immune cell?
(A) T cells
(B) B cells
(C) Neutrophils
(D) Eosinophils
This form of treatment is currently being trialled in some 
centres in the USA and may become available in the clinic 
in future.
KEY LEARNING OBJECTIVES
■■ Understand the mechanism of action of forms of 
immunotherapy in current clinical use, including 
allergen-specific immunotherapy, cancer vaccines 
and anti-interleukin-31 antibodies
■■ Describe the limitations and possible side effects 
associated with immunotherapies in current 
clinical use
■■ Identify possible novel targets for more specific 
therapies targeting the immune system
Glomerulonephritis
J.D. Foster 
Healthy dogs and cats will excrete small amounts of pro-
tein within their urine. The term proteinuria is used to 
indicate the presence of abnormal/excessive amounts of 
protein within urine. Proteinuria has numerous causes 
and can be differentiated due to its origin. This categori-
zation scheme can help guide diagnostic and  therapeutic 
decisions.
Prerenal proteinuria is the appropriate filtration of 
abnormally occurring proteins present in plasma. The 
condition may develop secondary to haemoglobinaemia 
and myoglobinaemia, respectively caused by red blood 
cell (RBC) haemolysis and muscle damage. Bence-Jones 
proteins are immunoglobulin light chains, which may be 
elevated in neoplastic disorders such as multiple  myeloma 
and can accumulate within urine. Similar to prerenal 
causes of proteinuria, in postrenal proteinuria the nephron 
and glomerular filtration barrier are normal. In this cate-
gory, protein enters the urine after the nephron (renal 
 pelvis and beyond). Most commonly, these proteins arise 
from the urinary tract itself. Inflammation, infection and 
neoplasia of the urinary tract can result in proteins exud-
ing from the urothelium into urine. 
While altered permeability within the glomeruli and 
the renal interstitium may both cause renal proteinuria, 
glomerular disease can produce the highest magnitude. 
Such a condition, glomerulonephropathy, is often 
referred to as glomerulonephritis (GN) although not all 
aetiologies truly involve inflammation. Major causes of 
GN include immune-complex deposition, amyloidosis, 
glomerulosclerosis (scarring of the glomerulus), con-
genital genetic disorders, and secondary infectious or 
inflammatory conditions. Renal biopsy with detailed 
 histopathological examination is the only method to 
 differentiate these disorders.
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IMMUNE-COMPLEX 
GLOMERULONEPHRITIS
In the largest study of renal histopathology in the dog, 
immune-complex glomerulonephritis (ICGN) was found 
in 48% of all samples submitted. Immune complexes may 
represent antigen–antibody (Ag–Ab) complexes pas-
sively trapped in the glomerular basement membrane 
(GBM) from circulation or could occur due to in situ 
 formation. Once antigens or Ag–Ab complexes are 
deposited in the glomerulus, several different immune 
responses may occur. Changes in glomerular permse-
lectivity result from glomerular capillary wall injury due 
to activation of inflammatory cascades secondary to the 
immune deposits. Antibodies against GBM antigens can 
directly increase glomerular permeability, as well as 
induce inflammation or complement cascade activation, 
further increasing permeability. 
NON-IMMUNE-COMPLEX 
GLOMERULONEPHRITIS
Non-ICGN is a broad category of glomerular lesions in 
which neither immune complexes nor amyloid can be 
identified and is therefore a diagnosis of exclusion. The 
non-ICGN group includes focal segmental to global 
 glomerulosclerosis, abnormalities of the GBMs without 
associated sclerosis, glomerular lipidosis, and congenital 
or developmental nephropathies that involve glomeruli. 
Glomerulosclerosis, specifically focal segmental glomer-
ulosclerosis, as a cause of proteinuria was once under-
recognized in veterinary medicine, even though it is 
considered to be a common cause of proteinuria in 
humans. Evidence points to podocyte injury as an inciting 
factor in the development of glomerulosclerosis, and 
mutated podocyte genes, toxic insults, viral infections and 
cytoskeletal stress from cell hypertrophy have all been 
demonstrated to injure this cell lineage. Genetic mutations 
in GBM proteins or collagen have been identified to cause 
protein-losing nephrpathy in numerous breeds.
MANAGEMENT
The recognition of ICGN is an important step in the man-
agement of proteinuria, as these patients typically require 
immunosuppressive therapy in addition to the standard 
medications. With the addition of immunosuppression, 
some patients have demonstrated complete and long-
term remission of their disease.
KEY LEARNING OBJECTIVES
■■ Review the common causes of proteinuria and how 
to identify patients with suspected glomerular 
disease
■■ Know the indications for renal biopsy, how to 
perform it, and how to have the samples analysed
■■ Learn how to tailor therapy for patients with 
glomerular disease, decreased kidney function and 
immune-complex disease
MULTIPLE CHOICE QUESTIONS
1. Which of the following scenarios is most likely 
to be representative of renal proteinuria?
(A) A dog with intravascular haemolytic 
anaemia and haemoglobinuria
(B) A dog with hypoalbuminaemia, 
normoglobulinaemia, 
hypercholesterolaemia and increased 
urine protein:creatinine ratio
(C) A dog with a positive microalbuminuria test 
identified as part of yearly wellness 
examination
(D) A dog with 4+ proteinuria on a urine 
dipstick with an active urinary sediment
2. Which of the following can be used to 
differentiate glomerular disease from other 
causes of proteinuria?
(A) Magnitude of proteinuria
(B) Breed of dog
(C) Renal biopsy result
(D) Renal ultrasonography results
3. A dog with immune-complex 
glomerulonephritis would benefit from 
long-term administration of all the below 
therapies EXCEPT which one?
(A) Doxycycline
(B) Benazepril
(C) Amlodipine
(D) Mycophenolate
How to collect CSF 
samples
Paul Higgs 
Once mastered this procedure is relatively simple, how-
ever, it should never be taken lightly.  There are some 
risks to the patient when performing the procedure and 
certain precautions should be taken. As long as a sensible 
routine is followed the risk is actually low. 
Indications for cerebrospinal fluid (CSF) sampling 
include:
■■ Seizure investigations
■■ Abnormal central nervous system (CNS) function
■■ Pyrexia of unknown origin 
■■ Optic neuritis
Contraindications for CSF sampling include:
■■ Coagulopathy
■■ Raised intracranial pressure (ICP)
■■ Chiari malformation or other significant 
abnormalities in skull anatomy
■■ Suspected bacterial meningitis
■■ Local skin infection at the site of sampling
In the presence of raised ICP, the rapid removal of CSF 
may precipitate a caudal shift of brain parenchyma. This 
may cause cerebral herniation with resultant  crowding of 
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the brainstem often accompanied by fatal compression of 
the medullary respiratory centre causing respiratory 
arrest. Ultimately, if findings consistent with raised ICP are 
present, the diagnostic advantages of CSF collection and 
analysis must be carefully weighed up against the risk of 
collection-induced herniation and owners counselled 
accordingly. 
PATIENT PREPARATION
A full anaesthetic is essential in these cases. Any move-
ment during sampling would risk damage to the spinal 
cord or major blood vessels in this region. It is also essen-
tial to consider the individual patient that is having this 
procedure; dogs with domed heads or those with known 
predisposition to Chiari malformation should either have 
a magnetic resonance imaging (MRI) scan prior to CSF 
sampling or the sample should be taken from the lumbar 
region. 
CEREBROSPINAL FLUID SAMPLING 
The technique will be discussed in the lecture with visual 
aids. Additional notes: 
■■ If the needle is slightly misdirected laterally it is 
common to get blood in the hub of the needle. 
This is very unlikely to cause significant bleeding, 
however, the needle should be immediately 
removed and the procedure started again. 
Contamination of CSF with blood may affect some 
results after this
■■ If the needle is misdirected caudally or cranially you 
will hit bone. It is possible to ‘walk’ the needle off of 
these boney processes and into the CSF space, 
however, the flexibility of the needles can make this 
difficult
■■ In cats and small dogs, the CSF space is a 
remarkably short distance from the skin surface. It is 
essential that the stylet is removed and the needle 
advanced with care as soon as the skin has been 
penetrated
■■ Once CSF is seen in the hub it is essential that the 
needle is not advanced any further, even if CSF 
stops flowing. This may result in penetration of the 
CNS tissue and damage to the spinal cord or caudal 
brain stem may result
SAMPLE HANDLING
The CSF is hypotonic and it would be expected that any 
nucleated cells in the CSF will have lysed within 24 hours 
and certainly by 48 hours. It is sensible to arrange for 
immediate transport of the sample to the laboratory for 
assessment. If this is not possible, however, contact your 
laboratory for advice.
KEY LEARNING OBJECTIVES
■■ Understand the correct positioning for obtaining 
cerebrospinal fluid (CSF) samples
■■ Identify the indications and contraindications for 
CSF sampling
■■ Understand the technique for obtaining and 
handling a CSF sample 
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements is CORRECT 
regarding positioning of patients for cisternal 
CSF sampling? 
(A) The patient should be positioned in sternal 
recumbency with a straight neck
(B) The patient should be positioned in lateral 
recumbency with a straight neck
(C) The patient should be positioned in lateral 
recumbency with a 90° flexion to the neck
(D) The patient should be positioned in sternal 
recumbency with a 90° flexion to the neck
2. Which of the following is a contraindication for 
CSF sampling?
(A) Status epilepticus
(B) Hind limb ataxia
(C) Pyoderma at the site of sampling
(D) Optic neuritis
3. Which of the following statements is CORRECT 
regarding cerebrospinal fluid? 
(A) The protein content in CSF is greater than 
that of plasma 
(B) Approximately 1 drop of serum can be 
added to CSF to help preserve cells for 
analysis
(C) Eosinophils are a normal finding in CSF
(D) A minimum of 3 ml of CSF is required for 
analysis
How to perform 
joint taps 
Paul Higgs 
Taking joint samples is sometimes an essential compo-
nent to investigations into lameness, pyrexia of unknown 
origin and joint swellings and, although not commonly 
performed in first-opinion practice, is certainly achievable. 
This lecture will focus on simplified techniques to obtain 
joint samples from common sites; specific approaches will 
be discussed with visual aids in the  presentation itself. 
EQUIPMENT
■■ Aseptic preparation equipment
■■ Sterile gloves
■■ Multiple 2.5-ml syringes
■■ Multiple size 23-g hypodermic needles (5/8”, 1”,  
1.5”, 2”) 
■■ EDTA blood collection tubes
■■ Microscope slides
■■ Blood culture bottles (if septic arthritis suspected)
171-178 Immunology.indd   176 08/03/2019   18:04
BSAVA CONGRESS 2019 PROCEEDINGS [ 177 ]
TECHNIQUE
The technique varies significantly depending on the 
joints that are being sampled. However, the following 
points apply in all cases:
■■ Arthrocentesis should only be performed under 
heavy sedation or, preferably, general anesthesia
■■ A small 3 cm x 3 cm area of hair should be clipped at 
the site of sampling and prepared aseptically
■■ Surgical gloves should be worn and needles and 
syringes should be handled in an aseptic manner
■■ Once in the joint space no more than gentle suction 
is required, this reduces the chance of blood 
contamination and subsequent difficulties with 
cytological evaluation
■■ Avoid repeated redirection of the needle; if you do 
not get a sample easily start again with a new needle
■■ If frank blood is obtained, stop immediately; attempt 
sampling again but expect the joint to be 
contaminated
■■ If mild blood contamination occurs these samples 
can be submitted, however, it is important to let the 
cytologist know that some contamination occurred 
as it helps with interpretation
SAMPLE HANDLING
■■ One drop of joint fluid should be smeared between 
two microscope slides. Both slides should be 
submitted 
■■ Only two slides are necessary per joint
■■ If a large volume of fluid is obtained it can be 
submitted in EDTA for tests such as Borrelia 
polymerase chain reaction. A fresh smear should 
still be submitted. 
■■ Slides should be air-dried completely before being 
put in a slide container
KEY LEARNING OBJECTIVES
■■ Identify the common and achievable sites for 
obtaining samples of joint fluid 
■■ Understand the indications and contraindications 
for joint sampling
■■ Understand the technique for obtaining and 
handling a joint fluid sample 
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements is CORRECT 
regarding joint fluid samples? 
(A) 1 ml of joint fluid should be obtained from 
each joint sampled
(B) A single joint sample is sufficient for the 
diagnosis of immune-mediated 
polyarthritis
(C) A single drop of joint fluid is sufficient for 
cytological evaluation
(D) Intracellular bacteria are commonly seen 
cytologically in septic arthritis samples
2. Which of the following is a contraindication for 
joint fluid sampling?
(A) Suspicion of septic arthritis
(B) Severe joint pain
(C) Coagulopathy
(D) Pyrexia greater than 40.5°C
3. Which of the following is an indication for joint 
fluid sampling? 
(A) Vomiting and diarrhoea
(B) Generalized stiffness associated with pyrexia
(C) Acute-onset lameness in an otherwise 
well dog
(D) Stranguria secondary to urinary tract 
infection
Stiff, painful and pyrexic: 
an interview with a 
medic, a neurologist 
and orthopod
Duncan Barnes, Vicki Black  
and Jeremy Rose
Pyrexia, or fever, in contrast to hyperthermia, is defined as 
an elevated body temperature that occurs due to altera-
tion of the thermoregulatory set point in the anterior 
hypothalamus in response to endogenous or exogenous 
pyrogens. Pyrexia is a highly conserved physiological 
adaptive response that in the short term confers an evo-
lutionary advantage, in particular when combating infec-
tious disease. An important emphasis is approach to these 
cases must focus on establishing the underlying cause for 
the pyrexia rather than symptomatic treatment and empiri-
cal therapy (e.g. antibiotic trials).
Pyrexia represents a challenge for the small animal 
practitioner, especially where signs can be vague and 
therefore differential diagnoses numerous. Differential 
diagnoses can be categorized as infectious, non- 
infectious inflammatory (including immune-mediated), 
neoplastic and miscellaneous disorders. In the approach 
to the pyrexic patient thorough history and clinical exam-
ination are essential. Stiff patients may present with sub-
tle clues, for example a reluctance to climb up and down 
stairs or jump from furniture, or, some may present with 
obvious localizing signs, including neurological deficits 
or severe lameness (monoarticular or polyarticular).
The most common diagnoses in stiff, pyrexic patients 
can be divided in to non-infectious inflammatory disor-
ders including immune-mediated disease, or infectious 
causes.
Non-infectious inflammatory disorders to consider in 
the stiff, pyrexic dog depend partly on their age; in young 
dogs, especially those less than 6 months of age, meta-
physeal osteopathy should be considered, in those less 
than 2 years of age steroid responsive meningitis-arteritis 
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is an important consideration, whereas  immune-mediated 
polyarthritis is a disorder affecting dogs of any age, 
although most commonly young to middle-aged.
Septic arthritis is relatively uncommon in the absence 
of known trauma, or prosthesis. Discriminating between 
an inflammatory or septic joint is notoriously challenging 
due to difficulties with culturing joint fluid. 
Patients affected by discospondylitis may present 
with pyrexia and spinal pain, or neurological deficits. 
Infection can be bacterial or fungal in nature, although 
fungal disease is uncommon in the United Kingdom 
(aside from systemic aspergillosis). Diagnostic investiga-
tion in these cases focuses not only on ideally procuring a 
sample for culture to guide therapy, but also considera-
tion for the underlying aetiology. Described initiating fac-
tors including migrating foreign bodies (e.g. grass seeds), 
haematogenous spread (e.g. urinary tract infections or 
endocarditis), or secondary to immunocompromise.  
KEY LEARNING OBJECTIVES
■■ Appreciate the importance of a thorough history 
and clinical examination in stiff pyrexic animals
■■ Understand the diagnostic approach and 
management for the most common causes of 
pyrexia and stiffness
MULTIPLE CHOICE QUESTIONS
1. What is the predominant cell type on joint 
aspirates of a dog affected with immune-
mediated polyarthritis?
(A) Lymphocytes
(B) Macrophages
(C) Mononuclear cells
(D) Neutrophils
2. Which bacterial infection typically involving the 
genital tract, is a consideration in approach to 
discospondylitis?
(A) Bacteroides capillosus 
(B) Brucella canis
(C) Nocardia sp
(D) Streptococcus canis
3. Why are joint radiographs recommended in a dog 
diagnosed with immune-mediated polyarthritis?
(A) To screen for ligament laxity
(B) To assess for erosive disease
(C) To look for concurrent stress fractures
(D) To look for Lyme’s disease
■■ Appreciate that despite gold-standard practice 
guidelines, often these cases require careful clinical 
judgement
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Common eye 
conditions: medical 
and surgical 
Charlotte Dawson
Most of this first lecture is terminology and getting you 
used to the new words in ophthalmology. See Figures 1 
and 2. 
Figure 1: Eyelids and tear film
Figure 2: Nasolacrimal duct
AGING CHANGES 
It is important to know what are normal aging changes 
within the eyes and of these changes which ones we 
need to do something about and which we can monitor. 
Entropion is common in elderly cats. It usually occurs 
at the lateral aspect of the lower eyelids and happens 
when they lose retrobulbar fat as they age. This causes a 
problem as the hairs rub on the cornea and can cause 
corneal ulcers. These are painful and so entropion should 
always be surgically corrected. This becomes a challenge 
when cats are elderly and have renal disease, making 
general anaesthesia a risk. 
In older dogs we can get corneal endothelial failure. 
This is when the corneal endothelial cells die off over the 
animal’s life and can no longer pump out the water. 
When the cornea becomes waterlogged it is oedema-
tous. This leads to corneal ulcers, which are painful and 
healing can be difficult without surgery. 
Another cause of blueness to the eyes is nuclear scle-
rosis. This is a normal aging change to the eyes and 
should not be confused with cataract. With nuclear scle-
rosis the patient can still see but the lens will have a blue 
colour. This is because throughout life the lens epithelial 
cells continue to make lens fibres. As the lens cannot 
expand inside the eye it compacts (like squeezing a snow-
ball until it becomes really hard). This makes the nucleus 
of the lens really dense and appear blue in colour. 
Cataracts are a true opacity of the lens and these 
come with visual deficits. Cataract surgery can be per-
formed in some cases to help restore vision and reduce 
inflammation caused by the cataracts.
Senile retinal atrophy is something we usually see on 
retinal examination but does not cause too much of a 
problem for our patients. It is usually seen as thinning of 
the peripheral retina with some blood vessel thinning too. 
EMERGENCIES
Ophthalmic emergencies can be very dramatic. It is 
important to remember to check the rest of the patient 
before turning your attention to the eye(s). It is also 
important in eye cases to minimize restraint as eyes are 
fragile and if there are very deep ulcers or the eye is per-
forated, any pressure can lead to retinal detachment and 
loss of vision and potentially the eye. 
KEY LEARNING OBJECTIVES
■■ Describe the basic anatomy and physiology of the 
eye and identify key features in the clinical patient
■■ Describe and identify common clinical signs in 
veterinary ophthalmic patients using appropriate 
terminology
■■ Identify an ocular emergency based on owner 
history and physical examination
MULTIPLE CHOICE QUESTIONS
1. Which of the following is NOT a function of 
the eyelids? 
(A) Provides nutrients to the cornea 
(B) Production of tear film components 
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(C) Guides tears to anterior chamber 
(D) Removal of debris from the cornea
2. Which of the following is NOT part of the uvea? 
(A) Cornea 
(B) Iris 
3. What is hyphaema? 
(A) Aqueous flare
(B) Uveal cysts 
(C) Blood in the anterior chamber
(D) High intraocular pressure 
Surgical preparation 
and instrumentation 
for ophthalmic patients 
Charlotte Dawson
Ideally two kits are required: extraocular (adnexal) and 
intraocular (also used for corneal surgery). The two kits 
differ with regards to different sized instruments and 
whether the surgeon is using loupes or an operating 
microscope. Each kit should contain scissors, forceps, 
needle holders and tying forceps in addition to many 
other very specific instruments. You may not have come 
across these unless working in referral practice or along-
side an ophthalmologist. 
Instruments should be handled with extreme care as 
they are very small and delicate. They should be cleaned 
as soon as possible, but the tips should not be scrubbed, 
nor should they be allowed to touch or be dropped as 
they are fragile and will break. They should be allowed to 
air dry and be autoclaved in a box with rubber spikes 
to keep them apart. 
The patient is positioned in sternal recumbency for 
eyelid and third eyelid procedures, and in dorsal recum-
bency for corneal and intraocular surgeries. A vacuum bag 
is important to make sure the patient does not move dur-
ing surgery as the surgeon will be working with magnifica-
tion. Diluted povidone–iodine solution (not scrub) should 
be made up weekly for skin disinfection. A 5% solution 
should be used for corneal contact and 10% for the eyelids 
( Figure 1). If the eye is ruptured the surgeon may not wish 
for any iodine to be used in case it gets into the eye. 
The hair should be clipped prior to perfoming eyelid 
surgery. Small clippers are usually required as large 
blades usually cannot get close to the eyelid due to the 
anatomy. Clipper blades should be clean and new to 
 prevent clipper rash. There is no need to clip for corneal 
or intraocular surgeries as the hair will be draped out of 
the surgical field. 
Suture material is very small and 0.7 metric (6/0 USP) is 
often used for eyelids (in big dogs, 1.5 metric (4/0 USP)) and 
0.3 metric (9/0 USP) is used for the cornea (this is about as 
thin as a human hair so can get lost easily!). See Figure 2.
There are many different ophthalmic surgeries which 
will be explained in more detail in the lecture. 
KEY LEARNING OBJECTIVES
■■ Identify common instruments used in ophthalmic 
surgery and describe their cleaning and sterilization 
care
■■ Describe what materials and equipment are needed 
to prepare a patient for ophthalmic surgery
■■ Describe how to prepare a patient for ophthalmic 
surgery
(C) Ciliary body 
(D) Choroid 
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements is FALSE? 
(A) Clipping for eyelid surgery is necessary 
(B) Clipping for intraocular surgery is necessary
(C) Use dilute 1:50 iodine solution for corneal 
preparation 
(D) Use dilute 1:10 iodine solution for eyelid 
surgery
2. Which of the following is NOT an eyelid surgery?
(A) Wedge resection 
(B) Celsus–Hotz
(C) Conjunctival graft 
(D) Medial canthoplasty 
3. When would phacoemulsification be 
recommended?
(A) Treatment of cataracts
(B) Treatment of entropion 
(C) Treatment of corneal ulcer 
(D) Treatment of dry eye 
Figure 1: Eyelid & corneal contact
Figure 2: 0.7 metric (6/0 USP) and 0.3 metric (9/0 USP) 
suture material
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Postoperative nursing 
considerations for 
ophthalmic patients 
Charlotte Dawson
Some ophthalmic patients are blind, some are painful 
and some are both! It is important to support them as 
they can be confused and scared. Speaking to them 
before you touch them and using your voice to help 
them navigate when walking around is important. It is 
also important that if you have picked them up or they 
are going onto the table that you hold them close to you 
so they know where you are and feel safe. They can get 
disorientated and feel like they will fall if you are too far 
away from them. 
If the eye is fragile or the patient is suffering from 
raised intraocular pressures then pressure on the neck or 
jugular area is not advisable. When taking blood samples 
(before general anaesthesia or for making serum eye 
drops, for example) it is important that if the eye is fragile 
you use a peripheral vein. 
Eyes are quite delicate structures and patients can 
often bump into things if they cannot see well or self-
harm if the eyes are itchy. For this reason, I usually rec-
ommend Elizabethan collars, even in cats! We tie them 
on like a harness to help keep them in place and, gener-
ally speaking, after a few hours the patients tend to get 
used to them. It is also nice to have patients with a fragile 
eye arrive at the referral hospital with a collar on so that 
the eye can be protected on the way in the car (or 
train etc.). Harnesses are used for walking dogs postopera-
tively and for those with raised intraocular pressures 
( glaucoma), for the reasons discussed above. Signs of a 
ruptured or leaking eye are: profuse tearing/wetting, 
blood coming from the eye, vocalizing, and marked 
blepharospasm/ squinting. 
HOW LONG BETWEEN MEDICATIONS 
■■ Drops are aqueous or suspension and ointments 
are ‘oily’
■■ Drops should be given first before ointments 
where possible
■■ Leave 10–15 minutes between drops
■■ Leave 30 minutes after giving an ointment
See Figure 1.
Figure 1: Example of a daily medication schedule
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WHAT TO EXPECT AFTER SURGERY OR 
DURING MEDICAL MANAGEMENT FOR 
OPHTHALMIC DISEASES 
■■ Redness – this is to be expected as it is a sign of 
inflammation, it should be gradually decreasing with 
time and not becoming more obvious
■■ Blueness – this is corneal oedema and depending 
on the type of surgery should again be decreasing 
with time
■■ Blackness – this can be more challenging as it could 
be a sign of a perforation and iris coming out, or can 
be pigment and not too much to worry about
■■ Squinting – again this should be decreasing with 
time, we generally say if the eye is becoming more 
uncomfortable, or is being held closed for more 
than part of the day (i.e. a morning or afternoon 
etc.) the patient should be checked
■■ Discharge – this should be decreasing, becoming 
clearer, less mucopurulent and maybe pinkish in colour 
(again depending on the type of surgery or disease)
Owners should be told to contact someone if they 
are at all concerned, as eyes can go downhill quickly.
KEY LEARNING OBJECTIVES
■■ Describe how to deliver optimal nursing care for 
veterinary ophthalmic patients and create 
appropriate nursing care plans
■■ Advise clients on common ophthalmic medications 
and how they should be used
■■ Be able to give advice on an appropriate medication 
schedule for discharged patients
MULTIPLE CHOICE QUESTIONS
1. Which of the following is NOT a sign of globe 
rupture? 
(A) Profuse tearing 
(B) Corneal oedema (blue cornea) 
(C) Blood coming from the eye 
(D) Marked blepharospasm 
2. Which of the following is a topical  
antibiotic? 
(A) Chloramphenicol 
(B) Ciclosporin 
(C) Dexathemasone 
(D) Dorzolamide 
3. How long should be left between administration 
of eye drops (not ointment)?
(A) 1–2 minutes 
(B) 5–10 minutes
(C) 10–15 minutes
(D) 30+ minutes
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Nursing the brain 
injury patient
Holly Smith 
Nursing a patient with a traumatic brain injury, inflam-
matory brain and brainstem condition or following a 
 craniotomy is often seen as problematic. There are 
some common nursing observations and treatments for 
most brain patients. These patients are in the general 
neurology ward and out of the intensive care ward 
where they would have been immediately post trauma 
or surgery.
The patient’s mentation and response are very 
important and need to be closely observed and recorded 
in the initial recovery period. The Modified Glasgow 
Coma Scale can be used for giving this a ‘score’, or cer-
tain responses can be listed and recorded on a kennel 
sheet. As long as the same responses and observations 
are made each time to achieve consistency, any deterio-
ration in the patient can be picked up quickly and 
reported to the veterinary surgeon. If a Coma scale is not 
used or available then making sure the basic checks are 
done is imperative (Figure 1). 
Some patients with brain injuries or post brain sur-
gery can have expected behaviour which can be miscon-
strued as an emergency or deterioration. An example of 
this would be compulsive pacing or circling, vocalization 
or being absent (not themselves), but will still interact to 
go for a walk, eat or drink. As long as these behaviours 
are noted, with the same checks being carried out at 
 regular intervals, they can be seen as ‘normal’ for that 
stage in the patient’s recovery. 
Many conditions have common behaviours associ-
ated with them. For example craniotomy patients will 
often have poor depth perception which makes eating 
and drinking more challenging and will mean they bump 
into doors and walls more frequently. 
Inflammatory brain conditions will often result in a 
patient needing to walk alongside a wall on the same 
side, trying to move them to the opposite side or along 
an area with no wall will mean they become unable to 
continue. They may stop, veer off in one direction or 
 circle. 
Level of consciousness
Response to calling name, touch and interaction
Motor function
Head carriage (turn, tilt, tremors, low), body shape 
(curved, twisted, rigid limbs)
Ability to stand or walk
Brainstem
Pupil size is equal and there is a pupillary light reflex 
present and is it equal bilaterally
Continuing to eat and drink normally (swallowing and 
gag reflex unchanged)
Figure 1: Essential basic checks for the brain injury patient
KEY LEARNING OBJECTIVES
■■ Understand how to monitor a brain injury patient 
in the general ward environment
■■ Differentiate between expected behaviour and 
possible signs of deterioration
■■ Observations to check and record for continuity 
of care
MULTIPLE CHOICE QUESTIONS
1. Which scale is used to record neurological status?
(A) Universal Coma Scale
(B) Glasgow Coma Scale
(C) Small Animal Coma Scale
(D) Modified Glasgow Coma Scale
2. Which three areas does the coma scale grade?
(A) Nerve, muscle and bone
(B) Brainstem, motor function and level of 
consciousness
(C) Pupils, limbs and behaviour
(D) Eating, drinking and sleep
3. What is likely to cause eating and drinking to be 
a challenge post surgery?
(A) Lack of depth perception
(B) Inability to open jaw
(C) Absent episodes
(D) Unable to stop pacing/circling to eat or drink
Nursing and 
rehabilitating patients 
with neuromuscular 
disease
Joe Fenn
Neuromuscular diseases include any condition that 
either primarily or secondarily affects the peripheral 
and cranial nerves (neuropathies, such as canine acute 
idiopathic polyradiculoneuritis), neuromuscular  junctions 
(junctionopathies, such as myasthenia gravis) or muscles 
(myopathies, such as immune-mediated polymyositis). 
Regardless of the specific diagnosis or category of 
 neuromuscular disease, these patients typically present 
with characteristic clinical signs that underscore their 
particular nursing and rehabilitation requirements. The 
typical signs often seen in neuromuscular disease perti-
nent to their supportive care needs include marked 
weakness, exercise intolerance, regurgitation, hypoven-
tilation, urinary incontinence and severe muscle atrophy.
The most severely affected patients with neuromus-
cular disease may have weakness of vital respiratory 
muscles, which may be a particular concern in the acute 
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phase of management. In these cases, it is vital to moni-
tor patient respiratory parameters, including physical 
assessments, such as thoracic auscultation, respiratory 
rate and effort, as well as pulse oximetry and blood gas 
analysis. Any evidence of reduced chest wall excursions 
or an abdominal breathing pattern should be acted on 
promptly as this may indicate hypoventilation and signal 
the requirement for mechanical ventilation. 
Patient positioning is a key nursing consideration, 
particularly as patients with neuromuscular disease can 
rapidly lose large amounts of muscle mass making them 
especially vulnerable to pressure sores whilst recum-
bent. Non-ambulatory neuromuscular patients should 
be turned every 4 hours, ideally also spending time in 
sternal recumbency. It is vital that appropriate bedding is 
used and changed frequently, to minimize the chance of 
urine scald. Appropriate bladder management is particu-
larly vital to minimize the risk of complications such as 
urinary tract infections. Neuromuscular patients will 
 typically present with a ‘lower motor neuron’ bladder and 
may therefore be prone to leaking urine between expres-
sions. Another important consideration in the nursing 
care of patients with neuromuscular disease is meeting 
their nutritional demands. Some patients may experience 
difficulties with food intake, such as dogs with myasthe-
nia gravis that often develop megaoesophagus, leading 
to persistent and debilitating regurgitation. In these 
cases, appropriate feeding protocols and equipment 
must be in place to allow feeding from a height and 
 regular monitoring for evidence of regurgitation or the 
development of aspiration pneumonia.
Physical therapy and rehabilitation should be at the 
forefront of the management plan for any patient with 
neuromuscular disease, regardless of the specific diag-
nosis. Due to the rapid loss of muscle mass and tone, 
maintaining muscle function through regular exercises, 
such as massage, passive range of motion (PROM) and 
strengthening exercises, is essential. As the patient’s 
strength increases, more independence is encouraged, 
and a gradual transition to a home exercise protocol may 
be performed. As an addition to physical therapy tech-
niques that can be used on wards and at home, hydro-
therapy can also be hugely beneficial in supporting the 
recovery and muscle strengthening of neuromuscular 
patients.
Successful nursing and rehabilitation of the patient 
with neuromuscular disease therefore depend on  effective 
collaboration between nurses, clinicians and owners. 
Although often challenging and time consuming, if per-
formed well, the care of these patients can be incredibly 
rewarding and effective. 
KEY LEARNING OBJECTIVES 
■■ To describe the characteristic clinical signs of 
patients with neuromuscular disease, including 
marked and rapid loss of muscle mass and tone
■■ To recognize the prolonged and intensive physical 
rehabilitation and nursing requirements of 
neuromuscular patients
■■ To understand the diagnosis and management 
of potential life-threatening complications 
associated with severe neuromuscular disease, 
including aspiration pneumonia and respiratory  
dysfunction
MULTIPLE CHOICE QUESTIONS
1. Which of the following conditions is most 
commonly associated with megaoesophagus 
and regurgitation in dogs?
(A) Canine acute idiopathic 
polyradiculoneuritis
(B) Myasthenia gravis
(C) Diabetic polyneuropathy
(D) Muscular dystrophy
2. Which of the following types of medication is 
most often used to treat dogs with acquired 
myasthenia gravis?
(A) Non-steroidal anti-inflammatory drugs
(B) Neuromuscular blocking agents
(C) Antibiotics
(D) Acetylcholinesterase inhibitors
3. A ‘lower motor neuron’ bladder in patients with 
neuromuscular disease is characterized by 
what features?
(A) Turgid bladder, but easy to express
(B) Flaccid bladder, but difficult to express
(C) Flaccid bladder, easy to express
(D) Turgid bladder, difficult to express
Rehabilitation post 
spinal injury
Holly Smith 
Spinal injuries can be varied, surgical and non-surgical. 
The rehabilitation plan will have to take into considera-
tion whether surgery was needed, the severity of the 
injury, where the injury is and how severely the patient is 
affected. The location of the injury will dictate how many 
limbs are affected.
Common surgical spinal injuries include:
■■ Fractured or luxated vertebra
■■ Intervertebral disc extrusion
■■ Atlantoaxial subluxation
Common non-surgical spinal injuries include:
■■ Acute non-compressive nucleus pulposus extrusion
■■ Fibrocartilaginous embolism
Rehabilitation can be divided into three sections:
■■ Hospitalization – accommodation
■■ Essential care – bladder, bowel, skin, respiratory, 
nutrition
■■ Rehabilitation – physiotherapy, hydrotherapy
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HOSPITALIZATION
If the patient is paraplegic, tetraplegic, paraparetic or 
tetraparetic they will need a mattress and soft bedding. 
Thought must go into the bedding depending on whether 
the patient can urinate, move away from their urine or has 
a urinary catheter in place. Bedding that wicks away fluid 
from the patient on to the backing is ideal. 
Pain should be assessed, especially in the early 
stages.
ESSENTIAL CARE
This is making sure the whole patient is cared for, not 
focusing solely on their spinal injury and rehabilitation 
(Figure 1). Ensuring adequate calorie intake is essential to 
recovery, to prevent weight loss, other than that due to 
muscle wastage.
Being aware of possible complications is key to early 
treatment and reducing the risk of occurrence, as pre-
vention isn’t always possible or realistic. Using indwelling 
urinary catheters with a closed collection system instead 
of manual expression will prevent urine scalding, over- 
distension or rupture. An associated complication of 
indwelling catheters is an ascending urinary tract 
 infection. Using barrier creams, sprays to protect the 
skin, frequent baths and assisted walking outside to 
encourage urination are all ways to try to prevent urine 
scalding. The same can be said for faecal scalding. Cath-
eters can be used per rectum with a closed collection 
system in cases of severe diarrhoea.
Frequent turning and offering food or water in a ster-
nal position will prevent both hypostatic and aspiration 
pneumonia. 
REHABILITATION
Both physiotherapy and hydrotherapy are essential for 
achieving the best recovery and function for spinal 
injury patients. Physiotherapy can be divided into three 
categories (Figure 2). Each patient should have their 
physiotherapy plan assessed each day and altered as 
their condition changes.
KEY LEARNING OBJECTIVES
■■ Understand how to assess a spinal injury patient to 
plan rehabilitation and prevent complications
■■ Awareness of surgical and non-surgical conditions
■■ Understand different categories of physiotherapy
Bladder
Urinary tract infection
Urine scalding
Incontinence
Over-distension
Rupture
Bowel
Faecal scalding
Incontinence
Diarrhoea
Constipation
Skin
Urine, faecal scalding
Decubital ulcers
Respiratory
Hypostatic pneumonia
Aspiration pneumonia
Nutrition
Weight loss
Figure 1: Possible complications for the spinal injury 
patient
MULTIPLE CHOICE QUESTIONS
1. What complication is most associated with an 
indwelling urinary catheter?
(A) Cystitis
(B) Ascending urinary tract infection
(C) Urethral stricture
(D) Bladder rupture
2. What are the categories of physiotherapy?
(A) Massage, walking and hydrotherapy
(B) Turning, shaking and vibrating
(C) Passive, active assisted and active
(D) Active and hydrotherapy
3. Which of the following are non-surgical spinal 
injuries?
(A) Acute non-compressive nucleus pulposus 
extrusion and fibrocartilagenous embolism
(B) Intervertebral disc extrusion and 
atlantoaxial subluxation
(C) Fibrocartilagenous embolism and 
intervertebral disc extrusion
(D) Spinal fracture and acute non-compressive 
nucleus pulposus extrusion
Passive Active assisted Active
Effleurage
Petrissage
Flexion, 
extension 
Passive range 
of motion
Supported standing
Rhythmic stabilization
Foot slides
Range of motion
Baiting
Half sit to stands
Harness walks
Standing
Rhythmic 
stabilization
Baiting
Sit to stands
Hydrotherapy
Walking
Figure 2: Physiotherapy for the spinal injury patient
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Surgical nursing clinics
Nicola Ackerman
As with medical nursing clinics, the Registered Veterinary 
Nurse (RVN) can be greatly utilized in undertaking a 
range of procedures that can aid in a number of positive 
outomes for the RVN, the pet, the client and the business 
as a whole. RVNs need to adhere to the Royal College 
of  Veterinary Surgeon’s (RCVS) Code of Professional 
 Conduct and the Veterinary Surgeon’s Act (VSA). 
Surgical nursing clinics should include postoperative 
checks, wound management, assessment of wounds/
trauma prior to repair, dentistry checks (routine and post 
procedure), presurgical discussions with clients and, of 
course, admissions for surgical procedures. Some prac-
tices will also have a dedicated person/team that will only 
book in all surgical procedures. These nurses will discuss 
the procedure, options such as preanaesthetic bloods, 
fluid therapy etc. This is to ensure that informed consent 
is gained and to help speed up admission times. 
Nursing clinics that look at postoperative checks are 
a good starting point. Utilization of resources such as 
https://vetaudit.rcvsk.org/poc/ can help give guidelines 
to RVNs. Clinical audits on postoperative neutering 
checks include classification of outcomes. Practice pro-
tocols can be set around these outcomes; for example, 
any animals in Group 1 or 2, would not require referral. 
Group 3 and above would. Use of digital photography 
should be used in recording any complications. This is 
similar to all wound-management cases.
■■ Group 0: lost to follow-up (when follow-up was 
expected)
■■ Group 1: no complication reported
■■ Group 2: complications noted but no treatment 
required
■■ Group 3: complications noted but only medical 
treatment was required
■■ Group 4: complications noted and surgical 
treatment was required
■■ Group 5: the animal died
KEY LEARNING OBJECTIVES
■■ Understand what RVNs can undertake in surgical 
clinics in accordance with the Veterinary Surgeon’s 
Act and the Professional Code of Conduct
■■ How to assess wounds and recording of wounds on 
practice management systems
■■ Use of clinical audits in nurse clinics to improve 
surgical outcomes
MULTIPLE CHOICE QUESTIONS 
1. Who can undertake surgical clinical audits 
in practice?
(A) RVNs
(B) Veterinary surgeons
(C) Anyone
(D) Only those that have additional 
qualifications
2. If you are unsure about the progression of a 
wound and the veterinary surgeon isn’t 
available for advice, what should you do?
(A) Take a picture of the wound, with the 
client’s permission
(B) Write very detailed clinical notes
(C) Refer the pet back to the veterinary surgeon 
for when you know they will be available
(D) All of the above
3. What acts of surgery can RVNs undertake?
(A) Minor surgery not involving entry into a 
body cavity
(B) Dentistry
(C) Castrations
(D) None of the above
How to implement 
running a clinic
Helen Tottey
There are many challenges facing veterinary practices. 
With reports showing declining pet numbers and the 
increase in veterinary practices for those owners with 
pets to choose to use, today’s veterinary practice needs to 
offer more than just clinical care to patients to attract 
them through their door. And then once the client is in 
your practice they will be looking for a great overall 
 experience of care for them and their pet and if this 
doesn’t match their expectations, they will leave and go to 
another veterinary practice. It is widely recognized that 
nurse consultations are an important part of what veteri-
nary practices offer to their clients to provide a more well 
rounded approach to pet care than just clinical care. 
However not all veterinary practices offer this valua-
ble service; or if they do, there is often reports of them not 
being successful for various reasons. To implement suc-
cessful nurse consultations it is important to first look at 
(or be reminded about) why you want to offer the consul-
tations. When we know why we are doing this, the next 
step is to ensure the whole team know why. Without a 
cohesive team approach, nurse consultations will strug-
gle to be successful. Only when the whole team under-
stands the benefits and how the consultation structure 
will work in the practice can we then look at how to start 
implementing them so that they become an integral part 
of what the veterinary practice offers their clients, the 
team and, most importantly, the pets and their owners.
This lecture will be suitable for registered veterinary 
nurses, student veterinary nurses, anyone with an inter-
est in implementing nurse consultations ‘from scratch’, 
or anyone working in a practice that already offers this 
service and would like to understand more about the 
benefits these bring to the veterinary team and pet 
owner. 
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KEY LEARNING OBJECTIVES
■■ Why nurse consultations are of benefit to the pet, 
the owner, the business and you
■■ How to ensure the whole veterinary team can 
promote the benefits to clients
■■ How to help new team members learn the value of 
nurse consultations, ensuring continual success 
even when team members change
MULTIPLE CHOICE QUESTIONS
1. Why should we offer nurse consultations?
(A) They benefit the pet and owner
(B) They benefit the business
(C) They benefit the team
(D) All of the above
2. What is needed for nurse consultations to be 
successful?
(A) Only the nursing team need to be  
involved
(B) You need your own consulting room 
(C) The times and days can change to suit the 
veterinary rota
(D) The whole practice team must understand 
the value of them and promote them
3. What can nurse consulting help with? 
(A) Continuity of care
(B) Educating pet owners in preventative 
healthcare
(C) Supporting pet owners after a clinical 
diagnosis
(D) All of the above 
How to do more 
clinics
Helen Tottey
Following the previous lecture on Setting Up Nurse 
 Consultations, this lecture will look at what topics you 
can add to help owners care for their pets so that:
■■ Clients value them and attend
■■ You are confident in delivering them  
■■ Pets receive all-round care from the veterinary 
practice team
With many different consultation topics it will be 
impossible to talk about how to implement each one 
during this lecture. But when a new topic is chosen, there 
is a process that should be followed that will ensure this 
becomes a successful addition to what you offer to your 
clients, their pets and the veterinary business. One of the 
first questions in the process that should be answered is 
why – why do you want to offer a certain topic? Some-
times the enthusiasms of the nursing team to provide 
consultations covering a topic are not as well received 
by the clients with the pets we are trying to help as we 
would like, and this can result in reduced numbers of pets 
attending. We will look at how you can ensure what you 
want to offer will be valued by your clients so that they 
bring their pets along to see you. 
As well as the clients and their pets, it is also impor-
tant to demonstrate to the managers and owners of the 
veterinary practice that your new consultation will be of 
value to the business. We will look at how SMART objec-
tives can help you present your case to your management 
team to get your consultation up and running. During this 
lecture we will use the example of how the first vaccina-
tion can be a nurse-led appointment that allows:
■■ The nurse to start building a trusting relationship 
with the client
■■ The client to build trust in the nursing team at a time 
they need a lot of help and support 
■■ The veterinary surgeon to reduce the time spent in a 
first vaccination appointment so they are free to see 
clinical cases
The same principles can be applied for all consulta-
tions that require the veterinary surgeon to be involved, 
such as seniors and any medical management cases.
This lecture will be suitable for registered veterinary 
nurses, student veterinary nurses, or anyone with an 
interest in implementing nurse consultations ‘from 
scratch’ or for anyone working in a practice that already 
offers this service and would like to understand more 
about the benefits these bring to the veterinary team and 
pet owner. 
KEY LEARNING OBJECTIVES
■■ How to find out if there is a need for your chosen 
nurse consultation topic
■■ Using the SMART acronym to help you achieve your 
objectives
■■ How you can work alongside the veterinary surgeon 
in a first vaccination appointment to help build a 
relationship and trust with the pet owner so it will be 
more normal for them to seek you help and advice 
in future
MULTIPLE CHOICE QUESTIONS
1. What does the M in SMART acronym stand for?
(A) Merchandise
(B) Medicine
(C) Measurable
(D) Money
2. It is important to find out if there is a need 
for your chosen consultation topic from 
your clients. How can you do this?
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(A) Diary analysis
(B) A client survey emailed 
(C) Asking clients on Facebook
(D) All of the above
3. As a professional you should do which of the 
following?
(A) Not charge for your consultations
(B) Ask for a donation only
(C) Feel confident charging for your time, 
expertise and skill
(D) Only charge if you have done something 
to the pet (e.g. clip nails)
Communication skills 
for consulting nurses
Helen Tottey
The previous lectures in this series on nurse consulta-
tions have looked at why nurse consulting is important 
for the veterinary team, the client and the pet, what 
should be considered before starting to offer nurse 
 consulting, the types of consultations that can be offered 
and how to add new topics. This final lecture will look at 
the communication skills required to ensure that when 
the client and pet are in the room with you, both you 
and the client communicate effectively for the benefit of 
their pet.
While studying to become a veterinary nurse, there 
is  very little time spent teaching student nurses about 
consulting. Compare this to veterinary students, who 
spend a lot of time observing consultations while ‘seeing 
practice’. It can be challenging to find yourself in a 
 consulting room with a client and expected to be able to 
‘consult’ without any prior training. However, as a veteri-
nary nurse, we all experience clients who turn to us to 
help interpret what the veterinary surgeons has told them 
so we do know how to explain clinical jargon in a way 
that the owner can understand. These are not the only 
type of skills required in the consulting room, however. 
During the consultation you need to find out the 
 reason for the visit, examine the pet, make recommenda-
tions and finalize an agreed plan, often in a fixed time 
which adds pressure and can make all these seem  difficult 
to achieve. Luckily there is an evidence-based structure 
to a consultation that, when followed, addresses all 
the  requirements of the consultation helping it to go 
smoothly for the benefit of all those in the room. 
As well as this structure, listening to clients is one 
of  the fundamental requirements of consulting and, 
although we all have the ability to listen, this is not always 
accomplished in the consulting room. Listening skills are 
an important part of the consultation but it is not just 
something for our ears nor is it only what the client tells 
you, it is also what isn’t said that needs to be ‘heard’ if you 
are going to make the right plan for the client and their 
pet to ensure compliance. This lecture will introduce 
the Calgary Cambridge Principles of the structure of a 
 consultation and explore the importance of listening 
skills required to ensure a successful outcome to your 
consultation and help to build your confidence in  offering 
nurse consultations.
This lecture will be suitable for registered veterinary 
nurses, student veterinary nurses or veterinary surgeons 
who want to learn about the structure to a consultation.
KEY LEARNING OBJECTIVES
■■ The importance of listening to ensure the clients’ 
needs are fully understood to reduce 
misunderstandings
■■ The Calgary Cambridge Principles to help structure 
the consultation to help formulate an agreed 
treatment plan
■■ Developing skills for consulting to help build 
confidence for the nurse delivering the consultation 
so that it is an enjoyable part of the veterinary 
nursing role
MULTIPLE CHOICE QUESTIONS
1. What is the evidence-based structure to a 
consultation called?
(A) Calgary Nottingham Principles
(B) Calgary Cambridge Principles
(C) Calgary Sussex Principles
(D) Calgary Edinburgh Principles
2. Which of the following is true about having a 
structured consultation? 
(A) Isn’t important
(B) Is only for vets
(C) Helps build rapport and trust with the 
owner
(D) Is only needed if you want a client to buy a 
product or service
3. What do good listening skills require you to do?
(A) Maintain eye contact
(B) Keep an open mind and not pre-judge
(C) Ask clarifying questions to check your 
understanding
(D) All of the above
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Medical clinics: what 
can we be doing?
Nicola Ackerman
Client education, increasing compliance and improving 
quality of life are all important elements of medical nurs-
ing clinics. Good understanding of the roles and tasks 
that registered veterinary nurses (RVNs) can undertake 
can help in the development of these clinics in general 
practice. 
Practices that have written protocols or guidelines to 
follow have better continuity of care, which really benefits 
the patient, the owner and the care givers. If each specific 
medical case has guidelines, for example a  diabetic cat, 
everyone involved knows what recommendations to give, 
which insulin to use, when to review the case etc. This 
means that, during the medical nurse clinic, the RVN knows 
what to say and there is no mis-communication. Having 
these protocols or guidelines is key to medical clinics.
All clients with a pet that has been diagnosed with a 
medically manged disease, should be recommended a 
nurse clinic. Specifics to be discussed in the clinic will 
include: client understanding, medications (administration 
and importance of compliance with the veterinary sur-
geon’s recommendations), diet, correct weight and lean 
muscle mass balance, environmental factors, behaviour, 
on-going management and monitoring of the disease. 
Collation of diagnostic results is a major part of medi-
cal clinics. Blood tests need to be requested by the 
 veterinary surgeon, but can be delegated to the RVN to 
perform in the clinic. Routine, regular blood tests can be 
performed by the RVN, with the results being interpreted 
by the veterinary surgeon. Reporting of the interpretation 
can be made by the RVN.
KEY LEARNING OBJECTIVES
■■ Understand what registered veterinary nurses can 
undertake in clinics in accordance with the 
Veterinary Surgeon’s Act and the Professional Code 
of Conduct
■■ What diagnostic tasks can be undertaken in  
clinics
■■ How medical nursing clinics can increase 
compliance, the animal’s quality of life and  
revenue
MULTIPLE CHOICE QUESTIONS
1. When can diagnostic tests, such as blood tests, 
be performed in nurse clinics? 
(A) If requested by the owner
(B) If recommended by the RVN
(C) If delegated by the veterinary surgeon to 
be taken
(D) RVNs can’t take blood samples
2. Changes to medications that are POM-Vs, for 
example dose rate or form (liquids to tablets), 
can only be performed by whom?
(A) The veterinary surgeon
(B) The RVN
(C) The client
(D) Receptionists
3. What do written protocols and/or guidelines 
for specific disease processes that RVNs can 
follow in clinics help?
(A) In the overall welfare of the patient
(B) Increased revenue to the practice
(C) Better compliance from all involved
(D) All of the above
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Mentoring and 
supporting students
Andrea Jeffery and Paula Hotston Moore
Mental health is at the forefront of all educational estab­
lishments. It is well recognized that students require 
 support in both their academic needs and their mental 
health needs, to both guide them through their studies 
and in preparation for the working environment. At one 
time or another, most of us will experience a period of 
stress in our lives. How we deal with that stressor, what 
we glean from it, how we cope with it and build up resil­
ience and move forwards towards the future determines 
how prepared we will be for future stressors that come 
our way. Students need mentoring and supporting to 
prepare them for such situations and guide them into 
getting the necessary support so that they can continue 
with their studies and develop as a person.
Students benefit from having someone who is fami­
liar to them and experienced either in the workplace or in 
the educational establishment, to whom they can turn to 
for advice. It is not this person’s role to solve all their 
problems but rather to support the student and to offer 
guidance from where to best seek further help. Students 
need a listening ear, someone in whom they trust, and 
someone who will treat them with respect. 
Support and mentoring can be offered in a variety of 
ways. Students will constantly learn from experiences 
happening around them and therefore the working and 
educational environment must be a supportive one. 
Somewhere where the student feels safe and is readily 
able to learn from role models, other staff and students in 
a supportive and nurturing environment is one that will 
teach the student much about life as well as about the 
veterinary industry. A busy college or university or veter­
inary practice needs to fulfil its job in caring for patients 
or in teaching together with nurturing and supporting 
students in its everyday life. Working in an environment 
that is supportive is important for everyone, not solely for 
students. Support should be at the core of everything 
that is done; indeed, various social media platforms have 
done much to raise awareness of such issues in the 
 veterinary practice. 
How to support and mentor students in everyday life 
as well as in times of poor mental health will be explored 
and discussed further during this lecture.  
KEY LEARNING OBJECTIVES 
■■ To recognize why students need mentoring and 
support
■■ To describe the qualities someone supporting 
students should have
■■ To illustrate how students can be mentored and 
supported in education and in the workplace
Infection control: a 
challenge for the 
whole team
Louise O’Dwyer 
Infection control is a vitally important consideration for 
the whole of the practice, but technicians can play an 
instrumental role in its implementation. As with human 
healthcare facilities, veterinary practices face similar 
challenges with hospital­acquired infections (HAIs). For 
veterinary practice, the close contact between people 
and their pets allows the transmission of infectious 
agents between humans and animals, and in both direc­
tions. As a result, many of the commonly seen HAIs in 
human hospitals are now seen in veterinary hospitals.
Commonly encountered HAIs include:
■■ Intravenous catheter infections 
■■ Surgical site infections 
■■ Pneumonia
■■ Urinary tract infections
In high­risk patients, a high index of suspicion should 
be maintained. In patients developing clinical signs of 
HAI, careful evaluation should be performed for identifi­
cation of an underlying source.
PREVENTING HAIS
Complete prevention of HAIs is impossible, but the inclu­
sion of strategies aimed at limiting infection should be 
present in all hospital situations. There is no current evi­
dence base on which to base these in the current veteri­
nary literature, although there is a wealth of information 
in the human field. Multiple interventions applied at the 
same time will be more efficacious than single interven­
tions, although implementation of this can be difficult.
The following interventions should be considered 
within the hospital environment for the prevention of 
HAIs:
■■ Hand hygiene
■■ Environmental cleaning and disinfection 
■■ Isolation and barrier nursing 
■■ Antimicrobial stewardship
Environmental cleaning and disinfection
Gloves and appropriate personal protective equipment 
(PPE) should be worn whenever using disinfectants. 
Additional PPE should be worn if there is the probability 
of splash from contaminated surfaces or disinfectants. 
Gross contamination will inactivate most disinfectants. 
Wash the area with water and detergent or soap; scrub­
bing or mechanical disruption is necessary to break 
down biofilms and residual debris that prevent or inhibit 
the proper disinfection process. Rinse the cleaned area 
to remove any detergent residue as detergents may 
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 inactivate some disinfectants. Allow area to drain or dry 
as much as possible to prevent dilution of disinfectants.
Isolation and barrier nursing
Guidelines for isolation and barrier nursing should be 
present in all large practices and should be considered 
for any busy emergency practice. These aim to protect 
staff, the patient and other patients from the risk of 
acquiring infectious disease. High­risk patients or those 
that have a HAI should be nursed appropriately to prevent 
the spread of infection. Considerations for the individual 
patient should include the risk to other patients which 
will depend on the agent and the severity of the patient’s 
clinical status. Protective clothing should be available for 
veterinary personnel dealing with the patient. 
CONCLUSIONS
Biosecurity and infection control are major considera­
tions within veterinary hospitals. Biosecurity policies and 
procedures should be developed in each hospital 
to reduce the risk of all nosocomial and zoonotic illness. 
All staff should be trained and confident in ensuring 
strict  adherence to biosecurity and infection­control 
 protocols. 
KEY LEARNING OBJECTIVES
■■ Understand the underlying principles behind 
infection control
■■ Recognize the commonly encountered hospital­
acquired infections and how their incidence can be 
minimized
■■ Gain an improved knowledge in dealing with 
patients in isolation and barrier nursing techniques
MULTIPLE CHOICE QUESTIONS
1. When is reduced compliance with hand 
hygiene protocols seen?
(A) During busier periods
(B) When new products are introduced
(C) When hand hygiene auditing is being 
performed
(D) When only hand gels are available
2. When should gloves ideally be changed?
(A) Moving from contaminated areas to clean 
areas on the same animal
(B) Moving from dirty to clean procedures on 
the same animal
(C) Between individual animals 
(D) All of the above
3. Which of the following describes cleaning and 
disinfection?
(A) Remove organic debris
(B) Protects organisms
(C) Decreases contamination by at least 90%
(D) All of the above
Lungworm: should we 
be worried?
Emily Thomas 
Angiostrongylus vasorum is an emerging and important 
parasite in dogs in the UK that can cause fatal disease 
if  left untreated. It is endemic in southeast England 
and south Wales, and has been reported as far north as 
Scotland. Distribution is patchy, but prevalence and 
spread have increased in recent years. 
The intermediate hosts are slugs and snails, which 
are ingested by the dog. After ingestion the larvae move 
through several life cycle changes, ending up as adults in 
the right side of the heart and pulmonary vasculature. 
Here the adults lay eggs that develop into larvae which 
migrate to the alveoli and are coughed up, swallowed, 
and eventually shed in faeces. Molluscs are infected by 
environmental contact, and the life cycle begins again. 
CLINICAL SIGNS
Angiostrongylus vasorum can cause a range of clinical 
signs in dogs, with disease varying from life threatening to 
subclinical. Pulmonary inflammation may result in cough­
ing, exercise intolerance or respiratory distress. Approxi­
mately one­third of patients present with a  coagulopathy. 
This may cause clinical signs including spontaneous 
bleeding, excessive bleeding after surgery, or  neurological 
signs secondary to bleeding into or around the brain and/
or spinal cord. 
DIAGNOSIS
The IDEXX Angio Detect® test is a rapid, in­house test 
that detects an antigen released by the adult nematode. 
Its sensitivity and specificity are good, but there is still a 
risk of false­negatives, particularly early during infection. 
Faecal smear evaluation is a rough and ready test that 
might be useful when client finances are limited. The 
smear is made by mixing a small quantity of faeces with a 
drop of tap water on a slide, and examined under ×10 
magnification for larvae (https://www.youtube.com/
watch?v=HMjzUNB1LpI). The test has low sensitivity but 
very high specificity, i.e. there is a risk of false­negatives. 
Faecal samples can also be submitted for Baermann 
analysis. Larval shedding can be intermittent, so ideally a 
3­day pooled sample is submitted. Diagnosis can also be 
made from cytology of bronchoalveolar lavage fluid, but 
this procedure is costly and carries risks in patients with 
respiratory compromise. 
Coagulation testing can be useful, including a 
 platelet count and, when available, prothrombin and 
activated partial thromboplastin times. However, there is 
no consistent pattern of coagulation test abnormalities 
characteristic for the parasite.  
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TREATMENT
Initial stabilization for severely affected patients may 
include oxygen supplementation for dyspnoea, fluid 
bolus treatment for hypovolaemia, transfusion of packed 
red blood cells to replace significant blood loss, and/or 
plasma transfusions for patients with abnormal clotting 
times and clinical bleeding.  
Two products are licensed to treat angiostrongylosis 
in the UK: imidacloprid/moxidectin spot­on (Advocate™) 
and milbemycin oxime/praziquantel (Milbemax). Spot­on 
treatment is particularly useful for dyspnoeic patients 
where tablet administration may exacerbate respiratory 
distress. In patients with severe respiratory compromise, 
death of the adult parasites may exacerbate inflamma­
tion. In these cases, an anti­inflammatory dose of dexa­
methasone could be considered.  
PREVENTION
Regular usage of the products listed above can prevent 
infection. Clients can minimize environmental contami­
nation by appropriate disposal of dog faeces. 
KEY LEARNING OBJECTIVES
■■ Describe key clinical signs associated with 
Angiostrongylus vasorum infection
■■ List appropriate diagnostic tests with the pros and 
cons of each 
■■ Outline the initial stabilization and subsequent 
treatment of angiostrongylosis
MULTIPLE CHOICE QUESTIONS
1. What is the most likely cause of neurological 
signs that are occasionally seen in patients with 
angiostrongylosis?
(A) Bleeding into the nervous system caused 
by coagulopathy
(B) Hypercalcaemia
(C) Increased circulating ammonia due to 
hepatic involvement
(D) Toxin released by adult worms
2. Which in­house test is appropriate for 
diagnosis of Angiostrongylus vasorum 
infection?  
(A) Blood smear examination 
(B) Commercially available enzyme­linked 
immunosorbent assay (ELISA) detecting 
circulating antigen
(C) In­saline agglutination test
(D) Real­time polymerase chain reaction 
(PCR) assay
3. What is the most appropriate treatment for a 
patient with severe respiratory distress caused 
by Angiostrongylus vasorum? 
(A) Dexamethasone
(B) Fenbendazole
(C) Imidacloprid/moxidectin spot­on
(D) Potentiated amoxicillin
Where have all the 
nurses gone and why 
are they leaving?
Andrea Jeffery
Where are all the nurses going and why are they leaving? 
The aim of this lecture is to discuss the key factors which 
influence retention within the veterinary nursing profession 
and discuss a set of recommendations relating to these. 
There has, for a period of time been anecdotal evidence 
that recruitment of registered veterinary murses (RVNs) has 
been difficult and that a significant number of veterinary 
nurses are leaving the profession year on year. The session 
will review current evidence surrounding the loss of RVNs 
and those who have indicated an intention to leave the 
 profession and consider the factors which influence this.
The lecture will go on to highlight the factors which 
are important to the many nurses who remain in the 
 profession and how we as a profession can influence 
change. The VN Futures initiative and how the voice of the 
profession was the driving force behind it will be dis­
cussed. The lecture will also cover the proposed structure 
of the new post­registration qualification and its accessi­
bility to all RVNs, as well as the rationale for the change 
to  the current RCVS Diploma in Advanced Veterinary 
Nursing and how the need for this became apparent.
KEY LEARNING OBJECTIVES
■■ The three key factors which influence retention 
within the profession
■■ How the VN Futures initiative might help with the 
factors associated with retention
■■ What the new RCVS post­registration qualifications 
offer in terms of personal professional  
development
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Nursing and treatment 
options for the 
hyperthyroid cat
Suzanne Rudd 
Hyperthyroidism is a common disorder in middle­aged 
to senior cats. Increased thyroxine will vastly increase the 
body’s metabolism and affect most major organs in the 
body. As a consequence of this, hyperthyroidism can 
cause secondary complications such as cardiac disease, 
renal disease and hypertension. 
Diagnosis of hyperthyroidism is made by measuring 
thyroxine levels in the blood. Blood should also be taken 
to look for concurrent illness and provide baseline 
parameters before starting any treatments.
There are four main treatment options for hyperthy­
roidism.
■■ Medical management is the most common 
treatment used for initial stabilization. Owners will 
need to medicate their cat once or twice daily either 
by tablet, liquid medicine or transdermal gel. Some 
cats will display side effects associated with the 
drugs. Another treatment option will have to be 
explored for cats showing side effects. While 
medical management will reduce T4 levels, the 
thyroid tumour will not reduce in size and may even 
continue to grow, meaning that drug dosage may 
need to be increased over time and the condition 
can become more difficult to treat
■■ A prescription diet reduced in iodine is available to 
treat hyperthyroid cats. The diet is an option for 
owners who are unable to medicate their cat and 
where the cat is not a candidate for surgery or 
radioactive iodine (RAI). To be effective a strict 
feeding regime has to be followed which can be 
difficult in cats that go outdoors and eat elsewhere 
or hunt and also in cats from a multicat household
■■ Surgical thyroidectomy involves removing either 
one or both thyroid glands. Risks include damage 
to, or in some cases, accidental removal of, the 
parathyroid gland which may result in 
hypocalcaemia. Calcium levels should be monitored 
for 3 days postoperatively. Hypocalcaemia will need 
to be treated with calcium supplementation along 
with vitamin D. Surgery is not an option if there is 
ectopic overactive thyroid tissue. This can be 
confirmed using scintigraphy
■■ RAI is a safe and effective cure. This treatment can 
only be given in licensed premises therefore only 
available in a few specialist centers around the UK. 
Post injection they are housed in an isolation unit 
until the radiation has reduced to an acceptable 
level. Depending on the centre this can be between 
1 and 6 weeks. Because of the period of 
hospitalization, it is important to ensure the cat has 
no serious underlying diseases. Every cat should be 
assessed for suitability by undergoing blood/urine 
analysis and diagnostic imaging. After RAI some cats 
may become hypothyroid. In a small number of 
cases thyroxine supplementation may be required
All treatments mentioned above are suitable to treat 
thyroid adenoma. However, adenocarcinoma tumours 
are more difficult to treat. RAI is a treatment option but 
much higher doses of iodine need to be given, meaning 
hospitalization in isolation will be much longer. 
Handling hyperthyroid cats can be challenging as 
they generally become stressed very quickly. Minimal 
handling should be employed with a calm and patient 
cat­friendly attitude. Procedures such as blood­pressure 
measurement, blood sampling and ultrasonography may 
need to be performed in stages. Persisting with a proce­
dure in an already stressed and uncontrolled hyperthy­
roid cat may cause arrhythmias and heart failure, so great 
care should be taken. Sedation for procedures such as 
radiography and ultrasonography is also advised in the 
stressed hyperthyroid cat. Hyperthyroid cats are at great 
risk of hypothermia during sedation, so monitoring 
 temperature and minimizing heat loss is advised. 
KEY LEARNING OBJECTIVES
■■ Free T4 is a more sensitive test than total T4, 
however free T4 is less specific, therefore total T4 
should be measured in the first instance
■■ Overactive thyroid tissue can sometimes be found 
in the thorax, therefore scintigraphy is needed to 
diagnose this
■■ Radioactive iodine treatment is the gold standard 
treatment for cats with hyperthyroidism and can be 
used to treat adenoma and carcinoma tumours
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements is FALSE?
(A) Scintigraphy can be used to diagnose 
hyperthyroidism
(B) Scintigraphy can be used to differentiate 
between a thyroid adenoma and 
carcinoma
(C) Scintigraphy can be used to locate ectopic 
thyroid tissue
(D) Scintigraphy involves using a radioactive 
substance
2. Hyperthyroidism in cats is best diagnosed by 
which diagnostic test?
(A) TSH
(B) Free T4
(C) Total T4
(D) T3
3. After a bilateral thyroidectomy calcium levels 
should be checked how often and for how long 
after surgery?
(A) One to two times daily for 3 days
(B) One to two times daily for 7 days
(C) Once after 24 hours
(D) Three times daily for 3 days
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Ill communication: 
effective team 
handovers 
Louise O’Dwyer 
Patient handovers, defined as ‘the transfer of information 
and professional responsibility and accountability 
between individuals and teams’ are high­risk, error­prone 
patient care episodes. Handover failures are common and 
can result in diagnostic and therapeutic delays and 
worsen the incidence of adverse events. The transfer of 
patients following surgery, to the ICU or recovery team, or 
between different shift teams, presents particular chal­
lenges to healthcare providers on both the delivering and 
receiving teams. The operating room (OR) anaesthesia 
and surgical team is charged with transporting the patient, 
along with clinical and monitoring equipment, from the 
OR to the receiving unit, while simultaneously monitoring 
and performing additional therapeutic tasks such as 
 manual ventilation. Upon arrival at the receiving unit, the 
technology and patient­support responsibilities are trans­
ferred to a different team of staff, for whom knowledge 
of  the patient is gained in an environment that is often 
 chaotic and busy, and to a team largely unfamiliar with 
the  patient. This knowledge transfer involves cross­ 
disciplinary staff with varied experience: the delivering 
team members with their diverse yet important perspec­
tives of the course of surgery and treatment, and the 
receiving team concurrently stabilizing, assessing, and 
making care plans for the patient. 
It is not surprising, under these circumstances, that 
patient handovers are rife with technical and communi­
cation errors.
 
As recognition of the risks inherent to 
patient handovers has grown, increasing attention has 
focused on this process of care. 
In 2007, the iSoBAR system was developed, the brief 
for this handover system was to develop a standardized 
and transferable clinical handover process and checklist. 
This system comprises:
■■ Identify: introduce yourself and your patient
■■ Situation: why are you calling? Briefly state the 
problem
■■ Observations: recent vital signs and clinical 
assessment
■■ Background: pertinent information related to the 
patient
■■ Agreed plan: what needs to happen? Assessment of 
the situation
■■ Read back: clarify and check for shared 
understanding. Who is responsible for what and 
by when?
The use of the iSoBAR approach will be discussed 
further during the lecture, along with surgical safety 
checklists and significant event reporting. 
KEY LEARNING OBJECTIVES
■■ Gain an understanding in how communication can 
fail in busy clinical environments
■■ Recognize how multiprofessional teams can work 
together to create seamless communication
■■ Gain an understanding of, and an ability to use, 
standardized handover systems and checklists
MULTIPLE CHOICE QUESTIONS 
1. Which of the following is NOT a component of 
the iSoBAR handover system?
(A) Instruction: give roles to specific member 
of your team
(B) Situation: why are you calling? Briefly state 
the problem
(C) Observations: recent vital signs and clinical 
assessment
(D) Background: pertinent information related 
to the patient
2. Which of the following can create challenges/
failures in terms of patient handovers?
(A) Teams unfamiliar with the patient
(B) Transfer of patients following surgery, to 
the ICU or recovery team, or between 
different shift teams
(C) Chaotic and busy environments
(D) All of the above
3. Which sport has a team which is viewed as the 
model example of how a multiprofessional 
team works together as a single unit?
(A) Champions League football
(B) Pit­stop in Formula 1 motor racing
(C) Ball boys/girls at Wimbledon 
(D) World Cricket series 
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Nursing the trauma 
patient 
Louise O’Dwyer 
TRAUMA: INITIAL ASSESSMENT 
AND STABILIZATION
Trauma is a common cause of emergency presentations 
in small animal practice. Due to our patients’ small size 
the potential for multisystem damage is high and their 
injuries need to be approached in a systematic manner 
to  ensure than no life-threatening abnormalities are 
missed. Appropriate management in the first few hours 
is vital for success. Many patients benefit from a multi-
modal approach in the successive days, concentrating 
on careful nursing, nutrition and pain relief.
MANAGEMENT OF MAJOR BODY SYSTEM 
ABNORMALITIES 
Cardiovascular
Mortality in hypovolaemic shock is related to duration of 
the ischaemic insult. Early replacement of circulating 
volume is key to successful patient management. Stabili-
zation of the cardiovascular system is aimed at replace-
ment of lost circulating volume with intravenous fluid 
therapy. First choice is always isotonic crystalloid fluids, 
e.g. lactated Ringer’s solution. The volume of fluid given 
is based upon the severity of hypoperfusion. A propor-
tion of ‘shock dose’ is administered over a short period of 
time (15–20 minutes) and the patient reassessed.
Respiratory
In severely dyspnoeic animals, actively taking control of 
the airway (which often only requires very small doses of 
sedative in severely dyspnoeic animals) is vastly superior 
to intubating them following a respiratory arrest.
The first part of the evaluation of the respiratory 
tract should be to watch and listen without a  stethoscope. 
An enormous amount of information can be gleaned 
from just observation, before even touching the patient. 
One should also be aware of the postural manifestations 
of dyspnoea such as extended neck, abducted elbows, 
open-mouth breathing, an anxious facial expression, 
increased abdominal movement and paradoxical 
abdominal movement. 
The differentiation between inspiratory and expira-
tory dyspnoea can also aid in the localization of the 
 disease process. Inspiratory dyspnoea with stridor or 
 stertor is associated with dynamic upper airway obstruc-
tion. In cats, chronic pleural effusions may be associated 
with inspiratory dyspnoea without stertor. Expiratory 
dyspnoea is a feature of feline allergic airway disease. 
Most  other causes of dyspnoea will be associated with 
mixed respiratory patterns. Short shallow respiration and 
sometimes panting may be seen in some pneumothoraces. 
Neurological
Neurological assessment should only really be inter-
preted in patients that are cardiovascularly stable. Any 
abnormalities found on initial examination should be 
corroborated later.
Where brain injury is suspected, cranial nerve testing 
should be carried out to evaluate for increased intracra-
nial pressure. This is usually seen as unilateral changes 
in  pupillary size. Unresponsive pupils that are mid-size 
occur with brainstem trauma that progresses into the 
medulla, and are usually a grave sign. There may also 
be  an associated Cushing’s response. This response 
occurs secondary to increased intracranial pressure (ICP) 
and results in systemic hypertension and associated 
 secondary bradycardia. 
The primary aim in patients with brain injury is to 
restore and maintain tissue perfusion and oxygen 
 therapy. Oxygen should be administered and efforts to 
restore circulating volume initiated.
KEY LEARNING OBJECTIVES
■■ Gain confidence in the assessment of trauma 
patients
■■ Recognize major body system abnormalities, to 
allow prioritization of treatment
■■ Understand the focus of stabilization of trauma 
patients in terms of normalization of the respiratory, 
cardiovascular and neurological systems
MULTIPLE CHOICE QUESTIONS
1. A cat involved in a road traffic accident 
presents with pale mucous membranes and a 
slow capillary refill time. Which of the following 
heart rates would cause most concern?
(A) 120 bpm
(B) 170 bpm
(C) 180 bpm
(D) 190 bpm
2. Which of the following is a normal blood 
lactate measurement?
(A) <2.5 mmol/l
(B) 2.5–7.5 mmol/l
(C) 7.5–10 mmol/l
(D) 10–15 mmol/l
3. What does hypovolaemic shock refer to?
(A) Loss of red blood cells
(B) Tissue dehydration
(C) Loss of intravascular circulating volume 
(D) Loss of extravascular fluid
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Nutrition myths 
in critical patients
Nicola Ackerman
Nutrition, in all patients, depends on the disease process 
and/or the individual’s specific requirements. Each case 
must be considered on its own specific requirements 
once a full clinical examination (including nutritional 
assessment) and history has been achieved. The sole aim 
can be defined as to prevent and/or treat malnutrition. 
To define any nutritional aims in more depth, it is more 
beneficial to split the aims in to short-term and long-
term goals. The short-term aims are to:
■■ Provide for any ongoing nutritional requirements 
(both in terms of energy and nutrients)
■■ Prevent or correct any nutritional deficiencies or 
imbalances
■■ Minimize metabolic derangements
■■ Prevention of further catabolism of lean body mass
Long-term nutritional aims should include:
■■ Restoration of optimal body condition (body 
condition score (BCS), and muscle condition score 
(MCS))
■■ Provide required nutrients to the animal within its 
own environment that aid in promoting good health
There are many nutritional myths that are commonly 
seen in veterinary practice. These range from misinf-
ormation in matters concerning certain ingredients 
 commonly found in pet foods, to what foods should be 
fed and how to calculate energy requirements. It is very 
common to see energy requirements being met, but 
specific nutrient requirements are often overlooked.  
The role of fats in the diet is often misunderstood. 
The types of fats and the fat levels are equally important. 
In gastrointestinal disease, fats play an important role in 
energy supply, reduction of inflammation, transport of 
fat-soluble vitamins and in repair of the cell phospholipid 
layer in cell walls. Foods that are severely restricted in fat 
levels might not be indicated in many disease processes. 
The role of grains in the diet is also often misunder-
stood. Grains provide an excellent fibre source, of differ-
ent fibre types (fermentable and non-fermentable). Fibre 
is important in normalizing gut transit time, providing 
nutrients to the gut biome and aiding in producing a 
more acceptable faecal stool. 
KEY LEARNING OBJECTIVES
■■ To be able to look at the nutrition evidence base in 
order to make a supported recommendation for the 
patient and client
■■ Understand some of the misinformation concerning 
nutrition and how to discuss this with pet owners
■■ How to calculate energy requirements based on 
nutritional assessment and ensure that the nutrient 
requirement is met
MULTIPLE CHOICE QUESTIONS
1. Which of the following is one of the 
calculations that can be used to calculate 
resting energy requirements (RER)?
(A) RER = 70 × (bwt kg)0.75
(B) RER = 30 × (bwt kg)0.75
(C) RER = 70 × (bwt kg)0.50
(D) RER = 30 × (bwt kg)0.50
2. When is the best time to start a diet transition?
(A) As soon as the animal has been diagnosed
(B) Once the animal is settled at home
(C) In the practice ward
(D) Once the animal is better
3. Which of the following is correct about 
high-fat diets? 
(A) Take a shorter time to empty from the 
stomach
(B) Take the same time to empty from the 
stomach
(C) Take a longer time to empty from the 
stomach
(D) Cause constipation
Common toxins 
in dogs
Sarah Egleston 
Toxins are a common complication dealt with in the 
referral and first-opinion veterinary setting. Dogs can be 
exposed to a variety of foods, drugs and chemicals which 
can pose a risk to their health. 
Adequate telephone triage is paramount in these 
patients. Ingestion of some toxins requires immediate 
intervention and may be immediately life-threatening. 
At home remedies to induce emesis should be avoided, 
as these can cause complications which would be  better 
dealt with in the veterinary environment (e.g. aspiration, 
choking or a vasovagal response). It is useful to know 
what toxin the patient has ingested and when. If the 
owner is aware what toxin their pet has ingested, asking 
them to bring it with them to the clinic can be useful. 
On presentation to the clinic, these patients 
should  have an immediate assessment of the major 
body  system and any life-threatening problem treated 
first. Decontamination can be performed if indicated. 
One type of decontamination is emesis; a medication 
used routinely in hospital to induce emesis in dogs is 
 apomorphine. This is indicated if the toxin has been 
ingested within the previous 4 hours. The patient will 
suffer more adverse effects due to the toxin, the longer 
we wait to induce emesis, so prioritizing these cases is 
key. Emesis should be avoided if a patient is drowsy or 
unconscious, seizuring, or has a reduced gag reflex. 
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Other forms of decontamination are topical, gastric 
 lavage and intralipid infusion.  
Contraindications to inducing emesis include any 
patient with:
■■ Respiratory distress
■■ Seizure activity
■■ Neurological impairments
■■ Oesophageal disease
Emesis is also contraindicated if the toxin is:
■■ Caustic or corrosive material
■■ Acid or alkali material
■■ Sharp objects, e.g. bone
■■ Large amounts of cloth or material
Activated charcoal can be administered orally and 
binds to some toxins left after decontamination. It is 
known not to effectively absorb certain toxins (e.g. 
 metals, detergents). Charcoal can be given in a small 
amount of food to promote ingestion, or via a  nasogastric 
feeding tube. Administration via a syringe should be 
avoided as there is the risk of the patient aspirating it. 
The goal of further therapy is to prevent any further 
toxin absorption and administering of any antidotes 
needed. Supportive care should also be provided. Organ 
damage can be caused by some toxins, so further treat-
ments based on clinical signs should be administered. 
See Figure 1.
KEY LEARNING OBJECTIVES
■■ To have good understand of the urgency of some 
ingested toxins
■■ To understand the need to prioritize these patients
■■ Know the common toxins in the dog, and how we 
treat them in a clinical setting
Chocolate The toxic ingredient in chocolate is theobromine and varies in concentration 
depending on the chocolate ingested (e.g. dark chocolate contains more than 
white chocolate). Signs: agitation, muscle tremors, tachyarrhythmias and 
hyperexcitability
Raisins and grapes The toxic quantity ingested of these depends on the dog, and the toxic 
mechanism is not currently understood. These are nephrotoxic
Non-steroidal anti-inflammatory 
medication (e.g. ibuprofen)
Used commonly in the home for pain management. Ibuprofen specifically can 
cause gastrointestinal signs and kidney damage
Xylitol An artificial sweetener commonly found in chewing gum and peanut butter. 
Causes liver damage, hypoglycaemia and seizures
Anticoagulant rodenticides Used to control rodent infestations. Not all rodenticides are anticoagulant, 
so the ingredients should be checked. Signs include petechiae and 
 haemorrhage
Figure 1: Some common toxins in the dog
MULTIPLE CHOICE QUESTIONS
1. Which of the following is a sign of xylitol 
toxicity?
(A) Hypoglycemia
(B) Liver damage
(C) Seizures
(D) All of the above
2. If emesis is indicated, should it be initiated less 
than 4 hours post ingestion?
(A) Yes
(B) No
3. Should activated charcoal be administered 
regardless of what type of toxin has been 
ingested?
(A) Yes 
(B) No
Bleeding nightmares
Emily Thomas 
Bleeding disorders are common in pets and can be life-
threatening. Nurses are involved with initial triage and 
stabilization of bleeding patients, diagnostic testing and 
facilitating treatment. Coagulation is a rapidly evolving 
and complex field, but a remarkable amount can be done 
based on first principles with minimal equipment. 
EMERGENCY APPROACH
The first step in any bleeding patient is to assess the 
major body systems and start emergency stabilization 
as  appropriate. Actively bleeding patients are at risk of 
hypovolaemic shock and, if present, this should be 
treated immediately with a bolus of isotonic crystalloid 
fluids. When possible, haemostasis is achieved by apply-
ing pressure using swabs. Tourniquets should be avoided. 
Patients bleeding into the lungs or pleural space may 
be dyspnoeic, in which case oxygen should be supple-
mented as a priority. Haemorrhage into the brain can 
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cause seizures or altered level of consciousness. These 
patients should have their front end elevated on a slant 
board at 15–30 degrees, flow-by oxygen provided, and 
anything restricting jugular outflow (e.g. collar) removed. 
Careful handling is essential for patients with a 
 suspected coagulopathy. Avoid jugular venepuncture, 
and neck leads (use a harness). Blood samples should be 
taken at intravenous catheter placement to avoid sticking 
the patient more than once. Therefore, think ahead and 
collect extra samples that may be required (e.g. citrate 
tube for coagulation times, extra EDTA for blood typing). 
TIPS FOR TRICKY HAEMOSTASIS
Epistaxis is treated with ice packs, cage rest and mild seda-
tion (care to avoid hypotension). Packing the nose using 
tampons soaked in dilute adrenaline (1:100,000) can be 
helpful but is often poorly tolerated without deep sedation. 
Abdominal wraps can be considered for peritoneal 
haemorrhage, but are controversial. There is increasing 
interest in the use of tranexamic acid (10 mg/kg slow i.v.) in 
veterinary medicine. This reduces breakdown of the fibrin 
clot, and may help mitigate haemorrhage. Autotrans fusion 
carries risks, but may be life-saving as a last resort. 
HOW DOES BLOOD CLOT?
Coagulation is traditionally divided into sequential pri-
mary and secondary haemostasis. Primary haemostasis 
is platelet activation and aggregation to form a ‘plug’ at 
the site of injury. Secondary haemostasis is the serial 
activation of coagulation factors in a cascade-like fash-
ion with ultimate formation of fibrin, which stabilizes the 
platelet plug. We now know that interactions between 
platelets and coagulation factors are more complex than 
this, and as research progresses our clinical approach is 
likely to change in the future. 
COAGULATION TESTING
Coagulation tests are notoriously unreliable and blood 
must be collected with minimal trauma (from a periph-
eral intravenous catheter at placement is fine), and tubes 
filled to exactly the volume required. Automated platelet 
counts must be confirmed with blood smear evaluation. 
Further details with videos and illustrations can be found 
at https://ahdc.vet.cornell.edu/Sects/Coag/samplingove-
rview.cfm and http://www.eclinpath.com/hematology/
tests/platelet-count/ (accessed September 2018). 
Point-of-care analysers are increasingly available for 
testing secondary haemostasis (prothrombin time (PT), 
activated partial thromboplastin time (aPTT)). If in-house 
analysis is unavailable but immediate results are required, 
then a local referral hospital may be able to run the tests 
for you. 
KEY LEARNING OBJECTIVES
■■ Recognize systemic consequences of severe 
haemorrhage and describe key nursing 
interventions for their stabilization
■■ Outline some basic and advanced techniques for 
non-surgical haemostasis
■■ Identify how routinely available coagulation tests 
relate to different stages of coagulation, and 
describe appropriate sample collection
MULTIPLE CHOICE QUESTIONS
1. Which of the following is an appropriate initial 
nursing intervention for a comatose patient 
with suspected intracranial haemorrhage?
(A) Administer tranexamic acid 10 mg/kg slow i.v.
(B) Apply ice packs over the head
(C) Elevate the patient’s front end on a slant 
board at 20 degrees
(D) Ensure body temperature is maintained 
(e.g. blanket, hot hands)
2. Which statement is correct about PT 
(prothrombin time) testing?
(A) Anticoagulant rodenticide toxicity causes 
prolongation of PT
(B) It tests for primary haemostasis
(C) Samples must be collected from the 
jugular through a 21-G needle
(D) This test can only be run at specialist 
laboratories
3. A 6-year-old female neutered Cocker Spaniel 
presents with severe epistaxis. Which of the 
following statements is true about nasal packing?
(A) A tampon soaked in dilute adrenaline can 
be used
(B) It is typically well tolerated but may cause 
sneezing
(C) Packing should not be attempted before 
diagnostic testing has been performed
(D) The patient is anaesthetized and swabs 
placed via the retropharyngeal space
How to manage a 
chest drain
Emily Thomas
The pleural space is a potential space around the lungs 
which can become filled with fluid, air, soft tissue masses 
or abdominal contents. Chest drains are placed to 
remove severe or recurrent accumulations of air or fluid 
from this space. Traditionally, trochar chest drains were 
placed, but less invasive Mila chest drains, placed using a 
Seldinger (over-the-wire) technique, are now often used 
(https://www.youtube.com/watch?v=MqnB_Eq6clo).
MAINTENANCE AND MONITORING
Chest drains should always be handled in a sterile fashion 
(i.e. scrub or wash/Sterillium® before sterile gloving). 
The insertion site is covered with a sterile dressing, and 
 padded for patient comfort. The dressing and padding 
are secured with stockinette or loose cohesive bandage 
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around the thorax. Ensure that this is not too tight and 
does not rub at pressure points (e.g. around forelimbs). 
The dressing is changed daily and the drain insertion site 
is inspected for abnormal skin colour, discharge or malo-
dour. The length of drain outside the chest should be 
checked daily to ensure it is not migrating. Sutures are 
also checked. An Elizabethan collar is essential to prevent 
interference with the drain and development of pneu-
mothorax. At least two different closure methods should 
be in place (e.g. clamp and bung) unless suction is being 
performed.
Chest drain complications include tension pneumo-
thorax, which can be rapidly life-threatening. Therefore, 
24-hour patient monitoring is essential. Respiratory rate 
and effort should be noted every couple of hours, and a 
full patient check including bilateral thoracic ausculta-
tion with a stethoscope should be performed several 
times daily. Subcutaneous emphysema may indicate 
migration of drain holes. New-onset pyrexia should 
prompt inspection of the drain site for possible infection.
ANALGESIA
Levels of pain will vary depending whether the patient 
has undergone thoracic surgery. However, chest drains 
are uncomfortable even in non-surgical patients. Fre-
quent assessment is recommended using a pain scoring 
tool (e.g. https://www.ava.eu.com/wp-content/uploads/ 
2015/11/GlasgowPainScale.pdf). Multimodal analgesia is 
useful and may include systemically administered anal-
gesics and local anaesthetics. A maximum total dose of 
2 mg/kg (dog) or 1 mg/kg (cat) 0.5% bupivacaine diluted 
1:10 with 0.9% NaCl instilled via the chest tube (sterile 
technique) can provide analgesia for up to 8 hours, 
although instillation can be painful. 
SUCTIONING
Intermittent suction is performed using sterile technique 
with a three-way tap and Luer-lock syringe (5–50 ml 
depending on patient size and volume expected). Take 
care that the drain is never left open to the environment, 
which may cause pneumothorax. Document the amount 
retrieved, appearance of any fluid, and side of thorax 
(if bilateral drains in place). 
Continuous suction is appropriate if large volumes are 
accumulating rapidly. Commercial single and  multi-use 
continuous suction units are available. These usually use a 
three chamber system with a water seal (for an explana-
tion of the mechanism see https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC4356865/). Continuous suction can also 
be achieved with a one-way valve known as a Heimlich 
valve. Heimlich valves can be useful in patients with large-
volume pneumothorax, but do not allow quantification of 
air that is drained.
KEY LEARNING OBJECTIVES
■■ Describe appropriate monitoring for a patient with a 
chest drain, including how to change dressings and 
monitor the drain insertion site
■■ List options for providing multimodal analgesia for 
chest drain patients
■■ Outline how to perform chest drain suction 
(intermittent or continuous)
MULTIPLE CHOICE QUESTIONS
1. What is a Heimlich valve used for?
(A) Continuous evacuation of pneumothorax 
via a chest drain
(B) Sterile intrapleural administration of drugs
(C) Maintenance of a patent water seal in three- 
chamber commercial suction systems
(D) Wire introduction during Seldinger 
technique chest tube placement
2. Which drug is often administered intrapleurally?
(A) Bupivacaine
(B) Buprenorphine
(C) Carprofen
(D) Ketamine
3. During a routine check of a chest drain patient 
you notice subcutaneous emphysema along 
the patient’s flank. What is the most appropriate 
next step? 
(A) Apply loose cohesive bandage around 
the area
(B) Check drain for migration
(C) Suction the chest drain
(D) Take the patient’s temperature
How to place nasal 
oxygen catheters
Sarah Egleston 
In patients with respiratory problems, oxygen should be 
administered. On presentation of the patient for the 
 initial stabilization and assessment, short-term oxygen 
therapy can be given via mask or flow-by. Ongoing 
 long-term oxygen therapy can be administered via a 
commercial oxygen cage, nasal prongs, nasal cannula or 
mechanical ventilation. Usually, nasal prongs are the first 
choice for long-term oxygen therapy, but these can eas-
ily become dislodged and are then unreliable for oxygen 
delivery. A nasal cannula can be placed, unilaterally or 
bilaterally. Oxygen can then be delivered directly into the 
respiratory tract via a silicone feeding tube attached to 
an oxygen source. It is necessary to humidify long-term 
oxygen therapy, to prevent desiccation and irritation of 
the respiratory mucous membranes. 
A unilateral nasal cannula can deliver an oxygen 
 percentage of 40–50%, and bilateral can deliver a per-
centage of 60–70%. The suggested oxygen flow rate for 
nasal cannulae is 50–100 ml/kg/min. 
Mild sedation (butorphanol 0.1–0.2 mg/kg) can be 
given before placement, to settle the patient and make 
them more amenable. 
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Equipment needed includes:
■■ 0.5% proxymetacaine 
■■ Skin suture 
■■ Silicon feeding tube 
■■ Sterile lubricating jelly 
■■ Adhesive tape
■■ Gloves
Method:
1. Measure the silicone feeding tube from the nostril to 
the medial lateral canthus and mark the point on the 
tube
2. Five minutes prior to placement, insert a few drops 
of the 0.5% proxymetacaine down the desired 
nostril, and in the eye of the same side. This acts as 
a local anaesthetic and helps prevent the patient 
being irritated
3. The patient’s head should be positioned dorsally 
and wearing gloves the lubricated tube is placed 
into the ventral meatus, aiming for the base of the 
opposite ear
4. The tube should then be advanced gently, until it is 
up to the marked spot
5. Butterfly winged tape is attached to the tube near 
the nostril, where it should be sutured in place
6. The catheter should then be looped dorsally 
between the eyes and sutured in place through 
butterfly winged tape
7. The process should then be repeated in the other 
nostril if desired
In an emergency, nasal cannulae can be secured 
with staples, but these should be replaced with a suture 
when the animal is stable, as staples can cause more pain 
and trauma to the skin. 
Complications can include:
■■ Excessive sneezing
■■ Dyspnoea if upper airway disease is present 
(e.g. brachycephalic breeds)
■■ Epistaxis
■■ Nasal cannulae should be avoided in the head 
trauma patient, to avoid sneezing, as this raises 
intracranial pressure
■■ Animals that are panting or open-mouth breathing 
are poor candidates, as the air mixes in the pharynx 
and reduces the efficiency of the cannula
Cannulae can stay in place for a prolonged period 
while the patient recovers from his/her respiratory injury, 
disease or infection. An Elizabethan collar can be used to 
ensure the patient doesn’t remove the cannula. 
KEY LEARNING OBJECTIVES
■■ Understand what equipment is needed for 
placement of nasal cannula
■■ Learn how to place a nasal cannula
■■ Understand what patients would benefit from 
placement, and complications that can be 
encountered
Nursing the septic 
abdomen patient
Sarah Egleston 
Septic abdomen is an inflammatory condition of the 
abdomen secondary to bacterial infection. Systemic 
inflammatory response syndrome (SIRS) happens in 
response to that infection. Some common causes of 
septic peritonitis in our veterinary patients are surgical 
contamination, abscesses, neoplasia and penetrating 
foreign bodies. Septic patients have a high rate of mortal-
ity. Management of these patients can present a chal-
lenge to the nursing team as they require constant 
monitoring and often one-on-one 24-hour nursing care. 
PATIENT ASSESSMENT
The level of observation pre- and postoperatively 
depends on numerous factors (maintaining homeostasis, 
managing pain and perfusion). Patients that are less  stable 
require more intensive monitoring (i.e. every 15 minutes), 
and the more stable patient may require assessment 
every 1–2 hours. It can be difficult to ensure all the 
patient’s needs are assessed, so it is important to take into 
account multiple critical parameters. 
■■ Cardiovascular system: heart rate can be monitored 
via thoracic auscultation, pulse rate and 
electrocardiogram (ECG). Mucous membranes and 
capillary refill time can indicate issues if abnormal, 
and blood pressure should be assessed
■■ Respiratory system: respiration rate, effort and 
pattern should be assessed before handling the 
patient. Lung sounds should be auscultated. Oxygen 
can be administered in a patient with impaired 
respiration
■■ Neurological status: this should be assessed every 
time we interact with the patient, and we can use 
the modified Glasgow Coma Scale to assess trends 
in neurological status
■■ Fluid balance: monitoring ins and outs is key in 
these patients to ensure adequate volume status. 
MULTIPLE CHOICE QUESTIONS
1. What is the suggested flow rate of oxygen for 
patients with nasal cannulae in place?
(A) 200 ml/kg/h
(B) 50–100 ml/kg/h
(C) 50–100 ml/kg/min
(D) 2 ml/kg/h
2. What oxygen percentage can bilateral nasal 
cannulae deliver?
(A) 30–40%
(B) 50–60%
(C) 60–70%
(D) 70–80%
3. Can long-term oxygen therapy be delivered via 
non-humified flow-by oxygen?
(A) Yes (B) No
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Dehydration should be corrected in 12–24 hours. 
Maintenance crystalloids can be used to maintain 
fluid balance. Synthetic colloids should be avoided 
as these are associated with the risk of acute kidney 
injury and impaired coagulation in our septic 
patients. To ensure the patient doesn’t become 
under- or overhydrated, fluid balance should be 
re-evaluated frequently
■■ Glucose and electrolytes: glucose is commonly 
altered in septic patients. We can administer a 
constant rate infusion (CRI) of glucose, or an insulin 
CRI if the patient is hyperglycaemic. Glucose should 
be monitored regularly to ensure euglycaemia. 
Electrolytes should also be checked regularly and 
any deficits corrected with appropriate fluid therapy 
and supplementation as needed
■■ Coagulation: these patients are at risk of developing 
disseminated intravascular coagulation (DIC). Platelet 
count and clotting times should be monitored
■■ Nutrition and proteins: where possible, enteral 
nutrition is preferred over parenteral nutrition. 
Enteral nutrition should be avoided if the patient is 
neurologically inappropriate, has a reduced gag or 
is regurgitating/vomiting. Early enteral nutrition 
(<24 hours postoperatively) has been associated 
with a better prognosis. A nasogastric feeding tube 
can be placed to facilitate this
We should be providing a gold-standard level of care 
to our patients and flagging up any concerns with the 
case veterinary surgeon when necessary. 
KEY LEARNING OBJECTIVES
■■ Challenges with the septic abdomen patient
■■ Gain improved knowledge on how to carry  
out an assessment in these septic abdomen  
patients
■■ Understand what clinical parameters we should be 
worried about in these patients
MULTIPLE CHOICE QUESTIONS
1. Is enteral feeding preferred in the septic patient 
over parenteral feeding?
(A) Yes
(B) No
2. What fluid therapy should be avoided in the 
septic abdomen patient?
(A) Compound sodium lactate
(B) Synthetic colloids
(C) Sodium chloride 0.9%
(D) Fresh frozen plasma
3. Within how long should dehydration be 
corrected?
(A) 0–12 hours
(B) 12–24 hours
(C) 24–36 hours
(D) 36–48 hours 
Dying to pee: Nursing 
the blocked cat
Suzanne Rudd 
A cat with a urethral obstruction will usually present with 
a large, firm, painful bladder. The nurse should triage the 
cat on arrival, paying particular attention to the bladder 
and the cardiovascular system, as hyperkalaemia is one 
of the most severe complications seen with urethral 
obstruction causing bradydysrhythmias, atrioventricular 
block and/or atrial standstill. An electrocardiograph (ECG) 
should be used for assessment and monitoring. Blood 
should be taken to measure electrolytes and renal values 
as a minimum. 
Intravenous fluid therapy should be given. It is essen-
tial that cats with blood results showing metabolic or 
cardiac abnormalities should be stabilized first before 
sedation or anesthesia (a protocol can be found in the 
BSAVA Manual of Feline Practice). 
If the bladder is so large and the cat is unfit to be 
anaesthetized, then the veterinary surgeon can consider 
careful decompressive cystocentesis or, in a collapsed 
cat, gentle conscious catheterization. 
Once stabilized, the cat can be anaesthetized. Opioid 
analgesia is essential during the unblocking procedure 
and postoperatively. Relieving the obstruction should be 
tried by catheterization and retrograde hydropulsion. 
Plain radiography as well as intrarectal palpation may 
help locate the blockage. If the obstruction cannot be 
felt then catheterization and flushing with saline should 
be tried initially. 
Once the blockage is relieved the urinary catheter can 
be passed and all of the urine removed. Samples can then 
be taken and diagnostic imaging performed to determine 
the cause of the obstruction. The bladder should then be 
lavaged, drained and the catheter removed. A catheter 
may need to be left in situ if the cat has had repeated 
obstructions that are difficult to relieve, severe inflamma-
tion and swelling of the penis and prepuce, or if there are 
persistent metabolic abnormalities where urine output 
needs to be monitored. If the catheter is to be left in place 
a soft catheter should be used and sutured in place. 
 Catheters are generally left in for 1–4 days to allow the 
urethra to relax and while any acute kidney injury (AKI) is 
resolving. If there is concern over detrusor muscle  function 
the  catheter can be left in for up to 5–7 days. 
Postanaesthesia intravenous fluids should be slowly 
titrated down accordingly monitoring for hyper- and 
hypokalaemia. Unless contraindicated (e.g. AKI), urethral 
relaxants can be given while the catheter is in place and 
for a week post catheter removal. Prazocin, a smooth 
muscle relaxant, and dantrolene, a skeletal muscle relax-
ant, can be used to provide comfort while the catheter is 
in place and after removal to prevent urethral spasm and 
possible re-obstruction due to this. 
If the cat is unable to have the obstruction relieved 
then it will have to undergo surgery for either a urethros-
tomy, tube cystostomy or pigtail catheter. 
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Long-term care will often involve looking at the cat’s 
lifestyle, weight, behaviour and diet. Owners will need a 
lot of support and guidance and the veterinary nurse can 
help to provide this.
KEY LEARNING OBJECTIVES
■■ It is essential that a cat with a urethral blockage is 
assessed for azotaemia, hyperkalaemia and with an 
electrocardiograph (ECG) before sedation or 
general anesthesia is considered
■■ Where fluid therapy alone cannot correct 
hyperkalaemia, other interventions may need to be 
considered
■■ Understanding when the urinary catheter should be 
removed
(B) Wide T waves, small P waves and a small 
QRS complex
(C) Tall spikey T waves, large P wave and a 
short QRS complex
(D) Tall spikey T waves, loss of P wave and a 
prolonged QRS complex
2. Which of the following statements is  
FALSE?
(A) A Jackson cat catheter had side holes so 
not ideal for unblocking cats with a urinary 
obstruction
(B) A Jackson cat catheter is ideal for 
long-term use
(C) A Jackson cat catheter is more likely to 
cause inflammation to the urethra than the 
other urinary cat catheters
(D) All of the above
3. What is prazocin?
(A) Smooth muscle relaxant
(B) Skeletal muscle relaxant
(C) Diuretic
(D) Anxiolytic
Managing the 
dyspnoeic patient
Emily Thomas 
Severe dyspnoea is life-threatening. Respiratory dys-
function causes blood oxygen content to fall, with 
 respiratory rate and effort increasing to compensate. 
How ever, compensation increases the oxygen demand 
of respiratory muscles. Severely dyspnoeic patients may, 
therefore, need all their physiological reserves simply to 
maintain breathing. Rapid stabilization and minimal 
stress are essential to prevent further decompensation. 
OBSERVATION OF THE PATIENT
Airway patency, respiratory rate, breathing pattern and 
degree of respiratory effort can all be rapidly ascertained 
at triage without even touching a dyspnoeic patient. Brief 
thoracic auscultation can usually be performed without 
causing stress. These simple, non-invasive observations 
allow presumptive localization of the anatomical source 
of respiratory distress (Figure 1). This helps to determine 
appropriate stabilization measures whilst avoiding 
 invasive testing that may cause decompensation. 
OXYGEN SUPPLEMENTATION
Immediate stabilization consists of oxygen supplemen-
tation. Flow-by oxygen is simple and quick. It is provided 
via an oxygen port and tubing or anaesthetic machine 
and circuit. A flow rate of 2–5 l/min with tubing held 
around 2 cm from the patient’s nose gives an inspired 
fraction of oxygen (FiO2) of 30–50%. Change the position 
of the flow if the patient is distressed, and in panting 
 animals hold the tubing to the mouth not the nose. A 
tight face mask provides FiO2 up to 70% but is stressful in 
conscious patients. 
Short nasal prongs designed for people can be used 
in dogs. These connect to oxygen tubing (Christmas tree 
connector). A flow rate of 50–100 ml/kg/min provides 
FiO2 of around 40–50%. Prongs are secured using a 
bridge of tape across the top of the nose. Nasal cannulae 
are longer, extending to the medial canthus of the eye, 
and are sutured in place (see http://www.delawarevalley-
academyvm.org/pdfs/oct11/6_Nasal_oxygen.pdf). 
Observation Upper airways Lower airways Pulmonary parenchyma Pleural space
Respiratory pattern Inspiratory effort Expiratory effort Variable Shallow breathing
Auscultation Stertor/stridor (heard 
without a stethoscope) 
Wheezes Harsh sounds or crackles Quiet lung and heart 
sounds
Figure 1: Localization of the anatomical source of respiratory distress
MULTIPLE CHOICE QUESTIONS
1. An ECG of a cat with hyperkalaemia may show 
which of the following characteristics?
(A) Wide T waves, large P wave and large QRS 
complex
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An oxygen hood is made by placing cling film over an 
Elizabethan collar, leaving a gap at the top to allow CO2 to 
vent, and prevent build-up of temperature/humidity. 
Oxygen tubing is inserted via the collar at the patient’s 
neck, and taped to the inside of the collar. A flow rate of 
1 l/min provides FiO2 around 40%. Oxygen chambers are 
less stressful for the patient, but temperature and humid-
ity can increase rapidly and must be carefully monitored. 
FURTHER STABILIZATION
If possible, an intravenous catheter should be placed in 
case emergency drugs are needed. Severely dyspnoeic 
patients may benefit from a period of oxygen administra-
tion before this is attempted. It is useful to plan ahead and 
start setting up for any further stabilization procedures, 
such as thoracocentesis (pleural space disease) or intu-
bation (upper airway obstruction). An equipment tray can 
be kept near the patient for rapid access if needed. 
People describe dypsnoea as ‘terrifying’ and ‘suffo-
cating’. The importance of gentle nursing care cannot be 
overstated. Careful handling, monitoring and, potentially, 
sedation may all be of benefit. 
KEY LEARNING OBJECTIVES
■■ Describe how to localize the source of respiratory 
distress based on triage examination
■■ Outline key techniques for providing oxygen to 
dyspnoeic patients
■■ List further stabilization measures for dyspnoeic 
patients and outline their preparation
MULTIPLE CHOICE QUESTIONS
1. What does auscultation of a patient with 
pulmonary parenchymal disease typically 
reveal?
(A) Crackles
(B) Quiet lung sounds
(C) Stertor 
(D) Wheezes
2. A cat in severe respiratory distress becomes 
cyanotic as you attempt to place a cephalic 
intravenous catheter. What is the most 
appropriate course of action?
(A) Apply EMLA cream to the skin and use a 
smaller gauge catheter 
(B) Attempt placement in the lateral 
saphenous vein to minimize stress 
caused by restraint
(C) Cover the cat’s eyes with a towel to 
reduce stress
(D) Place the cat in an oxygen cage and allow 
it to rest
3. What is an appropriate initial oxygen flow rate 
when using nasal cannulae?
(A) 10–50 ml/kg/min
(B) 50–100 ml/kg/min
(C) 500–1000 ml/kg/min
(D) 5000–10000 ml/kg/min
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Caesareans
Paul Aldridge
Dystocia, the difficulty in passing the foetus through the 
pelvic canal, is a common small animal emergency. 
Clini cal outcomes can be maximized when the clinical 
team has a thorough knowledge and understanding of 
normal canine parturition, the aetiology of dystocia, the 
criteria for diagnosing dystocia, and the appropriate 
medical and surgical interventions. 
NORMAL PARTURITION 
Gestation in the bitch is 63 days; this represents the time 
elapsed between ovulation and parturition. ‘Observed 
gestation’ in the bitch is approximately 57–72 days when 
established using breeding dates; this represents the 
time elapsed between observed mating and parturition.
A decline in rectal temperature to below 37.6°C 
(99.7°F) has been cited as the most consistent change 
indicating that parturition will take place within the next 
12–24 hours. This drop coincides with a decrease in the 
plasma progesterone level. Parturition is described as 
occurring in three distinct phases.
CAUSES OF DYSTOCIA
Dystocia is described as being maternal or foetal in ori-
gin. Maternal dystocia is encountered more frequently 
(60–70% of cases). The most common cause of maternal 
dystocia is uterine inertia, representing 40–72% of all 
dystocias attributed to the dam. Uterine inertia is the fail-
ure to expel the foetus from the uterus when no obstruc-
tion exists; it can be classified as primary or secondary. 
Foetal dystocia occurs due to relative oversize of the 
puppy, malpresentation, foetal death or foetal deformity.
MEDICAL MANAGEMENT OF DYSTOCIA
Once maternal and foetal obstruction shave been ruled 
out, medical management of dystocia can be initiated if 
appropriate. Blood calcium and glucose levels should be 
tested, and supplementation given where appropriate. 
The use of oxytocin to stimulate uterine contraction is 
widespread.
CRITERIA FOR CAESAREAN SECTION
■■ Complete primary uterine inertia
■■ Partial primary uterine inertia unresponsive to 
medical management
■■ Secondary uterine inertia
■■ Obstructive abnormality of the pelvic canal
■■ Foetal malposition that cannot be corrected
■■ Foetal death
■■ Relative or absolute foetal oversize
■■ Foetal distress: consistent foetal heart rates  
<150 bpm or foetal bowel movements can be seen 
on ultrasonography
CAESAREAN SECTION
Once the decision has been made to proceed to 
 Caesarean, thorough organization and preparation of the 
clinical team, the operating theatre and necessary equip-
ment are required. Consideration should be given to the 
dam’s current condition, and her altered physiology 
when planning induction and maintenance of general 
anaesthesia. The surgery itself will be classed as ‘clean– 
contaminated’, and efforts must be made to minimize the 
risk of postoperative infection and complications.
Resuscitating the puppies will require designated 
personnel. Attention should be given to clearing the 
 airway, providing oxygen and gentle resuscitation efforts.
KEY LEARNING OBJECTIVES
■■ Learn about the normal gestation and parturition of 
the bitch
■■ Learn about the possible causes of dystocia and 
their clinical signs
■■ Appreciate the difference in physiology of the 
pregnant dam, and how anaesthesia and surgery 
techniques must be adapted
MULTIPLE CHOICE QUESTIONS
1. What is gestation defined as?
(A) Time from observed mating to birth
(B) Time from fertilization to birth
(C) Time from ovulation to birth
(D) Time from mating to first stage of labour
2. What effect do high doses of oxytocin have on 
the uterus?
(A) Severe uncoordinated contractions with 
foetal distress
(B) A reduction in uterine contractions
(C) An increase in smooth, productive 
contractions 
(D) Induces complete uterine inertia and 
contractions stop
3. During pregnancy, what is expected with 
regard to the bitch’s packed cell volume?
(A) Reduces while the blood volume increases
(B) Reduces while the blood volume remains 
the same
(C) Increases while the blood volume stays the 
same
(D) Remains stable while the blood volume 
increases
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OPTIONS FOR REPLACING FLUID
Volume resuscitation in the hypovolaemic patient 
should aim to achieve a mean arterial pressure (MAP) of 
70 mmHg, but not above, as this will improve perfusion 
but minimize the risk of dislodging any clots that have 
formed. There is much debate about which is the best 
choice for fluid replacement although availability will have 
an impact on choice. Ideally if the patient has lost >20% of 
their total blood volume (>10% for debilitated animals), 
blood loss should be replaced with blood products such 
as whole blood or packed red blood cells. If crystalloids, 
such as Hartmann’s, are administered to treat blood loss, 
they should be administered at three times the volume 
lost; a colloid should be given at equal volume to that lost. 
Where rapid fluid resuscitation is required, or where 
huge volumes of crystalloids would put the patient at risk 
of overinfusion or haemodilution (decrease in the pro-
portion of red blood cells relative to plasma), hypertonic 
saline (7.5%) may be more appropriate. 
KEY LEARNING OBJECTIVES
■■ How to recognize acute blood loss in your surgical 
patient and the types of haemostasis available to the 
surgical team
■■ How to calculate your patient’s blood volume and 
volume of blood loss
■■ Options for fluid replacement
The veterinary nurse’s 
role during acute 
surgical haemorrhage
Claire Roberts 
Acute blood loss resulting from surgical haemorrhage 
can result in haemorrhagic hypovolaemic shock. It is 
often the veterinary nurse who will alert the veterinary 
team to cardiovascular changes, provide additional 
equipment to the surgical team to help achieve haemo-
stasis, calculate the percentage of blood loss and 
 facilitate the administration of replacement fluids.
PHYSIOLOGICAL CHANGES ASSOCIATED 
WITH ACUTE SURGICAL HAEMORRHAGE
In acute blood loss, fluid is lost directly from the intravas-
cular space. Intravascular fluid makes up a small propor-
tion of overall body water (1/15th of total body water). Any 
loss can have a profound effect with patients showing a 
varying degree of clinical signs depending on the  severity:
■■ Tachycardia
■■ Reduction in pulse quality
■■ Absent peripheral pulses
■■ Prolonged capillary refill time (CRT)
■■ Changes in mucous membrane colour
■■ Reduction in urine output
■■ Obtundation (altered level of consciousness)
If a patient experiences blood loss of more than 10% 
of their blood volume, this will result in hypoperfusion. 
See Figure 1. 
METHODS OF HAEMOSTASIS
There is a range of options available to deal with haemo-
stasis. The method used will depend on the size of the 
blood vessel and the amount of blood loss. It is the 
responsibility of the veterinary nurse to ensure that there 
are  sufficient supplies available and ready to use. Methods 
of haemostasis include:
■■ Digital pressure
■■ Haemostats
■■ Surgical swab packing
■■ Ligatures
■■ Haemostatic agents
■■ Tourniquets
■■ Diathermy
METHODS FOR CALCULATING 
SURGICAL BLOOD LOSS
The veterinary nurse should be able to calculate losses 
accurately, because an underestimation may lead to 
 significant complications and an overestimation may 
result in unnecessary transfusion.
The most common technique of calculating blood 
loss is using visual estimation, calculating the number of 
swabs saturated with blood and measuring the volume 
of blood in the suction bottle (remembering to subtract 
any lavage fluids used). 
Normal blood volume
Dog 80–90 ml/kg
Cat 60–70 ml/kg
Normal plasma volume
Dog 36–57 ml/kg
Cat 35–53 ml/kg
Figure 1: Normal blood volumes
MULTIPLE CHOICE QUESTIONS
1. What physiological changes might a patient 
experience with acute blood loss?
(A) Tachycardia
(B) Reduction in pulse quality
(C) Absent peripheral pulses
(D) All of the above
2. How do you calculate normal blood volume in 
a cat?
(A) 80–90 ml/kg
(B) 35–53 ml/kg
(C) 60–70 ml/kg
(D) 36–57 ml/kg 
3. During volume resuscitation, what mean 
arterial blood pressure should be maintained 
to improve perfusion but minimize the risk of 
dislodging any clots that have formed?
(A) 60 mmHg
(B) 90 mmHg
(C) 70 mmHg
(D) 120 mmHg
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Does what we wear 
in the theatre impact 
on patient safety?
Claire Roberts 
Surgical attire has remained relatively unchanged over 
the past 50 years; frustratingly there is limited evidence to 
support what is the best surgical attire in the operating 
room in relation to infection prevention. Most surgical 
site infections (SSIs) are caused by the patient’s own flora, 
but operating-room personnel are also a source of 
 bacterial contamination; the aim of surgical attire is to 
provide a functional barrier between the surgical team 
and the patient.
SCRUBS
Scrubs have been standard operating attire since the 
1950s. There have been several studies evaluating the 
effects of scrub material and design, but limited clinical 
trials looking at their effect on SSI rates. There is evidence 
to support that a cotton–polyester blend drastically 
reduced airborne colony forming units (CFU) compared 
to normal cotton clothing and that wearing scrubs with 
cuffs at the wrists and ankles, whilst tucking scrubs in, 
also reduced airborne CFUs. 
MASKS
Surgical masks were first developed in the early 20th 
century. There is evidence showing that wearing face 
masks has no effect on overall bacterial counts in the 
operating room. A study showed no correlation between 
SSI and the surgical team being masked or unmasked; 
however, they are worn as part of personal protective 
equipment for the scrubbed team.
HATS
Hair, ears and scalps are a potential source of contami-
nation in the operating room. There is a variety of head 
coverings available, including skull caps, bouffant and 
hoods. There is however no clear consensus in the 
 guidance relating to the use of headwear within the 
 surgical setting.
Recent literature reviews reveal there is no conclu-
sive evidence that covering the hair prevents SSIs, but 
does support that there is a serious risk to patients if they 
are exposed to the skin and hair of individuals working 
in the perioperative setting. 
GOWNS
Gustav Neuber first started wearing surgical gowns in 
1883 and soon after, reported a decrease in SSI. Gowns 
can be disposable or reusable. Permeable cotton gowns 
and drapes increase the risk of SSI compared with 
 impervious gowns.
GLOVES
William Halsted was the first to develop rubber gloves for 
the operating team, in 1894, and this resulted in a signifi-
cant reduction in SSIs, and later a dramatic reduction in 
SSIs when sterile gloves were used. Whilst double gloving 
is often used by orthopaedic surgeons, this serves to 
provide better self-protection to the surgeon but there 
isn’t enough supporting evidence that it reduces SSIs.
FOOTWEAR
A study looking at theatre shoes and their link in the 
common pathway of postoperative wound infection 
showed that theatre shoes and floors present a potential 
source for postoperative infection. A combination of 
dedicated theatre shoe and a good floor-washing proto-
col controls the level of shoe contamination and has a 
positive impact on SSIs.
KEY LEARNING OBJECTIVES
■■ What a surgical site infection is and the impact that 
surgical attire has in helping to combat them
■■ The challenges in implementing a protocol 
regarding what surgical attire is best at helping to 
reduce surgical site infections
■■ The arguments that certain surgical attire is still 
recommended despite lacking supporting evidence 
that it reduces surgical site infections 
MULTIPLE CHOICE QUESTIONS
1. What causes most surgical site infections?
(A) The surgical team’s hands
(B) The patient’s own flora
(C) The surgical environment
(D) The recovery area
2. What has an impact in reducing colony forming 
units in relation to theatre scrubs?
(A) A cotton–polyester blend
(B) Wearing scrubs with cuffs at the wrists and 
ankles 
(C) Tucking scrubs in 
(D) All the above
3. Whilst there is no conclusive evidence that 
covering the hair prevents SSI, why is it 
recommended to still wear them?
(A) There is a serious risk to patients if they are 
exposed to the skin and hair of individuals 
working in the perioperative setting
(B) Headwear protects the wearer from 
sources of infection
(C) Headwear reduces the chances of the 
wearer becoming a vector of infection
(D) All of the above
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Preoperative surgical 
site infection prevention 
Claire Roberts 
All surgical wounds are contaminated with bacteria, it is 
only when that level of contamination becomes critical, 
that an infection will occur. Surgical wounds can be 
 contaminated with bacteria from:
■■ Patient’s own flora (endogenous bacteria):
 – Skin
 – Mucous membranes
■■ Flora from the environment (exogenous  
bacteria):
 – Air
 – Theatre
 – Personnel
 – Surgical equipment
There are several factors that will affect surgical 
wound infection, including host factors, surgical wound 
factors and pathogen factors.
Thoracic wall trauma
Paul Aldridge
Trauma to the thoracic wall can occur through a variety 
of both sharp (penetrating) and blunt insults. These 
 traumas have the potential to damage the structure and 
integrity of the wall, with potentially fatal effects on the 
respiratory system contained within the confines of the 
thorax. To maintain effective ventilation, the pleural 
space needs to maintain its integrity, a negative intratho-
racic pressure needs to be present, the thoracic wall 
must be stable, but with the ability to expand and con-
tract with the pull of muscles and expansion of the lungs.
INITIAL PRESENTATION
All trauma presentations should immediately be brought 
through to a treatment area on arrival and an initial 
assessment performed. The initial examination is tar-
geted towards identifying any compromise of the major 
body systems: airway/breathing, circulation, and the 
central nervous system. If any deficiency is identified, 
stabilization measures are immediately taken.
DIAGNOSTIC IMAGING
Point of care ultrasound (POCUS) is increasingly used to 
assess trauma to both the abdomen and thorax; ultra-
sonography can be useful in the assessment of pleural 
space disease and for some lung parenchyma disease. 
Radiography is commonly used to assess the thoracic 
wall itself, identifying rib disruptions. Computed tomog-
raphy (CT) scanners are becoming more common within 
veterinary practices, and may be of use in determining 
thoracic wall and intrathoracic pathology.
BLUNT TRAUMA
Blunt trauma may result from road traffic accidents, falls 
or kicks. The insult may cause rib fractures and ‘flail chest’ 
segments. Respiratory compromise will be worsened by 
the pain associated with the injury. Analgesia, occasion-
ally dressings, and rarely surgery may be indicated.
PENETRATING TRAUMA
Penetrating trauma that breaches the thoracic wall may 
be caused by insults such as bite wounds, air gun pellets 
or impalement on objects. Priority is given initially to 
 trying to stabilize any dyspnoeic patients. Penetrating 
wounds overlying the thorax will need to be surgically 
explored, to debride the wound and perform routine 
wound management, but also to assess if the thoracic 
wall has been penetrated, and, if so, assess the thoracic 
viscera. 
KEY LEARNING OBJECTIVES
■■ Appreciate the importance of triage and stabilization 
in the trauma patient
■■ Learn the consequences of blunt trauma on the 
thorax
■■ Learn about the postoperative nursing of 
penetrating trauma patients
MULTIPLE CHOICE QUESTIONS
1. At which rib space is thoracocentesis routinely 
performed?
(A) Second or third
(B) Fourth or fifth
(C) Seventh or eighth
(D) Tenth or eleventh
2. Administering supplemental oxygen via a 
‘flow-by’ technique is likely to achieve which 
concentration of oxygen in the inspired air?
(A) 10%
(B) 21%
(C) 30%
(D) 70%
3. Which muscle overlying the thoracic wall is 
commonly used as a flap to cover thoracic wall 
deficits?
(A) Pectoral
(B) Lattisimus dorsi
(C) Scalenus
(D) Intercostal
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PREVENTION OF SURGICAL SITE 
INFECTIONS
For prevention of surgical site infections (SSIs), excellent 
surgery alone is not sufficient. It needs to be a team 
approach and the practice should have rigid protocols 
in  place. In a busy hospital setting it can be extremely 
useful to have a lead member of the team to focus on 
infection control surveillance. Hand hygiene is always 
high up on the list of infection prevention.
Whilst total eradication of SSIs is unrealistic, our aim 
should be to reduce the occurrence through hospital 
and patient management. This can be achieved in part 
through thorough patient assessment, which enables the 
anaesthetic and procedure times to minimized and 
 enables the surgical team to schedule clean procedures 
at the beginning of the day. 
The veterinary team are must understand and 
 perform strict aseptic technique in a variety of areas 
( Figure 1). 
KEY LEARNING OBJECTIVES
■■ How surgical wounds can be contaminated in the 
hospital
■■ The impact that poor theatre management can have 
on surgical site infections (SSIs)
■■ Factors to consider in the preoperative phase that 
can help in the reduction of SSIs
Hand hygiene Good hand hygiene is one of the most important aspects of infection control. Correct hand-
washing protocols should be visible with the provision of appropriate decontamination 
solutions
Patient preparation Vital in ensuring best patient outcome, is designed to reduce microorganisms at the skin 
surface, reduce pathogenic bacteria prior to surgery and reduce the risk of wound infection 
post surgery.
Hair removal should take care not to damage the skin and should be performed immediately 
before surgery
A surgical skin preparation should be performed with appropriate skin solutions at the 
correct dilution, allowing the correct contact time
Personnel dress and 
theatre conduct
The theatre team should wear designated theatre attire which is laundered to hospital 
standards
Unnecessary theatre movement should be avoided as this increases number of particles 
in the air which may increase the incidence of SSIs
Control of infection 
in the theatre suite
Written protocols should be taught, followed and upheld. Clutter should be kept  
to a minimum and a hospital-grade disinfectant should be used at the correct dilution rates
Surgical procedures should be classified as clean, clean–contaminated, contaminated 
and dirty. Clean procedures should ideally be performed at the beginning of the day
Equipment cleaning 
and sterilisation
Instruments should be cleaned, packaged, sterilized and stored correctly
Antibiotic use A hospital perioperative antibiotic protocol should be designed, implemented and adhered 
to, as over-reliance of antibiotic use does not make up for poor theatre practice and is 
associated with increased risk of SSIs 
Anaesthesia and 
surgical times 
Infection rates increase by 30% for every additional hour of surgery and anaesthesia
Patients ASA ≥3 increases risk of SSIs
Hypothermic patients are at increased risk of SSIs
Figure 1: Specific areas to consider in the pre-operative phase
MULTIPLE CHOICE QUESTIONS
1. Which of the following will not reduce the risk 
of SSIs?
(A) Hand hygiene
(B) Clipping prior to induction of  
anaesthesia
(C) Preoperative patient warming
(D) Correct wound classification
2. In relation to SSIs, what relevance does 
anaesthesia have?
(A) There is no correlation between the length 
of anaesthesia and SSIs
(B) For every hour a patient is anaesthetized, 
the risk of a SSI decreases by 30%
(C) Infection rates increase by 30% for every 
additional hour of anaesthesia
(D) Anaesthetic-related hypothermia 
decreases the risk of SSIs
3. Which of the following areas will contribute to 
reducing preoperative surgical site infections?
(A) Hand hygiene
(B) Reduction in theatre traffic
(C) Correct contact time for skin  
preparations
(D) All of the above
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How to reduce 
postoperative hospital-
acquired infections 
Claire Roberts 
In 2016, the World Health Organization (WHO) published 
‘Global Guidelines for the Prevention of Surgical Site 
Infection’. The guidelines include a list of 29 concrete 
recommendations with 16 of them focusing on during 
and post-surgical prevention. Surgical site infections 
are  the third most common type of hospital-acquired 
infections (HAI) in human medicine.
An HAI is classified as an infection that occurs:
■■ Up to 48 hours after hospital admission
■■ Up to 3 days after discharge
■■ Up to 30 days after an operation
■■ In a healthcare setting when the patient was 
admitted for reasons other than an infection
CAUSES OF HOSPITAL-ACQUIRED 
INFECTIONS
Bacteria, fungi and viruses can cause HAIs. In human 
medicine, bacteria alone cause about  90% of cases. 
Patients who are immunocompromised are at increased 
risk of contracting an infection during hospitalization. 
These microorganisms spread mainly through person- 
to- patient contact from unclean hands, medical and 
hospital equipment. HAIs also increase with excessive 
or  incorrect selection of antibiotics, which can lead to 
emergence of antibiotic resistance bacteria.
The most common types of HAIs are:
■■ Surgical site infections
■■ Intravenous catheter- and arterial line-associated 
infections
■■ Catheter-associated urinary tract infections
■■ Pneumonia
CLINICAL SIGNS 
Clinical signs of HAIs will vary depending on the source 
of the infection, but may include:
■■ Inflammation, swelling, discharge from the wound/
catheter site
■■ Tachycardia
■■ Tachypnoea
■■ Fever or hypothermia
■■ Dysuria/haematuria
■■ Dyspnoea
■■ Nausea, vomiting, diarrhoea
WHO IS AT RISK FOR HOSPITAL-ACQUIRED 
INFECTIONS?
Any patient admitted to the veterinary hospital is at risk 
for contracting an HAI. The following can affect the risk:
■■ Patients are incorrectly hospitalized (infectious 
cases not barrier nurses/isolated)
■■ Age (neonates and older patients at increased risk)
■■ Extended antibiotic use 
■■ Presence of indwelling devices (urinary catheters, 
intravenous catheters, chest drains etc.) 
■■ Prolonged stay in hospital
■■ Following trauma and/or shock
■■ Immunosuppression
■■ Surgical implants
■■ Long surgical procedures and anaesthesia
■■ Hypothermia
PREVENTING HOSPITAL-ACQUIRED 
INFECTIONS
A 70% decrease in HAI can be seen when a team takes 
steps in prevention. Whilst antibiotics are indicated for 
some surgical procedures and individual patients, they 
are not indicated in all surgical patients and can add 
unnecessary cost, lead to adverse drug reactions, and 
encourage the selection of resistant bacteria. 
It is recommended that all surgical wounds are cov-
ered with a dressing to provide a physical barrier to pro-
tect the wound from contamination from the external 
environment until the wound becomes impermeable to 
microorganisms. Human postoperative care bundles 
 recommend that surgical dressings are undisturbed for a 
minimum of 48 hours after surgery unless leakage occurs.
General recommendations include:
■■ Correct kennel selection (is isolation/barrier nursing 
needed?)
■■ Focus on exceptional five-point hand hygiene 
■■ The availability and correct use of personal 
protective equipment
■■ Correct cleaning of clinical environments
■■ Correct ventilation
■■ The use of strict aseptic techniques (intravenous 
catheter care, blood sampling, urinary catheter 
care etc.)
■■ Removal of unnecessary indwelling devices as soon 
as no longer required
■■ Provision of high-quality nursing care
KEY LEARNING OBJECTIVES
■■ What a hospital-acquired infection (HAI) is and 
the risks associated with them
■■ How to recognize a patient may have contracted 
a HAI
■■ Nursing measures used to help prevent HAI in the 
postoperative period
MULTIPLE CHOICE QUESTIONS
1. What of the following is NOT an HAI?
(A) An infection that was present at the time of 
admission
(B) An infection acquired up to 48 hours after 
hospital admission
(C) An infection acquired up to 3 days after 
discharge
(D) An infection acquired up to 30 days after 
an operation
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3. How long should a wound be covered to 
provide a physical barrier to protect the wound 
from contamination from the external 
environment until the it becomes impermeable 
to microorganisms 
(A) 12 hours
(B) 4 hours
(C) 24 hours
(D) 48 hours
2. Any patient admitted to the hospital is at risk of 
contracting a HAI, but which of the following 
can increase that risk?
(A) Extended antibiotic use 
(B) Presence of indwelling devices (urinary 
catheters, intravenous catheters, chest 
drains etc.) 
(C) Hypothermia
(D) All of the above
Difficult skin closures: 
what options do we 
have?
Paul Aldridge
With our veterinary patients we are frequently faced with 
potentially extensive wounds; these may be as a result of 
trauma or as a result of oncological surgery. When surgi-
cally reconstructing a wound it is essential that certain 
principles are adhered to: the wound edges should be 
apposed without tension, and drainage should be pro-
vided where appropriate. Both canine and feline skin is 
highly mobile and elastic, making very basic techniques 
viable to increase availability of skin at the wound 
 margins. Where there is insufficient skin to achieve these 
goals, additional reconstructive techniques can be used 
to bring additional skin into the area to achieve closure. 
When selecting an appropriate technique, the simplest 
technique that allows tension free closure is usually the 
most appropriate
PRIMARY CLOSURE WITH TENSION 
RELIEVING TECHNIQUES
■■ Undermining margins: a combination of sharp and 
blunt dissection below the panniculus muscle, to 
separate the skin from its deeper attachments and 
make use of the skin’s natural elasticity
■■ Walking sutures: a subdermal bite of the skin 
beneath the edges, followed by a bite on the wound 
bed closer to the centre. As the knot is tightened the 
skin edges are advanced towards the centre of the 
wound. This distributes tension away from the 
suture line
■■ Tension-relieving incisions and mesh expansion: 
techniques where smaller adjacent incisions are 
made to reduce tension on the main suture line
RANDOM SUBDERMAL PLEXUS FLAPS
These are skin flaps that rely on the randomly branch-
ing subdermal plexus for their blood supply. Because of 
this unpredictable blood supply, certain ratios in shape 
of  the flap are adhered to and so preserve perfusion. 
Examples include advancement flaps, rotation flaps and 
 transposition flaps.
AXIAL PATTERN FLAPS
These skin flaps rely on a direct cutaneous artery for their 
blood supply, as such their boundaries can be predicted 
from anatomical landmarks. This direct blood supply 
allows the creation of an often large, robust flap.
FREE SKIN GRAFTS
Trafts are harvested usually from the trunk of the patient, 
and usually applied to a granulation bed. The graft has no 
blood supply initially, and relies on imbibition of plasma 
from the wound bed to maintain viability. Repeated 
dressing changes are usually required to protect the graft 
and allow ‘take’ to occur.
KEY LEARNING OBJECTIVES
■■ Appreciate why reconstruction techniques are 
necessary in some wounds
■■ Learn about the various skin flap techniques 
available
■■ Learn about postoperative dressings and 
management of free skin grafts
MULTIPLE CHOICE QUESTIONS
1. Which of these is not a passive wound drain?
(A) Yeates drain
(B) Corrugated drain
(C) Fenestrated drain and suction grenade
(D) Penrose drain
2. An advancement flap should have a length to 
width ratio that doesn’t exceed which of the 
following?
(A) 4:1
(B) 3:1
(C) 2:1
(D) 1:1
3. Which of the following primary contact 
dressings are most appropriate for a free skin 
graft?
(A) Silicone mesh
(B) Allevyn
(C) Primapore
(D) Cotton guaze swabs
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Loco-regional blocks
Louise O’Dwyer 
The use of local anaesthetic blocks, as part of a multi-
modal approach to analgesia, is potentially the most 
effective form of analgesia for many small animal surger-
ies, but also is often the most underused. For the  majority 
of the blocks that will be discussed all that is needed is a 
syringe, a needle, local anaesthetic and a knowledge of 
the relevant anatomy. Technically these blocks do not 
require any specialist equipment, but nerve location 
equipment is recommended to guide perineural injec-
tions of local anaesthetics.
HEAD/DENTAL BLOCKS
Many of these blocks can be used for dental procedures, 
mandibular and maxillary surgery. When deciding which 
block is appropriate in a given case, it should be remem-
bered that only structures rostral to the injection site will 
be desensitized. 
RETROBULBAR OR PARABULBAR BLOCK
The retrobulbar block is useful for ocular surgery. The 
retrobulbar block involves injecting local anaesthetic 
behind the globe and will block cranial nerves II, III, IV, V 
(ophthalmic and maxillary branches) and VI. So, as well as 
desensitizing the globe, lids, conjunctiva and much of 
the upper face, it will block the extraocular muscles and 
therefore produce a central eye. 
INTRATESTICULAR BLOCKS
Intratesticular blocks are obviously a useful block to 
 perform on castrations. 
LIMB BLOCKS
As orthopaedic surgery becomes more and more com-
monplace in general practice, most aspects of limbs can 
be desensitized using a number of different regional 
blocks.
Brachial plexus block
Blocking the nerves of the brachial plexus will provide 
excellent analgesia for procedures below the elbow. 
The  traditional brachial plexus (axillary) block, injecting 
approximately 10–15 ml of local anaesthetic (for a 25-kg 
dog) into the axillary space at the level of the point of the 
shoulder blocks the lower forelimb, but not the shoulder 
or the proximal humerus.
Pelvic limb blocks
The sciatic nerve block may be combined with either a 
femoral nerve or lumbar plexus block to provide analge-
sia for pelvic limb surgery. Electro neurolocation is 
 recommended for these techniques to improve  accuracy, 
ensure safety and reduce the dose of local anaesthetic 
required. 
The sciatic nerve is blocked at its proximal location 
caudal to the greater trochanter of the femur. The punc-
ture site is located at the junction of the cranial and mid-
dle thirds between a line drawn between the greater 
trochanter of the femur and the ischial tuberosity. The 
femoral nerve is blocked at its location on the medial 
aspect of the pelvic limb in the femoral triangle. The 
femoral artery is palpated within the femoral triangle, 
held in place with light digital pressure and the femoral 
nerve is located and blocked cranial to the artery, usually 
in a superficial location.
INTERCOSTAL NERVE BLOCK
Intercostal nerve blocks are a useful analgesic adjunct for 
lateral thoracotomy surgeries, but also can be used to 
good effect to provide pain relief for rib fractures and for 
the placement of chest drains.
CONCLUSION
Local anaesthetic techniques are easily employed in 
practice as part of a balanced, multimodal approach to 
anaesthesia and analgesia and should be considered 
where appropriate. 
KEY LEARNING OBJECTIVES
■■ Identify the local blocks which can be used for a 
variety of procedures, along with their anatomical 
landmarks
■■ Understand the local anaesthetic agents which are 
appropriate for use
■■ Gain confidence in performing the techniques in a 
clinical environment
MULTIPLE CHOICE QUESTIONS
1. Which block may be useful for lateral 
thoracotomy surgeries, as well as rib  
fractures?
(A) Sciatic nerve block
(B) Intercostal nerve block
(C) Intratesticular block 
(D) Retrobulbar block
2. Which block may be useful for ocular surgery?
(A) Sciatic nerve block
(B) Intercostal nerve block
(C) Intratesticular block 
(D) Retrobulbar block
3. Which block may be useful in patients 
undergoing cruciate repair surgery?
(A) Sciatic nerve block
(B) Intercostal nerve block
(C) Intratesticular block 
(D) Retrobulbar block
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Rehabilitation of 
orthopaedic patients
Holly Smith
Orthopaedic patients may suffer from swelling, oedema 
and pain after trauma or surgery. There are some very 
effective ways to alleviate these symptoms, helping to 
achieve increased mobility and comfort for the patient. 
Useful rehabilitation techniques are cold compression, 
hydrotherapy, physiotherapy and mobilizing the patient. 
Hydrotherapy is hugely beneficial for many reasons 
in rehabilitation of the orthopaedic patient. The warm 
water can help soften muscles, loosen stiff joints and 
support weaker patients. Water allows the patient to be 
non-weightbearing, which will also contribute to pain 
relief and increased range of motion. Free swimming in a 
pool can lead to overextension of joints, which can lead 
to deterioration or pain. An underwater treadmill is much 
more controlled than free swimming in a pool. The level 
of the water, speed of the belt and incline or turbulence 
will determine how much support is being given, which 
muscle groups are being targeted and the amount of 
flexion or extension a joint goes through. This is also less 
strenuous for older, severely brachiocephalic patients or 
those who have had trauma to the thorax.
When carrying out rehabilitation on orthopaedic 
patients, it is also the muscle surrounding the injury or 
joint that is usually the most problematic, as it can be 
hypertonic, contracted or bruised. Oedema and inflam-
matory response swelling is also a problem which can 
limit the range of motion of a limb and be very painful. 
Cold compression is a very good treatment to reduce 
swelling and oedema in a limb. It will also provide pain 
relief for that limb or joint. The most effective way to 
achieve this is using a fully circumferential ice pack that 
can also deliver compression. There are cuffs available in 
the human field that can be used on dogs. These are 
cuffs that attach to a bucket of iced water and once the 
cuff is in place around the limb the bucket is lifted. The 
cuff the fills through gravity and as it does so it will also 
deliver compression. This is far more effective than a 
solid cold pack held against a limb as the whole limb is 
surrounded. The bucket can then be disconnected and 
the cuff left in place for 10 minutes. 
Slow walking after a surgery or injury is also hugely 
beneficial as this will encourage weightbearing on 
affected limbs. Using hoists, slings and harnesses to get a 
patient up and moving is also important. Movement will 
also help to reduce oedema. Standing a patient in the 
pool or underwater treadmill can also reduce oedema 
due to hydrostatic pressure exerted by the water. 
KEY LEARNING OBJECTIVES
■■ Modalities used to treat oedema, swelling and pain 
in orthopaedic patients
■■ Why hydrotherapy is beneficial in orthopaedic 
patient rehabilitation
■■ Understanding the differences between free 
swimming and underwater treadmill
MULTIPLE CHOICE QUESTIONS
1. What are we trying to reduce postoperatively 
after orthopaedic injuries or surgery?
(A) Swelling, oedema and pain
(B) Haemorrhage
(C) Weight bearing
(D) Patient mobility
2. Which rehabilitation techniques can be used to 
reduce oedema?
(A) Elevation
(B) Cold compression, hydrostatic pressure 
and slow walking
(C) Free swimming
(D) Passive range of motion, ice pack and free 
swimming
3. What properties does hydrotherapy have that 
are beneficial in reducing pain?
(A) Ability for patient to free swim
(B) To allow overextension of all limbs and 
range of motion
(C) Warm, non-weightbearing exercise
(D) Hydrostatic pressure
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Dog bite prevention: 
in practice or on the 
street? 
Shakira Free Miles 
Dogs make up a large percentage of our patients, and 
come in a wide variety of shapes, sizes and breeds. All of 
them have experienced life differently and each of them 
is an individual. Treating them all the same is simply not 
an option. Dog bites are a constant risk within our job 
roles and dog bites outside the clinic are something 
that we should take seriously. Dog bites involve multiple 
factors, and understanding them requires going back to 
basics and unlearning some of the language we may use.
DOG BITES
Dog bite incidents (DBI) occur at the clinic and may be 
seen as an occupational hazard, accepted and shrugged 
off, especially when the injury is considered minor. We 
are up close and personal constantly with dogs, some-
times we really do take their tolerance for granted. In 
my  experience, veterinary professionals often miss or 
ignore the body language the dog is using in an attempt 
to reduce their own anxiety and communicate their 
emotions. I rarely hear staff discuss behaviour as part of 
a  treatment plan or patient consideration, unless the 
 animal is very aggressive and a danger. Creating a plan of 
action to include behavioural considerations is unusual, 
but in my opinion is vital to maintain good welfare.
We also have to remember that dogs under our care 
can and do bite people outside of our clinics, or may 
even cause a fatality. This is of course an extremely 
 serious concern which may be preventable.
We should raise awareness among our veterinary 
colleagues of animal bites and their potentially devastat-
ing consequences. These incidents can result in pro-
found physical and psychological damage and could be 
preventable.
LANGUAGE AND LABELS
The language we use to describe patients may be inno-
cent ‘banter’ or a word just thrown around without true 
meaning or thought. Labels can stick with that animal 
throughout their journey and care at the clinic; this can 
then impact on the handling and care of that patient with 
a label that may actually not be fact based. Such labels 
include ‘evil’, ‘naughty’, ‘pain in the ass’ … the rest I won’t 
write here. As a profession we should be using terminol-
ogy that is fact based and based on the individual. We 
should also be asking ourselves questions as to why this 
behaviour has occurred.
BREED GUESSING
The obsession and focus on breed is something that is a 
major damaging factor to understanding dog bites and 
the perpetuating misconceptions that almost fuel the 
original myths and supposed rationale of breed-specific 
legislation (BSL) laws. The BVA and the majority of animal 
welfare organizations are against such unjust laws, as 
there is no evidence that supposed breed or conforma-
tion equates to risk. It is a subject that needs to be under-
stood to ensure we send a safe and fact-based message. 
By focusing on supposed breeds/types and expectations 
it gives breed a level of importance.
For people working with animals, animal policy 
 makers and veterinary staff, we must take responsibility 
for the language and labels used to describe the animal 
in our care or that we advocate for. These assumptions 
of breed we assign to individuals can carry serious con-
sequences. They impact on people’s perceptions and 
can influence policy makers’ decisions, with a negative 
impact on dogs.
KEY LEARNING OBJECTIVES
■■ Develop a deeper understanding how we can 
prevent dog bites in our profession
■■ Reconsider language and labels we assign to dogs
■■ Discuss advantages to change and inspire others in 
the team to do the same
MULTIPLE CHOICE QUESTIONS
1. Why do dog bites in the clinic most commonly 
occur?
(A) Certain breeds are more likely to bite than 
others
(B) The dog hasn’t been restrained correctly
(C) The dog’s body language was ignored at 
the time or previously
(D) The dog was angry and didn’t want to be 
handled
2. Who is responsible for dog bite prevention in 
the clinic?
(A) Veterinary surgeons
(B) Veterinary surgeons, veterinary nurses, 
reception, animal care staff, management 
and owners
(C) Veterinary surgeons and nurses
(D) Veterinary surgeons and owners
3. How should dogs considered dangerous be 
dealt with at the clinic?
(A) Be muzzled at all times and all team made 
aware of the behavioural concerns for that 
dog
Be given pharmaceutical intervention, 
muzzled at all times, attend training and a 
CARE label placed on file/kennel
(B) Be given a behavioural consultation, 
pharmaceutical intervention, CARE label 
on file with description, plan of action
(C) Be given a behavioural consultation, 
consider pharmaceutical intervention, 
CARE label on file/kennel with description, 
plan of action, communicate with all staff 
involved, start muzzle training
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Adopting street dogs: 
health and behaviour 
concerns 
Heather Bacon
Domestic dogs are thought to have originated at multiple 
geographic locations including Europe, the middle East, 
China and Russia. In some locations such as China and 
the Middle East, dogs may also have had genetic mixing 
with wolves since their domestication. Many of our mod-
ern dog breeds were created during the Victorian era, 
and this process of selective breeding has generated 
modern dog breeds with a wide variety of very specific 
conformations and some breed-specific behavioural 
traits, e.g. herding, retrieving etc. However with the intro-
duction of the PETS scheme and greater international 
travel we are seeing increasing numbers of non-pedigree 
and ancient dog breeds in the UK, imported from regions 
of the world where the use and role of dogs in society is 
often very different. 
Whilst some ‘ancient’ breeds are well known and 
familiar (Chow-chows, Akitas etc.), many street dogs of 
ancient origin are not classified as specific breeds but 
exist as ‘landraces’ or locally adapted, traditional varieties 
of dogs adapted to their region of origin. These types of 
dog make up the majority of the free-roaming dog pop-
ulation and are often referred to as ‘street dogs’. Street 
dogs are likely to have experienced a greater diversity of 
genetic and environmental influences that may mean 
their behaviour is less familiar or predictable than highly 
bred pedigree breeds. Factors that may influence dog 
behaviour include genetics and breeding, temperament, 
early life experiences and socialization, later learning 
experiences, health status, personal motivation and 
 environmental resources, and these are all factors which 
should be considered when interacting with dogs 
rehomed from overseas. Additionally, the process of 
rehoming and confining free-roaming dogs may impact 
on their behaviours. Whilst some of the challenges faced 
by these dogs may overlap with challenges faced by UK 
rescue dogs, dogs adopted from overseas may also 
 present with specific behavioural or health challenges, 
not all of which may be picked up during the importation 
screening process. 
This presentation will explore some of the health and 
behavioural issues that are common in street dogs and 
discuss how these issues might be considered when 
dealing with dogs adopted from abroad. Depending on 
the region of origin, such dogs may face a variety of 
potential health issues and may also present behavioural 
challenges that may be rather different to our more 
familiar UK pet dog population. This presentation will 
focus on behavioural issues contextualized by street dog 
ancestry and likely learning experiences, and give an 
overview of infectious disease challenges which may 
present in the veterinary clinic in dogs adopted from 
overseas.
KEY LEARNING OUTCOMES
■■ Outline the different categories of dogs and 
appreciate the impact on genetic and behavioural 
diversity that breed may have
■■ Describe a variety of behavioural issues that may 
occur in street dogs and those dogs adopted from 
overseas
■■ Describe a variety of health issues that may occur in 
street dogs and those dogs adopted from overseas
MULTIPLE CHOICE QUESTIONS
1. Which of the following is considered to be an 
‘ancient’ breed?
(A) Labrador Retriever
(B) German Shepherd Dog
(C) Afghan Hound
(D) St Bernard
2. Existing acute pain scales may be unreliable in 
street dogs due to the confound between pain 
behaviour and which other behaviour?
(A) Aggressive behaviour
(B) Fear/anxiety behaviour
(C) Maternal behaviour
(D) Escape behaviour
3. Where can transmissible venereal tumours be 
found?
(A) The genital area only
(B) The genitals and ears of dogs
(C) Any mucous membrane including genitals, 
eyes and oral cavity
(D) Any area of the body
Good intentions and 
good welfare outcomes
Hayley Walters  
We’ve all had the question at the end of a consultation I 
suspect. ‘Can I just ask you quickly? What can I do about 
my dog growling when I go near him when he eats?’ 
Or ‘My dog chews the front door and howls when I am 
at  work. What can I do?’ These questions, although 
 commonplace, can often be difficult to answer during a 
busy consulting period. As well as carefully considering 
the health status of the animal in question, the answers 
rely on you taking a detailed behavioural history from 
the owner and recognizing the many other factors that 
contribute to ‘behavioural problems’ in dogs and cats, 
including their previous experiences, learned behaviours 
and how the owner has dealt with the problem  previously. 
This is a great undertaking and a huge responsibility for a 
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veterinary surgeon or veterinary nurse who may have 
limited training in treating behaviour problems. It’s 
important that veterinary professionals recognize when a 
case is outside their area of competence and be prepared 
to refer it to a clinical animal behaviourist appearing on 
the Animal Behaviour and Training Council Register. The 
behaviourist can identify the motivational–emotional 
basis underlying the behavioural problem and design an 
appropriate behaviour-modification programme.
FENCE AT THE TOP OF THE CLIFF OR 
AN AMBULANCE AT THE BOTTOM?
What can the veterinary surgeon or veterinary nurse do 
then? We can help to prevent these problems from devel-
oping in the first place by recognizing that we are well 
placed to educate owners on how to foster emotional 
resilience in their pets, resulting in good welfare out-
comes. In other words, if they put the work in at the begin-
ning, then the chance of a behavioural problem developing 
reduces. Understanding how animals learn and how 
 owners inadvertently reinforce behaviour is key to advising 
owners on how to ensure emotionally stable, happy pets. 
Being able to read body language and  understand the 
social structure of dogs and cats is also vitally important to 
avoid inadvertently creating the behavioural problems 
owners desperately want to prevent.
KEY LEARNING OBJECTIVES
■■ Understand how an animal learns and how we 
reinforce their behaviour – good and bad
■■ Recognize the communication and body language 
that often precedes a dog bite – it’s not about 
dominance!
MULTIPLE CHOICE QUESTIONS
1. Which of the following best describes the 
social structure of domestic dogs?
(A) Similar to that of wolves
(B) Linear dominance hierarchy
(C) Solitary  
(D) Fluid and situation specific
2. What does it mean if a dog growls at you?
(A) It has a behaviour problem
(B) It must be punished as this is undesirable 
behaviour
(C) It feels threatened and is asking for space
(D) It is displaying dominant behaviour
3. Which of the following statements is NOT 
correct?
(A) A suitably qualified behaviourist will be 
able to successfully treat all problem 
behaviours
(B) All species of animals demonstrate 
behaviours for a reason
(C) Various environmental and husbandry 
issues can contribute to the development 
of problem behaviours
(D) Medical causes of behaviour problems 
must be ruled out prior to referral to a 
clinical animal behaviourist
■■ Be able to advise owners on how good intentions 
will lead to good welfare outcomes in a variety of 
common behavioural challenges
Positive patient 
welfare: what the 
RVN can do
Hayley Walters 
Most of us became veterinary nurses because we wanted 
to work with animals on a daily basis. We know that the 
patients we see are sentient beings, capable of feeling pos-
itive and negative emotions. However, as they can’t speak, 
they often fail to receive the care they should. In busy, 
understaffed, or financially constrained practices, we may 
overlook aspects of their care. How can we do better? 
We need to remember that welfare is a science and 
that a few simple changes to how a practice and its staff 
work can make a measurable impact. 
How we measure welfare can be broken down into 
four main categories: environmental resources, physiol-
ogy, physical state and behaviour. These ‘welfare indica-
tors’ help us to assess an animal’s situation or quality 
of  life without emotion and so objectively measure its 
welfare state. When we note areas of concern, we can 
 suggest and implement improvements, and then re-
measure the animal’s welfare state. 
It can be frustrating to work within time and financial 
constraints, but there are often many practical, quick 
and  cheap things a veterinary nurse can do to ensure 
the  patient’s experience is as positive as possible. For 
example: provide puzzle feeders for long-term bored 
patients or hiding places for the scared, music therapy to 
reduce stress, recognize pain behaviours adeptly, adopt 
low-stress handling techniques, allow patients to sleep 
uninterrupted for at least 6 hours a night and coincide 
all of a patient’s treatments, TPRs and examinations.
KEY LEARNING OBJECTIVES
■■ Understand how patient welfare is compromised 
in the practice by considering the animal’s 
behavioural, physical, physiological and 
environmental needs
■■ Recognize the practical steps a veterinary nurse can 
take to improve patient welfare with very little extra 
effort
■■ Appreciate that leading by example will help to 
create an environment of ‘this is normal patient 
care’ rather than the practical steps being 
considered ‘extras’
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MULTIPLE CHOICE QUESTIONS
1. Music therapy can be one way of reducing 
stress in kennelled dogs. Which genre of music 
do dogs appear to enjoy most?
(A) Reggae and soft rock
(B) Heavy metal
(C) Pop and jazz
(D) Garage
2. When performing euthanasia on a dog or cat, 
why is it a good idea to consider using the 
saphenous vein?
(A) It allows the owners to be at the head of 
their pet and cuddle it as much as they want
(B) The saphenous vein is very rarely used so 
is often in better condition than the 
cephalic vein
(C) The animal is not used to having the 
saphenous vein used and therefore may be 
less anxious and not anticipate discomfort 
when the back leg is handled as it might 
the front
(D) All of the above
3. Which of the following statements is NOT 
correct?
(A) Cortisol levels can rise temporarily during 
situations such as hunting, or mating and 
so raised cortisol is not always detrimental 
to an animal’s health
(B) Measuring salivary cortisol levels and 
observing behaviour is not a reliable 
method to measure stress levels
(C) Stress can originate when an animal 
experiences a reduction in predictability of 
events
(D) Chronic stress and prolonged periods of 
raised cortisol levels can affect an animal’s 
health
Breed-specific 
legislation
Shakira Free Miles 
Breed-specific legislation (BSL) is hopefully a term known 
to all working within veterinary clinics, as something 
known to restrict and or kill dogs based on conformation 
and supposed breed type. It is a myth-based legislation 
that is outdated and not supported by any science 
to date.
GOVERNMENT REVIEW AND CHANGES
A recent EFRA inquiry requested evidence from members 
of the public, professionals and government officials to 
review the effectiveness of BSL. It received a high volume 
of submissions, some from dog owners, victims of BSL, 
victims of dog bites, veterinary surgeons, campaign 
groups, animal welfare organizations, pet behaviour 
organizations, police and authorities. The outcome of 
this is currently pending (September 2018). Since 1991 
this law has been responsible for failing dogs, and dam-
aging their welfare and veterinary professional mental 
health, the tax payer, human safety and more. Multiple 
countries, cities and towns across the world have even 
banned BSL or repealed it, some have just reduced their 
restrictions or allow homing of suspected prohibited 
type dogs, but it is all progress supported by science.
OUR RESPONSIBILITY
Breed guessing, breed label assigning, and interpretation 
and expectations of dogs based on their supposed breed 
are dangerous and do not benefit the dog at all. The BVA 
states it is not our responsibility to in enforce the law or 
contact authorities based on a breed/type guess. The 
BVA also supports repealing this law as it is not evidence-
based. We must ensure that we take responsibility for the 
language and labels we use to describe animals in our 
care that we advocate for. Shifting blames to other 
breeds, using ‘deed not breed’ statements are all based 
on myth and media conditioning, not fact. So it is not all 
about ‘Pit Bulls’, it is about all dogs and treating them as 
the individuals we know them to be. BSL targets a huge 
variety of dogs, and is not a piece of legislation that any 
government would truly support and enforce if they were 
serious about dog bite prevention (its original aim). Dog 
discriminatory laws are  dangerous for people and dogs.
KEY LEARNING OBJECTIVES
■■ Where the UK is currently in terms of breed-specific 
legislation (BSL) enforcement, science and outcome 
compared with other countries
■■ To explain our role in the veterinary profession to rid 
the UK of BSL
■■ To discuss our responsibility in regards to dog 
discrimination and true dog bite prevention
MULTIPLE CHOICE QUESTIONS
1. Why does the UK have BSL?
(A) To reduce dog bites
(B) To reduce dog bites and eradicate the four 
prohibited type dogs
(C) To warn the public that certain dogs are 
more dangerous than others
(D) All of the above
2. What has BSL achieved?
(A) Dog bite reduction and education of value 
to people who are vulnerable to dog bite 
injuries
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(B) Reduced ‘Pit Bull’ type dogs and other 
prohibited breeds
(C) Not reduced dog bites
(D) Not reduced dog bite injuries, caused 
unintentional serious animal welfare issues 
and cost the tax payer millions of pounds 
and has achieved no educational value
3. As veterinary surgeon or veterinary nurse what 
am I obliged to do if I suspect a dog of being a 
prohibited type?
(A) Inform the police and hold the dog in the 
clinic
(B) Place in the clinical records and breed 
label what I think the dog is and tell the 
owner to muzzle the dog and be wary 
around children
(C) Do nothing and treat the dog like all other 
patients
(D) Advise the owner to go to the police to get 
assistance
Welfare of geriatric 
dogs and cats 
Heather Bacon
Our pet dogs and cats are living longer than ever – but 
what does this mean for their welfare? As veterinary 
 surgeons and veterinary nurses we are responsible not 
just for providing good physical welfare but also good 
behavioural and psychological welfare for our patients. 
However, this can be challenging for geriatric patients 
who may experience multiple co-morbidities, and who 
may often mask signs of their discomfort or distress. As 
animals age, cognitive and degenerative changes may 
impact upon their health and behaviour, as well as their 
psychological state. Whilst we often focus on the impor-
tant physical changes that may occur with age, such as 
degenerative changes to organs or increased disease 
risks, it is just as important that we consider the psycho-
logical and behaviour impacts of ageing and how these 
may interact with physical degeneration.
This presentation will review common challenges in 
veterinary management of the geriatric patient, including 
cognitive dysfunction, pain and anxiety, and explore how 
these issues may present and impact upon the health and 
welfare of our veterinary patients. We will explore some 
of the ethical challenges of effectively managing geriat-
ric patients and discuss the impact of common geriatric 
diseases on their welfare.
KEY LEARNING OUTCOMES
■■ Describe some of the conditions commonly 
experienced by geriatric cats and dogs
■■ Discuss the challenges of managing diseases in 
geriatric patients
■■ Outline some of the ethical concerns around the 
management of geriatric cats and dogs
MULTIPLE CHOICE QUESTIONS
1. Which of the following is a sign of senile 
cognitive dysfunction?
(A) Wall staring
(B) Toileting indoors
(C) Vocalizing 
(D) All of the above
2. Non-steroidal anti-inflammatory drugs are 
NOT effective in the management of which 
of the following?
(A) Neuropathic pain
(B) Nociceptive pain 
(C) Inflammatory pain
(D) Acute pain
3. What does good animal welfare comprise?
(A) Good health
(B) Physiological, physical and health
(C) Fitness, naturalness and feelings
(D) Food, water and shelter
Animal welfare 
conundrums
Heather Bacon
Companion animal veterinary practice regularly raises 
 ethical conundrums and generates many differences of 
opinion, both within the veterinary profession and through-
out our clients and society as a whole. This  presentation 
will outline some of the issues we face when dealing with 
animal welfare and ethical challenges in veterinary prac-
tice, and will particularly focus on challenges which are 
common within the veterinary profession, and which we 
may inadvertently overlook.
It is well documented that routine practices are often 
unquestioned and may become part of an organizational or 
professional ‘culture’, but as our pet owners have increasing 
access to a variety of sources for information, the chances of 
routine practices coming under scrutiny grow. As we move 
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towards an increasingly evidence-based profession, tradi-
tional approaches to routine  practices may be questioned.
This presentation will outline common practices in 
the management of our pet dogs and cats including 
socialization, neutering and behavioural management 
and explore some of the ethical challenges associated 
with these practices and the potential welfare impacts on 
our dogs and cats.
KEY LEARNING OUTCOMES
■■ Describe the basic ethology of cats and dogs
■■ Outline the process of socialization for cats and dogs
■■ Discuss the practical and ethical challenges of 
informed consent
(A) Social
(B) Solitary
(C) Selectively social
(D) None of the above
2. Which of the following is true of social 
behaviour in dogs?
(A) It is learned
(B) It is instinctive
(C) It is only developed during training
(D) It is only possible during the puppy 
socialization period
3. What does informed consent involve for 
clients?
(A) They make the initial request for the 
procedure
(B) They have the significance and main risks 
of the procedure explained to them
(C) They are able to pay the bill
(D) All of the above
MULTIPLE CHOICE QUESTIONS
1. Which of the following best describes 
behaviour of domestic cats?
Acute pain and its 
welfare implications 
Hayley Walters
Surgery, unfortunately, is guaranteed to inflict pain on a 
patient. Acute pain is something every surgical patient will 
experience if we don’t understand or recognize pain, and 
use appropriate analgesia. There are many practices for 
whom postoperative surgical pain barely exists for their 
patients. Pre-emptive analgesia is routinely given, animals 
are pain scored regularly and the analgesia plan reas-
sessed accordingly. But there are other practices where 
full understanding, recognizing or treating pain does not 
occur, resulting in a level of suffering for their patients. 
The reasons for not treating pain adequately are 
many. There are myths still obstructing some veterinary 
surgeons, such as ‘Some pain is good’, and there are 
practical challenges such as, ‘I don’t want the public to 
know I stock methadone’. There are knowledge issues, 
‘It’s already had analgesia in its premed’ and then there 
are financial concerns, ‘The client won’t want to pay for 
it’ and analgesia is something that the owner must opt in 
for during the patient’s surgical admission. And then 
there’s habit, ‘I’ve always done it this way.’ Whatever the 
reason may be, not treating acute pain has welfare con-
sequences as well as valid physical and physiological 
implications. Hypertension, tachycardia, increased stress 
response, anorexia, impaired wound healing, poor 
growth and weight gain, behavioural changes and sleep 
disturbances may occur when an animal experiences 
pain. The veterinary surgeon and nurse’s declaration on 
admission to membership of The Royal College of Veter-
inary Surgeons is ‘…. ABOVE ALL, my constant endeavour 
will be to ensure the health and welfare of animals com-
mitted to my care’, and therefore not only are there wel-
fare, physical and physiological motives for treating pain 
adequately, but professional ones too.
Pain due to surgery is predictable, but suffering is 
optional.
KEY LEARNING OBJECTIVES
■■ Understand how to recognize and measure pain and 
the multimodal approach to treating it
■■ Be aware of the myths and reasons for not treating 
pain 
■■ Recognize the welfare implications for not treating 
pain and the benefits to treating pain
MULTIPLE CHOICE QUESTIONS
1. When considering multimodal analgesia in 
dogs, which combination of drugs is NOT 
suitable?
(A) Methadone, lidocaine, meloxicam
(B) Methadone, paracetamol, ketamine
(C) Buprenorphine, lidocaine, ketamine
(D) Buprenorphine, meloxicam, methadone
2. Which of the following measures is NOT part of 
the Glasgow Composite Pain Scale for dogs?
(A) Increased respiratory rate/panting
(B) Slow or reluctant to walk
(C) Growling/guarding on palpation of wound
(D) Licking wound
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3. Which of the following statements is correct?
(A) All post-surgical patients should go home 
wearing an Elizabethan collar to prevent 
licking and infection of the surgical site
(B) A little bit of pain is good to stop the 
animal from moving too much and 
damaging the surgical site
(C) It is correct to assume that if a 
procedure would be painful for a 
human then it will be painful for an  
animal
(D) Renal failure cats that can’t have a 
non-steroidal anti-inflammatory drug 
should have paracetamol instead
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Common cancers 
and paraneoplastic 
syndromes 
Fiona McDowall
Paraneoplastic syndromes (PNSs) are defined as clinical 
signs or symptoms that can occur in a patient with can-
cer, however they are not due directly to local effects of 
the cancer cells. Substances that are not normally pro-
duced by the tumour cell of origin or abnormal amounts 
of substances produced by those cells are nearly always 
the cause of PNSs. Clinical signs induced by a tumour 
distant to its primary site, are often due to: hormone, 
cytokine, enzyme/peptide or hormone-like substance 
production.
PNSs may be responsible for more morbidity and 
mortality than the actual tumour itself, with effective 
treatment of the PNS requiring control of the underlying 
malignancy. Recognition of a PNS increases the effi-
ciency of diagnosis by revealing an underlying mass and/
or narrowing differentials. Some PNSs are emergencies 
and therefore require prompt treatment before the 
tumour is diagnosed. As the PNS usually resolves after 
effective treatment, return of the PNS can be used as 
a  marker of remission status. Failure to recognize an 
underlying tumour often prolongs morbidity and can 
lead to long-term complications and unnecessary 
expense, for example, renal failure in mismanaged hyper-
calcaemia.
PNSs can be endocrinological, haematological, 
 neurological, cutaneous and miscellaneous in nature. Com-
mon cancers associated with PNSs include  lymphoma, 
multiple myeloma, haemangiosarcomas, anal sac adeno-
carcinomas and thymomas.
This lecture will discuss PNSs and their associated 
tumours along with their systemic effects and appropri-
ate nursing treatments.
KEY LEARNING OBJECTIVES
■■ Identify common cancers and their associated 
paraneoplastic syndromes (PNSs)
■■ Discuss the systemic effects of PNSs and 
recommended treatments
■■ Determine appropriate nursing protocols
MULTIPLE CHOICE QUESTIONS
1. Polyuria and polydipsia are systemic effects 
commonly seen with which of the following?
(A) Hypercalcaemia
(B) Hypoglycaemia
(C) Hyperglobulinaemia
(D) Anaemia
2. Myasthenia gravis is a neurological PNS 
commonly associated with which of the 
following?
(A) Haemangiosarcoma
(B) Multiple myeloma
(C) Thymoma
(D) Mast cell tumours
3. Cancer cachexia can be associated with which 
of the following tumour types?
(A) Intestinal and hepatic tumours
(B) Haemagiosarcomas
(C) Renal and nasal tumours
(D) All of the above
Oncology emergencies
Nicola Read
Patients with underlying oncological disease can be pre-
sented for a myriad of reasons as an emergency to 
the  clinic. Here we discuss some presentations where 
neoplasia would be high on the differentials list. 
Ruptured viscera is the most common oncological 
emergency; organ rupture due to an invasive tumour can 
be malignant in origin. Emergency surgery is usually the 
only treatment to save the animal’s life, however this comes 
with risk that the animal may have significant life-limiting 
metastatic disease. Appropriate preoperative preparation 
includes restoration of circulating volume, ideally with 
whole blood, and wherever possible complementary 
imaging to assess metastasis to the lung parenchyma or 
abdominal organs. Splenic haemangiosarcoma is a likely 
cause, with a median survival time of approximately 
2 months reported for patients undergoing  splenectomy 
alone, and this plays a significant impact in the decision 
making for the management of these cases.
Pleural effusion, pericardial effusion, haemoptysis 
and respiratory obstruction can all be neoplastic in ori-
gin. Patients with effusions usually have a progressive 
history but if the fluid accumulation is haemorrhagic in 
origin, acute deterioration can be a result of a bleed 
caused by an invasive lesion. Initial stabilization should 
be focused on symptomatically supporting the patient 
with centesis, oxygen therapy, medical management and 
persistent, frequent monitoring whilst the diagnosis is 
investigated. Imaging of the thoracic cavity by means 
of  ‘thoracic-focused assessment with sonography for 
trauma’ (T-FAST), can help provide a clinical picture and 
identify any lesions whilst at the same time allow for 
guided biopsy. 
Patients presented with hypercalcaemia of malignancy 
are classically polydipsic and polyuric. Other clinical signs 
include dysuria, weakness, lethargy, altered behaviour and 
tremors. Potential causes include  lymphoma, anal sac 
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gland carcinoma or parathyroid tumour in the dog and 
oral squamous cell carcinoma in the cat. Patients 
 presented with the listed clinical signs can also have sig-
nificant damage to soft tissue structures from persistent 
calcium aberrations. Attempts can be made to stabilize 
the patient with fluids and diuretics and the administra-
tion of calcium bisphosphonate, but ultimately subse-
quent treatment of the primary cause will help normalize 
the patient’s calcium levels. 
Seizure activity related to a malignant cause can 
either be primary, secondary or paraneoplastic in origin. 
Primary brain tumours are common in brachycephalic 
breeds and, although many are categorized as benign, 
due to growth of the lesion they have a catastrophic 
effect. Treatment options are usually surgical or radia-
tion but the primary emphasis is on stabilization through 
reduction of swelling with hypertonic fluids and anti-
seizure medication whist the owner is advised about 
prognosis and treatment options. Secondary brain 
tumours from metastatic lesions can spontaneously 
bleed, therefore the re-presentation of an oncology 
patient with seizures may have this high up on the 
 differentials list.   
Other emergencies of neoplastic cause include 
 urinary or intestinal obstruction, acute blindness, haem-
orrhagic gastroenteritis, polycythaemia, acute lameness, 
and asepsis. In addition, patients undergoing treatment 
for their cancer may suffer ill-effects from their therapy 
and be represented to the clinic with severe adverse 
reactions. This subject is discussed in more detail within 
the oncology nursing stream. 
KEY LEARNING OBJECTIVES
■■ Build confidence to assist with some of the main 
oncological emergency cases presented in general 
practice
■■ Assist with tests which can help narrow down a 
diagnosis quickly in the emergency patient 
■■ Build on mindfulness when dealing with patients 
and clients with cancer in the emergency situation 
Staging the oncology 
patient
Nicola Read
The stage of a tumour is defined in simple terms as the 
extent of the neoplastic disease. It is an expression of the 
tumour volume and the degree of tumour spread – both 
locally and to distant sites. Tumour stage is of great 
importance in determining therapeutic options and 
prognosis, two concepts which are inextricably linked as 
each more or less defines the other. 
Strictly speaking we should differentiate clinical 
stage from pathological stage. Clinical stage classically 
summarizes the information from non-invasive proce-
dures, while pathological stage determination requires 
information from a pathologist’s inspection of excised 
tissue; the latter provides data of higher quality but 
requires more invasive testing, e.g. cytological examina-
tion of a pulmonary lesion in a patient with a splenic 
tumour. 
All procedures performed on a patient carry certain 
costs and in some cases risks (through sedation, general 
anaesthesia and haemorrhage of biopsy site), therefore it 
is not appropriate to perform the same clinical staging 
evaluations on all patients with neoplastic disease. 
The decision to undertake clinical staging procedures is 
made on the veterinarian’s clinical reasoning that the test 
will be beneficial in the further management of the case; 
by this they need to have a strong working knowledge of 
the clinical behaviour of the tumour. Factors that will 
define the evaluations performed will include tumour 
type, tumour grade and accompanying clinical signs. For 
example, the grade of a mast cell tumour (MCT) is likely 
to influence the veterinary surgeon’s (veterinarian’s) 
 recommendations from limited investigations (more 
likely for grade I cutaneous MCT), in contrast to full stag-
ing with advanced imaging and aspirates (more likely for 
grade III MCT). In summary, proceeding with extensive 
surgery without knowledge of the patient tumour stage 
may be contraindicated. 
Clinical staging through diagnostic imaging can be 
undertaken using a variety of imaging modalities; choos-
ing which to use will be based on the tumour type and 
location, plus availability to the veterinary surgeon. 
Essentially the purpose of imaging is to determine the 
tumour’s architecture and invasive extent plus facilitate 
performance of a biopsy for pathological staging.
The sentinel node is the hypothetical first lymph 
node or group of nodes draining a cancer location and 
this is the target for pathological staging. Assessment 
of  the node for metastatic spread can be determined 
through invasive sampling via direct or image guided 
biopsy. Cytological sampling is usually undertaken as a 
fine-needle aspirate. Representative samples via tissue 
MULTIPLE CHOICE QUESTIONS
1. Patients presented with hypercalcaemia could 
have which of the following neoplastic causes? 
(A) Anal sac carcinoma 
(B) Lymphoma
(C) Parathyroid tumour
(D) All of the above
2. What aggressive tumour has the highest 
incidence of re-presenting with metastatic 
brain lesions?
(A) Soft tissue sarcoma
(B) Haemangiosarcoma
(C) Osteosarcoma
(D) Fibrosarcoma
3. Patients with leukaemia may present with 
which of the following?
(A) Haemorrhage
(B) Sepsis
(C) Anaemia
(D) Any of the above
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core, punch or excisional biopsy can be also be used, 
however it will take longer for these to be analysed by the 
pathologist. Bedside assessment (prior to sample sub-
mission) to determine cellular yield can help speed up 
the staging process and allow for the staging picture to 
be communicated to the owner as soon as practicably 
possible.
Finally, advances in immunocytochemistry, immuno-
histochemistry (specialised staining) and DNA testing 
can help subcategorize certain cancers, therefore 
 providing the caregivers with more information to help 
predict how the animal’s cancer is likely to behave and 
or whether the neoplasia is likely to respond to available 
treatments. 
KEY LEARNING OBJECTIVES
■■ Understand the reasons for staging a patient with 
neoplasia
■■ Appreciate the pros and cons of each imaging 
modality
■■ Apply and/or improve practical sampling techniques 
Radiotherapy
Linda Roberts 
Radiation therapy (RT) is the locoregional medical use of 
ionizing radiation to control malignant disease. In veteri-
nary oncology, it may be used with curative intent, but 
is  also used as adjunctive or palliative therapy. RT may 
be  used alone, or in conjunction with surgery and/or 
chemotherapy, or other treatment protocols. 
RT is an effective treatment modality for animals but 
availability has been limited until recently. Now that is 
more accessible in the UK, with many cases being ‘care-
shared’ between multiple centres and between first- 
and  second-opinion practices, it is very relevant for 
veterinary nurses and general practitioners to have a 
working understanding of the process, uses and patient- 
management protocols.
RT is mainly used for local treatment for solid 
tumours, with/without surgery and chemotherapy; it 
may also be used for some systemic tumour treatment 
(e.g. half-body radiation for lymphoma), as well as for 
palliative care (e.g. analgesia for bone pain). Patients 
require general anaesthesia for each treatment, which 
is  carefully planned for, and may be administered 
 intensively (e.g. three to five times weekly) or less so (e.g. 
weekly).
Ideally the RT dose should cause high tumour cell 
kill, but spare normal cells; however, RT is not cancer cell 
specific, and produces damaging ionization within cells 
which affects cell survival, so careful planning (with 
advanced imaging modalities) and collimation are essen-
tial to protect healthy tissue and only target neoplastic 
cells as far as possible. 
Types of RT include:
■■ Internal (brachytherapy):
 – Radiopharmaceuticals in cavities, tumours or 
systemic
 – Patient is radioactive until implant is removed or 
material metabolized
 – Rarely used in veterinary medicine
■■ External (teletherapy) – beam directed at tumour:
 – Orthovoltage 150–500 kVp (X-rays)
 – Megavoltage >1 MeV, cobalt 60 or linear 
accelerator (photons and electrons)
RT may be delivered as photons or electrons, and is 
administered via:
■■ Teletherapy
■■ Orthovoltage
■■ Megavoltage – linear accelerator
■■ Megavoltage – cobalt 60
Side effects of RT are broadly divided into acute and 
late reactions. Acute effects (occurring immediately 
after  treatment) may include effects on rapidly dividing 
tissues, including normal cells; signs include erythema, 
desquamation and/or ulceration, oral mucositis, halito-
sis, skin erythema and conjunctivitis. Acute effects usu-
ally resolve spontaneously, generally 2–3 weeks after 
treatment ends, with symptomatic treatment being used 
to effect, depending on the signs seen, the location and 
the patient-specific needs. Chronic/longer-term effects 
may be seen months to years after RT ends, with slowly 
dividing tissues being affected, e.g. bone and connective 
tissue. These are potentially serious and irreversible, but 
are not seen as commonly as acute effects in veterinary 
patients due to the fact that most tumours are being 
managed/palliated, therefore prognosis may be limited; 
and the naturally shorter lifespans of small animal 
patients (i.e., in comparison with humans). Side effects 
MULTIPLE CHOICE QUESTIONS
1. What system do we often use when assessing 
the staging of a patient?
(A) Size, spread, invasion
(B) Size, symptoms, behaviour
(C) Tumour, node, metastasis
(D) Tumour, symptoms, metastasis
2. For what type of tumour is magnetic resonance 
imaging (MRI) most useful? 
(A) Lymphoma
(B) Osteosarcoma
(C) Meningioma 
(D) Pulmonary carcinoma
3. Which of the following tests can be indicated 
for a patient diagnosed with suspected 
lymphoma on cytology?
(A) Polymerase chain reaction (PCR) for 
antigen receptor rearrangements (PARR)
(B) Immunocytochemistry
(C) Flowcytometry
(D) Any of the above
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are minimized by dividing treatments into fractions, 
which gives time for normal cells to repair, for cells to 
move into a more susceptible stage of the cell cycle and 
for cancer cells to reoxygenate and become more 
 susceptible to damage. This also allows patients to rest 
and enjoy increased welfare.
KEY LEARNING OBJECTIVES
■■ To understand the common indications, uses and 
side effects of veterinary radiation therapy
■■ Gain insight into ways that veterinary nurses may be 
involved in and care for cancer patients undergoing 
radiation therapy
■■ Gain knowledge and understanding of the key 
concepts of radiation therapy, including the 
methods applied, schedules and outcomes 
expected through its use
Chemotherapy: 
administration and 
adverse effects
Fiona McDowall
The prevalence of various types of cancer in companion 
animals is high, so it is critical that veterinary practices are 
equipped to deal with the growing demands for advanced 
treatments. It has been reported that one in four dogs 
and one in six cats will develop cancer in their lifetime, 
with 50% of dogs over the age of 10 years dying from 
cancer-related complications. These figures highlight 
the importance of case throughput in companion animal 
practice.
Treatment protocols for cancer vary according to the 
tumour type, grade and stage of disease. Treatment will 
include either one of the following: chemotherapy, sur-
gical oncology, radiation therapy or a combination of 
treatments. This lecture will discuss the administration 
and adverse effects of chemotherapy only. The prescrib-
ing of cytotoxic drugs is extensive throughout the UK and 
the potential for occupational exposure of staff is there-
fore high. With this increased use of cytotoxic drugs, it is 
essential that all staff members are educated in the 
potential risks to those administering them, the immedi-
ate and delayed side effects for the patients receiving 
them, and the safe handling and disposal of cytotoxic 
waste for both staff members and clients. The toxicity of 
cytotoxic drugs has been well documented with many 
known as, or suspected to be, human carcinogens; they 
may also be mutagenic, teratogenic and some cause 
 tissue irritation.
The majority of cytotoxic drugs are either adminis-
tered orally in the form of tablets or capsules, or by 
 intravenous injection. It is essential that the registered vet-
erinary nurse (RVN) is competent in the correct route of 
administration of cytotoxic drugs, as some drugs may 
cause a fatal anaphylaxis if given incorrectly. As there are 
risks in the handling of cytotoxic drugs, individual practice 
policies and standard operating procedures should be in 
place to minimize risk of exposure to staff within the prac-
tice, the patients and owners of the animals being treated. 
Exposure to cytotoxic drugs includes absorption, inhala-
tion and self-inoculation.
Although the majority of chemotherapy protocols 
used in companion animal practice are designed to have 
a low incidence of adverse effects they can occasionally 
occur, with general delayed adverse effects including 
bone marrow suppression, gastrointestinal effects and 
alopecia. Immediate side effects can also occur and 
include anaphylaxis and extravasation.
KEY LEARNING OBJECTIVES
■■ To gain a thorough understanding of how to 
prepare and administer cytotoxic drugs safely
■■ To appreciate the adverse effects which can occur 
with cytotoxic drug administration
■■ To acknowledge the advice clients require on 
discharge of patients that have received 
chemotherapy
(A) Mucositis
(B) Bone tumours 
(C) Desquamation 
(D) Conjunctivitis
2. RT commonly used in veterinary medicine may 
include which of the following?
(A) Teletherapy, orthovoltage, megavoltage 
and orcanotovoltage
(B) Rontomerotherapy, orthovoltage, 
teletherapy and megavoltage 
(C) Megavoltage, brachylovoltage, 
orthovoltage and teletherapy
(D) Brachytherapy, megavoltage, orthovoltage 
and teletherapy
3. Which of the following cancers is NOT routinely 
treated using RT?
(A) Mast cell tumours in dogs and cats
(B) Small cell/gastrointestinal lymphoma 
in cats 
(C) Analgesia for bone pain, e.g. osteosarcoma
(D) Nasal carcinomas in cats and dogs
MULTIPLE CHOICE QUESTIONS
1. Which of the following is NOT a common, 
acute side effect of RT? 
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MULTIPLE CHOICE QUESTIONS
1. If extravasation occurred during the 
administration of vincristine which of the 
following should you NOT do?
(A) Apply a cold compress to the area
(B) Apply a hot compress to the area
(C) Place an Elizabethan collar on the  
patient
(D) Inject the area with hyaluronidase
2. Which of the following cytotoxic drugs can 
cause haemorrhagic cystitis?
(A) Vincristine
(B) Vinblastine
Palliative care for 
cancer patients 
Linda Roberts 
The ideal in veterinary oncology is to aim for curative 
outcomes in the treatment of cancer-bearing patients, 
however management/control of the disease may be the 
reality for some, with palliative care being important for 
ongoing welfare. 
Palliative care may be undertaken for various reasons, 
e.g. the primary cancer, or its metastases, are too far 
advanced for definitive treatment; the owner’s wishes, 
beliefs, and/or finances; the presence of other life-limiting 
comorbidities; the patient’s emotional health/behavioural 
welfare, etc. Many of the treatment options/standards of 
care for all types of cancers apply in the palliative setting, 
for example surgery, chemotherapy, radiotherapy and 
adjunctive treatments to maintain good quality of life. The 
intention and outcome objectives shift, however, from 
welfare and longevity, to control of clinical signs, mainte-
nance of optimum comfort and an ‘every day must be a 
great day’ focus, i.e. with minimum ‘borrow’ for maximum 
‘payback’ for the patient. Regardless of the reason(s), limi-
tations, or goals, compassionate care of all patients, cancer 
patients included, requires they are kept as free as possible 
from the adverse effects of their illnesses and treatment. 
Palliative care in cancer patients may take many 
forms, including monitoring of the primary illness; analge-
sia management; maintenance of optimal nutritional +/– 
hydration status; management of comorbidities; assess-
ment of ongoing therapies; lifestyle modifications, etc. 
Therefore, registered veterinary nurses (RVNs) are well 
placed to assess for, and provide, key aspects of palliative 
care in veterinary cancer therapy. RVNs are the patient’s 
advocate, acting as key liaison between the veterinary care 
team(s), educating and communicating with owners, and 
monitoring day-to-day quality of life and welfare. 
With our increasing population of pets living to 
greater ages, cancer is common – it is mainly a condition 
of older age, and the cause of death in up to one in four 
patients. Many more (than those that die from cancer) 
senior pets are living with cancer, and being well man-
aged, with some other condition being their eventual 
cause of death. Therefore much of the routine care pro-
vided to all senior pets, and/or those with chronic illness, 
applies to how we can apply our nursing skills to the 
acute and chronic care of cancer patients, particularly in 
the palliative care setting. 
Palliative care, in which RVNs may be involved, 
includes:
■■ Pain and comfort assessment/management – RVNs 
are key in managing pain, by constant re-evaluation, 
tailoring of analgesic protocols in liaison with the 
clinician, communication with owners and 
addressing patients’ changing needs
■■ Treatments such as non-steroidal anti-inflammatory 
drugs (NSAIDs), corticosteroids, small-molecule-
inhibitors, immunotherapy, emerging tailored 
therapies, adjunctive/complementary therapies and 
modalities, e.g. acupuncture and physiotherapy
 – Also, often chemotherapy and/or radiotherapy
■■ Ongoing monitoring of whole-patient health and 
welfare
■■ Nutritional advice/intervention where appropriate. 
Meeting clinical nutritional requirements is 
important in cancer care. Owners often need 
assistance with this too
 – Feeding tube placement and management; 
dietary calculations and tube care; owner 
instruction on tube use/care
RVNs may also facilitate palliative care via wellness 
clinics, aimed at keeping cancer-bearing pets enjoying 
great, long-term quality of life, making a real difference 
to the lives of owners and their cancer-bearing pets.
KEY LEARNING OBJECTIVES
■■ To understand the reasons for, and limitations and 
goals of palliative cancer care
■■ Gain insight into ways in which all aspects of 
veterinary nursing care may be applied to care of 
cancer patients undergoing palliative care
■■ Gain knowledge and understanding of the key 
concepts of cancer palliation
MULTIPLE CHOICE QUESTIONS
1. Which of the following is NOT commonly used 
in palliative cancer care?
(A) Multimodal analgesia
(B) Homeopathy 
(C) Radiation therapy and chemotherapy
(D) Feeding tubes for maintenance of 
hydration and calorie intake
(C) Doxorubicin
(D) Cyclophosphamide
3. What is the unique toxicity of lomustine?
(A) Renal toxicity
(B) Hepatic toxicity
(C) Cardiotoxicity
(D) Neuropathy
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2. Which of the following is NOT an option in 
veterinary oncology palliative care?
(A) Limb amputation for painful pathological 
fractures
(B) Radiotherapy for analgesia of bone pain
(C) Corticosteroid use for control of a 
tumour’s clinical signs
(D) Aggressive surgery, with protracted 
recovery times and curative intent 
3. Which of the following is NOT part of 
veterinary nurse input in palliative care of 
cancer patients?
(A) Communication and liaison on all aspects 
of care between all parties involved with 
the patient
(B) Intensive ‘no pain, no gain’ exercise and 
physiotherapy plans for post-surgical 
patients 
(C) Attention to the emotional well-being of 
the patient, including measures to alleviate 
distress
(D) Continuous assessment of behaviours and 
clinical signs to discern comfort and 
quality of life 
Novel treatments: what’s 
new and advances
Nicola Read
Companion animals share their environment with their 
owners; therefore a lot of comparisons to human onco-
logical diagnostics and treatments are being identified. 
During this lecture, some of the advances of veterinary 
oncology are discussed.
As veterinary clinical pathology advances, there has 
been much more availability in the UK to order special-
ized staining and DNA testing to allow for neoplasms to 
be identified and categorized. Immunohistochemisty, 
immunocytochemistry, flow cytometry and polymerase 
chain reaction (PCR) for antigen receptor rearrangement 
(PARR) can help identify biological markers that can help 
distinguish a neoplasm, which can allow for better pre-
diction of prognosis and sometimes likely treatment 
response.
Immunotherapy works to protect and boost the 
immune system; it enables the body to block cancerous 
pathways and promote the power of cytotoxic T cells, 
enhance the checkpoints of the cell cycle and activate 
other immune responses, such as antigen presentation 
and cytokine release. In some human patients with 
 lymphoma and melanoma, immunotherapy works well, 
so similar therapies have been made available to com-
panion animals. Solid tumours, however, have a poor 
response, so surgery, radiation and chemotherapy 
remain necessary treatments. Research is currently under-
way to assess tumour response to immunotherapy for 
our companion animals.
Non-surgical procedures are slowly becoming avail-
able in specialist practices that offer an alternative to 
 traditional surgical techniques. Photodynamic therapy 
(PDT) is commonly used for human head and neck can-
cers by using a light source combined with a photosensi-
tizing agent to destroy cancer cells. PDT has demonstrated 
good efficacy in feline squamous cell sarcoma. Electro-
chemotherapy (ECT) is a treatment used for superficial 
tumours; a dose of chemotherapy is injected systemically 
or into the lesion before an  electrical current is passed 
through the mass with an electrode. ECT is used currently 
for equine sarcoids and its efficacy has been documented 
for a number of other companion animal tumours. 
Rabacfosadine is marketed to target and kill lym-
phoma by inhibiting DNA synthesis; it is administered 
intravenously every 3 weeks for five doses and has a 
reported 77% response rate. This new medication requires 
a named patient special treatment licence and so is cur-
rently limited to a small number of veterinary specialists in 
the UK. As expected of any chemotherapy treatment, 
adverse effects are still likely and so far rabacfosadine has 
yet to become a go-to treatment before traditional thera-
pies; more positive research on efficacy would support 
this promising treatment option and may help reduce the 
visits and cost of treating canine lymphoma in the future. 
An increasing number of specialized surgeons are 
using interventional radiography to offer a wider range of 
palliative methods to improve quality of life for locally 
malignant tumours, in particular stenting of the urinary 
tract. Chemoembolization is offered by a handful of spe-
cialized oncology centres. The procedure involves cath-
eterization of the lesion to deliver a dose of chemotherapy 
in the form of microbeads that occlude the small vessels 
supplying the mass and provide a concentrated dose of 
cytotoxic drugs. 
KEY LEARNING OBJECTIVES
■■ What progression has there been in veterinary 
oncology treatments to date and what the future 
may hold
■■ Identification of specialist treatments available to 
patients with certain types of cancer
■■ Understanding of what diagnostic tests are available 
to allow for better categorization of tumours
MULTIPLE CHOICE QUESTIONS
1. What type of canine visceral tumour has had a 
positive response to chemoembolization?
(A) Hepatic
(B) Splenic
(C) Pancreatic
(D) Gastric
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2. What is the name given to chemotherapy 
treatments administered in small, regular doses?
(A) Systematic
(B) Metronomic
(C) Teratogenic
(D) Methodical
3. For what type of tumour can a stent improve 
survival time and quality of life?
(A) Pulmonary carcinoma
(B) Glioblastoma
(C) Mast cell tumour
(D) Transitional cell carcinoma
Client support for 
patients with terminal 
illness
Fiona McDowall
Compassion is core to nursing practice and it is essential 
that all registered veterinary nurses (RVNs) develop the 
skills necessary to communicate support and compas-
sion to their patients as well as the patient’s owners, as 
the nurse–client bond is central to the delivery of nursing 
care. Compassionate communication skills are essential 
for the RVN involved in the care of patients with terminal 
cancer, as this will facilitate minimizing fears associated 
with pain, suffering and death, aiding in informed deci-
sion making, discussing complex medical information 
and guiding clients through the physical and emotional 
difficulties associated with cancer.
Communicating with clients whose animals are 
approaching their end of life (EOL) can be stressful and 
emotional for pet owners and RVNs alike, therefore, 
timely, empathetic and non-judgemental communica-
tion is vital for effective client support. Post-euthanasia 
support is invaluable for clients, however EOL care 
requires owners to make immense decisions prior to 
their pet’s death at a time when they feel vulnerable and 
need support. An understanding of grief models will 
facilitate the RVN in providing an appropriate level of 
support. How the veterinary team responds to client grief 
plays a vital role in the client experience and their contin-
ued loyalty to the practice upon the loss of their pet. 
Communication is inevitable, unavoidable and one of the 
most common skills employed by the veterinary health 
team. The use of non-verbal communication skills such 
as shaping space and developing non-verbal rapport 
skills are essential for the RVN, as 80% of all communica-
tion between the client and the RVN is non-verbal and 
largely involuntary, with only 20% of communication 
involving verbal and voluntary acts.
This lecture will discuss various types of verbal and 
non-verbal communication techniques and the support 
clients require when making EOL decisions. Considera-
tion will be given to the use of grief models in practice 
and how an understanding of these models can benefit 
clients.
KEY LEARNING OBJECTIVES
■■ To develop an understanding of the use of verbal 
and non-verbal communications skills
■■ To establish the support required by grieving clients
■■ To identify and understand the various stages of the 
grieving process
MULTIPLE CHOICE QUESTIONS
1. The Kubler-Ross five stages of grief model 
consists of which of the following?
(A) Denial, anger, acceptance, bargaining and 
depression
(B) Rejection, hatred, acceptance, bargaining 
and depression
(C) Disapproval, anger, acceptance, bargaining 
and hopelessness
(D) Denial, annoyance, acceptance, bargaining 
and sorrow
2. When do clients start to grieve for their pets?
(A) Once euthanasia has been performed
(B) Clients don’t grieve for their pets
(C) When the animal starts to show clinical 
signs of a terminal illness post diagnosis
(D) On diagnosis of a terminal illness
3. What is the term used to describe grief which 
occurs before an impending loss?
(A) Prepared grief
(B) Adapted grief
(C) Anticipatory grief
(D) Expectant grief
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Inflammatory bowel 
disease 
Gina Parkes
The topic of gastrointestinal (GI) disease can be a con­
fusing one that is difficult to think about in a clear and 
coherent manner due to the large range of variables 
associated with it. There are so many different questions 
that a clinician must answer in order to successfully treat 
a patient with GI disease that, as nurses, it can sometimes 
result in us simply caring for the patient without fully 
understanding the reasons for the clinical signs that they 
are  showing.
In most of our careers, we commonly encounter and 
nurse patients with GI disease. We witness our clinicians 
investigating whether our patient may have ‘upper’ or 
‘lower’ GI tract clinical signs, have acute or chronic dis­
ease, or may have clinical signs associated with primary 
or secondary disease – but what does this all mean in 
relation to our patients’ GI disease? More importantly, 
where does inflammatory bowel disease (IBD) fit in? 
The term ‘IBD’ is an umbrella term that has been 
 historically used in practice to describe chronic idiopathic 
clinical signs associated with inflammation of GI mucosa. 
The ambiguous use of the term can cause increased con­
fusion for nurses trying to understand the topic. 
In current practice, a disease that causes chronic 
lower GI tract clinical signs is referred to as a chronic 
enteropathy. Within the bracket of chronic enteropathy 
diseases, a patient can suffer from any of the following: 
food­responsive diarrhoea, antibiotic­responsive diar­
rhoea and steroid­responsive disease, i.e. primary inflam­
matory disease (previously could be called IBD). Incorrect 
diagnosis of a patient’s disease can dramatically vary the 
treatment, cause considerable delay in recovery, and be 
detrimental to both the patient and the client. 
Raising awareness of the importance of a food trial in 
patients presenting with chronic lower GI signs is crucial. 
Patients with food­responsive diarrhoea will commonly 
respond to an elimination diet within 2–4 weeks and 
therefore undergo much less invasive therapy and inter­
vention associated with attempting to diagnose disease 
caused by antibiotic­responsive diarrhoea and steroid­
responsive disease. Knowledge of our patient’s nutri­
tional needs and an understanding of the importance of 
client compliance during a food trial is crucial. In order to 
successfully assist the clinician in practice when identify­
ing the underlying cause of a chronic enteropathy, as 
well as supporting the client and providing a high stand­
ard of care, a competent nurse must understand the 
pathophysiology and the relevance of the terms IBD and 
chronic enteropathy.  
KEY LEARNING OBJECTIVES
■■ Understanding lower gastrointestinal disease 
■■ Chronic enteropathy vs. Inflammatory bowel 
disease terminology
■■ Nursing considerations for patients suffering from 
chronic enteropathies 
MULTIPLE CHOICE QUESTIONS
1. What type of disease could a patient with a 
chronic enteropathy have?
(A) Nutrition­deficiency disease, steroid­
responsive disease, antibiotic­responsive 
diarrhoea
(B) Food­responsive diarrhoea, steroid­
responsive disease, antibiotic­responsive 
diarrhoea
(C) Indigestion, malabsorption, emesis, 
diarrhoea
(D) Food­responsive diarrhoea, steroid­
responsive disease, antibiotic resistance 
2. What does the term IBD stand for?
(A) Inflammatory bowel deficiencies
(B) Inflammatory bowel diarrhoea
(C) Infectious bowel disease
(D) Inflammatory bowel disease
3. How long does it typically take for a patient to 
respond to a successful diet trial?
(A) 7–10 days
(B) 5–6 weeks
(C) 2–4 weeks 
(D) 0–7 days
Diabetes mellitus: 
let’s not sugar coat it!
Gina Parkes
Diabetes mellitus has a range of underlying causes that 
can vary depending on the species, age and health of our 
patient. Studies in recent years have highlighted major 
differences in both canine and feline diabetic disease 
processes and, as such, an increase in the need for care­
ful diagnosis and greater treatment compliance. Various 
underlying reasons for patients to present in a hypergly­
caemic state range from insulin secretion abnormalities 
to insulin resistance, or an inability for glucose to enter 
the tissues once it has reached them. Causes include 
genetic, immune­mediated, idiopathic, or secondary to 
endocrinopathies or other disease. 
So what happens if the treatment that a patient is 
receiving does not match the reason that the patient is 
hyperglycaemic? How do we care for our patient and 
support our client if they do not have the money to pay 
for investigation into why their pet is diabetic but would 
still want to treat them? Alternatively, what does it mean 
for our patient’s health if a client cannot comply with our 
recommended treatment protocol?
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As veterinary nurses we are strategically involved in the 
management of diabetic patients throughout our career. 
We will often see our diabetic patients come back to the 
practice repeatedly for re­examinations, blood glucose 
curves and further tests or changes to treatment. We ask for 
a lot of compliance from our diabetic patient pet owners 
and may not always stop to think of whether the patient’s 
and client’s quality of life at home is being severely affected. 
Weighing up the balance of client support to sustain 
a  manageable treatment regime while avoiding the 
 consequence of poor glycaemic control that can induce 
life­threatening diabetic ketoacidosis is difficult. Diabetic 
cataracts, systemic hypertension, proteinuria, neuropathy 
and nephropathy are some of the secondary clinical prob­
lems associated with diabetes mellitus. Offering a gold 
standard level of nursing care means that we should fully 
understand the secondary clinical signs and seriousness 
of this long­term disease. We should aim to offer support 
to the client while helping them to comply with treatment 
that is achievable within their means and lifestyle. A client 
that is comfortable with the treatment regime and cost is 
more likely to continue treatment for longer. 
As competent nurses, we should recognize the serious­
ness of diabetes mellitus for both the patient and the  client. 
Understanding the gravity of the disease while helping the 
client to give their pet the best treatment they can sustain, 
will give the best outcome for both patient and client. 
KEY LEARNING OBJECTIVES
■■ Complications associated with diabetes mellitus
■■ The importance of a good assessment of the quality 
of life of clients and pets
■■ The impact of poor compliance on our patients’ health 
(B) Systemic hypertension, proteinuria, polyuria, 
polydipsia
(C) Pulmonary hypertension, tachycardia, 
polyuria, polydipsia
(D) Hypertrophic cardiomyopathy, proteinuria, 
polyuria, polydipsia
2. As competent nurses, which of the following 
should we do?
(A) Ensure we are knowledgeable on the 
disease processes in order to support the 
client appropriately. Encourage the client 
to comply with the best treatment that 
they can afford within their budget and 
lifestyle 
(B) Ensure we are knowledgeable on the 
disease processes in order to support 
the client appropriately. Encourage the 
client to comply with the most up­to­date 
advanced treatment regardless of the cost
(C) Ensure we are knowledgeable on the 
disease processes in order to support the 
client appropriately. Encourage the client 
to comply with the most up­to­date 
treatment if it is cheap, regardless of the 
intensity of the regime
(D) Try to support the client without fully 
understanding the disease state that their 
pet is suffering from or could deteriorate 
into
3. Which of the following are underlying 
causal factors of diabetes mellitus in cats 
and dogs?
(A) Genetics, breed, secondary to a blood 
disorder, immune­mediated
(B) Genetics, lifestyle, secondary to an 
endocrinopathy, immune­mediated
(C) Lifestyle, breed, dental health, immune­
mediated
(D) Lifestyle, depression, dental health, 
immune­mediated
MULTIPLE CHOICE QUESTIONS
1. Which of the following will patients with 
diabetes mellitus commonly present with?
(A) Systemic hypotension, proteinuria, anuria, 
polydipsia
Feline diabetes: 
they are not small 
diabetic dogs!
Gina Parkes
Insulin is a hormone that is produced in the endocrine 
pancreas and functions to allow glucose to enter the tar­
get cells within the tissues in both dogs and cats. While 
both species produce and metabolize insulin in a similar 
way within our healthy patients, there can be major 
 differences between the underlying factors driving the 
disease processes of canine and feline diabetes mellitus. 
When looking at how we complete successful patient 
care for feline diabetes within practice, it is useful to 
break down the whole package into three main sections 
of care: the investigation and treatment of the disease, 
the nursing care and the client support. 
Canine patients most commonly suffer from insulin­
dependent diabetes mellitus related to a combination of 
genetics, poor lifestyle and immune­mediated destruc­
tion of pancreatic beta cells, that closely resembles type 
1 diabetes in humans. In contrast, studies in recent years 
have highlighted that feline diabetic patients are more 
likely to present with disease that has more similarities to 
human type 2 diabetes. While genetics and endocrinopa­
thies also play a part, lifestyle management in cats is 
now  considered to play a major role in the successful 
 treatment of feline diabetes. Almost as important as 
 insulin therapy, good lifestyle management is key to 
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management of the disease due to the serious damage 
that obesity causes in compounding injury through islet 
amyloidosis to an already poorly functioning endocrine 
pancreas. 
Gold­standard nursing care for feline diabetes 
patients asks that we understand the disease processes 
behind the treatment in order to nurse to best of our 
ability. Feline patients require a comprehension of the 
species character and a commitment to feline friendli­
ness throughout their care. Nursing a cat through its 
 diabetic investigation and treatment pathway should 
involve a careful and considered approach that means 
we assess every aspect of our nursing and reflect on 
our  handling, housing, equipment, environments and 
 training. 
The journey of treatment of feline diabetes can be a 
difficult and frustrating one for our clients. Feline patients 
do not routinely stay indoors around the clock like their 
canine counterparts. Many cats are not reliable and rou­
tine feeders. Clients often struggle with the results of the 
mistrust that occurs through repeated trips to the vet and 
the insulin injections. Games of attempting to catch the 
cat indoors at the treatment time and inject during feed­
ing time to trick the cat become normal routine. Cats are 
natural hunters and, if they spend vast amounts of time 
outdoors, clients may struggle to monitor their health. 
All of these problems as well as many more can cause 
anxiety to our clients and remove the joy of being a pet 
owner. As nurses, understanding the problems that our 
cat owners face and the difficulties associated with treat­
ment of a cat, means that we can better support our 
 clients and that they may continue with the enjoyment 
and treatment of their pet for longer.  
KEY LEARNING OBJECTIVES
■■ Differences in underlying causes for diabetes 
mellitus in cats vs. dogs
■■ Nursing­care considerations for feline diabetes 
mellitus
MULTIPLE CHOICE QUESTIONS
1. Which underlying causes are more commonly 
associated with diabetes mellitus in cats?
(A) Genetics, obesity, immune­mediated, 
cardiopathies
(B) Genetics, obesity, endocrinopathies, 
cardiopathies
(C) Genetics, obesity, endocrinopathies, islet 
amyloidosis
(D) Genetics, infection, endocrinopathies, islet 
amyloidosis 
2. Gold­standard nursing care for feline diabetes 
mellitus patients asks that we reflect on which 
of the following?
(A) Handling, housing, equipment, 
environments and training
(B) Handling, housing, equipment, cost and 
grooming
(C) Speed of service, cost, training and 
recruitment
(D) Speed of service, cost, training and 
equipment
3. Which of the following are aspects of home 
care of a diabetic cat which may cause anxiety 
for the owner?
(A) Feeding, palpating, monitoring, owner 
enjoyment
(B) Feeding, injecting, monitoring, owner 
enjoyment 
(C) Fasting, palpating, monitoring, owner 
enjoyment
(D) Fasting, injecting, monitoring, owner 
enjoyment
■■ Client­support considerations for feline diabetes 
mellitus
Diabetic ketoacidosis
Gina Parkes
Diabetic ketoacidosis (DKA) is a life­threatening and seri­
ous metabolic state that occurs most commonly to 
patients suffering from diabetes mellitus, where a dimin­
ished level of insulin or an inability to use insulin that is 
produced, results in a serum hyperglycaemia. The cells in 
the body are unable to use the circulating glucose for its 
intended purpose and the body attempts to source 
energy through the breakdown of fatty acids to triglycer­
ides and ketone bodies or ketones. 
In a healthy patient, insulin will suppress the produc­
tion of glucose in the liver at times of hyperglycaemia, 
and glucagon released by the alpha cells of the pancreas 
will cause glycogen to covert to glucose at times of 
hypoglycaemia. The two hormones work together to 
maintain homeostasis of glucose levels. 
In a patient with reduced insulin levels, despite the 
excess glucose in circulation, tissues in the body that are 
starved of energy cause the liver to produce further glu­
cose through both gluconeogenesis and glycogenolysis. 
As mentioned, free fatty acids are converted to triglycer­
ides and ketone bodies and some tissues are able to use 
ketones for energy. In a healthy patient, a certain level of 
ketone bodies is normal, however in a persistent hyper­
glycaemic state, the ketone levels surpass the patient’s 
ability to metabolize them. Increased levels of acidic 
ketones in the bloodstream may cause the pH of the 
blood to drop and the patient develops DKA.
Patients with DKA will commonly have excess levels 
of ketones and glucose in the blood that overspill in 
the  urine and take electrolytes with them. Electrolyte 
imbalances, such as hypokalaemia, along with dehydra­
tion, that is compounded further by fluid loss through 
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 vomiting and diarrhoea, can cause serious and rapidly 
deteriorating disease. Treatment for patients diagnosed 
with DKA therefore starts with administration of fluid 
therapy and electrolyte correction. Glucose levels are 
commonly corrected acutely and micromanaged using 
soluble insulin therapy in these patients.
There are many nursing considerations for patients 
with DKA. Patient comfort and cleanliness during times of 
severe illness and lethargy are key to ensuring patient 
demeanour remains as good as it can. Placement and 
maintenance of central lines are useful for reduced venous 
blood sampling. Intense monitoring during times of solu­
ble insulin administration and fluid electrolyte resuscitation 
are crucial, as serum potassium levels along with other 
electrolytes will drop when the electrolytes move back into 
the intracellular space, in line with an increase in blood pH 
and insulin administration. Hypoglycaemia is also a possi­
ble complication of treatment with soluble insulin. 
Interstitial fluid glucose monitors can help in the 
assessment and ongoing care of patients on insulin in the 
monitoring of glucose levels in a non­invasive manner. 
Going forward, client support is key. These monitors can 
improve control of the disease through use at home, 
offering increased client compliance if supported appro­
priately by the knowledgeable and competent nurse.
KEY LEARNING OBJECTIVES
■■ Why diabetic ketoacidosis (DKA) occurs in the 
diabetic patient
■■ Nursing considerations of DKA
■■ How to use an interstitial fluid glucose monitor 
(B) A serious metabolic state in which the 
blood stream pH rises and electrolyte 
imbalances occur
(C) A normal metabolic state in which 
electrolytes spill over in the urine 
due to excess electrolytes in the  
body
(D) A serious metabolic state in which the 
blood pH falls and electrolytes are  
normal 
2. Nursing considerations for a patient with DKA 
can include which of the following?
(A) Electrolyte monitoring, ensuring patient is 
awake, central line maintenance, interstitial 
fluid glucose monitoring
(B) Electrolyte and glucose monitoring, 
ensuring comfort and cleanliness, central 
line maintenance, interstitial fluid glucose 
administration
(C) Electrolyte and glucose monitoring, 
ensuring comfort and cleanliness, central 
line removal, intracellular fluid glucose 
monitoring 
(D) Electrolyte monitoring, ensuring 
comfort and cleanliness, central line 
maintenance, interstitial fluid glucose 
monitoring 
3. Which of these statements is correct?
(A) Glucose and glycerol work together 
to allow glucose levels to remain  
balanced
(B) Insulin and glycerol work together to allow 
glucose levels to remain balanced
(C) Insulin and glycogen work together to 
allow glucose levels to remain balanced
(D) Gluconeogenesis and potassium work 
together to allow glucose levels to remain 
balanced
MULTIPLE CHOICE QUESTIONS 
1. What is DKA?
(A) A serious metabolic state in which the 
bloodstream pH falls and electrolyte 
imbalances occur
Transfusion medicine 
and common bleeding 
disorders
Rachel Pickles 
Blood transfusions, products 
and monitoring
There are different blood products available to treat 
 different specific diseases and deficiencies in the most 
effective way.
Whole blood contains both red blood cells and 
plasma. This can be used to treat symptomatic anaemia, 
platelet deficiencies and coagulation deficits in the 
absence of a suitable component.
Packed red blood cells are obtained from whole 
blood that has been centrifuged, where the red blood 
cells and the plasma are separated. This can be used to 
treat symptomatic anaemia.
Fresh frozen plasma is plasma that has been frozen 
immediately after collection. It contains clotting factors V, 
anti­haemophilic (VIII) and von Willebrand factor. This is 
used for the treatment of clotting factor deficiencies and 
disseminated intravascular coagulation (DIC), for plasma 
volume expansion and plasma protein replacement.
Frozen plasma contains albumin and other plasma 
proteins fibrinogen, factor VII and factor IX. It is used in 
the treatment of deficiencies of the clotting factors and 
plasma protein deficiencies.
Cryoprecipitate is a plasma fraction that has been 
separated from whole plasma. It is used specifically for 
inherited clotting factor deficiencies.
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Cryosupernatant contains non­labile clotting factors 
fibrinogen, factor VII and factor IX. It also contains albu­
min and other plasma proteins. It is used for the treatment 
for most clotting factor deficiencies except haemophilia A 
and von Willebrand disease.
There are blood typing kits available to test for canine 
DEA 1.1. If a dog has not had a previous transfusion, it can 
be given either positive or negative type blood. To be safe 
in case further transfusions are required, it is best prac­
tice to blood type first. If a patient requires further blood 
transfusions cross­matching is necessary if more than 
72 hours have elapsed since the last transfusion, to avoid 
transfusion reactions.
Blood typing kits are available for feline type A, B and 
AB. Blood typing should always be carried out in the 
case of feline transfusion and the wrong type could be 
fatal. Type A is the most common type in Domestic 
Shorthair cats.
Frequent monitoring during a blood transfusion is 
vital. For the initial hour, temperature, pulse rate, quality 
and rhythm, respiratory rate, depth and pattern should be 
monitored every 15 minutes. If no transfusion reactions 
are evident in this time, recording vital parameters can be 
performed every 30 minutes until the end of transfusion. 
It is advised that for the first hour of the transfusion the 
rate should be gradually increased as this is when most 
reactions will occur. Packed cell volume should be 
 measured before and after the transfusion to assess the 
success of the transfusion and treatment. The demean­
our and behaviour of the patient should also be closely 
monitored, and cardiac and thoracic auscultation should 
be performed. Urine output is another parameter that is 
significant.
Blood transfusion reactions include weakness, 
depression, tremors, agitation, vocalization, tachypnoea, 
dyspnoea, tachycardia (bradycardia in cats), arrhythmias, 
salivation, nausea, vomiting, diarrhoea, angioedema, 
urticaria, seizures, coma and cardiopulmonary arrest. 
Transfusion reactions are undetectable under general 
anaesthesia.
KEY LEARNING OBJECTIVES
■■ To understand the different blood products 
available
■■ To be able to monitor a patient during blood 
transfusion 
■■ To be able to identify signs of transfusion reactions 
and know how to minimize them
MULTIPLE CHOICE QUESTIONS
1. What would you use cryoprecipitate plasma to 
treat?
(A) Symptomatic anaemia
(B) Hypoalbuminaemia
(C) von Willebrand disease and haemophilia A
(D) Platelet deficiency
2. Which of the following is not a symptom of a 
blood transfusion reaction? 
(A) Vomiting
(B) Tachypnoea
(C) Urticaria
(D) Hypothermia
3. If a patient requires a second blood transfusion, 
cross­matching is required after how long?
(A) 24 hours
(B) 72 hours
(C) 1 hour
(D) 1 week
Common bleeding disorders
IMMUNE-MEDIATED HAEMOLYTIC 
ANAEMIA 
Immune­mediated haemolytic anaemia (IMHA) can be 
primary or secondary. In primary IMHA, the immune 
 system mistakenly produces antibodies that attack its 
own red blood cells. This is the most common cause of 
anaemia in dogs.
Secondary IMHA can be caused by cancer, infection, 
blood parasites, drug reactions, snake bite, certain 
chemicals and toxins and bee stings or other allergic 
reactions. It might occure as a vaccination reaction 
(controversial).  
History and clinical findings may show pale mucous 
membranes, lethargy and weakness, increased respira­
tory rate, tachycardia, anorexia, weight loss, melaena and 
pica.
Presence of spherocytes on a blood smear is typical 
of IMHA. A positive saline autoagglutination is also 
 indicative.
Treatment of primary IMHA is administration of 
immunosuppressive medication. Thromboembolism is a 
common complication of IMHA. Prognosis is guarded.
IMMUNE-MEDIATED 
THROMBOCYTOPENIA 
Immune­mediated thrombocytopenia (ITP) occurs 
when the immune system makes antibodies that destroy 
 platelets or platelet­producing cells in the bone marrow. 
Clinical signs are petechiae of the gums and skin or larger 
bruising called ecchymosis, melaena and epistaxis. An 
evaluation of the bone marrow may be necessary to help 
determine if circulating platelets or the platelet­forming 
cells are targeted by the antibodies. Immunosuppressive 
therapy is often the treatment. A blood transfusion may 
be necessary for anaemic dogs. If an animal has repeated 
episodes of the disease, the spleen can be removed. 
 Vincristine can be given to temporarily increase platelet 
count. Soft food is fed to minimize gingival bleeding. 
Cystocentesis, intramuscular injections and jugular 
venepuncture in patients with severe thrombocytopenia 
must be avoided. Direct pressure should be applied to 
any venepuncture or injection site for 5 minutes to ensure 
haemostasis. 
Middle­aged dogs are most commonly affected by 
ITP, but the disease can occur in dogs of any age. A high 
prevalence has been reported in Miniature, Toy, and stand­
ard poodles, Cocker Spaniels, Old English Sheepdogs and 
German Shepherd Dogs but any breed may be affected.
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VON WILLEBRAND DISEASE (VWD) 
VWD is caused by defective or deficient von Willebrand’s 
factor. It is the most common inherited bleeding disorder 
in dogs and occurs in any breed. There is an over­ 
representation of Dobermanns, German Shepherd Dogs, 
Golden Retrievers, Miniature Schnauzers, Pembroke 
Welsh Corgis, Shetland Sheepdogs, Basset Hounds, 
Scottish Terriers, Standard Poodles, and Standard 
 Manchester Terriers. 
Clinical signs include bleeding of the gums, nose 
bleeds and blood in the urine. Some puppies may bleed 
excessively after vaccination, microchipping or surgery. 
Laboratory tests are required to confirm the diagnosis. 
Active bleeding episodes may require transfusion with 
whole blood or plasma. 
HAEMOPHILIA A (FACTOR VIII  
DEFICIENCY)
Females carry the gene for the disease without showing 
any signs, while males show signs. In affected puppies, 
prolonged bleeding is seen from the gums during teeth­
ing and after surgery. Lameness due to bleeding into a 
joint, sudden clot formation, and oozing of blood in the 
body cavity also are common signs in dogs. Treatment 
requires repeated transfusions of whole blood or plasma 
until bleeding has been controlled.
KEY LEARNING OBJECTIVES
■■ To understand the common immune­mediated and 
inherited deficiencies that require blood products
■■ To identify the clinical presentation and clinical 
signs of these diseases
■■ To know which is the best blood product to use in 
these diseases
MULTIPLE CHOICE QUESTIONS
1. Which of the following is not a cause of 
secondary IMHA?
(A) Cancer
(B) Drug reactions
(C) Snake bite (allergic reaction)
(D) Immune system reaction
2. Which of the following is not a clinical sign 
of ITP?
(A) Petechiae
(B) Melaena
(C) Dysuria
(D) Epistaxis
3. Which of the following is a common 
complication of IMHA?
(A) Thromboembolism
(B) Volume overload
(C) Hypocoagulation 
(D) Polyarthritis
Endocrinology
Rachel Pickles 
Feline hyperthyroidism
Feline hyperthyroidism is the most common endo­
crinopathy of the geriatric feline patient. Thirty percent 
of hyperthyroid cases have hyperplasia of one thyroid 
gland and 70% of cases affect both thyroid glands. The 
cause of hyperthyroidism remains unknown.
Hyperthyroidism is a disease that affects middle­
aged to older cats. Average age of onset is 12–13 years. 
Clinical signs include polyuria, polydipsia, weight loss, 
raised liver enzymes, hyperactivity, gastrointestinal signs 
and polyphagia. Clinical findings can be palpable thyroid 
goitre, cardiac murmur, tachycardia and a dull hair coat. 
A total T4 blood test result above the reference range 
gives a diagnosis in 90% of cats.
There are multiple approaches to treatment of 
hyperthyroidism. Treatment of feline hyperthyroidism 
can decrease the glomerular filtration rate (GFR), raising 
serum urea and creatinine values, occasionally unmask­
ing renal failure.
Surgery is often curative and is a quick procedure 
in experienced hands. There is a very high risk of hyper­
thyroidism reoccurring if a unilateral thyroidectomy is 
carried out. The anaesthetic risk is increased in elderly 
patients and there is also a higher risk of intraoperative 
bleeding. In addition, the possibility of developing 
hypocalcaemia after bilateral thyroidectomy is high. 
Medical management prior to surgery is recommended 
short term to normalize T4 and reduce tachycardia. 
 Surgery has irreversible effects on the GFR. 
Medical management is easy to implement. Methi­
mazole is available in tablets, to be taken once or twice 
daily, liquids or topical gels. This method avoids anaes­
thesia, is reasonably inexpensive and the GFR effect is 
reversible. Some owners may find it difficult to give their 
cat daily medication. Poor compliance and side effects, 
such as vomiting, diarrhoea, anorexia and dermatologi­
cal changes, have been reported.
Radioactive iodine treatment is a safe, simple and 
single treatment that does not involve anaesthesia or 
 surgery. It is the most effective definitive treatment 
( curative in 95% of cases) with rapid effect. Authorized 
facilities are required, working closely with the Radiation 
Protection Adviser. Whilst the cats are hospitalized after 
iodine therapy no physical contact is allowed except in 
cases of emergency. Staff looking after the cats wear 
personal protective equipment (PPE) to enter the 
 isolation ward. Radiation dose monitors are worn by staff. 
Levels of radiation of the cats are monitored using a 
 Radhound contamination monitor. Staff also monitor 
themselves using the Radhound monitor before and after 
entering the isolation ward. Demeanour, appetite, respir­
atory rate and pattern, together with urine and faecal 
output are monitored twice a day. Hospitalization is 
required for 7–14 days post treatment.  After treatment 
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owners must keep their pet indoors for a further 17 days 
and close contact must be restricted. Soiled litter must 
be stored, double bagged and sealed for 3 weeks and can 
then be disposed of normally. Follow­up bloods tests are 
required to monitor success.
A specialized diet needs to be fed exclusively. It is not 
ideal for a multicat household. It is recommended the cat 
stays indoors to ensure it cannot access any other food 
source.
KEY LEARNING OBJECTIVES
■■ To comprehend the clinical signs and presentation 
of hyperthyroid cats
■■ To understand the different treatment methods of 
hyperthyroidism
■■ To be aware of the side effects and complications of 
hyperthyroid treatment
MULTIPLE CHOICE QUESTIONS
1. What percentage of feline hyperthyroid cases 
have bilateral disease?
(A) 15%
(B) 50%
(C) 90%
(D) 70%
2. Which is the following is a clinical sign of 
hyperthyroidism?
(A) Weight gain
(B) Bradycardia
(C) Polyphagia
(D) Lethargy
3. Which of the following is a possible 
complication of surgical thyroidectomy?
(A) Increased urea and decreased creatinine
(B) Decreased urea and increased creatinine
(C) Hypocalcaemia
(D) Hyperglycaemia
Hyperadrenocorticism 
and hypoadrenocorticism
The adrenal cortex is responsible for mineralocorticoid 
(aldosterone) and glucocorticoid (cortisol) production. 
The medulla is responsible for catecholamine produc­
tion (dopamine, norepinephrine and epinephrine). 
Aldosterone’s release is influenced by the renin–
angiotensin–aldosterone system and by plasma potas­
sium levels. It is essential to the maintenance of 
electrolyte balance and extracellular fluid volume. 
 Aldosterone regulates blood volume and systemic blood 
pressure. Cortisol release is controlled almost entirely 
by adrenocorticotropic hormone (ACTH). Cortisol con­
trols blood pressure, vascular reactivity of catechola­
mines, counteracts the effects of stress in the body 
and the immune system response.
A lack of glucocorticoids would indicate hypoadren­
ocorticism (atypical Addison’s disease) and an excess 
would indicate hyperadrenocorticism (Cushing’s disease).
HYPERADRENOCORTICISM
There are three types of hyperadrenocorticism: exces­
sive secretion of ACTH, pituitary­dependent (PDH 
80–85%), functional adrenal tumour (ADH 15%) and 
 iatrogenic causes.
Hyperadrenocorticism usually effects middle­aged 
to older dogs. Any breed can be affected, however 
Toy  Poodles, Dachshunds and small terriers are over­ 
represented (PDH). Adrenal tumours occur more 
 frequently in larger dogs. 
Clinical signs are polyuria and polydipsia (90% cases), 
polyphagia, raised liver enzymes, low urine specific 
 gravity, weight gain, abdominal distension, muscle weak­
ness, lethargy, panting and hair loss (symmetrical truncal 
 alopecia).
Endocrine testing involves the ACTH stimulation 
test and low­dose dexamethasone suppression test 
(LDDST). Various diagnostic imaging is helpful in 
 diagnosis.
Treatment is with trilostane, medication that blocks 
adrenal synthesis of glucocorticoids and mineralocorti­
coids. Nursing care is very important. These patients will 
need regular blood tests and monitoring of vital signs. 
Bruising can occur after blood sampling, so observation 
for haematoma formation is vital. Blood samples should 
be taken 4–6 hours post trilostane and the treatment 
should be indicated on laboratory submission forms. 
These patients should always have access to water and 
frequent opportunities to urinate.
HYPOADRENOCORTICISM
Hypoadrenocorticism may be a primary disease due to 
adrenal gland disease or secondary due to pituitary 
 problems. The most common primary diseases is an 
immune­mediated destruction of the adrenocortical 
 layers, resulting in deficiencies of mineralocorticoids 
and glucocorticoids. It usually affects young to middle­
aged dogs. Dog breeds over­represented are Standard 
Poodles, Leonbergers and German Shepherd Dogs. 
Females are also over­represented. 
Hypoadrenocorticism can present as an emergency 
(Addisonian crisis), and the patient may be collapsed, 
hypovolaemic, bradycardic, have melaena and other 
gastrointestinal signs. It can also present with a gradual­
onset history, often waxing and waning. Most commonly 
anorexia, vomiting and diarrhoea, lethargy, weakness, 
poor weight gain, painful muscle cramps or collapse 
when stressed are seen. Blood test analysis will most 
often show hyperkalaemia and hyponatraemia, non­ 
regenerative anaemia and a lack of a stress leucogram. 
Abdominal ultrasonography is used as a diagnostic aid. 
An ACTH stimulation test provides definitive diagnosis.
Treatment for the acute presentation is fluid therapy, 
correction of hyperkalaemia and glucocorticoid therapy. 
Patients can respond very rapidly. Treatment for chronic 
cases is medical management with glucocorticoid and 
mineralocorticoid therapy. 
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Nurses will play a large part in the initial triage and 
then monitoring the patient’s therapy. Initially monitoring 
vital signs and clinical signs, together with regular blood 
tests, is required. Hospitalized patients should be encour­
aged to eat. Long­term management is required as well 
as client support.
KEY LEARNING OBJECTIVES
■■ To understand the difference between hyper­ and 
hypoadrenocorticism
■■ To be able to identify the clinical signs and 
presentation of patients with hyper­ and 
hypoadrenocorticism
■■ To be able to monitor patients with both 
diseases and to understand the treatments  
available
MULTIPLE CHOICE QUESTIONS
1. What percentage of hyperadrenocorticism 
cases have functional adrenal tumours?
(A) 85%
(B) 50%
(C) 5%
(D) 15%
2. Which of the following is a clinical sign of 
hypoadrenocorticism? 
(A) Tachycardia
(B) Polyphagia
(C) Vomiting
(D) Constipation
3. Which of the following is NOT a laboratory 
finding in hypoadrenocorticism?
(A) Hyperkalaemia
(B) Hyponatraemia
(C) Non­regenerative anaemia
(D) Low urine specific gravity
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The pre-anaesthestic 
exam
Emma Archer
The importance of preoperative preparation cannot be 
overemphasized to optimize patient safety and to mini­
mize the risk of complications under anaesthesia or 
postoperatively, and preanaesthetic patient assessment 
is an important part of this. A logical approach to the pre­
anaesthetic assessment means important considerations 
are less likely to be missed. 
SIGNALMENT
Once informed consent has been obtained in writing 
along with owner contact details and specific considera­
tions such as ‘do not resuscitate’, the species, breed, age, 
gender and whether they have been neutered should be 
assessed and recorded. Knowledge of breed characteris­
tics and specific medical conditions applicable to parti­
cular breeds may provide information about anaesthetic 
considerations or concerns. For example, brachycephalic 
breeds (Pugs, Bulldogs, French Bulldogs etc) often have 
brachycephalic obstructive airway syndrome (BOAS). 
Additionally, there is a high incidence of Von Willebrand 
factor deficiency in Dobermanns, putting them at risk of 
inadequate coagulation and excessive surgical haemor­
rhage. Miniature Schnauzers, particularly females, may 
have occult sick sinus syndrome, often normal on  physical 
examination, but severe bradycardia may become appar­
ent under anaesthesia. 
REASON FOR SURGERY/PRIMARY 
COMPLAINT
Duration and severity of complaint, abnormal physical 
signs and treatment administered are recorded.
COMPLETE MEDICAL HISTORY
It is important to be aware of any pertinent medical 
 history or concurrent illnesses as these may affect the 
anaesthetic protocol, such as concurrent heart disease 
or diabetes mellitus. Good record keeping in your veteri­
nary practice can also provide useful information with 
regard to previous anaesthesia and any adverse effects.
FASTING AND WATER DEPRIVATION
Based on evidence suggesting prolonged withholding 
of  food increases the risk of regurgitation and makes 
stomach contents more acidic, a starving time of around 
4–6 hours is usually suggested.
PHYSICAL EXAMINATION
A full clinical examination should be performed in the 
week before the anaesthetic by a veterinary surgeon. On 
the day of the anaesthetic a brief clinical examination 
should be performed including the following. 
Body condition 
Patients can easily be assigned a body condition score 
ranging from 1–9 (1 being cachexic and 9 obese) to aid 
anaesthetic planning.
Cardiovascular system
Peripheral pulses should be palpated to assess, quality, 
rate and rhythm. The pulse should be felt concurrently to 
auscultating the heart to check that the pulse is synchro­
nous with the heart beat and there are no pulse deficits. 
The heart should be auscultated for murmurs or arrhyth­
mias. Peripheral pulses should be used as they are more 
sensitive to changes in circulating volume than central 
pulses, hopefully identifying inadequate circulation such 
as hypovolaemia or haemorrhage more easily. Mucous 
membrane colour and capillary refill time should be 
recorded.
Pulmonary system
Respiratory rate, depth and pattern should be assessed at 
rest. The lungs should be auscultated all over to listen for 
breath sounds and any areas of diminished breath 
sounds, crackles or wheezes identified. 
CONCURRENT DRUG USE
Patients may present already on drugs for pre­existing 
conditions. A knowledge of these drugs and how they 
may affect the patient under anaesthesia as well as when 
they were last administered is important.
BLOOD TESTS
If the patient is ‘sick’ or elderly, a blood sample for packed 
cell volume/total protein (PCV/TP), urea and creatinine 
should be analysed.
KEY LEARNING OBJECTIVES
■■ To understand the nurse’s role in preanaesthetic 
assessment
■■ To understand the importance of performing a 
preanaesthetic assessment
■■ To understand how the anaesthetic protocol can be 
adapted according to parameters identified in the 
preanaesthetic examination
MULTIPLE CHOICE QUESTIONS
1. Which of these is most useful to examine 
during the immediate preoperative 
examination?
(A) Dorsal metatarsal artery and cardiac 
auscultation
(B) Femoral artery and cardiac auscultation
(C) Dorsal metatarsal artery and lung sounds
(D) Any artery with cardiac auscultation
2. Why do brachycephalic breeds need special 
consideration under anaesthesia?
(A) They are at risk of upper respiratory tract 
obstruction in recovery
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3. For how long prior to anaesthesia is it currently 
recommended to withhold food in dogs and cats?
(A) Withholding food is not necessary
(B) 4–6 hours
(C) 8 hours
(B) They can be difficult to intubate due to an 
elongated soft palate, stenotic nares and 
hypoplastic trachea
(C) They are at greater risk of regurgitation 
(D) All of the above (D) <3 hours
Anaesthesia of the 
head trauma patient
Denise Prisk 
Anaesthesia of patients with head injuries brings specific 
challenges, as any disruption to brain activity can affect 
the anaesthetic process. In addition, drugs may behave 
differently in these patients. It is important to have a basic 
understanding of neuroanatomy and neurophysiology, in 
order to be aware of any problems that patients with 
head injury and trauma can experience. 
Head injuries may present as one of several types, 
depending on the cause. Primary injury is trauma 
incurred as a direct result of injury, for example, mechan­
ical injury. Because of the composition of the brain tissue 
and lack of support, forces to the skull and brain are not 
well tolerated. Secondary injury occurs as an indirect 
result, which may be subsequent to the primary injury 
or  it may be that there is a systemic reason that is not 
related to, or in the absence of, a primary injury. Exam­
ples include hypotension, hyper­ and hypoglycaemia, 
hypoxia, hypercapnia or a very high temperature. The con­
sequences include increased intracranial pressure (ICP), 
decreased cerebral delivery of oxygen and damage to 
the blood–brain barrier. Polytrauma patients, such as 
those involved in road traffic accidents, will often have 
some sort of head or brain injury that may not be imme­
diately apparent. A full assessment should be undertaken 
prior to anaesthesia, to detect the presence of brain 
injury. The quicker any injury is detected, the better the 
chances of a positive outcome.
The main goals for anaesthesia of the patient with 
head injury are to preserve brain tissue and neuronal 
function and to prevent secondary injury. Cerebral 
 perfusion must be maintained as hypoxaemia leads to 
cerebral vasodilation with a subsequent increase in ICP. 
Venous drainage must be preserved and careful posi­
tioning is required – a head­up position of 15–30 degrees 
is recommended, as long as there are no spinal injuries. 
The neck must be level and it is preferable to incline the 
entire patient on a board or using bedding.
The use of capnography for monitoring end­tidal 
carbon dioxide levels is optimal as this has a knock­on 
effect on the pH of blood and cerebrospinal fluid (CSF). 
Hypercapnia causes acidosis with decreased pH of blood 
and CSF, leading to vasodilation of cerebral vessels, 
increased ICP and hypoxaemia. Hypocapnia causes 
 alkalosis with increased pH of blood and CSF, cerebral 
vasoconstriction and cerebral ischaemia. The goal under 
anaesthesia is to maintain eucapnia or slight hypocapnia.
Oxygenation and ventilation must be monitored and 
maintained as altered levels of oxygen and carbon diox­
ide in arterial blood affect cerebral blood flow and ICP. 
Blood pressure should also be monitored and a mean 
arterial pressure of over 70–80 mmHg should be the aim. 
Assessment of the electrocardiogram (ECG) allows 
observation of waves and complexes, changes in which 
can indicate imminent crisis. Monitoring heart rate, res­
piratory rate and temperature are all important. The tem­
perature may be high or low. Heart rate, respiratory rate 
and blood pressure are used to identify the Cushing 
reflex, which comprises bradycardia, hypertension and 
abnormal respiration. When all three components are 
present, this is called the Cushing triad. The Cushing 
reflex indicates rising ICP and is a life­threatening 
 condition.
Early extubation prevents gagging, although con­
stant monitoring is essential. A calm, stress­free recovery 
is desirable. Supplemental oxygen may be necessary and 
attention must be paid to positioning the recovering 
patient. Cardiovascular and respiratory functions must 
be supported as necessary at all times during the periop­
erative period, to try and keep the anaesthetized head 
trauma patient safe.
KEY LEARNING OBJECTIVES
■■ To understand basic neuroanatomy and 
neurophysiology 
■■ To understand the goals of anaesthesia for patients 
with head injury
■■ To be able to monitor an anaesthetized head trauma 
patient
MULTIPLE CHOICE QUESTIONS
1. What does the Cushing triad, which indicates 
rising intracranial pressure, comprise?
(A) Bradycardia, hypertension and abnormal 
respiration 
(B) Bradycardia, hypotension and 
hyperventilation
(C) Tachycardia, hypertension and tachypnoea
(D) Tachycardia, hypotension and bradypnoea
2. To which angle should head be elevated in a 
patient with known or suspected brain injury to 
preserve venous drainage from the head?
(A) 5–10 degrees
(B) 10–15 degrees
(C) 15–30 degrees
(D) 30–40 degrees
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(B) The concentration of inhalant agent 
should be kept low
(C) Intravenous fluid administration should be 
withheld during anaesthesia
(D) A small endotracheal tube should be 
placed to ensure successful intubation
3. What should be done to avoid a rise in 
intracranial pressure in an anaesthetized patient 
with head trauma? 
(A) Nitrous oxide should be used in the fresh 
gas flow
Anaesthesia of the 
RTA cat
Claire Woolford 
On arrival at the clinic, an initial examination must be 
quickly completed. Is the Airway patent? Is the cat able to 
Breathe without showing signs of hypoxaemia? and is the 
Circulation effective – what is the blood pressure (BP), 
heart rate (HR), pulse quality, mucous membrane (MM) 
colour & capillary refill time (CRT)?
Following this initial survey, the patient should be 
provided with oxygen (mask or flow­by). Intravenous 
access must be quickly gained and fluid therapy started. 
Crystalloid fluids can be given as a bolus and the HR, 
pulse quality etc. assessed to determine if a repeat bolus 
is required. 
Blood should be taken for baseline parameters: 
packed cell volume (PCV), total protein (TP), lactate, 
electrolytes. Be aware that if the patient has lost blood, 
the PCV may not fall for several hours (up to 24 hours).
Radiographs should be taken of chest/abdomen, and 
a focused assessment with sonography for trauma (FAST) 
of the abdomen can be performed if possible to rule 
out pneumothorax, effusions, herniation of organs and 
 pulmonary contusions (after 24 hours).
After initial stabilization, the priority must be analgesia. 
Inadequately treated pain increases the stress response 
which will increase morbidity. Following severe trauma 
there is significant tissue damage and activation of inflam­
matory pathways. This will activate pain pathways, NMDA 
receptors will cause ‘wind up’ or sensitization to pain. 
Chronic pain is likely to develop which can last a lifetime.
Once stabilized, the patient may require anaesthesia 
for surgery to treat injuries, e.g. diaphragmatic hernia. 
Always preoxygenate prior to anaesthesia, use a safety 
checklist to ensure you have all the equipment required, 
the team is aware of the likely complications of the pro­
cedure and what interventions can be taken to correct or 
prevent them. Choose short­acting and reversible drugs, 
start at a fraction of the published doses and titrate to 
effect. Most anaesthetic drugs cause dose-dependent 
cardiovascular depression which can be catastrophic in 
patient with a low cardiovascular reserve.
Use all the monitoring methods you have available; 
blood pressure monitoring is essential during  anaesthesia. 
Capnography, pulse oximetry,  electrocardiogram (ECG) 
and temperature monitoring should be used if possible to 
gain the most information about the status of the patient.
Intraoperative analgesia can be provided with meth­
adone which can be topped up if required. Ketamine 
constant rate infusion (CRI) plus fentanyl or dexme­
detomdine CRI will provide excellent analgesia which 
can be continued into the postoperative period. Local 
analgesic techniques, such as epidurals, dental blocks 
(for fractured jaws) or an incisional block should be used 
if possible. Avoid non­steroidal anti­inflammatory drugs 
(NSAIDs) in patients with hypovolaemia and anaemia. 
They are best used in the postoperative period when the 
patient is stable.
Continue to monitor the patient closely in the post­
anaesthetic period. Assess the patient’s blood pressure, 
pain, HR, respiratory rate and temperature every 15–30 
minutes for the first 3–4 hours or until they are stable. 
Reassess PCV/TP, electrolytes and lactate.
KEY LEARNING OBJECTIVES
■■ Understand the importance of preanaesthetic 
stabilization
■■ Understand the importance of analgesia
■■ Be able to choose the correct anaesthetic protocol 
for the patient
MULTIPLE CHOICE QUESTIONS
1. Following haemorrhage, how quickly does the 
PCV change? 
(A) Within minutes
(B) Within hours
(C) Within days 
(D) Within weeks
2. Preanaesthetic stabilization is vital to prevent 
which of the following?
(A) Peri­anaesthetic decompensation
(B) Further haemorrhage
(C) Arrhythmias
(D) Hypertension
3. Multi­modal analgesia is vital to prevent which 
of the following?
(A) Chronic pain development
(B) Hypoalgesia
(C) Hypoventilation
(D) Hypothermia
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Anaesthesia of the 
brachycephalic patient
Denise Prisk 
Brachycephalic dog breeds present the anaesthetist 
with several challenges. Many brachycephalic dogs have 
some degree of brachycephalic obstructive airway syn­
drome (BOAS). This comprises a group of anatomical 
variations which lead to upper airway obstruction. This is 
made worse if the patient is obese. In addition, BOAS is 
associated with gastrointestinal problems. 
Brachycephalic breeds have a high resting vagal 
tone, which results in a slow heart rate. Furthermore, 
these breeds are often hyperthermic, due to the degree 
of work involved in normal respiration. The anaesthetized 
and sedated patient cannot compensate in the same way 
that the conscious animal does and this is why unfortu­
nate events may occur. Many issues stated here also apply 
to some brachycephalic cat breeds. These cats have a 
short, flat head and can suffer from various grades of 
dyspnoea, depending on the length and breadth of the 
skull. Special consideration should be paid to the lubrica­
tion of their eyes, as tear drainage is impaired due to 
abnormalities of the nasolacrimal duct. 
If the patient will allow, pulse oximetry can be 
assessed in the preanaesthetic period by clipping the 
sensor to the lip of amenable dogs (or reflectance 
 oximetry used in the rectum). This will give an idea of 
oxygen saturation before induction. In order to prevent 
or delay desaturation, preoxygenation is necessary. 
Desaturation is more likely to occur in brachycephalic 
breeds as intubation may prove difficult. The administra­
tion of oxygen before inducing anaesthesia maximizes 
the oxygenation of tissues and helps prevent hypoxae­
mia. If possible, flow­by oxygen should be given through­
out the  induction process.
The periods of highest risk are from premedication 
until the trachea has been intubated, then after extuba­
tion until full recovery. As much monitoring as possible 
before induction will be helpful, for example, attaching 
the electrocardiogram (ECG) cables and blood pressure 
cuff. Any abnormalities, such as cardiac arrhythmias, may 
then be detected.
The head should be supported until the trachea has 
been intubated and the tube cuff filled with air, if neces­
sary. Brachycephalic dog breeds often have large, heavy 
heads and if the head and neck are not supported, the 
airway can become compromised. In addition, regurgita­
tion and aspiration may occur. Gentle intubation must be 
observed, as irritation of the pharyngeal structures can 
lead to post­extubation problems. If several attempts at 
intubation are needed, giving oxygen via a tight­fitting 
mask in between attempts will help prevent or treat 
hypoxaemia.
These patients often do not ventilate well under anaes­
thesia and capnography is a very useful tool for assessing 
ventilation. Ventilation is furthermore  compromised if 
the patient is positioned in dorsal recumbency and it may 
be necessary to ventilate artificially, either manually, with 
a suitable breathing system, or mechanically, with a 
 ventilator.
Extubation of brachycephalic breeds is generally 
performed as late as is safely possible. Supplemental 
oxygen should be provided and recovery in an oxygen­
enriched environment is ideal, such as placing small 
patients in an incubator or oxygen cage. Care must be 
taken to ensure overheating does not occur, as the 
 temperature in oxygen cages can rise and cause hyper­
thermia. Recovery in sternal recumbency optimizes oxy gen­
ation of both lungs. It may be necessary to prop the 
patient up so it maintains this position. Pain leads to pant­
ing, which can lead to obstruction. Postoperative analge­
sia is therefore very important, as are close monitoring 
and pain assessment or scoring. Ideally, recovery will take 
place in a quiet and calm environment, to minimize stress.
KEY LEARNING OBJECTIVES
■■ To understand the specific challenges that exist 
when anaesthetizing a brachycephalic breed
■■ To be able to prepare for anaesthesia of a 
brachycephalic dog
■■ To optimize perianaesthetic nursing care for 
brachycephalic animals
MULTIPLE CHOICE QUESTIONS
1. Brachycephalic dog breeds have which of the 
following?
(A) High resting vagal tone, resulting in a slow 
heart rate
(B) Low resting vagal tone, resulting in a slow 
heart rate
(C) High resting vagal tone, resulting in a high 
heart rate
(D) Low vagal tone, resulting in a high heart 
rate
2. What are three anatomical variations that form 
brachycephalic obstructive airway syndrome?
(A) Short soft palate, pharyngeal hyperplasia, 
widened nares
(B) Pharyngeal hypoplasia, large tongue, 
hyperplastic trachea
(C) Inversion of the laryngeal saccules, 
hyperplastic trachea, stenotic nares
(D) Eversion of the laryngeal saccules, long 
soft palate, hypoplastic trachea
3. What is a particular concern during anaesthesia 
of a Persian cat?
(A) Hyperthermia due to panting
(B) Difficult intubation due to overlarge 
tongue
(C) Corneal drying due to abnormality of the 
nasolacrimal duct
(D) Inability to fully open the mouth, making 
assessment of jaw tone difficult
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Anaesthesia for the 
young and old
Emma Archer
There are several anatomical, physiological, equipment 
and pharmacological considerations for the young and 
old compared to adult patients. 
PAEDIATRIC PHYSIOLOGY 
Cardiovascular physiology
Cardiac output (and blood pressure) is largely heart­rate 
dependent in paediatric patients. They have less func­
tional contractile cardiac muscle and low ventricular 
compliance compared to adults. Furthermore, they also 
have an underdeveloped sympathetic nervous system, 
have reduced baroreceptor reflexes and are less able to 
vasoconstrict/vasodilate when required. This means that 
bradycardia in paediatric patients may profoundly affect 
cardiac output and blood pressure. 
Respiratory physiology
A relatively larger tongue with a narrower upper airway 
means upper respiratory tract obstruction is of greater 
risk in the absence of intubation. A smaller functional 
residual capacity means hypoxia is more likely at induc­
tion of anaesthesia or in times of apnoea. Pulmonary 
reserve is limited, oxygen consumption is two to three 
times higher than adults due to their increased metabolic 
rate. This increase in oxygen consumption is met by an 
increased respiratory rate and the respiratory pattern is 
sinusoidal with little or no end­expiratory pause. Lung 
and chest wall compliance is high and hypoventilation 
and respiratory muscle fatigue are common under 
anaesthesia, especially in the presence of respiratory 
depressive anaesthetic agents. 
Hepatic physiology
The hepatic system is underdeveloped in paediatric 
patients. The enzyme systems responsible for metabo­
lism and biotransformation of many anaesthetic drugs 
are not fully functional until at least 8 weeks of age, 
 leading to prolonged drug metabolism and recovery. 
Where possible, drugs metabolized extensively by the 
liver should be avoided and, if not possible, doses 
reduced and longer recovery times executed. Due to 
minimal glycogen storage, excessive preanaesthesia 
starvation can cause hypoglycaemia. Avoid excessive 
fasting, monitoring of blood glucose should occur and 
glucose­containing intravenous fluids may be required. 
Renal physiology
Plasma albumin levels are lower until about 8 weeks of 
age thus highly protein­bound drugs like propofol will 
exert a greater initial effect due to the greater proportion 
of free drug in circulation (less albumin available to 
bind to). Total fluid volume and extracellular fluid volume 
are higher than in adults and there is a greater tendency 
to dehydrate with smaller fluid losses. Renal function is 
reduced in the first 6–8 weeks of life and paediatric 
patients cannot tolerate large volumes of rapidly adminis­
tered fluids. Fluids should be administered via a burette 
or fluid pump. 
Temperature control
Paediatric patients are extremely prone to hypothermia 
due to low fat reserves, a high surface­area­to­volume 
ratio and poor thermoregulation.
GERIATRIC PHYSIOLOGY
There is no clear definition of ‘geriatric’ in relation to cats 
and dogs however it is generally used when an animal 
has reached 75–80% of its anticipated life expectancy.
Cardiovascular physiology
Geriatrics have decreased blood volume and barorecep­
tor reflex with reduced cardiac output, increased vagal 
tone and circulation time. Furthermore, they may also be 
predisposed to arrhythmias and have underlying degen­
erative or progressive cardiac disease, such as mitral valve 
disease or dilated cardiomyopathy.
Respiratory physiology
Pulmonary changes lead to decreased lung elasticity, 
respiratory rate, tidal volume and oxygen­diffusion 
capacity. There is decreased respiratory muscle strength 
and chest wall compliance. 
Hepatic physiology
In geriatrics there is decreased functional liver mass, a 
decrease in hepatic blood flow due to reduced cardiac 
output and decreased metabolic activity.
Renal physiology
There is a reduced renal blood flow due to reduced 
 cardiac output, decreased glomerular filtration rate and a 
loss of functional nephrons in conjunction with a 
decreased ability to concentrate urine and secrete hydro­
gen ions. 
Central nervous system
Geriatric patients may have altered cognition and motor 
function. Neuronal degeneration means a reduction in 
brain mass and decreased thermoregulatory centre 
function may lead to hypothermia.
Summary
Geriatrics have a reduced ability to compensate for 
 cardiovascular and respiratory depression caused by 
anaesthetic drugs and are less able to tolerate haemor­
rhage or hypovolaemia. The implications of this will be 
discussed in detail in the lecture.
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KEY LEARNING OBJECTIVES
■■ To identify the main anatomical and physiological 
differences for paediatrics and geriatrics (compared 
to adults)
■■ To understand how these affect our anaesthetic 
drug protocol and our anaesthetic equipment 
choices and our non­pharmacological approaches 
to anesthesia
■■ To gain hints and tips you can practically apply to 
your daily working practices
MULTIPLE CHOICE QUESTIONS
1. Which of the following is incorrect when 
considering cardiovascular physiology? 
(A) Paediatrics have a reduced baroreceptor 
reflex
(B) Paediatrics have increased sympathetic 
tone
(C) Paediatrics have reduced functional 
cardiac contractile tissue
(D) Paediatrics have an underdeveloped 
sympathetic nervous system
2. Which equipment consideration is INCORRECT 
for paediatrics?
(A) Their small tidal volume may mean the 
equipment dead space is significant
(B) Resistance to breathing will be relatively 
increased
(C) A large surface­area­to­volume ratio 
means hypothermia is likely
(D) All of the above
3. Which of the following are important 
considerations for geriatric anaesthesia?
(A) Reduced ability to compensate for the 
respiratory and cardiovascular depressive 
effects of anaesthetic drugs
(B) A reduction in functioning nephrons
(C) An increased likelihood of joint disease 
means patient positioning and analgesia 
are important
(D) All of the above
Anaesthesia of the 
acute abdomen
Claire Woolford 
The acute abdomen is any abdominal disease process 
that has a sudden onset of severe pain, e.g. septic perito­
nitis, intestinal foreign body or gastric dilatation–volvulus.
Take the time to get a full history. Baseline parame­
ters and full clinical examination should be completed.
Temperature, pulse, respiration (TPR), pulse quality/
rhythm, mucous membrane (MM) colour, capillary refill 
time (CRT). Check packed cell volume/total solids 
(PCV/TS), glucose, lactate, biochemistry and haematol­
ogy. Blood gases give information on acid–base status.
Patients will often present in shock. This occurs due 
to poor tissue perfusion, blood flow is low and unevenly 
distributed. Oxygen delivery to tissues is impaired. In 
early shock the body compensates through peripheral 
vasoconstriction to promote flow to major organs. Pale 
MM’s, prolonged CRT, poor peripheral pulses, cold 
extremities and dull mentation are seen.
Anaesthesia dulls the compensatory mechanisms 
and can push patients into a rapid decompensation. 
Gaining intravenous access is a priority. Choose large­
bore cannulas and consider placing two!
Start fluids with a balanced crystalloid solution. 
Goal­directed fluid therapy should be used. Patients in 
shock should not be automatically given 90 ml/kg/h. The 
goals are to restore circulating volume, improve oxygen 
delivery and improve tachycardia. Give a 10 ml/kg bolus 
then recheck HR, blood pressure (BP), MM colour and 
CRT. Repeat the bolus if required. When improvement in 
vitals is seen, reduce rate to 2–4 ml/kg/h and monitor 
closely. Correct electrolytes prior to anaesthesia.
Analgesia is extremely important for these patients. 
Pain makes patients more prone to complications, e.g. 
arrhythmias, it increases stress and morbidity. Start with 
opioids like methadone 0.2–0.3  mg/kg slowly i.v. and 
repeat if required. Fentanyl continuous rate infusion (CRI) 
will provide excellent analgesia. Lidocaine is very useful in 
abdominal pain, it provides analgesia, prevents ilieus, and 
may help with reperfusion injury. It can be given as a CRI 
alongside opioids. Non­steroidal anti­inflammatory drugs 
(NSAIDs) are contraindicated for patients in shock, hypo­
tension and with gastrointestinal disease. Consider local 
anaesthetic techniques, e.g. incisional blocks, epidurals.
Use a safety checklist to ensure you have everything 
ready and that everyone understands the possible com­
plications. https://ava.eu.com/resources/checklists/
Give anaesthetic drugs slowly and only to effect, con­
sider a co­induction technique, e.g. propofol/midazolam.
Hypotension should be treated rapidly.  Reduce inha­
lation anaesthetics and ensure good analgesia. Fluid 
boluses can be given. If hypotension persists then drugs, 
e.g. dopamine or noradrenaline, may be required. Arrhyth­
mias are common and require treatment if they affect BP. 
Pulse pressure variation (PPV) monitors fluid responsive­
ness under anaesthesia. Using the pulse waveform, look 
for ‘dips’ in the waveform during inspiration which show 
the vena cava is collapsing under pressure of inspiration 
indicating hypovolaemia. This is seen before changes HR 
and BP.  An improvement will be seen if the fluid bolus is 
successful, if not then consider drug therapy to improve BP.
Do not stop monitoring in recovery, continue check­
ing TPR, BP, MM colour, CRT and, most importantly, pain 
regularly. Provide oxygen supplementation if required 
and consider placing a urinary catheter. Do not forget a 
comfortable bed and TLC.
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KEY LEARNING OBJECTIVES
■■ Understand how to stabilize a critical patient for 
anaesthesia
■■ Learn best practice for fluid therapy in the acute 
abdomen patient
■■ Learn the best analgesia options for critical patients
MULTIPLE CHOICE QUESTIONS
1. Which of the following is true about oxygen 
delivery to the tissues in hypovolaemic shock?
(A) Impaired
(B) Increased
(C) Unchanged
(D) Diverted peripherally
2. What may insufficient analgesia result in?
(A) Increased morbidity
(B) Improved demeanour 
(C) Decreased respiratory rate
(D) Improved patient stabilization
3. Which of the following drugs are 
contraindicated in hypovolaemia?
(A) NSAIDs
(B) Opioids
(C) Antibiotics
(D) Lidocaine
Central lines
Claire Woolford 
Central venous catheters are useful in critical patients 
that require multiple infusions or infusions of incompati­
ble fluids. They can also be used for patients that need 
regular blood sampling such as diabetic patients requir­
ing serial blood glucose samples.
Central lines are contraindicated in patients that have 
coagulopathies, risk of thrombosis and skin infection at 
the intended site.
Most central lines are placed with a guide wire using 
the Seldinger technique. These tend to come in com­
mercially prepared kits and are available in sizes 4–7 Fr 
single, double or triple lumens. 
Anaesthesia is required. Aseptic technique is abso­
lutely vital; most infections are due to poor asepsis during 
placement. A wide clip is required to prevent contamina­
tion of the site and allow it to be easily inspected.
THE SELDINGER TECHNIQUE
1. Place the patient in lateral recumbency with a 
sandbag under the neck to raise it and make the 
jugular easier to see
2. Clip the area and aseptically prepare with 
chlorhexidine and isopropyl alcohol
3. Surgically scrub hands and put sterile gloves on
4. Drape the patient in a sterile manner with a large 
drape
5. Prepare the catheter by flushing all the lumens with 
sterile saline and closing the gate clamps
6. Ask an assistant to raise the vein so you can identify 
its position
7. Over the vein, tent and lift the skin, perform a small 
stab incision using a No. 11 blade. Be sure to go 
through all the layers of the skin
8. Insert the introductory needle (or large­bore 
intravenous catheter) through the incision and into 
the vein
9. Place swab under the needle to catch blood
10. Feed the guide wire through the needle, watch the 
patient’s electrocardiogram (ECG) for arrhythmias 
which may occur if the guide wire enters the heart. 
If you see an arrhythmia then stop and withdraw the 
wire a short way. Once the wire is inserted you 
should maintain a hold on the wire to prevent it 
being pushed into the patient and becoming lost
11. Over the wire withdraw your needle, place a sterile 
swab over the insertion site if there is bleeding
12. Over the guide wire feed the dilator into the vein, 
use a twisting and pushing technique to insert the 
dilator and make a sufficiently large hole in the 
jugular for the catheter
13. Withdraw the dilator over the wire, again place a 
swab over the site as it is likely to bleed
14. Over the wire insert the catheter, feed the guide 
wire out of the patient until it appears through the 
port (likely brown port). Hold on to the wire and 
feed the catheter into the patient
15. Monitor the ECG for arrhythmias and withdraw the 
catheter a little if they are seen
16. Close the gate as you take the wire out of the 
catheter to prevent air embolism
17. Using sterile saline, aspirate blood and flush each 
port with saline to ensure they are patent
18. Suture the catheter in place
19. Dress with sterile swabs and a neck bandage
KEY LEARNING OBJECTIVES
■■ Understand the Seldinger technique for placing 
central lines
■■ Understand the contraindications of central line 
placement
■■ Understand the indications for placement of a 
central line
MULTIPLE CHOICE QUESTIONS
1. Which of the following is contraindication of 
central line placement?
(A) Risk of thrombosis
(B) Cardiac disease
(C) Brachycephalic breed
(D) Risk of fluid overload
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2. Which of the following would be a suitable 
patient for central placement?
(A) Diabetic cat
(B) Dog with von Willebrand’s disease
(C) Patient with skin infection
(D) Patient with hypercoagulapathy
3. As the guide wire is removed, what must be 
done?
(A) Close the gate clamp
(B) Open all the ports
(C) Open only the brown port
(D) Close only the blue port
Arterial lines
Claire Woolford 
Arterial catheterization can be a very important tech­
nique for monitoring critical patients. Any patient that 
requires continuous blood pressure (BP) monitoring or 
repeated blood gas sampling will benefit from an arterial 
catheter. Contraindications are: haemostatic abnor­
malities, hypercoagulable states (risk of thrombosis) or 
 pyoderma at insertion site.
There is a variety of arteries that are suitable for 
 catheterization; dorsal pedal artery, auricular artery, 
 coccygeal artery, radial artery and even the lingual artery. 
The most commonly used is the dorsal pedal artery 
which runs dorsomedially across the metatarsal bones. 
Arterial line placement can be more painful than venous 
catheters therefore heavy sedation or anaesthesia is 
required, local anaesthesia can be used in patients that 
are unsuitable for anaesthesia.
Aseptic technique is very important, critical patients 
are more susceptible to hospital­acquired infections. 
Washing your hands is the best way to prevent passing 
infection to your patient. Clip a wide area of hair around 
the intended site again to prevent infection but also so that 
the insertion site is visible making problems easier to spot.
For placing an arterial catheter you will need; chlorhex­
idine, swabs, no.  11 surgical scalpel, intravenous catheter 
(24–20 g), zinc oxide tape, t­connector or injection cap.
1. Place patient in lateral recumbency with the leg 
being catheterized lowermost
2. Clip and gently prepare the area with chlorhexidine. 
Do not ‘scrub’ the area because arteries are very 
sensitive and may go into spasm
3. Wash your hands
4. Palpate the artery. It can be useful to use two fingers 
for this to give an idea of the direction the artery
5. You may want to use the scalpel blade to make a 
very small ‘nick’ in the skin to help the catheter pass 
smoothly
6. While palpating the artery insert the catheter 
directly over where the pulse is felt. Hold the 
catheter as you would hold a pen at a roughly 
15­degree angle
7. Arteries are hard walled compared to veins and a 
degree of confidence is required when inserting the 
catheter or the artery will bounce away from it
8. When a flash of blood is seen in the hub of the 
catheter advance the catheter off the stylet into the 
artery
9. Once the stylet is removed quickly attach your 
connector
10. Use a dry swab to clean away excess blood. Apply 
zinc oxide tape under the catheter around the leg 
and back over the catheter. Apply the tape fairly 
tightly as the patient’s blood pressure may push the 
catheter out
11. Use more strips of tape to further secure the 
catheter and connector
12. Flush the catheter with heparinized saline
The arterial catheter must not have anything other 
than saline injected into it. Clearly label the catheter as 
‘Arterial’ to prevent it being mistaken for a intravenous 
catheter. Flush the catheter regularly to maintain patency. 
When not in use ensure the catheter is not able to 
become dislodged and any gates are closed to prevent 
haemorrhage.
Top tip: arterial catheterization can take time to learn – 
don’t give up!
KEY LEARNING OBJECTIVES
■■ Choose a suitable arterial catheterization site
■■ Understand the procedure for placing an arterial 
catheter
■■ Understand the contraindications and risks of 
arterial lines
MULTIPLE CHOICE QUESTIONS
1. What is the most common site for arterial 
catheterization?
(A) Dorsal pedal artery
(B) Carotid artery 
(C) Brachial artery
(D) Radial artery
2. Which of the following is a contraindication to 
arterial catheterization?
(A) Heart disease
(B) Coagulopathy
(C) Metabolic acidosis
(D) Hypovolaemia
3. Which of the following can be administered via 
an arterial line?
(A) Heparinized saline
(B) Colloids
(C) Opioids
(D) Anaesthetic drugs
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Anaesthesia and 
analgesia of patients 
with complex medical 
conditions
Emma Archer
Anaesthetizing patients with complex medical conditions 
can present a challenge to even the most experienced 
nurse. Careful planning will prevent many complications 
from arising and good communication with the veteri­
nary surgeon will save valuable minutes in the event of a 
crisis. Many medically ill patients will need analgesia, 
general anaesthesia or sedation during their stay in hos­
pital. Anaesthesia may be required for many reasons, 
whether therapeutic or diagnostic, and can present a 
challenge to even the most experienced nurse who is 
expected to safely monitor and recover these patients. 
Contrary to popular belief, in critically ill patients seda­
tion is NOT safer than general anaesthesia. Generally 
with critical patients, general anaesthesia allows 
 establishment of a protected airway by endotracheal 
intubation, allowing administration of 100% oxygen 
and provides provision of intermittent positive pressure 
ventilation and often more thorough monitoring. 
There are many groups of patient that may be classi­
fied as having complex medical conditions which will 
be challenging to anaesthetize, including respiratory dis­
ease, heart disease, liver or kidney disease, sepsis, intrac­
ranial disease, diabetes mellitus and anaemia. These will 
be discuussed in this lecture.
Patients with complex medical conditions often 
 present with hypoalbuminaemia and electrolyte and 
acid–base disturbances, hypovolaemia and polyuria and 
polydipsia. Compensatory mechanisms present in ‘sick’ 
patients act to maintain circulation to essential organs, 
thus a patient may appear relatively cardiovascularly 
 stable; nonetheless, they may in fact be ‘teetering on the 
edge’ using all their reserves to compensate for the dis­
ease processes. Because almost all anaesthetic agents 
cause dose­dependent cardiovascular and respiratory 
depression, the patient may be more susceptible to these 
adverse effects as they are unable to mount additional 
compensatory mechanisms to counteract them. There­
fore, it is vital to identify and treat as many derangements 
as possible prior to anaesthesia.
It is worth remembering that very few situations require 
anaesthesia immediately and most procedures can be 
delayed to allow proper and effective patient stabilization. 
Hypovolaemia, electrolyte imbalances and arrhythmias 
should be corrected prior to induction of anaesthesia. 
Many will require fluid therapy prior to induction of anaes­
thesia to correct hypovolaemic shock, dehydration, elec­
trolyte imbalances, acid–base disturbances and anaemia.
‘There are no safe drugs, only safe anaesthetists.’ It is 
how we use the drug that makes them safe. Small doses 
titrated to effect through an intravenous catheter is 
important, preoxygenate and keep the patient calm. 
Consideration of patient positioning and analgesia is 
important too.
In patients with complex medical conditions, appro­
priate monitoring equipment in conjunction with assess­
ment of patient parameters, such as peripheral pulse 
quality and mucous membrane colour, is crucial to antic­
ipate and treat complications before they become 
 serious. An important principle is to monitor all the vital 
signs you can and combine the information to build up a 
picture of what is happening to the patient. 
The recovery period (especially the initial 3 hours) is 
the most critical time for many of these patients. Appro­
priate monitoring should continue, with particular atten­
tion to airway maintenance, body temperature and 
peripheral pulse rate and quality. Warming devices are 
usually required and facilities for oxygen supplementa­
tion should be available.
KEY LEARNING OBJECTIVES
■■ To understand the importance of stabilization of 
patients with complex medical conditions
■■ To understand how to stabilize these patients
■■ To understand how to effectively monitor and 
recover these patients
MULTIPLE CHOICE QUESTIONS
1. Which of the following is true for patients with 
complex medical conditions?
(A) Should have their medical condition cured 
before anaesthesia
(B) Where possible, consequences of their 
medical condition, such as electrolyte 
abnormalities, should be corrected prior to 
anaesthesia
(C) Should only be anaesthetized in a 
life­threatening emergency
(D) Should be sedated rather than have a 
general anaesthetic
2. Why do patients with unstable medical 
conditions require special consideration prior 
to anaesthesia?
(A) They may already be using all their 
compensatory mechanisms to deal with 
the disease process, so cannot cope with 
the cardiovascular and respiratory 
depressive effects of anaesthesia
(B) They may have electrolyte or acid–base 
abnormalities
(C) They may have arrythmias
(D) All of the above
3. Which of the following is correct when 
considering the recovery period?
(A) The recovery period is the most risky time 
of the perianaesthetic period
(B) The recovery period does not require close 
monitoring
(C) Hypothermia is less likely in the recovery 
period
(D) Oxygen supplementation will not be 
required in recovery
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Help: rabbit anaesthetic
Jo Hinde
Rabbit anaesthetics have a bad reputation for being diffi-
cult, stressful and going wrong, however this doesn’t 
have to be the case. Rabbit mortality rates are signifi-
cantly higher than in cats and dogs, however, this can be 
reduced by improving standards within your team.
Taking the holistic approach means your patient is in 
the best possible condition for the procedure. Postpon-
ing non-urgent cases whilst pre-existing disease or hus-
bandry deficits are improved is recommended.
On the day, keep stress and pain to a minimum (use 
local anaesthetic (EMLA) prior to intravenous catheteri-
zation, minimize the use of intramuscular injections) and 
ensure adequate analgesia is used pre-, peri- and post-
operatively. Consider a multimodal approach, including 
opioids, non-steroidal anti-inflammatory drugs (NSAIDs), 
local anaesthetics, surgical techniques to cause less 
 tissue trauma and distraction analgesia to reduce the 
impact of pain in the recovery period.
Have a good understanding of rabbit respiratory 
anatomy and try, whenever possible, to position them in 
sternal recumbancy, or with the thorax slightly elevated 
above the abdomen to reduce the pressure on the dia-
phragm.
AIRWAY OPTIONS
There is no ‘gold standard’ way, however it is vital that a 
patent airway is secured and constantly monitored. 
There are three main options:
■■ Small, well fitting face mask
■■ Endotracheal tube (ETT)
■■ Supraglottic airway device (v-gel)
Each has pros and cons and all can be used with the 
correct monitoring. It is recommended that rabbits receive 
supplemental ventilation so the option you choose should 
allow this. 
Always:
■■ Check and flush the mouth
■■ Ensure the rabbit is at a surgical plane of anaesthesia 
before intubating
■■ Preoxygenate 
■■ Use lidocaine spray and lubricate ETTs/v-gels
■■ Use a new single-use Portex ETT (2.5–3 mm 
uncuffed) to reduce contamination and damage to 
the trachea
MONITORING
It is vital that all rabbits are continually monitored and 
results recorded, from the time of premedication through 
to recovery. Frequency can be reduced once the patient 
is standing, but checks should continue until the rabbit is 
eating and passing faeces. 
There is no substitute for a qualified veterinary nurse, 
but there are things that the nurse cannot measure with-
out a machine to help. These machines include:
■■ Pulse oximeter
■■ Blood pressure Doppler
■■ Capnograph
Capnography is the most important of these as there 
is no other way to assess the patient’s CO2 levels. Many 
rabbits are hypercapnic as soon as the anaesthetic starts. 
Understand the importance of the ‘trend’, how to identify 
and compensate for hypocapnia and hypercapnia and 
the after-effects this can have on the patient’s recovery.
RECOVERY
This is often the most dangerous part and it is vital that 
the patient is monitored closely. Oxygenate the rabbit 
after finishing the operation, ensuring the end-tidal car-
bon dioxide (ETCO2) is within the normal range. Continue 
temperature, pulse and respiration (TPR) checks until the 
rabbit is standing, then offer a measured amount of food 
and water. If the patient has not eaten within 1 hour of 
walking, then check the analgesia levels are adequate 
and syringe feed 10–15 ml/kg. Only discharge the patient 
after they are eating well and passing faeces and give at 
least 3 days’ of pain relief (usually meloxicam).
KEY LEARNING OBJECTIVES
■■ Understand the importance of the holistic  
approach
■■ Explore the monitoring options available
■■ Learn how to create rabbit-specific protocols
MULTIPLE CHOICE QUESTIONS
1. What is the normal ETCO2 range for rabbits?
(A) 22–35 mmHg
(B) 32–45 mmHg
(C) 42–55 mmHg
(D) 52–65 mmHg
2. What is the best positioning for rabbits?
(A) Lateral
(B) Dorsal
(C) Sternal
(D) Caudal
3. Where is the best place to site an intravenous 
cannula?
(A) Marginal ear vein
(B) Auricular artery
(C) Jugular vein
(D) Cephalic artery
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Preventative medicine 
for rabbits
Jo Hinde
Rabbits are the UK’s third most popular pet and have an 
average lifespan of 7–10 years. As such, we should be 
ensuring we understand their specific healthcare needs 
and offer appropriate preventative treatments. 
A good-quality, balanced diet, along with the correct 
enclosure, really is the key to preventative rabbit care. 
Feed adults an 80% hay diet with just a couple of table-
spoons of good quality, extruded commercial pellets. Do 
not feed multi-component mixes as these have been 
shown to increase selective feeding, and dietary and 
digestive problems. A small handful of fresh greens can 
be fed per day. Avoid fruit and sweet or starchy treats. 
Rabbit’s enclosures need to meet the RWAF’s mini-
mum guidelines of 10 ft × 6 ft. This should comprise of a 
living and exercise space permanently attached. It is vital 
rabbits have room to exhibit their natural behaviour of 
grazing and exploring both horizontally and vertically. If 
the enclosure is too small it can cause skeletal problems 
as well as behavioural ones. It also increases the risk of 
digestive or urinary problems, as well as increasing the 
risk of myiasis.
Myiasis is a common problem that can be prevented 
in most cases. Correct diet and husbandry are vital and it 
is recommended to use a preventative product, such as 
Rearguard or F10 Wound Spray.
Infectious diseases such as myxomatosis and rabbit 
viral haemorrhagic disease (RVHD) are spread through-
out the UK and are a risk to both indoor and outdoor 
 rabbits. Vaccinations are available and should be recom-
mended to all clients along with environmental and 
 biosecurity advice. Make sure your clients understand 
biosecurity including quarantine, cleaning vs disinfection 
and barrier nursing.
Neutering is an important part of preventative 
healthcare, especially for females who have an 80% risk 
of developing uterine cancer before they are 5 years of 
age. As rabbits are social creatures that should ideally live 
in opposite sex pairs, neutering is also needed to prevent 
unplanned litters and unwanted behaviours.
Encephalitozoon cuniculi (EC) is a complex subject. 
There are no real preventatives against this and it is 
 commonly found in over half of the domestic UK rabbits 
tested. It is often misdiagnosed and treatment started 
before any tests have been done. It is advised to be 
 cautious about treating this condition and explore all 
possible differentials, as a seropositive EC result may 
not be the reason for the current clinical signs.
Routine worming is not recommended for domestic 
rabbits as they rarely have any pathogenic worms. 
 Fenbendazole should be used with caution as it is not a 
benign molecule and can cause anaemia.
Gastrointestinal stasis is a symptom and not a cause. 
It is important to highlight the signs to owners and find 
the underlying trigger. Corrections to the diet can help 
reduce the frequency of some cases.
Providing good levels of owner education and sup-
port are vital and this can be done in a variety of ways, 
including nurse clinics, posters, handouts and social 
media pages. Prevention really is better than cure.
KEY LEARNING OBJECTIVES
■■ Understand the main diseases and conditions that 
can be prevented
■■ Know the range of preventatives available and when 
to use each one
■■ Update and create practice protocols including 
educational displays and nurse clinics
MULTIPLE CHOICE QUESTIONS
1. What is the scientific name for flystrike?
(A) Mydriasis
(B) Myiasis
(C) Mitosis
(D) Miosis
2. Which diseases should domestic rabbits be 
vaccinated against?
(A) Myxomatosis
(B) RHD1
(C) RHD2
(D) All of the above
3. What percentage of entire female rabbits have 
been shown to develop uterine cancer?
(A) 60%
(B) 70%
(C) 80%
(D) 90%
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Rabbit obesity clinics
Jo Hinde
Obesity is a growing concern and a high proportion of 
rabbits seen within clinic are overweight. 
HUSBANDRY
Correct husbandry is vital to owning a healthy rabbit. 
The  diet should be of high quality and suitable for the 
individual’s life stage.
■■ Junior: up to 6 months old. Feed mainly alfalfa hay 
and approximately 5 tablespoons of junior pellet 
food per day. Greens can be introduced around 
4 months old
■■ Adult: 6 months to 4 years. Feed mainly timothy hay 
(alfalfa should just be an occasional treat). Feed 
approximately 1 tablespoon of adult pellets per kg of 
ideal bodyweight per day. Offer one small handful 
of safe greens (no bigger than the size of the rabbit’s 
head) per day
■■ Mature: 4 years+. Feed as per adult but switch to 
mature pellets
Constant access to fresh water via a bowl must be 
provided for all life stages.
Housing also has a direct effect on the rabbit’s 
weight. Enclosures that are too small mean the rabbit 
cannot move around adequately and can result in obe-
sity, muscle wastage, ileus, urinary problems and podo-
dermatitis, as well as behavioural issues. The Rabbit 
Welfare Association’s current guidelines state that the 
minimum space requirement is 10 ft × 6 ft × 3 ft high.
ASSESSING CONDITION
A thorough nose-to-tail check should be carried out at 
every visit:
■■ Vaccination status
■■ Respiratory rate, heart rate and demeanour
■■ Nose and eyes
■■ Ears
■■ Skin and fur
■■ Body and weight
■■ Genitals and tail
■■ Feet and nails
■■ Jaw and teeth
■■ History (taken throughout)
Body condition and muscle condition scoring are 
vital – teach the owner to carry these out at home on a 
weekly basis. When dealing with obesity it is important to 
look beyond the rabbit’s weight for any underlying 
 medical conditions that may be causing or exacerbating 
the problem, such as arthritis, pododermatitis and dental 
 disease.
WEIGHT-MANAGEMENT CLINICS
This may be a tricky subject to broach with the owner so 
be tactful. Once they understand the reasons why obe-
sity is a problem then they are more likely to comply with 
your recommended changes. Teach the owner what to 
monitor at home and then get them to report back to you 
weekly with updates via email. You can then get the 
owner to bring the rabbit to the clinic just once every 
3–4  weeks to reduce the stress of the visits. Request 
photos in the standard body condition score poses as 
well as information on behaviour, exercise and diet. Make 
sure you give the client a targeted, clear action plan to 
follow that ensures a gradual increase in exercise and 
slow dietary modification to avoid complications.
Use enrichment techniques to prolong feeding 
 activity and promote exercise. Hanging fresh greens up 
so the rabbit has to stand up tall and scattering feeding 
pellets are a couple of the options available.
Always remember that dietary modification will be 
needed throughout the rabbit’s life depending on well-
ness and age.
KEY LEARNING OBJECTIVES
■■ Understand the main causes and consequences of 
obesity and how these can be treated and prevented
■■ Know the recommended husbandry guidelines
■■ Understand how to set up and run weight-
management clinics for rabbits
MULTIPLE CHOICE QUESTIONS
1. What are the current RWAF minimum housing 
guidelines?
(A) 8 ft × 6 ft × 2 ft
(B) 8 ft × 6 ft × 3 ft
(C) 10 ft × 6 ft × 3 ft
(D) 10 ft × 8 ft × 3 ft
2. Which problem can be associated with obesity?
(A) Pododermatitis
(B) Arthritis
(C) Urinary sludge
(D) All of the above
3. From what age is it recommended to feed 
mature pellets?
(A) 4 years
(B) 5 years
(C) 6 years
(D) 7 years
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Nursing ileus
Jo Hinde
Ileus refers to slowing of the digestive tract. It is one of 
the most commonly presenting problems, however it is a 
symptom not a cause.
PRESENTATION
Stasis is usually a direct result of pain and/or stress and 
this releases catecholamines as part of the flight or fight 
response. Almost all unwell rabbits will present with ileus, 
the symptoms of which include:
■■ Lethargy
■■ Hunching
■■ Tooth grinding
■■ Anorexia (or fussiness with food)
■■ Reduction/cessation of faecal pellets (or shape 
change)
This wide range of symptoms could point to a variety 
of differential diagnoses. It is important to check and 
monitor the patient’s clinical parameters – many of these 
cases will be dehydrated. Assess the behavioural signs 
too and ensure you are pain scoring frequently.
TREATMENT
Initial treatment options for stasis follow. It is, however, 
vital that the underlying condition(s) are also treated 
once the patient is stabilized.
■■ Start analgesia! This is the most important part of 
the treatment. Use a multimodal approach and keep 
the analgesia topped up
■■ Provide fluid therapy as needed (via intravenous 
canula initially and moving to oral as soon as stable 
enough). Doing this via slow bolus is recommended 
rather than using a giving set. Use caution when 
considering giving subcutaneous fluids as these may 
not be well absorbed if the patient is hypothermic/
hypovolaemic
■■ Restore normothermia by warming/cooling as 
needed
■■ Consider the use of prokinetics but ONLY after 
ruling out an obstruction
■■ Start supportive feeding. Initially this will often be via 
syringe feeding a commercial liquid diet such as 
Recovery Plus or Critical Care. Standard amount is 
10–15 ml/kg q6h, but this needs to be tailored to 
each patient. As they improve, you can switch to 
assisted feeding by offering fresh herbs or treats
■■ Ensure the rabbit has space to move around as this 
will naturally stimulate the gut. Always keep bonded 
partners together to reduce stress
■■ Check blood glucose frequently. This, combined 
with the other clinical parameters, can give a good 
indication of the stress and pain levels of the 
rabbit and can be a useful tool to identify possible 
obstruction. Rabbits with a blood glucose result of 
15 mmol/l or higher should be admitted for 
supportive treatment and retested every 
10–15 minutes to ensure the treatment is working 
(the blood glucose value should stabilize and drop). 
If the value is 20–25+ mmol/l, then this is an 
extremely unwell patient that needs intensive care
Diagnostic images can be helpful to rule out obstruc-
tion and look for the underlying causes of the ileus. 
 However, it is important to stabilize the patient before 
anaesthesia. Conscious radiographs are rarely of any 
diagnostic value.
DISCHARGE
The patient can be discharged once they have started 
eating and passing faeces. They must be sent home with 
analgesia and possibly prokinetics for a few days. Ensure 
you have taught the client how to administer all medica-
tions, including syringe feeding.
KEY LEARNING OBJECTIVES
■■ Understand the main causes and consequences of 
ileus 
■■ Know the basic treatment protocols
■■ Be able to identify, monitor and treat pain in rabbits
MULTIPLE CHOICE QUESTIONS
1. What blood test is recommended for rabbits in 
stasis?
(A) Glucose
(B) Glucogen
(C) Globulin
(D) Glyceride
2. What are the current syringe feeding 
guidelines?
(A) 5–10 ml/kg q6h
(B) 5–10 ml/kg q12h
(C) 10–15 ml/kg q6h
(D) 10–15 ml/kg q12h
3. What is the recommended route for initial fluid 
therapy?
(A) Intravenous
(B) Orally
(C) Intraperitoneal
(D) Subcutaneous
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Is it all about hay and 
grass: rabbit nutrition
Nicola Ackerman
We all know that rabbits need to consume their own 
body size in grass and hay, on a daily basis, with limited 
amounts of concentrates (pellets) and fresh vegetables. 
However, not all grass and hays are the same. Many cli-
ents aren’t aware that there are different types of grasses 
(and hence hays), many are not aware of the difference 
between hay and straw. 
Alfalfa (lucerne) hay is often fed to rabbits as it has a 
very green colour and pleasant looks and smell to the 
rabbit owner. Alfalfa is part of the pea family and is not 
naturally found in Northern Europe and the UK. Alfalfa 
hay is high in protein, phosphorus and calcium; it is ideal 
for growing animals, especially horses, which is why it 
was initially used for commercially. It is not ideal for adult 
rabbits.
Timothy hay is produced from grass found in the UK. 
The fibre content is much higher than that of alfalfa hays, 
it has a low protein content and lower values of calcium 
and phosphate. Timothy hay doesn’t look as appealing as 
alfalfa hay, but for rabbits it is nutritionally superior. 
The type of vegetables that owners are feeding their 
rabbits is important. Ideally the same type and volume of 
vegetables should be fed daily. Vegetables have varying 
amounts of vitamins, minerals and carbohydrates. Some 
can be fairly high in phosphates, some in calcium and 
some in simple sugars. Knowledge of the different nutri-
tional content of vegetables in order to educate rabbit 
owners is important. 
KEY LEARNING OBJECTIVES
■■ Different nutritional values for different types  
of hay
■■ What can/should we be recommending to clients 
to feed their rabbits
■■ What vegetables are best for rabbits and why
MULTIPLE CHOICE QUESTIONS
1. Alfalfa hay has which nutritional characteristics 
in comparison to timothy hay?
(A) Lower protein, higher fibre, lower calcium
(B) Higher protein, higher calcium, higher 
phosphate
(C) Higher protein, lower calcium, lower fibre
(D) They are the same
2. Why do the brassica vegetables (kale, broccoli, 
cabbage, brussel sprouts) need to be fed in 
moderation?
(A) They are high in calcium oxalate
(B) They give rabbits diarrhoea
(C) Rabbits shouldn’t eat vegetables
(D) They don’t contain enough calcium
3. Why are feeding behaviours important in 
rabbits?
(A) We need to increase foraging behaviour to 
help relieve boredom
(B) Helps to increase exercise and decrease 
obesity rates
(C) Correct time eating helps with overall 
digestion
(D) All of the above
Exotic pet welfare 
and ethics
Shakira Free-Miles
Exotic pets or wild animals? Why have we categorized 
them differently, they are not pets, they are wild animals. 
Is this a subconscious way to make them appear more 
domesticated than they ever will be, or to help these 
 animals become more socially acceptable? 
ETHICS
Animals considered as ‘exotic pets’ range from parrots, to 
snails, meerkats to monkeys and leopards to lizards, all of 
whom need specialist care, due to their basic species-
specific needs. Meeting their ‘welfare’ needs seems to be 
not only a challenge, but in some cases almost  impossible 
to define or guarantee. Yet legislation is poorly enforced 
around their species-specific needs, making ‘welfare’ 
itself difficult; it is questionable whether they should even 
exist in captivity. 
When it comes to ethics, can we morally justify keep-
ing such complex animals at all in an artificial environment 
when even their most basic needs of survival are so diffi-
cult to achieve? Data and research show that mortality 
rates are high, longevity often not reached and quality of 
life questionable in terms of the benefits of their  captivity.
When taking the journey of a potential wild animal 
owner there is no obligation to research their specific 
needs or have any basic knowledge.  The system allows 
multiple failures leading to suffering and premature 
deaths. Veterinary knowledge, care and access to spe-
cialists are also sometimes limited. Referrals and second 
opinions at specialist clinics reflect that these complex 
creatures are not getting the same level of care as cats 
and dogs due to simple lack of knowledge. The animals 
themselves therefore suffer the consequences of being 
kept in peoples homes. 
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WELFARE
The five welfare needs are basic needs of pets (compa-
nion animals), however for wild animals these needs are 
far more complex. Most pet owners know their animals 
need food and water and how to provide this which 
is  enough for a dog or cat, but for wild animals this is 
far more complex than a bowl of tap water and some 
complete food presented in a boring bowl.
The reality is that the complex needs of these ani-
mals are often not met at a basic level, leading to suffer-
ing, simply down to lack of knowledge and the difficulty 
involved to recreate their natural life. Some owners do 
meet the majority of their needs and care for wild ani-
mals they consider as pets incredibly well. But does this 
justify us keeping them in the first place? 
KEY LEARNING OBJECTIVES
■■ To encourage delegates to question the suitability 
of wild animals as ‘pets’
■■ Understand the current legislation covering wild 
animals as pets 
■■ The concerns of knowledge of so many species 
and its sometimes detrimental effect on welfare
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Leadership: what are 
the benefits for RVNs? 
Elizabeth Cox 
‘I’m a veterinary nurse or I’m not the boss, leadership 
doesn’t apply to me!’ Leadership is a word that we are all 
using more, often followed by, but that doesn’t apply 
to me.
Leadership, management, diversifying, practice 
ownership and career opportunities are phrases that 
were rarely on a veterinary nurse’s horizon, just a few 
years ago. Now with changes in veterinary business 
models and change in traditional employment hierarchy, 
veterinary nurses have more opportunities available to 
them than ever before. Discussions are happening now 
with view to thoughts on advanced practitioner status for 
nurses or even veterinary nurse prescribers. With all the 
developments that are ongoing and more that can’t be 
imagined, the future for veterinary nursing looks bright.
Older traditional thoughts on leadership lead us to 
believe that a leader is a person that others follow, often 
a team when in veterinary practice. We are now all 
encouraged to think of ourselves as leaders whether that 
is personally, in the consultation room, heading up a 
large organization or somewhere in-between. 
Being a leader can often feel lonely, especially when 
you have effectively moved out of the team, after a pro-
motion for example. Leadership may require direction, 
but a leader is still part of a team. It can be an opportunity 
to make a difference, simply from ways of working to 
developing people. Traditionally, veterinary nurses felt 
they had little control of their position in practice, beyond 
the possibility of them becoming head nurse. Head 
nurses have historically been appointed on a time-served 
basis or the next in line. Little consideration was given to 
ensuring the nurse had or was trained in the specific skills 
required of a leader. It is becoming more common to 
hear of roles such as senior theatre nurse, or medical 
nursing manager, which better describe the role of 
shared leadership in areas specific to skills and interests. 
The title of head nurse may not be commonplace in a 
few years. 
This presentation will explore what leadership is from 
a nursing perspective, and what your leadership role is. It 
will also discuss areas of opportunity, areas that you can 
learn from, and hopefully make you think differently. You 
are a veterinary nurse, you are a leader already, now it’s 
time for you to explore it, and, if you want to, develop it 
further.
KEY LEARNING OBJECTIVES
■■ Understanding and defining the benefits of 
leadership, both personal and for a team
■■ Understanding your role as a leader and where 
it happens
■■ Identify areas for your development and opportunity
MULTIPLE CHOICE QUESTIONS
1. What is a personal benefit of leadership?
(A) Direction
(B) Empowering
(C) Control
(D) More work
2. What is the aim of a leader? 
(A) Ignoring obstacles
(B) Directing personal agenda
(C) Providing clear direction
(D) Shielding your team from challenges
3. What opportunity does leadership bring?
(A) Personal gain
(B) Development of a team
(C) Keeping things the same
(D) Control of situations 
Challenges of the 
head nurse and how 
to lead your team 
effectively
Renay Rickard
During this session we will be discussing the role of a 
team leader and how that may differ from a manager 
or  ‘head’ person. It is important for a leader to know 
the  expectations of their team along with the owners/ 
directors of a business, as without a clear path for 
 themself it makes it difficult for a leader to be followed. 
We will also talk about the challenges faced by someone 
who has evolved into a leadership role versus someone 
who has been employed specifically for that role. It is 
important that as an effective leader we are aware of 
our own  leadership and communication style and how 
this will be key to how effective we are. Learning to 
 understand  ourselves as communicators and how we 
need to be adaptable at times to work effectively with 
individuals and groups within the practice team is 
 important. There are also situations where a different 
leadership style is needed. 
KEY LEARNING OBJECTIVES
■■ Understanding the difference between leading and 
managing effectively
■■ Knowing your own leadership style 
■■ Being able to adapt your style to different teams and 
situations
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(B) Organizing an open day 
(C) Scrubbed in during orthopaedic surgery 
with an experienced surgeon
(D) Working alongside a new graduate 
veterinary surgeon during their induction 
period
3. What is an indicator that you are leading a team 
effectively?
(A) Apathy
(B) Resistance to change
(C) Engagement
(D) Conflict
MULTIPLE CHOICE QUESTIONS
1. Which of the following is a quality of a good 
leader? 
(A) Controlling
(B) Unfair
(C) Dictatorial
(D) Forward thinking
2. Which of these situations is not a scenario that 
could see the veterinary nurse as the main 
leader? 
(A) A nursing consultation
Leadership skills  
for all roles
Elizabeth Cox 
It is common for veterinary nurses to believe they don’t 
have a leadership role within practice. With an ever 
increasing market of leadership training provision, it is 
important that nurses take this opportunity to develop 
this skill. Leadership and management training is not 
generally provided as part of the student veterinary nurse 
training. Whilst a newly qualified nurse should be spend-
ing an initial period honing their skills post registration, 
nurses are often required to step into roles such as head 
nurse or clinical coach. Moving from being part of the 
team to leading a team is a challenge for most people, 
without the added pressures of being recently qualified. 
It is not surprising that many nurses struggle with the 
changes that are required of them, without ever being 
formally taught the skills that are required of such roles. 
One size does not fit all, and the art of leadership and 
management is knowing where different approaches are 
required for individuals and situations, but that different 
roles also require different skills. The role of a mentor is 
very different to that of a coach. 
Now with further changes in veterinary business 
models and ownership, traditional employment hierar-
chy and expectations have changed. Veterinary nurses 
have greater opportunities than ever before. Career 
 progression may lead to increased requirements of 
 leadership and management skills, but do nurses see that 
they have a lot of these abilities already and are using 
them on a daily basis? 
The role of a veterinary nurse certainly is diverse 
and  requires the wearing of many different hats. This 
 presentation will discuss and explore the various areas 
where a veterinary nurse uses leadership skills. It will 
examine the different skills required for various roles. It 
will also help you to examine and question what the 
needs of an individual or situation are, and how to adapt 
your approach. The presentation will examine several 
case examples.
KEY LEARNING OBJECTIVES
■■ Understand the different skills required for different 
roles
■■ Identify the needs of the individual 
■■ Adapt your approach with differing requirements
MULTIPLE CHOICE QUESTIONS
1. What is the specific requirement of a mentor?
(A) Telling the mentee what to do
(B) Doing things for them
(C) Dismissing their concerns
(D) Listening to them
2. What is an ideal way of supporting the needs of 
a team?
(A) Telling them what is required
(B) Collaborative discussion
(C) Providing solutions
(D) Time limitation 
3. Which changes don’t require an alternative 
approach?
(A) Change in circumstances
(B) Change in requirements
(C) Changes of time allocation
(D) Where agreed objectives have been 
completed 
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Managing your team 
through change
Renay Rickard
Change is a stress trigger – whether a minor day-to-day 
operational protocol adjustment or a full change in owner-
ship of the business and this needs to be recognized and 
managed appropriately. We know that the stress trigger is 
a feeling of a lack of control over a situation and if we can 
minimize this as far as possible then the effect it has on a 
team or individual can be reduced. Learning to appreciate 
how a change could affect our team, whether physically 
or emotionally, and how they could react is key, as people 
will react differently and sometimes unexpectedly. A team 
that has been led in a way that makes them feel secure and 
resilient to change will function better than one that starts 
to panic and becomes closed and defensive. The way that 
a leader responds to change is the most important factor 
as to how their team will also  respond, so we will also 
 discuss a personal strategy for this.  
KEY LEARNING OBJECTIVES
■■ Recognizing and understanding when a change is 
happening
■■ Recognizing the effects on your team of a period of 
change
■■ Learning to manage an adaptive strategy for leading 
your team through change 
MULTIPLE CHOICE QUESTIONS
1. Which of these situations is not a change?
(A) Salary review meeting
(B) Promotion
(C) Qualification
(D) Change of ownership
2. Which of these reactions is not an effect of 
change if managed positively?
(A) Apathy
(B) Conflict
(C) Team motivation
(D) Insecurity
3. When forming an adaptive strategy which of 
these statements is FALSE?
(A) New opportunities and challenges must 
be dealt with effectively
(B) It is not necessary to deal with change
(C) Projects and tasks should have time 
deadlines to work towards
(D) Outcomes should be able to be measured
Swapping between 
leadership and 
management: 
multitasking nurses!
Elizabeth Cox 
Leader, manager, coach and mentor – you are often the 
same person several times a day. How does that work? 
What skills are specific to each role? 
Leadership and management are words to many in 
the veterinary nursing profession that are rarely used 
or  understood. This is unsurprising when many nurses 
find themselves in a senior position in practice, with little 
or no training. Traditionally, senior nurses have been 
app ointed on a time-served basis or next in line. 
 Commonly CPD allowances have been used for clinical 
training and, even with a role change, non-clinical 
 training is often overlooked. 
The role of a veterinary nurse shares common skills 
that a leader and a manager also require: skills of adapt-
ability, seeing the wider picture, future planning and 
reacting well to changing circumstances and people. 
These skills are used every day as a veterinary nurse. 
When stepping in to the role of a leader, those skills are 
often forgotten, moving to a telling staff what to do, 
replacing the previous teamwork ethos. Adding a move 
to a different work location for long periods of time, be 
that in an office or another building, and a feeling of lack 
of control can fog previous thinking. In large organiza-
tions, leaders and separate managers are employed, but 
in veterinary practice that person is more commonly 
both the leader and the manager. No matter where a 
 person is working, leadership requires us to be both, and 
to understand where and how to apply the different skills. 
Clinical coaches in practice will alter their approach 
and style depending on the individual student, and the 
various stages a student nurse travels through. Clinical 
coach training is one of the few non-clinical areas where 
training and ongoing CPD are expected. 
The lines between leadership and management are 
often blurred, requiring a flexible approach. Identifying 
when and what is needed can be a challenge. These skills 
are rarely taught and it is common for nurses in a senior 
role to confuse them or use them incorrectly. This pres-
entation will look at the similarities and differences 
between the two skills. It will discuss why and when to 
swap between them. It will also look at how to identify 
your specific skills and gaps as a leader and manager. 
KEY LEARNING OBJECTIVES
■■ Understand the difference between leadership and 
management
■■ Knowing why and when to swap between 
leadership and management
■■ How to identify your personal skills and gaps of a 
leader and manager
273-278 VN Leadership & management.indd   276 08/03/2019   18:06
BSAVA CONGRESS 2019 PROCEEDINGS [ 277 ]
MULTIPLE CHOICE QUESTIONS
1. Which of the following is a trait of a good 
manager?
(A) Poor organisation
(B) Control of events
(C) Poor time management 
(D) Overruling
2. Which of the following is an example of a need 
to swap between leader and manager?
(A) Sudden change
(B) Personal choice
(C) Unhappy with outcomes
(D) Frustration with team
3. Which of the following is an indication of a gap 
in personal skills in management?
(A) Lack of team engagement
(B) Organized work schedule
(C) Happy effective leader
(D) Improved team performance
A simple approach to 
development reviews
Renay Rickard
A development review is a very specific tool that should 
be used to ensure that the team member knows what is 
expected of them over a period of time, and it can be dis-
cussed as to how this will be achieved with support and 
guidance from the team leader or other members of the 
practice team.  The outdated ‘annual appraisal’ approach 
has often been seen as an annual telling-off where the 
employee feels there is a one-sided approach with 
regard to how they should do better. The development 
review is very much a two- (or more) sided dialogue that 
focuses on the forward development of an individual and 
therefore the team and practice team. The benefits of 
this are also positive for clients, animals in our care and 
the overall business. We will be discussing a practical 
framework and plan that can be implemented by a new 
team leader from scratch or that could be introduced 
to  a wellestablished team for which a more structured 
approach could be used. 
This session will also discuss the challenges of 
 working within a team whilst leading and being responsi-
ble for its development. For veterinary nurses who have 
evolved into a leadership role this can be daunting. We 
will be looking at ways that difficult conversations can 
be avoided or managed so that the veterinary nurse gains 
confidence in this area. 
KEY LEARNING OBJECTIVES
■■ The benefits of an effective development review 
process for your team
■■ How to develop a simple plan for carrying out 
development reviews for your team members
■■ How to implement a development action plan
MULTIPLE CHOICE QUESTIONS
1. Which of these is a negative effect of not 
carrying out regular development reviews 
for your team members?
(A) Improved clinical skills
(B) Increased or maintained high morale 
amongst the team
(C) Demotivated team 
(D) Increased business performance
2. Which of these is not required during a 
development review?
(A) Pay review
(B) Planning
(C) Communication
(D) Time
3. Which of the following are not vital within 
an action plan?
(A) Measurable outcome
(B) Complete confidentiality  
(C) A realistic timescale
(D) Training or CPD requirement
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Making and 
implementing a 
nutritional assessment
Georgia Woods 
Nutritional assessments require a wealth of information, 
not only on the current nutritional provision but also 
 taking into consideration the many medical and lifestyle 
factors that affect nutritional requirements for each 
patient. As nutrition plays a vital role in di sease manage-
ment, health and well-being, it is essential to make 
 accurate assessments in order to deliver optimal  nutrition 
to every patient. 
Understanding other factors in the patient’s life can 
also assist you in making the correct assessment of what 
the nutritional requirements are, for example, is the dog 
in training, and so does the owner require a high-value 
reward to facilitate this? Taking a detailed history or 
inventory of all activities the pet and owner undertake 
and using this information in conjunction with the nutri-
tional information already obtained means that a holistic 
approach can be taken and this will improve the quality 
of the advice given. Repeated questioning via a variety of 
methods will often be needed and careful listening and 
observation during the conversation will be essential to 
extract all the necessary information. Although each 
assessment and plan must be tailored to the individual 
there will be common factors to all assessments that 
should be considered.
This lecture will discuss the various elements essential 
to all nutritional assessments and how creating a stand-
ardized approach by creating bespoke nutritional assess-
ments for your practice can be very useful. Practice- 
specific assessment forms will ensure that the correct 
information is gathered and that everyone within the prac-
tice is  familiar with the nutritional plans subsequently set. 
It is also useful to have a nutrition champion within 
the practice who can oversee the development of the 
assessment forms and who can monitor and review how 
the practice makes nutritional assessments both within 
the hospital and in consultations. 
KEY LEARNING OBJECTIVES
■■ Recognize the best methods for obtaining key 
pieces of information needed to make a thorough 
nutritional assessment
■■ Describe the important elements of all nutritional 
plans and how to implement them
■■ Discuss how the nutritional needs of the patients 
must be balanced against the owners wishes, 
understanding, level of compliance and resources
MULTIPLE CHOICE QUESTIONS
1. What are the four most useful pieces of 
information to gather when assessing a 
patient’s nutritional need?
(A) Age, sex, health status, owner preference
(B) Breed, age, sex, health status
(C) Age, sex, owner income, breed
(D) Owner preference, breed, environment, sex
2. In practice, which is the best estimation for the 
energy requirement of the patient?
(A) Basal Energy requirement (BER)
(B) Maintenance energy requirement (MER)
(C) Resting energy requirement (RER)
(D) Daily energy requirement (DER)
3. Which amino acid is essential for all feline 
diets?
(A) Arginine
(B) Valine
(C) Lysine
(D) Taurine
Compliance for 
nutritional 
recommendations
Georgia Woods 
Within a first-option practice or a referral hospital setting, 
compliance with any nutritional advice given to clients 
can at times be challenging. Due to the huge amount of 
information available, which is often conflicting, it can be 
confusing for owners to know where to turn for the 
 correct information for their pet and whose information 
it would be best to follow. When discussing nutrition with 
owners it is important to let them know that the informa-
tion being given will be evidence based and so can be 
relied upon. 
When making nutritional recommendations, it is vital 
the pet owner understands the importance of good 
compliance, and how poor compliance may adversely 
affect the health of their pet. Poor nutritional compliance 
and subsequent nutritional inadequacy may be detri-
mental to the pet and in the worse cases may even be 
fatal, so the correct recommendation must be made, and 
it must be explained clearly to the owner why a change in 
diet from the current diet may be necessary. 
It is not, however, simply what advice is given, it is also 
the manner in which it is delivered and the relationship of 
trust that is formed between veterinary professional and 
client that will influence the level of compliance. Often 
owners require support though nutritional change, as 
this can be a difficult time and the owners’ resolve may 
diminish without appropriate support. 
This lecture will discuss firstly how gathering dietary 
history, medical history and lifestyle information will be 
key to making recommendations that the owner is able 
to comply with. It will also discuss the various elements 
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that will be common to those recommendations and 
how the language used during the information gathering 
and delivery can affect the level of compliance. 
KEY LEARNING OBJECTIVES
■■ Recognize the reasons behind why some pet 
owners struggle to comply with the nutritional 
advice given
■■ Describe the ways in which compliance and 
communication can be improved, with an emphasis 
on the importance of the relationship built between 
veterinary professional and client
■■ Discuss ways of tailoring the nutritional advice 
given, considering the individual set of 
circumstances and how recommendations may 
require compromise on both sides
(A) Less than 5 time
(B) More than 3 times
(C) More than 10 times
(D) Less than 3 times
2. Who in the household is it most important to 
speak to when making nutritional 
recommendations for a family pet?
(A) The person who feeds and exercises the 
pet most frequently
(B) All adults living with the pet
(C) All members of the household
(D) The person who exercises the pet most 
often
3. What is the most helpful thing you can do 
to help create good compliance from pet 
owners?
(A) Write down all instructions for the owner 
to take away
(B) A follow up phone call 24 hours after the 
advice is given
(C) Regular check-ups/check-ins
(D) All of the above
MULTIPLE CHOICE QUESTIONS
1. On average, how many times would you need 
to ask a client what they are currently feeding 
their pet?
Feeding the renal 
patient
Georgia Woods 
The main function of the kidneys of the dog and cat is 
homeostasis, the regulation of water, electrolytes, acid–
base balance and the excretion of waste products such 
as urea. Renal disease in both cats and dogs is a degener-
ative condition that sadly has no cure. In many instances, 
however, the patient’s life can be prolonged and their 
quality of life improved through dietary management. 
Patients with renal disease have very specific nutri-
tional needs to support the reduced or impaired kidney 
function. In cases of chronic kidney disease, which 
affects a greater proportion of cats than dogs, patients 
often lose weight and muscle mass as the disease 
 progresses and so optimal, tailored nutrition for these 
patients is essential. The lecture will discuss the point at 
which a renal diet is needed and the many ways in which 
diet can reduce renal load.
To provide optimal nutrition an assessment must 
firstly be made. It should consider the medical impli-
cations of the disease stage, the preferences of the pet, 
the lifestyle of the pet and the preferences of the owner. 
Without all of this information, compliance with the 
nutritional plan may be difficult for the pet and owner.
Patients with renal disease will often become ano-
rexic or partially inappetent so alternative solutions for 
feeding these patients may be required and must be con-
sidered when setting a plan to feed them. As patients 
with acute or advanced renal disease will be admitted 
into the veterinary hospital, the lecture will also discuss 
techniques for providing nutrition to these patients and 
the necessity of placing a feeding tube in some instances.
KEY LEARNING OBJECTIVES
■■ Recognize the challenges created by the disease 
process, and the specific elements of a diet that will 
support the patient
■■ Describe the finer details of the micro- and 
macronutrient requirements for both cats and dogs 
in chronic and acute renal disease cases
■■ Discuss the various factors to consider when 
feeding a patient with poor appetite, changing 
preferences as the disease progresses
MULTIPLE CHOICE QUESTIONS
1. What percentage of cats over 10 years old have 
some degree of chronic kidney disease?
(A) 30%
(B) 22%
(C) 45%
(D) 10%
2. What is the most important macronutrient to 
restrict but balance correctly, for patient with 
renal disease?
(A) Carbohydrates
(B) Fats
(C) Proteins
(D) Water
3. What micronutrient is it most important to 
restrict to prevent stimulation of the 
parathyroid gland in patients with chronic 
kidney disease?
(A) Magnesium
(B) Calcium
(C) Sodium
(D) Phosphorus
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Nutritional 
management of the 
hyperthyroid cat
Georgia Woods 
Hyperthyroidism is a common disease of senior cats 
(over 8 years old) and in the UK, one in 10 cats is thought 
to have the condition. Cats often present with poor 
body  condition despite owners reporting a ferocious 
appe tite. Poor skin and coat, tachycardia, vocal changes 
and hyperactivity are also commonly seen, alongside the 
presence of a palpable goitre in the neck. As the thy-
roxine produced by the thyroid gland drives metabolism, 
an overactive thyroid gland means that the metabolism 
works at an abnormally high level, burning calories at a 
higher rate and, together with the tachycardia commonly 
observed in these patients, it puts extra load on the heart. 
Subsequently cardiac structure and function are often 
affected which, if left untreated, may be very serious for 
the patient. Renal disease is also frequently seen and is 
the most common concurrent disease, found in around 
30% of cases.
There are four main ways hyperthyroidism in cats 
can be managed or permanently cured. Medication and 
dietary management can reverse the condition whereas 
performing a surgical thyroidectomy or delivering radio-
therapy can permanently cure the cat of the disease. The 
lecture will discuss how the recently developed dietary 
solution forcats has become a viable treatment method 
and can be a very successful way to manage the produc-
tion of thyroid hormones within the patient, thus con-
trolling the disease.
KEY LEARNING OBJECTIVES
■■ Recognize the physiology that is occurring within 
the cat with hyperthyroidism and the pros and cons 
of the various treatment methods available
■■ Describe the ways in which diet is able to have a 
positive effect on the management of the disease 
but also the need to guard against iatrogenic 
hypothyroidism
■■ Discuss the need for complete compliance with the 
dietary advice given, how this may be achieved 
MULTIPLE CHOICE QUESTIONS
1. What is the most common concurrent disease 
seen but often masked by hyperthyroidism in 
cats?
(A) Urinary disease
(B) Renal disease
(C) Cardiac disease
(D) Obesity
2. How can diet be used to treat hyperthyroidism?
(A) By reducing the amounts of thyroid 
hormone being produced
(B) By increasing the amounts of thyroid 
hormone being absorbed
(C) By blocking the absorption of thyroid 
hormones
(D) By increasing the amounts of iodine in the 
diet
3. In what year was the first diet specifically 
design to treat hyperthyroidism in cats 
launched?
(A) 2001
(B) 2011
(C) 2012
(D) 2016
Nutritional 
management of 
gastrointestinal disease I
Aarti Kathrani
Acute gastroenteritis is a common presentation in veteri-
nary practice. There are several different causes, such as 
infectious, toxic and dietary factors. Collection of a diet 
history is critical for these cases to rule out food-induced 
diarrhoea, which can include a recent change to a high-
fat diet or dietary indiscretion from consuming table food 
or access to garbage. A commercial therapeutic gastroin-
testinal (GI) diet, such as Hill’s Prescription Diet i/d, Purina 
ProPlan Veterinary Diets EN and Royal Canin Veterinary 
Diet Gastrointestinal, is recommended for management 
of acute gastroenteritis, as these diets are highly digesti-
ble and some formulas for dogs are lower in fat (Hill’s 
 Prescription Diet Canine i/d Low Fat and Royal Canin 
 Veterinary Diet Canine Gastrointestinal Low Fat). It is best 
to feed patients with acute gastroenteritis little and often. 
Some patients with acute gastroenteritis may need an 
increased-fibre diet to manage their clinical signs, there-
fore if their stool quality worsens or does not improve 
with a highly digestible diet then a higher-fibre diet should 
be considered (e.g. Royal Canin Veterinary Diet Gastroin-
testinal Fibre Response, Hill’s Prescription Diet w/d). 
The term food-responsive enteropathy (FRE) des-
cribes a group of diseases resulting in chronic gastrointes-
tinal signs that are responsive to dietary management 
alone. There are three categories of commercial thera-
peutic diets that are available for the diagnosis and mana-
gement of FRE in dogs and cats: hydrolysed diets (Purina 
ProPlan Veterinary Diets HA dry food, Hill’s Prescription 
Diet z/d, Royal Canin Veterinary Diet Hypoallergenic, 
Dechra Specific Allergen Management), limited- ingredient 
novel-protein diets (e.g. Hill’s Prescription Diet d/d, Royal 
Canin Veterinary Diet Sensitivity) and gastrointestinal diets 
(see above). In addition, a limited-ingredient, complete 
and balanced home-cooked diet, formulated by a board-
certified veterinary nutritionist could also be used. 
Dogs and cats with constipation may exhibit  tenesmus, 
dyschezia and abdominal pain. Owners of  constipated pets 
should be questioned about consumption of bones and 
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raw food as this can result in constipation in dogs. Main-
taining normal hydration status is important in managing 
patients with chronic constipation or obstipation. For 
patients with chronic constipation that still have some 
level of colonic motility, insoluble or mixed fibre may 
help. The constipated animal should be well hydrated 
before a highe-fibre diet is introduced. The motility pat-
terns of patients with obstipation are completely abol-
ished and therefore, in these patients, fibre-enhanced 
food and fibre supplements should not be used as this 
may worsen their clinical signs. In these cases a highly 
digestible, low-residue diet with a high energy density 
should be used to markedly reduce faecal mass. If the 
animal is overweight, a weight-reduction programme 
should be considered. 
KEY LEARNING OBJECTIVES
■■ To describe the nutritional strategies for the 
management of acute gastroenteritis in dogs 
and cats
■■ To list the advantages and disadvantages of the 
different categories of diets used for the 
management of food-responsive enteropathy in 
dogs and cats 
■■ To describe the nutritional strategies for the 
management of constipation/obstipation in cats 
MULTIPLE CHOICE QUESTIONS
1. Low-fat diets are sometimes preferred for the 
management of acute gastroenteritis in dogs. 
Which one of the following statements is 
correct with regards to the effect of low-fat 
diets on the gastrointestinal tract?
(A) Low-fat diets increase gastric retention time
(B) Low-fat diets are more palatable and more 
calorically dense compared to high-fat diets
(C) Low-fat diets increase gastroesophageal 
tone
(D) Low-fat diets increase pancreatic secretion 
2. Hydrolysed diets can be used to manage 
food-responsive enteropathy in dogs and cats. 
Which one of the following statements is 
correct with regards to the advantages of using 
a hydrolysed diet for the treatment of food-
responsive enteropathy in dogs and cats?
(A) Hydrolysed diets are more palatable 
compared to over-the-counter or 
novel-protein diets
(B) Hydrolysed diets are cheaper than 
novel-protein and over-the-counter diets 
as they contain less protein
(C) Hydrolysed diets contain more calories  
per gram than novel-protein and  
over-the-counter dry foods
(D) A complete diet history of antigen 
exposure is not necessary before starting a 
hydrolysed diet
3. Which one of the following therapeutic diets 
would be most suitable for a cat with 
obstipation due to megacolon and a body 
condition score of 6/9?
(A) Purina ProPlan Veterinary Diets Feline OM 
tinned food
(B) Purina ProPlan Veterinary Diets Feline EN 
tinned food 
(C) Hill’s Prescription Diet Feline w/d dry food
(D) Royal Canin Veterinary Diet Feline Obesity 
Management dry food
Nutritional 
management of 
gastrointestinal 
disease II
Aarti Kathrani
Nutritional management of canine pancreatitis centres 
on the reduction of dietary fat by at least 50% of what is 
currently being fed. Commercial therapeutic options for 
low-fat diets include Royal Canin Veterinary Diet Gastro-
intestinal Low Fat and Hill’s Prescription Diet i/d Low Fat. 
If further fat reduction is desired, then a home-cooked 
diet using ingredients such as low-fat cottage cheese, 
skinless boneless chicken breast, tilapia and lean minced 
turkey with white rice can be tried. An unbalanced diet 
using these ingredients can be fed for 3–5 days, however 
longer-term feeding requires formulation by a board-
certified veterinary nutritionist. Fasting dogs with pan-
creatitis is no longer recommended, as enteral nutrition, 
even in small amounts, is important for enterocyte 
health. As obesity can predispose to recurrent episodes 
of pancreatitis, addressing weight loss in overweight and 
obese dogs needs to be considered in the long-term 
feeding plan. 
Dietary fat reduction is not a common strategy for 
the management of feline pancreatitis; instead, as these 
cats can be affected by triaditis (cholangiohepatitis, pan-
creatitis and inflammatory bowel disease), a commercial 
therapeutic hydrolysed diet is selected for management 
of these cases. Purina ProPlan Veterinary Diets Feline HA 
dry food is commonly selected due to its lower fat 
 content compared to the other commercial therapeutic 
hydrolysed diets available for cats. However, if a wet 
 formulation is required, Hill’s Prescription Diet Feline z/d 
or the Dechra Specific hydrolysed salmon feline formula 
can be tried. 
Commercial therapeutic hepatic diets (e.g. Hill’s 
 Prescription Diet l/d, Royal Canin Veterinary Diet Hepatic) 
are generally indicated when the dog or cat has evidence 
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of protein intolerance, such as urate urolithiasis or 
hepatic encephalopathy associated with their liver dis-
ease. Raised liver enzyme activities or liver changes on 
imaging without signs of protein intolerance or reduced 
liver function are not usually an indication for use of 
these diets. However, these diets can be used for the 
management of copper hepatopathy in dogs, as they 
are suitably copper restricted. These diets are also com-
monly used in the management of canine and feline 
 portosystemic shunts. Vegetarian diets such as Purina 
ProPlan Veterinary Diets Canine HA dry food or a home-
prepared diet of cottage cheese, egg and white rice, 
 formulated by a board-certified veterinary nutritionist, 
are also suitable options. Diets suitable for growth also 
need to be taken into consideration when considering a 
diet for a puppy or kitten with a portosystemic shunt.  
KEY LEARNING OBJECTIVES
■■ To describe the nutritional strategies for the 
management of pancreatitis in dogs and cats
■■ To list the indications for use of commercial 
therapeutic hepatic diets in dogs and cats with 
liver disease
■■ To describe the nutritional strategies for the 
management of liver disease and list the different 
dietary options available  
MULTIPLE CHOICE QUESTIONS
1. Which one of the following statements is 
correct with regard to nutritional management 
of dogs with acute pancreatitis?
(A) A diet with at least a 50% increase in 
dietary fibre should be fed
(B) A diet with at least a 50% decrease in 
dietary fat should be fed
(C) The dog should be fasted for at least 3 
days after the onset of clinical signs 
(D) The dog should be a diet at no more 
than 50% of its daily resting energy 
requirement throughout the length of 
hospitalization
2. Which one of the following is an indication for 
starting a commercial therapeutic hepatic diet 
in a dog?
(A) A dog with an alkaline phosphatase (ALP) 
activity five times the upper reference 
range, with no other abnormalities on the 
biochemistry
(B) A dog with increased pre- and post-
prandial bile acids, with no other 
abnormalities on the haematology and 
biochemistry
(C) A dog with a 5-cm mass in the liver, 
documented on ultrasonography, but no 
abnormalities of liver function on the 
biochemistry
(D) A dog with a portosystemic shunt with no 
hepatic encephalopathy but presence of 
urate uroliths 
3. Which one of the following diets would be 
LEAST desirable in a dog with hepatic 
encephalopathy from a portosystemic shunt?
(A) Royal Canin Veterinary Diet Canine Renal 
dry food
(B) Purina ProPlan Veterinary Diet Canine HA 
dry food
(C) A home-prepared diet of cottage cheese 
and white rice, formulated by a board-
certified veterinary nutritionist
(D) Royal Canin Veterinary Diet Canine 
Hepatic dry food
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Leadership: the art of 
managing uncertainty 
in veterinary practice
Brian Faulkner
Leadership is a mysterious commodity. Many theories 
have been used to try and conceptualize and teach it 
over the ages but many seem abstract, impractical or 
 difficult to apply. Rarely do we have the time to think 
abstractly during a particular moment of crisis.
This lecture will look at the impact of uncertainty, 
not  just on our need for leadership in general but with 
a  particular focus within veterinary practice. Uncertainty 
is  often assumed to occur during times of dramatic 
change. And whilst major changes heighten our sense 
of  uncertainty, life is in fact uncertain on a day-to-day 
basis. What’s more, certainty occurs irrespective of how 
knowledgeable or competent we are. This is because 
uncertainty often results, not necessarily from an igno-
rance about which information is needed, but from 
a  lack  of that information right now whilst trying to 
decide what to do.
Furthermore, it is important that we are aware of the 
impact of how we interpret and deal with feelings of 
uncertainty on our levels of stress, self-doubt and self-
confidence. This is reflected in my stress equation which 
states stress = uncertainty × urgency.  Making decisions 
and living with the doubt, the disappointment and the 
disapproval if or when we get them wrong often provoke 
feelings of anxiety and stress. 
If we are to be effective (i.e. make decisions intelli-
gently) when faced with doubt we need to be able to 
decide despite a lack of the desired levels of information. 
The hallmark of intelligence is the ability to adapt and I 
call the ability to do so when feeling uncertain UQ, which 
I define as ‘our ability to make decisions with and about 
the information available’. 
This lecture will demonstrate how these moments of 
uncertainty complicate our team’s ability to make deci-
sions during our pursuit of the four outcomes of clinical 
resolution, client satisfaction, financial resolution and 
colleague satisfaction, whilst working in general  practice. 
KEY LEARNING OBJECTIVES 
■■ The relevance of uncertainty in veterinary practice 
■■ The impact of uncertainty on leadership 
■■ UQ: our ability to make decisions with and about 
the information available
MULTIPLE CHOICE QUESTIONS
1. What is the concept of leadership?
(A) The same as management
(B) A passing ‘fad’
(C) Only of importance to those in the armed 
forces
(D) Essential to the suitability of all 
organizations
2. What is the hallmark of intelligence?
(A) Loads of A stars in your A levels
(B) Coming top in your year at school or 
university
(C) Making the most money
(D) The ability to adapt to emerging 
circumstances
3. Which of the following do you believe?
(A) Leadership is genetic and cannot  
be taught
(B) Leadership is correlated with  
intelligence
(C) Leadership requires an ability to deal with 
the unknown
(D) Leadership doesn’t apply to veterinary 
contexts because veterinary practice is 
different
Acquiring the ‘right’ 
to lead: the difference 
between knowledge 
and self-belief
Brian Faulkner
Leadership requires having a sense of command, where 
being in command means having authority over and res-
ponsibility for those you lead. Authority means having ‘the 
right to exercise power’. In other words, to ‘be in charge’ 
requires a sense of having the right (i.e. an  entitlement) 
to  enforce or prevent other people from doing things. 
As we all know, having a sense of entitlement with respect 
to ‘enforcing or preventing’ others to do certain things can 
manifest either negatively or positively. 
The ‘negative’ view of a sense of entitlement to 
‘enforce and prevent’ manifests as people who crave – 
or assume – power, authority and control in pursuit of 
the elevated personal status they believe it represents. 
These people either feel they already do, or should, 
‘own this ground’ and their desire to enforce or prevent 
others from doing certain things is usually motivated 
by personal goals. 
In contrast, the ‘positive’ view of a sense of entitle-
ment to ‘enforce and prevent’ manifests as people who 
want to make the world a better place for their group, as 
well as themselves. These people are more concerned 
about gain for the greater good than simply elevating 
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their personal status. History is, of course, full of many 
celebrated martyrs who ‘died for the cause’, often in 
opposition to tyranny and oppression. 
If you asked most people which sense of entitlement 
they would like to be seen as, they would, of course, opt 
for the more socially acceptable and altruistic positive 
view. Most people want to be seen as ‘nice people’. And 
this is normal. From an early age we are encouraged to 
get along and build relationships based on trust, empathy 
and respect. We are encouraged to be humble and not to 
bully or intimidate. 
The challenge however with this ‘nice person’ mind-
set is that it is not automatically conducive to embracing 
‘command’ which by nature requires us to enforce or 
prevent other people from doing certain things. Enforc-
ing or preventing means taking a stand and making deci-
sions which probably won’t please all of the people all of 
the time; it means defining and upholding standards by 
addressing and correcting inappropriate behaviour. A 
failure to make tough decisions or a tolerance of self-
indulgent behaviours or disrespect for social boundaries 
is ultimately a failure to lead. 
Therefore, in order for ‘nice people’ to lead and com-
mand successfully (i.e. advance their mission) – and be 
respected and popular – they often need to have a con-
scious moment of realization that they need to learn how 
to ‘reconcile’ their admirable social values of trust, empa-
thy, humility and respect, which makes them popular and 
credible leadership candidates on the one hand, with the 
need to enforce or prevent people from doing things, on 
the other. This ‘moment’ is the essence of acquiring – i.e. 
learning – ‘the right to lead’. Most respected leadership 
training academies (Harvard, Sandhurst, plus most 
respected MBA providers) help aspiring leaders concep-
tualize, understand and develop this ‘right to lead’ by 
 fostering what I call ‘cultures of command’
MULTIPLE CHOICE QUESTIONS
1. Which of the following do you believe to be TRUE?
(A) Vets don’t make good leaders because 
they are generally nice people
(B) Command means authority over and 
responsibility for your group
(C) Leaders must always be formally 
commissioned
(D) Command means exercising power over 
weaker followers
2. Which of the following do you believe to be TRUE?
(A) Leadership is not possible by people who 
hold immoral values
(B) Leadership is not possible by people who 
break the law
(C) Leadership is not possible unless you have 
been formally commissioned to lead
(D) A person’s desire to lead is driven by their 
values and attitudes about their right to do so
3. Which of the following do you believe to be 
FALSE?
(A) Some rights entitle people to do things
(B) Some rights prevent people from doing 
things
(C) Some rights are enshrined in law
(D) A right isn’t a right unless it is enshrined in 
law
KEY LEARNING OBJECTIVES 
■■ The meaning of ‘being in command’
■■ The impact of self-beliefs on your motivation to lead 
■■ Cultures of command 
Leadership and culture: 
two sides of the 
same coin
Brian Faulkner
We all live within groups (nations, workplaces, families, 
clubs etc.) which teach us to believe that there are right 
and wrong ways of defining good outcomes and dealing 
with problems in pursuit of them. These social ‘forces’, 
which act as the blueprint of what we refer to as a group’s 
culture, help members of that group ‘know where 
they stand’ in relation to what behaviours and standards 
are acceptable, rejected or encouraged. Culture gives 
 people a template of how to interpret the world as 
well as a sense of how to respond when certain things 
happen. This template makes the ‘world’ meaningful and 
 predictable by helping us contain the anxiety that comes 
from chaos and uncertainty. We are not born with opin-
ions about what is good or bad, right or wrong. Instead 
we acquire them as we go through life when we learn 
what goals are worth striving for and why, as well as how 
we should go about achieving them. We learn our beliefs 
from the people we spend time with and through the 
experiences we share.
The process of creating and managing a group’s cul-
ture has been described as the essence of leadership, 
whereby both concepts should be viewed as ‘two sides 
of the same coin’. In other words, it is impossible to con-
sider one without the other, as a group’s beliefs about 
‘right and wrong, good and bad’ often originate from and 
are propagated by the leader’s own sense of ‘right and 
wrong, good and bad’. If the group is successful, the 
leader’s opinions will be adopted, shared and taken for 
granted by its members ‘as the right way to do things’. 
Group members who do not agree with the leader’s val-
ues will often leave during this phase. Whilst managers 
may monitor and measure how well an organization is 
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achieving its stated objectives, leaders decide what those 
objectives are (i.e. what defines a good outcome) and 
often how they should be achieved (i.e. what is the right 
way to go about doing things). It has been asserted that it 
is essential for leaders to achieve a critical level of con-
sensus about right and wrong, good and bad if they wish 
to unite and mobilize their team in pursuit of a common 
goal. It is therefore essential that leaders understand the 
nature of the invisible psychological forces at play within 
their group if they wish to harness them in order to 
achieve their objectives. 
This talk will look at how this manifests in in gen-
eral practice using Brian’s Colourful Culture as an 
example of a cultural philosophy which advocates the 
pursuit of the four outcomes of clinical resolution, 
 client satisfaction, financial resolution and colleague 
satisfaction, as well as how tensions arise when differ-
ent parties value and pursue each of these four 
 outcomes differently.
KEY LEARNING OBJECTIVES
■■ The definition of culture
■■ The role of intangible assumptions and beliefs on 
what, why and how people spend their time, money 
and efforts
■■ The relationship between leadership and culture
MULTIPLE CHOICE QUESTIONS
1. Which of the following do you believe to be TRUE?
(A) Culture is always visible
(B) Vets make good leaders because they are 
generally very cultured people
(C) Leaders must indoctrinate their followers
(D) Culture is underwritten by a form of 
psychological DNA which influences a 
group’s behaviour
2. Which of the following is FALSE?
(A) Leadership and culture are two sides of the 
same coin
(B) Leadership and culture are unrelated
(C) Leadership and culture affect each other
(D) Leadership and culture both have tangible 
and intangible aspects
3. Which of the following do you believe to be TRUE?
(A) All veterinary cultures are unique
(B) Veterinary cultures always revolve around 
clinical values
(C) Veterinary cultures always revolve around 
financial values
(D) Veterinary cultures always revolve around 
client values
Leading your sub-team 
managers
Brian Faulkner 
Leadership is particularly challenging when you do not 
have very much direct contact with the various members 
within sub-teams that form functional units under your 
command. In veterinary practices there are traditionally 
four sub-teams (the veterinary team, the nursing team, 
the receptionist team and the management team) and 
each of these teams may have team managers or leaders.
In order to be able to do this effectively the leader 
needs to be able to translate the themes of the previous 
lectures (containing uncertainty, influencing culture by 
exercising their right to enforce and prevent others from 
doing certain things) into a practical system of polices, 
protocols and behaviours that represent an effective, 
efficient and coherent operational system for the entire 
practice. 
It is important that sub-teams are clear about how 
their sub-systems contribute towards the practice’s 
wider overarching themes as well as ensuring that 
 conflicting systems (and orientations) are not creating 
‘conflict’ within the system. To do this well, site leaders 
need to be able to recognize, understand and articulate 
which habits and skills are desirable – and undesirable – 
as well as knowing how to track them via manageable 
and measurable key performance indicators (KPIs). It is 
also important that the site leader regularly meets up 
with his/her sub-team leaders and discusses meaningful 
 metrics as well identifying any operational issues that 
need attention.
This talk will build on the previous talks and will use 
Brian’s Colourful Culture which advocates the pursuit of 
the four outcomes of clinical resolution, client satisfac-
tion, financial resolution and colleague satisfaction, as a 
template upon which to create operational systems that 
are coherent across all four functional roles. The talk will 
show how this translates into sub-team systems which 
can be tracked via manageable and measurable KPIs as 
well as how to audit and develop the skills, knowledge 
and attitudes each sub-team leader must nurture within 
their own team. 
KEY LEARNING OBJECTIVES
■■ What is a sub-team?
■■ How do practice leaders conceptualize and 
integrate sub-team systems and behaviors?
■■ Measuring outcomes at the sub-team level
MULTIPLE CHOICE QUESTIONS
1. Which of the following do you believe to be 
TRUE?
(A) It is important to develop policies and 
systems that are coherent across all 
sub-teams
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(B) Sub-teams shouldn’t have sub-team 
leaders
(C) Sub-team leaders must indoctrinate their 
team members
(D) Sub-team meetings should only happen 
once a year
2. Which of the following do you believe to be 
TRUE?
(A) Sub-team meetings should always be led 
by a veterinary surgeon
(B) Sub-teams to not need leaders
(C) Sub-team meetings should always be held 
outside of the practice
(D) Sub-team meetings will most likely focus 
on operational issues
3. Which of the following do you believe to be 
TRUE?
(A) Sub-team meetings should deal with 
clinical, client, financial and team member 
issues as required
(B) Sub-team meetings should never include 
issues about clinical standards
(C) Sub-team meetings should never include 
issues about customer service
(D) Sub-team meetings should never include 
issues about money
Setting up from scratch
Brian Faulkner
Setting a veterinary practice up from scratch requires 
leadership. Doing so is probably one of the quickest ways 
of developing the skills, knowledge and attitudes required 
to lead. This talk will focus less on the actual skills, knowl-
edge and attitudes required as well as helping you decide 
whether – and how – setting up is for you. The lecture 
will look at the upsides of setting up as well as the risks 
and challenges of doing so. 
It is essential that you know how to distil your ambi-
tions and objectives into a business plan, either to apply 
for finance or at the very least manage your own expec-
tations, as well as contingency planning by running 
worst, best or most-likely case scenarios. 
Your business plan will need various sub-sections: 
summary, leadership–management team, site location 
and market analysis, operating strategy and tactics, skills, 
training and development plan, marketing plan as well as 
finance and management accounts. 
We will look at how to analyse a market opportunity 
in terms of locations in relation to existing competitors 
and how this relates to your own ‘objectives–strategy–
tactics’ decisions. We will look at how to create a budget 
plan based upon assumptions of various scenarios of 
 client recruitment and retention multiplied by average 
spends and annual yields. We will look at marketing 
 tactics and how to get the word out about who you are 
and why clients should try you out, as well as external 
and internal marketing tactics that can encourage them 
to register and buy. 
And finally we will look at how to exit your practice 
and what you need to consider at the beginning to ensure 
you have not worked, toiled and created something that 
isn’t going to be saleable in order to finance your ‘retire-
ment’ plan years after you have left the business you set 
up and sold. 
KEY LEARNING OBJECTIVES 
■■ Skills, knowledge and attitudes required to lead a 
set-up practice
■■ The key sections of a business plan 
■■ Competitor/market analysis 
MULTIPLE CHOICE QUESTIONS
1. Which of the following is TRUE?
(A) There’s no point in setting up as the UK 
veterinary market is saturated
(B) There’s no point in setting up as the 
corporates will out-compete you
(C) One ownership model is as good as the 
other
(D) Veterinary practice ownership is life 
changing in many ways
2. Which of the following is TRUE?
(A) Business plans are essential even if you 
don’t have to borrow money to set up
(B) Business plans are only needed if you don’t 
have to borrow money to set up
(C) Business plans are meaningless as the 
forecasts are almost always wrong
(D) Business plans must be created by a 
qualified accountant
3. Which of the following is TRUE?
(A) There’s no point in thinking about how you 
can exit a business at the set-up stage
(B) You can only exit a veterinary business 
after at least 10 years
(C) Veterinary practices never make a profit in 
the first year
(D) Considering your exit strategy whilst 
setting up is always sensible, otherwise you 
might get stuck with a business you cannot 
sell
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So you’re now a 
clinical director. Help!
Brian Faulkner
The title CD means clinical director. The CD role is the 
core leadership/management role within veterinary 
practice. This usually means that you are ‘in command’ of 
the veterinary practice’s business operations and it is 
likely that all the veterinary surgeons in the practice as 
well as the head nurse and possibly even the practice 
manager will report to you. 
CD roles are typically used with corporate organiza-
tions, although they can be used within larger indepen-
dently owned veterinary groups. You can become a CD 
via various routes:
■■ You many have been promoted from a veterinary 
clinical role into clinical directorship
■■ You may have been the former owner of the 
practice and are now employed as site leader
■■ In some instances, veterinary nurses also act  
as CDs
If you have been promoted from a veterinary clinical 
role into clinical directorship, this can be daunting due to 
the breadth and number of areas and colleagues you 
now have authority over and responsibility for. In many 
ways, it feels much like your first week in practice. The 
challenge is knowing where to start and what to prior-
itize, and this of course is something you have to do 
alongside managing your own clinical case load. 
It is therefore important to have a ‘big picture’ scope 
of what you need to deliver as well as which key 
 performance metrics track (and represent) success. A 
CD’s specific duties, tasks and responsibilities can be 
listed as four overarching objectives, and may include 
the following.
CLINICAL CARE AND SERVICE 
■■ Define, demonstrate and maintain clinical standards 
including hospitalized patients
■■ Conduct periodic clinical audits and act  
accordingly
■■ Apply policies, protocols and preferred products as 
determined by the group’s clinical committee
■■ Achieve and comply with RCVS Practice Standards 
Scheme
■■ Ensure compliance with The Veterinary Medicines 
Regulations with respect to the acquisition, 
storage, prescribing and dispensing of veterinary 
medicines
CLIENT CARE AND SERVICE
■■ Define, demonstrate and maintain client service 
standards
■■ Define, demonstrate and maintain communication 
systems to ensure clients are given regular and 
accurate updates about their pets and accounts
■■ Ensure that all client complaints are handled 
sensitively and in accordance with the Complaints 
Policy
■■ Ensure the practice complies with current GDPR/
Data Protection Legislation
■■ Promote the business in accordance with the 
group’s marketing guidelines
DRIVING THE INCOME AND MANAGING 
THE PROFITABILITY OF THE PRACTICE 
■■ Awareness of the practice’s budget and business 
plan with respect to achieving turnover and profit 
targets
■■ Implement and adhere to pricing policies
■■ Conduct periodic charging audits and act 
accordingly
■■ Ensure cash management and banking policies are 
adhered to
■■ Promote the business in accordance with the 
group’s marketing guidelines
OVERSEEING THE GROWTH, 
DEVELOPMENT, MOTIVATION, MORALE 
AND WELL-BEING OF THE STAFF 
■■ Recruit, manage and discipline staff in accordance 
with corporate policies and procedures
■■ Ensure that staff are given appropriate leadership, 
guidance, development and appraisal
■■ Ensure staff are aware of and adhere to health and 
safety policies
■■ Record HR and personnel matters
■■ Appraise and review pay of all staff in accordance 
with policy
■■ Ensure vets and nurses complete and comply with 
continuing professional development (CPD) 
requirements 
KEY LEARNING OBJECTIVES 
■■ The meaning of the role clinical director 
■■ Ways to becoming a clinical director 
■■ Duties of a clinical director
MULTIPLE CHOICE QUESTIONS
1. Which of the following is TRUE?
(A) Being a CD means only being responsible 
for the practice’s controlled drugs records
(B) Being a CD means only being responsible 
for the practice’s clinical governance
(C) Being a CD means you don’t report to 
anyone else
(D) Being a CD is an excellent stepping stone 
from clinical work to practice ownership
2. Which of the following is FALSE?
(A) Only veterinary surgeons can be CDs
(B) CDs are usually responsible for overseeing 
client service standards
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(C) CDs are usually responsible for overseeing 
clinical care standards
(D) CDs are usually responsible for overseeing 
the financial performance of the practice
3. Which of the following is the most relevant to 
veterinary practice?
(A) CDs should have a MBA
(B) CDs need ongoing non-clinical CPD
(C) CDs should have a post-graduate 
certificate in an area of clinical study
(D) CDs are obsolete nowadays as a way of 
purchasing music
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Internal marketing
Stacey Davidson
Workplace culture sounds mysterious and intangible 
doesn’t it? In many ways it is difficult to define, but it sur­
rounds us all the time, and has a daily impact on our 
working lives. 
Workplace culture is made up of the values, beliefs, 
mission, ethics, attitudes and behaviours shared by a 
group of people and helps us to create unwritten rules on 
how to work together. Very simply put, ‘it is the way we 
do things around here’.
When we go to work, we want to be around people 
who understand us, believe what we believe and who are 
trying to achieve the same things that we are striving for. 
But how do we know that we are aligned? 
It all starts with communication and demonstrating 
genuine care for the people in our teams. By communi­
cating our values, mission, ethics and attitudes through­
out the organization, we can create clarity around our 
expectations for our workplace culture. By articulating 
our, hopefully, shared vision, we can create authen­
ticity, understanding and transparency  throughout our 
 organization.  
As managers and leaders, we need to start by under­
standing our current culture. We also need to have a clear 
vision of what we want our culture to be. What are the 
behaviours that we want to demonstrate consistently and 
that are authentic to our culture? And then how do we 
start to create the culture that we want? 
In this session, we will explore the underpinnings of a 
resilient workplace culture which include:
■■ Ensuring our workplace and team­member 
behaviours reflect our mission and values
■■ Sharing successes, failures and challenges with our 
teams
■■ Prioritizing the well­being of every teammember
■■ Recognizing, rewarding and appreciating the 
valuable contributions of teammembers
■■ Creating a just culture in practice – a culture of 
trust and proactive learning, centred on 
understanding why
■■ Supporting a growth mindset where teammembers 
are encouraged to advance, develop and learn from 
failure
■■ Creating an environment of feedback and  
learning
KEY LEARNING OBJECTIVES
■■ What do we mean when we use the term workplace 
culture?
■■ The roles that trust and authenticity play in 
workplace culture
■■ Identifying your own current workplace culture
MULTIPLE CHOICE QUESTIONS
1. What are the benefits of a positive workplace 
culture?
(A) Elevated team enthusiasm and better 
productivity
(B) Teams that thrive
(C) Increased organization performance
(D) All of the above
2. What is the best way to establish and maintain 
core values? 
(A) Document your organization’s core values 
and talk about them (all the time!)
(B) Don’t have too many and keep them 
simple; they need to be top­of­mind
(C) Create core values that mean something to 
the organization, even if that means being 
unconventional
(D) All of the above
3. What are the hallmarks of a resilient workplace 
culture?
(A) A culture that reflects the organization’s 
mission and values
(B) An environment that supports a growth 
mindset
(C) Prioritization of well­being
(D) All of the above
External marketing
Richard Casey
Practice management is truly a multidisciplined role. One 
minute you can be arranging equipment maintenance, 
recruiting for a new team member, dealing with a com­
plaint and the next, you need to develop a new marketing 
strategy to increase client numbers. But what if you’re not 
a marketing expert and the word strategy alone sends 
shivers down your spine? This needn’t be the case. 
Remember strategy is just another word for plan and in 
this lecture we’ll explore a simple and straightforward 
method for developing a marketing plan for your practice 
that’s aligned to the world you’re working in and what 
you want to achieve.
Taking time to capture your current situation can 
help inform your short­ and long­term plans. So we’ll 
start our lecture by exploring ways to understand what’s 
happening within your practice, as well as the immediate 
and wider external environment. This exercise will help 
you to define clear objectives for your plan from which 
we can create strategies and tactics to achieve them. 
We’ll end with some basic action plan and control 
 techniques to ensure you keep on track and achieve 
what you set out to. By the end of the session you’ll 
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 understand how you can approach answering the fol­
lowing  questions:
■■ What environment is my practice operating in?
■■ What do we want to achieve in the short/long  
term?
■■ What is my practice’s position in the market  
place?
■■ Who are our target clients?
■■ What are the best ways to get our message to our 
target clients?
■■ What steps do we need to take and when, to achieve 
our objectives?
■■ How will we know if we’ve achieved what we set out 
to do?
KEY LEARNING OBJECTIVES
■■ Describe the SOSTAC® approach to marketing 
planning
■■ List various tools and models to use when 
developing a marketing plan
■■ Describe ways to involve your practice team in 
developing your marketing plan
MULTIPLE CHOICE QUESTIONS
1. What do the two S’s in SOSTAC stand for?
(A) Situation and significance
(B) Sales and strategy
(C) Situation and strategy
(D) Send and sales
2. What will your marketing mix include?
(A) How you will communicate your services 
to your target audience
(B) A list of competitors
(C) Timelines of what you’re going to do and 
when
(D) Key performance indicators of your 
marketing plan
3. The 7Ps of marketing are useful when 
developing which stage of your marketing plan? 
(A) Situation
(B) Objectives
(C) Control
(D) Tactics
Understanding 
financial basics
Georgina Hills 
Often when new to a management role one of the big­
gest challenges is the understanding and the effective 
use of the monthly reports you receive. Rather than just 
putting them in a large file on the shelf, they should be 
used to understand the health of your business and help 
make decisions and plan forwards. Much as taking a TPR 
monitors the health of your patient, the profit and loss 
report and key performance indicators (KPIs) do the 
same for your business.
The first item to understand is the difference between 
management accounting and financial accounting. Man­
agement accounting is the set of reports a manager uses 
to inform themselves about the business performance 
and to make decisions. The financial accounting 
(yearend) reports focus on financial transactions, analysis 
and summaries which are built into a financial statement 
for public consumption.
Management accounting reports include: 
■■ Profit and loss
■■ Balance sheet
■■ Cash flow report
■■ Budget/forecast
■■ Debtors
■■ KPIs
As a manger involved in the day­to­day running of a 
business and needing to make real­time decisions and 
plans, understanding of the profit and loss report and KPIs 
can have a significant impact on the decisions you make. 
The difference between informed decisions and guessing.
The profit and loss account or report shows the 
income generated and the amount of income left after 
costs and running expenses are deducted for a fixed 
period of time, usually generated as a monthly report. 
Selecting the right KPIs to monitor alongside the profit 
and loss will help inform on key factors crucial to the 
business success and enable the recognition of trends 
which can be responded to with relevant decisions. From 
these reports you will be able to understand how your 
business is performing and plan ahead.
KEY LEARNING OBJECTIVES
■■ Understand how to read a profit and loss report
■■ Which key performance indicators will help 
understanding of the business
■■ How to use management reports to make informed 
business decisions?
MULTIPLE CHOICE QUESTIONS
1. In a profit and loss report what does the term 
sales/revenue refer to?
(A) The payments received in a given period
(B) The invoices generated including VAT but 
not any payment/health schemes
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(C) The invoices generated without VAT (net) 
and any payment/health schemes  
income
(D) The invoices generated in a given period 
including VAT that have been paid
2. What does the term EBITDA stand for?
(A) Earnings before interest, tax, depreciation 
and amortization
(B) Earnings before interest, tax, discounts and 
amortization
(C) Earnings before inspection, tax, 
depreciation and amortization
(D) Earnings before inspection, tax, discounts 
and amortization
3. Which of the following reports shows what a 
business owns, owes and is owed?
(A) Debtors report
(B) Cash flow report
(C) Budget/forecast report
(D) Balance sheet
How practice 
finances work 
Miles Russell
To be profitable, income needs to be more than expen­
diture. This lecture will discuss how to achieve this in 
 veterinary business.
INCOME
■■ Sorts of income, e.g. service and drug income, and 
how to set prices
■■ How to measure income performance with key 
performance indicators (KPIs) and regular monthly 
figures
■■ How to maximize income but give clients good 
value for money as well, by charging correctly and 
getting the cash in for work done
EXPENDITURE
■■ What makes up the cost of a veterinary practice and 
how to ensure you get best value from costs and 
that expenditure does not outstrip income
■■ Drugs – most drugs come from a wholesaler with a 
professional price list, so it is helpful to know how to 
get the best price and not be fooled by the ‘smoke and 
mirrors’ of drug company retro and discounts policies
■■ Consumables – about balancing quality to price. 
This area will not make or break a business but adds 
a small amount to the bottom line
■■ Laboratory costs – negotiation of contract is 
important but also ensuring all lab fees are charged
■■ Wages – largest fixed cost for any veterinary 
practice and one that you can control, but it is also 
determined by market. Getting the most out of staff 
is key to a good return on staff
■■ Motoring expenses – not a significant cost to small 
animal practice, a fixed cost. There are a few 
cost­saving methods, checking service charges, 
possible use of fuel cards, different capital 
purchasing options
■■ Overheads – overhead control needs to be done as 
good income generation can be whittled way by 
overspend on overheads. The lecture will talk about 
cost control through regular reviewing of contracts
■■ Challenging suppliers on costs but not always going 
for lowest cost by looking at best value and what 
suits the practice
FINANCE
The lecture will discuss finance options, how to get 
finance and how to control it.
FIGURES
Finally, the lecture will discuss the importance of monthly 
figures and what these are made up of and who should 
see them.
KEY LEARNING OBJECTIVES
■■ Measurement of income and charging correctly
■■ Drug purchasing, discount and retro payment are 
unseen income
■■ Regular review of figures 
MULTIPLE CHOICE QUESTIONS
1. Below what should your practice’s percentage 
of non­discountable items purchased from a 
wholesaler be?
(A) 10%
(B) 2.5%
(C) 5%
(D) 7.5%
2. What do you consider to be a good gross 
margin percentage for small practice?
(A) 70%
(B) 80%
(C) 65%
(D) 75% 
3. How often should the veterinary team see 
KPIs?
(A) Monthly
(B) Quarterly 
(C) 6­monthly
(D) Yearly
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Team development
Renay Rickard
This will be a practical approach for the new manager 
or  leader as to the benefits of developing your team 
effectively. These benefits affect all stakeholders within 
a  veterinary business – the individual team member, 
the  practice team, the leader/manager, the employer/
veterinary business, clients and patients, and therefore 
we will be discussing why team development should be a 
priority for any leader or manager. 
In an industry that is facing challenges to recruit and 
retain members of the profession, this is an area that is 
very important to any member of the practice team. 
Development is not just about fulfilling your obligations 
to remain a registered professional, but it is about pro­
gressing through your chosen career path as a well 
rounded, confident and competent person. A team or 
individual will soon become demoralized and demoti­
vated if they feel they are not progressing or learning 
and  are starting to stagnate. A common stress factor 
is a person who feels out of control within a certain 
 environment or that they have no clear plan. An effec­
tive team leader will show an active interest in the pro­
gression of their team and will support and encourage 
this. We will be looking at the ways as leaders we can 
do  this – whilst also ensuring our own development 
strategies. 
MULTIPLE CHOICE QUESTIONS
1. What is the indication that your team is not well 
developed?
(A) Adaptable to change
(B) High morale
(C) Diminishing skill set
(D) Low staff turnover
2. Which is the key to your team engaging with 
their development?
(A) Higher pay
(B) Seeing the benefits and being part of the 
process
(C) Better holiday allowance
(D) More profitable business
3. Who is involved in the development culture of a 
business?
(A) Directors/owners of a business
(B) The clinical and customer team
(C) RCVS
(D) All of the above
KEY LEARNING OBJECTIVES
■■ Identifying why you should develop your team 
effectively and who benefits from this
■■ How to communicate with your team effectively 
and how to engage team members in their 
individual and their team development
■■ How to progress with a team­development strategy 
and culture
Getting the best out 
of clinical workflow 
Gillian Page 
At a time when it’s a challenge to plan and sustain the 
future veterinary surgeon and veterinary nurse work­
force, the veterinary market is more competitive and with 
over 50% of practices showing little or no profit, address­
ing workflow in practice could help to ease individual 
stress, increase staff well­being (aiding retention), 
increase client confidence and have the desired result of 
improved clinical outcome, business performance and 
increased profit.
In 2015, the BVA & RCVS launched Vet Futures & VN 
Futures, an action plan with the aim of ‘a profession fit to 
face the future’. Ambitions include:
■■ ‘Thriving, innovative, user­focused businesses’ 
■■ ‘Structured and rewarding career paths’ for 
veterinary nurses 
■■ ‘Maximizing nurses’ potential’
It is vital that veterinary practices have a sustainable, 
profitable future so that they can care for and protect the 
health and welfare of animals.
In 2018, the BVA expressed concern over a survey 
demonstrating more than half of responding veterinary 
practices had below average profitability, while 15% 
 generated ‘a negative value for net profit’.
To meet the increasing complexity of todays’ ever­
changing veterinary environment, progressive business 
models can be adopted and flow of work should be a 
 primary consideration. 
WHAT IS CLINICAL WORKFLOW?
■■ Flow: the action of moving along steadily and 
continuously in a stream
■■ Workflow: process involving a series of tasks 
(events or interactions). How the tasks are 
accomplished, in what order, and by whom
■■ Clinical workflow: the delivery of clinical  
services
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BENEFITS AND OUTCOMES OF WELL 
MANAGED CLINICAL WORKFLOW 
Patient
■■ Enhances healthcare quality and safety, reduces 
errors
■■ Improves co­ordination of care and clinical 
outcome
Client 
■■ Better clinical outcome for pet
■■ Reduced waiting times
■■ Improved patient welfare leads to increased client 
satisfaction
■■ Confidence in profession
Veterinary team
■■ Growth of individuals through tasks given
■■ Reduces stress by removal of practice chaos 
■■ Happier veterinary team improves mental well­
being
■■ Retention of staff
■■ Professional confidence
Financial
■■ Maximize efficiencies – more efficient practice, 
higher caseload it can accommodate
■■ Retention of staff reduces advertising and interview 
costs
■■ No need for additional veterinary salary if tasks 
undertaken by growth of capable veterinary nurses 
■■ Satisfied clients – encourages increased footfall
■■ Increased profit margins
IMPLEMENTING CLINICAL WORKFLOW
■■ Starts before the client and patient arrive at the front 
door of the practice
■■ Consider patient journey; begin at the front door 
and work through to the end of that journey back 
out through the door
■■ Considerations include: who to communicate with, 
who does what, how, when will that happen, where 
will that happen, what are the protocols to consider 
and what administrative records need to be 
completed?
KEY LEARNING OBJECTIVES
■■ Understand the term ‘clinical workflow’ and 
the relationship to patient care and practice 
profitability
■■ Demonstrate an understanding of the clinical 
decision­making requirements of workflow, including 
who, what, when, how and information needed
■■ Identify the consequences of suboptimal clinical 
workflow in the delivery and outcome of patient care
Crisis, what crisis?
Julie Beacham 
One important aspect of management is dealing with the 
inevitable problems that arise and making decisions 
quickly under pressure. The key to doing that well is 
training, preparation and having essential information to 
hand. As a new manager you must establish the bounda­
ries of your role, lines of authority and knowing who to 
ask for help when unsure. Have that conversation and 
prepare before something happens. 
Veterinary practices are complex environments and 
things will go wrong. Problems can be patient related, 
people focused (clients and team), equipment failures or 
emergencies affecting the premises such as fire and 
power failures. A combination of reference documents, 
standard operating procedures (SOPs) and some simple 
business continuity planning will enable you and the 
practice team to cope with all eventualities. Compliance 
with legislation will also put much of this in place. Fire 
safety is one area where the requirements of the legisla­
tion give the team the procedures, training and knowl­
edge to cope.
People problems require careful handling and a 
 cautious approach, particularly where client complaints 
MULTIPLE CHOICE QUESTIONS
1. A busy veterinary team has no time to maintain 
an agreed clinical workflow, patients need to 
be seen. What is your approach to getting the 
team onboard?
(A) Cancel consultations
(B) Reschedule clients 
(C) Find additional cover
(D) Block time out in advance
2. Lack of time, vision and communication skills 
are examples of leadership failures that damage 
the implementation of a successful clinical 
workflow. What could be introduced to help 
limit this?
(A) Have a mission statement, long­term 
strategy and clinical governance 
(B) Accept it can be difficult 
(C) Hire a head veterinary nurse to ensure 
compliance
(D) Have a self­review with each team 
member
3. Which of the following leadership qualities 
would be most important for senior team 
members to display when implementing a 
clinical workflow?
(A) Charismatic 
(B) Task­oriented 
(C) Supportive
(D) Driven
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or employment law issues are concerned. It is always 
 safest to acknowledge any upset, take full details of the 
problem and promise to investigate before providing a 
date by which a full response will be received. This gives 
you time to think, take advice and achieve the best out­
come for the person and the practice. External providers 
of this advice will include your professional indemnity 
insurers, HR advisors or ACAS. Poor communication is 
the main cause of complaints.
Dealing with premises and equipment problems is 
made much easier by establishing a network of trusted 
local suppliers who know you and your business. These 
will include a handyman for general repairs, plumber, 
electrician and IT support person. They should spend 
time familiarizing themselves with your system and 
premises before problems occur to enable them to 
respond quickly in an emergency. A list of contact num­
bers with key details, such as the location of the mains 
water stopcock and gas and electricity connections 
into  the building, is a vital reference document for the 
practice team.
Equipment failures are sadly inevitable but building 
good relationships with suppliers will often make them 
willing to help out with loan machines or speedy repairs 
when items break down. Alternatively, neighbouring 
practices may be willing to help out. Regular servicing 
and maintenance and keeping a stock of spares such as 
bulbs and batteries will minimize downtime. Contact 
details for your key companies should be readily accessi­
ble together with SOPS for IT failures and power cuts to 
allow the practice to function until the supply is restored. 
Being prepared involves making up document packs for 
each consulting room and a supply of torches.  
Dealing with problems is stressful for new managers 
but having a useful general approach to dramas large 
and small will enable you to keep calm and carry on. I 
will detail this during the session and take you from the 
first step – communication – to the last, which is always 
to review. 
KEY LEARNING OBJECTIVES
■■ How to be prepared for managing problems in 
veterinary practice
■■ Collating the essential information and resources 
and writing a simple business continuity plan  
■■ Developing confidence in your abilities and reducing 
your stress levels by preparing and planning
MULTIPLE CHOICE QUESTIONS
1. What is the main cause of complaints in 
veterinary practice?
(A) Cost
(B) Clinical outcome
(C) Communication
(D) Out of hours’ provision
2. Which of these are the key pieces of 
information for your team?
(A) Contact numbers for contractors and 
equipment suppliers
(B) Location of mains water, gas and electricity 
supplies to the building
(C) SOPs for power and IT failures
(D) All of the above
3. What is the essential last step when things go 
wrong?
(A) Review
(B) Retire
(C) Rewind 
(D) Restart 
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Section V
Management 
streams
Saturday 6 April
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Saturday 6 April
Hall 7
Key Skill Focus: 
Effective 
communication
308 08:30–09:15You’re different from me: four communication styles
Alan Robinson
308 09:25–10:10Meetings, meetings: make them work
Alan Robinson
309 11:05–11:50When they say ‘No’: managing expectations
Alan Robinson
310 12:00–12:45Could do better: managing high performers
Alan Robinson
311 14:05–14:50All together now: creating team dynamics
Alan Robinson
312 15:00–15:45Five signs of a high performance team
Alan Robinson
313 16:50–17:35Yes, please: improving client compliance
Alan Robinson
314 17:45–18:30Difficult client or difficult communication?
Alan Robinson
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You’re different 
from me: four 
communication styles
Alan Robinson
In our work in veterinary practice our minds are con-
stantly absorbing information from all sides. To manage 
this information, we filter it in a variety of ways, allowing 
us to make meaning of what we see, hear and feel. The 
filters help us focus our attention on what seems to be 
important, screening out what seems unimportant or 
might confuse. 
There are many filters, some of which have been 
identified in recent years by neurolinguistic program-
ming, often demonstrated by the language patterns 
and  behaviours we choose. Talent Dynamics profiling 
draws on these recent developments as well as on an 
understanding of human behaviour from the fields of 
neurology, psychology and philosophy. We describe 
these energies as Dynamo, Blaze, Tempo and Steel.
All of us at times can be cool and objective; all of us 
have feelings and emotions. We can be goal-oriented 
and logical, and also illogical, intuitive and inexplicable. 
Talent Dynamics profiling explores these four types of 
thinking in more detail, showing how being rational, 
dependable, instinctive and curious all have their place in 
creating success. 
Most of us choose to use one or two filters more 
often than the others. Our choices may be influenced by 
our history – what made us successful as we were learn-
ing to make our way in the world or what our parents and 
teachers thought important. Our current context may 
also affect our choices – the demands of our job and 
what we need for success now. And a third determining 
factor may be our relationships – making room for the 
thinking styles of partners or colleagues or compensat-
ing for a missing approach. 
Our chosen filters may vary according to context, but 
there will probably be some activities or approaches we 
value more than others. The ideal is more choice and 
flexibility. It is not to be equal in all thinking styles, but to 
develop flexibility in our behaviour and approach, so that 
in each situation with clients and team members we can 
choose which filters are the most appropriate to give us 
the result we are looking for. Enjoy trying some new 
approaches and rediscovering your genius! 
KEY LEARNING OBJECTIVES
■■ An overview of the different energies and thinking 
styles and the values and behaviours that are 
important in each thinking style
■■ A self-assessment of your current thinking style and 
some questions to ask about how you operate now 
■■ How to work and communicate with others by 
understanding their thinking style
MULTIPLE CHOICE QUESTIONS
1. You typically like to work with facts and figures, 
like systems and processes and are good at 
maintaining stability. Your Talent Dynamics 
profile energy is likely to be high in which of 
the following?
(A) Dynamo
(B) Blaze
2. You work with someone who is very creative, 
always coming up with great ideas and starting 
projects, but not always good at finishing them. 
Their Talent Dynamics profile energy is likely to 
be high in which of the following?
(A) Dynamo
(B) Blaze
(C) Tempo
(D) Steel
(C) Tempo
(D) Steel
3. One of your veterinary surgeons is very 
analytical, has a specialist field of expertise and 
works very well on their own improving the 
process and outcomes, but may be limited by a 
sense of perfectionism and working with 
others effectively. Their Talent Dynamics profile 
energies are likely to be high in which of the 
following?
(A) Dynamo and Tempo
(B) Blaze and Steel
(C) Tempo and Blaze
(D) Steel and Dynamo
Meetings, meetings: 
make them work
Alan Robinson
Meetings can be either a time-consuming waste or they 
can be a huge benefit to the organization if run correctly, 
such as:
■■ Developing a strong team working together for a 
common goal
■■ Resolving issues
■■ Making improvements 
■■ Educating team members  
■■ Resolving indifference between team members
■■ Helping the business to run more smoothly and 
more efficiently
■■ Ensuring people know what to do, when to do it and 
being accountable for particular tasks
For meetings to realize the benefits above they need 
to have some rules around them. They also need to have 
structure and purpose, and everyone needs to under-
stand these rules, the structure and the purpose of each 
meeting. 
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TEAM MEETINGS 
Team meeting can be held each week or fortnight at the 
same time, say 12.00 pm each second Monday over the 
lunch period. Everyone is to attend these meetings if at 
all possible. These meetings are to have a purpose. The 
main benefit of a team meeting is to have the team work-
ing towards a unified objective or goal. This strengthens 
the team dynamic and helps the team work more closely 
and in harmony towards the common goal. However 
firstly, we need to establish what the common goal is. 
Business goal and vision
In most businesses, the business owner or manager 
decides what the goals of the business are and then 
rarely communicates this with his or her team. However, 
even when this goal is communicated, the team are not 
committed to it. Why? Because they had no input into it. 
People will always participate more actively in something 
that they had some input into developing. Therefore, it is 
important that everyone is involved in developing the 
organizational goals and vision. 
Continuous improvement 
The next step of your journey is to build a sustainable way 
to have the team continually improve the processes (the 
way things are done) within the business. A way where 
everyone in the whole team can each identify problems 
or opportunities to help reach the vision and become a 
learning, continually improving business, and where the 
team can work together to come up with resolutions and 
better ways of doing things. This needs to be effective 
and time efficient; once the system is up and running it 
will only take 15–30 minutes a week. 
Please note that the continuous improvement sys-
tem should be launched and be up and running effec-
tively before introducing and working through purpose, 
shared vision, ‘rules to live by’ and the client journey.
THE EXECUTIVE TEAM MEETINGS 
These meetings are purely to discuss direction and to 
make management decisions on things like major spend-
ing, business direction etc. These are strategy meetings 
and operational matters should not be discussed. It is 
 suggested that these meeting occur monthly soon after 
the end of the month, so the prior month can be discussed, 
as well as matters coming up in the month to come.
KEY LEARNING OBJECTIVES
■■ How to structure efficient and effective team 
meetings to fit into practice schedules
■■ Understand the rules of effective meetings
■■ The three key meetings for strategy implementation: 
executive team, functional team and continuous 
improvement meetings
MULTIPLE CHOICE QUESTIONS
1. Which one of these is not necessary as a team 
meeting rule?
(A) Meetings start and finish when everything 
has been discussed 
(B) Get rid of distractions  
(C) Focus on the problem/solution – not 
the people  
(D) Clarify action points, decisions and 
outcomes 
2. Why do team meetings often fail or become 
a waste of time?
(A) There is no clear agenda or outcome
(B) Actions decided are not followed up on
(C) They are over ruled by one individual and 
others do not or cannot contribute
(D) All of the above
3. Which one is false about continuous 
improvement meetings?
(A) They should run at least every 2 weeks 
to be effective
(B) Should run no more than 30 minutes
(C) Should attempt to solve all the problems 
in the meeting
(D) Should involve and have input from all 
team members
When they say ‘No’: 
managing expectations
Alan Robinson 
Not all team members want to comply with your instruc-
tions and may resist actively or passively. Either way there 
is always a communication mismatch that you need to 
address. Here is a model for G.R.E.A.T. communication.
1. Write a behavioural description of the problem. Take 
out all the emotional and judgemental language 
that normally accompanies your reaction to their 
behaviour
2. Before your meeting decide how you plan to 
approach each element of G-R-E-A-T:
■■ Goals. What is the behavioural goal or goals you 
would like to achieve? How would things be 
different if you got the change you wanted? 
What are the reasons you want or need to 
achieve these goals?
■■ Roles. What are the roles you want to play and 
have the other person play in your work situation? 
(Check that they are defined in behavioural terms.)
■■ Expectations. What are your expectations for 
satisfactory performance? For outstanding 
performance? Have expectations changed from 
previous situations? How do you expect to be 
treated? How do you expect a good employee 
to act when there is a problem?
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■■ Abilities. Is the problem a ‘don’t know’, ‘can’t do’ 
or ‘won’t do’? (always assume it’s a ‘don’t know’ 
first, then escalate – you’ll be more successful 
that way)
 – Don’t Know. How can I best give the 
information or instruction in behavioural 
terms?
 – Can’t Do. Could the employee do the job 
for £1 Million? If not, it’s a ‘can’t do’ 
problem. What steps could you take to help 
the employee become more able to do the 
job: training, changes in job structure, tools 
and resources, reassignment
 – Won’t Do. What are the rewards and 
punishments (from the team member’s 
point of view) for refusing to do the job the 
way it needs to be done? Performance is 
punished (list negative consequences of 
doing the job correctly); failure is rewarded 
(list positive consequences of not doing the 
job correctly); performance doesn’t matter 
(Why not? Lack of reward or sanctions?) 
Maybe there are ways you can change the 
rewards and punishments to achieve the 
desired behavioural change
■■ Time: What is your timetable? Is this an ‘instant 
change’ situation or one calling for gradual, steady 
improvement? What support will you provide? 
How will you measure progress toward the goal?
WHEN WILL YOU FOLLOW UP?
■■ What actions will they take?
■■ What actions will you take?
■■ What is the timescale for change and/or completion?
■■ How will you measure it?
■■ What are the consequences both positive and negative
■■ Plan regular follow-ups
■■ Write it down and agree
REASONS FOR FAILURE
Ask yourself, ‘Have I…’
■■ Failed to anticipate the employee’s reaction to 
feedback?
■■ Put too much emphasis on why the employee’s 
performance is decreasing?
■■ Failed to analyse the employee’s performance in 
concrete terms?
■■ Failed to spend time on what the employee is doing 
correctly?
■■ Failed to follow-up?
KEY LEARNING OBJECTIVES
■■ How to observe others behaviour more objectively 
and understand how communication mismatches 
result in conflict
■■ Develop a method of managing conflict with team 
members to get changes in behaviour and improved 
performance
■■ Understand how to set expectations with team 
members that are clear and can be complied with
MULTIPLE CHOICE QUESTIONS
1. In dealing with poor behaviour in a team 
member, what would the first step be? 
(A) Decide that they are to blame and tell 
them immediately
(B) Threaten them with punishment as soon 
as possible
(C) Say nothing so they can get into further 
trouble
(D) Think about the incident and record the 
actual behaviour without the emotion and 
judgement
2. Which two communication styles would 
typically struggle the most to see each other’s 
points of view?
(A) Blaze and Tempo
(B) Dynamo and Steel
(C) Steel and Blaze
(D) Tempo and Steel
3. Which of these is NOT good practice when 
setting expectations with team members?
(A) Establishing a few specific goals that are 
clearly understood
(B) Not assigning clear one-person 
accountability for each key goal
(C) Requiring a plan for how and when the 
goals will be achieved
(D) Stating goals in ways that are definable 
or measurable
Could do better: 
managing high 
performers
Alan Robinson
No matter how elegant the strategy, vision and values 
you still have to look at the results occasionally. Your 
team are ultimately responsible for the business out-
comes and your veterinary surgeons are particularly 
responsible for financial and clinical outcomes. These 
are your top performers. Key performance indicators are 
simply the goals and outcomes you wish them to achieve 
in a set time.
It is the job of the practice owners or leadership team 
to set the vision and direction of the practice. This can be 
done using tools such as SWOT and PEST analysis, Vision 
Orbits etc. Then decide which are the top three areas 
from your Vision Orbit, that if you could just crack these 
three in the next 3 months they would give you the 
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 greatest breakthroughs in your life and the practice. We 
would recommend that these become the three main 
objectives for the year that will guide your practice and 
the team.
Your team members then check to see what they are 
responsible for and the three WHATs they need to achieve 
to make this happen. That doesn’t mean you won’t also 
be working on the other areas as well, but if time is 
 limited, these are the three areas to keep your focus 
firmly on.
Then for the period from now until the end of 
90 days from now decide on three supporting HOWs or 
process goals for each WHAT (outcome goal) project 
you have. Make them clear, concise and in SMART for-
mat: specific, measurable, achievable, realistic and time 
dependent. 
TIPS FOR POWERFUL GOALS
Start each goal with a strong, active verb such as earn, 
arrange, complete, ensure, choose, train, etc. Decide 
whether to express the goal as a results goal (WHATs) or 
a process goal (HOWs). Examples include:
■■ Results goal: achieve turnover per vet of £320,000 
per year on average for the next 90 days. Process 
goal: have understood and used the new pricelist 
and structure by end of September
■■ Results goal: improve C2:C1 ratio to 80% over next 
3 months. Process goal: review opportunities for 
follow-up consultations and book within 48 hours
■■ Results goal: improve communication and 
engagement of the clinical team. Process goal: hold 
monthly team meetings informing them of progress 
and working out protocols
KEY LEARNING OBJECTIVES
■■ Designing key performance indicators for teams 
and individuals
■■ Setting outcome goals and process goals
■■ Examples of outcome and process goals
MULTIPLE CHOICE QUESTIONS
1. The vision and strategy of the business should 
be set by, and agreed by which of the 
following?
(A) The owners of the business
(B) The departmental managers in charge of 
business functions
(C) All the employed staff
(D) All of the above
2. Goals set for key performance indicators 
should be which of the following?
(A) Specific and measurable
(B) Achievable and time dependent
(C) Individual and managed
(D) Realistic and achievable
3. Process goals are NOT which of the following?
(A) Better if they start with a strong verb such 
as earn, arrange, meet
(B) Clear outcomes of what you are trying to 
achieve
(C) Milestones or actions that show how you 
are progressing towards a specific goal
(D) Helpful in maintaining motivation and 
direction for high performers
All together now: 
creating team dynamics
Alan Robinson
Some practices have great teams, all pulling in the same 
direction, happy and motivated, whilst others haemor-
rhage staff members, have massive recruitment costs 
and there’s no feeling of ‘we love coming to work’ around 
the place. What is the difference in these businesses, 
and do the good ones always know how they made that 
 happen?
Successful practices have successful teams working 
together for a common goal and common purpose. 
Owners often get stuck in the clinical/management 
dilemma of having a full-time clinical role and then 
 having to manage the spare-time management role. The 
only way through this is to develop an autonomous and 
self-directed team to take on some of the management 
and leadership responsibilities of the practice. So where 
do we start in building a successful team?
For teams to work together, with divergent needs 
and outcomes, there need to be two essential elements 
in place: 
■■ A clear and powerful vision of where the practice is 
going that is shared and understood across the 
team. Also, the team needs to have had some input 
into the vision. If they don’t write the plan they will 
fight the plan. Often practice owners, particularly 
veterinary surgeons, struggle to articulate and 
define the big-picture thinking of crafting a 
vision – some don’t even know what that means. 
Others struggle to get their teams involved or fear 
the consequences of asking for team feedback. 
Often some facilitated help is needed at this stage
■■ If the team is going to be expected to act and make 
decisions they need some clear guidelines for 
action and decision making that the owners can 
trust. These guidelines are based on a set of shared 
values that guide behaviour and ‘the rules to live by’. 
Again, this can appear as ‘soft’ management skills 
and often others in the practice are better placed to 
elicit and develop these ideas. A fundamental 
principle here is the idea of the owner letting go of 
control (scary)
There are some key processes and structures that 
need to be in place if the process is to be sustainable. 
Often these initiatives fall away within months because of 
the lack of effective underpinning systems.
The vision will provide the direction, or ‘the sky 
above’, and the values provide the ‘ground beneath 
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our feet’ for the team to find autonomy, motivation and 
improve performance at all levels and provide the frame-
work within which the practice can succeed. 
This talk will take practice owners and managers 
through the process and tools of creating a shared vision 
and values of a successful team.
KEY LEARNING OBJECTIVES 
■■ The two essential elements of a successful practice 
team – vision and values
■■ How to craft a strong vision the team can engage 
with
■■ How to create a set of shared values that guide 
behaviour
MULTIPLE CHOICE QUESTIONS
1. What is the practice vision a statement of? 
(A) The future reality of the practice as life 
should be to engage all the team
(B) The business plan
(C) A list of goals to be achieved in the next 
few years
(D) A list of all the practice achievements in 
the last year
2. What are the practice values? 
(A) Protocols to be used when dealing with 
clients
(B) How much the practice is worth
(C) A set of agreed attributes that drive the 
culture and behaviour of all team members
(D) A set of rules to follow blindly to maintain 
consistency
3. What are team engagement and motivation 
driven by?
(A) Strict rules and protocols dictating 
behaviour
(B) An intrinsic sense of legacy, autonomy 
and mastery
(C) Extrinsic rewards such as bonuses, money 
and time off
(D) Removing all stress and pressure to 
perform well
Five signs of a high 
performance team
Alan Robinson
HIGH PERFORMANCE SIGN 1:  
TRUST AND FLOW
Trust lies at the heart of a functioning, cohesive team. 
Without it, teamwork is impossible. Essentially, this stems 
from willingness to be vulnerable within the group and 
understanding each other’s strengths and weaknesses.
Suggestions:
■■ Personal history exercise
■■ Personality and behavioral profiles
■■ 360-degree feedback
The role of the leader:
■■ Demonstrate vulnerability first
■■ Create an environment that does not punish 
vulnerability
■■ Vulnerability must be genuine, not staged
HIGH PERFORMANCE SIGN 2: 
MANAGEMENT OF CONFLICT
All great relationships require productive conflict in order 
to grow. Teams that lack trust are incapable of engaging 
in unfiltered and passionate debate of ideas. Instead, 
they resort to veiled discussions and guarded comments. 
All people have different contributions and perspectives 
on any subject. Understanding when and where those 
perspectives are useful improves the innovation process.
Suggestions:
■■ Mining: someone who extracts ‘buried’ 
disagreements and exposes them
■■ Real-time permission: being uncomfortable  
is OK!
■■ Assessment tools
The role of the leader:
■■ Demonstrate restraint when people engage in 
conflict
■■ Allow resolution to occur naturally
■■ Model conflict behaviour
HIGH PERFORMANCE SIGN 3: 
HIGH COMMITMENT
Great teams make clear and timely decisions and move 
forward with complete buy-in from every member of the 
team, even those who voted against the decision. This is 
accomplished through the airing of opinions in the 
course of passionate and open debate. 
Suggestions:
■■ Cascading messaging: review key decisions made 
to be communicated consistently throughout the 
organization
■■ Clear and honoured deadlines
■■ Contingency and worst-case scenario analysis
■■ Low-risk exposure therapy
The role of the leader:
■■ Willingness to be wrong
■■ Constantly pushing the group for closure 
around issues
■■ DO NOT place a premium on certainty or  
consensus
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HIGH PERFORMANCE SIGN 4: 
ACCOUNTABILITY AND AUTONOMY
Without committing to a clear plan of action, even the 
most focused and driven people often hesitate to call their 
peers on actions and behaviours that seem counterpro-
ductive to the good of the team. The clearer the plan and 
the more input the team have the more accountability you 
create. If the team don’t write the plan, they fight the plan.
Suggestions:
■■ Publications of 1-year and 90-day goals and 
standards
■■ Simple and regular progress reviews
■■ Team rewards
The role of the leader:
■■ Allow the team to serve as the first and primary 
accountability mechanism
■■ Willingness to serve as the ultimate arbiter of 
discipline when the team fails itself
HIGH PERFORMANCE SIGN 5: 
ATTENTION TO RESULTS
An unrelenting focus on specific objectives and clearly 
defined outcomes is a requirement for any team that 
judges itself on performance. Inattention to results 
occurs when team members put their individual needs or 
even the needs of their ‘divisions’ above the collective 
goals of the team. Clear and timely dashboarding of 
practice, branch and individual metrics that are focused 
on the progress and completion of goals is required.
Suggestions:
■■ Public declaration of results
■■ Results-based rewards
The role of the leader:
■■ Set the tone for a focus on results
■■ Selfless and objective: reserving rewards and 
recognition for those who make real contributions 
to the achievement of group goals
KEY LEARNING OBJECTIVES
■■ Understand the five drivers of a high-performing 
team
■■ Learn some tools to create high-performing teams
■■ Understand the role of the leader in a  
high-performing team
MULTIPLE CHOICE QUESTIONS
1. What is the first requirement of a high-
performing team?
(A) Accountability and autonomy
(B) Attention to results
(C) Trust and flow
(D) Commitment
2. In managing conflict in a team which of the 
following can you use?
(A) Profiling tools to assess different people’s 
perspectives
(B) Review key decisions consistently 
throughout the organization
(C) Clear and honoured deadlines
(D) All of the above
3. In managing commitment in a team a leader 
should not do which of the following?
(A) Show willingness to be wrong
(B) Constantly push the group for closure 
around issues
(C) Place a premium on certainty or consensus
(D) Answer five key questions in the decision 
process: why, what, who, when and how
Yes, please: improving 
client compliance  
Alan Robinson
Managing client compliance is the secret to a high 
 performing and profitable practice. High compliance 
means that you create more work and sales from far 
fewer clients. There are two areas to improve client 
compliance: preventative healthcare and clinical recom-
mendations.
A well structured preventative healthcare plan takes 
advantage of all the opportunities available for preventa-
tive healthcare that the practice has to offer, including 
a  regular comprehensive physical examination (health 
check), routine vaccinations, nutritional advice, parasite 
control, dental check-ups, regular weighing, neutering, 
pet health insurance and diagnostic tests as required. 
Once you have bonded clients, clinical compliance 
becomes much easier. However, in clinical care it is 
important to understand and manage the clients’ 
 expectations – which are often different from the veteri-
nary perception.
Poor clinical compliance from a veterinary percep-
tion is due to:
■■ Cost – the vet deciding that the treatment is too 
expensive, the client couldn’t afford it or it might be 
rejected as expensive
■■ Communication/client education – usually giving 
too many options without a definitive 
recommendation or not explaining the benefit of 
the recommended treatment
■■ Client time/convenience – having to come back or 
scheduling at a time inconvenient to the client
■■ Perceived value – the client not seeing the value in 
regard to the prognosis of the case
■■ Process error at the clinic – failure in processing the 
booking or follow-up
Poor compliance from the clients’ reality is due to:
■■ Lack of effective recommendation from the 
veterinary surgeon, therefore didn’t know or 
confused about the options available or were given 
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too much information in a short time causing 
confusion and uncertainty:
 – Ask open questions to gain clarity about the 
clients’ understanding
 – Differentiating the ‘disease’ (the pathology in 
the patient) from the ‘illness’ (addressing the 
emotional perceptions in the clients’ mind)
■■ Need or benefit not explained as to why the 
procedure is necessary:
 – Clients want a prognosis! – not a diagnosis – 
explaining what the outcome is rather than 
what the problem is
■■ Lack of reinforcement by veterinary team – 
following systems and protocols to get to a 
resolution:
 – Use agreed consistent practice protocols – 
follow-up systems for all consultations
In any consultation communication mismatch there 
are consistent and costly missed opportunities:
■■ Discounting professional time – selling yourself at 
too low a rate and not charging for everything you 
do, giving it away
■■ Not listening to the client’s concerns 
■■ Failure to recommend treatment – not doing the 
work presented
■■ Failure to practice good protocols and not following 
up case work appropriately
To reduce this compliance gap in every consultation 
there needs to be a discussion of the four Cs:
■■ Clinical – what’s the problem and process?
■■ Compliance – what we have to do next?
■■ Compassion – what are our concerns?
■■ Cost – what’s it going to cost?
The space between the consultation room door 
and the reception desk is where clients and cash disap-
pear … at any time, someone in the practice holds the 
baton of the client. The baton has the ‘four Cs’ of infor-
mation.
KEY LEARNING OBJECTIVES
■■ The two key areas for improving client compliance 
are preventative work and clinical care
■■ Preventative compliance is best bundled into a 
preventative healthcare scheme
■■ Clinical compliance is down to managing the 
consultation process
MULTIPLE CHOICE QUESTIONS
1. Which one of these is NOT a feature of a 
preventative healthcare plan?
(A) To improve the health of pets under care, 
leading to a better quality of life and 
greater longevity of the pet
(B) To get as many clients as possible having 
their pets vaccinated and buying products
(C) To provide a quality client service through 
better pet healthcare 
(D) To enhance client bonding (repeat visits 
and taking up more products and services).
2. What are the missed opportunities from poor 
communication in the consultation?
(A) Discounting professional time – selling 
yourself at too low a rate and not charging 
for everything you do 
(B) Not listening to the client’s concerns 
(C) Failure to recommend treatment – not 
doing the work presented
(D) All of the above
3. Which option is NOT one of the four Cs of 
consultation that need to be communicated?
(A) Clinical – what’s the problem?
(B) Complexity – how difficult the treatment 
will be for the veterinary surgeon?
(C) Compassion – what are our concerns?
(D) Cost – what’s it going to cost?
Difficult client or difficult 
communication?
Alan Robinson
Is it about difficult clients or is it about difficult COMMU-
NICATION?
Clarity of communication is about being clear in your 
own mind about what you want to communicate; deliv-
ering the message succinctly and ensuring that the mes-
sage has been clearly and correctly understood. Good 
communication means saying what you mean – and fully 
comprehending any feedback. It is often said that we 
have failed to deliver client needs in these circumstances, 
however, in reality it’s not about meeting client ‘needs’, 
it’s about meeting client expectations!
Creating expectations involves:
■■ Estimates, costs and updates
■■ Written instructions 
■■ Client fact-sheets
■■ Clear practice procedures and protocols
■■ Staff consistency and communication
Delivering expectations requires:
■■ Staff consistency and communication
■■ Clear, comprehensive clinical notes
■■ Written instructions pre- and postoperative
■■ Client fact-sheets
■■ Clear practice procedures and protocols
■■ Ongoing client communication
Managing failed expectations requires:
■■ Acknowledge the problem
■■ Be polite
■■ Be patient and listen
■■ Restate the customer’s complaint for accuracy
■■ Let the client steam!! 
Resolving client complaints requires time and energy 
and someone trained and empathetic to client emotion 
as well as their own. They need to stay detached, stay 
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focused, be able to choose their words carefully, take 
responsibility, and solve the problem by having options 
ready. They also need to always follow up with the client. 
Repeat clients are the foundation of a healthy busi-
ness. However, not all clients are alike. Here’s how to deal 
with the tough customers. 
■■ Listen carefully to a client’s criticism. By asking calm 
questions, see whether you can discern the main 
thing that is bothering the client
■■ Don’t interrupt immediately. Unless the client is 
abusive, it pays to hear what they’re saying in full. 
If someone is abusive, politely ask them to tone 
down his or her language
■■ Keep records of your dealings with difficult clients 
and steps you have taken to deal with their concerns
■■ Try to see things from the client’s point of view, no 
matter how unreasonable or how irrational he or 
she seems. What seem to you to be nagging, 
repetitive phone calls may simply be an expression 
of the customer feeling stressed for reasons that 
have nothing to do with the work you’re doing
■■ Avoid arguments. Your goal is to come to an 
understanding, not to win a confrontation. 
Acknowledge different viewpoints
■■ Be encouraging. Often people become hostile 
when they feel frustrated or confused
■■ Stay calm. If you can’t stay calm, terminate the call 
or meeting until you can respond less heatedly
It’s easier to not start a relationship than it is to sever 
an ongoing relationship. Keep an eye out for warning 
signs such as potential conflicts of interest or involve-
ment in a high-risk business. But be warned. Some clients 
just aren’t worth the trouble. Beware of any client who 
tries to involve you in illegal or unethical schemes. 
Don’t quibble over small stuff. Remember, the client 
is always right, even when he or she is wrong.
Learn as much about your client’s needs and pet as 
possible. The more you know, the more you’ll be able to 
give the client what he or she needs.
KEY LEARNING OBJECTIVES
■■ Difficult clients are usually difficult for a reason – 
either due to distress or poor communication
■■ How to create, deliver and manage expectations, 
especially failed expectations
■■ Know how to deal with the client’s and your own 
emotions in a resolution discussion
MULTIPLE CHOICE QUESTIONS
1. What is clarity of communication NOT  
about? 
(A) Being clear in your own mind about what 
you want to communicate 
(B) Delivering the message succinctly
(C) Telling people repeatedly what you want 
them to understand 
(D) Ensuring that the message has been clearly 
and correctly understood
2. What should you do when managing actual or 
perceived failed expectations from a client?
(A) Be polite, be patient and listen
(B) Restate to the customer’s what they did 
wrong
(C) Deny that there is a problem really 
(D) Let the client scream! 
3. Using the GROW coaching model R  
stands for 
(A) Realistic – as in ‘please be realistic’
(B) Right – as in ‘there is a right (and wrong) 
answer here’
(C) Routine – as in ‘we have a protocol that 
needs to be followed’
(D) Reality – as in ‘what are the facts, situation, 
current status?’
305-316 Key skill focus.indd   315 08/03/2019   18:20
305-316 Key skill focus.indd   316 08/03/2019   18:20
BSAVA CONGRESS 2019 PROCEEDINGS [ 317 ]
Section V
Management 
streams
Sunday 7 April
317-322 Management.indd   317 08/03/2019   18:19
317-322 Management.indd   318 08/03/2019   18:19
BSAVA CONGRESS 2019 PROCEEDINGS [ 319 ]
Sunday 7 April
Hall 7
Management
320 08:45–09:35Top five reasons vets get sued and how to avoid them 
as a recent graduate
Dave Nicol
321 10:05–10:55Putting you first: how to manage body and mind to avoid 
burnout, depression and other negatives
Dave Nicol
321 11:00–11:45Personal branding for vets: why you need one and how 
to become the local pet celebrity
Dave Nicol
317-322 Management.indd   319 08/03/2019   18:19
Management
[ 320 ] BSAVA CONGRESS 2019 PROCEEDINGS
Top five reasons vets 
get sued and how to 
avoid them as a recent 
graduate
Dave Nicol
How do new veterinary graduates generally find them­
selves slapped with lawsuits? Typically, what happens is 
we get complaints from disgruntled pet owners. These 
complaints, if deemed sufficiently serious, are then fol­
lowed up with some form of legal investigative process. 
The objective of the process is usually to try to recover 
money but also to ensure the required standard of prac­
tice was met, or will be met in the future. 
The good news is that such complaints rarely follow 
this course. It is far more common, for example, for a 
complaint to be dealt with internally, without resorting to 
legal recourse. As new graduates we are genuinely afraid 
of being sued but the truth is, it doesn’t occur that often. 
And that’s good news for us all. 
New graduates should take comfort and encourage­
ment from data I unearthed from one of the larger veteri­
nary boards (the organizations that regulate veterinarians) 
in Australia. This reliable data showed that, in Australia, 
there appeared to be no correlation between years of 
experience and complaints to veterinary authorities. For 
example, the average number of complaints in the first 
year after graduation was three, while the highest num­
ber of complaints was eight, and that came 24 years after 
graduation. In fact, on a graph, each of the tall skyscrap­
ers were for experienced doctors, which is the opposite 
of what you might expect. Incidentally, these trends were 
also present in the data documented within the United 
Kingdom. 
When you delve into the reasons for complaints, the 
questions answer themselves. As new graduates, we 
think bad things will happen because we are inexperi­
enced. Of course, that’s true to some extent. But we’re 
also aware of the potential for getting sued, which makes 
us more careful and more tentative. We’re not yet at a 
stage where we begin to take chances or start believing 
our own hype. So we’re cautious and that probably pro­
tects us a bit. 
COMMON REASONS FOR COMPLAINTS 
LODGED AGAINST VETERINARY 
SURGEONS 
There are five common ways people receive complaints:
■■ Poor communication
■■ Misdiagnosis leading to delayed or wrong treatment
■■ Poor standard leading to negative outcome for patient
■■ Unrealistic expectations set by veterinary surgeon
■■ Doing too much with too little
And there are also ways to avoid negative outcomes. 
Here’s how you minimize your risk.
■■ Build rapport: people are less likely to sue you if they 
like you
■■ Treat your clients and their pets with respect and 
kindness
■■ Be confident but know your limits
■■ Make sure you have delivered a clear and coherent 
plan to your pet owner
■■ Communicate costs before doing any work
■■ Communicate changes to the plan before doing work
■■ Master complaint resolution
■■ Stay current
■■ Get a second opinion on anything if you are unsure
■■ Keep clear, detailed and contemporaneous clinical 
records
KEY LEARNING OBJECTIVES
■■ To know the common ways veterinary surgeons get 
sued
■■ To be able to develop the skills required to minimize 
the risk of having a serious complaint lodged against 
you as a veterinary surgeon
■■ To not be stressed about being sued
MULTIPLE CHOICE QUESTIONS
1. Which is NOT a reason for getting sued?
(A) You made the wrong diagnosis and an 
animal suffered as a result
(B) You had porridge for breakfast
(C) You promised to cure an inoperable cancer 
and the client paid a lot of money to try
(D) You were practising as a veterinary 
surgeon without a degree
2. Which of the following is TRUE?
(A) You will be more likely to be sued 
immediately on graduating
(B) You will be more likely to be sued 1 year 
post graduation
(C) You will be more likely to be sued 10 years 
post graduation
(D) There is no correlation with years post 
graduation and getting sued
3. What things should you do to reduce your 
chances of being sued?
(A) Build rapport: people are less likely to sue 
you if they like you
(B) Treat your clients and their pets with 
respect and kindness
(C) Be confident but know your limits
(D) All of the above
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Putting you first: how 
to manage body and 
mind to avoid burnout, 
depression and other 
negatives
Dave Nicol
The job of being a veterinary surgeon is hard on both 
body and mind. If not managed carefully then the daily 
efforts required by veterinary surgeons can and do wear 
many professionals down, leading to mental, emotional 
and physical exhaustion. Those affected inevitably enter 
a negative feedback loop that results in poor perfor­
mance, low esteem and unhappiness (and worse). 
In this presentation Dr Dave Nicol explores the topic 
and looks into the emotional triggers and internal story 
telling that lead to this outcome. And will show delegates 
how to successfully rewire their thinking. Delegates will 
learn the classic signs of burnout. They will also explore 
the part that emotions, beliefs and internal storytelling 
play in the development of a poor emotional state.
They will learn some effective tools that will allow 
them to recognize:
■■ Risk moments
■■ How to spot a poor story or belief
■■ What things can contribute to a poor emotional 
state and create anxiety
Delegates will also then learn some highly effec­
tive tools to manage mental state and to become more 
 resilient in the face of challenge. These fall into two 
 categories:
■■ Mental judo – managing the internal dialogue and 
telling a better story
■■ Daily habits to improve mental state
KEY LEARNING OBJECTIVES
■■ For delegates to clearly understand that burnout is a 
sign of a mismanaged mental and physical state and 
to be absolutely clear who is responsible for 
managing this state
■■ To understand the contributors to anxiety and the 
warning signs of running in the red ‘danger zone’
■■ To be able to effectively deploy countermeasures to 
be able to handle the daily routine events that are 
unavoidable, but with the right mindset can be 
handled effectively without mental harm
MULTIPLE CHOICE QUESTIONS
1. Which of the following is NOT a sign of a 
negative mental state?
(A) Tiredness
(B) Irritability
(C) Singing out loud in the shower
(D) Poor sleep
2. Who has the greatest responsibility for your 
mental and physical health?
(A) Your boss
(B) The government
(C) The RCVS
(D) You
3. Which of the following does NOT help your 
mental state?
(A) Sleep
(B) Spending time with people you love
(C) Walking in nature
(D) Social media
Personal branding for 
vets: why you need 
one and how to 
become the local pet 
celebrity
Dave Nicol
Personal brands are everywhere nowadays with influ­
encers changing the course of businesses in every field 
and facet of business. Veterinary medicine is no different. 
While the older generation seem to have avoided or 
ignored social tools, the same cannot be said of the 
 millennials, who are embracing the technology with both 
hands.
Customers do business with those people and 
brands they know, trust and like. So a personal brand can 
be a massive tool to support and accelerate the career of 
any savvy young veterinary surgeons out there.
A personal brand is developed when an individual 
starts to create content that is noteworthy and other peo­
ple start to take notice of and follow. So it is not for the 
feint hearted. Most will not have the determination to put 
in the work required. And many will run from the spot­
light, but for those willing to engage, they sky is the limit.
Content creation is the basis of any personal brand­
ing strategy. This content can come in many forms: 
words, sounds, video and images. A good strategy will 
take advantage of as many formats as possible. My advice 
is to publish content to a blog or Youtube channel every 
week or a Facebook/Instagram page every day. Anything 
less and you are invisible. 
Here are three techniques I rely on that will work for 
you too. 
■■ Think about your audience first. What do they want, 
what do they need? What do they love or hate? 
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What keeps them awake or drives them crazy about 
animals. What things get them super­curious? What 
makes them laugh? What things make them go 
‘awwww’ about their pets? Write about things that 
evoke emotions not put people to sleep
■■ Your story is amazing, so tell it. veterinary surgeons 
have a gift that many business owners would kill 
for – subject matter that is genuinely interesting. 
Saving lives is sexy. Pets are engaging (which is why 
kittens dominate the internet). Our path in life is an 
emotional journey, an engaging soap opera 
unfolding before our eyes daily. The simplest way to 
write a meaningful blog is to simply describe the 
things you see and do each day. Just do so with the 
pet owner in mind. They are unlikely to care about 
the specific technique you used to repair the 
problem. But they will care about the impact or your 
fears and hopes going into the surgery. Veterinary 
medicine is a wonderful daily mash­up of tragedy 
and comedy, use this to your advantage
■■ Write a list. ‘Top Tips’ articles are quick, easy and 
when done well, grab attention. Think of a topic. 
Start with the title and then the rest flows easily
Regardless of the technique you use to generate 
your content, the most important thing is simply hav­
ing the will to meet your deadline whenever that falls. 
Most people fail because they lack the commitment 
and  patience required to execute a content marketing 
 strategy. 
KEY LEARNING OBJECTIVES
■■ Understand what a personal brand is
■■ To understand some easy ways to begin 
generating the type of content required to build 
a personal brand
■■ To avoid the common pitfalls for those who wish 
to develop a personal brand
MULTIPLE CHOICE QUESTIONS
1. What is a personal brand?
(A) A tool that can help you build relationships 
with clients
(B) A way of differentiating yourself and 
increasing your value to a practice
(C) A strategy that requires you to have 
something useful to say
(D) All of the above
2. A personal brand can be built using which of 
the following?
(A) Blogs
(B) Youtube
(C) Youtube
(D) TV
(C) Instagram
(D) All of the above
3. People connect best with which of the 
following?
(A) Stories
(B) Facebook
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The principles of weight 
management: using 
scientific evidence to 
maximize success
Alexander German
Recently, canine and feline obesity has recently been 
 formally classified as a disease by the American Veterinary 
Medical Association, and, arguably, it is now the biggest 
health and welfare issue affecting pet dogs. Although 
successful weight loss has health benefits, current strate-
gies are suboptimal, with many obese pets that start a 
weight programme failing to lose weight, or subsequently 
rebounding. Given that current weight-loss strategies are 
not perfect, clinicians need to focus carefully on tailoring 
the programme, perhaps setting a pragmatic target for 
weight loss, so as to ensure the benefits are maximized. 
This review will summarize key findings from recent 
 clinical research into pet obesity, and present a frame-
work for improving success, by better tailoring weight-
management regimes and endpoints to the individual.
KEY LEARNING OBJECTIVES
■■ Outline the factors associated with failure of 
overweight dogs and cats to reach target during 
weight management or to rebound subsequently
■■ Explain the concept of ‘the law of diminishing 
returns’ as it relates to weight management in dogs 
and cats
■■ Suggest pragmatic targets for overweight dogs and 
cats undergoing controlled weight loss
MULTIPLE CHOICE QUESTIONS
1. What proportion of pets regain weight after 
successfully completing a weight-loss 
programme?
(A) 10%
(B) 25%
(C) 50%
(D) 75%
2. You have recently started an obese dog on 
a weight-loss programme. What would the 
expected rate of weight loss be in the first 
4 weeks?
(A) 2.0–3.0% of starting body weight per week
(B) 1.5–2.0% of starting body weight per week
(C) 1.0–1.5% of starting body weight per week
(D) 0.5–1.0% of starting body weight per week
3. When during a weight-loss programme would 
you expect to start seeing significant lean 
tissue loss?
(A) After 10% weight loss
(B) After 20% weight loss
(C) After 25% weight loss
(D) After 30% weight loss
The practicalities of 
weight management: 
making it work in your 
practice
Georgia Woods
Given that obesity is now such a prevalent disease, prac-
tices must have robust systems in place to address it. 
Successful weight management requires a combination 
of dietary restriction and increased physical activity. 
Knowing these basic principles is essential but how this 
information is explained to owners will be vital to manag-
ing obesity effectively. Forming strong bonds with the 
owners of the obese patient will be influential through-
out the programme, so should be given careful consider-
ation alongside the more practical advice given on 
feeding and activity.
This lecture will discuss the practical approach to 
weight management and give useful guidance on how to 
make it work in your clinic. Communication is key, not 
only for obtaining all the necessary information on med-
ical and dietary history, lifestyle and normal routines, but 
also in the delivery of the advice that is given. The com-
munication style will affect the owner’s acceptance, 
understanding and compliance with the programme. 
Information gathering is vital in the initial assessment, so 
the lecture will discuss the various ways in which infor-
mation may be gathered both verbally and in written 
form. Each weight-management programme should be 
individualized for pet and owner, so the lecture will also 
describe the common factors that all good weight-loss 
programmes need to give the best chance of success. 
KEY LEARNING OBJECTIVES
■■ Recognize obesity in cats and dogs and factors that 
might influence the success of weight management
■■ Describe strategies used for weight management in 
dogs and cats, and outline some of the sources of 
potential difficulty, areas where things commonly 
go wrong and how to prevent these 
■■ Discuss different techniques that can be used to 
communicate with owners about pet obesity and 
demonstrate how they can be used to ensure good 
compliance with the weight-management 
programme 
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chart represents what percentage above 
optimal weight?
(A) 40%
(B) 10%
(C) 35%
(D) 30%
3. What is the best food type for weight loss?
(A) Wet only
(B) Dry only
(C) Wet and dry in combinations
(D) It doesn’t matter
MULTIPLE CHOICE QUESTIONS
1. What percentage of dogs in the UK are 
currently thought to be overweight or  
obese?
(A) 33%
(B) 65%
Tackling the obese 
patient with concurrent 
disease: what are your 
priorities?
Alexander German
Obesity is now a major health and welfare concern in com-
panion animals. Overweight dogs and cats are at increased 
risk of developing comorbidities including: diabetes melli-
tus, musculoskeletal disease, neoplasia, oral cavity disease, 
skin disease and urinary tract disease. Increased adiposity 
can adversely affect respiratory function, cause metabolic 
derangements including insulin resistance and also affect 
renal function and health. Although weight-management 
programmes can be successful, outcomes are often disap-
pointing with many animals either failing to reach target 
weight or regaining weight subsequently.
This talk will consider obesity as a disease and pro-
vide guidance on clinical priorities for weight manage-
ment when other diseases are present. The concept of 
tailoring weight management to the individual will be 
considered, whereby the target for weight loss is set 
according to individual circumstances. Case examples 
will be used to illustrate the concepts covered.
KEY LEARNING OBJECTIVES
■■ Appraise the health and welfare benefits of weight-
management regimens in overweight dogs and cats
■■ Compare and contrast the characteristics of 
complete and partial weight-management regimens, 
and give examples of when each would be used
■■ Suggest pragmatic targets for weight-management 
regimens in overweight dogs and cats with 
concurrent illness
programme. The dog weighs 62 kg and has a 
body condition score of 8/9. At what weight 
would you predict to start seeing 
improvements in mobility?
(A) 58 kg
(B) 56 kg
(C) 54 kg
(D) 52 kg
2. What influence does concurrent orthopaedic 
disease have on the outcome of weight 
management in overweight dogs?
(A) Dietary energy intake will need to be 
restricted more severely, weight loss will 
be slower and the dog will be less likely to 
reach its target weight
(B) Dietary energy intake will need to be 
restricted more severely and weight loss 
will be slower, but there will be no effect 
on the likelihood of the dog reaching its 
target weight
(C) Dietary energy intake will need to be 
restricted more severely and the dog will 
be less likely to reach its target weight, but 
rate of weight loss will not be slower
(D) Dietary energy intake will need to be 
restricted more severely, but rate of weight 
loss will not be slower and  
there will be no effect on the likelihood  
of the dog reaching its target  
weight
3. You have just diagnosed a grade II mast cell 
tumour in an obese 6-year-old English Bulldog. 
The dog weighs 25.0 kg and has a body 
condition score of 9/9. There is also severe 
concurrent brachycephalic airway disease and 
you suspect that the weight is exacerbating 
this. What would a sensible target body weight 
be for this dog?
(A) No weight loss is appropriate in this case
(B) 23.7 kg would be a suitable target in this 
case
(C) 22.5 kg would be suitable target in this 
case
(D) 18.0 kg would be a suitable target in this 
case
MULTIPLE CHOICE QUESTIONS
1. You have just started an obese Labrador 
Retriever with osteoarthritis on a weight-loss 
(C) 12%
(D) 54%
2. WSAVA now recommends that all practices 
should use a 9-point body condition score 
chart when assessing the severity of obesity. A 
score of 8/9 on a 9-point body condition score 
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Can obesity be 
prevented?
Alexander German
Obesity is now a major and highly prevalent medical 
 disease in dogs and cats, which affects the quality of life 
of many dogs and cats throughout the world. Whilst 
weight-loss protocols aimed at treating the disease are 
commonly used, long-term outcomes are disappointing. 
Indeed, many obese pets who start a programme fail 
to  complete it, and those who do frequently rebound 
subsequently. As a result, it makes sense to focus on pre-
vention rather than cure. This talk will first review the out-
comes of weight management in obese dogs and cats, 
before defining types of prevention and applying them to 
obesity management. Suggestions will be made for a 
lifelong practice monitoring programme for prevention 
of obesity.
KEY LEARNING OBJECTIVES
■■ Identify risk factors for the development of obesity 
in dogs and cats, and explain how they can be used 
in an obesity-prevention plan
■■ Define the terms primary prevention, secondary 
prevention and tertiary prevention; and then give 
examples of each in the context of companion 
animal obesity
■■ Outline an obesity-prevention plan for dogs and 
cats attending a primary care veterinary practice
MULTIPLE CHOICE QUESTIONS
1. A veterinary surgeon examines an obese 
domestic shorthair cat, bodyweight 9.40 kg, 
body condition score 9+/9. On history and 
physical examination, there are no obvious 
concurrent disorders. The veterinary surgeon 
decides to start a weight-management plan 
with the final target being the cat’s ideal 
weight. Which type of prevention is this?
(A) Primary prevention
(B) Secondary prevention
(C) Tertiary prevention
(D) Neither primary, secondary nor tertiary 
prevention
2. After the Christmas/New Year vacation, a 
veterinary practice decides to promote its 
weight-management programme to all clients 
using a combination of emails, social media, 
information on their website, and posters 
displayed in the practice waiting room.Owners 
are encouraged to assess the body condition of 
their own pet and schedule an appointment 
with the veterinary practice if they are 
concerned. Which type of prevention is this?
(A) Primary prevention
(B) Secondary prevention
(C) Tertiary prevention
(D) Neither primary, secondary nor tertiary 
prevention
3. A recently diagnosed neutered female diabetic 
cat has a bodyweight of 6.5 kg and a body 
condition score of 7/9. The cat is stable on PZI 
insulin 2 units q12h s.c. and a high-protein 
low-carbohydrate diet fed twice daily at 
maintenance energy requirement. The 
veterinarian elects not to change the therapy. 
Which type of prevention is this?
(A) Primary prevention
(B) Secondary prevention
(C) Tertiary prevention
(D) Neither primary, secondary nor tertiary 
prevention
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Hormone testing 
Gary England 
A variety of hormones can be measured to facilitate 
investigation of reproductive function. Common indica-
tions for hormone measurement will be discussed.
WHEN TO BREED
Measurement of oestrogen concentrations are unhelp-
ful, however there is a good relationship between the 
peri-ovulatory rise in progesterone and the fertilization 
period (Figure 1). 
PREGNANCY DIAGNOSIS
Progesterone concentrations differ between pregnant 
and non-pregnant dogs but not sufficiently for a single 
sample to be diagnostic. Placental relaxin is specific to 
pregnancy and is elevated from day 20 (but easily detect-
able from day 25).
PREGNANCY FAILURE
Whilst after pregnancy failure progesterone declines, 
there is no good evidence (except in German Shepherd 
Dogs and related breeds) that low progesterone causes 
failure. In affected breeds, detecting low progesterone 
may allow exogenous supplementation but this should 
be undertaken with extreme caution (risk of neonatal 
genital tract abnormalities and prolonged parturition).
PREDICTION OF WHELPING
Pregnancy length is remarkably consistent at 62–64 days 
from ovulation; whelping can therefore be anticipated by 
measurement of progesterone during oestrus.
■■ Progesterone ≈ 21 nmol/l(7 ng/ml) = ovulation = 
whelping in 63 ± 1 day
■■ Progesterone ≈ 32 nmol/l(10 ng/ml) = beginning of 
fertilization period = whelping in 61 ± 1 day
At the end of pregnancy progesterone decreases to 
basal levels (24–36 hours before whelping). Detection of 
high progesterone concentrations indicate that whelping 
is not imminent, whereas basal concentrations indicate 
that whelping should have begun (Figure 2).
Overall, first detection of progesterone <6 nmol/l 
(2.0 ng/ml) is associated with whelping within 26 hours. 
First detection of progesterone <10 nmol/l(3.0 ng/ml) is 
associated with whelping within 50 hours.
INCOMPLETE OVARIECTOMY 
Incomplete ovariectomy is not uncommon and usually 
results in a return of oestrous behaviour. Depending 
upon the time of examination a variety of hormone 
measurements may be diagnostic (simplest methods are 
shown in bold).
■■ Currently thought to be in oestrus:
 – Progesterone – not diagnostic
 – Oestrogen – not reliable (use vaginal cytology)
 – Oestrogen stimulation test – not reliable
 – Anti-Mullerian hormone – no data available
 – Basal LH – not reliable
■■ Oestrus was observed within the last 2 months:
 – Progesterone – diagnostic
 – Oestrogen – not diagnostic
 – Oestrogen stimulation test – diagnostic
 – Anti-Mullerian hormone – likely to be diagnostic
 – Basal LH – not diagnostic
■■ Oestrus was observed 2–7 months previously:
 – Progesterone – not diagnostic
 – Oestrogen – not diagnostic
 – Oestrogen stimulation test – diagnostic
 – Anti-Mullerian hormone – likely to be  
diagnostic
 – Basal LH – diagnostic
KEY LEARNING OBJECTIVES
■■ Understand the normal endocrinology of the 
reproductive cycle of the bitch and recognize 
how measurement of reproductive hormones  
can be diagnostic of various stages of the  
cycle
■■ Appreciate changes in progesterone 
concentration during oestrus and prior to 
parturition and how measurement of 
progesterone can be used to predict the likely 
time of whelping
■■ Be able to differentiate the endocrine 
environment in a neutered bitch from a normal 
cycling bitch
Stage of cycle Progesterone 
concentration 
nmol/l(ng/ml)
Range  
(ng/ml)
Luteinizing hormone 
surge
8 (2.5) 2.3–3.0
Ovulation 21 (7.0) 5.0–9.0
Beginning of 
 fertilization period
32 (10.0) 8.0–15.0
Middle of fertilization 
period
45 (15.0) 10.0–30.0
End of fertilization 
period
 85 (28.0) 25.0–40.0
Figure 1: Relationship between progesterone 
concentration and the fertilization period
Days in relation 
to parturition
Progesterone 
(nmol/l)
Progesterone 
(ng/ml)
–5 15 4.7 ± 0.7
–2 7 2.4 ± 0.5
–1 4 1.4 ± 0.2
0 1 0.4 ± 0.3
Figure 2: Progesterone concentration and whelping
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MULTIPLE CHOICE QUESTIONS
1. To determine the optimal time to breed which 
one of the following statements is CORRECT in 
relation to measurement of plasma 
progesterone?
(A) Detecting progesterone less than 
8 nmol/l(2.5 ng/ml) indicates that the bitch 
is still in pro-oestrus
(B) Detecting progesterone less than 8 
nmol/l(2.5 ng/ml) indicates that the bitch 
has already ovulated and the fertilization 
period has been missed
(C) Detecting progesterone concentrations of 
21 nmol/l(7.0 ng/ml) indicates that the 
bitch has ovulated and therefore it is too 
late to mate
(D) Detecting progesterone concentrations 
greater than 85 nmol/l (28 ng/ml) indicates 
that the bitch just ovulated and therefore 
mating should occur immediately
2. You examine a bitch to determine the optimal 
time to breed and take a blood sample for 
progesterone measurement using a qualitative 
enzyme-linked immunosorbent assay (ELISA). 
Progesterone concentrations are ‘high’ and you 
advise mating immediately. However, the bitch 
refuses to stand. Vaginal cytology shows 
5% parabasal, 15% small intermediate, 
40% large intermediate, 40% anuclear epithelial 
cells, with 10 polymorphonuclear leucocytes 
per high power field. Which one of the 
following is the MOST LIKELY diagnosis?
(A) The bitch is still in early proestrus and 
should be re-examined in 2–3 days
(B) The bitch is in oestrus but for behavioural 
reasons will not stand and so should be 
inseminated
(C) The bitch has ovulated today and should 
be mated in 2 days
(D) The bitch has ovulated and the fertilization 
period has ended
3. A 3-year-old bitch was neutered 3 months 
after the end of oestrus. Four months later she 
has a swollen vulva and a serosanginous 
vulval discharge. Plasma progesterone 
concentrations are 1.6 nmol/l(0.5 ng/ml) (low) 
and plasma oestrogen concentrations are 
55 pmol/l(15 pg/ml) (low). Which one of the 
following is the MOST LIKELY explanation?
(A) Ovarian remnant is not likely since both 
oestrogen and progesterone 
concentrations are low
(B) Ovarian remnant is likely since both 
oestrogen and progesterone 
concentrations are low
(C) Ovarian remnant is probable but is not 
likely to be detected by hormone 
measurement at this time
(D) Clinical signs of oestrus are most likely due 
to reasons not associated with the 
reproductive tract
Managing the 
pregnant bitch
Angelika von Heimendahl
After successful conception breeders need support to 
look after a pregnant animal to maximize the number of 
healthy puppies and the chances of a normal birth.
PREGNANCY DIAGNOSIS
The most common method of pregnancy diagnosis is 
ultrasonography. Depending on the quality of the equip-
ment and the experience of the operator, ultrasonogra-
phy gives good results from 25 days of pregnancy 
onwards, including the number of puppies and foetal 
heartbeats. The breeder’s wish for very early scans 
should be resisted in order to have a meaningful result. 
Although exact numbers are not important, single- or 
two-puppy pregnancies should be diagnosed in order to 
prepare for a possible elective Caesarean. 
MEDICATION DURING PREGNANCY
If bitches fall ill during pregnancy or have chronic condi-
tions that need continued treatment, there are drugs that 
can be used with relative safety in order to support the 
bitch without endangering the health and development 
of the puppies. Some common conditions that may 
develop through pregnancy are discussed.
DEALING WITH SINGLE-PUPPY 
PREGNANCIES
These have a higher percentage of inertia and dystocia 
and therefore need to be managed carefully during 
 pregnancy and at the time of parturition.
LOSS OF ONE OR MORE PUPPIES 
DURING PREGNANCY
Abortion of one or more foetuses whilst the pregnancy 
continues is not uncommon. This is very worrying for the 
breeder and diagnosis of the possible causes is important 
to try to take the remaining foetuses to full term.
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NUTRITION DURING PREGNANCY
A rising plane of nutrition and a different composition 
of  food are especially important in the last trimester of 
pregnancy.  
PREPARATION FOR THE BIRTH
The drop in progesterone at the end of pregnancy 
induces a drop of body temperature, which can easily be 
monitored by the breeder. Parturition should take place 
within 24 hours of the temperature dropping. Most expe-
rienced breeders have their specific set-up for the birth, 
but new breeders may need help with normal parameters 
at birth, such as first- and second-stage labour, time 
between puppies being born and what to do with the 
placentas. Colostrum replacer should be ready in case it 
is needed in the first 24 hours after parturition.
INFORMATION LEAFLET FROM THE 
VETERINARY PRACTICE FOR BREEDERS 
The practice should provide a leaflet suggesting the set-up 
of the area for whelping, temperature requirements for 
neonates, behaviour around labour and normal parame-
ters at birth. It should include a clear guide to surgery hours 
and out-of-hours services, giving telephone numbers and 
the address of the premises to go to if help is needed.
KEY LEARNING OBJECTIVES
■■ Pregnancy diagnosis and advising clients about a 
normal pregnancy
■■ Emergencies during pregnancy 
■■ Preparing for parturition depending on different 
scenarios
MULTIPLE CHOICE QUESTIONS
1. A bitch has been scanned with five puppies at 
30 days after progesterone testing and 
ovulation. On day 50 she develops 
haemorrhagic discharge and foetal parts are 
expelled. The animal is well in herself 
otherwise. How would you proceed?
(A) Perform elective Caesarean to save the 
other puppies
(B) Administer antibiotics and non-steroidal 
anti-inflammatory drugs (NSAIDs) to 
stabilize the bitch
(C) Monitor progesterone and perform 
ultrasound scan to check viability of 
remaining foetuses
(D) Administer aglepristone to abort the other 
foetuses and prevent further death in utero
2. A new breeder is concerned how much food 
she should be feeding her pregnant bitch, a 
3-year-old healthy Springer Spaniel that has 
been confirmed pregnant with seven puppies. 
What would you advise?
(A) Feed rising slowly toward normal 
maintenance + 30% at the end of 
pregnancy
(B) Feed rising slowly toward normal 
maintenance + 80% at the end of pregnancy
(C) Feed rising slowly toward normal 
maintenance + 100% at the end of pregnancy
(D) Keep on normal maintenance to get bitch 
into optimum body condition at whelping
3. A heavily overweight 4-year-old Newfoundland 
bitch is presented for ultrasound scan to 
determine if she is pregnant 38 days after the 
first mating. No blood progesterone was taken 
at the time to determine ovulation and she was 
mated three times over 6 days. This would be 
her first litter. Ultrasonography, due to the size 
of the abdomen is inconclusive, and a foetus 
cannot be visualized. How should you proceed?
(A) Radiograph to determine whether she is 
pregnant and how many foetuses
(B) Ask the breeder to come back in 10 days to 
repeat ultrasound scan when the 
pregnancy will be more visible
(C) Ask the breeder to monitor outward signs 
such as mammary development and nesting
(D) Advise the breeder to get ready anyway in 
case she is pregnant and any monitor 
temperature drop
Managing parturition: 
when do I reach for 
the scalpel?
Angelika von Heimendahl
NORMAL PARTURITION
To feel comfortable with the progression of labour and 
parturition it is important to have normal parameters for 
first- and second-stage labour, times between puppies 
and the length of a birth form start to finish. Knowing 
when a bitch should give birth and when she is ‘overdue’ 
can also be difficult given the long survival of canine 
spermatozoa and oocytes in the reproductive tract. 
CAESAREANS IN GENERAL
Caesareans are highly successful obstetrical interven-
tions that can save the lives of puppies and/or bitch. Per-
formed at the right time they are often the only option 
when normal progression of parturition has not set in or 
has stopped. On the other hand, they are invasive, more 
costly, have a higher percentage of complications and 
lower fertility for future breedings
The increased popularity of elective Caesareans for 
brachiocephalic breeds and bitches in first-stage labour 
can present an ethical dilemma for the practitioner. 
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Some of these breed have a 100% section rate. The UK 
Kennel Club runs a scheme that releases the veterinary 
surgeon from the professional obligation to maintain 
confidentiality (RCVS Guide to Professional Conduct 
part 2A) and encourages the registration of Caesareans. 
To be able to register puppies the bitch must not have 
more than two sections.
PREDISPOSITIONS FOR CAESAREANS 
■■ Brachiocephalic breeds have, not surprisingly, the 
highest section rates. Dimensions of the maternal 
inner pelvis and size of the foetal head and shoulder 
can be a problem. These breeds also have a 
relatively high percentage of malformed foetuses 
that can lead to dystocia
■■ The second biggest group are giant breeds, which 
due to their large litter sizes, are prone to secondary 
inertia
■■ Single- or two-puppy pregnancies have an 
increased risk of primary inertia and a tendency for 
the puppies to grow very large which causes 
problems at birth
■■ Secondary inertia can be hereditary and certain 
lines or families within the breed can have higher 
Caesarean section rates
■■ Inexperienced breeders and stress during the birth 
can lead to prolonged labour endangering the lives 
of the puppies
UNPLANNED CAESAREANS 
■■ Primary and secondary uterine inertia, are common 
in the bitch and may happen spontaneously even 
without any prior predisposition
■■ Foetal oversize can be a single puppy within a 
normal sized litter that causes dystocia and 
endangers the timely delivery of the rest of the litter
■■ More rare events such as uterine torsions, ruptures, 
prolapses and hernias may require immediate 
interventions during pregnancy and parturition
■■ Partial foetal death, whilst littermates are still alive, 
forces a crucial decision on when to keep going and 
when to intervene
AGLEPRISTONE OR SURGERY?
The use of aglepristone as alternative to surgery is dis-
cussed for the different scenarios.
KEY LEARNING OBJECTIVES
■■ Normal parameters for parturition
■■ Pregnancies that may predispose for a Caesarean 
section
■■ When to wait, when to use aglepristone and when 
to reach for the scalpel
MULTIPLE CHOICE QUESTIONS
1. A bitch, confirmed pregnant with eight puppies, 
is showing greenish-black vaginal discharge on 
day 52 of her pregnancy. What would you do?
(A) Ultrasound scan to confirm heartbeats and 
wait if there are live foetuses to enable 
them to go full term
(B) Utero verdin is a sign that the pregnancy 
has been terminated and aglepristone 
should be given to empty the uterus to 
avoid foetal remnants and infection 
(C) Once the first puppy has been born and 
parturition does not progress, a Caesarean 
section should be performed
(D) If the ultrasound scan confirms that all the 
foetuses have died a Caesarean should be 
performed immediately 
2. A bitch confirmed pregnant with 10 puppies 
has given birth to two of them in the last 
5 hours. It has been 3.5 hours since the last 
puppy and the bitch is not showing signs of 
labour. What would you do?
(A) Try small increasing doses of oxytocin and 
deliver the puppies giving the bitch a rest 
between injections
(B) As she has delivered two puppies the 
cervix is fully dilated and she has to be 
given more time to progress with labour
(C) Progress to do a Caesarean when she is 
still well and due to the large number of 
puppies still to be delivered
(D) The bitch should be taken to the surgery 
for further observation and to deliver the 
puppies under veterinary care 
3. A Bulldog breeder rings up to book an elective 
Caesarean for a maiden bitch. She has been 
mated three times over 4 days and no blood 
progesterone levels were analysed. He is 
confident that she took to the first mating and 
she is obviously pregnant. He would like the 
section 63 days after the first mating. What do 
you recommend to the breeder?
(A) Due to oocyte and sperm survival, mating 
dates are not reliable to determine the end 
of pregnancy 
(B) 63 days is ample time to produce mature 
puppies even if she has taken to the 
second or third mating
(C) Bulldogs cannot give birth naturally so it is 
better to be realistic and book the 
Caesarean
(D) He is an experienced breeder and there 
have not been problems in the past
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First 48 hours 
Sylvie Chastant 
The first 2 days of life are challenging for newborns, 
which have to succeed in many physiological adapta-
tions from intra- to extrauterine life: finding oxygen and 
nutrients on their own are difficult but crucial steps for 
survival. These first 2 days of life are especially critical, 
and account for 35% of all neonatal deaths (0–21 days). 
Clinical examination and follow-up over these 2 risky 
days is based on a limited number of criteria (Figure 1), 
evaluating intrauterine growth (birthweight), cardiorespi-
ratory function (APGAR) and energy provision (glycae-
mia, rectal temperature). Thresholds above which the risk 
of neonatal mortality is increased are defined by breed. 
Roughly, the 25% lightest puppies (within a given breed) 
require a specific nursing. The quality of passive immune 
transfer, usually assessed in large animals through IgG 
blood concentration, is more easily evaluated in puppies 
indirectly through growth rate over the first 2 days of 
life. 
Around 40% of puppies suffer from an energy and/or 
immune deficit over the first 2 days of life. In cases of 
 negative growth rate over the first 2 days of life, risk of 
neonatal mortality increases seven-fold. Whereas a defi-
cit in energy can easily be compensated, immune deficit 
cannot: the intestinal barrier is closed as early as 12 hours 
after birth. If the absence/insufficiency of dam colostrum 
can be anticipated, passive immune transfer can be 
obtained using frozen/thawed colostrum (but not effec-
tively by oral administration of canine serum). Colostrum 
provides not only energy and IgG, but also IgA and a great 
variety of antibacterial substances (ensuring intraluminal 
local intestinal protection), together with hormones and 
growth factors, responsible for gut development and 
maturation. Even after intestinal barrier closure, colos-
trum ingestion is beneficial for puppies’ health. 
KEY LEARNING OBJECTIVES
■■ Learning the criteria determining the health status of 
a puppy within the first 2 days of life
■■ Knowing the critical thresholds (in numbers) 
indicating that specific nursing is required
■■ Learning specific nursing procedures to be 
implemented in case critical thresholds are reached
Day Observation to be 
performed
Situation causing 
increased risk of 
neonatal 
mortality
BIRTH Maternal behaviour (takes 
care of newborns or not)
Absence
Presence of colostrum Absence
Congenital abnormality Presence
Birthweight <breed-specific 
threshold
Efficient suckling Absence
APGAR score <6 
DAY 1 Glycaemia <5.1 mmol/l  
(< 92 mg/dl)
Rectal temperature <35°C 
DAY 2 Glycaemia <5.1 mmol/l  
(<92 mg/dl) 
Rectal temperature <35°C 
Growth rate 0–2 days <0 (did not get 
weight from 
birth)
Figure 1: Clinical examination of puppies in the  
first 2 days of life
MULTIPLE CHOICE QUESTIONS
1. What is the critical threshold for glycaemia of 
the puppy at 2 days of age? 
(A) 8.3 mmol/l 
(B) 5 mmol/l
(C) 2.5 mmol/l
(D) 1.1 mmol/l
2. When is the intestinal barrier closed in puppies?
(A) 12 hours after birth
(B) 24 hours after birth
(C) 48 hours after birth
(D) 72 hours after birth
3. Which of the following statements about 
neonatal mortality risk is correct?
(A) Does not increase if the weight of the 
puppy decreases by 10% between birth and 
the age of 2 days
(B) Increases if the weight of the puppy is not 
higher than the birthweight
(C) Does not increase if the APGAR score 
within the first 8 hours of life is below 6
(D) APGAR score is predictive of survival only if 
performed within the first 10 minutes of 
life as in humans
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Graduate Outcomes 
Review: looking  
to the future
Stephen May
Throughout the English-speaking world, it is acknowl-
edged that there is an issue involving the preparation of 
veterinary graduates for the career destination of the 
majority – general practice. Recent publications suggest 
that this is associated with a failure of new graduates to 
recognize the challenge of the sheer variety and nature 
of, and uncertainty around, the primary care caseload. All 
acknowledge that veterinary schools have made consid-
erable strides in the development of technical skills in 
recent years but progress in this aspect of the veterinary 
skill set has heightened awareness of deficiencies in the 
so-called non-technical skills. This has led to a renewed 
focus of educational leaders on the overall capability 
and employability of veterinary graduates and renewed 
attention to the development of curricular frameworks 
that embrace a full range of professional knowledge and 
competences.
The RCVS pioneered Day One Competences in the 
late 1990s, and this and its subsequent revisions have 
contributed to the gradual reorientation of curricular 
designers from inputs (content) to outcomes (compe-
tences). However, to ensure appropriate outcomes are 
achieved, attention needs to be paid to the delivery of 
educational programmes, in particular clinical educa-
tion, so that they prepare students with the skills and 
resilience to deal with uncertainty and decision-making 
based on incomplete data sets. This development emb-
races a trajectory of learning that runs through the 4–6 
years of educational degree programme and supports 
new graduates through their early years in practice. The 
RCVS Professional Development Phase (PDP) is now 
accepted and ready for further development, as are the 
Day One Competences and Year One Competences. 
All have an interest in this – the public, the employers, 
the  educators, and not least the students and young 
graduates who are the future of our profession.
KEY LEARNING OBJECTIVES
■■ The requirements for an effective modern 
curriculum
■■ The challenges for veterinary students and new 
graduates
■■ The process through which the RCVS as regulator 
responds to public and professional needs
MULTIPLE CHOICE QUESTIONS
1. In relation to general practice, in particular, 
what has been identified as the major deficit of 
new graduates?
(A) Scientific knowledge
(B) Clinical knowledge
(C) Technical skills
(D) Non-technical skills
2. Which was the first non-technical skill that 
veterinary schools explicitly started to develop?
(A) Communication
(B) Ethical reasoning
(C) Mindset
(D) Resilience
3. Why did the RCVS first develop its Day One 
Competences and incorporate these into 
veterinary school accreditation?
(A) It was required by the EU directive that 
deals with professional education 
(B) The veterinary schools asked for help with 
professional skills in academic 
programmes
(C) The profession was concerned that 
graduates were deficient in technical skills
(D) The government required it following 
‘Tomorrow’s Doctors’ in medical education
VN Futures: a VN’s 
guide to wellbeing
Laura Black 
Well-being has been the focus of the RCVS Mind Matters 
initiative for a few years, with a focus on mental health, 
caring for our colleagues and learning to thrive within 
the veterinary profession. As a registered veterinary nurse 
(RVN), what can you do to improve not only your own 
well-being, but also that of your colleagues? 
As a starting point ensuring you look after your physi-
cal and mental health, by raising awareness within your 
team and asking are you OK if you notice any changes in 
a colleague’s behaviour. Well-being is personal to each 
of us, but by following some basic principles you can 
enhance your own well-being. 
BE ACTIVE 
As RVNs we generally have a physical and active role, 
however taking time out for yourself and being active 
outside of work is a major influence in our personal well-
being. 
KEEP LEARNING 
Within our roles we are learning every day, however once 
the exams stop we can get into a rut of same old same 
old. Learning new things, or taking on additional res-
ponsibilities helps build confidence and self-esteem, 
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sharing knowledge is also a great way to improve team 
well-being. 
GIVING BACK 
Do something nice for someone else, a friend or a 
 stranger, volunteer your time. Look out, as well as in. 
CONNECT 
Take time to see friends, family and colleagues, think of 
these as the cornerstones to your life, invest in develop-
ing the relationships and ensure you don’t neglect these 
for day-to-day demands.
TAKE NOTICE  
Many people are aware of mindfulness and the positive 
benefits it can bring. Take notice of your surroundings 
and take the time to engage with them. 
CARE FOR THE PLANET 
Don’t take our community for granted, look to see what 
you can do, even if it is recycling the plastics and paper in 
the practice and at home.  
MANAGING WELL-BEING WITHIN YOUR 
PRACTICE 
There are simple steps to building a well-being 
 programme/strategy for your practice. Start to look at 
small areas you could change, having time to talk to each 
other and recognizing when someone is maybe not 
managing as well. 
Identify the areas which are your practice’s priorities. 
These may be simple things which would help everyone. 
Do you take a lunch break? How do you reduce stigma of 
mental health issues? Does your practice have policies in 
place to help ensure everyone is treated equally? 
Where would the team benefit most? Identify training 
which could help build confidence in managing issues, 
The RCVS Mind Matters and Mental Health First Aid are a 
great place to start (Mind Matters and  MHFA England).
Each practice will have different priorities, for us it 
was Managing Mental Health, Mental Health awareness 
for all our employees, manual handling to reduce health 
issues including back problems and looking at the health 
issues for our teams. By putting focus on these areas, we 
can improve the way individuals work and how the team 
manages. This, in turn, improves well-being and helps 
build individuals resilience, resulting in better care for our 
patients and retention of our team. 
VN Futures: a VN’s 
guide to the Practice 
Standards Scheme
Elizabeth Cox 
More than half of veterinary practices in the UK are now 
accredited under the RCVS Practice Standards Scheme. 
With the addition of optional practice awards in 2015, 
the  scheme continues to grow. This presentation will 
explain the scheme, examine the awards and look at the 
 relevance and benefits to practice. A lot of preparation 
for the assessment is commonly completed by nurses, in 
addition to ensuring continued compliance. The presenta-
tion will look at common pitfalls, commonly asked ques-
tions, but more importantly examine how the scheme 
supports practice, and aids quality of care. Everyone 
knows you need time to prepare, the presentation can’t 
give you that. It will ensure you leave knowing some 
handy tips, a good understanding of the scheme and 
how nurses can use the scheme in their daily role, not 
just on assessment day.
KEY LEARNING OBJECTIVES
■■ Understand the RCVS Practice Standards Scheme 
and the awards
■■ Understand the role of the RVN in the Practice 
Standards Scheme
■■ Understand common pitfalls, and the benefits to 
practice and patient care
MULTIPLE CHOICE QUESTIONS
1. What is the purpose of a Practice Standards 
Scheme assessment? 
(A) A box-ticking exercise
(B) A legal requirement
(C) To help the RCVS know who has 
completed their CPD requirement
(D) An assessment to check standards are 
met against set criteria
2. What must every practice premises comply 
with?
(A) All requirements of the scheme
(B) Every award relevant to the scheme
(C) All requirements relevant to the level of 
accreditation applied for
(D) A random selection made by the assessor
3. What is the main role of Stanley?
(A) To collect payments due to RCVS
(B) See where the assessors are working
(C) A storage system for documents
(D) Check behaviours and outcomes in 
practice 
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VN Futures: a VN’s 
guide to Schedule 3 
and delegation
Julie Dugmore
What does the future hold for registered veterinary 
nurses (RVNs)? Join Julie Dugmore, Director of Veteri-
nary Nursing at the Royal College of Veterinary Surgeons 
(RCVS), as she walks us through the developing role of 
veterinary nurses and updates us on the RCVS’s review of 
Schedule 3.
Schedule 3 was first introduced back in 1991 when 
the RVN role was less defined than it is today. In early 
2015, with the granting of the new RCVS Royal Charter, 
RVNs became recognized as true professionals in their 
own right and whilst it is still a young profession it now 
has firm foundations upon which to build its future.
In 2016 the RCVS therefore teamed up with the 
 British Veterinary Nursing Association (BVNA) to launch 
the VN Futures project, designed to create a blueprint 
for the future of the veterinary nursing profession. During 
the evidence-gathering sessions for this project there 
was found to be a great appetite to increase the number 
of tasks that RVNs are allowed to undertake, and a great 
deal of discussion around existing guidance on which 
surgical tasks (not involving entry into a body cavity) can 
be delegated. One of the recommendations of the VN 
Futures report was to ‘clarify and bolster the VN role via a 
reformed Schedule 3’ and to this end, RCVS began to 
undertake a review of Schedule 3.  
There will be an opportunity to ask those sticky 
questions and tell us your thoughts. 
KEY LEARNING OBJECTIVES
■■ Delegation – who, how and when
■■ Activities of the Legislation Working Party
■■ What the future of the RVN may look like
VN Futures: a VN’s 
guide to Advanced 
Practitioner Status
Susan Howarth
The current RCVS Diploma in Advanced Veterinary 
 Nursing is the only post-qualification veterinary nursing 
professional award made by the Royal College of Veteri-
nary Surgeons under Royal Charter. 
The award, which has been running for 13 years, is 
set within the Framework for higher education qualifica-
tions in England, Wales and Northern Ireland (FHEQ) 
at  Level 5 and requires achievement of a minimum of 
120 credits (each credit point equating to a notional 10 
hours of learning) delivered and assessed by a Higher 
Education Institution (HEI). In addition, candidates must 
also achieve the final integrative assessment which has 
traditionally been assessed by the HEI. 
Continuing professional development (CPD) is man-
datory for all registered veterinary nurses (RVNs); not 
only does this ensure the best possible patient care, it 
also facilitates career progression. Throughout the VN 
Futures roadshow meetings, the need for further post-
registration qualifications that are accessible, flexible and 
cost effective was strongly expressed. In addition to spe-
cialist clinical pathways, other areas for post-registration 
awards, such as leadership and management, advanced 
first opinion and advanced practitioner nursing were also 
highlighted.
With the above in mind, we have developed a new 
post-registration framework designed to provide acces-
sible, flexible and affordable professionally recordable 
post-registration certificates. The framework has been 
devised to incorporate all levels of registerable veterinary 
nursing qualifications, to provide a continuum of educa-
tion and professional advancement for veterinary nurses. 
The profession is seeing the value of focused post-
registration qualifications to help the development of 
specialist areas of interest. Veterinary nurses are recog-
nized as true professionals in their own right and now is 
the time to open the mind to new possibilities and ideas. 
The introduction of an Advanced Practitioner Status 
would clearly identify, to the profession and the public, 
those veterinary nurses who have gained knowledge, 
competence, skills and experience in a specialist field.
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The lab report says 
MRSP: what do I need 
to know?
Anette Loeffler
MRSP (methicillin-resistant Staphylococcus pseudinter-
medius) infections continue to be amongst the most 
challenging multidrug-resistant bacterial infections in 
small animal practice. While some practitioners, particu-
larly in the UK, may not have encountered any, others will 
be seeing increasing numbers (in North America, MRSP 
nowadays account for up to 50% of staphylococcal skin 
infections). MRSP is most often identified from skin, 
wound and ear infections, particularly in patients with 
chronic skin disease or those undergoing surgery. The 
prognosis for infection tends to be good, especially if the 
infection is amenable to topical antibacterial therapy 
(with a compliant owner and patient). However, MRSP 
has a zoonotic potential, can be transmitted directly and 
indirectly between animals and the environment and is 
nowadays considered a veterinary nosocomial patho-
gen. Furthermore, dogs can continue to carry MRSP on 
healthy skin and mucosae for months after infection has 
resolved, and thus contribute to a public health risk.
This session will summarize information from recently 
published MRSP guidelines and highlight how they can be 
applied to general practice in order to  mitigate the spread 
of this multidrug-resistant pathogen. With a focus on the 
most common types of MRSP infection, discussion 
points will include diagnosis, how to get the best out of 
the microbiology report, treatment recommendations 
and hygiene requirements. Important points for owner 
education and managing owner expectations and on 
how to manage patients after infection has resolved will 
be outlined. 
KEY LEARNING OBJECTIVES
■■ Understand the wider implications of methicillin-
resistant Staphylococcus pseudintermedius (MRSP) 
infection for the patient and the practice
■■ What is relevant with regard to treatment choices?
■■ How to prevent MRSP recurrences in my patient and 
spread to other animals and people
MULTIPLE CHOICE QUESTIONS
1. Which of the following is TRUE for MRSP 
infections?
(A) They can have a good prognosis given 
appropriate therapy and provided primary 
causes can be controlled
(B) They are typically severe and have a 
guarded prognosis
(C) Most often affect young or 
 immuno compromised animals
(D) Can be resolved with most licensed 
antimicrobials provided long enough 
courses are given
2. If an MRSP is isolated, which of these drugs is 
likely to be ineffective in vivo even if in vitro 
susceptibility is reported?
(A) Tetracycline
(B) Co-amoxiclav
(C) Potentiated sulphonamide
(D) Enrofloxacin
3. Why is accurate species differentiation between 
MRSP and MRSA is important?
(A) Their epidemiology and hostpreferences 
differ
(B) Missed identities can lead to unnecessary 
implementation of hygiene measures
(C) Treatment choices are determined based 
on species identification
(D) MRSP is more virulent than MRSA
Tough choices: 
treatment options for 
MRSP pyoderma 
Anette Loeffler
This session will provide treatment recommendations 
for  different types of infection and outline common 
approaches to treatment decisions. As for other 
 multidrug-resistant opportunistic pathogens, the con-
cept ‘less is more’ with regard to the systemic use of 
 antimicrobials can be applied to many MRSP infections. 
Case examples will be provided of how, for the most 
superficial infections, stopping systemic antibacterial 
treatment, removing implants where possible and using 
topical antibacterial therapy can be effective. The pros 
and cons of topical antibacterial therapy as the sole 
treatment of superficial pyoderma and MRSP otitis will be 
discussed. For deep infections where systemic therapy is 
indicated, treatment options for MRSP can be extremely 
limited. Basic principles and drug- specific characteristics 
important for MRSP infections (inducible resistance to 
clindamycin, class resistance for fluoroquinolones and 
tetracycline, lack of in vivo efficacy for co-amoxiclav 
despite occasional in vitro susceptibility) will be dis-
cussed. In some cases, where no licensed drugs are suit-
able, older drugs or those with smaller safety  margins 
may have to be considered. 
Case examples will be presented for the most fre-
quently chosen agents, including a discussion of ethical 
considerations and responsibilities. In addition, the need 
for close monitoring of clinical progress will be high-
lighted as cases of multi-MRSP isolates have emerged 
where initial improvement on therapy is followed by 
relapses while on therapy. Drug combination therapies 
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will be mentioned where appropriate and the impor-
tance of treatment for underlying causes will be shown.
KEY LEARNING OBJECTIVES
■■ Make correct treatment decisions for different types 
of methicillin-resistant Staphylococcus 
pseudintermedius (MRSP) pyoderma
■■ Understand when and how to use some critically 
important antimicrobials for MRSP
■■ Manage the wider implications of MRSP pyoderma 
to prevent recurrences
(D) Broad-spectrum antimicrobials will be 
effective against MRSP
2. Which adverse reactions are associated with 
amikacin therapy in the dog?
(A) Hepatotoxicity and orange urine
(B) Nephrotoxic and ototoxic
(C) Central nervous system adverse effects 
and blindness
(D) Transient diarrhoea
3. Which of the following applies to topical 
antibacterial shampoo therapy for MRSP 
superficial canine pyoderma?
(A) It is quick and easy to do for owners but 
should not be used without resistance 
testing
(B) Resistance to topically used agents is a 
major cause of treatment failure
(C) It should always be combined with 
systemic therapy 
(D) It can be effective as the sole treatment if 
used correctly
MULTIPLE CHOICE QUESTIONS
1. Which of the following is TRUE? 
(A) MRSP superficial pyoderma should always 
be treated systemically
(B) MRSP superficial pyoderma is best treated 
with topical therapy alone
(C) MRSP infections are not of concern unless 
they progress to bacteraemia
Top hygiene tips for 
dealing with multidrug-
resistant skin 
pathogens in practice
Anette Loeffler
The benefits of hygiene measures in hospitals (and by 
extension in veterinary establishments) have been well 
recognized and documented for the past nearly 200 
years. However, the importance of hygiene may have 
been neglected again during the more recent golden era 
of antimicrobials when bacterial infections could be 
treated more easily and when hygiene levels had 
improved overall in line with increased sanitation. Now, 
at a time when antimicrobial resistance presents a major 
threat to human and animal health, attention to hygiene 
is warranted again. Even though implementation of 
hygiene measures may appear cumbersome, not imme-
diately rewarding, time-consuming and costly, it will be 
one of the major tools for some time to come in prevent-
ing and limiting multidrug-resistant (MDR) bacterial 
pathogens when effective drugs are no longer available 
or potentially their use is restricted. In the veterinary 
environment, the potential for contamination of the 
practice environment with MDR pathogens is particularly 
great for patients with skin, ear or wound infections, 
which shed pathogens from skin and mucosal infection 
and carriage sites and are likely to be visiting the practice 
frequently for chronic or recurrent primary disease.
With a focus on MRSP and other skin pathogens, this 
session will provide practical tips on hygiene measures 
achievable in most practice and hospital settings (includ-
ing some tips on improving hand hygiene, a practice 
 traffic light system for barrier nursing and isolation pro-
cedures). Examples of ‘dos’ and ‘don’ts’ will be provided, 
focusing on three areas: before, during and after a poten-
tial outbreak. A lot can be achieved with simple, inexpen-
sive measures through awareness, some behavioural 
changes and a microbiologically trained mindset. Lastly, 
involving owners and the practice team in discussion, 
funding and implementation of hygiene measures is 
 critical for a successful outcome.
KEY LEARNING OBJECTIVES
■■ Recognize practical opportunities for disease 
prevention through hygiene
■■ Understand and communicate the benefits of good 
practice hygiene
■■ Manage known methicillin-resistant Staphylococcus 
pseudintermedius (MRSP) patients in the practice
MULTIPLE CHOICE QUESTIONS
1. Which of the following multidrug-resistant 
bacteria is NOT considered zoonotic?
(A) Methicillin-resistant Staphylococcus 
pseudintermedius (MRSP)
(B) Pseudomonas aeruginosa
(C) Methicillin-resistant Staphylococcus 
aureus (MRSA)
(D) Mycobacterium bovis
2. How long can staphylococci remain viable on 
dry surfaces?
(A) Only a few minutes
(B) Up to 2 days
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(C) Over 1 year
(D) Many years as they produce spores
3. Which of the following have NOT been 
identified as risk factors for MRSA or MRSP?
(A) Prior hospitalization
(B) Prior antibiotic usage
(C) Prior history of pregnancy and whelping
(D) Prior surgery
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Clinical pathology on a budget
346 08:30–09:15Getting more for no more from your laboratory
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Kathleen Tennant
347 11:05–11:50Cytology: don’t forget the blood smear
Kathleen Tennant
348 12:00–12:45Cytology: fluids
Kathleen Tennant
349 14:05–14:50When to test and when to treat?
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350 15:00–15:45Point-of-care meters
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for exotics
351 16:50–17:35Small mammals
John Chitty
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Getting more for 
no more from your 
laboratory
Ian Ramsey 
The ‘white heat’ of modern veterinary science comes 
with a price tag that some owners are unable to contem-
plate. Clinical pathology can be a significant part of that 
final invoice. This cost can be reduced by careful case 
selection and choice of test. However, there are risks in 
this approach both in terms of patient welfare and prac-
tice economics. It is important to discuss all these costs 
and the risks of cost reduction with clients before 
embarking on any given course. Few in-house laborato-
ries are cheaper than their commercial counterparts. 
Commercial laboratories can offer a more reliable ser-
vice but there is an increased delay in getting results. 
Equally some tests are much cheaper if performed in 
practice (for example examination of a blood smear) but 
training, practice and experience are important.
Many external laboratories encourage the use of 
 panels of tests. These selections can be beguilingly easy 
to choose, but some of the tests included within them 
are unnecessary in certain clinical situations. What con-
stitutes an ‘adequate work-up’ should not be determined 
by a text book. The diagnostic criteria presented in 
research papers or used by referral practices may not be 
appropriate in a first-opinion practice. In general, the 
greater the number of clinical signs that are consistent 
with a diagnosis then the less rigorous the confirmation 
of  the diagnosis is required to be. Large panels of tests 
increase the likelihood of results being outwith ‘reference 
ranges’ that may not be relevant to the patient, leading to 
misleading information and potentially incorrect diagno-
ses. Clinicians can save their clients considerable expense 
by contacting clinical pathologists to discuss the clinical 
history and the results of any diagnostic tests. All external 
laboratories provide telephone advice and can direct clini-
cians to further specialist advice on treatment if needed. 
Getting all the help and advice that you can reduces the 
risks of misdiagnosis and incorrect treatment.
The use of external laboratories also provides a huge 
opportunity for unofficial CPD. Examining blood smears 
and cytological preparations for yourself in those cases 
where samples are submitted allows you to better help 
those cases where owners cannot afford external exper-
tise. Experience only comes with practice – and lack of 
practice damages self-confidence. Examining our own 
cytological preparations and blood smears allows us to 
better appreciate the comments made by external labo-
ratories. Similarly, with biochemical results, a clinician is 
well advised to consider their own interpretation before 
looking at all interpretations that are provided both as an 
educational exercise and as critical control point. A clini-
cian may never be as good as an expert in clinical path-
ology in an external laboratory, but that does not mean 
we can resign our responsibility for the final diagnosis. 
Therefore, we need to some extent to check that the 
 laboratory report fits in with our clinical impression and not 
be led by the numbers or other people’s interpretations.
Key to effective case selection is a detailed clinical 
examination with a focused patient history. This then 
needs to be communicated to the laboratory. The author 
believes that this communication is the attending clini-
cian’s responsibility and should not be delegated. How-
ever, this communication must also be brief – a PDF file 
of 78 pages of clinical notes is no more appropriate than 
one word. It is helpful to try to identify, then refine, the 
question that the clinician hopes the clinical pathologist 
will be able to help answer. ‘What is wrong with my 
patient?’ is too general! 
KEY LEARNING OBJECTIVES 
■■ You will know what is meant by the term ‘clinical 
pathology on a budget’ and the limitations and 
shifts in responsibilities that it imposes
■■ You will consider the range of outputs of external 
laboratories and how you can use these to their 
maximal effect in specific examples
■■ You will know the advantages of providing external 
laboratories with a good summary of the medical 
history and what is contained (and not contained) 
within that history
MULTIPLE CHOICE QUESTIONS 
1. You are presented with a 13-year-old cat with a 
3-month history of weight loss and lethargy 
but the owner reports no recent changes in 
appetite, thirst, urination and defecation. 
A detailed clinical examination is unremarkable. 
Your laboratory offers you an ‘old thin cat 
profile’ (consisting of T4, blood urea nitrogen 
(BUN), creatinine, alanine aminotransferase 
(ALT), alkaline phosphatase, glucose, urinalysis). 
What would be the most effective way of 
reducing the cost to the client?
(A) Just test blood glucose first
(B) Just test T4 first
(C) Just test creatinine first
(D) Just perform urinalysis first
2. Which group of clinical pathology tests is 
nearly always best done at an external 
laboratory?
(A) Biochemistry
(B) Endocrinology
(C) Haematology
(D) Urinalysis
3. What is the approximate incidence of 
abnormalities on a ‘pre-anaesthetic profile’ 
performed in otherwise healthy dogs such that 
anaesthesia would be postponed or the 
protocol changed? 
(A) 10%
(B) 3%
(C) 1%
(D) 0.3%
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Cytology: fine-needle 
aspirate techniques 
and solid lumps
Kathleen Tennant
Fine-needle aspiration of lumps and bumps can be a 
quick and relatively cheap way of screening lesions for 
those requiring more intensive treatment/assessment 
from those expected to have a more benign course. 
Sampling with a variety of needle sizes and smear 
techniques may lead to a better cell yield and preservation 
on some smears than others and increase chances of 
obtaining at least one diagnostic sample. Taking care of 
the sample (drying quickly, not exposing to formalin fumes 
or water vapour, not loading into slide carriers while still 
wet) also results in better samples for  assessment. 
Be familiar with the charging structure of the external 
laboratory you send your slides to and make the most 
of it. 
Even if you do not receive a definitive diagnosis with 
your aspirate of a lump, sometimes determining what it 
is  not can be enough to help you manage your case, 
whether this is treatment or further diagnostics. 
■■ If the sample is inflammatory in nature, be patient 
and spend time specifically looking for a cause
■■ If the sample yields tissue cells, ask yourself if the 
type of cell is appropriate for that anatomical 
location – knowing which cells are expected to be 
present helps you to spot interlopers
■■ The appearance of cells often signals their 
behaviour. Cells performing the same task usually 
look similar to each other. Wide variation may signal 
a loss of growth inhibition and should be regarded 
with suspicion
■■ Cells also warn of imminent or current proliferation 
with the presence of coarser chromatin, nucleoli 
and mitotic figures – marked increases in these in 
what should be a slow-growing tissue may not be 
appropriate
In short, screening cytology samples may save time 
and money by directing treatment and rationalizing 
 further diagnostics. 
KEY LEARNING OBJECTIVES
■■ Pick the best sampling techniques for the aspiration 
of lumps and bumps
■■ Appreciate the common artefacts seen on cytology 
and how to avoid them
■■ Screen cytology samples for inflammatory and 
neoplastic processes
MULTIPLE CHOICE QUESTIONS
1. Which of these is NOT associated with 
malignancy?
(A) Marked variation in cell size within a single 
population
(B) Uniformity of size within a cell population
(C) Marked variation in nuclear size within a 
single population
(D) Increased numbers of mitotic figures
2. Which of the following is NOT a cytology ‘sin’? 
(A) Staining a slide before you send out a 
sample to ensure that you have cells
(B) Placing the slides in a plastic slide 
container while they are still wet
(C) Placing the cytology slides in the same 
plastic bag as the histopathology samples
(D) Blowing on the slides to ensure quick 
drying
3. Which of the following is required to be certain 
that a cytology sample demonstrates a septic 
bacterial cause? 
(A) Many different bacterial types being 
present
(B) A monomorphic population of bacteria 
being present
(C) Bacteria being present inside macrophages
(D) Bacteria being present inside neutrophils
Cytology: don’t forget 
the blood smear
Kathleen Tennant
Haematology in the practice or external laboratory 
involves the generation of numerical values and often 
graphs or scatter plots. Often these give a strong indi-
cation of underlying haematological abnormalities – 
 however, there are still some clinically relevant findings 
which can only be identified on the blood smear. 
Platelet counts through the machine are subject to 
many artefacts which may result in incorrect numerical 
values. Assessing the smear can lead to a very different 
interpretation of what may initially appear to be a very 
thrombocytopenic sample. 
Although many erythrocyte abnormalities do 
result in abnormal smear values, there are some which 
will be missed entirely without smear examination. 
An example of this would be the presence of red cell 
shear injury products, which might be caused by micro-
angiopathic damage from underlying conditions, such 
as disseminated intravascular coagulation or abnormal 
small vessels in some neoplasms. The presence of 
Heinz bodies secondary to oxidative damage to eryth-
rocytes can be seen on the routine smear, but is more 
obvious on a New Methylene Blue smear – not only 
does the presence of these suggest possible underly-
ing pathologies (e.g. diabetic ketoacidosis, toxicity), 
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but may also affect the haemoglobin measurement 
through the machine. 
Leucocytes are counted by different machines using 
different methodologies, and while total counts are often 
reliable, differential leucocyte counts can be variable. 
Looking at the smear helps to confirm the presence of 
left shift and toxic change in neutrophils, allowing a full 
appreciation of the degree of demand for neutrophils. 
Abnormal nucleated cells present in the blood smear 
can be assessed for possible origin, although this is not 
always fruitful. Nucleated red cell precursors can be 
identified and counted differently in different machine 
types and being able to enumerate and assess these can 
avoid acceptance of a spurious leucocytosis. 
Although unusual, some pathogens, can be seen on 
the blood smear. Although haemoplasmas are extremely 
difficult to identify, some larger organisms such as 
 Babesia sp. can be demonstrated inside erythrocytes. 
Assessing the smear is worthwhile where there are 
abnormalities in the machine values, and, where possi-
ble, in any clinically unwell animal to provide the full 
 haematological picture and direct further management.
KEY LEARNING OBJECTIVES
■■ Assess some changes in erythrocyte morphology 
and appreciate how these may signal underlying 
pathology
■■ Identify certain pathogens on the blood smear
■■ Use the smear to confirm or refute platelet 
measurements through the machine
MULTIPLE CHOICE QUESTIONS
1. Which of the following is true of a blood smear 
showing red cell regeneration? 
(A) Neutrophils will also be left shifted
(B) Microcytosis will be visible in the red cells 
due to younger red cell precursors being 
present
(C) Larger, more basophilic red cells will be 
visible on the smear
(D) Nucleated red cells are always present
2. Which of the following is true of platelets? 
(A) Very low counts through the machine will 
be due to clots in the sample and should 
be ignored
(B) Platelet clumps in the sample means that 
the animal definitely has adequate platelet 
numbers
(C) Larger platelets can be associated with 
platelet regeneration
(D) All Cavalier King Charles Spaniels have 
larger platelets and their platelet mass 
cannot be assessed
3. Which of the following is NOT a sign of toxic 
change in a neutrophil?
(A) A U-shaped nucleus
(B) Cytoplasmic basophilia
(C) Cytoplasmic vacuolation
(D) Doehle bodies in the cytoplasm
Cytology: fluids
Kathleen Tennant
Cytology of fluid samples can come with its own chal-
lenges. Depending on the cellularity and viscosity of the 
fluid, direct ‘slide over slide’ techniques may be appropri-
ate for higher cellularity or thick samples, but in many 
cases a degree of concentration of the sample may be 
appropriate to ensure the best cell yield. Line prepara-
tions or sedimentation techniques can be employed 
where the cells are too fragile to concentrate easily in the 
centrifuge. 
Drying slides made from fluids is best done quickly – 
thick, slow-drying preparations (such as synovial fluid 
placed into slide holder while still wet) can result in 
 artefacts which can severely hamper assessment. 
When assessing the smear, attention should be paid 
not only to the cells present but to the background as 
well. The first question should always be ‘Is this slide of 
diagnostic quality?’ If the cells are difficult to assess, it 
may be worth stopping and making another preparation. 
Low-cellularity fluids with a transudative origin, 
whether pleural, peritoneal or cerebrospinal fluid (CSF) 
can be challenging in terms of cell yield, but frequently 
have a limited number of cell types associated with 
them. 
Addition of proteins or cells to fluids (e.g. in exudates) 
usually results in preparations which are easier to assess, 
but thicker areas should be avoided. If inflammatory cells 
are present, a careful search for possible causes is always 
worthwhile. As well as more obvious causes such as 
organisms in septic peritonitis/pyothorax, other causa-
tive substances such as bile pigment in biliary rupture can 
occasionally be seen on the smear. Degenerative change 
in neutrophils can occur with septic causes, but also with 
exposure to bile pigments, urine or pancreatic enzymes. 
It should be noted that neutrophils in septic synovial 
 fluids rarely show degenerative change – and phagocy-
tosed bacteria are extremely rarely noted. 
Neoplastic populations can be easy to pick up in 
some conditions (such as large cell lymphomas), but may 
exfoliate poorly in others (e.g. haemangiosarcomas) and 
finding them requires patience. 
The presence of reactive mesothelial cells in pleural, 
peritoneal and pericardial fluids can complicate the 
 picture – these cells undergo changes which mirror 
 criteria for malignancy, and it is often impossible to 
 distinguish mesothelioma/carcinoma from a merely 
 dysplastic, reactive population. 
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KEY LEARNING OBJECTIVES
■■ Pick the best sampling, storage and preparation 
techniques for fluids
■■ Appreciate the common artefacts seen on fluid 
cytology and how to avoid them
■■ Screen fluid cytology samples for inflammatory 
and neoplastic processes
(D) If there will be a delay in processing, store 
on the bench side
2. Which of the following is required for a 
confident diagnosis of septic pyothorax?
(A) Bacteria seen in the  
background
(B) Bacteria adherent to squamous 
epithelial cells
(C) Bacteria inside macrophages
(D) Bacteria inside neutrophils
3. Which of the following would NOT be a 
criterion for malignancy in a mesothelial 
peritoneal fluid population?
(A) A population in regular sheets
(B) A population showing variation in size
(C) A population with multiple nucleoli present 
in most cells
(D) A population with uneven multinucleation
MULTIPLE CHOICE QUESTIONS
1. Which of the following is an acceptable way to 
handle fluids for cytological analysis? 
(A) Make a direct preparation as well as a 
concentrated sample
(B) Routinely add a drop of formalin to fluid 
samples before making a preparation
(C) If there will be a delay in processing the 
sample, store in the freezer
When to test and 
when to treat?
Ian Ramsey 
It is one of the perversities of life as a veterinary surgeon 
that the more experience of a particular condition that a 
clinician has, the cheaper the average total bill for that 
condition (author’s unpublished observations). Some of 
this difference is the willingness of experienced clinicians 
to reduce the number and frequency of diagnostic tests, 
preferring to rely on therapeutic trials. Such trials are 
often highly effective management strategies. Preferring 
a treatment trial to a diagnostic test should not mean 
reducing the value placed on your time. The costs and 
benefits in treating dogs with a specific diagnosis need 
to  be discussed with an owner before embarking on a 
therapeutic trial. Not all cases – even with a confirmed 
diagnosis – require treatment. Some cases may be 
 monitored without treatment for months to years. Other 
cases may benefit from practical advice such as provid-
ing a  dog-coat for dogs with non-pruritic alopecia.
Central to any discussion about treatment trials is to 
think about the necessity of diagnosis. Common presen-
tations that do not usually require a diagnosis to be made 
include the first presentations of many acute clinical signs 
such as cough (without a heart murmur), vomiting, fever, 
diarrhoea, pruritis and stranguria. These presentations are 
noted for their ability to self-resolve, the availability of 
symptomatic treatment and one or two very common 
clinical causes. In contrast other presentations such as 
polyuria and polydipsia (PU/PD), yellow or white mucous 
membranes, ascites, abdominal masses and collapse do 
require some investigation to ascertain likely diagnoses 
and/or prognosis. Usually such presentations have no 
‘symptomatic treatment’ options, may require urgent 
 surgical intervention, or multiple possible differential 
diagnoses some of which may be rapidly  progressive. 
Therapeutic trials have their limitations. If the first 
attempt is unsuccessful then repeating them is unlikely 
to work. Second and subsequent presentations of many 
of the above clinical signs require at least an attempt at 
diagnosis. Cytological analyses of aspirates from fluids 
and masses are probably the most diagnostically useful 
form of clinical pathology. In contrast, haematology in 
non-anaemic, non-pyrexic animals is probably the least 
likely to be diagnostic. Urinalysis is best done in-house, 
whereas non-urgent biochemistry is often best done in 
an external laboratory. 
It has been shown by several studies in several dis-
eases that the clinical signs of a condition are often the 
best monitoring tools available. The better the owner 
monitors the clinical condition of the patient then the 
fewer blood tests etc. are needed. Asking owners to 
record water consumption, the time taken to eat the 
food, the faecal quality in an objective or semi-objective 
way will help to reduce the uncertainty factor which 
encourages clinicians to perform additional blood tests. 
KEY LEARNING OBJECTIVES 
■■ You will know a selection of case presentations that 
may be successfully managed without the use of 
diagnostic testing
■■ You will be able to develop a set of criteria for the 
assessment of any case to determine if diagnostic 
testing is likely to be productive
■■ You will appreciate the increased need for clinical 
monitoring with a reduction in diagnostic testing
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MULTIPLE CHOICE QUESTIONS 
1. You are presented with an 8-year-old Cocker 
Spaniel with a 2-day history of frequent bilious 
vomiting, lethargy and anorexia. There is no 
history of toxin or foreign body ingestion. A 
detailed clinical examination only suggests 
mild abdominal pain and dehydration. Your 
laboratory offers a Vomiting Dog screen 
(consisting of blood urea nitrogen (BUN), 
creatinine, alanine aminotransferase (ALT), 
alkaline phosphatase, electrolytes, qualitative 
pancreatic lipase). How would you manage this 
case if the client had a limited budget?
(A) Don’t test but rather treat with fluids, 
maropitant and pain relief for 24–48 hours 
and then reassess
(B) As in a. and submit samples for the 
Vomiting Dog screen 
(C) As in a. and also perform diagnostic 
imaging but not clinical pathology
(D) As in a. and just perform an in-house 
qualitative pancreatic lipase
2. What is the most effective method of 
monitoring a 12-year-old Minature Pinscher 
with diabetes?
(A) Clinical examination 
(B) Fructosamine
(C) Glucose curve
(D) Owner monitoring of urination, thirst, 
appetite and weight
3. You are presented with a 9-year-old  
neutered female Dobermann with a 2-day 
history of stranguria and the owner has  
noticed blood in the urine (which the dog is 
still able to pass in small volumes frequently). 
What is the most appropriate symptomatic 
treatment?
(A) Marbofloxacin and buprenorphine
(B) Amoxicillin and increased water added 
to the food
(C) N-acetyl glucosamine and hyaluronic  
acids
(D) A prescription diet formulated to regulate 
urinary pH and time
Point-of-care meters
Ian Ramsey 
In the last 20 years many point-of-care (POC) meters 
have been introduced to the veterinary market. These 
differ from in-house biochemical analysers in offering a 
smaller range of tests that are designed to be taken to the 
patient, used repeatedly and provide near-instant results. 
POC devices include meters not only for glucose 
(with which many primary care clinicians are already 
familiar) but also for blood gases, electrolytes, ammonia, 
lactate, haemoglobin, ketones, coagulation tests and 
many others. These devices often have their origins in 
human medical POC tests. Such devices are subject to 
statutory regulation in the human healthcare market 
ensuring that certain performance criteria are met. No 
such regulations exist within the veterinary market and 
therefore it is important that practices are aware of the 
performance characteristics of these devices, so they 
can interpret results from them effectively. 
POC devices offer economies of scale that make indi-
vidual tests much cheaper than conventional in-house or 
external laboratory testing. However, as they often only 
measure one parameter they are usually best seen as 
monitoring devices rather than diagnostic tools. Their 
convenience can be offset by a reduction in the quality of 
the results, but providing the quality is still  sufficient then 
the immediacy of those results may be of significant 
 clinical benefit. In some cases the quality of the results is a 
significant improvement on those available from in-house 
analysers (e.g. ammonia). In others the quality is better 
than existing alternatives (e.g.  haemoglobin compared to 
the traditional spun packed cell  volume).
These devices can be very accurate and reliable – 
but they can be inaccurate or, worse, inconsistent both 
between samples and when used repeatedly on the same 
sample. There are published papers in respected peer-
reviewed journals on the performance parameters for 
some POC devices, however some POC devices have 
never been independently evaluated in the clinical set-
ting and performance data are limited and hard to obtain. 
Veterinary practices need to know how their devices 
 perform over time and wherever possible against other 
machines and clinical expectations. 
These devices can be easy to use – and easy to use 
wrongly. Incorrect use may not produce error alerts. 
Instructions provided with the device are not always 
clear or well illustrated. Veterinary practices using such 
devices must therefore have clear training protocols 
(and it is good working practice to have a list of nomi-
nated trainers and who have been trained to use the 
device). 
The convenience of POC testing will mean that the 
number and range of these devices is likely to increase in 
the future. Newer technologies will expand the range of 
tests available and the number that any one device can 
deliver. 
KEY LEARNING OBJECTIVES 
■■ You will appreciate the current range, value and 
limitations of point-of-care (POC) meters with 
specific examples
■■ You will be able to develop protocols within your 
own small animal practice that ensure the optimal 
value and use of these meters 
■■ You will be aware of the likely future for POC meters 
in small animal practice and be better prepared for 
their introduction in your working life
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MULTIPLE CHOICE QUESTIONS 
1. Which of the following tests is available on 
portable POC devices?
(A) Bile acids
(B) Ammonia
(C) Liver enzymes
(D) Bilirubin
2. Which one of the following statements about 
the sensitivity of POC devices is correct?
(A) Sensitivity is calculated by dividing the 
number of affected animals by the number 
of affected and unaffected animals in a 
population
(B) Sensitivity is more important than specificity 
when considering a test that, if positive, will 
likely result in the euthanasia of an animal
(C) Sensitivity is affected by the frequency of 
disease in a population and so needs to be 
determined in each population
(D) Sensitivity increases the accuracy of the 
measurement of the analyte in  
question 
3. Why are traditional PCV measurements better 
than POC devices for haemoglobin in some 
primary care practices?
(A) They produce less sharps and are therefore 
safer
(B) They are less susceptible to operator  
error
(C) They are a better indicator of the oxygen-
carrying capacity of the blood
(D) The senior partners still use the Fahrenheit 
scale and don’t speak to doctors
Small mammals
John Chitty 
Although haematology and serology will also be discussed in the talk, this is a basic guide to interpretation of biochem-
istries in small mammals (Figure 1).
Parameter High Low
Glucose Very variable in an animal that ‘continuously’ feeds on 
high-carbohydrate foods. Not reliable enough to 
diagnose diabetes mellitus unless levels are persistently 
elevated and accompanied by  persistent glucosuria. 
Even then it may simply reflect excessive feeding of 
simple carbohydrate. Glycosylated haemaglobin and 
fructosamine may assist
Stress!!!!
Pain!!! May allow assessment of pain
Important critical care 
parameter in moribund 
animals –  hypoglycaemia may 
be  accompanied by ketosis
Protein parameters – 
total, albumin, globulin
Similar interpretation to other mammals – ideally 
should be assessed by electrophoresis. Diet and 
husbandry play a major part in determining plasma 
albumin levels
Low albumin most likely to 
result from nutritional 
problems though liver or renal 
disease may play a part
Cholesterol/triglyceride Potentially of great use given the frequency with which 
hepatic lipidosis is seen. However, diurnal rhythms and 
feeding changes make these hard to interpret (need to 
use fasted sample)
However, in the anorexic rabbit elevated values and/or 
lipaemia can be important prognostic indicators
Liver enzymes Alanine aminotransferase (ALT) – sign of  hepatocellular 
damage but not organ specific and has short half-life
Aspartate aminotransferase (AST) – less specific and 
will rise with muscular exertion or tissue damage
Gammaglutamyl transferase (GGT) – biliary stasis. Also 
found in the kidneys but not always increased in renal 
disease
Alkaline phosphatase (ALP) – nearly all tissues
Glutamate dehydrogenase (GLDH) – specific but not 
very sensitive
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Bile acids Diurnal rhythm. Fasting samples not easily possible, 
so dynamic testing not likely
Very high single samples may indicate hepatic 
dysfunction
Urea Renal disease (sensitive??)
Also, prerenal – dehydration, water deprivation, 
cardiac disease, etc
Also gut effects
Impaired hepatic function??
Creatinine Renal disease – not very sensitive
Calcium Found as bound and unbound (ionized) forms. Values 
vary greatly compared to other species. High values 
not necessarily abnormal
Hypocalcaemic tetany seen in 
pregnant/lactating does. Must 
measure ionized form!
Renal disease may cause raised 
or lowered levels of total 
calcium
Phosphate May rise in renal disease May fall in renal disease – 
effects dependent on diet
Electrolytes Probably the same as in other mammals Don’t forget effects of 
anaesthesia and lipaemia
In rabbits, sodium levels may 
be used as a prognostic 
indicator in gut stasis cases – 
lower levels are associated 
with a guarded prognosis
Figure 1: Interpretation of biochemistry results in small mammals
NB. Guinea pigs. Hyperthyroidism is well recognised 
in older animals showing weight loss and a rapid heart 
rate. Enlarged thyroids may be palpable. Normal ranges 
seem similar to cats, and measurement of total T4 is 
 recommended in these cases.
In all species a euthyroid sick syndrome may be 
 recognized. Hypothyroidism is rare in all these species.
KEY LEARNING OBJECTIVES
■■ To understand blood sampling methods in small 
mammals
■■ To understand interpretation of biochemical and 
haematology parameters
■■ To understand use and possibilities of faecal, urinary 
and bacteriology sampling in small mammals
(C) Confirms an animal will show signs of that 
disease in the future
(D) Guarantees the animal is not a carrier of 
that disease
2. Which of the following is CORRECT about a 
glucose level >30 mmol/l in a rabbit?
(A) Confirms that surgery is needed in a gut 
stasis case
(B) Suggests that obstruction of the gut is a 
strong possibility
(C) Is of no help at all in determining severity 
of disease in these cases
(D) Confirms that fluids and analgesia are all 
that will be required in this case
3. A rabbit is sneezing. What does the finding of 
Pasteurella spp. from an adult rabbit nasal swab 
show?
(A) This rabbit has pasteurellosis
(B) Is of no significance – Pasteurella is a 
commensal
(C) Should only be interpreted in the light of 
radiological and cytological findings
(D) Means the rabbit should be isolated from 
other rabbits
MULTIPLE CHOICE QUESTIONS
1. Which of the following is CORRECT about 
serology?
(A) Provides information regarding exposure 
to infectious agents
(B) Confirms infection with an agent as cause 
of disease
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Reptiles and Birds
John Chitty 
Clinical pathology is an essential tool in exotic pet medi-
cine. While it can only ever be an aid to diagnosis rather 
than diagnostic in its own right, the generalized signs 
with which these animals are often presented and their 
ability to hide signs, means that ‘tools’ other than physi-
cal examination and history are helpful.
Good reliable results depend on many factors.
■■ Correct sample taking. Sites for sampling of birds 
and reptiles will be discussed as will the need for 
sedation/anaesthesia and handling techniques. The 
volumes suitable for collection will be discussed as 
will choices of tests for very small samples. In 
summary, the following sites are generally used:
 – birds – right jugular vein, brachial vein, caudal 
tibial vein;
 – chelonia – jugular vein, dorsal tail vein, 
subcarapacial vein, brachial vein;
 – lizards – ventral tail vein, heart;
 – snakes – ventral tail vein, heart
■■ Good-quality samples. Correct anticoagulant 
selection and sample handling are vital
■■ Choice of laboratory. As a minimum, in-house 
laboratories should be able to check packed cell 
volume (PCV), glucose, electrolytes, ionized calcium 
and cytology. External laboratories should be 
selected on the basis of experience with exotics’ 
haematology, interest in exotics and range of tests 
available
■■ Choice of tests. Few tests have been evaluated in all 
the species that may be seen. In many cases tests 
used in other species are ‘applied’ to exotics. In 
addition, few ‘normals’ using large numbers of 
individuals have been generated. As such, choice of 
test and interpretation of results can be difficult 
 – In all cases, full haematology is essential and 
often provides more information than 
biochemistries
 – Protein assessment is also extremely useful 
though it is recommended that electrophoresis 
is used to measure this as it is not only more 
accurate (especially in birds where a pre-
albumin fraction may confuse differentiation of 
globulins) but provides an assessment of any 
inflammatory response
 – Electrolytes should be measured (sodium, 
potassium, chloride, ionized calcium) wherever 
possible and may be done patientside or on a 
spun heparin gel sample
 – Similarly, total calcium and phosphorus 
assessment are required in many cases
 – Creatinine kinase (CK) is often included as a 
marker of tissue damage, as many of the liver 
enzymes (e.g. aspartate aminotransferase (AST), 
lactate dehydrogenase (LDH)) are non-specific 
to liver, comparison to CK may assist in 
determining whether an enzyme rise is due to 
hepatocellular damage or tissue damage
 – Beta-hydroxybutyrate (especially chelonia), 
cholesterol and triglycerides are often used 
to assess nutritional state and risk of hepatic 
lipidosis
KEY LEARNING OBJECTIVES
■■ Understand sampling methods in birds and  
reptiles
■■ Understand interpretation of biochemical and 
haematology parameters
■■ Understand use and possibilities of faecal, urinary 
and bacteriology sampling in birds and reptiles
MULTIPLE CHOICE QUESTIONS
1. You have a 2-year-old grey parrot showing 
twitching and neurological signs. You suspect 
hypocalcaemia. Which test is most likely to be 
diagnostic?
(A) Total calcium 
(B) Total calcium + phosphate
(C) Ionized calcium tested patientside
(D) Ionized calcium tested at an external 
laboratory using posted spun serum
2. A faecal sample from a healthy Mediterranean 
tortoise reveals some ciliated protozoa and a 
number of flagellates. What is the significance 
of this?
(A) These are a potential cause of diarrhoea 
and metronidazole should be given
(B) These are a potential cause of diarrhoea 
and probiotics should be given
(C) These are normal commensals
(D) The tortoise may be infectious to others
3. What is the significance of azurophils in 
snakes?
(A) Raised in chronic inflammatory conditions, 
analogous to monocytes in mammals
(B) Artefact
(C) Part of the acute inflammatory response
(D) Of no significance in interpretation
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Odontogenic tumours
Philippe Hennet
Odontogenic tumours (OT) are tumours derived from 
ectomesenchymal and/or epithelial tissues that consti-
tute the tooth-forming apparatus. Odontogenic rem-
nants that may develop into cysts, tumours and 
hamartomas include rests of Serres, rests of Malassez 
and reduced enamel epithelium. The same way as occurs 
during normal tooth development (odontogenesis), 
inductive interactions between the oral epithelium and 
the underlying odontogenic ectomesenchyme may 
occur during development of an OT. These interractions 
may lead to formation of tooth-like mineralized material. 
CLASSIFICATION
OT represent a heterogeneous group of lesions of diverse 
clinical behaviour and histopathological types, ranging 
from hamartomatous lesions to malignancy. OT are 
divided in two categories according to their biological 
behaviour, benign and malignant, and further divided 
based on which cellular component (epithelial, ectomes-
enchymal, mixed) gives rise to the tumour and on the 
presence of induction of mineralized tooth-like material 
within the tumour. The new 2017 World Health Organi-
zation (WHO) classification has brought some changes 
(reincorporation of odontogenic cysts) but confirms this 
general classification. A veterinary WHO classification 
system was proposed in 2003. Although OT found in 
humans and animals shows similarities, the veterinary 
classification system includes entities which do not have 
exact counterparts in humans (amyloid-producing odon-
togenic tumour (APOT), feline inductive odontogenic 
tumour). However, a recent retrospective German study 
analysing 250 OT in dogs and cats has shown that four 
of  the 12 entities could be classified according to both 
WHO classifications of OT. Seven and two of the 12  entities 
could only be classified according to the  current human 
WHO classification and veterinary WHO  classification, 
respectively. A revision of the 2003 WHO  classification is 
therefore needed. 
PREVALENCE IN DOGS AND CATS
In a recent German retrospective study, a total of 1390 
canine and 317 feline oral tumours were reviewed. 
 Eighteen percent (n = 250) of the canine and 3.2% (n = 10) 
of the feline oral tumours proved to be of odontogenic 
origin. They could be divided into 12 different entities. 
The odontogenic fibroma was the most common canine 
(n = 167) and feline (n = 4) OT. The second most common 
OT for dogs was ameloblastoma (n = 74) and that for cats 
was ameloblastic fibroma (n = 2).
In a 2018 USA retrospective study, results of oral 
 histopathological diagnoses showed a prevalence of 34% 
(138/403) of OT in dogs and 3% (2/73) in cats. Peripheral 
odontogenic fibroma (POF) was the most common 
OT (52%) followed by canine acanthomatous  ameloblas-
toma (CAA) (40%).
In another study of 152 oral tumors of possible odonto-
genic origin, CAA accounted for 45% and POF for 31% of the 
histopathological diagnoses. Other OT identified included 
APOT, ameloblastic carcinoma, complex odontoma, com-
pound odontoma, desmoplastic ameloblastoma, odonto-
genic carcinoma and odontoameloblastoma.
KEY LEARNING OBJECTIVES
■■ Explain the embryological basis of the development 
of odontogenic tumours
■■ Name the biological behaviour of the most 
predominant odontogenic tumour
■■ Recall the appropriate treatment of odontogenic 
tumours
MULTIPLE CHOICE QUESTIONS 
1. Which answer is NOT correct regarding the 
development of odontogenic tumours?
(A) They originate from ectomesenchymal 
and/or epithelial tissues that constituted 
the tooth-forming apparatus 
(B) They are located at the periphery of the 
bone in the gingival tissue
(C) They may incorporate tooth-like 
mineralized material
(D) They may have epithelial or 
ectomesen chymal cellular components, 
or both
2. Which answer is NOT correct regarding canine 
acanthomatous ameloblastoma (CAA)?
(A) It is mostly observed on the rostral aspect 
of the mandible
(B) It is a benign tumour
(C) It is mostly located on the gingival margin 
with limited bone involvement
(D) It has been wrongly named in the past an 
acanthomatous epulis
3. Which answer is CORRECT regarding feline 
inductive odontogenic tumour?
(A) It is a uncommon benign tumour mainly 
observed on the mandible
(B) It is a uncommon benign tumour affecting 
cats of all ages
(C) It is an uncommon odontogenic tumour of 
epithelial origin rarely invading bone
(D) It is an uncommon, benign, locally  
invasive neoplasm primarily observed 
in young cats
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Jaw opening and 
closing disorders
Philippe Hennet
Inability to fully open or close the oral cavity is a disorder 
that can be easily identified clinically but which may be 
due to various causes interfering with the biomechanics 
of the jaws. 
CLINICAL PRESENTATIONS
Disorders affecting mouth opening/closing may arise 
from dental, osteoarticular and soft tissue causes. Disease 
processes affecting mouth opening are more  frequent 
than these affecting mouth closing. Clinical examination 
helps differentiate between both. Trismus (restricted 
mouth opening) is most frequently due to a painful local 
condition resulting in a constriction of the masticatory 
muscles. In specific cases, a systemic cause may also be 
identified. Clinical examination under general anaesthesia 
is mandatory to help determine whether the restricted 
opening is transitory or permanent. Aetiological diagnosis 
may require blood tests, tissue biopsy, electrodiagnostic 
tests and diagnostic imaging (radiographs, computed 
tomography (CT) or magnetic  resonance imaging (MRI)).
OSTEOARTICULAR DISEASES
Craniomandibular osteopathy (CMO)
This inherited condition, affecting mainly West Highland 
White Terriers, usually occurs in young dogs (3–8 months 
of age) as a painful ventral mandibular bony swelling, 
which can extend to the temporomandibular joint (TMJ) 
and tympanic bulla. The condition is self-limiting and 
resolves in most dogs at the age of 1 year.  
Temporomandibular joint diseases
Any TMJ trauma (luxation/fracture) may lead mouth 
opening or mouth closing disorders. Trauma, and less 
commonly infection or tumours, may also further lead to 
TMJ ankylosis. 
Jaw fractures
Pain, displacement of bony parts and subsequent maloc-
clusion may prevent normal mouth opening/closing.
Coronoid process displacement
This condition mostly occurs in Basset Hounds and setters. 
Due to muscular dysfunction and abnormal TMJ anatomy, 
the coronoid process (tip of the ramus) is  displaced laterally 
during opening and closure of the jaw. At the time of clo-
sure, the coronoid process may hit the ventral border of 
the zygomatic arch or move lateral to it, thus preventing 
full closure of the mouth, which appears locked. 
SOFT TISSUE CONDITIONS
Muscular diseases
Masticatory muscles are particular as myosin fibres are of 
a different type than other muscles, type-2M fibres. A 
specific immune-mediated condition, named mastica-
tory muscle myositis (MMM), specifically affects this 
group of muscles and results in progressive closure of 
the mouth and impossibility to open it, even with anaes-
thesia. 
Trigeminal neuropathy
Clinical presentation is a dog with inability to close its 
mouth. It appears as a dropped mandible. The mandible 
is flaccid and can be moved but the dog is not able to 
hold it. Usually no other neurological signs are present. 
The exact aetiology is unknown although trauma to the 
trigeminal nerve is likely. 
Infections
Infection in the oral cavity, especially in the caudal area, 
but also in the pharyngeal, orbital and retro-orbital areas, 
may induce pain, swelling and restriction in mouth open-
ing due to the space-occupying lesion. Orbital cellulitis 
of dental origin and wood stick penetration are some of 
the recognized conditions. 
Tumours
Tumours of the mucosa or connective tissue may restrict 
jaw mobility because of pain, fibrosis or space- occupying 
lesion.  
DENTAL DISEASES
Pain and soft tissue swelling associated with infections as 
well as tooth displacement associated with trauma or 
mobile teeth, secondary to periodontitis and bone loss, 
or may prevent normal mouth opening/closing.
SYSTEMIC CAUSES
Tetanus is the most common systemic cause that can 
interfere with mouth opening. As there is no specific 
test, diagnosis is based on the specific clinical presenta-
tion and on the exclusion of other neuromuscular 
causes. 
KEY LEARNING OBJECTIVES
■■ Understand the biomechanics of jaw opening/jaw 
closing
■■ Select the appropriate examination to confirm the 
cause of the condition
■■ Understand the treatment of the various causes
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MULTIPLE CHOICE QUESTIONS
1. Which masticatory muscle is only involved in 
jaw opening?
(A) Digastricus
(B) Masseter 
(C) It is an autosomal recessive inherited 
condition, mostly affecting young West 
Highland White Terriers
(D) It is an immune-mediated condition 
secondary to severe dental disease in 
middle-aged dogs
3. Which condition does NOT affect jaw  
opening?
(A) Lateral coronoid process displacement
(B) Retro-orbital inflammation/swelling
(C) Trigeminal paralysis 
(D) TMJ ankylosis 
(C) Pterygoid
(D) Temporalis
2. Which answer is CORRECT regarding 
craniomandibular osteopathy?
(A) It is the consequence of trauma at a young 
age in very active dogs
(B) It is a precancerous lesion that my lead to 
the development of osteosarcoma in 
small-breed dogs
Flap techniques in 
palatal surgery
Philippe Hennet 
Different surgical techniques (palatorrhaphy) may be 
used for midline defects. Usually, the palatal defect is 
closed with soft tissue. Palatal axial pattern flaps are 
used. Direct vascularization of the flap is from the major 
palatine artery exiting on the medial surface of the max-
illary fourth premolar tooth. With congenital defects, no 
effort is made to create an osseous partition between the 
nasal and oral cavities, although techniques involving 
bone graft have been described. With recent traumatic 
injuries, one can attempt to close the bony midline 
defect with an intraosseous ligature. 
TRANSLATION (MODIFIED VAN 
LANGENBECK TECHNIQUE) AND 
ROTATION (VEAU–WARDILL–KILNER 
TECHNIQUES) FLAPS 
An incision is made along the cleft margins, lateral inci-
sions are made along the dental arches on both side and 
the mucoperiosteum is elevated from the palatal shelves 
and displaced medially in translation. Care is taken not to 
sever the major palatine artery exiting on the palatal side 
of the fourth maxillary premolar tooth. The mucoperios-
teum is sutured in one or two layers (use of nasal mucosa 
flaps – four-flap technique – as a first layer).
When mobilization of the flap is needed, large 
U-shaped pedicled grafts centred on the palatine artery 
are made on both sides of the defect. The flaps are dis-
placed by rotation medially and caudally. The disadvan-
tage of these techniques is that the suture line is located 
above the bony defect, which is more likely to be associ-
ated with dehiscence. A submucoperiosteal graft (e.g. 
auricular cartilage) can be used to provide some under-
lying support for the flaps and favour retention of the 
blood clot. The advantage of the technique is that very 
little maxillary bone (hard palate) is left uncovered, 
decreasing the likelihood of abnormal facial growth or 
bone necrosis. 
OVERLAPPING FLAP TECHNIQUE  
This consists of an upsidedown rotation flap technique 
based on the palatine artery. On one side, two transverse 
incisions are made at the most rostral and the most cau-
dal extent of the defect and an incision is made along the 
dental arch allowing free dissection of the mucoperios-
teum from the palatal shelf up to the border of the defect. 
Care is taken not to lacerate the mucoperiosteum at this 
level as it will be used as the hinge for rotation of the flap. 
On the other side, an incision is made along the cleft and 
the mucoperiosteum dissected over a few millimetres. 
The flap is rotated upside down and the free end is intro-
duced under the mucoperiosteum on the other side of 
the cleft. Sutures are placed over the bony edge on this 
side of the cleft. By doing this, the connective tissue 
 surface of the flap, and the palatine artery, are exposed in 
the oral cavity. This technique gives very predictable 
results in various types of palatal defects (congenital or 
traumatic). A side effect of the technique is that a large 
part of the palate is left exposed and heals by second 
intention within weeks. This type of healing on a large 
part of the hard palate may lead to abnormal palatal 
development in young animals. 
KEY LEARNING OBJECTIVES
■■ Locate the main vascularization of the palate
■■ Enumerate the basic principles of flap surgery in the 
oral cavity
■■ Describe the surgical procedure
MULTIPLE CHOICE QUESTIONS
1. Which answer is CORRECT regarding the 
vascularization of the palate?
(A) The major palatal artery exits caudal to the 
last maxillary molar and runs rostrally 
along the midline
(B) The minor palatal artery plays an important 
role in the vascularization of the rostral 
part of the palate
(C) The facial artery, not the palatal artery, is 
the major vessel providing blood to the 
hard palate
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(D) The major palatine foramen in the dog is 
located halfway between the palate 
midline and dental arcade at the level of 
the distal root of the fourth maxillary 
premolar
2. Which answer is NOT correct regarding the 
principles of palatal flap surgery?
(A) The mucoperiosteal flap can be stretched 
because of its elastic property
(B) Large flaps should be harvested even for 
small defects
(C) Axial pattern flaps based on the major 
palatal artery are preferred
(D) Rotation flaps allow more displacement 
than translation flaps
3. Which is the correct answer regarding the 
upsidedown overlapping flap?
(A) An incision is made along all margins of 
the defect to achieve clean free edges
(B) The upsidedown flap is sutured over the 
opposite mucoperiosteal mucosa
(C) The upsidedown flap is rotated along 
one of the margin of the defect to act as 
an hinge 
(D) The upsidedown flap is rotated inside the 
defect and sutured to the nasal mucosa
Mandibular fracture 
repair considerations
Alexander Smithson
Orofacial trauma frequently results in mandibular frac-
ture. It is important to know how to efficiently and effec-
tively deal with these cases when they present in practice 
and at A&E centres. Emergency case assessment is 
 fundamental; a systematic approach then applied to the 
non-emergency and stable patient helps confidence in 
dealing with these cases.  
INVESTIGATION
Extraoral and intraoral X-ray imaging, and computed 
tomography (CT) scan, aid identification of injuries. 
Whilst all have particular strengths and uses, CT enables 
a much higher proportion of abnormalities to be more 
easily diagnosed. Each injury can thus be assessed and 
triaged, with consideration given to pain and complica-
tions anticipated. 
In addition to mandibular fracture, temporomandibu-
lar joint (TMJ) injury, soft tissue trauma and dental or den-
toalveolar compromise is common. Thorough appraisal 
of all injuries guides treatment. It is important to assess 
the dentition thoroughly to ensure that healthy teeth 
which may contribute to stabilization, occlusion and 
return to function are maintained, whilst diseased teeth 
likely to frustrate healing are eliminated. Injuries such as 
fracture, intrusion, luxation and avulsion may be found.
TREATMENT
A variety of mandibular fixation techniques exist. Some 
are more suitable than others in certain situations. Knowl-
edge of the treatment options and ability to select the 
most appropriate treatment is key to success in mandibu-
lar fracture cases. This must also be weighed along with 
patient, client and operator factors, for example comor-
bidities and available funds. It is unusual for a mandibular 
fracture to exist in isolation, without  concomitant injury, 
thus a variety of techniques may be  necessary for each 
patient. Ultimately the simplest, least invasive approach, 
most likely to give success on first application, and ideally 
with the lowest associated cost, is ideal. This is not always 
possible, however, and familiarity with techniques aids 
appropriate selection. Wire and acrylic minimally invasive 
techniques are a useful addition to the arsenal available. 
Selecting technique and its application to ensure occlu-
sion is critical. 
KEY LEARNING OBJECTIVES
■■ Select and assess investigations to identify  
injuries
■■ Select appropriate stabilization techniques in 
common mandibular fracture cases 
■■ Understand key factors in mandibular fracture repair 
to avoid complications 
MULTIPLE CHOICE QUESTIONS
1. Which factor is unlikely to predispose to jaw 
fracture?
(A) Tooth discoloration
(B) Large root size
(C) Periodontitis
(D) Tooth abscess
2. Which area is most likely to be injured when 
placing mandibular symphyseal cerclage wires?
(A) Caudal mental foramen 
(B) Middle mental foramen
(C) Mandibular foramen
(D) Infraorbital foramen
3. Which technique does NOT aid reduction and 
stabilization of a mandibular fracture in correct 
occlusion?
(A) Transmylohyoid intubation
(B) Acrylic application primarily to the buccal 
aspect of mandibular teeth
(C) Acrylic application primarily to the lingual 
aspect of mandibular teeth
(D) Acrylic trimming
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Oral masses in cats: 
inflammatory or 
neoplastic?
Philippe Hennet 
Cats quite frequently develop conditions resulting in 
enlargement of oral or perioral tissues with a soft or hard 
consistency. These conditions may share similar clinical 
features, which can lead to a wrong diagnosis unless 
thorough clinical examination is followed by diagnostic 
imaging and histopathology. Because both benign dental 
diseases and cancerous lesions, such as squamous cell 
carcinoma, are frequently encountered in the feline oral 
cavity, early and thorough assessment is essential in 
achieving the correct diagnosis.
DIAGNOSTIC APPROACH
Signalment and history
Some disease processes are more likely to occur in 
young animals (pyotraumatic mucosal lesions, feline 
inductive odontogenic tumour) whereas others more 
frequently affect older ones (malignant tumours). Breed 
is seldom a criterion of importance. History of previous 
recurrent diseases is to be taken into account as well as 
the rate of growth of the lesion.  
Extraoral examination
Facial structures, including lymph nodes, are palpated to 
assess the consistency and the presence of pain on pal-
pation. Nostrils and nasal airflow are inspected to assess 
potential nasal involvement and the eyes are assessed for 
potential periorbital diseases. 
Intraoral examination
This includes assessment of both mucosal surfaces and 
teeth. Any mass or bump must be clinically evaluated for 
its size, location pertaining to gingival or other oral 
mucosae, consistency (soft, fluctuant, firm, hard), appear-
ance (smooth or irregular surface, ulcerative or prolifera-
tive). A thorough clinical dental examination is performed 
using a dental probe and dental explorer.
Cytology and histopathology
Cytology and/or histopathology are ways of achieving 
true diagnosis. Most of the time biopsy followed by his-
tology is the preferred means. Cytology may be comple-
mentary to biopsy to evaluate lymph nodes (fine-needle 
aspiration) and superficial masses (exfoliation cytology). 
Diagnostic imaging
Dental radiography is an essential diagnostic tool for 
assessing dental-related lesions. Masses localized along 
the dental arch or along the palate are suitable diagnos-
tic imaging. Depending on the lesion’s localization, its 
potential extent and on the presumptive diagnosis fol-
lowing clinical examination, dental radiographs, skull 
radiographs, computed tomography (CT) scan or mag-
netic resonance imaging (MRI) may be indicated to assess 
the lateral and deep extents of the mass, loco-regional 
extent and distant metastasis.
CLINICAL CONDITIONS
Eosinophilic granuloma complex
This may be found in cats in the perioral area (indolent 
ulcer on the maxillary lip facing the canine teeth and 
eosinophilic granuloma of the mandibular lip appear-
ing as an enlarged ‘chin’) and in the oral cavity (lingual, 
sublingual mucosa, palatal or pharyngeal mucosa). 
Pyotraumatic mucosal lesions
Chronic traumatic lesions of the oral mucosa, especially 
in the sublingual area or on the alveolar mucosa, may 
appear as red proliferative or ulceroproliferative lesions. 
Dental-related lesions
Dental resorptive lesions are frequently encountered in 
cats. Dental infections due to pulpal necrosis or perio-
dontitis, as well as tooth root resorptive lesions, may be 
associated with alveolar/jaw bone osteomyelitis. Clini-
cally, a suppurative or non-suppurative appearance can 
be observed together with soft tissue swelling and bony 
changes. 
Oral tumours
Oral tumours comprise almost 10% of all tumours 
encountered in the cat, and the mouth is the third site of 
tumours after the haemolymphatic system and the skin. 
Squamous cell carcinoma is the most prevalent tumour 
and accounts for about 70% of oral tumours in cats. 
Other tumours comprise odontogenic tumours and 
fibrosarcoma. 
KEY LEARNING OBJECTIVES
■■ Understand the diagnostic approach to oral masses 
in cats
■■ Select the appropriate examination to confirm the 
cause of the condition
■■ Understand the treatment of the various causes
MULTIPLE CHOICE QUESTIONS
1. Which strategy is NOT appropriate when facing 
a non-healing extraction socket in a cat?
(A) Take a dental intraoral radiograph to assess 
for tooth root remnant
(B) Perform a biopsy if proliferative and/or 
ulcerative tissue is present at the site of 
extraction
(C) Change the antibiotic treatment based on 
culture and sensitivity
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(D) Take an intraoral radiograph or perform a 
CT scan to evaluate bony changes at the 
site of extraction 
2. Which is the most common oral neoplasm 
in cats?
(A) Ameloblastoma
(B) Fibrosarcoma
(C) Giant cell tumour 
(D) Squamous cell carcinoma
3. Which answer is NOT correct regarding 
pyotraumatic mucosal lesions?
(A) This lesion is usually observed on the 
alveolar mucosa buccal and/or distal to the 
mandibular first molar
(B) Most of these lesions resolve with surgical 
excision and extraction of the 
maloccluding/interfering tooth 
(C) Extraction of the maloccluding/interfering 
tooth alone may allow spontaneous 
healing of the lesion in some patients
(D) Most of these lesions recur as they are 
precancerous lesions, leading to 
carcinoma transformation
Feline chronic 
stomatitis: a frustrating 
and debilitating  
disease
Philippe Hennet
Feline chronic gingivostomatitis (FCGS) is a syndrome 
 clinically characterized by pain on eating and/or opening 
the mouth, pawing at the mouth, dysphagia, weight loss, 
poor general condition, grooming deficiency, ptyalism and 
sometimes bleeding from the mouth. 
HYPOTHETICAL CAUSE
FCGS is considered a multifactorial condition resulting 
from an inappropriate individual response to chronic 
antigenic oral stimulation of bacterial and viral origins. 
Chronic oral carriage of calicivirus is thought to play a 
role in cats presenting with caudal stomatitis. Other fac-
tors acting on the host’s immune response may exacer-
bate the expression of clinical lesions. Dental-related 
conditions, including periodontal disease and, possibly, 
dental resorption, are chronic inflammatory processes 
which may play a role. 
DIAGNOSIS
FCGS is a condition where inflammation extends beyond 
the mucogingival line to the alveolar mucosa and retro-
molar area (caudal stomatitis) and is not related to the 
intensity of periodontal disease. Dental radiographs 
allow the identification of the extent of periodontitis 
and of the presence of dental resorptions. Biopsy of the 
mucosa should be performed when the appearance, the 
extent or the severity of the lesion is unusual (to rule out 
neoplasia, e.g. carcinoma). Polymerase chain reaction 
(PCR) technology can be used to identify oral calicivirus/
herpesvirus carriage. 
TREATMENT
Dental extraction
Various treatments have been advocated for this condi-
tion. Most of them have been aimed at reducing the 
inflammatory process, decreasing discomfort and allow-
ing better nutrition. The current therapeutic approach to 
chronic gingivitis/stomatitis with chronic caudal stomati-
tis is to eliminate all sources of infection and chronic 
inflammatory processes from the mouth in order to facil-
itate the action of body’s defence system against calicivi-
rus. The results of dental extraction in calicivirus-positive 
cats with chronic caudal stomatitis can be summarized as 
follows: 50–60% of cats are cured, 25–30% are markledy 
improved and about 15% are totally non-responsive.
Antibiotics
The most commonly used drugs include co-amoxiclav, 
clindamycin, doxycycline and metronidazole. They are 
mostly used to decrease oral secondary infection and 
subsequent antigenic stimulation. 
Pain killers
Opioids and non-steroidal anti-inflammatory drugs 
(NSAIDs) are used in the peri- and postoperative periods. 
Anti-inflammatory drugs
Glucocorticoids can be used but high dosage are best 
avoided in calicivirus-positive or herpesvirus-positive cats. 
A tapering 3-week course can be prescribed. As far as 
possible, it is better to use NSAIDs for inflammation con-
trol in calicivirus-positive cats. When insufficient effect is 
observed, mininum dose (to effect) of corticosteroids may 
be used.
Supportive therapy 
Vitamins, fatty acids and specific food for critical care 
patients are used as necessary. Tube feeding can be done 
through an oesophageal tube after surgery for the most 
debilitated cats but is rarely necessary.
Immunomodulating drugs
Recent randomized double-blind controlled-studies 
have shown that a daily oral administration of a diluted 
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dose of feline recombinant interferon omega and daily 
administration of ciclosporin had a significant effect on 
cats with refractory cases of chronic caudal stomatitis 
(not improved after extraction) compared to control. 
Additionally, preliminary studies on mesenchymal stem 
cells have shown very encouraging results.
KEY LEARNING OBJECTIVES
■■ Summarize the aetiopathogenesis of the condition
■■ Explain the rationale for treatment of the condition
■■ Understand the outcome of treatment
MULTIPLE CHOICE QUESTIONS 
1. Which lesion is typical of feline chronic 
gingivostomatitis?
(A) Ulcerative gingivitis
(B) Lingual ulcerative lesions
(C) Caudal stomatitis
(D) Dental resorptive lesions 
2. Which answer is CORRECT regarding feline 
chronic gingivostomatitis?
(A) It is the consequence of active bacterial 
infection in feline immunodeficiency virus 
(FIV)-positive immunodeficient cats
(B) It is the consequence of the 
cytopathological effect of Bartonella sp. 
infection in cats
(C) It is an immune-mediated allergic 
condition in domestic cats exposed to 
industrial food and antiparasitic drugs
(D) It an immune-mediated inflammatory 
condition mediated by various causes 
among which oral bacteria and viruses play 
a role
3. Which answer is NOT correct regarding 
treatment of feline chronic  
gingivostomatitis?
(A) Full-mouth extractions are mandatory as 
studies have shown that only extracting 
cheek teeth is insufficient
(B) Best results require dental extractions to 
be performed 
(C) Immunomodulating drugs, such as feline 
recombinant interferon omega and 
ciclosporin, have been shown to play a role 
in the control of refractory cases after 
dental extractions
(D) The type of antibiotic and anti-inflammatory 
drugs has not been shown to have an 
influence on the severity of the lesion
Periodontal therapy
Alexander Smithson
It fundamental to understand that plaque is a soft biofilm 
and major causative factor of periodontal disease. Calcu-
lus is mineralized plaque and does not cause periodontal 
disease, but is a predisposing factor as it is a rough, 
plaque-retentive material.
Scaling, whether by hand, sonic or ultrasonic equip-
ment, is used to remove calculus. Several aims are achieved:
■■ Teeth are made fully visible to the operator for 
assessment
■■ Areas of plaque trapping and stagnation are reduced
■■ The smooth enamel surface is easily cleaned, 
assisting homecare (tooth-brushing)
■■ The water spray irrigates the area, removing debris
■■ Plaque biofilm disruption
However small particles of adherent calculus remain on 
the tooth surface, creating a more plaque-retentive 
 surface than clean enamel. 
The aims of polishing are:
■■ Create a smooth tooth surface by removal of 
calculus fragments
■■ Mechanically disrupt the plaque biofilm
Thus, both scaling and polishing are methods of  biofilm 
disruption; if no calculus is present, polishing may be more 
appropriate. Biofilms require mechanical  disruption for 
removal – their organized adherence sequence and matrix 
makes them highly resistant to other forms of removal and 
antimicrobials.
Unfortunately scaling and polishing both pose 
potential risks:
■■ Scratching and roughening of the enamel surface 
■■ Thermal pulpitis
Where a client is willing and able to brush their pet’s 
teeth, polishing has a useful role in reducing plaque 
retention (via smoothing) and thus assisting homecare, 
oral hygiene and ultimately periodontal health. However, 
if no homecare will be performed, the potential risks 
inherent to polishing, in addition to time under general 
anaesthesia to polish the teeth and its associated finan-
cial cost, likely outweigh the possible benefits. It could be 
argued that where no calculus exists and an owner is 
willing to brush, they will disrupt the biofilm themselves 
once brushing at home. To achieve periodontal health, 
plaque removal is required on a daily basis; without daily 
tooth-brushing following a scale and polish procedure, 
benefit is transient and largely cosmetic.
KEY LEARNING OBJECTIVES
■■ Understand the role of plaque and risk factors in 
periodontal disease 
■■ Understand when and how to perform safe and 
effective periodontal therapies 
■■ Know what works – select effective oral hygiene 
regimes for canine and feline patients
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MULTIPLE CHOICE QUESTIONS
1. Which factor is least likely to predispose to 
periodontal disease? 
(A) Overcrowding
(B) Diabetes
(C) Wet food
(D) Plaque accumulation
2. Which statement is UNTRUE regarding 
periodontitis?
(A) Periodontitis is reversible
(B) Periodontitis is irreversible
(C) Periodontitis is caused by plaque
(D) Periodontitis is attachment loss
3. Which statement is UNTRUE regarding 0.12% 
chlorhexidine gluconate oral rinse? 
(A) Should be used at a different time to 
brushing with toothpaste
(B) Should be used at the same time as 
brushing with toothpaste
(C) May cause tooth stain
(D) Has a substantive effect
Feline extraction 
techniques
Alexander Smithson 
Feline dentistry is frequently performed but can be highly 
frustrating; the small size and fragility of cats’ teeth, com-
pounded by pathologies, predispose to difficulty and 
complications. This lecture aims to assist veterinary sur-
geons in their approach to the problems encountered in 
practice and how best to select extraction techniques.
INVESTIGATION
Thorough examination of cases, along with the addi-
tion of appropriate tests – most notably intraoral X-ray 
imaging – enables identification of normal anatomy and 
diagnosis of pathology. The findings are assessed both in 
terms of need to extract and potential difficulty. This ena-
bles treatment planning; consideration of treatment 
need, treatment options and, where extraction is elected, 
the optimal technique to be selected. 
EQUIPMENT
Feline patients require a number of specially selected 
items of equipment to aid efficiency of extraction. Since 
most equipment has its origins in the human field much 
is more suitable for larger dogs with bigger teeth than 
those of cats. Creation of a dedicated feline extraction kit 
keeps optimum instruments immediately to hand. Appro-
priate instruments must be kept in good working order – 
sharpening is essential and can reduce potential for 
complications due to slippage. 
EXTRACTION TECHNIQUE
Whilst extraction technique is typically divided into sim-
ple (closed) and surgical (open), a number of technique 
elements are involved in each. These elements form an 
arsenal from which individual techniques are selected, 
hybridized and combined to best suit a particular case. 
Patient, client and operator factors should be evaluated. 
Patient factors can then be more closely inspected to 
focus on each tooth requiring extraction, and selection 
of the optimum technique. Further, differences in tech-
nique may be required on a per root basis. Variance in 
normal tooth anatomy dictates the approach (for exam-
ple differences between an upper and lower canine and 
upper and lower molar). Pathologies such as tooth resorp-
tion greatly influence technique; the type of pathology, 
location and severity must be considered.
Prevention of complications is key, and risks with 
specific dentition are considered. Examples include 
 oronasal communication and lip trauma in upper canine 
extraction and jaw fracture in lower canine extraction. 
Root fracture is a common complication in all cases and 
avoidance relies on use of only sufficient force, applied at 
the correct speed and in the correct direction. 
KEY LEARNING OBJECTIVES
■■ Assessment of clinical and radiographic findings to 
select extraction technique
■■ Select the appropriate extraction technique and 
equipment for feline cases
■■ Understand how to apply extraction technique 
elements for optimal efficacy in cats
MULTIPLE CHOICE QUESTIONS
1. What cases may be appropriate for crown 
amputation?
(A) Advanced periodontitis
(B) Advanced type 1 tooth resorption  
(C) Advanced type 2 tooth resorption
(D) Pulp necrosis
2. What is NOT a typical complication of upper 
canine extraction?
(A) Oronasal communication
(B) Mandibular fracture
(C) Lip trauma
(D) Flap dehiscence
3. Which of the following is TRUE about use of 
extraction forceps?
(A) Should never be used
(B) Should first apply apical pressure
(C) Should first apply traction
(D) Should have two-point contact
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Tooth extraction
Alexander Smithson 
Dentistry forms a large proportion of most surgical lists 
yet can be difficult and frustrating. Anatomy of our 
patients, combined with many pathologies, predispose 
to difficulty and complications. This lecture aims to guide 
your approach to cases in practice and enable extraction 
technique selection.
INVESTIGATION
Appropriate case examination requires the addition of 
appropriate tests – most notably intraoral radiographs – 
to both identify normal anatomy and diagnose pathol-
ogy. Examples of common pathologies in general 
practice include:
■■ Gingivitis
■■ Periodontitis
■■ Stomatitis
■■ Oral masses
■■ Tooth fracture
■■ Discoloured teeth
■■ Luxation
■■ Caries
■■ Tooth resorption
In addition to the multiple pathology types, their 
location and severity or grade typically influence treat-
ment options, timing and technique. Findings must be 
assessed on multiple levels to enable treatment planning; 
this includes: 
■■ Treatment need 
■■ Treatment options 
■■ Potential difficulty 
■■ Optimal technique
EQUIPMENT
Equipment selection is key to effective extraction. Hand 
and power instruments are required in order to perform 
extractions and knowledge of how to identify these and 
how best to use them is critical. Surgical instruments 
must be kept in good working order – sharpening and 
sterilization are essential and can reduce potential for 
complications. 
EXTRACTION TECHNIQUE
Extraction technique may be divided into simple (closed) 
and surgical (open); a number of technique elements are 
involved in each. These elements form an arsenal from 
which individual techniques are selected, hybridized and 
combined to best suit a particular case and tooth or even 
individual root. Ultimately practical experience in a wet-
lab environment is optimal to learn and gradually improve 
upon technique for the variety of tooth anatomy encoun-
tered in our patients.
Patient, client and operator factors should be 
 evaluated:
■■ Patient factors – age, comorbidities, tooth 
pathology 
■■ Client factors – wishes, treatment options, financial
■■ Operator factors – experience, time and equipment 
available
Most essentially, informed consent must be obtained 
in order to protect patients, clients and veterinary staff.
KEY LEARNING OBJECTIVES
■■ Understand key clinical and radiographic findings to 
identify pathology and treatment options
■■ Select appropriate extraction technique
■■ Understand key elements of informed consent in 
dentistry cases (how to avoid serious issues if it goes 
wrong!)
MULTIPLE CHOICE QUESTIONS
1. What is involved in closed extraction 
technique?
(A) Alveolus widening and periodontal 
ligament breakdown
(B) Soft tissue flap elevation
(C) Bone window formation
(D) Bone gutter formation
2. Extraction is most appropriate in a fractured 
tooth in which of the following circumstances? 
(A) Periodontitis is present
(B) Root canal treatment is possible
(C) Complicated lower canine fracture is 
present
(D) Uncomplicated lower canine fracture is 
present
3. Which of the following is true about extraction 
forceps?
(A) Should never be used
(B) Should only be used on the root
(C) Should first apply traction
(D) Should have two-point contact
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Pale, bruised, bleeding: 
what’s going on?
Dan Batchelor 
Haemostasis involves three overlapping phases: primary 
haemostasis, secondary haemostasis and fibrinolysis. 
 Primary haemostasis refers to interactions between 
platelets, von Willebrand factor (vWF) and the blood 
 vessel wall, leading to formation of a platelet plug. Clinical 
features that suggest a primary haemostatic problem 
include petechiae/ecchymoses, bleeding from mucous 
membranes (e.g. epistaxis, melaena) and oozing from 
small wounds (in contrast, subcutaneous haematomas, 
muscle/joint bleeds, or body cavity haemorrhage suggest 
a disorder of secondary haemostasis). Petechiae and 
ecchymoses are most commonly seen with severe throm-
bocytopenia (platelet count <30 × 109/l, although this can 
vary). They can also be seen with platelet function defects 
(thrombopathias) and vasculitis. Von  Willebrand disease 
(VWD) tends to present with mucosal bleeding or exces-
sive bleeding following surgery rather than petechiation/
ecchymosis. 
Thrombocytopenia is usually a result of platelet 
destruction (e.g. immune-mediated thrombocytopenia, 
IMTP), lack of platelet production (bone marrow prob-
lem) or platelet consumption (either in disseminated 
intravascular coagulation (DIC) or vasculitis). Platelet 
sequestration in splenomegaly can lead to thrombocy-
topenia but the count is rarely <100 × 109/l and it is the 
least likely cause of severe thrombocytopenia. Platelet 
loss after acute haemorrhage can lead to thrombocyto-
penia but this is rarely severe, so if an animal presents 
with severe bleeding and severe thrombocytopenia, the 
low platelets should be considered the problem not the 
consequence. Thrombocytopenia is commonly  spurious, 
so a machine count should be verified on a blood smear: 
1 platelet/hpf is equivalent to about 15 × 109/l. Healthy 
animals should have 10–30 platelets/hpf. The smear 
should also be checked for platelet clumps. 
IMTP is considered the most common cause of 
severe thrombocytopenia in dogs. IMTP may be primary, 
or secondary to an underlying disease. Diagnosis of pri-
mary IMTP is presumptive, based on exclusion of known 
causes of thrombocytopenia, exclusion of underlying 
diseases and response to immunosuppressive treatment. 
The recommended approach includes history (including 
vaccinations, drugs), clinical examination, haematology 
including smear, biochemistry, urinalysis, clotting times 
(helps rule out DIC), diagnostic imaging, testing for tick-
borne disease, and ideally bone marrow aspirate/biopsy. 
Treatment is with glucocorticoids along with supportive 
treatment and management of any underlying disease, if 
present. Vincristine and intravenous immunoglobulins 
have been suggested based on a small number of stud-
ies, but there is not enough published evidence to be 
able to make firm recommendations about management 
of IMTP.
VWD is the most common of the hereditary bleeding 
disorders seen in dogs. It should be suspected with dogs 
that show mucosal bleeding or excessive bleeding 
 following surgery but have normal platelet count and 
normal clotting times. A prolonged buccal mucosal 
bleeding time would be expected. Diagnosis is made by 
measuring plasma vWF antigen. 
Thrombopathia should be suspected when there are 
signs of a primary haemostatic problem but normal plate-
let count, normal clotting times and normal plasma vWF 
antigen. Platelet dysfunction can occur secondary to 
 systemic problems such as uraemia or hyperproteinaemia. 
Hereditary function problems, such as  Glanzmann throm-
basthenia and others, are recognized in several breeds. 
KEY LEARNING OBJECTIVES
■■ List the clinical signs that indicate a problem of 
primary haemostasis
■■ List the common causes of thrombocytopenia
■■ Describe how to investigate a case presenting with 
petechiae or ecchymoses
MULTIPLE CHOICE QUESTIONS
1. A dog presents with ecchymosis of the skin 
over the ventral abdomen and is passing black 
tarry faeces. What type of clotting problem is 
most likely to be present?
(A) Accelerated fibrinolysis
(B) Disseminated intravascular coagulation
(C) Disorder of primary haemostasis 
(e.g. thrombocytopenia)
(D) Disorder of secondary haemostasis 
(e.g. anticoagulant rodenticide ingestion)
2. You are considering the possibility of von 
Willebrand disease in a 6-month-old female 
Dobermann prior to ovariohysterectomy. What 
screening test is most appropriate?
(A) Buccal mucosal bleeding time
(B) Coagulation panel (prothrombin time (PT) 
and activated partial thromboplastin time 
(aPTT))
(C) Platelet count and blood smear
(D) Screening is unnecessary here because 
von Willebrand disease is X-linked: clinical 
bleeding is only seen in males
3. Which drug commonly used in cancer 
chemotherapy is associated with an increase in 
platelet count?
(A) Carboplatin
(B) Cyclophosphamide
(C) Doxorubicin
(D) Vincristine
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Is this murmur 
significant?
Ruth Willis
Auscultation of a heart murmur during routine examina-
tion raises suspicion of underlying heart disease. Further 
investigation may be indicated and this is likely to be 
guided by history, clinical examination findings and also 
the owner’s wishes.
PHYSIOLOGICAL MURMURS
Physiological murmurs may be detected at any age and 
are not associated with underlying structural heart dis-
ease. These murmurs tend to be soft (grade 1–2/6), 
 timing may be early systolic or intermittent, and the 
 murmur is localized to the left cranial heart base. 
CONGENITAL MURMURS 
Congenital heart murmurs are more commonly detected 
in puppies than in kittens and it can be challenging to 
 differentiate pathological and physiological murmurs. Even 
with severe congenital heart disease, clinical signs may not 
always be apparent. Continuous and diastolic murmurs 
are highly likely to be significant and echocardiography is 
indicated. In patients where the murmur is loud, radiates 
widely and is either holo- or pansystolic,  echocardiography 
is advisable to determine cause and  significance.
ADULT CATS
In adult cats, the incidence of heart murmurs is relatively 
high – around 30%. Differentiating physiological from 
pathological murmurs purely on the basis of auscultation 
in cats is challenging and approximately half of all cats 
with murmurs will have structural heart disease identified 
on echocardiography. The presence of a gallop rhythm is 
concerning, as gallop sounds are commonly associated 
with significant heart disease causing diastolic  dysfunction. 
ADULT DOGS
Auscultation of a murmur during a routine examination 
should alert the clinician to the presence of heart dis-
ease. Further investigation is likely to be indicated but the 
tests selected and interpretation of results depend on the 
clinical situation. In a small-breed adult dog, a left apical 
systolic murmur is likely to be attributable to degenera-
tive mitral valve disease. In these cases if cardiac size is 
normal then no treatment is indicated, however if there is 
cardiac enlargement and/or referable clinical signs then 
further treatment is advisable. Cardiac chamber dimen-
sions are most accurately measured using echocardiog-
raphy but thoracic radiographs can also be useful to 
assess overall cardiac shape and size and also to assess 
the pulmonary vessels and lung pattern.
In contrast, in large- or giant-breed dogs, a new mur-
mur raises the suspicion of dilated cardiomyopathy. In 
these cases, further investigations such as echocardiog-
raphy are helpful to confirm the diagnosis and ambulatory 
electrocardiogram (ECG) monitoring may also be required 
to assess the frequency and severity of arrhythmias. 
In cases where the patients do not fit into these 
 categories, further investigation regarding the cause of 
the murmur is always warranted.
KEY LEARNING OBJECTIVES
■■ Be able to recognize the characteristics of an 
innocent heart murmur in dogs 
■■ Know when further investigations are appropriate
■■ Know which cases are likely to benefit from 
treatment 
MULTIPLE CHOICE QUESTIONS
1. In dogs a physiological murmur is likely to be 
which of the following?
(A) Loud, continuous murmur that radiates 
widely
(B) Soft, short, systolic murmur localized to 
the left cranial heart base
(C) Soft, short, diastolic murmur localized to 
the right cranial heart base
(D) Loud, systolic murmur with point of 
maximal intensity at the left apex
2. A soft, intermittent, systolic left apical murmur 
is detected in an asymptomatic adult cat. 
Echocardiography does not reveal evidence of 
significant structural heart disease. Which is the 
best diagnosis and treatment advice?
(A) Physiological murmur, no treatment 
required
(B) Preclinical hypertrophic cardiomyopathy, 
start diltiazem
(C) Physiological murmur, start  
anti-thrombotic therapy
(D) Systolic anterior motion of the mitral valve, 
start atenolol
3. According to the ACVIM staging system for 
myxomatous atrioventricular valve disease, 
what does stage B2 in a dog describe?
(A) Asymptomatic, has an acquired heart 
murmur caused by atrioventricular valve 
regurgitation but normal cardiac chamber 
dimensions 
(B) Symptomatic with clinical signs referable 
to congestive heart failure and cardiac 
enlargement 
(C) Asymptomatic, has an acquired heart 
murmur caused by atrioventricular valve 
regurgitation and an increase in left atrial 
and left ventricular dimensions 
(D) Asymptomatic and no audible murmur but 
at risk of developing the disease
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How to manage cases 
that aren’t going well 
Dan Batchelor 
There is a reason that we speak in terms of ‘practising 
medicine’! We are faced with the challenge of working 
out what is wrong with an animal who cannot speak to 
us, who may be trying to attack us, and who belongs to a 
human or humans who may have multiple complex 
expectations and demands. We are expected to diagnose 
and treat the problem, often on a limited budget, and are 
expected to do it quickly. There may not even be much 
known about the disease in question, or, worse, what we 
think we know may be wrong. Considering all this it’s no 
surprise that, as in other areas of life, things don’t always 
go to plan. It can seem overwhelming to any new or 
experienced graduate. Some suggestions:
■■ Don’t forget the core skill of taking a thorough 
history – this is a skill like any other and will get 
better with practice. Often the key to the case is in 
the clinical history. Try and maintain a client-
focused approach – understanding what their main 
concern is really helps
■■ Remember the importance of the physical 
examination: another vital skill, often overlooked. 
No amount of expensive testing can compensate for 
things missed on the physical examination. As with 
history-taking, practice is essential
■■ For complex cases, use the ‘problem-oriented 
approach’; taking a short-cut by ‘pattern spotting’ 
can lead to trouble. If you have a suspected 
diagnosis but the animal is not responding to 
appropriate treatment, going back to your original 
problem list and differential lists is often best. 
Be prepared to revise your diagnostic plan 
■■ Choose your diagnostic tests in a logical order and 
in the right context. Help your laboratory give you 
useful answers by giving them good samples and 
providing them with relevant clinical details. 
Understand what you hope to achieve by each test: 
what you hope to rule out, and what you hope to 
rule in. Don’t run multiple tests indiscriminately
■■ Don’t necessarily try and explain everything with one 
theory – the animal may have two or more diseases
■■ Don’t feel you have to solve every case immediately – 
nobody can know everything. Talk through cases with 
peers and colleagues. Know where to look for extra 
information, and call for advice if necessary. Consider 
referral if the owner is up for it
■■ Remember that many cases will get better 
regardless of what you do – avoid overtreating and 
avoid polypharmacy. Also remember that many 
cases will do badly or get worse no matter what you 
do – depressing but sadly true
■■ We are all human and mistakes can happen. Most 
client dissatisfaction comes from poor 
communication so keep your communication skills 
up and get training if necessary. Always be totally 
honest with owners, keep good records, warn about 
complications and get informed signed consent for 
all interventions. When using drugs, especially 
off-label, get consent and read the data sheet
KEY LEARNING OBJECTIVES
■■ Explain the problem-oriented approach to diagnosis 
in small animal practice
■■ List the resources for additional information to assist 
in managing difficult cases
■■ List the most common reasons for errors in 
veterinary practice
MULTIPLE CHOICE QUESTIONS
1. What is the most common reason for litigious 
complaints in small animal practice in the UK?
(A) Problems arising from anaesthetic 
complications
(B) Problems arising from medical treatment
(C) Problems arising from parturition
(D) Problems arising from surgery
2. What is the most important component of the 
investigation of a dog or cat that is unwell?
(A) The clinical history
(B) Blood sample for haematology
(C) Blood sample for biochemistry profile
(D) Radiographs of chest and abdomen
3. What is the first rule of medicine?
(A) All vomiting stops eventually
(B) Do no harm
(C) Keep testing until you find the answer
(D) Things can always get worse 
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How good are you 
and can you prove it?
Chris Gush
All veterinary surgeons and veterinary nurses strive to 
provide the best possible care for the animals in their 
care. They take responsibility for the care they provide to 
patients, and for their clinical and professional non- 
clinical practice. 
The Code to Professional Conduct and its associated 
Guidance state that it is the responsibility of every veteri-
nary surgeon and veterinary nurse to be undertaking 
clinical governance activities. Clinical governance is des-
cribed by the RCVS as a continuing process of reflection, 
analysis and improvement in professional practice for 
the benefit of the animal patient and the client owner. 
But what does this practically mean for veterinary teams 
and what can we learn from what is happening in the 
NHS? 
Quality improvement in the NHS has been described 
as, ‘The combined and unceasing efforts of everyone ... 
to make the changes that will lead to better patient out-
comes (health), better system performance (care) and 
better professional development (learning)’ (BMJ Quality 
& Safety 2007;16:2-3). All these aims are linked and rele-
vant in veterinary care, the challenge is to balance them.
A framework from the Institute of Medicine defines 
six domains of healthcare quality.
■■ Safe: avoiding harm to patients 
■■ Effective: providing evidence-based care and 
refraining from providing services that are unlikely 
to be of benefit
■■ Patient-centred: ensuring that care is responsive to 
individual patient preferences, needs and values
■■ Timely: reducing waiting times for care and avoiding 
harmful delays
■■ Efficient: avoiding waste
■■ Equitable: ensuring that care is of the same quality 
regardless of personal characteristics such as 
gender, ethnicity, location or socioeconomic status
With an expansion to ‘patient-centred’ to include the 
client, each of these domains is applicable to the delivery 
of veterinary care and can be used to start to measure 
a  quality service. In this session Chris Gush, Executive 
Director of RCVS Knowledge, will share his NHS back-
ground to show why continuous quality improvement is 
crucial for animal health and welfare and for every mem-
ber of the veterinary team. He will discuss the broader 
concept of quality and present practical tools for veteri-
nary teams to use with the very limited amount of time 
that they have and will go into more detail about how 
veterinary teams can begin to unlock the benefits of 
 continuous quality improvement.
KEY LEARNING OBJECTIVES
■■ Provide a critical analysis of the factors that have led 
to a greater international emphasis on quality 
measurement and improvement in healthcare
■■ Identify a range of approaches, tools and 
strategies to quality improvement, and critical 
success factors
■■ Understand how to plan, develop and evaluate a test 
of change on a small scale in veterinary practice
MULTIPLE CHOICE QUESTIONS
1. What is a core concept of quality 
improvement?
(A) Quality is improved by repeating the same 
activity again and again
(B) Develop a good team
(C) Everything can be improved
(D) Perfection can be achieved
2. What does quality improvement seek to 
improve?
(A) Individual work habits
(B) Processes
(C) Leadership styles
(D) Organizational culture
3. How does quality improvement encourage 
accountability?
(A) Enabling employees to facilitate change in 
company processes
(B) Asking for individuals to inform supervisors 
when they have done something wrong
(C) Blaming individuals for mistakes with 
processes
(D) Forcing accountability at every step of a 
process, even if there is no action
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How to apply best 
evidence to manage 
and care for epilepsy 
patients in daily clinical 
practice
Paul Pollard and Holger Volk 
Evidence-based veterinary medicine (EBVM) is one of the 
three core pillars for good clinical practice. The other 
two pillars should also not be ignored, as they are of 
equal importance. The most questioned one is ‘clinical 
expertise’, which if used in extreme has also be named 
‘eminence-based veterinary medicine’. Clinical expertise, 
however, is important as it will help to translate effec-
tively the information from publications to daily clinical 
practice and back. It will provide the reading-frame to 
ensure group effects seen in well designed studies can 
be applied to the individual patient. The last pillar, which 
is the owner’s understanding and value system, is often 
forgotten and not yet sufficiently researched in veterinary 
medicine. Evidence and clinical expertise are of limited 
value for the patient’s care if the information is not com-
municated effectively to the owner. Bad compliance will 
limit the effect of treatment significantly. In this presenta-
tion, we will use case examples of patients with epilepsy 
to discuss how we can create synergy between the three 
core factors of good clinical practice. 
We will discuss the difference between statistical 
 significance and clinical significance. The placebo and the 
regression to the mean effect is around 30%. This means 
that an epilepsy management option needs to provide at 
least a 30% improvement before an effect can be noted 
clinically. Considering this, we will discuss how the cur-
rent published systematic reviews and meta-analysis can 
be used in clinical practice. It is essential that clinicians 
evaluate both effectiveness of treatment and tolerability 
before tailoring it to the individual patient. Currently, 
phenobarbital is likely to be the first-line medication for 
feline patients with epilepsy, followed by levetiracetam 
and imepitoin. In dogs, phenobarbital and imepitoin, as 
well as potassium bromide, are likely to be effective and 
relatively safe for the treatment of idiopathic epilepsy. For 
some of the medications we have good evidence, but for 
other treatments, combination therapy and especially in 
cats the evidence is less good. We will discuss how to 
overcome this gap in knowledge in clinical practice and 
have a discussion of how to improve this in the future. 
Further studies are crucial in order to establish guidelines 
for every eventuality. However, saying this we have made 
great progress in recent years and this will be highlighted 
in the presentation.
KEY LEARNING OBJECTIVES
■■ To consider how to evaluate the evidence base for 
epilepsy
■■ To understand the value of clinical guidelines in 
applying that evidence
■■ To understand the interplay between the different 
factors to ensure good clinical practice
MULTIPLE CHOICE QUESTIONS
1. What are the three core factors influencing 
good clinical practice?
(A) Evidence-based veterinary medicine
(B) Clinical expertise
(C) Owner’s understanding and values
(D) All of the above
2. With regard to epilepsy, when reading a paper, 
the treatment effect needs to be at least how 
large to be considered clinically significant?
(A) 50%
(B) 40%
(C) 30%
(D) 20%
3. What is the percentage of dogs with idiopathic 
epilepsy which will respond adequately to 
treatment in first-opinion practice?
(A) 15–29%
(B) 30–49%
(C) 50–69%  
(D) 100%
Research into small 
animal practice: why 
evidence matters
Peter Denys Cockcroft
There is often a considerable time delay in the outcomes 
of clinical research being translated into clinical practice 
and decisions are not always made based upon the 
best current evidence for the case specific context. The 
terms ‘research into practice’, ‘science into practice’, 
‘from publication to patient’ or ‘ just-in-time learning’ 
and ‘bridging the gap’ are sometimes used to describe 
evidence-based veterinary medicine. The process has 
been defined in a number of ways with one of the 
 simplest being ‘the use of current best evidence in 
 making clinical decisions’. 
An understanding of the meaning of scientific evi-
dence and how this is expressed is critical when translat-
ing science into practice. This presentation will explore 
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the nature and meaning of scientific evidence. The paper 
will discuss what the strength of evidence of a study is 
how it can be expressed. Measures that are used to 
 capture clinical significance will be presented.
Knowledge summaries, which are published in the 
Veterinary Evidence Journal, are short critical summa-
ries of the best available evidence for a defined clinical 
question. They provide a concise conclusion. The 
 process used to identify and classify the strength of 
 evidence when generating knowledge summaries will 
be described. Small animal examples will be described.
In an ideal world there would be a checklist of the 
full  range of important information needs when mana-
ging a  specific case. The current best evidence for the 
check list would be available as a framework or cluster of 
 knowledge summaries presented in an accessible and 
appropriate structure to inform decision making. This 
case-specific cluster of knowledge summaries provides 
the practitioner with a one-stop shop for all aspects of 
the case management in a framework that is aligned to 
the process of case management. 
Small animal examples of the knowledge cluster 
framework will be described. Once complete the cluster 
of ‘knowledge summaries’ can be compiled into a 
 decision-support framework and published in a visual 
format with links to the appropriate knowledge summa-
ries within the journal.
KEY LEARNING OBJECTIVES
■■ To be able to define the term ‘strength of evidence’ 
when applied to a scientific study
■■ To understand which measures can capture the 
utility of the evidence
■■ To understand the process which underpins the 
knowledge summary bottom line
MULTIPLE CHOICE QUESTIONS
1. Which of the following is a measure of the 
‘strength of evidence’ when applied to a scientific 
study when two treatments are compared?
(A) The magnitude of the difference identified 
by the study
(B) The magnitude of the statistical difference 
identified by the study (p-value)
(C) The quality of the design and 
implementation of the study
(D) The number of animal used in the study 
groups
2. Which one of the following statements is TRUE 
regarding the statistical difference of a scientific 
study which compares two treatments?
(A) A statistical difference measures the 
magnitude of the difference in outcomes
(B) No significant difference indicates there is 
no difference between the treatment 
outcomes
(C) A statistical difference indicates the 
treatment outcomes are different
(D) A statistical difference indicates the 
probability of the treatment outcomes 
being different
3. What is a knowledge summary?
(A) It is a literature review of the primary 
published papers on a topic
(B) It summarizes the current best scientific 
evidence for a specific information need
(C) It provides a list of primary published 
papers on a topic
(D) It provides a summary of the knowledge 
on a given topic
Learning from a rabbit 
anaesthetic death: 
an evidence-based 
approach to rabbit 
anaesthesia in practice 
Pam Mosedale and Molly Varga
Many practitioners find the prospect of anaesthetizing a 
rabbit daunting, particularly if an adverse event has previ-
ously occurred. This presentation will look at all aspects 
of rabbit anaesthesia and present the evidence base 
behind creating protocols. 
Through the use of a case study, the session will 
show how one practice reacted to an anaesthetic death 
and used a significant event audit to analyse why the 
death happened and how they could improve their sys-
tems of work to avoid making the same mistake again. 
By  discussing their mistakes supportively and without 
judgement, with a commitment to openness and under-
standing rather than discipline and blame, this practice 
was able provide support for their team and advocate for 
the needs of their patients. 
The case study will show how root cause analysis 
can help a practice to consider the human factors, sys-
tem factors and patient factors in reducing avoidable 
death. It will consider husbandry prior to anaesthesia, 
handling and accommodation before and after proce-
dures, suitable equipment, analgesia, fluid therapy, 
anaesthetic drugs and anaesthetic monitoring. 
Because rabbits are a prey species that tend to mask 
symptoms of disease and distress, they need to be treated 
in a different way to dogs and cats. Empathetic and 
achievable evidence-based care will be the core of this 
presentation, showing a practical approach for busy 
 veterinary teams to include a consideration of the best 
available evidence in an afternoon’s consultations.
371-376 RCVS knowledge.indd   374 08/03/2019   18:24
BSAVA CONGRESS 2019 PROCEEDINGS [ 375 ]
KEY LEARNING OBJECTIVES
■■ To learn how to use significant event audit to 
improve systems of work in practice 
■■ To learn how to use evidence-based medicine to 
make safe and practical decisions about rabbit 
anaesthesia
■■ To learn how to monitor the changes made to show 
if they have improved patient outcomes 
2. When is the most common time for anaesthetic 
deaths to occur?
(A) On induction
(B) During the surgical procedure
(C) Once the surgical procedure has finished
(D) During the 48 hours directly after 
anaesthesia
3. Which of the following statements is NOT 
applicable to rabbit anaesthesia?
(A) Rabbits can hide ongoing medical issues – 
a preanaesthetic blood sample can help to 
reveal these
(B) Rabbits have a very narrow trachea, and 
therefore intubation is not indicated
(C) Rabbits in gut stasis rapidly develop 
electrolyte abnormalities which can affect 
the safety of an anaesthetic
(D) Comprehensive analgesia is required for all 
surgical procedures – it is anaesthetic 
sparing and prevents the patient being 
flooded with pain on recovery
MULTIPLE CHOICE QUESTIONS
1. The results of a significant event should NOT 
do which of the following?
(A) Identify CPD and training needs 
(B) Draw up or alter protocols or  
guidelines after considering the  
evidence base 
(C) Blame the individual concerned
(D) Lead to planning further outcome or 
process audits
First do no harm: how 
systems can reduce 
the rate of morbidity 
and mortality by 50%
Richard Byrne, Richard Killen  
and Laura Playforth 
Members of the veterinary team are dedicated and 
 passionate about the quality of care we provide to our 
patients. In our world, nothing is black or white, which 
leads us all to develop skills in critical problem solving 
and innovation. Therefore, the areas in which improve-
ments can be made and the systems we establish are as 
diverse as the individuals who strive to make them.
Our discussion aims to show this diversity in action 
with examples of how improvement systems have been 
implemented in different settings, in order to demon-
strate the benefits which can be achieved, and the 
 lessons that can be learnt in the process.
In addition to internal team-led systems, some of the 
many pre-existing resources will be discussed, which can 
be applied or modified to suit differing circumstances. 
There’s no point in reinventing the wheel when you don’t 
have to!
In this session, each of the speakers will provide you 
with practical examples of how they are supporting their 
colleagues to overcome barriers and to engage with 
quality improvement. This will be followed by an open 
discussion between the speakers and delegates.
No matter what size your team – from the largest 
groups to the smallest independent practices – there will 
be a system or a process change that you could apply in 
your setting which can drive significant and meaningful 
improvements.
KEY LEARNING OBJECTIVES
■■ To be introduced to of a wide range of quality-
improvement strategies to help you get started in 
your practice
■■ To consider key benefits and challenges of 
establishing successful systems
■■ To understand the importance of all team members 
setting and engaging with a culture which facilitates 
continual improvement in practice
MULTIPLE CHOICE QUESTIONS
1. What success levels can be achieved using 
some quality-improvement methods?
(A) Up to 10% reduction in morbidity and 
mortality
(B) Up to 25% reduction in morbidity and 
mortality
(C) Up to 33% reduction in morbidity and 
mortality
(D) Up to 50% reduction in morbidity and 
mortality
2. How long does it usually take to get a new 
process embedded within the team?
(A) Around 1 month
(B) Around 3 months
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(C) Around 6 months
(D) Around 12 months
3. What is the most important prerequisite for a 
successful quality-improvement implementation?
(A) Significant financial resources
(B) A fully staffed team
(C) A proactive learning culture
(D) Senior manager involvement
Reliable care in the 
NHS: building safer 
systems in a just 
culture
Margaret Mary Devaney
People make errors. Errors can cause accidents. In 
healthcare, errors and accidents result in morbidity and 
adverse outcomes and sometimes in mortality. Seeking 
out errors and identifying the ‘responsible individual’ can 
often result in punitive actions. This approach does not 
solve the root of the problem, and without changing the 
system this may not only perpetuate the problem, rather 
than solving it, it can also produce emotional and some-
times professionally life-changing consequences.
A healthy learning system is characterized by its 
 ability to self-reflect and identify strengths and defects, 
both in real time and in periodic review intervals. In 
healthcare, this entails leaders highlighting the impor-
tance of continuous reflection to assess performance. 
It  entails consistently performing agreed-upon team 
behaviours and values. Strong learning systems identify 
defects and act on them; they reward proactivity rather 
than reactivity. Learning, and a healthy safety culture, 
reinforce one another by identifying and resolving 
 clinical, cultural, and operational defects. 
A safe care system needs to collect productive inves-
tigative data that can be analysed and acted upon to 
improve patient safety. This process is not possible unless 
members of the organization remain vigilant and mindful 
and maintain continuous surveillance. Similarly, people 
within the organization must believe that they are 
required to report errors. However, institutions cannot 
afford a totally blame-free culture; deliberate reckless 
errors do warrant disciplinary action. Finding an organi-
zational balance between actual or perceived punish-
ment and actual or perceived blamelessness is the goal 
of developing a just culture. A just culture balances the 
need for an open and honest reporting environment with 
the end of a quality learning environment and culture. 
While the organization has a duty and responsibility 
to employees (and ultimately to patients), all employees 
are held responsible for the quality of their choices. Just 
 culture requires a change in focus from errors and 
 outcomes to system design and management of the 
behavioural choices of all employees.
KEY LEARNING OBJECTIVES
■■ To understand the importance of creating 
psychological safety, recognizing the risk of second 
victims 
■■ To understand how to guard a safety learning 
system based on transparency and candor 
■■ To know how to ensure value alignment: applying 
organizational values to every decision made
MULTIPLE CHOICE QUESTIONS
1. Which of the following does psychological 
safety require?
(A) Early identification of who is to blame for 
incidents and ask them to change
(B) Spending lots of money to support staff
(C) Fostering trust to create an environment of 
non-negotiable respect, ensuring that 
people feel their opinions are valued, and 
any negative or abusive behaviour is swiftly 
addressed
(D) The team to avoid confrontational 
conversations
2. Which of the following does a learning safety 
culture require?
(A) Training individuals the same information 
again
(B) E-mailing reminders of local policy to staff
(C) Continuous reflection to assess 
performance against best evidence and 
associated behaviours
(D) Formal training for all in Health and Safety
3. Which of the following does a just culture 
require?
(A) Strict disciplinary actions for individuals 
involved in safety incidents
(B) Dismissing information that challenges 
personal preference
(C) A movement of focus from errors and 
outcomes to system design and 
management of the behavioural choices of 
all employees
(D) Acceptance that you cannot change the 
culture
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Basic introduction to 
the use of blood gases
Dan Lewis
This presentation will outline a standard approach to 
acid–base blood gas interpretation applicable to and 
useful in the vast majority of cases.
Before discussing this approach, we must revise 
some chemistry concepts: an acid is defined as a mole-
cule that will donate a proton/hydrogen ion; a base is the 
opposite – a molecule that will accept a proton; and a 
buffer is a molecule that can either accept or donate 
 protons/hydrogen ions from its environment. Finally, 
remember that pH is the negative base 10 logarithm of 
[H+] – the hydrogen ion concentration. This means that a 
solution with pH 6 has 10 times the number of hydrogen 
ions (1 µmol/l) as a solution of pH 7 (0.1 µmol/l).
Why worry about [H+] anyway? For their mass, hydro-
gen ions are highly charged and therefore potentially 
very reactive. Most metabolic processes depend upon 
enzymes – proteins – that are, in turn, dependent upon 
their structure and shape to function effectively. Large 
changes in the acidity of their environment runs the risk 
of altering enzyme and therefore cellular function, 
potentially leading to cell death.
The next concept to grasp is that alterations in the 
acid–base balance in the body have two origins – respir-
atory (actually ventilatory) and metabolic (everything 
else!). The respiratory side is solely determined by the 
level (partial pressure) of CO2 in solution – the PCO2. 
As metabolic rate does not usually change much from 
minute to minute, the CO2 level in the body is controlled 
by ventilation and is an ‘open system’. This means that 
according to the chemical reaction:
CO2 + H2O ↔ H2CO3 ↔ H+ + HCO3–
the body can convert excess acid (H+) into CO2 and 
breathe it out. This means that the respiratory side usu-
ally functions as a very effective, rapid counterbalance 
for acid–base changes driven by metabolic processes. 
The metabolic side can affect acid–base balance in 
two main ways: either by generating extra molecules that 
are acids/bases, for example lactic acid production dur-
ing anaerobic exercise, or by causing the loss of a normal 
component of the buffering system, for example gastro-
intestinal loss of bicarbonate in diarrhoea. Whilst meta-
bolic disturbances will sometimes cause very important 
alterations in [HCO3–], the close relationship with ventila-
tion means that HCO3– is not an independent variable, 
and therefore cannot be relied upon to tell you about the 
metabolic side.
Remember also that these metabolic processes are 
constantly occurring, and that large numbers of buffer 
molecules are present in intra- and extracellular fluids to 
enable the body to cope, most of the time.
So having obtained your sample, run it through the 
blood gas analyser and examine the results: 
1. Check the pH
2. Check the pCO2 
3. Check the patient for ventilatory abnormalities
4. Check the metabolic side
(A) Check the base excess (BE)
(B) If there is a metabolic acidosis, check the anion 
gap; if there is a metabolic alkalosis, check the 
chloride
5. Check the patient for metabolic abnormalities
6. Review the overall picture
KEY LEARNING OBJECTIVES
■■ To understand how respiratory acidoses/alkaloses 
are created
■■ To understand how metabolic acid–base changes 
are identified, and the most likely clinical conditions 
that drive such abnormalities
■■ To appreciate the concept of compensatory acid–
base changes and when these occur in patients
MULTIPLE CHOICE QUESTIONS 
1. A patient presents with a PCO2 of 52 mmHg 
and a blood pH of 7.25. What would this be 
described as?
(A) Respiratory acidosis caused by 
hyperventilation
(B) Respiratory acidosis caused by 
hypoventilation
(C) Respiratory alkalosis caused by 
hyperventilation
(D) Respiratory alkalosis caused by 
hypoventilation
2. What are the three most common causes of 
metabolic acidosis in dogs?
(A) Ethylene glycol, lactate and 
hypochloraemia
(B) Azotaemia, lactate and hypernatraemia
(C) Azotaemia, lactate and ketoacidosis
(D) Ethylene glycol, ketoacidosis and 
hypochloraemia
3. A patient has a blood pH of 7.36, base excess 
–7 mmol/l and PCO2 24 mmHg. What is the 
most likely explanation?
(A) Primary metabolic acidosis with 
compensatory respiratory alkalosis
(B) Primary metabolic alkalosis with 
compensatory respiratory acidosis
(C) Primary respiratory acidosis with 
compensatory metabolic alkalosis
(D) Primary respiratory alkalosis with 
compensatory metabolic acidosis
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Advanced blood 
gas analysis
Dan Lewis
The ‘standard’ approach to acid–base blood gas inter-
pretation will provide answers as to the underlying 
pathophysiology of most emergency and critical care 
patients, most of the time. However, as the underlying 
chemistry behind acid–base balance in the body is 
extremely complex and, as yet, incompletely elucidated, 
a different technique may be needed in some critically ill 
animals. These will often give greater insight into the 
metabolic disturbances taking place and (most impor-
tantly) be utilized to alter clinical therapies to benefit the 
patient. All current methods of acid–base blood gas 
interpretation assess the [H+] (pH) and respiratory (PCO2) 
components in a similar fashion – according to the 
‘standard’ approach.
More advanced techniques for interpreting acid–base 
balance revolve around the ‘strong ion’ approach, devel-
oped (sequentially) by Singer & Hastings, Stewart  and 
Constable. The simplified Stewart approach considers six 
potential reasons for acidosis or alkalosis (Figure 1).
Figure 1: Independent variables influencing acid-base 
balance according to the simplified Stewart approach. 
SID is Strong Ion Difference, PCO2 refers to the partial 
pressure of carbon dioxide and Atot corresponds to the 
level of non-volatile weak buffers (weak acids/bases) in 
the extracellular fluid
A further development of this is to consider influenc-
ers of acid–base in terms of their effect on electrochem-
ical balance – normally the net positive (cationic) charge 
matches the net negative (anionic) charge (Figure 2). If a 
change to this equilibrium is initiated, buffering mecha-
nisms try to restore balance, usually involving the move-
ment of hydrogen ions to and from buffer molecules 
(and occasionally into and out of cells).
Figure 2: Figure indicates the normal electrostatic 
balance present in the extracellular fluid
So if an acid–base disturbance takes place (Figure 3), the 
balance is upset and H+ are mobilized to reset the net 
ECF  charge (Figure 4), therefore, restoring the balance 
(Figure 5).
Figure 3: Figure indicating the addition of extra anionic 
charge (as might be caused by the addition of molecules 
such as lactate) to the extracellular fluid
Figure 4: Figure indicates the consequence of the 
imbalance induced by the addition of extra anionic 
charge to the extracellular fluid and the resultant 
increase in level of hydrogen ions, re-establishing 
electrostatic balance (Figure 5, below), but creating a 
metabolic acidosis
Figure 5: Indicates the return to electrostatic balance 
within the extracellular fluid
Therefore, it is possible to see how alterations in the major 
players in the extracellular fluid (ECF) will impact upon the 
[H+] and therefore acid–base balance. An increase in ECF/
plasma concentrations of any of the positively charged 
ions (Na+, K+, Ca++, Mg++) will cause a drive to push more 
H+ ions onto buffer molecules (or into cells). This there-
fore will make the ECF/plasma a less acidic environment: 
a metabolic alkalosis. This same effect would be caused 
by a decrease in the level of negatively charged ECF 
molecules, such as albumin, Cl– or phosphate.
The converse of this is also true – decreased ECF 
cations results in a metabolic acidosis, as does increased 
ECF anions (such as lactic or ketoacids). It is possible 
to  further develop this technique to permit a semi-
quantitative assessment of the relative contributions of 
the various molecules concerned.
ARTERIAL BLOOD GAS ANALYSIS
The main purpose of this is to assess the functioning of 
the respiratory system. To this end, two equations are 
useful:
A-a gradient = [(Pbarometric – PH2O)*0.21 – PaCO2/
Respiratory quotient] – PaO2
although in most circumstances this can be summa-
rized as:
A-a gradient = [149 – 1.25*PaCO2] – PaO2
with a normal result being <15 mmHg. 
Non-volatile weak 
buffers in the ECF
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The major advantage of this is that ventilation is 
accounted for, although this equation is only valid when 
breathing room air.
A more generally applicable way of assessing pulmo-
nary gas exchange (the health of the lungs) irrespective 
of the percentage of oxygen being breathed is:
PF ratio (Carrico index) = PaO2/FiO2
with values >450 indicating normal gas exchange, <380 
indicating pulmonary compromise and <285 indicating 
severe pulmonary dysfunction.
KEY LEARNING OBJECTIVES
■■ To understand the six mechanisms for acid–base 
disturbances according to the simplified Stewart 
approach
■■ To understand the concept of electrochemical 
balance in acid–base interpretation and the key 
players involved
■■ To understand the utility of the A-a gradient and the 
Carrico index in assessing pulmonary function 
Techniques for oxygen 
therapy
Dan Lewis
The purpose of normal, physiological ventilation is to 
deliver enough fresh gas to the alveoli to enable the car-
riage of oxygen to, and carbon dioxide from, the tissues. 
Ultimately, if tissue oxygen demand is not satisfied by 
oxygen supply, cellular hypoxia will ensue, with deleteri-
ous and potentially life-threatening results – reduced cell 
energy levels, ischaemia and cell death. In the presence 
of low blood oxygen levels, hypoxaemia, increased 
 cardiac and respiratory work will try to compensate, but 
these mechanisms will eventually become exhausted.
The causes of hypoxaemia can be broadly divided 
into four main pathophysiological mechanisms:
■■ Hypoventilation
■■ Ventilation–perfusion mismatch
■■ Shunt
■■ Diffusion impairment
Several different disease processes lead to these. Obvi-
ously, an inadequate supply of oxygen (due to altitude, 
anaesthetic errors, etc.) or a reduced oxygen-carrying 
capacity (anaemia, impaired haemoglobin binding, etc.) 
will also impact upon blood oxygen content. 
Many of the above processes can be ameliorated 
by  the provision of oxygen supplementation to our 
 dyspnoeic patients; indeed, there are few occasions 
when this is not of benefit! This lecture will explore some 
of the different techniques that can be used to increase 
the amount of oxygen our patients receive, involving 
specialized equipment but also ‘DIY’ solutions achievable 
in all practices. Some advice will also be given as to what 
to do when these techniques appear inadequate. Finally, 
some mention will be made of new, ‘high-flow’ tech-
niques, their applicability to companion animals, and 
their potential advantages for our most severely affected 
patients.
KEY LEARNING OBJECTIVES
■■ To understand when oxygen supplementation may 
be beneficial to patients
■■ To appreciate a variety of different techniques and 
when to best employ them
■■ To recognize the downsides to oxygen 
supplementation
(A) Increased SID, increased PCO2 and 
reduced Atot
(B) Reduced SID, increased PCO2 and 
reduced Atot
(C) Increased SID, increased PCO2 and 
increased Atot
(D) Reduced SID, increased PCO2 and 
increased Atot
2. For a dog, which of the following sets of results 
indicate significant pulmonary disease?
(A) FiO2 0.21, PaCO2 45 mmHg, PaO2 
79 mmHg
(B) FiO2 0.4, PaCO2 24 mmHg, PaO2 
113 mmHg
(C) FiO2 0.4, PaCO2 45 mmHg, PaO2 
144 mmHg
(D) FiO2 0.21, PaCO2 24 mmHg, PaO2 
107 mmHg
3. What are some of the major components 
assessed in quantitative base excess  
analysis?
(A) Sodium, chloride, globulins, ketoacids
(B) Sodium, chloride, albumin, ketoacids
(C) Sodium, chloride, albumin, lactate
(D) Sodium, chloride, albumin, creatinine
MULTIPLE CHOICE QUESTIONS 
1. According to the Stewart model, how can 
acidifying processes can be summarized?
MULTIPLE CHOICE QUESTIONS
1. When should supplemental oxygen should be 
humidified?
(A) Always
(B) Only if part of the airway is bypassed
(C) Only at high gas flow rates
(D) Never
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Nutrition in critical care
Isuru Gajanayake 
METABOLISM DURING CRITICAL ILLNESS 
Starvation that is not associated with illness (e.g. when 
food is scarce) is highlighted by two key features, 
including a reduction in the basal metabolic rate and 
the preferential utilization of the body’s fat stores for 
energy. In contrast, during illness there is preferential 
catabolism of lean body tissue (i.e. muscle) and an 
increase in the body’s energy requirements. These 
 metabolic derangements (termed stressed starvation) 
are driven by inflammatory mediators and other factors 
associated with illness. The consequences of these 
derangements can include hyperglycaemia, insulin 
resistance and increased carbon dioxide production, 
with subsequent effects on myocardial, respiratory and 
immune function.
NUTRITIONAL REQUIREMENTS DURING 
CRITICAL ILLNESS 
Despite the body’s increased energy needs during critical 
illness, a relatively conservative energy provision is usu-
ally recommended because an overzealous energy 
 provision can lead to metabolic complications. The cur-
rent recommendation is to provide the resting energy 
requirement (RER) to critically ill dogs and cats. This can 
be calculated by the formula: 
RER in kilocalories per day = 70 x (bodyweight in kg)0.75
Use of illness multipliers (e.g. 1.8–2 x RER for sepsis) is no 
longer recommended.
In addition to the amount of energy provided to crit-
ically ill patients, the source of energy (i.e. relative pro-
portions of the three energy-providing macronutrients) 
is also important. Fat provides more energy per gram 
than carbohydrate and protein. For this reason, high-fat 
diets can be useful to maximize energy consumption 
when food intake is reduced. Carbohydrate is also an 
essential source of readily available energy for critically ill 
patients. However, in patients with pre-existing hypergly-
caemia, some care must be taken not to exacerbate this 
with high-carbohydrate diets. Protein is essential both as 
a source of energy and amino acids, and to minimize the 
muscle wasting associated with critical illness. High- 
protein diets may, however, be poorly tolerated in certain 
medical conditions (e.g. azotaemia). Finally, it is vital that 
all diets fed to critically ill patients are balanced for their 
micronutrient needs (i.e. vitamins and minerals). 
PRACTICAL NUTRITION FOR 
CRITICAL ILLNESS 
Prior to instituting a nutritional intervention (e.g. feeding 
tube, parenteral feeding), it is vital that fluid, electrolyte 
and acid–base deficits are restored. This is not only 
important to reduce some of the risks associated with 
feeding, but correction of these abnormalities may also 
improve the appetite in some patients.
Most critically ill veterinary patients are managed with 
enteral feeding, however parenteral nutrition is becoming 
more available. Enteral feeding usually necessitates 
placement of a feeding tube. Attempts at force-feeding 
are counterproductive and use of appetite stimulants 
(e.g.  mirtazapine) is not ideal in critically ill patients. 
 Naso-oesophageal feeding tubes are useful for short-term 
feeding of critically ill patients, especially if they are not 
good candidates for anaesthesia or surgery. Oesophagos-
tomy tubes are a more robust option for short- to medium-
term feeding and this method also allows use of a larger 
range of diets. Parenteral feeding techniques are usually 
used when enteral feeding is not tolerated, however this 
form of nutrition requires close monitoring. 
KEY LEARNING OBJECTIVES 
■■ To comprehend the nutritional metabolic changes 
associated with illness 
■■ To assess a critically ill patient’s calorie and nutrient 
needs 
■■ To appreciate the pros and cons of various 
nutritional interventions 
2. How is inadequate ventilation most often defined?
(A) PaCO2 >60 mmHg
(B) ETCO2 <20 mmHg
(C) PaO2 <80 mmHg
(D) PvO2 >40 mmHg
3. Nasal oxygen supplementation at 100 ml/kg/
min should increase inspired oxygen levels to 
which of the following?
(A) 30%
(B) 21%
MULTIPLE CHOICE QUESTIONS 
1. Which of these is feature of metabolism during 
critical illness? 
(A) Increased muscle catabolism 
(B) Increased fat catabolism 
(C) Hypoglycaemia due to insulin resistance
(D) Reduced basal metabolic rate 
2. Which of the following should be the energy 
provision for a critically ill patient? 
(A) Illness energy requirement
(B) Maintenance energy requirement 
(C) Resting energy requirement 
(D) Exercise energy requirement 
(C) 37%
(D) 58%
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Approach to diabetic 
ketoacidosis
Sophie Keyte 
DIAGNOSIS
■■ Diabetic ketoacidosis (DKA) – glucosuria, 
hyperglycaemia, ketonuria/ketonaemia and 
metabolic acidosis (pH < 7.3)
CLINICAL PATHOLOGY 
AND DIAGNOSTIC TESTING
■■ Urinalysis
■■ Emergency database:
 – Blood glucose (BG)
 – Acid–base status – metabolic acidosis with 
increased anion gap (ketone accumulation)
 – Serum sodium concentration – most 
hyponatraemic (urinary sodium loss from 
osmotic diuresis)
 – Serum potassium concentration – usually 
normal to low
 – Serum urea and creatinine – often increased 
due to prerenal +/– renal factors. Interpret with 
urine specific gravity (USG)
■■ Additional investigations: significant concurrent 
infectious, inflammatory or hormonal diseases such 
as pancreatitis common
 – Haematology – usually stress leucogram; look 
for evidence of concurrent disease
 – Liver enzymes, total bilirubin – increases 
common
 – Canine pancreatic lipase immunoreactivity 
(cPLI)/trypsin-like immunoreactivity (TLI) – 
consider abdominal ultrasonography
 – Phosphate – usually normal to low 
pretreatment. Can fall dangerously low during 
treatment
 – Magnesium deficiency is also common
 – Diagnostic imaging – survey thoracic/abdominal 
radiography to screen for concurrent disease; 
+/– abdominal ultrasound. Not usually done 
until appropriate treatment has been initiated
TREATMENT OF THE ILL DKA ANIMAL
Aims:
■■ Restore water and electrolyte balance
■■ Provide adequate insulin to ‘switch off’ ketone 
production (neutral insulin)
■■ Correct acidosis
■■ Identify any underlying disease
■■ Provide a carbohydrate substrate when required by 
the insulin treatment
Abnormal parameters should be returned slowly towards 
normal (over 36–48 hours); rapid changes can be harmful 
and potentially dangerous (e.g. causing cerebral oedema).
Fluid therapy
■■ Crystalloids (e.g. Hartmann’s or lactated ringers) 
usually adequate (can consider 0.9% normal saline)
■■ Aim to rehydrate over 24 hours and allow for 
ongoing losses (generally a rate of at least 4ml/kg/hr 
is appropriate initially)
■■ Rapid administration rarely needed unless patient is 
in shock (give as intermittent 10–20ml/kg boluses 
over 15–20 minutes – assess after each one)
Electrolyte supplementation
■■ Potassium – body depletion often severe even if 
serum potassium concentration within normal limits 
and starting insulin therapy shifts potassium into 
cells; therefore, all cases should receive potassium 
supplementation ideally before starting insulin 
therapy. Do not exceed 0.5 mmol/kg/h. 
■■ Phosphate – hypophosphataemia precipitated by 
insulin treatment, regular monitoring 
recommended. 
■■ Magnesium – monitoring; especially if non-
responsive hypokalaemia.
Insulin therapy
■■ Essential
■■ Regular crystalline insulin (neutral insulin)
■■ Continuous rate I/V infusion (Intermittent IM 
technique an alternative)
■■ Aim for gradual decline in BG concentration, until 
glucose is 10–15 mmol/l. Increase/decrease hourly 
dose as required.  Begin glucose infusion at BG 
concentration noted above to hold BG within this 
range and thus allow continued insulin 
administration
■■ When animal is well hydrated, eating, drinking, 
not vomiting or ketoacidotic, change to an 
intermediate-acting insulin as for an uncomplicated 
DM patient
Supportive therapy
■■ Pancreatitis common
3. Which of the following is correct for 
oesophagostomy feeding tubes?
(A) They must be placed under general 
anaesthesia 
(B) They require endoscopy to place 
(C) They should be avoided in pancreatitis 
(D) They are not appropriate for home- 
feeding 
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Patient monitoring
■■ BG measurement every 1–2 hours initially; adjust 
insulin therapy and begin glucose infusion when 
10–15 mmol/l
■■ Hydration status every 2–4 hours; adjust fluids 
accordingly
■■ Serum electrolyte and acid/base every 6–12 hours; 
adjust fluids accordingly
■■ Urine output, glycosuria, ketonuria; adjust fluid 
therapy accordingly
 – Ketonuria may initially appear worse on dipstix 
as beta-hydroxybutyrate (not measured) is 
converted into acetone and acetoacetate 
(measured)
■■ Body weight, packed cell volume/total protein (PCV/
TP), temperature and blood pressure daily
KEY LEARNING OBJECTIVES
■■ Outline the pathophysiology and diagnosis of 
diabetic ketoacidosis (DKA) in dogs and cats
■■ Outline the management and treatment of the 
clinical spectrum of DKA patients
■■ Outline the complications associated with DKA 
including electrolyte changes and likely prognosis
Emergency 
management of 
urethral obstruction
JD Foster 
Acute urethral obstruction (UO) can quickly result in 
 life-threatening complications, including hyperkalaemia, 
azotaemia and uroabdomen. Prompt diagnosis and emer-
gency stabilization are needed to provide optimal patient 
safety and the best chance for survival. Numerous fac-
tors may affect the success of urinary decompression 
and the risk for reblockage. 
RECOGNIZING THE PATIENT WITH 
URETHRAL OBSTRUCTION
Although clients observing a male cat make several unpro-
ductive attempts to urinate may quickly lead to the suspi-
cion for UO, cats may be presented for other problems. 
Cats with UO may be lethargic, tachypnoeic with open-
mouth dyspnoea, or even laterally recumbent and poorly 
responsive. Upon triage examination, abdominal pal-
pation often reveals a large, tense, unexpressible urinary 
bladder. However, the absence of a urinary bladder should 
raise the concern for bladder rupture and uroabdomen. 
Laboratory analysis typically reveals azotaemia, hyper-
kalaemia and a metabolic acidosis. The constellation of 
these findings should also prompt the clinician to consider 
UO if it weren’t previously a differential diagnosis.
INITIAL PATIENT STABILIZATION
While the most important step in managing the patient 
with UO is relieving the obstruction, many patients are 
too cardiovascularlly unstable to undergo such a proce-
dure. Hyperkalaemia may produce bradycardia, atrial 
standstill and cardiac arrest, and should be addressed 
prior to unblocking the patient. The most effective 
 therapy in correcting hyperkalaemia is to restore urine 
output, however therapies such as intravenous dextrose 
with regular insulin and beta-agonist (terbutaline or 
albuterol) therapy may help improve hyperkalaemia by 
moving potassium from serum to the intracellular space. 
This process may take 20 minutes or more to occur, 
therefore additional therapy may be needed. Intravenous 
calcium gluconate, while having no effect on hyper-
kalaemia, alters the threshold potential for cardiac myo-
cytes and can almost immediately resolve the bradycardia 
and bring a return of normal sinus rhythm. This is often 
helpful to improve the cardiovascular stability of the 
patient while waiting for potassium-lowering  medications 
to take effect.
DECOMPRESSING URINARY OBSTRUCTION
Sedation is typically required for urethral unblocking; 
however a severely unstable patient may only require 
local anaesthesia. Obstruction may be caused by mucus 
plugs, crystalline grit, uroliths and other intraluminal 
objects, which may require several different types of 
 urethral catheters for effective unblocking. Several sizes, 
configurations (open vs. closed) and types of catheter 
materials (polyurethane vs. hydrophilic, etc.) should be 
available. Local anaesthesia may be very beneficial in 
improving success and the speed of unblocking.
MULTIPLE CHOICE QUESTIONS
1. What biochemical findings are present in 
diabetic ketoacidosis?
(A) Glucosuria, hyperglycaemia and ketonuria/
ketonaemia
(B) Glucosuria, hyperglycaemia, ketonuria/
ketonaemia and metabolic acidosis
(C) Persistent fasting glucosuria and 
hyperglycaemia
(D) Ketonuria/ketonaemia
2. If you encounter a non-responsive 
hypokalaemia in your DKA patient, what 
electrolyte could be implicated?
(A) Sodium
(B) Phosphorus
(C) Chloride
(D) Magnesium 
3. What is the predominant hormone involved in 
development of DKA?
(A) Glucagon
(B) Growth hormone
(C) Cortisol
(D) Ghrelin
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PREVENTING REOBSTRUCTION
After urethral catheterization, the next focus is prevent-
ing the patient from developing further UO. Studies have 
shown that medical therapies, choice of catheter size 
and duration of catheterization may all affect the rate of 
reblocking. Decreasing patient stress, alleviating ure-
throspasm, increasing urine output and correcting any 
underlying cause are all important considerations and 
may have important consequences on UO recurrence. 
Surgical interventions, such as urethrostomy, may be 
considered for patients with recurrent UO that cannot be 
prevented with medical management. However, risk of 
ascending infection and proper client education should 
be considered in such cases.
KEY LEARNING OBJECTIVES
■■ Know how to quickly recognize urethral  
obstruction (UO) and stabilize the patient for 
unblocking
■■ Review the various techniques that may allow for 
fast and successful urethral catheterization
■■ Recognize the treatments that could help decrease 
the rate of UO recurrence as well as their limitations
MULTIPLE CHOICE QUESTIONS
1. A male cat with a urethral obstruction has a 
heart rate of 50 beats per minute. What is the 
most appropriate initial therapy to help stabilize 
this patient?
(A) Calcium gluconate
(B) Sodium bicarbonate
(C) Regular insulin and dextrose
(D) Terbutaline
2. What medication has been shown to reduce 
the risk of recurrent UO?
(A) Phenylpropanolamine
(B) Glucagon
(C) Phenoxybenzamine
(D) Prazosin
3. Which of the following therapies is not necessary 
for managing UO in a 2-year-old male cat?
(A) Antibiotics
(B) Feeding a canned food diet
(C) Analgesia
(D) Anxiolytics
Acute kidney injury
JD Foster
The term acute renal failure has been replaced with acute 
kidney injury (AKI) in both human and veterinary medi-
cine. Focusing on kidney injuries helps identify earlier 
opportunities for patient intervention compared to wait-
ing for the late stage of kidney dysfunction when the 
development of azotaemia occurs. Thorough diagnostic 
evaluation and treatment of the underlying cause of AKI 
may lead to recovery of kidney function, which is not 
encountered with chronic kidney disease.
Acute kidney injury is a clinical syndrome of varying 
severity that can be initiated by a multitude of aetiologies. 
It is characterized by a rapid decline in glomerular filtration 
rate (GFR) and renal function, however many forms are 
reversible (at least partially). AKI can be divided into three 
clinical categories based on the underlying aetiology:
■■ Prerenal AKI: characterized by renal hypoperfusion, 
however the renal parenchyma is not damaged
■■ Intrinsic renal AKI: damage occurs to the renal 
parenchyma, usually caused by ischaemia or a 
nephrotoxin
■■ Postrenal or obstructive AKI: acute obstruction of 
the urinary tract
PRERENAL ACUTE KIDNEY INJURY
Also called haemodynamic AKI, prerenal AKI is a 
decreased GFR due to diminished renal perfusion, with no 
pathological changes to the renal parenchyma. The hall-
mark of prerenal AKI is the rapid correction of GFR with 
restoration of renal perfusion. Prerenal AKI can result 
from a variety of conditions, including hypovolaemia, 
decreased cardiac output, systemic vasodilation, or intra-
renal vasoconstriction. Drugs that impair the mainte-
nance of effective circulating volume, including systemic 
vascular resistance or renin–angiotensin–aldosterone 
system activity, may contribute to decreased hypoperfu-
sion. Such classes of drugs include non-steroidal anti-
inflammatory drugs, diuretics and angiotensin-converting 
enzyme inhibitors, amongst others.
INTRINSIC ACUTE KIDNEY INJURY
Damage to the renal parenchyma may occur due to: 
 disease of the large renal vessels, disease of the renal 
microvasculature and glomeruli, ischaemic and nephro-
toxic acute tubular necrosis, and other tubulointerstitial 
disease. Infectious and toxic injuries are quite common 
in veterinary patients. Persistent prerenal and postrenal 
reductions in GFR can result in intrinsic renal pathology 
and AKI.
POSTRENAL ACUTE KIDNEY INJURY
Obstruction of the renal pelvis, ureter, urinary bladder or 
urethra leads to postrenal AKI. Such conditions result in 
increased hydrostatic pressure within the lumen of the 
 urinary tract upstream from the obstruction due to the 
continued production of urine by the kidney(s). Persistent 
obstruction increases intratubular pressure in Bowman’s 
capsule causing a dramatic fall in GFR, however unilateral 
nephroureteral obstruction will not result in isosthenuria or 
azotaemia due to the preserved function of the contra-
lateral kidney. Increased intratubular pressure will impair 
tubular function and subsequent sodium  reabsorption, 
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potassium excretion and urine-concentrating capabilities. 
A back leak of tubular contents through tight junctions of 
renal epithelial cells may occur, causing further ischaemia 
and inflammation.
MANAGEMENT OF ACUTE  
KIDNEY INJURY
Meticulous patient care is needed to provide opportunity 
for renal recovery and to prevent iatrogenic nephron 
injury. Although challenging, medical therapy should 
reverse the derangements occurring with renal dysfunc-
tion, particularly electrolyte and acid–base disturbances, 
dysvolaemia, anorexia and uraemia. Proper therapy may 
stop ongoing renal injury and provide support to allow 
time for renal recovery.
KEY LEARNING OBJECTIVES
■■ Understand how acute kidney injury (AKI) can be 
identified prior to the development of azotaemia
■■ Review the diagnostic evaluation of the AKI patient 
in order to determine the aetiology
■■ Recognize when veterinary intervention may cause 
further renal injury 
MULTIPLE CHOICE QUESTIONS
1. All of the following medications may cause 
prerenal AKI except which one?
(A) Diuretics
(B) Angiotensin-converting enzyme inhibitors
(C) Antioxidants
(D) Non-steroidal anti-inflammatory drugs 
2. How would a cat with postrenal AKI caused by 
a ureterolith be best managed?
(A) Surgical intervention to allow for urine to 
bypass the obstruction (ureteral stent or 
bypass)
(B) Aggressive intravenous fluid therapy to 
cause diuresis
(C) Dietary dissolution of the ureterolith
(D) Non-steroidal anti-inflammatory drug to 
reduce ureteral inflammation
3. Why should intravenous fluids be administered 
to the patient with intrinisic AKI?
(A) To increase GFR
(B) To maintain renal perfusion
(C) To achieve maximal urine output
(D) To flush intratubular debris and obstruction
Management of canine 
acute pancreatitis 
Isuru Gajanayake 
CLINICAL PRESENTATION 
Pancreatitis is a very heterogeneous disease in dogs, 
however most dogs display signs of nausea, dehydration 
and abdominal pain, and thus require hospitalization for 
supportive care. Some dogs can develop life-threatening 
complications, such as disseminated intravascular coag-
ulation (DIC) and systemic inflammatory response 
 syndrome (SIRS). Gastrointestinal ileus and jaundice are 
more common, but less concerning. Chronic sequelae of 
pancreatitis include abscessation and pseudocysts. 
DIAGNOSIS 
It is imperative that diagnostic testing for pancreatitis is 
only performed in dogs with appropriate clinical signs, 
because false diagnoses are common. For this reason, 
both blood testing and diagnostic imaging are usually 
needed to confirm pancreatitis. Serological testing for 
acute pancreatitis necessitates measurement of lipase of 
pancreatic origin, but even this analyte can be elevated in 
diseases other than pancreatitis. 
Diagnostic imaging is also essential for confirmation 
of pancreatitis. Imaging is usually performed using ultra-
sonography, with the identification of a hypoechoic pan-
creas surrounded by hyperechoic fat being consistent 
with pancreatitis. Abdominal computed tomography is 
also very useful for the diagnosis of pancreatitis, particu-
larly in large or obese dogs. 
MEDICAL MANAGEMENT 
Medical management is the cornerstone of canine acute 
pancreatitis management. Firstly, this entails correction 
of fluid, electrolyte and acid–base imbalances with 
appropriate crystalloid fluid therapy. Correction of 
hypokalaemia, in particular, can help improve the clinical 
picture in some dogs. Antiemetic therapy is also vital in 
this disease, even if vomiting is not a feature, because 
the  inappetence associated with pancreatitis is usually 
due to nausea. Maropitant is a safe and very effective 
medication for this purpose, however occasionally other 
medications such as ondansetron are needed. 
Finally, analgesia is vital in canine acute pancreatitis. 
This is most effectively provided using opiods, such as 
buprenorphine or methadone. Use of multimodal analge-
sia infusions (e.g. methadone +/- lidocaine +/- ketamine) 
can optimize analgesia and reduce the adverse effects 
associated with each component. Non-opioid options for 
analgesia include paracetamol and non-steroidal anti-
inflammatory medications, however these should be used 
with some caution. Other medications used in canine 
pancreatitis include gut protectants and antibiotics. Ant-
acids and prokinetics are usually only indicated when 
there is regurgitation of gastric contents due to ileus. 
NUTRITIONAL MANAGEMENT 
Nutrition plays an integral role in the management of 
dogs with acute pancreatitis. This is usually achieved 
by enteral (tube) feeding; however post-pyloric feeding 
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(i.e. using a jejunostomy tube) is not necessary. Enteral 
feeding is most effectively provided by an oesophagos-
tomy feeding tube. Naso-oesophageal tubes can also be 
used for short-term enteral nutrition. Appetite stimulants 
are not recommended. Parenteral nutrition is not readily 
available to the general practitioner, however this 
method can be very useful to provide nutrition when 
enteral methods are not tolerated. 
The nutrient profile of diets fed to dogs with acute 
pancreatitis is also important. The calorie provision 
should be calculated to meet the dog’s resting energy 
requirement, whilst the macronutrient (i.e. protein, fat 
and carbohydrate) provision is usually tailored to meet 
each dog’s specific needs. 
KEY LEARNING OBJECTIVES 
■■ To use clinical, serological and imaging information 
to correctly diagnose pancreatitis 
■■ To understand the pros and cons of various 
medications used for pancreatitis 
■■ To formulate a feeding plan for dogs with acute 
pancreatitis  
MULTIPLE CHOICE QUESTIONS 
1. Which of the following is the best test for 
canine acute pancreatitis? 
(A) Amylase 
(B) Pancreatic lipase 
(C) Trypsin-like immunoreactivity 
(D) Faecal proteinase inhibitor 
2. Which of the following is a potent centrally 
acting antiemetic? 
(A) Metoclopramide 
(B) Ondansetron 
(C) Maropitant 
(D) Omeprazole 
3. Feeding to manage acute pancreatitis is best 
achieved by which of the following?
(A) Naso-oesophageal feeding tube
(B) Parenteral nutrition 
(C) Oesophagostomy feeding tube
(D) Mirtazapine medical therapy
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PU/PD
Sophie Keyte
Polyuria (PU) is defined as urine output >50 ml/kg/24h. 
Normal dogs and cats drink 20–90 ml/kg/24h depending 
on diet moisture content. Polydipsia (PD) is defined as a 
fluid intake >90–100 ml/kg/24h in dogs and >45 ml/kg/ 
24h in cats. 
Water balance in the body is controlled primarily 
by  water intake (thirst – controlled by osmolality) and 
water  loss (primarily renal – controlled by anti-diuretic 
 hormone (ADH)). Causes of PU/PD can be divided into 
dis orders causing primary polyuria and those causing 
primary polydipsia. 
INVESTIGATION
Step 1 
This will give you the diagnosis in the majority of cases. 
■■ History:
 – Including reproductive history (recent season?), 
diet/environmental changes, drugs/toxins
 – Quantify PD if possible; ensure genuinely PU 
rather than just incontinence (though PU may 
lead to incontinence in some dogs)
■■ Physical examination:
 – Evidence of renal or liver disease, or 
endocrinopathies?
 – Lymphadenopathy (lymphoma is most common 
cause of hypercalcaemia) or any neoplasia (e.g. 
anal gland mass – anal gland carcinomas are 
another common cause of hypercalcaemia)?
 – Vaginal discharge?
■■ Haematology, complete biochemistry (including 
electrolytes and bile acid stimulation), and urinalysis 
(including culture):
 – Evidence of renal or liver disease, 
hypercalcaemia, diabetes mellitus, 
hyponatraemia, hypokalaemia?
 – Stress leucogram, increased liver enzymes, 
urinary tract infection (UTI) without pyuria – 
consider hyperadrenocorticism (HAC), perform 
specific testing
 – Hyperkalaemia, hyponatraemia, lack of stress 
leucogram in sick dog – consider 
hypoadrenocorticism, perform specific testing
 – Hospital water diary and urine specific gravity 
(USG) can be helpful: USG <1.006 excludes 
generalized renal dysfunction; lack or inhibition 
of ADH or psychogenic polydipsia more likely; 
USG >1.020 makes DI unlikely; USG 1.008–
1.029 with proteinuria increases suspicion of 
chronic kidney disease or HAC
 – Serum T4 (cats)
Step 2
■■ Consider abdominal imaging (renal disease, 
pyelonephritis, pyometra)
■■ Consider specific endocrine testing for hyper-/
hypoadrenocorticism:
 – Adrenocorticotropic hormone (ACTH) 
stimulation test to rule out 
hypoadrenocorticism; only approximately 
60–80% sensitive for HAC
 – Low-dose dexamethasone suppression test 
(LDDST) or urine cortisol:creatinine (UCCR); 
highly sensitive for HAC but poor specificity. 
Useful in this situation as you are trying to 
exclude it – normal LDDST or UCCR makes 
HAC very unlikely
Step 3
If ALL the above are unhelpful:
■■ Consider HAC again (most commonly!), early 
chronic kidney disease, or occult pyelonephritis. 
Further assessment of renal function, if appropriate, 
may include creatinine or iohexol clearance tests, 
renal biopsy, or trial treatment for pyelonephritis
■■ Remaining differentials are central diabetes insipidus 
(DI), primary nephrogenic DI or psychogenic 
polydipsia – consider water deprivation test (WDT) 
or treatment trial with desmopressin (DDAVP, an 
ADH analogue) to differentiate between these. 
However, this is NOT WITHOUT RISK. Both of these 
approaches require careful monitoring. WDT is very 
labour intensive, and usually requires bladder 
catheterization
■■ It is essential to rule out above diseases first before 
performing a water deprivation test
■■ As a general rule, don’t do this test without speaking 
to a specialist first; for further details, refer to 
endocrinology textbooks
KEY LEARNING OBJECTIVES
■■ Understand the pathophysiology leading to 
polyuria/polydipsia (PU/PD)
■■ Apply a logical approach to listing causes of PU/PD
■■ Outline an appropriate diagnostic approach to PU/PD
MULTIPLE CHOICE QUESTIONS
1. Along with a hypertonic renal medulla what is 
the other main factor affecting urine 
concentration at the collecting tubules?
(A) Plasma urea concentration 
(B) Medullary glucose concentration 
(C) ADH concentration 
(D) Renal cortisol concentration
2. Primary polydipsia can occur as a result of 
which disease process? 
(A) Chronic kidney disease
(B) Urinary tract infection
(C) Pyometra
(D) Malabsorptive gastrointestinal disease
3. What urine specific gravity achieved in a clinical 
case makes true PU/PD very unlikely? 
(A) 1.040
(B) 1.008
(C) 1.010
(D) 1.004
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Hypercalcaemia
Sophie Keyte 
PATHOPHYSIOLOGY
The concentration of serum ionized calcium (physiologi-
cally ‘active’ calcium) is kept within narrow limits by the 
action of parathyroid hormone (PTH) on bone resorption, 
renal calcium excretion and metabolism of  vitamin D. PTH 
is secreted from the parathyroid glands and is controlled by 
serum calcium concentration. Hypercalcaemia is an impor-
tant differential diagnosisfor polyuria/polydipsia (PU/PD).
DIFFERENTIAL DIAGNOSIS OF 
HYPERCALCAEMIA (HARD IONS)
■■ Hyperparathyroidism (primary, common; secondary 
nutritional, uncommon)
■■ Addison’s (hypoadrenocorticism, common) – up to 
33% of Addison’s cases are hypercalcaemic
■■ Renal disease – 10–20% of chronic kidney disease 
(CKD) have hypercalcaemia, but usually have 
lowered ionized calcium; also seen in acute disease
■■ D – hypervitaminosis D (uncommon), can be 
secondary to cholecalciferol rodenticides, vitamin D 
skin preparations (treatment for psoriasis) or 
granulomatous disease
■■ Idiopathic – an important cause in cats
■■ Osteolytic (uncommon)
■■ Neoplasia (hypercalcaemia of malignancy, 
lymphoma, anal gland adenocarcinoma, multiple 
myeloma, carcinomas of various organs, 
melanoma) – the most common cause of 
hypercalcaemia, usually due to production of a 
PTH-related peptide (PTH-rP)
■■ Spurious – laboratory error
Most common are lymphoma (dogs), idiopathic (cats).
INVESTIGATION OF HYPERCALCAEMIA
1. History and physical examination – including lymph 
nodes and anal glands
2. Haematology/biochemistry (see Figure 1) – confirm 
serum hypercalcaemia. Consider serum albumin 
concentrations (low albumin results in falsely low 
calcium) and phosphorus (Ca × P >5 results in 
increased risk of soft tissue calcification). Check 
ionized calcium if available
3. Look for lymphoma/other neoplasia – fine-needle 
aspiration of lymph nodes; survey radiographs; scan 
liver/spleen; bone marrow aspiration?
4. If no evidence of neoplasia:
(A) Suspicious of hypoadrenocorticism? – 
adrenocorticotropic hormone (ACTH) 
stimulation test
(B) To further investigate primary 
hyperparathyroidism or occult neoplasia – PTH 
± PTH-rP, special sampling requirements (frozen 
EDTA samples), contact laboratory directly
(C) Suspicious of primary hyperparathyroidism? – 
Ultrasonography of neck, any evidence of 
enlarged parathyroid glands (may be palpable in 
cats)? Exploratory cervical surgery?
(D) Consider measurement of vitamin D 
metabolites (contact laboratory)
KEY LEARNING OBJECTIVES
■■ Outline the pathophysiology of hypercalcaemia
■■ Outline the differential diagnoses for 
hypercalcaemia in dogs and cats
■■ Outline a logical approach to the hypercalcaemic 
patient
Serum Ca Ionized Ca PO4 Ureaa PTH PTHrP
Hypercalcaemia of malignancy ↑ ↑ ↓ Normal or ↑ ↓ ↑
Primary hyperparathyroidism ↑ ↑ Low N or ↓ Normal or ↑ ↑ ↓
Chronic kidney disease ↑ 10–20% cases Normal or ↓ ↑ ↑ ↑
Hypoadrenocorticism ↑ Normal Variable ↑ Normal
Hypervitaminosis D ↑ ↑ ↑ Normal or ↑ Normal
Figure 1: Biochemical abnormalities in hypercalcaemia.  
aUrea can be elevated with hypercalcaemia of any cause due to dehydration and, in severe prolonged cases, due to 
renal tubular damage – it is sometimes difficult to know whether azotaemia is the cause or effect of hypercalcaemia. 
Ionized calcium may be useful to differentiate these
MULTIPLE CHOICE QUESTIONS
1. What is the predominant hormone in control 
of body calcium concentrations?
(A) Parathyroid hormone
(B) Calcitonin
(C) Growth hormone
(D) Cortisol 
2. What is the most common cause of 
hypercalcaemia in dogs? 
(A) Vitamin D toxicity 
(B) Hypoadrenocorticism
(C) Chronic kidney disease
(D) Lymphoma
3. When measuring calcium concentrations, which 
electrolyte should be measured concurrently to 
help in refining differential diagnoses?
(A) Potassium
(B) Sodium
(C) Phosphate
(D) Magnesium
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Juvenile lameness 
Duncan Barnes 
Lameness is a common presenting complaint in juvenile 
animals. Many cases are due to minor knocks and strains 
and will resolve with a brief period of rest and analgesics. 
However, some causes of juvenile lameness can have 
long-term consequences if they are not treated promptly. 
Such conditions include:
■■ Physeal fractures, that can lead to premature or 
asymmetric closure of the growth plates, resulting 
in angular limb deformity or joint incongruency
■■ Septic arthritis in juveniles, which can cause rapid 
irreversible destruction of the articular cartilage
■■ Medial patellar luxation, which can cause the 
trochlear groove to develop abnormally along with 
permanent changes to the shape of the femur and 
tibia
Many developmental disorders can lead to chronic 
arthritis including:
■■ Hip dysplasia
■■ Elbow dysplasia 
■■ Osteochondritis dissecans
For some of these conditions, there are treatment 
options available at an early age which are relatively 
straightforward and allow the avoidance of more com-
plex procedures later in life. For example, the simple 
 procedure of juvenile pubic symphysiodesis for a dog 
with hip dysplasia can allow the avoidance of the need 
for a total hip replacement as an adult. In other cases, 
early diagnosis can allow a change in management, to 
reduce the impact of the disease on the patient. It is, 
therefore, important to take a pragmatic approach to 
help identify which cases need further investigation, and 
how urgently this should occur. When investigating juve-
nile lameness, a systematic approach can help to avoid 
missing rare causes of lameness, however, it is good to 
remain pragmatic and remember that common things 
are common. The desire to avoid missing significant 
problems must be balanced against the risks of repeated 
anaesthetics, the loss of client confidence due to per-
ceived overinvestigation, and the financial impracticality 
of fully investigating every episode of juvenile lameness.
Central to any investigation of juvenile lameness is a 
good clinical history, gait evaluation and clinical exami-
nation. This will usually allow the source of the lameness 
to be narrowed down to one or more regions of one or 
more limbs and/or the axial skeleton. Armed with this 
information the clinician can then decide whether  further 
investigation is necessary, when it should be  performed, 
and what further diagnostic tests are needed. Further 
diagnostics could include examination under sedation 
or anaesthesia, radiography, ultrasonography, advanced 
imaging and arthrocentesis. 
Using an interactive case-based presentation, the 
following common scenarios will be studied.
■■ The traumatized juvenile patient:
 – Long bone fracture
 – Physeal fracture
 – Avulsion fracture
■■ Persistent juvenile lameness:
 – Congenital malformation
 – Hip dysplasia
 – Elbow dysplasia
■■ Multifocal juvenile lameness:
 – Panosteitis
 – Metaphyseal osteopathy
 – Septic arthritis
KEY LEARNING OBJECTIVES
■■ Know the common causes of juvenile lameness
■■ Identify clinical situations in which further 
investigation of lameness is indicated and how 
urgently this should be performed
■■ Understand the long-term consequences of some 
causes of juvenile lameness
MULTIPLE CHOICE QUESTIONS
1. Which of these clinical situations needs to be 
investigated further?
(A) Crepitus and severe pain on elbow 
manipulation
(B) Pyrexia with swelling and pain of multiple 
joints
(C) Non-weightbearing lameness with 
abnormal angulation of the femur
(D) All of the above
2. Which of the following is a common 
developmental cause of juvenile lameness?
(A) Fragmented medial coronoid process
(B) Tibial tuberosity avulsion
(C) Lumbosacral disease
(D) Cranial cruciate ligament rupture
3. Which of the following is NOT a potential 
consequence of physeal fracture?
(A) Angular limb deformity
(B) Metaphyseal osteopathy
(C) Limb shortening
(D) Elbow incongruency
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Seizures
Jeremy Rose
Seizures are a common neurological complaint in small 
animal practice. Managing seizures can be challenging. 
This is because seizures have a wide spectrum of clinical 
signs, a range of different causes and varying conse-
quences to the pets and their owners. Adopting a prac-
tical and systematic approach to epileptic seizures allows 
better management of even the most difficult cases. The 
systematic approach revolves around three major steps:
1. Confirming the episode is a seizure
2. Trying to identify the cause of seizure
3. Offering treatment of the seizure
Confirming an episode is a seizure can be challeng-
ing and the key to starting management of these cases. 
We need to differentiate seizures from other paroxys-
mal episodes such as syncope, narcolepsy/cataplexy, 
 obsessive–compulsive disorders, movement disorders, 
idiopathic head tremors, vestibular disease and general-
ized neuromuscular diseases. Given the paroxysmal 
 episodes are rarely seen by the practitioner, this needs to 
be done by taking a thorough history and performing a 
general and neurological examination. If classifying the 
paroxysmal episode is particularly challenging, videoing 
the problem can be useful but the owner’s history is key. 
Identifying a pre-ictal, ictal and post-ictal phase is unique 
to seizures and localizes your patient to the forebrain.
Identifying the cause of the seizures allows you to 
provide a prognosis and select an appropriate treatment 
for your seizuring patient. The causes of seizures can 
be divided into reactive or epileptic categories. Reactive 
causes are either metabolic or toxic in nature, whilst 
 epileptic seizures are structural or idiopathic. Making a 
differential list and then performing further investigations 
will allow you to identify the cause of seizures. Ruling out 
reactive seizures is important for all seizuring cases and 
should include a haematology, starved biochemistry, and 
liver function test. Once this has been done, determining 
the causes of epileptic seizures often requires advanced 
imaging and this may not be possible for some owners or 
practices. Where epileptic seizures are present your his-
tory and neurological examination will allow you to order 
your differential list. This can help you determine the like-
lihood of finding something on further investigations that 
would alter your therapy of the case. Where a case with an 
initially normal neurological examination does not go for 
further investigations, repeated examinations over time 
can be helpful to try and rule out progressive diseases 
which may warrant further investigations or therapy. 
When and how to treat seizures will be based on your 
presumptive diagnosis and a host of factors related to 
your patient’s history and various owner considerations. 
It is important to balance your patient’s risks of morbidity 
and mortality with adhering to the cascade, costs and 
side effects of treatment to try and optimize quality of 
life. Where an anti-seizure drug is used you should pro-
vide information on the side effects of the medication 
alongside the aim of treatment, the need for routine 
monitoring, the efficacy of drugs and situations that may 
warrant alterations of medications. Education of owners 
is key to helping them cope with having a seizuring 
patient and helping you manage your cases effectively.
KEY LEARNING OBJECTIVES
■■ Analyse a patient to decide if it is having epileptic 
seizures
■■ Utilize the neurological examination to help form a 
differential list
■■ Decide when to start treatment for seizuring patients
MULTIPLE CHOICE QUESTIONS
1. Which paroxysmal episodes can be 
interrupted?
(A) Idiopathic head tremors
(B) Seizures
(C) Syncope
(D) Vestibular disease
2. What is reported to be the most common 
reactive cause of seizure on serum 
biochemistry in dogs?
(A) Hypercalcaemia
(B) Hyperkalaemia
(C) Hypokalaemia
(D) Hypoglycaemia
3. What is the only UK licensed drug for treating 
structural epilepsy in dogs?
(A) Imepitoin
(B) Levetiracetam
(C) Phenobarbital
(D) Potassium bromide
Prescription foods
Isuru Gajanayake 
REASONS TO USE PRESCRIPTION FOODS 
Prescription diets are generally used for three reasons:
■■ To treat or cure a disease 
■■ To improve the clinical signs and outcome 
■■ To prevent recurrence of a disease. 
Apart from a few examples (e.g. food allergies and 
obesity), it is uncommon for dietary therapy to cure a 
 disease. In most cases, prescription diets are used to 
improve clinical signs (e.g. hydrolysed diets in inflamma-
tory bowel disease), improve longevity (e.g. renal formu-
lated diets for chronic kidney disease) and to prevent 
recurrence of disease (e.g. for urolithiasis). 
It is important that the veterinary surgeon (veterina-
rian) prescribing these diets has an understanding of the 
specific nutrient modulation(s) in these diets and how 
these help to manage and/or prevent certain diseases. 
It  is also important to appreciate the relative evidence 
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base behind the recommendations for prescription diets. 
For example, strong evidence supports the use of 
 protein- and phosphorus-restricted renal diets to both 
improve clinical signs and prolong life in canine and 
feline chronic kidney disease. Recommendations for 
other prescription diets may be based on weaker evi-
dence, such as physiological principles and extrapolation 
from studies in other species. It is imperative that any 
 dietary therapy in a patient is based on strong evidence so 
that unnecessary and sometimes expensive dietary mod-
ifications are not recommended. Where the evidence is 
sparse, the client must be counselled about this so that an 
appropriate nutrition plan can be implemented. 
RISKS OF PRESCRIPTION FOODS
As with any medical or surgical procedure, dietary inter-
ventions are not without risks. Protein-restricted diets 
(e.g. renal or hepatic formulated) can cause detrimental 
effects in susceptible groups (e.g. growing animals). 
 Similarly, markedly sodium-restricted diets designed 
for   cardiac disease can potentially worsen signs if used 
inappropriately. Sodium- and fat-restricted diets can 
negatively influence the palatability of the food and thus 
reduce consumption. 
ALTERNATIVES TO PRESCRIPTION FOODS 
Alternatives to prescription diets include generic com-
mercial diets and home-cooked diets. Examples of the 
former category includes, use of ‘light’ diets for obe-
sity and use of single-source protein diets for food- 
responsive skin or gut disease. Some caution should be 
exercised when using these diets because the nutrient 
profiles and/or ingredient lists may not be as desired 
to  manage these conditions. In some diseases, a key 
nutrient used in the dietary modulation can be provided 
as a solitary supplement (e.g. omega-3 fish oils).
Although home-cooked diets can be formulated to 
be nutritionally balanced and to provide a desired nutri-
ent profile, these diets can be expensive and time con-
suming to produce. Feeding of unbalanced home-cooked 
diets during illness (e.g. chronic kidney disease) can lead 
to detrimental consequences. Formulation of a balanced 
home-cooked diet requires the services of a veterinary 
nutritionist and a micronutrient supplement(s) to ensure 
the diet is balanced. Home-cooked diets can, however, 
play a role in dogs and cats with multiple medical condi-
tions, where a suitable prescription diet is not available. 
KEY LEARNING OBJECTIVES 
■■ To understand the rationale and evidence behind 
prescription diets
■■ To be aware of the possible adverse effects of 
prescription diets 
■■ To appreciate the advantages and limitations of the 
alternatives to prescription diets
MULTIPLE CHOICE QUESTIONS 
1. What are the most important nutrient 
modulations in renal formulated diets?
(A) Protein restriction and sodium restriction 
(B) Phosphorus restriction and potassium 
supplementation 
(C) Protein restriction and phosphorus 
restriction 
(D) Phosphorus restriction and fish oil 
supplementation 
2. What is the main risk of feeding renal diets to 
growing animals?
(A) Cataracts due to amino acid deficiency 
(B) Orthopaedic disease due to phosphorus 
restriction 
(C) Pancreatitis due to the high fat content 
(D) Hepatic encephalopathy due to protein 
content 
3. Which of the following is true about home-
cooked diets?
(A) Are a cheap and easy alternative to 
prescription foods
(B) Require formulation by a veterinary 
nutritionist 
(C) Can be balanced without using 
micronutrient supplements 
(D) Have been shown to be superior to 
prescription foods 
Pruritic skin disease
Laura Buckley 
The investigation and management of pruritic skin dis-
ease is a lot like cooking; if you start with the right ingre-
dients and follow the recipe, you are likely to end up with 
something that resembles the suspected outcome. How-
ever, if you get the basics wrong and either miss out or 
add extra stages into the method, then the outcome is a 
lot less predictable. Diagnostic investigations are very 
important in confirming the diagnosis but unless they 
have been selected and interpreted in the light of an 
accurate history and appropriate clinical signs, they can 
be misleading. For example, a dog with sarcoptic mange 
may be negative on skin scrapings but show positive 
reactions to house dust mites on allergy testing, similarly 
a dog with pemphigus foliaceus will be negative on skin 
sampling and treatment trials for ectoparasites and will 
not respond to an elimination diet; however, neither of 
these animals will present with a history and skin lesions 
typical of atopic dermatitis. 
INGREDIENTS
■■ Pruritus; many skin lesions look like they should be 
pruritic, but it is easy to omit this essential 
ingredient, particularly in cats
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■■ Key historical features (Figure 1)
■■ Typical lesion character (Figure 1)
■■ Typical distribution of skin lesions (Figure 1)
■■ +/– Favrot’s diagnostic criteria; developed for the 
clinical diagnosis of atopic dermatitis in dogs and 
feline non-flea hypersensitivity dermatitis in cats
PREPARATION 
Use key historical features and character and distribution 
of skin lesions to formulate a rational, prioritized differ-
ential diagnosis list (Figure 1).
METHOD 
1. Select diagnostic tests based on your differential 
diagnosis list (Figure 1)
2. Avoid uncritical use of comprehensive ‘dermatology 
panels’ as they may include unnecessary tests that 
may be misinterpreted and/or lead to unnecessary 
treatment; testing should be driven by your 
differential diagnoses
3. Perform 6–8-week parasite treatment trial (patient, 
in-contact animals and environment) to rule out 
sarcoptic mange and flea bite hypersensitivity even 
if skin sampling is negative
4. Do not perform serological IgE/IgG food allergen 
tests; they have no utility in confirming or ruling out 
food-induced atopic dermatitis; at best they may 
indicate suitable for foods for a food trial. They 
should never replace a proper appropriate 
elimination diet
5. Do not perform serological IgE or intradermal 
testing for environmental allergens to confirm a 
diagnosis of environmental allergen-induced atopic 
dermatitis; they are used as a guide for allergen 
specific immunotherapy only
6. Make a diagnosis
SERVING SUGGESTIONS
Make a treatment plan based on your diagnosis. For atopic 
dermatitis make an initial plan by selecting treatments 
from each of the following groups:
■■ Allergen avoidance and allergen specific 
immunotherapy (not possible for animals with 
atopic-like dermatitis)
■■ Anti-inflammatories/immunomodulators
■■ Skin barrier care
■■ Avoidance of flare factors (e.g. parasitic infestation 
or microbial infection).
Disease History Lesion character Lesion distribution Diagnostic 
investigation
Parasitic
Sarcoptic mange Intense pruritus, any 
age, more common in 
young 
Crusted, erythematous 
papules, scale, 
 lichenification, alopecia
Pinnal margins, elbows, 
hocks, ventrum
Skin scrapes, 
treatment trial
Otoacariasis 
(Otodectes 
cynotis)
Any age, more 
common in young 
Brown/black ceruminous 
discharge, erythema 
Ear canals, can have 
ectopic disease
Observe mites, 
indirect 
 impression smear
Neotrombiculosis Late summer– 
autumn, contact with 
woods/fields
Diffuse/papular 
erythema, crusted 
papules
Feet, ventrum, pinnae Observe larvae, 
treatment trial
Cheyletiellosis Any age, more 
common in young
Scale, erythema, miliary 
dermatitis in cats, 
alopecia
Dorsum Coat brushings, 
acetate tape test, 
superficial skin 
scrape
Demodicosis
■■ Demodex 
canis, D. injai
■■ D. cornei, 
D. gatoi
Young/middle 
aged-senior animals, 
may be concurrent 
internal disease
Alopecia, erythema, +/– 
signs consistent with 
bacterial folliculitis
Variable Skin scrapes, 
trichography, 
(biopsy)
Pediculosis Debilitation/lethargy, 
overcrowding/poor 
sanitation
Matted hair, erythema-
tous papules, miliary 
dermatitis in cats
Any, may accumulate 
at ears and body 
openings
Acetate tape test
Coat brushings
Endoparasite 
dermatosis
■■ Pelodera
■■ Hookworms
Poor housing and 
sanitation
Erythematous papules, 
lichenification, footpad 
hyperkeratosis
Sites in contact with 
ground
Skin scrapes 
(Pelodera), faecal 
floatation
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Microbial infections
Bacterial 
pyoderma (rarely 
a primary disease)
Any age, breed or sex, 
often secondary to HD
Papules, pustules, 
erythema, epidermal 
collarettes ± alopecia
Depends on primary 
cause, often ventrum 
when HD
Direct impression 
smear cytology
Malassezia 
dermatitis
As above, seen with 
internal disease 
in cats
Erythema, lichenification, 
brown sebaceous 
discharge
Skin folds, interdigital 
skin, inguinum, axillae, 
ears, ventral neck
Acetate tape 
cytology
Dermatophytosis 
(rarely pruritic)
Any age, more 
common in young
Alopecia (often annular), 
scale, erythema, (rarely 
pustules)
Any Trichography, 
fungal culture
Hypersensitivity
Flea bite 
 hypersensitivity
Any age, breed or sex Diffuse/papular 
erythema, miliary 
dermatitis in cats, 
scale, alopecia
Caudal dorsum/pelvic 
limbs, inguinum
Coat brushings, 
wet paper test, 
flea  treatment 
trial
Food-induced 
atopic dermatitisa
6 months–3 years, 
relapsing pruritus and 
skin lesions
Diffuse to papular 
erythema, lichenification, 
feline reaction patterns*
Face, feet, ears, flexor 
elbows, ventrum
Favrot’s criteria, 
rule out 
differentials,
elimination diet
Environmental 
allergen-induced 
atopic dermatitisa
As above but may be 
seasonal
As above As above As above
Allergic contact 
 dermatitis
Contact with suspect 
allergen
Macular/papular 
erythema
Sparsely haired skin in 
contact with allergen
Avoidance and 
provocative 
exposure
Other
Pemphigus 
foliaceus
Any age, more 
common middle age 
to  senior, Akita, Chow 
Large pustules and crusts 
± alopecia
Face, pinnae, footpads, 
may be generalized
Direct impression 
smear cytology, 
biopsy
Epitheliotrophic 
 lymphoma
Older animals Erythematous patches/
plaques/nodules, scaling, 
depigmentation, 
erosions, ulcers, footpad 
hyperkeratosis
Localized or 
 generalized ± 
mucosa, footpads
Biopsy
Figure 1: Summary of typical history, lesion character (excluding pruritus and self-trauma) and distribution and 
essential diagnostic tests for pruritic skin diseases
aSee Favrot’s criteria for clinical diagnosis of atopic dermatitis in dogs and feline non-flea hypersensitivity dermatitis in 
cats. HD, hypersensitivity dermatitis
KEY LEARNING OBJECTIVES
■■ Evaluate patient history and clinical signs to create 
differential diagnosis lists
■■ Use differential diagnosis lists to lead the 
investigation of pruritic skin disease
■■ Accurately interpret diagnostic tests to make a 
definitive diagnosis and initial treatment plan
(C) Epidermal collarette
(D) Erythematous plaque
2. Which of the following lesion distributions is most 
commonly seen in canine sarcoptic mange?
(A) Face, pinnae, footpads
(B) Skin folds, interdigital skin, axillae
(C) Feet, ventrum, pinnae
(D) Pinnae, hocks, ventrum
3. Which of the following is a diagnostic test 
required in the investigation of atopic dermatitis?
(A) Elimination diet trial
(B) Food allergen IgE/IgG serology
(C) Skin biopsy and histopathology
(D) Intradermal allergy testing
MULTIPLE CHOICE QUESTIONS
1. Which of the following is a typical lesion seen 
in canine atopic dermatitis?
(A) Pustule
(B) Diffuse erythema
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Chronic diarrhoea
Eilidh Gunn
The investigation and management of chronic diarrhoea 
can be a frustrating process for owners and veterinary sur-
geons alike, however by adopting a logical and common- 
sense approach, the majority of cases can usually be 
rewarding to treat. It is often helpful to remember a basic 
differential list for chronic diarrhoea:
■■ ‘Gastrointestinal’ causes:
 – Inflammatory (e.g. dietary hypersensitivity, 
inflammatory bowel disease, antibiotic-
responsive diarrhoea syndrome)
 – Infectious (e.g. Giardia, Tritrichomonas in cats)
 – Neoplastic (e.g. lymphoma)
■■ ‘Extra-gastrointestinal’ causes:
 – Pancreatic (e.g. exocrine pancreatic 
insufficiency/pancreatitis)
 – Renal disease/liver disease
 – Endocrine disease (e.g. hypoadrenocorticism)
Using a careful history and physical examination, 
many of these differentials can be refined. For example: 
diarrhoea in the poorly, polyuric polydipsic patient may 
prompt the clinician to consider extra-gastrointestinal 
causes first and perform a biochemistry panel and basal 
cortisol early on. Weight loss should alert the clinician to 
consider a malabsorptive process and check albumin, 
trypsin-like immunoreactivity (TLI), folate and cobalamin 
concentrations while the presence of vomiting and 
abdominal pain may prompt the measurement of pan-
creatic lipase immunoreactivity (PLI). 
Where chronic diarrhoea is the only presenting prob-
lem and the dog is otherwise well then ruling out infec-
tious differentials is a sensible beginning. Whilst faecal 
cultures are usually performed routinely in such cases, 
their interpretation can be somewhat of a challenge. 
Often a dialogue with your commercial laboratory can 
help clarify the significance of a particular isolate. Whilst 
faecal flotation examinatons are relatively cheap diag-
nostic tools at least three samples (pooled) are recom-
mended to screen for Giardia and it can sometimes 
be easier all round to perform a quick fenbendazole trial 
(50 mg/kg orally q24h for 5 days) instead. 
The next logical step is to consider a diet trial. It is 
usually useful to educate clients on the intended strate-
gies behind a highly digestible diet, novel protein diet or 
hydrolysed diet to ensure compliance and avoid frustra-
tion down the line. The author usually adopts a hydro-
lysed diet in most cases for a 3–4-week trial with 
telephone follow-up 1–2 weeks in to ensure things are 
not deteriorating in the interim. 
Should diet fail to incite sufficient improvement then 
further diagnostics (as outlined above) are indicated. 
Assuming these initial investigations are normal/negative 
and the animal is still ‘well’ with a stable weight and 
 normal albumin concentration, then it is reasonable to 
consider empirical therapy with an antibiotic, e.g. oral 
metronidazole (10–15 mg/kg q12h).
Beyond this, biopsies are often considered. Prior to 
considering the best approach for performing biopsies, 
the author prefers to perform abdominal ultrasonogra-
phy to ensure that there are no obvious focal areas of 
pathology (e.g. loss of layering within the jejunum) that 
would dictate exploratory laparotomy over endoscopic 
biopsy. 
Should biopsies not be an option for any reason 
(finances, morbidity…) then a corticosteroid trial is rea-
sonable provided the adverse effects and limitations of 
this as a ‘trial treatment’ are fully explained to the client 
from the outset. The author usually prefers an initial 
‘ anti-inflammatory’ dose of 1 mg/kg/day that can titrated 
up or down as required (although usually not beyond 
2 mg/kg/day in dogs and 3–4 mg/kg/day in cats).
KEY LEARNING OBJECTIVES
■■ Use key history and physical examination findings to 
dictate the order and urgency of routine diagnostics
■■ Spending the time communicating diagnostic/
therapeutic strategies with clients from the outset 
can avoid frustration further down the line
■■ The timing and type of intestinal biopsy should be 
dictated by the patient’s overall clinical status, 
previous diagnostics and presumed distribution of 
gastrointestinal pathology 
MULTIPLE CHOICE QUESTIONS
1. Which of the following is NOT a differential 
diagnosis for chronic diarrhoea?
(A) Hypoadrenocorticism
(B) Exocrine pancreatic insufficiency
(C) Hypothyrodisim
(D) Giardiasis
2. What is the most appropriate initial diagnostic 
strategy for a dog with chronic diarrhoea, 
weight loss and polydipsia?
(A) Faecal flotation test
(B) Biochemistry
(C) Abdominal ultrasonography
(D) Upper gastrointestinal endoscopy
3. In which of the following circumstances would 
you consider performing biopsies (endoscopic 
or surgical as appropriate) before performing a 
diet trial?
(A) Marked weight loss
(B) Hypoalbuminaemia
(C) Identifiable structural changes within the 
gastrointestinal tract on ultrasonography
(D) All of the above
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Forelimb lameness 
in cats: sources and 
solutions
Karen Perry 
INTRODUCTION
■■ Non-traumatic conditions affecting the feline elbow 
include degenerative joint disease (DJD) and medial 
humeral epicondylitis (MHE)
■■ Non-traumatic shoulder conditions in the cat are 
rarely encountered but include glenoid dysplasia, 
bicipital tenosynovitis, accessory centres of 
ossification and osteochondritis dissecans of the 
humeral head
■■ Carpal conditions in cats are generally traumatic 
with hyperextension injuries and medial collateral 
ligament injuries being the most commonly 
reported
Elbow DJD and MHE and glenoid dysplasia will be 
concentrated on in this talk.
ELBOW DEGENERATIVE JOINT DISEASE
Elbow DJD is common in domestic cats but the aetiology 
remains controversial. Cats with unilateral lameness 
associated with elbow DJD may have a noticeable lame-
ness. However many cats are bilaterally affected making 
the lameness less obvious. Thickening of the elbows 
and/or joint effusion may be palpable and the range of 
motion of the elbow may be reduced. 
Osteophyte formation is a key radiographic feature. 
Soft tissue mineralization and intra-articular mineralized 
bodies may also be evident. 
Treatment depends on the severity of the associated 
clinical signs. Most cats can be managed non-surgically. 
For cases with osteochondral intra-articular fragments, 
arthroscopy or arthrotomy can be performed to remove 
these. In cases with marked disability which does not 
respond to either medical management or more con-
servative surgical management, salvage options may be 
considered. 
MEDIAL HUMERAL EPICONDYLITIS 
MHE is caused by avulsion and calcification of the 
 antebrachial flexor tendons at their insertion site on the 
medial humeral epicondyle. The cause of MHE is essen-
tially unknown but may be related to trauma or overuse. 
MHE cases tend to have a mild–moderate lameness and 
they may be reluctant to jump down from heights. In 
cases where MHE is causing a clinical problem, a pain 
response can often be elicited by palpation over the 
flexor muscles and medial epicondyle. 
In the early stages, MHE may be overlooked as there 
will be no radiographic signs. In mild cases radiographic 
signs are relatively subtle with rounding and slight irregu-
larity of the medial humeral condyle; in advanced cases, 
large semicircular mineralized structures may be seen at 
the caudomedial aspect of the joint.  
Mild cases of MHE can be treated non-surgically. In 
cases where this is ineffective, treatment consists of sur-
gical removal of the calcified tendon and muscle tissue. 
DYSPLASIA OF THE SHOULDER JOINT
Dysplasia of the shoulder joint is a congenital condition. 
The altered joint conformation can lead to instability or 
subluxation of the glenohumeral joint and subsequent 
DJD.  The lameness in cases with shoulder joint dyspla-
sia can vary in intensity from mild to severe. As this 
 condition has been reported in conjunction with other 
conditions, the clinical presentation can vary widely. 
Radiography reveals incongruity; the glenoid cavity 
is normally short and shallow with a thickened subchon-
dral bone plate. The humeral head may also be slightly 
displaced. 
Treatment options include non-surgical manage-
ment with physical rehabilitation, weight reduction and 
analgesic therapy. In cases where this is not effective, 
the  only surgical option available is arthrodesis of the 
shoulder joint. 
KEY LEARNING OBJECTIVES
■■ Distinguish between common causes of forelimb 
lameness in cats based on presenting signs and 
findings on orthopaedic examination
■■ Identify appropriate diagnostic tests to enable a 
definitive diagnosis to be achieved in cases of feline 
forelimb lameness
■■ Differentiate between cases where non-surgical 
management is appropriate and those where 
surgical treatment should be pursued
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements regarding 
elbow DJD in cats is CORRECT?
(A) Most cases occur secondary to medial 
coronoid process disease
(B) The most severe disease affects the medial 
compartment of the joint
(C) The key radiographic feature is soft tissue 
mineralization
(D) Surgical management is necessary in order 
to regain satisfactory function in the 
majority of cats
2. Which of the following statements regarding 
MHE in cats is CORRECT?
(A) The ulnar head of the flexor carpi ulnaris 
muscle is most frequently affected
(B) The condition is always clinically 
significant and should be treated
(C) In the early stages, mild new bone 
formation will be noted over the medial 
humeral condyle
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(D) If non-surgical management has not 
resulted in improvement within 4 weeks, 
surgical treatment should be seriously 
considered 
3. Which of the following statements regarding 
shoulder joint dysplasia in cats is CORRECT? 
(A) Cats with shoulder joint dysplasia are 
predisposed to luxation of the 
glenohumeral joint
(B) As the condition is congenital, cats 
normally present very young at 6–12 
months of age
(C) Radiography normally reveals an altered 
shape to the humeral head with a normal 
glenoid cavity
(D) Most cases require shoulder arthrodesis in 
the medium-to-longer term to maintain 
comfort
Hindlimb lameness 
in cats: sources and 
solutions
Karen Perry 
THE HIP JOINT
Degenerative joint disease (DJD) of the hips secondary to 
hip dysplasia (HD) is relatively common in the domestic 
cat. Clinical signs include inactivity, hindlimb lameness, 
difficulty climbing and walking in a crouched position. 
Lameness varies from mild to severe. Physical examina-
tion findings include pain and crepitus upon hip exten-
sion and abduction and muscle atrophy. 
The most common radiographic finding is a shallow 
acetabulum. Radiographic degenerative changes seem 
to develop later and are less marked than in the dog. 
Non-surgical management may include:
■■ Environmental and activity modulation
■■ Physical rehabilitation
■■ Dietary modulation
■■ Weight reduction
■■ Nutraceuticals
■■ Drug therapy:
 – Non-steroidal anti-inflammatory drugs (NSAIDs)
 – Multimodal analgesia
In cases where non-surgical management does 
not  relieve discomfort there are two recommended 
options for surgical management: femoral head and 
neck  excision and total hip replacement. 
THE STIFLE JOINT
Cranial cruciate ligament rupture
Cranial cruciate ligament (CrCL) rupture is not as  common 
in cats as in dogs but it may be under-reported. Whether 
CrCL rupture in cats is largely traumatic or whether some 
cats suffer degenerative rupture is a  matter of some 
debate. The history is generally of an acute-onset marked 
lameness. Diagnosis is generally straightforward based 
on clinical signs including  lameness, stifle pain, cranial 
tibial thrust and laxity in cranial drawer. 
Radiographs typically show joint effusion. Cranial 
displacement of the tibia may be apparent and in degen-
erative or chronic cases, degenerative changes may be 
evident. 
Non-surgical management consists of a short course 
of NSAIDs, exercise restriction and weight loss. Recovery 
is protracted following non-surgical management with 
limb-loading taking many months to return to near nor-
mal. Cats may return to normal function more quickly 
after surgical stabilization. While numerous surgical pro-
cedures have been described to stabilize CrCL-deficient 
stifles in cats, extracapsular procedures are generally 
favoured. Prognosis for return to normal function after 
CrCL rupture is good to excellent. 
Patellar luxation
Patellar luxation (PL) is less common in cats than in dogs, 
however, the incidence may be underestimated. PL is 
more commonly medial than lateral. As in dogs, the most 
common abnormalities seen are a shallow trochlear 
groove and medial displacement of the tibial tuberosity. 
Most cats presenting for developmental PL are rela-
tively young. Diagnosis differs to that in dogs in that clini-
cally normal cats have some degree of laxity of the stifle 
joint with subluxation of the patella being considered a 
normal finding. In a compliant cat, PL can be detected 
with the patient either standing or in lateral recumbency. 
Luxation is generally easiest to achieve with the stifle in 
extension and the tibia internally rotated. 
Radiographs typically show mild changes only. The 
position of the patella on the radiograph will depend 
on the grade of luxation and cannot be relied upon for 
 diagnosis. 
Treatment is only recommended in high-grade 
cases or in low-grade cases with associated clinical 
signs. Surgical repair provides more favourable results 
when compared to non-surgical management. Surgical 
techniques include femoral trochlear sulcoplasty, tibial 
tuberosity transposition, soft tissue balancing and partial 
parasaggital patellectomy with a combination of tech-
niques being employed in a single stifle as required. The 
outcome following surgery is excellent in the majority 
of cases. 
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KEY LEARNING OBJECTIVES
■■ Distinguish between common causes of hindlimb 
lameness in cats based on presenting signs and 
findings on orthopaedic examination
■■ Summarize salient differences between cats and 
dogs in the aetiopathogenesis and diagnosis of 
common causes of hindlimb lameness
■■ Discuss the advantages and disadvantages of 
different forms of surgical management for treatment 
of common causes of hindlimb lameness in cats
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements regarding 
radiographic assessment of cats with hip 
dysplasia and associated DJD is CORRECT?
(A) The most common finding is subluxation 
of the hips
(B) Degenerative changes develop later in cats 
and to a less severe extent than in dogs
(C) The most extensive remodelling normally 
involves the femoral neck
(D) Less than 50% coverage of the femoral 
head is indicative of hip dysplasia
2. Which of the following statements regarding 
cranial cruciate ligament rupture in cats is 
CORRECT? 
(A) Concurrent meniscal damage is common
(B) Concurrent lateral meniscal damage is 
more common than concurrent medial 
meniscal damage
(C) Partial cranial cruciate ligament tears occur 
commonly in cats
(D) Cranial cruciate ligament rupture in cats is 
almost always degenerative
3. Which of the following statements regarding 
patellar luxation in cats is CORRECT?
(A) Radiographs of cats with patellar luxation 
normally show severe degenerative changes
(B) If clinical signs are associated with the 
condition, non-surgical management should 
be trialed before proceeding to surgery
(C) In surgical treatment a partial parasagittal 
patellectomy may be required to allow the 
patella to seat within the trochlear groove
(D) If the distal fascial attachment remains 
intact, a tension-band wire is not required 
following a tibial tuberosity transposition
Feline osteoarthritis: 
diagnosis and 
management
Karen Perry 
INTRODUCTION
Degenerative joint disease (DJD) has a high prevalence in 
domestic cats, affecting both the appendicular and axial 
skeleton, and can be associated with pain. The hip, stifle, 
tarsus and elbow are all frequently affected. While most 
feline cases of DJD appear to be primary, secondary DJD 
is also recognized, most commonly following trauma 
and hip dysplasia. 
HISTORY AND ORTHOPAEDIC 
EXAMINATION
Due to the chronicity and gradual onset of the pain asso-
ciated with DJD, the accompanying behavioural changes 
can be subtle. Alterations in jumping, becoming less 
graceful, changes in toileting, sleeping or resting more, 
playing less, grooming less and overgrowth of nails have 
all been reported secondary to DJD. 
With DJD, pain is most frequently found on extremes 
of joint motion but this can be difficult to assess in cats. 
The presence of crepitus, joint thickening and joint 
 effusion has also been shown to be predictive of the 
presence of radiographic DJD, as has a decreased range 
of motion in the shoulder, elbow, carpus and tarsus. 
RADIOGRAPHY
The sensitivity of radiographs for detection of DJD in cats 
is unknown but orthogonal views of joints likely to be 
affected, based on physical examination findings, should 
be obtained. If radiographic signs consistent with DJD 
are not seen, DJD should not be ruled out. It appears that 
cats do not form as much radiographic pathology as 
other species, so the absence of obvious radiographic 
signs does not preclude the presence of DJD that may be 
associated with pain. 
The radiographic appearance of feline DJD often dif-
fers from that seen in the dog. Osteophytosis is generally 
less evident in cats than in other species and soft tissue 
thickening and joint effusion also appear to be less 
apparent. Additionally, it is not unusual to see ossicles 
and soft tissue mineralization within feline joints affected 
by DJD. 
TREATMENT OF DEGENERATIVE 
JOINT DISEASE
Whilst less is known about feline DJD than about this 
condition in other species and the changes associated 
with it are less obvious, there is little doubt that cats 
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 suffer pain associated with DJD and that this warrants 
appropriate therapy. A multimodal management plan 
comprising environmental and activity modulation, 
physical rehabilitation, dietary modulation, weight reduc-
tion and drug therapy where required should be 
 instigated in the first instance and appropriate monitor-
ing adopted to ensure success. Non-steroidal anti-
inflammatory drugs (NSAIDs) are the mainstay of drug 
therapy for DJD in other species and there is a lot of evi-
dence to support their effectiveness in cats. Multimodal 
analgesic therapy is now being introduced to the feline 
patient, although experience in this is relatively lacking 
at  this stage. While there are many medications which 
can be used, most of these are off-licence. Amantadine, 
gabapentin and tramadol are the ones most commonly 
added in to the treatment plan when NSAID therapy 
alone proves ineffective. 
Where clinical signs cannot be controlled using this 
plan, surgical options are available including joint 
replacement, arthrodesis, excision arthroplasty, removal 
of intra-articular fragments and decompressive spinal 
surgery.
KEY LEARNING OBJECTIVES
■■ Recognize the diverse range of clinical signs which 
can be associated with feline degenerative joint 
disease (DJD)
■■ Compare and contrast the radiographic signs of 
DJD between cats and dogs
■■ Construct a multimodal treatment plan for a cat 
suffering mobility impairment associated with DJD
MULTIPLE CHOICE QUESTIONS
1. Which of the following statements is CORRECT 
regarding the radiographic appearance of 
feline DJD?
(A) Osteophytosis is more proliferative in cats 
than in dogs
(B) Soft tissue thickening and joint effusion are 
readily appreciable in the majority of cases
(C) Thinning of cartilage is often evident
(D) Soft tissue mineralization is frequently seen
2. Which of the following statements is CORRECT 
regarding the use of NSAIDs for cats with DJD?
(A) There is no evidence that NSAIDs are 
effective for treatment of DJD in cats
(B) Monitoring of blood pressure is 
recommended during NSAID use
(C) Meloxicam and robenacoxib are both 
licensed for long-term use
(D) Detection of abnormalities in kidney status 
is a complete contraindication to NSAID use
3. Which of the following statements regarding 
feline DJD is CORRECT? 
(A) DJD has a low prevalence in domestic cats
(B) Most cases of DJD in cats appear to occur 
secondary to joint dysplasia
(C) There is a mismatch between clinical and 
radiographic signs of DJD in cats
(D) DJD can be completely ruled out on the 
basis of a radiographically normal joint
Coronoid disease in 
dogs: where are we 
now?
Laura Cuddy 
This lecture will review recent developments in the under-
standing, diagnosis and treatment of medial coronoid 
disease in dogs. 
Medial coronoid disease is the most common cause 
of forelimb lameness in dogs. Lesions may be identified 
at the apex of the medial coronoid process or radial 
incisure of the ulna, and range from softened cartilage to 
fissuring or fragmentation of underlying subchondral 
bone. Although initially thought to be a manifestation of 
osteochondrosis, histopathological studies have identi-
fied microcrack formation consistent with supraphysio-
logical loading. Microcracks propagate and coalesce, 
resulting in eventual fatigue failure of the subchondral 
bone. The exact cause of the overload, however, remains 
somewhat unclear. Purported causes include static or 
dynamic proximal radioulnar step incongruence, ellipti-
cal trochlear notch, rotational instability and musculo-
tendinous mismatch.
Secondary osteoarthritic changes and subtrochlear 
sclerosis may be identified on plain radiographs.
 
The gold 
standard for diagnosis of medial coronoid disease is a 
combination of computed tomography (CT) and arthro-
scopic examination. CT permits evaluation of subchon-
dral bone surfaces and elbow congruency, but does not 
yield information on status of the overlying cartilage.
 
Conversely, arthroscopy can assess surface cartilage, but 
cannot identify isolated underlying subchondral bone 
lesions. 
Conservative management consists of weight man-
agement, non-concussive exercise and medications to 
treat inflammation and pain. Intraarticular injections of 
corticosteroids, platelet-rich plasma or stem cells are 
becoming widely used.
Fragment removal and debridement of the medial 
coronoid process via arthroscopy is best performed early 
in the disease process, and appears superior to arthrot-
omy or conservative management. Subtotal coronoid 
ostectomy (SCO) may be performed to remove a larger 
portion of pathological cartilage and bone. Bi-oblique 
dynamic proximal ulnar osteotomy (BODPUO) may be 
considered if proximal radioulnar incongruence (short 
radius) is present. 
Medial compartment disease refers to erosion of 
cartilage on both the ulnar and humeral sides of the joint. 
Canine unicompartmental elbow (CUE) arthroplasty 
 system (Arthrex Vet Systems) is an option for cases with 
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medial compartment disease and secondary osteoarthri-
tis. CUE involves resurfacing the diseased area of the 
medial portion of the humeral condyle and the medial 
coronoid process of the ulna with UHMWPE implants 
that are in contact during stance phase. Other options 
for  medial compartment disease are techniques that 
redistribute the load from the medial to lateral elbow 
compartments, such as sliding humeral osteotomy 
(SHO), or  proximal abducting ulnar osteotomy (PAUL). 
Total elbow replacement may be considered in cases 
with global end-stage osteoarthritis.
Overall, the effective treatment of medial coronoid 
disease remains complicated by our limited understand-
ing of the exact aetiopathogenesis.
KEY LEARNING OBJECTIVES
■■ Explain the proposed aetiopathogenesis of medial 
coronoid disease
■■ Outline the pros and cons of diagnostic modalities 
for medial coronoid disease
■■ Compare and contrast available treatment options 
for medial coronoid disease and medial 
compartment disease
MULTIPLE CHOICE QUESTIONS
1. What is the purported aetiopathogenesis of 
medial coronoid disease?
(A) Osteochondrosis
(B) Incomplete ossification
(C) Overload phenomenon
(D) Acute trauma
2. What is the current gold standard for diagnosis 
of medial coronoid disease?
(A) Plain radiographs
(B) Computed tomography
(C) Arthroscopy
(D) Computed tomography and arthroscopy
3. What structures in the elbow joint are affected 
by medial compartment disease?
(A) Humeral trochlea and medial coronoid 
process
(B) Humeral capitulum and lateral coronoid 
process
(C) Radial head and medial coronoid process
(D) Humeral trochlea and capitulum
Humeral intracondylar 
fissures in dogs
Laura Cuddy 
The humeral condyle develops as two separate centres of 
ossification. Failure of the lateral and medial portions of the 
humeral condyle to fuse results in a persistent  cartilaginous 
plate in the sagittal plane, and is referred to as incomplete 
ossification of the humeral condyle (IOHC). While it was tra-
ditionally believed that all fissures identified in the humeral 
condyle were due to IOHC, it has recently been postulated 
that stress fractures are to blame for the majority of cases 
identified in middle-aged to older dogs. Referring to these 
cases as IOHC would therefore be a misnomer, and the 
term humeral intracondylar fissure (HIF) is preferred. 
Whilst some fissures may be identified on plain radi-
ographs, identification may be complicated by obliquity 
and superimposition of the ulna. Computed tomography 
(CT) has become modality of choice for identification of 
intracondylar fissures. 
The best course of treatment for HIF remains con-
troversial. Many surgeons do not treat clinically silent 
HIF  due to the risk of complications with intervention. 
A  recent observational study found that when HIF is 
identified as an incidental finding, 18% progress to frac-
ture. The goals of intervention in patients with pain and 
lameness referrable to the elbow are to prevent future 
condylar fracture, resolve lameness and to promote 
fusion. A transcondylar screw is most commonly used to 
achieve these goals. Transcondylar screws may be placed 
in positional or lag fashion. Application from medial- 
to-lateral, although technically more challenging, is 
reported to have a significantly lower complication rate 
than  lateral-to-medial. Many surgeons now place these 
screws percutaneously, with or without fluoroscopic 
guidance, and using C-shaped aiming devices.
It is important that the largest feasible screw size is 
used; the screw is likely to undergo cyclic loading as the 
humeral condyle commonly fails to heal, leading to 
cyclic fatigue and screw breakage. As a guide, the screw 
should approximate 30–50% of the diameter of the mid-
point of the humeral condyle. This typically translates to 
a 4.5-mm cortical or shaft screw in a spaniel size dog. 
Some surgeons prefer to use a 5.0-mm locking screw as 
it has a larger core diameter. In larger breeds, a 5.5-mm 
cortical screw may be appropriate.
Complications associated with transcondylar screw 
placement include seroma, infection, screw breakage 
and non-union. Screw breakage is often identified as 
recrudescence of lameness and may be difficult to 
 identify, even on CT. The broken screw is removed and 
replaced with a larger size. When placing a transcondylar 
screw it is prudent to anticipate screw breakage may 
occur and to use a longer screw for future retrieval.
Some surgeons advocate a biological approach 
rather than a biomechanical approach to HIF; combining 
implants with grafting techniques may promote osseous 
fusion and relieve stress on implants. The primary con-
cern with a biological approach in stress fractures is that 
the bone may re-fracture if the underlying stressor is not 
identified and addressed.
KEY LEARNING OBJECTIVES
■■ Understand the aetiopathogenesis of humeral 
intracondylar fissures 
■■ Recall useful diagnostic modalities for humeral 
intracondylar fissures
■■ Compare and contrast treatment options for 
humeral intracondylar fissures 
401-408 Orthopaedics.indd   406 08/03/2019   18:22
BSAVA CONGRESS 2019 PROCEEDINGS [ 407 ]
MULTIPLE CHOICE QUESTIONS
1. What is the proposed aetiopathogenesis of 
humeral intracondylar fissures in dogs?
(A) Stress fracture
(B) Traumatic injury
(C) Osteochondritis dissecans
(D) Retained cartilaginous core
2. If a humeral intracondylar fissure is identified as 
an incidental finding, what is the reported 
subsequent fracture rate?
(A) 8%
(B) 18%
(C) 58%
(D) 98%
3. What is the ideal size of transcondylar screw  
for stabilization of humeral intracondylar 
fissure?
(A) 10–15% midpoint humeral condyle
(B) 30–50% midpoint humeral condyle
(C) 60–80% midpoint humeral condyle
(D) 100% midpoint humeral condyle
Ununited anconeal 
process: what to do?
Laura Cuddy 
Ununited anconeal process (UAP) is an uncommon con-
dition seen primarily in specific large- and giant-breed 
dogs, particularly German Shepherd Dogs. In breeds 
predisposed to UAP, the anconeal process is a distinct 
centre of ossification that should fuse with the ulna 
before 20 weeks. Therefore, a definitive diagnosis of UAP 
cannot be made prior to 20 weeks. It is believed that 
asynchronous growth of the radius and ulna (short ulna) 
results in abnormal pressure on the anconeal process 
during development. Male dogs are twice as likely to 
have UAP than females, and the condition is bilateral in 
11–30% of affected dogs. Dogs with UAP typically 
 demonstrate lameness between 5 and 9 months of age, 
or less commonly at an older age. UAP may also be an 
incidental radiographic finding in mature and middle-
aged dogs with no lameness. 
Diagnosis of UAP can be usually made on a flexed 
mediolateral radiograph of the elbow. Congruency of 
the proximal radioulnar joint should be assessed to see 
whether short ulna is present. Secondary degenerative 
changes of the elbow are often present. Other compo-
nents of elbow dysplasia may be identified on computed 
tomographic or arthroscopic evaluation.
Treatment options for UAP include:
■■ UAP excision
■■ Bi-oblique dynamic proximal ulnar osteotomy 
(BODPUO)
■■ UAP stabilization (lag screw fixation)
■■ UAP stabilization in combination with BODPUO
■■ Distal segmental ulnar ostectomy (very young dog 
with short ulna)
■■ No treatment or conservative management 
(middle-aged to older dog with no clinical signs)
UAP excision may be performed via arthrotomy 
( caudolateral approach or modified Wendelburg medial 
approach). Arthroscopic-assisted removal can be per-
formed, however, it is often challenging as the anconeal 
process is generally not mobile due to extensive fibrous 
adhesions and is quite large. Seroma is a common post-
operative complication. Many dogs obtain surprisingly 
good limb function following UAP excision, although the 
prognosis for working and athletic dogs remains guarded. 
UAP excision is preferred in older dogs with sudden-
onset lameness due to dislodgement of UAP with elbow 
hyperextension.
Proximal ulnar osteotomy (PUO) is recommended 
to address elbow incongruence associated with UAP. In 
young dogs, the anconeal process should subsequently 
fuse to the ulna, albeit in a slightly abnormal position. 
BODPUO is performed in younger dogs; fixation of 
the  PUO may be prudent in older dogs as persistent 
non-union of the ulnar osteotomy may ensue. Long-
term functional results may be superior to UAP excision. 
Dynamic PUO may also be combined with UAP excision 
in older puppies with a very mobile anconeal process.
Fixation of the UAP with a lag screw alone has been 
described, but does not address underlying incongru-
ency. Combining lag screw fixation with PUO has higher 
rates of radiographic fusion compared with lag screw 
 fixation alone and is treatment of choice when UAP is 
identified early. 
Regardless of the technique performed, progression 
of degenerative joint disease is inevitable. Prognosis is 
dependent on age at time of surgery, condition of 
 anconeal process and degree of secondary change.
KEY LEARNING OBJECTIVES
■■ Explain the aetiopathogenesis of ununited anconeal 
process
■■ Outline how to diagnose ununited anconeal process
■■ Describe treatment options for ununited anconeal 
process with reference to age and degree of 
secondary osteoarthritis
MULTIPLE CHOICE QUESTIONS
1. After what age can a diagnosis of ununited 
anconeal process be made?
(A) At birth
(B) 12 weeks
(C) 20 weeks
(D) 1 year
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2. Which radiographic view of the elbow is the 
most useful to diagnose ununited anconeal 
process?
(A) Craniocaudal
(B) Craniolateral caudomedial oblique
(C) Extended mediolateral
(D) Flexed mediolateral
3. What is often the preferred treatment option 
for a middle-aged dog with an incidental 
finding of ununited anconeal process?
(A) Bi-oblique proximal ulnar osteotomy
(B) Excision of the ununited anconeal process
(C) Lag screw fixation with proximal ulnar 
osteotomy
(D) No surgical treatment
Elbow incongruence: 
what to do when
Laura Cuddy 
The elbow joint is a complex and highly congruent joint 
that is composed of the humeroulnar, humeroradial and 
proximal radioulnar articulations. Although technically 
disparity between any of the surfaces of the three 
joints  comprising the elbow joint may result in elbow 
incongruence, elbow incongruence traditionally refers to 
a step incongruence at the proximal radioulnar joint 
( radioulnar incongruence or RUI). Other potential forms 
of elbow incongruence include elliptical trochlear notch 
and dynamic radioulnar incongruence. Dynamic radioul-
nar incongruence (approximately 0.7 mm axial radioulnar 
translation) during the stance phase has been described 
as a normal finding in healthy dogs.
As the paired radius and ulna form the distal joint sur-
face, any disparity of growth between these paired bones 
may result in a step incongruence. Negative radioulnar 
incongruence refers to short ulna, whereas positive radi-
oulnar incongruence refers to a short radius. Incongru-
ence is thought to play a major part in developmental 
elbow disease in dogs. Step incongruence may result in 
overloading of the medial coronoid process (short radius) 
or anconeal process (short ulna), and the presence of RUI 
has been positively associated with cartilage lesions.
Diagnosing radioulnar step incongruence is not as 
simple as it may seem. Elbow joints with a step between 
the radius and ulna of ≥2 mm are considered to be incon-
gruent. Radiography, computed tomography (CT) and 
arthroscopy have been used to assess elbow incongru-
ence in dogs, with reconstructed CT considered the gold 
standard. However, imaging modalities do not appear to 
reliably predict arthroscopic assessment of RUI in either 
degree or location; RUI is most commonly detected 
at  the ulnar commissure with CT and at the apex with 
arthroscopy.
Ulnar osteotomies and ostectomies may be indicated 
to correct elbow incongruence. Bi-oblique dynamic prox-
imal ulnar osteotomy (BODPUO) was described in 2016 
and has become the most common configuration of 
 proximal ulnar osteotomy performed. When BODPUO is 
performed correctly there is no need for implants and the 
risk of triceps inclining the proximal fragment caudally is 
reduced. However, as the ulna is not stabilized, there is 
often postoperative discomfort and the risk of non-union. 
Some surgeons prefer to stabilize a proximal ulnar osteo-
tomy or perform distal ulnar osteotomy or ostectomy. 
 In-vitro analysis of distal ulnar osteotomy suggests compa-
rable outcomes to proximal ulnar osteotomy, but only if the 
interosseous ligament is released. Distal ulnar ostectomy is 
often performed in growing dogs with  premature closure 
of the distal ulnar physis to permit  continued radial growth 
and to limit the effect of short ulna and RUI within the 
elbow joint. Definitive angular and length corrections may 
be performed when the dog is skeletally mature.
There is still significant work to be done to under-
stand the full spectrum of RUI beyond simple step incon-
gruency and to identify the most effective strategies to 
restore elbow congruence.
KEY LEARNING OBJECTIVES
■■ Recall the complex anatomy of the elbow joint and 
understand the various forms of elbow 
incongruence and their effects on elbow 
development
■■ Explain the limitations of various diagnostic 
modalities for elbow incongruence
■■ Discuss treatment strategies for elbow incongruence 
MULTIPLE CHOICE QUESTIONS
1. What is the most common form of elbow 
incongruence?
(A) Elliptical trochlear notch
(B) Radioulnar step incongruence
(C) Dynamic radioulnar step incongruence
(D) Radioulnar rotational incongruence
2. What amount of radioulnar step defect is 
considered incongruence?
(A) Any
(B) 1 mm
(C) 2 mm
(D) 3 mm
3. What is the direction of cut in bi-oblique 
proximal ulnar osteotomy?
(A) Beginning proximal, caudal and lateral and 
aiming distal, cranial and medial
(B) Beginning proximal, caudal and medial and 
aiming distal, cranial and lateral
(C) Beginning distal, caudal and medial and 
aiming proximal, cranial and lateral
(D) Beginning distal, caudal and lateral and 
aiming proximal, cranial and medial
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Pre-op safety and 
preparation: what really 
helps and do pre-op 
bloods improve 
outcome?
Matt Read
This session will review what is currently known about 
anaesthetic risk in small animal patients. The factors that 
are known to increase a patient’s risk of dying will be 
 discussed, as well as the indications for, and limitations 
of, preoperative blood testing and other diagnostics as 
they relate to patient risk. The results of several studies 
on adverse incidents and patient safety will be reviewed.
Including some excellent studies from researchers in 
the UK, investigators from around the world have 
 conducted numerous studies in attempt to learn about 
the factors that affect the risk of a dog or cat dying as a 
result of anaesthesia. One interesting area of research is 
the relationship between the usefulness of conducting 
 preoperative blood work and patient risk. Although 
 preanaesthetic screening is generally well accepted by 
today’s clients, the value of performing these sometimes 
expensive tests as a way of minimizing anaesthetic risk 
remains somewhat controversial. 
Studies relating preanaesthetic laboratory testing to 
risk in people have failed to support the case for routine 
preoperative hematological and biochemical testing 
in  the absence of abnormalities in history or physical 
exami nation. However, in veterinary medicine, we deal 
with indirect and relatively subjective histories provided 
by the owner, and the quality of the information we 
receive may mean that some abnormalities may remain 
unreported or undetected. For this reason, laboratory 
testing might detect more underlying disease in animals 
than it does in people.
The veterinary literature provides us with important 
information about the benefits of performing diagnostic 
work-ups prior to anaesthesia. In general, the criteria that 
are used to determine which tests should be performed 
are based on a patient’s state of health and/or age. To be 
most effective, methods of patient assessment, whether 
it be blood work, radiographs, ultrasound examination, 
etc., should focus on the patient’s cardiac, pulmonary, 
renal and hepatic functioning, since these are the body 
systems that are most likely to have underlying dysfunc-
tion, be affected by the anaesthetic agents that will be 
used, or be affected by the alterations in normal physiol-
ogy as a result of the surgical procedure. 
Veterinary studies have shown that if patients 
undergo preanaesthetic blood work, up to one third of 
‘normal’ patients will have abnormalities that were not 
able to be detected based on history taking or physical 
examination alone. Most commonly, signs of haemo-
concentration and elevations in kidney or liver enzymes 
result in reallocation of ASA status to a higher level, and, 
in some cases, the anaesthetic procedure will be delayed 
or cancelled while the patient is stabilized or the abnor-
malities are worked up further. Although anaesthetic 
protocols (i.e. drugs and doses) are infrequently altered 
as a result of these new findings, modifications to the 
patient’s overall anaesthetic management can be made, 
including preoperative fluid support, plans to more 
aggressively monitor and treat blood pressure or other 
parameters under anaesthesia, etc. By working to stabi-
lize the patient prior to anaesthesia, its overall risk can be 
lessened.
However, the opposite is not true. ‘Normal’ blood 
work does not mean that problems cannot occur. Equip-
ment malfunction, human error and the depressive car-
diopulmonary effects of the drug can still happen, and it 
is very important not to promote or offer preanaesthetic 
screening to pet owners in such a way that they will 
assume that if the results come back unremarkable, the 
anaesthetic and recovery will also proceed without 
 incident. Normal blood work does not guarantee anything 
other than the bill to the client being a little bit higher.
KEY LEARNING OBJECTIVES
■■ List at least three of the documented factors that 
increase the risk of anesthetized dogs and cats 
dying in the perioperative period
■■ Discuss the usefulness of performing blood work as 
it relates to anaesthesia safety and patient outcomes
■■ Recognize at least two steps that could be taken in 
your own clinic to decrease patient risk prior to 
anaesthesia
MULTIPLE CHOICE QUESTIONS
1. Which of the following have been shown to 
increase anaesthetic risk in small animals?
(A) Use of pulse oximetry for patient 
monitoring
(B) Dogs and cats that are greater than 
12 years old
(C) Dogs that are heavier than 5 kg
(D) Patients that have been assigned an ASA 
patient status of 1 or 2
2. Which of the following statements is TRUE?
(A) Human error is rarely a root cause of 
adverse anaesthetic incidents 
(B) Introduction of checklists into anaesthetic 
practice is typically met with great 
enthusiasm and they are usually easily 
adopted
(C) Instituting a ‘time out’ prior to induction of 
anaesthesia can decrease the occurrence 
of adverse incidents
(D) Performance of preoperative blood work 
can reduce the incidence of common 
anaesthetic complications such as 
hypotension and hypoventilation
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How equipment 
harms patients
Matthew McMillan 
Modern machines and electronic equipment are very 
safe. They rarely go wrong in a way that could harm an 
animal. What tends go wrong is our use of these machines. 
Failure to check equipment prior to use and to regularly 
service it is an example of where corners are cut, often 
with the well intentioned desire of reducing time spent on 
a task or to costs for the owner. However, there are risks 
involved with these omissions. For example, an anaes-
thetic machine oxygen flow failure is far more likely to be 
due to a human not checking the level of gas in a cylinder 
than it is the flowmeter or pipeline failing.
Where a risk with a piece of equipment is known then 
there are generally ways of mitigating this risk, which 
should be performed whenever using that piece of 
equipment. When harm occurs more often than not it is 
due to the fact that a human has not fully performed 
these mitigating tasks. For example monopolar cautery is 
known to pose a risk of burns. However, if the site of the 
monopolar plate is properly prepared and fully in contact 
with an animal, over the flank or back, and no electronic 
wiring, for example from the anaesthetic monitor, is 
placed across the animal, then that risk is minimized. 
Missing one of these tasks, however, can lead to a burn. 
Harm may not result every time a piece of equipment is 
used inappropriately but the risk is there and at some 
point an animal will be injured. Heat mats and dental 
descalers/polishers are known to also cause burns in 
certain circumstances, but this is unlikely if they are used 
within certain limits.
As veterinary surgeons we are great innovators and 
make doers. We are generally used to not having all the 
equipment we may need for a task so we adapt and alter 
existing equipment to fit our needs or make do with 
equipment which does not have feature that may be 
desirable or which is out of date. This innovative streak 
has made us extremely successful and often allowed us 
to perform tasks that previously would not have been 
possible. However, this adaptation can have unforeseen 
circumstances.
Finally, anaesthetic monitoring can also harm but 
typically not in an obvious way. Most commonly we have 
an optimistic obsession with numbers; we like to believe 
happy numbers and disbelieve bad ones, so we often 
fail  to interpret how these numbers were generated. 
This  misinterpretation of monitored parameters can 
cause us to miss impending crises which may risk serious 
harm to our patients. On the flipside, overinterpreting a 
number can lead to us treating a problem that is not really 
there and no intervention is without the risk of harm.
KEY LEARNING OBJECTIVES
■■ Recognize that everyday equipment can harm 
patients
■■ Recognize that the risks posed by equipment are 
typically due to misuse
■■ Recognize that monitoring equipment can harm 
patients through over- or underinterpretation and 
subsequent action or inaction
3. Which of the following is true in terms of small 
animal anaesthetic risk?
(A) Cats are higher risk than dogs
(B) Healthy small animals are at less risk of 
dying than healthy people
(C) Time of day has no effect on a patient’s risk 
of dying
(D) Intubation of cats lowers their risk 
when used for short, uncomplicated  
procedures
MULTIPLE CHOICE QUESTIONS
1. Which of the following is the appropriate 
maximum intracuff pressure for PVC high-
volume, low-pressure cuffs?
(A) 15 cmH2O
(B) 30 cmH2O
(C) 45 cmH2O
(D) 60 cmH2O
2. Which of the following statements about 
electrocautery burns is FALSE?
(A) Monopolar has less risk of burns than 
bipolar
(B) Insulated quivers can reduce the risk of 
accidental firing
(C) Monopolar burns are more likely to occur 
when there is only partial contact between 
the patient and the diathermy plate
(D) Short circuits between a monopolar 
hand-piece and electrical wiring or a metal 
table can lead to burns
3. Which of the following is NOT recommended 
when using electrocautery or laser techniques 
in and around an animal’s upper airway or oral 
cavity?
(A) Use nitrous oxide to avoid using 
100% oxygen
(B) Use wet swabs to protect the endotracheal 
tube
(C) Ensure a seal between the endotracheal 
tube and trachea
(D) Have a fire blanket or bucket of water 
immediately available
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How to use checklists 
to improve safety 
(and how not to)
Matthew McMillan
Checklists are often touted in the mainstream and scien-
tific media as being a simple solution to improving patient 
safety. They are viewed as a straightforward way to ensure 
that critical tasks are performed and therefore act to 
reduce the risk of tasks essential to safety being missed. 
The WHO surgical safety checklist is perhaps the 
most famous safety checklist and produced some 
incredible results reducing complication rates such as 
surgical site infections as well as fatalities in a wide range 
of socioeconomic environments. However, the WHO 
checklist was not always successful. Part of this lack of 
universal success was because it is the performance of 
the tasks themselves not the performance of a checklist 
which improves safety; checklists are not a box-ticking 
exercise for clinical record and bureaucratic purposes. 
Just having a checklist there does not confirm that the 
tasks will be performed in a proper and timely fashion.
With this in mind, there are several cultural, organiza-
tional and human factors that can cause a checklist to 
fail. Many times checklists can fail because some of their 
main benefits are not taken into account; these benefits 
are communication and teamwork. Checklists require 
the entire team involved in the process to engage with 
them if they are to work. Everyone needs to be working 
from the same page and needs to have the critical infor-
mation they need to ensure the task is performed safely. 
So proper implementation of checklists is key to their 
success but unfortunately this often faces difficulties. 
For example, some people view checklists as a waste 
of time, arguing the tasks outlined are always performed. 
In truth actually many of these tasks, despite being vital 
and often simple, are too easily missed in the complex 
hustle and bustle of practice. That these omissions do 
not lead to harm is often just a matter of luck. Others 
argue against the use of checklists as they view them as 
interfering with their clinical judgement. However this 
view is also flawed, checklists shouldn’t dictate work 
but merely act as a scaffold; they are not an algorithm 
as  such, they just ensure all critical tasks have been 
 performed. They may in fact free up the clinician’s mind, 
allowing their clinical judgement and decision making 
to flourish unimpeded by improving recall and reducing 
the necessity to remember all the critical tasks and all 
common differentials. The decision making still belongs 
to the clinician but the reliance on memory is removed. 
This principle is perhaps best demonstrated in 
 aviation-style crisis checklists, for which large amounts 
of safety data have accumulated over the last 50 years. 
With this in mind a number of checklists for crises during 
anaesthesia and surgery have recently been developed. 
In simulator settings these have been demonstrated to 
reduce the time to diagnosis and intervention as well as 
reducing omissions of critical steps and considerations. 
These could help teams in veterinary settings react to 
complications rapidly and effectively when interventions 
are time critical.
So the problem with checklists is predominantly in 
the way that they are used. They are not the solution to all 
safety problems but they can have a role to play in 
improving safety.
KEY LEARNING OBJECTIVES
■■ Recognize the value of checklists in improving 
patient safety
■■ Recognize that checklists will only work as part of 
a wider cultural change
■■ Recognize the importance of communication and 
teamwork in making checklists work successfully
MULTIPLE CHOICE QUESTIONS
1. Which of the following is not on the WHO 
Surgical Safety Checklist?
(A) Owner consent
(B) Administration of antibiotics where 
appropriate
(C) Communication of anaesthetist concerns
(D) Risk of blood loss
2. In the study reported by Hofmeister et al. 
(2012) which of the following was not 
introduced as a patient safety intervention?
(A) Full anaesthetic machine check
(B) Checklist comprising of ‘technician 
confirmed intubation’ and  ‘technician 
checked operating room’
(C) Unique coloured bandage for wrapping 
arterial catheters
(D) Prior to administration, individuals will read 
out loud the drug name, patient name and 
route of administration
3. In the study reported by Hofmeister et al. (2012), 
what was the most common safety incident?
(A) Medication errors
(B) Oesophageal intubation
(C) Closed APL valves
(D) Wrong site surgery
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What anaesthetic 
monitoring really helps?
Matthew McMillan
Physiological monitoring undoubtedly improves safety 
in  anaesthesia. Anaesthesia can be thought of as con-
trolled, reversible intoxication of the central nervous 
 system which also has profound secondary effects on 
homeostasis. Most importantly for patient survival, 
anaesthetics impair the respiratory and cardiovascular 
systems. Although we often take it for granted, during 
anaesthesia we put the patient in a fragile state, com-
pletely at the mercy of the anaesthetist. Many times we 
are only saved from the unenviable position of telling an 
owner their animal has had a problem under anaesthesia 
and been harmed or worse died by the robustness of our 
patients and their ability to recover after an insult. 
Fortunately there is an array of methods for monitor-
ing patients under anaesthesia. These range from basic 
hands-on monitoring to advanced electronics. 
Even in the age of multiparameter monitors when 
pulse oximetry, blood pressure, end-tidal carbon dioxide 
monitoring and electrocardiography can all be easily 
 displayed, an anaesthetist’s senses of sight, hearing and 
touch are still vital. One of the most basic skills in anaes-
thesia, assessing the depth of anaesthesia, is far easier and 
more reliable when performed by a welltrained anaesthe-
tist then it is when measured by one of the numerous 
electronic machines designed for this purpose. The abil-
ity to assess pulses manually and observe the chest and 
reservoir bag of the breathing system moving are still 
invaluable in the rapid assessment of a patient at critical 
times such as post induction and in a potential crisis.
Where electronic monitors are giving good data, 
they still require someone to interpret the waveform and 
numbers produced, as even modern machines are prone 
to give false information and an ability to perform quality 
control on the data is critical. Moreover, it takes advanced 
clinical reasoning to take the data from the various 
 moni toring modalities being used, interpret and cross- 
reference it and then put it together to gain an overall 
picture of the patient’s physiological state. As such, elec-
tronic monitors should be considered as an extension of 
the anaesthetist’s senses not a replacement for them.
Saying this, electronic monitoring can give incredibly 
useful data that can help us make decisions and interven-
tions throughout an anaesthetic to keep the patient safe 
if they are used properly. Alongside monitoring classic 
numbers generated by monitors, such as heart rate, res-
piratory rate, SpO2, blood pressure and end-tidal carbon 
dioxide tensions, there are also some slightly more com-
plex waveform analyses that can be performed and 
applied to our patients. Pulse profile variation can give an 
indication of a patient’s volume status. Capnography not 
only tells us how well a patient is ventilating but also gives 
information on the patency of the airway and breathing 
system, the adequacy of fresh gas flow, and can help 
identify airway obstructions and sudden changes in 
 cardiac output. All of these can be quickly identified by a 
knowledgeable anaesthetist.
In conclusion, despite massive advances in technol-
ogy, the most important factor in anaesthetic monitoring 
is still the anaesthetist. We are a long way off a well-
trained anaesthetist being replaced. 
KEY LEARNING OBJECTIVES
■■ Recognize that all electronic monitors depend on 
appropriate interpretation by a trained anaesthetist
■■ Recognize that all electronic monitors are prone to 
error
■■ Recognize that the numbers that a monitor 
generates are not the only useful data they produce
MULTIPLE CHOICE QUESTIONS
1. Which of the following does not reduce the 
signal quality and therefore accuracy of pulse 
oximetry?
(A) High carbon dioxide tensions
(B) Ambient light (fluorescent strip lighting)
(C) Poor pulse strength
(D) Anaemia
2. Which gases/vapours can cause errors in 
capnography measurement?
(A) Oxygen and nitrous oxide
(B) Nitrogen and oxygen
(C) Nitrogen and nitrous oxide
(D) Isoflurane and sevoflurane
3. Approximately what proportion of adverse 
events in anaesthesia could be identified by the 
combination of pulse oximetry, capnography 
and blood pressure monitoring?
(A) 39%
(B) 67%
(C) 76%
(D) 93%
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Clinical audit: how to 
set up 
Pam Mosedale 
Understanding the performance of your practice is criti-
cal, if you don’t measure it you don’t know what needs to 
improve. Clinical audit can assess many areas such as 
outcome, process and performance. This presentation 
will point out the difference between clinical audit and 
in-practice research. It will discuss outcome audits, pro-
cess audits, structure audits and significant-event audits 
and where each is appropriate.
Choosing an area to audit, choosing the right type of 
audit and motivating the team are all important to the 
success of the audit. To overcome barriers to audit it is 
important that careful planning, involving the whole of 
the team who will be involved, occurs right from the 
start. The subject chosen must be relevant to the team, 
easily measureable, happen often enough and have a 
possibility of change or improvement.
Once a subject has been chosen then suitable crite-
ria need to be selected, a standard or target set, and the 
method for collecting the data shared with the team. The 
data then need to be analysed, any changes needed as a 
result implemented, then after a while a re-audit should 
take place. Another result of the audit might be deciding 
that protocols or clinical guidelines are needed, and 
looking at the evidence base in order to draw these up.
Examples of how outcome audits, benchmarking 
and process audits can be implemented will be given. 
MULTIPLE CHOICE QUESTIONS
1. Which of the following is true for clinical audit?
(A) It answers the question what is best 
practice 
(B) It is a process for monitoring and assessing 
clinical care 
(C) It needs ethical approval
(D) It must be statistically significant 
2. What does an outcome audit do?
(A) Looks at how we follow protocols in practice
(B) Checks we have the right facilities available
(C) Looks at the results of a procedure
(D) Follows one case through from beginning 
to end 
3. What may a clinical audit result in?
(A) Changing protocols or guidelines
(B) Establishing protocols or guidelines
(C) Training or CPD for the team
(D) All of the above 
All practices could benefit from auditing commonly car-
ried out procedures or processes. This has an important 
role to play in improving clinical effectiveness and patient 
safety.
KEY LEARNING OBJECTIVES
■■ The different types of clinical audit
■■ How to choose a subject to audit 
■■ How to set up an audit in your practice 
An anaesthetist’s day 
from hell: what we 
can do after things 
go wrong
Matthew McMillan and Matt Read
All of us are capable of experiencing a bad day. Perhaps 
one of the worst days for a veterinary surgeon or veteri-
nary nurse is one where things go wrong and a patient 
is  subsequently harmed when ‘under our care’. This is 
especially poignant if mistakes are made in patient man-
agement. As an anaesthetist this is a significant problem 
as often, if things do go wrong, they go wrong in an acute 
and extreme manner and there may be little or no time to 
correct them. This can lead to the patient rapidly deteri-
orating and potentially even result in the patient’s death. 
The uncomfortable truth is that most complications 
in anaesthesia are associated with the drugs we are 
administering or the procedure we are performing. A 
patient’s underlying health undoubtedly has a part to 
play, but through the pharmacological manipulation of 
its central nervous system, a patient invariably experi-
ences some degree of cardiovascular and respiratory 
compromise as well. Although some side effects may be 
unavoidable, many can be managed if predicted and 
planned for appropriately.
References on how to manage perianaesthetic crises 
are numerous. They typically outline what to do when a 
patient is hypotensive or tachycardic, the things that 
should be checked and the interventions that should be 
performed. Other literature will tell you how to plan for 
these crises in advance, such as what risk factors to look 
out for when performing preanaesthetic patient assess-
ments. What is less common is information on how to 
investigate and consider critical incidents after the fact, 
once the situation has come to an end.
In the immediate aftermath, it is too easy for blame to 
be attributed to the person or piece of equipment in 
closest proximity to the incident. Often, the individuals 
involved will hold themselves personally responsible, 
taking the blame squarely on their own shoulders. Others 
may look to shift the blame elsewhere to someone or 
something else, such as a colleague or a piece of equip-
ment. The truth, however, is messier. Most incidents have 
a number of factors involved in their generation. They 
evolve through a chain of events and contributing factors 
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all coming together in a perfect storm. These incidents 
do not simply occur out of the blue, but, rather, are the 
result of a set of factors which existed long before the 
event. An important first step when investigating signifi-
cant events is to properly identify what these contribut-
ing factors might be. There are many different ways of 
analysing events from simple ‘ask why five times’ through 
to more complicated multilayer ‘systems’ or ‘human 
 factors’ analysis. Thankfully, it is possible to modify these 
techniques into a form that can be effectively performed 
in veterinary practices.
Using these methods allows us to create a picture of 
the weaknesses within a practice’s systems and pro-
cesses. This can help to establish why individuals acted 
and thought in the way they did, can highlight gaps in 
their knowledge, training, experience and supervision, 
and identify issues with communication, teamwork, dis-
traction and organization. This information can then be 
used to adapt the practice to work in a more safety- 
conscious manner. In this way, complications can be 
turned into learning experiences that can benefit patients 
and the veterinary team in the future.
This session will use real-life examples of adverse 
anaesthetic events to illustrate how easily things can go 
wrong in practice and to show how the staff responded 
to them in attempt to prevent similar problems from 
 happening in the future.
KEY LEARNING OBJECTIVES
■■ Recognize that complications, significant events, 
near misses and error can all be used as learning 
experiences to improve future patient care
■■ Recognize that in most circumstances a number of 
contributing factors can be identified in the lead-up 
to a significant event
■■ Recognize that attributing blame to individuals or to 
a piece of equipment does not help to reduce the 
chance of a similar problem occurring again
MULTIPLE CHOICE QUESTIONS
1. According to the 2018 study by McMillan & 
Lehnus, which of these was the most common 
contributing factor identified in safety incidents?
(A) Lack of knowledge
(B) Lack of experience
(C) Equipment malfunction
(D) Decision making
2. According to the 2018 study by McMillan & 
Lehnus, what approximate percentage of safety 
incidents which involved an individual factor 
also involved either an organisational, 
teamwork or environmental factors?
(A) 25%
(B) 50%
(C) 66%
(D) 90%
3. Which of these is NOT a recognized method 
of safety incident analysis?
(A) Ask why five times
(B) Systems analysis
(C) Fishbone analysis
(D) Keystone analysis
Mortality and 
morbidity rounds in 
veterinary practice 
Catherine Oxtoby 
Mortality and morbidity rounds have been traditional 
methods of discussing poor outcomes and mistakes in 
medicine since the early 20th century. They provide a 
format for the discussion of errors, the aim of which is to 
learn from and prevent the recurrence of mistakes or 
poor-quality care. They have more recently been viewed 
as a mechanism to improve patient safety, medical 
knowledge and facilitate quality improvement.
Mortality and morbidity rounds are being used more 
and more in veterinary practice, to varying degrees of 
effectiveness. Described by the RCVS Practice Standards 
Scheme as ‘honest open discussions’ with clear actions 
and no barriers to feedback, to be held face to face, at 
least monthly and demonstrate evidence of change. 
However, the concept of mortality and morbidity rounds 
has been described as ‘familiar yet lacking in clear 
 definition’ in the veterinary literature. 
Structured formats for running such meetings have 
been developed in human healthcare, the aim of which 
is to increase the quality of mortality and morbidity 
rounds, improve the case selection, analysis and dis-
tribution of meeting summaries and to increase the 
amount of positive change and improvement initiatives 
from meetings. Frameworks such as the Ottowa M&M 
model offers a structure to facilitate these discussions 
which can be adapted for use in the veterinary setting, 
together with adverse event data gathering systems 
such as VetSafe, the Veterinary Defence Society’s error 
reporting system.
However, barriers to successful mortality and mor-
bidity meetings are often present. Reflective learning in 
the public domain can be difficult, embarrassing and 
nerve wracking. Clinicians who are involved in errors 
which harm their patients are often themselves trauma-
tized by the event, leading to ‘second victim’ syndrome. It 
is important therefore that meetings are conducted in a 
constructive and supportive environment, with the use of 
human factors frameworks to identify contributory fac-
tors and the explicit aim of identifying system changes, 
rather than seeking to blame or punish individuals.
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KEY LEARNING OBJECTIVES
■■ Identify the benefits of mortality and morbidity 
rounds and their place in the RCVS Practice 
Standards Scheme
■■ Identify the potential barriers to mortality and 
morbidity rounds
■■ Describe a format for running effective mortality 
and morbidity rounds
(C) Quarterly 
(D) Following any significant event 
2. What is the main aim of mortality and 
morbidity rounds?
(A) Improve patient safety 
(B) Institutional quality improvement 
(C) Medical education
(D) All of the above
3. ‘Second victim’ refers to the effect of clinical 
error on whom?
(A) The patient
(B) The clinician 
(C) The organization 
(D) The owner
MULTIPLE CHOICE QUESTIONS
1. How frequently does the RCVS PSS demand 
that mortality and morbidity rounds are 
undertaken?
(A) Monthly (B) Weekly 
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Taking time out to get 
time back
Penny Barker
With so many demands and everyone wanting a piece of 
you – both in your personal and professional life – it is 
important to be both effective and efficient with the time 
you have. Unfortunately, what often happens is that you 
get caught up on the hamster wheel, feeling out of 
 control, not getting anything done or feeling that you are 
 letting people down.
We often talk about ‘time management’ whilst what 
we really need to do is manage ourselves better and be 
purposeful and proactive with our time. In order to feel in 
control, we need to understand each of our roles and 
what are the priority tasks, both for us and for other 
 people – what is important and what is urgent and how 
we differentiate between them. Once we have done this 
we can then determine which of the tasks we need to do, 
in what order, and which we can delegate or simply leave. 
Procrastination leads to feelings of frustration and 
guilt. We often do it when we feel out of control which 
only reinforces the feeling of being overwhelmed. Taking 
active control of our tasks and our time and breaking 
things down into manageable, time-boxed chunks are 
just some of the strategies that can help us to make 
 tangible progress. 
Being aware of our own natural preferences is a key 
part of self-management. Some people are focused on 
results, which helps get things done but are they the right 
things? Others are more concerned with detail and 
 accuracy, which creates high-quality work but can also 
lead to a lack of progress and decisionmaking. Some 
people love variety but this can lead to them volunteering 
for too many tasks with little sense of priority. Many peo-
ple are great team players but find themselves putting the 
needs of other people ahead of their own and unable to 
say ‘no’. Understanding how and why we trip ourselves up 
helps us to put strategies in place to overcome our natu-
ral tendencies, making us more effective and resilient.
Take time to think how you want to show up to the 
day and what you need to accomplish. Check in with 
yourself at regular intervals and assess whether you are 
on track or if things have changed; this helps to keep you 
in control and gives you time to think. It allows you to be 
flexible and responsive whilst still focusing on what’s 
important to you. 
KEY LEARNING OBJECTIVES
■■ Learn how to feel more in control by prioritizing 
your tasks effectively
■■ Understand what procrastination is and key 
strategies to overcome it
■■ Understand how being purposeful and proactive 
helps you to balance your roles in practice
MULTIPLE CHOICE QUESTIONS
1. Which book by Brian Tracy has great tips for 
beating procrastination?
(A) Eat that Frog!
(B) Eat that Camel!
(C) Eat that Horse!
(D) Eat that Giraffe!
2. Which is a useful way of prioritising tasks?
(A) Urgent, useful
(B) Urgent, important 
(C) Important, useful
(D) Urgent, impactful
3. Which categories should all tasks go into?
(A) Do, dump, despair, decide
(B) Do, delegate, deliver, drop
(C) Deliver, dump, delegate, drop
(D) Do, ditch, defer, delegate
The three Ps for having 
a good day: present, 
proactive and positive
Carolyne Crowe 
In order for us to be successful and happy in both our 
personal and professional lives, we need to know what’s 
important to us and what outcomes we want to achieve. 
This allows us to be proactive in our approach to getting 
it, taking positive steps towards our goals and being 
 present in the moment, aware of whether we are on track 
or if we need to take action to get back on course. This is 
the essence of personal leadership and helps us to get 
what we need and want from each day as well as fulfilling 
our roles and responsibilities.
What does a good day at work look and feel like for 
you? What’s happening to make it a good day? Setting 
ourselves up for success requires a proactive and pur-
poseful approach to our day. How can you start feeling 
refreshed and ready to go? What other preparations do 
you need to put in place to save you time and mental 
energy during the day? 
Take time to consider your potential challenge 
points – what could stop you from having a good day? 
What outcomes do you need from these situations? 
Think about how you can approach these situations 
 positively and with purpose.
During the day, try to be ‘mindful’ and keep yourself 
in the present – this stops your mind ruminating about 
the future and worrying about the past. Press pause 
 periodically and check in with yourself. Think about 
what’s going well and what needs to change to keep you 
on track. This allows you to keep a sense of control and 
to be aware of what’s going on for you rather than being 
swept along by people and circumstance.
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Personal leadership is for everyone, whatever your 
position in practice. Actively working to be more present, 
proactive and positive will help you to have more good 
days and feel more fulfilled at work and at home.
KEY LEARNING OBJECTIVES
■■ Learning how to set yourself up for success on a 
daily basis, whatever the challenges
■■ Knowing the benefits of being present, proactive 
and positive through the day
■■ Defining what a ‘good day at work’ is for you and 
how to have more of them
MULTIPLE CHOICE QUESTIONS
1. Why is personal leadership is important?
(A) Everyone will follow you
(B) You are the boss
(C) It makes every day a good day
(D) It allows you to be in control of yourself 
and your time
2. What does being mindful require us to do?
(A) Be present and focus our attention on the 
moment
(B) Close our eyes and focus on breathing
(C) Meditate 
(D) Be relaxed all the time
3. Why is having a good day important?
(A) The practice makes more money
(B) You get a lunch break every day
(C) You are happy, healthy and  
connected
(D) Everyone gets on all the time
Leaning into colleagues, 
clients and cases
Carolyne Crowe
Working with people is a key part of our profession; every 
day we are interacting with clients, colleagues and our 
bosses and this is often the part of the job that is most 
difficult and stressful. Do you find yourself frustrated by 
people not doing what you want or expect them to do, or 
in a conflict situation over something seemingly trivial? 
Do certain clients or colleagues make you feel anxious or 
irritated, or do you simply find some people hard to read 
or talk to?
We are taught to ‘treat others like you would wish to 
be treated’, but in reality, we need to treat others the way 
that they would wish to be treated. If we are able to do 
this, we are much more likely to get the best out of them 
and, in turn, to get the best out of any given situation. It 
means, however, that we need to know more about 
them. We also need to understand that people are not 
their behaviour; what we see and hear can give us useful 
information about how to interact with them, but we 
should refrain from judgement, as we know little about 
them at a deeper level. 
People are different, but they are predictably differ-
ent. Learning how to identify different behaviours and 
preferences gives you the opportunity to flex your own 
style; you cannot choose how another person will 
respond to you but you can maximize your chances of a 
positive response by communicating with them in the 
right way. Pay attention to how other people are interact-
ing with you, both through their verbal and non-verbal 
communication. This helps you to develop your emo-
tional intelligence (EI), being aware of yourself and of the 
impact that you are having on others. EI is something that 
can be developed and is a key part of personal leadership .
Knowing more about the different behavioural styles 
allows you to recognize your own strengths and  challenges. 
It helps you to understand when you are tripping yourself 
up and when you are at your best. This allows you to com-
municate effectively and to influence positive behaviours. 
Through doing this you will improve your  client inter-
actions and get the best out of your colleagues, creating a 
happier and more productive working  environment.
KEY LEARNING OBJECTIVES
■■ Understanding your own and others behaviours and 
preferences
■■ Knowing the key principles of emotional intelligence 
(EI) and why EI is important
■■ Learning how to get the best out of every 
interaction
MULTIPLE CHOICE QUESTIONS
1. What are the the four different behavioural 
styles?
(A) Dominant, influencing, steady and 
compliant
(B) Direct, inspiring, slow and cautious
(C) Dominant, influencing, supportive and 
correct
(D) Determined, insightful, steady and critical
2. What does emotional intelligence require?
(A) Self-awareness and the ability to ability to 
manage ourselves
(B) A high IQ
(C) To like everybody
(D) Everyone to have done behavioural profiling
3. What do you need to do to get the best out of 
others?
(A) Flex your style and pay attention to what 
happens
(B) Manipulate them
(C) Put people in boxes according to their style
(D) Not be yourself
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Stepping up and 
speaking out
Penny Barker
Are you able to say ‘no’ to people when you need to, or to 
ask for what you want without anxiety? Do you some-
times feel steam-rollered by pushy clients or find that 
people don’t do what you ask them? Would you like to 
feel more confident, more of the time?
Confidence and assertiveness are essential to feeling 
in control and being effective both at work and in our 
personal lives. They go hand in hand; if we lack confi-
dence in ourselves we are unable to be assertive and this 
can not only hold us back, but further damage our self-
belief, creating a negative spiral.
Confidence comes from knowing our strengths and 
capabilities, focusing on the outcome that we want to 
achieve and being able to recognize the challenges that 
we may face. It requires us to be realistic in the expecta-
tions we set ourselves and others. Confidence is not 
about always knowing the answer or how to fix every 
problem, it’s about believing that you have the ability to 
handle whatever comes up.
Our ability to be assertive is directly related to how 
we handle conflict; our so-called ‘fight, flight or freeze 
and play dead’ response. Some people lack confidence 
and self-esteem, not believing that they have anything to 
offer and that everyone else is always better. This leads 
to  overly passive behaviour and avoidance of conflict. 
Others are more aggressive, focusing on their own needs 
and unaware of the impact that they are having on oth-
ers. Passive–aggressive people are not open about how 
they feel, looking after their own interests but avoiding 
confrontation. 
Many people confuse assertiveness with aggression, 
often because the more aggressive people are the ones 
that seem to get their own way, although often only in the 
short term. Being assertive, however, is about being open 
and honest about what what’s important to you and what 
your values are and then communicating this confidently 
and clearly. It requires us to respect the values and needs 
of others whilst knowing that we are not responsible 
for how they respond. Assertiveness allows us to create 
choice, both for ourselves and other people, and encour-
ages collaboration towards a successful outcome.
KEY LEARNING OBJECTIVES
■■ Understand the importance of knowing our 
strengths and values in both our personal and 
professional lives
■■ Know what confidence is and how to develop it
■■ Learn why being assertive is important and how to 
develop an assertive approach
MULTIPLE CHOICE QUESTIONS
1. What do you need to do to be confident?
(A) Look at the evidence for your competence 
to handle a situation
(B) Know everything
(C) Have all the answers
(D) Stick your chest out and talk loudly
2. Which of the following is true about assertive 
people?
(A) They express what is important to them 
whilst respecting other people
(B) They get what they want every time
(C) They are aggressive
(D) They don’t take responsibility for their 
actions
3. What will being more assertive help you to do?
(A) Get more of what you want and need
(B) Never have to do anything you don’t 
want to
(C) Avoid any form of conflict
(D) Spend less time with clients
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Double-blind, placebo-
controlled, randomized 
study to evaluate the 
weight gain drug, 
mirtazapine 
transdermal ointment, 
in cats experiencing 
unintended weight 
loss: A post-hoc 
analysis of cats with 
suspected renal 
disease
Beasley Mason, Valentine Williams, 
Tianhua Hu, Jessica Lee, Melinda Poole 
Kindred Biosciences, Inc., Burlingame, USA 
OBJECTIVES
To evaluate the safety and effectiveness of mirtazapine 
transdermal ointment in cats with unintended weight 
loss. This post-hoc analysis was conducted in cats with 
suspected renal disease, as there is a potential delayed 
clearance of mirtazapine in these cats.
METHODS
Client-owned cats ≥1 year of age, weighing ≥2 kg, with a 
documented loss (≥5%) in body weight (BW) were 
included. Cats were treated once daily with either 2 mg/
cat mirtazapine transdermal ointment (Kindred Bio-
sciences, Inc.) or placebo ointment applied to the inner 
surface of the pinna for 14 ± 3 days. Mean percent change 
in BW between the mirtazapine and placebo group was 
evaluated from Day 1-to-14. A post-hoc analysis was 
conducted to evaluate the subset of enrolled cats with 
suspected renal disease (defined as having urine specific 
gravity <1.035 and serum creatinine >122 µmol/L [1.6 mg/
dL] at baseline).
RESULTS
A total of 230 cats were enrolled (n = 115 in both groups). 
Of the intent-to-treat population, suspected renal dis-
ease was identified in 49 mirtazapine and 44 placebo 
cats. The mean percent change in BW was + 3.9% (SE ± 
0.8%) in the mirtazapine and + 0.9% (± 0.5%) in the pla-
cebo group (p = 0.0022). There was no significant differ-
ence between groups in incidence of overall adverse 
events (AEs)(p = 0.774) or behavioral AEs of vocalization 
(p = 0.1183) and hyperactivity (p = 0.3637).
STATEMENT (CONCLUSIONS)
Daily topical application of mirtazapine transdermal 
 ointment to the inner pinna of the ear effectively 
increased body weight within 14 days in client-owned 
cats with   suspected renal disease experiencing unin-
tended weight loss.
Renaltec attenuates 
serum levels of indoxyl 
sulfate in geriatric cats
Jose Mottet1, Nikolaus Kowollik2 
1 Vera Icon, Tongeren, Belgium
2 Porus GmbH, Monheim, Germany 
OBJECTIVES
Indoxyl sulfate (IS) is an important uremic toxin that orig-
inates from the metabolic breakdown of tryptophan into 
indole by intestinal bacteria and conversion into IS in the 
liver. Serum IS concentrations are directly related to loss 
of renal function in cats and IS serves as a marker of pro-
gression risk in cats with chronic kidney disease (CKD). 
Renaltec has been shown to be a potent and selective 
binder of indole in the feline gut. The objective of this 
study was to evaluate the efficacy of renaltec in lowering 
serum IS levels in cats.
METHODS
Eighteen apparently healthy geriatric cats (11–16 years) 
were divided into two groups. Twelve cats received 
500 mg renaltec mixed with 10 gram of a liquid cat snack 
once daily for 56 days (treatment group) while 6 cats 
served as negative control. All cats received the same 
type of food. Blood samples were taken every 2 weeks 
and serum IS concentrations were measured by Liquid 
Chromatography Mass Spectrometry.
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RESULTS
The mean serum IS concentration dropped significantly 
from 1637.6 mg/L (day 0) to 650.6 mg/L (day 56) in the 
treatment group (p = 0.0058) while no significant change 
was observed in the control group (from 323.8 mg/L on 
day 0 to 599.7 mg/L on day 56; p = 0.5670).
STATEMENT (CONCLUSIONS)
Daily administration of renaltec reduced serum IS levels 
by more than 60% in this cohort of cats after 8 weeks of 
treatment. Further studies are needed to investigate the 
effects of renaltec on IS levels in cats with confirmed 
CKD.
Prevalence and 
characterization of 
urinary cultures in 
owned dogs and 
cats from Spain
Anna Vila1, Eduardo Hernándo1, 
Jaume Rodón2, Xavier Roura1 
1 Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, 
Barcelona, Spain
2 Idexx Laboratories, Barcelona, Spain 
OBJECTIVES
Due to the lack of information among urinary tract infec-
tion (UTI) in Spain, our objective is to describe the 
 prevalence and characterization of urinary tract patho-
gens in urine samples from dogs and cats with urinary 
clinical signs.
METHODS
This is a cross-sectional study with records of canine and 
feline urine cultures from all Spain during a one-year 
study period (March 2017–2018). The urine samples were 
collected from dogs and cats with clinical signs of UTI 
and delivered by the veterinary on duty to Idexx’s labora-
tories for culture.
RESULTS
A total of 9,957 (6772 canine; 3185 feline) urinary cultures 
were performed with 34.6% yielded positive. Although 
110 different bacterial and fungal species were isolated, 
only 7 bacterial genera accounted for 90.6% of the 
 urinary isolates, including: Escherichia coli (49.56%), 
 Proteus spp. (12.12%), Enterococcus spp. (9.80%), Staph-
ylococcusspp. (8,40%), Klebsiella spp. (4.55%), Pseu-
domonas spp.(4.03%), and Streptococcus spp. (2.11%). 
Among these genera, dogs had a generally higher 
 predisposition than cats did, 39.29% and 24.7% respec-
tively. Distributions of UTI diagnosis tended to be similar 
between species, although Enterococcus spp. had been 
more prevalent in cats. Infection with single bacteria was 
responsible for 93.76% of UTI in both species.
STATEMENT (CONCLUSIONS)
Given the results of the present study, canine and feline 
UTI in Spain can be characterized as follows: (1) bacterial 
UTIs were more prevalent than in previous reports; 
(2) the vast majority of canine UTI were caused by single 
bacteria; (3) Escherichia coli  was singularly the most 
prevalent agent in canine and feline UTI. 
Canine urinary 
extracellular vesicles 
as bactericidal agents 
in vitro
Samantha Raettig1, Fiona E. Karet Frankl2, 
Tim Williams3 
1 School of Veterinary Sciences, University of Bristol, Bristol, 
United Kingdom
2 Departments of Medical Genetics and Division of Renal 
Medicine, University of Cambridge, Cambridge, United Kingdom
3 Department of Veterinary Medicine, University of Cambridge, 
Cambridge, United Kingdom 
OBJECTIVES
Urinary extracellular vesicles (UEVs) from healthy human 
volunteers exhibit bactericidal activity in vitro which is 
independent of the bacteriostatic urinary protein, uro-
modulin. Thus, UEVs are postulated to be innate immune 
effectors of the urinary tract. This study aimed to evalu-
ate the bactericidal activity of canine UEV preparations.
METHODS
Free-catch urine samples were collected from client-
owned dogs. Triplicate aliquots of UEVs isolated by 
 differential centrifugation were co-incubated with 
luminescent BL21 E.coli, previously transfected with the 
luxCDABE operon. Luminescence was determined half-
hourly and area under the growth curve (AUC) calcu-
lated. UEVs were classified as bactericidal if AUC of BL21 
E.coli  co-incubated with UEVs was significantly lower 
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than AUC of BL21 E.coli  co-incubated with phosphate 
buffered saline (control). Statistical comparisons were 
made using the Student’s t-test. UEV preparations were 
immunoblotted for TSG101 (canonical UEV marker) and 
uromodulin, and quantified by densitometry.
RESULTS
Samples were collected from 13 dogs (8 males, 
5  females). UEVs from eleven dogs were classified as 
bactericidal (7 males and 4 females) and two as non- 
bactericidal. Uromodulin content of UEV preparations 
was not different between those with and without 
 bactericidal activity. Furthermore, UEV preparations that 
were non-bactericidal did not contain fewer UEVs (based 
on TSG101 densitometry) compared to bactericidal prep-
arations, which could indicate bactericidal dysfunction of 
UEVs within these individuals.
STATEMENT (CONCLUSIONS)
Canine UEV preparations from most dogs demonstrated 
in vitro bactericidal activity, therefore UEVs may also be 
innate immune effectors of the urinary tract in dogs. 
However, further work to exclude a bacteriostatic effect 
of canine uromodulin is warranted.
Developing methods 
to study the endothelial 
glycocalyx in cats
Sara Hillyer1, Chris Neal2, Rebecca Foster2, 
Angie Hibbert3, Severine Tasker1,3,4, 
Gavin Welsh2, Simon Satchell2, 
Natalie Finch2 
1 Bristol Veterinary School, University of Bristol, Bristol,  
United Kingdom
2 Bristol Renal, University of Bristol, Bristol, United Kingdom
3 The Feline Centre, Langford Vets, University of Bristol, Bristol, 
United Kingdom
4 The Linnaeus Group, Shirley, United Kingdom 
OBJECTIVES
The study objectives were: to visualise the endothelial 
glycocalyx for the first time in cats; to validate assays to 
quantify serum glycocalyx breakdown products (sul-
phated glycosaminoglycans [sGAG] and hyaluronan [HA]) 
in cats; and to compare serum glycocalyx breakdown 
products in healthy cats with those with hyperthyroidism 
and chronic kidney disease (CKD).
METHODS
Uterine artery samples from healthy cats undergoing 
routine neutering were perfused with 0.1% Alcian 
blue/2.5% glutaraldehyde/0.1M sodium cacodylate and 
fixed with 2.5% glutaraldehyde/0.1M sodium cacodylate, 
then visualised using transmission electron microscopy. 
Validation of an Alcian blue assay and commercially 
available ELISA were performed for measurement of 
sGAG and HA, respectively, in cat sera. Serum HA was 
measured in cats with hyperthyroidism (n = 9), CKD 
(n = 6) and in healthy cats (n = 9) and compared across 
groups by Kruskal-Wallis testing. 
RESULTS
Median (range) glycocalyx depth in uterine artery was 
64.44 (37.28–119.34)nm. Non-specific binding in serum, 
particularly to albumin, prevented reliable measurement 
of sGAG with the Alcian blue assay. The HA ELISA was 
reliable. Median (range) HA in cats with hyperthyroidism, 
CKD and in healthy cats was 118.40 (50.11–636.88)ng/ul, 
155.06 (41.17–517.00)ng/ul and 184.74 (62.92–532.36)
ng/ul, respectively, with no significant difference across 
groups (P = 0.778).
STATEMENT (CONCLUSIONS)
Definitive glycocalyx visualisation will facilitate its future 
study ex vivo. The HA ELISA enabled measurement of 
serum HA as a glycocalyx breakdown product in cats 
but HA was not significantly different across healthy 
cats and those with hyperthyroidism or CKD. However, 
this study was likely underpowered and larger studies 
are needed to evaluate glycocalyx breakdown in these 
diseases. 
Oral presentations
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Neutering and early-
onset urinary 
incontinence in 
bitches under primary 
veterinary care in the 
UK: A VetCompass 
cohort study
Camilla Pegram1, Dave Brodbelt1, 
David Church1, Jon Hall2, Laura Owen3, 
Yu-Mei Chang1, Dan O’Neill1 
1 The Royal Veterinary College, Hatfield, United Kingdom
2 University of Edinburgh, Edinburgh, United Kingdom
3 University of Cambridge, Cambridge, United Kingdom 
OBJECTIVES
Urinary incontinence commonly affects bitches and 
has  been attributed to neutering. This study aimed to 
evaluate associations between neutering and early-onset 
(≤8 years) urinary incontinence (EUI) in bitches under pri-
mary veterinary care in the UK.
METHODS
This retrospective cohort study followed bitches within 
VetCompass born from January 1st 2010 to December 
31st 2012 over time until 31st March 2018. EUI cases were 
identified and the incidence risk over the study period 
was calculated. Cox regression modelling evaluated the 
hazard of neutering for EUI outcome a) from the date of 
birth for all bitches both neutered and entire and b) from 
the date of neutering for just the neutered subset of 
bitches. Confounding variables considered included 
breed, bodyweight and veterinary practice group.
RESULTS
The study included 493 EUI cases and 72 478 non-cases. 
Incidence risk was 0.68% (95% confidence intervals 
0.62 to 0.74). After accounting for confounding factors, 
increased hazard of EUI was identified in a) neutered 
bitches, with the effect increasing with age and b) bitches 
neutered prior to 6 months within the first two years 
 following neuter. In both models, increased hazard was 
additionally associated with increasing bodyweight and 
the Irish setter had the highest hazard of EUI by breed.
STATEMENT (CONCLUSIONS)
Neutering and early-age neuter (<6 months) were identified 
as major time-dependent factors associated with increased 
EUI. Although neutering decision-making cannot be just 
based on EUI risk alone, the reduced time to EUI diagnosis 
in early-neutered bitches is a consideration, particularly in 
high-risk breeds and bitches of larger bodyweights.
Effect of treatment 
of hyperthyroidism 
on serum SDMA 
concentrations and 
the utility of SDMA as 
a marker of chronic 
kidney disease in 
hyperthyroidism
Emma Tarrant, Tim Williams 
Department of Veterinary Medicine, University of Cambridge, 
Cambridge, United Kingdom 
OBJECTIVES
To compare serum SDMA concentrations in hyperthyroid 
cats before and after medical treatment and evaluate the 
sensitivity and specificity of serum SDMA and creatinine 
concentrations for concurrent chronic kidney disease 
(CKD) in hyperthyroidism.
METHODS
Hyperthyroid cats that commenced medical treatment 
and in which euthyroidism was achieved (n = 12) were 
identified from samples submitted to Central Diagnostic 
Services, Cambridge. Cats that were azotaemic before 
(n = 3) and/or after treatment (n = 4, up to 8 months) 
were classified as having concurrent CKD. SDMA con-
centrations (measured in stored frozen samples) in 
hyperthyroid cats pre- and post-treatment were com-
pared using Wilcoxon signed-rank test. Sensitivity and 
specificity of elevated pre-treatment serum creatinine 
(>153 µmol/L) and SDMA concentrations (>14 µg/dL) for 
concurrent CKD were calculated. Data are presented as 
median [range].
RESULTS
Serum SDMA concentrations did not change significantly 
after 1 month (pre-treatment 14 [7–21] µg/dL vs. 1 month 
post-treatment 17 [11–29] µg/dL, n = 6; P = 0.248] or 
3–8 months of treatment (3–8 months post treatment 
17  [9–30] µg/dL, n = 10; P = 0.167). Sensitivity and 
 specificity of elevated pre-treatment serum SDMA 
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 concentrations for concurrent CKD were 43% (95% confi-
dence interval [CI] 10–82%) and 80% (95% CI 28–100%) 
respectively. Sensitivity and specificity of elevated pre-
treatment serum creatinine concentrations for concur-
rent CKD were 43% (95% CI 10–82%) and 100% 
respectively (95% CI 48–100%).
STATEMENT (CONCLUSIONS)
Serum SDMA concentrations did not change significantly 
with treatment although this may reflect low statistical 
power. The sensitivity and specificity of SDMA and creati-
nine for the detection of concurrent CKD in hyperthyroid 
cats were similar in this small study.
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Magnetic resonance 
imaging of the brain 
in dogs with portal 
vein hypoplasia
Chloe Smith1, Vicki Black1, Kate Bradley1, 
Michael. S Tivers2 
1 Langford Veterinary Services, Bristol, United Kingdom
2 Langford Veter, Bristol, United Kingdom 
OBJECTIVES
To determine if there are T1-weighted signal hyperinten-
sities in the lentiform nucleus on magnetic resonance 
imaging (MRI) of dogs with portal vein hypoplasia, 
 suggestive of hepatic encephalopathy.
METHODS
The medical records from 2014 to 2018 were retrospec-
tively reviewed for dogs diagnosed with portal vein 
 hypoplasia on histopathology, with no macroscopic 
shunt. Dogs were included if they had also had a brain 
MRI scan performed. Control dogs with a diagnosis of 
idiopathic epilepsy that had a brain MRI scan were age 
and breed matched. T1-weighted MRI signal intensity of 
the lentiform nucleus was quantified by a blinded 
observer, using a previously described technique. The 
mean lentiform nucleus index was compared between 
groups with an independent samples T-test.
RESULTS
In total 6 portal vein hypoplasia and 6 control dogs were 
identified. The mean lentiform nucleus index for portal 
vein hypoplasia dogs was 0.925 (standard deviation 
+/– 0.084) and for control dogs was 0.902 (standard 
deviation +/– 0.060). This difference was not statistically 
significant (p = 0.601).
STATEMENT (CONCLUSIONS)
This study did not find evidence of lentiform nucleus 
changes on MRI as previously described in dogs with con-
genital portosystemic shunts. Portal vein hypoplasia may 
not result in hepatic encephalopathy, or alternatively this 
may be less severe than in dogs with macroscopic shunts, 
however larger studies are required to further establish this.
Breed, age and gender 
distribution of canine 
hepatobiliary disease 
in the United Kingdom
Yuvani Bandara1, William A Bayton1, 
Nick Bexfield1, Tim Scase2 
1 University of Cambridge, Cambridge, United Kingdom
2 Bridge Pathology, Bristol, United Kingdom 
OBJECTIVES
Canine hepatobiliary disease is common. However, data 
determining disease prevalence and breed, age and gen-
der predispositions of affected dogs in the UK is lacking. 
The primary objective was to identify the frequency of 
canine hepatobiliary disease in a UK population of dogs 
and consequently determine breeds at increased risk of 
hepatobiliary disease based on age and gender.
METHODS
Histopathology reports from canine liver tissues submit-
ted to a commercial laboratory between December 2012 
and February 2018 were retrospectively evaluated. Each 
diagnosis was categorised according to World Small 
 Animal Veterinary Association standards, and recorded 
along with breed, age and gender. Cases with incomplete 
data or no definitive diagnosis were excluded. Breed 
 predisposition was calculated by odds ratios and 95% 
confidence intervals against a UK-based control popula-
tion of microchipped dogs.
RESULTS
In total 5663 canine liver samples were assessed with 
271  excluded. The most frequent histologic diagnoses 
were reactive hepatitis (n = 901), chronic hepatitis (n = 
856); reversible hepatocellular injury (n = 718); hepato-
cellular neoplasia (n = 660); disorders of impaired hepatic 
perfusion (n = 439); nodular hyperplasia (n = 428); gall 
bladder disease (n = 314); metastatic neoplasia (n = 181); 
neutrophilic cholangitis (n = 168) and hepatocellular 
death (n = 132). Breed, age and gender predispositions 
were calculated within several of these categories.
STATEMENT (CONCLUSIONS)
This is the first study to document the histopathological 
frequency of hepatobiliary diseases in a large cohort of 
dogs in the UK, as well as novel breed, age and gender 
predispositions. This data may help increase the index of 
suspicion of a particular disease in the absence of a 
biopsy-confirmed diagnosis.
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Evaluation of preprandial 
and two-hour 
postprandial serum bile 
acid concentrations 
in referral population 
of dogs
Veronica Gonzalo Nadal, Rodolfo Cappello, 
Alenka Hrovat 
North Downs Specialist Referrals, Bletchingley, United Kingdom 
OBJECTIVES
To examine preprandial (PreSBA) and postprandial serum 
bile acid (PostSBA) concentrations in dogs referred for a 
work up of neurological, hepatobiliary disease and 
 portosystemic shunts (PSS).
METHODS
All dogs with measured PreSBA and PostSBA concentra-
tions were included retrospectively from 2014–2017. 
Dogs with increased bilirubin and incomplete BA test 
results were excluded. Dogs were divided into four 
groups based on the final diagnose, i.e. neurological, 
hepatobiliary disease, PSS and other.
RESULTS
182 dogs met the inclusion criteria. Primary neurological 
disease was diagnosed in 48/182 dogs. Idiopathic 
 epilepsy was established in 29 and intracranial or spinal 
disease in 19 dogs with median PostSBA 3.4 (range, 0.8–
31.8 µmol/L) and 12.1 (range, 0.2–60.5 µmol/L), respec-
tively. Hepatobiliary disease was diagnosed in 32/182 
dogs with PostSBA 19.2 (range, 0.1–147.5 µmol/L). PSS 
was diagnosed in 21/ 182 dogs with PostBA 140.2 (range, 
43.5–283.3 µmol/L). 81 dogs presented with conditions 
other than hepatobiliary and neurological disease with 
median PostSBA 4.3 (range, 0.1–61.6 µmol/L). PreSBA 
and PostSBA concentrations in dogs with PSS were 
 significantly higher (p < 0.01) than in dogs with primary 
neurological and hepatobiliary diseases. PreSBA and 
PostSBA concentrations in 19/21 dogs with PSS exceeded 
75  µmol/L. All dogs with primary neurological disease 
and idiopathic epilepsy had PreSBA and PostSBA 
 concentrations below 75 µmol/L.
STATEMENT (CONCLUSIONS)
Bile acid concentrations in dogs with neurological and 
hepatobiliary disorders are significantly lower than in 
dogs with PSS. Based on results of this study PSS is 
unlikely in dogs with PreSBA and PostSBA concentrations 
below 75 µmol/L.
Assessment of visceral 
pain and quality of life 
in dogs with chronic 
enteropathy – A 
controlled questionnaire 
based pilot study
Jorge Pérez-Accino, Amy Miele, 
Silke Salavati 
Royal (Dick) School of Veterinary Studies, Roslin, United Kingdom 
OBJECTIVES
Assessing visceral pain in dogs diagnosed with chronic 
enteropathy (CE) and its relation to quality of life (QOL).
METHODS
Institutional veterinary and human ethic committees 
approved the study. Adult dogs presenting with chronic 
gastrointestinal (GI) signs to a referral hospital (n = 28) 
were prospectively enrolled and received a standard 
diagnostic work-up; 18/28 were diagnosed with CE and 
10/28 with suspected CE, lacking histopathology. A 
modi fied Canine Brief Pain Inventory© (mCBPI) question-
naire was completed by the owners and a visceral pain 
score (modified Colorado State University Canine 
Chronic Pain Scale, mCSUCCPS) completed by a veteri-
narian. A group of control dogs (n = 22) was scored as 
well. Mann-Whitney U test was used to assess differences 
in scores between cases and controls. Spearman’s rank 
correlation was determined for specific parameters. 
 Significance was set at p < 0.05.
RESULTS
The mCBPI and mCSUCCPS scores were significantly 
higher in dogs with CE compared to controls (p = 0.0001, 
p = 0.0008 respectively): 15/28 CE dogs (54%) were 
 perceived to have fair to poor QOL. There was a strong 
negative correlation between owner perceived pain and 
QOL (r = –0.81, p < 0.05). No significant correlation was 
found between praying position frequency and mCBPI 
(r = 0.31, p = 0.09) or between mCBPI and mCSUCCPS 
(r = 0.30, p = 0.11).
STATEMENT (CONCLUSIONS)
Visceral pain is an important feature of canine CE, which 
might not readily detected on physical examination. 
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It  significantly impacts on owner’s perception of QOL. 
This  could lead to reduced treatment compliance or 
 euthanasia of patients. Assessment and potential treat-
ment of visceral pain in canine CE demands further study.
Combined endoscopic 
and fluoroscopic 
assisted balloon 
dilation as a treatment 
method for benign 
oesophageal strictures 
in dogs
Mariette Pilot, Jen O’Keeffe, 
Gerard Mclauchlan 
Fitzpatrick Referral Oncology & Soft Tissue, Guildford,  
United Kingdom 
OBJECTIVES
To assess the effectiveness of combined endoscopic and 
fluoroscopic assisted balloon dilation in dogs with benign 
oesophageal strictures.
METHODS
A retrospective study was performed in dogs that under-
went combined endoscopic and fluoroscopic assisted 
balloon dilation for benign oesophageal strictures. Cases 
were assigned a Modified Dysphagia Score (MDS) at 
presentation based on previously published literature 
(MDS = 0 if no dysphagia present with normal diet; 
MDS = 1 if able to swallow some solid food; MDS = 2 if 
able to swallow semi-solid food; MDS = 3 if able to swal-
low liquids only; MDS = 4 if unable to swallow liquids).
Information recorded included the location and 
number of strictures, duration of clinical signs, fluoro-
scopic confirmation of full stricture dilation, number of 
balloon dilations performed and final MDS score. Cases 
were excluded if assigning a MDS (either pre or post 
 procedure) was not possible due to lack of information in 
the medical record. 
RESULTS
Five dogs were included in the study. One patient had 
undergone 4 endoscopic balloon dilations prior to refer-
ral. Combined endoscopic and fluoroscopic dilatation 
was well tolerated in all cases with no complications 
reported. Patients underwent an average of 2 dilation 
procedures and all patients were discharged within 
24 hours of treatment. The MDS improved in 4/5 cases 
and remained static in the remaining case. The mean pre 
treatment MDS was 2 and mean post-treatment MDS 
was 0.4. 
STATEMENT (CONCLUSIONS)
Combined endoscopic and fluoroscopic assisted balloon 
dilation appears an effective method of treating benign 
oesophageal strictures in dogs. 
Indications for 
administration of 
gastroprotectant 
medications in 
hospitalised dogs 
and cats
Rachel McCormack1, James Swann2, 
Barbara Glanemann2 
1 Queen Mother Hospital for Small Animals, Royal Veterinary 
College, University of London, North Mymms, United Kingdom
2 Dep. of CSS, Royal Veterinary College, University of London, 
North Mymms, United Kingdom 
OBJECTIVES
To establish how frequently gastroprotectant medica-
tions are administered in a specialist veterinary hospital 
and the stated indications for their use. 
METHODS
A prospective, nurse-led survey was performed over a 
period of 9 weeks, including all dogs and cats referred to a 
specialist internal medicine clinic that were hospitalised for 
more than 24 hours. The use and dosages of gastropro-
tectant drugs were recorded; attending clinicians com-
pleted a questionnaire to establish indications for their use.
RESULTS
Of 189 dogs and 58 cats hospitalised for more than 
24 hours, 74 (39%) dogs and 24 (41%) cats received gas-
troprotectant drugs. Omeprazole was the drug adminis-
tered most frequently in 50 dogs and 8 cats, all at a dose 
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of 1 mg/kg twice daily. Among dogs, major stated indica-
tions included vomiting (44%), decreased appetite (20%), 
regurgitation (14%), gastrointestinal ulceration (10%), 
pancreatitis (8%), administration of glucocorticoids (8%), 
azotaemia (6%), haemorrhagic gastroenteritis (4%), and 
hepatic disease (4%).
Ondansetron was prescribed at 1–2 mg/kg/day in 20 
dogs and 1 cat. Among dogs, the major indications were 
nausea (55%), vomiting (35%), decreased appetite (25%), 
and pancreatitis (10%).
Maropitant was prescribed at a dose of 1 mg/kg/day 
in 37 dogs and 8 cats. Indications in dogs included 
 vomiting (46%), nausea (32%), decreased appetite (30%), 
whereas the major indication in cats was decreased 
appetite (50%).
STATEMENT (CONCLUSIONS)
There was considerable variation in the rationale for 
administration of gastroprotectant drugs, with no 
 uniform pattern of prescribing. These results will inform 
development of guidelines for use of these drugs in 
 veterinary practice.
Does sedation increase 
the frequency of 
radiographic 
oesophageal dilation 
in dogs without signs 
of clinical oesophageal 
disease?
Giulia Marceglia, Alix McBrearty, 
Gawain Hammond 
University of Glasgow, Glasgow, United Kingdom 
OBJECTIVES
Sedatives are thought to cause artefactual oesophageal 
dilation in dogs and therefore to assess for oesophageal 
disease, conscious thoracic radiography is recommended. 
Evidence to support this recommendation is limited. The 
aim was to compare the frequency of radiographic 
oesophageal dilation in dogs without clinical evidence of 
oesophageal disease when radiographed either with, or 
without sedation.
METHODS
Dogs undergoing thoracic radiography between 
20/12/17 and 19/9/18 and without vomiting/regurgitation 
in the previous 30 days were eligible. Cases radiographed 
under anaesthesia, with oesophagostomy tubes or 
oesophageal foreign bodies were excluded. Sedative/
opioids administered were recorded. Radiographs were 
blindly reviewed for oesophageal dilation. If dilated, 
maximum oesophageal diameters (mm) were measured 
and the ratio of this to thoracic inlet diameter was calcu-
lated (mm). 
RESULTS
298 dogs were included; 108 dogs were conscious, 
42 had butorphanol alone, 92 butorphanol and mede-
tomidine and 56 other opioids and/or sedatives. The 
proportion of dogs with oesophageal dilation was simi-
lar in all groups (29.6%, 33.3%, 23.9% and 26.8%, respec-
tively). Median maximum oesophageal diameters were 
10.7  mm (range: 3–28.6), 8.4  mm (range: 2.8–20.9), 
10.1  mm (range: 1.6-23.9) and 16.4  mm (range: 3.3–
40.1) respectively, and median ratios of maximum 
oesophageal diameter to thoracic inlet diameters were 
0.17 (range: 0.04–0.34), 0.11 (range: 0.04–0.28), 
0.14  (range: 0.03–0.34) and 0.18 (range: 0.06–0.35) 
 respectively.
STATEMENT (CONCLUSIONS)
Conscious animals without signs of oesophageal dis-
ease may have radiographic oesophageal dilation. 
Sedated dogs were no more likely to have oesopha-
geal dilation than conscious dogs, nor was it more 
severe. Based on this study, there is no evidence that 
sedation increases the risk of radiographic oesopha-
geal  dilation.
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Evaluating the renal 
ultrastructure in cats 
with diabetes mellitus
Holly Reyes-Hughes1, Chris Neal2, 
Natalie Finch2 
1 Bristol Veterinary School, Bristol, United Kingdom
2 Bristol Renal, Bristol, United Kingdom 
OBJECTIVES
The study objectives were to be the first study to report 
the ultrastructural changes in the kidneys of diabetic cats 
compared to control cats and to evaluate whether evi-
dence exists for the development of diabetic  nephropathy 
in cats.
METHODS
Formalin-fixed kidney tissue was collected from three 
diabetic and five control cats undergoing post-mortem 
examination. Samples were processed prior to imaging 
with a transmission electron microscope. Glomerular 
micrographs were analysed by a blinded investigator 
using image analysis software. The following measure-
ments were recorded; glomerular endothelial cell (GEnC) 
fenestration density and width, podocyte filtration slit 
density and width, foot process width and glomerular 
basement membrane (GBM) width and compared bet-
ween diabetic and control cats using the Mann-Whitney 
U test.
RESULTS
For diabetic and control cats respectively: GEnC fenestra-
tion density was 5.7 (3.8–7.5) and 5.8 (5.0–6.8) µm–1, 
GEnC fenestration width was 86 (76–143) and 83 (73–
97)  nm; filtration slit density was 4.4 (3.1–5.9) and 4.4 
(3.8–5.6) µm–1, foot process width was 341 (263–532) and 
383 (338–484) nm, filtration slit width 38 (31–47) and 34 
(29–45) nm, GBM width was 377 (260–475) and 247 9 
(127–405) nm. Only GBM width was significantly 
increased in diabetic compared to control cats (P = 0.012).
STATEMENT (CONCLUSIONS)
This is the first study to report the renal ultrastructural 
changes in cats with diabetes. The GBM width was signif-
icantly increased in diabetic cats suggesting evidence for 
the development of diabetic nephropathy. The study is 
limited by the small number of cats included and larger 
studies are warranted.
Study funded by a PetSavers student research grant.
The value of serum 
cortisol as a prognostic 
indicator in critically ill 
dogs 
Harry Swales, Daniel Batchelor, 
Erin O’Connell 
University of Liverpool Small Animal Teaching Hospital, Liverpool, 
United Kingdom 
OBJECTIVES
Studies in humans with septic shock have demon-
strated an inverse correlation between serum cortisol 
(SC) concentrations and survival whereas veterinary 
studies have yielded conflicting results. The aim of this 
retrospective study was to investigate the prognostic 
value of SC in a referral-centre intensive care unit (ICU) 
population as well as the influence of sepsis on this 
association. 
METHODS
Retrospective study of critically ill dogs admitted to the 
University of Liverpool Small Animal Teaching Hospital 
ICU between January 2010 and May 2018 that had SC 
measured within three days of admission. The predictive 
value of SC was investigated. The current human defini-
tion of sepsis was used. 
RESULTS
229 patients met the inclusion criteria and the mortality 
rate was 20%. SC concentrations were significantly higher 
in non-survivors (234 nmol/L) than survivors (123 nmol/L) 
(P  < .001). SC demonstrated good predictive value for 
non-survival with an area under the curve of 0.72 
(CI 0.64–0.80). An optimum cut-off of 210 nmol/L was 
calculated corresponding to an OR of 5.4 (CI 2.7–10.9) for 
non-survival with a sensitivity and specificity of 58% and 
80% respectively. SC levels were higher in septic patients 
(253 nmol/L) than non-septic patients (124 nmol/L) 
(P < .001) but was not predictive of survival (P = 0.15).
STATEMENT (CONCLUSIONS)
Serum cortisol may be used as part of the overall assess-
ment of a critically-ill dog’s prognosis.
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Diagnosis and 
management of 
hyperadrenocorticism 
in dogs attending UK 
primary-care practice
Imogen Schofield1, David Brodbelt1, 
Stijn Niessen1, Anna Wilson2, Dan O’Neill1 
1 Royal Veterinary College, London, United Kingdom
2 University of Cambridge, Cambridge, United Kingdom 
OBJECTIVES
To describe the diagnosis and management of hyper-
adrenocorticism in dogs attending primary-care practice 
in the UK. 
METHODS
The VetCompass database contains electronic patient 
records for dogs attending UK primary-care practices. 
The records of dogs diagnosed with hyperadrenocorti-
cism were reviewed and additional diagnostic and 
 management data were extracted including: diagnostic 
testing, treatment, trilostane dose and monitoring 
 cortisol measurements. 
RESULTS
The study identified 219 dogs diagnosed with hyper-
adrenocorticism. The most commonly used diagnostic 
tests were the ACTH stimulation test (n = 206 cases, 
94.1%), low-dose dexamethasone suppression test 
(70,  32.0%) and urine cortisol-creatinine ratio (58, 
26.5%). Differentiation between pituitary- and adrenal- 
dependent aetiology was performed in 44 cases (20.1%). 
Trilostane was given in 206 cases (94.1%) with a mean 
starting dose of 3.30 mg/kg/day (SD 1.28). Ninety-four 
cases (45.6%) had no changes made to their initial trilos-
tane dose. Of dogs with cortisol concentrations 
recorded after initiation of therapy, post-ACTH stimula-
tion cortisol did not drop below the upper reference 
range of 250 nmol/L in any test in 32 (32.0%) and results 
fell below the lower reference range of 40 nmol/L in 21 
(21.0%). Iatrogenic hypoadrenocorticism or a suspected 
adverse response was recorded in 28 (13.6%) dogs 
receiving trilostane.
STATEMENT (CONCLUSIONS)
This study provides benchmark data describing the diag-
nosis and management of hyperadrenocorticism in 
 primary-care practice. Findings show the ACTH stimula-
tion test predominates in diagnosis and differentiation 
between pituitary and adrenal disease is infrequently 
performed, contrary to current expert recommenda-
tions. Further work evaluating the benefits of disease dif-
ferentiation and survival after treatment in a primary-care 
setting is merited. 
The Cushing’s clinical 
score: development 
of a primary-care 
practice tool to 
quantify the clinical 
signs of dogs with 
hyperadrenocorticism
Imogen Schofield, Dan O’Neill, 
David Brodbelt, Stijn Niessen 
Royal Veterinary College, London, United Kingdom 
OBJECTIVES
With doubts raised over the accuracy of hormonal test-
ing of hyperadrenocorticism, monitoring recommenda-
tions for dogs undergoing trilostane treatment emphasise 
the importance of clinical sign assessment. This study 
aimed to produce a tool to enable standardised quantifi-
cation of the clinical signs associated with hyperadreno-
corticism in primary-care practice.  
METHODS
Structured focus groups were held with 19 clinicians and 
13 owners of dogs with hyperadrenocorticism, 21 veteri-
nary publications were reviewed and 20 randomly 
selected electronic health records of hyperadrenocorti-
cism cases were analysed to identify potential clinical 
signs associated with hyperadrenocorticism. Qualitative 
thematic analysis identified five categories of clinical 
signs. A scoring system was designed based on the 
severity of clinical signs in each category ranging from 
0–3, producing a score out of 15 (higher score indicate 
more clinical hyperadrenocorticism). The tool was 
piloted with 16 owners and 12 clinicians to assess its 
readability and clarity.
RESULTS
A list of 24 clinical signs associated with hyperadreno-
corticism was drafted. Qualitative thematic analysis iden-
tified polydipsia and polyphagia as the most commonly 
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discussed clinical signs in the focus groups, with changes 
in demeanor and lethargy more frequently mentioned by 
owners than clinicians. Clinical signs were summarised 
into five categories: drinking, urination, appetite, appear-
ance and attitude/activity. Clinicians and owners reported 
the tool to be clear, concise and practical for a primary-
care setting. 
STATEMENT (CONCLUSIONS)
The developed tool standardises the recording of clinical 
signs of hyperadrenocorticism and could be used in 
practice to assess medical management of hyperadren-
ocorticism. Further validation is planned through corre-
lation with biological parameters and patient outcomes. 
Breed influence 
on canine thyroid 
reference intervals 
and age-related 
thyroid decline
Olivia Barnard-Jones1, Kent Refsal2, 
Peter Graham1
1 University of Nottingham, Sutton Bonington, United Kingdom
2 Michigan State University, East Lansing, USA 
OBJECTIVES
Hypothyroidism is a common canine condition which 
can be difficult to diagnose. Misdiagnosis can result in 
unnecessary life-long treatment. One complicating 
 factor may be variation in thyroid hormone reference 
intervals between breeds, previously shown to be diag-
nostically important in sighthounds. Increasing age is 
associated with decreasing thyroxine and increasing TSH 
serum concentrations, but breed influence on this effect 
has not previously been explored.
This projects aimed to investigate whether more, 
non-sighthound, breed-specific reference intervals 
would be appropriate and to discover whether breed 
influenced age-related thyroid changes.
METHODS
The study explored total and free, thyroxine and 
3-5-3’-triiodothyronine (TT4, FT4, TT3, FT3), and thyro-
tropin (TSH) in 81,985 euthyroid dogs from 214 breeds 
using a database of serum thyroid profile results. Breed 
reference intervals (2.5 to 97.5 percentile) were created 
for 77 breeds with more than 140 cases.
RESULTS
Breed-specific reference limits differed; the lower limit 
for TT4 ranged from 7 (Sharpei) to 17 nmol/L (Cavalier 
King Charles Spaniel; CKCS) and the upper TSH limit from 
0.44 (Soft Coated Wheaten Terrier) to 0.63 ng/ml 
( Keeshond). There was a breed effect on age-related 
 thyroid hormone decline and TSH increase. TT4 decline 
ranged from –0.021 (Basenji) to –1.324 (CKCS) nmol/L/yr. 
TSH increase ranged from 0.00097 (Bulmastiff) to 0.0137 
(CKCS) ng/ml/yr.
STATEMENT (CONCLUSIONS)
Breeds other than the sighthound group would benefit 
from their own breed-specific thyroid reference inter-
vals, such as CKCS, as they differed significantly from 
 all-breed intervals with a consequent risk of misdiagno-
sis. Some breeds also have quicker “thyroid-axis-ageing” 
than others.
Factors influencing 
thyroid function and 
deiodinase indices
Emma Campbell1, Kent Refsal2, 
Peter Graham1 
1 University of Nottingham, Sutton Bonington, United Kingdom
2 Michigan State University, East Lansing, USA 
OBJECTIVES
Age, breed, gender and obesity have been shown to 
influence thyroid function and concentrations of thyroid 
hormones in the dog. This study investigated whether 
these factors, breed size and geographical location 
( climate) influenced deiodinase activity (tri- iodothyronine 
(T3): thyroxine (T4) ratio) and thyroid functional ‘set-
point’ (T4:Thyrotropin (TSH) ratio).
METHODS
Analysis of a USA database of canine laboratory thyroid 
function assessments (n  >  70,000 euthyroid cases). 
Regression was used to assess associations between 
numerical values and Kruskal-Wallis to compare differ-
ences between categories.
RESULTS
Age was associated with an increased deiodinase activity 
(P  <  0.05) and lower thyroid functional ‘set-point’ 
(P < 0.001). ‘Set-point’ was affected by breed (P < 0.001) 
and T4:TSH ratio was lower in overweight dogs (P < 0.05). 
Overweight was associated with higher T3, T4 and TSH 
concentrations (p < 0.001) but there was no difference in 
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deiodinase activity. Gender and neuter status influenced 
deiodinase activity which was greater in males than in 
females (P  <  0.001) and lower in entire than neutered 
females (P < 0.001). Breed size and geographical location 
(average state temperature) did not affect deiodinase 
activity or ‘set-point’ (P > 0.05). Higher TSH concentra-
tions were associated with higher de-iodinase activity 
(p < 0.05).
STATEMENT (CONCLUSIONS)
Deiodinase activity acts as an additional control point for 
thyroid function and is influenced by age, sex and TSH 
concentrations. Being overweight is associated with 
higher thyroid hormones and TSH. ‘Set-point’ is influ-
enced by age, breed and weight status. These factors 
may need considering in laboratory definitions of canine 
hypothyroidism.
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Effect of the ingredient 
A97614A1 on the 
adhesion and biofilm 
formation of 
Staphylococcus 
pseudintermedius in a 
model of reconstructed 
canine epidermis
Elodie Ollivier1, Claudine Zemirline1, 
Laetitia Marchand2, Brigitte Closs2 
1 Ceva Santé Animale, Libourne, France
2 Silab, Brive, France
OBJECTIVES
Dogs with atopic dermatitis present a loss of diversity of 
their skin microbiota with relative increases in Staphylo-
coccus spp. abundances during flares. There is a strong 
correlation between this dysbiosis, inflammation and 
skin barrier defect. Staphylococcus pseudintermedius is 
also the most frequent pathogen isolated from skin and 
ear infections in dogs. The objective of this study was to 
evaluate the efficacy of the ingredient coded A97614A1 on 
the adhesion and biofilm formation of Staphylococcus 
pseudintermedius in a model of Reconstructed Canine 
Epidermis (RCE).
METHODS
Primary keratinocytes extracted from skin samples of 
two dogs were cultured in a specific medium for 12 days 
in order to develop RCEs. On day 12, RCEs were either 
treated topically with A97614A1 during 24 hours or not 
treated (controls). On day 13, 50 µL of a 106 CFU/mL sus-
pension of Staphylococcus pseudintermedius isolated 
from a dog with pyoderma were topically applied on 
RCEs. Twenty-four hours later (day 14), RCEs were 
observed using scanning electron microscopy to assess 
the adhesion and biofilm formation of Staphylococcus 
pseudintermedius. 
RESULTS
RCEs treated with A97614A1 presented much less Staph-
ylococcus pseudintermedius than control RCEs. The 
ingredient A97614A1 therefore limited the adhesion and 
biofilm formation of Staphylococcus pseudintermedius 
at the surface of the RCEs. 
STATEMENT (CONCLUSIONS)
These results support the potential interest of incorpo-
rating this ingredient into topical products intended for 
dogs presenting an alteration of their skin microbiota, 
including atopic dogs. 
Efficacy of the 
ingredient A97614A1 in a 
model of reconstructed 
human epidermis 
stressed by cytokines
Elodie Ollivier1, Claudine Zemirline1, 
Nicolas Amalric2, Valérie Rahoul2, Nadège 
Reymond3, Marie-Christine Cadiergues4 
1 Ceva Santé Animale, Libourne, France
2 Synelvia, Labège, France
3 Consultant, Villeneuve Loubet, France
4 UDEAR, Université de Toulouse, INSERM, ENVT, Toulouse, 
France 
OBJECTIVES
In dogs and cats as in humans, dermatological disorders 
are associated with impaired skin barrier, comprising a 
defective mechanical barrier, a disregulation of the 
immune response and an alteration of the skin microbi-
ota. The objective of this study was to evaluate the effi-
cacy of a new ingredient coded A97614A1 on the 
mechanical and immunological skin barrier, using an 
 in-vitro model of Reconstructed Human Epidermis (RHE) 
stressed by cytokines to induce a skin barrier defect. 
METHODS
RHE stressed by cytokines were treated with A97614A1 
and compared to non-treated stressed RHE and to nor-
mal (not stressed and non-treated) RHE. The evaluation 
of the effect of A97614A1 on the mechanical skin barrier 
(including hydration) was assessed through the analysis 
of RHE morphology, outside-inside permeability (Lucifer 
yellow test), transepidermal water loss (TEWL), Natural 
Moisturising Factors (NMFs) and ceramides. The analysis 
of the pro-inflammatory cytokines IL-8 and TSLP 
( markers of the immune response) served as criteria to 
evaluate the immunological skin barrier. 
RESULTS
Compared to normal RHE, stressed RHE present a disor-
ganisation of the structure (dissociation of cells, spongi-
osis, fewer and smaller keratohyaline granules), increased 
permeability and TEWL, and decreased amount of NMFs 
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and ceramides; the IL-8 and TSLP release is increased. 
Treatment with A97614A1 allowed stressed RHE to 
recover normal morphology, impermeability, TEWL, IL-8 
and TSLP amounts, and close to normal amounts of 
NMFs and ceramides. 
STATEMENT (CONCLUSIONS)
The ingredient A97614A1 was shown to have beneficial 
effects on the mechanical and immunological skin 
 barrier. These results support the potential interest of 
incorporating it into topical products. 
Two case reports of 
novel cutaneous 
mycoses in cats in the 
UK using molecular 
identification for rapid 
and accurate diagnosis
Nikoleta Makri1, Gavin Paterson2,  
Fiona Gregge3, Catriona Urquhart4,  
Holly McCluskey5, Tim Nuttall1
1 Hospital for Small Animals, Royal (Dick) School of Veterinary 
Studies, Edinburgh, United Kingdom
2 Easter Bush Pathology, Royal (Dick) School of Veterinary Studies, 
Edinburgh, United Kingdom
3 Aberdeen PDSA Pet Hospital, Aberdeen, United Kingdom
4 Abervet, Aberdeen, United Kingdom
5 Riverside Veterinary Practice, Livingston, United Kingdom 
OBJECTIVES
Phaeohyphomycosis and sporotrichosis are saprophytic 
mycoses affecting humans and animals. Traumatic inoc-
ulation results in cutaneous and subcutaneous lesions 
that can be locally invasive. Traditional culture based 
methods can be slow and may not sufficiently classify the 
fungi. Molecular testing however, can achieve a fast 
definitive identification.
METHODS
Two cats (cat 1–15-year-old male neutered domestic 
short hair; cat 2–11-year-old female neutered domestic 
long hair) developed focal suppurative nodular lesions 
on the dorsal nose. Both cats had been previously diag-
nosed with diabetes mellitus and were on insulin therapy. 
There was no response to broad spectrum antibiotics 
selected following antimicrobial susceptibility tests. 
 Fungal elements were seen on cytology, although initial 
culture was negative in cat 2. Subsequent isolates were 
obtained after overnight incubation of fresh discharge on 
Sabouraud dextrose agar with chloramphenicol. These 
were submitted for PCR and sequencing of the ribosomal 
internal transcribed spacers (ITS)with the primers ITS-F 
and ITS-R.
RESULTS
PCR and sequencing confirmed phaeohyphomycosis 
with Exophiala dermatitidis (cat 1) and sporotrichosis with 
Sporothrix pallida complex (cat 2).Further sequencing of 
calmodulin and beta-tubulin partial gene sequences 
confirmed Sporothrix humicola.
STATEMENT (CONCLUSIONS)
These are the first reports of Exophiala dermatitidis 
and Sporothrix humicola in cats in the UK. The use of 
molecular methods provided a rapid and definite identi-
fication of the fungi. Clinicians and pathologists need to 
be aware of the emerging use of molecular techniques to 
achieve rapid and accurate identification of rare fungal 
microorganisms. This will help reduce unnecessary anti-
biotic use.
Antimicrobial 
susceptibility of 
bacterial isolates 
from canine wounds 
in a referral population
Catrina Pennington1, Tim Nuttall2,  
Jon Hall3 
1 University of Edinburgh, Edinburgh, United Kingdom
2 University of Edinburgh, Edinburgh, United Kingdom
3 University of Edinburgh, Edinburgh, United Kingdom 
OBJECTIVES
To report the prevalence and antimicrobial susceptibility 
of bacteria isolated from canine wounds in a referral 
population.
METHODS
Data was collected from clinical records of dogs with 
wounds cultured between 01/01/2008 and 01/01/2018. 
Cases with incomplete clinical information or results 
were excluded. 1 isolate was included where the same 
bacteria were isolated from multiple samples in a dog.
RESULTS
392 cases (499 samples) were included. 83.5% of cultures 
were positive; 54.7% isolated a single organism and 
28.8% two or more.   
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45.8% of the positive cultures comprised gram- 
positive isolates only, 31.6% gram-negative only, 15.7% 
gram-positive and gram-negative, and 3.9% included 
obligate anaerobic organisms. Other cultures involved 
unidentified isolates.
The most frequent isolates were: Staphylococcus 
pseudintermedius (27.8%), E. coli (18.3%), Staphylococ-
cus aureus (6.5%), Pseudomonas aeruginosa (5.9%) and 
Pasteurella multocida (4.9%). 
Meticillin-resistance (MecA) was detected in 19.5% of 
the Staphylococcus isolates. AmpC and/or ESBL (extended 
spectrum beta-lactamase) expression was detected in 
19.8% of E. coli, Klebsiella and Enterobacter isolates.
Antimicrobial susceptibility of the S. pseudintermedius 
at first culture was 81.3% (cephalexin), 76.7% ( enrofloxacin), 
68.7% (clavulanate-amoxicillin), 68% (TMPS), 68% (clinda-
mycin), 33.3% (amoxicillin) and 29.2% (erythromycin). For 
E. coli it was 91.3% (gentamicin), 75% (enrofloxacin), 64% 
(TMPS), 52.7% (doxycycline), 49.4% (clavulanate- amoxicillin) 
and 44% (cefalexin).  
No clear pattern was detected in antimicrobial 
 susceptibility, although the prevalence AmpC/ESBL 
expression has increased. 
STATEMENT (CONCLUSIONS)
Knowledge of common wound pathogens and their 
 antimicrobial susceptibility will aid appropriate drug 
selection. This is key to antimicrobial stewardship. 
The Antimicrobial 
Stewardship and Pets 
(ASAP) project: 
performance and 
evaluation of an 
Antimicrobial 
Stewardship 
Improvement Strategy 
in 44 Dutch companion 
animal clinics
Nonke Hopman1, Lützen Portengen1, 
Marlies Hulscher2, Dick Heederik1,  
Jaap Wagenaar1, Ingeborg van Geijlswijk1, 
Els Broens1 
1 Faculty of Veterinary Medicine, Utrecht, Netherlands
2 Radboud University Medical Center, IQ healthcare, Nijmegen, 
Netherlands 
OBJECTIVES
To evaluate an Antimicrobial Stewardship Programme 
(ASP) designed to promote responsible antimicrobial use 
(AMU) in companion animal clinics. This will contribute 
to containing the further development and spread of 
antimicrobial resistance in companion animals. 
METHODS
An ASP was developed based upon an interview and a 
survey study among companion animal veterinarians. 
The effect of the ASP on AMU was assessed in 44 Dutch 
companion animal clinics over a three year period, 
between 2016–2018, using a stepped-wedge design. This 
multifaceted intervention consisted of post- educational 
training, an information leaflet for pet owners and clinic 
specific feedback on AMU.
Monthly information on AMU, differentiated in first, 
second and third choice antimicrobials (based upon 
Dutch policy on veterinary AMU) was collected from the 
Practice Management Systems before and after the inter-
vention. The ASP effect was estimated by meta-analyses 
of estimated intervention effects for each clinic. 
RESULTS
AMU had already been reduced prior to implementation 
of the ASP (intervention) in many of the clinics. Using 
trend extrapolation from auto-regressive models, a fur-
ther decrease in total, second and third choice AMU 
could be attributed to the ASP in several clinics, resulting 
in an overall significant decrease for total and second 
choice AMU as estimated in the meta-analyses. 
Participants reported to be more aware of AMU after 
participation in the ASP. 
STATEMENT (CONCLUSIONS)
The ASAP project shows that AMU in Dutch companion 
animal clinics can be optimised by introducing an ASP. 
More refined data analyses will follow and feasibility of 
implementation of ASP on a larger scale will be further 
explored.
421-550 Clinical Abstracts.indd   444 08/03/2019   18:39
BSAVA CONGRESS 2019 PROCEEDINGS [ 445 ]
Prevalence and trends 
in antimicrobial 
resistance of bacteria 
from canine urinary 
tract isolates from an 
Australian referral 
hospital over a five-
year period
Maddie Roberts 
Small Animal Specialist Hospital, Sydney, Australia 
OBJECTIVES
To identify the prevalence of bacteria from canine urine 
tract isolates and to assess for any trends in antimicrobial 
resistance of the most frequently identified isolate over a 
five-year period from a referral hospital in Australia. 
METHODS
Retrospective analysis of positive canine urinary bacterial 
cultures between January 2013 and December 2017 
inclusive. Bacteria were classified as sensitive, intermedi-
ate or resistant, with intermediate and resistant grouped 
together as ‘non-susceptible’. Resistance of the most 
prevalent bacteria towards select antimicrobials (when 
evaluated in over 100 isolates) was examined using Chi 
squared or Fisher’s exact test for low cell frequencies 
with a p-value of <0.05 of statistical significance. 
RESULTS
A total of 382 positive cultures returned with 412 bacte-
rial isolates. Of these, 27 were polymicrobial (≥2) cul-
tures. Escherichia coli was the most prevalent bacteria 
(49.5%), followed by Proteus sp., Staphylococcus sp., 
Enterococcus sp., Klebsiella sp., and Pseudomonas sp. 
respectively (12.3; 12.0; 9.7; 5.0 and 4.2%). Antimicrobials 
where over 100 E. coli isolates were evaluated included 
amoxicillin-clavulanate, trimethoprim-sulphonamide, 
amoxicillin, enrofloxacin and doxycycline. When com-
paring resistance of E. coli in 2013 against each year, and 
2013 to the final study year there were no statistically 
 significant trends in antimicrobial resistance towards any 
of the antimicrobials evaluated.
STATEMENT (CONCLUSIONS)
E. coli was the most prevalent bacteria isolated in canine 
urine samples at our institution, similar to what has been 
described elsewhere. There were no significant trends in 
resistance of E. coli towards any of the antimicrobials 
evaluated during our study period. 
Patterns of 
antimicrobial resistance 
in canine wound 
infections from two 
large scale electronic 
datasets
Laura Holloway, Jonathan Massey, 
Fernando Sánchez-Vizcaíno, Tristan Cogan, 
Andrew Dowsey, Michael Tivers 
University of Bristol, Bristol, United Kingdom 
OBJECTIVES
To investigate temporal trends in sensitivity profiles and 
multi-drug resistance of bacteria cultured from wounds 
in dogs in the United Kingdom. 
METHODS
Two datasets of culture and sensitivity results from 
 samples taken from wounds in dogs were retrospec-
tively analysed. Dataset 1 (D1) was sourced from a com-
mercial laboratory (2011–18), whilst dataset 2 (D2) was 
sourced from four laboratories compiled by the Small 
Animal Veterinary Surveillance Network (SAVSNET) 
(2010–2017). Statistical analyses were conducted using 
R language. Temporal trends were analysed following 
orthogonal polynomial and forward difference coding 
with either a mixed effects binomial logistic regression 
model (D1) when data included practice postcode to 
counteract clustering, or a binomial logistic regression 
model (D2).
RESULTS
D1 contained 9302 samples, 5858 of which had specific 
bacteria isolated, whilst D2 contained 10,024 samples 
with bacterial species isolated. Significant (p < 0.05) tem-
poral observations which correlated across both datasets 
were seen. There were reductions in both amoxicillin-
clavulanic acid (D1 73.3% to 22.2%; D2 54.1% to 23.5%) 
and marbofloxacin (D1 59.1% to 23.8%; D2 51.4% to 19.7%) 
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resistance in Staphylococcus aureus and enrofloxacin 
and marbofloxacin resistance (both D1 34.7% to 5.8%; D2 
18.2% to 1.0%) in Escherichia coli. A reduction in multi-
drug resistant Staphylococcus aureus, defined as resist-
ance to 3 or more antimicrobial categories, was also 
observed (D1 72.7% to 27.0%; D2 55.5% to 26.4%).
STATEMENT (CONCLUSIONS)
Significant observations in both datasets suggest a reduc-
tion in antimicrobial resistance in organisms recognised 
as nosocomial pathogens. This may reflect an increased 
awareness of antimicrobial resistance among practising 
vets and hence more responsible use of antimicrobials. 
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Rhythm disturbances 
in dogs and cats with 
congestive heart failure 
and their impact on 
prognosis
Felicia Ann Robertson1, Malcolm Cobb2 
1 The University of Nottingham, School of Veterinary Medicine & 
Science, Nottingham, United Kingdom
2 The University of Nottingham, School of Veterinary Medicine & 
Science, Nottingham, United Kingdom 
OBJECTIVES
Do rhythm disturbances in dogs and cats with congestive 
heart failure contribute to a poorer prognosis? 
METHODS
This study retrospectively reviewed 101 cases of conges-
tive heart failure, 47 dogs and 54 cats and the presence 
or absence of a concurrent rhythm disturbance at diag-
nosis was determined. The nature of rhythm disturbance 
and the underlying cause for the heart failure were also 
recorded. The data was analysed using Microsoft excel 
and SPSS statistics. The median survival time was calcu-
lated for animals with and without a rhythm disturbance 
and Mann-Whitney U and Log-Rank tests were used to 
evaluate any significant difference in survival time. 
RESULTS
Rhythm disturbances were more prevalent in dogs with 
congestive heart failure, with 60% having a concurrent 
rhythm disturbance compared to 46% of cats. Supraven-
tricular dysrhythmias, in particular atrial fibrillation, were 
most common and accounted for 68% of all rhythm dis-
turbances in dogs, more variation was shown in cats. The 
median survival time for dogs with a rhythm disturbance 
was 84 days compared to 203 days for those without, for 
cats these were 39 and 41 days respectively. In dogs, a 
significant difference in survival time after diagnosis 
with  congestive heart failure was identified between 
the two groups (U = 150, p = 0.017/Log-Rank, p = 0.030). 
In cats, no significant difference was detected (U = 347, 
p = 0.792/Log-Rank, p = 0.323). 
STATEMENT (CONCLUSIONS)
This study suggests that rhythm disturbances compli-
cating congestive heart failure contribute to a poorer 
prognosis in dogs but are less detrimental in cats.
A retrospective study 
into the association 
between survival time 
and markers of renal 
dysfunction and heart 
failure severity in dogs 
with acute congestive 
heart failure
Christopher Ray, Joon Seo,  
Virginia Luis Fuentes 
The Royal Veterinary College, London, United Kingdom 
OBJECTIVES
To evaluate markers of renal dysfunction, heart failure 
severity and treatment versus survival in dogs with acute 
congestive heart failure.
METHODS
Retrospective study of dogs admitted with congestive 
heart failure between October 2006 and February 2018. 
The effect of disease duration, cause of heart failure, atrial 
fibrillation, furosemide dose, blood pressure, urea, creati-
nine, sodium, potassium, lactate, phosphorus, respiratory 
rate, dobutamine administration, and pimobendan admin-
istration on survival from admission were analysed with 
Kaplan Meier graphs, and log-rank analysis.
RESULTS
83 dogs met the inclusion criteria (36 female, 47 male). 
Reduced survival time was associated with chronic disease 
(p = 0.049); blood pressure ≤112.5 mm Hg (p = 0.0002); 
mean furosemide dose >8 mg/kg (p = 0.043); mean potas-
sium level ≤3.77 mmol/l (p = 0.004); dobutamine adminis-
tration (p = 0.001); and mean respiratory rate ≤48 (p = 
0.039). Survival time was increased with plasma urea 
between 13.1–18.78  mmol/l (p = 0.016); mean sodium 
concentration 145.7–150.25 mmol/l (p = 0.027); and mean 
phosphorus concentration ≤1.79 mmol/l (p = 0.021).
STATEMENT (CONCLUSIONS)
We found no association between creatinine concen-
trations and survival, although survival was worse for 
both  low and high urea concentrations. Only higher 
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 furosemide doses were associated with worse survival, 
identifying worse cases or suggesting a detrimental 
effect of over-diuresis. Lower blood pressure was also 
associated with decreased survival, probably because of 
lower cardiac output and worse cardiac disease. The 
relationship between heart failure, renal function and 
diuresis should be explored prospectively in larger study 
populations.
The effect of heart 
disease on red cell mass
Madeleine Stein, Jenny Wilshaw, 
Nicola Lotter, Adrian Boswood 
Royal Veterinary College, London, United Kingdom 
OBJECTIVES
This study aims to demonstrate whether a link exists 
between increasing severity of heart disease and red 
blood cell count in dogs with Myxomatous mitral valve 
disease.
METHODS
Data were obtained from 426 dogs enrolled in a longitu-
dinal study from first opinion practices based in London 
between 2004 and 2017. PCV was compared between 
dogs at different American College of Veterinary Internal 
Medicine (ACVIM) stages of disease and factors related 
to  changes in PCV were evaluated including; age, sex, 
breed, total protein, blood urea nitrogen, the left atrial 
to  aortic root ratio and the normalised left ventricular 
 internal diameter (LVIDDN).
RESULTS
One-way ANOVA showed a significant difference 
(p < 0.001) between all four ACVIM stages. Dogs in stage 
B2 (41.12 ± 6.15, p < 0.001) had a significantly lower PCV 
than all other stages (A: 46.14 ± 4.97, p  <  0.001, B1: 
43.44 ± 5.80, p = 0.012, C: 43.98 ±4.57, p = 0.048). The 
results additionally demonstrated that the mean PCV of 
dogs in stage A was the greatest and differed significantly 
from both stage B1 (p = 0.007) and B2 (p < 0.001).
A multivariable linear regression analysis revealed 
that patient age (–0.154 ± 0.111, p = 0.006), ACVIM stage 
(–0.122 ± 0.496, p = 0.40), LVIDDN (–0.160 ± 1.122, p = 
0.008) and breed (0.471 ± 0.661, p = 0.001) all had a 
 significant and independent effect on PCV.
STATEMENT (CONCLUSIONS)
There is a link between mitral valve disease and red blood 
cell count in dogs, which differs from human disease. A 
decrease in red blood cell count is seen with diseased 
progression until patients enter congestive heart failure 
when there is an increase. 
A new hope? 
Transvascular 
pulmonic stents in six 
dogs with severe 
pulmonic stenosis
Kieran Borgeat1, Melanie Hezzell1, 
Guillaume Chanoit1, Jessie Rose Payne1, 
Pedro Oliveira2 
1 Langford Vets, University of Bristol, Bristol, United Kingdom
2 Davies Veterinary Specialists, Hitchin, United Kingdom 
OBJECTIVES
Dogs with type B (hypoplastic) pulmonic stenosis have 
been traditionally considered poor candidates for mini-
mally invasive treatment. We report six cases of type B 
pulmonic stenosis treated using pulmonic stents.
METHODS
Retrospective description of six dogs with pulmonic 
 stenosis undergoing a transvascular pulmonic stent 
 procedure in two cardiology referral centres, describing 
the approach and short-term outcomes.
RESULTS
Six dogs underwent a pulmonic stent procedure over a 
12-month period. All dogs were diagnosed with severe, 
type B pulmonic stenosis based on echocardiographic 
criteria. Five French Bulldogs and one English Bulldog 
were treated. Two patients presented with signs of right 
sided congestive heart failure, two with erythrocytosis 
(concurrent right-to-left intracardiac shunts), one with 
syncope and one with marked exercise intolerance/ 
lethargy. Five dogs successfully received balloon- 
expandable metallic stents via a venous approach. In one 
dog, the stent could not be positioned appropriately and 
a hybrid procedure was successfully performed to place 
the stent retrograde, via the left pulmonary artery. No 
major complications were reported, although all dogs 
experienced reduced cardiac output and arrhythmias 
 during stent deployment. All dogs experienced an improve-
ment in clinical signs at one month post- operatively.
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STATEMENT (CONCLUSIONS)
Pulmonic stents represent a new frontier in interven-
tional cardiology to manage dogs with type B pulmonic 
stenosis that previously were considered poor candi-
dates for minimally invasive procedures.
Infiltrative laryngeal 
disease in 11 dogs
Amy Dixon1, Michael S. Tivers2, 
Leo Packham1, Vicki Black1 
1 Bristol Vet School, Bristol, United Kingdom
2 Paragon Veterinary Referrals, Wakefield, United Kingdom 
OBJECTIVES
To describe the clinical features and outcome of infiltra-
tive laryngeal disease in dogs.
METHODS
Medical records at a single referral centre (2013–2018) 
were retrospectively reviewed for dogs with infiltrative 
laryngeal disease diagnosed by cytology and/or histo-
pathology. Referring veterinarians were contacted for 
 follow-up.
RESULTS
Eleven dogs were included, with a median age of 5 years 
(range 1–14 years). Signs included inspiratory noise 
(n = 5), cough (n = 5) and dysphagia (n = 4), with a median 
duration of 6 weeks (1–16 weeks).
Laryngeal lesions were unilateral in eight dogs and 
bilateral in three. Ten dogs were diagnosed with inflam-
matory disease including neutrophilic (n = 3), septic neu-
trophilic (n = 1), granulomatous (n = 2), eosinophilic 
(n  =  1), lymphocytic/plasmacytic (n = 1) and mixed 
(n = 2). Three dogs underwent surgical excision of the 
lesion with adjunctive prednisolone (n = 2) or firocoxib 
(n = 1). Four dogs received corticosteroids without sur-
gery (+/– antimicrobials) and one received antimicrobials 
alone. One dog was diagnosed with large cell lymphoma 
and was treated with chemotherapy. Nine dogs survived 
to discharge.
Follow-up was available for eight dogs diagnosed 
with inflammatory disease. Three had fully recovered 
(1, 23 and 32 months), one dog was receiving predniso-
lone (2 months) and four dogs had recurrence of clinical 
signs at 1, 5, 17 and 26 months, of which two were eutha-
nased. The dog with lymphoma was in remission at 
8 months.
STATEMENT (CONCLUSIONS)
Dogs can suffer infiltrative disease of the larynx and, in 
this cohort, inflammatory disease was more common 
than neoplasia. For dogs that survived to discharge out-
come was fair although relapse was possible.
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Outcome of dogs with 
histologically low/
immunohistochemistry 
high grade mast cell 
tumour treated with 
adjuvant 
chemotherapy
Slavomíra Néčová, Sarah Mason, 
Susan North 
Southfields Veterinary Specialists, Laindon, United Kingdom 
OBJECTIVES
This retrospective study evaluates the outcome of dogs 
with histologically low/immunohistochemistry high grade 
mast cell tumour (MCT) treated with adjuvant lomus tine 
and reports treatment toxicity. 
METHODS
The records of dogs treated with adjuvant chemotherapy 
for intermediate grade mast cell tumour with low mitotic 
index (< or = 5/10HPF) and high Ki67 (> or = 1.8%) with no 
evidence of metastatic disease at presentation were 
reviewed. Lomustine was administered every 3 weeks 
with 3 or 4 planned cycles. Patients were followed up 
by  regular re-staging ultrasound with or without cyto-
pathological examination of liver and spleen or through 
medical records from the referring veterinarian. Disease 
free interval (DFI) and median survival time (MST) were 
calculated using Kaplan-Meier method.
RESULTS
Twenty-five dogs were included. All dogs underwent 
surgical excision and four dogs received adjuvant radio-
therapy. None of the patients developed local recur-
rence. Three dogs (12%) developed metastatic disease. 
The DFI of these dogs was 141, 186 and 223 days. DFI of 
the whole study population was 1063 days (141–2619). 
MST for patients with metastatic disease was 417 days. 
MST of the whole group was not reached. One-year, 
2-year and 3-year survivals was 96%, 92% and 85%, 
respectively. The main adverse event was hepatotoxicity 
which occurred in 28% of patients.
STATEMENT (CONCLUSIONS)
This study population showed low rates of tumour recur-
rence and improved survival compared to previously 
published data of dogs with immunohistologically high 
grade MCT without adjuvant chemotherapy. Prospective 
studies should be considered to evaluate this further.
Canine anal sac 
adenocarcinoma in a 
single referral centre – 
signalment, treatment 
and outcomes
Clare Doherty, Charles Pittaway 
University of Cambridge, Cambridge, United Kingdom 
OBJECTIVES
Canine anal sac adenocarcinoma (ASAC) is a neoplasm 
with a diverse clinical behaviour and no gold standard of 
care apart from surgical excision of disease. This study 
aimed to report the signalment, treatment and outcomes 
of dogs with ASAC treated at a single referral centre.
METHODS
This was a retrospective study that included dogs 
 diagnosed with ASAC that presented for diagnostics or 
treatment. 41 dogs were identified following review of 
clinical records, between 2015 and 2018. Signalment, 
stage, treatment and outcomes were recorded.
RESULTS
Labradors and cocker spaniels were the most commonly 
represented breeds. 27 dogs were male neutered and 
13 dogs were female neutered. 28 dogs (68%) had metas-
tasis to the loco-regional lymph nodes, of which 7 dogs 
(17%) also had distant metastases. 14 dogs were hyper-
calcaemic (34%). 5 dogs (13%) presented with bilateral 
tumours. Median survival time was 265 days (range: 
76–670 days). Dogs treated only with surgery had the 
highest median survival time (433 days), and multiple 
 surgeries were associated with longer survival. 16 dogs 
were treated with toceranib phosphate. Overall clinical 
benefit was seen in 10 dogs (63%). The median duration 
of response was 91 days (range 30–382 days).
STATEMENT (CONCLUSIONS)
This study suggests that surgery is the most effective 
treatment for ASAC. Overall clinical benefit was seen 
using toceranib phosphate in >60% of dogs treated for a 
median duration of 3 months.
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Immunohistochemical 
expression of 
lipoxygenase-5 (LOX-5) 
in canine normal 
urinary bladder, cystitis 
and transitional cell 
carcinoma
Luca Schiavo1, Ranieri Verin2, 
Lorenzo Ressel2, Eva Frohmader3, 
Paolo Silvestrini1, Riccardo Finotello1
1 Department of Small Animal Clinical Science, Institute of 
Veterinary Science, University of Liverpool, Leahurst Campus, 
Neston, United Kingdom
2 Department of Veterinary Pathology and Public Health, Institute 
of Veterinary Science, University of Liverpool, leahrust campus, 
Neston, United Kingdom
3 Institute of Veterinary Science, University of Liverpool, Liverpool, 
United Kingdom 
OBJECTIVES
Canine transitional cell carcinoma (TCC) mimics human 
invasive TCC. Human TCC overexpress lipoxygenase 
(LOX)-5 and the use of target inhibitors has been proved 
effective. In this study, we investigated the immunohisto-
chemical (IHC) expression of LOX-5 in normal canine 
 urinary bladder, cystitis and TCC. LOX-5, cyclooxygenase 
(COX)-1, COX-2 IHC expression and their relationship 
among the different groups were investigated.  
METHODS
Biopsies of cystitis and TCC were reviewed (2012–2016). 
Dogs were excluded if had received steroids, non- 
steroidal antinflammatory drugs (NSAIDs) and/or chem-
otherapy prior to tissue collection. Samples of 
histologically normal bladder were retrieved from the 
necropsy archive. Representative sections were submit-
ted for anti-LOX5, COX-1 and COX-2 IHC. Distribution 
and intensity were assessed semi-quantitatively and an 
IHC score was obtained for each marker. Immunohisto-
chemical results were compared among normal epithe-
lium, cystitis and TCCs. Correlations between variables 
were analysed with Spearman and Mann Whitney.
RESULTS
Twenty-nine TCCs, 13 cystitis and 10 controls were 
included. All TCCs were diagnosed as invasive and histo-
logically high-grade. Cystitis were characterised by 
 similar lymphoplasmacytic and occasionally neutrophilic 
infiltrates. LOX-5 was expressed in 95% of TCCs, 23% of 
cystitis and 10% of controls. LOX-5 and COX-2 IHC scores 
were significantly (P < 0.01) higher in TCCs vs cystitis and 
normal bladders. 
STATEMENT (CONCLUSIONS)
TCC is the most common canine urinary-tract tumour. 
Chemotherapy is commonly advised, but responses are 
poor to modest. Results of this study place the rationale 
for the investigation of new agents such as tepoxalin, an 
NSAID with anti COX-2 and LOX-5 effect. 
Genome-wide analysis 
of canine oral 
malignant melanoma 
(OMM) metastasis-
associated gene 
expression
Kelly Bowlt Blacklock1, Zeynap Birand1, 
Laura Selmic2, Pieter Nelissen3, 
Sue Murphy4, Laura Blackwood5, 
Joyce Bass6, Jenny McKay7, Trevor 
Whitbread8, Richard Fox6, Tom Eve6, 
Stuart Beaver9, Mike Starkey1 
1 Animal Health Trust, Newmarket, United Kingdom
2 Ohio State University, Ohio, United Kingdom
3 Dick White Referrals, Newmarket, United Kingdom
4 University of Edinburgh, Edinburgh, United Kingdom
5 University of Liverpool, Liverpool, United Kingdom
6 Finn pathologists, Harleston, United Kingdom
7 IDEXX laboratories, Newmarket, United Kingdom
8 Abbey Veterinary Services, Devon, United Kingdom
9 Nationwide Laboratories, Leeds, United Kingdom 
OBJECTIVES
Melanoma of the oral cavity is the most common mel-
anocytic neoplasm in dogs and has a high metastatic 
potential. The study objective was to identify a canine 
primary OMM pro-metastatic gene expression signature.
METHODS
Canine Gene 1.1 ST Arrays were employed for compara-
tive genome-wide expression profiling of formalin-fixed 
paraffin-embedded biopsies of 18 canine primary OMM 
that metastasised and 10 canine primary OMM that did 
not metastasise. Results were validated by RT-qPCR.
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RESULTS
Differential expression of the C-X-C Motif Chemokine 
Ligand 12 (CXCL12) between the M and NM OMMs 
 suggests that canine OMM metastasis is mediated by 
interaction between CXCL12and CXCR4. Increased 
expression of Apolipoprotein B mRNA Editing Enzyme 
Catalytic Subunit 3A (APOBEC3A) in the M OMMs may 
be  indicative of APOBEC3A-induced double-strand 
DNA  breaks and pro-metastatic APOBEC3A-mediated 
hypermutation. DNA double strand breakage triggers 
activation of the DNA damage response network and two 
members of the Falconi anaemia DNA repair pathway 
show elevated expression in the M OMMs. 
RT-qPCR analysis validated the greater than two-fold 
differences in expression between M and NM OMMs 
observed for 3 genes (APOBEC3A, CXCL12and RPL29). 
A  Linear Discriminant Analysis classifier featuring the 
3 genes was estimated to categorise M OMMs as metas-
tasising with an accuracy of 94% and NM OMMs as non-
metastasising with an accuracy of 86%.
STATEMENT (CONCLUSIONS)
Metastasis-associated differences in gene expression 
may highlight genes that constitute targets for anti-
metastasis treatments, and that may be effective as pre-
dictive biomarkers of OMM metastasis.
Strontium 90 
plesiotherapy in the 
treatment of eyelid 
squamous cell 
carcinoma in cats
Onne-Marju Russak1, Sara Verganti1, 
Davide Berlato2 
1 Animal Health Trust, Newmarket, United Kingdom
2 Dick White Referrals, Six Mile Bottom, United Kingdom 
OBJECTIVES
Squamous cell carcinoma (SCC) is the most common 
tumour in cats’ eyelid. Aggressive surgery is the treat-
ment of choice, but in some cases a more conservative 
approach could be considered.  Strontium 90 plesiother-
apy (Sr90) is a form of radiotherapy targeting superficial 
tumours. The aim of this study was to describe response, 
outcome and tolerance of eyelid SCCs treated with Sr90.
METHODS
The clinical database was searched for cats diagnosed 
with SCC located on an eyelid and treated with Sr90.  The 
response to the treatment was evaluated every 4–6 
weeks initially and then every 3 months. Descriptive 
 statistics were applied on data collected.
RESULTS
Eight cats were treated with Sr90 between 2014 and 
2017, six as a primary and two as adjuvant treatment. Four 
cats received a single dose between 100–120 Gy and 
four cats five fractions in 10 days to a total dose of 140 Gy. 
Five of six cats treated with primary Sr90 achieved com-
plete response (CR) and one partial response (PR) for an 
overall response rate of 100%. The five cats achieving CR 
were free of disease after a median of 17 months, while 
the cat with PR did not present evidence of progression 
at 18 months. One cat treated with adjuvant Sr90 was 
free of disease at 17 months, while the other one died in 
clinical remission 9 months post-treatment. Acute and 
late side effects were minimal.
STATEMENT (CONCLUSIONS)
Sr90 provided good local control in this small cohort of 
cats and was well tolerated.
Correlation between 
BRAF variant V595E 
and histological grade 
in canine transitional 
cell carcinoma
Corinna N. Weber1, Peter Pantke2, 
Julia Grassinger1, Hannah Erhard1, 
Robert Klopfleisch3, Francesco Cian4, 
Heike Aupperle-Lellbach1 
1 Laboklin GmbH & Co. KG, Bad Kissingen, Germany
2 Anicura Bielefeld Tierärztliche Klinik für Kleintiere, Bielefeld, 
 Germany
3 Institute of Veterinary Pathology, Freie Universitaet Berlin, Berlin, 
Germany
4 Batt Laboratories Ltd., Coventry, United Kingdom 
OBJECTIVES
Mochizuki et al. (PLoS ONE 2015a, 10(6):e0129534; PLoS 
ONE 2015b, 10(12):e0144170) found BRAF mutation 
( Variant c.1784T > A) in 67–75% canine transitional cell 
carcinomas (TCCs). Maeda et al. detected BRAF mutation 
in 54.5% of TCC cases (BMC Cancer 2018). In our recent 
publication the mutation was found in 22 out of 31 (71%) 
canine TCC cases (Tierärztl. Prax. 5/2018). The objective 
of the present study was to investigate the correlation of 
BRAF variant V595E and histological grading of TCC.
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METHODS
Biopsies from 92 dogs with TCC were routinely pro-
cessed for histopathology and graded into low grade or 
high grade, according to Meuten & Meuten (2017). DNA-
isolation from paraffin embedded material was per-
formed with the use of commercially available sets. Exon 
15 was examined for the presence of the BRAF variant 
c.1784T > A by TaqMan® SNP Assay. 
RESULTS
64/92 TCCs were classified as high grade and 28/92 as 
low grade. BRAF mutation was found in 33/64 (51.5%) 
of the high grade and in 12/28 (42.8%) of low grade 
TCCs.
STATEMENT (CONCLUSIONS)
BRAF variant analysis is a new, highly specific diagnostic 
test for TCC. However, it is important to note that only 
identification of the mutation is diagnostic. It must be taken 
into consideration that histologically low grade TCCs 
showed the mutation in only about 40% of the cases. Fur-
ther studies of clinical outcome are ongoing to evaluate 
the prognostic relevance of this finding. Additional factors, 
such as breed and anatomical site of the neoplasm may 
also influence the prevalence of BRAF mutation.
Ki67 index in canine 
dermal mast cell 
tumours: do we only 
identify proliferating 
mast cells?
Jean-Benoit Tanis1, Riccardo Finotello1, 
David Brewer2, Giulia Scarin3, 
Lorenzo Ressel2 
1 Department of Small Animal Clinical Science, Institute of 
Veterinary Science, University of Liverpool, Neston, United 
Kingdom
2 Department of Veterinary Pathology and Public Health, Institute 
of Veterinary Science, University of Liverpool, Neston, United 
Kingdom
3 Faculty of Veterinary Medicine, University of Padova, Padova, 
Italy 
OBJECTIVES
Ki67 index is considered to be a prognostic marker for 
canine mast cell tumours (MCTs). High Ki67 index is asso-
ciated with shorter survival times, however long-term 
outcomes can also be observed. Ki67 index is deter-
mined by counting the number of Ki67 positive cells but 
this method does not discriminate proliferating mast 
cells from other proliferating cells. Our objective was to 
assess the “true” number of Ki67 positive mast cells in 
canine MCTs.
METHODS
Patnaik grade-II MCTs were stained with a double KIT/Ki67 
immunohistochemistry (IHC) technique. Mast cells were 
defined as “KIT positive (+)” and stromal cells were defined 
as “KIT negative (–)” cells. Proliferating cells were Ki67+ 
and non-proliferating cells were Ki67–. The proportion 
of  Ki67+/KIT+, Ki67+/KIT–, Ki67–/KIT+, Ki67–/KIT– was 
 evaluated.
RESULTS
Twenty-one MCTs were assessed. The median percent-
age of mast cells per MCT was 56.3% (9.7–87.6%). Ki67 
index was correlated with both proliferating mast cells 
and proliferating stromal cells. There was no correlation 
between the number of proliferating mast cells and the 
number of proliferating stromal cells. In seven MCTs 
(33%), proliferating stromal cells outnumbered proliferat-
ing mast cells. Among the eight MCTs with high Ki67, two 
had more proliferating stromal cells than proliferating 
mast cells and the percentage of proliferating mast cells 
was low. 
STATEMENT (CONCLUSIONS)
Ki67 index can overestimate the number of proliferating 
mast cells and double KIT/Ki67 IHC allows to determine 
the “true” number of proliferating mast cells. This method 
might provide better prognostic information and should 
be prospectively evaluated in canine MCT.  
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Canine hepatosplenic 
T-cell lymphoma 
treated with a 
lomustine-based 
chemotherapy 
protocol
Bryn Jones, Katarzyna Purzycka 
Department of Clinical Science and Services, The Royal Veterinary 
College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, 
AL9 7TA, United Kingdom 
OBJECTIVES
T-cell hepatosplenic lymphoma is a distinct anatomical 
entity in dogs and humans. It is characterized by neo-
plastic infiltration of the liver and/or spleen with gamma-
delta T-cells without peripheral lymphadenopathy. 
Typically the clinical course is very aggressive and 
responses to treatment are very poor in dogs and 
humans. Currently, there are no studies reporting suc-
cessful treatment outcome in dogs with confirmed 
T-cell immunophenotype treated with lomustine-based 
chemotherapy protocols. The aim was to describe a 
small cohort of dogs diagnosed with hepatosplenic 
T-cell  lymphoma and treated with lomustine-based 
chemotherapy protocols.
METHODS
We retrospectively identified 5 dogs fulfilling the criteria.
RESULTS
All patients presented in substage B with the most com-
mon clinical signs being lethargy and gastro-intestinal 
signs. All patients had T-cell immunophenotype con-
firmed by PARR (n = 4) or flow cytometry (n = 1) and 
lacked peripheral lymphadenomegaly. Hepatic involve-
ment was documented cytologically in all patients. 
Splenic involvement was documented in one, although 
splenic aspirate was performed in only two patients. 
In 2/5 patients, pulmonary involvement was suspected. 
All dogs received a lomustine-based protocol with 
L- asparaginase and with (n = 4) or without (n = 1) procar-
bazine. 3 dogs showed complete and 2 dogs partial 
 resolution of clinical signs. The median duration of the 
response was 117 days. The mean and median overall 
survival times were 98 and 134 days respectively.
STATEMENT (CONCLUSIONS)
To our knowledge, this is the first report describing 
favourable responses to treatment of hepatosplenic 
T-cell lymphoma with a lomustine-based protocol, with 
clinical improvement documented in all dogs. Inclusion 
of more cases is necessary to further explore this treat-
ment option.
The frequency of 
immunophenotyping 
and clonality detection 
in the diagnosis of 
feline lymphoma
Anne Aworinde1,2, Rachel Dean1, 
Peter Graham1 
1 University of Nottingham, Nottingham, United Kingdom
2 Consolidated Veterinary Services, Norfolk, United Kingdom 
OBJECTIVES
T-cell lymphomas in dogs generally have a relatively worse 
prognosis than B-cell lymphomas. Few reports in cats 
with lymphoma have attempted to prove or refute this 
notion. This study aims to determine the proportion of 
cats with lymphoma that are subtyped as part of a larger 
study on the frequency of lymphoma-specific treatment 
and the relationships between subtype and survival.
METHODS
Consolidated Veterinary Services (CVS) laboratory data-
bases were retrospectively searched to identify cats 
diagnosed with lymphoma by cytology and histopathol-
ogy from 2014 to 2018. Data was collated in Microsoft 
Excel.
RESULTS
1,682 cats with lymphoma were identified. Immunohis-
tochemistry (IHC) (n = 88) and/or PCR for Antigenic 
Receptor Rearrangement (PARR) (n = 13) were requested 
in only 6% of the cases (n = 99), identifying 57 B-cell, 
38 T-cell lymphomas, whilst 4 were inconclusive. Based 
on the lymphoid cell staining pattern observed at IHC, a 
further diagnosis of T-cell rich B cell lymphoma (TCRBCL) 
was made in 3 cases and Enteropathy-associated T-cell 
lymphoma (EATCL) in 2 cases.
STATEMENT (CONCLUSIONS)
Immunophenotyping of feline lymphoma is seldom 
requested following a diagnosis of lymphoma, posing a 
challenge both for its evaluation as a prognostic tool in 
large retrospective studies and potentially its future 
 utilisation as a prognostic tool.
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Comparison of 
rehabilitation and 
euthanasia rates of birds 
of prey at a UK raptor 
rehabilitation centre in 
2007 and 2017
Helen Inzani1, David Williams2 
1 All Creatures Healthcare, Taverham, United Kingdom
2 University of Cambridge Veterinary School, Cambridge, 
United Kingdom 
OBJECTIVES
The proportion of rescued birds rehabilitated and 
released into the wild in a UK raptor rehabilitation were 
compared between 2007 and 2017 after greater enforce-
ment by the Department of Environment Food and Rural 
Affairs of legislation regarding temporary captivity of 
birds for rehabilitation.
METHODS
Records kept by the rehabilitation centre for raptors 
brought to the centre were evaluated to determine which 
birds were subsequently treated and released, treated 
and retained alive as unable to be released, treated and 
died, or euthanased on welfare grounds. Proportions 
were compared for 2007 and 2017.
RESULTS
Proportions of birds which were released, died, were 
euthanased or kept in captivity were 59.8%, 28.6%, 
9.8% and 1.8% in 2007 and 30.3%, 30.4%, 39.4% and 
0%  in 2017. A significant difference was determined 
between birds released in 2007 and 2017 (p = 0.007) 
and birds euthanased in those years (p = 0.0001). 
There was not a significant difference in birds that died 
between the two years. Significantly more kestrels 
were admitted in 2017 and Tawny owls in 2007 but 
 differences in these numbers did not account for the 
variation in proportion released or euthanased 
between 2007 and 2017.
STATEMENT (CONCLUSIONS)
The greater number of birds released in 2007 com-
pared with 2017 and euthanased in 2017 compared 
with 2007 were most likely related to increased 
enforcement of legislation requiring the centre to 
euthanase birds which could not rapidly be rehabili-
tated and released. Whether this change is beneficial to 
the individual birds or the avian population is a topic 
worthy of further discussion.
Do rodents in 
radioactive areas 
around Chernobyl, 
Ukraine have high 
prevalence of 
cataracts?
David Williams 
University of Cambridge, Cambridge, United Kingdom 
OBJECTIVES
Previous reports suggested that rodents in the highly 
radioactive zones of the Chernobyl Exclusion Zone have 
increased prevalence of cataracts, these seen at post-
mortem examination. While radiation-induced catarac-
togenesis might be conceivable in long-lived birds, and 
25% of the liquidators who sought to control the spread 
of radiation after the nuclear disaster in 1986 developed 
cataracts characteristic of radiation exposure 15 years 
after the disaster, bank voles and field mice, which only 
live for up to 2 years, are unlikely to develop cataracts 
with the levels of radiation now seen around the contam-
inated reactor site. This study investigated the lenses of 
live bank voles and field mice trapped around Chernobyl 
as part of a study on radiation-induced disease.
METHODS
Rodent species were trapped in a number of areas around 
the Chernobyl radiation contamination exclusion zone 
and examined ophthalmoscopically with slit-lamp biomi-
croscopy. Degree of correlation was evaluated between 
prevalence of cataract and level of radioactive contami-
nation in the area from which the animal was trapped. A 
control population from the UK was also examined.
RESULTS
While small lens opacities were noted, these were not the 
substantial mature cataracts noted in previous reports of 
animals examined after death. No correlation could be 
made between cataract prevalence and radioactivity in 
the areas from which the animals were obtained.
STATEMENT (CONCLUSIONS)
If cataract were associated with the levels of radioactivity 
noted around Chernobyl our understanding of radiation 
safety would have to change. As it is, there does not seem 
to be such a correlation in the rodents around Chernobyl.
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Nidoviruses in snakes 
in Europe
Rachel E. Marschang, Ekaterina Kolesnik, 
Elisabeth Müller 
Laboklin GmbH & Co. KG, Bad Kissingen, Germany 
OBJECTIVES
Nidoviruses are single stranded RNA viruses that were 
first described in reptiles in 2014. They can cause severe 
respiratory disease in numerous python species. The aim 
of this study was to determine the prevalence of these 
pathogens in samples from snakes submitted to a diag-
nostic laboratory in Europe.
METHODS
Samples from 1171 snakes were tested for the presence of 
nidoviruses between January 2016 and September 2018. 
The majority of samples were oral swabs. Each sample 
was tested for the presence of nidoviral RNA by  PCR. 
Samples were from a wide range of species, including ball 
pythons (Python regius, 343 animals) and green tree 
pythons (Morelia viridis, 214 animals). In many cases, the 
species was not specified.
RESULTS
A total of 300 of the snakes examined (25.6%) were posi-
tive for nidoviruses, including 76 (22.2%) ball pythons and 
69 (32.2%) green tree pythons. There was a significant 
difference in the likelihood of virus detection between 
these two species (p = 0.008329). Evaluation of the 
results over time showed no seasonal pattern in the 
detection rates. Positive samples were obtained from 
animals in Great Britain, Germany, Austria, Switzerland, 
Spain, France, Belgium, the Netherlands, Denmark, 
Poland, Sweden, Italy, and the Czech Republic.
STATEMENT (CONCLUSIONS)
This study shows that nidoviruses are important patho-
gens in pythons in Europe and are widespread through-
out the continent. Interestingly, green tree pythons 
appear to be more commonly infected than other python 
species.
Patterns of 
antimicrobial 
prescription in rabbits 
attending first-opinion 
practices in the UK
Samuel Pearce, Dr Fernando  
Sánchez-Vizcaíno 
Bristol Veterinary School, University of Bristol, Bristol,  
United Kingdom 
OBJECTIVES
To describe antimicrobial prescription patterns in rabbits 
attending first-opinion practices in the UK.
METHODS
Electronic health records (EHRs) were collected through 
the Small Animal Veterinary Surveillance Network from 
March 2014 to June 2018. EHRs included information 
on  the consultation date, animal signalment and main 
 presenting complaint. EHRs further included product 
descriptions as defined by individual practices and, 
where possible, further product information. Product 
descriptions with no pharmaceutical information 
recorded were reviewed and if an antimicrobial was 
 identified, it was manually defined with reference to the 
 Veterinary Medicines Directorate’s Product Information 
Database for veterinary authorised products, and the 
electronic Medicines Compendium for human author-
ised products. Descriptive statistics and data visualisation 
were conducted using R language.
RESULTS
A total of 74,621 rabbit consultations were gathered from 
498 veterinary premises nationwide. During the study, 
21.7% of rabbits were exposed to at least one antimicro-
bial. A negative trend was observed for the prescription 
rate over the 4-year period. Antimicrobials were most 
commonly prescribed in respiratory disease-related con-
sultations (67.7% of respiratory consultations). Systemic 
and topical antimicrobial agents represented 63.7% and 
35.9% of all prescriptions, respectively, the rest being 
 unidentified. The most commonly used antimicrobials 
were fluoroquinolones (49.8% of all prescriptions). Finally, 
12.7% of all prescriptions were human authorised.
STATEMENT (CONCLUSIONS)
The study suggests a reduction in antimicrobial prescrib-
ing in rabbits, which may reflect the success of aware-
ness campaigns. This study will form the basis of future 
research into antimicrobial prescribing and antimicrobial 
resistance in rabbits, providing valuable data that the 
profession needs to ensure antimicrobials are used 
responsibly.
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Enterobacter asburiae 
infection in Dusky 
(Pseudeos fuscata) 
and Ornate Lorikeets 
(Trichoglossus ornatus)
Sarah Pellett1, Mary Pinborough2 
1 Animates Veterinary Clinic, Thurlby, United Kingdom
2 Pinmoore Animal Laboratory Services, Clotton, United Kingdom 
OBJECTIVES
Diseases may spread within collections if birds are pur-
chased with underlying conditions and owners do not 
follow appropriate quarantine methods. This case study 
follows an 18-month history of Lorikeets that were dying 
of progressive hyperkeratotic lesions around and inside 
the oral cavity. Five years previously Chlamydia psittaci 
infection had been diagnosed and the birds treated with 
doxycycline. 
METHODS
Nutritional causes were ruled out on history. Diagnostics 
included faecal analysis; avian pox virus PCR; and biopsy 
for histopathology and for bacterial and fungal culture 
and sensitivity.
RESULTS
Escherichia coli and Enterobacter asburiae were iso-
lated with sensitivities to enrofloxacin, marbofloxacin, 
 trimethoprim/sulfamethoxazole and ceftiofur. Selective 
yeast/fungal cultures were positive for yeasts, which was 
confirmed on histopathology using Periodic acid–Schiff 
stain. Avian pox virus PCR was negative. Faecal analysis 
was unremarkable. 
E. asburiae may cause necrotising fasciitis and has 
zoonotic implications in immunocompromised indi-
viduals. E. asburiae strains have been isolated from the 
soil and water. Antimicrobial resistance has also been 
detected among Enterobacteriaceae isolated from wild 
bird faeces. 
The affected birds were prescribed enrofloxacin 
(Baytril, Bayer) at a dose of 15 mg/kg administered daily 
for 21 days, with resolution of the lesions and no further 
recurrence.
STATEMENT (CONCLUSIONS)
This case describes two species of lorikeet, diagnosed 
with Chlamydia psittaci initially and then E. asburiae more 
recently, both with zoonotic potential. E. asburiae,  the 
causative agent for the skin lesions was deemed unusual. 
This case emphasises the importance of both routine 
screening and preventive hygiene measures such as 
assiduous hand washing, biosecurity and quarantine. 
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Homeless people and 
their dogs: a study of 
health and welfare 
and the human-
companion animal 
bond (H-CAB)
Louise Scanlon1,2, Jenny Stavisky1, 
Pru Hobson-West1, Anne McBride3, 
Kate Cobb1 
1 The University of Nottingham, Nottingham, United Kingdom
2 Dogs Trust, London, United Kingdom
3 University of Southampton, Southampton, United Kingdom
OBJECTIVES
Pet ownership is common amongst the UK’s growing 
homeless population. Pet ownership can have positive 
impacts on physical, psychological and social health. For 
homeless owners, some of the most vulnerable mem-
bers of society, dogs provide a crucial source of support 
and companionship. In spite of these benefits, dogs often 
exist as barriers to homeless services such as accommo-
dation. 
The study aims were to assess the impact of pet 
ownership and the H-CAB on the health and wellbeing of 
both homeless owners and their dogs.
METHODS
Participants were recruited from services that accommo-
dated homeless dog owners; Nottingham’s Vets in the 
Community clinic and other outreach initiatives, and by 
direct approach to homeless owners on the streets. The 
PDSA’s Petwise MOT was used to assess canine health 
and welfare. Semi-structured interviews were used to 
investigate the implications of the H-CAB, these were 
anonymised, transcribed and analysed thematically.
RESULTS
Preliminary results suggest that the health and welfare of 
dogs belonging to homeless owners is not significantly 
compromised and that dogs often provide crucial sup-
port for issues such as mental ill-health, drug and alcohol 
abuse. Initial findings also indicate that many homeless 
owners struggle to access services as a result of their dog.
STATEMENT (CONCLUSIONS)
Dogs belonging to homeless owners provide key sources 
of support and companionship, often helping them 
 manage physical, psychological and even social health. 
Contrary to the opinion of some, the health and welfare 
of these dogs is not significantly compromised by the 
homelessness of the owner, although specific challenges 
were identified.
Why didn’t my client 
give the medication? 
A descriptive study of 
the communication 
surrounding medicine 
administration
Louise Corah1, Liz Mossop2, Rachel Dean3, 
Kate Cobb1 
1 School of Veterinary Medicine and Science, University of 
Nottingham, Sutton Bonington, United Kingdom
2 University of Lincoln, Lincoln, United Kingdom
3 VetPartners, York, United Kingdom 
OBJECTIVES
Adherence with medication is critical to achieving 
 opti mal patient health outcomes. Unfortunately, there is 
 limited evidence regarding factors affecting adher-
ence in   veterinary medicine. The aim of this study is to 
describe  the communication surrounding medicine 
 administration.
METHODS
Clients attending six practices for specific health pro-
blem appointments were invited to participate in the 
study, which involved consultation recording and post-
consultation surveys. If the pet was prescribed medica-
tion, drug labelling information was recorded, and the 
client was contacted 4–8 days later to complete a survey 
regarding adherence. Descriptive statistics were per-
formed and proportional frequencies of responses 
reported.
RESULTS
Of the 65 consultations recorded, 43 were prescribed 
medication. Of these 29 responded, giving a response rate 
of 67.4%. Adherence was 100% in 27.6% (8/29) of res-
pondents but assessment of adherence wasn’t possible 
in 69% (20/29) due to drug formulation (e.g. oral liquid) or 
deficiencies in drug labelling; dosing duration was not 
stated on the medication label for 86.2% (25/29) of 
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 prescriptions. One respondent elected not to give the 
medication. Only 55% of clients reported being shown 
how to administer the medication, and if they were 
shown, 75% reported being shown by their vet. Finally, 
83% of clients reported no discussion of their personal 
situation to assess the suitability of the treatment 
 schedule. 
STATEMENT (CONCLUSIONS)
Despite the small sample size, this study highlights signi-
ficant issues in the communication of medicine adminis-
tration which could affect adherence and subsequently 
patient outcomes. A larger study is needed to evaluate 
the scale of the problem.
Factors that affect 
intended adoption of 
reward-based training 
reported by a cohort 
of puppy owners
Joshua Woodward1, Rachel Casey1, 
Michelle Lord1, Rachel Kinsman1,  
Séverine Tasker2,3, Toby Knowles2,  
Rosa Da Costa1, Emma Buckland1, 
Jane Murray1 
1 Dogs Trust, London, United Kingdom
2 University of Bristol, Bristol, United Kingdom
3 Linnaeus Group, Shirley, United Kingdom 
OBJECTIVES
Almost all dog owners use reward-based training methods, 
but some additionally use aversive methods (e.g. physical 
reprimands, sound/spray distractions). Our objective was to 
identify factors associated with intended use of training 
approaches that used only reward-based methods.
METHODS
A nested case-control study was conducted on a sample 
of owners of puppies <16 weeks of age, living in the UK 
and Republic of Ireland recruited to a longitudinal study. 
For owners with >1 study dog, one dog was randomly 
selected for analysis. 
Associations between intended training methods 
(reward-based methods only/training that included >1 
aversive method) and potential risk factors (previous 
dog ownership, owning ≥1 other dog(s), dog-related 
employment [e.g. dog trainer, rehoming centre] and 
intentions for the dog) were tested using Chi-square 
(alpha ≤0.05).
RESULTS
Of 819 owners, 256 (31.3%) intended to use only reward-
based methods. Owners who worked with dogs were 
three times more likely to report intention to use reward-
based methods only, compared with owners without 
such employment (OR = 2.87, 95%CI = 1.79–4.60, 
P  <  0.001). Compared with owners who did not own 
another dog, owners with ≥1 other dog(s) were more 
likely to report intentions for training based only on 
reward-based methods (OR = 1.60, 95%CI = 1.19–2.16, 
P = 0.002).
STATEMENT (CONCLUSIONS)
Intention to use a mixture of reward-based/aversive 
training methods was very common within this cohort, 
despite existing evidence of the disadvantages of using 
mixed training approaches. Increased awareness of opti-
mal training approaches for dogs is needed, especially 
for owners without dog-related employment and with-
out other household dogs.
Opinions of veterinary 
graduates on the value 
of an undergraduate 
veterinary practical 
class
David Williams
University of St Elsewhere Veterinary School, St Elsewhere, 
United Kingdom 
OBJECTIVES
It is widely accepted that animal tissue is required for 
teaching veterinary students various aspects of anatomy 
and physiology in their undergraduate years. Yet what are 
the views of veterinary graduates on the use of such 
practical classes in their education? Here the opinions of 
veterinary graduates were sought on the value of one 
practical class during their preclinical training and the 
justification for that class.
METHODS
Fifty veterinary graduates were surveyed by e-mail asking 
for their opinions on the value of a preclinical practical 
class which aimed to demonstrate the effect of different 
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cardiac drugs. Their text responses were subjected to a 
thematic analysis and appropriately coded. Respondents 
were also asked to score their opinion of four statements 
regarding the educational value and ethical justification 
of the class on a Likert scale from strongly agree to 
strongly disagree. A small number of respondents took 
part in a telephone based semi-structured interview.
RESULTS
All 50 graduates replied to the request for their opinions. 
The majority (46 of 50) considered that the practical class 
was of little educational value and thus not particularly 
ethically justified. Several respondents noted that a video 
demonstration and computer-based learning would be 
more appropriate.
STATEMENT (CONCLUSIONS)
As a result of the survey the practical class was changed 
to a predominantly video demonstration and computer-
based learning session. The study shows the value of 
appraising student opinion in optimising practical classes 
in their education.
 interviews. Data was transcribed intelligent verbatim, a 
thematic analysis performed, and themes identified. 
Subsequently, clients attending six practices for specific 
health problem appointments were invited to participate 
in consultation recording and post-consultation surveys 
assessing vet and client satisfaction, and client trust in 
the vet. 
RESULTS
Qualitative analysis highlighted the importance of trust in 
the vet-client relationship, leading to easier decision 
making, especially in high-emotion and uncertain situa-
tions. In post consultation surveys, percentage client 
 satisfaction was high (median 88.7%, IQR 15.8), as was 
percentage trust in the vet (median 100%, IQR 5.5). In 
addition, client trust was positively correlated with client 
satisfaction (Spearman’s rho = 0.531, p < 0.005).
STATEMENT (CONCLUSIONS)
This research highlights the mis-match between vet and 
client perceptions of trust and provides an insight into 
the importance and complexity of the vet-client relation-
ship. The findings add further support for a relationship-
centred approach to small animal consultations and 
could impact the morale and wellbeing of the veterinary 
profession.
“Trust me I’m a vet…” 
Vet-client trust in small 
animal consultations: 
a mixed methods 
approach
Louise Corah1, Liz Mossop2, Rachel Dean3, 
Kate Cobb1 
1 School of Veterinary Medicine and Science, University of 
Nottingham, Sutton Bonington, United Kingdom
2 University of Lincoln, Lincoln, United Kingdom
3 VetPartners, York, United Kingdom 
OBJECTIVES
In human medicine, doctor-patient trust is correlated 
with positive outcomes such as medication adherence 
and patient satisfaction. The aim of this study is to report 
the perceptions and assessments of vet and client trust. 
METHODS
A convenience sample of vets and clients were invited 
to  participate in focus groups and semi-structured 
Owner perceptions of 
problem behaviours in 
dogs aged 6 months
Michelle Lord1, Rachel Casey1,  
Séverine Tasker2,3, Toby Knowles2,  
Rachel Kinsman1, Rosa Da Costa1,  
Joshua Woodward1, Jane Murray1 
1 Dogs Trust, London, United Kingdom
2 University of Bristol, Bristol, United Kingdom
3 Linnaeus Group, Shirley, United Kingdom 
OBJECTIVES
To investigate early recognition of potentially problem-
atic canine behaviours by UK and Republic of Ireland dog 
owners.
METHODS
Puppy owners taking part in a longitudinal study relating 
to canine health and behaviour completed online 
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 questionnaires detailing their dogs’ responses to varied 
situations and experiences, and any canine behaviour(s) 
they found a problem.
RESULTS
In the questionnaire for 6-month old dogs, owners 
reported problem behaviours in 199/636 (31.3%) dogs. Of 
the 199 dogs, help had only been sought for 78 (39.2%); 
from dog trainers (57/199;28.6%), behaviourists (22/199; 
11.1%) and/or vets (9/199;4.5%). 
Behaviours most commonly reported as problems 
were pulling on lead (26/199;13.1%), jumping up at 
 people (22/199;11.1%), mouthing people (22/199;10.1%), 
and separation-related behaviour (SRB) (unwanted/
undesirable behaviour in owner absence) (17/199;8.5%). 
Elsewhere in the 6-month questionnaire, data were 
available as to whether ’ jumping up at people’ and SRB 
were  displayed. Despite not noting the behaviour as ‘a 
problem’, a further 128/621 (20.6%) of dogs were reported 
to have jumped up at people and 345/619 (55.7%) had 
shown SRB (≥2 signs were considered an accurate indi-
cation of SRB). Owners were more likely to report SRB 
than ‘ jumping up at people’ as a problem, (OR = 4.85, 
95% CI 3.77–6.23, P = <0.0001).
STATEMENT (CONCLUSIONS)
This study highlights behaviour(s) that owners of 
6-month old dogs find problematic, thus enabling devel-
opment of specific training plans to address these prob-
lems. Future work will include analysis of risk factors for 
owner-reporting of specific canine behaviours and 
assess escalation/resolution of specific behaviours in 
relation to perception of a problem and help sought.
The referral surgeon-
first opinion practitioner 
interaction is a source 
of communication 
breakdown in the 
surgical care pathway – 
a review of 112 
questionnaire 
responses from first 
opinion practitioners
Barnaby Dean1, Danny Chambers2 
1 Southern Counties Veterinary Specialists, Ringwood, 
United Kingdom
2 Langford Veterinary Services, Bristol, United Kingdom 
OBJECTIVES
Communication breakdown in the human healthcare 
environment has been identified as a source of patient 
morbidity and mortality. While many clinicians across all 
clinical veterinary roles employ protocols to ensure effec-
tive communication within their own institutions, the 
referral surgeon-first opinion practitioner interaction has 
not been previously investigated. The aim of this study 
was to identify sources of communication breakdown in 
the referral surgeon-first opinion practitioner interaction.
METHODS
A 15-question questionnaire was designed to investigate 
first opinion practitioner attitudes and approaches to 
performing postoperative examinations on referred 
 surgical cases. The questionnaire was posted on a social 
media-based veterinary discussion forum (Veterinary 
Voices UK) inviting anonymous responses from small 
animal first opinion practitioners who referred at least 
one surgical case to a referral institution during the 
 previous 12-months. The questionnaire remained open 
to responses for seven days. Results were presented as 
descriptive data.
RESULTS
One-hundred and twelve first opinion practitioners 
responded to the questionnaire. Results reveal that 75.0% 
and 58.0% of respondents never, rarely or sometimes felt 
adequately prepared to formulate future care plans in 
referred surgical cases with and without complications, 
respectively. In addition 23.2% of respondents never, 
rarely or sometimes informed referral surgeons of com-
plications and 26.8% of respondents never, rarely or 
sometimes discussed future management of complica-
tions with the referral surgeon.
STATEMENT (CONCLUSIONS)
Results of this study suggest that the referral surgeon-
first opinion practitioner interaction is a source of 
 communication breakdown bilaterally. Referral surgeons 
and first opinion practitioners should ensure that 
 communication between both parties is sufficient to 
ensure appropriate continuity of care.
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Retrospective clinical 
evaluation of cats 
receiving whole blood 
transfusions and 
frequencies of blood 
types at a UK private 
referral hospital
Harriet Hall1,2, Simon Tappin1,2 
1 Dick White Referrals, Newmarket, United Kingdom
2 The University of Nottingham, School of Veterinary Medicine 
and Science, Nottingham, United Kingdom 
OBJECTIVES
To assess prevalence of blood type and indication for 
transfusion including patient outcome, transfusion effi-
cacy and reactions in cats admitted to a single institution.
METHODS
A retrospective case series was performed selecting 
feline patients where whole blood transfusions were 
indicated, that were blood typed using typing kits and 
identified through database searches between 01-01-
2008 and 01-08-2018. 
RESULTS
Searches identified 166 blood typed patients; 64 received 
68 whole blood transfusions. Prevalence of blood types 
for domestic cats (n = 116) was 76.7%, 18.1% and 5.2%; for 
pedigree cats (n = 50), 78.0%, 20.0% and 2.0% for groups 
A, B and AB respectively. Transfusions (n = 68) were 
divided into groups 1–3 respectively; destruction of red 
blood cells (RBC’s) (n = 25), reduced erythropoiesis 
(n = 15) and loss of RBC’s (n = 28). Survival rate to >30 
days post-transfusion was 56.0%, 6.7% and 53.6% for 
groups 1–3. For trauma patients within group 3 (n = 14) 
survival rate to >30 days was 78.6%. Total transfusion and 
transfusion naive reaction incidences were 22.1% and 
21.3% respectively. Half of cross matched patient reac-
tions (26.7%) and of the two severe reactions were trans-
fusion naive. Three formulae previously used to estimate 
post-transfusion packed cell volume (PCV) were applied 
to a subpopulation (n = 43); donor PCV and post- 
transfusion PCV (≤48 hours) were recorded. Bland-Altman 
analysis compared PCV rise with each formula’s estima-
tion. Formula 1 assumed 2 ml/kg of whole blood increased 
PCV by 1%, achieving the lowest overall bias (0.27%). 
STATEMENT (CONCLUSIONS)
Sourcing feline blood is challenging therefore prognosis 
should be thoroughly considered before transfusion. 
Overall prevalence of transfusion reactions was 22.1%.
Red blood cell blood 
transfusions and 
occurrence of 
adverse reactions: 
a retrospective study 
in 101 dogs
Consuelo Alonzi, Simon Tappin 
Dick White Referrals, Six Mile Bottom, Cambridgeshire, 
United  Kingdom
OBJECTIVES
To describe type and frequency of canine transfusion 
reactions; to investigate any correlation as to their 
 occurrence.
METHODS
Retrospective study of dogs receiving red blood cell 
transfusions between 1/10/15 and 1/7/18 at a single refer-
ral centre.
RESULTS
165 transfusion events were recorded in 101 dogs. 129 
transfusions were packed red blood cells (pRBCs), 36 
whole blood (WB). Chlorphenamine was administered 
before 9/165 transfusions.
Adverse reactions were recorded in 44/165 transfu-
sion events; 23/44 were febrile non-haemolytic reactions 
(increase in rectal temperature >39.2°C). Vomiting alone 
was recorded in 7/44 dogs; 5/44 with hyperthermia and 
1 vomit with increased respiratory effort. Acute haemolytic 
reactions occurred in 5/44 dogs, 2 dogs showed haema-
turia. Increased respiratory effort (4/44), acute tachycardia 
(3/44) cases, acute tachypnoea (1/44), anaphylactoid 
reaction (1/44), respiratory arrest (1/44) and neurological 
signs compatible with thromboembolic event (1/44).  
59/101 dogs receiving a transfusion were affected 
by  an immune mediated disease; 30/59 (52%) had a 
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 transfusion reaction. 25/30 adverse events occurred 
after a pRBCs transfusion; 5/30 after WB transfusion. The 
portion of adverse reactions was (37/129) with pRBCs 
and (7/36) after WB.  23/44 (52%) reactions occurred in 
dogs receiving single transfusions; 17/44 (38%) occurred 
after multiple transfusions. Of the 43 dogs receiving mul-
tiple transfusions, 10 (23%) had repeated reactions.
STATEMENT (CONCLUSIONS)
Immune-mediated disease was the commonest cause of 
transfusion-dependent anaemia. Treatment with corti-
costeroids did not decrease the incidence of transfusion 
reactions. Performance of more than one transfusion 
was not associated with an increased risk of adverse 
reactions.
The influence of prior 
corticosteroid 
administration on 
diagnostic imaging 
findings in dogs with 
Immune-Mediated 
Haemolytic Anaemia
Joshua Hardwick1, Jennifer Reeve2 
1 University of Bristol, Bristol, United Kingdom
2 Langford Veterinary Services, Bristol, United Kingdom 
OBJECTIVES
To evaluate whether prior corticosteroid administration 
influences imaging findings in dogs with immune- 
mediated haemolytic anaemia (IMHA). 
METHODS
Retrospective review of case records of a referral popu-
lation of dogs with IMHA, for whom medical histories 
and  thoracic and/or abdominal imaging studies were 
available. 
Cases were classified based upon presence (S+) or 
absence (S–) of corticosteroid administration prior to 
referral. Thoracic and abdominal imaging findings were 
categorized into (a) clinically significant findings altering 
case management or follow-up, including potential trig-
gers; (b) incidental, clinically insignificant; (c) attributable 
to IMHA; (d) normal. For statistical analysis, significant 
imaging findings (a) versus non-significant imaging find-
ings (b, c and d) were compared in S+ and S– dogs, using 
χ2 test to determine whether prior corticosteroids signifi-
cantly influenced imaging findings.
RESULTS
55 dogs met the inclusion criteria, comprising 23 S+ and 
32 S–. 46 had thoracic and abdominal imaging. 2 and 
7 dogs had only thoracic or abdominal imaging, respec-
tively. The 48 thoracic studies comprised 25 computed-
tomographic and 23 plain radiographic. The 53 abdom inal 
studies comprised 24 computed-tomographic and 29 
ultrasonographic. 
Thoracic imaging findings were clinically significant 
in 6/19 S+ dogs and 6/29 S– dogs. Abdominal imaging 
findings were clinically significant in 13/22 S+ dogs and 
19/31 S– dogs. Incidence of clinically significant thoracic 
or abdominal imaging findings did not differ between 
S+ and S– dogs (p < 0.05). 
STATEMENT (CONCLUSIONS)
In this population, prior corticosteroid administration 
did  not significantly influence imaging findings. Ima-
ging for underlying disease in IMHA is therefore 
consid ered worthwhile, even if corticosteroids have 
been  administered. 
Presenting signs and 
clinical outcome in 
dogs with metaphyseal 
osteopathy, 32 cases 
(2009–2018)
Alison Robertson1, Sophie Adamantos2, 
Victoria Black1, Katherine Clarke3, Ian Faux4 
1 University of Bristol, Bristol, United Kingdom
2 Langford Vets, Bristol, United Kingdom
3 Davies Veterinary Specialists, Hitchin, United Kingdom
4 Royal (Dick) School of Veterinary Studies, Edinburgh, 
United Kingdom 
OBJECTIVES
To describe presentation, treatment, and clinical out-
come of dogs with metaphyseal osteopathy.
METHODS
Multi-centre retrospective review of medical records 
from January 2009 to September 2018 at three referral 
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centres to identify dogs with radiographical evidence of 
metaphyseal osteopathy. 
RESULTS
Thirty-two dogs were identified. Median age at onset was 
13 weeks old (range 8–32 weeks old), males were over-
represented (75% male entire, 22% female entire, 3% 
female neutered). The most commonly recorded clinical 
signs were pain (32/32), pyrexia (29/32), lethargy (28/32), 
and being non-ambulatory (17/32). Sixteen of thirty-two 
dogs were affected in all four limbs, thirteen had fore-
limbs affected, three were affected in three limbs. Where 
information was available, 18/27 dogs were vaccinated 
within 30 days of presentation. Twenty-nine dogs 
required hospitalisation for analgesia and supportive 
care, 16/32 were discharged on corticosteroids (dose 
range 0.9–2.6  mg/kg/day), 14/32 were discharged on 
non-steroidal anti-inflammatories, 2/32 were discharged 
on analgesia only. Dogs were discharged when ambula-
tory, with a median duration of hospitalisation of 5 days 
(range 2–21 days). Relapse occurred in 10/32 cases 
before reaching skeletal maturity. Seven cases went on to 
develop other immune-mediated conditions. 
STATEMENT (CONCLUSIONS)
Metaphyseal osteopathy should be considered in non-
ambulatory painful young dogs. Recent vaccination was 
common, however causation cannot be established 
given age at onset of signs. Some dogs went on to 
develop other immune mediated conditions, further 
studies with a larger cohort are required to determine the 
clinical significance of this. 
Characterisation and 
outcome of idiopathic 
sterile steroid-responsive 
lymphadenitis in English 
Springer Spaniels: 
a multicentre study 
of 64 cases
Cécile Dor1, Isuru Gajanayake2,  
Andre Kortum3, Micheal Day4,  
Simon Tappin5, Ben Harris6, Ian Battersby7, 
David Walker8, Peter Myatt1,  
Mark Dunning1,2, Nicholas Bexfield3 
1 Department of Veterinary Medicine and Science, University of 
Nottingham, Nottingham, United Kingdom
2 Willows Veterinary Centre and Referral Service, Solihull, West 
Midlands, United Kingdom
3 Department of Veterinary Medicine, University of Cambridge, 
Madingley Road, Cambridge, United Kingdom
4 Bristol Veterinary School, University of Bristol, Langford House, 
Bristol, United Kingdom
5 Dick White Referrals, Station Farm, London Road, Six Mile 
Bottom, Cambridge, United Kingdom
6 Northwest Veterinary Specialists, Delamere House, Ashville 
Point, Sutton Weaver, Cheshire, United Kingdom
7 Davies Veterinary Specialists, Manor Farm Business Park, Hitchin, 
Hertfordshire, United Kingdom
8 Anderson Moores Veterinary Specialists, Bunstead Barns, Poles 
Lane, Hursley, Winchester, United Kingdom 
OBJECTIVES
To describe the history, clinicopathological abnormali-
ties, diagnostic imaging findings, lymph node  cytological/
histological appearance, treatment and outcome of 
 English Springer Spaniels (ESS) diagnosed with idiopathic 
sterile steroid-responsive lymphadenitis (SSRL).
METHODS
In this retrospective UK-based multicentre study, 64 
cases were recruited from ten referral centres, twenty-
two first-opinion practices and three histopathology/
clinical pathology laboratories, between 2010 and 2016.
RESULTS
The median age at presentation was 6 years (range: 0.17–
11.75 years). Neutered females were over-represented. 
Pyrexia (83.8%), peripheral lymphadenopathy (78.4%), 
dermatological lesions (72.9%), lethargy (67.6%), hypo-
rexia (54%), epistaxis, sneezing or nasal discharge (21.6%), 
diarrhoea (29.7%), coughing (24.3%), ocular signs (21.6%) 
and vomiting (16.2%) were reported in dogs for which the 
history and physical examination records were available. 
Popliteal (50%), prescapular (42.9%), and submandibular 
(41.1%) lymphadenopathy was frequently reported. 
 Haematology and biochemistry revealed non-specific 
changes. When performed, testing for infectious dis-
eases was negative in all cases. Lymph node cytology 
and/or histology demonstrated mainly mixed inflamma-
tory (27%), pyogranulomatous (24%), neutrophilic/ 
suppurative (20%), or granulomatous (11%) lymphadenitis. 
Treatment details were available for 38 dogs, with 34 
receiving prednisolone (mean starting dose: 2  mg/kg/
day). A variety of other supportive treatments were used. 
Mean duration of prednisolone therapy was 15 weeks 
(range: 1–28 weeks). A good to excellent clinical response 
was reported in all dogs receiving prednisolone but one. 
Ten cases relapsed after discontinuing prednisolone.
STATEMENT (CONCLUSIONS)
Idiopathic SSRL should be considered as a differential 
diagnosis for lymphadenopathy and pyrexia in ESS. The 
disease characteristics, lack of an identifiable underlying 
cause, and response to corticosteroids may suggest an 
immune-mediated aetiology.
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Feline bone marrow 
aspiration: triggers for 
sampling and disease 
prevalence
Alba Maldonado-Moreno1, Paola Monti1, 
Paolo Silvestrini2, Rachel Miller1 
1 Dick White Referrals, Six Mile Bottom, United Kingdom
2 University of Liverpool, Liverpool, United Kingdom 
OBJECTIVES
To determine the clinical settings that lead to bone mar-
row (BM) aspiration in cats and the prevalence of BM dis-
ease according to the initial reason for sampling. 
METHODS
The records of all feline patients undergoing BM exami-
nation were retrospectively reviewed. Identified cases 
were classified into 6 categories based on the reason for 
the procedure: anaemia, bicytopenia, pancytopenia, 
neutropenia, tumour staging and other triggers. The final 
diagnosis was recorded for each patient.
RESULTS
A total of 93 patients were identified and included in the 
study. Triggers for BM aspiration included: anaemia (35), 
bicytopenia (27), pancytopenia (13), neutropenia (8), and 
tumour staging (7), circulating eosinophilia (1), suspected 
BM suppression secondary to chemotherapy (1), and 
thrombocytopenia (1).
No significant BM abnormalities were found in 20 
cases from all categories: anaemia (6) group, bicytopenia 
(4), pancytopenia (1), neutropenia (3), tumour staging (4) 
and others (2).
Non-regenerative immune-mediated haemolytic 
anaemia (NR-IMHA) was the most commonly identified 
disease in the anaemia (23/35), bicytopenia (11/27) and 
pancytopenia (8/13) groups. In the neutropenic group, 
immune-mediated neutropenia was most common, 
diagnosed in 5/8 cats. In the tumour staging group 1 cat 
had a normal BM, one was diagnosed with multiple mye-
loma and 1 with neoplastic mast cell infiltration. 
STATEMENT (CONCLUSIONS)
Anaemia and bicytopenia were the most common trig-
gers for BM sampling in cats. Non-regenerative IMHA 
was the most prevalent disease identified in this study 
population accounting for 42/93 patients and account-
ing for 65% and 40% of anaemic and bicytopenic cats 
respectively.
Proteinuria in canine 
non-erosive immune 
mediated polyarthritis
Lucy Barker, Sophie Adamantos, 
Simon McManus, Vicki Black 
University of Bristol, Bristol, United Kingdom 
OBJECTIVES
To evaluate the point prevalence of proteinuria and 
assess for association with risk of relapse in dogs with 
primary non-erosive immune-mediated polyarthritis.  
METHODS
Single-centre retrospective referral-based study. The 
hospital database was searched for dogs with a diagnosis 
of primary non-erosive immune-mediated polyarthritis 
and concurrent urinalysis between January 2009 and 
August 2018. Data analysed included signalment, investi-
gation findings, treatment and long-term follow-up 
including repeat UPC results. Dogs were defined as 
either non-proteinuric (UPC <0.2), borderline- proteinuric 
(UPC 0.2–0.5), or overtly-proteinuric (UPC > 0.5). Within 
the overt proteinuria group those with UPC >2 were 
defined as markedly-proteinuric. Statistical analysis was 
undertaken using point prevalence and Chi-squared test 
to assess presence of proteinuria and whether marked 
proteinuria was associated with an increased risk of 
relapse respectively. 
RESULTS
Fifty-eight dogs were eligible for inclusion. Twenty-eight 
dogs (48%) were non-proteinuric, 8 dogs (14%) were bor-
derline proteinuric and 22 dogs (37%) were overtly pro-
teinuric. Marked proteinuria was present in 12 dogs (20%). 
Repeated urinalysis was performed in 9/12 dogs with 
marked proteinuria, 7/9 (77%) had improvement to a UPC 
<1.2  (median 0.46, range 0.1–1.2) within 1 month, in four 
of these dogs improvement was documented despite 
treatment with prednisolone. There was no association 
between the presence of marked proteinuria and risk of 
relapse of clinical signs (p = 0.35).  
STATEMENT (CONCLUSIONS)
Proteinuria, including marked proteinuria, was common 
in this cohort of dogs diagnosed with primary non- 
erosive immune-mediated polyarthritis, and was not 
associated with increased risk of relapse of clinical signs. 
Presence of proteinuria did not appear to preclude pred-
nisolone therapy.
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Incidence of 
microcytosis in 
hyperthyroid cats 
referred for radioiodine 
treatment
Claudia Gil Morales1, Angie Hibbert2, 
Marta Costa1,3, Kathleen Tennant3 
1 School of Veterinary Sciences, University of Bristol, Bristol, 
United Kingdom
2 The Feline Centre, Langford Veterinary Services, Bristol, 
United Kingdom
3 Langford Veterinary Diagnostic Lab, Langford Veterinary 
Services, Bristol, United Kingdom 
OBJECTIVES
To document the incidence of erythrocyte microcytosis 
in a population of hyperthyroid cats referred for radioio-
dine (RAI) treatment. Microcytosis has been observed but 
not described in feline hyperthyroid patients; in humans 
it is associated with hyperthyroidism.
METHODS
Retrospective clinicopathological data were collected 
for cats undergoing RAI between January and December 
2017. Microcytosis was defined as mean corpuscular 
 volume (MCV).
RESULTS
There were 41 female and 37 male cats; age range 7.2–
20.8 years. Most were non-pedigree (98.7%). Microcyto-
sis (median MCV 39.3 fL, interquartile range 32.3–41.2) 
was present in 41% (32/78) of the cats; 1/32 pre-RAI, 9/32 
post-RAI and 22/32 pre- and post-RAI. Of the 54 micro-
cytic samples, 85.2% were confirmed as microcytic on 
smear examination. Of mildly, moderately and severely 
hyperthyroid cats, 36% (9/25), 37.5% (12/32) and 55% 
(11/20) were microcytic respectively. Two microcytic 
cats had low red blood cell counts (<6 x 1012/L). There 
was no correlation between TT4 and MCV. Microcytosis 
resolved in 63.6% (7/11) cases with follow-up. Two micro-
cytic cats had comorbidities (portosystemic shunt; 
 triaditis).
STATEMENT (CONCLUSIONS)
Microcytosis was present in a significant proportion 
of  hyperthyroid cats, most without significant co- 
morbidities, and resolved in some following RAI. 
Urinary thromboxanes 
are increased in dogs 
with IMHA
Elizabeth Conway, Neil P. Evans,  
Alison E. Ridyard 
University of Glasgow, Glasgow, United Kingdom 
OBJECTIVES
Thromboembolic disease is a significant cause of mor-
tality in dogs with immune-mediated haemolytic anae-
mia (IMHA), but determining which patients are at risk 
of  thrombosis is problematic. A biomarker to predict 
thrombotic risk would allow individualisation of therapy. 
Thromboxane-A2, produced by both platelets and the 
vascular endothelium, is a potent platelet activator and 
may be involved in the pathogenesis of thrombosis in 
IMHA. Thromboxane-A2 has a short half-life in plasma, 
being spontaneously converted to more stable metabo-
lites 11-dehydro-thromboxane B2 (11-dTXB2) and 2,3- 
dinor-11-dehydro-TxB2, which are excreted in urine. An 
11-dTXB2 ELISA has previously been validated in canine 
urine. The aim of this study was to compare  urinary 
11-dTXB2 levels between healthy dogs and dogs with 
IMHA, with the hypothesis that dogs with IMHA are pro-
thrombotic, and will have higher 11-dTXB2 levels. 
METHODS
Free-catch urine samples were collected from healthy 
dogs (n = 8), and newly diagnosed IMHA patients (n = 10). 
Samples were frozen at –80oC until batch analysis. Uri-
nary 11-dTXB2 was measured using a commercially avail-
able monoclonal ELISA (Caymen Chemicals, Ann Arbor, 
MI, USA) and expressed relative to urine creatinine (mg). 
Normality of the data was assessed using a Shapiro-Wilk 
test and results compared between groups using a T-test. 
RESULTS
Dogs with IMHA had significantly higher urinary 11-dTXB2 
levels (3.11 +/–1.61 ng/mg creatinine, range 0.97–5.91) 
than healthy controls (0.68 +/–0.30 ng/mg creatinine, 
range 0.29–1.32)(p = 0.01).
STATEMENT (CONCLUSIONS)
Dogs with IMHA have increased urinary 11-dTXB2 con-
sistent with heightened thromboxane-A2 production. 
Further studies correlating 11-dTXB2 levels with clinical 
outcome measures such as incidence of thrombosis and 
mortality are warranted.
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Immune-mediated 
polyarthritis in fourteen 
cats (2009–2018)
Florence Wootton1, Sorrel Langley-Hobbs1, 
Fiona Whitworth1, Anna Threlfall2, 
Thomas Anderson3, Craig Breheny4, 
Vicki Black1 
1 Bristol Vet School, Bristol, United Kingdom
2 Davies Veterinary Specialists, Higham Gobion, United Kingdom
3 Dick White Referrals, Six Mile Bottom, United Kingdom
4 Edinburgh University, Edinburgh, United Kingdom 
OBJECTIVES
To describe the clinical features and outcome in cats with 
non-erosive immune-mediated polyarthritis.
METHODS
Multicentre retrospective case series. Cats with non- 
erosive immune-mediated polyarthritis were identified by 
searching five hospital databases between 2009 and 2018. 
Data including signalment, history, investigation findings 
including presence of a trigger and category (infectious, 
gastrointestinal, or neoplastic), and treatment was ana-
lysed. Referring vets were contacted for follow-up.
RESULTS
Fourteen cases were identified; there was no obvious sex 
predisposition (7 MN, 2 ME, 5 FN), median age was 8.5 
years (range 1–14 years), and most common breeds were 
domestic shorthairs (7) and Maine coons (3). Common 
clinical signs included lameness (14/14) and pyrexia 
(6/12). In half of the cases (7/14) a trigger was identified; 
this was considered to be infectious in four cats (FIV 2/4, 
infectious discospondylitis 1/4, pneumonia 1/4) and 
 gastrointestinal in three cats.
Ten cats received immunosuppressive therapy (pred-
nisolone 8/10, ciclosporin 1/10, prednisolone and chlo-
rambucil 1/10). In four cats adjunctive immunosuppressants 
were later instituted (chlorambucil 3/4, ciclosporin 1/4) 
due to poor response (2/4) or side-effects (2/4). The four 
cats considered to have an infectious trigger received 
anti-inflammatories +/– antimicrobials. At short-term 
follow-up four cases were euthanased due to poor 
response (3/4) or drug side-effects (1/4).
STATEMENT (CONCLUSIONS)
Pyrexia is not a consistent feature in cats with immune-
mediated polyarthritis and a trigger, specifically infectious 
or gastrointestinal disease should be considered. Progno-
sis appears fair, some cats experienced drug side-effects or 
had a poor response to immunosuppressive monotherapy.
Does duration of 
clinical signs prior 
to diagnosis affect 
outcome in dogs with 
immune-mediated 
polyarthritis
Simon Mcmanus, Lucy Barker, 
Sophie Adamantos, Vicki Black 
University of Bristol, Bristol, United Kingdom 
OBJECTIVES
To explore outcome in dogs diagnosed with primary 
non-erosive immune-mediated polyarthritis and to eval-
uate whether duration of clinical signs for more than 
30 days prior to diagnosis affects risk of relapse.
METHODS
Retrospective single referral-centre study. The hospital 
database was searched January 2009 to August 2018 for 
dogs with a diagnosis of idiopathic non-erosive IMPA. 
Data extracted included signalment, duration of clinical 
signs, outcome and relapse episodes. Long-term follow-
up was achieved by contacting referring veterinary prac-
tices. Data was recorded descriptively and categorised. A 
Chi squared test was used to assess whether clinical 
signs of >30 days duration prior to diagnosis was associ-
ated with a risk of relapse.
RESULTS
One hundred and one dogs were identified. Long-term 
follow-up was available for 75 dogs. Median age at diag-
nosis was 4.49 years (range 0.38–11.02 years). Median 
duration of clinical signs was 30 (range 1–632) days, 
37/75 cases (49%) relapsed, with a median relapse time of 
119 (range 3–1410) days after diagnosis. There was no 
association between duration of clinical signs and risk of 
relapses (p = 0.54). Fifty-six dogs were alive at the time of 
follow-up, 12/19 (63%) died or were euthanised as a 
result of their disease.
STATEMENT (CONCLUSIONS)
Long-term prognosis in this cohort of dogs with primary 
non-erosive immune-mediated polyarthritis was fair, 
with a high risk of relapse (49%) and death due to disease 
(16%). Although duration of signs prior to diagnosis was 
highly variable, this was not associated with risk of 
relapse.
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Evaluation of 
alterations in mean 
platelet volume in 
dogs with pancreatitis
Pak Kan Tang, Carlos Martinez, 
Emma O’Neill, Robert E. Shiel 
School of Veterinary Medicine, University College Dublin, 
Dublin, Ireland 
OBJECTIVES
To evaluate mean platelet volume (MPV), an indicator of 
platelet activation and aggregation, in dogs with  pancreatitis. 
METHODS
Dogs with pancreatitis (acute or chronic) or inflammatory 
bowel disease (IBD) and healthy controls were identi-
fied retrospectively within the hospital database. The 
MPV, measured using the ADVIA 2120 (Siemens), was 
documented in each case. A diagnosis of pancreatitis 
was  based upon presence of consistent clinical signs 
( vomiting, inappetence or cranial abdominal discomfort) 
 combined with canine pancreatic lipase concentration 
≥400  µg/L or abdominal ultrasonographic findings 
 supportive of pancreatitis, or both. Cases were excluded 
if concurrent immune-mediated thrombocytopenia, 
immune- mediated haemolytic anaemia or thromboem-
bolic disease was diagnosed. Showing non-parametric 
data distribution, the results are reported as median 
(interquartile range) and Kruskal-Wallis ANOVA with 
Dunn post-test used to compare groups.
RESULTS
In 52 dogs with pancreatitis and 42 dogs with IBD, the 
MPV (13.7fL (11.9–15.4)) and (12.2fL (10.9–13.9)) were sig-
nificantly higher compared to 79 healthy controls (11.2fL 
(10.0–12.2)) and (p  <  0.0001 and p = 0.0104, respec-
tively). However, there was no significant difference 
between pancreatitis and IBD groups (p = 0.074). When 
comparing pancreatitis and healthy groups, an optimal 
cut-off of 13.65fL yielded a sensitivity and specificity of 
53.8% and 91.1% respectively; the area under ROC curve 
(AUC) was 0.795. When pancreatitis and IBD groups were 
compared, a cut-off value of 13.5fL yielded a sensitivity 
and specificity of 53.5% and 73.8%, respectively; the AUC 
was 0.639. 
STATEMENT (CONCLUSIONS)
MPV is higher in dogs with pancreatitis compared to 
healthy controls; however, the extensive overlap between 
dogs with pancreatitis and gastrointestinal disease limits 
its diagnostic value in dogs.
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Boxing clever: 
unravelling Boxer dog 
health in the UK using 
primary-care veterinary 
records
Kate Barrett, Dave C. Brodbelt,  
David B. Church, Dan G. O’Neill 
Royal Veterinary College, Hertfordshire, United Kingdom 
OBJECTIVES
The Boxer dog is reportedly predisposed to many disor-
ders but these reports (often decades-old or non-UK) 
generalize to the current UK Boxer dog population.
METHODS
Demographic, disorder and mortality data were extracted 
from VetCompassTM anonymized clinical records on 
Boxer dogs under UK primary veterinary care during 
2016. We hypothesized ‘the prevalence of ulcerative 
 keratitis is higher in Boxer dogs aged ≥6 years than in 
those aged <6 years’.
RESULTS
This study comprised 3219 Boxer dogs (0.96% of all dogs). 
Median age was 5.81 years (IQR 3.10–8.79, range 0.18–
18.37). Median adult bodyweight was 29.9 kg (IQR 26.3–
33.9, range 15.1–52.5); males were heavier (32.4  kg, IQR 
29.3–36.5) than females (27.0 kg, IQR 24.4–30.3) (p < 0.001).
The most common disorders were otitis externa 
(7.14%, 95% CI: 6.31–8.09), epulis (5.84%, 95% CI: 5.08–
6.70) and ulcerative keratitis (5.00%, 95% CI: 4.30–5.81).  
Boxer dogs aged ≥ 6 years had 13.6 times the odds of 
ulcerative keratitis (95% CI: 7.5–24.7 and p < 0.001) com-
pared with those aged <6 years.
Median longevity of 346 Boxer dog deaths was 10.57 
years (IQR 8.90–12.19, range 1.02–18.37). The most com-
mon grouped causes of death were neoplasia (15.8%, 95% 
CI: 11.91–20.54), brain disorder (12.1%, 95% CI: 8.74–
16.49) and mass lesions (10.6%, 95% CI: 7.50–14.84).
STATEMENT (CONCLUSIONS)
We identified and distinguished common disorders, e.g. 
otitis externa, from predisposed disorders, e.g. epulis and 
ulcerative keratitis (increasing predisposition over 6 years 
old) in the current UK general Boxer dog population. This 
perspective can assist veterinarians to prioritise their 
treatments and advisory activities.
Clinical usage of 
gabapentin in dogs 
under primary 
veterinary care  
in the UK
Lavinia F Mitton, Sandra Sanchis-Mora, 
Ludovic Pelligand, Holger Volk,  
David C Brodbelt, Dan G O’Neill 
Royal Veterinary College, Hertfordshire, United Kingdom 
OBJECTIVES
This retrospective study aimed to explore gabapentin use 
in dogs in the UK. We aimed to report usage prevalence, 
conditions treated, therapeutic effectiveness, treatment 
duration and dose regimens, suspected adverse reac-
tions and accompanying treatments.
METHODS
The study included 318,922 dogs within the  VetCompass™ 
Program under primary veterinary care in 2016. Data were 
collected from anonymised electronic medical records.
RESULTS
Usage prevalence of gabapentin was 0.44% (95% CI: 
0.42–0.47%; n = 1415). Twenty condition types were 
treated including: spinal pain and/or lesion (31.7%), pain – 
musculoskeletal (23.9%), osteoarthritis (13.2%), Chiari-
like  malformation/syringomyelia (4.7%), intervertebral 
disc disease (4.3%), unspecified neuromuscular signs 
(4.0%), unspecified pain (3.8%), cruciate disease (2.7%) 
and seizure(s) (1.9%). Gabapentin was reported to 
improve clinical signs in 47.3% of dogs. The course dura-
tion was generally short term (59.7%; <30 days between 
first and last dispense) and 59.6% of doses were given 
twice daily. The prevalence of suspected adverse reac-
tions was 7.85% (95% CI: 6.57%–9.36%; n = 1438) and the 
most common were sedation (5.2%) and ataxia (1.3%). 
The most common accompanying treatments alongside 
gabapentin were non-steroidal anti-inflammatory drugs 
(27.2%), tramadol (9.0%), glucocorticoids (5.6%) and opi-
oids (4.8%).
STATEMENT (CONCLUSIONS)
This study provides useful benchmarking data on 
gabapentin usage in primary-care practice and sug-
gests a low occurrence of mild side effects. Despite the 
subjective nature of the efficacy assessment, gabapen-
tin showed a good therapeutic efficacy. These results 
can assist practicing clinicians to benchmark their clini-
cal use of gabapentin and to predict suspected adverse 
reactions.
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Getting under the 
skin of West Highland 
White Terriers using 
primary practice 
clinical data
Zoie F. Ballantyne, Dave C. Brodbelt, 
David B. Church, Dan G. O’Neill 
Royal Veterinary College, Hertfordshire, United Kingdom 
OBJECTIVES
West Highland White Terriers (WHWT) are often consid-
ered by veterinarians as ‘the itchy/scratchy breed’ but little 
prevalence exists on their overall health. This study aimed 
to report demography, mortality and common disorders 
in WHWTs under UK primary veterinary care and to explore 
co-morbid disorder associations with otitis externa (OE).
METHODS
Demographic, mortality and disorder data for the year 
2016 were extracted from VetCompassTM de-identified 
patient records.
RESULTS
This study included 2053 WHWTs. Median age was 7.8 
years (IQR 4.3–11.1). Of 164 deaths recorded, the median 
longevity was 13.4 years (IQR 11.0–15.0). The most com-
monly recorded causes of death were lower respiratory 
tract disorder (10.2%, 95% CI 4.9–15.4), neoplasia (10.2%, 
95% CI 4.9–15.4) and spinal cord disorder 7.8% (95% CI 
3.2–12.5).The most common specific disorders were 
periodontal disease (15.7%, 95% CI 14.1–17.3), OE (10.6%, 
95% CI 9.3–11.9), overgrown nails (7.2%, 95% CI 6.1–8.4), 
hypersensitivity (allergic) skin disorder (6.5%, 95% CI 5.4–
7.6%) and obesity (6.1%, 95% CI 5.1–7.2%). Of the top 20 
disorders, no non-epidermal disorders were co- morbidly 
associated with OE while 3 of the 10 epidermal disorders 
(pododermatitis, pyoderma and dermatitis) were associ-
ated with OE. 
STATEMENT (CONCLUSIONS)
Compared with other common breeds, WHWTs were 
heavily over-represented for skin disease. High comor-
bidity between skin diseases suggests common under-
lying aetiopathogenesis pathways that may offer 
opportunities to control several skin conditions simulta-
neously. High mortality due to lower respiratory tract 
 disease suggests that clinical focus should be placed on 
respiratory function in older WHWTs.
Factors associated 
with owner acquisition 
of puppies under 
8 weeks of age
Rachel H Kinsman1, Rachel Casey1, 
Michelle Lord1, Joshua Woodward1, 
Séverine Tasker2,3, Toby Knowles2,  
Rosa Da Costa1, Jane Murray1 
1 Dogs Trust, London, United Kingdom
2 University of Bristol, Bristol, United Kingdom
3 Linnaeus Group, Shirley, United Kingdom 
OBJECTIVES
To identify owner- and dog-related risk factors associ-
ated with acquisition of puppies
under the recommended age of 8 weeks.
METHODS
The owner-reported data used in this analysis were col-
lected from online questionnaires completed by puppy 
owners living in the UK and ROI who registered puppies 
<16 weeks of age into a longitudinal study.
Multivariable logistic regression was used to test for 
associations between acquisition at <8 weeks of age and 
potential explanatory variables (including breed (specific 
named/mixed/unknown), source of puppy, whether pup-
pies were viewed with mother and/or father, previous 
dog ownership and number of times the puppy was 
viewed before acquisition).
RESULTS
Excluding home-bred puppies, 26.5% (423/1597) were 
acquired <8 weeks of age. Two variables were retained in 
the model:
1. Owners who had owned other dogs during 
adulthood were more likely to acquire puppies  
<8 weeks old, compared with ‘first time owners’ or 
those ‘who had a family dog as a child but not 
subsequently’ (OR = 1.45, 95%CI 1.09–1.92, 
P < 0.010)
2. owners who visited their puppy at least once before 
acquisition were more likely to obtain puppies <8 
weeks old, compared with owners who did not see 
their puppy before acquisition (OR = 1.74, 95%CI 
1.34–2.27, P < 0.001)
STATEMENT (CONCLUSIONS)
Advice regarding minimum acquisition age was not fol-
lowed by 26.5% of this cohort, particularly those with 
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previous dog ownership experience. Future research 
within this longitudinal study will investigate the influ-
ence acquisition age has on various health/behaviour 
outcomes, with the potential to provide evidence for 
puppy purchasing recommendations regarding mini-
mum age at acquisition.
Identifying disorders 
of greatest importance 
to Staffordshire Bull 
Terriers under 
veterinary care
Holly Roberts, Dave C Brodbelt,  
David B Church, Dan G O’Neill 
RVC, Hertforshire, United Kingdom 
OBJECTIVES
Staffordshire Bull Terriers (SBT) are a common UK dog 
breed, but reliable and generalisable health data are lim-
ited. This study aimed to report demography, mortality and 
common disorders in SBTs under first-opinion veterinary 
care in the UK during 2016, with a special focus on obesity. 
METHODS
Signalment, diagnosis and mortality information were 
extracted from anonymised VetCompass™ clinical 
records. A cross-sectional analysis was used to report 
the  1-year period prevalence of the most commonly 
 diagnosed disorders. 
RESULTS
The study included 20,837 (6.19%) SBTs from 336,865 
dogs overall. Adult bodyweight of males (median 21.5 kg, 
IQR 19.1–24.0) was heavier than females (18.6 kg, IQR 
16.5–21.0) (p < 0.001). Median longevity was 12.0 years 
(range 0.60–19.82). The most common causes of death 
were neoplasia (n = 34, 16.66%) and mass-associated 
lesion (n = 23, 11.27%).
The most prevalent disorders overall were over-
grown nail(s) (n = 216, 6.67%, 95% CI 5.81–7.53), 
 overweight/obesity (176, 5.44%, 95% CI: 4.66–6.22), per-
iodontal disease (170, 5.25%, 95% CI: 4.48–6.02),  otitis 
externa (167, 5.16%, 95% CI: 4.4–5.92) and skin (cutane-
ous) disorder (163, 5.04%, 95% CI: 4.29–5.79).
Female SBTs had 1.5 times the odds of overweight/
obese than males. SBTs aged 10 years and over were over 
twice as likely to be diagnosed as overweight/obese as 
dogs aged below 10. 
STATEMENT (CONCLUSIONS)
This presentation will discuss the most common disor-
ders of SBTs and explore how this information can be 
used to prioritise health management in the breed. The 
results will provide veterinarians with a solid evidence-
base when advising owners on clinical and lifestyle deci-
sions for their SBT.
What factors influence 
the development and 
outcome of Gastric 
dilatation and volvulus 
(GD/GDV) in 
Greyhounds?
Sarah Dolbear1, Mark Dunning2,1 
1 University of Nottingham, School of Veterinary Medicine 
and Science, Nottingham, United Kingdom
2 Willows Veterinary Centre and Referral Service, Solihull, 
United Kingdom 
OBJECTIVES
Greyhounds appear anecdotally to be at an increased risk 
of developing GD/GDV. Little specific research has been 
conducted into particular factors influencing the onset 
of GD/GDV in the breed. This study aimed to identify 
 epidemiological characteristics that influence the devel-
opment and outcome of GD/GDV in Greyhounds.
METHODS
A survey containing multiple choice and free text ques-
tions was constructed and distributed to Greyhound 
owners in person and via email. Microsoft Excel was used 
for descriptive and inferential statistics.  
RESULTS
Data was available for 83 Greyhounds, of which 19 suffered 
from GD/GDV. Significantly, 14 (78%) of the dogs which 
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suffered a GD/GDV episode were fed from a height com-
pared with 27 (53%) unaffected dogs (p = 0.032). 
 Significantly, a larger proportion of the dogs which suf-
fered from GD/GDV suffered from borborygmi (p = 0.037). 
Seven Greyhound owners reported their dogs undergoing 
previous abdominal surgery, 6 of these went on to develop 
GD/GDV (p = 0.0001). Six (38%) Greyhounds suffering a 
GD/GDV had a relative which suffered from the condition 
compared with 5 (24%) dogs which did not suffer bloat (p = 
0.026).Twelve (86%) dogs undergoing surgery for the GD/
GDV survived and 9 (75%) were subsequently discharged.
STATEMENT (CONCLUSIONS)
This study indicates that feeding from a height, presence 
of borborygmi, having an affected relative and previous 
abdominal surgery could be important factors influenc-
ing the development of GD/GDV in Greyhounds. This 
information may be valuable for Greyhound owners 
attempting to minimise the chances of their dogs devel-
oping GD/GDV. 
Effect of dog 
ownership experience 
on the uptake of 
preventative health 
care practices  
reported by puppy 
owners
Emma Buckland1, Rosa Da Costa1,  
Rachel Casey1, Michelle Lord1,  
Rachel Kinsman1, Joshua Woodward1, 
Séverine Tasker2,3, Toby Knowles2,  
Jane Murray 1 
1 Dogs Trust, London, United Kingdom
2 University of Bristol, Bristol, United Kingdom
3 Linnaeus Group, Shirley, United Kingdom 
OBJECTIVES
To summarise preventative health care practices reported 
by owners of puppies aged ≤16 weeks, and to determine 
whether previous dog ownership affected engagement 
in preventative health care.
METHODS
Owners who acquired a single puppy at ≤11.5 weeks of 
age and lived in the UK or Republic of Ireland were 
recruited onto a longitudinal cohort study. Online ques-
tionnaires were completed at study registration and 
when puppies were aged 16 weeks. Chi-squared tests 
were used to examine associations between previous 
dog ownership and the use of flea and worm treatment/
preventative products, vaccinations and pet insurance, 
on puppies at or before 16 weeks of age.  
RESULTS
Of 1,288 owners, 1,118 (87%) and 1,230 (95%) reported that 
by 16 weeks of age their puppies had been administered at 
least one flea product and at least one worming product, 
respectively; 1,259 (98%) of puppies had been vaccinated 
at least once and 1,066 (83%) were insured by 16 weeks.  
First-time puppy owners were more likely than own-
ers with previous dog ownership experience to use a flea 
product (OR: 2.63; 95%CI: 1.66–4.16: P < 0.001) and have 
pet insurance (OR: 1.92; 95%CI: 1.33-2.79: P < 0.001) by 
16 weeks of age, respectively. No differences were found 
for the use of worming products (P = 0.3) nor vaccina-
tions by 16 weeks of age (P = 0.2).
STATEMENT (CONCLUSIONS)
Flea product use and pet insurance acquisition were less 
commonly reported than worming product use and vac-
cination amongst our cohort subjects. Factors, including 
previous dog ownership, may influence uptake of pre-
ventative health care, suggesting advice could be tailored 
to different audiences.
Retrospective  
analysis of Canine 
Bronchoalveolar 
Lavage submissions 
to referral veterinary 
laboratories in the UK
Guy Davies1,2, Rand Wilson2,  
Peter Graham1 
1 School of Veterinary Medicine and Science,  
University of Nottingham, Nottingham,  
United Kingdom
2 Finn Pathologists, Norfolk, United Kingdom 
OBJECTIVES
The aim of this study was to investigate the prevalence of 
bacterial respiratory disease in dogs using the results of 
canine bronchoalveolar lavage (BAL) submissions.
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METHODS
A retrospective epidemiological study was performed on 
the results of canine BAL submissions to three referral 
veterinary laboratories between July 2013 and July 2018. 
Data on signalment, microbial culture, and cytological 
findings were collected. Cases were excluded if insuffi-
cient information was available. Data was collated using 
Microsoft Excel and descriptive statistics were performed 
using GraphPad Prism.
RESULTS
2501 cases were collected from a 5 year period. Cases 
ranged in age from 1 to 17 years with a mean age of 7.87 
years. 1735 (69%) of those cases had microbial culture 
performed, with 767 yielding a positive culture. 405 cases 
(16.2%) had a cytological diagnosis of neutrophilic 
inflammation with sepsis, 237 of which had a concurrent 
positive microbial culture result. 1100 cases had findings 
of neutrophilic inflammation with no overt signs of  sepsis 
found. Bordetella spp., Beta haemolytic Streptococcus, 
Coagulase-positive Staphylococcus, Coliform spp., and 
Pasteurella spp. were the most frequent bacterial  species 
isolated in cases of sepsis. Oropharyngeal contamination 
was found in 308 submissions, and 315 proved non-
diagnostic. There was no significant difference in age or 
sex between disease groups.
STATEMENT (CONCLUSIONS)
Bacterial infection of the lower respiratory tract is a 
 frequent finding, more commonly made via cytological 
signs of sepsis, rather than microbial culture.
Core outcomes in 
feline Chronic Kidney 
Disease: what should 
we be measuring?
Hannah Doit1, Marnie Brennan1,  
Rachel Dean2, Marco Duz1,  
Richard Emes1 
1 University of Nottingham, Nottingham, United Kingdom
2 VetPartners, York, United Kingdom 
OBJECTIVES
Over 100 different parameters are measured in the pub-
lished treatment efficacy studies for cats with Chronic 
Kidney Disease (CKD), making it impossible to compare 
or combine the results of studies.  Developing an agreed 
Core Outcome Set (COS) would resolve some of the 
issues as all future studies can use these when assessing 
treatment efficacy. The overall aim of this study was to 
create a COS for CKD in cats.
METHODS
Using a Delphi methodology, an anonymous, international 
panel of 73 stakeholders, including clinical experts, journal 
editors, regulatory agencies and cat owners, completed a 
series of online questionnaires to build consensus on the 
most important parameters to measure when treating cats 
with CKD. They were asked to rate the importance of 
parameters using Likert scales (1–9). Consensus was 
defined a priori as 80% of participants rating the parame-
ter as 8 or 9. The study contained 3 rounds in total. 
RESULTS
Response rate was between 78 and 95% across the first 
questionnaires, with 14 parameters reaching consensus 
for inclusion within the first round of the study. These 
included specific parameters from urine and serum tests, 
quality of life, survival time/renal survival end-point, IRIS 
stage and clinical examination. 
STATEMENT (CONCLUSIONS)
This research highlights the outcomes which all stake-
holders consider important when making treatment 
decisions for cats with CKD. Including this COS in future 
clinical trials will ensure results will be relevant to both 
first opinion and referral practice, strengthening the 
 evidence base available for decision making. 
A cat and mouth 
game: Investigation 
of odontoclast 
dysregulation in feline 
tooth resorption
Nicola Mawson, Seungmee Lee, Professor 
Colin Farquharson, Dr Gurå Bergkvist 
The Royal (Dick) School of Veterinary Studies and the Roslin Institute, 
Edinburgh, United Kingdom 
OBJECTIVES
Feline tooth resorption (TR) is a painful and progressive 
clinical condition that affects at least 30% of adult cats. 
Recently, a RNA sequencing study (unpublished data) 
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identified >1000 differentially expressed (DE) genes 
between TR negative (TR–) and TR positive (TR+) teeth. 
Many of the DE genes were involved in pathways relating 
to TR, odontoclast differentiation, and tooth remodeling 
processes. From this data, six genes (MMP9, P2XR4, SPI.1, 
OPG, RANK, RANKL) were chosen for closer inspection. 
The objectives of this study were: 1. To confirm if these 
six genes are truly differentially expressed between TR+ 
and TR– teeth, and 2. To localize protein expression from 
these genes in feline dental tissues.
METHODS
A case-control study was conducted on feline teeth 
 collected from clinical samples and at post mortem with 
owner consent. Quantitative-PCR using the delta-delta 
method was used to validate the selected genes, fol-
lowed by immunohistochemical staining to label the 
proteins in tissue samples. H&E-stained tooth sections 
were also evaluated to investigate the histological fea-
tures of TR+ teeth. 
RESULTS
Quantitative-PCR analysis revealed increased MMP9 and 
P2XR4 expression in TR+ teeth. The RANKL/OPG expres-
sion ratio did not change significantly between paired 
teeth. H&E and immunohistochemical staining of feline 
tooth sections identified the presence of odontoclasts, 
strong MMP9 expression, and ankylosis at sites of TR. 
STATEMENT (CONCLUSIONS)
Identification of specific genetic factors involved in feline 
tooth resorption could have important implications 
for  the development of therapeutic treatments for the 
 condition.
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The use of contrast-
enhanced computed 
tomography for the 
diagnosis of hiatal 
hernia in 
brachycephalic dogs 
suffering from the 
Brachycephalic 
Obstructive Airway 
Syndrome (BOAS)
Olivia Oginska, Jane Ladlow,  
Marie-Aude Genain, Micheal O’Cathasaigh,  
Jonny Hughes and Nai-Chieh Liu
University of Cambridge, Cambridge, United Kingdom 
OBJECTIVES
To assess the prevalence of hiatal hernia (HH) in BOAS 
dogs and review the utility of the contrast-enhanced CT 
in the process of diagnosing HH in those patients.
METHODS
A retrospective study was performed on the CT images 
obtained from 88 patients, 42 of them were contrast 
enhanced. All images were reviewed by 3 imagers and 
the presence of HH was assessed. The prevalence of HH 
was calculated within both the plain and the contrast-
enhanced groups. 
21 randomly chosen contrast-enhanced studies 
were initially viewed without the contrast in order to 
diagnose HH. Subsequently, they were re-assessed with 
contrast enhancement.
RESULTS
In the plain group HH was diagnosed in 28% of the cases, 
whereas among the contrast-enhanced studies HH was 
found in 50% of them. The assessment of the 21 studies 
showed that in 50% of the cases the presence of contrast 
changed the final diagnosis. Additionally, all the imagers 
equivocally stated that introduction of the contrast sig-
nificantly increased the level of the decision confidence 
in borderline cases.
STATEMENT (CONCLUSIONS)
The study revealed a high prevalence of HH in BOAS-
affected dogs. It also showed an increase in the detecta-
bility of HH, when the contrast CT is performed. 
Contrast-enhanced images allow more precise recogni-
tion of the tomographic features of HH and differentia-
tion from other soft-tissue malformations such as 
esophageal diverticulum. To the author’s knowledge, this 
the first study in the veterinary literature that describes 
the tomographic features of HH.
Computed 
tomographic and 
surgical findings of 
retained surgical 
sponges in two dogs
Kyriakos Chatzimisios, Michael Patsikas, 
Vasileia Angelou, Lysimachos Papazoglou 
Companion Animal Clinic, School of Veterinary Medicine, 
Aristotle University of Thessaloniki, Thessaloniki, Greece 
OBJECTIVES
The aim of this case report is to assess the relationship 
between the computed tomographic and the explora-
tory laparotomy findings in two dogs with retained surgi-
cal sponges.
METHODS
Two dogs were referred with a history of depression and 
chronic vomiting following previous ovariohysterec-
tomy. Clinical examination revealed a palpable abdomi-
nal mass in both dogs. In the first dog computed 
tomography (CT) scan of the abdomen revealed a 
36 x 44 mm well demarcated intramural small intestinal 
mass with air attenuating center surrounding by a soft 
tissue attenuating ring. In the second dog CT demon-
strated a 32 x 31 mm well demarcated soft tissue atten-
uating peritoneal mass with no intestinal loops 
dis placement. Enhanced CT examination demonstrated 
peripheral ring enhancement of the mass in both cases 
finding compatible with the presence of abscess or 
 granuloma. 
RESULTS
Surgical exploration was performed in both dogs. In the 
first dog, a retained surgical sponge was detected within 
the intestinal lumen and intestinal resection and 
 anastomosis were followed. One day after surgery the 
dog had showed signs of intestinal dehiscence and 
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 peritonitis but the owner declined further surgery and 
decided to have the dog euthanized. In the second dog 
an encapsulated surgical sponge was found adhered to 
the jejunum. Following release of the adhesions the 
mass was removed and the dog was discharged 2 days 
after surgery. 
STATEMENT (CONCLUSIONS)
CT is a valuable method for the diagnosis of retained 
 surgical sponges. The retained sponges usually have a 
characteristic CT appearance resembling granulomas 
and this may be helpful in preoperative diagnosis and 
prognosis of them.
Duplex and 
compressibility 
ultrasound examination 
in canine thoracic limb
Joanna Lodzinska, Hannah Leigh, 
Magdalena Parys, Tiziana Liuti 
University of Edinburgh HFSA, Edinburgh, United Kingdom 
OBJECTIVES
To describe Duplex ultrasound (US) and compressibility 
technique for superficial vascular examination in dogs. 
To characterize ultrasonographic features of normal 
canine cephalic vein and compare them with veins of 
dogs with clinically diagnosed phlebitis and thrombo-
phlebitis.
METHODS
Prospective, descriptive study was performed in dogs 
presented for radiotherapy at the Hospital for Small 
 Animals. Thirty dogs with no evidence of vascular disease 
and 17 dogs with positive Visual Infusion Phlebitis (VIP) 
score were recruited for the study. All US examinations 
were performed and interpreted by one observer who 
was blinded to the clinical score. Cephalic veins were 
assessed for multiple criteria and Spearman’s rank corre-
lation coefficient was calculated between the findings 
and time the intravenous catheter (IVC) was in place.
RESULTS
Successful and complete US examination was conducted 
in less than 5 minutes in all dogs. Scanning procedure 
was well tolerated in all patients. No abnormal US find-
ings were detected in normal dogs group. All dogs with 
clinical phlebitis showed ultrasonographic changes 
(15/17 dogs increased wall thickness; 8/17 increased wall 
echogenicity; 7/17 disturbed Doppler flow; 10/17 incom-
plete compressibility; 10/17 presence of intraluminal 
thrombus). No strong correlation was found between the 
time the IVC was in place and US changes.
STATEMENT (CONCLUSIONS)
Duplex and compressibility ultrasonographic studies are 
feasible and safe techniques for evaluation of cephalic 
veins in dogs. Dogs with phlebitis show ultrasonographic 
changes therefore ultrasound is a diagnostic tool in cases 
of clinically suspected phlebitis and thrombophlebitis.
Retrospective 
evaluation of dietary 
management in 
glycaemic stabilisation 
and cataract formation 
in 152 dogs with 
diabetes mellitus
Mike Davies1, Emma Smith2 
1 Provet Limited, Rotherham, United Kingdom
2 University of Nottingham, Nottingham, United Kingdom 
OBJECTIVES
Cataract formation secondary to hyperglycaemia is 
common in dogs with insulin-dependent diabetes melli-
tus (IDDM). Dietary management should facilitate stabili-
sation of hyperglycaemia with insulin and thereby delay 
or prevent cataract formation. Obectives: Evaluation of 
effect of dietary management on glycaemic stabilisation 
and cataract formation in dogs with IDDM. 
METHODS
Data for 152 diabetic dogs attending a UK Veterinary 
Hospital were obtained from clinical records and a ques-
tionnaire survey circulated. 100/152 (65.8%) developed 
cataracts after diagnosis of IDDM.
RESULTS
From point of diagnosis there was no significant differ-
ence in the time to stabilisation of glycaemia, in the 
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 likelihood of cataracts forming or in the time interval 
from diagnosis to cataract formation irrespective of diet 
type provided or whether dogs were given treats or not 
(p > 0.05). Stabilisation was quicker in dogs with a high 
compared to dogs with a low body condition score 
(p = 0.0045).
STATEMENT (CONCLUSIONS)
The type of diet fed, wet or dry, with or without additional 
treats did not affect stabilisation or cataract formation. As 
high BCS made glycaemic stabilisation easier screening 
of middle-age obese dogs to detect IDDM early prior to 
weight loss due to disease is recommended.
Nutritional standards 
and diet considerations 
of owners and their 
pets: a two-country 
study
Meagan Burtynsky1, Teresa Hollands2 
1 University of Surrey, Guildford, United Kingdom
2 University of Surrey, Guildford, United Kingdom 
OBJECTIVES
With over half of the UK canine population overweight 
and the human population in the UK surpassing the 
 obesity rates of Canada, a two-country study was con-
ducted to understand the reasons for these differences. 
This study aims to identify the perception of obesity, the 
human animal bond, and the veterinary consult as areas 
influencing canine obesity and diet.
METHODS
Both UK and Canadian dog owners were surveyed using 
a cross-sectional questionnaire study online and a 
 veterinary practice. Data was analyzed using descriptive 
statistics, chi square test, and regression, with p < 0.05 
(calculated probability) indicating significance.
RESULTS
The consult length was significantly longer in Canada 
(31% were 20–30 mins) compared to the UK (35% was <10 
mins) (p = 5.98 x 10–6). Canadian owners were more likely 
to have a specific nutritional consult with their veterina-
rian (p = 0.0003) facilitated partly by nurses taking histo-
ries to allow more opportunity for nutritional and obesity 
discussions with the veterinarian. More alternative treat-
ments, such as nutritional management (p = 0.013) and 
supplemental management (p = 0.0063), were used to 
treat conditions in the Canadian canine population when 
compared to the UK. Canadian owners listed their veteri-
narian as the primary source of nutritional information, 
whereas UK owners listed the internet.
STATEMENT (CONCLUSIONS)
The awareness and use of veterinary nutrition in preven-
tion and treatment of small animals is greater in Canada 
compared to the UK. Modifying veterinary consults in the 
UK, incorporating nutrition as the 5th vital sign and plac-
ing an economical value on the nutritional consult could 
have a positive influence on canine obesity. Barriers to 
this need studying. 
Batch-to-batch 
variation in the iodine 
content of complete, 
wet foods for cats
Rebecca Alborough, David Gardner 
University of Nottingham School of Veterinary Medicine and Science, 
Sutton Bonington, United Kingdom 
OBJECTIVES
Hyperthyroidism is the most common endocrinopathy 
diagnosed in domestic cats[1]. Many risk factors have 
been proposed and development of the disease is likely 
multifactorial[2]. Clinically and histopathologically, feline 
hyperthyroidism resembles toxic nodular goitre (TNG), a 
form of human hyperthyroidism caused by excessive die-
tary iodine intake after a period of iodine deficiency[3,4]. 
Thus, fluctuation in dietary iodine intake may also pro-
mote development of feline hyperthyroidism. Here, we 
determined iodine content of cat foods, across multiple 
batches to test for consistency.
METHODS
Two to five different batches of nine complete-labelled, 
wet foods for cats were freeze-dried, powdered, sam-
pled in duplicate and microwave-digested using tetra-
methylammonium hydroxide (TMAH) for analysis of 
iodine content by inductively-coupled plasma-mass 
spectrometry (ICP-MS). A certified reference material 
(Seronorm L2, LGC Standards: iodine = 295 µg/L) was 
used as a QC.
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RESULTS
Food 3 had the greatest between-batch variation in 
iodine content, closely followed by Foods 5 and 7 (min-
max [range]: 0.720–1.392 [0.673], 0.644–1.217 [0.573] 
and 0.312–0.731 [0.419] mg/100g DM, respectively). All 
other foods analysed showed only minimal batch-to-
batch variation in iodine content. Further, some batches 
of Foods 1, 3, 5 and 9 had iodine content outside of the 
nutritional range for complete, adult cat foods recom-
mended by FEDIAF[5].
STATEMENT (CONCLUSIONS)
Diets analysed here with high dietary iodine tended to 
have highest batch-to-batch variation and could under-
pin a susceptibility to feline hyperthyroidism. 
Fat dog slim: impact 
of a social marketing 
video on the behaviour 
of pet owners 
regarding obesity 
in the dog
Eleni Androutsou, Samuel Rosenbaum,  
Mya Murray, Philippa Yam 
University of Glasgow, Glasgow, United Kingdom 
OBJECTIVES
Obesity causes a serious threat to the health, quality of 
life and longevity of pets. Prevention of obesity has been 
identified as a priority area for canine welfare but current 
strategies have failed to halt its inexorable rise. Social 
marketing has been an effective tool for treating human 
obesity and potentially could be used in veterinary 
 medicine to more effectively tackle this problem. The 
project aims were firstly, to create a social marketing 
video and secondly, to determine its effectiveness.
METHODS
A video was produced about canine obesity containing 
clear information to reduce and prevent canine obesity. 
A questionnaire was conducted pre and post viewing of 
the video to determine its effectiveness in imparting 
knowledge about, and strategies to treat and prevent, 
obesity. Statistical analysis was performed using SPSS 
software programme.
RESULTS
A video of 2 min 20s was produced with 5 clear take home 
points about obesity (https://youtu.be/Ta2k9voS2po). 204 
participants completed the questionnaire. Pre and post 
viewing of video, knowledge about obesity prevention 
strategies increased significantly (p < 0.001).
STATEMENT (CONCLUSIONS)
Social marketing for the prevention of canine obesity is a 
viable option and should be considered as a means for 
widespread education of the public. 
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Study of intra-
abdominal pressure 
elevation after 
mastectomy in dogs
Styliani Kleftouri1, Maria Vafeiadou2, 
George Kazakos3, Erika Kirmanidou3, 
Lysimachos Papazoglou3 
1 Private Practice, Thessaloniki, Greece
2 Private Practice, Limassol, Cyprus
3 Aristotle University of Thessaloniki, Thessaloniki, Greece 
OBJECTIVES
To assess the intra-abdominal pressure (IAP) after 
regional mastectomy as well as to evaluate the predis-
posing factors and the clinical significance of its potential 
increase.
METHODS
Nineteen female dogs that underwent regional mastec-
tomy were enrolled in a prospective study. IAP was meas-
ured five times; preoperatively, at the end of surgical 
procedure and 1, 6 and 18 hours postoperatively. Simul-
taneously, the arterial pressure as well as the urine output 
were monitored, abdominal perfusion pressure (APP) 
was calculated and a pain score was determined.
RESULTS
Preoperatively, mean IAP was 4.56 mm Hg, with 1.40 mm 
Hg standard deviation (SD). These figures were elevated 
in the postoperative measurements, with the maximum 
being detected 1 hour after surgery at 8.58 mm Hg mean 
IAP (SD: 2,9 mm Hg), remaining at similar levels for the 
rest study period. The mean arterial pressure was slightly 
increased postoperatively, while the urine output did not 
fall below 1 ml/kg/h. Furthermore, APP was kept above 
70 mmHg throughout the whole study. Although pain 
was at low levels, in 4 cases with a greater score than the 
average, IAP appeared higher in all postoperative meas-
urements. Moreover, IAP showed a tendency to increase 
the more extended the mastectomy was.
STATEMENT (CONCLUSIONS)
An elevation of the intra-abdominal pressure can be 
observed postoperatively in dogs undergoing regional 
mastectomy, presumed due to the tension caused in the 
abdominal wall after the closure of the skin. This indi-
cates that these pressure alterations should be identified 
and controlled for possible clinical impacts.
Gastrostomy feeding 
tube placement in dogs 
with septic peritonitis: 
a retrospective study 
of 54 dogs
Kine Elmenhorst1, Pablo Perez Lopez2, 
Alex Belch3, Jackie L. Demetriou2 
1 PDSA Croydon, London, United Kingdom
2 Dick White Referrals, Six Mile Bottom, United Kingdom
3 Langford Vets Small Animal Referral Hospital, Bristol, 
United Kingdom 
OBJECTIVES
To describe the utility and determine the safety of surgi-
cally placed gastrostomy feeding tubes in dogs with 
 septic peritonitis.
METHODS
A retrospective analysis of fifty-four dogs from one insti-
tution with septic peritonitis that had undergone surgical 
exploration that either had or did not have a gastrostomy 
tube (De Pezzer or Foley) placement as part of the surgi-
cal procedure. Postoperative recovery time, hospitalisa-
tion time, complication rate and overall survival time 
were documented. 
RESULTS
Eleven dogs had no gastrostomy tube placed, fifteen dogs 
had a Foley gastrostomy tube placed and twenty-three dogs 
had a de Pezzer gastrostomy tube placed. The most 
 common cause of septic peritonitis was dehiscence of an 
enterotomy or enterectomy site. The median time from 
 surgery to first intake of enteral nutrition was 18 hours (range 
3–60 hours). No major complications related to the 
 gastrostomy tube were seen, and minor complications were 
seen in 32% and 13% of the de Pezzer and the Foley gastros-
tomy group respectively. The overall median time spent in 
hospital were 5 days (range 3–29 days) in patients surviving 
to discharge, and an overall survival rate of 52% were 
recorded. There were no differences between the three 
groups in terms of time spent in hospital or survival rate.
STATEMENT (CONCLUSIONS)
This study suggests that gastrostomy feeding tubes are a 
straightforward method of providing enteral nutrition to 
dogs with septic peritonitis, have similar complication 
rates to placement in non-septic patients and do not 
appear to cause any detrimental effect on survival rate. 
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The in vitro 
antimicrobial activity 
of triclosan coated 
polydioxanone suture 
material on bacteria 
commonly isolated 
from canine wounds
Joanna McCagherty1, Donald Yool2, 
Gavin Paterson3, Tim Nuttall1 
1 Hospital for Small Animals, University of Edinburgh, Edinburgh, 
United Kingdom
2 University of Glasgow, Glasgow, United Kingdom
3 University of Edinburgh, Edinburgh, United Kingdom 
OBJECTIVES
1. To determine the in vitro effects of triclosan coated 
(PDS Plus®) and non-coated (PDS II®) suture material 
on bacterial growth
2. To determine the in vitro duration of bacterial 
inhibition of PDS Plus® suture 
METHODS
10 clinical isolates of Pseudomonas aeruginosa, Staphy-
lococcus pseudintermedius, methicillin-resistant S. 
pseudintermedius (MRSP), Escherichia coli, and extended 
spectrum beta-lactamase (ESBL)-producing E. coli plus 
appropriate National Collection of Type Cultures con-
trols. Isolates were incubated with PDS Plus®, PDS II®, an 
antibiotic disc of known efficacy, and a negative control 
following EUCAST guidelines. The zone of inhibition (ZI) 
around the suture material and antimicrobial discs was 
recorded. Sustained efficacy assays were performed as 
above (excluding P. aeruginosa), moving the suture 
material to a fresh culture every 24 hours. 
RESULTS
ZIs were seen around PDS Plus® but not PDS II®. Conflu-
ent growth occurred with all the P. aeruginosa isolates. 
ZIs were seen with PDS Plus® for 20 days with S. pseud-
intermedius and MRSP, 15 days for E. coli, and 11 days for 
ESBL-E.coli. 
STATEMENT (CONCLUSIONS)
PDS Plus® exhibits sustained in vitro antimicrobial  activity 
against S. pseudintermedius, MRSP, E. coli and ESBL-E. 
coli. PDS Plus® could therefore reduce the prevalence of 
these wound infections in veterinary patients, although 
further studies are required to confirm this in vivo. 
A comparison of the 
rates of postoperative 
complications between 
dogs undergoing 
laparoscopic and open 
ovariectomy
Tim Charlesworth, Francisco Torres Sanchez 
Eastcott Referrals, Swindon, United Kingdom 
OBJECTIVES
To test the hypothesis that dogs undergoing laparo-
scopic ovariectomy have a lower overall and wound-
healing complication rate than dogs undergoing an open 
surgical approach.
METHODS
A retrospective study of dogs who underwent ovariec-
tomy between January 1st 2013 and January 1st 2018. 
Cases were all operated on by the same team of simi-
larly experienced surgeons using standard, practice 
anaesthetic, theatre and perioperative protocols. Gen-
eral complications were recorded, and graded using 
the Clavien-Dindo system. Complication rates were 
compared between the two groups of dogs. Wound 
complications were further subdivided using CDC 
guidelines into inflammation only, superficial SSI and 
deep SSI categories. Rates of wound dehiscence were 
also recorded.
RESULTS
Using strict definitions and adhering to the Clavien-
Dindo system, 44.3% of 106 dogs undergoing open ova-
riectomy developed a recorded complication. 30 dogs 
(28.3%) had wound healing complications the majority of 
which were minor and self limiting. Superficial SSI was 
seen in 4.7% cases and deep SSI in 0.9%. Incisional herni-
ation occurred in 3.7% cases. 
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20.1% of 154 dogs undergoing laparoscopic ovariec-
tomy developed a recorded complication. 11% devel-
oped wound healing complications most of which were 
minor and self limiting. The rate of superficial SSI was 
3.2% with no cases of deep SSI recorded. No incisional 
herniation occurred in any laparoscopic cases.
STATEMENT (CONCLUSIONS)
Laparoscopic ovariectomy is associated with a decreased 
risk of postoperative complication and SSI compared to 
open ovariectomy. Laparoscopy should be considered 
the approach of choice when performing ovariectomy 
in dogs.
Incidence and risk 
factors for post-
attenuation 
neurological signs 
in 50 cats with  
a single Congenital 
Portosystemic Shunt
Rhiannon Strickland1, Mickey Tivers2,  
Vicky Lipscomb1 
1 Department of Clinical Science and Services, Royal Veterinary 
College, London, United Kingdom
2 Paragon Veterinary Referrals, Wakefield, United Kingdom 
OBJECTIVES
To determine the incidence, outcome, and risk  factors for 
post attenuation neurological signs (PANS) and seizures 
after attenuation of single congenital portosystemic 
shunts (CPSS) in cats.
METHODS
Medical records of cats treated at a single institution 
by surgical attenuation of a single CPSS between 2003 
and 2017 were reviewed for signalment and preopera-
tive and postoperative clinical outcomes, including 
the occurrence of PANS and seizure activity. Binary 
logistic regression was performed to investigate risk 
factors.
RESULTS
Fifty cats undergoing surgical CPSS attenuation were 
included (80% extrahepatic, 20% intrahepatic). Eleven 
(22%) of cats had complete attenuation, 39 (68%) had a 
partial attenuation. Thirty one (62%) cats suffered PANS, 
including 11 (22%) cats that experienced seizures. Of the 
31  cats that suffered PANS, 5 (16.1%) did not survive to 
 discharge. 
There were no significant associations between 
PANS or seizures and the type of CPSS, degree of atten-
uation, age, the use of pre-operative anti-seizure medi-
cation or the presence of HE immediately before surgery. 
Osmolality at time point 3 (median 24 hours) was lower 
in  cats with PANS and this was a significant risk factor 
(p = 0.049, odds ratio 0.855). 
STATEMENT (CONCLUSIONS)
PANS is a significant complication and cause of mortality 
in cats treated surgically for CPSS. Peri-operative leveti-
racetam did not seem to protect against the develop-
ment of PANS.  Postoperative changes in osmolality were 
associated with the development of PANS. Further stud-
ies are required to determine the importance of this 
 finding. 
Thoracic dog bite 
wounds: a retrospective 
study of 123 dogs 
(2003–2016)
Anna Frykfors von Hekkel, Zoë Halfacree 
Royal Veterinary College, London, United Kingdom 
OBJECTIVES
To compare clinical findings, investigate indications for 
thoracotomy and identify factors associated with out-
come in dogs with thoracic dog bite wounds.
METHODS
Medical records of dogs with thoracic dog bite wounds 
presenting to a single institution were retrospectively 
reviewed. Data relating to clinical presentation, wound 
depth and management, radiographic findings and mor-
tality were collected. Wound management was defined 
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as conservative, exploratory or requiring thoracotomy. 
Statistical analyses were performed using Chi-squared 
and Fisher’s Exact Test.
RESULTS
123 dogs met inclusion criteria, (54% first opinion, 46% 
referral), median age was 48 months and median body-
weight was 12.75 kg. Thirty dogs (24%) suffered penetrat-
ing wounds, 35 (29%) deep wounds, 44 (36%) full 
thickness skin wounds and 14 (11%) partial thickness skin 
wounds. Sixtynine dogs (56%) suffered wounds else-
where, most commonly to the cervical region (n = 22), 
abdomen (n = 21) and limbs (n = 21). Bacterialculture was 
positive in 50% of cases, frequently polymicrobial, and 
most commonly revealed Staphylococcus, E.coli,  Pas-
teurella  or  Enterococcus species. The most common 
radiographic lesions were pneumothorax (n = 31), rib 
fracture/avulsion (n = 29), pulmonary contusions (n = 23) 
and pleural effusion (n = 13). These radiographic lesions 
were all significantly associated with each other, pres-
ence of a penetrating wound and decision to perform 
thoracic exploration. Undergoing thoracic exploration 
was not significantly associated with mortality, however 
undergoing exploratory coeliotomy was. The mostcom-
mon cause of death was suspected sepsis/SIRS. The 
overall mortality rate was 18%.
STATEMENT (CONCLUSIONS)
Clinical application of the presented data may facilitate 
both specialist and general practitioners’ decision 
regarding management of canine thoracic bite wounds.
Prevalence of 
pulmonary changes 
detected using 
computerised 
tomography in 
brachycephalic 
breeds compared to 
mesaticephalic breeds
Aaron Lutchman, Lynda Rutherford 
Department of Clinical Science and Services, The Royal Veterinary 
College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire,  
AL9 7TA, Hatfield, United Kingdom 
OBJECTIVES
The aims of this observational, analytical, retrospective 
study were to (i) obtain computed tomographic (CT) data 
on pulmonary alterations visible in extreme brachyce-
phalic breeds, and (ii) compare the pulmonary alterations 
between brachycephalic and mesaticephalic breeds. It 
has been demonstrated that extreme brachycephalic 
dog breeds (English Bulldogs, French Bulldogs and Pugs) 
are at increased risk of developing aspiration pneumonia 
but it is not known if they are more susceptible to pulmo-
nary parenchymal changes detected on CT scan com-
pared to weight matched mesaticephalic dogs. This 
study is important to help to further evaluate and under-
stand components of brachycephalic airway syndrome 
(BAS), including lower airway changes. 
METHODS
246 CT scans were analysed, with 213 brachycephalic 
dogs and 33 mesaticephalic dogs. CTs from dogs in the 
mesaticephalic control group were excluded if they had 
any current or historical clinical signs relating to respira-
tory disease.
RESULTS
87/213 (40%) of the brachycephalic group had pulmo-
nary changes documented compared with 7/33 (21%) of 
the mesaticephalic group. 36/213 (16%) of the brachyce-
phalic dogs had pulmonary changes consistent with 
pneumonia compared with 0/33 of the mesaticephalic 
dogs. 20/213 (9%) of the brachycephalic dogs had 
 pulmonary consolidation compared to 1/33 (3%) of the 
mesaticephalic dogs. 63/213 (29%) of the brachycephalic 
dogs had atelectasis compared with 6/33 (18%) of the 
mesaticephalic dogs.
STATEMENT (CONCLUSIONS)
Individual variation was found among the brachycephalic 
breeds and further studies investigating the relationship 
between pulmonary changes, clinical disease and sever-
ity of brachycephalic airway syndrome are warranted.
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Masticatory Muscle 
Myositis in Dogs: 
the use of 
Dexamethasone 
as an alternative 
corticosteroid 
treatment - outcomes 
and side effects 
(Preliminary Results)
Max Foreman, Giunio Bruto Cherubini
Dick White Referrals, Six Mile Bottom, United Kingdom 
OBJECTIVES
This study aims to assess the efficacy of dexamethasone as 
the corticosteroid treatment for masticatory muscle 
myositis (MMM) in dogs. We hypothesise that dexametha-
sone is an effective treatment, either alone or in conjunc-
tion with other immunosuppressant medications, for MMM 
in dogs and that side effects of treatment are  minimal.
METHODS
This retrospective single-centre case series describes the 
outcome following treatment of dogs diagnosed with 
MMM with Dexamethasone +/– additional immunosup-
pressive agents (Azathioprine/Ciclosporine). The study 
population consists of 18 dogs presented to our referral 
hospital between March 2011 and September 2018 that 
were subsequently diagnosed with MMM.
RESULTS
Of the 18 dogs diagnosed over the study period with MMM, 
follow up records were available at the time of abstract 
submission for 14 dogs. On examination between two and 
four weeks after instigation of treatment, eight dogs (57%) 
showed a full resolution of signs, five (38%) showed a 
 partial response and one (7%) showed no response. 
Records were available for follow up examination 
between six and ten weeks for 10 dogs. Of these dogs, 
seven (70%) showed a full resolution of signs and three 
(30%) showed a partial resolution. 
In all cases an acceptable quality of life was achieved, 
with all dogs having good response to treatment. Six 
(40%) experienced side effects attributed to steroid treat-
ment, only one (7%) necessitated modification of the 
treatment regime.
STATEMENT (CONCLUSIONS)
These preliminary results demonstrate that dexametha-
sone can be used effectively to treat MMM in dogs, as 
an alternative corticosteroid to prednisolone. A mild degree 
of morbidity is associated with dexamethasone use.
Troponin I elevation 
in dogs with acute 
cerebrovascular disease
Rita Goncalves, Daniel Sanchez-Masian, 
Joanna Dukes-McEwan 
University of Liverpool, Neston, United Kingdom 
OBJECTIVES
Cardiac troponin I (cTnI) is a highly selective and specific 
marker of myocardial necrosis. It is elevated in some 
human patients with acute cerebrovascular accidents 
(CVA) and carries a worse prognosis in terms of fatality 
and disability. Our main aims were to determine if dogs 
with CVAs have elevated cTnI concentrations and if so, if 
this associated with a worse prognosis and with possible 
underlying cardiac disease.
METHODS
Dogs presented for investigation of acute neurological 
deficits (less than 1 week duration) and diagnosed with 
CVA by magnetic resonance imaging were prospectively 
enrolled and cTnI levels, systolic blood pressure, electro-
cardiogram and echocardiogram were performed in 
these patients. Short and long-term follow-up were sub-
sequently obtained to determine if there is an association 
between the cTnI levels and survival. 
RESULTS
Eighteen dogs met the inclusion criteria. Clinical signs var-
ied depending on the location of the infarct but were in 
most cases compatible with central vestibular disease with 
10/18 dogs being non-ambulatory on presentation.  cTni 
levels were increased in all dogs but 1 (median 0.95 ng/ml, 
range 0.146–153). Echocardiography revealed preclinical 
myxomatous valve disease in 12/18, dilated cardiomyopa-
thy in 1/18 and aortic stenosis in 1/18 dogs but this was not 
considered to be the underlying cause for the CVA in any 
dog. Concurrent medical conditions identified included 
primary hypertension (5), renal disease and hypertension 
(4) and hyperadrenocorticism (2). 
STATEMENT (CONCLUSIONS)
cTni levels were commonly increased in dogs with CVA 
but were not thought to be associated with underlying 
cardiovascular disease. 
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Clinical reasoning in 
canine cervical 
hyperaesthesia: 
which presenting 
factors are important?
Nick Grapes, Steven De Decker, 
Rowena Packer 
Royal Veterinary College, London, United Kingdom 
OBJECTIVES
To identify parameters from the history, presentation, 
physical and neurological examination of dogs present-
ing with cervical hyperaesthesia that were statistically 
associated with the underlying disease diagnosis.
METHODS
A retrospective study was performed containing 385 dogs 
presenting with cervical hyperaesthesia as the primary 
reason for clinical presentation between January 2010 
and October 2018. Only cases presenting for cervical 
hyperaesthesia were included, while those presenting for 
others reasons with neck pain as a secondary problem 
were excluded.
Univariate analysis of variables (breed, age, weight, 
onset, progression, asymmetry, neuroanatomical locali-
sation, haematology changes and pyrexia) were per-
formed and variables with P  <  0.30 were retained in a 
multinomial logistic regression model. Non-normally 
distributed continuous variables were analysed with a 
Kruskal-Wallis test.
RESULTS
95.3% of cervical hyperaesthesia presentations were rep-
resented by only 8 conditions which included interverte-
bral disc extrusion (IVDE) (n = 121), steroid-responsive 
meningitis arteritis (SRMA) (n = 100), syringomyelia (SM) 
(n = 63), intervertebral disc protrusion (IVDP) (n = 49), 
neoplasia (n = 11), cervical spondylomyelopathy (CSM) 
(n = 10), meningitis of unknown aetiology (MUA) (n = 8) 
and immune-mediated polyarthritis (IMPA) (n = 5). 
Younger age, pyrexia and haematology changes were 
associated with a diagnosis of SRMA (all p < 0.001). Neo-
plasia was common in older dogs (p  <  0.001). Breed 
associations were evident with 81.4% (n = 35) of French 
Bulldogs diagnosed with IVDE and 84.1% (n = 53) of Cav-
alier King Charles Spaniels diagnosed with syringomyelia.
STATEMENT (CONCLUSIONS)
Easy-to-recognise clinical features can be used to iden-
tify the most likely differential diagnosis for dogs present-
ing with cervical hyperaesthesia. This information can be 
implemented by veterinary surgeons evaluating dogs with 
this clinical presentation.
Thoracic vertebral 
canal stenosis in 
screw-tailed 
brachycephalic 
dog breeds
Alessandro Conte1, Marco Bernardini2, 
Steven De Decker3, Cristoforo Ricco4, 
Sebastien Behr4, Daniel Sanchez-Masian5, 
Giunio Bruto Cherubini6, Luisa De Risio7, 
Rodrigo Gutierrez-Quintana8 
1 Animal Health Trust, Newmarket, United Kingdom
2 Ospedale Veterinario ‘I Portoni Rossi’, Zola Pedrosa, Italy
3 Royal Veterinary College - RVC, London, United Kingdom
4 Willows Veterinary Centre & Referral Service, Solihull,  
United Kingdom
5 University of Liverpool, Liverpool, United Kingdom
6 Dick White Referrals, Six Mile Bottom, United Kingdom
7 Animal Health Trust, Newmarket, United Kingdom
8 Small Animal Hospital - University of Glasgow, Glasgow,  
United Kingdom 
OBJECTIVES
To 1) describe clinical and imaging features of thoracic 
vertebral canal stenosis secondary to hypertrophy of the 
vertebral lamina and articular processes in screw-tailed 
brachycephalic dogs, to 2) evaluate its prevalence and to 
3) determine if the degree of stenosis is associated with 
neurological signs. 
METHODS
Retrospective multicentre study. Clinical records of 
screw-tailed brachycephalic dogs (French bulldogs, 
 English bulldogs, Boston terriers and pugs) presented to 
seven institutions were reviewed. Twelve dogs with neu-
rological deficits secondary to thoracic vertebral canal 
stenosis diagnosed on MRI were identified (Group 1). 
 Signalment, clinical signs, imaging findings and treatment 
were recorded. One hundred and twenty-five neurologi-
cally normal dogs of the same breeds underwent CT 
imaging of the thoracic vertebral column for other medi-
cal reasons (Group 2). Cross-sectional measurements at 
the vertebral canal stenosis and immediately cranially 
were used to calculate a stenotic ratio. Both groups were 
compared using Mann-Whitney U test (p < 0.05).  
RESULTS
Group 1 consisted of three French bulldogs, eight English 
bulldogs and one pug. Nine were males. All dogs were 
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paraparetic on presentation; one was non-ambulatory. 
Twenty-three stenotic regions were identified with the 
most common region being T4–T5. Three dogs were 
treated surgically and all had a good long-term outcome. 
In Group 2, 33/175 dogs had at least one stenotic region 
with the most common being T2–T3. The degree of the 
stenosis was significantly higher in Group 1 (p = .01928).
STATEMENT (CONCLUSIONS)
Thoracic vertebral canal stenosis can affect screw- 
tailed brachycephalic breeds. The vertebral canal in 
 neurologically-affected screw-tailed brachycephalic 
dogs was 21.2% smaller compared to non-neurologically 
affected dogs.
Assessment of quality 
of life in untreated mild 
idiopathic canine 
epilepsy
Lara Baptista1, Laura Barlow1, Lisa Alves2 
1 University of Cambridge, Cambridge, United Kingdom
2 University of Cambridge, Cambridge, United Kingdom 
OBJECTIVES
To assess and compare the quality of life of a population 
of untreated dogs with mild idiopathic epilepsy versus a 
control group medicated with anti-epileptic drugs. 
METHODS
Cross-sectional study. Two online questionnaires were 
developed for dogs receiving treatment and dogs 
untreated, and included quality of life associated ques-
tions. Carers were contacted by email and data acquired 
from 2009 to 2017. The results were analysed using 
Microsoft Excel® and Graphpad Software.
RESULTS
A total of 41 surveys were sent, with 26 replies for the 
control group and 7 for the untreated group and included 
5 themes: “Abnormal behaviours”, “Carers’ quality of life”; 
“Dog’s quality of life” and “Acceptability and progression 
of seizure frequency and severity”. The untreated dogs 
did not show progression of seizure frequency or 
 severity. There were statistically significant differences 
between the two groups in the quality of life of both the 
dogs and the carers. Epilepsy did not seem to impact the 
lives of carers in the non-medicated group. Equally, 
untreated dogs were perceived to have higher quality of 
life rates when compared to the medicated group. 
STATEMENT (CONCLUSIONS)
Untreated patients with mild idiopathic epilepsy dis-
played higher quality of life ratings, as well as their carers, 
when compared to the medicated group. Moreover, 
there was no progression of disease in either frequency 
or severity, which contrasts with the accepted definition 
of epilepsy as a progressive condition, suggesting that in 
some patients there may be no disease progression.
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Vestibular disease in 
dogs under UK primary 
veterinary care: 
epidemiology and 
clinical management
Sinziana Maria Radulescu1, Karen Humm1, 
Louis Mark Eramanis2, Holger Volk1,  
Dave C. Brodbelt1, David B. Church1,  
Dan G. O’Neill1 
1 Royal Veterinary College, Hertfordshire, United Kingdom
2 University of Melbourne, Werribee Animal Hospital, Werribee, 
Australia 
OBJECTIVES
Vestibular disease, central and/or peripheral, can be a 
dramatic primary-care presentation. Current literature 
describes mostly referral caseloads. This study aimed to 
investigate the prevalence, presentation, management, 
and outcomes of vestibular disease in dogs in primary-
care UK practices.
METHODS
The study explored the VetCompass™ primary-care 
database. Potential vestibular disease cases during 2016 
were identified before manual verification and further 
information was extracted.
RESULTS
From 905,544 study dogs, 759 vestibular cases were 
confirmed giving an overall prevalence of 0.08% (95% CI 
0.07–0.09%). Springer Spaniels had 3.74 (95% CI 2.97–
5.06, P < 0.001), Golden Retrievers 3.30 (95% CI 2.19–
4.97, P < 0.001), Border Collies 2.78 (95% CI 2.03–3.80, 
P < 0.001) and Cavalier King Charles Spaniels 2.70 (95% 
CI 1.90–3.84, P < 0.001) times the odds for vestibular dis-
ease compared with crossbreeds. 
Mean age at first diagnosis was 12 (SD: 3) years. The 
most common presenting signs were head tilt (69.8%), 
nystagmus (68.1%) and ataxia (64.5%). Central involve-
ment was recorded in 14.1% cases. 
The most frequently used treatments were antiemet-
ics (43.2%), corticosteroids (33.1%), antimicrobials (25%) 
and propentofylline (23.25%). Only 27/759 (3.6%) cases 
were referred. Improvement was recorded in 317/759 
(41.8%) of the cases after a mean of 10 days from diagno-
sis. Of 232/759 (30.6%) deaths during the study period, 
vestibular disease contributed to death in 144/232 (62%).
STATEMENT (CONCLUSIONS)
This study confirms low referral rates for vestibular dis-
ease cases, suggesting that primary-care data sources 
offer more generalisable information for benchmarking 
to help clinicians review their own clinical activities. 
 Veterinarians should be aware of the strong breed pre-
dispositions identified here.
Incidence and clinical 
significance of Cystic 
Pharyngeal Hypophysis 
(Rathke’s Pouch)  
in the dog
Mike Targett, Amy Gillespie,  
Kerstin Baiker 
University of Nottingham, Nottingham, United Kingdom 
OBJECTIVES
The pharyngeal hypophysis is the embryonic precursor 
to  the anterior pituitary gland. Cystic expansion of this 
structure in the nasopharynx (previously termed Rathke’s 
Pouch) has been reported on MRI images in a small 
case series of dogs and was associated with suspected 
clinical significance. The aim of this study was to investi-
gate the  incidence and clinical significance in a large 
cohort of dogs.
METHODS
A retrospective review of a database of canine head MRI 
was performed with subsequent post-mortem examina-
tion of a cohort of preserved canine cadaver specimens.
RESULTS
Imaging changes consistent with a cystic pharyngeal 
hypophysis were identified on MRI images of 56 of 474 
dogs (11.8%). Cysts were hyperintense to the surrounding 
mucosa on both T1 and T2 weighted images and could 
be identified in both sagittal and transverse planes. All 
cysts occurred in the roof of the nasopharynx on the 
midline. There was no evidence to suggest that the pres-
ence of these cysts was consistently associated with any 
clinical significance.
Gross examination of 25 preserved canine cadaver 
specimens demonstrated a grossly visible cystic mass 
lesion on the midline in the roof of the nasopharynx in 
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2 animals. Histopathological examination demonstrated 
a mucosal fluid containing cyst lined by ciliated, pseu-
dostratified epithelium consistent with previous reports 
of pharyngeal hypophysis.
STATEMENT (CONCLUSIONS)
Cystic pharyngeal hypophysis is a common finding on 
canine MRI which contrary to previous reports has no 
apparent consistent clinical significance
Preliminary findings of 
an investigation into 
the association 
between vaccination 
and immune-mediated 
diseases of the canine 
central nervous system
Man Ching Chan, Lisa Alves, Paul Freeman 
University of Cambridge, Cambridge, United Kingdom 
OBJECTIVES
To determine whether there is a temporal relationship 
between vaccination of any type and the onset of 
immune-mediated central nervous system diseases (MUO 
and SRMA) in dogs.
METHODS
Retrospective, case-control study was conducted using 
data from the clinical records collected at a referral 
 hospital between 2011 and 2018 where vaccination 
records were available. 27 dogs with a diagnosis of 
inflammatory central nervous system disease were age- 
and gender-matched with an equal number of control 
dogs presented in the same time period for other dis-
eases. Dogs who were vaccinated within 28 days before 
the onset of clinical signs of immune-mediated central 
nervous  system disease were considered as a positive 
case in this study. To assess the association between 
recent vaccination and the onset of disease, odds ratio 
were calculated and categorical data was analysed using 
Fisher’s exact test. 
RESULTS
Three of the 27 dogs in the immune-mediated central 
nervous system disease group had been vaccinated 
within 28 days before onset of clinical signs versus nine 
dogs in the control group. The odds ratio for a dog show-
ing signs of MUO or SRMA if vaccinated within the last 28 
days was 0.25 (95% confidence interval 0.06 to 1.06; 
p = 0.10).
STATEMENT (CONCLUSIONS)
In this population of dogs, recent vaccination did not 
increase the likelihood of development of immune-
mediated CNS diseases, although a larger sample size is 
required to confirm this finding.
Is CT an alternative to 
MRI in a morphometric 
analysis system for 
prediction of  
Chiari-like 
malformation 
associated pain 
and syringomyelia?
Clare Rusbridge1,2, Angus McFadyen3, 
Felicity Stringer1, Susan Knowler2 
1 Fitzpatrick Referrals, Godalming, United Kingdom
2 University of Surrey, Guildford, United Kingdom
3 AKM-Stats, Glasgow, United Kingdom 
OBJECTIVES
A system of MRI morphometric analysis to predict Chiari-
like malformation associated pain (CM-P) and syringo-
myelia (SM) has been developed. The analysis relies on 
bony landmarks and computer tomography (CT) of the 
skull and cervical vertebrae may be useful to predict 
 disease risk i.e. as a more economical pre-breeding 
screening test.
METHODS
This proof of principle pilot study compared morpho-
metric analysis between MRI and CT. Medical records 
over 4 years were searched for dog breeds predisposed 
to CM-P and SM that had both MRI and CT head imaging. 
13 dogs were identified (5 Chihuahua, 7 Cavalier King 
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Charles Spaniels, 1 Griffon Bruxellois). 13 measurements 
(1 circle, 1 ellipse, 7 lines, 4 angles) were taken on mid-
sagittal T2 weighted MRI and CT images of the skull and 
cervical spinal cord. 
RESULTS
ICC Model (2,1) absolute agreement showed very good 
agreement for 9 measurements (ICC range 0.790–0.987); 
3 measurements had some agreement (ICC range 0.585–
0.687) and 1 angle had poor agreement (0.288). Measure-
ments that used bony landmarks had better agreement.  
STATEMENT (CONCLUSIONS)
Morphometric analysis to predict risk of CM-P and SM 
can be applied to CT but refinement will be necessary. 
This may eventually be useful as a pre-breeding screen-
ing test especially if anatomical analysis software is 
developed. CT is not sensitive for SM and for the foresee-
able future any hypothetical CT pre-breeding test for 
skeletally mature dogs would be combined with MRI 
from 5 years of age to determine the final CM-P/SM 
 status. All data would be used in an estimated breeding 
value programme.
The Erector Spinae 
Plane block for 
intraoperative analgesia 
in dogs undergoing 
hemilaminectomy: 
a retrospective study
Amanda Herron, Cristina Bianchi,  
Jaime Viscasillas, Sandra Sanchis,  
Andrew Foster, Roger Medina 
Royal Veterinary College, London, United Kingdom 
OBJECTIVES
To evaluate retrospectively the erector spinae plane 
block as part of a multimodal analgesia protocol for dogs 
undergoing hemilaminectomy, with regards to intraop-
erative rescue analgesia requirements and clinical safety.
METHODS
In this retrospective, observational study, anaesthetic 
records of dogs receiving an ultrasound guided ESP 
block with ropivacaine for hemilaminectomy for interver-
tebral disc extrusion between December 2017 and July 
2018 were reviewed. Parameters recorded for the study 
included: signalment, surgical area, number of discs, 
premedication, induction agent, volatile agent, heart 
rate, respiratory rate, blood pressure, percentage of inha-
lation anaesthetic used and temperature. Any analgesia 
given intraoperatively was documented and assessed as 
to whether this was given for rescue analgesia purposes 
(rescue was given when there was an increase in heat 
rate and/or blood pressure and/or respiratory rate). Fac-
tors affecting the use of rescue analgesia were analysed 
using binary logistic regression.
RESULTS
Forty-eight dogs were included in the study. All dogs 
received 0.2 mg/kg of methadone and nine of them had 
NSAIDs as premedication. From the 48 dogs, 18 required 
rescue analgesia. From those 18, 10 required an addition 
of 0.1  mg/kg methadone, with the other 8 requiring 
higher levels of rescue analgesia. On the logistic regres-
sion, signalment, sedative used, surgical area and num-
ber of discs had no effect on the requirements for rescue 
analgesia. No complications were reported with the use 
of the ESP block.
STATEMENT (CONCLUSIONS)
Ultrasound guided ESP can be a simple and safe tech-
nique for provision of intraoperative analgesia for patients 
undergoing hemilaminectomy.
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Optimising topical 
ophthalmic drug 
delivery in the canine 
eye by reducing drop 
volume–preliminary 
investigations
David Williams1, Florence Clark2 
1 Queen’s Veterinary School Hospital, University of Cambridge, 
Cambridge, United Kingdom
2 The Perse School, Cambridge, United Kingdom 
OBJECTIVES
The standard volume of a drop from an ophthalmic bot-
tle is much larger than the volume of the canine tear lake. 
Previous studies regarding changes in heart rate and 
blood pressure associated with the use of topical phe-
nylephrine show that trans-conjunctival absorption of 
topical drops can provoke systemic effects. Here we 
investigate whether drug delivery can be optimised by 
reducing drop volume.
METHODS
Pupils of greyhounds used for clinical teaching were 
dilated for fundoscopy either using 1% tropicamide from 
a standard minim vial or from one with a Gilson pipette 
tip attached to reduce the drop volume. Drop volume 
was measured by determining drop weight on a micro-
balance. Degree of mydriasis was measured photo-
graphically and pupil size and time to full dilation were 
compared for the two delivery methods.
RESULTS
Volumes of drops from the two delivery devices were 
31.4 ± 15.0ul for the minim single dose dispenser vial and 
10.0 ± 3.4ul from the minim vial with attached pipette tip, 
these volumes being significantly different at p < 0.0001. 
Even though only one third of the volume was dispensed, 
the degree of maximum dilation (12.1 and 13.0 mm) and 
time to maximum dilation (60 minutes for both methods) 
was not significantly different.
STATEMENT (CONCLUSIONS)
The fact that a drop only one third the volume of one from 
the standard minim dispenser still gave the same mydriatic 
effect shows that methods to reduce drop volume should 
be used to minimise systemic absorption of topically 
administered drugs. Further work is required to investigate 
systemic effects of drugs at different drop volumes.
Difference in 
prevalence of age-
related cataract in 
dogs in the UK and 
New Zealand: a 
consequence of 
differential ultraviolet 
light exposure?
Alice Prodger1, David Williams2 
1 Ryder and Davies Veterinary Surgeons, Woodbridge,  
United Kingdom
2 Queen’s Veteronary School Hospital, University of Cambridge, 
Cambridge, United Kingdom 
OBJECTIVES
Daylight exposure, and particularly ultraviolet (UV) irradi-
ation, is accepted as an important factor in the genesis of 
age-related cataract in humans. Here cataract preva-
lence in dogs was compared between the UK and New 
Zealand (NZ) two areas with substantially different levels 
of UV irradiance.
METHODS
Data already collected on cataract prevalence for 2000 
dogs in the UK was compared with data gathered through 
ophthalmic examination in this study for 97 dogs in 
Kaitaia, NZ. The age at which 50% of the population had 
cataract (C50) was calculated for each population and 
compared with a Chi squared test.
RESULTS
The age profile of the dogs in both populations was not 
significantly different (p = 0.98) but cataracts occurred at 
a younger age in NZ dogs (C50 = 7.5 years) compared 
with those in the UK (C50 = 9.4) these values significantly 
different at p = 0.0047. All dogs in the UK population 
had lens opacity by the age of 13.5 while the comparable 
figure was 11.5 years in the NZ population.
STATEMENT (CONCLUSIONS)
Kaitaia is located at a latitude of 35.1° South and the UK at 
55° North, with total annual  hours of sunlight estimated 
at 2115 for Kaitaia and 1374 for the UK and at least twice 
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the UV irradiance in Kaitaia. Given that other factors such 
as diet and medical treatment were not significantly dif-
ferent between the two populations, the substantially 
earlier onset of age-related cataract in NZ dogs is highly 
likely to be related to high UV levels associated with 
depletion in the ozone layer at southern latitudes.
Survey of owner 
attitudes toward the 
application of eye drops 
in dogs and cats with 
ophthalmic disease
Sophie Mead, David Williams 
University of Cambridge, Cambridge, United Kingdom 
OBJECTIVES
Compliance of veterinary clients in administering oph-
thalmic medication to their pets has received little atten-
tion compared to compliance in human medicine. This 
study aimed to investigate owner attitudes regarding the 
ease of eyedrop administration.  
METHODS
This study used questionnaire-guided interviews, asking 
what the temperament and ease of handling of the pet was, 
how often owners successfully applied drops, how easy 
they found it to apply medication (ease score: 1 very easy to 
7 not possible), whether they needed help in providing treat-
ment, whether the temperament of their pet had changed 
during treatment and if so in what manner, whether they had 
developed techniques to render  treatment less stressful and 
how they felt about treating their pet. A convenience sam-
pling method was used. All respondents gave informed con-
sent to their opinions being evaluated.
RESULTS
Results from 15 cat owners and 33 dog owners showed 
an ease score for dogs was 3.3 ± 0.4 and for cats 4.5 ± 
0.4 and that temperament was not a predictor of ease of 
treatment. More compliant owners had more success 
treating their pets. 64% of dog owners and 93% of cat 
owners reported negative behavioural changes during 
treatment, including avoidance, nervousness and 
aggression. 58% of dog owners and 80% of cat owners 
associated treating their pets with negative emotions 
such as stress, worry, nervousness and guilt.
STATEMENT (CONCLUSIONS)
This study suggests that emotional factors and the impact 
of the client’s relationship with their pet are important 
factors in compliance to prescribed treatment protocols.
Evaluation of the I-PEN, 
a hand-held device for 
rapid measurement of 
tear osmolarity in the 
canine patient
Yuvani Bandara, David Williams 
Queen’s Veterinary School Hospital, Cambridge, United Kingdom 
OBJECTIVES
Previous reports have documented the use of elec-
tronic devices to measure tear-film osmolarity but 
devices such as the TearLab osmometer are cumber-
some and expensive to use. Here a handheld solid 
state  electronic diagnostic device for the quantitative 
measurement of tear-film osmolarity is evaluated for 
use in canine patients. The disposable tip of the device 
is held adjacent to the conjunctiva of the lower conjunc-
tival sac and measures the impedance of the tear film 
 bathing this  tissue, calculating tear osmolarity within a 
few  seconds.
METHODS
Animals assessed included twenty dogs with a normal 
tear film as diagnosed by ophthalmic examination and a 
Schirmer tear test (STT) reading over 15 mm/min, and ten 
dogs with keratoconjunctivitis sicca (KCS), diagnosed by 
finding of ocular surface pathology characteristic of dry 
eye and a STT reading of less than 15 mm/min. 
RESULTS
The I-PEN device was easy to use and tolerated well by all 
animals. Osmolarity was 331.9 ± 11.4 mOsm/L in normal 
eyes and 348.9 ± 18.4 mOsm/L in eyes with KCS, these val-
ues being significantly different from each other (p < 0,05).
STATEMENT (CONCLUSIONS)
This study shows that the IPEN is a useful device to deter-
mine tear-film osmolarity in canine patients. Given that 
high osmolarity is thought to be a key factor in ocular 
 surface pathology in dry eye, determination of tear osmo-
larity may be valuable in assessment of dogs with KCS.
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Comparison of 
behaviour in blind and 
sighted dogs
Helen Inzani, David Williams
Queen’s Veterinary School Hospital, Cambridge, United Kingdom 
OBJECTIVES
Assessing welfare of blind dogs requires an objective 
evaluation of their behaviour. Here we sought to com-
pare the behaviour of blind and visual dogs to determine 
which measures would be best to assess their welfare.
METHODS
The behaviours of twenty blind dogs and twenty matched 
visual dogs were evaluated by documenting their behav-
iours at intervals of 30 seconds over a ten minute period 
in a 10 m by 5 m room. The number of times they were 
observed performing a specific behaviour (sniffing, tail 
wagging, standing, sitting, lying, staring, looking around, 
interacting with the observer, ear-raising, wandering, 
whining, growling or barking) was documented. These 
data were compared for blind and visual dogs. A rating 
system based on Gosling’s cross-species personality 
traits was used to assess the curiosity, friendliness, play-
fulness, alertness, aggressiveness of dogs and how alert 
and attentive, subdued or anxious they appeared to be 
during the test.
RESULTS
The only significant differences between blind and visual 
dogs was in ear raising, tail wagging and looking around, 
all of which occurred significantly more in visual than 
blind dogs. No other behaviours were observed to be 
significantly different in either group. Personality trait 
assessment suggested that blind dogs were less friendly 
and more anxious than visual dogs although such an 
evaluation is substantially more subjective than the eval-
uation of specific behaviours and so more difficult to use 
in an objective manner.
STATEMENT (CONCLUSIONS)
This comparison of behaviours in blind and visual dogs 
suggests that few behaviour traits are significantly differ-
ent between blind and visual dogs.
A descriptive 
retrospective study of 
11 cases of neurogenic 
dry eye in a referral 
population and the 
response to 
pilocarpine treatment
Michaela Wegg 
Rowe Referrals-ophthalmology, Bristol, United Kingdom 
OBJECTIVES
To assess the response to pilocarpine in dogs with neu-
rogenic dry eye in a UK referral centre. 
METHODS
A descriptive retrospective study reviewing medical 
records from dogs with neurogenic dry eye treated with 
oral pilocarpine and/or topical pilocarpine (0.1%, four 
times daily), at a UK referral centre, between 2015 and 
2018. Cases were excluded if there were low Schirmer 
tear test (STT) values bilaterally, if the follow up time was 
less than thirty days and if surgical measures were under-
taken within the first thirty days. 
RESULTS
Medical records from 11 cases, 7 females and 4 males 
with mean age of 10 years (5y5m to 16y3m) were 
reviewed. Seven cases (64%) were positive for pilocarpine 
treatment and return to normal STT (15–25 mm/minute) 
values after treatment. The average time to normal tear 
production on treatment was 34 days (range of 15–53 
days) and the average time for initial response was 
7.7 days (range 2 to 17 days). There was no correlation 
between xeromycteria (dry nose) and response to pilo-
carpine treatment. The number of systemic drops until 
positive response varied between individuals, from 
0.8  drops/10  kg, to 7 drops/10  kg. There is individual 
 variation in the dose tolerated systemically and the dose 
required for a positive response.
STATEMENT (CONCLUSIONS)
In conclusion, you should trial treatment with pilocarpine 
for at least 34 days in dogs diagnosed with neurogenic 
dry eye prior to opting for surgical intervention.
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Comparison of 
intraocular pressure 
measurement by three 
tonometers, the 
TonopenXL, Tonovet 
and TonovetPlus in the 
eyes of 50 dogs with a 
range of normal and 
abnormal intraocular 
pressures
Natalia Giannakopoulou, David Williams 
University of Cambridge Veterinary School, Cambridge,  
United Kingdom 
OBJECTIVES
Intraocular pressure (IOP) measurement is important in 
ophthalmic examinations being achieved by use of 
applanation tonometers such as the Tonopen or rebound 
tonometers such as the Tonovet or more recently the 
Tonovet-plus. Here we seek to determine correlation 
between iop as measured by these tonometers.
METHODS
The Tonovet, Tonovet-plus and Tonopen were used to 
measure iop in eyes of 50 dogs with normal eyes (iop 
between 10 and 25 mmHg), glaucomatous (iop > 25 mmHg) 
and uveitic (iop  <  10  mmHg) eyes. Comparison of iop 
 values was achieved using analysis of variance (ANOVA).
RESULTS
Descriptive statistical analysis and ANOVA of measure-
ments for all eyes showed iop values for Tonopen, 
Tonovet and Tonovet-plus of 20.0 ± 11.4, 22.2 ± 12.8 and 
25.7 ± 14.2 mmHg, an f-ratio value of 2.52 and p of 0.084. 
For the 20 eyes with uveitis the iop measures were 
9.85 ± 3.39, 10.45 ± 4.54 and 13.65 ± 5.01 mmHg and the 
f-ratio value was 4.4 at p < 0.05. For the 36 glaucomatous 
eyes iop measures were 43.89 ± 12.11, 47.72 ± 14.38 and 
52.86 ± 15.53  mmHg with an f-ratio value of 3.68 at 
p  <  0.05. For the 42 normal eyes iop measures were 
16.93 ± 2.53, 18.69 ± 3.34 and 21.26 ± 3.28 mmHg with 
f-ratio value of 21.1 and significance at p < 0.0001. In all 
cases iop measured higher using the Tonovet-plus than 
the Tonovet with the Tonopen providing the lowest 
measurements.
STATEMENT (CONCLUSIONS)
That different tonometers give different iop values does 
not invalidate any particular device; correlation with 
manometric measurement is the only method of deter-
mining measurement validity. Measurement with different 
tonometers did not change a diagnosis of glaucoma or 
uveitis, however this study does show that comparisons 
between tonometers is not appropriate.
AI and the eye!
David` Williams, Richard Dybowsky 
Department of Veterinary Medicine, University of Cambridge, 
Cambridge, United Kingdom 
OBJECTIVES
The rise of artificial intelligence (AI) in medical diagnosis 
has been rapid–a PubMed search of ‘artificial intelligence, 
clinical diagnosis and medicine’ gave 7225 results. Veteri-
nary medicine has not been as quick on the uptake. A 
similar PubMed search in veterinary medicine gives only 
22 relevant publications. Yet the use of pattern recogni-
tion and flowchart methodology renders veterinary diag-
nosis quite as amenable to computer-aided modelling as 
is human medicine. Here we sought to develop an AI sys-
tem for the diagnosis of the causes of canine red eye.
METHODS
An AI system for diagnosis that can run on a standard lap-
top was developed by clinical veterinary ophthalmologists 
in conjunction with researchers in mathematics and 
 computational biology.
RESULTS
The AI system developed is based on a Bayesian network 
in which each node of the network corresponds to an 
attribute of interest e.g., ‘breed’, ‘disease’, “’intraocular 
pressure’. An arrow from one node to another indicates 
that the value taken by one node influences the value 
taken by the other; thus, ‘breed’ > ’disease’ indicates that 
the probability of a dog having a particular disease is 
influenced by the breed. ‘disease’ > ’intraocular pressure’ 
indicates that the probability a particular level of intraoc-
ular pressure is influenced by which disease is present. 
The network enables clinicians to evaluate which disease 
is likely to be manifest by specific clinical signs observed 
and allows students to learn the probabilistic causal rela-
tionships between eye diseases and their clinical signs.
STATEMENT (CONCLUSIONS)
This system illustrates the value of AI in clinical diagnosis 
and veterinary education.
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Development of an 
information booklet for 
small animal pain 
management clinic 
clients
Tate Preston, Ian Self 
The University of Nottingham, Nottingham, United Kingdom 
OBJECTIVES
Ascertain from veterinary clients what information would 
be useful in the management of their dog’s pain.
Produce an information booklet based on this infor-
mation.
Subsequently improve the welfare of pet dogs pre-
sented with painful conditions to veterinary surgeons.
METHODS
Semi-structured interviews were held with clients 
attending a referral pain clinic and a hydrotherapy centre 
regarding what information would be useful for them 
and their attitudes towards dog pain.   Interviews were 
recorded and results analysed using NVivo (qualitative 
data analysis software). A booklet was produced answer-
ing the main questions raised by the owners, together 
with background information provided by veterinary 
analgesia specialists.
RESULTS
166 codes were generated from 7844 references from 
which 6 themes were identified; Variety of treatment 
options, Dog pain is comparable to human pain, Not 
being normal shows the dog is in pain, Owner responsi-
bility, Trust, Understanding your dog and its pain.
Pain Treatment was mentioned 652 times (the high-
est number of references).
STATEMENT (CONCLUSIONS)
Participants believe a combination of treatments work 
best including therapies, pharmaceuticals, surgery and 
environmental management. Owners feel a responsibi-
lity as advocates of their dog’s quality of life. Owners 
need to be able to trust their vet/professional when 
 treating and making decisions about their dog’s pain, this 
includes knowing that they are competent. People want 
to be able to understand the signs of pain or lack of signs 
that their dog shows, they understand that dogs cannot 
communicate pain the same way as humans do.
Acetabular fractures in 
30 dogs: presentation, 
classification and 
management and 
short-term outcome
Victoria Roberts, Richard Meeson 
Royal Veterinary College, London, United Kingdom 
OBJECTIVES
To describe the presentation, classification, manage-
ment and short-term outcome of dogs with acetabular 
fractures. 
METHODS
Retrospective analysis of the clinical data of dogs with at 
least one acetabular fracture between January 2010 and 
March 2018. 
RESULTS
30 dogs with 32 radiographically confirmed acetabular 
fractures met inclusion criteria, of which 27 had  confirmed/
suspected vehicular trauma. Mean age was 34 months 
(range: 5–120), mean weight was 10.7  kg (range: 2.66–
27.55), 14/30 were entire, 17/30 were female. 
The majority were unilateral (28/32) and simple 
(19/32). Most commonly seen in the mid (20), or caudal 
acetabulum (10), rarely in the cranial quadrant (2). 28/30 
had additional orthopaedic injuries and 2 were euthan-
ised due to co-morbidities. 22/32 underwent surgical 
stabilisation; acetabular plate (AP)(n = 8), femoral head 
and neck excision (FHNE)(n = 5), screws, wires and 
 polymethylmethacrylate (SW-PMMA)(n = 3), dynamic 
compression plate (n = 1), AP and SW-PMMA (n = 1), 
FHNE and locking compression plate (n = 1), AP and wire 
(n = 1), FHNE and wire (n = 1), screws and wire (n = 1). 
8/32 were managed conservatively, with 4 undergoing 
other pelvic surgery. 27 dogs (28 fractures) survived to 
discharge. 18 dogs had follow-up with 11 lameness 
scores recorded, mean 3.7/10 (range: 0–10). 15 fractures 
had  radiographs after 28 days, all showed evidence of 
bone healing. Complications seen were: 1 had FHNE 
9 days post-operatively due to subsequent coxofemoral 
luxation, 1 acetabular plate failed not requiring revision 
 surgery. 
STATEMENT (CONCLUSIONS)
Canine acetabular fractures commonly occur secondary 
to vehicular trauma and are usually unilateral, simple and 
occupy the mid or caudal acetabulum. The majority were 
surgically managed and complications were rare. 
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Retrospective study 
of occurrence and 
types of complications 
associated with 
different procedures 
to correct traumatic 
hip luxation in  
44 dogs
Aaron Lutchman, Pilar Lafuente 
Department of Clinical Science and Services, The Royal Veterinary 
College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, 
AL9 7TA, Hatfield, United Kingdom 
OBJECTIVES
Retrospective, observational and analytical study assess-
ing the demography of traumatic hip luxation in dogs 
and the complications associated with different correc-
tion techniques. This study aims to assess whether 
 certain techniques are superior with regard to  outcomes, 
associated complications and the respective complica-
tion rate.
METHODS
The cases of animals with unilateral or bilateral luxation of 
the coxo-femoral joint as a result of trauma between 
2009 and 2018 were reviewed. Signalment, clinical signs, 
treatment type (closed reduction, closed reduction 
 followed by surgical reduction and stabilization, or imme-
diate surgical reduction and stabilization), outcome and 
complications were recorded for each patient. Statistical 
evaluation was performed to identify relationships 
between treatment type and outcome or rate of compli-
cations.
RESULTS
Forty-four dogs were included in the study. Mean age was 
4 years (range 3 months–12 years) with a mean weight of 
19 kg (range 4–48 kg). Road traffic accidents (n = 17) and 
animals exercising (n = 8) were the most common causes 
of traumatic luxation.  Seven surgical procedures were 
represented in this data set, the most common being 
 ilio-femoral suture. Closed reduction was attempted pri-
marily in 33/44 cases however a significant proportion of 
these cases re-luxated (n = 24), requiring further surgical 
correction. Complication of re-luxation post-surgical 
reduction was notably less (n = 4). Post surgical infection 
was uncommon, recorded in (n = 2) cases.
STATEMENT (CONCLUSIONS)
Given the increased rate of re-luxation in animals man-
aged with closed reduction it could be suggested that 
surgical intervention is warranted as the primary course 
of treatment.
The effectiveness of 
marine based fatty acid 
compound (pcso-524) 
alone and combined 
with previcox in the 
treatment of canine 
osteoarthritis
Brian Beale 
Gulf Coast Veterinary Specialists, Houston, USA 
OBJECTIVES
The purpose of this study is to assess the effectiveness of 
a marine-based fatty acid compound alone and in 
 combination with firocoxib for treatment of osteoarthritis- 
associated pain in dogs using objective measures of limb 
use and validated subjective assessments.
METHODS
A double-blinded randomized prospective clinical trial 
was performed with 31 dogs. Dogs were randomly 
 allocated to a PCSO-524 group (PCSO) or a Firocoxib + 
PCSO-524 (FCX-PCSO) group. Owners were masked to 
use of firocoxib by using identical placebo tablets in the 
PCSO-524 group. Force plate gait analysis and the 
owner-completed Canine Brief Pain Inventory toolwere 
used to evaluate patients at 0, 2 and 4 weeks. Data were 
analyzed using repeated measurement analysis with 
 significant level set a 5%(α = 0.05).
RESULTS
Peak Vertical Force (PVF) values were significantly 
increased over baseline at week 2 and week 4 in both 
groups (p < 0.05). A significant decrease in the CBPI scores 
(improvement) was seen at week 2 and 4 in the PCSO 
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group and week 4 in the FCX+PCSO group compared 
with pre-treatment values. No differences were seen 
between the groups. Pearson Correlation Coefficients 
demonstratednegative correlation between PVF and 
CBPI (R = –0.335, p = 0.001).
STATEMENT (CONCLUSIONS)
These data suggest that marine-based PCSO-524 alone, 
and the combination of firocoxib and PCSO-524 are equally 
beneficial in treating dogs with osteoarthritis, but patients, 
may have a lower risk of side effects with PCSO-524. 
Vertical mandibular 
range of motion and 
mandibular length ratio 
as a non-invasive tool 
for assessment of 
temporomandibular 
joint function in dolicho 
and brachycephalic 
dogs under anaesthesia: 
9 breeds, 111 dogs
Olivia Oginska, Miguel A Solano 
Fitzpatrick referrals, Godalming, United Kingdom 
OBJECTIVES
To establish a reliable reference in assessment of the 
temporomandibular joint (TMJ) function using a user-
friendly instrument in order to improve the diagnostics of 
TMJ disorders and monitor response to surgical and 
non-surgical management of TMJ disease in dog. Fur-
thermore, to observe the influence of skull conformation 
(dolicho- and brachycephalic) and body weight on verti-
cal mandibular range of motion and mandibular length. 
METHODS
Prospective study focused on measuring vertical mandib-
ular range of motion (vmROM) and mandibular length 
using a caliper in 111 anesthetized dogs, undergoing vari-
ous surgical procedures unrelated to TMJ, representing 
nine phenotypically different breeds, both dolicho- and 
brachycephalic: Labrador Retrievers, Border collies, 
Dachshunds, English Springer Spaniels, German Shepherd 
Dogs, Staffordshire Bull Terriers, French Bulldogs, Pugs 
and Rottweilers. The ratio between vmROM and mandib-
ular length (mandibL) was calculated for each patient.
RESULTS
Differences in measured parameters were found among 
certain breeds, ex. in Rottweilers–mean vmROM 132.75 mm, 
mandibL 139.5  mm, whereas in Pugs - 68.09  mm and 
76.9  mm respectively. Despite those differences, the 
vmROM/mandibL ratio was similar: 0.93 in dolicho- and 
0.94 in brachycephalic breeds with minimal variations (+/– 
0.06). A significant correlation was found between body 
weight and both vmROM and mandib/L, with correlation of 
0.696 and 0.791 (p-value < 0.01) respectively. 
STATEMENT (CONCLUSIONS)
The ratio vmROM/mandibL is a potential reliable and 
simple tool to assess TMJ disease. It can help guiding the 
need for advanced imaging and may improve TMJ disor-
ders detectability. Using the ratio may facilitate TMJ post-
surgical outcome assessment and rehabilitation progress 
with a simple instrument.
Accuracy of medial to 
lateral transcondylar 
screw placement using 
a C-guide for the 
treatment of humeral 
intracondylar fissure
Maite Pardo, Andy Morris, Fabio Frazzica, 
Duncan Barnes 
Eastcott Referrals, Swindon, United Kingdom 
OBJECTIVES
To retrospectively compare the position of transcondylar 
screws on post-operative Computed Tomography (CT) 
scans with the ideal position planned using a previously 
defined technique.
METHODS
A retrospective study of 24 elbows of 18 dogs treated for 
humeral intracondylar fissures, using a 4.5  mm screw 
inserted from medial to lateral. Humeral condyle diame-
ter was measured from the CT. Planned entry and exit 
points of the transcondylar screw were 0.3 x humeral 
condyle diameter cranial and 0.2 x humeral condyle 
diameter distal to the medial epicondyle and 0.3 x 
humeral condyle diameter cranial and 0.3 x humeral 
condyle diameter distal to the lateral epicondyle. Follow-
ing a medial approach, a C-shaped drill guide was used 
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to drill a pilot hole from the medial entry point to the lat-
eral exit point. A post-operative CT scan was performed 
to determine successful placement of the screw within 
the humeral condyle and to assess:
 Q Distance of achieved entry and exit points from the 
planned entry and exit points
 Q Angular deviation from planned screw axis
RESULTS
All screws were completely within the humeral condyle. 
Mean distance between the planned entry point and the 
achieved entry point was 0.58 mm cranially and 1.26 mm 
distally. Mean distance between the planned exit point 
and the achieved exit point was –0.02 mm cranially and 
0.51 mm distally. Mean maximum screw angular devia-
tion was 5.7°.
STATEMENT (CONCLUSIONS)
Use of CT planning and a C-guide allowed the accurate 
placement of transcondylar screws from medial to lateral 
via a medial surgical approach.
Outcome’s and 
complication’s 
associated with 
standard elbow 
arthrodesis
Brian Crowley, Noel Fitzpatrick 
Fitzpatrick Referrals, Godalming, United Kingdom 
OBJECTIVES
To report the surgical management of end stage devel-
opmental disease (DJD) by arthrodesis following failure 
of previous surgical intervention. 
METHODS
Retrospective case series from historical clinical records. 
Data collected included signalment, primary surgical 
technique, mode of failure, revision surgical technique, 
preoperative and postoperative radiographic findings, 
complications, owner assessment and veterinary assess-
ment.
RESULTS
23 elbows from 21 dogs were included, bodyweight 
range 1.9  kg–48.9  kg. All surgeries performed in the 
same centre by 5 different surgeons. All elbows were 
considered end stage due to failure of joint replacement, 
congenital/traumatic malformations and progression 
of  aggressive osteoarthritis (OA). All elbows underwent 
arthrodesis as a salvage procedure. 13 complications 
occurred in 10 elbows (43.5%) including surgical site 
infection (SSI), seroma, screw breakage, plate removal 
and amputation. Outcome data was available for all 
22 elbows. An excellent outcome was seen in 3 (13.6%) 
elbows, good in 10 (45.5%) elbows, acceptable in 7 
(31.8%) elbows and unacceptable in 2 (9.1%) elbows.
STATEMENT (CONCLUSIONS)
Persistent lameness and pain associated with treating 
advanced elbow DJD by joint resurfacing/replacement 
surgery in an attempt to salvage limb function is an ongo-
ing putative challenge. Surgical revision by elbow arthro-
desis, while technically challenging may show potential in 
regaining or improving limb function and may contribute 
to overall improvement in reported quality of life.
Measuring the impact 
of regenerative 
medicine (RM) on 
chronic degenerative 
conditions in dogs, 
using a validated 
owner-reported 
outcome measure 
(VetMetrica) which 
provides scores in 
4 domains of health-
related quality of life 
(HRQL)
Andrew Armitage1, Jacky Reid2,3 
1 Greenside Veterinary Practice, St Boswells,  
United Kingdom
2 NewMetrica Ltd, Glasgow, United Kingdom
3 University of Glasgow, Glasgow, United Kingdom 
421-550 Clinical Abstracts.indd   515 08/03/2019   18:39
Oral presentations
[ 516 ] BSAVA CONGRESS 2019 PROCEEDINGS
OBJECTIVES
RM is a relatively new treatment modality with the poten-
tial to control pain and inflammation, improve mobility 
and reverse degeneration in osteoarthritis (OA) and asso-
ciated soft tissue pathologies (STP). Treatment with stem 
cell therapy (SCT) and platelet rich plasma (PRP) in dogs 
with OA and associated STP was investigated with a view 
to demonstrating an improvement in HRQL.
METHODS
Owners of dogs with chronic OA and STP, non – respon-
sive to conservative management, were recruited and 
requested to complete HRQL assessments online before 
treatment (baseline) and at set intervals after treatment 
with RM. Group mean and 95% confidence intervals 
at all time points and significance between baseline and 
6–8 weeks and 14–16 weeks using paired T-test was 
 calculated.
RESULTS
Owners of 28 dogs completed a baseline assessment 
and of these owners 23 and 12 completed assessments 
after treatment at 6–8 weeks and 14–16 weeks respec-
tively. Significant improvement at 6–8 weeks and 14–16 
weeks relative to baseline in HRQL domains energetic/
enthusiastic (p = 0.02 and p = 0.03), happy/content 
(p = 0.008 and p = 0.01) and active/comfortable 
(p = <0.001 and p = 0.002) was demonstrated. There was 
no significant improvement in calm/relaxed at either 
timepoint (p = 0.3, 0.61 respectively)
STATEMENT (CONCLUSIONS)
This study demonstrated a significant improvement in 
3  of 4 HRQL domains in dogs with OA and associated 
STP, treated with SCT and PRP. RM should be considered 
as an effective minimally invasive treatment option where 
conservative management has failed.
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An investigation into 
clients’ perception of 
physiotherapy for dogs 
after cranial cruciate 
ligament rupture 
(CCLR) surgery
Stephanie Lau1, JC Alves1,2, Pilar Lafuente1 
1 Royal Veterinary College, London, United Kingdom
2 Guarda Nacional Republicana (Portuguese Gendarmerie), 
Lisbon, Portugal 
THIS ABSTRACT HAS BEEN WITHDRAWN 
BY THE AUTHOR
Comparison of 
perioperative 
(0–3 months) 
complications and 
outcomes in dogs 
weighing ≥15 Kg with 
bilateral medial patellar 
luxation undergoing 
single-session bilateral 
corrective surgery with 
staged historical 
control surgeries: 
14 cases (28 stifles)
Gary Campbell, Miguel A Solano,  
Noel Fitzpatrick 
Fitzpatrick referrals, Godalming, United Kingdom 
OBJECTIVES
To describe the surgical management, peri-operative 
(0–3 months) complication rates and clinical outcomes 
of dogs weighing 15  kg or more with bilateral medial 
patellar luxation (MPL) undergoing bilateral repair during 
a single anaesthetic episode.
METHODS
Medical records of dogs undergoing single-session bilat-
eral MPL repair during an eight-year period (2006–2014) 
were analysed retrospectively and compared to paired 
controls of similar body weight and patella luxation 
grade, undergoing staged repair of bilateral MPL during 
the same time period. Each group consisted of seven 
dogs (14 stifles).
RESULTS
The minor complication rate for single session bilateral 
repair was 0%. The major complication rate was 29% 
(4/14 stifles) which was due to one case with surgical site 
infection and another with surgical wound  breakdown 
421-550 Clinical Abstracts - WITHDRAWN ABSTRACTS.indd   518 08/03/2019   19:26
BSAVA CONGRESS 2019 PROCEEDINGS [ 519 ]
and implant loosening. The minor complication rate for 
staged repair was 43% (6/14 stifles) due to three cases of 
patellar tendonitis, two of MPL recurrence and one of 
pin breakage. The major complication rate was 0%. 
No  catastrophic complications were experienced. All 
stifles in the single session group and 12 stifles in the 
staged group had full function at final post-operative 
examination. The two remaining stifles had acceptable 
function.
STATEMENT (CONCLUSIONS)
Based on our study, single session bilateral MPL repair is 
feasible in dogs weighing 15 kilograms or more but led to 
an increased rate of major complications when  compared 
with animals undergoing staged bilateral repair. These 
complications did not affect perioperative outcome with 
all animals in the single session group returning to full 
function at 6–12 weeks post-operatively.
Bilateral locking-
compression plate 
fixation for stabilization 
of canine Y-T humeral 
fractures
Javier Garcia, Miguel A Solano,  
Russell Yeadon 
Fitzpatrick referrals, Godalming, United Kingdom 
OBJECTIVES
To report the surgical management, complications and 
outcomes for dogs with humeral Y-T fractures stabilized 
with medial and lateral Locking Compression Plates 
(LCP).
METHODS
Medical records of 28 dogs presented with 29 consecu-
tive Y-T fractures approached bilaterally, reduced and 
stabilized using a transcondylar and two or three LCP 
locking plates were reviewed. All dogs had at least six 
weeks clinical follow-up and, for some, long-term 
 owner’s-based outcome with LOAD questionnaire was 
obtained.
RESULTS
Twenty-eight dogs (twenty-nine fractures) met the inclu-
sion criteria. Most commonly affected breeds were 
French Bulldog (n = 7) and English Cocker Spaniel (n = 4). 
Age at presentation ranged from 4 months to 9.5 years 
(mean 43.53 months), seven dogs (25%) were considered 
skeletally immature. In twelve dogs, the fracture was 
consequence of a high-energy trauma and in sixteen 
dogs of gentle activity. Twenty-seven (96.4%) dogs were 
considered to have resolution of lameness at 6 weeks 
follow-up. Complications were registered in two cases; 
one major complication required surgical revision and 
one dog (3.5%) showed a catastrophic complication 
leading to amputation. Mid and Long-term follow-up 
was available for twenty-one cases (75%), mean of 798 
days (range from 180 to 1582 days). Fourteen (71%) own-
ers classified their dogs’ mobility as very good and five 
owners (23%) found it good. 
STATEMENT (CONCLUSIONS)
Based on our study, management of Y-T humeral frac-
tures with bilateral LCP plates and transcondylar screw 
leads to low complication rate and good to excellent 
clinical outcome. 
Current perceptions 
of minimally invasive 
osteosynthesis 
techniques in small 
animal orthopaedic 
practice
William Robinson, Kevin Parsons,  
Toby Knowles 
Bristol Veterinary School, Bristol, United Kingdom 
OBJECTIVES
To report the current perceptions of minimally invasive 
osteosynthesis techniques in a population of veterinary 
orthopaedic surgeons.
METHODS
Two electronic questionnaires were created using the 
Bristol Online Survey tool. The first contained questions 
addressing multiple aspects of minimally invasive osteo-
synthesis (MIO) and the second specifically focussed on 
minimally invasive plate osteosynthesis (MIPO). This was 
circulated amongst members of the European College of 
Veterinary Surgeons (ECVS) and the Veterinary Ortho-
paedic Society (VOS). Responses were collected between 
February and May 2018.
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RESULTS
There were 257 and 238 respondents to the two surveys 
respectively. The most common canine fracture 
addressed with MIO techniques were tibial fractures. The 
most frequently stated advantages of MIO were faster 
healing time (26%) and less post-operative pain (20%). 
The most commonly stated disadvantages of MIO tech-
niques were need for new equipment (27%) and chal-
lenges to achieving adequate fracture reduction (18%). 
When considering MIPO specifically 71% of respondents 
stated that they performed MIPO rarely or occasionally. 
151 respondents (63%) were keen to perform more MIPO 
than their current level. The most common fracture 
 stabilised with MIPO in both cats and dogs were tibial 
fractures. MIPO was less commonly performed in cats 
than dogs (39% vs 15%). 24% of respondents stated that 
there were not enough MIPO training opportunities. 
STATEMENT (CONCLUSIONS)
This study demonstrated recognition of the benefits of 
MIO and MIPO techniques amongst veterinary ortho-
paedic surgeons. Despite this there remains limitations to 
its application within clinical practice and the study has 
highlighted areas for further development to improve its 
use clinically. 
“If it looks straight, it is 
straight?”–establishing 
the normal axes and 
joint angles in small 
breed dog
Ben Mielke, Pilar Lafuente 
Queen Mother Hospital for Animals, Royal Veterinary College, 
Hertfordshire, United Kingdom 
OBJECTIVES
Angular limb deformities are difficult cases to manage. 
When animals are bilaterally affected having a normal 
reference value for joint axes and angles ensures optimal 
patient outcome through preoperative management. 
Although this has been established for medium-large 
breed dogs no such values exist in small dogs. The pur-
pose of this study was to establish the normal anatomic 
axis of the canine radius in the frontal and sagittal planes, 
in a population of adult small breed dogs
METHODS
Radiographs of the antebrachium in skeletally mature 
small breed dogs were reviewed from the electronic 
database of the hospital. Radiographs were used to deter-
mine normal ranges of frontal and sagittal plane anato-
mic axes and relevant angles; aMPRA, aLDRA, aPCRA, 
aDCdRA, procurvatum and frontal plane angle.
RESULTS
28 dogs met the inclusion criteria. Mean ± SD reference 
ranges for these dogs were aMPRA 80.5° ± 2.7, aLDRA 
85.2° ± 2.1, aPCRA 88.7° ± 2.9, aDCdRA 82.8° ± 3.1, Pro-
curvatum 19.8° ± 5.2.
STATEMENT (CONCLUSIONS)
Ranges for normal canine radial axis in small breed dogs 
are similar to those previously reported for Labradors and 
medium-large breed dogs. These reference ranges can 
be used for management and preoperative planning of 
small-breed dogs with antebrachial growth deformities, 
when a bilateral condition prevents the use of the oppo-
site limb as a reference. 
Abbreviations: aMPRA – anatomical edial proximal 
radial angle, aLDRA – anatomical lateral distal radial 
angle, aPCRA – anatomical proximal caudal radial angle, 
aDCdRA – anatomical distal caudal radial angle
Double locking plates 
and screw fixation after 
Tibial Plateau Leveling 
Osteotomy: effect on 
postoperative infection 
rate in dogs over 50 kg
Jayson Tuan, Miguel A Solano 
Fitzpatrick referrals, Godalming, United Kingdom 
OBJECTIVES
To investigate and analysis the effect of double locking 
plates and screw fixation (DLP) in dogs >50 kg  undergoing 
tibial plateau leveling osteotomy (TPLO) on postopera-
tive infection rate. 
METHODS
This is a retrospective study using medical records 
(J anuary 2003–October 2017) from a single orthopae-
dic referral hospital. The inclusion criteria were body 
weight >50 kg and a DLP or standard locking plate and 
screw fixation (LP) or conventional non-locking plate 
and screw fixation (NLP) was used. Logistic regression 
 analysis evaluated for associations with infection 
 occurrence. 
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RESULTS
275 dogs were included for the study and postoperative 
antibiotics were dispensed to 168 (61.1%) dogs. NLP was 
used in 114 (41.5%), LP in 128 (46.5%) and DLP in 33 (12%) 
dogs. Postoperative infection was diagnosed in 48 
(17.5%) dogs. Dogs with NLP, LP, and DLP had postoper-
ative infection rates of 24.5%, 13.3%, and 9.1%, respec-
tively. The usage of a locking construct and postoperative 
antibiotic therapy were associated with significant 
reductions in postoperative infection. A non-locking 
construct increased and postoperative antibiotics 
decreased the risk of infection by 2.08 and 2.37 times, 
respectively. 
However, DLP did not result in a statistically signifi-
cant reduction in infection. 
STATEMENT (CONCLUSIONS)
A locking construct and postoperative antibiotic therapy 
significantly reduced the risk of postoperative infections 
in dogs >50 kg undergoing TPLO. Further investigations 
are required to determine if the use of DLP could be 
 justified in this cohort of dogs. 
Gait analysis of 
lameness-free dogs: 
experience with a 
Tekscan pressure-
sensitive walkway 
system
James Miles, Michelle Nielsen, Amalie 
Mouritzen, Tenna Pedersen, Lise Nikolic 
Nielsen, Anne Vitger, Helle Harding Poulsen 
Department of Veterinary Clinical Sciences, University  
of Copenhagen, Copenhagen, Denmark 
OBJECTIVES
To define reference intervals and investigate repeatability 
for key gait parameters in a lameness-free canine popu-
lation using a pressure-sensitive walkway (PSW) system. 
METHODS
Following institutional ethical approval, 40 healthy client-
owned dogs of various breeds weighing 15–40  kg  and 
between 2–6 years old were recruited. Orthopaedic 
pathology was ruled out by clinical examination and 
using validated owner questionnaires. Six valid trials (3 in 
each direction) were obtained using a 2 m by 0.46 m PSW 
(Tekscan 5101E-VH4), equilibrated daily and calibrated 
weekly. For a valid trial, all paws had to contact the PSW 
for two or more consecutive strides, with a constant 
velocity of 0.9–1.1 m/s, while walking with a loose leash 
without overt head movements. Measurements were 
repeated for 10 dogs on a different day. Symmetry indices 
for key gait parameters were derived and reference 
 intervals for these created from bootstrapped 2.5% and 
97.5% percentiles.
RESULTS
Stance time, stride length and peak vertical force refer-
ence intervals were typically under ± 10%, and narrower 
for forelimbs than hindlimbs. Coefficient of variation for 
repeated measurements was typically under 10%. Direc-
tion of travel had statistically significant, but clinically 
unimportant effects, on several gait parameters.
STATEMENT (CONCLUSIONS)
Pressure-sensitive walkway data are repeatable and 
show relatively little variation, such that deviations 
beyond reference intervals may permit identification and 
monitoring of lameness in clinical patients. Pressure-
sensitive walkways may be useful in assessing clinical gait 
profiles and monitoring response to treatments such as 
surgery or physiotherapy.
Complications and 
outcomes following 
feline dorsal pantarsal 
arthrodesis using a 
pre-contoured plate in 
32 cats (2010–2018)
Nuria Comas, Miguel A Solano,  
Noel Fitzpatrick 
Fitzpatrick referrals, Godalming, United Kingdom 
OBJECTIVES
To report the clinical perioperative (0–3 months) out-
come and complications of pantarsal arthrodesis (PTA) 
with dorsal plating in 32 cats without postoperative 
external coaptation, and to report long-term outcome 
based on owner’s perception with the Feline Musculo-
skeletal Pain Index (FMP) questionnaire. 
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METHODS
Medical records of cats undergoing dorsal pantarsal 
arthrodesis using a feline pre-contoured dorsal PTA plate 
(Feline Dorsal Pantarsal Arthrodesis Plate; Veterinary 
Instrumentation) performed in a single referral veterinary 
hospital between January 2010 and April 2018 were 
 analysed. Clinical and radiographic assessment were 
performed perioperatively (0–3 months) and the FMP 
questionnaire was used to evaluate owners’ perceptions 
of outcome with a minimum of 6 months follow-up.
RESULTS
32 cats met the inclusion criteria. 11 patients had compli-
cations (34%): 2 mild (6%), 7 major (2 medical; 7 surgical) 
(22%) and 2 catastrophic (6%). Among all the complica-
tions, skin wounds and infection (n = 5), swelling (n = 1), 
implant loosening or breaking (n = 3), lameness (n = 3) 
and plantar necrosis (n = 1) were seen. Radiographic 
recheck at 4–12 weeks after surgery showed good pro-
gression of arthrodesis. Good clinical progression was 
seen at the last recheck for 91% of cats. Twenty owners 
answered the FMP questionnaire a mean of 35 months 
(min 7–max 82) with good to excellent outcomes.
STATEMENT (CONCLUSIONS)
Based on our results, pantarsal arthrodesis using dorsal 
specifically designed pre-countoured plate without 
external coaptation is a suitable method to treat tarsal 
and distal tibial/fibular lesions in cats.
Outcomes of 17 talar 
ridge replacements 
using a medial malleolar 
osteotomy approach 
for the treatment of 
osteochondritis 
dissecans in 10 dogs
Sarah Austin, Noel Fitzpatrick 
Fitzpatrick Referrals, Eashing, United Kingdom 
OBJECTIVES
To report short to long term outcomes in dogs with medial 
talar ridge osteochondritis dissecans (OCD) treated with a 
talar ridge replacement (TRR) via a medial malleolar oste-
otomy approach. 
METHODS
Data of dogs treated with a custom made TTR fitted via a 
medial malleolar osteotomy approach were  retrospectively 
sourced from medical records at a single referral hospital. 
A graded outcome was assigned from clinical exam at last 
known recheck. Follow up intervals vary from long term 
(742 days post operative) to more recent cases (41 days). 
The outcomes are classified as one (excellent) no lame-
ness, two (good) mild lameness after exercise, three (fair) 
mild to moderate lameness but consistent weight bearing, 
four (catastrophic) requiring arthrodesis, amputation or 
euthanasia.
RESULTS
Of the ten dogs, seven had bilateral OCD lesions with 
staged or concurrent bilateral TRR performed and four 
had unilateral. Overall outcomes were excellent in seven 
TRR’s and good in ten. Long term data (12–24 months) 
showed four TRR’s with excellent and one with good 
outcomes. Median term data (6-12months) showed four 
with good outcomes and short term (less than 6 months) 
showed three TRR’s with excellent and five with good 
outcomes.
STATEMENT (CONCLUSIONS)
Talar ridge replacement via a medial malleolar osteotomy 
presents a surgical option with good to excellent out-
comes for the management of OCD of the medial talar 
ridge. Encouragingly these outcomes are sustained into 
long term follow up. 
421-550 Clinical Abstracts.indd   522 08/03/2019   18:39
BSAVA CONGRESS 2019 PROCEEDINGS [ 523 ]
Presentation, treatment 
and outcome of 
fractures in pet rabbits 
(Oryctolagus cuniculus)
Sofia Garcia-Pertierra, John Ryan, Jenna 
Richardson, Emma Keeble, Kevin Eatwell, 
Dylan Clements 
Royal (Dick) School of Veterinary Studies and Roslin Institute, 
Edinburgh, United Kingdom 
OBJECTIVES
To identify the incidence, aetiology, characteristics, 
assessment, management and outcome of bone  fractures 
in rabbits presenting to a single institution.  
METHODS
Medical records of pet rabbits diagnosed with fractures 
over a twelve-year period were analysed. Patient signal-
ment, insurance status, case type (first opinion/referral), 
fracture aetiology, fracture location, fracture description, 
time from fracture occurrence to veterinary  presentation, 
fixation method, post-operative complications, clinical 
outcome and follow-up were recorded. 
RESULTS
Forty rabbits that sustained forty-two fractures were 
included in the study (femoral (n = 12), tibial (n = 6), spinal 
(n = 6), metacarpal/metatarsal (n = 5), mandibular 
(n = 4),radius and ulna (n = 4), tarsal (n = 3), and pelvic (n = 
2)). Twenty-four fractures had no identifiable cause, sev-
enteen were traumatic and one was infectious. Only one 
fracture was open. Surgical stabilisation was performed in 
twenty-two fractures (external skeletal fixation (ESF) and 
intramedullary pinning (IMP) (n = 9), bone plating (n = 5), 
ESF (n = 3), IMP (n = 1), K-wire (n = 2),screws (n = 2)),nine 
were non-surgically managed, eight were euthanased 
(including all spinal fractures) and three had one limb 
amputated.Postoperative complications occurred in 
twelve cases (major (n = 9), minor (n = 3)).Overall twenty-
five cases made a functional recovery, eleven were 
 euthanased and six underwent limb amputation.
STATEMENT (CONCLUSIONS)
Fractures in rabbits are typically closed, diaphyseal frac-
tures without an obvious aetiology. The majority of the 
rabbits treated achieved a functional recovery, although 
postoperative complication rate was high. Plate fixation 
did not appear to result in worse outcomes thanESF. The 
most commonly reported reasons for euthanasia or 
amputation were a poor prognosis or outcome.
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Management of gastro-
oesophageal reflux and 
regurgitation during 
anaesthesia in a dog, 
using a supraglottic 
airway device (SGAD) 
with an integrated 
oesophageal drain
Ivan Crotaz 
Kynoch Vets, Bracknell, United Kingdom 
OBJECTIVES
Gastro-oesophageal reflux and regurgitation are com-
mon and serious anaesthetic complications in dogs. 
Supraglottic airway devices (SGADs) form a seal over 
the  larynx. The device tip enters the oesophagus and 
incorporates an oesophageal drainage tube to channel 
regurgitate away from the airway.
This case study describes the first use of a species 
specific dog SGAD with an anaesthetic case in which a 
high volume regurgitation event occurred.
METHODS
A 26kg male Staffordshire Bull Terrier was undergoing 
general anaesthesia for a neutering procedure. Informed 
consent had been obtained from a representative of 
the  rescue centre responsible for this dog. Following 
routine premedication and induction, a size 4 dog SGAD 
was placed into the pharynx. The device was connected 
to a Humphreys ADE circuit to supply oxygen and isoflu-
rane. Multiparameter monitoring was used during the 
 procedure. 
The dog was positioned in dorsal recumbency on a 
surgical bean bag.
RESULTS
As surgery commenced, a noise was audible from the 
neck region. Approximately 100ml of brown fluid exited 
the gastric channel. A gastric drain tube was inserted into 
the gastric channel of the v-gel, allowing removal of 
material and oesophageal flushing with sterile saline 
to  remove remaining debris. Intra-airway endoscopy 
demonstrated that no regurgitate had entered the air-
way channel.
STATEMENT (CONCLUSIONS)
This demonstrates that regurgitation can occur without 
warning during anaesthesia in the dog and that placing a 
drainage channel in the oesophagus can help to channel 
unexpected material away from the airway. An integrated 
drainage channel can also make placement of an 
oesophageal or gastric drainage tube easier.
A case of recurrent 
obstructive fibrinous 
tracheal 
pseudomembrane  
in a dog
Louise Dawson1, Kirsty Baird2 
1 IDEXX Laboratories UK, Wetherby, United Kingdom
2 Hird & Partners LLP, Halifax, United Kingdom 
OBJECTIVES
Recurrent obstructive fibrinous tracheal pseudomem-
branes are a rare complication of endotracheal intuba-
tion in humans. Only one case is reported in the veterinary 
literature to our knowledge. The clinical presentation and 
histopathological findings in another case is described in 
this case report.
METHODS
Samples from the trachea of a 9 year-old border terrier 
were submitted to IDEXX Laboratories, Inc. for histo-
pathological evaluation. The patient presented with 
 respiratory difficulties following a previous general 
anaesthetic.
RESULTS
Histopathology was consistent with aggregates of debris, 
fibrin and inflammatory cells, consistent with fibrinous 
tracheal pseudomembrane. The dog recovered unevent-
fully following removal of the intratracheal fibrinous 
material.
STATEMENT (CONCLUSIONS)
Recurrent obstructive fibrinous tracheal pseudomem-
branes are a rare complication of endotracheal intuba-
tion and should be on the differential diagnosis list for 
dogs presenting with dyspnoea following a recent gen-
eral anaesthetic.
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Use of tiletamine-
zolazepam in 
common kestrels 
(Falco tinnunculus)
Margarita Galka1, Jose Maria Aguilar2, 
Miguel Angel Quevedo2, Celia Sánchez3, 
Jose Maria Santisteban1,  
Rafael Gómez-Villamandos1 
1 Departamento de medicina y cirugía animal, Cordoba, Spain
2 Zoobotánico, Jerez de la Frontera, Spain
3 Consejo de Seguridad Nacional, Madrid, Spain 
OBJECTIVES
Important work is carried out in wildlife rehabilitation 
centers all over the world, frequently with little funding. 
Light anaesthesia can be used to reduce stress caused by 
daily clinical routines of birds. Ketamine combinations 
are safe and are frequently used in theses settings with 
good results. Due to the present threat of the banning of 
ketamine, new products need to be evaluated. We 
decided to use tiletamine instead of ketamine. 
METHODS
We included a total of 15 common kestrels (Falco tinnun-
culus). Different doses of tiletamine/zolazepaml were 
administered IM: 2 patients received 20 mg kg–1, 2 30 mg 
kg–1, 5 40 mg kg–1 and 6 received 20 mg kg–1 plus xylazine. 
HR, fR, cloacal temperature, muscle tone and response to 
pain were recorded every 5 minutes. Quality of induction, 
anaesthesia and recovery were also evaluated. 
RESULTS
All patients responded well to induction and rapidly 
became recumbent. Patient handling was easy due to no 
struggling, although muscle relaxation was not good and 
33,3% shivered. All patients maintained vital constants 
within normal limits, although cloacal temperature 
dropped drastically over time (5 minutes 41,0 ± 1,0ºC, 
30 minutes 38,7 ± 2,5ºC). All patients recovered calmly.
STATEMENT (CONCLUSIONS)
Doses of 20 mg kg, 30 and 40 tiletamine/zolazepam, 
with or without xylazine in common kestrels (Falco tin-
nunculus), made patient handling easier, thus reducing 
stressful time during clinical routines, although it failed to 
provide good anaesthesia quality. Tiletamine/zolazepam 
combinations, although safe, should not be recom-
mended for general anaesthesia of common kestrels 
(Falco tinnunculus), at these doses, but further studies 
would be interesting.
Use of butorphanol 
in sevoflurane 
anaesthetized Greylag 
geese (Anser anser)
Margarita Galka1, Miguel Angel Quevedo2, 
Jose Maria Aguilar2, Celia Sánchez3,  
Jose Maria Santisteban1,  
Rafael Gómez-Villamandos1 
1 Departamento de medicina y cirugía animal, Córdoba, Spain
2 Zoobotánico, Jerez de la Frontera, Spain
3 Consejo de Seguridad Nuclear, Madrid, Spain 
OBJECTIVES
Pinioning is a method used to prevent flight of birds kept in 
captivity. Traditionally inhalatory agents are used for avian 
anaesthesia. Opiods are strong analgesic agents used widely 
in numerous species, although there are few studies in 
aquatic birds. We wanted a pain free protocol for pinioning.
METHODS
6 Greylag geese (Anser anser) were submitted to pinion-
ing. 2 received only sevoflurane anaesthesia (SEVO group) 
and 4 received 4mg kg–1 butorphanol 20 minutes prior to 
gas induction (SEVO+BUT group). Induction was carried 
out with 8% sevoflurane delivered via facemask attached 
to a semiopen circuit using Ayre’s “T” piece. HR, fR, cloa-
cal temperature, % sevoflurane, SpO2 and PECO2 were 
recorded every 5 minutes. Quality of induction, anaes-
thesia and recovery were also evaluated. 
RESULTS
A swift and smooth induction was achieved in all cases. 
All patients presented an excellent degree of muscle 
relaxation maintaining all vital constants within normal 
limits. All SEVO cases, responded slightly to some of 
the  painful surgical stimuli, while this occurred only in 
50% of SEVO + BUT group. Mean sevoflurane concentra-
tions were 6,7 ± 1,5% (SEVO) and 7,0 ± 1,4% (SEVO + 
BUT). Recovery was also excellent in all cases.
STATEMENT (CONCLUSIONS)
Sevoflurane anaesthesia, with and without butorphanol 
is a safe option for anaethetizing Greylag geese (Anser 
anser) for pinioning, although can not be recommended 
due to lack of analgesia in some cases. Adding 4 mg kg–1 
20 minutes prior to sevoflurane anaesthesia did not 
reduce % sevoflurane requirements and only improved 
analgesia quality in 50% of the patients. Further studies 
are needed, perhaps with higher doses of butorphanol.
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Presumed acute 
polyradiculoneuritis 
in two dogs associated 
with snake bite caused 
by a Montpellier snake 
(Malpolon insignitus)
Virginia Papageorgiou1, George Kazakos1, 
Zacharias Vougioukalos2,  
Zoi Polizopoulou1, Alexia Bourgazli2 
1 Companion Animal Clinic, Aristotle University of Thessaloniki, 
Thessaloniki, Greece
2 Private practinioner, Thessaloniki, Greece 
OBJECTIVES
The aim of this presentation is to describe the clinical 
signs, treatment and outcome of two dogs with Monpel-
lier snake (Malpolon insignitus) envenomation. 
METHODS
This is a report of two adult, male dogs presented at the 
ICU in lateral recumbency a day after a witnessed snake 
bite. According to the owners, the snake population of 
the region, and the macroscopic appearance of the 
wound, the snake was identified as a Montpellier snake 
(Malpolon insignitis). Clinical examination of both dogs 
was unremarkable with the exception of an obvious 
puncture wound on their upper lips, but the neurologic 
examination revealed flaccid, non ambulatory tetrapare-
sis with generalised hyporeflexia, normal functioning 
cranial nerves and hyperesthesia at the site of injury. 
Complete blood count and routine biochemical para-
meters were unremarkable for both dogs except from 
creatine kinase, which was measured in only one dog 
and was elevated. Electromyography findings were com-
patible with polyneuropathy, and a presumptive  diagnosis 
of acute polyradiculoneuritis due to Montpellier snake 
venom was made.
RESULTS
Both dogs were hospitalized in the ICU. Supportive care 
in order to provide adequate food intake, along with a 
combination of antibiotics (cephalosporins) and analge-
sics (tramadol and non steroid anti-inflammatory drugs) 
was provided. In both dogs there was a regression of 
neurological signs. They fully recovered and were dis-
charged in a week. 
STATEMENT (CONCLUSIONS)
This is the first report of a presumptive acute polyradicu-
loneuritis due to Montpellier snake (Malpolon insignitus) 
bite in dogs.
Propofol as a 
postoperative appetite 
stimulant (preliminary 
results)
Virginia Papageorgiou, George Kazakos, 
Charalampos Ververidis, Ioannis Savvas 
Small Animal Clinic, Aristotle University of Thessaloniki,  
Thessaloniki, Greece 
OBJECTIVES
The purpose of this study was to assess the appetite 
stimulant effects of the intravenous administration of 
propofol in dogs postoperatively.
METHODS
In this cohort study, adult, female dogs, submitted for 
elective ovariohysterectomy (ASA status 1) were enrolled. 
All dogs received the same anaesthetic protocol (dexme-
detomidine 180  µg/m2 im, methadone 0.2 mg/kg im, 
meloxicam 0.2 mg/kg sc for premedication, induction 
with propofol to effect and maintenance with isoflourane 
in O2). Inclusion criteria were: the dogs to be fully alert, 
with mild or no pain and stress. Dry food was offered 6 
hours after surgery to all dogs. If any dog was anorectic, 
an intravenous bolus of propofol (2mg/kg) was adminis-
tered. The amount of food consumed was recorded, as 
well as the time from the administration of propofol until 
the consumption of food. In the dogs that did not 
respond to the administration of propofol, the same pro-
cedure was repeated 12 hours later. 
RESULTS
Fifteen dogs were included in the study. All dogs were 
 anorectic 6 hours postoperatively. Ten dogs started eating, 
after the first propofol administration, whereas five dogs 
started eating after the second bolus of propofol, 12 hours 
later. One dog remained anorectic. The dogs that res-
ponded to the propofol bolus consumed one fourth of their 
daily energy requirements, which was offered to them, on 
average 3.7 minutes after the propofol administration.
STATEMENT (CONCLUSIONS)
Preliminary results of this study suggest a positive, short-
term effect of propofol as an appetite stimulantin dogs, 
postoperatively.
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Spontaneous 
haemothorax in 
juvenile dogs:  
a case series
Jen Stallwood1, Sophie Adamantos2, 
Shelley Allen1, Fergus Allerton3, Vicki Black1 
1 Bristol Vet School, Bristol, United Kingdom
2 Langford Vets, Bristol, United Kingdom
3 Willows Veterinary Centre and Referral Service, Solihull, 
United Kingdom 
OBJECTIVES
To describe the clinical features, treatment, and outcome 
of juvenile dogs presenting with spontaneous haemo-
thorax.
METHODS
Multi-centre retrospective referral-based study. Hospital 
databases were searched for dogs aged 1–24 months 
with a diagnosis of spontaneous haemothorax. Dogs 
were defined as spontaneous haemothorax provided 
there was no history of trauma, evidence of a coagulop-
athy (platelet count < 50 x 109/l, prolonged PT or APTT), 
or intrathoracic mass. Data extracted for analysis 
included signalment, history, investigation findings, 
treatment, and outcome.
RESULTS
Seven dogs from two referral centres were identified. 
Median age was 11 months (range 3.5–20 months) with 
no obvious sex predisposition (3 FE, 1 FN, 2 ME, 1 MN), 
there were two Chihuahuas and two whippets, remain-
ing breeds were represented once. Commonly reported 
clinical signs included lethargy (n = 7) and pyrexia (n = 6). 
Thymic pathology was suspected in six dogs based on 
thoracic imaging. Three dogs were managed surgically 
and four were managed conservatively. Medications 
administered included antimicrobials (n = 7), non- 
steroidal anti-inflammatories (n = 3), glucocorticoids 
(n  =  1), one dog managed surgically received a blood 
transfusion. Histopathology of thymic tissue was availa-
ble from the surgically managed dogs and compatible 
with thymic haemorrhage in all cases.
Two out of three dogs managed surgically died, 
recorded reasons were phrenic nerve dysfunction 
 secondary to thoracotomy and acute lung injury follow-
ing mechanical ventilation respectively. All four dogs 
managed conservatively survived with no recorded 
recurrence.
STATEMENT (CONCLUSIONS)
Spontaneous haemothorax can occur in young dogs. 
Pyrexia was a common feature although causality is not 
established. Outcome with conservative management 
appeared to be superior to surgery in this cohort of dogs.
A survey investigating 
factors influencing a 
surgeon’s choice of 
ovariohysterectomy 
Vs ovariectomy when 
neutering female 
dogs in UK small 
animal vet practices
Talya Beattie
Royal Veterinary College, London, United Kingdom 
OBJECTIVES
Ovariohysterectomy (OVH) is the commonest proce-
dure for routine neutering of bitches in the UK, with 
 ovariectomy (OVE) and laparoscopic techniques (LOVH 
and LOVE) becoming more popular. The aim of this 
research was to determine what factors influence tech-
niques chosen by veterinary surgeons (VS) to neuter 
bitches and, in particular, if the most important factor 
influencing choice is undergraduate teaching.
METHODS
Prospective observational cross sectional study. An 
online survey, designed on Survey Monkey, was distrib-
uted to practice email addresses obtained from the 2018 
Royal College of Veterinary Surgeons (RCVS) practice 
database. 3072 emails were delivered, generating 788 
responses (24.3% response rate).
RESULTS
OVH was the most commonly taught technique at uni-
versity (99.3%), followed by OVE. Mann Whitney U tests 
indicated that <5yrs graduates had been taught and 
observed a greater number of techniques than >5 year 
graduates (p < 0.0001, p < 0.0001).
The majority of VS learnt most in their first job 
(62.0%), did not learn a new technique post-graduation 
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(78.2%) and preferred OVH (83.0%). A Kruskall Wallis test 
indicated the most important factor influencing a sur-
geon’s choice of bitch neutering technique was their 
own clinical experience and lack of training in other 
techniques (p  <  0.0001). Cost was the least important 
 factor.
STATEMENT (CONCLUSIONS)
The results of this survey show that despite OVH still 
being the most commonly used neutering technique in 
the UK, most surgeons have a desire to practice different 
techniques. Our data suggest that OVH may be the main-
stay technique used in UK practices due to the lack of 
post-graduate training offered to employees.
Identifying risk factors 
for cardiac murmurs 
in dogs and cats
Becky Milner 
University of Liverpool, Liverpool, United Kingdom 
OBJECTIVES
To identify risk factors associated with the presence of a 
cardiac murmur in dogs and cats using data from the 
Small Animal Surveillance Network (SAVSNET).  
METHODS
A retrospective case-control study using text mining to 
screen over 4 million consultation notes from participat-
ing small animal practices across the UK. Using a regular 
expression and classification system, 1419 consultations 
where a murmur was recorded in the free text were 
 randomly identified. These were compared to 20,000 
 control animals which did not have the word ‘murmur’ 
identified in their records. Both odds ratios (OR) and con-
fidence intervals were calculated for species, breed, age, 
gender and neutering status for both species.
RESULTS
Certain dog breeds were shown to have a higher risk of 
murmurs in this population, the top being the Cavalier 
King Charles Spaniel (OR 10.6). The results also showed 
males (dogs OR 1.07, cats 1.28) and neutered (dogs OR 
1.18, cats OR 1.19) animals had a higher risk. Overall cats 
were more at risk than dogs (OR 1.57). 
STATEMENT (CONCLUSIONS)
The results show certain animals appear to be at a higher 
risk of developing a murmur. This is the first time that 
such data has been used to evaluate murmurs in a large 
population of animals. Murmurs are common and often 
the first sign of heart disease, so by identifying animals at 
risk of murmurs, the management of cardiac disease in 
animals could be improved. 
This was a non-funded summer research project 
carried out by a student hoping to pursue a career in 
small animal cardiology. 
Impact on ear 
concentrations of the 
active ingredients 
following ear cleaning 
with a ceruminolytic 
cleaner in dogs 
receiving a unique 
otic gel (florfenicol, 
terbinafine, 
betamethasone 
acetate)
Kelly Doucette1, Sophie Forster2,  
Merilyn Dobbs3, Rudolph Parrish1 
1 Elanco Animal Health, Greenfield, USA
2 Elanco Animal Health, Basingstoke, United Kingdom
3 Elanco Australasia, Yarrandoo, Australia 
OBJECTIVES
To determine the impact of a ceruminolytic cleaner on 
ear canal depletion of active ingredients of a unique otic 
gel for dogs, after two doses, and beyond the labelled 
period of efficacy. 
METHODS
Twelve adult dogs (4 groups of 3 dogs) with clinically 
normal ears were enrolled in this randomized, unblinded 
depletion study. 
On Day 0 (D0), before first treatment, both ears of all 
dogs were cleaned with saline and ear swabs taken from 
both ears. 
All dogs were treated bilaterally with the otic gel on 
D0 and D7. 
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Bilateral ear swabs were collected from three dogs 
each as follows: D28 post-cleaning with ceruminolytic 
cleaner and additional ear swab on D30; D45 post- 
cleaning with ceruminolytic cleaner and additional ear 
swab on D47; D60 (no cleaning); and D80 (no cleaning). 
RESULTS
Concentrations of actives were substantially higher after 
cleaning on D28 compared to swabs collected 48 hours 
later (D30) with similar results from D45 to D47. This is due to 
actives measured from loosened cerumen immediately 
post-cleaning resulting in an increase of cerumen on swabs. 
Cleaning on D28 or D45 enhanced the removal of active 
ingredients as demonstrated by lower concentrations com-
pared to those measured on D60 without cleaning.
STATEMENT (CONCLUSIONS)
Ear cleaning with a ceruminolytic removes active ingre-
dients but may need repeating to further clean out 
 loosened cerumen. Without cleaning, concentrations of 
actives remain measurable for at least 60 days after 
administration on D0 followed by a second adminis-
tration on D7, with measurements at or below level of 
quantification by D80.
Pylorogastric 
intussusception in a 
puppy with a congenital 
intrahepatic shunt
Petra Černá1,2, Pavel Proks1, 
Joep Timmermans2, Václav Ceplecha1 
1 University of Veterinary and Pharmaceutical Sciences Brno, 
Brno, Czech Republic
2 Vets Now Emergency and Referral Hospital Glasgow,  
Glasgow, United Kingdom 
OBJECTIVES
To report the first case of intrahepatic portosystemic shunt 
and concurrent pylorogastric intussusception in a dog.
METHODS
Case report of a single patient describing intrahepatic 
portosystemic shunt and concurrent pylorogastric intus-
susception in a dog.
RESULTS
A 16-week-old female entire Akita-Inu puppy presented 
for investigation of abdominal distention, acute vomiting 
and transient diarrhoea. After removal of transudate by 
abdominocentesis, abdominal ultrasound revealed a 
small and diffusely hyperechoic liver without visualisa-
tion of parenchymatous branching of portal vessels and 
abnormal tortuous course of the intrahepatic vessel 
 connecting the portal vein and caudal vena cava in the 
right liver lobes. Additionally, pylorogastric intussuscep-
tion was detected. The pylorus and proximal duodenum 
were displaced into the pyloric antrum and fundus. 
 Multiple concentric echogenic and echolucent rings 
were visible on transverse sectionand colour Doppler 
ultrasonography revealed blood flow in vessels of the 
intussuscepted segment of stomach. Due to high  surgical 
costs, medical management with amoxicillin clavulanic 
acid (12.5 mg/kg PO q12h), lactulose (5ml PO q8h), famo-
tidine (0.5 mg/kg PO q24)and probiotics (1g PO q24) was 
elected. Three weeks later, abdominal ultrasound 
revealed a large amount of free anechogenic fluid in the 
abdomen and due to clinical deterioration, poor progno-
sis and financial concerns for coil embolisation, the 
puppy was  euthanised. 
STATEMENT (CONCLUSIONS)
This is the first report in veterinary literature describing 
the occurrence of an intrahepatic portosystemic shunt 
and concurrent pylorogastric intussusception. Pyloro-
gastric intussusceptions can resolve spontaneously, 
however, they can be life threatening and the diagnosis 
can be made based on abdominal ultrasonographic 
 findings.
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Unusual bilateral 
retrobulbar abscess 
in the rabbit
Norbert Czubaj1,2, Jakub Kliszcz3,  
Jacek Sobczyński4, Aneta Gralak5 
1 Department of Morphological Sciences, Faculty of Veterinary 
Medicine, Warsaw University of Life Sciences, Warsaw, Poland
2 Funded by KNOW (Leading National Research Centre) Scientific 
Consortium “Healthy Animal - Safe Food”, decision of Ministry of 
Science and Higher Education No. 05-1/KNOW2/2015, Warsaw, 
Poland
3 Veterinary Clinic “Pulsvet, Warsaw, Poland
4 Veterinary Clinic “Bemowo”, Warsaw, Poland
5 Faculty of Veterinary Medicine, Warsaw University of Life 
Sciences, Student, Warsaw, Poland 
OBJECTIVES
Retrobulbar abscesses are common problem in rabbits. 
Typically they have odontogenic origin. One of the most 
characteristic features of this disease entity is unilateral 
exophthalmos. Differential diagnosis includes: retrobul-
bar neoplasia, cellulitis, prolapse of retrobulbar fat, sali-
vary mucocele, thymoma or other mass within thoracic 
cavity.
We present a case of exophthalmos in a pet rabbit 
suspected as bilateral abscess of the lacrimal gland.
METHODS
Female pet rabbit was presented for dental consultation 
with bilateral asymmetrical exophthalmos and eye dis-
charge. Previous treatment involved eyedrops (diclofenac, 
tobramycin), analgesia (tramadol) and antibiotics (peni-
cylin and streptomycin). Dental examination and X-rays 
in various views were unremarkable (Fig. 1). Dual phase 
CT examination was performed (CereTom®, 8-slice 
portable scanner).
RESULTS
CT examination showed bilateral abscess in the retrobul-
bar region with thinning of the alveolar bulla, more pro-
foundly on the left side (Fig. 2). Due to deterioration of 
the clinical signs the surgery was performed via intraoral 
approach. Last 4 left maxillary cheek teeth, including 
alveolar bulla were extracted. No connection between 
abscess capsule and the bulla was noticed, but lots of pus 
and detritus was drained. The socket was left for healing 
by secondary intention. Due to persisting purulent dis-
charge from the wound decision was made for subse-
quent surgeries – bilateral resection of the zygomatic 
arch with abscess capsule dissection (Fig. 3).
STATEMENT (CONCLUSIONS)
Although no histopathological examination was per-
formed most likely diagnosis was lacrimal gland abscess. 
CT is a great tool in describing pathologies of a dental 
and retrobulbar disease in rabbits. 
Free-floating fat in a 
furry! A mobile necrotic 
lipoma in the abdomen 
of a guinea pig
Chris Webb 
Locum Veterinary Surgeon, High Wycombe, United Kingdom 
OBJECTIVES
To report a mobile intra-abdominal necrotic lipoma in a 
male guinea pig.
METHODS
An adult male neutered guinea pig (age approximately 
3  years) was presented for routine health check after 
being adopted. Recent history was unremarkable though 
physical examination revealed an incidental non-painful, 
firm, highly mobile, bi-convex mass in the mid abdomen. 
Repeat examination 2 months later revealed no pal-
pable changes to the mass, though investigation was 
sought as he had become less interactive. Ultrasound 
examination revealed an approximately 60mm x 40mm 
mass with heterogenous architecture and a thin hypere-
choic rim.
A detached, ovoid, brown, irregular mass with a thin 
friable exterior was identified and removed via a midline 
laparotomy without the need for ligation.
RESULTS
Histopathological examination revealed the mass was 
almost entirely composed of necrotic adipose tissue. Adi-
pocytes were well differentiated and the necrotic outlines 
of the cells were retained. Multifocal areas of necrotic 
fibrous connective tissue and necrotic debris admixed 
with degenerate neutrophils were noted. Multi-focally, 
small to moderate amounts of mineralised material was 
present. The mass was surrounded by a thin rim of fibrous 
connective tissue and diagnosed as a necrotic lipoma.
STATEMENT (CONCLUSIONS)
Several reports of intra-abdominal mobile encapsulated 
adipose tissue in cows have been described with com-
parisons being made to those found in the subcutis of 
extremities in humans.
To the authors knowledge this is the first case of a 
free-floating necrotic lipoma in the coelomic cavity of a 
guinea pig.
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Annual weigh variation 
in mature cats
Nathalie Dowgray1, Kelly Eyre1, 
Gina Pinchbeck2, Eithne Comerford1, 
Vincent Biourge3, Alexander German1 
1 Institute of Ageing and Chronic Disease, Liverpool,  
United Kingdom
2 Institute of Infection and Global Health, Liverpool,  
United Kingdom
3 Royal Canin Research Centre, Aimargue, France 
OBJECTIVES
To determine the magnitude and seasonality of variations 
in bodyweight measurements from client-owned cats 
enrolled in a wellness programme. 
METHODS
Records were available from 31 mature cats (≥7 years) 
attending the Royal Canin Healthy Ageing Clinic. Varia-
tion as a percentage of body weight at enrolment was 
calculated for each cat.
RESULTS
Weight change was minimal, 
Median 
(% change in BW)
IQR
Six month –0.4% –2.7% to 4.4% 
Twelve Month –0.6% –5.3% to 2.4%
Cats were then assigned to groups based upon the time 
of year they were enrolled (Q1 winter, 4; Q2 spring, 16; 
Q3 summer, 11).
Six Month Median 
(% change in BW)
Twelve Month Median 
(% change in BW)
Winter –1.45% (IQR – 
2.035 – –0.85%)
–1.55% (IQR –3.13 – 
–0.55)
Spring 0.18% (IQR – 3.0 
– 4.85)
1.5% (IQR 0.55 – 
3.89)
Summer –0.31% (IQR –3.1 
– 4.58)
–4.8% (IQR – 7.58 
– 1.625) 
There were no statistically significant differences found 
between these three groups at the 6-month time point. 
However, at the 12-month time point, cats enrolled in Q2 
were significantly more likely (P = 0.020) to have gained 
weight then cats that were enrolled in Q3.
STATEMENT (CONCLUSIONS)
This preliminary work suggests a seasonal effect on the 
bodyweight of mature cats. However, these findings 
should be confirmed by assessing a larger group of cats 
over a longer period.
How old is your cat?
Kelly Eyre1, Nathalie Dowgray1,  
Gina Pinchbeck2, Vincent Biourge3, 
Alexander German1 
1 Institute of Ageing and Chronic Disease , Liverpool, United 
Kingdom
2 Institute of Infection and Global Health, Liverpool,  
United Kingdom
3 Royal Canin Research Centre, Aimargues, France 
OBJECTIVES
To explore the accuracy of veterinary age assessment in 
mature cats and the effect that health status may have on 
the visual appearance of age. 
METHODS
Data were collected from 135 mature cats (7–10 years) 
enrolled at the Feline Healthy Ageing Clinic at the 
 University of Liverpool. At time of enrolment, owners 
 completed a questionnaire which gathered information 
on date of birth, whether this was an estimate or was 
known, details of where the owner had acquired the cat, 
and how old the cat was when acquired. At their initial 
appointment, each cat had a thorough physical examina-
tion, and routine clinicopathological assessments (hae-
matology, serum biochemistry and urinalysis). The 
attending veterinary staff (KJE, NJD) also subjectively 
assessed whether the cat: looked ‘younger than their 
reported age’, was ‘age-appropriate’, or was ‘older than 
their reported age’. Cats were also subjectively classified 
as being ‘healthy’, ’in fair health’ or ‘in poor health’ based 
upon physical examination findings, details in their elec-
tronic patient records, and results of routine clinicopatho-
logical tests. For comparison, cats were grouped 
according to the accuracy of their age, summarised below. 
RESULTS
An accurate age was known for 73 cats (54%), a close 
estimation was known for 22 cats (16%), and age was not 
accurately known for 40 (30%) cats.  
Cats with an inaccurate age were 5.9 times more 
likely to have poor health (95% CI 1.2 – 29.3). A cat that 
looked older than its purported age was 18.6 times more 
likely to have poor health (95% CI 3.9 – 88.0).
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STATEMENT (CONCLUSIONS)
A significant proportion of middle-aged cat have a poten-
tially inaccurate age. The observation that cats who appear 
Subjective age assessment and health status
Number 
of cats
Younger Age appropriate Older
Accurate age (DOB known or 
acquired as a kitten <12w)
73 (54%) 15 (0 in poor health) 53 (0 in poor health) 5 (1 in poor health)
Close estimate (DOB not known but 
acquired as a kitten <24 w)
22 (16 %) 3 (0 in poor health) 17 (1 in poor health) 2 (0 in poor health)
Inaccurate >12 years (exact age not 
known, but acquired as adult)
40 (30%) 4 (0 in poor health) 27 (1 in poor health) 9 (4 in poor health)
older than their purported age are at higher risk of being in 
poor health is clinically applicable. Such  observation could 
be used to prompt veterinarians to perform further diag-
nostic investigations. 
Deslorelin implant  
as a treatment for 
temporary infertility 
in tomcats
Kaisa Savolainen1, Merja Dahlbom2 
1 Estonian University of Life Sciences, Tartu, Estonia
2 University of Helsinki, Helsinki, Finland 
OBJECTIVES
Biggest reasons for temporary infertility treatment in 
tomcats are undoubtedly unwanted urine marking, 
vocalization, behavioural changes and poor appetite. 
Deslorelin is synthetic gonadotropin-releasing hormone 
agonist used to induce temporary infertility. At the 
moment use in cats is off-label and there is only little 
research done on the subject.
METHODS
Study was done as online survey to cat owners who have 
used the implant on their tomcats.
RESULTS
In total 486 answers were given from 28 countries and 
31 different breeds. 70.8% of cats had offspring before 
implant and 89.2% of the cats got offspring after implant. 
Average age at implantation was 24.1 ± 14.6 months. In 
average the effect lasted 14.8 ± 6.0 months. It signifi-
cantly reduced (p < 0.0001) urine marking, vocalization, 
aggressiveness, restlessness and weight loss. Smell of 
pee decreased in 87% and testicle size decreased in 91% 
of the cats. Weight gain was reported in 77.5% of the 
cats. The implant had no effect in 2.1% of the cats. 19.5% 
tried to mate females in heat even without any other 
signs of stud behaviour and 5.3% got offspring during 
the implant. In 17% of cats the effect of second implant 
lasted longer than first and in 27.4% the effect ended 
earlier. 93% of owners had positive overall experience of 
the implant. 
STATEMENT (CONCLUSIONS)
In conclusion, deslorelin implant is easy to use and can 
be used as a temporary infertility treatment in tomcats, 
but it is not 100% effective and tomcats with the implant 
should be kept separated from females they are not 
allowed to mate.
421-550 Clinical Abstracts.indd   535 08/03/2019   18:39
Poster presentations
[ 536 ] BSAVA CONGRESS 2019 PROCEEDINGS
Differences between 
the gut microbial 
composition of 
diarrheic and  
healthy dogs
Ronnie Gueta, Tamara Wunder, Anton 
Heusinger, Elisabeth Müller 
Laboklin GmbH & Co. KG, Bad Kissingen, Germany 
OBJECTIVES
Imbalances in the microbial composition of the intestinal 
microbiome are associated to various gastrointestinal 
diseases like chronic inflammatory enteropathy (CED) or 
inflammatory bowel disease (IBD). Recent studies have 
identified eight bacterial groups that are altered in dogs 
with chronic or acute gastrointestinal signs in compari-
son to healthy individuals and may be used as biomarkers 
for dysbiosis. Aim of the study was to establish a method 
suitable for the routine diagnostic screening of the intes-
tinal microbiota for dysbiotic changes in dogs.
METHODS
DNA from fecal samples from dogs (n = 10) with acute 
diarrhea and healthy dogs (n = 10) as control group was 
extracted during veterinary routine diagnostics. Subse-
quently qPCR assays targeting 16S rRNA genes for eight 
different bacterial groups (Faecalibacterium prausnitzii, 
Fusobacteria, Blautia, Turicibacter, Escherichia coli, 
Clostridium hiranonis, Streptococcus and total bacteria) 
were performed and total copy numbers per g faeces 
calculated.
RESULTS
The intestinal microbiota of dogs with acute diarrhea 
were different to the one of the healthy control group. 
Particularly F. prausnitzii, an anaerobic species that has 
been reported to have beneficial effects on the integrity 
of the intestinal mucosal barrier was decreased 5-fold. In 
contrast, proteolytic microorganisms that may induce 
intestinal tumorogenesis or have pro-inflammatory 
potential like Fusobacteria were increased up to 10-fold.
STATEMENT (CONCLUSIONS)
This study supports the hypothesis that alterations of the 
intestinal microbiota correlate with acute enteropathies 
in dogs. Furthermore, we highlight the additional insights 
this type of analysis offers in the future for differential-
diagnostic purposes.
Suspected Choledochal 
Cyst in a DSH cat
Konstantinos Fontas 
Downs Veterinary Referrals, Bristol, United Kingdom 
OBJECTIVES
To present an uncommon cystic disease of the biliary 
tract in a cat.
METHODS
A 9-year old female neutered cat was presented with 
polyphagia, weight loss, urinating in the house and 
behaviour change. In the clinical examination, jaundice 
and a palpable mass in the cranial abdomen were found. 
Haematology and biochemistry showed increased liver 
enzymes, total bilirubin and leucocytosis. Abdominal 
radiology and ultrasonography confirmed a large cystic 
structure caudal to the liver. Also, ultrasound-guided 
needle aspiration was taken, revealing a highly proteina-
ceous fluid with mixed bacterial growth. After stabiliza-
tion, exploratory laparotomy was performed, revealing a 
large, thick, fluid-filled structure within the cranial 
 abdomen. The gall bladder and the pancreas were 
oedematous. Examination within the cyst showed poten-
tial communications with the duodenum and the biliary 
tree. Therapeutically, subtotal resection of the cyst wall 
was performed and after closing the connections, the 
remaining cavity was omentalised. Histopathology 
 samples revealed multi-loculated cystic structure, 
chronic cholangitis and lymphoplasmacytic pancreatitis. 
Postoperatively, ursodeoxycholic acid, antioxidants and 
antibiotics were administered .
RESULTS
The cat had an unremarkable recovery and so far the 
prognosis appears to be favourable. However, close 
monitoring is indicated to prevent recurrent biliary 
obstruction and ongoing hepatic and pancreatic disease. 
STATEMENT (CONCLUSIONS)
A choledochal cyst is rare in the cat. In the current case, 
the cyst was possibly of congenital origin and gradual 
distension resulted in late onset clinical signs due to bil-
iary obstruction and bacterial infection from the intes-
tine. Furthermore, late onset cyst development can be 
associated with underlying intestinal, pancreatic or  biliary 
pathology. 
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Novel causes of  
Budd-Chiari-like 
syndrome in two dogs
Harry Swales1, Elizabeth Bode1,  
Francisco Fernández Flores2,  
Alistair Freeman1, Jeremy Mortier1,  
Matteo Rossanese1, Yi Lin Tan1,  
Ranieri Verin2, Erin O’Connell1 
1 University of Liverpool Small Animal Teaching Hospital, 
Liverpool, United Kingdom
2 University of Liverpool Veterinary Pathology, Liverpool, 
United Kingdom 
OBJECTIVES
To outline the investigation of two unusual cases of Budd- 
Chiari-like syndrome.
METHODS
N/A
RESULTS
Case 1: A 6-year-old, male-neutered Brittany spaniel 
presented with a week’s history of progressive ascites. 
Investigations revealed hypoalbuminaemia (20g/L) but 
normal globulins (26g/L). Resting bile acids (5.6µmol/L), 
ammonia (6µmol/L) and the UP:C (0.12) were within nor-
mal limits. Abdominocentesis yielded a high protein tran-
sudate. CT-angiography revealed progressive narrowing 
of the caudal vena cava (CaVC) at the level of the dia-
phragm but no evidence of intra- or extra-mural com-
pression. No improvement was seen following caval 
stenting or after administration of human serum albumin 
or dexamethasone. Post-mortem examination revealed 
hepatic cirrhosis and a spherical appearance to the cra-
nial liver resulting in extra-mural compression of the 
CaVC and hepatic veins. This was deemed the primary 
cause of the recurrent ascites.
Case 2: A 10-year-old, male neutered Border terrier 
presented with a four-day history of recurrent ascites. 
Biochemistry revealed hypoalbuminaemia (21g/L) and 
mild hypoglobulinaemia (24g/L). Post-prandial bile 
acids  were not suggestive of a portosystemic shunt 
(16.7µmol/L) and the UP:C (0.14) was within normal 
 limits. Peritoneal fluid analysis was consistent with a high 
protein transudate. CT-angiography revealed focal 
 stenosis of the CaVC caudal to the right atrium due to 
 circumferential wall thickening. Post-mortem gross 
examination revealed mediastinal lymphadenomegaly, 
microscopically characterised by nodal histiocytic 
anthracosis, causing extra-mural compression of the 
CaVC. This abnormality was deemed the primary cause 
of the recurrent ascites.
STATEMENT (CONCLUSIONS)
These cases represent two previously unreported causes 
of Budd-Chiari-like syndrome in dogs, both caused by 
extra-mural compression of the CaVC.
Fanconi-Syndrome  
in a Labrador Retriever
Corinna N. Weber1, Sabine Gerber-Andries1, 
Albert Schmidt2, Katrin Jaeger1,  
Elisabeth Mueller1 
1 Laboklin GmbH & Co. KG, Bad Kissingen, Germany
2 Kleintierpraxis Graesser, Grossostheim, Germany 
OBJECTIVES
Fanconi syndrome is a inadequate reabsorption in the 
proximal renal tubules because of congenital or acquired 
causes, resulting in a selective or generalized aminoaci-
duria and the loss of electrolytes, glucose, lactate and 
bicarbonate with the urine. Left untreated, Fanconi syn-
drome leads to progressive kidney failure. 
METHODS
A male 11 year old Labrador Retriever was presented to 
the clinic with vomiting, lethargy, weakness, and polydip-
sia. Increased levels of urea and creatinine were found in 
the blood, as well as a mild anemia. Urinalysis showed a 
severe aminoaciduria and glucosuria.
RESULTS
The findings of the clinical examination together with 
blood work and urinalysis were consistent with Fanconi 
syndrome. In the following months, the general condi-
tion deteriorated, and serum concentrations of urea and 
creatinine increased. The dog was euthanized 17 months 
after the first presentation. Both kidneys showed a highly 
uneven surface of firm consistency and massive concre-
tion deposits in the renal pelvis. Pathohistological exam-
ination revealed a bilateral severe chronic interstitial 
lymphoplasmacellular pyelonephritis with severe neph-
rolithiasis and cyst formation. The concrements found in 
the renal pelvis were beige and smooth and mostly com-
posed of struvite together with calcium-rich apatite. 
STATEMENT (CONCLUSIONS)
For Labrador Retrievers, several cases of Fanconi syn-
drome have been reported in the literature, in some 
cases linked to a copper-mediated hepatitis. In the 
 present case, no copper storage disease was detected, 
and there was no evidence of alimentary or drug related 
reasons. Further research is needed to identify possible 
congenital causes in the Labrador Retriever.
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Steroid responsive 
Meningitis Arteritis and 
concurrent Osteoma 
cutis in a dog
James Barton, Daniela Alder,  
Filippo De Bellis 
Southern Counties Veterinary Specialists, Ringwood, United Kingdom 
OBJECTIVES
Osteoma cutis refers to heterotropic ossification within the 
skin. Whilst veterinary reports are few, a number of cases 
suggest an association of osteoma cutis in dogs with 
chronic glucocorticoid therapy. Steroid Responsive Men-
ingitis Arteritis (SRMA) is an immune mediated inflamma-
tory disorder of the leptomeninges and associated arteries. 
It is typically seen in young dogs between 6 and 18 months. 
Patients commonly present with cervical pain and pyrexia. 
Prednisolone monotherapy is the mainstay of treatment.
We report a case of osteoma cutis in a dog with a 
concurrent relapse of SRMA. We also report the use of 
cytarabine as a successful treatment for the SRMA.
METHODS
A one-year old female neutered Border Collie presented 
with cervical pain and pyrexia. Clinical examination 
also revealed multiple hard non-painful plaques beneath 
the skin between the shoulder blades and base of the 
tail. Wedge biopsies of the skin lesions and a cisternal 
CSF tap were taken for histopathology and cytology 
respectively.
RESULTS
Cytology of CSF revealed a neutrophilic pleocytosis con-
sistent with SRMA. Histopathology showed the presence 
of calcified bone within the subcutis.
Given the association within the literature of osteoma 
cutis and steroid use, the dog was started on intravenous 
cytarabine infusions. As they were not causing any mor-
bidity, the osteoma cutis lesions were monitored.
After 6 months of follow up the dog is in remission 
and showing no ill effects from her skin lesions.
STATEMENT (CONCLUSIONS)
To the best of our knowledge, we report the first case in 
the literature of cytarabine as an effective monotherapy 
for SRMA and only the fourth case in the literature of 
osteoma cutis.
Prevalence of 
neurological disorders 
in Cavalier King 
Charles Spaniels in 
neurology referral 
populations
Katie Brown1, Rowena Packer2, 
Holger Volk3, Clare Rusbridge 1,4 
1 University of Surrey, Guildford, United Kingdom
2 The Royal Veterinary Collage, Hertfordshire, United Kingdom
3 The Royal Veterinary College, Hertfordshire, United Kingdom
4 Fitzpatrick Referrals, Godalming, United Kingdom 
OBJECTIVES
This study aimed to determine the distribution of clini-
cal presentations and the prevalence of neurological 
 conditions in  Cavalier King Charles Spaniels (CKCS). A 
particular focus was placed upon establishing if syringo-
myelia was a prevalent disease in CKCS and a frequent 
diagnosis in referral populations.
METHODS
Records of 500 CKCS presenting to Fitzpatrick Referrals 
and the Royal Veterinary College neurology departments 
over a selected four-year period (September 2013– 
 September 2017) were searched. Data was examined to 
determine the presenting clinical signs and final diagno-
sis made and analysis was carried out to establish the 
prevalence and frequency of these.
RESULTS
The most common clinical presentations of all neurolog-
ical conditions were behavioural signs of pain (312 cases; 
62.4%), spinal pain (238; 47.6%), phantom scratching (121; 
24.2%) and gait abnormalities (90; 18.0%). The most 
common final diagnosis was syringomyelia (216 affected; 
43.2% prevalence), orthopaedic conditions (74; 14.8%) 
and intervertebral disc disease (60; 12.0%). Other less fre-
quently documented conditions included Chiari-like 
malformation associated pain (56; 11.2%), myoclonus (19; 
3.8%), epilepsy (18;3.6% and skin disease (12; 2.4%).
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STATEMENT (CONCLUSIONS)
This study provides vital information for veterinarians, 
breeders and owners of CKCS about common presenta-
tions of syringomyelia and other neurological diseases to 
allow for earlier recognition of these potentially painful 
disorders. It concludes that syringomyelia is the most 
prevalent neurological disease in referral practices and 
emphasizes the frequency of pain associated with neuro-
logical disorders, but when compared to previous studies, 
it may be underdiagnosed in first opinion practices.
Rostral skull changes in 
Cavalier King Charles 
spaniels with Chiari-like 
malformation and 
syringomyelia
Eleonore Dumas1, Susan Penny Knowler1, 
Felicity Stringer2, Clare Rusbridge2 
1 School of Veterinary Medicine, Faculty of Health & Medical 
Sciences, University of Surrey, Guildford, United Kingdom
2 Fitzpatrick Referrals, Godalming, United Kingdom 
OBJECTIVES
Chiari-like malformation (CM) and secondary syringo-
myelia (SM) have proven associations to multiple mor-
phological traits of the caudal cranium and cervical spine 
in Cavalier King Charles Spaniels (CKCS). Since brachy-
cephaly increases risk for disease, this study focused on 
the morphology of the rostral skull and forebrain and 
aimed to identify physical features associated to devel-
opment of CM associated pain (CM-P) and SM with a 
more severe phenotype.
METHODS
Analysis of 12 measurements (11 lines and 1 angle) taken 
on T2 weighted midsagittal MRI of the skull and cervical 
spinal cord of 66 CKCS enabled the comparison of 3 
phenotypic groups: dogs without SM or CM-P (control 
group; n = 11), dogs with CM-P only (n = 15), dogs with 
clinically severe CM/SM (syrinx transverse diameter 
≥4mm and clinical signs relating to SM; n = 40).
RESULTS
SM-affected CKCS had an increased height of the cra-
nium (p = 0.028) and reduced depth of the stop 
(p  =  0.006) compared to controls. SM-affected CKCS 
also had a significant reduction in height of the nasal 
cavity compared to CM-P (p = 0.014). There were 2 addi-
tional significant traits comparing dogs with and without 
SM; SM affected dogs had a more ventral orientation of 
the olfactory bulbs (p = 0.014) and shorter distance 
between basicranium and hard palate (p = 0.031). 
STATEMENT (CONCLUSIONS)
Dogs with symptomatic CM/SM are more likely to have 
brachycephalic features of the rostral skull with “midface” 
hypoplasia similar to craniosyostosis Crouzan syndrome. 
This not only enhances our understanding of the disease 
and “at risk” head conformation but could also impact 
assessment of MRI and disease diagnosis.
Unusual clinical 
presentation of 
dystrophin-deficient 
feline muscular 
dystrophy in the UK
Aldara Eiras-Diaz, Jessica Florey 
Dick White Referrals, Six Mile Bottom, United Kingdom 
OBJECTIVES
Dystrophin-deficient feline muscular dystrophy is a rare 
myopathy caused by absence of dystrophin, a large pro-
tein found in cardiac and skeletal muscles. The majority 
of previously reported cases have presented with gener-
alised muscle hypertrophy and overt gait abnormalities. 
METHODS
An eight month old male neutered domestic short hair 
was referred for further investigation of a four day history 
of regurgitation and tongue lesions. Multiple non-painful 
raised white plaques were visualised on the tongue. Mild 
pelvic limb stiffness and plantigradism was detected. 
Cranial nerves were assessed to be normal.
RESULTS
Moderately increased ALT, AST and markedly raised 
 Creatine Kinase were documented. Thoracic radiographs 
revealed severe oesophageal dilation, cardiomegaly, 
scalloped diaphragm and sternal malformation. Tongue 
lesion histology revealed calcinosis circumscripta. These 
features raised the suspicion of feline muscular  dystrophy. 
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Further investigations were declined given the poor 
prognosis and the patient was humanely euthanised.
Post-mortem histopathology exhibited severe 
myofiber diameter variability with degenerative changes 
and prominent calcific deposits in the tongue and 
 diaphragm. Similar findings were detected in multiple 
skeletal muscles.
Generally, fresh or frozen samples are needed for 
immunohistochemical investigations. An alternative 
immunohistochemistry technique (HRP method) using 
anti-DYS1, DYS2, DYS3, α-sarcoglycan and γ-sarcoglycan 
antibodies in formalin-fixed samples was performed. The 
negativity for dystrophin confirmed the diagnosis of 
feline muscular dystrophy. 
STATEMENT (CONCLUSIONS)
An unusual clinical presentation of feline muscular dys-
trophy is described. This condition should be considered 
in cats presenting with regurgitation and tongue lesions. 
The HRP method can be used in formalin-fixed muscle 
samples to confirm the diagnosis. 
Comparison of 
outcome of dogs with 
thoracolumbar spinal 
injuries based on 
treatment and severity 
of neurologic status
Panagiotis Kokkinos1, Georgios Kazakos2, 
Nikitas Prassinos2, Michael Patsikas2, 
Leonidas Panagiotis Ntioukas3 
1 Animal Health Trust, Lanwades Park, Kentford, Newmarket, 
Suffolk CB8 7UU, United Kingdom
2 Companion Animal Clinic, School of Veterinary Medicine, 
Aristotle University of Thessaloniki, Thessaloniki, Greece
3 Department of Statistics, Athens University of Economics and 
Business, Athens, Greece 
OBJECTIVES
To retrospectively compare the outcome of dogs with 
fractures/luxations of the thoracolumbar spine based on 
neurologic status and treatment method.
METHODS
In our study period, 53 dogs with injury of the thora-
columbar spine and a recorded outcome were enrolled. 
Neurologic status was classified in a 5-grade scale; an 
additional grade (“grey zone”) introduced between para-
plegic cases with (grade 4) and without (grade 5) nocice-
ption and included subjects with reduced, but not absent, 
deep pain perception. The statistical models used for the 
purposes of this study aimed to reveal useful insights 
about the variables that affect final clinical outcome the 
most. Additionally, the distribution of incidents between 
each possible level of neurologic grade, final clinical out-
come and treatment were examined and tested indepen-
dently. The R software was used for the statistical analysis 
and a value of p < 0.05 was considered significant.
RESULTS
The neurologic status was the only statistically signifi-
cant variable affecting outcome. No other variable 
or comparison revealed a statistically significant result. 
Furthermore, the newly introduced grey-zone showed 
to have a trend towards the less severe cases (grade 1 
to 4) regarding treatment, whereas a trend towards the 
most severe cases (grade 5) was shown regarding 
 outcome.
STATEMENT (CONCLUSIONS)
The severity of neurological status affects the outcome. 
Cases classified in the grey zone had similar outcome to 
the severe cases (grade 5), despite being treated in a pat-
tern similar to the milder cases (grades 1 to 4). Conclud-
ing, in severe thoracolumbar syndrome the reduced but 
not absent deep pain perception did not significantly 
improve outcome of affected dogs.
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Delayed forebrain 
syndrome due to 
traumatic intranasal 
meningoencephalocele 
in a cat
Theophanes Liatis1, Alberta De Stefani2, 
Panagiotis Mantis3, Giunio Bruto Cherubini1 
1 Neurology & Neurosurgery, Dick White Referrals, Six Mile 
Bottom, United Kingdom
2 Queen Mother Hospital for Animals, Royal Veterinary College, 
Hatfield, United Kingdom
3 Diagnostic Imaging, Dick White Referrals, Six Mile Bottom, 
United Kingdom 
OBJECTIVES
Meningoencephalocele is a protrusion of meninges and 
brain through an opening in the cranium; in humans it 
may be congenital, traumatic, neoplastic or idiopathic, 
whilst in small animals mostly congenital form has been 
reported.
METHODS
A 3-year-old, client-owned, neutered male DSH cat was 
referred with one-month history of three generalized 
tonic-clonic seizures and intermittent left thoracic limb 
spontaneous knuckling. Nine months ago, the animal 
had been bitten on the head by a wild carnivore. Prior to 
the traumatic event the cat was reported to be neurolog-
ically normal.
RESULTS
On admission, physical examination was unremarkable. 
Neurological examination revealed left hemi-neglect 
syndrome, characterised by decreased postural reac-
tions on the left thoracic and pelvic limb, and absent 
menace bilaterally, most likely post-ictal. Neuroanatom-
ical localisation was right forebrain. Haematology, 
 biochemistry and bile acid stimulation test were unre-
markable. Blood serology for Toxoplasma gondii, FIV, 
FeLV and FCoV were all negative. MRI of the head 
revealed protrusion of brain and meninges into the right 
frontal sinus, mild meningeal contrast uptake of the 
 protruding tissue and the adjacent brain in the calvarium. 
CSF analysis was unremarkable. Final diagnosis was 
 traumatic intranasal (frontoethmoidal) meningoenceph-
alocele with late-onset forebrain syndrome due to 
 presumptive post-traumatic encephalomalacia. The cat 
remained seizure-free on the four-month follow-up.
STATEMENT (CONCLUSIONS)
This is the first report of traumatic meningoencepha-
locele in cats. The finding in this case emphasizes the 
importance of a complete neurological investigation in 
patients with history of head trauma despite the absence 
of initial neurological signs. Differentials for delayed neu-
rological signs after traumatic meningoencephalocele 
include encephalomalacia, recurrent meningitis with/
without CSF rhinorrhea or cerebral ischaemic infarction.
Key factors that 
influence an owner’s 
decision to feed their 
dog a senior diet
Elinor Tedds, Teresa Hollands 
School of Veterinary Medicine, University of Surrey, Guildford,  
United Kingdom 
OBJECTIVES
To determine what influences an owner’s decision to feed 
a senior diet. Few senior dogs in the UK are fed age- 
appropriate diets despite evidence that these dogs have 
reduced maintenance energy requirements, increased pro-
tein requirements and a reduced basal metabolic rate and 
that diet can be used to manage or treat age-related disease.
METHODS
A mixed methods questionnaire was distributed to dog 
owners via seven UK dog Facebook groups. Dogs age 
seven and over were classed as senior. Data analysis was 
carried out in Microsoft Excel.
RESULTS
59% (n = 214) of dogs in the study were classed as senior. 
Despite 27% of owners worrying about their dog’s ageing 
and 84% recognising that diseases such as obesity and 
diabetes can be supported by diet, only 25% of senior 
dogs were fed senior diets. Factors influencing this deci-
sion were if the dog was fed a commercial diet, if the 
owner was worried about their dog’s ageing, recognition 
that their dog’s nutritional requirements change, the pro-
vision of joint support within the diet, specific ingredients 
in the food and if the diet was ‘good quality’. 64% of own-
ers thought glucosamine should be added to senior dog 
diets and 60% had spoken to their vet about nutrition of 
their dog.
STATEMENT (CONCLUSIONS)
Many owners speak to their vet about their dog’s diet, but 
few feed an age-appropriate diet. This highlights a 
missed opportunity for veterinarians to be more proac-
tive in discussing diet with clients and to use diet in the 
treatment and prevention of disease.
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The use of toceranib 
phosphate after 
surgical resection of 
haemangiosarcoma 
from the aortic arch 
in a German 
Shepherd dog
Petra Černá1,2, Liz Welsh1, Pamela Martin1 
1 Vets Now Emergency and Referral Hospital Glasgow, Glasgow, 
United Kingdom
2 University of Veterinary and Pharmaceutical Sciences Brno, 
Brno, Czech Republic 
OBJECTIVES
To report the post-operative outcome and survival of a 
dog after surgical resection of a haemangiosarcoma 
from the aortic arch using toceranib phosphate as an 
adjunctive therapy.
METHODS
Case report of a single patient treated with metronomic 
chemotherapy instead of conventional high-dose 
 chemotherapy for adjuvant therapy of hemangiosar-
coma of the aortic wall.
RESULTS
A 7-year-old male German Shepherd dog presented for 
investigation of lethargy. Pleural, peritoneal and pericar-
dial effusion were identified, and echocardiography was 
indicative of a heart-based mass. The mass was surgically 
excised from the aortic arch and a subtotal pericardiec-
tomy performed. Histology confirmed the mass was an 
incompletely excised haemangiosarcoma. The patient 
was started on epirubicin protocol (25mg/m2)but devel-
oped a severe septic neutropenia and thrombocytope-
nia. This recurred following the second treatment of 
epirubicin despite a dose reduction of 10%. Conse-
quently, the patient was started on metronomic chemo-
therapy with toceranib phosphate (80mg orally Monday, 
Wednesday and Friday weekly). Eight months following 
the diagnosis the patient remains systemically well on 
metronomic chemotherapy with an excellent quality of 
life. Repeat staging has been negative for local and dis-
tant metastases but shows tissue thickening at the level 
of the aortic arch.
STATEMENT (CONCLUSIONS)
Metronomic chemotherapy has been proposed for adju-
vant therapy in dogs that do not tolerate conventional 
anthracycline based chemotherapy protocols. This is the 
first reported case of the use of a tyrosine kinase inhibitor 
as an adjuvant therapy for cardiac haemangiosarcoma.
Hemipelvectomy  
in a rabbit: surgical 
technique and outcome
Laura Homer, Nicholas Bacon 
Fitzpatrick Referrals Oncology & Soft Tissue, Guildford,  
United Kingdom 
OBJECTIVES
To describe the clinical presentation, surgical technique 
and postoperative outcome of a rabbit after a right-sided 
hemipelvectomy to treat a proximal femoral sarcoma.
METHODS
A seven-year-old female rabbit was presented with a six-
month history of chronic right pelvic limb lameness. 
Radiographs revealed a lytic coxofemoral lesion and 
computerized tomography detailed an expansile lesion 
within the proximal femur, with an appearance consistent 
with a soft tissue mass. Incisional biopsies revealed a 
poorly differentiated sarcoma. A right-sided hemipelvec-
tomy was performed. The pubis was cut paramedian at 
the cranial and caudal edges of the right obturator fora-
men and the sacroiliac joint was disarticulated. The 
resultant defect in the pelvic diaphragm was repaired by 
opposing the thoracolumbar fascia with external abdom-
inal oblique and rectus abdominus with polydioxanone. 
Histopathology confirmed the biopsy findings, with 
tumor free margins achieved. 
RESULTS
The patient recovered well from surgery and had good 
mobility. The patient survived 21 months post-surgery 
and died of non-cancer related disease. 
STATEMENT (CONCLUSIONS)
To the authors’ knowledge this is the first report of a 
hemipelvectomy performed in a rabbit. We describe the 
anatomical dissection in a cadaver to aid future surgeries. 
Hemipelvectomy is a surgery that is more routinely per-
formed in canine and feline patients, but with the right 
candidate and owner commitment to aftercare, it can 
safely and successfully be performed in rabbits.
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Oral histiocytic 
sarcoma in a cat
Slavomíra Néčová1, Stephen Cahalan2, 
Susan North3, Smita Das4 
1 Southfields Veterinary Specialists , Laindon , United Kingdom
2 Bridge Pathology Ltd. , Bristol , United Kingdom
3 Southfields Veterinary Specialists , Laindon, United Kingdom
4 Davies Veterinary Specialists , Higham Gobion, United Kingdom 
OBJECTIVES
Feline histiocytic disease is poorly reported in the veteri-
nary literature. Here we describe a tumour of the feline 
soft palate most consistent with histiocytic sarcoma. To 
the author’s knowledge this is the first report of a feline 
histiocytic sarcoma of the oral cavity. 
METHODS
A 15 year-old male neutered domestic shorthair cat pre-
sented with a mass on the caudal soft palate. An inci-
sional biopsy was performed and sarcoma was highly 
suspected. Computed tomography (CT) of the patient’s 
head and thorax identified a discrete, left-sided, soft tis-
sue mass lesion cranial to the tonsil. Surgical removal 
achieved cytoreduction. Adjuvant lomustine chemother-
apy was initiated but was discontinued after one treat-
ment cycle due to pancreatitis. 
RESULTS
Histopathology of the mass showed proliferation of 
large, polygonal to occasionally spindled neoplastic cells 
forming solid sheets and poorly defined streams. There 
was marked anisocytosis, anisokaryosis and frequent 
multinucleated giant cells. Periodic acid–Schiff and 
Ziehl–Neelsen stains were negative. Immunohistochem-
istry showed strong membranous HLA-DR positivity 
along with membranous CD18 immunopositivity within 
tumour macrophages. There was weaker CD18 and IBA 1 
staining of neoplastic cells. Immunohistochemistry for 
Melan A, PNL2 and CD117 was negative. The patient was 
diagnosed with suspected local recurrence 3 months 
post-operatively and was euthanised 6 months after ini-
tial diagnosis due to disease progression. 
STATEMENT (CONCLUSIONS)
Histiocytic sarcoma should be considered as a differen-
tial diagnosis in feline patients with an oral mass, espe-
cially if histopathology suggests a pleomorphic and 
poorly differentiated sarcoma. Immunohistochemistry 
for the confirmation of cell line origin would be strongly 
recommended.
Unusual presentation 
of a bone metastasis in 
canine prostatic 
carcinoma
Slavomíra Néčová1, Poppy Winter2, 
Sarah Mason1 
1 Southfields Veterinary Specialists , Laindon , United Kingdom
2 Maltman Cosham Veterinary Clinic, Horsham, United Kingdom 
OBJECTIVES
The objective of this case report is to describe the 
 radiological appearance of an elbow metastasis from a 
prostatic carcinoma. 
METHODS
An eight year old male neutered Chesapeake Bay 
Retriever presented with a few day history of dysuria and 
tenesmus. The dog was diagnosed with prostatic adeno-
carcinoma with urinary bladder involvement and regional 
lymph node metastases. The dog developed mild lame-
ness on left fore limb one month after initial presentation 
which progressed over two weeks to non-weight bearing 
despite pain relief and anti-inflammatory medication. 
Significant left elbow thickening was present. The com-
puted tomography (CT), arthrocentesis and FNA of mac-
roscopically abnormal tissue was performed. 
RESULTS
CT revealed a polyostic aggressive lesion, characterised 
by irregular periosteal proliferation, affecting the proxi-
mal ulna and radius, and humeral condyles. Mild cortical 
thinning and lysis at the anconeal and lateral coronoid 
processes was present. The primary differential for these 
changes was an inflammatory, degenerative and/or 
infectious process. Neoplasia was considered less likely 
due to the distribution of the lesions. Cell morphology of 
a changed bone was consistent with metastatic carci-
noma. There were rare atypical cells within the joint fluid 
which also raised concern for a neoplastic process asso-
ciated with the joint. Histopathological evaluation of the 
left elbow confirmed metastatic carcinoma with peri-
osteal new bone formation, cartilage erosion and sub-
chondral fibrosis.   
STATEMENT (CONCLUSIONS)
This case demonstrates that metastatic carcinoma can 
radiologically appear as an inflammatory/infectious pro-
cess and involve multiple bones including joint. Cytolog-
ical or histological confirmation of similar changes in 
carcinoma patients is advised. 
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Peritoneal 
lymphomatosis in a cat
Marie Vagney1, Nicolas Noel1, Julie Duboy2, 
Hélène Le Pommellet1, Julien Dahan1 
1 Clinique Vétérinaire Vetoption, Aix en Provence, France
2 Laboratoire Vet-Histo, Marseille, France 
OBJECTIVES
The aim of this case report is to describe features of per-
itoneal lymphomatosis, a rarely described form of intra-
peritoneal spread of lymphoma, in a11-year-old female 
spayed domestic shorthair cat presented for pleural and 
abdominal effusions with a recent history of a hepatic 
icterus resolved with a short course of corticosteroids 
and antibiotics.
METHODS
Physical examination, diagnostic imaging, clinical and 
histopathological analysis were performed. 
RESULTS
Physical examination revealed a poor body condition, 
restrictive dyspnea and abdominal distension with a fluid 
thrill. Hematology, biochemistry, coagulation times, FIV/
FeLV Elisa test were unremarkable. Analyses of the effu-
sions were consistent with exsudates (specific gravity 
1.030, proteins 40 g/L, presence of mature lymphocytes, 
no infectious agents on cytology, negative Coronavirus 
polymerase chain reaction, chylothorax excluded). 
Abdominal ultrasound showed a hepatomegaly, multiple 
small hypoechoic nodules localized to the peritoneum 
and diffuse steatitis. CT scan revealed bicavitary effusion 
associated with post-contrast enhancement of an irreg-
ular peritoneum consistent with disseminated small 
 nodules, sternal and mesenteric lymphadenopathy. 
Exploratory laparotomy confirmed the diffuse infiltration 
of the peritoneum by small nodules, a rounded firm left 
pancreatic lobe, and severe mesenteric adenomegaly. 
Manual inspection of the gastro-intestinal tract did not 
reveal any abnormality. Histopathological analysis of the 
liver, peritoneum and mesenteric lymph nodes, and 
cytological analysis of the pancreas were diagnostic of a 
small cell lymphoma. Immunohistochemistry was con-
sistent with an initial low-grade T cell-lymphoma trans-
formed into a high-grade type within the liver. The cat 
was treated with prednisolone as owners denied chemo-
therapy.
STATEMENT (CONCLUSIONS)
This case describes features of peritoneal lymphomato-
sis, a rarely described form of lymphoma dissemination, 
reported for the first time of low-grade T-cell origin.
Computed tomography 
densitometry of eyes: a 
method to assess feline 
ocular diseases
Faezeh Asadi1, Yasamin Vali2,  
Mohammad Molazem3 
1 Faculty of Veterinary Medicine, University of Semnan, Semnan, 
Iran, Islamic Republic of
2 Diagnostic Imaging, Department of the Companian Animal and 
Horses, University of Veterinary Medicine (Vetmeduni), Vienna, 
Australia
3 Department of Radiology and Surgery, Faculty of Veterinary 
Medicine, Tehran, Iran, Islamic Republic of 
OBJECTIVES
The objective of this study was to clinically apply Com-
puted Tomography (CT) to determine the density of 
aqueous humor, lens, and vitreous in normal feline eyes. 
METHODS
Sixteen domestic short hair (DSH) cats including 10 males 
and 6 females were selected based on their normal 
 physical and ophthalmological examinations. CT of skull 
was performed in the sternal recumbency in all animals 
under the general anesthesia. CT scans were recon-
structed at 1 mm and the density of the ocular structures 
was calculated by software Syngo 5.5, which regions of 
interest (ROI) about 0.04 cm2, 0.1 cm2, and 0.2 cm2 were 
chosen in the anterior chamber, lens, and vitreous, 
respectively in the parasagittal and dorsal planes. 
RESULTS
The mean ± SD aqueous humour, lens, and vitreous 
 density were 21.36 ± 6.42 HU, 158.18 ± 10.23 HU, and 
17.34 ± 4.49 HU, respectively in parasagittal plane, and 
21.48 ± 8.39 HU, 153.7 ± 9.73 HU and 16.88 ± 6.05 HU, 
respectively in dorsal plane. No statistically significant 
differences were found in the density of both planes 
(P-value > 0.31). Besides, there was no statistically signif-
icant correlation between the density and weight 
(P-value > 0.062), as well as the density and sex (P-value 
> 0.26), in both planes. 
STATEMENT (CONCLUSIONS)
Considering the widespread use of CT for assessing 
 ocular structures, it may be  beneficial for veterinary 
 radiologists and ophthalmologists to have baseline value 
of ocular densities in CT beforehand in order to evaluate 
and diagnose ocular abnormalities in cats accurately. 
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Isolated traumatic 
radial head dislocation 
in a feline
Jane Oatley 
Seadown veterinary group, Southampton, United Kingdom 
OBJECTIVES
To describe a novel method for surgical stabilisation of 
the radial head dislocation while maintaining the gliding, 
rotational movement between the radius and ulna essen-
tial to normal locomotion in the cat. Aim to describe 
methods for overcoming the difficulties of rehabilitation 
in cats.
METHODS
A craniolateral approach was made to the radial head at a 
traumatic puncture wound. A small bone fragment could 
be seen in this region in the radiographs. Monofilament 
nylon suture was used as a synthetic annular ligament 
tunnelled beneath the cranial musculature over the cra-
nial aspect of the proximal radius and passed caudally 
through a bone tunnel drilled in the ulna. The suture was 
secured with a knot laterally between the muscle bellies. 
No support dressings were applied and the cat was con-
fined to room rest for 3 weeks.
RESULTS
The cat walked on a stiff antebrachium, absent rotation in 
the swing phase by 10 days post surgery. After 3 weeks, 
she progressed to walking around the whole house and 
allowed on and off furniture. 5 weeks post surgery 3/10 
lameness but good range of movement at the walk gait. 
From 6 weeks free exercise, encouraged to play with toys 
and start complex paw movements Sound 9 weeks post 
surgery (see videos).
STATEMENT (CONCLUSIONS)
Annular ligament disruption is rare in cats. The range of 
supination and pronation in the cat is much larger than 
the canine and attention to preserving this function is 
essential for a good functional outcome.
A biomechanical study 
comparing the use of 
the LokRod™ plate to 
plate and screw fixation 
for ex vivo stabilisation 
of femoral and tibial 
fractures in cats
Jamie Rahman, Peter Delisser, Julie Etches, 
Sorrel Langley-Hobbs 
University of Bristol, Bristol, United Kingdom 
OBJECTIVES
To compare the biomechanical performances of the Lok-
Rod™ Plate and a Standard Locking Plate when applied to 
ex vivo osteotomised gap model feline tibiae and femora.
METHODS
15 feline tibiae and 15 feline femora were tested 
 separately and randomly assigned a LokRod™ Plate or 
Standard Locking Plate, creating 4 groups. Tibiae were 
plated with 14 hole 101mm Standard Locking Plates, fem-
ora with 13 hole 94mm Standard Locking Plates. Both 
bone types were plated with 90mm LokRod™ Plates. 
Plates were applied using 4x 2.4mm locking screws. 1cm 
mid-diaphyseal osteotomies were performed after 
implant placement. Constructs underwent 3 series of 
6000 loading cycles, then a further 45000 cycles, at 60% 
of mean bodyweight. Stiffness was measured at the start 
and end of each cycles series. Axial displacement was 
measured throughout. Constructs were loaded to failure 
at 5mm/min with failure modality digitally recorded. Ulti-
mate load and displacement were also recorded.
RESULTS
No constructs failed pre failure testing. Femoral con-
structs displayed no significant differences. Tibial Lok-
Rod™ Plate constructs showed significantly lower 
stiffnesses after 12000 cycles (p = 0.04) and 18000 cycles 
(p = 0.018). Tibial LokRod™ Plate constructs yielded 
higher loads before failure (678.66 ± 83.58 N) (p = 0.000). 
The main construct failure modality was implant bending.
STATEMENT (CONCLUSIONS)
By yielding reduced stiffness during cyclical loading and 
increased load before failure, the LokRod™ Plate may 
result in more reliable plate and screw fixation for feline 
patients, particularly where post-operative exercise restric-
tion is more difficult. Clinical study validation is required.
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Safety profile of 
methylprednisolone 
acetate epidural 
injection in dogs treated 
for lumbosacral disease
Bettina Salmelin, Noel Fitzpatrick,  
Jeremy Rose, Colin Driver 
Fitzpatrick Referrals, Orthopaedics and Neurology, Eashing,  
United Kingdom 
OBJECTIVES
To report side-effects after methylprednisolone acetate 
epidural injection in dogs treated for lumbosacral degen-
erative stenosis. Side-effects caused by inadvertent sys-
temic administration of methylprednisolone acetate 
during epidural treatment has been reported in humans 
to range from 9 to 32.8%, however data in the canine 
population is limited (n = 15 to n = 38) and highly variable 
(0 to 50%). 
METHODS
Computer records at a single referral institution in the 
UK were searched for dogs with MRI confirmed 
 lumbosacral degenerative stenosis who were treated 
with at least three methylprednisolone acetate epidural 
injections between April 2012–May 2018. Details on 
side-effects reported by owners at re-check examina-
tion approximately two weeks after treatment were 
analysed. 
RESULTS
A total of 730 methylprednisolone epidural injections 
were analysed within a population of 150 dogs. After 
excluding cases without full follow-up information (n = 
249), this resulted in a total of 481 cases. The following 
temporary side-effects were reported: 4.9% (n = 24) 
systemic side-effects including polyuria, polydipsia 
and/or polyphagia; 2.1% (n = 10) clinical deterioration or 
subdued temperament, 0.8% (n = 4) urinary inconti-
nence and 0.8% (n = 4) diarrhoea. All side-effects 
resolved within a few days after treatment without inter-
vention. No major or permanent side-effects were 
reported. 
STATEMENT (CONCLUSIONS)
Epidural methylprednisolone acetate injection is a rela-
tively safe medical treatment option for lumbosacral 
degenerative stenosis in dogs. Our retrospective analysis 
revealed an incidence of 8.6% transient side-effects that 
resolved without further intervention. This is comparable 
to human literature. No major catastrophic side-effects 
were noted. 
A case management 
Framework for 
complex decisions  
in a shelter setting
Runa Hanaghan 
Dogs Trust, London, United Kingdom 
OBJECTIVES
To provide a clear management framework for complex 
cases between veterinary professionals and other experts 
within a shelter environment. To aid collaboration and 
communication between multiple stakeholders.
METHODS
A simple framework established through an iterative pro-
cess assists in case decisions. This allows for a careful 
balance between progressions within veterinary science 
and ethical assessments, inclusive of situational factors.
A complex case may arise when a dog has more than 
one problem to tackle or where there may be a lack of 
accessible resources for their ongoing care. Animal wel-
fare and logical clinical decision making provides the 
basis of the Complex Case Management (CCM) frame-
work to evaluate individual cases across multiple inter-
disciplinary teams arriving at a solution.
RESULTS
The CCM Diagram (Figure 1) provides broad topics (prob-
lem list, solutions, ability for the dog to cope and 
resources available) within the CCM Framework (Fig-
ure 2) comparable against expert opinions (behavioural 
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STATEMENT (CONCLUSIONS)
Using this approach, pragmatic and welfare focused 
decisions can be made for individual animals where both 
circumstance and resource may be influential. Providing 
clarity in a decision process can reducing the stress and 
easing the burden for all parties when a sensitive decision 
may be required.
Surgical management 
and outcome in a 
male puppy with 
urethrorectal fistula 
associated with type 
1 atresia ani
Phil Franklin , Anna Cronin, Jane Ladlow, 
Laura Owen 
Department of Veterinary Medicine, University of Cambridge, 
Cambridge, United Kingdom 
OBJECTIVES
To describe the first reported case of a male puppy with 
congenital urethrorectal fistula and type 1 atresia ani. 
METHODS
Congenital urethrorectal fistulae have been associated 
with anorectal malformations in the human, equine and 
feline literature, with atresia ani being reported most fre-
quently. In contrast, such an association has not been 
or veterinary problem elements) leading to a clear 
approach for multifactorial decision making.
Time-frame for treatment or recovery as well as the 
impact that each solution may provide must be included. 
Success of a solution may crucially rely on specific 
resources being available (personnel, pain medication or 
vet skills).
reported in the canine literature. The clinical presenta-
tion, diagnostic findings, surgical management and out-
come are described for a puppy diagnosed with a 
congenital urethrorectal fistula and type 1 atresia ani.
RESULTS
A four-month-old German short-haired pointer was pre-
sented for investigation of tenesmus and production of 
urine and faeces from a common perineal opening. A 
positive contrast retrograde urethro-cystogram identi-
fied a urethrorectal fistula, an abnormal distal trajectory 
to the caudal rectum and stenosis of the penile urethra. 
Abdominal ultrasound, haematology and biochemistry 
were unremarkable. Urine culture identified a heavy 
mixed bacterial growth. A 3.5F urinary catheter was 
placed retrograde into the fistula to aid identification and 
the fistula was ligated and transected via a perineal 
approach. The atresia ani was addressed by surgical ano-
plasty and a scrotal urethrostomy was performed to 
bypass the urethral stenosis. Postoperatively, resolution 
of the tenesmus and long-term satisfactory urination 
through the urethrostomy site was achieved.
STATEMENT (CONCLUSIONS)
Surgical management of a urethrorectal fistula and asso-
ciated atresia ani in this dog was successful, with resolu-
tion of clinical abnormalities. Surgical correction should 
be considered as a potential treatment option in similar 
cases. 
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Wild boar injuries 
in hunting dogs: 
A retrospective study 
(2012–2016)
Panagiotis Kokkinos1, Demetris Tselekis2, 
Georgios Kazakos3, Lysimachos 
Papazoglou3, Ioannis Tsokatarides4 
1 Animal Health Trust, Lanwades Park, Kentford, Newmarket, 
Suffolk CB8 7UU, United Kingdom
2 Private Practice, Sparti, Greece
3 Companion Animal Clinic, School of Veterinary Medicine, 
Aristotle University of Thessaloniki, Thessaloniki, Greece
4 Private Practice, Drama, Greece 
OBJECTIVES
Description of signalment, wound characteristics, treat-
ment and outcome of wild boar injuries in hunting dogs.
METHODS
In this retrospective study, medical records of hunting 
dogs from a first opinion and a referral setting were 
reviewed for wild boar injuries. Data for 117 dogs were 
collected and included signalment, physical examination 
findings, wound characteristics, season of injury, boar 
sex, type of treatment and outcome among others. 
RESULTS
The majority of both the injured dogs (82%) and the boars 
(85%) were males. Over three quarters of dogs (77%) had 
a prior history of wild boar injury. The incidents occurred 
more frequently in December (30%). The most common 
site of injury was the abdomen (43.6%), followed by the 
hindlimbs (31.6%) and the thorax (21.4%), whereas 44% 
suffered multiple injuries. Wound exploration was indi-
cated in 64% of abdominal and 72% of thoracic injuries. 
Pneumothorax and shock were seen in 20% and 22.4% of 
dogs, respectively. Surgical treatment was undertaken in 
95.6% of the cases. The mean hospitalization time was 
4.65 days. The outcome in 95.6% of the cases was good; 
moreover, 99% of the dogs returned to hunting activity in 
26.3 days on average. 
STATEMENT (CONCLUSIONS)
The confliction of hunting dogs with wild boars resulted 
in severe and extended injuries in dogs, usually requiring 
surgical intervention. Nevertheless, most of the dogs had 
a good outcome and returned to hunting activity after 
recovery period. To the authors’ knowledge this is the first 
descriptive study about wild boar injuries in hunting dogs.
Results of artificial 
urethral sphincter 
placement in female 
dogs with refractory 
urinary incontinence
Joep Timmermans1, Bart Van Goethem1, 
Bouvien Brocks2, Hilde De Rooster1 
1 Ghent University, Merelbeke, Belgium
2 Anicura Dierenkliniek Eersel, Eersel, Netherlands 
OBJECTIVES
To determine if placement of an artificial urethral sphinc-
ter provides continence in female dogs with refractory 
urinary incontinence.
METHODS
A retrospective analysis of multi-institutional patient 
databases resulted in 15 female dogs with refractory uri-
nary incontinence without concurrent underlying dis-
ease, treated between September 2010 and March 2018. 
A hydraulic artificial urethral sphincter with  subcutaneous 
access port was placed according to the manufacturer’s 
instructions. Treatment success was evaluated using a 
continence scoring system (scale 1 to 10, complete 
incontinence to complete continence, respectively) 
through telephone enquiry. 
RESULTS
Median continence score preoperatively was 2/10 (range, 
1 to 5). Median follow-up was 6 months (range, 3 months 
to 5,8 years). Postoperative percutaneous cuff inflation 
was performed in 7/15 dogs (47%). Complete continence 
was achieved in 8/15 dogs (53%), improvement in 4/15 
dogs (27%), no effect in 2/15 dogs (13%), and worsening 
in 1/15 dogs (7%). In the patients that improved but were 
not cured postoperatively, additional medical therapy 
resulted in a postoperative continence score of ³9/10 in 
2/5 dogs. Major complications necessitating implant 
removal surgery occurred in 3/15 dogs (20%), minor 
complications occurred in 10/15 dogs (67%). Continence 
scores were awarded to 10/15 dogs (67%). Median conti-
nence score postoperatively at follow-up was 9.5/10 
(range, 9 to 10).
STATEMENT (CONCLUSIONS)
The artificial urethral sphincter provides promising 
results in the treatment of bitches with refractory incon-
tinence. In dogs that improve but are not cured after 
 artificial urethral sphincter placement, supplementary 
medical therapy can further improve the continence rate.
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Simultaneous 
Incidence of 
Diaphragmatic Hernia 
and Intestinal 
Perforation in a Cat
Seyedsadra Izadi1, Maryam Zabihi2, 
Mohammad Sadegh Ghodrati3,  
Mohammad Amin Reisdanaei1,  
Seyed Reza Ghiasi4 
THIS ABSTRACT HAS BEEN WITHDRAWN 
BY THE AUTHOR
Accidental fentanyl 
exposure in pets
Fiona Finlay1, James Dunne2 
1 Virgin care, Bath, United Kingdom
2 Wiltshire CCG, Devizes, United Kingdom 
OBJECTIVES
Fentanyl is a highly potent opioid - accidental transder-
mal exposure resulting in fatalities has been reported in 
pets and children. Discussion of the topic prompted us to 
review the literature 
METHODS
Literature review
RESULTS
 Q Many human patients are prescribed fentanyl – a 25 
microgram/hour fentanyl patch is equivalent to an 
oral morphine dose of 60–90mg in 24 hours
 Q Discarded patches may still contain 50% of original 
drug – enough to cause serious harm/death
 Q Used patches should be disposed of carefully and 
not be put in a wastepaper bin where pets may find 
and ingest them - there is more than a 30-fold 
increase in absorption from the buccal mucosa if 
chewed compared with the transdermal route
 Q Swallowing an intact patch results in less rapid drug 
release compared with chewing, but systemic 
absorption is still significant
 Q Patches may also accidentally stick to an animal’s skin
 Q Discarded patches should be folded putting the 
sticky sides of each patch together so that it sticks 
to itself. They should then be wrapped in paper or 
plastic before disposal
 Q Patients should check regularly that patch has not 
fallen off. May cover it with adhesive film to ensure it 
stays on
 Q Identifying signs of fentanyl exposure in animals is 
challenging as many are non-specific eg 
excitement, pacing, panting
 Q Police sniffer dogs are at risk of fentanyl exposure 
and in some forces dog handlers are trained in the 
administration of naloxone
STATEMENT (CONCLUSIONS)
Veterinary surgeons should ask about fentanyl exposure 
in pets were there are concerns re symptoms.
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Maintaining 
compassion and 
preventing 
compassion fatigue
Fiona Finlay1, Anna Baverstock2 
1 Virgin Care, Bath, United Kingdom
2 Musgrove Park Hospital, Taunton, United Kingdom 
OBJECTIVES
Compassion may be defined as a deep awareness of the 
suffering of another human or animal, coupled with the 
wish to relieve it. To enable vets to continue to provide 
compassionate they need to look after themselves and 
those in their team.
Using the analogy of the charge in a mobile phone 
battery, on some days you do not use it much and your 
battery strength is good, whereas on other days, there is 
a bigger drain on reserves, and your battery needs 
recharging. If there is no chance to recharge, over time, 
compassion fatigue and burnout may occur. We aim to 
help you recognise signs of compassion fatigue, and look 
at ‘drainers’ and ‘chargers’ from both an individual and a 
team perspective.
METHODS
A review of the literature coupled with examples from our 
experience as paediatricians.
RESULTS
Individual drainers
 Q Complaints
 Q Discrimination
 Q Colleague sickness
 Q Long hours
 Q Intra-operative death
 Q Busy on-call
Individual chargers
 Q CPD
 Q Reflection
 Q Coaching
 Q Mentoring
 Q Supervision
 Q Exercise, cinema, reading, music
Team drainers
 Q Recruitment problems
 Q Bullying
 Q Unrealistic targets
 Q Financial difficulties
 Q Practice take-over
 Q Poorly functioning team
Team chargers
 Q Debriefing after stressful events
 Q Regular breaks 
 Q Peer support 
 Q Teaching sessions
 Q ‘Away-days’
STATEMENT (CONCLUSIONS)
We need to think about how we recharge through the 
day to ensure compassionate, high quality care from the 
beginning of our shift to the end. We need to become 
more aware of our own reserves, identifying individual 
and team ‘drainers’ thereby allowing us to implement ‘re-
charging’ strategies to try to prevent compassion fatigue 
and burnout.
421-550 Clinical Abstracts.indd   550 08/03/2019   18:39
BSAVA CONGRESS 2019 PROCEEDINGS [ 551 ]
Section VII 
Appendix:  
answers to multiple 
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VETERINARY 
Thursday 4 April 
MY TOP TIPS IN…
Neurology 1=D, 2=B, 3=B
Oncology 1=A, 2=A, 3=C
Reproduction 1=D, 2=A, 3=A
Soft tissue surgery 1=D, 2=C, 3=B
Cardiology 1=C, 2=D, 3=A
Orthopaedic surgery 1=D, 2=C, 3=A
SURGICAL COMPLICATIONS
My wound broke down: what now? 1=C, 2=C, 3=D
My enterotomy is leaking: what now? 1=B, 2=C, 3=A
Having difficult conversations 1=B, 2=A, 3=B
Something is bleeding: what now? 1=A, 2=D, 3=C
I didn’t get surgical margins: what now? 1=B, 2=A, 3=B
I left a urolith behind:  what now? 1=B, 2=C, 3=B 
ONCOLOGY
Paraneoplastic syndromes 1=B, 2=C, 3=A
Biopsies: getting good results 1=B, 2=D, 3=D
Pathology reports: what a clinician needs to know 1=B, 2=C, 3=C
Is advanced imaging always better? 1=D, 2=A, 3=C
Planning oncological surgery 1=C, 2=D, 3=B
Chemotherapy: the basics 1=D, 2=C, 3=D
Oncology treatments: new and on the horizon 1=D, 2=B, 3=C
EXOTICS
Updates on rabbit medicine & surgery 1=D, 2=A, 3=B
Sedation, analgesia and anaesthesia in small mammals 1=C, 2=B, 3=C
Managing chelonian shell disorders 1=C, 2=B, 3=C
Avian clinical techniques 1=D, 2=B, 3=C
Clinical applications of rabbit endoscopy 1=D, 2=B, 3=B
Clinical applications of reptile endoscopy 1=A, 2=D, 3=A
Top tips for ferret surgery 1=C, 2=B, 3=D
Reptile diagnostic imaging 1=B, 2=A, 3=D 
DERMATOPHYTOSIS
Dermatophytosis casebook: common impersonators and atypical 
presentations 1=A, 2=B, 3=B
Is it a false positive? Current recommendations for diagnosis of 
 dermatophytosis 1=D, 2=B, 3=A
Managing multiples: dermatophytosis disease outbreaks 1=D, 2=A, 3=B
Friday 5 April 
OPHTHALMOLOGY
The cracked or dirty windshield: disorders of the ocular surface 1=B, 
2=D, 3=D
The “bulging eye”: how do I know; how do I treat? 1=D, 2=C, 3=D
Glaucoma:  understanding & treating a leading, and painful cause of 
blindness 1=A, 2=B, 3=D
Ophthalmic manifestations of endocrinopathies 1=D, 2=A, 3=D
Masquerading eye disease: when one disease looks like another 1=B, 
2=D, 3=D
Cataract: what can I do about it? 1=B, 2=D, 3=C
Will my dog see again? Examination, assessment and differential 
 diagnosis of the blind patient 1=A, 2=C, 3=B
HAEMATOLOGY
Approach to anaemia 1=B, 2=B, 3=C
Transfusion medicine 1=B, 2=C, 3=A
Management of IMHA 1=C, 2=A, 3=A
Approach to the suspected coagulopathic patient 1=D, 2=A, 3=C
Management of thrombocytopenia 1=A, 2=B, 3=C
Investigation of polycythaemia 1=A, 2=C, 3=D
Investigation of leucopenia 1=D, 2=C, 3=A
Haemolytic anaemia: when is it not IMHA? 1=C, 2=A, 3=C
BOURGELAT
Imaging the adrenals 1=A, 2=B, 3=C
Atypical hypoadrenocorticism 1=B, 2=A, 3=D
Diagnosis of canine hyperadrenocorticism. Is it always  straightforward? 
1=B, 2=C, 3=B
Monitoring treatment in canine hyperadrenocorticism 1=A, 2=C, 3=B 
AVP
Management of intraoperative hypotension 1=B, 2=C, 3=A 
Infection control for the surgical patient.  1=C, 2=C, 3=D 
Options for the treatment of combined cranial cruciate ligament 
 insufficiency and medial patellar luxation 1=D, 2=B, 3=C 
CT
I want a CT scanner: considerations prior to purchase 1=C, 2=C, 3=C
I have a CT scanner: what now? 1=D, 2=C, 3=B
How to look at a CT scan: a beginner’s guide 1=D, 2=C, 3=D
Breathe in: thoracic CT 1=D, 2=A, 3=C
Around the abdomen: indications for abdominal CT 1=A, 2=C, 3=D
A headache or a pain in the neck? Head and Neck CT 1=C, 2=D, 3=C
Give the dog a bone; orthopaedic CT 1=C, 2=B, 3=A
Could I, Should I, Would I? When can I use spinal CT? 1=C, 2=B, 3=C
Saturday 6 April
FANTASTIC FOREIGN BODIES AND HOW TO FIND THEM!
Tracking foreign bodies: a review of imaging techniques 1=C, 2=D, 3=D
Foreign bodies of the head 1=B, 2=B, 3=C
Endoscopic management of foreign bodies 1=D, 2=B, 3=B
“For the chop”: surgical management of thoracic and abdominal 
 foreign bodies 1=D, 2=C, 3=A
Needle in a haystack: dealing with tracking foreign bodies 1=C, 2=C, 
3=A
The recurrent foreign body: what to do next? 1=D, 2=C, 3=D
NEUROLOGY
How to get the most from your neuro exam 1=B, 2=C, 3=A
Cerebrovascular disease: do dogs have strokes? 1=C, 2=C, 3=C
Poorly puppies: neurological disease in the young animal 1=D, 2=B, 3=A
Cervical spondylomyelopathy (‘Wobblers’): diagnosis and treatment 
options 1=C, 2=B, 3=A
Spinal cord disorders on a budget 1=B, 2=D, 3=B
Cranial nerve disorders: figuring out the floppy faces 1=A, 2=D, 3=D
A logical approach to vestibular disease 1=B, 2=C, 3=A
CARDIORESPIRATORY
Approach to the young coughing dog 1=B, 2=D, 3=D
Older dog with a cough: is it cardiac or respiratory? Top tips on how to 
tell 1=A, 2=C, 3=D
Approach to pulmonary hypertension 1=A, 2=C, 3=B
How I perform a bronchoscopy 1=B, 2=C, 3=D
Thoracic imaging picture quiz: is it cardiac or is it respiratory? 1=A, 
2=C, 3=D
The punctured pet: dealing with thoracic bite wounds/stick injuries 
1=A, 2=D, 3=C
Top tips on chest drain placement 1=B, 2=C, 3=A
Top tips on thoracic cytology 1=C, 2=B, 3=D
Diagnosis and medical management of pyothorax 1=D, 2=D, 3=D
Diagnosis and surgical management of pyothorax 1=C, 2=C, 3=A
SHELTER MEDICINE
A pragmatic approach to dog diarrhoea in the shelter environment 
1=D, 2=B, 3=B
Prepubertal neutering: a pragmatic approach 1=C, 2=D, 3=B
A pragmatic approach to the skinny old cat in the shelter environment 
1=A, 2=D, 3=A
AVP
Ophthalmological manifestation of systemic disease 1=C, 2=A, 3=D
Cardiac manifestation of systemic disease 1=B, 2=C, 3=A
Management of refractory epilepsy 1=D, 2=D, 3=B
Acute kidney injury: practical management 1=C, 2=C, 3=B
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IMAGING
Is this a bone tumour? Differentiating benign and malignant bone 
 disease with radiographs 1=C, 2=C, 3=A
A waste of time? Should we still be doing skull radiographs in 2019? 
1=B, 2=B, 3=C
Is this elbow dysplasia? What radiographs tell us and when to use CT 
1=D, 2=B, 3=B
From head to tail, imaging the neurological patient: when are 
 radiographs still useful? 1=D, 2=B, 3=C
Now, your turn: interactive orthopaedic film reading 1=C, 2=B, 3=A
Now, your turn: interactive head and neck film reading 1=B, 2=C, 3=A 
Orthopaedic weird and wonderful: an interactive radiographic journey 
1=A, 2=C, 3=A
Now, your turn: interactive spine film reading 1=D, 2=B, 3=D
LOCO-REGIONAL ANAESTHESIA STREAM
Basic LA plus pharmacology 1=A, 2=A, 3=B
LA equipment 1=D, 2=C, 3=C
Local block in the head 1=A, 2=D, 3=B 
Thoracic limb LA techniques 1=D, 2=A, 3=B
Epidural anaesthesia 1=A, 2=D, 3=B 
Pelvic limb LA techniques 1=B, 2=A, 3=C
Abdominal/thoracic LA techniques 1=D, 2=B, 3=A
LA and analgesia cases: interactive stream 1=A, 2=D, 3=C 
Sunday 7 April
CARDIOLOGY
Cardiac therapeutics: atrioventricular valve disease 1=A, 2=D, 3=A
Cardiac therapeutics: feline cardiology 1=B, 2=D, 3=B
Cardiac therapeutics: dilated cardiomyopathy 1=A, 2=D, 3=D
Cardiac therapeutics: medical treatment of arrhythmias (in dogs with 
DCM) 1=A, 2=C, 3=D
Challenging cases: approach to the patient with cardiac disease and 
renal dysfunction 1=C, 2=D, 3=B
Challenging cases: approach to the cardiac patient with concurrent 
respiratory disease 1=A, 2=B, 3=D
Cardiac therapeutics: pericardial disease 1=D, 2=C, 3=C
IMMUNOLOGY
Understanding immunological testing 1=A, 2=B, 3=C
Immune-mediated skin disease 1=B, 2=A, 3=A
Novel immunotherapy 1=B, 2=A, 3=B
Glomerulonephritis 1=B, 2=C, 3=A
How to: collect CSF samples 1=C, 2=C, 3=B
How to: perform joint taps 1=C, 2=C, 3=B
Stiff painful and pyrexic: an interview with a medic, neurologist & 
orthopod 1=D, 2=B, 3=B
NURSING
Thursday 4 April 
VN – OPHTHALMOLOGY 
Common eye conditions: medical and surgical 1=C, 2=A, 3=C
Surgical preparation and instrumentation for ophthalmic patients 1=B, 
2=C, 3=A
Post-op nursing considerations for ophthalmic patients 1=B, 2=A, 3=C
VN – NEUROLOGY
Nursing the brain injury patient 1=D, 2=B, 3=A
Nursing and rehabilitating patients with neuromuscular disease 1=B, 
2=D, 3=C
Rehabilitation post spinal surgery 1=B, 2=C, 3=A
VN – CONSULTATIONS
Surgical nursing clinics 1=C, 2=D, 3=A
How to implement running a clinic 1=D, 2=D, 3=D
How to do more clinics 1=C, 2=D, 3=C
Communication skills for consulting nurses 1=B, 2=C, 3=D
Medical clinics: what can we be doing? 1=C, 2=A, 3=D
VN – GENERAL NURSING
Infection control: a challenge for the whole team 1=A, 2=D, 3=D
Lungworm: should we be worried? 1=A, 2=B, 3=C
Nursing and treatment options for the hyperthyroid cat 1=B, 2=C, 3=A
Ill communication: effective team handovers 1=A, 2=D, 3=B
Friday 5 April 
VN – ECC
Nursing the trauma patient 1=A, 2=A, 3=C
Nutrition myths in critical patients 1=A, 2=B, 3=C
Common toxins in dogs 1=D, 2=A, 3=B
Bleeding nightmares 1=C, 2=A, 3=A
How to manage a chest drain 1=A, 2=A, 3=B
How to place nasal oxygen catheters 1=C, 2=C, 3=B
Nursing the septic abdomen patient 1=A, 2=B, 3=B
Dying to pee: nursing the blocked cat 1=D, 2=B, 3=A
Managing the dyspnoeic patient 1=A, 2=D, 3=B
VN – SURGICAL
Caesareans 1=C, 2=A, 3=A
The VN’S role during acute surgical haemorrhage 1=D, 2=C, 3=C
Does what we wear in the theatre impact patient safety? 1=B, 2=D, 3=D
Thoracic wall trauma 1=C, 2=C, 3=B
Pre-op surgical site infection prevention 1=D, 2=C, 3=C
How to reduce post-op HAI 1=A, 2=D, 3=D
Difficult skin closures: what options do we have? 1=B, 2=D, 3=D
Loco-regional blocks 1=B, 2=D, 3=A
Rehabilitation of orthopaedic patients 1=A, 2=B, 3=C
VN – BEHAVIOUR, WELFARE & ETHICS
Dog bite prevention 1=C, 2=B, 3=D
Street dog health and behaviour 1=C, 2=B, 3=C
Good Intentions & good welfare outcomes 1=D, 2=C, 3=A
Positive patient welfare:  what the RVN can do 1=A, 2=D, 3=B
Breed-specific legislation 1=C, 2=D, 3=C
Geriatric welfare 1=D, 2=A, 3=C
Welfare conundrums 1=C, 2=A, 3=B
Acute pain and its welfare implications 1=D, 2=A, 3=C
Saturday 6 April 
VN – ONCOLOGY 
Common cancers and paraneoplastic syndromes 1=A, 2=C, 3=D
Oncology emergencies 1=D, 2=B, 3=D
Staging the oncology patient 1=C, 2=C, 3=D
Radiotherapy 1=B, 2=D, 3=B
Chemotherapy: administration and adverse effects 1=A, 2=D, 3=B
Palliative care for cancer patients 1=B, 2=D, 3=B
Novel treatments: what’s new and advances 1=A, 2=B, 3=D
Client support for patients with terminal illness 1=A, 2=D, 3=C
VN – MEDICINE
IBD 1=D, 2=B, 3=C 
Diabetes mellitus: let’s not sugar coat it! 1=A, 2=B, 3=C
Feline diabetes: they are not small diabetic dogs 1=A, 2=B, 3=C
DKA 1=D, 2=D, 3=B
Haematology: Blood transfusions, products and monitoring 1=C, 2=D, 
3=B
Haematology: Common bleeding disorders 1=D, 2=C, 3=A
Endocrinology: Feline hyperthyroidism 1=D, 2=C, 3=C
Endocrinology: Hyperadrenocorticism and hypoadrenocorticism 1=D, 
2=C, 3=D
VN – ANAESTHESIA
The pre-anaesthestic exam 1=A, 2=D, 3=B
Anaesthesia of the head trauma patient 1=A, 2=C, 3=B
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Anaesthesia of the RTA cat 1=B, 2=A, 3=A
Anaesthesia of the brachycephalic patient 1=A, 2=D, 3=C
Anaesthesia of the young and old 1=D, 2=B, 3=D
Anaesthesia for the acute abdomen 1=A, 2=A, 3=A
Central lines 1=A, 2=A, 3=A   
Arterial Lines 1=A, 2=B, 3=A
Anaesthesia and analgesia of patients with complex medical  conditions 
1=B, 2=D, 3=A
Sunday 7 April 
VN – EXOTICS
Help: Rabbit anaesthetic. 1=B, 2=C, 3=A
Preventative medicine for rabbits 1=B, 2=D, 3=C
Rabbit obesity clinics 1=C, 2=D, 3=A
Nursing ileus 1=A, 2=C, 3=A
Is it all about hay and grass: rabbit nutrition 1=B, 2=A, 3=D
VN – NURSING LEADERSHIP AND MANAGEMENT STREAM
Leadership: what are the benefits for RVNs 1=B, 2=C, 3=B
Challenges of the head nurse and how to lead your team effectively 
1=D, 2=C, 3=C
Leadership skills for all roles 1=D, 2=B, 3=D
Managing your team through a change 1=A, 2=C, 3=B
Swapping between leadership and management: multi-tasking nurses! 
1=B, 2=A, 3=A
A simple approach to development reviews 1=C, 2=A, 3=B 
VN – NUTRITION
Making and Implementing a nutritional assessment 1=B, 2=B, 3=D
Compliance for nutritional recommendations 1=B, 2=B, 3=D
Feeding the renal patient 1=A, 2=C, 3=D
Nutritional management of the hyperthyroid cat 1=B, 2=C, 3=D
Nutritional Management of Gastrointestinal Disease I 1=C, 2=D, 3=B
Nutritional Management of Gastrointestinal Disease II 1=B, 2=D, 3=A
MANAGEMENT
Thursday 4 April 
NEW TO BUSINESS LEADERSHIP  
Leadership: the art of managing uncertainty in veterinary practice 1=D, 
2=D, 3=C
Acquiring the ‘right’ to lead: the difference between knowledge and 
self-belief 1=B, 2=D, 3=D
Leadership and culture: two sides of the same coin 1=D, 2=B, 3=A
Leading your sub-team managers 1=A, 2=D, 3=A
Setting up from scratch 1=D, 2=A, 3=D
So you’re now a Clinical Director. Help! 1=D, 2=A, 3=B
Friday 5 April 
NEW TO MANAGEMENT
Internal marketing 1=D, 2=D, 3=D
External marketing 1=C, 2=A, 3=D
Understanding the financial basics 1=C, 2=A, 3=D
How practice finances work 1=B, 2=D, 3=B
Team development 1=C, 2=B, 3=D
Getting the best out of clinical workflow 1=D, 2=A, 3=C
Crisis, what crisis? 1=C, 2=D, 3=A
Saturday 6 April 
KEY SKILL FOCUS: EFFECTIVE COMMUNICATION  
You’re different from me: four communication styles 1=D, 2=A, 3=D
Meetings, meetings: make them work 1=A, 2=D, 3=C
When they say ‘No’: managing expectations 1=D, 2=C, 3=B
Could do better: managing high performers 1=D, 2=C, 3=B
All together now: creating team dynamics 1=A, 2=C, 3=B
Five signs of a high performance teams 1=C, 2=D, 3=C
Yes, please: improving client compliance 1=B, 2=D, 3=B
Difficult client or difficult communication? 1=C, 2=A, 3=D
Sunday 7 April 
MANAGEMENT
Top 5 ways vets get sued & how to avoid them as a recent graduate. 
1=D, 2=D, 3=D
Putting you first: how to manage body and mind to avoid burnout, 
depression and other negatives 1=C, 2=D, 3=D
Personal branding for vets: why you need one and how to become the 
local pet celebrity. 1=D, 2=D, 3=A
OPEN TO ALL
Thursday 4 April 
OBESITY
The principles of weight management: using scientific evidence to 
maximise success 1=C, 2=C, 3=B
The practicalities of weight management: making it work in your 
 practice 1=B, 2=D, 3=D
Tackling the obese patient with concurrent disease: what are your 
 priorities? 1=A, 2=D, 3=C
Can obesity be prevented? 1=B, 2=A, 3=C
REPRODUCTION
Hormonal testing 1=A, 2=D, 3=C
Managing the pregnant bitch 1=C, 2=A, 3=A
Managing parturition: when do I reach for the scalpel? 1=A, 2=C, 3=A
First 48 hours 1=B, 2=A, 3=B
DEALING WITH MULTI-DRUG RESISTANT 
STAPHYLOCOCCAL INFECTIONS
The lab report says MRSP: what do I need to know? 1=A, 2=B, 3=A
Tough choices: treatment options for MRSP pyoderma 1=B, 2=B, 3=D
Top hygiene tips for dealing with multi-drug resistant skin pathogens in 
practice 1=B, 2=C, 3=C
Friday 5 April 
CLINICAL PATHOLOGY ON A BUDGET
Getting more for no more from your laboratory 1=D, 2=B, 3=B
Cytology: fine-needle aspirate techniques and solid lumps 1=B, 
2=A, 3=D
Cytology: don’t forget the blood smear 1=C, 2=C, 3=A
Cytology: fluids 1=A, 2=D, 3=A
When to test and when to treat 1=A, 2=D, 3=B
Point-of-care meters 1=B, 2=C, 3=D
CLINICAL PATHOLOGY REFRESHER EXOTICS
Small Mammals 1=A, 2=B, 3=C 
Reptiles and Birds 1=C, 2=C, 3=A 
DENTISTRY
Odontogenic tumours 1=B, 2=C, 3=D
Jaw opening and closing disorders 1=A, 2=C, 3=C
Flap techniques in palatal surgery 1=D, 2=A, 3=C
Mandibular fracture repair considerations 1=A, 2=B, 3=B
Oral masses in cats: inflammatory or neoplastic 1=C, 2=D, 3=D
Feline chronic stomatitis: a frustrating and debilitating disease 1=C, 
2=D, 3=A
Periodontal therapy 1=C, 2=A, 3=B
Feline extraction techniques 1=C, 2=B, 3=B
RECENT GRADUATES
Tooth extraction 1=A, 2=A, 3=B
Pale, bruised, bleeding: what’s going on? 1=C, 2=A, 3=D
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Is this murmur significant? 1=B, 2=A, 3=C
How to manage cases that aren’t going well 1=D, 2=A, 3=B
RCVS KNOWLEDGE
How good are you and can you prove it? 1=C, 2=B, 3=A
How to apply best evidence to manage and care for epilepsy patients 
in daily clinical practice 1=D, 2=C, 3=C
Research into small animal practice: why evidence matters 1=C, 2=D, 
3=B
Learning from a rabbit anaesthetic death, evidence-based approach to 
rabbit anaesthesia in practice 1=C, 2=D, 3=B
First do no harm: how systems can reduce the rate of morbidity and 
mortality by 50% 1=D, 2=B, 3=C
Reliable care in the NHS: building safer systems in a just culture 1=C, 
2=C, 3=C
Saturday 6 April 
CRITICAL CARE
Basic introduction to the use of blood gases 1=B, 2=C, 3=A
Advanced blood gas analysis 1=D, 2=B, 3=C
Techniques for oxygen therapy 1=B, 2=A, 3=C
Nutrition in critical care 1=C, 2=C, 3=A
Approach to DKA 1=B, 2=D, 3=A
Emergency management of urethral obstruction 1=A, 2=D, 3=A
Acute kidney injury 1=C, 2=A, 3=B
Management of canine acute pancreatitis 1=B, 2=C, 3=C
Sunday 7 April 
MY PRAGMATIC APPROACH TO…
PU/PD 1=C, 2=D, 3A
Hypercalcaemia 1=A, 2=D, 3=C
Juvenile lameness 1=D, 2=A, 3=B
Seizures 1=A, 2=D, 3=C
Prescription foods 1=C, 2=B, 3=B
Pruritic skin disease 1=B, 2=D, 3=A
Chronic diarrhoea 1=C, 2=B, 3=D
ORTHOPAEDICS
FL lameness in cats: sources and solutions 1=B, 2=D, 3=A
HL lameness in cats: sources and solution 1=B, 2=A, 3=C
Feline OA: diagnosis and management 1=D, 2=B, 3=C
Coronoid disease in dogs: where are we now? 1=C, 2=D, 3=A
Humeral intercondylar fissures in dogs 1=A, 2=B, 3=B
Ununited anconeal process: what to do? 1=C, 2=D, 3=D
Elbow incongruence: what to do when 1=B, 2=C, 3=A
SAFETY STREAM
Pre-op safety and preparation: what really helps and do pre-op bloods 
improve outcome? 1=B, 2=C, 3=A
How equipment harms patients 1=B, 2=A, 3=A
How to use checklists to improve safety (and how not to) 1=A, 2=A, 
3=A
What anaesthetic monitoring really helps? 1=A, 2=A, 3=D
Clinical Audit: how to set up 1=B, 2=C, 3=D
An anaesthetist’s day from hell:  interactive cases 1=D, 2=D, 3=D
M and M rounds 1=A, 2=D, 3=B
VDS TRAINING
Taking time out to get time back 1=A, 2=B, 3=D
The three Ps for having a good day: present, proactive and positive 
1=D, 2=A, 3=C
Leaning into colleagues, clients and cases 1=A, 2=A, 3=A
Stepping up and speaking out 1=A, 2=A, 3=A
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3D printing 93
A
Abyssinian cats 73
accounting 299
acid-base balance 380–1
acidosis 380–1
acromegaly 137
Actinomyces 126–7
acute abdomen 259–60
acute kidney injury 139, 212, 386–7
intrinsic 386
management 387
postrenal 386–7
prerenal 386
Addison’s disease 82
atypical 250
and hypercalcaemia 393
adopting pets
neutering 131
from a shelter 131
street dogs 227
adrenal glands 63
atrophy 82
imaging 82
adrenal tumours 250
adrenaline 82
as treatment for bleeding disorders 209
adrenocorticotrophic hormone (ACTH) 82–3, 250
stimulation test 84, 85, 392
and treatment of hyperadrenocorticism 85
Akitas 227, 532
Alaskan Mamalutes 73
aldosterone 250
alkalosis 380–1
allergies 172
food 397
and skin disease 398
alopecia 239, 250, 349
Alsatians see German Shepherds
American College of Veterinary Internal Medicine  
69, 449
2009 Consensus Statement 162
on chronic atrioventricular disease (CVD) 162
diagnosis of hyperadrenocorticism 84
anaemia 68
blood transfusion treatment 247
causes 68
diagnosing 68
and hypoxaemia 382
indications 68
and renal dysfunction 166
as sign of hypoadrenocorticism 250
see also haemolytic anaemia; immune-mediated 
haemolytic anaemia (IMHA)
anaesthesia see general anaesthesia; local anaesthesia
anal sac adenocarcinoma 236
in dogs 452
anal sac gland carcinoma 237
analgesia 45
acute abdomen 259
acute pain 231
aneasthetising rabbits 266
as cause of hypotension 76
and chest drains 210
ileus 269
pancreatitis 387
post-surgical 103
radiotherapy as 238
road traffic accidents 256
thoracic puncture wounds 123
see also local anaesthesia
anaphylaxis 72
androgen 82
Angiostrongylus vasorum 118–9, 199–200
causes 199
clinical signs 199
diagnosis 199
prevention 200
treatment 200
angiotensin-converting enzyme inhibitor (ACEI) 164
Animal Behaviour and Training Council Register 228
anorexia 549
abdominal foreign bodies 103
acute pain 231
feline hyperthyroidism 249
in ferrets 49
hypoadrenocorticism 250
ileus 269
in rabbits 44
renal disease 281
septic peritonitis 29
antibiotics
clinical abstracts 493
and diarrhoea 244
for feline chronic gingivostomatitis (FCGS) 361
perioperative 220
post-surgery 23, 65, 77, 123
for rabbits 459
resistance 443–5
and retrobulbar cellulitis 61
treatment of pyothorax 126
usage statistics 459
antibodies 71, 172
and blood transfusion 69
and glomerulonephritis 175
monoclonal therapy 174
role in haemolytic anaemia 248
role in thrombocytopenia 248
antimicrobial resistance
in canine wounds 443–4, 445–6
limiting spread 444–5
urinary cultures 445
see also multidrug resistant bacterial pathogens
Antimicrobial Stewardship and Pets project (ASAP) 444
anti-seizure medications 138, 395
anuria 139
APGAR 334
apomorphine 207
arrhythmias
assessment 164
in congestive heart failure patients 448
as manifestation of systemic disease 137
as sign of cardiac tamponade 168
treatment 165–6
arterial lines 261
arterial thromboembolism 163
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arteritis 110
arthritis see osteoarthritis; rheumatoid arthritis;  
septic arthritis
artificial intelligence 509
aspirin 163
atenolol 163
atlanto-axial instability 110
atresia ani 547
atrial fibrillation 24
diagnostic tests 24
in large dogs 24
atropine 76
axial pattern flaps 222
azathioprine 69, 498
azotaemia 383, 385, 427
B
B cells 172
Bacterioides 127
Baermann analysis 199
Basenjis 73
Basset Hounds 249
Beagles 73
behavioural problems 227–8
body language 228
dog bites 226
and neurological disease 538
owner perception 464–5
owner questions 227
and pain 231
street dogs 227
Bence-Jones proteins 174
beta-blockers 62, 163
biopsies 29, 37–8
contra-indications 37
excisional vs incisional 37
of feline oral masses 360
indications 37
of skin 173
staging cancer 238
birds 47
collecting blood 47
euthanasia rate 458
pathology 353
pinioning 528
quarantine and infection 460
sedation 47
see also chickens; Greylag geese;  
kestrels; parrots
bitches
caesareans 216
incontinence 427
neutering techniques 530–1
pregnancy 330–1
spaying 22
bite wounds 219
snakes 529
statistical analyses 495
thoracic 123–4, 494–5
bleeding disorders 70, 208–9,  
248–9, 367
frozen plasma transfusion 247
see also haemorrhage
blindness
behavioural changes 508
differential diagnosis 65–6
dogs 508
and endocrinopathies 63
paraneoplastic cause 237
as result of glaucoma 62
block recession trochleoplasty (BRT) 79
blood gases 380–2
anlysis techniques 381
biochemistry of 380
blood pressure 76, 123, 164
control 166
diabetic ketoacidosis 384
during general anaesthesia 255, 258
hyperthyroidism 201
pre-surgical monitoring 410
septic abdomen 166
blood sample collection
from birds 47, 353
and bleeding disorders 208–9
from the eye 184
and hyperadrenocorticism 250
from reptiles 353
blood transfusions 68–9, 247–8
adverse reactions 468–9
blood products 247
cats 468
under general anaesthesia 248
monitoring 248
and thrombocytopenia 71
treating haemophilia A 249
blood typing 248
cats 468
bone lysis (bone loss)
aggressive 142
dental 357
radiography 142
bone marrow 71
aspiration 471
and leucopenia 72
bone tumors
differentiating malignant/benign 142
radiography 142
Border Collies 514, 538
Bordetella bronchiseptica 118
Boxer dogs 478
brachial plexus block 152
brachycephalic dog breeds
anaesthesia complications 254, 257, 514
brain cancers 237
caesarian sections 333
and eye prolapse 61
hiatal hernias 486
hydrocephalus 110
jaw range of motion 514
vs mesaticephalic breeds 495
screw-tailed 499
thoracic hemivertebra 110
thoracic vertebral canal stenosis 499–500
brachycephalic obstructive airway syndromes 254, 257
and hiatal hernias 486
bradysdysrhythmias 212
branding see marketing
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breed-specific legislation 229–30
bronchitis 119
bronchoalveolar lavage 121, 125
cytology of 199
in dogs 481–2
risks 199
bronchoscopy 121–2
BSAVA Manual of Feline Practice 212
Budd-Chiari-like syndrome 537
“bulging eye” see eye, traumatic prolapse of Bulldogs
anaesthesia 254
bupivacaine 150, 156, 210
buprenorphine 45, 387
butorphanol 210, 528
and birds 47
and small mammals 45
C
caesareans 22, 216, 332–3
in brachycephalic dog breeds 333
criteria 216
non-surgical alternatives 333
Calgary Cambridge Principles 194
Campylobacter 131
cancer
in ferrets 50
imaging of 543
increasing rate 240
mast cell tumours 21, 238, 455
mesenchymal tumours 38
of the mouth and jaw 360–1
and old age 240
and paraneoplastic syndromes 236
staging 237–8
of the thyroid 201
see also odontogenic tumours; oncology; 
 paraneoplastic syndromes; retrobulbar tumours; 
specific cancers
capillary refill time 259
capnography 255, 257
and rabbit anaesthesia 266
carbonic anhydrase inhibitors 62
cardiac disease
effect on red blood cell mass 449
left atrial dilation 163
prescription diets for 396
and renal dysfunction 166–7, 448–9
and respiratory disease 167–8
respiratory symptoms 119
systolic dysfucntion 163
see also congestive heart failure
cardiac tamponade 168
cardiology 24–5, 161–9
cats 163
clinical abstracts 447–50
diagnostic tests 24
dogs 162
left atrial size assessment 122–3
manifestions of systemic disease 137–8
physiology and age 258
cardiorespiratory issues 117–28
case reports
advice for writing 78–9
castration 223
cataracts 63–5, 182
and age 506–7
causes 64, 506–7
classification 64–5
and diabetes 136, 244, 487–8
and diet 487–8
and glaucoma 65
and hypocalcaemia 63
and radiation exposure 458
rate in UK vs New Zealand 506–7
in rodents 458
treatment 65
cats
age assessment 534
anaemia 68
blood types 248
bone marrow aspiration 471
bronchoscopy 121
cardiac disease 163
causes of haemolysis 73
chronic kidney disease 482
congestive heart failure 448
cranial nerve otitis 113
cutaneous mycoses 443
dermatophytosis rate in 54
diabetes 244–6, 436
dietary iodine 488–9
elderly 132–3, 182, 230, 249, 258, 424–5
extracting teeth 363
eye drops 507
eye problems 182, 544
gastroprotectants 432–3
general practice 477–84
head trauma 541
heart murmurs 368, 531
hind limb fractures 545
histiocystic sarcoma 543
hypercalcaemia 237
hyperthyroidism 201, 249, 282, 474, 488–9
lameness 402–4
left ventricular hypertrophy 137
lymphoma 456
muscular dystrophy 539–40
neutering 132
odontogenic tumours 356
oral masses 360–1
orthopaedic surgery 521–2
pancreatitis treatment 283
patellar luxation 403
penetrating injuries 549
pericardial disease 169
polyarthritis 475
portosystemic shunt complications 494
radial dislocation 545
renal disease 424, 426
road traffic accidents 256
in shelters 132–3
from Spain 425
squamous cell carcinoma 454
tooth resoprtion 482
urethral obstruction 212–13
urinary tract infections 425
uveitis 136
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weight 534
see also specific breeds
Cavalier King Charles Spaniels 438, 593
heart murmurs 531
neurological disorders 538–9
rostral skull changes 539
cavernous sinus syndrome 114
central lines 260–1
technique 260
cephalexin 444
cerebro-spinal fluid (CSF)
pH level 255
cerebro-spinal fluid (CSF) sampling 175–6
contraindications 175
diagnosis meningitis 538
handling samples 176
indications for 175
preparation 176
cerebrovascular disease 109
clinical signs 109
diagnosis 109
troponin levels 498
cervical hyperaesthesia 499
cervical spondylomyelopathy 111–12, 499
disc-associated 111
forms 111
osseous-associated 111–12
checklists 412
chelonia
bladder 49
blood sample collection 353
cystoscopy 49
endoscopy 49
radiographic diagnosis of 50
shell disorders 46
and ultrasound 50
see also reptiles
chemotherapy 32, 41, 239–40
mast cell tumours 452
metronomic 32, 542
and radiotherapy 238
risks and side effects 41, 238
T-cell lymphoma 456
Chernobyl 458
Chesapeake Bay Retriever 543
chest drain
infection 199
management 209–10
and penetrating injuries 123
placement 124
pyothorax 126
cheyletiellosis 397
chickens
fluid therapy 47
Chihuahuas 503
chinchillas 45
Chlamydia psittaci 460
choledochal cysts 536
chondrodystrophic dog breeds 94
CT scanning 145
Chow-chows 227
chronic atrioventricular valve disease (CVD) 162
classification 162
management 162
chronic enteropathy 244
in dogs 431–2
circlosporin 69, 498
clavulanate-amoxicillin 444
clindamycin 126, 340, 444
clinical audits 414
clinical directors 292
clinical research 373–4
clinical workflow 301–2
clopidogrel 163
co-amoxiclav 126, 340
Cockapoos 73
Cocker Spaniels 452
haemolytic anaemia 73
idiopathic facial nerve paralysis 113
thrombocytopenia 248
Collies
congenital neutropenia 72
combination therapy
and cancer 40
communication skills
and breaking bad news 242
for consulting nurses 194
importance 30, 280
managing expectations 309–10
between nurses 202
owner-vet conflict 314
styles and methods 308
and surgical referrals 465
team leaders 274, 298, 412
VDS training 419
see also leadership; management
compassion fatigue 550
computed tomography (CT) 39, 88–95
abdominal 91–2
of adrenal glands 82
advances in technology 89
brachycephalic dog breeds 486
brachycephalic vs mesaticephalic breeds 495
of the brain 109
and coronoid disease 405
disc-associated cervical spondylomyelopathy 111
elbow dysplasia 144
elbow incongruence 408
exophthalmos diagnosis 61
of the eyes 544
and fine-needle aspiration 90
for foreign bodies 61, 91–92
of genitourinary tract 91
of head and neck 92
hiatal hernia 486
for humeral intracondular fissures 514–15
increase in use 91
of intracondular fissures 406
of jaw fractures 359
vs magnetic resonance imaging 92, 503–4
orthopaedic 93–4
penetrating injuries 100
post-surgery 486, 515
pulmonary 495
purchasing equipment 88
vs radiographs 89–90, 144
reading and interpreting results 89–90
and reptiles 50
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of the skull 143
of the spine 94–5
techological specifications 88
thoracic 90–1
types of scan 88
vascular lesions 91
congenital bone disease 147
congenital intrahepatic shunt 532
congenital portosystemic shunt 494
congestive heart failure
arrhythmias 448
identifying 122
and pericardial disease 168
and renal dysfunction 448–9
conjunctiva
anatomy and function 60
disorders 60
conjunctivitis
and feline calicivirus 136
as manifestation of lymphoma 64
as side effect of radiotherapy 238
constipation 282–3
continuous renal replacement therapy (CRRT) 139
contrast radiography see radiography
Coombs’ test 172
cornea
anatomy and function 60
endothelial failure 182
coronoid disease 405–6
corticosteroids
for immune-mediated haemolytic anaemia 469
palliative cancer care 240
side effects 72
cortisol
as indicator of septic shock 436
coughing
bronchoscopic assessment 121
older dogs 119
young dogs 118
cranial cruciate ligament disease 25
in cats 403
post-surgical physio therapy 518
treatment 79–80
cranial nerve disorders 113–14
craniomandibular ostopathy 357
Curshmann’s spirals 125
Cushing reflex 255
Cushing’s disease 82, 250
cutaneous mycoses 443
cystic pharyngeal hypophysis 502–3
cytology
blood smears 347–8
diagnostic 37
fluid samples 348–9
thoracic 125
D
Dachshunds 73, 514
hyperadrenocorticism 250
degenerative joint disease 404
of the elbow 402
radiography 404
treatment 404–5
dental extraction 366
equipment 366
feline teeth 363
technique 366
dentistry 355–64
CT assessment 92
equipment 363
oral masses in cats 360–1
palatal surgery 358–9
rabbits 48
surgery 151
see also jaw disorders; odontogenic tumours; 
periodontal therapy
depression 321
dermatitis 36, 442
alergic contact 398
food-induced 398
Malassezia 398
new treatments 174
dermatology
clinical abstracts 441–6
dermatophytosis 54–7, 398
atypical presentations 54
diagnosis 55
environmental contamination 56
false-positives 56
multiple outbreaks 56
nodular infections 54
presentation 54
species 54
treatment 55, 56
dermoid sinus 105
deslorelin 535
development reviews 277
dexamethasone 200
for masticatory muscles myositis 498
diabetes mellitus 244–5
in cats 245–6, 436
as cause of cataracts 244, 487–8
as cause of haemolysis 73
causes 244
and obesity 327
opthalmic complications 63
opthalmic manifestation 136
and risk of surgical site infection 77
diabetic ketoacidosis 246–7, 384–5
clinical pathology 384
diagnosis 384
treatment 384–5
diagnostic tests
acute adbomen 259
for Angiostrongylus vasorum 199
cancer 21
choosing 369
coagulation 209
for diabetic ketoacidosis 384
diarrhoea 536
faecal 118
for hyperadrenocorticism 84, 250, 437–8
for hyperthyroidism 201
for hypoadrenocorticism 83, 250
new developments 241
nurses performing 195, 199
peritoneal lymphomatosis 544
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pruritic skin disease 397
shelter intake 133
vs therapeutic trials 349–50
diaphragmatic hernie 549
diarrhoea 130–1
causes 399
chronic 399
effect on blood gas 380
gut culture 536
and inflammatory bowel disease 244
as side effect 249
diet
cat food 488–9
chelonian shell disorders 46
and diarrhoea 244
ferrets 50
home-cooked 396
owner choices 541
prescription 395–6
rabbits 48, 267–8
and radioactive iodine treatment 250
and refractory epilepsy 138
treating feline hyperthyroidism 201, 282
and urethral obstruction 213
and weight management 326
see also feeding; nutrition; obesity
dilated cardiomyopathy (DCM) 164–6, 368
classification 164
diagnosis 164
treatment 165–6
discospondylitis 94
and pyrexia 178
disseminated intravascular coagulation 387
distemper 72
Dobermanns
anaesthesia risks 254
Von Willebrand’s disease 249
dog bite incidents (DBIs) 227
and breed-specific legislation 229
dogs
acetabulbar fractures 512
acute pancreatitis 387
adopting street animals 227
anaemia 69
Angiostrongylus vasorum 199
appetite stimulation 529
atopic dermatitis 442
atrial fibrillation 24
autoimmine diseases 69
B cell lymphoma 42
blind 508
blood transfusions 468–9
blood types 248
breed and thyroid function 438
bronchoalveolar lavage referrals 481–2
Budd-Chiari-like syndrome 537
cardiac disease 162, 164–5
cataracts 64
cerebrovascular disease 498
chemotherapy 452
common toxins 207–8
congestive heart failure 448
coronoid disease 405–6
cranial cruciate ligament disease 25, 518
cranial nerve otitis 113
dermatophytosis rate in 54
diabetes 63, 136, 244
ear cleaning 531–2
elderly 182, 230, 258
epilepsy 500
eye drops 506
eye problems 182
forelimb lameness 405
gastroprotectants 432–3
general practice 477–84
glomerulonephritis 175
heart murmurs 368, 531
hepatobilary disease 430
history of domestication 227
hunting 548
hyperadrenocorticism 84, 437
hypercalcaemia 237
hypoadrenocorticism 82–3
infiltrative laryngeal disease 450
ingestion of foreign bodies 104
joint angles and range of motion 520
juvenile 25, 177
lameness causes 79–80, 407
large breeds 24
local anaesthesia 504
mastectomy 492
odontogenic tumours 356
oesophageal strictures 432
osteoarthritis 513–14, 515–16
owner diet choices 541
pancreatitis treatment 283
parasites 199
patellar luxation 403
pericardial disease 168–9
polyarthritis 471
portal vein hypoplasia 430
proteinuria in 471
puberty 132
pyrexia causes 177
radiography and sedation of 433
reproductive cycle 22–3
snake bites 529
from Spain 425
spinal fractures 541
strokes 109
trigeminal neuritis 113
urinary tract infections 425
uveitis studies 136
vaccination study 503
wild boar injuries 548
Y-T fracture setting 519
see also bitches; brachycephalic dog breeds; 
chondrodystrophic dog breeds; puppies;  
specific breeds
Dogs Trust 130
dolichocephalic dog breeds 514
Domestic Shorthaired cats 73
dopamine 259
dorsal cervical laminectomy 112
dorsal pantarsal arthrodesis 521–2
doxycycline 444, 460
dry eye see neurogenic dry eye
dyscospondylitis 147
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dyspnoea 213–14
as result of trauma 219
dystocia 216
causes 216
E
ear cleaning 531–2
echocardiography 24, 119, 162
cardiac tamponade 169
of cerebrovascular disease patients 498
dilated cardiomyopathy 164
left atrial size assessment 122–3
pericardial effusion 168
pulmonary hypertension 120, 137
pulmonic stenosis 449
elbow arthrodesis 515
elbow dysplasia
arthritis 394
imaging 144
elbow incongruence 408
electrocardiography 24–5
ambulated 368
diagnosing dilated cariomyopathy 164
diagnosing ventricular arrhythmia 165
monitoring during anaesthesia 257
monitoring septic peritonitis 211
signs of cardiac tamponade 169
electrochemotherapy 241
electrolytes
abnormalities 137
and diabetic ketoacidosis 247
regulation of 281
supplementation 384
urethral obstruction 212
Elizabethan collar 184, 210–1, 214
emergency critical care (ECC) 205–14,  
379–88
clinical abstracts 501–4
diabetic ketoacidosis 384–5
kidney injury 386–7
nutrition in 207, 383–4
oxygen therapy 382–3
urethral obstruction 385–6
emesis 207
emotional intelligence 419
Encephalitozoon cuniculi 267
endocrine testing 83, 84
endocrinology 249–50
clinical abstracts 435–40
endocrinopathies
and opthalmic conditions 63
endoscopy
of the airway 118, 119
balloon dilation 432
foreign body management 102, 103
in rabbits 48
of reptiles 49
treating oesophageal strictures 432
see also bronchoscopy
endothelial glyocolayx 426
English Bulldogs 499
English Springer Spaniels 73, 514
lymphadenitis 470
enrofloxacin 444, 460
enterectomy 29
Enterobacter asburiae 460
Enterococcus
antimicrobial resistance 445
enterotomy 29
removing foreign bodies 103
entropion 182
environmentalism 337
eosinophilic granuloma complex 360
ephedrine 76
epilepsy 373
epinephrine see adrenaline
equipment
accidents and malfunctions 411
anaesthesia and airway control 527
central line kits 260
clinical studies on 507
CT scanners 88
dental extraction 363, 366
for joint taps 176
loco-regional blocks 223
maintenence 298
nasal oxygen catheters 211
needle types and specifications 151
opthalmic surgery 183
orthopaedic surgery 519–20, 545
radiation protection 249
surgical gowns and clothing 218
tonometers 509
erector spinae plane block 504
erythrocytosis see polycythaemia
erythromycin 444
Escherichia coli 126, 127, 460
antimicrobial resistance 445
canine extracellular vesicles 426
skin infections 444
and UTIs 425
ethics
breed-specific legislation 229
exotical animal ownership 270–1
of practical classes 464
and quality of life 431–2
euthanasia 432
of birds 458
owner support 242
evidence-based veterinary medicine 373
examination
of acute abdomen 259
of hair and skin 55
importance of 369
neurological 20, 108
of newbown puppies 334
opthalmic 509
oral 48, 360
orthopaedic 404
pre-anaesthetic 254
shelter animals 132
exophthalmos 61
exotic animals 43–51
clinical abstracts 457–60
ethics of ownership 270–1
legislation 270
nursing issues 265–71
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pathology 351–3
vs wild animals 270–1
exploratory laparotomy see laparotomy
eye
aging changes 182
anatomy 182
blood sampling 184
computed tomography of 544
perforation 182
physiology 136
surgery on 151
and systemic hypertension 136
eye drops
owner administering 507
volume 506
eye, traumatic prolapse of 61
prognostic indicators 61
treatment 61
F
factor VIII 248–9
faecal cultures 118
for Angiostrongylus vasorum 199
of birds 460
diarrhoea 131
fanconi-syndrome 537
Favrot’s diagnostic criteria 397
feeding
appetite stimulants 529
critical patients 383
enteral 383
feline chronic gingivostomatitis (FCGS) 361
hypoadrenocorticism patients 251
of neuro-muscular patients 189
parenteral 383
recovering spine injuries 190
renal patients 281
and thrombocytopenia 248
see also diet; nutrition; obesity
feeding tubes 383
for septic peritonitis patients 492
feline calicivirus (FCV) 136
feline chronic gingivostomatitis (FCGS) 361–2
causes 361
diagnosis 361
symptoms 361
treatment 361–2
feline herpesvisus type 1 (FHV-1) 136
feline immunodeficiency virus (FIV) 136
feline infectious peritonitis 136
feline viral disease
opthalmic manifestation 136
fenbendazole 267
fentanyl 549
ferrets 45
anatomy 50
diet 50
surgery 49–50
fever see pyrexia
finances 299–300
CT scanning 143
expenditure 300
income 300
pathology costs 346
purchasing equipment 88
spinal cord disorders 112–13
fine-needle aspiration (FNA) 21, 37
techniques 347
use of CT scanning 61, 90
fluconazole 55
fluid therapy 47, 166
acute abdomen 259
for Angiostrongylus vasorum 200
diabetic ketoacidosis 384
for hypoadrenocorticism 250
kidney injuries 139
oncological hypercalcaemia 237
pancreatitis 387
rabbit ileus 269
septic peritonitis 211
and surgical haemorrhage 217
trauma patients 206
flumazenil 47
fluoroquinolone 126
fluoroscopy
foreign body removal 102
treating oesophageal strictures 432
food-responsive enteropathy 282
forceps
foreign body retrieval 100, 102
foreign bodies 99–105
abdominal 103
airway 118, 121
as cause of pyothorax 126
CT scanning for 61, 91–2
endoscopy 102
gastrointestinal 100
in the head 101–2
hypersalivation 48
imaging for 50
imaging techniques 100
infection risk 123
ingested 103–4
intestinal obstruction 91
migrating 100, 104, 126
nasal 101
oesophageal 100, 102
penetrating injuries 123, 549
and pericardial disease 168
recurrence 104–5
as result of surgery 486
retrieval 100
retrobulbar 101
surgical removal 29, 49, 103
and surgical site infection 77
thoracic 103
see also stick injuries
fractures
acetabulbar 512
chelonian shells 46
femoral 545
humeral 519
of the jaw 357, 359
physeal 394
in rabbits 523
in reptiles 50
of the ribs 219
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small birds 47
of the spine 540
stabilisation techniques 545
surgical repair 25
tibial 545
French Bulldogs 499, 514
anaesthesia 254
spinal arachnoid diverticula 110
fungal cultures
and diagnosis 55–6
fungal infections
of the airway 118
of the bones 147
of the pericardia 168
and pyrexia 178
see also dermatophytosis
fungal osteomyelitis 147
furosemide 139, 163–4, 449
Fusobacterium 127
G
gabapentin 478
gastric stasis see ileus
gastroenterology
clinical abstracts 429–34
gastrointestinal diets 282
gastrointestinal disease 244
and bracycephalic obstructive airway  
syndrome 257
nutritional management 282–4
gastro-oesophageal reflux 527
gastroprotectant medications 432–3
gastrostomy 103
general anaesthesia 45
acute abdomen 259–60
of birds 528
and blood pH 255
blood transfusion 248
bronchoscopy 121
and central lines 260
clinical abstracts 501–4
and complex medical conditions 262–3
complications 414–15
duration and infection risk 77, 220
elderly animals 258–9
equipment 411, 413, 527
fasting 254
fatalities 374–5
and head trauma 255–6
and hypotension 76
and hypoxaemia 382
monitoring 413
nursing and 253–63
pre-anaesthetic exam 254
pre-anaesthetic tests 410
of rabbits 48, 266, 374–5
risks in elderly patients 249
road traffic accidents 256
vs sedations 262
and skull imaging 143
and thoracic CT scanning 90
urethral obstructions 212
young animals 258
general practice
clinical abstracts 477–84
genitourinary tract
CT scanning of 91
gentamici 444
German Shepherds 248–9, 514
hormone levels and pregnancy 330
hypoadrenocorticism 250
joint problems 407
oncological surgery 542
German Spaniels 73
Giardia 131, 399
Glasgow Pain Scale 210
glaucoma 62
as complication of cataracts 65
diagnosis 62
and lymphoma 64
treatment 62
glomerulonephritis 174–5
causes 174
immune-complex 175
management 175
non-immune-complex 175
glucocorticoids 82, 250
side effects 173–4
glycopyrrolate 76
goblet cells
in the eye 60
Golden Retrievers 73
Von Willebrand’s Disease 249
gonadectomy 132
gonioscopy 62
Gosling’s cross-species personality traits 508
granulocytes 172
G.R.E.A.T communication model 309–10
Great Danes
cervical spondylomyelopathy 111
Greyhounds 506
fibrinolysis disorders 70
gastric dilation and volvulus 480–1
Greylag geese 528
guidelines
Association of Shelter Veterinarians 131
EUCAST guidelines 493
on MRSP 340
for nursing clinics 195
WHO Global Guidelines for the Prevention of 
Surgical Site Infection 221
WSAVA 131
Guinea pigs 45
hyperthyroidism 352
necrotic lipoma 533
H
haemangiosarcoma 542
haematocrit 71
haematology 68–74
clinical abstracts 467–76
and gastrointestinal foreign bodies 103
hypercalcaemia 393
of hypoadrenocorticism 83
immune-mediated skin diseases 173
polyuria 392
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pre-anaesthesia 410
in small mammals 351–2
see also blood transfusions
haematuria 70–1
haemilaminectomy 504
haemolysis 73
haemolytic anaemia 73
non-autoimmune causes 73
see also immune-mediated haemolytic  
anameia
haemophilia 247–8
type A (factor VII deficiency) 249
haemorrhage
in the brain (stroke) 109, 208
causes 30
diagnosis 30–1
internal 70
ocular 64
post-operative 30–1
pyshiological changes 217
as result of bleeding disorders 70
as result of cancer 236
retinal 136
surgical 217
and thrombocytopenia 71
see also bleeding disorders
haemothorax 123
clinical signs 530
in juvenile dogs 530
Halsted, William 218
surgical principles 77
Hartmann’s solution 76, 217
hay 270
heart
radiography of 162
see also cardiac disease; cardiology; left atrium; 
specific heart conditions
heart murmurs 368
gender difference 531
risk factors 531
hedgehogs 45
hemipelvectomy 542
hepatic encephalopathy 284
hepatobilary disease 430
hepatology
clinical abstracts 429–34
Hill’s Prescription diets 282
hip luxation 513
histiocytic sarcoma 543
histopathology 37, 430
history see patient medical history
holistic approach 280
hookworms 397
Hope Scheme 130
Horner’s syndrome 63, 113
hospital-acquired infections (HAIs)  
198–9
arterical catheters 261
at-risk groups 221
causes 221
clinical signs 221
definition 221
prevention 198, 221
human-companion animal bond 462
humeral intracondular fissures 406–7
treatment 514–15
use of computed tomography  
514–15
hydrocephalus 110
hydrolised diets 282
hydrotherapy 224
hyperadrenocorticism 63, 250
clinical signs 437–8
diagnosis 84–5, 437
in dogs 437
management 437
screening 84
treatment 85–6
hypercalcaemia 36, 393
differential diagnosis 393
pathophysiology 393
and polyuria 393
as sign of cancer 236–7
hyperglycaemia 245–6
and cataract formation 487
and head trauma 255
hyperkalaemia 137
complications 385
as result of urethral obstruction 212
as sign of hypoadrenocorticism 250
hypertension 63
due to pain 231
feline cardiac manifestations 137
opthalmic manifestation 136
see also pulmonary hypertension
hyperthyroidism
in cats 201, 249, 282, 474, 488
and chronic kidney disease 427–8
diagnosis 201
dietary causes 488–9
feline cardiac manifestations  
137, 282
in Guinea pigs 352
microcytosis 474
ocular complications 63
opthalmic manifestation 136
symptoms 282
treatments 249
hypoadrenocorticism 82–3, 250–1
acute vs chronic 83
cardiac manifestations 137
causes 82–3
clinical signs 83
diagnosis 83
pathophysiology 82–3
hypocalcaemia 201
hypoglycaemia 82
and head trauma 255
seizures 110
as side effect of insulin therapy 247
hyponataemia 250
hypotension 76
causes 76
and head trauma 255
as result of anaesthesia 259
hypothyroidism
age-related 438
breed influence 438
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hypoxaemia
and anaemia 382
and anaesthesia 382
in brachycephalic dogs 257
causes 382
as result of trauma 255–6
hypoxia
and head trauma 255
I
IDEXX Angio Detect 199
idiopathic facial paralysis 113
idiopathic vestibular syndrome 113
ileus 269
imaging 141–8
of adrenal glands 82
advanced 39
bowel obstruction 269
cancer 543
clinical abstracts 485–91
cost/benefit analysis 39
diagnosing polyuria 392
foreign bodies 50
immune-mediated haemolytic anaemia 469
interpreting results 146–7
and oncological surgery 40
of oral masses 360
penetrating injuries and foreign bodies 100
post-operative 33, 148
and pyothorax surgery 127
and reptiles 50–1
thoracic 122–3
thoracic trauma 219
see also computed tomography (CT);  
magnetic resonance imaging (MRI); radiography; 
 ultrasonography
imidacloprid 200
immune-mediated haemolytic anaemeia (IMHA)  
69, 248
cardiac manifestations 137
corticosteroids and imaging 469
different types 248
in dogs 474
as sign of cancer 248
testing for 172
and urinary thromboxanes 474
see also haemolytic anaemia
immune-mediated polyarthritis 475
in dogs 475
immune-mediated polymyositis 188
immune-mediated skin diseases 172–3
clinical signs 172–3
diagnosis 173
history 172–3
treatment 173
immune-mediated thrombocytopenia 248, 367, 476
immunohistochemistry 241
immunology 171–7
clinical abstracts 467–76
new therapies 173–4
testing 172
immunosuppressive therapy 248
for feline polyarthritis 475
immuno-suppressors 173–4
and glomerulonephritis 175
and skin diseases 173
immunotherapy 241
incontinence 427
surgical treatment 548
indoxyl sulfare 424–5
infections see hospital-acquired infections (HAIs); 
sepsis; surgical site infection (SSI); urinary tract 
infection
infectious tracheobronchitis 118–9
infertility 22
in cats 535
treatment 535
infiltrative laryngeal disease 450
inflammatory bowel disease 244
and platelet count 476
insulin 245, 246
for diabetic ketoacidosis 384
resistance and obesity 327
interdigital furunculosis 105
intervertebral disc extrusion 499
use of anaesthesia 504
intervertebral disc protrusion 499
intestinal obstruction
CT assessment 91
foreign bodies 104
post-surgical adhesions 105
intestinal perforation 549
intra-abdominal pressure
post-mastectomy 492
intra-ocular pressure 509
intubation
endoscopic 48
and oral examination 48
I-PEN 507
Irish Setters
leucocyte adhesion deficiency 172
isofluorine 151, 529
itrazconazole 55
J
Jack Russel Terriers 73
jaw disorders 357–8
in brachycephalic dogs 514
coronoid process displacement 357
infection 357
temporomandibular joint diseases 357, 514
tumours 357
joint taps 176–7
equipment 176
sample handling 176
technique 176
K
kestrels 458, 528
ketamine 256, 387, 528
ketoconazole 55
Ki67 index 455
kidneys
and adrenal glands 82
and diabetes 436
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function 281
hypoxia of 72
physiology and age 258
reptiles 50
see also acute kidney injury; renal disease
kittens
anaesthesia of 258
physiology 258
Klebsiella 127
antimicrobial resistance 445
L
Labradors 452, 514
Fanconi-Syndrome 537
lameness 406
in cats 402–4
common causes 79
in dogs 405, 407
due to foreign body 104
due to neoplasia 237
forelimb 402–3, 405
gait analysis 521
hindlimb 403–4
and joint taps 176
in juveniles 394
neurological 108
as symptom of haemophilia 249
laparotomy 29
diagnosing peritoneal lymphomatosis 544
removing foreign bodies 103
lateral rhinostomy 44
leadership 288–92
accountability 313
conflict resolution 310, 312
and culture 289–90, 298
nursing 274
performance indicators 311
personal 418–19
“right to lead” 289
self-belief 288
staff well-being 336–7
and starting a practice 291–2
sub-teams 290–1
trust 312
see also management
left atrium 122–3
dilation and poor function 163
left ventricular hypertrophy 137
left ventricular outflow tract obstruction  
163
legal action 320
Leonbergers 250
leucocytes 72–3
adhesion deficiency 172
cytology 348
and immunodeficiency 172
see also specific cell types
leucopenia 72–3
causes 72
lidocaine 45, 150, 259, 387
ligamentum flavum hypertrophy 111
limited ingredient novel-protein diets 282
lipoxygenase-5 453
liver
physiology and age 258
lizards
blood sample collection 353
renal disease 50
local anaesthesia 149–57, 223
abdominal-thoracic 155–6, 223
arterial catheterization 261
case studies 156–7
and chest drains 210
epidural 153–4
equipment 150–1
in the head 151–2, 223
intra-testicular 223
nursing 223
pelvic limb 154–5, 223
pharmacology 150
road traffic accidents 256
thoracic limb 152–3, 223
use of imaging 150, 152, 154
Lok-Rod Plate 545
lomustine 452, 456
low-dose dexamethasone-suppression test (LDDST) 84
lufenuron 55
lumbosacral disease 546
lungs
abcess surgery 127
CT scanning 90
lungwom see Angiostrongylus vasorum
lymphadenitis 470
lymphoma
in cats 456
cytology 125
diagnosis 456
in dogs 42
epitheliotrophic 398
new treatments 174, 241
ocular manifestations 64
rare forms 544
subtypes 21
treatment 456
vaccine 42
lymphopenia 72
M
macrophages 125
magnetic resonance imaging (MRI) 39
brain imaging 92
vs computed tomography 92–3, 503–4
and CSF sampling 176
and cystic pharyngeal hyophosis 502–3
disc-associated cervical spondylomyelopathy 111
migrating foreign bodies 100, 104
and neurological diagnoses 109
neurological imaging 145
orthopaedic assessment 93
portal vein hypoplasia 430
of the spine 94
management
balancing clinical duties 311
of the budget 292
decreasing morbidity 375, 415–16
high performers 310–11
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managing expectations 309–10
nurses as 274–7
owner compliance 313–14
and quality of care 375
of shelters 546–7
of the staff 292
staff meetings 308–9
team development 301, 311–12, 312–13
of yourself 321
see also leadership
Manchester Terriers 249
mannitol 62
for kidney injury 139
marbofloxacin 460
marketing
external 298–9
internal 298
and obesity prevention 489
personal 321–2
maropitant 387, 433
mastectomy 492
masticatory muscle myositis 357
treatments 498
medial humeral epicondylitis 402
medial patellar luxation 79–80
juvenile lameness 394
and weight 518–19
meloxicam 45
meningitis (steroid responsive) 110, 499, 538
meningoencephalocele 541
meningoencephalomyelitis 95
mepivacaine 150
metabolic bone disease 147
metaphyseal osteopathy 469–70
metastasis 21
of bones 543
chemotherapy 41
detection 39
melanoma 453–4
methadone 231, 259, 387
methicillin-resistant Staphylococcus pseudintermedius 
(MRSP) 339–42
hygiene and prevention 341–2
transmission 340
treatment options 340–1
methimazole 249
methylprednisolone acetate 546
metronidazole 126
Micocytosis 474
Microsporum canis 54
midazolam
and birds 47
and small mammals 45
milbemycin 200
mineralcorticoids 82
Miniature Schnauzers
anaesthetic risks 254
Von Willebrand’s Disease 249
miotics (topical) 62
mirtazapine 383, 424
Modified Glasgow Coma Scale 188, 211
monopolar cautery 411
mortality and morbidity rounds 415–16
motor functions 20
moxidectin 200
multidrug resistant bacterial pathogens 341
multiple myeloma 142
diagnostic signs 174
and paraneoplastic syndromes 236
muscular dystrophy 539–40
myasthenia gravis 188
mycophenolate mofetil 69
myelography 94
diagnosing disc-associated cervical 
 spondylomyelopathy 111
myiasis 267
myxomatosis 267
N
nasal oxygen catheters 210–11
as site of infection 184
necrotic lipoma 533
necrotising fasciitis 460
neoplasia
as cause of cervical hyperaesthesia 499
as cause of pericardial disease 168
radiographic imaging 147
spinal 94–5
thoracic cytology 125
of urinary tract 174
neotrombiculosis 397
nephrology
clinical abstracts 423–8
nerve sheath tumours 113
neurogenic dry eye 508
neurological disease
in Cavalier King Charles Spaniels 538–9
in puppies 110
rehabilitation 188–9
as result of trauma 541
neurology
clinical abstracts 497–504
nursing 187–90
use of radiographs 145
neuruology 20, 107–15
neutering 131–2
and adopting pets 131
ethics 230
and heart murmurs 531
and incontinence 427
of rabbits 267
techniques 530–1
neutropenia 72
New Methylen Blue smear 347
nidoviruses 459
Nocardia 126
non-steroidal anti-inflammatory drugs (NSAIDs) 151
for feline chronic gingivostomatitis (FCGS) 361
palliative care 238
road traffic accidents 256
and shock 259
noradrenaline 76, 259
North Carolina State University 136
nuclear sclerosis 182
nursing 197–202
advanced practitioner status 338
anaesthesia 253–63
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behaviour and welfare 226–32
brain-injured patients 188
consultations 191–6
decrease in numbers 200, 301
diabetes 244–5
diagnostic tests 195
diverse roles 275–6
of dyspnoeic patients 213–14
emergency critical care 205–14
exotic pets 265–71
geriatric animals 230
leadership and management 273–8
medical 243–50
medical clinics 195
mentoring students 198
oncology 235–43
orthopaedic rehabilitation 224
post-operative 184
qualifications 338
spinal injuries 189–90
staff wellbeing 336–7
surgical 215–25
surgical clinics 192
trauma patients 206
see also VN Futures initiative
nutrition 279–84
assessment 280
clinical abstracts 485–91
in critical care 383–4
in critical patients 207
macronutrients 383
managing gastrointestinal disease 282–4
owner compliance 280–1
pacreatitis treatment 387–8
palliative care 240
during pregnancy 332
rabbits 270
and septic peritonitis 212
see also diet; feeding; obesity
O
obesity 325–9
disease risks 327
dogs 488–9
epidural anaesthesia 153
feline diabetes 246
prevention 328, 489
rabbits 268
and thyroid function 438
weight management principles 326
see also diet; feeding; nutrition
obstructive fibrinous pseudomembrane 527
odontoclast dysregulation 482
odontogenic tumours 356
in cats 360
classification 356
prevalence 356
odontogenisis 356
oedema
and orthopaedic rehab 224
pulmonary 120, 163
oestrogen 82
Old English Sheepdogs 248
oliguria 139
omeprazole 71, 433
oncology 21, 36–43
clinical abstracts 451–6
combination therapy 40
emergencies 236–7
new treatments 42, 241–2
pathology 38
surgery 40–1
see also cancer; specific cancers
ondansetron 433
opthalmology 60–6, 181–5
clinical abstracts 505–11
differentiating similar presentations 64
and endocrinopathies 63
equipment 507, 509
manifestations of systemic disease 136–7
post-operative nursing 184
surgery 61, 62, 183–4
topical medication 506
see also exophthalmos; eye, traumatic prolapse of; 
glaucoma; retrobulbar tumours
oral malignant melanoma 453–4
orthopaedics 401–9
clinical abstracts 512–25
interpreting imaging 146–7
rehabilitation 224
stabilising hind limb fractures 545
stabilising radial dislocations 545
surgery 25–6, 223
use of CT 93
oseltamivir 131
Oslerus osleri 118
osteoarthritis 404–5
in dogs 405
treatment 478, 513–14, 515–16
osteochondrosis dissecans (OCD) 93
arthritis 394
treatment 522
osteoma cutis 538
osteosynthesis 519–20
otitis interna 113
in Boxer dogs 478
Otodectes cynotis 397
ovariectomy 330, 493–4
complications 493
laparoscopic vs open 493–4
vs ovariohysteractomy 530–1
ovariohysteractomy 530–1
owners
adminstering drugs 41, 462–3, 507
advice for palliative care 240
behaviour questions 227
consent 254
diabetes treatment plans 244
diabetic cats 246
dietary choices 541
epileptic pets 138
eye drop administering 507
financial limitations 112–13, 143, 518
homeless 129–33, 462
nutrition and diet standards 488
nutrition plan compliance 280–1
obesity prevention 489
557-582 Subject-Author Index.indd   571 08/03/2019   18:31
Subject index
[ 572 ] BSAVA CONGRESS 2019 PROCEEDINGS
on physiotherapy 518
of puppies 463, 479–80, 481
support for terminal patients 242–3
UK vs Canada 488
see also owner-vet relationship
owner-vet relationship
cancer treatment plans 40
compassion 550
conflict 314–15
discussing surgical complications 30
improving compliance 313–14, 462–3
managing expectations 138
nursing clinics 193
nutrition plans 280
physiotherapy plans 518
trust 464
see also legal action
oxygen therapy 382–3
P
pain
acute 231–2
assessment 240, 431–2
diagnosing septic peritonitis 29
evaluation of 108
glaucoma 62
management 512 (see also analgesia)
mast cell tumours 21
and migrating foreign bodies 104
physiological mechanism 150
palatorrhaphy 358–9
palliative care
radiotherapy as 238
pancreatitis
cardiac manifestations 137
critical care 387–8
CT assessment 91
and diabetic ketoacidosis 384
diagnosis 387
effect on platelet count 476
management 387
nutritional management 283
pain management 153
presentation 387
paraneoplastic syndromes  
36, 236
causing seizures 237
definition 236
emergencies 237
parathyroid tumours 237
parrots
fluid therapy 47
parvovirus 72
in shelters 130–1
Pasteurella
cranial nerve otitis 113
pyothorax 127
patellar luxation 403
pathology 345–54
and cancer 38
exotic animals 351–3
financial considerations 346
see also diagnostic tests
patient medical history
acute abdomen 259
birds and reptiles 353
cardiomyopathy 164
coughing 119
and differential diagnosis 173
importance 85, 178, 369
juvenile lameness 394
management of epilepsy 138
nutritional plans 280
and pathology 346
pre-anaesthesia 254
pediculosis 397
Pelodera 397
Pembroke Welsh Corgis 249
penetrating injuries
computed tomography (CT) 100
thoracic 123–4, 219
see also bite wounds; stick injuries
Peptostreptocous 127
pericardial disease 168–9
cats 169
causes 168
dogs 168–9
periocardiocentesis 168
periodontal therapy 362–3
aims 362
risks 362–3
peritoneal lymphomatosis 544
personal branding 321–2
photodynamic therapy 241
physiotherapy 189, 518
for coronoid disease 405
palliative care 240
and weight management 326
physitis 147
pica 248
and foreign body ingestion 104–5
as sign of anaemia 68
pimobendan 163, 164
Pit Bulls 229
placebo effect 373
plasma 71
testing and ACTH levels 83
platelets 70, 71
cytology 347
diseases affecting 248
and pancreatitis 476
as treatment for osteoarthritis 516
pleural effusion 123
and neoplasia 236
pneumonia
hospital acquired infection 198, 221
pneumothorax 123
point-of-care meters 350
polycythaemia 71–2
paraneoplastic cause 237
types and causes 72
polydioxanone stutures 493
polydipsia see PU/PD
polymerase chain reaction  
241
polypoid cystitis 48
polyradiculoneuritis 529
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Poodles
hypoadrenocorticism 250
immune-mediated thrombocytopenia 248
Von Willebrand’s disease 249
portal vein hypoplasia 430
post attentuation neurological signs 494
povidone-iodine solution 183
praziquantel 200
prazocin 212
prednisolone 69
pregnancy 330–2
birth 332–3
diagnosis 331
hormone levels 330
loss of puppies 331–2
medication during 331
nutrition during 332
single-puppy 331–2
whelping 330
see also caesareans
previcox 513–14
procaine 150
progesterone 22, 82, 330
propofol 529
prostatic carcinoma 543
prostglandin 62
proteinuria 174
immune mediated polyarthritis 471–2
Proteus
antimicrobial resistance 445
cranial nerve otitis 113
proxial ulnar osteotomy 407
pruritic skin disease 396–7
Pseudomonas
antimicrobial resistance 445
cranial nerve otitis 113
Pugs 499, 514
anaesthesia 254
haemolytic anaemia 73
neurological diseases in 110
pulmonary abcess 127
pulmonary hypertension 120–1
cardiac manifestations 137
causes 137
classification 120–1
diagnosis 137
physiology 120
pulmonary oedema 120
treatment 163
pulmonic stenosis 449
puncture wounds see penetrating injuries
PU/PD 392
and chronic diarrhea 399
and hypercalcaemia 393
puppies
acquisition 479–80
anaesthesia of 258
behavioural problems 464–5
haemophilia A 249
intrahepatic shunt 532
loss of, during pregnancy 331–2
neurological diseases 110
newborns 334
owners 481
physiology 258
preventative medicine 481
signs of Von Willebrand’s Disease 249
spontaneious haemothorax 530
training 463
urethrorectal fistula 547
Purina ProPlan Veterinary diets 282
pylorogastric intussesception 532
pyothorax 126–7
diagnosis 126–7
medical management 126
surgical management 127
pyrexia 177–8
differential diagnosis 177
and haemothroax 530
and head trauma 255
as result of fungal infection 178
as symptom of discospondylitis 178
as symptom of meningitis 499
Q
qualifications 463–4
nursing 338
undergraduate 463
quality of care 372
and compassion fatigue 550
improvement 376, 415
reducing morbidity 375–6
quality of life 431–2
and epilepsy 500
R
rabacfosadine 241
rabbit viral haemorrhagic disease 267
Rabbit Welfare Association 268
rabbits 44, 45
anaesthesia 266, 374–5
antibiotics 459
blood biochemistry 44
compared to dogs & cats 374
diet 267
dietary calcium 48
endoscopy 48
fractures 523
gastric stasis 269
lateral rhinostomy 44
neutering 267
nutrition 270
obesity 268
ownership statistics 267
preventative medicine 267
retrobulbar abcess 533
surgery on 542
thymomas 44
radial head dislocation 545
radioactive iodine treatment 249, 474
radiography
vs advanced imaging 145, 147
bone tumors 142
vs computed tomography 89–91, 144
contrast 32
detecting osteroarthritis 404
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diagnosis lameness 402
of the elbow 408
elbow dysplasia 144
of head and neck 146
of the heart 162
of jaw fractures 359
metaphyseal osteopathy 469–70
neurological 145
orthopaedic 146
post-operative 148
and reptiles 50
of road traffic accident victims 256
and sedation 45
sedation during 433
of the skull 143
and stick injuries 101
thoracic 118–9, 122, 433
urethral obstruction 212
radiotherapy 32, 238–9
dosing 238
on feline squamous cell carcinoma 454
limited availability 238
rabbit thymomas 44
side effects 238
types 238
“Rathke’s Pouch” see cystic pharyngeal hypophysis
recycling 337
red blood cells
haemolysis 174
heart disease effect on 449
lifespan 73
transfusion products 247
refractory epilepsy 138
renal disease 537
and cardiac disease 166–7, 448
cats 482
in cats 424
as cause of anaemia 68
and hyperthyroidism 427–8
in lizards 50
and nutrition 281
prescription diets for 396
see also acute kidney injury
renal failure see acute kidney injury
Renaltec 424–5
reproduction 329–35
in dogs 22–3
homeless cats 132
hormone testing 330
whelping 330
see also caesareans; pregnancy; spaying
reptiles
diagnositc imaging 50–1
endoscopy 49
pathology 353
see also chelonia
respiratory disease
and cardiac issues 167–8
in snakes 459
see also dyspnoea
respiratory distress see dyspnoea
retinal detachment 64, 182
diagnosis 66
as result of hypertension 136
retrobulbar abcess 533
retrobulbar tumours 61
retrohydropulsion 33
reward-based training 463
rheumatoid arthritis
treatments 174
road traffic accidents 256, 512
analgesia 256
common injuries 512
radiography 256
triage 256
rodents
cataracts 458
ropivacaine 150
Rottweilers 514
spinal arachnoid diverticula 110
Royal Canin Veterinary diets 282
Royal College of Veterinary Surgeons 78, 335–9,  
371–7
Code of Professional Conduct  
192
Graduate Outcome Review 336
Guife to Professional Conduct 333
Mind Matters initiative 336
nurse’s declaration 231
Practice Standards 337, 415
Vet Futures action plan 301
RUMM block 152
S
safety issues 409–16
checklists 412
equipment 411
pre-surgery 410–11
Salmonella 131
sarcoptic mange 397
Schirmer tear test 508
Schwann cells 113
Scottish Terriers 249
SDMA 427–8
sedation 45
and abdominal CT scanning 92
and arthrocentesis 176
of birds 47
vs general anaesthesia 262
and nasal catheter placement 211
and oesophageal dilation 433
during radiography 433
species specific 45
and thoracic CT scanning 90
seizures 138, 395
and bleeding disorders 209
as complication of haemolytic anaemis 248
as post-surgical complication 494
as result of hypoglycaemia 110
as sign of forebrain disease 108
as symptom of cancer 237
treatment 395
sepsis 29, 72
and foreign bodies 101
indicators 436
septic arthritis 178
in juveniles 394
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septic peritonitis 259
cytological signs 348
diagnosis 29
feeding tube placement 492
management 29
nursing 211–12
surgical foreign bodies 486–7
serum bile acid concentration  
431
sevorflurane 528
Sharpei 438
shelters 129–33
diarrhoea 130–1
intake policies 130
management of 546–7
neutering 131–2
parvovirus outbreaks 130–1
Shetland Sheepdogs 249
shock 72
and acute abdomen 259
contraindicated medications 259
hypovolaemic 206
puncture wounds 123
shoulder dysplasia 402
Simonsiella 125
skin grafts 222
skin masses 23
skull
anatomical complexity 143
CT scanning 92, 143
radiographs 143
trauma and anaesthesia 255–6
small mammals
sedation and anaesthesia 45
snakes 459
bites 529
blood sample collection 353
endoscopy of 49
social media 322
spaying 22
see also reproduction
sphincter (artificial) 548
spinal arachnoid diverticula 110
spine
CT scanning 92, 94–5
infection 94–5
interpreting imaging 147
neoplasia 94–5
post-injury rehabilitation 189–90
preventative care 112
thoracolumbar injuries 540
trauma 94
spironolactone 164
splenic haemangiosarcoma 236
spondylitis 147
squamous cell carcinoma
eyelid 454
oral 237, 360
surgery 454
Staffordshire Bull Terriers  
514
anaesthesia 527
clinical studies 480
homeless owners 130
Staphylococcus
antimicrobial resistance 445
aureus 444
cranial nerve otitis 113
pseudintermedius 442, 444
see also methicillin-resistant Staphylococcus 
pseudintermedius (MRSP)
stem cell therapy 516
stick injuries
pharyngeal 101
thoracic 123–4
Streptococcus 127
cranial nerve otitis 113
Strontium 90 plesiotherapy 454
subdermal plexus flaps 222
supraglottic airway devices (SGAD) 527
surgery
atlanto-axial instability repair 110
caesarean section 22, 216, 332–3
cataracts 65, 182
cervical spondylomyelopathy 111, 112
on chelonian shells 46
clothing 218
complications 28–33, 513, 521–2
coronoid disease 405
on cranial cruciate ligament 518
equipment 23, 183
ferrets 49–50
foreign body removal 103
glaucoma 62
haemothroax 530
hyperthyroidism 201, 249, 282
infection control 77
for intracondular fissures 406
margins 31–2
nursing 215–25
nursing clinics 192
ocular 61, 182–3, 223
oncological emergency 236
orthopaedic 25–6, 223
pain management 231
palatal 358–9
post-operative imaging 148
post-operative nursing 184, 192
preparation for 183, 410–11
pyothorax 127
rabbits 44
on rabbits 542
removing urethral obstruction 212–13
road traffic accidents 256
safety precautions 410–11
skin closures 222–3
soft tissue 23–4, 492–7
spinal arachnoid diverticula 110
squamous cell carcinoma 454
tumours 21, 31–2, 40–1
ununited anconeal process 407
urethral obstructions 386
see also surgical site infection (SSI);  
specific procedures
surgical debridement 104
surgical nursing clinics 192
guide to operating 192–3
surgical referrals 465
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surgical site infection (SSI) 77–8, 221
after tibial plateau levelling osteotomy 520–1
causes 218–9
foreign bodies 77
pre-operative prevention 219–20
prevention 198, 220, 493
risk factors 77
WHO guidelines 221
synovial cell sarcoma 142
syringomyelia 499
in Cavalier King Charles Spaniels 539
T
T cells 172
treatment of B cell lymphoma 42
talar ridge replacement 522
Tamiflu see oseltamivir
Tawny owls 458
Tekscan system 521
terbinafine 55
terbutaline 121
terrapins see chelonia
tetanus 357
therapeutic trials 133, 349–50
for dry eye 508
thoracic hemivertebra 110
thoracic vertebral canal stenosis 499
thoracocentesis 126
thorocolumbar myelopathy 94
thrombocytopathia 70
thrombocytopenia 70, 71, 367
cardiac manifestations 137
causes 71
treatment 71
see also immune-mediated thrombocytopenia
thymoma 236
in rabbits 48
thyroidectomy 201, 249, 282
thyroxine 201
tibial plateau levelling osteotomy (TPLO)  
25, 79
postoperative infection rate 520–1
and weight 520–1
tibial tuberosity advancement (TTA) 25
tibial tuberosity transposition (TTT) 79
tiletamine-zolazepam 528
time management 418
toceranib phosphate 542
tooth resorption 482
tortoises see chelonia
toxic nodular goitre 488
toxins 207–8
toy breeds
hydrocephalus 110
hypoglycaemia 110
Toy Poodles 250
tramadol 45
transitional cell carcinoma 453
histological studies 454–5
transvascular pulmonic stents 449–50
trauma
assessment 206
blunt force 219
cardiovascular 206
to the eye 61
to the head 255–6, 541
to the hip 513
to the jaw 357, 359
to the kidney 212
lameness 402
neurological 206
nursing 206
respiratory 206
to the spine 94
thoracic 219
use of radiography 147
see also penetrating injuries; road traffic accidents
triage
and anaemia 68
of dyspnoeic patient 213
of road traffic accident victims 256
telephone 207
triclosan 493
trigeminal neuritis 113
trilostane 85, 250, 437
turtles see chelonia
U
ulcerative keratitis 478
ultrasonography 44
of adrenal glands 82
vs computed tomography 91
diagnosing chronic diarrhoea 399
diagnosing hypoadrenocorticism 250
duplex 487
and fine-needle aspiration 90
gastroninestinal foreign bodies 100
and local anaesthesia 150, 152, 154–5, 504
orthopaedics 93
and reptiles 50
strengths and weaknesses 145
thoracic limb 487
thoracic trauma 219, 236
ultraviolet light therapy 173
ununited anconeal process 407–8
urethral obstruction 212–13
decompressing 385
emergency treatment 385–6
post-removal care 212
preventing recurrence 386
recognition and diagnosis 385
surgery 386
urethrorectal fistula 547
urinalysis 133, 173, 349
for fanconis-syndrome 537
urinary cultures 425
urinary extracellular vesicles 425–6
urinary tract infection 174, 178, 188, 425
hospital acquired 198
urine cortisol to creatine ratio  
(UCCR) 84
uroliths 32–3
urology
clinical abstracts 423–8
uveitis
opthalmic manifestation 136
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V
vaccines
anti-fungal 55
B-cell lymphoma 42
homeless pet owners 130
and immune-mediated disease 503
melanoma 174
for rabbits 267
side-effects 470, 503
vagotonia 137
vascular lesions
CT scanning 91
ventricular tachyarrhythmias 137
ventricular tachycardia 24–5
vestibular disease 114–15
causes 115
clinical signs 114
in dogs 502
epidemiology 502
peripheral vs central 114–15
vestibulocochlear nerve 114
veterinarians
communication between 465
compassion and compassion fatigue 550
dealing with poor outcomes 369
decreasing numbers 301
depression 321
importance of positive attitude 418–19
self-assessment 372, 415
self-confidence 420
self-marketing 321–2
time management 418
workplace stress 321
veterinary business models 274–5
and starting a new pracitce 291
Veterinary Cooperative Oncology Group  
(VCOG) 41
Veterinary Defence Society (VDS) 415,  
417–20
confidence and assertiveness training 420
personal leadership training 418–19
teamwork and communication training 419
time management training 418
Veterinary Evidence Journal 374
veterinary practices
closures and decline in business 301
vs human healthcare 376
income and profitability 292
legal action against 320
mortality and morbidity rounds 415–16
RCVS standards 337, 415
safety issues 409–16
staff wellbeing 337
starting up 291–2
Veterinary Surgeon’s Acts 192
visual infusion phlebitis (VIP) score 487
vitamin D 393
vitamin K 70
VN Futures initiative 200, 338
aims 301
delegation 338
practice standards scheme 337
staff well being 336–7
von Willebrand’s Disease (VWD) 249
and general anaesthesia 254
von Willebrand’s factor 367
W
Wachtelhund see German Spaniel
welfare 228–9, 231–2
acute pain 231
animal shelters 546
in animal shelters 132
animals and homeless owners 462
and behavioural issues 226
blind dogs 508
elderly animals 230
exotic animals 271
palliative care 240
West Highland White Terriers 73
clinical data 479
Wheaten Terriers 438
Whippets 73
white blood cells see leucocytes; specific cell types
Wilcoxon signed-rank test 427
wild boar 548
“Wobblers” see cervical spondylomyelopathy
Wood’s lamp inspection 55, 56
workplace stress 321
World Health Organization (WHO) 221
classification of odontogenic tumours 256
worming 267
wound breakdown 23, 28
causes 28
prevention 28
X
X-rays see radiography
Y
Y-T fractures 519
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Black, Vicki 68, 70, 73
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167, 449
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Bray, Jonathan 37, 40, 101, 104
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C
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Corah, Louise 462, 464
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Are you recently graduated, 
mentoring a new graduate or 
returning to work after a break?
Exclusive to BSAVA members, our online 
PDP Resource Bank provides hours of 
FREE CPD matched directly to the 
RCVS professional development 
phase (PDP) requirements.
■ Online CPD at home, work 
or on the move
■ Access via phone, tablet 
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